Citrus Sinensis ID: 004732
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 733 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGG9 | 1035 | Probable LRR receptor-lik | yes | no | 0.381 | 0.270 | 0.748 | 1e-124 | |
| C0LGG8 | 1038 | Probable LRR receptor-lik | no | no | 0.381 | 0.269 | 0.744 | 1e-123 | |
| C0LGN2 | 1020 | Probable leucine-rich rep | no | no | 0.466 | 0.335 | 0.628 | 1e-123 | |
| C0LGE0 | 1014 | Probable LRR receptor-lik | no | no | 0.448 | 0.324 | 0.645 | 1e-122 | |
| C0LGG7 | 953 | Probable LRR receptor-lik | no | no | 0.427 | 0.328 | 0.660 | 1e-121 | |
| Q9ASQ6 | 1019 | Probable LRR receptor-lik | no | no | 0.462 | 0.332 | 0.560 | 1e-109 | |
| Q9FXF2 | 1021 | Probable LRR receptor-lik | no | no | 0.375 | 0.269 | 0.637 | 4e-97 | |
| C0LGH3 | 1033 | Probable LRR receptor-lik | no | no | 0.435 | 0.308 | 0.542 | 5e-93 | |
| C0LGH2 | 1032 | Probable LRR receptor-lik | no | no | 0.459 | 0.326 | 0.504 | 3e-90 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.837 | 0.557 | 0.318 | 2e-77 |
| >sp|C0LGG9|Y5344_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53440 OS=Arabidopsis thaliana GN=At1g53440 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 447 bits (1150), Expect = e-124, Method: Compositional matrix adjust.
Identities = 214/286 (74%), Positives = 246/286 (86%), Gaps = 6/286 (2%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIK ATNNF +N IGEGGFGPVYKG+LADG IAVKQLSSKSKQGNREF+ EIGMISAL
Sbjct: 659 QIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISAL 718
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 503
QHPNLVKLYGCCIEG +LLL+YEYLENNSLARALF + RL LDW TR ++C+GIA+GL
Sbjct: 719 QHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKVCIGIAKGL 778
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
AYLH ESR+K+VHRDIKATNVLLD LN+KISDFGLAKLDEEENTHISTR+AGTIGYMAP
Sbjct: 779 AYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTHISTRIAGTIGYMAP 838
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELVD 620
EYAMRG+LT+KADVYSFG+V LEIVSG+SN KE+ YLLDWA VL+EQG L+ELVD
Sbjct: 839 EYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWAYVLQEQGSLLELVD 898
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 666
+ G++F K++ M M+N+ALLC N SPT+RP MSSV+ ML+ + V
Sbjct: 899 PDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQGKIKV 944
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|C0LGG8|Y5343_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53430 OS=Arabidopsis thaliana GN=At1g53430 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 444 bits (1141), Expect = e-123, Method: Compositional matrix adjust.
Identities = 213/286 (74%), Positives = 246/286 (86%), Gaps = 6/286 (2%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIK ATNNF +N IGEGGFGPVYKG+LADG IAVKQLSSKSKQGNREF+ EIGMISAL
Sbjct: 661 QIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQGNREFVTEIGMISAL 720
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 503
QHPNLVKLYGCCIEG +LLL+YEYLENNSLARALF + RL LDW TR +IC+GIA+GL
Sbjct: 721 QHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDWSTRNKICIGIAKGL 780
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
AYLH ESR+K+VHRDIKATNVLLD LN+KISDFGLAKL+++ENTHISTR+AGTIGYMAP
Sbjct: 781 AYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLNDDENTHISTRIAGTIGYMAP 840
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELVD 620
EYAMRG+LT+KADVYSFG+V LEIVSG+SN KE+ YLLDWA VL+EQG L+ELVD
Sbjct: 841 EYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFVYLLDWAYVLQEQGSLLELVD 900
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 666
+ G++F K++ M M+N+ALLC N SPT+RP MSSV+ MLE + V
Sbjct: 901 PDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLEGKIKV 946
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGN2|Y3148_ARATH Probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840 OS=Arabidopsis thaliana GN=LRR-RLK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1139), Expect = e-123, Method: Compositional matrix adjust.
Identities = 220/350 (62%), Positives = 273/350 (78%), Gaps = 8/350 (2%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIK AT+NF N IGEGGFGPV+KG++ DGT IAVKQLS+KSKQGNREF+NEI MISAL
Sbjct: 664 QIKVATDNFDPANKIGEGGFGPVHKGIMTDGTVIAVKQLSAKSKQGNREFLNEIAMISAL 723
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 503
QHP+LVKLYGCC+EG+QLLL+YEYLENNSLARALF E ++ L+WP R++IC+GIARGL
Sbjct: 724 QHPHLVKLYGCCVEGDQLLLVYEYLENNSLARALFGPQETQIPLNWPMRQKICVGIARGL 783
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
AYLH ESR+K+VHRDIKATNVLLDK+LN KISDFGLAKLDEEENTHISTRVAGT GYMAP
Sbjct: 784 AYLHEESRLKIVHRDIKATNVLLDKELNPKISDFGLAKLDEEENTHISTRVAGTYGYMAP 843
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNV---TKEDMFYLLDWALVLKEQGKLMELVD 620
EYAMRGHLT+KADVYSFG+VALEIV G+SN +K D FYLLDW VL+EQ L+E+VD
Sbjct: 844 EYAMRGHLTDKADVYSFGVVALEIVHGKSNTSSRSKADTFYLLDWVHVLREQNTLLEVVD 903
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE--CGVDVLDLVSDSSVSDI 678
G++++K++ ++MI + +LC + +P RPSMS+V+ MLE V+V L+ S ++
Sbjct: 904 PRLGTDYNKQEALMMIQIGMLCTSPAPGDRPSMSTVVSMLEGHSTVNVEKLLEASVNNEK 963
Query: 679 DETKAEAMRKYYQFCVENTASTTQSTSSIYGPPPGSSTAGVDLHPFSVDS 728
DE AM+++Y E + T +T + S+ DL+P +DS
Sbjct: 964 DEESVRAMKRHYATIGEEEITNTTTTDGPFTSSSTSTANANDLYPVKLDS 1013
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGE0|Y1765_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g07650 OS=Arabidopsis thaliana GN=At1g07650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1126), Expect = e-122, Method: Compositional matrix adjust.
Identities = 220/341 (64%), Positives = 273/341 (80%), Gaps = 12/341 (3%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIKAAT+NF IGEGGFG VYKG L++G IAVKQLS+KS+QGNREF+NEIGMISAL
Sbjct: 670 QIKAATDNFDVTRKIGEGGFGSVYKGELSEGKLIAVKQLSAKSRQGNREFVNEIGMISAL 729
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF----EHRLKLDWPTRRRICLGIARG 502
QHPNLVKLYGCC+EGNQL+L+YEYLENN L+RALF RLKLDW TR++I LGIA+G
Sbjct: 730 QHPNLVKLYGCCVEGNQLILVYEYLENNCLSRALFGKDESSRLKLDWSTRKKIFLGIAKG 789
Query: 503 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 562
L +LH ESRIK+VHRDIKA+NVLLDKDLN+KISDFGLAKL+++ NTHISTR+AGTIGYMA
Sbjct: 790 LTFLHEESRIKIVHRDIKASNVLLDKDLNAKISDFGLAKLNDDGNTHISTRIAGTIGYMA 849
Query: 563 PEYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELV 619
PEYAMRG+LTEKADVYSFG+VALEIVSG+SN ED YLLDWA VL+E+G L+ELV
Sbjct: 850 PEYAMRGYLTEKADVYSFGVVALEIVSGKSNTNFRPTEDFVYLLDWAYVLQERGSLLELV 909
Query: 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDID 679
D S++ +E+ M+M+NVAL+C NASPT+RP+MS V+ ++E + +L+SD S S ++
Sbjct: 910 DPTLASDYSEEEAMLMLNVALMCTNASPTLRPTMSQVVSLIEGKTAMQELLSDPSFSTVN 969
Query: 680 ETKAEAMRKYYQFCVENTASTTQSTSSIYGPPPGSSTAGVD 720
K +A+R ++ +N S + S S+ GP S+ + VD
Sbjct: 970 P-KLKALRNHFW---QNELSRSLSFST-SGPRTASANSLVD 1005
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGG7|Y1534_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g53420 OS=Arabidopsis thaliana GN=At1g53420 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 437 bits (1124), Expect = e-121, Method: Compositional matrix adjust.
Identities = 214/324 (66%), Positives = 259/324 (79%), Gaps = 11/324 (3%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIK ATNNF + N IGEGGFGPVYKG L DGT IAVKQLS+ SKQGNREF+NEIGMISAL
Sbjct: 616 QIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNREFLNEIGMISAL 675
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 503
HPNLVKLYGCC+EG QLLL+YE++ENNSLARALF E +L+LDWPTRR+IC+G+ARGL
Sbjct: 676 HHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPTRRKICIGVARGL 735
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
AYLH ESR+K+VHRDIKATNVLLDK LN KISDFGLAKLDEE++THISTR+AGT GYMAP
Sbjct: 736 AYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHISTRIAGTFGYMAP 795
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNV---TKEDMFYLLDWALVLKEQGKLMELVD 620
EYAMRGHLT+KADVYSFGIVALEIV GRSN +K + FYL+DW VL+E+ L+ELVD
Sbjct: 796 EYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEVLREKNNLLELVD 855
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDE 680
GS +++E+ M MI +A++C ++ P RPSMS V++MLE G ++++ S E
Sbjct: 856 PRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLE-GKKMVEVEKLEEASVHRE 914
Query: 681 TK----AEAMRKYYQFCVENTAST 700
TK M+KYY+ + +++
Sbjct: 915 TKRLENMNTMKKYYEMIGQEISTS 938
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ASQ6|Y1972_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g29720 OS=Arabidopsis thaliana GN=RFK1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 396 bits (1018), Expect = e-109, Method: Compositional matrix adjust.
Identities = 195/348 (56%), Positives = 260/348 (74%), Gaps = 9/348 (2%)
Query: 385 YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMIS 444
+ Q++ ATNNF N +GEGGFG V+KG L+DGT IAVKQLSSKS QGNREF+NEIGMIS
Sbjct: 663 WRQLQTATNNFDQANKLGEGGFGSVFKGELSDGTIIAVKQLSSKSSQGNREFVNEIGMIS 722
Query: 445 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF-EHRLKLDWPTRRRICLGIARGL 503
L HPNLVKLYGCC+E +QLLL+YEY+ENNSLA ALF ++ LKLDW R++IC+GIARGL
Sbjct: 723 GLNHPNLVKLYGCCVERDQLLLVYEYMENNSLALALFGQNSLKLDWAARQKICVGIARGL 782
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
+LH S +++VHRDIK TNVLLD DLN+KISDFGLA+L E E+THIST+VAGTIGYMAP
Sbjct: 783 EFLHDGSAMRMVHRDIKTTNVLLDTDLNAKISDFGLARLHEAEHTHISTKVAGTIGYMAP 842
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE---DMFYLLDWALVLKEQGKLMELVD 620
EYA+ G LTEKADVYSFG+VA+EIVSG+SN ++ D L++WAL L++ G ++E+VD
Sbjct: 843 EYALWGQLTEKADVYSFGVVAMEIVSGKSNTKQQGNADSVSLINWALTLQQTGDILEIVD 902
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDE 680
F++ + + MI VAL+C N+SP++RP+MS ++MLE +++ ++SD + D
Sbjct: 903 RMLEGEFNRSEAVRMIKVALVCTNSSPSLRPTMSEAVKMLEGEIEITQVMSDPGIYGHDW 962
Query: 681 TKAEAMRKYYQFCVENTASTTQSTSSIYGPPPGSSTAGVDLHPFSVDS 728
+ ++ +R +T+ T T++ SS +G DL+P +S
Sbjct: 963 SISK-LRDIDTHSSSSTSGVTDQTTTTM----KSSVSGCDLYPLYPES 1005
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FXF2|RKF1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RFK1 OS=Arabidopsis thaliana GN=RKF1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 356 bits (913), Expect = 4e-97, Method: Compositional matrix adjust.
Identities = 179/281 (63%), Positives = 218/281 (77%), Gaps = 6/281 (2%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIK AT++F N IGEGGFG V+KG+LADG +AVKQLSSKS+QGNREF+NEIG IS L
Sbjct: 673 QIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCL 732
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGL 503
QHPNLVKL+G C+E QLLL YEY+ENNSL+ ALF + K +DWPTR +IC GIA+GL
Sbjct: 733 QHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKGL 792
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
A+LH ES +K VHRDIKATN+LLDKDL KISDFGLA+LDEEE THIST+VAGTIGYMAP
Sbjct: 793 AFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAP 852
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSN---VTKEDMFYLLDWALVLKEQGKLMELVD 620
EYA+ G+LT KADVYSFG++ LEIV+G +N + D LL++A E G LM++VD
Sbjct: 853 EYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESGHLMQVVD 912
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
D+++ +I VAL+C++ASPT RP MS V+ MLE
Sbjct: 913 ERLRPEVDRKEAEAVIKVALVCSSASPTDRPLMSEVVAMLE 953
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH3|Y5614_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56140 OS=Arabidopsis thaliana GN=At1g56140 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 342 bits (878), Expect = 5e-93, Method: Compositional matrix adjust.
Identities = 179/330 (54%), Positives = 233/330 (70%), Gaps = 11/330 (3%)
Query: 385 YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMIS 444
Y ++K+AT +F N +GEGGFGPVYKG L DG +AVK LS S+QG +F+ EI IS
Sbjct: 683 YSELKSATQDFDPSNKLGEGGFGPVYKGKLNDGREVAVKLLSVGSRQGKGQFVAEIVAIS 742
Query: 445 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF-EHRLKLDWPTRRRICLGIARGL 503
A+QH NLVKLYGCC EG LL+YEYL N SL +ALF E L LDW TR ICLG+ARGL
Sbjct: 743 AVQHRNLVKLYGCCYEGEHRLLVYEYLPNGSLDQALFGEKTLHLDWSTRYEICLGVARGL 802
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
YLH E+R+++VHRD+KA+N+LLD L K+SDFGLAKL +++ THISTRVAGTIGY+AP
Sbjct: 803 VYLHEEARLRIVHRDVKASNILLDSKLVPKVSDFGLAKLYDDKKTHISTRVAGTIGYLAP 862
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELVD 620
EYAMRGHLTEK DVY+FG+VALE+VSGR N +++ YLL+WA L E+G+ +EL+D
Sbjct: 863 EYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEDEKRYLLEWAWNLHEKGREVELID 922
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSS-VSD-- 677
+ + F+ E+ MI +ALLC S +RP MS V+ ML V+V D+ S ++D
Sbjct: 923 -HQLTEFNMEEGKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEVSDVTSKPGYLTDWR 981
Query: 678 IDETKAEAMRKYYQFCVENTASTTQSTSSI 707
D+T A ++ F + NT ++ TS +
Sbjct: 982 FDDTTASSISG---FPLRNTQASESFTSFV 1008
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGH2|Y1561_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g56130 OS=Arabidopsis thaliana GN=At1g56130 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 333 bits (854), Expect = 3e-90, Method: Compositional matrix adjust.
Identities = 177/351 (50%), Positives = 232/351 (66%), Gaps = 14/351 (3%)
Query: 381 YYGFYLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEI 440
Y Y ++K+AT +F N +GEGGFGPVYKG L DG +AVK LS S+QG +F+ EI
Sbjct: 680 YIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEI 739
Query: 441 GMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF-EHRLKLDWPTRRRICLGI 499
IS++ H NLVKLYGCC EG +L+YEYL N SL +ALF + L LDW TR ICLG+
Sbjct: 740 VAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLHLDWSTRYEICLGV 799
Query: 500 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG 559
ARGL YLH E+ +++VHRD+KA+N+LLD L +ISDFGLAKL +++ THISTRVAGTIG
Sbjct: 800 ARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIG 859
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLM 616
Y+APEYAMRGHLTEK DVY+FG+VALE+VSGR N +E+ YLL+WA L E+ + +
Sbjct: 860 YLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDI 919
Query: 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSS-V 675
EL+D + ++F+ E+ MI +ALLC S +RP MS V+ ML V++ D+ S V
Sbjct: 920 ELID-DKLTDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAMLSGDVEIGDVTSKPGYV 978
Query: 676 SD--IDETKAEAMRKYYQFCVENTASTTQSTSSIYGPPPGSSTAGVDLHPF 724
SD D+T ++ + TT + S+ P S D P
Sbjct: 979 SDWRFDDTTGSSLSGF------QIKDTTGYSMSLVAPGSEISPRDSDFKPM 1023
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 290 bits (743), Expect = 2e-77, Method: Compositional matrix adjust.
Identities = 211/662 (31%), Positives = 333/662 (50%), Gaps = 48/662 (7%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
L NL+G +P + L + L N L G P L + + + N+F G +P
Sbjct: 440 LGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPR 499
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 143
E+G+ L++L L+ N FTGELP+ L+ + IS N+ TG++PS I N L++L
Sbjct: 500 EVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLD 559
Query: 144 IQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFP-QLGNM-KMTKLILRNCNITGELP 201
+ + +G +PS + SL L L++S+ N T P LGN+ ++T+L + G +P
Sbjct: 560 MCCNNFSGTLPSEVGSLYQLELLKLSN-NNLSGTIPVALGNLSRLTELQMGGNLFNGSIP 618
Query: 202 RYLGKMTKLKV-LDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKI- 259
R LG +T L++ L+LS+N+L G+IP +L ++++ N L+G IP +
Sbjct: 619 RELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLG 678
Query: 260 -DLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKTYYSLHINCGGKQVTANGNTTFEE 318
+ SYN S+TG + LR++ ++ CG F
Sbjct: 679 YNFSYN--------------SLTGPIPLLRNISM-SSFIGNEGLCGPPLNQCIQTQPFAP 723
Query: 319 DTSEAGPSTFSQSG----TNWVLSSTGHFLENGLKLGPYIQTNTSRLLMNDYQLYTTARL 374
S P S T V+ L + L Y+ R + + Q +
Sbjct: 724 SQSTGKPGGMRSSKIIAITAAVIGGVSLML---IALIVYLMRRPVRTVASSAQ---DGQP 777
Query: 375 SAISLTYY-----GFYLQ-IKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK 428
S +SL Y GF Q + AAT+NF +G G G VYK +L G +AVK+L+S
Sbjct: 778 SEMSLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASN 837
Query: 429 SKQGNR-----EFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEH 483
+ GN F EI + ++H N+VKL+G C LL+YEY+ SL L +
Sbjct: 838 HEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDP 897
Query: 484 RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543
LDW R +I LG A+GLAYLH + + ++ HRDIK+ N+LLD + + DFGLAK+
Sbjct: 898 SCNLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 957
Query: 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-L 602
+ ++ + +AG+ GY+APEYA +TEK+D+YS+G+V LE+++G++ V D +
Sbjct: 958 DMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDV 1017
Query: 603 LDWALVLKEQGKLMELVDTNPGSNFDKEQV----MVMINVALLCANASPTIRPSMSSVLR 658
++W + L V + + E++ + ++ +ALLC + SP RPSM V+
Sbjct: 1018 VNWVRSYIRRDALSSGV-LDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVL 1076
Query: 659 ML 660
ML
Sbjct: 1077 ML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 733 | ||||||
| 255567058 | 985 | ATP binding protein, putative [Ricinus c | 0.467 | 0.348 | 0.727 | 1e-141 | |
| 255567064 | 1007 | ATP binding protein, putative [Ricinus c | 0.466 | 0.339 | 0.710 | 1e-137 | |
| 302142829 | 1036 | unnamed protein product [Vitis vinifera] | 0.466 | 0.330 | 0.697 | 1e-134 | |
| 359493983 | 1007 | PREDICTED: probable leucine-rich repeat | 0.466 | 0.339 | 0.697 | 1e-134 | |
| 147807566 | 561 | hypothetical protein VITISV_025180 [Viti | 0.466 | 0.609 | 0.694 | 1e-134 | |
| 302142841 | 710 | unnamed protein product [Vitis vinifera] | 0.465 | 0.480 | 0.704 | 1e-134 | |
| 357451937 | 899 | Receptor-like protein kinase [Medicago t | 0.489 | 0.399 | 0.670 | 1e-133 | |
| 357451935 | 1208 | Receptor-like serine/threonine kinase [M | 0.465 | 0.282 | 0.702 | 1e-133 | |
| 359493981 | 1007 | PREDICTED: probable leucine-rich repeat | 0.466 | 0.339 | 0.685 | 1e-132 | |
| 357492929 | 996 | Cysteine-rich receptor-like protein kina | 0.455 | 0.335 | 0.684 | 1e-131 |
| >gi|255567058|ref|XP_002524511.1| ATP binding protein, putative [Ricinus communis] gi|223536185|gb|EEF37838.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 509 bits (1311), Expect = e-141, Method: Compositional matrix adjust.
Identities = 256/352 (72%), Positives = 292/352 (82%), Gaps = 9/352 (2%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIKAATNNF DN IGEGGFG VYKGLL+DGTAIAVKQLSSKSKQGNREFI EIGMISAL
Sbjct: 628 QIKAATNNFDPDNKIGEGGFGSVYKGLLSDGTAIAVKQLSSKSKQGNREFITEIGMISAL 687
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 503
QHP+LVKLYGCCI+GNQL L+YEY+ENNSLARALF E +L LDWPTR +IC+GIARGL
Sbjct: 688 QHPHLVKLYGCCIDGNQLFLLYEYMENNSLARALFGPEECQLNLDWPTRHKICVGIARGL 747
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
A+LH ESR+K+VHRDIKATNVLLDK+L+ KISDFGLAKLDEEENTHISTRVAGT GYMAP
Sbjct: 748 AFLHEESRLKIVHRDIKATNVLLDKNLDPKISDFGLAKLDEEENTHISTRVAGTFGYMAP 807
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT-----KEDMFYLLDWALVLKEQGKLMEL 618
EYAMRGHLT+KADVYSFGIVALEIVSGRSN + KED FYLLDWALVLKE+G L+EL
Sbjct: 808 EYAMRGHLTDKADVYSFGIVALEIVSGRSNTSLRQNMKEDCFYLLDWALVLKEKGSLLEL 867
Query: 619 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDI 678
VD G+N+DK QVM MINVAL CA+ S RP+MSSV+ +LE V DLV D S
Sbjct: 868 VDPRMGTNYDKNQVMTMINVALQCASVSSVARPAMSSVVSILEGKTTVQDLVLDDSNVSH 927
Query: 679 DETKAEAMRKYYQFCVENTASTTQSTS-SIYGPPPGSSTAGVDLHPFSVDSD 729
DE K EAMRK++Q +E+ S +Q+ S S+ GP GSS++ DL+P ++DS+
Sbjct: 928 DEKKIEAMRKHFQHNIESQTSESQTQSMSLDGPWTGSSSSAGDLYPITLDSN 979
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255567064|ref|XP_002524514.1| ATP binding protein, putative [Ricinus communis] gi|223536188|gb|EEF37841.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 494 bits (1273), Expect = e-137, Method: Compositional matrix adjust.
Identities = 250/352 (71%), Positives = 290/352 (82%), Gaps = 10/352 (2%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIKAAT+NF DN IGEGGFG VYKGLL+DGT IAVKQLSSKSKQGNREF+NEIGMISAL
Sbjct: 651 QIKAATHNFNLDNKIGEGGFGSVYKGLLSDGTIIAVKQLSSKSKQGNREFVNEIGMISAL 710
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 503
QHP+LVKLYGCCIE NQLLL+YEY+ENNSLARALF E +L LDWPTR +IC+GIARGL
Sbjct: 711 QHPHLVKLYGCCIEENQLLLVYEYMENNSLARALFGPEECQLDLDWPTRHKICVGIARGL 770
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
A+LH ESR+K+VHRDIKATNVLLDK+LN KISDFGLAKLDEEENTHISTRVAGT GYMAP
Sbjct: 771 AFLHEESRLKIVHRDIKATNVLLDKNLNPKISDFGLAKLDEEENTHISTRVAGTFGYMAP 830
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT-----KEDMFYLLDWALVLKEQGKLMEL 618
EYAMRGHLT+KADVYSFGIVALEIVSGRSN + KE+ YLLDWALVLKE+G L+EL
Sbjct: 831 EYAMRGHLTDKADVYSFGIVALEIVSGRSNTSYRLNLKENCVYLLDWALVLKEKGSLLEL 890
Query: 619 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDI 678
VD G+N++K +VM +INVAL CA+ SP +RP+MSSV+ MLE V D ++S S
Sbjct: 891 VDPRMGTNYNKAEVMTVINVALQCASVSPGVRPAMSSVVSMLEGKTVVQDFTQETS-SSF 949
Query: 679 DETKAEAMRKYYQFCVENTASTTQSTS-SIYGPPPGSSTAGVDLHPFSVDSD 729
DE K EAM K++Q +E+ S +Q S S+ GP SST+ DL+P ++DS+
Sbjct: 950 DEMKDEAMSKHFQHSIEHKTSESQIQSMSLDGPWVASSTSEQDLYPVTLDSN 1001
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142829|emb|CBI20124.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1251), Expect = e-134, Method: Compositional matrix adjust.
Identities = 244/350 (69%), Positives = 289/350 (82%), Gaps = 8/350 (2%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIKAATNNF N IGEGGFG VYKG+L+DGT IAVKQLSSKSKQGNREF+NE+GMISAL
Sbjct: 682 QIKAATNNFDAANKIGEGGFGSVYKGVLSDGTIIAVKQLSSKSKQGNREFVNELGMISAL 741
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 503
QHP+LVKLYGCCIEGNQLLLIYEY+ENNSLARALF E +L+LDWPTR RIC+GIARGL
Sbjct: 742 QHPHLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEECQLQLDWPTRHRICVGIARGL 801
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
AYLH ESR+K+VHRDIKATNVLLDKDLN KISDFGLAKLDEE+NTHISTR+AGT GYMAP
Sbjct: 802 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP 861
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELVD 620
EYAMRG+LT+KADVYSFGIVALEIVSGRSN T KE+ YLLDWAL LKE+G LM+LVD
Sbjct: 862 EYAMRGYLTDKADVYSFGIVALEIVSGRSNTTYRPKEECTYLLDWALSLKEKGNLMDLVD 921
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDE 680
GS+F+KE+VM M+N+ALLC N S +RP+MSSV+ MLE V D+VSD S D+
Sbjct: 922 PRLGSDFNKEEVMAMLNIALLCTNISSAVRPAMSSVVSMLEGITAVQDIVSDPSAPS-DD 980
Query: 681 TKAEAMRKYYQFCVENTASTTQSTS-SIYGPPPGSSTAGVDLHPFSVDSD 729
K + M+++Y+ E + ++S + S+ P +S++ DL+P ++DS+
Sbjct: 981 LKLKEMKEHYRHIQEKSMDVSESKAQSMPDGPWTASSSITDLYPVTLDSE 1030
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493983|ref|XP_002283596.2| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 486 bits (1250), Expect = e-134, Method: Compositional matrix adjust.
Identities = 244/350 (69%), Positives = 289/350 (82%), Gaps = 8/350 (2%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIKAATNNF N IGEGGFG VYKG+L+DGT IAVKQLSSKSKQGNREF+NE+GMISAL
Sbjct: 653 QIKAATNNFDAANKIGEGGFGSVYKGVLSDGTIIAVKQLSSKSKQGNREFVNELGMISAL 712
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 503
QHP+LVKLYGCCIEGNQLLLIYEY+ENNSLARALF E +L+LDWPTR RIC+GIARGL
Sbjct: 713 QHPHLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEECQLQLDWPTRHRICVGIARGL 772
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
AYLH ESR+K+VHRDIKATNVLLDKDLN KISDFGLAKLDEE+NTHISTR+AGT GYMAP
Sbjct: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP 832
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELVD 620
EYAMRG+LT+KADVYSFGIVALEIVSGRSN T KE+ YLLDWAL LKE+G LM+LVD
Sbjct: 833 EYAMRGYLTDKADVYSFGIVALEIVSGRSNTTYRPKEECTYLLDWALSLKEKGNLMDLVD 892
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDE 680
GS+F+KE+VM M+N+ALLC N S +RP+MSSV+ MLE V D+VSD S D+
Sbjct: 893 PRLGSDFNKEEVMAMLNIALLCTNISSAVRPAMSSVVSMLEGITAVQDIVSDPSAPS-DD 951
Query: 681 TKAEAMRKYYQFCVENTASTTQSTS-SIYGPPPGSSTAGVDLHPFSVDSD 729
K + M+++Y+ E + ++S + S+ P +S++ DL+P ++DS+
Sbjct: 952 LKLKEMKEHYRHIQEKSMDVSESKAQSMPDGPWTASSSITDLYPVTLDSE 1001
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147807566|emb|CAN66180.1| hypothetical protein VITISV_025180 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 485 bits (1249), Expect = e-134, Method: Compositional matrix adjust.
Identities = 243/350 (69%), Positives = 288/350 (82%), Gaps = 8/350 (2%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIKAATNNF N IGEGGFG VYKG+L+DGT IAVKQLSSKSKQGNREF+NEIGMISAL
Sbjct: 207 QIKAATNNFDAANKIGEGGFGSVYKGILSDGTIIAVKQLSSKSKQGNREFVNEIGMISAL 266
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 503
QHP+LVKLYGCCIEGNQLLLIYEY+ENNSLARALF E +L+LDWPTR RIC+GIARGL
Sbjct: 267 QHPHLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEECQLQLDWPTRHRICVGIARGL 326
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
YLH ESR+K+VHRDIKATNVLLDKDLN KISDFGLAKLDEE+NTHISTR+AGT GYMAP
Sbjct: 327 TYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTFGYMAP 386
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELVD 620
EYAMRG+LT+KADVYSFGIVALEIVSGRSN T KE+ YLLDWAL LKE+G LM+LVD
Sbjct: 387 EYAMRGYLTDKADVYSFGIVALEIVSGRSNTTYRPKEECTYLLDWALSLKEKGNLMDLVD 446
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDE 680
GS+F+KE+VM M+N+ALLC N S +RP+MSSV+ MLE V D+VSD S D+
Sbjct: 447 PRLGSDFNKEEVMAMLNLALLCTNISSAVRPAMSSVVSMLEGITAVQDIVSDPSAPS-DD 505
Query: 681 TKAEAMRKYYQFCVENTASTTQSTS-SIYGPPPGSSTAGVDLHPFSVDSD 729
K + ++++Y+ E + ++S + S+ P +S++ DL+P ++DS+
Sbjct: 506 LKLKELKQHYRHIQEKSMDVSESKAQSMPDGPWTASSSITDLYPVTLDSE 555
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142841|emb|CBI20136.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 485 bits (1248), Expect = e-134, Method: Compositional matrix adjust.
Identities = 246/349 (70%), Positives = 282/349 (80%), Gaps = 8/349 (2%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIKAATNNF N IGEGGFG VYKGLL DGT IAVKQLSSKSKQGNREF+NEIGMISAL
Sbjct: 355 QIKAATNNFDAANKIGEGGFGSVYKGLLLDGTIIAVKQLSSKSKQGNREFVNEIGMISAL 414
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 503
QHP+LVKLYGCCIEGNQLLL+YEY+ENNSLARALF + +LKLDWPTR +IC+GIARGL
Sbjct: 415 QHPHLVKLYGCCIEGNQLLLVYEYMENNSLARALFGPKDSQLKLDWPTRHKICVGIARGL 474
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
AYLH ESR+K+VHRDIKATNVLLDKDLN KISDFGLAKLDEEENTHISTR+AGT GYMAP
Sbjct: 475 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEENTHISTRIAGTFGYMAP 534
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSN---VTKEDMFYLLDWALVLKEQGKLMELVD 620
EYAMRGHLTEKADVYSFG+VALEIVSG+SN + K+ YLLDWAL+LKE G L+ELVD
Sbjct: 535 EYAMRGHLTEKADVYSFGVVALEIVSGKSNTNHILKDGCVYLLDWALLLKENGNLLELVD 594
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDE 680
SNF KE+VM MINVALLC + SP RP+MSSV+ +LE V ++ S S+S DE
Sbjct: 595 PILESNFKKEEVMAMINVALLCTSFSPVARPTMSSVVSILEGRAHVQEISSGLSISS-DE 653
Query: 681 TKAEAMRKYYQ-FCVENTASTTQSTSSIYGPPPGSSTAGVDLHPFSVDS 728
K + +R+ Y + +NT+ S GP SST+G DL+P +++S
Sbjct: 654 IKLKELRQQYDLYHAKNTSEGQIPCLSTDGPWTASSTSGADLYPITMNS 702
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357451937|ref|XP_003596245.1| Receptor-like protein kinase [Medicago truncatula] gi|355485293|gb|AES66496.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 483 bits (1242), Expect = e-133, Method: Compositional matrix adjust.
Identities = 248/370 (67%), Positives = 290/370 (78%), Gaps = 11/370 (2%)
Query: 369 YTTARLSAISLTYYGFYL-QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSS 427
Y L+++ L F L QIKAATNNF N IGEGGFGPVYKG L +GT +AVKQLSS
Sbjct: 524 YLARELNSLDLQTGIFTLRQIKAATNNFDISNKIGEGGFGPVYKGCLPNGTLVAVKQLSS 583
Query: 428 KSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHR 484
KSKQGNREF+NEIGMISALQHP LVKL+GCC+EG+QLLLIYEYLENNSLARALF EH+
Sbjct: 584 KSKQGNREFLNEIGMISALQHPYLVKLHGCCVEGDQLLLIYEYLENNSLARALFGPAEHQ 643
Query: 485 LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544
+KLDW R++IC+GIARGLAYLH ESR+KVVHRDIKATNVLLDKDL KISDFGLAKLDE
Sbjct: 644 IKLDWSIRQKICIGIARGLAYLHEESRLKVVHRDIKATNVLLDKDLEPKISDFGLAKLDE 703
Query: 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV---TKEDMFY 601
E+NTHIST++AGT GYMAPEYAM G+LT+KADVYSFGIVALEIVSG+SN +KE FY
Sbjct: 704 EDNTHISTKIAGTYGYMAPEYAMHGYLTDKADVYSFGIVALEIVSGKSNTLYRSKEQAFY 763
Query: 602 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
LLDWA +LK++G LMELVD G +FDK + MVMINVALLC N + +RP MSSV+ MLE
Sbjct: 764 LLDWAHLLKDRGDLMELVDRRLGLDFDKNEAMVMINVALLCTNVTSNLRPPMSSVVSMLE 823
Query: 662 CGVDVLDLVSDSSVSDIDETKAEAMRKYYQFCVENTASTTQSTSS---IYGPPPGSSTAG 718
V + VSDSS +DE E +R+YY EN+ S +Q+ S I GP +S++
Sbjct: 824 GRTVVPEFVSDSS-EVMDEKNMEVLRQYYYQMEENSTSKSQTQSQSLLIDGPWTATSSSA 882
Query: 719 VDLHPFSVDS 728
VDL+P +DS
Sbjct: 883 VDLYPVHLDS 892
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357451935|ref|XP_003596244.1| Receptor-like serine/threonine kinase [Medicago truncatula] gi|355485292|gb|AES66495.1| Receptor-like serine/threonine kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 482 bits (1240), Expect = e-133, Method: Compositional matrix adjust.
Identities = 245/349 (70%), Positives = 284/349 (81%), Gaps = 8/349 (2%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIKAATNNF N IGEGGFGPVYKG L +GT IAVKQLSSKSKQGNREF+NEIGMISAL
Sbjct: 860 QIKAATNNFDISNKIGEGGFGPVYKGCLPNGTLIAVKQLSSKSKQGNREFLNEIGMISAL 919
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 503
QHP LVKLYGCC+EG+QLLLIYEY+ENNSL+RALF E+++KLDWP R++IC+GIARGL
Sbjct: 920 QHPYLVKLYGCCVEGDQLLLIYEYMENNSLSRALFGPEEYQIKLDWPIRQKICVGIARGL 979
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
AYLH ESR+KVVHRDIKATNVLLD L+ KISDFGLAKLDEE+ THISTR+AGT GYMAP
Sbjct: 980 AYLHEESRLKVVHRDIKATNVLLDTSLDPKISDFGLAKLDEEDKTHISTRIAGTYGYMAP 1039
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNV---TKEDMFYLLDWALVLKEQGKLMELVD 620
EYAMRG+LT+KADVYSFGIVALEIVSGRSN +KE+ FYLLDWA +LKE+G LMELVD
Sbjct: 1040 EYAMRGYLTDKADVYSFGIVALEIVSGRSNTMYRSKEEAFYLLDWAELLKERGDLMELVD 1099
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDE 680
+ GS+F+K++ MVMINVALLC N + +RPSMSSV+ MLE V + VSDSS +DE
Sbjct: 1100 SRLGSDFNKKEAMVMINVALLCTNDTSNLRPSMSSVVSMLEGRTVVPEFVSDSS-EVMDE 1158
Query: 681 TKAEAMRKYYQFCVENTASTTQSTS-SIYGPPPGSSTAGVDLHPFSVDS 728
K E MR+YY +N +QS S S SS++ VDL+P +DS
Sbjct: 1159 QKLEVMRQYYSQMEKNKVCKSQSRSLSSDDQCTASSSSAVDLYPVQLDS 1207
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493981|ref|XP_003634703.1| PREDICTED: probable leucine-rich repeat receptor-like serine/threonine-protein kinase At3g14840-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 479 bits (1234), Expect = e-132, Method: Compositional matrix adjust.
Identities = 240/350 (68%), Positives = 286/350 (81%), Gaps = 8/350 (2%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIKAATNNF N IGEGGFG VYKG+L+DGT IAVKQLSSKSKQGNREF+NEIGMISAL
Sbjct: 653 QIKAATNNFDAANKIGEGGFGSVYKGVLSDGTIIAVKQLSSKSKQGNREFVNEIGMISAL 712
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 503
QHP+LVKLYGCCIEGNQLLLIYEY+ENNSLARALF E +L+LDWPTR RIC+GIARGL
Sbjct: 713 QHPHLVKLYGCCIEGNQLLLIYEYMENNSLARALFGPEECQLQLDWPTRHRICVGIARGL 772
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
AYLH ESR+K+VHRDIKATNVLLDKDLN KISDFGLAKLDEE+NTHISTR+AGT GYMAP
Sbjct: 773 AYLHEESRLKIVHRDIKATNVLLDKDLNPKISDFGLAKLDEEDNTHISTRIAGTYGYMAP 832
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELVD 620
EYAMRG+LT+KADVYSFG+VALEIVSGRSN T KE+ YLLD AL LKE+G LM++VD
Sbjct: 833 EYAMRGYLTDKADVYSFGVVALEIVSGRSNTTYRPKEESIYLLDRALSLKEKGSLMDIVD 892
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDE 680
GS+F+KE+VM M+N+ALLC S +RP+MSSV+ MLE V D+VSD S D+
Sbjct: 893 PRLGSDFNKEEVMAMLNIALLCTTISSAVRPAMSSVVSMLEGRTAVQDIVSDPSAPS-DD 951
Query: 681 TKAEAMRKYYQFCVENTASTTQSTSSIYGPPPGSSTAGV-DLHPFSVDSD 729
K E M+++Y+ E + ++S + P ++++ + DL+P ++DS+
Sbjct: 952 LKLEEMKEHYRHIQEKSMGVSESKAQSMPDGPWTASSSIPDLYPVNLDSE 1001
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357492929|ref|XP_003616753.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] gi|355518088|gb|AES99711.1| Cysteine-rich receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 477 bits (1227), Expect = e-131, Method: Compositional matrix adjust.
Identities = 241/352 (68%), Positives = 283/352 (80%), Gaps = 18/352 (5%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIK ATNNF N IGEGGFGPVYKG L+DGT IAVK LSSKSKQGNREF+NEIGMISAL
Sbjct: 652 QIKGATNNFDISNKIGEGGFGPVYKGRLSDGTLIAVKLLSSKSKQGNREFLNEIGMISAL 711
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGL 503
QHP+LVKLYGCC+EG+QL+LIYEYLENNSLARALF EH+++LDWPTR +IC+GIARGL
Sbjct: 712 QHPHLVKLYGCCVEGDQLMLIYEYLENNSLARALFGPAEHQIRLDWPTRYKICVGIARGL 771
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
AYLH ESR+KVVHRDIKATNVLLDKDLN KISDFGLAKLDEEENTHISTR+AGT GYMAP
Sbjct: 772 AYLHEESRLKVVHRDIKATNVLLDKDLNPKISDFGLAKLDEEENTHISTRIAGTYGYMAP 831
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWALVLKEQGKLMELVD 620
EYAM G+LT+KADVYSFGIVALEI+ G +N KE+ F+LLDWA +LKE+G +ELVD
Sbjct: 832 EYAMHGYLTDKADVYSFGIVALEILHGSNNTILRQKEEAFHLLDWAHILKEKGNEIELVD 891
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDE 680
GSNF+KE+ M+MINVALLC N + ++RP+MSSV+ MLE + + +LV +SS +DE
Sbjct: 892 KRLGSNFNKEEAMLMINVALLCTNVTSSLRPAMSSVVSMLEGKIAIQELVLESS-EVLDE 950
Query: 681 TKAEAMRKYYQFCVENTASTTQSTSSIYGP-PPGSSTAGVDLHPFSVDSDRL 731
K EAMRK+YQ + S+ GP SS+ DL+P ++DS L
Sbjct: 951 KKMEAMRKHYQ----------DQSISMEGPWTASSSSVTTDLYPVNLDSSYL 992
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 733 | ||||||
| TAIR|locus:2009630 | 953 | AT1G53420 [Arabidopsis thalian | 0.444 | 0.342 | 0.646 | 7.1e-204 | |
| TAIR|locus:2203718 | 1035 | AT1G53440 [Arabidopsis thalian | 0.392 | 0.278 | 0.735 | 4.5e-178 | |
| TAIR|locus:2019367 | 1078 | AT1G29740 [Arabidopsis thalian | 0.375 | 0.255 | 0.667 | 1.3e-152 | |
| TAIR|locus:2203847 | 1021 | RKF1 "receptor-like kinase in | 0.444 | 0.319 | 0.566 | 4.7e-146 | |
| TAIR|locus:2205250 | 1032 | AT1G56130 [Arabidopsis thalian | 0.380 | 0.270 | 0.570 | 3.5e-122 | |
| TAIR|locus:2019317 | 969 | AT1G29730 [Arabidopsis thalian | 0.487 | 0.368 | 0.558 | 9.4e-122 | |
| TAIR|locus:2205260 | 1047 | AT1G56120 [Arabidopsis thalian | 0.379 | 0.265 | 0.577 | 1.7e-120 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.376 | 0.213 | 0.424 | 1.7e-84 | |
| TAIR|locus:2181017 | 951 | AT5G01950 [Arabidopsis thalian | 0.394 | 0.303 | 0.37 | 3.8e-82 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.373 | 0.229 | 0.419 | 3.3e-79 |
| TAIR|locus:2009630 AT1G53420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1087 (387.7 bits), Expect = 7.1e-204, Sum P(2) = 7.1e-204
Identities = 219/339 (64%), Positives = 260/339 (76%)
Query: 376 AISLTYYGFYL-QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNR 434
++ L F L QIK ATNNF + N IGEGGFGPVYKG L DGT IAVKQLS+ SKQGNR
Sbjct: 604 SLELMIASFSLRQIKIATNNFDSANRIGEGGFGPVYKGKLFDGTIIAVKQLSTGSKQGNR 663
Query: 435 EFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPT 491
EF+NEIGMISAL HPNLVKLYGCC+EG QLLL+YE++ENNSLARALF E +L+LDWPT
Sbjct: 664 EFLNEIGMISALHHPNLVKLYGCCVEGGQLLLVYEFVENNSLARALFGPQETQLRLDWPT 723
Query: 492 RRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551
RR+IC+G+ARGLAYLH ESR+K+VHRDIKATNVLLDK LN KISDFGLAKLDEE++THIS
Sbjct: 724 RRKICIGVARGLAYLHEESRLKIVHRDIKATNVLLDKQLNPKISDFGLAKLDEEDSTHIS 783
Query: 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV---TKEDMFYLLDWALV 608
TR+AGT GYMAPEYAMRGHLT+KADVYSFGIVALEIV GRSN +K + FYL+DW V
Sbjct: 784 TRIAGTFGYMAPEYAMRGHLTDKADVYSFGIVALEIVHGRSNKIERSKNNTFYLIDWVEV 843
Query: 609 LKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGXXXXX 668
L+E+ L+ELVD GS +++E+ M MI +A++C ++ P RPSMS V++MLE G
Sbjct: 844 LREKNNLLELVDPRLGSEYNREEAMTMIQIAIMCTSSEPCERPSMSEVVKMLE-GKKMVE 902
Query: 669 XXXXXXXXXIDETKA----EAMRKYYQFCVENTASTTQS 703
ETK M+KYY+ + ST+ S
Sbjct: 903 VEKLEEASVHRETKRLENMNTMKKYYEM-IGQEISTSMS 940
|
|
| TAIR|locus:2203718 AT1G53440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1113 (396.9 bits), Expect = 4.5e-178, Sum P(2) = 4.5e-178
Identities = 217/295 (73%), Positives = 249/295 (84%)
Query: 374 LSAISLTYYGFYL-QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQG 432
L + L F L QIK ATNNF +N IGEGGFGPVYKG+LADG IAVKQLSSKSKQG
Sbjct: 645 LRGLDLQTGSFTLKQIKRATNNFDPENKIGEGGFGPVYKGVLADGMTIAVKQLSSKSKQG 704
Query: 433 NREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDW 489
NREF+ EIGMISALQHPNLVKLYGCCIEG +LLL+YEYLENNSLARALF + RL LDW
Sbjct: 705 NREFVTEIGMISALQHPNLVKLYGCCIEGKELLLVYEYLENNSLARALFGTEKQRLHLDW 764
Query: 490 PTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549
TR ++C+GIA+GLAYLH ESR+K+VHRDIKATNVLLD LN+KISDFGLAKLDEEENTH
Sbjct: 765 STRNKVCIGIAKGLAYLHEESRLKIVHRDIKATNVLLDLSLNAKISDFGLAKLDEEENTH 824
Query: 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVT---KEDMFYLLDWA 606
ISTR+AGTIGYMAPEYAMRG+LT+KADVYSFG+V LEIVSG+SN KE+ YLLDWA
Sbjct: 825 ISTRIAGTIGYMAPEYAMRGYLTDKADVYSFGVVCLEIVSGKSNTNYRPKEEFIYLLDWA 884
Query: 607 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
VL+EQG L+ELVD + G++F K++ M M+N+ALLC N SPT+RP MSSV+ ML+
Sbjct: 885 YVLQEQGSLLELVDPDLGTSFSKKEAMRMLNIALLCTNPSPTLRPPMSSVVSMLQ 939
|
|
| TAIR|locus:2019367 AT1G29740 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 951 (339.8 bits), Expect = 1.3e-152, Sum P(2) = 1.3e-152
Identities = 187/280 (66%), Positives = 225/280 (80%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
Q+K AT++F N IGEGGFG VYKG L +GT IAVK+LSSKS QGN+EFINEIG+I+ L
Sbjct: 669 QLKVATDDFNPLNKIGEGGFGSVYKGRLPNGTLIAVKKLSSKSCQGNKEFINEIGIIACL 728
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAY 505
QHPNLVKLYGCC+E QLLL+YEYLENN LA ALF LKLDW TR +ICLGIARGLA+
Sbjct: 729 QHPNLVKLYGCCVEKTQLLLVYEYLENNCLADALFGRSGLKLDWRTRHKICLGIARGLAF 788
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 565
LH +S +K++HRDIK TN+LLDKDLNSKISDFGLA+L E++ +HI+TRVAGTIGYMAPEY
Sbjct: 789 LHEDSAVKIIHRDIKGTNILLDKDLNSKISDFGLARLHEDDQSHITTRVAGTIGYMAPEY 848
Query: 566 AMRGHLTEKADVYSFGIVALEIVSGRSNVT----KEDMFYLLDWALVLKEQGKLMELVDT 621
AMRGHLTEKADVYSFG+VA+EIVSG+SN E LLDWA VL+++G E++D
Sbjct: 849 AMRGHLTEKADVYSFGVVAMEIVSGKSNANYTPDNECCVGLLDWAFVLQKKGAFDEILDP 908
Query: 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
FD + MI V+LLC++ SPT+RP+MS V++MLE
Sbjct: 909 KLEGVFDVMEAERMIKVSLLCSSKSPTLRPTMSEVVKMLE 948
|
|
| TAIR|locus:2203847 RKF1 "receptor-like kinase in flowers 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 889 (318.0 bits), Expect = 4.7e-146, Sum P(2) = 4.7e-146
Identities = 191/337 (56%), Positives = 240/337 (71%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QIK AT++F N IGEGGFG V+KG+LADG +AVKQLSSKS+QGNREF+NEIG IS L
Sbjct: 673 QIKFATDDFNPTNKIGEGGFGAVFKGVLADGRVVAVKQLSSKSRQGNREFLNEIGAISCL 732
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF--EHR-LKLDWPTRRRICLGIARGL 503
QHPNLVKL+G C+E QLLL YEY+ENNSL+ ALF +H+ + +DWPTR +IC GIA+GL
Sbjct: 733 QHPNLVKLHGFCVERAQLLLAYEYMENNSLSSALFSPKHKQIPMDWPTRFKICCGIAKGL 792
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
A+LH ES +K VHRDIKATN+LLDKDL KISDFGLA+LDEEE THIST+VAGTIGYMAP
Sbjct: 793 AFLHEESPLKFVHRDIKATNILLDKDLTPKISDFGLARLDEEEKTHISTKVAGTIGYMAP 852
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSN---VTKEDMFYLLDWALVLKEQGKLMELVD 620
EYA+ G+LT KADVYSFG++ LEIV+G +N + D LL++A E G LM++VD
Sbjct: 853 EYALWGYLTFKADVYSFGVLVLEIVAGITNSNFMGAGDSVCLLEFANECVESGHLMQVVD 912
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGXXXXXXXXXXXXXXIDE 680
D+++ +I VAL+C++ASPT RP MS V+ MLE G +
Sbjct: 913 ERLRPEVDRKEAEAVIKVALVCSSASPTDRPLMSEVVAMLE-GLYPVPESTPGVSRNAGD 971
Query: 681 TKAEAMRKYYQFCVENTASTTQSTSSIYGPPPGSSTA 717
+ +A + + +EN + T S S Y P SST+
Sbjct: 972 IRFKAFKDLRRG-MENNSKTQCSVKS-Y--PSSSSTS 1004
|
|
| TAIR|locus:2205250 AT1G56130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 816 (292.3 bits), Expect = 3.5e-122, Sum P(2) = 3.5e-122
Identities = 162/284 (57%), Positives = 207/284 (72%)
Query: 381 YYGFYLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEI 440
Y Y ++K+AT +F N +GEGGFGPVYKG L DG +AVK LS S+QG +F+ EI
Sbjct: 680 YIFTYSELKSATQDFDPSNKLGEGGFGPVYKGNLNDGRVVAVKLLSVGSRQGKGQFVAEI 739
Query: 441 GMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF-EHRLKLDWPTRRRICLGI 499
IS++ H NLVKLYGCC EG +L+YEYL N SL +ALF + L LDW TR ICLG+
Sbjct: 740 VAISSVLHRNLVKLYGCCFEGEHRMLVYEYLPNGSLDQALFGDKTLHLDWSTRYEICLGV 799
Query: 500 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG 559
ARGL YLH E+ +++VHRD+KA+N+LLD L +ISDFGLAKL +++ THISTRVAGTIG
Sbjct: 800 ARGLVYLHEEASVRIVHRDVKASNILLDSRLVPQISDFGLAKLYDDKKTHISTRVAGTIG 859
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK---EDMFYLLDWALVLKEQGKLM 616
Y+APEYAMRGHLTEK DVY+FG+VALE+VSGR N + E+ YLL+WA L E+ + +
Sbjct: 860 YLAPEYAMRGHLTEKTDVYAFGVVALELVSGRPNSDENLEEEKKYLLEWAWNLHEKSRDI 919
Query: 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRML 660
EL+D ++F+ E+ MI +ALLC S +RP MS V+ ML
Sbjct: 920 ELIDDKL-TDFNMEEAKRMIGIALLCTQTSHALRPPMSRVVAML 962
|
|
| TAIR|locus:2019317 AT1G29730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 979 (349.7 bits), Expect = 9.4e-122, Sum P(2) = 9.4e-122
Identities = 210/376 (55%), Positives = 265/376 (70%)
Query: 297 YSLHINCGG--KQVTANGNTTFEEDTSEAGPSTFSQSGTNWVLSSTGHF--LENGLKLGP 352
+S+ G K+V NTT ++T E ++ GT ++ G++ L + + + P
Sbjct: 545 FSIREEANGTHKEVIREVNTTVTDNTLEIR-LYWAGKGT-MIIPQRGYYGSLISAVSVCP 602
Query: 353 YIQTNTSRLLMNDYQLYTTARLSAISLTYYGFYL-QIKAATNNFATDNNIGEGGFGPVYK 411
++ + ++L L F L Q+K ATN+F N IGEGGFG VYK
Sbjct: 603 SSESECGGMKKK------ISKLKGPDLRTGSFSLRQLKVATNDFDPLNKIGEGGFGSVYK 656
Query: 412 GLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471
G L DGT IAVK+LSSKS QGN+EF+NEIGMI+ LQHPNLVKLYGCC+E NQLLL+YEYL
Sbjct: 657 GRLPDGTLIAVKKLSSKSHQGNKEFVNEIGMIACLQHPNLVKLYGCCVEKNQLLLVYEYL 716
Query: 472 ENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD 529
ENN L+ ALF R LKL+W TR +ICLGIARGLA+LH +S +K++HRDIK TNVLLDKD
Sbjct: 717 ENNCLSDALFAGRSCLKLEWGTRHKICLGIARGLAFLHEDSAVKIIHRDIKGTNVLLDKD 776
Query: 530 LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
LNSKISDFGLA+L E+ +HI+TRVAGTIGYMAPEYAMRGHLTEKADVYSFG+VA+EIVS
Sbjct: 777 LNSKISDFGLARLHEDNQSHITTRVAGTIGYMAPEYAMRGHLTEKADVYSFGVVAMEIVS 836
Query: 590 GRSNV--TKED--MFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANA 645
G+SN T +D LLDWA VL+++G + E++D FD + MI V+LLCAN
Sbjct: 837 GKSNAKYTPDDECCVGLLDWAFVLQKKGDIAEILDPRLEGMFDVMEAERMIKVSLLCANK 896
Query: 646 SPTIRPSMSSVLRMLE 661
S T+RP+MS V++MLE
Sbjct: 897 SSTLRPNMSQVVKMLE 912
|
|
| TAIR|locus:2205260 AT1G56120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 821 (294.1 bits), Expect = 1.7e-120, Sum P(2) = 1.7e-120
Identities = 164/284 (57%), Positives = 209/284 (73%)
Query: 382 YGF-YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEI 440
Y F Y ++K AT +F N +GEGGFG VYKG L DG +AVKQLS S+QG +F+ EI
Sbjct: 696 YTFTYSELKNATQDFDLSNKLGEGGFGAVYKGNLNDGREVAVKQLSIGSRQGKGQFVAEI 755
Query: 441 GMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF-EHRLKLDWPTRRRICLGI 499
IS++ H NLVKLYGCC EG+ LL+YEYL N SL +ALF + L LDW TR ICLG+
Sbjct: 756 IAISSVLHRNLVKLYGCCFEGDHRLLVYEYLPNGSLDQALFGDKSLHLDWSTRYEICLGV 815
Query: 500 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG 559
ARGL YLH E+ ++++HRD+KA+N+LLD +L K+SDFGLAKL +++ THISTRVAGTIG
Sbjct: 816 ARGLVYLHEEASVRIIHRDVKASNILLDSELVPKVSDFGLAKLYDDKKTHISTRVAGTIG 875
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK---EDMFYLLDWALVLKEQGKLM 616
Y+APEYAMRGHLTEK DVY+FG+VALE+VSGR N + E YLL+WA L E+ + +
Sbjct: 876 YLAPEYAMRGHLTEKTDVYAFGVVALELVSGRKNSDENLEEGKKYLLEWAWNLHEKNRDV 935
Query: 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRML 660
EL+D S ++ E+V MI +ALLC +S +RP MS V+ ML
Sbjct: 936 ELIDDEL-SEYNMEEVKRMIGIALLCTQSSYALRPPMSRVVAML 978
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 549 (198.3 bits), Expect = 1.7e-84, Sum P(2) = 1.7e-84
Identities = 123/290 (42%), Positives = 178/290 (61%)
Query: 388 IKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK-QGNREFINEIGMISAL 446
I AT NF+ + IG+GGFG VYK L +G +A+K+L + QG+REF+ E+ I +
Sbjct: 995 ILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGDREFLAEMETIGKV 1054
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLD---WPTRRRICLGIARGL 503
+HPNLV L G C+ G++ LIYEY+EN SL L L+ WP R +ICLG ARGL
Sbjct: 1055 KHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEALGWPDRLKICLGSARGL 1114
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
A+LH ++HRD+K++N+LLD++ ++SDFGLA++ TH+ST +AGT GY+ P
Sbjct: 1115 AFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACETHVSTDIAGTFGYIPP 1174
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF---YLLDWALVLKEQGKLMELVD 620
EY + T K DVYSFG+V LE+++GR +E++ L+ W + +GK EL D
Sbjct: 1175 EYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQEEVQGGGNLVGWVRWMIARGKQNELFD 1234
Query: 621 TN-PGSNFDKEQVMVMINVALLCANASPTIRPSMSSV---LRM---LECG 663
P S+ +EQ+ ++ +A C P RP+M V L+M +ECG
Sbjct: 1235 PCLPVSSVWREQMARVLAIARDCTADEPFKRPTMLEVVKGLKMTHGMECG 1284
|
|
| TAIR|locus:2181017 AT5G01950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 523 (189.2 bits), Expect = 3.8e-82, Sum P(2) = 3.8e-82
Identities = 111/300 (37%), Positives = 187/300 (62%)
Query: 370 TTARLSAISLTYYGF-YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK 428
++++ S ++ GF + ++ AT++F++ +G GG+G VY+G+L+D T A+K+
Sbjct: 600 SSSKASLLNSGIRGFSFKELAEATDDFSSSTLVGRGGYGKVYRGVLSDNTVAAIKRADEG 659
Query: 429 SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF-EHRLKL 487
S QG +EF+NEI ++S L H NLV L G C E ++ +L+YE++ N +L L + + L
Sbjct: 660 SLQGEKEFLNEIELLSRLHHRNLVSLIGYCDEESEQMLVYEFMSNGTLRDWLSAKGKESL 719
Query: 488 DWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL----D 543
+ R R+ LG A+G+ YLH E+ V HRDIKA+N+LLD + N+K++DFGL++L +
Sbjct: 720 SFGMRIRVALGAAKGILYLHTEANPPVFHRDIKASNILLDPNFNAKVADFGLSRLAPVLE 779
Query: 544 EEENT--HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY 601
+EE+ H+ST V GT GY+ PEY + LT+K+DVYS G+V LE+++G ++
Sbjct: 780 DEEDVPKHVSTVVRGTPGYLDPEYFLTHKLTDKSDVYSIGVVFLELLTGMHAISHGKN-- 837
Query: 602 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
++ +++ ++ L+D + E V +AL C++ SP +RP M+ V++ LE
Sbjct: 838 IVREVKTAEQRDMMVSLIDKRM-EPWSMESVEKFAALALRCSHDSPEMRPGMAEVVKELE 896
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 553 (199.7 bits), Expect = 3.3e-79, Sum P(2) = 3.3e-79
Identities = 118/281 (41%), Positives = 170/281 (60%)
Query: 388 IKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ 447
I AT++F+ N IG+GGFG VYK L +AVK+LS QGNREF+ E+ + ++
Sbjct: 910 IVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVK 969
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHR--LK-LDWPTRRRICLGIARGLA 504
HPNLV L G C + LL+YEY+ N SL L L+ LDW R +I +G ARGLA
Sbjct: 970 HPNLVSLLGYCSFSEEKLLVYEYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLA 1029
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
+LH ++HRDIKA+N+LLD D K++DFGLA+L +H+ST +AGT GY+ PE
Sbjct: 1030 FLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPE 1089
Query: 565 YAMRGHLTEKADVYSFGIVALEIVSGRS----NVTKEDMFYLLDWALVLKEQGKLMELVD 620
Y T K DVYSFG++ LE+V+G+ + + + L+ WA+ QGK ++++D
Sbjct: 1090 YGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVGWAIQKINQGKAVDVID 1149
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
S K + ++ +A+LC +P RP+M VL+ L+
Sbjct: 1150 PLLVSVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKALK 1190
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00027899001 | SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (1036 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 733 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-56 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-54 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-54 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-51 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-48 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-43 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-39 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-37 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-37 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-35 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-34 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-34 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-34 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-33 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-31 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-31 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-30 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-29 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-29 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-28 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 7e-28 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 8e-28 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-27 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-27 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-27 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-26 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-26 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-26 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-26 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-25 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-25 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-24 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-24 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-24 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-24 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-24 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-24 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 8e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-23 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-23 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-23 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-23 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 8e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-22 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-22 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-22 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-22 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-22 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-22 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-22 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-22 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-22 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-22 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-21 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-21 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-21 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-21 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-21 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-21 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 7e-21 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-20 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-20 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-19 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-19 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-18 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 8e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-17 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-17 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-17 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-17 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-17 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-16 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-16 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 8e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-15 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 6e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-14 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-14 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-14 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-14 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-14 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-14 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-14 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 6e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-14 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 9e-14 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-13 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-13 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-12 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-12 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-12 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 5e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-12 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 8e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 9e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-11 | |
| pfam11721 | 164 | pfam11721, Malectin, Di-glucose binding within end | 5e-11 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-11 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-11 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 8e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 9e-11 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-10 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-10 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-10 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-10 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-10 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-09 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 6e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-07 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 6e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 7e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 8e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 6e-05 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 5e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 0.004 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 2e-56
Identities = 87/272 (31%), Positives = 130/272 (47%), Gaps = 33/272 (12%)
Query: 401 IGEGGFGPVYKGLL-----ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 454
+GEG FG VYKG L +AVK L S+Q EF+ E ++ L HPN+VKL
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G C E L ++ EY+E L L ++R KL L IARG+ YL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNF 123
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
+HRD+ A N L+ ++L KISDFGL++ D++ ++ I +MAPE G T
Sbjct: 124 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEGKFT 181
Query: 573 EKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628
K+DV+SFG++ EI + G ++ E++ L + G + P
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL-------KNGYRLPQPPNCPPE--- 231
Query: 629 KEQVMVMINVALLCANASPTIRPSMSSVLRML 660
+ ++ L C P RP+ S ++ +L
Sbjct: 232 ------LYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 85/273 (31%), Positives = 129/273 (47%), Gaps = 34/273 (12%)
Query: 401 IGEGGFGPVYKGLLADG-----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 454
+GEG FG VYKG L +AVK L S+Q EF+ E ++ L HPN+VKL
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIK 513
G C E L+++ EY+ L L ++R K L L IARG+ YL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKN 123
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHL 571
+HRD+ A N L+ ++L KISDFGL++ D++ ++ I +MAPE G
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEGKF 181
Query: 572 TEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627
T K+DV+SFG++ EI + G ++ ++ L ++G + P
Sbjct: 182 TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL-------KKGYRLPKPPNCPPE-- 232
Query: 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRML 660
+ + L C P RP+ S ++ +L
Sbjct: 233 -------LYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 9e-54
Identities = 88/279 (31%), Positives = 133/279 (47%), Gaps = 37/279 (13%)
Query: 401 IGEGGFGPVYKGLLADG----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 455
+GEG FG VYKG L T +AVK L S++ ++F+ E ++ L HPN+V+L
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR--------RICLGIARGLAYLH 507
G C E L L+ EY+E L L + R P + + IA+G+ YL
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA 122
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYA 566
K VHRD+ A N L+ +DL KISDFGL++ + +++ T I +MAPE
Sbjct: 123 ---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179
Query: 567 MRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTN 622
G T K+DV+SFG++ EI + G + ++ E++ L +G +
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-------RKGYRLP----K 228
Query: 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
P E + + L C P RP+ S ++ LE
Sbjct: 229 P-EYCPDE----LYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 1e-52
Identities = 89/271 (32%), Positives = 132/271 (48%), Gaps = 30/271 (11%)
Query: 401 IGEGGFGPVYKGLL-----ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 454
+GEG FG VYKG L T +AVK L S++ EF+ E ++ L HPN+V+L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G C +G L ++ EY+ L L +H KL ++ L IA+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT-IGYMAPEYAMRGHLTE 573
VHRD+ A N L+ ++L KISDFGL++ E++ + I +MAPE G T
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTS 183
Query: 574 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629
K+DV+SFG++ EI + G ++ E++ LL E G + + P
Sbjct: 184 KSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL-------EDGYRLPRPENCP-----D 231
Query: 630 EQVMVMINVALLCANASPTIRPSMSSVLRML 660
E +M L C P RP+ S ++ L
Sbjct: 232 ELYELM----LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 1e-52
Identities = 76/191 (39%), Positives = 107/191 (56%), Gaps = 8/191 (4%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLYGCC 458
+GEGGFG VY G +A+K + + E + EI ++ L HPN+VKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
+ N L L+ EY E SL L E+ KL RI L I GL YLH ++HRD
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLH---SNGIIHRD 117
Query: 519 IKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTEKAD 576
+K N+LLD D K++DFGL+KL + + + T V GT YMAPE +G+ +EK+D
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKSD 176
Query: 577 VYSFGIVALEI 587
++S G++ E+
Sbjct: 177 IWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 9e-51
Identities = 73/211 (34%), Positives = 108/211 (51%), Gaps = 12/211 (5%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
+G G FG VYK G +AVK L S+ + ++ EI ++ L HPN+V+L
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 517
+ + L L+ EY E L L L ++I L I RGL YLH ++HR
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLSRGG-PLSEDEAKKIALQILRGLEYLHSNG---IIHR 122
Query: 518 DIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTEKAD 576
D+K N+LLD++ KI+DFGLAK + ++ ++T V GT YMAPE K D
Sbjct: 123 DLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPKVD 181
Query: 577 VYSFGIVALEIVSGR---SNVTKEDMFYLLD 604
V+S G++ E+++G+ S D L+
Sbjct: 182 VWSLGVILYELLTGKPPFSGENILDQLQLIR 212
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 9e-48
Identities = 183/664 (27%), Positives = 295/664 (44%), Gaps = 63/664 (9%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
N TG +P L L LQ + L +N+ G IPK L + L L + N +GE+PE L S
Sbjct: 319 NFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCS 378
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF---I 144
NL KL L SN+ GE+PK+ +++ R+ DN F+G++PS +TKL ++ I
Sbjct: 379 SGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS---EFTKLPLVYFLDI 435
Query: 145 QPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQL-GNMKMTKLILRNCNITGELPRY 203
+ L G I S + + +L L ++ N P G+ ++ L L +G +PR
Sbjct: 436 SNNNLQGRINSRKWDMPSLQMLSLA-RNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRK 494
Query: 204 LGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERG--DKIDL 261
LG +++L L LS N+L G+IP + + + N L+G IP E ++DL
Sbjct: 495 LGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL 554
Query: 262 SYNNFTD------GSAESSCQKRSVTGIVSCLRSVQCPKTYYSLHINCGGKQVTANGNTT 315
S N + G+ ES Q I P T L IN V N +
Sbjct: 555 SQNQLSGEIPKNLGNVESLVQ----VNISHNHLHGSLPSTGAFLAIN--ASAVAGNIDLC 608
Query: 316 FEEDTSEAGPSTFSQSGTNW---VLSSTGHFLENGLKLGPYIQTNTSRLL---------- 362
+ TS P + +W + + G FL L ++ L
Sbjct: 609 GGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDG 668
Query: 363 MNDYQLYTTARLSAISLTYYGFYLQIKAATNNFATDNNIGEGGFGPVYKG-LLADGTAIA 421
+ Q + + +I+ I ++ +N I G G YKG + +G
Sbjct: 669 TWELQFFDSKVSKSIT---------INDILSSLKEENVISRGKKGASYKGKSIKNGMQFV 719
Query: 422 VKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF 481
VK++ N +EI + LQHPN+VKL G C LI+EY+E +L+ L
Sbjct: 720 VKEI----NDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL- 774
Query: 482 EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541
L W RR+I +GIA+ L +LH VV ++ +++D D +
Sbjct: 775 ---RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID------GKDEPHLR 825
Query: 542 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY 601
L T+ + Y+APE +TEK+D+Y FG++ +E+++G+S E +
Sbjct: 826 LSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH 885
Query: 602 --LLDWALVLKEQGKLMELVDTNPGSN--FDKEQVMVMINVALLCANASPTIRPSMSSVL 657
+++WA L +D + + ++ +++ ++N+AL C PT RP + VL
Sbjct: 886 GSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVL 945
Query: 658 RMLE 661
+ LE
Sbjct: 946 KTLE 949
|
Length = 968 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 66/194 (34%), Positives = 105/194 (54%), Gaps = 8/194 (4%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLYGCC 458
+GEG FG VY G +A+K + K + +RE + EI ++ L+HPN+V+LY
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
+ ++L L+ EY E L L + +L R I L YLH +VHRD
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKRG-RLSEDEARFYLRQILSALEYLH---SKGIVHRD 122
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
+K N+LLD+D + K++DFGLA+ + ++T V GT YMAPE + + D++
Sbjct: 123 LKPENILLDEDGHVKLADFGLARQ-LDPGEKLTTFV-GTPEYMAPEVLLGKGYGKAVDIW 180
Query: 579 SFGIVALEIVSGRS 592
S G++ E+++G+
Sbjct: 181 SLGVILYELLTGKP 194
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 9e-45
Identities = 76/197 (38%), Positives = 104/197 (52%), Gaps = 10/197 (5%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
+G G FG VY L D G +AVK LS S++ EI ++S+LQHPN+V+ YG
Sbjct: 8 LGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGS 67
Query: 458 CI--EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
E N L + EY+ SL+ L + KL P R+ I GLAYLH +V
Sbjct: 68 ERDEEKNTLNIFLEYVSGGSLSSLL-KKFGKLPEPVIRKYTRQILEGLAYLHSN---GIV 123
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 574
HRDIK N+L+D D K++DFG AK L + E + V GT +MAPE
Sbjct: 124 HRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRA 183
Query: 575 ADVYSFGIVALEIVSGR 591
AD++S G +E+ +G+
Sbjct: 184 ADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 68/192 (35%), Positives = 103/192 (53%), Gaps = 6/192 (3%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IG+GGFG VYK G +A+K + +SK+ + INEI ++ +HPN+VK YG +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
+ ++L ++ E+ SL L L +C + +GL YLH ++HRDI
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDI 124
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 579
KA N+LL D K+ DFGL+ + +T + GT +MAPE KAD++S
Sbjct: 125 KAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWS 182
Query: 580 FGIVALEIVSGR 591
GI A+E+ G+
Sbjct: 183 LGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 4e-39
Identities = 70/194 (36%), Positives = 114/194 (58%), Gaps = 12/194 (6%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
IGEG G VYK A G +A+K+ L ++K+ INEI ++ +HPN+V Y
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELI---INEILIMKDCKHPNIVDYYDS 83
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 517
+ G++L ++ EY++ SL + ++ ++++ P +C + +GL YLH ++ I HR
Sbjct: 84 YLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI---HR 140
Query: 518 DIKATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
DIK+ N+LL KD + K++DFG A+L +E++ S V GT +MAPE R K D
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPEVIKRKDYGPKVD 198
Query: 577 VYSFGIVALEIVSG 590
++S GI+ +E+ G
Sbjct: 199 IWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 73/204 (35%), Positives = 109/204 (53%), Gaps = 28/204 (13%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS--SKSKQGNREFINEIGMISALQHPNLVKLYGC 457
IG G FG VYKGL L G +A+KQ+S ++ + + EI ++ L+HPN+VK G
Sbjct: 8 IGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGS 67
Query: 458 CIEGNQLLLIYEYLENNSLARAL-----FEHRLKLDWPTRRRICLGIA---RGLAYLHGE 509
+ L +I EY EN SL + + F L + + + +GLAYLH +
Sbjct: 68 IETSDSLYIILEYAENGSLRQIIKKFGPFPESL---------VAVYVYQVLQGLAYLHEQ 118
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPE-YAM 567
V+HRDIKA N+L KD K++DFG+A KL++ V GT +MAPE M
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPEVIEM 173
Query: 568 RGHLTEKADVYSFGIVALEIVSGR 591
G + +D++S G +E+++G
Sbjct: 174 SGA-STASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 85/269 (31%), Positives = 127/269 (47%), Gaps = 36/269 (13%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
IG+G FG V G G +AVK L S F+ E +++ L+HPNLV+L G ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 461 GNQLLLIYEYLENNSL-------ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
GN L ++ EY+ SL RA+ +L + L + G+ YL E +
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF------ALDVCEGMEYL--EEK-N 122
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
VHRD+ A NVL+ +DL +K+SDFGLAK E S ++ + + APE +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFST 178
Query: 574 KADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632
K+DV+SFGI+ EI S GR + + ++ E+G ME + P + +V
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV----EKGYRMEAPEGCPPEVY---KV 231
Query: 633 MVMINVALLCANASPTIRPSMSSVLRMLE 661
M C P RP+ + L
Sbjct: 232 MKD------CWELDPAKRPTFKQLREQLA 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 68/199 (34%), Positives = 106/199 (53%), Gaps = 11/199 (5%)
Query: 398 DNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLV 452
+ IG G FG V +G L +A+K L + S R +F+ E ++ HPN++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
+L G + +++I EY+EN SL + L E+ K + GIA G+ YL S +
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEM 125
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG--YMAPEYAMRGH 570
VHRD+ A N+L++ +L K+SDFGL++ E+ +T+ G I + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAIAYRK 184
Query: 571 LTEKADVYSFGIVALEIVS 589
T +DV+SFGIV E++S
Sbjct: 185 FTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 1e-34
Identities = 83/225 (36%), Positives = 128/225 (56%), Gaps = 7/225 (3%)
Query: 29 LTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSL 88
L+G +P + + L+ + L N L G IP L N+++L LT+ NQ G++P ELG +
Sbjct: 152 LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM 211
Query: 89 LNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSG 148
+L+ ++L NN +GE+P LT++ + N TG IPS + N L+ LF+ +
Sbjct: 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNK 271
Query: 149 LAGPIPSGIFSLENLTDLRISD--LNG--PEATFPQLGNMKMTKLILRNCNITGELPRYL 204
L+GPIP IFSL+ L L +SD L+G PE QL N+++ L L + N TG++P L
Sbjct: 272 LSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI-QLQNLEI--LHLFSNNFTGKIPVAL 328
Query: 205 GKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 249
+ +L+VL L N+ G+IP N ++ + + N LTG IP
Sbjct: 329 TSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIP 373
|
Length = 968 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 72/202 (35%), Positives = 99/202 (49%), Gaps = 13/202 (6%)
Query: 399 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLY 455
N IG G FG VY + L G +AVK++ + +E +E+ ++ L+HPNLVK Y
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G + ++ + EY +L L EH LD R L + GLAYLH I V
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL-EHGRILDEHVIRVYTLQLLEGLAYLH-SHGI--V 121
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG---YMAPEYAMRGHLT 572
HRDIK N+ LD + K+ DFG A + T + V G YMAPE G
Sbjct: 122 HRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK 181
Query: 573 EK---ADVYSFGIVALEIVSGR 591
AD++S G V LE+ +G+
Sbjct: 182 GHGRAADIWSLGCVVLEMATGK 203
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 82/285 (28%), Positives = 129/285 (45%), Gaps = 35/285 (12%)
Query: 399 NNIGEGGFGPVYKG---LLADGTA--IAVKQLS-SKSKQGNREFINEIGMISALQHPNLV 452
+GEG FG V L D T +AVK L+ S +Q +F EI ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 453 KLYGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
K G C + G L LI EYL + SL L HR +++ I +G+ YL +
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ- 128
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMR 568
+ +HRD+ A N+L++ + KISDFGLAK+ E+ + + G I + APE
Sbjct: 129 --RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 569 GHLTEKADVYSFGIVALEIVS-GRSN-----------VTKEDMFYLLDWALVLKEQGKLM 616
+ +DV+SFG+ E+ + G + + + +LKE +L
Sbjct: 187 SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERL- 245
Query: 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ E +M LC A P RPS + ++ +++
Sbjct: 246 -----PRPPSCPDEVYDLMK----LCWEAEPQDRPSFADLILIVD 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 7e-34
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 21/199 (10%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+GEG +G VYK + G +A+K + + +E I EI ++ P +VK YG
Sbjct: 11 LGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 460 EGNQLLLIYEYLENNSLA-------RALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
+ L ++ EY S++ + L E + I +GL YLH
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAA-------ILYQTLKGLEYLH---SN 118
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
K +HRDIKA N+LL+++ +K++DFG++ + +T V GT +MAPE
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYN 177
Query: 573 EKADVYSFGIVALEIVSGR 591
KAD++S GI A+E+ G+
Sbjct: 178 NKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 76/200 (38%), Positives = 107/200 (53%), Gaps = 20/200 (10%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYGC 457
+G G FG V+ G T +AVK L K G F+ E ++ L+H LV+LY
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 458 CIEGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
C E + ++ EY+ SL L +L+L P + IA G+AYL ESR
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRL--PQLVDMAAQIAEGMAYL--ESR-NY 124
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
+HRD+ A N+L+ ++L KI+DFGLA+L D+E + I + APE A G T
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFT 182
Query: 573 EKADVYSFGIVALEIVS-GR 591
K+DV+SFGI+ EIV+ GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 46/285 (16%)
Query: 401 IGEGGFGPVYKGLLAD------GTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVK 453
+G+G FG VY+GL T +A+K ++ + R EF+NE ++ ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLK------LDWPTRRRI---CLGIARGLA 504
L G G L++ E + L L R + L PT ++ IA G+A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAP 563
YL + K VHRD+ A N ++ +DL KI DFG+ + + E + + + +MAP
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLKEQGKLM 616
E G T K+DV+SFG+V E+ + G SN +E + +++D G +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--EEVLKFVID--------GGHL 240
Query: 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+L + P + +M M C +P +RP+ ++ L+
Sbjct: 241 DLPENCPDKLLE---LMRM------CWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 2e-31
Identities = 70/213 (32%), Positives = 103/213 (48%), Gaps = 30/213 (14%)
Query: 401 IGEGGFGPVYKGLLA------DGTAIAVKQLS-SKSKQGNREFINEIGMISALQHPNLVK 453
+GEG FG V+ G D +AVK L + S ++F E +++ QH N+VK
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEH-----RLKLDWPTRRR--------ICLGIA 500
YG C EG+ ++++EY+E+ L + L H LK I + IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 501 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--- 557
G+ YL + VHRD+ N L+ DL KI DFG+++ D + RV G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSR-DVYTTDYY--RVGGHTML 186
Query: 558 -IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
I +M PE M T ++DV+SFG+V EI +
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 395 FATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL 454
F + +G G FG V++GL + +A+K L S ++F E+ + L+H +L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIK 513
+ C G + +I E +E SL L + L + + +A G+AYL E +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL--EEQ-N 124
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEE-----ENTHISTRVAGTIGYMAPEYAMR 568
+HRD+ A N+L+ +DL K++DFGLA+L +E + I + + APE A
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYK------WTAPEAASH 178
Query: 569 GHLTEKADVYSFGIVALEIVS 589
G + K+DV+SFGI+ E+ +
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 65/196 (33%), Positives = 112/196 (57%), Gaps = 11/196 (5%)
Query: 401 IGEGGFGPVYKGL-LADG----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 454
+G G FG VYKG+ + +G +A+K L S + N+E ++E +++++ HP++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G C+ +Q+ LI + + L + H+ + C+ IA+G++YL E R+
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLE-EKRL-- 130
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
VHRD+ A NVL+ + KI+DFGLAK LD +E + + I +MA E + T
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 574 KADVYSFGIVALEIVS 589
K+DV+S+G+ E+++
Sbjct: 191 KSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 4e-31
Identities = 83/250 (33%), Positives = 129/250 (51%), Gaps = 31/250 (12%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANIS-TLVNLTVQYNQFSGELP 82
L +N++G + + L ++Q I+L N+L GPIP + S +L L + N F+G +P
Sbjct: 76 LSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIP 135
Query: 83 EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 142
GS+ NLE L LS+N +GE+P +++K + N G+IP+ + N T LE L
Sbjct: 136 R--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFL 193
Query: 143 FIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLI-LRNCNITGELP 201
+ + L G IP +LG MK K I L N++GE+P
Sbjct: 194 TLASNQLVGQIPR------------------------ELGQMKSLKWIYLGYNNLSGEIP 229
Query: 202 RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP--WMLERGDKI 259
+G +T L LDL +N L G IPS+ +L ++ Y++ N L+G IPP + L++ +
Sbjct: 230 YEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISL 289
Query: 260 DLSYNNFTDG 269
DLS +N G
Sbjct: 290 DLS-DNSLSG 298
|
Length = 968 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 4e-31
Identities = 70/198 (35%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS-----SKSKQGNREFINEIGMISALQHPNLVKL 454
+G G FG VY+GL L DG AVK++S ++ ++ EI ++S LQHPN+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G E + L + E + SLA+ L + P R I GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAK-LLKKYGSFPEPVIRLYTRQILLGLEYLHDR---NT 123
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTE 573
VHRDIK N+L+D + K++DFG+AK E + S G+ +MAPE + G
Sbjct: 124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQQGGYGL 181
Query: 574 KADVYSFGIVALEIVSGR 591
AD++S G LE+ +G+
Sbjct: 182 AADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 5e-31
Identities = 86/243 (35%), Positives = 132/243 (54%), Gaps = 4/243 (1%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
NLTG +P L L LQ + L N+L GPIP + ++ L++L + N SGE+PE +
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 147
L NLE LHL SNNFTG++P L ++ ++ N+F+G+IP + L L + +
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366
Query: 148 GLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ-LGNMK-MTKLILRNCNITGELPRYLG 205
L G IP G+ S NL L I N E P+ LG + + ++ L++ + +GELP
Sbjct: 367 NLTGEIPEGLCSSGNLFKL-ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFT 425
Query: 206 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-LERGDKIDLSYN 264
K+ + LD+S N L+G+I S D+ + + A N G +P +R + +DLS N
Sbjct: 426 KLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRN 485
Query: 265 NFT 267
F+
Sbjct: 486 QFS 488
|
Length = 968 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREF-INEIGMISALQHPNLVKLYGC 457
IG+G FG VY +DG +K++ S + RE +NE+ ++ L HPN++K Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYES 67
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLK---------LDWPTRRRICLGIARGLAYLHG 508
E +L ++ EY + L++ + + + + LDW + +CL L YLH
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ--LCLA----LKYLHS 121
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 568
K++HRDIK N+ L + K+ DFG++K+ T V GT Y++PE
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQN 177
Query: 569 GHLTEKADVYSFGIVALEIVSGR 591
K+D++S G V E+ + +
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLK 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 67/192 (34%), Positives = 100/192 (52%), Gaps = 8/192 (4%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-EIGMISALQHPNLVKLYGCC 458
IG+G FG VYK + +A+K + + + E I EI +S + P + K YG
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
++G++L +I EY S L KLD I + GL YLH E +HRD
Sbjct: 69 LKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEE---GKIHRD 123
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
IKA N+LL ++ + K++DFG++ + +T V GT +MAPE + EKAD++
Sbjct: 124 IKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEKADIW 182
Query: 579 SFGIVALEIVSG 590
S GI A+E+ G
Sbjct: 183 SLGITAIELAKG 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 5e-30
Identities = 69/206 (33%), Positives = 111/206 (53%), Gaps = 16/206 (7%)
Query: 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPN 450
+F N IG+G FG V+K + AD A+KQ LS +++ E I+E +++ L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-----LDWPTRRRICLGIARGLAY 505
+++ Y ++ +L ++ EY EN L + L R + W R + I GLA+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 565
LH + K++HRDIK+ N+ LD N KI D G+AKL +NT+ + + GT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTNFANTIVGTPYYLSPEL 172
Query: 566 AMRGHLTEKADVYSFGIVALEIVSGR 591
EK+DV++ G+V E +G+
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 96/304 (31%), Positives = 143/304 (47%), Gaps = 56/304 (18%)
Query: 394 NFATDNNIGEGGFGPVYKGL------LADGTAIAVKQLSSKSKQGN-REFINEIGMISAL 446
N +GEG FG V K A T +AVK L + R+ ++E ++ +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHR---------------LKLDWPT 491
HP+++KLYG C + LLLI EY + SL L E R LD P
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 492 RRRICLG--------IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543
R + +G I+RG+ YL + +K+VHRD+ A NVL+ + KISDFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 544 EEENTHISTRVAGTI--GYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSN----VTKE 597
EE++++ R G I +MA E T ++DV+SFG++ EIV+ N + E
Sbjct: 178 YEEDSYVK-RSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 598 DMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 657
+F LL + G ME + N +E M N+ L C P RP+ + +
Sbjct: 237 RLFNLL-------KTGYRMERPE-----NCSEE----MYNLMLTCWKQEPDKRPTFADIS 280
Query: 658 RMLE 661
+ LE
Sbjct: 281 KELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 59/192 (30%), Positives = 96/192 (50%), Gaps = 8/192 (4%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
+G G FG V+ G +A+K + + +FI E ++ L HPNLV+LYG C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 461 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 520
+ ++ EY+ N L L E + KL +C + + YL +HRD+
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLA 127
Query: 521 ATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
A N L+ +D K+SDFGLA+ LD++ + T+ + + PE + K+DV+
Sbjct: 128 ARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VKWAPPEVFDYSRFSSKSDVW 185
Query: 579 SFGIVALEIVSG 590
SFG++ E+ S
Sbjct: 186 SFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 89/313 (28%), Positives = 139/313 (44%), Gaps = 74/313 (23%)
Query: 393 NNFATDNNIGEGGFGPVYK----GLLA--DGTAIAVKQLSSK-SKQGNREFINEIGMISA 445
NN +IG+G FG V++ GLL T +AVK L + S +F E +++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 446 LQHPNLVKLYGCCIEGNQLLLIYEYLE----NNSL-----------------ARALFEHR 484
HPN+VKL G C G + L++EY+ N L AR +
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 485 LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA---- 540
L L + I +A G+AYL S K VHRD+ N L+ +++ KI+DFGL+
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 541 -----KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS------ 589
K E + A I +M PE T ++DV+++G+V EI S
Sbjct: 182 SADYYKASEND--------AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPY 233
Query: 590 -GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPT 648
G ++ +E ++Y+ D G ++ D P + N+ LC + P+
Sbjct: 234 YGMAH--EEVIYYVRD--------GNVLSCPDNCPLE---------LYNLMRLCWSKLPS 274
Query: 649 IRPSMSSVLRMLE 661
RPS +S+ R+L+
Sbjct: 275 DRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 63/195 (32%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
+G G FG V++GL + T +AVK L + +F+ E ++ L+HP L++LY C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 461 GNQLLLIYEYLENNSLARAL-FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
+ ++ E ++ SL L L P + +A G+AYL ++ I HRD+
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYI---HRDL 129
Query: 520 KATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 577
A NVL+ ++ K++DFGLA++ ++ + I + APE A+ + K+DV
Sbjct: 130 AARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFP--IKWTAPEAALYNRFSIKSDV 187
Query: 578 YSFGIVALEIVS-GR 591
+SFGI+ EIV+ GR
Sbjct: 188 WSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 60/189 (31%), Positives = 101/189 (53%), Gaps = 4/189 (2%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
IG G FG V+ G + +A+K + + +FI E ++ L HP LV+LYG C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIR-EGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 461 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 520
+ + L++E++E+ L+ L R K T +CL + G+AYL + V+HRD+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLA 127
Query: 521 ATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSF 580
A N L+ ++ K+SDFG+ + ++ ST + + +PE + K+DV+SF
Sbjct: 128 ARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSF 187
Query: 581 GIVALEIVS 589
G++ E+ S
Sbjct: 188 GVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 84/272 (30%), Positives = 129/272 (47%), Gaps = 31/272 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREFINEIGMISALQHPNLVKLYGCC 458
IG G VY + L + +A+K++ K + E E+ +S HPN+VK Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGLAYLHGESRIKVV 515
+ G++L L+ YL SL + + LD + + +GL YLH +I
Sbjct: 69 VVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQI--- 124
Query: 516 HRDIKATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRV----AGTIGYMAPEYAMRGH 570
HRDIKA N+LL +D + KI+DFG+ A L + + +V GT +MAPE + H
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASL--ADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 571 -LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG---KLMELVDTNPGSN 626
KAD++SFGI A+E+ +G + +K Y L+L Q L D S
Sbjct: 183 GYDFKADIWSFGITAIELATGAAPYSK----YPPMKVLMLTLQNDPPSLETGADYKKYSK 238
Query: 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
++ MI+ LC P+ RP+ +L+
Sbjct: 239 SFRK----MIS---LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 71/206 (34%), Positives = 109/206 (52%), Gaps = 19/206 (9%)
Query: 401 IGEGGFGPVYKGLLA-DGTAIAVKQL-----SSKSKQGNREFIN----EIGMISALQHPN 450
IG G FG VY G+ A G +AVKQ+ S+ SK R ++ EI ++ LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+V+ G ++ + L + EY+ S+A AL + + R I +GL YLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVA-ALLNNYGAFEETLVRNFVRQILKGLNYLHNR- 125
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA-----GTIGYMAPEY 565
++HRDIK N+L+D KISDFG++K E + T A G++ +MAPE
Sbjct: 126 --GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
Query: 566 AMRGHLTEKADVYSFGIVALEIVSGR 591
+ T KAD++S G + +E+++G+
Sbjct: 184 VKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 9/203 (4%)
Query: 401 IGEGGFGPVYK-GLLADGTAIAVKQLSSKSKQGNREF---INEIGMISALQHPNLVKLYG 456
+G+G FG V G A+K L K +E + E ++S + HP +VKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+L L+ EY L L + R I L YLH + +++
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHL-SKEGRFSEERARFYAAEIVLALEYLH---SLGIIY 116
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
RD+K N+LLD D + K++DFGLAK E + +T GT Y+APE + + D
Sbjct: 117 RDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGYGKAVD 175
Query: 577 VYSFGIVALEIVSGRSNVTKEDM 599
+S G++ E+++G+ ED
Sbjct: 176 WWSLGVLLYEMLTGKPPFYAEDR 198
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-28
Identities = 70/215 (32%), Positives = 104/215 (48%), Gaps = 22/215 (10%)
Query: 394 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHP- 449
++ +GEG FG VY D +A+K L+ K + F+ EI ++++L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 450 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHR---LKLDWPTRRRICLGIARGLAYL 506
N+VKLY + L L+ EY++ SL L + L I I L YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSL-EDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 507 HGESRIKVVHRDIKATNVLLDKDLN-SKISDFGLAKLDEEENTHISTR-----VAGTIGY 560
H ++HRDIK N+LLD+D K+ DFGLAKL + + S GT GY
Sbjct: 118 H---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 561 MAPEYAM---RGHLTEKADVYSFGIVALEIVSGRS 592
MAPE + + + +D++S GI E+++G
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 78/269 (28%), Positives = 127/269 (47%), Gaps = 32/269 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQH---PNLVKLY 455
IG G +G VY+G + G +A+K ++ + + I E+ ++S L+ PN+ K Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR----GLAYLHGESR 511
G ++G +L +I EY E S+ R L + P + I R L Y+H +
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSV-RTLMKAG-----PIAEKYISVIIREVLVALKYIH---K 119
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 571
+ V+HRDIKA N+L+ N K+ DFG+A L + ++ ST V GT +MAPE G
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 572 TE-KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630
+ KAD++S GI E+ +G + D F + L+ K + + + + K
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM--LIPKSKPPRL------EDNGYSKL 230
Query: 631 QVMVMINVALLCANASPTIRPSMSSVLRM 659
+ C + P R S +L+
Sbjct: 231 ----LREFVAACLDEEPKERLSAEELLKS 255
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 63/194 (32%), Positives = 96/194 (49%), Gaps = 16/194 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IG G +G VYK +A G +A+K + + EI M+ +HPN+V +G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
++L ++ EY SL R L +C +GLAYLH +HRDI
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDI 127
Query: 520 KATNVLLDKDLNSKISDFGL-AKLDE---EENTHISTRVAGTIGYMAPEYA---MRGHLT 572
K N+LL +D + K++DFG+ A+L + + I GT +MAPE A +G
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAAVERKGGYD 182
Query: 573 EKADVYSFGIVALE 586
K D+++ GI A+E
Sbjct: 183 GKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 7e-27
Identities = 71/215 (33%), Positives = 104/215 (48%), Gaps = 32/215 (14%)
Query: 401 IGEGGFGPVYKGLL------ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVK 453
+GEG FG VYKG L T++A+K L + +EF E ++S LQHPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEH---------------RLKLDWPTRRRICLG 498
L G C + +++EYL + L L + + LD I +
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT- 557
IA G+ YL S VHRD+ A N L+ + L KISDFGL++ + + RV
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYYRVQSKS 186
Query: 558 ---IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
+ +M PE + G T ++D++SFG+V EI S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 66/203 (32%), Positives = 110/203 (54%), Gaps = 17/203 (8%)
Query: 394 NFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFI-NEIGMISALQH 448
IGEG G V +A G +AVK++ + KQ RE + NE+ ++ QH
Sbjct: 20 YLDNFVKIGEGSTGIV---CIATDKSTGRQVAVKKMDLR-KQQRRELLFNEVVIMRDYQH 75
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 508
PN+V++Y + G++L ++ E+LE +L + R ++ +CL + + L++LH
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLAVLKALSFLHA 133
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAM 567
+ V+HRDIK+ ++LL D K+SDFG A++ +E S + GT +MAPE
Sbjct: 134 Q---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPEVIS 188
Query: 568 RGHLTEKADVYSFGIVALEIVSG 590
R + D++S GI+ +E+V G
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 9e-27
Identities = 74/249 (29%), Positives = 113/249 (45%), Gaps = 31/249 (12%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
L L G +P +L ++ L+ I L N L G IP + +++L +L + YN +G +P
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPS 254
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 143
LG+L NL+ L L N +G +P + L + +SDN +G+IP + LE L
Sbjct: 255 SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILH 314
Query: 144 IQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRY 203
+ + G IP + SL L L+ L + +GE+P+
Sbjct: 315 LFSNNFTGKIPVALTSLPRLQVLQ-----------------------LWSNKFSGEIPKN 351
Query: 204 LGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-----LERGDK 258
LGK L VLDLS N L G+IP ++ + N L G IP + L R
Sbjct: 352 LGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRR--- 408
Query: 259 IDLSYNNFT 267
+ L N+F+
Sbjct: 409 VRLQDNSFS 417
|
Length = 968 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 72/196 (36%), Positives = 104/196 (53%), Gaps = 13/196 (6%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLYGC 457
+G G FG V+ G T +A+K L KQG+ F+ E ++ LQHP LV+LY
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL----KQGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 458 CIEGNQLLLIYEYLENNSLARAL-FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+ + +I EY+EN SL L +KL + IA G+A++ R +H
Sbjct: 70 -VTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIH 125
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
RD++A N+L+ + L KI+DFGLA+L E+ I + APE G T K+D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 577 VYSFGIVALEIVS-GR 591
V+SFGI+ EIV+ GR
Sbjct: 186 VWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 65/196 (33%), Positives = 108/196 (55%), Gaps = 10/196 (5%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLY 455
IG G FG V++G+L A+A+K L + R +F++E ++ H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G + ++I EY+EN +L + L +H + + GIA G+ YL S + V
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMNYV 129
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
HRD+ A N+L++ +L K+SDFGL+++ D+ E T+ ++ I + APE T
Sbjct: 130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTS 189
Query: 574 KADVYSFGIVALEIVS 589
+DV+SFGIV E++S
Sbjct: 190 ASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 67/195 (34%), Positives = 102/195 (52%), Gaps = 11/195 (5%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLYGCCI 459
IG+G FG VYKG+L T +AVK S + F+ E ++ HPN+VKL G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
+ + ++ E + SL L + + +L ++ L A G+ YL ES+ +HRD+
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIHRDL 119
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT----IGYMAPEYAMRGHLTEKA 575
A N L+ ++ KISDFG+++ EE I T G I + APE G T ++
Sbjct: 120 AARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 576 DVYSFGIVALEIVSG 590
DV+S+GI+ E S
Sbjct: 177 DVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 68/260 (26%), Positives = 120/260 (46%), Gaps = 26/260 (10%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVK--QLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
+G G G V K L G +AVK +L ++ + E+ ++ P +V YG
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAI-QKQILRELDILHKCNSPYIVGFYGA 67
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 517
+ + EY++ SL + L E + ++ +I + + +GL YLH + K++HR
Sbjct: 68 FYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH--EKHKIIHR 125
Query: 518 DIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 577
D+K +N+L++ K+ DFG++ + N+ ++ GT YMAPE + K+D+
Sbjct: 126 DVKPSNILVNSRGQIKLCDFGVSG--QLVNS-LAKTFVGTSSYMAPERIQGNDYSVKSDI 182
Query: 578 YSFGIVALEIVSGR-----SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632
+S G+ +E+ +GR N + +F LL +V + +L P F +
Sbjct: 183 WSLGLSLIELATGRFPYPPENDPPDGIFELLQ-YIVNEPPPRL-------PSGKFSPD-- 232
Query: 633 MVMINVALLCANASPTIRPS 652
+ LC P RPS
Sbjct: 233 --FQDFVNLCLIKDPRERPS 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREF----INEIGMISALQHPNLVKLY 455
IGEG +G VYK G +A+K++ + + F I EI ++ L+HPN+V+L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 456 GCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
+ +++EY++++ L L +K + + GL YLH
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHD-LTGLLDSPEVKFTESQIKCYMKQLLEGLQYLH---SNG 120
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST-RVAGTIGYMAPE-------Y 565
++HRDIK +N+L++ D K++DFGLA+ + N+ T RV T+ Y PE Y
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLLGATRY 179
Query: 566 AMRGHLTEKADVYSFGIVALEIVSGR 591
+ D++S G + E+ G+
Sbjct: 180 ------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 61/207 (29%), Positives = 103/207 (49%), Gaps = 34/207 (16%)
Query: 401 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 458
+G+G G VYK G A+K++ + R+ + E+ + + + P +VK YG
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR----GLAYLHGESRIKV 514
+ ++ ++ EY++ SLA L + P + IAR GL YLH + I
Sbjct: 69 YKEGEISIVLEYMDGGSLADLLKKVGK---IP--EPVLAYIARQILKGLDYLHTKRHI-- 121
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKL----DEEENTHISTRVAGTIGYMAPE------ 564
+HRDIK +N+L++ KI+DFG++K+ ++ NT + GT+ YM+PE
Sbjct: 122 IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-----GTVTYMSPERIQGES 176
Query: 565 YAMRGHLTEKADVYSFGIVALEIVSGR 591
Y+ AD++S G+ LE G+
Sbjct: 177 YSY------AADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-26
Identities = 76/252 (30%), Positives = 124/252 (49%), Gaps = 14/252 (5%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
L + +L+G +P + +L L+ + L +N G IP L ++ L L + N+FSGE+P+
Sbjct: 291 LSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPK 350
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 143
LG NL L LS+NN TGE+P+ N+ + N G+IP + L ++
Sbjct: 351 NLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVR 410
Query: 144 IQPSGLAGPIPSGIFSLENLTDLRISD------LNGPEATFPQLGNMKMTKLILRNCNIT 197
+Q + +G +PS L + L IS+ +N + P L +M L RN
Sbjct: 411 LQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSL---QMLSLA-RN-KFF 465
Query: 198 GELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LER 255
G LP G +L+ LDLS N+ G +P L ++ + + N L+G IP + ++
Sbjct: 466 GGLPDSFGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524
Query: 256 GDKIDLSYNNFT 267
+DLS+N +
Sbjct: 525 LVSLDLSHNQLS 536
|
Length = 968 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 61/205 (29%), Positives = 103/205 (50%), Gaps = 18/205 (8%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQL------SSKSKQGNREFI----NEIGMISALQHP 449
IG+G +G VY L G +AVKQ+ + + ++ + +EI + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 450 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
N+V+ G L + EY+ S+ L + + + R + GLAYLH +
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS-TRVAGTIGYMAPE--YA 566
++HRD+KA N+L+D D KISDFG++K ++ + + G++ +MAPE ++
Sbjct: 128 G---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHS 184
Query: 567 MRGHLTEKADVYSFGIVALEIVSGR 591
+ K D++S G V LE+ +GR
Sbjct: 185 YSQGYSAKVDIWSLGCVVLEMFAGR 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 66/204 (32%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 399 NNIGEGGFGPVYKG--LLADGT--AIAVKQLS-SKSKQGNREFINEIGMISALQHPNLVK 453
+G G FG V KG L+ G +AVK L G +EF+ E +++ L HP +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHR------LKLDWPTRRRICLGIARGLAYLH 507
L G C +G L+L+ E L + L + R LK + +A G+AYL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE-LAHQ------VAMGMAYLE 112
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEY 565
+ VHRD+ A NVLL +KISDFG+++ + + AG + + APE
Sbjct: 113 SK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169
Query: 566 AMRGHLTEKADVYSFGIVALEIVS 589
G + K+DV+S+G+ E S
Sbjct: 170 INYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 24/210 (11%)
Query: 401 IGEGGFGPVY----KGLL--ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL 454
+GEG FG V+ LL D +AVK L S+ ++F E +++ LQH ++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRL--------------KLDWPTRRRICLGIA 500
YG C EG LL+++EY+ + L R L H +L I IA
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 501 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIG 559
G+ YL + VHRD+ N L+ + L KI DFG+++ + + + R I
Sbjct: 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
+M PE + T ++D++SFG+V EI +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 77/290 (26%), Positives = 131/290 (45%), Gaps = 49/290 (16%)
Query: 401 IGEGGFGPVYKGLLAD------GTAIAVKQL-SSKSKQGNREFINEIGMISAL-QHPNLV 452
+GEG FG V K + +AVK L +++ + ++E+ M+ + +H N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHR-------LKLDWPTRRRI--------CL 497
L G C + L ++ EY + +L L R P +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 498 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG- 556
+ARG+ +L S+ K +HRD+ A NVL+ +D KI+DFGLA+ D + G
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR-DIHHIDYYRKTTNGR 195
Query: 557 -TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKE 611
+ +MAPE T ++DV+SFG++ EI + G S + E++F LL +
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-------K 248
Query: 612 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+G ME N +E +M + C + P+ RP+ ++ L+
Sbjct: 249 EGYRME-----KPQNCTQELYHLMRD----CWHEVPSQRPTFKQLVEDLD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 71/194 (36%), Positives = 99/194 (51%), Gaps = 16/194 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYG 456
IG G FG VY + +A+K++S KQ N ++ I E+ + L+HPN ++ G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
C + + L+ EY S + L H+ L IC G +GLAYLH RI H
Sbjct: 83 CYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI---H 138
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE--YAM-RGHLTE 573
RDIKA N+LL + K++DFG A L N+ + GT +MAPE AM G
Sbjct: 139 RDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDG 193
Query: 574 KADVYSFGIVALEI 587
K DV+S GI +E+
Sbjct: 194 KVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 74/222 (33%), Positives = 99/222 (44%), Gaps = 33/222 (14%)
Query: 391 ATNNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISAL-QH 448
T F IGEG +G VYK G +A+K + + E E ++ H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDE-EEEIKEEYNILRKYSNH 62
Query: 449 PNLVKLYGC------CIEGNQLLLIYEYLENNS---LARALFEH--RLKLDWPTRRRICL 497
PN+ YG +QL L+ E S L + L + RLK +W I
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY--ILR 120
Query: 498 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL-AKLDEEE---NTHISTR 553
RGLAYLH KV+HRDIK N+LL K+ K+ DFG+ A+LD NT I
Sbjct: 121 ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI--- 174
Query: 554 VAGTIGYMAPE-----YAMRGHLTEKADVYSFGIVALEIVSG 590
GT +MAPE ++DV+S GI A+E+ G
Sbjct: 175 --GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 63/197 (31%), Positives = 102/197 (51%), Gaps = 12/197 (6%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLYGC 457
IGEG G V+K G +A+K+++ + +G + + EI + A QHP +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 517
G+ +L+ EY+ + L+ L + L + + +G+AY+H ++HR
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHR 123
Query: 518 DIKATNVLLDKDLNSKISDFGLAKL-DEEENTHISTRVAGTIGYMAPE--YAMRGHLTEK 574
D+K N+L+ D KI+DFGLA+L EEE S +VA T Y APE Y R
Sbjct: 124 DLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGAR-KYDPG 181
Query: 575 ADVYSFGIVALEIVSGR 591
D+++ G + E+++G
Sbjct: 182 VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 60/191 (31%), Positives = 100/191 (52%), Gaps = 8/191 (4%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
+G G FG V G +A+K + S + EFI E ++ L H LV+LYG C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 461 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 520
+ ++ EY+ N L L EH + +C + G+AYL ES+ + +HRD+
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL--ESK-QFIHRDLA 127
Query: 521 ATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
A N L+D K+SDFGL++ LD+E + + ++ + + PE + + K+DV+
Sbjct: 128 ARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VRWSPPEVLLYSKFSSKSDVW 185
Query: 579 SFGIVALEIVS 589
+FG++ E+ S
Sbjct: 186 AFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 66/191 (34%), Positives = 103/191 (53%), Gaps = 7/191 (3%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IG+G G VY + +A G +A+KQ++ + + INEI ++ +HPN+V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
G++L ++ EYL SL + E +D +C + L +LH +V+HRDI
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDI 141
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 579
K+ N+LL D + K++DFG E + ST V GT +MAPE R K D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 580 FGIVALEIVSG 590
GI+A+E+V G
Sbjct: 201 LGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 58/199 (29%), Positives = 101/199 (50%), Gaps = 15/199 (7%)
Query: 400 NIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREF----INEIGMISALQHPNLVKL 454
+GEG +G VYK G +A+K++ + + EI ++ L+HPN+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
+L L++EY + + L + L + L + I + RGLAY H ++
Sbjct: 64 LDVIHTERKLYLVFEYCDMD-LKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH---SHRI 119
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE--YAMRGHLT 572
+HRD+K N+L+++D K++DFGLA+ + V T+ Y APE + + T
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYST 178
Query: 573 EKADVYSFGIVALEIVSGR 591
D++S G + E+++G+
Sbjct: 179 A-VDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-25
Identities = 77/251 (30%), Positives = 128/251 (50%), Gaps = 14/251 (5%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
L +G +P L + L + L N L G IP+ L + L L + N GE+P+
Sbjct: 339 LWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPK 398
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 143
LG+ +L ++ L N+F+GELP F KL + IS+N G+I S + L+ L
Sbjct: 399 SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLS 458
Query: 144 IQPSGLAGPIP--SGIFSLENLTDLRISDLNG--PEA--TFPQLGNMKMTKLILRNCNIT 197
+ + G +P G LENL DL + +G P + +L +K+++ ++
Sbjct: 459 LARNKFFGGLPDSFGSKRLENL-DLSRNQFSGAVPRKLGSLSELMQLKLSE-----NKLS 512
Query: 198 GELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LER 255
GE+P L KL LDLS N+L GQIP++F ++ + + + N L+G IP + +E
Sbjct: 513 GEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVES 572
Query: 256 GDKIDLSYNNF 266
++++S+N+
Sbjct: 573 LVQVNISHNHL 583
|
Length = 968 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 83/286 (29%), Positives = 130/286 (45%), Gaps = 41/286 (14%)
Query: 401 IGEGGFGPVYK---GLLADGTA--IAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLY 455
+G+G FG V L D T +AVK+L + + R+F EI ++ +LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 456 GCCIEG--NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
G C L L+ EYL SL L +HR +LD I +G+ YL + +
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---R 128
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHL 571
VHRD+ N+L++ + KI DFGL K+ ++ + R G I + APE
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188
Query: 572 TEKADVYSFGIVALEIVS----------------GRSNVTKEDMFYLLDWALVLKEQGKL 615
+ +DV+SFG+V E+ + G + +++L++ +LK G+L
Sbjct: 189 SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE---LLKNNGRL 245
Query: 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
PG + +M C N P+ RPS S + +E
Sbjct: 246 ----PAPPGCPAEIYAIM------KECWNNDPSQRPSFSELALQVE 281
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-24
Identities = 70/229 (30%), Positives = 117/229 (51%), Gaps = 4/229 (1%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
L NLTG +P L L + L +N L+G IPK L +L + +Q N FSGELP
Sbjct: 363 LSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPS 422
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 143
E L + L +S+NN G + + +++ ++ N+F G +P + +LE L
Sbjct: 423 EFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS-KRLENLD 481
Query: 144 IQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFP-QLGNMK-MTKLILRNCNITGELP 201
+ + +G +P + SL L L++S+ N P +L + K + L L + ++G++P
Sbjct: 482 LSRNQFSGAVPRKLGSLSELMQLKLSE-NKLSGEIPDELSSCKKLVSLDLSHNQLSGQIP 540
Query: 202 RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP 250
+M L LDLS N+L G+IP N ++ + + + N L G++P
Sbjct: 541 ASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 28/223 (12%)
Query: 393 NNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSK--SKQGNREFIN-EIGMISAL-Q 447
++F IGEG F V A+K L + K+ +++ E +++ L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 507
HP ++KLY + L + EY N L + + LD R I L YLH
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYI-RKYGSLDEKCTRFYAAEILLALEYLH 119
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA------------ 555
++HRD+K N+LLDKD++ KI+DFG AK+ + ++ S +
Sbjct: 120 S---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNR 176
Query: 556 -------GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 591
GT Y++PE + +D+++ G + ++++G+
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 69/201 (34%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
+G G FG V+ G + T +AVK L + + F+ E ++ LQH LV+LY +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 461 GNQLLLIYEYLENNSLARAL-FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
+ +I EY+ SL L + K+ P IA G+AY+ R +HRD+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDL 129
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 579
+A NVL+ + L KI+DFGLA++ E+ I + APE G T K+DV+S
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 189
Query: 580 FGIVALEIVS-------GRSN 593
FGI+ EIV+ G SN
Sbjct: 190 FGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 25/210 (11%)
Query: 401 IGEGGFGPVYKG----LLADGTA---IAVKQLSSKSK-QGNREFINEIGMISALQHPNLV 452
+G G FG VY+G +L G+ +AVK L + Q +EF+ E ++S HPN+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK------LDWPTRRRICLGIARGLAYL 506
KL G C+ +I E +E L L + R++ L ICL +A+G YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 507 HGESRIKVVHRDIKATNVLL-----DKDLNSKISDFGLAKLDEEENTHISTRVAGTIG-- 559
++ +HRD+ A N L+ D D KI DFGLA+ D ++ + G +
Sbjct: 123 E---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKSDYYRKEGEGLLPVR 178
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
+MAPE + G T ++DV+SFG++ EI++
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 82/285 (28%), Positives = 129/285 (45%), Gaps = 46/285 (16%)
Query: 401 IGEGGFGPVYKGLLA--DGTA----IAVKQL-SSKSKQGNREFINEIGMISALQHPNLVK 453
+G G FG VY+GL DG A +AVK L S S+Q +F+ E ++S H N+V+
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR------ICLGIARGLAYLH 507
L G E ++ E + L L E+R + + P+ +A+G YL
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 508 GESRIKVVHRDIKATNVLLD---KDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAP 563
E+ +HRDI A N LL +KI+DFG+A+ + R I +M P
Sbjct: 134 -ENHF--IHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLKEQGKLM 616
E + G T K DV+SFG++ EI S GR+N +E M ++ G +
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--QEVMEFVT--------GGGRL 240
Query: 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ PG + ++M C +P RP+ +++L ++
Sbjct: 241 DPPKGCPGPVY---RIMTD------CWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 64/196 (32%), Positives = 105/196 (53%), Gaps = 10/196 (5%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLY 455
IG G FG V G L +A+K L + +++ R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G + ++++ EY+EN SL L +H + + GIA G+ YL S + V
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMGYV 128
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG--YMAPEYAMRGHLTE 573
HRD+ A N+L++ +L K+SDFGL+++ E++ T G I + APE T
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS 188
Query: 574 KADVYSFGIVALEIVS 589
+DV+S+GIV E++S
Sbjct: 189 ASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 17/206 (8%)
Query: 399 NNIGEGGFGPVYKGL-LADGTAIAVKQLS-----SKSKQGNREFINEIGMISALQHPNLV 452
IG+G FG V K +DG + K++ K KQ + ++E+ ++ L+HPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQ---QLVSEVNILRELKHPNIV 62
Query: 453 KLYGCCI-EGNQLLLIY-EYLENNSLARAL---FEHRLKLDWPTRRRICLGIARGLAYLH 507
+ Y I NQ L I EY E LA+ + + R ++ RI + L H
Sbjct: 63 RYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH 122
Query: 508 --GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 565
+ V+HRD+K N+ LD + N K+ DFGLAK+ +++ T V GT YM+PE
Sbjct: 123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQ 181
Query: 566 AMRGHLTEKADVYSFGIVALEIVSGR 591
EK+D++S G + E+ +
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 92/282 (32%), Positives = 132/282 (46%), Gaps = 35/282 (12%)
Query: 401 IGEGGFGPV--YKGLLA-DGTA--IAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKL 454
+GEG FG V Y A DGT +AVK L + Q N + EI ++ L H N+VK
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 455 YGCCIEGNQ--LLLIYEYLENNSLARALFEHRLKLDWPT--RRRICLGIARGLAYLHGES 510
GCC E L LI EY+ SL L +H+L L ++IC G+AYLH +
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQIC----EGMAYLHSQH 127
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMR 568
I HRD+ A NVLLD D KI DFGLAK E + + R G + + A E
Sbjct: 128 YI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184
Query: 569 GHLTEKADVYSFGIVALEIV----SGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN-- 622
+ +DV+SFG+ E++ S +S K ++ +L+EL++
Sbjct: 185 NKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLIELLERGMR 242
Query: 623 ---PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
P N +E ++M N C RP+ S++ +L+
Sbjct: 243 LPCP-KNCPQEVYILMKN----CWETEAKFRPTFRSLIPILK 279
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 62/194 (31%), Positives = 96/194 (49%), Gaps = 9/194 (4%)
Query: 401 IGEGGFGPVYKG----LLADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLY 455
IGEG FG VY+G + A+AVK + + RE F+ E ++ HP++VKL
Sbjct: 14 IGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLI 73
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G E N + ++ E L L ++ LD + ++ LAYL + V
Sbjct: 74 GVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRFV 129
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 575
HRDI A NVL+ K+ DFGL++ E+E+ + +++ I +MAPE T +
Sbjct: 130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSAS 189
Query: 576 DVYSFGIVALEIVS 589
DV+ FG+ EI+
Sbjct: 190 DVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 28/206 (13%)
Query: 401 IGEGGFGPVYK------GLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL 454
+G+G FG VYK GL A A K + +S++ +F+ EI ++S +HPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFA-----AAKIIQIESEEELEDFMVEIDILSECKHPNIVGL 67
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
Y N+L ++ E+ + +L + E L P R +C + L +LH KV
Sbjct: 68 YEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KV 124
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE- 573
+HRD+KA N+LL D + K++DFG++ ++ T + GT +MAPE E
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVA----CET 179
Query: 574 --------KADVYSFGIVALEIVSGR 591
KAD++S GI +E+
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 6e-24
Identities = 66/199 (33%), Positives = 105/199 (52%), Gaps = 7/199 (3%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IG+G G VY + +A G +A+KQ++ + + INEI ++ ++PN+V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
G++L ++ EYL SL + E +D +C + L +LH +V+HRDI
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDI 141
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 579
K+ N+LL D + K++DFG E + ST V GT +MAPE R K D++S
Sbjct: 142 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 580 FGIVALEIVSGRSNVTKED 598
GI+A+E+V G E+
Sbjct: 201 LGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 80/265 (30%), Positives = 128/265 (48%), Gaps = 30/265 (11%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
IGEG FG V +G G +AVK + K + F+ E +++ L H NLV+L G I
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNI--KCDVTAQAFLEETAVMTKLHHKNLVRLLGV-IL 69
Query: 461 GNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
N L ++ E + +L L R + + L +A G+ YL ES+ K+VHRD+
Sbjct: 70 HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL--ESK-KLVHRDL 126
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEE--ENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 577
A N+L+ +D +K+SDFGLA++ +N+ + + + APE + K+DV
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSKSDV 180
Query: 578 YSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMI 636
+S+G++ E+ S GR+ K + + + E+G ME + P V V++
Sbjct: 181 WSYGVLLWEVFSYGRAPYPKMSLKEVKECV----EKGYRMEPPEGCPAD------VYVLM 230
Query: 637 NVALLCANASPTIRPSMSSVLRMLE 661
C P RPS + LE
Sbjct: 231 TS---CWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 7e-24
Identities = 66/193 (34%), Positives = 102/193 (52%), Gaps = 7/193 (3%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
+G+G FG V+ G T +A+K L + F+ E ++ L+H LV+LY E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 461 GNQLLLIYEYLENNSLARALF-EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
+ ++ EY+ SL L E L P + IA G+AY+ R+ VHRD+
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDL 128
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 579
+A N+L+ ++L K++DFGLA+L E+ I + APE A+ G T K+DV+S
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188
Query: 580 FGIVALEIVS-GR 591
FGI+ E+ + GR
Sbjct: 189 FGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-24
Identities = 75/269 (27%), Positives = 122/269 (45%), Gaps = 26/269 (9%)
Query: 398 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
+ +G G FG V+ T +AVK + S F+ E ++ LQH LVKL+
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAV 69
Query: 458 CIEGNQLLLIYEYLENNSLARAL-FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+ + +I E++ SL L + K P IA G+A++ E R +H
Sbjct: 70 -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQR-NYIH 125
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
RD++A N+L+ L KI+DFGLA++ E+ I + APE G T K+D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185
Query: 577 VYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632
V+SFGI+ +EIV+ GR ++ ++ L E+G M + P ++
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-------ERGYRMPRPENCPEELYN---- 234
Query: 633 MVMINVALLCANASPTIRPSMSSVLRMLE 661
+ + C P RP+ + +L+
Sbjct: 235 -----IMMRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 16/199 (8%)
Query: 401 IGEGGFGPVYKG--LLADGTAI--AVKQLSSKSKQGN-REFINEIGMISALQHPNLVKLY 455
+G+G FG V +G + G I AVK L S +F+ E ++ +L H NL++LY
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKV 514
G + + L+++ E SL L + L T + IA G+ YL ES+ +
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYL--ESK-RF 118
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHIST---RVAGTIGYMAPEYAMRGH 570
+HRD+ A N+LL D KI DFGL + L + E+ ++ +V + APE
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPESLRTRT 176
Query: 571 LTEKADVYSFGIVALEIVS 589
+ +DV+ FG+ E+ +
Sbjct: 177 FSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 67/199 (33%), Positives = 106/199 (53%), Gaps = 7/199 (3%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IG+G G V+ + +A G +A+KQ++ + + INEI ++ L++PN+V +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
G++L ++ EYL SL + E +D +C + L +LH +V+HRDI
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDI 141
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 579
K+ NVLL D + K++DFG E + ST V GT +MAPE R K D++S
Sbjct: 142 KSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 580 FGIVALEIVSGRSNVTKED 598
GI+A+E+V G E+
Sbjct: 201 LGIMAIEMVEGEPPYLNEN 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 76/278 (27%), Positives = 134/278 (48%), Gaps = 31/278 (11%)
Query: 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQ------LSSKSKQGNREFINEIGMIS 444
NF + IG+G F VYK + L DG +A+K+ + +K++Q + + EI ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57
Query: 445 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK----LDWPTRRRICLGIA 500
L HPN++K IE N+L ++ E + L+R + +H K + T + + +
Sbjct: 58 QLDHPNVIKYLASFIENNELNIVLELADAGDLSR-MIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 501 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 560
L ++H S+ +++HRDIK NV + K+ D GL + + T + V GT Y
Sbjct: 117 SALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172
Query: 561 MAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMELV 619
M+PE K+D++S G + E+ + +S + M ++L K E+ L
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL---YSLCKKIEKCDYPPL- 228
Query: 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 657
P ++ E++ +++ C N P RP +S VL
Sbjct: 229 ---PADHY-SEELRDLVSR---CINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 67/195 (34%), Positives = 102/195 (52%), Gaps = 11/195 (5%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
+G G FG V+ G T +AVK L + F+ E ++ L+H LV+LY E
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVSE 72
Query: 461 GNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 517
+ ++ EY+ SL L + LKL P + +A G+AY+ R+ +HR
Sbjct: 73 -EPIYIVTEYMSKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 518 DIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 577
D+++ N+L+ L KI+DFGLA+L E+ I + APE A+ G T K+DV
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 578 YSFGIVALEIVS-GR 591
+SFGI+ E+V+ GR
Sbjct: 187 WSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 68/196 (34%), Positives = 103/196 (52%), Gaps = 7/196 (3%)
Query: 398 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
D +G+G FG V+ G T +A+K L + F+ E ++ L+H LV LY
Sbjct: 11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAV 69
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKVVH 516
E + ++ E++ SL L E K L P + IA G+AY+ R+ +H
Sbjct: 70 VSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
RD++A N+L+ +L KI+DFGLA+L E+ I + APE A+ G T K+D
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185
Query: 577 VYSFGIVALEIVS-GR 591
V+SFGI+ E+V+ GR
Sbjct: 186 VWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 3e-23
Identities = 63/198 (31%), Positives = 107/198 (54%), Gaps = 12/198 (6%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLY 455
IG G FG V +G L +A+K L S +++ R+F++E ++ HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G + +++I E++EN +L L ++ + + GIA G+ YL S + V
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMNYV 128
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAG---TIGYMAPEYAMRGHL 571
HRD+ A N+L++ +L K+SDFGL++ L+++ + T G I + APE
Sbjct: 129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF 188
Query: 572 TEKADVYSFGIVALEIVS 589
T +DV+S+GIV E++S
Sbjct: 189 TSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 5e-23
Identities = 65/199 (32%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G+G +G VY L+ IA+K++ + + + EI + S L+H N+V+ G
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 460 EGNQLLLIYEYLENNSLARALFEHR---LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
E + E + SL+ AL + LK + T I GL YLH ++VH
Sbjct: 76 ENGFFKIFMEQVPGGSLS-ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVH 131
Query: 517 RDIKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPE---YAMRGHLT 572
RDIK NVL++ KISDFG +K N T GT+ YMAPE RG+
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQYMAPEVIDKGPRGY-G 189
Query: 573 EKADVYSFGIVALEIVSGR 591
AD++S G +E+ +G+
Sbjct: 190 APADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 5e-23
Identities = 67/220 (30%), Positives = 107/220 (48%), Gaps = 21/220 (9%)
Query: 399 NNIGEGGFGPVYKGLLADGTAIAVKQL---SSKSKQGNREFIN---EIGMISALQHPNLV 452
+G+G +G VY GL G IAVKQ+ +S +E+ E+ ++ +L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRL-KLDWPTRRRICLGIARGLAYLHGESR 511
+ G C++ N + + E++ S++ L +R L P + I G+AYLH
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL--NRFGPLPEPVFCKYTKQILDGVAYLHNNC- 122
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS-----TRVAGTIGYMAPEYA 566
VVHRDIK NV+L + K+ DFG A+ H + + GT +MAPE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 567 MRGHLTEKADVYSFGIVALEIVSGRSNVTKED----MFYL 602
K+D++S G E+ +G+ + D MFY+
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI 220
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 5e-23
Identities = 79/293 (26%), Positives = 134/293 (45%), Gaps = 44/293 (15%)
Query: 393 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
+N +GEG FG V+ D +AVK L S ++F E +++ L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEH------------RLKLDWPTRRR 494
QH ++VK YG C+EG+ L++++EY+++ L + L H +L
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 495 ICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV 554
I IA G+ YL + VHRD+ N L+ ++L KI DFG+++ + + RV
Sbjct: 125 IAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY---RV 178
Query: 555 AG----TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK 610
G I +M PE M T ++DV+S G+V EI + + +Y L V++
Sbjct: 179 GGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFT-----YGKQPWYQLSNNEVIE 233
Query: 611 --EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
QG++++ T P +D + L C P +R ++ + +L+
Sbjct: 234 CITQGRVLQRPRTCPKEVYD---------LMLGCWQREPHMRLNIKEIHSLLQ 277
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 71/276 (25%), Positives = 129/276 (46%), Gaps = 37/276 (13%)
Query: 394 NFATDNNIGEGGFGPVYK-GLLADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPN 450
+F +G+G +G VYK L+D A+K+ L S S++ + +NEI +++++ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-------LDWPTRRRICLGIARGL 503
++ ++GN+L ++ EY L++A+ + + K W RI + + RGL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIFIQLLRGL 116
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE--NTHISTRVAGTIGYM 561
LH + K++HRD+K+ N+LL + KI D G++K+ ++ T I GT YM
Sbjct: 117 QALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-----GTPHYM 168
Query: 562 APEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621
APE + K+D++S G + E+ + M L + K+
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---------RYKVQRGKYP 219
Query: 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 657
+ ++ + N P +RP+ +L
Sbjct: 220 PIPPIYSQD----LQNFIRSMLQVKPKLRPNCDKIL 251
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 61/192 (31%), Positives = 105/192 (54%), Gaps = 9/192 (4%)
Query: 401 IGEGGFGPV-YKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IGEG G V + + G +AVK++ + +Q NE+ ++ QH N+V++Y +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
G++L ++ E+LE +L + R+ + +CL + + L+ LH + V+HRDI
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--AVCLAVLKALSVLHAQG---VIHRDI 142
Query: 520 KATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
K+ ++LL D K+SDFG A++ +E S + GT +MAPE R + D++
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYGPEVDIW 200
Query: 579 SFGIVALEIVSG 590
S GI+ +E+V G
Sbjct: 201 SLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 1e-22
Identities = 55/200 (27%), Positives = 101/200 (50%), Gaps = 19/200 (9%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQG--NREFINEIGMISALQHPNLVKLYGC 457
IGEG +G VYK G +A+K++ + + + + EI ++ L HPN++KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 517
L L++E+++ + L + + + + L + + +GLA+ H ++HR
Sbjct: 67 FRHKGDLYLVFEFMDTD-LYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122
Query: 518 DIKATNVLLDKDLNSKISDFGLAKL---DEEENTH-ISTRVAGTIGYMAPE--YAMRGHL 571
D+K N+L++ + K++DFGLA+ TH + TR Y APE +G+
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGDKGY- 176
Query: 572 TEKADVYSFGIVALEIVSGR 591
+ D++S G + E++S R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 98.3 bits (244), Expect = 2e-22
Identities = 62/200 (31%), Positives = 108/200 (54%), Gaps = 9/200 (4%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IG+G G VY + +A G +A++Q++ + + INEI ++ ++PN+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
G++L ++ EYL SL + E +D +C + L +LH +V+HRDI
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDI 142
Query: 520 KATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
K+ N+LL D + K++DFG A++ E++ + + GT +MAPE R K D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 579 SFGIVALEIVSGRSNVTKED 598
S GI+A+E++ G E+
Sbjct: 201 SLGIMAIEMIEGEPPYLNEN 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 81/269 (30%), Positives = 123/269 (45%), Gaps = 27/269 (10%)
Query: 395 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-EIGMISALQHPNLV 452
F IG+G FG V+KG+ +A+K + + + E I EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 453 KLYGCCIEGNQLLLIYEYLENNS---LARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
K YG ++G +L +I EYL S L RA ++ + I +GL YLH E
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKE-----ILKGLDYLHSE 120
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 569
+I HRDIKA NVLL + + K++DFG+A + +T V GT +MAPE +
Sbjct: 121 KKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 176
Query: 570 HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629
KAD++S GI A+E+ G DM + +++ L+ N
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP--PNSDMHPM-----------RVLFLIPKNNPPTLTG 223
Query: 630 EQVMVMINVALLCANASPTIRPSMSSVLR 658
E C N P+ RP+ +L+
Sbjct: 224 EFSKPFKEFIDACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 76/272 (27%), Positives = 130/272 (47%), Gaps = 31/272 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAI----AVKQLSSKS-KQGNREFINEIGMISALQHPNLVKL 454
+G G FG V+KG+ + +G +I A+K + +S +Q +E + + + +L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G C G L L+ + SL + +HR LD C+ IA+G+ YL E R+
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE-EHRM-- 130
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
VHR++ A N+LL D +I+DFG+A L ++ + + I +MA E + G T
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTH 190
Query: 574 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV- 632
++DV+S+G+ E++S + + E L+E G + Q+
Sbjct: 191 QSDVWSYGVTVWEMMSYGAEPYA---------GMRPHEVPDLLE-----KGERLAQPQIC 236
Query: 633 -----MVMINVALLCANASPTIRPSMSSVLRM 659
MVM+ ++ N PT + + RM
Sbjct: 237 TIDVYMVMVKCWMIDENVRPTFKELANEFTRM 268
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 20/212 (9%)
Query: 394 NFATDNNIGEGGFGPVYKGLLADGTA--IAVKQLS---------SKSKQGN-REFINEIG 441
+A ++G G FG VYK + +A+K+++ + + + + ++E+
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 442 MI-SALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR---ICL 497
+I L+HPN+V+ Y +E ++L ++ + +E L + K T R I +
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 498 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT 557
+ L YLH E RI VHRD+ N++L +D I+DFGLAK + E+ T V GT
Sbjct: 121 QMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK--LTSVVGT 176
Query: 558 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
I Y PE EKADV++FG + ++ +
Sbjct: 177 ILYSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 82/266 (30%), Positives = 123/266 (46%), Gaps = 21/266 (7%)
Query: 395 FATDNNIGEGGFGPVYKGLLADGT-AIAVKQLSSKSKQGNREFIN-EIGMISALQHPNLV 452
F IG+G FG VYKG+ +A+K + + + E I EI ++S P +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
+ YG ++G +L +I EYL S L L+ + I I +GL YLH E +I
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT--ILREILKGLDYLHSERKI 123
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
HRDIKA NVLL + + K++DFG+A + +T V GT +MAPE +
Sbjct: 124 ---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYD 179
Query: 573 EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632
KAD++S GI A+E+ G D+ + L+ K +E + P F +
Sbjct: 180 FKADIWSLGITAIELAKGEP--PNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEA-- 235
Query: 633 MVMINVALLCANASPTIRPSMSSVLR 658
C N P RP+ +L+
Sbjct: 236 ---------CLNKDPRFRPTAKELLK 252
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 2e-22
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 12/203 (5%)
Query: 394 NFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSK---SKQGNREFINEIGMISALQHP 449
+F IG+G FG V D A+K ++ + K R +NE ++ L HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 450 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
LV L+ + + L+ + L L R ++K + I L YLH +
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFSEEQVKFWICEIVLALEYLHSK 119
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPEYAMR 568
++HRDIK N+LLD+ + I+DF +A K+ + T T +GT GYMAPE R
Sbjct: 120 ---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAPEVLCR 173
Query: 569 GHLTEKADVYSFGIVALEIVSGR 591
+ D +S G+ A E + G+
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGK 196
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 68/243 (27%), Positives = 116/243 (47%), Gaps = 35/243 (14%)
Query: 401 IGEGGFGPVY----KGLLA-----------DGTAIAVKQLSSK-SKQGNREFINEIGMIS 444
+GEG FG V+ +GL +AVK L + +K +F+ EI ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 445 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRI--------- 495
L++PN+++L G C+ + L +I EY+EN L + L + ++ + I
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 496 --CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHIST 552
+ IA G+ YL + + VHRD+ N L+ KI+DFG+++ L + I
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 612
R I +MA E + G T +DV++FG+ E+ + + KE + LL V++
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT----LCKEQPYSLLSDEQVIENT 245
Query: 613 GKL 615
G+
Sbjct: 246 GEF 248
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 4e-22
Identities = 68/210 (32%), Positives = 117/210 (55%), Gaps = 27/210 (12%)
Query: 395 FATDNNIGEGGFGPVYKGL-LADGTAI----AVKQL-SSKSKQGNREFINEIGMISALQH 448
F +G G FG VYKGL + +G + A+K+L + S + N+E ++E +++++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK------LDWPTRRRICLGIARG 502
P++ +L G C+ + + LI + + L + EH+ L+W C+ IA+G
Sbjct: 69 PHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121
Query: 503 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIG 559
+ YL E R ++VHRD+ A NVL+ + KI+DFGLAKL DE+E +V I
Sbjct: 122 MNYL--EER-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVP--IK 176
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
+MA E + T ++DV+S+G+ E+++
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-22
Identities = 70/271 (25%), Positives = 123/271 (45%), Gaps = 35/271 (12%)
Query: 401 IGEGGFGP--VYKGLLADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYG 456
+G+G FG +Y+ D + + K+ L+ S++ R+ +NEI ++S LQHPN++ Y
Sbjct: 8 LGKGAFGEATLYRRT-EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 457 CCIEGNQLLLIYEYLENNSLA-------RALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
++ N LL+ EY +L LFE + L + I ++Y+H
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWY------LFQIVSAVSYIHKA 120
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 569
++HRDIK N+ L K K+ DFG++K+ E + T V GT YM+PE
Sbjct: 121 G---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGV 176
Query: 570 HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629
K+D+++ G V E+++ + + L+ K+++ T S +
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV---------KIVQGNYTPVVSVYSS 227
Query: 630 EQVMVMINVALLCANASPTIRPSMSSVLRML 660
E + ++ + P RP+ VL
Sbjct: 228 ELISLVHS----LLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 10/192 (5%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
+G G FG V+ G +A+K ++ + +FI E ++ L HP LV+LYG C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 461 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 520
L ++ E++EN L L + + KL +C + G+ YL R +HRD+
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLA 127
Query: 521 ATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAG-TIGYMAPEYAMRGHLTEKADV 577
A N L+ K+SDFG+ + LD+E + S+ A + + PE + K+DV
Sbjct: 128 ARNCLVSSTGVVKVSDFGMTRYVLDDE---YTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184
Query: 578 YSFGIVALEIVS 589
+SFG++ E+ +
Sbjct: 185 WSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 6e-22
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 401 IGEGGFGPVY------------KGLLADGTA-----IAVKQLSSKSKQGNR-EFINEIGM 442
+GEG FG V+ K D + +AVK L + + R +F+ EI +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 443 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK----------LDWPTR 492
+S L+ PN+++L CI + L +I EY+EN L + L H + + + T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 493 RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHIS 551
+ IA G+ YL S + VHRD+ N L+ K+ KI+DFG+++ L + I
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
R I +M+ E + G T +DV++FG+ EI++
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 6e-22
Identities = 82/266 (30%), Positives = 124/266 (46%), Gaps = 30/266 (11%)
Query: 401 IGEGGFGPVYKGLLAD--GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCC 458
IG+G FG V +L D G +AVK + K+ + F+ E +++ L+H NLV+L G
Sbjct: 14 IGKGEFGDV---MLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 459 IEGN-QLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+E L ++ EY+ SL L R L + L + + YL + VH
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
RD+ A NVL+ +D +K+SDFGL K E +T + ++ + + APE + K+D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSD 181
Query: 577 VYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVM 635
V+SFGI+ EI S GR + L + E+G M+ D P +D VM
Sbjct: 182 VWSFGILLWEIYSFGRVPYPR----IPLKDVVPRVEKGYKMDAPDGCPPVVYD-----VM 232
Query: 636 INVALLCANASPTIRPSMSSVLRMLE 661
C + RPS + LE
Sbjct: 233 KQ----CWHLDAATRPSFLQLREQLE 254
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 6e-22
Identities = 67/204 (32%), Positives = 116/204 (56%), Gaps = 27/204 (13%)
Query: 401 IGEGGFGPVYKGL-LADGTAI----AVKQLSSKS-KQGNREFINEIGMISALQHPNLVKL 454
+G G FG VYKG+ + +G + A+K L+ + + N EF++E +++++ HP+LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHR------LKLDWPTRRRICLGIARGLAYLHG 508
G C+ + L+ + + + L + EH+ L L+W C+ IA+G+ YL
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYL-- 125
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIGYMAPEY 565
E R ++VHRD+ A NVL+ + KI+DFGLA+L DE+E ++ I +MA E
Sbjct: 126 EER-RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMP--IKWMALEC 182
Query: 566 AMRGHLTEKADVYSFGIVALEIVS 589
T ++DV+S+G+ E+++
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 7e-22
Identities = 80/290 (27%), Positives = 135/290 (46%), Gaps = 53/290 (18%)
Query: 401 IGEGGFGPVYKGLLA---------DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL 451
+GEG FG V+ LA D +AVK L + ++F E +++ LQH ++
Sbjct: 13 LGEGAFGKVF---LAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 452 VKLYGCCIEGNQLLLIYEYLENNSLARALFEH----RLKLDWPTRR-----------RIC 496
VK YG C +G+ L++++EY+++ L + L H + +D R+ I
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 497 LGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG 556
IA G+ YL + VHRD+ N L+ +L KI DFG+++ + + RV G
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGG 183
Query: 557 ----TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-- 610
I +M PE M T ++DV+SFG++ EI + K+ F L + V++
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT----YGKQPWFQLSN-TEVIECI 238
Query: 611 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRML 660
QG+++E P +D + L C P R ++ + ++L
Sbjct: 239 TQGRVLERPRVCPKEVYD---------IMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 8e-22
Identities = 61/191 (31%), Positives = 103/191 (53%), Gaps = 6/191 (3%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLYGCCI 459
+G+G FG V+KG L D T +AVK Q + +F++E ++ HPN+VKL G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
+ + ++ E + L + + +L + L A G+AYL ES+ +HRD+
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYL--ESK-NCIHRDL 119
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT-IGYMAPEYAMRGHLTEKADVY 578
A N L+ ++ KISDFG+++ E++ + S+ + I + APE G + ++DV+
Sbjct: 120 AARNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVW 178
Query: 579 SFGIVALEIVS 589
S+GI+ E S
Sbjct: 179 SYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 9e-22
Identities = 63/197 (31%), Positives = 95/197 (48%), Gaps = 12/197 (6%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQ-----LSSKSKQGNREFINEIGMISALQHPNLVKL 454
+G+G FG VY D G +AVKQ S ++K+ EI ++ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
YGC + L + EY+ S+ L + + TR+ I G+ YLH +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRK-YTRQILEGVEYLH---SNMI 125
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS--TRVAGTIGYMAPEYAMRGHLT 572
VHRDIK N+L D N K+ DFG +K + + + V GT +M+PE
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 573 EKADVYSFGIVALEIVS 589
KADV+S G +E+++
Sbjct: 186 RKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 72/272 (26%), Positives = 129/272 (47%), Gaps = 32/272 (11%)
Query: 399 NNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
+ +G G +G VY+G+ +AVK L + + EF+ E ++ ++HPNLV+L G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 458 CIEGNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
C +I E++ +L L E +R +++ + I+ + YL ++ I H
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI---H 127
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLTE 573
RD+ A N L+ ++ K++DFGL++L + T AG I + APE +
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGD---TYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 574 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629
K+DV++FG++ EI + G S + ++ LL E+G ME + P ++
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKGYRMERPEGCPPKVYE- 236
Query: 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ C +P+ RPS + + + E
Sbjct: 237 --------LMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 9/192 (4%)
Query: 401 IGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IGEG G V G +AVK++ + +Q NE+ ++ H N+V +Y +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
G++L ++ E+LE +L + R+ + +CL + R L+YLH + V+HRDI
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLSVLRALSYLHNQG---VIHRDI 144
Query: 520 KATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
K+ ++LL D K+SDFG A++ +E S + GT +MAPE R + D++
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYGTEVDIW 202
Query: 579 SFGIVALEIVSG 590
S GI+ +E++ G
Sbjct: 203 SLGIMVIEMIDG 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 31/210 (14%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS----SKSKQGN--REFINEIGMISALQHPNLVK 453
+G G F Y+ + GT +AVKQ++ + S+Q EI +++ L HP++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARAL-----FEHRLKLDWPTRRRICLGIARGLAYLHG 508
+ G E + L E++ S++ L F+ + + + RGL+YLH
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII------NYTEQLLRGLSYLH- 120
Query: 509 ESRIKVVHRDIKATNVLLD---KDLNSKISDFGLAKLDEEENT---HISTRVAGTIGYMA 562
E++I +HRD+K N+L+D + L +I+DFG A + T ++ GTI +MA
Sbjct: 121 ENQI--IHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 563 PEYAMRGH-LTEKADVYSFGIVALEIVSGR 591
PE +RG DV+S G V +E+ + +
Sbjct: 177 PE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 65/201 (32%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 395 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPN 450
F+ IG G FG VY + + +A+K++S KQ N ++ I E+ + L+HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGE 509
++ GC + + L+ EY + A L E H+ L + G +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-- 567
+ ++HRD+KA N+LL + K+ DFG A + N + GT +MAPE +
Sbjct: 135 N---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAM 186
Query: 568 -RGHLTEKADVYSFGIVALEI 587
G K DV+S GI +E+
Sbjct: 187 DEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 61/195 (31%), Positives = 103/195 (52%), Gaps = 15/195 (7%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYG 456
IGEG G V +A G +AVK + + +Q NE+ ++ QH N+V++Y
Sbjct: 29 IGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+ G +L ++ E+L+ +L + + RL + +C + + L YLH + V+H
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA--TVCESVLQALCYLHSQG---VIH 140
Query: 517 RDIKATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 575
RDIK+ ++LL D K+SDFG A++ ++ S + GT +MAPE R +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRTPYGTEV 198
Query: 576 DVYSFGIVALEIVSG 590
D++S GI+ +E+V G
Sbjct: 199 DIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 69/201 (34%), Positives = 100/201 (49%), Gaps = 18/201 (8%)
Query: 395 FATDNNIGEGGFGPVYKGLLADGTAI-AVKQLSSKSKQGN---REFINEIGMISALQHPN 450
F + IG G FG VY + + AVK++S KQ N ++ I E+ + L+HPN
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGE 509
++ GC ++ + L+ EY + A L E H+ L I G +GLAYLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 140
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-- 567
+ I HRDIKA N+LL + K++DFG A N+ + GT +MAPE +
Sbjct: 141 NMI---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAM 192
Query: 568 -RGHLTEKADVYSFGIVALEI 587
G K DV+S GI +E+
Sbjct: 193 DEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-21
Identities = 62/196 (31%), Positives = 102/196 (52%), Gaps = 16/196 (8%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G+G FG VYK + G A K + +KS++ +++ EI +++ HP +VKL G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
+L ++ E+ ++ + E L P + IC + L YLH +K++HRD+
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDL 136
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG---YMAPEYAMRGHLTE--- 573
KA NVLL D + K++DFG++ +N R IG +MAPE M + +
Sbjct: 137 KAGNVLLTLDGDIKLADFGVSA----KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPY 192
Query: 574 --KADVYSFGIVALEI 587
KAD++S GI +E+
Sbjct: 193 DYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 2e-21
Identities = 84/267 (31%), Positives = 124/267 (46%), Gaps = 23/267 (8%)
Query: 395 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-EIGMISALQHPNLV 452
F IG+G FG V+KG+ +A+K + + + E I EI ++S P +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
K YG ++ +L +I EYL S A L E LD I I +GL YLH E +I
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS-ALDLLEPG-PLDETQIATILREILKGLDYLHSEKKI 123
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS-TRVAGTIGYMAPEYAMRGHL 571
HRDIKA NVLL + K++DFG+A + +T I GT +MAPE +
Sbjct: 124 ---HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178
Query: 572 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631
KAD++S GI A+E+ G ++ +L L+ K +E + P F +
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVL--FLIPKNNPPTLEGNYSKPLKEFVEA- 235
Query: 632 VMVMINVALLCANASPTIRPSMSSVLR 658
C N P+ RP+ +L+
Sbjct: 236 ----------CLNKEPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 60/198 (30%), Positives = 109/198 (55%), Gaps = 15/198 (7%)
Query: 401 IGEGGFGPVYKGLLA-DG----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 454
+G G FG VYKG+ DG +A+K L + S + N+E ++E +++ + P + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G C+ + + L+ + + L + E++ ++ C+ IA+G++YL +++
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRL 130
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIGYMAPEYAMRGHL 571
VHRD+ A NVL+ + KI+DFGLA+L DE E +V I +MA E +
Sbjct: 131 VHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVP--IKWMALESILHRRF 188
Query: 572 TEKADVYSFGIVALEIVS 589
T ++DV+S+G+ E+++
Sbjct: 189 THQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 4e-21
Identities = 78/278 (28%), Positives = 133/278 (47%), Gaps = 31/278 (11%)
Query: 394 NFATDNNIGEGGFGPVYKG-LLADGTAIAVKQ------LSSKSKQGNREFINEIGMISAL 446
NF + IG G F VY+ L DG +A+K+ + +K++ + I EI ++ L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQL 59
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARAL--FEHRLKLDWPTRR--RICLGIARG 502
HPN++K Y IE N+L ++ E + L+R + F+ + +L P + + + +
Sbjct: 60 NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTVWKYFVQLCSA 118
Query: 503 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 562
L ++H SR +V+HRDIK NV + K+ D GL + + T + V GT YM+
Sbjct: 119 LEHMH--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 563 PEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622
PE K+D++S G + E+ + +S + M L K +E D
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--------NLYSLCKKIEQCDYP 226
Query: 623 P-GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659
P S+ E++ ++N +C N P RP ++ V +
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQG-NREFINEIGMISALQHPN 450
+ +GEG G V K L G A+K +++ ++ + E+ + + + P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 451 LVKLYGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIA----RGLA 504
+VK YG ++ + + + EY E SL ++++ K ++ IA +GL+
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
YLH SR K++HRDIK +N+LL + K+ DFG++ E N+ T GT YMAPE
Sbjct: 120 YLH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVS--GELVNSLAGTFT-GTSFYMAPE 173
Query: 565 YAMRGHLTEKADVYSFGIVALEIVSGR 591
+ +DV+S G+ LE+ R
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 7e-21
Identities = 66/201 (32%), Positives = 99/201 (49%), Gaps = 18/201 (8%)
Query: 395 FATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPN 450
F IG G FG VY +A+K++S KQ N ++ I E+ + ++HPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGE 509
++ GC + + L+ EY + A L E H+ L I G +GLAYLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-- 567
+ ++HRDIKA N+LL + K++DFG A + N+ + GT +MAPE +
Sbjct: 145 N---MIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVILAM 196
Query: 568 -RGHLTEKADVYSFGIVALEI 587
G K DV+S GI +E+
Sbjct: 197 DEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-21
Identities = 58/194 (29%), Positives = 96/194 (49%), Gaps = 8/194 (4%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 455
+G G FG + +G L +A+ L + S + R F+ E + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G GN ++++ EY+ N +L L +H +L + G+A G+ YL S + V
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---SEMGYV 129
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 575
H+ + A VL++ DL KIS F + D+ E + + + + APE H + +
Sbjct: 130 HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS 189
Query: 576 DVYSFGIVALEIVS 589
DV+SFGIV E++S
Sbjct: 190 DVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 32/219 (14%)
Query: 400 NIGEGGFGPVY------------KGLLADGTA-----IAVKQL-SSKSKQGNREFINEIG 441
+GEG FG V+ K + A +AVK L S +F+ E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 442 MISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK----------LDWPT 491
++S L PN+ +L G C L +I EY+EN L + L +H + L + T
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 492 RRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHI 550
+ IA G+ YL + VHRD+ N L+ K+ KI+DFG+++ L + +
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188
Query: 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
R I +MA E + G T K+DV++FG+ EI++
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 2e-20
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 22/206 (10%)
Query: 401 IGEGGFGPVY----KGLLADG--TAIAVKQLSSKSKQG-NREFINEIGMISALQHPNLVK 453
+G G FG V+ KG+ +G T + VK L + EF E+ M L H N+V+
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVR 72
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLK--------LDWPTRRRICLGIARGLAY 505
L G C E +I EY + L + L + K L + +C IA G+ +
Sbjct: 73 LLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAP 563
L S + VHRD+ A N L+ K+S L+K + E + + + ++AP
Sbjct: 133 L---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP--LRWLAP 187
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVS 589
E + K+DV+SFG++ E+ +
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.8 bits (229), Expect = 2e-20
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 31/207 (14%)
Query: 400 NIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN--EIGMISALQ-HPNLVKLY 455
+G+G FG VY G +A+K++ K E +N E+ + L HPN+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLK 64
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFE----HRLK-LDWPTRRRICLGIARGLAYLHGES 510
E ++L ++EY+E N L++ + K R I I +GLA++H
Sbjct: 65 EVFRENDELYFVFEYMEGN-----LYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN-----THISTRVAGTIGYMAPEY 565
+ HRD+K N+L+ KI+DFGLA+ E + ++STR Y APE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR-----WYRAPEI 169
Query: 566 AMR-GHLTEKADVYSFGIVALEIVSGR 591
+R + D+++ G + E+ + R
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 63/196 (32%), Positives = 100/196 (51%), Gaps = 16/196 (8%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G+G FG VYK + G A K + +KS++ +++ EI ++++ HPN+VKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
N L ++ E+ ++ + E L P R +C L YLH K++HRD+
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDL 129
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG---YMAPEYAMRGHLTE--- 573
KA N+L D + K++DFG++ +NT R IG +MAPE M +
Sbjct: 130 KAGNILFTLDGDIKLADFGVSA----KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185
Query: 574 --KADVYSFGIVALEI 587
KADV+S GI +E+
Sbjct: 186 DYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 77/287 (26%), Positives = 130/287 (45%), Gaps = 38/287 (13%)
Query: 393 NNFATDNNIGEGGFGPVYK----GLLADGTAI--AVKQLSSKSKQGNRE-FINEIGMISA 445
NN + +G G FG V + GL + AVK L + RE ++E+ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 446 L-QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG--IARG 502
L H N+V L G C G +L+I EY L L R + +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESF-LTLEDLLSFSYQVAKG 153
Query: 503 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI---STRVAGTIG 559
+A+L ++ +HRD+ A NVLL KI DFGLA+ ++ ++ + R+ +
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLP--VK 208
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSN----VTKEDMFYLLDWALVLKEQGKL 615
+MAPE T ++DV+S+GI+ EI S SN + + FY L +KE ++
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL-----IKEGYRM 263
Query: 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662
+ ++ ++ C +A P RP+ +++++
Sbjct: 264 AQPE-------HAPAEIYDIMKT---CWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 67/249 (26%), Positives = 108/249 (43%), Gaps = 34/249 (13%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHP 449
N + +GEG +G V K A G +A+K+ S + + + E+ ++ L+H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 450 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
N+V L +L L++EY+E L L L R + + +AY H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLL-ELLEASPGGLPPDAVRSYIWQLLQAIAYCH-- 117
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPE---- 564
++HRDIK N+L+ + K+ DFG A+ L + ++ VA T Y APE
Sbjct: 118 -SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVG 175
Query: 565 YAMRGHLTEKADVYSFGIVALEIVSGR------SNVTKEDMFYLLDWALVLKEQGKL--- 615
G + DV++ G + E++ G S++ D Y L+ K G L
Sbjct: 176 DTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDI---DQLY-----LIQKCLGPLPPS 224
Query: 616 -MELVDTNP 623
EL +NP
Sbjct: 225 HQELFSSNP 233
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 8e-20
Identities = 64/207 (30%), Positives = 105/207 (50%), Gaps = 21/207 (10%)
Query: 401 IGEGGFGPVYKGLLA--DGTA--IAVK--QLSSKSKQGNREFINEIGMISALQHPNLVKL 454
+GEG FG V +G L+ DG+ +AVK +L + EF++E + HPN++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 455 YGCCIEGNQL------LLIYEYLENNSLARALFEHRL-----KLDWPTRRRICLGIARGL 503
G C E + L ++I ++++ L L RL KL T + + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT-IGYMA 562
YL S +HRD+ A N +L +D+ ++DFGL+K + + R+A + ++A
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 563 PEYAMRGHLTEKADVYSFGIVALEIVS 589
E T K+DV++FG+ EI +
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 58/190 (30%), Positives = 97/190 (51%), Gaps = 23/190 (12%)
Query: 420 IAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLAR 478
+AVK L +K +F+ E+ ++S L+ PN+++L G C++ + L +I EY+EN L +
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 479 ALFEHRLK------------------LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 520
L H L + + + + L IA G+ YL S + VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 521 ATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 579
N L+ ++L KI+DFG+++ L + I R I +MA E + G T +DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 580 FGIVALEIVS 589
FG+ EI+
Sbjct: 226 FGVTLWEILM 235
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-19
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 32/208 (15%)
Query: 399 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYG 456
N IG G G VYK + G A+K + + R I EI ++ + HPN+VK +
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
++ ++ E+++ SL L R+ I G+AYLH R +VH
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQ-----ILSGIAYLH---RRHIVH 191
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE------------ 564
RDIK +N+L++ N KI+DFG++++ + ++ V GTI YM+PE
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYD 250
Query: 565 -YAMRGHLTEKADVYSFGIVALEIVSGR 591
YA D++S G+ LE GR
Sbjct: 251 GYA--------GDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 56/198 (28%), Positives = 87/198 (43%), Gaps = 12/198 (6%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 456
+G+GGFG V + G A K+L K ++G + +NE ++ + +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKVV 515
+ L L+ + L ++ I GL +LH + ++V
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIV 117
Query: 516 HRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 574
+RD+K NVLLD N +ISD GLA +L + AGT GYMAPE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR---AGTPGYMAPEVLQGEVYDFS 174
Query: 575 ADVYSFGIVALEIVSGRS 592
D ++ G E+++GRS
Sbjct: 175 VDWFALGCTLYEMIAGRS 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 3e-19
Identities = 58/203 (28%), Positives = 93/203 (45%), Gaps = 19/203 (9%)
Query: 401 IGEGGFGPVYKGLLADGTAIA---VKQL-SSKSKQGNREFINEIGMISALQHPNLVKLYG 456
IG G FG V G G + A VK+L +S + F+ E+ L HPN+++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKL----DWPTRRRICLGIARGLAYLHGESRI 512
CIE LL+ E+ L L +R + +R+ +A GL +LH +
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QA 119
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST-RVAGTIGYMAPEYAMRGH- 570
+H D+ N L DL+ KI D+GLA E+ +I+ A + ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQ 179
Query: 571 ------LTEKADVYSFGIVALEI 587
T+K++++S G+ E+
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 3e-19
Identities = 70/283 (24%), Positives = 129/283 (45%), Gaps = 48/283 (16%)
Query: 394 NFATDNNIGEGGFGPVYKGLLADGTA---------IAVKQLSSKSKQGNREFINEIGMIS 444
+ IGEG FG +Y LA + I + ++ K K+ ++ E+ +++
Sbjct: 1 RYEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEKEASK---KEVILLA 54
Query: 445 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLAR-------ALFEHRLKLDWPTRRRICL 497
++HPN+V + E +L ++ EY + L + LF L W +
Sbjct: 55 KMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ----- 109
Query: 498 GIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAKLDEEENTHISTRVAG 556
I+ GL ++H K++HRDIK+ N+ L K+ + +K+ DFG+A+ ++ ++ G
Sbjct: 110 -ISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ-LNDSMELAYTCVG 164
Query: 557 TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE-QGKL 615
T Y++PE K D++S G V E+ + + ++ LVLK QG
Sbjct: 165 TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----LVLKICQGYF 219
Query: 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
+ +P + D ++ + SP RPS++S+L+
Sbjct: 220 API---SPNFSRDLRSLISQL------FKVSPRDRPSITSILK 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 81/275 (29%), Positives = 134/275 (48%), Gaps = 34/275 (12%)
Query: 401 IGEGGFGPVYKGLLADGTAI----AVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLY 455
IG+G FG VY G L D AVK L+ + E F+ E ++ HPN++ L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 456 GCCI--EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRIC---LGIARGLAYLHGES 510
G C+ EG+ L+++ Y+++ L + R + PT + + L +A+G+ YL +
Sbjct: 63 GICLPSEGSPLVVL-PYMKHGDLRNFI---RSETHNPTVKDLIGFGLQVAKGMEYLASK- 117
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEE-ENTHISTRVAGTIGYMAPEYAM 567
K VHRD+ A N +LD+ K++DFGLA+ D+E + H T + +MA E
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 568 RGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626
T K+DV+SFG++ E+++ G D F + + L QG+ + + P
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL----QGRRLLQPEYCPDP- 230
Query: 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ V L C + P +RP+ S ++ +E
Sbjct: 231 --------LYEVMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 5e-19
Identities = 76/283 (26%), Positives = 128/283 (45%), Gaps = 42/283 (14%)
Query: 401 IGEGGFGPVYKGLLAD------GTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVK 453
+G+G FG VY+G D T +AVK ++ + R EF+NE ++ ++V+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---------RICLGIARGLA 504
L G +G L++ E + + L L R + + R ++ IA G+A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT----IGY 560
YL+ + K VHRD+ A N ++ D KI DFG+ + E + + R G + +
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY---RKGGKGLLPVRW 187
Query: 561 MAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK--EQGKLMEL 618
MAPE G T +D++SFG+V EI S E + L VLK G ++
Sbjct: 188 MAPESLKDGVFTTSSDMWSFGVVLWEITS-----LAEQPYQGLSNEQVLKFVMDGGYLDQ 242
Query: 619 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
D P + ++ +C +P +RP+ ++ +L+
Sbjct: 243 PDNCPER---------VTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 1e-18
Identities = 74/270 (27%), Positives = 123/270 (45%), Gaps = 32/270 (11%)
Query: 401 IGEGGFGPVYKGLL-ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLYGCC 458
IG G FG V+ G L AD T +AVK + +F+ E ++ HPN+V+L G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
+ + ++ E ++ L +L ++ A G+ YL ES+ +HRD
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL--ESK-HCIHRD 119
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT----IGYMAPEYAMRGHLTEK 574
+ A N L+ + KISDFG+++ +EE+ + ST G + + APE G + +
Sbjct: 120 LAARNCLVTEKNVLKISDFGMSR-EEEDGVYAST--GGMKQIPVKWTAPEALNYGRYSSE 176
Query: 575 ADVYSFGIVALEIVSGRS----NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630
+DV+SFGI+ E S + N++ + + EQG + + P + +
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-------EQGVRLPCPELCPDAVY--- 226
Query: 631 QVMVMINVALLCANASPTIRPSMSSVLRML 660
+ C P RPS S+V + L
Sbjct: 227 ------RLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 16/199 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
IGEG +G VYK G +A+K+ L ++ + I EI ++ L HPN+V+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 458 CIEGNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
N+L L++E+L + L + + LD P + + +G+AY H +V+H
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLH 122
Query: 517 RDIKATNVLLDKDLNSKISDFGLAK---LDEEENTHISTRVAGTIGYMAPEYAMRG-HLT 572
RD+K N+L+D++ K++DFGLA+ + TH V T+ Y APE + +
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-TLWYRAPEILLGSRQYS 178
Query: 573 EKADVYSFGIVALEIVSGR 591
D++S G + E+V+ R
Sbjct: 179 TPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 75/278 (26%), Positives = 129/278 (46%), Gaps = 40/278 (14%)
Query: 401 IGEGGFGPVYKGLLADG-------TAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLV 452
+G+G FG VY+G+ A G T +A+K ++ + R EF+NE ++ ++V
Sbjct: 14 LGQGSFGMVYEGI-AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDW-------PTRRRICLG--IARGL 503
+L G +G L+I E + L L R +++ ++ I + IA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG--TIGYM 561
AYL+ K VHRD+ A N ++ +D KI DFG+ + D E + G + +M
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR-DIYETDYYRKGGKGLLPVRWM 188
Query: 562 APEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK--EQGKLMELV 619
+PE G T +DV+SFG+V EI + E + + VL+ +G L++
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIAT-----LAEQPYQGMSNEQVLRFVMEGGLLDKP 243
Query: 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 657
D P ++ + +C +P +RPS ++
Sbjct: 244 DNCPD---------MLFELMRMCWQYNPKMRPSFLEII 272
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 68/267 (25%), Positives = 119/267 (44%), Gaps = 34/267 (12%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREFINEIGMISALQHPNLVKLYGCC 458
+G G G VYK L +AVK + + + ++ ++E+ ++ P ++ YG
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 459 IEGNQLLLIYEYLENNSLA--RALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
N++ + E+++ SL R + EH L RI + + +GL YL +K++H
Sbjct: 69 FVENRISICTEFMDGGSLDVYRKIPEHVLG-------RIAVAVVKGLTYLWS---LKILH 118
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
RD+K +N+L++ K+ DFG++ + I+ GT YMAPE +D
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYGIHSD 175
Query: 577 VYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL------VDTNPGSNFDKE 630
V+S GI +E+ GR + + K QG LM L VD +P +
Sbjct: 176 VWSLGISFMELALGR-----------FPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQ 224
Query: 631 QVMVMINVALLCANASPTIRPSMSSVL 657
++ C P RP+ +++
Sbjct: 225 FSEKFVHFITQCMRKQPKERPAPENLM 251
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 66/205 (32%), Positives = 115/205 (56%), Gaps = 14/205 (6%)
Query: 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN-REFINEIGMISALQHPNL 451
NF +GEG + VYKG G +A+K++ +++G I EI ++ L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 452 VKLYGCCIEGNQLLLIYEYLENNSLARALFEH--RLKLDWPTRRRICLGIARGLAYLHGE 509
V+L+ N+L+L++EY++ + L + + H R LD T + + +G+A+ H E
Sbjct: 61 VRLHDVIHTENKLMLVFEYMDKD-LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH-E 118
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAM- 567
+R V+HRD+K N+L++K K++DFGLA+ NT + V T+ Y AP+ +
Sbjct: 119 NR--VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLG 174
Query: 568 -RGHLTEKADVYSFGIVALEIVSGR 591
R + T D++S G + E+++GR
Sbjct: 175 SRTYSTS-IDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 401 IGEGGFGPVYKGLLA-DGTAI--AVKQLSS-KSKQGNREFINEIGMISAL-QHPNLVKLY 455
IGEG FG V + ++ DG + A+K L S+ +R+F E+ ++ L HPN++ L
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRR--------------RICLGIA 500
G C L + EY +L L + R L+ D + + +A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129
Query: 501 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 560
G+ YL S + +HRD+ A NVL+ ++L SKI+DFGL++ +E R+ + +
Sbjct: 130 TGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP--VRW 184
Query: 561 MAPEYAMRGHLTEKADVYSFGIVALEIVS 589
MA E T K+DV+SFG++ EIVS
Sbjct: 185 MAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 4e-18
Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 400 NIGEGGFGPVY------KGLLADGTAIAVKQLSSKSKQGN-REFINEIGMISALQHPNLV 452
++GEG FG V +G G +AVK L +S + + EI ++ L H N+V
Sbjct: 11 DLGEGHFGKVELCRYDPEGD-NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 453 KLYGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
K G C E GN + LI E+L + SL L ++ K++ + + + I +G+ YL S
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG--S 127
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMR 568
R + VHRD+ A NVL++ + KI DFGL K ++E + + + + APE ++
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 569 GHLTEKADVYSFGIVALEIVS 589
+DV+SFG+ E+++
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 87/303 (28%), Positives = 135/303 (44%), Gaps = 73/303 (24%)
Query: 401 IGEGGFGPVYKGLLADG-----------TAIAVKQLSSKSKQGN-REFINEIGMISAL-Q 447
+GEG FG V ++A+ T +AVK L S + + + + I+E+ M+ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG--------- 498
H N++ L G C + L +I EY +L L R P C
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR-----PPGMEYCYNPTQVPEEQL 137
Query: 499 -----------IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547
+ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ +
Sbjct: 138 SFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DI 190
Query: 548 THISTRVAGTIG-----YMAPEYAMRGHLTEKADVYSFGIVALEIV----SGRSNVTKED 598
HI T G +MAPE T ++DV+SFG++ EI S V E+
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250
Query: 599 MFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
+F LL ++G M+ P SN E M+M + C +A P+ RP+ ++
Sbjct: 251 LFKLL-------KEGHRMD----KP-SNCTNELYMMMRD----CWHAVPSQRPTFKQLVE 294
Query: 659 MLE 661
L+
Sbjct: 295 DLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 70/209 (33%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCI 459
+G G +G VYKG +A ++ ++ E EI M+ H N+ YG I
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83
Query: 460 E------GNQLLLIYEYLENNS---LARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+ +QL L+ E+ S L + + LK DW IC I RGLA+LH
Sbjct: 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHAH- 140
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGL-AKLDE---EENTHISTRVAGTIGYMAPEYA 566
KV+HRDIK NVLL ++ K+ DFG+ A+LD NT I GT +MAPE
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEVI 193
Query: 567 M-----RGHLTEKADVYSFGIVALEIVSG 590
++D++S GI A+E+ G
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 5e-18
Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 15/201 (7%)
Query: 401 IGEGGFGPVY---KGLLADGTAI-AVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYG 456
I +G +G V+ K D AI +K+ K + + E ++S Q P +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
L L+ EYL LA L E+ LD R I L YLH ++H
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLAS-LLENVGSLDEDVARIYIAEIVLALEYLH---SNGIIH 116
Query: 517 RDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHIST-----RVAGTIGYMAPEYAMRG 569
RD+K N+L+D + + K++DFGL+K L + R+ GT Y+APE +
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQ 176
Query: 570 HLTEKADVYSFGIVALEIVSG 590
++ D +S G + E + G
Sbjct: 177 GHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 6e-18
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 401 IGEGGFGPVYKGLL-----ADGTAIAVKQLSS-KSKQGNREFINEIGMISALQHPNLVKL 454
+GE FG +YKG L +A+K L + Q EF E +++ L HPN+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEH----------------RLKLDWPTRRRICLG 498
G + + +++EYL L L + LD I +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGT 557
IA G+ YL VH+D+ A N+L+ + L+ KISD GL++ + + + +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 558 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
I +M PE M G + +D++SFG+V EI S
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 72/229 (31%), Positives = 106/229 (46%), Gaps = 34/229 (14%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGT------AIAVKQLSSKSKQGNRE-FINE 439
+I +T F + +GE FG VYKG L A+A+K L K++ RE F +E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 440 IGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEH---------------R 484
M S LQHPN+V L G + L +I+ Y ++ L L +
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 485 LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544
L+ I IA G+ +L S VVH+D+ NVL+ LN KISD GL +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR--- 172
Query: 545 EENTHISTRVAGT----IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
E ++ G I +M+PE M G + +D++S+G+V E+ S
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 8e-18
Identities = 72/281 (25%), Positives = 127/281 (45%), Gaps = 37/281 (13%)
Query: 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQ------LSSKSKQGNREFINEIGMISAL 446
NF + IG G F VY+ L D +A+K+ + +K++Q + + EI ++ L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQL 59
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARAL--FEHRLKLD-----WPTRRRICLGI 499
HPN++K IE N+L ++ E + L++ + F+ + +L W ++C +
Sbjct: 60 NHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAV 119
Query: 500 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG 559
H SR +V+HRDIK NV + K+ D GL + + T + V GT
Sbjct: 120 E------HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 171
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMEL 618
YM+PE K+D++S G + E+ + +S + M +L K EQ L
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF---SLCQKIEQCDYPPL 228
Query: 619 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659
P ++ ++ + + +C P RP + V ++
Sbjct: 229 ----PTEHYSEK----LRELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 19/199 (9%)
Query: 399 NNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREF-INEIGM---ISALQHPNLV 452
IGEG +G VYK L G +A+K++ S++G + EI + + + +HPN+V
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64
Query: 453 KLYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYL 506
+L C +L L++E+++ + LA L + L T + + + RG+ +L
Sbjct: 65 RLLDVCHGPRTDRELKLTLVFEHVDQD-LATYLSKCPKPGLPPETIKDLMRQLLRGVDFL 123
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 566
H ++VHRD+K N+L+ D KI+DFGLA++ E T V T+ Y APE
Sbjct: 124 HSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRAPEVL 178
Query: 567 MRGHLTEKADVYSFG-IVA 584
++ D++S G I A
Sbjct: 179 LQSSYATPVDMWSVGCIFA 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 401 IGEGGFGPVYKGLLA-DGTAI--AVKQLSS-KSKQGNREFINEIGMISAL-QHPNLVKLY 455
IGEG FG V K + DG + A+K++ SK +R+F E+ ++ L HPN++ L
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRR--------------RICLGIA 500
G C L L EY + +L L + R L+ D +A
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 501 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 560
RG+ YL S+ + +HRD+ A N+L+ ++ +KI+DFGL++ E R+ + +
Sbjct: 123 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 177
Query: 561 MAPEYAMRGHLTEKADVYSFGIVALEIVS 589
MA E T +DV+S+G++ EIVS
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 1e-17
Identities = 69/269 (25%), Positives = 125/269 (46%), Gaps = 37/269 (13%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGC 457
+G G FG V+ AD + +KQ+ + +K NE ++ L HPN+++ Y
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 458 CIEGNQLLLIYEYLENNSLA-------RALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+E L+++ EY +LA +L + L + + I L ++H +
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQ------ILLALHHVHTK- 120
Query: 511 RIKVVHRDIKATNVLLDKDLN-SKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 569
++HRD+K N+LLDK KI DFG++K+ ++ + V GT Y++PE
Sbjct: 121 --LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AYTVVGTPCYISPELCEGK 176
Query: 570 HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMELVDTNPGSNFD 628
+K+D+++ G V E+ S + ++ ALVLK G + D S
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLP-----ALVLKIMSGTFAPISDRY--SPDL 229
Query: 629 KEQVMVMINVALLCANASPTIRPSMSSVL 657
++ ++ M+N+ P+ RP +S ++
Sbjct: 230 RQLILSMLNL-------DPSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 2e-17
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 32/212 (15%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADGTAI-AVKQLSS----KSKQGNREFINEIGMISALQ 447
++F +G G FG V A+K LS K KQ +NE ++ +++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR------ 501
HP LV LYG + + L L+ EY+ L F H K R +AR
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSHLRK-----SGRFPEPVARFYAAQV 110
Query: 502 --GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG 559
L YLH +V+RD+K N+LLD D KI+DFG AK + T+ + GT
Sbjct: 111 VLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRTYT---LCGTPE 163
Query: 560 YMAPEYAM-RGHLTEKADVYSFGIVALEIVSG 590
Y+APE + +G+ + D ++ GI+ E+++G
Sbjct: 164 YLAPEIILSKGY-GKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 2e-17
Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQG-NREFINEIGMISALQHPN 450
F N IGEG +G VY+ G +A+K++ + G + EI ++ L+HPN
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 451 LVKLYGCCIEGNQL---LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 507
+V+L + G L L+ EY E + LA L + + L + RGL YLH
Sbjct: 68 IVELKE-VVVGKHLDSIFLVMEYCEQD-LASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE--Y 565
++HRD+K +N+LL KI+DFGLA+ ++ +V T+ Y APE
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLL 181
Query: 566 AMRGHLTEKADVYSFGIVALEIVSGR 591
+ T D+++ G + E+++ +
Sbjct: 182 GCTTY-TTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 64/197 (32%), Positives = 97/197 (49%), Gaps = 16/197 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 458
+G G G V K + GT +A K + +K R+ I E+ ++ + P +V YG
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIA----RGLAYLHGESRIKV 514
+ N + + E+++ SL R K P I IA GL YL+ RI
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY-----KKGGPIPVEILGKIAVAVVEGLTYLYNVHRI-- 125
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 574
+HRDIK +N+L++ K+ DFG++ E N+ T V GT YM+PE G T K
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS--GELINSIADTFV-GTSTYMSPERIQGGKYTVK 182
Query: 575 ADVYSFGIVALEIVSGR 591
+DV+S GI +E+ G+
Sbjct: 183 SDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 57/203 (28%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 400 NIGEGGFGPVYKGL-LADGTAIAVKQL-SSKSKQGNREFINE--IGMISALQHPNLVKLY 455
+G G +G V K + GT +AVK++ ++ + Q + + + I M S P V Y
Sbjct: 8 ELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSV-DCPYTVTFY 66
Query: 456 GCCIEGNQLLLIYEYLEN--NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
G + + E ++ + + +++ L + +I + I + L YLH S++
Sbjct: 67 GALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH--SKLS 124
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-----YAMR 568
V+HRD+K +NVL++++ K+ DFG++ ++ T AG YMAPE +
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVDSVAKTIDAGCKPYMAPERINPELNQK 182
Query: 569 GHLTEKADVYSFGIVALEIVSGR 591
G+ K+DV+S GI +E+ +GR
Sbjct: 183 GY-DVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 3e-17
Identities = 69/209 (33%), Positives = 99/209 (47%), Gaps = 29/209 (13%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCI 459
+G G +G VYKG +A ++ + E EI M+ H N+ YG I
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 460 EGN------QLLLIYEYLENNSLARALFEHR---LKLDWPTRRRICLGIARGLAYLHGES 510
+ N QL L+ E+ S+ + + LK +W IC I RGL++LH
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH- 130
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGL-AKLDE---EENTHISTRVAGTIGYMAPEYA 566
KV+HRDIK NVLL ++ K+ DFG+ A+LD NT I GT +MAPE
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEVI 183
Query: 567 MRGHLTE-----KADVYSFGIVALEIVSG 590
+ K+D++S GI A+E+ G
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 3e-17
Identities = 76/237 (32%), Positives = 103/237 (43%), Gaps = 53/237 (22%)
Query: 385 YLQI-----KAATNNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNREFIN 438
YL I A N+ IG G G VYK G +AVKQ+ + GN+E
Sbjct: 2 YLTIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENK 58
Query: 439 EIGM---ISALQH--PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTR 492
I M + H P +VK YG I + + + E L + LK + P
Sbjct: 59 RILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME------LMSTCLDKLLKRIQGPIP 112
Query: 493 RRICLG-----IARGLAYL---HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544
I LG I + L YL HG V+HRD+K +N+LLD N K+ DFG++
Sbjct: 113 EDI-LGKMTVAIVKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166
Query: 545 EENTHISTRVAGTIGYMAPE----------YAMRGHLTEKADVYSFGIVALEIVSGR 591
+ TR AG YMAPE Y +R ADV+S GI +E+ +G+
Sbjct: 167 DSKAK--TRSAGCAAYMAPERIDPPDPNPKYDIR------ADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 34/206 (16%)
Query: 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-----EIGMISALQ 447
+ +GEG + VYK G +A+K++ ++ ++ IN EI ++ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIA------- 500
HPN++ L + + L++E++E + E +K + I L A
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETD------LEKVIK-----DKSIVLTPADIKSYML 109
Query: 501 ---RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT 557
RGL YLH ++HRD+K N+L+ D K++DFGLA+ N ++ +V T
Sbjct: 110 MTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165
Query: 558 IGYMAPE--YAMRGHLTEKADVYSFG 581
Y APE + R H D++S G
Sbjct: 166 RWYRAPELLFGAR-HYGVGVDMWSVG 190
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 88/341 (25%), Positives = 150/341 (43%), Gaps = 62/341 (18%)
Query: 401 IGEGGFGPVY--------KGLLADGTAIAVKQLSSKSKQGN-REFINEIGMISAL-QHPN 450
+GEG FG V K +AVK L + + + ++E+ M+ + +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDW-------PTRRRIC------ 496
++ L G C + L ++ EY +L L R +D+ P +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 497 -LGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK----LDEEENTHIS 551
+ARG+ YL + K +HRD+ A NVL+ +D KI+DFGLA+ +D + T
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKT--- 193
Query: 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIV----SGRSNVTKEDMFYLLDWAL 607
T + +MAPE T ++DV+SFG++ EI S + E++F LL
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL---- 249
Query: 608 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667
++G M+ P +N E M+M C +A P+ RP+ ++ L+ VL
Sbjct: 250 ---KEGHRMD----KP-ANCTHELYMIMRE----CWHAVPSQRPTFKQLVEDLD---RVL 294
Query: 668 DLVSDSSVSDIDETKAEAMRKYYQFCVENTASTTQSTSSIY 708
+ S D+ + +Y C ++ +S + S++
Sbjct: 295 TVTSTDEYLDL----SVPFEQYSPGCPDSPSSCSSGDDSVF 331
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 85/294 (28%), Positives = 135/294 (45%), Gaps = 55/294 (18%)
Query: 401 IGEGGFGPVYK----GLLAD----GTAIAVKQLSSKSKQGN-REFINEIGMISAL-QHPN 450
+GEG FG V + G+ +AVK L + + + I+E+ ++ + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRL---------------KLDWPTRRRI 495
++ L G C + L +I EY +L L R +L +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 496 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK----LDEEENTHIS 551
+ARG+ YL ESR + +HRD+ A NVL+ +D KI+DFGLA+ +D + T +
Sbjct: 140 AYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTS-N 195
Query: 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIV----SGRSNVTKEDMFYLLDWAL 607
R+ + +MAPE T ++DV+SFGI+ EI S + E++F LL
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL---- 249
Query: 608 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+G M+ P SN E M+M C +A PT RP+ ++ L+
Sbjct: 250 ---REGHRMD----KP-SNCTHELYMLMRE----CWHAVPTQRPTFKQLVEALD 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 5e-17
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 401 IGEGGFGPVYKGLLADG---TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLYG 456
IG G FG V G + G + VK+L S S Q +F+ E +LQH NL++ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHR----LKLDWPTRRRICLGIARGLAYLHGESRI 512
C E LL+ E+ L L R + D T +R+ IA GL +LH +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KN 119
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYA--MRG 569
+H D+ N LL DL KI D+GL+ +E+ ++ ++ + ++APE + G
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 570 HL-----TEKADVYSFGIVALEI 587
+L T++++V+S G+ E+
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 67/201 (33%), Positives = 101/201 (50%), Gaps = 18/201 (8%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQL--SSKSKQGNREFIN----EIGMISALQHPNLVK 453
+G G FG VY AD G +AVKQ+ S++ ++E +N EI ++ L+H +V+
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-VNALECEIQLLKNLRHDRIVQ 68
Query: 454 LYGCC--IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
YGC E +L + EY+ S+ L + L RR I +G++YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSN-- 125
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE---ENTHISTRVAGTIGYMAPEYAMR 568
+VHRDIK N+L D N K+ DFG +K + T I + V GT +M+PE
Sbjct: 126 -MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPYWMSPEVISG 183
Query: 569 GHLTEKADVYSFGIVALEIVS 589
KADV+S +E+++
Sbjct: 184 EGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 7e-17
Identities = 74/267 (27%), Positives = 128/267 (47%), Gaps = 30/267 (11%)
Query: 401 IGEGGFGPVYKGLL---ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLY 455
+G+G +G V L+ DG +K+L+ + S++ + E ++S L+HPN+V Y
Sbjct: 8 VGKGSYGEV--SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIV-AY 64
Query: 456 GCCIEGN--QLLLIYEYLENNSLARALFEHRLKLDWPTRRRI--CLGIARGLAYLHGESR 511
EG L ++ + E L L E + KL P + + + IA L YLH +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL-LPENQVVEWFVQIAMALQYLHEK-- 121
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 571
++HRD+K NV L + K+ D G+A++ E + ST + GT YM+PE
Sbjct: 122 -HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPY 179
Query: 572 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631
K+DV++ G E+ + + +DM L+ + ++ +GKL + ++ E
Sbjct: 180 NYKSDVWALGCCVYEMATLKHAFNAKDMNSLV-YRII---EGKLPPM-----PKDYSPE- 229
Query: 632 VMVMINVALLCANASPTIRPSMSSVLR 658
+ + +L P RPS+ S+LR
Sbjct: 230 -LGELIATMLSKR--PEKRPSVKSILR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 10/195 (5%)
Query: 401 IGEGGFGPVYKG---LLADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLYG 456
+G G FG V KG + +A+K L +++++ R E + E ++ L +P +V++ G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
C E L+L+ E L + L + ++ + ++ G+ YL G++ VH
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVH 118
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHLTEK 574
RD+ A NVLL +KISDFGL+K ++++ R AG + + APE + +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178
Query: 575 ADVYSFGIVALEIVS 589
+DV+S+GI E S
Sbjct: 179 SDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 1e-16
Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 20/211 (9%)
Query: 396 ATDNNIGEGGFGPVYKGLLADGTAI---AVK--QLSSKSKQGNREFINEIGMISALQHPN 450
A +GEG FG V +G L +I AVK +++ ++ +F++E + HPN
Sbjct: 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 451 LVKLYGCCIEGNQL------LLIYEYLENNSLARALFEHRL---KLDWPTRR--RICLGI 499
+++L G C++ + ++I ++++ L L RL PT+ + I
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 500 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT-I 558
A G+ YL +S I HRD+ A N +L++++N ++DFGL+K + + R+A +
Sbjct: 122 ASGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 559 GYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
++A E T K+DV+SFG+ EI +
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 34/227 (14%)
Query: 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQ-LSSKSKQGNREF----INEIGMIS 444
++ +GEG FG VYK + G +A+K+ L K G F + EI ++
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 445 ALQHPNLVKLYGCCIE-----GNQLLLIY---EYLENNSLARALFEHRLKLDWPTRRRIC 496
L+HPN+V L +E + +Y Y++++ L+ L +KL +
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHD-LSGLLENPSVKLTESQIKCYM 121
Query: 497 LGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE----------E 546
L + G+ YLH ++HRDIKA N+L+D KI+DFGLA+ +
Sbjct: 122 LQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178
Query: 547 NTHISTRVAGTIGYMAPEYAM--RGHLTEKADVYSFGIVALEIVSGR 591
T T + T Y PE + R + T D++ G V E+ + R
Sbjct: 179 GTRKYTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 2e-16
Identities = 77/291 (26%), Positives = 134/291 (46%), Gaps = 49/291 (16%)
Query: 401 IGEGGFGPVY--------KGLLADGTAIAVKQLSSKSKQGN-REFINEIGMISAL-QHPN 450
+GEG FG V K + +AVK L + + + + ++E+ M+ + +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHR---LKLDWPTRR------------RI 495
++ L G C + L +I EY +L L R ++ + R
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 496 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRV 554
+ARG+ YL + K +HRD+ A NVL+ ++ KI+DFGLA+ ++ + +T
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 555 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIV----SGRSNVTKEDMFYLLDWALVLK 610
+ +MAPE T ++DV+SFG++ EI S + E++F LL
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL------- 252
Query: 611 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
++G M+ P +N E M+M + C +A P+ RP+ ++ L+
Sbjct: 253 KEGHRMD----KP-ANCTNELYMMMRD----CWHAIPSHRPTFKQLVEDLD 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQLS--SKSKQGNREFIN---EIGMISALQHPNLVKL 454
+G+G FG VY D G +A KQ+ +S + ++E EI ++ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 455 YGCCIE-GNQLLLIY-EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
YGC + + L I+ EY+ S+ L + L R+ I G++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSN--- 125
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE---ENTHISTRVAGTIGYMAPEYAMRG 569
+VHRDIK N+L D N K+ DFG +K + T I + V GT +M+PE
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPEVISGE 184
Query: 570 HLTEKADVYSFGIVALEIVSGR 591
KADV+S G +E+++ +
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 26/202 (12%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKL 454
IGEG FG K +L DG +K++ S S + E E+ ++S ++HPN+V+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQY 64
Query: 455 YGCCIEGNQLLLIYEYLENNSLAR-------ALFEHRLKLDWPTRRRICLGIARGLAYLH 507
E L ++ +Y E L + LF LDW + ICL L ++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQ--ICLA----LKHVH 118
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 567
K++HRDIK+ N+ L KD K+ DFG+A++ ++ GT Y++PE
Sbjct: 119 DR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICE 174
Query: 568 RGHLTEKADVYSFGIVALEIVS 589
K+D+++ G V E+ +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 80/286 (27%), Positives = 132/286 (46%), Gaps = 57/286 (19%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKS-KQGNREFINEIGMISALQH-PNLVKLYG- 456
IG G FG V K L GT +AVK++ S ++ + + ++ ++ P +VK YG
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 457 ------C--CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR--RRICLGIARGLAYL 506
C C+E L+ L+ + ++E LK P +I + + L YL
Sbjct: 72 LFREGDCWICME-----LMDISLDK--FYKYVYEV-LKSVIPEEILGKIAVATVKALNYL 123
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPE- 564
E +K++HRD+K +N+LLD++ N K+ DFG++ +L ++ TR AG YMAPE
Sbjct: 124 KEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPER 178
Query: 565 --------YAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM 616
Y +R +DV+S GI E+ +G+ F W V +Q L
Sbjct: 179 IDPSARDGYDVR------SDVWSLGITLYEVATGK--------FPYPKWNSVF-DQ--LT 221
Query: 617 ELVDTNP---GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659
++V +P ++ ++E +N LC + RP +L
Sbjct: 222 QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 68/214 (31%), Positives = 98/214 (45%), Gaps = 20/214 (9%)
Query: 392 TNNFATDNNIGEGGFGPVYK-GLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHP 449
T+ + IG+G +G VYK DG+ AVK L S + E E ++ +L HP
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNILQSLPNHP 79
Query: 450 NLVKLYGCCIE-----GNQLLLIYEYLENNS---LARALFEHRLKLDWPTRRRICLGIAR 501
N+VK YG + G QL L+ E S L + L +LD I G
Sbjct: 80 NVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALL 139
Query: 502 GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYM 561
GL +LH +++HRD+K N+LL + K+ DFG++ +T V GT +M
Sbjct: 140 GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWM 195
Query: 562 APEY-----AMRGHLTEKADVYSFGIVALEIVSG 590
APE + DV+S GI A+E+ G
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPN 450
NF IGEG +G VYK G +A+K+ L ++++ I EI ++ L HPN
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGE 509
+VKL N+L L++E+L + L + + L + P + + +GLA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK---LDEEENTHISTRVAGTIGYMAPEYA 566
+V+HRD+K N+L++ + K++DFGLA+ + TH T+ Y APE
Sbjct: 120 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 172
Query: 567 MRGHLTEKA-DVYSFGIVALEIVSGRS 592
+ A D++S G + E+V+ R+
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRRA 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 8e-16
Identities = 56/184 (30%), Positives = 89/184 (48%), Gaps = 26/184 (14%)
Query: 399 NNIGEGGFGPVYKGL-LADGTAIAVKQ-LSSKSKQGNREF----INEIGMISALQHPNLV 452
IG+G FG V+K +A+K+ L K+G F + EI ++ L+H N+V
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVV 74
Query: 453 KLYGCC----IEGN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 504
L C N L++E+ E++ LA L +K +++ + GL
Sbjct: 75 NLIEICRTKATPYNRYKGSFYLVFEFCEHD-LAGLLSNKNVKFTLSEIKKVMKMLLNGLY 133
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL----DEEENTHISTRVAGTIGY 560
Y+H R K++HRD+KA N+L+ KD K++DFGLA+ + + RV T+ Y
Sbjct: 134 YIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWY 189
Query: 561 MAPE 564
PE
Sbjct: 190 RPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 64/217 (29%), Positives = 108/217 (49%), Gaps = 25/217 (11%)
Query: 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAI--AVKQLSS-KSKQGNREFINEIGMISAL-Q 447
N+ + IGEG FG V K + DG + A+K++ SK +R+F E+ ++ L
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSL------ARAL-------FEHRLKLDWPTRRR 494
HPN++ L G C L L EY + +L +R L + +++
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 495 ICLG--IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552
+ +ARG+ YL S+ + +HRD+ A N+L+ ++ +KI+DFGL++ E
Sbjct: 127 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 183
Query: 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
R+ + +MA E T +DV+S+G++ EIVS
Sbjct: 184 RLP--VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 28/218 (12%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
IGEG +G V+K + G +A+K+ S + + EI M+ L+HPNLV L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 517
+L L++EY ++ ++ L ++ + ++I + + + H +HR
Sbjct: 69 FRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHR 124
Query: 518 DIKATNVLLDKDLNSKISDFGLAKL----DEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
D+K N+L+ K K+ DFG A++ ++ +++TR Y APE + G
Sbjct: 125 DVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAPEL-LVGDTQY 178
Query: 574 KA--DVYSFGIVALEIVS------GRSNVTKEDMFYLL 603
DV++ G V E+++ G+S+V D YL+
Sbjct: 179 GPPVDVWAIGCVFAELLTGQPLWPGKSDV---DQLYLI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 61/201 (30%), Positives = 100/201 (49%), Gaps = 19/201 (9%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
IGEG +G VYKG G +A+K+ L S+ + I EI ++ LQHPN+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 458 CIEGNQLLLIYEYLENNSLARAL--FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
++ ++L LI+E+L + L + L +D + I +G+ + H +V+
Sbjct: 68 LMQESRLYLIFEFLSMD-LKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVL 123
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV----AGTIGYMAPEYAMRGHL 571
HRD+K N+L+D K++DFGLA+ I RV T+ Y APE +
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLAR-----AFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 572 -TEKADVYSFGIVALEIVSGR 591
+ D++S G + E+ + +
Sbjct: 179 YSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 22/199 (11%)
Query: 401 IGEGGFGPVY---KGLLADGTAIAV---KQLSSKSKQGNREFINEIGMISALQHPNLVKL 454
I +G FG VY K D AI V + +K++ N + I MI + P + KL
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQG-ESPYVAKL 62
Query: 455 YGCCIEGNQLLLIYEYLENN---SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
Y + L L+ EYL SL + L L DW ++ + G+ LH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWA--KQYIAEVVLGVEDLHQRG- 117
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 571
++HRDIK N+L+D+ + K++DFGL+ N + + GT Y+APE +
Sbjct: 118 --IIHRDIKPENLLIDQTGHLKLTDFGLS-----RNGLENKKFVGTPDYLAPETILGVGD 170
Query: 572 TEKADVYSFGIVALEIVSG 590
+ +D +S G V E + G
Sbjct: 171 DKMSDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 39/216 (18%)
Query: 401 IGEGGFGPVYKGLL---ADGTAIAVKQLSSKSKQG---NREFINEIGMISALQHPNLVKL 454
IG G +G VYK DG A+K+ +Q ++ EI ++ L+H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 455 YGCCIEGNQ--LLLIYEYLENNSLARALFEHRLK----LDWPTRRRICLGIARGLAYLHG 508
+E + L+++Y E++ F HR + + + I G+ YLH
Sbjct: 68 VEVFLEHADKSVYLLFDYAEHDLWQIIKF-HRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 509 ESRIKVVHRDIKATNVLLDKDLNS----KISDFGLAKL---------DEEENTHISTRVA 555
V+HRD+K N+L+ + KI D GLA+L D + V
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD-------PVV 176
Query: 556 GTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVS 589
TI Y APE + G H T+ D+++ G + E+++
Sbjct: 177 VTIWYRAPELLL-GARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 56/194 (28%), Positives = 102/194 (52%), Gaps = 8/194 (4%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQG-NREFINEIGMISALQHPNLVKLYGCC 458
+GEG + VYKG+ +G +A+K +S K+++G I E ++ L+H N+V L+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
L ++EY+ + LA+ + +H L R + RGLAY+HG+ ++HRD
Sbjct: 73 HTKETLTFVFEYMHTD-LAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRD 128
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADV 577
+K N+L+ K++DFGLA+ + S+ V T+ Y P+ + + D+
Sbjct: 129 LKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYSSALDI 187
Query: 578 YSFGIVALEIVSGR 591
+ G + +E++ G+
Sbjct: 188 WGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 42/144 (29%), Positives = 75/144 (52%), Gaps = 7/144 (4%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVK--QLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
IGEG +G V+K + +A+K +L + + EI ++ L+H N+V+LY
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 517
+L L++EY + + L + +D + + +GLA+ H V+HR
Sbjct: 68 LHSDKKLTLVFEYCDQD-LKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHR 123
Query: 518 DIKATNVLLDKDLNSKISDFGLAK 541
D+K N+L++K+ K++DFGLA+
Sbjct: 124 DLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 4e-15
Identities = 57/220 (25%), Positives = 97/220 (44%), Gaps = 34/220 (15%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS---SKSKQGNREFINEIGMISALQHPNLVKLYG 456
IG+GG G VY +A+K++ S++ + F+ E + + L HP +V +Y
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 457 CCIEGNQLLLIYEYLENNSLARAL----------FEHRLKLDWPTRRRICLGIARGLAYL 506
C +G+ + Y+E +L L E K I I + Y+
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYV 129
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK---LDEEE--------------NTH 549
H S+ V+HRD+K N+LL I D+G A L+EE+ +
Sbjct: 130 H--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMT 186
Query: 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
I ++ GT YMAPE + +E D+Y+ G++ ++++
Sbjct: 187 IPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 55/210 (26%), Positives = 105/210 (50%), Gaps = 12/210 (5%)
Query: 393 NNFATDNNIGEGGFGPVYK-GLLADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPN 450
++F + +G G G V K G +A K + + K R + I E+ ++ P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+V YG ++ + E+++ SL + L E + ++ ++ + + RGLAYL +
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKH 123
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAPEYAMR 568
+I +HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE
Sbjct: 124 QI--MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQG 176
Query: 569 GHLTEKADVYSFGIVALEIVSGRSNVTKED 598
H + ++D++S G+ +E+ GR + D
Sbjct: 177 THYSVQSDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 6e-15
Identities = 65/200 (32%), Positives = 109/200 (54%), Gaps = 19/200 (9%)
Query: 401 IGEGGFGPVY---KGLLAD-GTAIAVKQLSSKS-KQGNR-EFINEIGMISALQHPNLVKL 454
+G+G FG V+ K D G A+K L + K +R E +++ + HP +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 455 -YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
Y EG +L LI ++L L L + + + + + +A L +LH +
Sbjct: 64 HYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLHS---LG 118
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAPEYAMR-GH 570
+++RD+K N+LLD++ + K++DFGL+K +D E+ + GT+ YMAPE R GH
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---SFCGTVEYMAPEVVNRRGH 175
Query: 571 LTEKADVYSFGIVALEIVSG 590
T+ AD +SFG++ E+++G
Sbjct: 176 -TQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 9e-15
Identities = 61/216 (28%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 401 IGEGGFGPVYKGL--LADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLYGC 457
+GEG + V+KG L + +A+K++ + ++G I E+ ++ L+H N+V L+
Sbjct: 14 LGEGTYATVFKGRSKLTE-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 458 CIEGNQLLLIYEYLENN------SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
L L++EYL+ + + H +K+ I RGLAY H R
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKI-------FLYQILRGLAYCH---R 122
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RGH 570
KV+HRD+K N+L+++ K++DFGLA+ S V T+ Y P+ +
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSE 181
Query: 571 LTEKADVYSFGIVALEIVSGR---SNVTKEDMFYLL 603
+ + D++ G + E+ SGR T ED +L+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 27/208 (12%)
Query: 401 IGEGGFGPVYKG--LLADGTAIAVKQLSSKSKQGNREF--INEIGMISALQ---HPNLVK 453
IGEG +G V+K L G +A+K++ ++ + I E+ ++ L+ HPN+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 454 LYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLKLDWP-----TRRRICLGIARGL 503
L+ C +L L++E+++ + L + K+ P T + + + RGL
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQD-----LTTYLDKVPEPGVPTETIKDMMFQLLRGL 123
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
+LH +VVHRD+K N+L+ K++DFGLA++ + T V T+ Y AP
Sbjct: 124 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAP 178
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGR 591
E ++ D++S G + E+ +
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 71/269 (26%), Positives = 116/269 (43%), Gaps = 53/269 (19%)
Query: 477 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 536
R EH L L I LA H S+ ++HRDIK+ N+LL + K+ D
Sbjct: 137 NRTFREHEAGL---------LFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGD 186
Query: 537 FGLAKLDEEENTHISTRVAGTIG--------YMAPEYAMRGHLTEKADVYSFGIVALEIV 588
FG +K + V+ +G Y+APE R ++KAD++S G++ E++
Sbjct: 187 FGFSK-------MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELL 239
Query: 589 SGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPT 648
+ + E+M ++ L G+ L + E M I ALL ++ P
Sbjct: 240 TLKRPFDGENMEEVMHKTLA----GRYDPLPP-----SISPE--MQEIVTALLSSD--PK 286
Query: 649 IRPSMSSVLRMLECGV---DVLDLVS----------DSSVSDIDETKAE--AMRKYYQFC 693
RPS S +L M C + +L++V D+ I +TK R+
Sbjct: 287 RRPSSSKLLNMPICKLFISGLLEIVQTQPGFSGPLRDTISRQIQQTKQLLQVERRRIVRQ 346
Query: 694 VENTASTTQSTSSIYGPPPGSSTAGVDLH 722
+E + ST ST+ + G P ++ G+ L+
Sbjct: 347 MEESLSTAASTTILEGATPLTTLGGLTLY 375
|
Length = 496 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQL--SSKSKQGNREFIN----EIGMISALQHPNLVK 453
+G+G FG VY AD G +AVKQ+ +S + ++E +N EI ++ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKE-VNALECEIQLLKNLLHERIVQ 68
Query: 454 LYGCCIEGNQ--LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
YGC + + L + E++ S+ L + L R+ I G++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSN-- 125
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE---ENTHISTRVAGTIGYMAPEYAMR 568
+VHRDIK N+L D N K+ DFG +K + T + + V GT +M+PE
Sbjct: 126 -MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPYWMSPEVISG 183
Query: 569 GHLTEKADVYSFGIVALEIVSGR 591
KAD++S G +E+++ +
Sbjct: 184 EGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 62/205 (30%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
IGEG +G VYK IA+K+ L + + I EI ++ +QH N+V+L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 458 CIEGNQLLLIYEYLE------NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
+L L++EYL+ +S RL + I RG+AY H
Sbjct: 70 VHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLI------KTYLYQILRGIAYCHSH-- 121
Query: 512 IKVVHRDIKATNVLLDKDLNS-KISDFGLAK---LDEEENTHISTRVAGTIGYMAPEYAM 567
+V+HRD+K N+L+D+ N+ K++DFGLA+ + TH T+ Y APE +
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV----TLWYRAPEILL 176
Query: 568 RG-HLTEKADVYSFGIVALEIVSGR 591
H + D++S G + E+V+ +
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 37/101 (36%), Positives = 59/101 (58%), Gaps = 1/101 (0%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
L Q L G +P +++L LQ I+L N ++G IP L +I++L L + YN F+G +PE
Sbjct: 425 LDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPE 484
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTF-AKLTNMKDFRISDN 123
LG L +L L+L+ N+ +G +P +L + F +DN
Sbjct: 485 SLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 1e-14
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 452
+F IG G +G VYK + G A+K + + + EI M+ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
+G + ++L + E+ SL + ++ L + +GL YLH + ++
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSL-QDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA------GTIGYMAPEYA 566
HRDIK N+LL + + K++DFG++ I+ +A GT +MAPE A
Sbjct: 129 ---HRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMAPEVA 178
Query: 567 M---RGHLTEKADVYSFGIVALEI 587
+G + D+++ GI A+E+
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 65/200 (32%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKS---KQGNREFINE---IGMISALQHPNLVK 453
IG GGFG VY AD G A+K L K KQG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
+ ++L I + + L L +H + R I GL ++H
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV-FSEKEMRFYATEIILGLEHMHNRF--- 117
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
VV+RD+K N+LLD+ + +ISD GLA ++ H S GT GYMAPE +G +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGTAYD 174
Query: 574 -KADVYSFGIVALEIVSGRS 592
AD +S G + +++ G S
Sbjct: 175 SSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-14
Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 401 IGEGGFGPVYK-GLLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 456
+G+GGFG V + A G A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG--IARGLAYLHGESRIKV 514
+ L L+ + L ++ H + + R + I GL LH E ++
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFEEGRAVFYAAEICCGLEDLHQE---RI 123
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 574
V+RD+K N+LLD + +ISD GLA E T I RV GT+GYMAPE T
Sbjct: 124 VYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTFS 181
Query: 575 ADVYSFGIVALEIVSGRS 592
D ++ G + E+++G+S
Sbjct: 182 PDWWALGCLLYEMIAGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.4 bits (181), Expect = 2e-14
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 14/221 (6%)
Query: 401 IGEGGFGPVYK-GLLADGTAIAVKQLSSKSKQGNR--EFI-NEIGMISALQHPNLVKLYG 456
+G GGFG V + + A+K + + E I +E ++ HP +VKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+ + ++ EY L L + L D T R + YLH +++
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL-FDEYTARFYIACVVLAFEYLH---NRGIIY 116
Query: 517 RDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAM-RGHLTEK 574
RD+K N+LLD + K+ DFG AK L + T T GT Y+APE + +G+
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW--TFC-GTPEYVAPEIILNKGY-DFS 172
Query: 575 ADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 615
D +S GI+ E+++GR ++D + + +LK GKL
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKL 213
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
+GEG +G V K + G +A+K+ S K + + EI M+ L+H NLV L
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 458 CIEGNQLLLIYEYLENNSLAR-ALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+L L++E++++ L + + LD R+ I RG+ + H + ++H
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN---IIH 123
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA- 575
RDIK N+L+ + K+ DFG A+ + VA T Y APE + +A
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAPELLVGDTKYGRAV 182
Query: 576 DVYSFGIVALEIVSG 590
D+++ G + E+++G
Sbjct: 183 DIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 59/210 (28%), Positives = 103/210 (49%), Gaps = 25/210 (11%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLY---- 455
+G G G V+ + +D +AVK++ Q + + EI +I L H N+VK+Y
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 456 ----------GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 505
G E N + ++ EY+E + LA L + L + R + RGL Y
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYMETD-LANVLEQGPLSEEHA--RLFMYQLLRGLKY 129
Query: 506 LHGESRIKVVHRDIKATNVLLD-KDLNSKISDFGLAKLDEEENTHISTRVAGTIG--YMA 562
+H + V+HRD+K NV ++ +DL KI DFGLA++ + +H G + Y +
Sbjct: 130 IHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRS 186
Query: 563 PEYAMR-GHLTEKADVYSFGIVALEIVSGR 591
P + + T+ D+++ G + E+++G+
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 61/210 (29%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 386 LQIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI--NEIGM 442
+ + +++ +G G +G VYK L G AVK + K + G+ + EI M
Sbjct: 2 ILRRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKII--KLEPGDDFSLIQQEIFM 59
Query: 443 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARG 502
+ +H N+V +G + +L + EY SL + ++ L +C +G
Sbjct: 60 VKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL-QDIYHVTGPLSELQIAYVCRETLQG 118
Query: 503 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA--GTIGY 560
LAYLH + ++ HRDIK N+LL + + K++DFG+A + I+ R + GT +
Sbjct: 119 LAYLHSKGKM---HRDIKGANILLTDNGDVKLADFGVAA---KITATIAKRKSFIGTPYW 172
Query: 561 MAPEYAM---RGHLTEKADVYSFGIVALEI 587
MAPE A G + D+++ GI A+E+
Sbjct: 173 MAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 3e-14
Identities = 74/274 (27%), Positives = 130/274 (47%), Gaps = 41/274 (14%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLS------------SKSKQGNREFINEIGMISALQH 448
+G+G FG VY L+ D A+A ++L +++ Q N+E ++S L H
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSKLDH 61
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRIC---LGIARGLAY 505
P +VK + +E + +I EY E L L E + + ++C + + G+ Y
Sbjct: 62 PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 565
+H + RI +HRD+KA N+ L +L KI DFG+++L + ++T GT YM+PE
Sbjct: 122 MH-QRRI--LHRDLKAKNIFLKNNL-LKIGDFGVSRL-LMGSCDLATTFTGTPYYMSPEA 176
Query: 566 AMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMELVDTNPG 624
K+D++S G + E+ ++ ++VL+ +G L +T
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL-----SVVLRIVEGPTPSLPETYS- 230
Query: 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
Q+ ++ L N P++RPS + +LR
Sbjct: 231 -----RQLNSIMQSML---NKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 64/205 (31%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGC- 457
IG+G +G V+K L +G+ AVK L + E E ++ AL HPN+VK YG
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDP-IHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 458 ----CIEGNQLLLIYEYLENNS---LARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
G+QL L+ E S L + + +++ P I GL +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN- 143
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY----- 565
K +HRD+K N+LL + K+ DFG++ +T V GT +MAPE
Sbjct: 144 --KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 200
Query: 566 AMRGHLTEKADVYSFGIVALEIVSG 590
+ + DV+S GI A+E+ G
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 3e-14
Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 30/208 (14%)
Query: 401 IGEGGFGPVYKGLLADGTAIA---VKQL--SSKSKQGNREFINEIGMISALQHPNLVKLY 455
IG G FG V + T +A VK+L ++ SK+ N EF+ + LQHPN+++
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN-EFLQQGDPYRILQHPNILQCL 61
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR-------RRICLGIARGLAYLHG 508
G C+E LL++EY E L L + W R +R+ IA G+ ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE----QWHRRNSQLLLLQRMACEIAAGVTHMH- 116
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST--RVAGTIGYMAPEYA 566
+ +H D+ N L DL K+ D+G+ +E+ +I T + ++APE
Sbjct: 117 --KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED-YIETEDDKCVPLRWLAPELV 173
Query: 567 MRGH-------LTEKADVYSFGIVALEI 587
H T+ ++V++ G+ E+
Sbjct: 174 GEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 52/158 (32%), Positives = 78/158 (49%), Gaps = 7/158 (4%)
Query: 442 MISALQHPNLVKLYGCCIEGNQ-LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIA 500
+ A +HP L L+ C + + L + EYL L + + + D R I
Sbjct: 49 LALAWEHPFLTHLF-CTFQTKEHLFFVMEYLNGGDLMFHI-QSSGRFDEARARFYAAEII 106
Query: 501 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 560
GL +LH + +++RD+K NVLLDKD + KI+DFG+ K + ST GT Y
Sbjct: 107 CGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDY 162
Query: 561 MAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED 598
+APE E D +SFG++ E++ G+S ED
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 401 IGEGGFGPVYKG---LLADGTAIAVKQLSSKSKQG--NREFINEIGMISALQHPNLVKLY 455
+G G FG V KG + +AVK L + + E + E ++ L +P +V++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G C E +L+ E E L + L +++ + + ++ G+ YL + V
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETN---FV 117
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTE 573
HRD+ A NVLL +KISDFGL+K L +EN + T + + APE +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 574 KADVYSFGIVALEIVS 589
K+DV+SFG++ E S
Sbjct: 178 KSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 63/198 (31%), Positives = 95/198 (47%), Gaps = 16/198 (8%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKS---KQGNREFINEIG-MISALQHPNLV 452
IG+G FG V LLA + AVK L K+ K+ + ++E ++ ++HP LV
Sbjct: 3 IGKGSFGKV---LLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
L+ ++L + +Y+ L L R L+ P R IA L YLH +
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE-PRARFYAAEIASALGYLHS---L 115
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
+V+RD+K N+LLD + ++DFGL K + E N ST GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST-FCGTPEYLAPEVLHKQPYD 174
Query: 573 EKADVYSFGIVALEIVSG 590
D + G V E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 54/214 (25%), Positives = 99/214 (46%), Gaps = 42/214 (19%)
Query: 403 EGGFGPVYKGLLADGTAIAVKQLSSKS-KQGNRE-----FINEIGMISALQHPNLVKLYG 456
EG FG ++ G+L D +++ K+ K E + E ++ L H N++ +
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 457 CCIEGNQ---LLLIYE-------YLENNSLARALFEHRLKLDWPTRRRICLG--IARGLA 504
CIE + +L Y +L+ L A L T++ + + IA G++
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS----TQQLVHMAIQIACGMS 131
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK---------LDEEENTHISTRVA 555
YLH + V+H+DI A N ++D++L KI+D L++ L + EN +
Sbjct: 132 YLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK---- 184
Query: 556 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
+MA E + + +DV+SFG++ E+++
Sbjct: 185 ----WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 5e-14
Identities = 56/197 (28%), Positives = 93/197 (47%), Gaps = 23/197 (11%)
Query: 417 GTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLY--GCCIEGNQLLLIYEYL 471
G +A+K L + + + + F E + + L HPN+V L G G L ++EY+
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPG-LLFAVFEYV 61
Query: 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DK 528
+L R + L R+ L + LA H +VHRD+K N+++
Sbjct: 62 PGRTL-REVLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQTGV 117
Query: 529 DLNSKISDFGLAKL-------DEEENTHISTRVAGTIGYMAPEYAMRGH-LTEKADVYSF 580
++K+ DFG+ L D T +T V GT Y APE +RG +T +D+Y++
Sbjct: 118 RPHAKVLDFGIGTLLPGVRDADVATLT-RTTEVLGTPTYCAPE-QLRGEPVTPNSDLYAW 175
Query: 581 GIVALEIVSGRSNVTKE 597
G++ LE ++G+ V
Sbjct: 176 GLIFLECLTGQRVVQGA 192
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 39/112 (34%), Positives = 59/112 (52%), Gaps = 10/112 (8%)
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTI 558
I RGL YLH ++HRDIK N+L++ + KI DFGLA+++E + + T+ T
Sbjct: 112 ILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 559 GYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGR------SNVTKEDMFYLL 603
Y APE M H T D++S G + E++ R S + + D+ L
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDL 220
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 22/203 (10%)
Query: 399 NNIGEGGFGPVYKGL--LADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLY 455
+ +GEG + VYKG L D +A+K++ + ++G I E+ ++ L+H N+V L+
Sbjct: 12 DKLGEGTYATVYKGRSKLTD-NLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70
Query: 456 GCCIEGNQLLLIYEYLENN------SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
L L++EYL+ + ++ H +KL + RGL Y H
Sbjct: 71 DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKL-------FLFQLLRGLNYCH-- 121
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-R 568
R KV+HRD+K N+L+++ K++DFGLA+ S V T+ Y P+ +
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGS 179
Query: 569 GHLTEKADVYSFGIVALEIVSGR 591
+ + D++ G + E+ +GR
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 6e-14
Identities = 60/205 (29%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ--GNREFINEIGMISALQHPNLVKLYGC 457
IGEG +G V G +A+K++S Q R + EI ++ +H N++ +
Sbjct: 13 IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRT-LREIKILRRFKHENIIGILDI 71
Query: 458 CIEG-----NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL---GIARGLAYLHGE 509
N + ++ E +E + L + + L D I I RGL Y+H
Sbjct: 72 IRPPSFESFNDVYIVQELMETD-LYKLIKTQHLSND-----HIQYFLYQILRGLKYIHSA 125
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD--EEENTHISTRVAGTIGYMAPEYAM 567
+ V+HRD+K +N+LL+ + + KI DFGLA++ E ++T T T Y APE +
Sbjct: 126 N---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIML 182
Query: 568 RGHLTEKA-DVYSFGIVALEIVSGR 591
KA D++S G + E++S R
Sbjct: 183 NSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 65/200 (32%), Positives = 94/200 (47%), Gaps = 15/200 (7%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKS---KQGNREFINE---IGMISALQHPNLVK 453
IG GGFG VY AD G A+K L K KQG +NE + ++S P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
+ ++L I + + L L +H + R I GL ++H
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEAEMRFYAAEIILGLEHMHNRF--- 117
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLT 572
VV+RD+K N+LLD+ + +ISD GLA ++ H S GT GYMAPE +G
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGVAYD 174
Query: 573 EKADVYSFGIVALEIVSGRS 592
AD +S G + +++ G S
Sbjct: 175 SSADWFSLGCMLFKLLRGHS 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 394 NFATDNNIGEGGFGPVY----KGLLADGTAIAVKQLSSKS---KQGNREFI-NEIGMISA 445
NF +G G +G V+ G G A+K L + K E E ++ A
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 446 LQH-PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG-IARGL 503
++ P LV L+ +L LI +Y+ L L+ R + R+ + I L
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFT-ESEVRVYIAEIVLAL 118
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
+LH ++ +++RDIK N+LLD + + ++DFGL+K E + GTI YMAP
Sbjct: 119 DHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175
Query: 564 EYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKED 598
E GH + D +S G++ E+++G S T +
Sbjct: 176 EVIRGGSGGH-DKAVDWWSLGVLTFELLTGASPFTVDG 212
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 62/198 (31%), Positives = 91/198 (45%), Gaps = 16/198 (8%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKS----KQGNREFINEIGMISALQHPNLV 452
IG+G FG V LLA DG+ AVK L K+ K+ N ++ L+HP LV
Sbjct: 3 IGKGSFGKV---LLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
L+ +L + +Y+ L L R L+ P R +A + YLH +
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLE-PRARFYAAEVASAIGYLHS---L 115
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
+++RD+K N+LLD + ++DFGL K E ST GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKEPYD 174
Query: 573 EKADVYSFGIVALEIVSG 590
D + G V E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 55/205 (26%), Positives = 97/205 (47%), Gaps = 15/205 (7%)
Query: 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSS--KSKQGNREFINEIGMISALQH 448
TN + +G G FG V G +A+K++ + + E+ ++ L+H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 508
N++ L I + + L L R L L+ + + I RGL Y+H
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFI--QYFLYQILRGLKYVHS 126
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAM 567
VVHRD+K +N+L++++ + KI DFGLA++ + + T ++STR Y APE +
Sbjct: 127 AG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIML 178
Query: 568 RGH-LTEKADVYSFGIVALEIVSGR 591
+ D++S G + E++ G+
Sbjct: 179 TWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 12/202 (5%)
Query: 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNL 451
+F +G G G V K L G +A K + + K R + I E+ ++ P +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61
Query: 452 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
V YG ++ + E+++ SL + L + ++ +I + + RGL YL +
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREK-- 118
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAPEYAMRG 569
K++HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE
Sbjct: 119 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQGT 173
Query: 570 HLTEKADVYSFGIVALEIVSGR 591
H T ++D++S G+ +E+ GR
Sbjct: 174 HYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 52/210 (24%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPN 450
++F + +G G G V+K G +A K + + K R + I E+ ++ P
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+V YG ++ + E+++ SL + L + ++ ++ + + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKVSIAVIKGLTYL--RE 121
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYMAPEYAMR 568
+ K++HRD+K +N+L++ K+ DFG++ +D N+ + TR YM+PE
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTR-----SYMSPERLQG 176
Query: 569 GHLTEKADVYSFGIVALEIVSGRSNVTKED 598
H + ++D++S G+ +E+ GR + D
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 52/224 (23%), Positives = 104/224 (46%), Gaps = 36/224 (16%)
Query: 398 DNNIGEGGFGPVYKGL-LADGTAIAVKQLS----SKSKQGNREFINEIGM---------- 442
++GEG +G V K G +A+K++ S +R+ + G+
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 443 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARG 502
++ ++H N++ L +EG+ + L+ + + ++ + + + +++L + I L I G
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILLQILNG 131
Query: 503 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA----------KLDEEENT---- 548
L LH +HRD+ N+ ++ KI+DFGLA L ++E
Sbjct: 132 LNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 549 HISTRVAGTIGYMAPEYAMRGHLTEKA-DVYSFGIVALEIVSGR 591
++++V T+ Y APE M A D++S G + E+++G+
Sbjct: 189 EMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (176), Expect = 2e-13
Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 34/213 (15%)
Query: 399 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN---------EIGMISALQH 448
IG G +G V + G +A+K++ + F + EI ++ L+H
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 449 PNLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 503
N++ L + N + ++ E +E + L + + + L + I RGL
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMETD-LHK-VIKSPQPLTDDHIQYFLYQILRGL 116
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIGY 560
YLH V+HRD+K +N+L++ + + KI DFGLA+ DE+E ++ V T Y
Sbjct: 117 KYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWY 172
Query: 561 MAPEYAMRG-HLTEKADVYSFG-IVALEIVSGR 591
APE + T+ D++S G I A E+++ +
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFA-ELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 60/206 (29%), Positives = 107/206 (51%), Gaps = 25/206 (12%)
Query: 399 NNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREF----INEIGMISALQHPNLV 452
N I EG +G VY+ G +A+K+L K K+G F + EI ++ LQHPN+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIV 67
Query: 453 KL----YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL--GIARGLAYL 506
+ G + +++ ++ EY+E++ ++L E +K + CL + G+A+L
Sbjct: 68 TVKEVVVGSNL--DKIYMVMEYVEHD--LKSLMET-MKQPFLQSEVKCLMLQLLSGVAHL 122
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 566
H ++HRD+K +N+LL+ KI DFGLA+ + T++ T+ Y APE
Sbjct: 123 H---DNWILHRDLKTSNLLLNNRGILKICDFGLAR-EYGSPLKPYTQLVVTLWYRAPELL 178
Query: 567 M-RGHLTEKADVYSFGIVALEIVSGR 591
+ + D++S G + E+++ +
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 61/210 (29%), Positives = 94/210 (44%), Gaps = 17/210 (8%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNREFINEIGMIS------ALQHPNLVK 453
+G+G FG V+ L A+K L + + E M+ A +HP L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDV--ECTMVEKRVLSLAWEHPFLTH 60
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
LY L + EYL L + + K D P I GL +LH +
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHI-QSCHKFDLPRATFYAAEIICGLQFLHSKG--- 116
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
+V+RD+K N+LLD D + KI+DFG+ K + + T GT Y+APE +
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDYIAPEILLGQKYNT 175
Query: 574 KADVYSFGIVALEIVSGRS---NVTKEDMF 600
D +SFG++ E++ G+S +E++F
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 6e-13
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 5/158 (3%)
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 506
+HP L +L+ C ++L + EY+ L + + D P R I GL +L
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFL 112
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 566
H +++RD+K NVLLD + + KI+DFG+ K ST GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST-FCGTPDYIAPEIL 168
Query: 567 MRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD 604
D ++ G++ E+++G+S +D L
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 31/204 (15%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ----HPNLVKLY 455
IGEG F V K G A+K + K + E +N + I AL+ HPN+++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64
Query: 456 GCCIE--GNQLLLIYEYLENNSLARALFE----HRLKLDWPTRRRICLGIARGLAYLHGE 509
+ +L L++E ++ N L+E + L + + + L ++H
Sbjct: 65 EVLFDRKTGRLALVFELMDMN-----LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH-- 117
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENT-HISTRVAGTIGYMAPEYA 566
R + HRDIK N+L+ D+ K++DFG + + T +ISTR Y APE
Sbjct: 118 -RNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTR-----WYRAPECL 170
Query: 567 MR-GHLTEKADVYSFGIVALEIVS 589
+ G+ K D+++ G V EI+S
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 401 IGEGGFGPVYKGLLADGTA----IAVKQLSS----KSKQGNREFINEIGMISALQHPNLV 452
+G+GG+G V++ G A+K L ++++ E ++ A++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL---GIARGLAYLHGE 509
L G +L LI EYL L F H + C I+ L +LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSEISLALEHLH-- 117
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 569
+ +++RD+K N+LLD + K++DFGL K E T T GTI YMAPE MR
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT-FCGTIEYMAPEILMRS 175
Query: 570 HLTEKADVYSFGIVALEIVSGRSNVTKED 598
+ D +S G + ++++G T E+
Sbjct: 176 GHGKAVDWWSLGALMYDMLTGAPPFTAEN 204
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 61/198 (30%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKS---KQGNREFINEIG-MISALQHPNLV 452
IG+G FG V LA DG AVK L K+ K+ + + E ++ ++HP LV
Sbjct: 3 IGKGSFGKVL---LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
L+ ++L + +Y+ L L R + P R IA L YLH +
Sbjct: 60 GLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPE-PRARFYAAEIASALGYLHS---L 115
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
+++RD+K N+LLD + ++DFGL K E + ST GT Y+APE +
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQPYD 174
Query: 573 EKADVYSFGIVALEIVSG 590
D + G V E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 18/204 (8%)
Query: 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS----KQGNREFINEIGMISALQH 448
+ +G G FG V+ A+K ++ KQ + NE ++ + H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSH 60
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 508
P +++L+ + L ++ EY+ L L + + T I L YLH
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPE-YA 566
+ +V+RD+K N+LLDK+ + K++DFG AK L + T + GT Y+APE
Sbjct: 120 KE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGTPEYLAPEVIQ 171
Query: 567 MRGHLTEKADVYSFGIVALEIVSG 590
+GH + D ++ GI+ E++ G
Sbjct: 172 SKGH-NKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 51/202 (25%), Positives = 99/202 (49%), Gaps = 20/202 (9%)
Query: 399 NNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLYG 456
+ +GEG + V+KG +A+K++ + ++G I E+ ++ L+H N+V L+
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70
Query: 457 CCIEGNQLLLIYEYLENN------SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
L L++EYL+++ + + H +K+ + RGL+Y H
Sbjct: 71 IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKI-------FMFQLLRGLSYCH--- 120
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RG 569
+ K++HRD+K N+L+++ K++DFGLA+ S V T+ Y P+ +
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGST 179
Query: 570 HLTEKADVYSFGIVALEIVSGR 591
+ D++ G + E+ +GR
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 56/205 (27%), Positives = 99/205 (48%), Gaps = 33/205 (16%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQL----SSKSKQGNREFINEIGMISALQHPNLV 452
+GEG FG + LL A+K++ SS + + +R+ E +++ ++HPN+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHPNIV 61
Query: 453 KLYGCCIEGN-QLLLIYEYLENNSLARA-------LFEHRLKLDWPTRRRICLGIARGLA 504
+ E + L ++ EY + L + LF L W + +CLG+
Sbjct: 62 A-FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ--MCLGVQ---- 114
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
++H + +V+HRDIK+ N+ L ++ K+ DFG A+L + T V GT Y+ PE
Sbjct: 115 HIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPE 170
Query: 565 YAMRGHLTEKADVYSFGIVALEIVS 589
K+D++S G + E+ +
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 60/211 (28%), Positives = 95/211 (45%), Gaps = 17/211 (8%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 456
+G+GGFG V + + G A K+L K K G + + E ++ + P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 457 CCIEGNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
L L+ + L ++ L+ I G+ +LH + +V
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 575
+RD+K NVLLD N ++SD GLA E ++ T+ AGT GYMAPE +
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAV--ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV 175
Query: 576 DVYSFGIVALEIVSGRS-------NVTKEDM 599
D ++ G E+V+GR+ V KE++
Sbjct: 176 DWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 401 IGEGGFGPVYK-GLLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 456
+G+GGFG V + A G A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR------RICLGIARGLAYLHGES 510
+ L L+ + L ++ + + R I G L LH E
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIY-NMGNPGFDEERAVFYAAEITCG----LEDLHRE- 121
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 570
++V+RD+K N+LLD + +ISD GLA ++ E I RV GT+GYMAPE
Sbjct: 122 --RIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRV-GTVGYMAPEVVKNER 177
Query: 571 LTEKADVYSFGIVALEIVSGRS 592
T D + G + E++ G+S
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 3e-12
Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 8/193 (4%)
Query: 401 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLYGCC 458
+GEG + VYKG +G +A+K + + ++G I E ++ L+H N+V L+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
L L++EY+ + L + + +H L + + RGL+Y+H ++HRD
Sbjct: 73 HTKETLTLVFEYVHTD-LCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRD 128
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RGHLTEKADV 577
+K N+L+ K++DFGLA+ + S V T+ Y P+ + + D+
Sbjct: 129 LKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYSTCLDM 187
Query: 578 YSFGIVALEIVSG 590
+ G + +E++ G
Sbjct: 188 WGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 4e-12
Identities = 33/95 (34%), Positives = 57/95 (60%), Gaps = 10/95 (10%)
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGT 557
I RGL Y+H ++HRD+K +N+ +++D KI DFGLA+ ++E T +++TR
Sbjct: 127 ILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR---- 179
Query: 558 IGYMAPEYAM-RGHLTEKADVYSFGIVALEIVSGR 591
Y APE + H + D++S G + E+++G+
Sbjct: 180 -WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 56/201 (27%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN-REFINEIGMISALQHPNLVKLYGCC 458
+G+G +G VYK L G +A+K++ + + + I E+ ++ P +V YG
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 459 IEGNQLLLIYEYLENNSLAR--ALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+ + EY++ SL + A + RRI + +GL +L E I +H
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI--IH 126
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY------AMRGH 570
RD+K TNVL++ + K+ DFG++ ++ G YMAPE
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVAS---LAKTNIGCQSYMAPERIKSGGPNQNPT 183
Query: 571 LTEKADVYSFGIVALEIVSGR 591
T ++DV+S G+ LE+ GR
Sbjct: 184 YTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 5e-12
Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 26/158 (16%)
Query: 442 MISALQHPNLVKLYGCCIEGNQLLLI--------YEYLENNSLARALFEHRLKLDWPTRR 493
++ + HP+++++ + G ++ Y YL S R L P +
Sbjct: 110 LLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRS--RPL---------PIDQ 158
Query: 494 RICL--GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551
+ + I GL YLH + +++HRD+K N+ ++ I D G A+ +
Sbjct: 159 ALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG 215
Query: 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
+AGT+ APE R KAD++S GIV E+++
Sbjct: 216 --LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251
|
Length = 357 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREF---INEIGMIS-ALQHPNLV 452
+G+G FG V +LA G AVK L + + + E ++S A HP L
Sbjct: 3 LGKGSFGKV---MLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 59
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
+LY C ++L + E++ L + + R + D R I L +LH +
Sbjct: 60 QLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKG-- 116
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
+++RD+K NVLLD + + K++DFG+ K + N ++ GT Y+APE
Sbjct: 117 -IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLYG 174
Query: 573 EKADVYSFGIVALEIVSGRSNV---TKEDMF 600
D ++ G++ E++ G + ++D+F
Sbjct: 175 PSVDWWAMGVLLYEMLCGHAPFEAENEDDLF 205
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 6e-12
Identities = 71/286 (24%), Positives = 122/286 (42%), Gaps = 55/286 (19%)
Query: 400 NIGEGGFGPVYKGL---LADG-----TAIAVKQLSSKSKQGNREFINEIGMISALQHPNL 451
++G+G F ++KG+ + D T + +K L + + F M+S L H +L
Sbjct: 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHL 61
Query: 452 VKLYGCCIEGNQLLLIYEYLENNSLARALFE--HRLKLDWPTRRRICLGIARGLAY-LHG 508
V YG C+ G++ +++ EY++ SL L + + + + W L +A+ LA+ LH
Sbjct: 62 VLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALHF 115
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT------IGYMA 562
+ H ++ A NVLL ++ + K + KL + IS V I ++
Sbjct: 116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD---PGISITVLPKEILLERIPWVP 172
Query: 563 PEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621
PE +L+ AD +SFG EI SG K + +D+
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGD---------------------KPLSALDS 211
Query: 622 NPGSNF--DKEQVMV--MINVALL---CANASPTIRPSMSSVLRML 660
F D+ Q+ +A L C + P RPS +++R L
Sbjct: 212 QKKLQFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 8e-12
Identities = 55/207 (26%), Positives = 97/207 (46%), Gaps = 21/207 (10%)
Query: 401 IGEGGFGPVYKGLLA--DGT--AIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKL 454
+G+G FG V + L DG+ +AVK L + S EF+ E + HPN++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 455 YGCCIEGNQL------LLIYEYLENNSLARALFEHRL-----KLDWPTRRRICLGIARGL 503
G + ++I ++++ L L R+ L T R + IA G+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG-TIGYMA 562
YL S +HRD+ A N +L++++ ++DFGL+K + + + + ++A
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183
Query: 563 PEYAMRGHLTEKADVYSFGIVALEIVS 589
E T +DV++FG+ EI++
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 55/158 (34%), Positives = 80/158 (50%), Gaps = 17/158 (10%)
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR--RICLG-IARGL 503
Q P LV L+ +L LI +Y+ + F H + D + R G I L
Sbjct: 63 QSPFLVTLHYAFQTEAKLHLILDYVSGGEM----FTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYM 561
+LH ++ +V+RDIK N+LLD + + ++DFGL+K L EE+ S GTI YM
Sbjct: 119 EHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS--FCGTIEYM 173
Query: 562 APEY--AMRGHLTEKADVYSFGIVALEIVSGRSNVTKE 597
APE GH + D +S GI+ E+++G S T E
Sbjct: 174 APEIIRGKGGH-GKAVDWWSLGILIFELLTGASPFTLE 210
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 55/204 (26%), Positives = 92/204 (45%), Gaps = 11/204 (5%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADGTAI-AVKQLSSKSKQGNREF----INEIGMISALQ 447
N F +GEG +G V K + I A+K+ K + N E + E+ M+ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLK 58
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 507
N+V+L +L L++EY+E N L L E + R + + + + H
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 567
+ +VHRDIK N+L+ + K+ DFG A+ E + T T Y +PE +
Sbjct: 118 ---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174
Query: 568 RGHLTEKADVYSFGIVALEIVSGR 591
+ D++S G + E+ G+
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 63/204 (30%), Positives = 93/204 (45%), Gaps = 24/204 (11%)
Query: 401 IGEGGFGPVYK-GLLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 456
+G+GGFG V + A G A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67
Query: 457 CCIEGNQLLLIYEYLENNSLARAL-------FEHRLKLDWPTRRRICLGIARGLAYLHGE 509
+ L L+ + L + FE L + I GL LH E
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE------ILCGLEDLHRE 121
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPEYAMR 568
+ V+RD+K N+LLD + +ISD GLA K+ E E+ I RV GT+GYMAPE
Sbjct: 122 N---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVLNN 175
Query: 569 GHLTEKADVYSFGIVALEIVSGRS 592
T D + G + E++ G+S
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQS 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 30/210 (14%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQH-PNLVKLYG 456
IGEG +G VYK G +A+K+ L + + EI ++ L +V+L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL- 67
Query: 457 CCIEGN-------QLLLIYEYLENNSLARALFEHRLK----LDWPTRRRICLGIARGLAY 505
+E L L++EYL+++ L + + + L T + + +G+A+
Sbjct: 68 -DVEHVEEKNGKPSLYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAH 125
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNS-KISDFGLAK---LDEEENTHISTRVAGTIGYM 561
H V+HRD+K N+L+DK KI+D GL + + + TH T+ Y
Sbjct: 126 CHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TLWYR 178
Query: 562 APEYAMRG-HLTEKADVYSFGIVALEIVSG 590
APE + H + D++S G + E+
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 52/201 (25%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREF--INEIGMISALQ---HPNLVKL 454
IG G +G VYK G +A+K + ++ + + E+ ++ L+ HPN+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 455 YGCCIEGN-----QLLLIYEYLENNSLARALFEHRLKLDWP--TRRRICLGIARGLAYLH 507
C ++ L++E+++ + R + P T + + RGL +LH
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQD--LRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS-TRVAGTIGYMAPEYA 566
+VHRD+K N+L+ K++DFGLA++ + ++ T V T+ Y APE
Sbjct: 126 AN---CIVHRDLKPENILVTSGGQVKLADFGLARI---YSCQMALTPVVVTLWYRAPEVL 179
Query: 567 MRGHLTEKADVYSFGIVALEI 587
++ D++S G + E+
Sbjct: 180 LQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 60/198 (30%), Positives = 89/198 (44%), Gaps = 16/198 (8%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 452
IG+G FG V LLA DG AVK L K +E + + ++ ++HP LV
Sbjct: 3 IGKGSFGKV---LLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
L+ +L + +++ L L R P R IA L YLH I
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRER-SFPEPRARFYAAEIASALGYLHS---I 115
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
+V+RD+K N+LLD + ++DFGL K + + +T GT Y+APE +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 573 EKADVYSFGIVALEIVSG 590
D + G V E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 26/215 (12%)
Query: 395 FATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLS-SKSKQGNREF----INEIGMISALQH 448
F IGEG +G VYK D G +A+K++ K+G F I EI ++ L H
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNH 65
Query: 449 PNLVKLYGCCIEGNQLL----------LIYEYLENNSLARALFEHRL-KLDWPTRRRICL 497
N+V L + L L++EY++++ + L E L +
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMG--LLESGLVHFSEDHIKSFMK 123
Query: 498 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT 557
+ GL Y H ++ +HRDIK +N+LL+ K++DFGLA+L E + T T
Sbjct: 124 QLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180
Query: 558 IGYMAPEYAM-RGHLTEKADVYSFGIVALEIVSGR 591
+ Y PE + DV+S G + E+ + +
Sbjct: 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 401 IGEGGFGPVYKGLLADGTAI-AVKQLSSKSKQGNREFINEIGMISALQH------PNLVK 453
IG+G FG VY+ D I A+K LS K +E + IG + L P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR---GLAYLHGES 510
L + L L+ +Y+ L F H K + R IA L +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFSEDRAKFYIAELVLALEHLH--- 113
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM--R 568
+ +V+RD+K N+LLD + + DFGL+K + +N +T GT Y+APE + +
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT-FCGTTEYLAPEVLLDEK 172
Query: 569 GHLTEKADVYSFGIVALEIVSGRSNVTKED 598
G+ T+ D +S G++ E+ G S ED
Sbjct: 173 GY-TKHVDFWSLGVLVFEMCCGWSPFYAED 201
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 62/275 (22%), Positives = 108/275 (39%), Gaps = 40/275 (14%)
Query: 417 GTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 474
T +AVK+ L S SK+ + EI LQHPN++ I ++L ++ +
Sbjct: 25 NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84
Query: 475 SLARALFEHRLKLDWPTR--RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 532
S L + P I + L Y+H +HR +KA+++LL D
Sbjct: 85 S-CEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKV 140
Query: 533 KISDF----GLAKLDEEENT-HISTR-VAGTIGYMAPEY---AMRGHLTEKADVYSFGIV 583
+S + K + + H + + +++PE ++G+ EK+D+YS GI
Sbjct: 141 VLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGIT 199
Query: 584 ALEIVSGR---SNVTKEDMF---------YLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631
A E+ +G ++ M LLD + + + + +N N +++
Sbjct: 200 ACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPN-NRDS 258
Query: 632 VMVMIN---------VALLCANASPTIRPSMSSVL 657
V LC P RPS S +L
Sbjct: 259 VDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 4e-11
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 43/215 (20%)
Query: 401 IGEGGFGPVYKGLLAD---GTAIAVK------QLSSKSKQGNRE--FINEIGMISALQHP 449
+G+G +G V+K + D +A+K + ++ +++ RE F+ E+G HP
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG-----DHP 67
Query: 450 NLVKLYGC--CIEGNQLLLIYEYLE---NNSLARALFE--HRLKLDWPTRRRICLGIARG 502
N+VKL + L++EY+E + + + E H+ R I + +
Sbjct: 68 NIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHK--------RYIMYQLLKA 119
Query: 503 LAYLH-GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK----LDEEENTHISTRVAGT 557
L Y+H G V+HRD+K +N+LL+ D K++DFGLA+ L+E + T T
Sbjct: 120 LKYIHSGN----VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 558 IGYMAPEYAMRGHLTEKA-DVYSFGIVALEIVSGR 591
Y APE + K D++S G + E++ G+
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 4e-11
Identities = 44/147 (29%), Positives = 73/147 (49%), Gaps = 5/147 (3%)
Query: 445 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 504
A +HP L L+ C ++L + EY+ L + R K D P R + L
Sbjct: 52 AAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALM 110
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
+LH R V++RD+K N+LLD + + K++DFG+ K + N +T GT Y+APE
Sbjct: 111 FLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPE 166
Query: 565 YAMRGHLTEKADVYSFGIVALEIVSGR 591
D ++ G++ E+++G+
Sbjct: 167 ILQELEYGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|221187 pfam11721, Malectin, Di-glucose binding within endoplasmic reticulum | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 5e-11
Identities = 27/92 (29%), Positives = 35/92 (38%), Gaps = 22/92 (23%)
Query: 297 YSLHINCGGKQVTANGNTTFEEDT-SEAGPSTFSQSGTNWVLSSTGHFLENGLKLGPYIQ 355
L INCGG + T + T+E DT G + + S TN S G
Sbjct: 1 VVLAINCGGPEHTDSDGITYEADTYFTGGSADYYVSDTNGSSSIAG-------------- 46
Query: 356 TNTSRLLMNDYQLYTTARLSAISLTYYGFYLQ 387
D +LY T R S S +YY L+
Sbjct: 47 -------TTDPELYQTERYSPSSFSYYIPCLE 71
|
Malectin is a membrane-anchored protein of the endoplasmic reticulum that recognises and binds Glc2-N-glycan. It carries a signal peptide from residues 1-26, a C-terminal transmembrane helix from residues 255-274, and a highly conserved central part of approximately 190 residues followed by an acidic, glutamate-rich region. Carbohydrate-binding is mediated by the four aromatic residues, Y67, Y89, Y116, and F117 and the aspartate at D186. NMR-based ligand-screening studies has shown binding of the protein to maltose and related oligosaccharides, on the basis of which the protein has been designated "malectin", and its endogenous ligand is found to be Glc2-high-mannose N-glycan. Length = 164 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 67/232 (28%), Positives = 102/232 (43%), Gaps = 17/232 (7%)
Query: 401 IGEGGFGPVYKGLL----ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVK 453
+G+G FG V +L A G A+K L + +K + E ++ +HP L
Sbjct: 3 LGKGTFGKV---ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTS 59
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
L ++L + EY+ L L R+ + TR I L YLH K
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRF-YGAEIVSALDYLHSG---K 115
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
+V+RD+K N++LDKD + KI+DFGL K + + T GT Y+APE
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGR 174
Query: 574 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625
D + G+V E++ GR +D L + L+L E K + + S
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE--LILMEDIKFPRTLSADAKS 224
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 65/213 (30%), Positives = 92/213 (43%), Gaps = 17/213 (7%)
Query: 401 IGEGGFGPVYKGLL----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQ---HPNLVK 453
+G+G FG V +L A G A+K L + E + + LQ HP L
Sbjct: 3 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 59
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
L ++L + EY L L R+ R I L YLH E
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALDYLHSEK--N 116
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
VV+RD+K N++LDKD + KI+DFGL K ++ + T GT Y+APE
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGR 175
Query: 574 KADVYSFGIVALEIVSGR---SNVTKEDMFYLL 603
D + G+V E++ GR N E +F L+
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 47/154 (30%), Positives = 78/154 (50%), Gaps = 12/154 (7%)
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL---GIARGL 503
Q P LV L+ +L LI +Y+ L F H + + + + + I L
Sbjct: 63 QSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
+LH ++ +++RDIK N+LLD + + ++DFGL+K E+ + GTI YMAP
Sbjct: 119 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 564 EYAMRGHLT-EKA-DVYSFGIVALEIVSGRSNVT 595
+ G +KA D +S G++ E+++G S T
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 5/148 (3%)
Query: 445 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 504
A HP LV L+ C ++L + EY+ L + R KL R I+ L
Sbjct: 52 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALN 110
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
YLH +++RD+K NVLLD + + K++D+G+ K + ++ GT Y+APE
Sbjct: 111 YLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPE 166
Query: 565 YAMRGHLTEKADVYSFGIVALEIVSGRS 592
D ++ G++ E+++GRS
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-11
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNREFINEIGMIS------ALQHPNLVK 453
+G+G FG V L G AVK L + + E M+ A ++P L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDV--ECTMVEKRVLALAWENPFLTH 60
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG--IARGLAYLHGESR 511
LY L + E+L L +F + K + R I GL +LH +
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 571
+++RD+K NV+LD+D + KI+DFG+ K + + ST GT Y+APE
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKY 173
Query: 572 TEKADVYSFGIVALEIVSGRSNVTKED 598
T D +SFG++ E++ G+S +D
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 22/203 (10%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQLSS--KSKQGNREFINEIGMISALQHPNLVKLYGC 457
+G G +G V G +AVK+LS +S + E+ ++ ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 458 CI------EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
E N + L+ +L L + +L D + + I RGL Y+H
Sbjct: 85 FTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDD--HVQFLIYQILRGLKYIHSAD- 140
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRG- 569
++HRD+K +N+ +++D KI DFGLA+ D+E +++TR Y APE +
Sbjct: 141 --IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWM 193
Query: 570 HLTEKADVYSFGIVALEIVSGRS 592
H + D++S G + E+++GR+
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 9e-11
Identities = 60/207 (28%), Positives = 85/207 (41%), Gaps = 29/207 (14%)
Query: 401 IGEGGFGPVYKGLLAD----GTAIAVKQLSSKSKQGNREF--------INEIGMISALQH 448
+G G FG V LLA+ G A+K L E I E ++ +H
Sbjct: 7 LGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFET--ANSERH 61
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR---GLAY 505
P LV L+ C + + + EY L + + R A GL Y
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVF-----SEPRAVFYAACVVLGLQY 116
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 565
LH K+V+RD+K N+LLD + KI+DFGL K ST GT ++APE
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST-FCGTPEFLAPEV 172
Query: 566 AMRGHLTEKADVYSFGIVALEIVSGRS 592
T D + G++ E++ G S
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGES 199
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 55/207 (26%), Positives = 93/207 (44%), Gaps = 24/207 (11%)
Query: 394 NFATDNNIGEGGFGPV-YKGLLADGTAIAVKQLSS----KSKQGNREFINEIGMISALQH 448
+F +G G FG V G A+K L K KQ + E ++ L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSH 77
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEH-RLKLDWPT--RRRICLGIARGLAY 505
P +V + + N++ + E++ + LF H R +P + + Y
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFV----VGGELFTHLRKAGRFPNDVAKFYHAELVLAFEY 133
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 565
LH + +++RD+K N+LLD + K++DFG AK + + + GT Y+APE
Sbjct: 134 LHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR----TFTLCGTPEYLAPEV 186
Query: 566 AM-RGHLTEKA-DVYSFGIVALEIVSG 590
+GH KA D ++ G++ E ++G
Sbjct: 187 IQSKGH--GKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 45/143 (31%), Positives = 76/143 (53%), Gaps = 6/143 (4%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLYGCC 458
+GEG + VYKG G +A+K++ + ++G I E ++ L+H N+V L+
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
L L++EYL+ + L + + + L R + RGLAY H +V+HRD
Sbjct: 73 HTKKTLTLVFEYLDTD-LKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRD 128
Query: 519 IKATNVLLDKDLNSKISDFGLAK 541
+K N+L+ + K++DFGLA+
Sbjct: 129 LKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 5/148 (3%)
Query: 445 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 504
A +P LV L+ C ++L L+ EY+ L + R KL R I L
Sbjct: 52 ASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQR-KLPEEHARFYAAEICIALN 110
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
+LH +++RD+K NVLLD D + K++D+G+ K ST GT Y+APE
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTST-FCGTPNYIAPE 166
Query: 565 YAMRGHLTEKADVYSFGIVALEIVSGRS 592
D ++ G++ E+++GRS
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 53/176 (30%), Positives = 85/176 (48%), Gaps = 29/176 (16%)
Query: 494 RICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553
R +A+G+ +L ++ I HRD+ A NVLL +KI DFGLA+ ++ ++
Sbjct: 216 RFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV--- 269
Query: 554 VAGT----IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDW 605
V G + +MAPE T ++DV+S+GI+ EI S G+S + FY +
Sbjct: 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKM-- 327
Query: 606 ALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+K G M D P E +M +C N PT RP+ S + ++++
Sbjct: 328 ---VKR-GYQMSRPDFAP-----PEIYSIM----KMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 2e-10
Identities = 59/240 (24%), Positives = 91/240 (37%), Gaps = 56/240 (23%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFI------NEIGM 442
++F IG G FG V+ L G A+K L KS R I +I +
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLR-KSDMIKRNQIAHVRAERDI-L 55
Query: 443 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFE-HRLKLDWPTR---RRICLG 498
A P +VKLY + L L+ EY+ L L + R + L
Sbjct: 56 ADA-DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEET-ARFYIAELVLA 113
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK----------------- 541
+ +H ++ +HRDIK N+L+D D + K++DFGL K
Sbjct: 114 LD----SVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166
Query: 542 -----------LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG 590
D ++ + GT Y+APE + D +S G++ E++ G
Sbjct: 167 LLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 65/219 (29%), Positives = 96/219 (43%), Gaps = 17/219 (7%)
Query: 401 IGEGGFGPVYKGLL----ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVK 453
+G+G FG V +L A G A+K L + +K + E ++ +HP L
Sbjct: 3 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 59
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
L ++L + EY L L R+ + R I L YLH
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE-ERARFYGAEIVSALEYLHSRD--- 115
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
VV+RDIK N++LDKD + KI+DFGL K + + T GT Y+APE
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGR 174
Query: 574 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 612
D + G+V E++ GR +D L + L+L E+
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFE--LILMEE 211
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 26/238 (10%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQLSS--KSKQGNREFINEIGMISALQHPNLVKLYGC 457
+G G +G V +AVK+LS +S R E+ ++ ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGI---ARGLAYLHGESRIKV 514
+ E +L A + +K + + I RGL Y+H +
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---I 139
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRG-HLT 572
+HRD+K +NV +++D +I DFGLA+ D+E +++TR Y APE + H
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLNWMHYN 194
Query: 573 EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630
+ D++S G + E++ G++ +F D+ LK ++ME+V T P K+
Sbjct: 195 QTVDIWSVGCIMAELLKGKA------LFPGNDYIDQLK---RIMEVVGT-PSPEVLKK 242
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 3e-10
Identities = 56/201 (27%), Positives = 88/201 (43%), Gaps = 17/201 (8%)
Query: 401 IGEGGFGPVYK-GLLADGTAIAVKQLSSKSKQGNREFINEIGM----ISALQHPNLVKLY 455
+G+GGFG V + A G A K+L+ K + + + E M I A H +
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGY--EGAMVEKRILAKVHSRFIVSL 58
Query: 456 GCCIEGNQLLLIYEYLENNSLAR----ALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
+ L + + N R + E P I GL +LH
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPEYAMRGH 570
++++RD+K NVLLD D N +ISD GLA +L + ++ + AGT G+MAPE
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEE 173
Query: 571 LTEKADVYSFGIVALEIVSGR 591
D ++ G+ E+++ R
Sbjct: 174 YDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 46/145 (31%), Positives = 64/145 (44%), Gaps = 5/145 (3%)
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 506
+HP L L ++L + EY L L R+ R I L YL
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAEIVSALGYL 111
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 566
H VV+RD+K N++LDKD + KI+DFGL K + + T GT Y+APE
Sbjct: 112 H---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVL 167
Query: 567 MRGHLTEKADVYSFGIVALEIVSGR 591
D + G+V E++ GR
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 49/262 (18%), Positives = 102/262 (38%), Gaps = 29/262 (11%)
Query: 409 VYKGLLADGTAIAVKQL---SSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN--- 462
+YKG+ + + ++ K NEI + + N++K+YG I+
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 463 -QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKA 521
+L LI EY L L + + L + T+ + + +GL L+ ++++ +
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLY--KYTNKPYKNLTS 151
Query: 522 TNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR--GHLTEKADVYS 579
+ L+ ++ KI GL K+ + + Y + + T K D+YS
Sbjct: 152 VSFLVTENYKLKIICHGLEKILSSP----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYS 207
Query: 580 FGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVA 639
G+V EI +G + E++ + L++ + N + + + +
Sbjct: 208 LGVVLWEIFTG--KIPFENLTTKEIYDLIINK----------NNSLKLPLDCPLEIKCIV 255
Query: 640 LLCANASPTIRPSMSSVLRMLE 661
C + RP++ +L L
Sbjct: 256 EACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 54/197 (27%), Positives = 93/197 (47%), Gaps = 23/197 (11%)
Query: 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD 529
Y++ + + L E L LD +A+G+++L ++ I HRD+ A N+LL
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHG 250
Query: 530 LNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIV 588
+KI DFGLA+ + + N + + +MAPE T ++DV+S+GI+ EI
Sbjct: 251 RITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIF 310
Query: 589 S-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCAN 644
S G S + + FY + +KE G M + P M ++ C +
Sbjct: 311 SLGSSPYPGMPVDSKFYKM-----IKE-GYRMLSPECAPSE---------MYDIMKSCWD 355
Query: 645 ASPTIRPSMSSVLRMLE 661
A P RP+ +++++E
Sbjct: 356 ADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 5e-10
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 15/208 (7%)
Query: 389 KAATNNFATDNNIGEGGFGPVYKGLLADGT--AIAVKQLSS----KSKQGNREFINEIGM 442
K +F +G G FG V + +A+K+ K KQ + F +E +
Sbjct: 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKI 84
Query: 443 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARG 502
++ + HP V LYG + + L L+ E++ L R +P C A+
Sbjct: 85 LNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL---RRNKRFPNDVG-CFYAAQI 140
Query: 503 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 562
+ + +V+RD+K N+LLDKD K++DFG AK+ + + + GT Y+A
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIA 196
Query: 563 PEYAMRGHLTEKADVYSFGIVALEIVSG 590
PE + + AD ++ GI EI+ G
Sbjct: 197 PEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 7/151 (4%)
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 508
P L +L+ C ++L + EY+ L + + + P IA GL +LH
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFFLHS 119
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV-AGTIGYMAPEYAM 567
+ +++RD+K NV+LD + + KI+DFG+ K E ++T+ GT Y+APE
Sbjct: 120 KG---IIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIA 174
Query: 568 RGHLTEKADVYSFGIVALEIVSGRSNVTKED 598
+ D ++FG++ E+++G++ ED
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 7e-10
Identities = 58/202 (28%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 401 IGEGGFGPVYK-GLLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 456
+G+GGFG V + A G A K+L K ++G +NE ++ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG--IARGLAYLHGESRIKV 514
+ L L+ + L ++ + +R I + GL L E ++
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRE---RI 123
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 574
V+RD+K N+LLD + +ISD GLA + E + RV GT+GYMAPE T
Sbjct: 124 VYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETVRGRV-GTVGYMAPEVINNEKYTFS 181
Query: 575 ADVYSFGIVALEIVSGRSNVTK 596
D + G + E++ G+S K
Sbjct: 182 PDWWGLGCLIYEMIQGQSPFRK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 7e-10
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 7/151 (4%)
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 508
P L +L+ C ++L + EY+ L + + K P I+ GL +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLH- 118
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV-AGTIGYMAPEYAM 567
R +++RD+K NV+LD + + KI+DFG+ K E ++TR GT Y+APE
Sbjct: 119 --RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 568 RGHLTEKADVYSFGIVALEIVSGRSNVTKED 598
+ D +++G++ E+++G+ ED
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 9e-10
Identities = 46/150 (30%), Positives = 75/150 (50%), Gaps = 7/150 (4%)
Query: 444 SALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 503
+A HP LV L+ C ++L + E++ L + R KL R I+ L
Sbjct: 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLAL 109
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
+LH +++RD+K NVLLD + + K++D+G+ K ST GT Y+AP
Sbjct: 110 NFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTST-FCGTPNYIAP 165
Query: 564 EYAMRGHLTE-KADVYSFGIVALEIVSGRS 592
E +RG D ++ G++ E+++GRS
Sbjct: 166 E-ILRGEDYGFSVDWWALGVLMFEMMAGRS 194
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 39/220 (17%)
Query: 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPN 450
+ NIG G +G V + G +A+K++ + + E+ ++ +H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 451 LVKLYGCCI---------EGNQLLLIYEYLENNSLARALFEHRLKLDWP-TRRRIC--LG 498
++ I + + ++ + +E++ H + D P T I L
Sbjct: 66 II-----AIRDILRPPGADFKDVYVVMDLMESD------LHHIIHSDQPLTEEHIRYFLY 114
Query: 499 -IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL----DEEENTHISTR 553
+ RGL Y+H V+HRD+K +N+L+++D +I DFG+A+ E ++
Sbjct: 115 QLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEY 171
Query: 554 VAGTIGYMAPE--YAMRGHLTEKADVYSFGIVALEIVSGR 591
VA T Y APE ++ + T D++S G + E++ GR
Sbjct: 172 VA-TRWYRAPELLLSLPEY-TTAIDMWSVGCIFAEML-GR 208
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 16/226 (7%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSK---SKQGNREFINEIGMISALQH 448
+F +G+GG+G V+ D G +A+K++ R + E +++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 508
LVKL + L L EY+ R L + L R + + LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDF-RTLLNNLGVLSEDHARFYMAEMFEAVDALH- 118
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 568
+ +HRD+K N L+D + K++DFGL+K + V G+ YMAPE
Sbjct: 119 --ELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEVLRG 172
Query: 569 GHLTEKADVYSFGIVALEIVSG----RSNVTKEDMFYLLDWALVLK 610
D +S G + E + G + E L W L+
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ 218
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 32/89 (35%), Positives = 51/89 (57%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
L E L+G +P +L+ L + L N+L G IP + + L L + NQ SGE+P+
Sbjct: 506 LSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKL 112
LG++ +L ++++S N+ G LP T A L
Sbjct: 566 NLGNVESLVQVNISHNHLHGSLPSTGAFL 594
|
Length = 968 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 35/101 (34%), Positives = 57/101 (56%), Gaps = 6/101 (5%)
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV-AGT 557
IA GL +LH + +++RD+K NV+LD + + KI+DFG+ K E +TR GT
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164
Query: 558 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED 598
Y+APE + D ++FG++ E+++G+ ED
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 83/291 (28%), Positives = 124/291 (42%), Gaps = 66/291 (22%)
Query: 401 IGEGGFGPVYKGLL-------ADGTAIAVKQLSSKSKQGNR---EFINEIGMISALQHPN 450
+G+G F +YKG+L G V + +R F ++S L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 451 LVKLYGCCI-EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL--GIARGLAYLH 507
LVKLYG C+ + N ++ EY++ L +F HR K + ++ + +A L YL
Sbjct: 63 LVKLYGVCVRDENIMVE--EYVKFGPL--DVFLHREKNNVSLHWKLDVAKQLASALHYL- 117
Query: 508 GESRIKVVHRDIKATNVLLDK-DLNS------KISDFGLAK--LDEEENTHISTRVAGTI 558
E + K+VH ++ N+L+ + LN K+SD G+ L EE RV I
Sbjct: 118 -EDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE------RVE-RI 168
Query: 559 GYMAPEYAMRGH--LTEKADVYSFGIVALEIVSG-------RSNVTKEDMFYLLDWALVL 609
++APE G LT AD +SFG LEI S S+ KE FY L +
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-RFYQDQHRLPM 227
Query: 610 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRML 660
+ +L L++ C PT RPS ++LR L
Sbjct: 228 PDCAELANLINQ--------------------CWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 50/202 (24%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSS--KSKQGNREFINEIGMISALQHPNLVKLYGC 457
+G G +G V L G +A+K+L +S+ + E+ ++ ++H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82
Query: 458 CI------EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
+ L+ ++ L + + +L D + + + +GL Y+H
Sbjct: 83 FTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSED--RIQFLVYQMLKGLKYIHAAG- 138
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRG- 569
++HRD+K N+ +++D KI DFGLA+ D E ++ TR Y APE +
Sbjct: 139 --IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVILNWM 191
Query: 570 HLTEKADVYSFGIVALEIVSGR 591
H T+ D++S G + E+++G+
Sbjct: 192 HYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 45/178 (25%), Positives = 77/178 (43%), Gaps = 22/178 (12%)
Query: 430 KQGNRE-FINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLD 488
K G R E ++ A+ HP++++L G + Y + L ++ L
Sbjct: 123 KAGQRGGTATEAHILRAINHPSIIQLKG----------TFTYNKFTCLILPRYKTDLYCY 172
Query: 489 WPTRRRICL--------GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540
+R I + + R + YLH ++HRDIKA N+ ++ + + DFG A
Sbjct: 173 LAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA 229
Query: 541 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED 598
+ N + AGTI APE R D++S GIV E+ + ++ ++D
Sbjct: 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287
|
Length = 391 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 3e-09
Identities = 46/157 (29%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 438 NEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR--- 494
+E+ ++A H +VK + ++LLLI EY L + + + RLK P +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI-KQRLKEHLPFQEYEVG 172
Query: 495 -ICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHIST 552
+ I L +H SR K++HRD+K+ N+ L K+ DFG +K + + +++
Sbjct: 173 LLFYQIVLALDEVH--SR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
GT Y+APE R ++KAD++S G++ E+++
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 19/213 (8%)
Query: 393 NNFATDNNIGEGGFGPVYKGLL---ADGTAIAVKQLSSKSKQGNRE----FINEIGMISA 445
+F + +G G FG V ++ A G A+K + KS +E F E ++S
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMK-KSVLLAQETVSFFEEERDILSI 57
Query: 446 LQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 505
P + +L + + L L+ EY L L + + D + +A +
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQ---FYLAELVLA 114
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 565
+H ++ VHRDIK NVL+D+ + K++DFG A S GT Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEV 174
Query: 566 --AMRGHLTEKADV----YSFGIVALEIVSGRS 592
M G V +S G++A E++ GRS
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS 207
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 17/214 (7%)
Query: 386 LQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNRE----FINEIG 441
LQ+KA ++ IG G FG V + +L SK + R F E
Sbjct: 38 LQMKA--EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 442 MISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR 501
+++ P +V+L+ + L ++ EY+ L + + + W A
Sbjct: 96 IMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAK-----FYTAE 150
Query: 502 GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGY 560
+ L + ++HRD+K N+LLDK + K++DFG K+DE T V GT Y
Sbjct: 151 VVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDY 209
Query: 561 MAPEYAMR----GHLTEKADVYSFGIVALEIVSG 590
++PE G+ + D +S G+ E++ G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 64/262 (24%), Positives = 114/262 (43%), Gaps = 39/262 (14%)
Query: 365 DYQLYTTARLSAISLTYYGFYLQIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVK 423
D Q Y+ +++ + T Y Q+K IG G G V G +AVK
Sbjct: 4 DSQFYSV-QVADSTFTVLKRYQQLKP----------IGSGAQGIVCAAFDTVLGINVAVK 52
Query: 424 QLS------SKSKQGNREFINEIGMISALQHPNLVKLYGCCI------EGNQLLLIYEYL 471
+LS + +K+ RE + ++ + H N++ L E + L+ E +
Sbjct: 53 KLSRPFQNQTHAKRAYRELV----LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 531
+ N L + + ++LD + + G+ +LH ++HRD+K +N+++ D
Sbjct: 109 DAN-LCQVI---HMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCT 161
Query: 532 SKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 591
KI DFGLA+ + T T Y APE + E D++S G + E+V G
Sbjct: 162 LKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG- 218
Query: 592 SNVTKEDMFYLLDWALVLKEQG 613
+V + ++ W V+++ G
Sbjct: 219 -SVIFQGTDHIDQWNKVIEQLG 239
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 4e-09
Identities = 62/241 (25%), Positives = 114/241 (47%), Gaps = 39/241 (16%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSS--KSKQGNREFINEIGMISALQHPNLVKL--- 454
+G G +G V + G +A+K+LS +S+ + E+ ++ +QH N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 455 YGCCIEGNQL---LLIYEYLENNSLARALFEHRL---KLDWPTRRRICLGIARGLAYLHG 508
+ + G++ L+ Y++ + + + H L K+ + + +C GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLC-----GLKYIHS 135
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAM 567
++HRD+K N+ +++D KI DFGLA+ D E ++ TR Y APE +
Sbjct: 136 AG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187
Query: 568 RG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626
H + D++S G + E+++G++ +D YL +LK G PG
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD--YLDQLTQILKVTG--------VPGPE 237
Query: 627 F 627
F
Sbjct: 238 F 238
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 8/94 (8%)
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI---STRVA 555
+ARG+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ ++ ++ S R+
Sbjct: 183 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 556 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
+ +MAPE T ++DV+SFG++ EI S
Sbjct: 240 --LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 24/208 (11%)
Query: 401 IGEGGFGPVYKGLLADGT---AIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
+G G +G VYK DG A+KQ+ + EI ++ L+HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKV 66
Query: 458 CIEGN--QLLLIYEYLENN-----SLARALFEHRLKLDWPTR--RRICLGIARGLAYLHG 508
+ + ++ L+++Y E++ RA ++ + P + + I G+ YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 509 ESRIKVVHRDIKATNVLL----DKDLNSKISDFGLAKLDEEENTHIS--TRVAGTIGYMA 562
V+HRD+K N+L+ + KI+D G A+L ++ V T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 563 PEYAMRG-HLTEKADVYSFGIVALEIVS 589
PE + H T+ D+++ G + E+++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 35/92 (38%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG-T 557
+ARG+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ ++ ++ A
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 558 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
+ +MAPE T ++DV+SFG++ EI S
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 47/177 (26%), Positives = 82/177 (46%), Gaps = 17/177 (9%)
Query: 423 KQLSSKSKQGNREFI---NEIGMISALQHPNLVKLYGCC-IEGNQLLLIYEYLENNSLAR 478
+ ++ + K G+R I NEI + L H N++K+ E N ++ +Y + L
Sbjct: 194 RLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY--DFDLYS 251
Query: 479 ALFEHRLKLDWPTR------RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 532
+++ DW R R I + + Y+H + K++HRDIK N+ L+ D
Sbjct: 252 FMYDE--AFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKI 306
Query: 533 KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
+ DFG A E+E GT+ +PE E D++S G++ L+++S
Sbjct: 307 VLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 21/206 (10%)
Query: 401 IGEGGFGPV----YKGLLADGTAIAVKQLS---SKSKQGNREFINEIGMISALQ-HPNLV 452
+G+G +G V ++ +A+K+++ SK R + E+ ++ + H N+
Sbjct: 8 LGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRA-LRELKLLRHFRGHKNIT 65
Query: 453 KLYGCCI---EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
LY I L +YE L L + L + I GL Y+H
Sbjct: 66 CLYDMDIVFPGNFNELYLYEELMEADLH-QIIRSGQPLTDAHFQSFIYQILCGLKYIHSA 124
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK---LDEEENTHISTRVAGTIGYMAPEYA 566
+ V+HRD+K N+L++ D KI DFGLA+ + EN T T Y APE
Sbjct: 125 N---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIM 181
Query: 567 MRGHLTEKA-DVYSFGIVALEIVSGR 591
+ KA DV+S G + E++ +
Sbjct: 182 LSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 498 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAG 556
+ LAYLHG ++HRD+K N+ LD+ N+ + DFG A KLD +T +G
Sbjct: 193 RLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 557 TIGYMAPEYAMRGHLTEKADVYSFGIVALEI 587
T+ +PE K D++S G+V E+
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
|
Length = 392 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 53/208 (25%), Positives = 95/208 (45%), Gaps = 24/208 (11%)
Query: 401 IGEGGFGPVYKGLLADGTA---IAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
+G G +G VYK DG A+KQ+ + EI ++ L+HPN++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 66
Query: 458 CIE--GNQLLLIYEYLENN-----SLARALFEHRLKLDWP--TRRRICLGIARGLAYLHG 508
+ ++ L+++Y E++ RA ++ + P + + I G+ YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 509 ESRIKVVHRDIKATNVLL----DKDLNSKISDFGLAKLDEEENTHIS--TRVAGTIGYMA 562
V+HRD+K N+L+ + KI+D G A+L ++ V T Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 563 PEYAMRG-HLTEKADVYSFGIVALEIVS 589
PE + H T+ D+++ G + E+++
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST-RVAGT 557
+ARG+ +L ++ VHRD+ A NVLL + KI DFGLA+ ++ ++S
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 558 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
+ +MAPE T +DV+S+GI+ EI S
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 63/242 (26%), Positives = 112/242 (46%), Gaps = 48/242 (19%)
Query: 436 FINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRI 495
F ++S + H +L ++G C+ G++ +++ E++E+ L L + + ++ + +
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122
Query: 496 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDK----DLNS---KISDFG--LAKLDEEE 546
+A L+YL ++ +VH ++ A N+LL + + S K+SD G L EE
Sbjct: 123 AQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREE 179
Query: 547 NTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEI-------VSGRSNVTKED 598
RV I ++APE G L+ AD +SFG LEI + R+ KE
Sbjct: 180 ------RVE-RIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE- 231
Query: 599 MFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
FY +++ +L E P +++ +I+ C PT RPS ++LR
Sbjct: 232 RFY--------EKKHRLPE-----PSC----KELATLIS---QCLTYEPTQRPSFRTILR 271
Query: 659 ML 660
L
Sbjct: 272 DL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 42/159 (26%), Positives = 74/159 (46%), Gaps = 20/159 (12%)
Query: 447 QHPNLVKLYGCCIEGNQ-LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 505
++P +V ++ C E + L ++ EY+E A L ++ L R L Y
Sbjct: 59 ENPFVVSMF-CSFETKRHLCMVMEYVEGGDCA-TLLKNIGALPVDMARMYFAETVLALEY 116
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK--------------LDEEENTHIS 551
LH +VHRD+K N+L+ + K++DFGL+K ++++ +
Sbjct: 117 LHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173
Query: 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG 590
+V GT Y+APE +R + D ++ GI+ E + G
Sbjct: 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 6e-08
Identities = 57/228 (25%), Positives = 103/228 (45%), Gaps = 32/228 (14%)
Query: 401 IGEGGFGPV---YKGLLADGTAIAVKQLS------SKSKQGNREFINEIGMISALQHPNL 451
IG G G V Y +L +A+K+LS + +K+ RE + ++ + H N+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNI 78
Query: 452 VKLYGCCI------EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 505
+ L E + L+ E ++ N L + + +++LD + + G+ +
Sbjct: 79 ISLLNVFTPQKSLEEFQDVYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKH 134
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 565
LH ++HRD+K +N+++ D KI DFGLA+ + + T T Y APE
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189
Query: 566 AMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 613
+ E D++S G + E+V + D Y+ W V+++ G
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD--YIDQWNKVIEQLG 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 34/228 (14%)
Query: 389 KAATNNFATDNNIGEGGFGPVYKGLLADGT-AIAVKQLSSKSKQGNREFINEIGMISALQ 447
++ ++ N IG G FG VY+ + D + +A+K++ + NRE + ++ L
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLN 117
Query: 448 HPNLVKL----YGCCIEGNQ----LLLIYEYLENNSLARALFEHRLKLDWPTR--RRICL 497
H N++ L Y C + N+ L ++ E++ R P +
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 498 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS-KISDFGLAK---LDEEENTHISTR 553
+ R LAY+H + + HRD+K N+L+D + ++ K+ DFG AK + ++I +R
Sbjct: 178 QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSR 234
Query: 554 VAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIV------SGRSNV 594
Y APE + + T D++S G + E++ SG+S+V
Sbjct: 235 F-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV 277
|
Length = 440 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 9e-08
Identities = 56/227 (24%), Positives = 103/227 (45%), Gaps = 30/227 (13%)
Query: 401 IGEGGFGPV---YKGLLADGTAIAVKQLS------SKSKQGNREFINEIGMISALQHPNL 451
IG G G V Y +L +A+K+LS + +K+ RE + ++ + H N+
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELV----LMKCVNHKNI 85
Query: 452 VKLYGC-----CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 506
+ L +E Q + I L + +L + + +++LD + + G+ +L
Sbjct: 86 IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVI---QMELDHERMSYLLYQMLCGIKHL 142
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 566
H ++HRD+K +N+++ D KI DFGLA+ + + T T Y APE
Sbjct: 143 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 567 MRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 613
+ E D++S G + E++ G D ++ W V+++ G
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD--HIDQWNKVIEQLG 242
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 34/92 (36%), Positives = 55/92 (59%), Gaps = 4/92 (4%)
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG-T 557
+A+G+ +L SR K +HRD+ A N+LL ++ KI DFGLA+ ++ ++ A
Sbjct: 188 VAKGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 558 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
+ +MAPE T ++DV+SFG++ EI S
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 1e-07
Identities = 39/148 (26%), Positives = 73/148 (49%), Gaps = 18/148 (12%)
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLA 504
+PN +KLY +LI +Y+++ L F+ KL ++I + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
LH + ++H DIK NVL D+ + + D+GL K+ + + GT+ Y +P
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175
Query: 564 EYAMRGHLTEKA-DVYSFGIVALEIVSG 590
E ++GH + + D ++ G++ E+++G
Sbjct: 176 E-KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 393 NNFATDNNIGEGGFGPV-YKGLLADGTAIAVKQLSSKSKQGNREFIN----EIGMISALQ 447
+F T IG+G FG V G A+K L KS+ ++ + E +++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLL-KSEMFKKDQLAHVKAERDVLAESD 59
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 507
P +V LY + L LI E+L L L ++ + TR +A + +
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR----FYMAECVLAIE 115
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540
++ +HRDIK N+L+D+ + K+SDFGL+
Sbjct: 116 AVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 5/87 (5%)
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY--AM- 567
++ VHRDIK NVLLDK+ + +++DFG + T S GT Y++PE AM
Sbjct: 120 QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 568 --RGHLTEKADVYSFGIVALEIVSGRS 592
+G + D +S G+ E++ G +
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGET 206
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 35/94 (37%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTI 558
+ RGL Y+H + V+HRD+K +N+LL+ + + KI DFGLA+ E+ ++ V T
Sbjct: 117 LLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TR 172
Query: 559 GYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGR 591
Y APE + T DV+S G + E++ GR
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GR 205
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 35/212 (16%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSS--KSKQGNREFINEIGMISALQHPNLVKLYGC 457
IG+G +G V + G +A+K+++ + + EI ++ L+HP++V++
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 458 CI-----EGNQLLLIYEYLE---------NNSLARALFEHRLKLDWPTRRRICLGIARGL 503
+ E + +++E +E N+ L EH + + R L
Sbjct: 68 MLPPSRREFKDIYVVFELMESDLHQVIKANDDLTP---EHH--------QFFLYQLLRAL 116
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENTHISTRVAGTIGYM 561
Y+H + V HRD+K N+L + D KI DFGLA+ ++ T T Y
Sbjct: 117 KYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173
Query: 562 APEY--AMRGHLTEKADVYSFGIVALEIVSGR 591
APE + T D++S G + E+++G+
Sbjct: 174 APELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 3e-07
Identities = 33/102 (32%), Positives = 47/102 (46%), Gaps = 23/102 (22%)
Query: 148 GLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKM 207
GL G IP+ I L +L + +S GN +I G +P LG +
Sbjct: 429 GLRGFIPNDISKLRHLQSINLS------------GN-----------SIRGNIPPSLGSI 465
Query: 208 TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 249
T L+VLDLS+N G IP + L + + GN L+G +P
Sbjct: 466 TSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 3e-07
Identities = 65/240 (27%), Positives = 99/240 (41%), Gaps = 47/240 (19%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFI----NEIGMISALQ 447
++F + IG G FG V D G A+K+L KS+ +E + E +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR-KSEMLEKEQVAHVRAERDILAEAD 59
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 507
+P +VKLY + N L LI EYL + L +K D T IA + +
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLL----MKKDTFTEEETRFYIAETILAID 115
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGL----------------------AKLDEE 545
++ +HRDIK N+LLD + K+SDFGL LD
Sbjct: 116 SIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFI 175
Query: 546 ENTHISTRVA---------------GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG 590
S R A GT Y+APE ++ ++ D +S G++ E++ G
Sbjct: 176 SKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 32/202 (15%)
Query: 417 GTAIAVK--QLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 474
GT + V+ L + +++ + NE+ + +HPN++ + G+ L +I ++
Sbjct: 25 GTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84
Query: 475 SLARALFEHRLKLDWPTR------RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK 528
S A +L LK +P I G RGL YLH I HR+IKA+++L+
Sbjct: 85 S-ANSL----LKTYFPEGMSEALIGNILFGALRGLNYLHQNGYI---HRNIKASHILISG 136
Query: 529 DLNSKISDFGLAKLDEEENTHISTRVA--------GTIGYMAPEYAMRGHL---TEKADV 577
D +S GL+ L +V + +++PE +R L K+D+
Sbjct: 137 D--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPEL-LRQDLYGYNVKSDI 193
Query: 578 YSFGIVALEIVSGRSNVTKEDM 599
YS GI A E+ +GR V +DM
Sbjct: 194 YSVGITACELATGR--VPFQDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 6e-07
Identities = 48/194 (24%), Positives = 87/194 (44%), Gaps = 9/194 (4%)
Query: 401 IGEGGFGPVYKGLLADGTAI----AVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYG 456
IG+G FG V + D I +++ S+ + E +++ + P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+L L+ ++ L F H + R A L L + V++
Sbjct: 61 SFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIY 116
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
RD+K N+LLD + + DFGL KL+ +++ +T GT Y+APE + T+ D
Sbjct: 117 RDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT-FCGTPEYLAPELLLGHGYTKAVD 175
Query: 577 VYSFGIVALEIVSG 590
++ G++ E+++G
Sbjct: 176 WWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 44/145 (30%), Positives = 67/145 (46%), Gaps = 12/145 (8%)
Query: 462 NQLLLIYEYLENNSLARAL--FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
N L L+ +Y L L FE RL D IA + +H ++ VHRDI
Sbjct: 74 NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR-----FYIAEMVLAIHSIHQLHYVHRDI 128
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY--AMR---GHLTEK 574
K NVLLD + + +++DFG ++ T S+ GT Y++PE AM G +
Sbjct: 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 188
Query: 575 ADVYSFGIVALEIVSGRSNVTKEDM 599
D +S G+ E++ G + E +
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 7e-07
Identities = 51/199 (25%), Positives = 87/199 (43%), Gaps = 15/199 (7%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNRE----FINEIGMISALQHPNLVKLYG 456
IG G FG V + +L SK + R F E +++ P +V+L+
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+ L ++ EY+ L + + + W R + L +H + +H
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWA--RFYTAEVVLALDAIHS---MGFIH 165
Query: 517 RDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPEYAMR----GHL 571
RD+K N+LLDK + K++DFG K+++E T V GT Y++PE G+
Sbjct: 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYY 224
Query: 572 TEKADVYSFGIVALEIVSG 590
+ D +S G+ E++ G
Sbjct: 225 GRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 7e-07
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNRE----FINEIGMISALQHPNLVKLYG 456
IG G FG V L + + ++ +K + R F E ++ + + L+
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 457 CCIEGNQLLLIYEYLENNSLARAL--FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
+ N L L+ +Y L L FE RL D +A + + ++
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR-----FYLAEMVIAIDSVHQLHY 123
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY--AM---RG 569
VHRDIK N+L+D + + +++DFG E+ T S+ GT Y++PE AM +G
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183
Query: 570 HLTEKADVYSFGIVALEIVSGRSNVTKEDM 599
+ D +S G+ E++ G + E +
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESL 213
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 1e-06
Identities = 58/217 (26%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 386 LQIKAATNNFATDNNIGEGGFGPV----YKGLLADGTAIAVKQLSSKS--KQGNREFINE 439
L++KA +F IG G FG V +K + A+K LS K+ + F E
Sbjct: 38 LRMKAE--DFDVIKVIGRGAFGEVQLVRHK---SSKQVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 440 IGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG 498
I A +V+L+ + L ++ EY+ L + + + W R
Sbjct: 93 ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWA--RFYTAE 150
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGT 557
+ L +H + +HRD+K N+LLDK + K++DFG K+D T V GT
Sbjct: 151 VVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206
Query: 558 IGYMAPEYAMR----GHLTEKADVYSFGIVALEIVSG 590
Y++PE G+ + D +S G+ E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 33/92 (35%), Positives = 51/92 (55%), Gaps = 4/92 (4%)
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST-RVAGT 557
+A G+ +L ++ VHRD+ A NVL+ + KI DFGLA+ ++ +IS
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 558 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589
+ +MAPE T +DV+SFGI+ EI +
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 51/211 (24%), Positives = 94/211 (44%), Gaps = 40/211 (18%)
Query: 401 IGEGGFGPV---YKGLLADGTAIAVKQLS------SKSKQGNREFINEIGMISALQHPNL 451
IG G G V Y + G +A+K+LS + +K+ RE + ++ + H N+
Sbjct: 24 IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTHAKRAYRELV----LMKLVNHKNI 77
Query: 452 VKLYGCCI------EGNQLLLIYEYLENN--SLARALFEHRLKLDWPTRRRICLGIARGL 503
+ L E + L+ E ++ N + + +H ++ + + +C G+
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE-RMSYLLYQMLC-----GI 131
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT---HISTRVAGTIGY 560
+LH ++HRD+K +N+++ D KI DFGLA+ ++ TR Y
Sbjct: 132 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----Y 183
Query: 561 MAPEYAMRGHLTEKADVYSFGIVALEIVSGR 591
APE + E D++S G + E++ G
Sbjct: 184 RAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 2e-06
Identities = 73/295 (24%), Positives = 129/295 (43%), Gaps = 58/295 (19%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADG--------TAIAVKQLSSKSKQGNREFINEIGMIS 444
N + IG G FG V+ L+ AI+ + L + K + + E+ ++
Sbjct: 13 NEYEVIKKIGNGRFGEVF--LVKHKRTQEFFCWKAISYRGLKEREKS---QLVIEVNVMR 67
Query: 445 ALQHPNLVKLYGCCI-EGNQ-LLLIYEYLENNSLARAL---FEHRLKLDWPTRRRICLGI 499
L+H N+V+ + + NQ L ++ E+ + L+R + ++ K++ I +
Sbjct: 68 ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQL 127
Query: 500 ARGLAYLH----GESRIKVVHRDIKATNVLLD-------------KDLN----SKISDFG 538
LAY H G + +V+HRD+K N+ L +LN +KI DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187
Query: 539 LAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLT----EKADVYSFGIVALEIVSGRSN 593
L+K + E H GT Y +PE + H T +K+D+++ G + E+ SG++
Sbjct: 188 LSKNIGIESMAH---SCVGTPYYWSPELLL--HETKSYDDKSDMWALGCIIYELCSGKTP 242
Query: 594 VTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPT 648
K + F L + E + +L P KE +++ N+ L A P+
Sbjct: 243 FHKANNFSQL-----ISELKRGPDL----PIKGKSKELNILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 22/79 (27%), Positives = 44/79 (55%)
Query: 79 GELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTK 138
G +P ++ L +L+ ++LS N+ G +P + +T+++ +S N F G IP + T
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 139 LEKLFIQPSGLAGPIPSGI 157
L L + + L+G +P+ +
Sbjct: 492 LRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 53/213 (24%), Positives = 92/213 (43%), Gaps = 32/213 (15%)
Query: 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL 446
QI A N+ D+ + K +L K L + + F M+ +
Sbjct: 10 QIYAGILNYKDDDEDDGYSYEKEIKVIL--------KVLDPSHRDISLAFFETASMMRQV 61
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK--LDWPTRRRICLGIARGLA 504
H ++V LYG C+ + +++ E++E L LF HR L P + ++ +A L+
Sbjct: 62 SHKHIVLLYGVCVRDVENIMVEEFVEFGPL--DLFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 505 YLHGESRIKVVHRDIKATNVLLDKD-LNS------KISDFG--LAKLDEEENTHISTRVA 555
YL + +VH ++ N+LL ++ ++ K+SD G + L +E
Sbjct: 120 YLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE------ 170
Query: 556 GTIGYMAPEYAM-RGHLTEKADVYSFGIVALEI 587
I ++APE +L+ AD +SFG EI
Sbjct: 171 -RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 47/190 (24%), Positives = 72/190 (37%), Gaps = 48/190 (25%)
Query: 439 EIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG 498
E +++ L HP L LY L L+ +Y L R L + +
Sbjct: 51 EQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQP-------GKCLSEE 103
Query: 499 IAR--------GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550
+AR L YLH +V+RD+K N+LL + + +SDF L+K + E +
Sbjct: 104 VARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160
Query: 551 S------------------TRVA----------GTIGYMAPEY-AMRGHLTEKADVYSFG 581
S T GT Y+APE + GH D ++ G
Sbjct: 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLG 219
Query: 582 IVALEIVSGR 591
I+ E++ G
Sbjct: 220 ILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 8e-06
Identities = 39/147 (26%), Positives = 69/147 (46%), Gaps = 8/147 (5%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNR----EFINEIGMISALQHPNLVKLYG 456
I G FG VY G + + + ++ K+ N+ + E ++ + P +V LY
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
N + L+ EYL + ++L D + +A L YLH R ++H
Sbjct: 72 SLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEMAVKYISEVALALDYLH---RHGIIH 127
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLD 543
RD+K N+L+ + + K++DFGL+K+
Sbjct: 128 RDLKPDNMLISNEGHIKLTDFGLSKVT 154
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 1e-05
Identities = 19/60 (31%), Positives = 25/60 (41%)
Query: 185 KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLL 244
+ L L N +T + LKVLDLS N L P F L + + +GN L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 56/246 (22%), Positives = 95/246 (38%), Gaps = 68/246 (27%)
Query: 401 IGEGGFGPVYKGLLADGTAI-AVKQLSSKSKQGNREFINEIGMISA-------LQHPNLV 452
IG G FG V D A+ A+K L K+ R N+ + A + +V
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLR-KADVLMR---NQAAHVKAERDILAEADNEWVV 64
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARAL-----FEHRLKLDWPTRRRICLGIARGLAYLH 507
KLY + + L + +Y+ + L FE L R + + +H
Sbjct: 65 KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA------RFYIAELTCAIESVH 118
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGL---------------------------- 539
++ +HRDIK N+L+D+D + K++DFGL
Sbjct: 119 ---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175
Query: 540 --AKLDEEENTHISTR------------VAGTIGYMAPEYAMRGHLTEKADVYSFGIVAL 585
+++D + R + GT Y+APE +R T+ D +S G++
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235
Query: 586 EIVSGR 591
E++ G+
Sbjct: 236 EMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE-EENTHISTRVAGTIGYMAP 563
Y+HGE ++HRDIK NVL++ + + DFG A +T +AGT+ AP
Sbjct: 275 YIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331
Query: 564 EYAMRGHLTEKADVYSFGIVALE 586
E T D++S G+V E
Sbjct: 332 EVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-05
Identities = 55/255 (21%), Positives = 98/255 (38%), Gaps = 46/255 (18%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEI----GMISALQH 448
++F + IG G FG V D I ++ K+ +E + I ++
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 508
+VK++ + L LI E+L + L +K D + IA + +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL----MKKDTLSEEATQFYIAETVLAIDA 116
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGL----------------------------- 539
++ +HRDIK N+LLD + K+SDFGL
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 540 -----AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR--- 591
A+ ++ ++ GT Y+APE M+ + D +S G++ E++ G
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236
Query: 592 -SNVTKEDMFYLLDW 605
S +E +++W
Sbjct: 237 CSETPQETYRKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 58/257 (22%), Positives = 100/257 (38%), Gaps = 52/257 (20%)
Query: 394 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISA-----LQH 448
+F + IG G FG V D + ++ K+ +E ++G I A ++
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE---QVGHIRAERDILVEA 58
Query: 449 PNL--VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 506
+L VK++ + L LI E+L + L +K D T IA + +
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL----MKKDTLTEEETQFYIAETVLAI 114
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGL--------------------------- 539
++ +HRDIK N+LLD + K+SDFGL
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 540 -------AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR- 591
A+ + ++ GT Y+APE M+ + D +S G++ E++ G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 592 ---SNVTKEDMFYLLDW 605
S +E +++W
Sbjct: 235 PFCSETPQETYKKVMNW 251
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 28/80 (35%), Positives = 40/80 (50%), Gaps = 3/80 (3%)
Query: 94 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPI 153
L L + G +P +KL +++ +S N G IP + + T LE L + + G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 154 PSGIFSLENLTDLRISDLNG 173
P SL LT LRI +LNG
Sbjct: 483 PE---SLGQLTSLRILNLNG 499
|
Length = 623 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 32/145 (22%), Positives = 53/145 (36%), Gaps = 13/145 (8%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLV-KLYGCC 458
+ G VY L +K S+ K +RE E+ ++ L + V K+
Sbjct: 6 LKGGLTNRVYL-LGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLASG 62
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
L+ E++E +L E + I +A LA LH + + H D
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKED--------IAEQLAELLAKLHQLPLLVLCHGD 114
Query: 519 IKATNVLLDKDLNSKISDFGLAKLD 543
+ N+L+D I D+ A
Sbjct: 115 LHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 30/97 (30%), Positives = 36/97 (37%), Gaps = 27/97 (27%)
Query: 495 ICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD-----EEENTH 549
+CL L LH R K+ N+LL D GL KLD +
Sbjct: 22 VCLQCLGALRELH---------RQAKSGNILLTWD--------GLLKLDGSVAFKTPEQS 64
Query: 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALE 586
+MAPE TEKAD+YS GI E
Sbjct: 65 RPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYE 96
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 53/201 (26%), Positives = 83/201 (41%), Gaps = 36/201 (17%)
Query: 57 IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS------------------- 97
+P L N+ L NL + +N S +LP+ L +L NL L LS
Sbjct: 155 LPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEE 213
Query: 98 ---SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP 154
SNN EL + + L N+ +S+N+ +P I N + LE L + S
Sbjct: 214 LDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDL--SNNQISSI 270
Query: 155 SGIFSLENLTDLRISDLNGPEAT--FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKV 212
S + SL NL +L DL+G + P + + + +L N +T + KL
Sbjct: 271 SSLGSLTNLREL---DLSGNSLSNALPLIALLLLLLELLLNLLLTLKALEL-----KLNS 322
Query: 213 LDLSFNRLRGQIPSNFDDLYD 233
+ L+ N L S+ + L
Sbjct: 323 ILLNNNILSNGETSSPEALSI 343
|
Length = 394 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 29/86 (33%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 393 NNFATDNNIGEGGFGPVYK----GLLADGTA--IAVKQLSSKSKQGNRE-FINEIGMISA 445
+N +G G FG V + GL + +AVK L + + RE ++E+ ++S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 446 L-QHPNLVKLYGCCIEGNQLLLIYEY 470
L QH N+V L G C G +L+I EY
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 29/127 (22%), Positives = 50/127 (39%), Gaps = 46/127 (36%)
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLA---------------------------KLD 543
++ +HRDIK N+L+D+D + K++DFGL +
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178
Query: 544 EEENTHISTR-------------------VAGTIGYMAPEYAMRGHLTEKADVYSFGIVA 584
+ N R + GT Y+APE +R T+ D +S G++
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238
Query: 585 LEIVSGR 591
E++ G+
Sbjct: 239 YEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 6e-04
Identities = 52/247 (21%), Positives = 92/247 (37%), Gaps = 54/247 (21%)
Query: 395 FATDNNIGEGGFGPVYKGLLADGTAI-AVKQLSSKSKQGNREFIN---EIGMISALQHPN 450
F +G G FG V D A+ A+K L K + + E +++ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+VKLY + + L + +Y+ + L ++++ IA +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLL----IRMEVFPEVLARFYIAELTLAIESVH 118
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAK---------------------------LD 543
++ +HRDIK N+L+D D + K++DFGL D
Sbjct: 119 KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 544 EEENTHISTR-------------------VAGTIGYMAPEYAMRGHLTEKADVYSFGIVA 584
+ N R + GT Y+APE +R T+ D +S G++
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 585 LEIVSGR 591
E++ G+
Sbjct: 239 FEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.8 bits (86), Expect = 0.002
Identities = 22/60 (36%), Positives = 27/60 (45%), Gaps = 2/60 (3%)
Query: 209 KLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNF 266
LK LDLS NRL F L ++ + +GN LT P L +DLS NN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.004
Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 20/164 (12%)
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYL 506
HPN+V I N+L ++ ++ S + H + + I G+ + L Y+
Sbjct: 58 HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYI 117
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV--------AGTI 558
H + VHR +KA+++L+ D K+ GL N RV +
Sbjct: 118 H---HMGYVHRSVKASHILISVD--GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVL 172
Query: 559 GYMAPEYA---MRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM 599
+++PE ++G+ K+D+YS GI A E+ +G +V +DM
Sbjct: 173 PWLSPEVLQQNLQGY-DAKSDIYSVGITACELANG--HVPFKDM 213
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.004
Identities = 43/201 (21%), Positives = 72/201 (35%), Gaps = 39/201 (19%)
Query: 41 TFLQDISLIANRLKGPIPKYLA-----NISTLVNLTVQYNQFSGELPEELGSLL----NL 91
+ LQ++ L N L + LA L L + N+ G E L L +L
Sbjct: 108 SSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDL 167
Query: 92 EKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFT----GQIPSFIQNWTKLEKLF 143
++L+L++N L + N++ +++N T + + + LE L
Sbjct: 168 KELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLN 227
Query: 144 IQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGE---- 199
NLTD + L A+ N+ + L L +IT +
Sbjct: 228 --------------LGDNNLTDAGAAAL----ASALLSPNISLLTLSLSCNDITDDGAKD 269
Query: 200 LPRYLGKMTKLKVLDLSFNRL 220
L L + L LDL N+
Sbjct: 270 LAEVLAEKESLLELDLRGNKF 290
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 733 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.93 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.93 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.9 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.88 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.87 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.84 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.81 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.79 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.78 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.76 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.75 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.74 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.72 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.72 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.71 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.71 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.7 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.7 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.56 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.49 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.48 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.41 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.27 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.26 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.25 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.2 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.14 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.14 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.14 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.1 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.09 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.08 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.06 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.05 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.05 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.03 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.03 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.0 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.98 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.85 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.81 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.7 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.63 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.63 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.61 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.6 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.57 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.51 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.5 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.5 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.42 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-70 Score=660.85 Aligned_cols=631 Identities=27% Similarity=0.427 Sum_probs=392.8
Q ss_pred cceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceee
Q 004732 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 95 (733)
Q Consensus 16 ~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 95 (733)
.+.++.|+|++|++++.+|..+..+++|+.|+|++|.+++.+|..+..+++|+.|+|++|.+++.+|..++.+++|+.|+
T Consensus 283 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~ 362 (968)
T PLN00113 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLD 362 (968)
T ss_pred ccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEE
Confidence 34455555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred ccCccccc------------------------cCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCcc
Q 004732 96 LSSNNFTG------------------------ELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 151 (733)
Q Consensus 96 Ls~N~l~~------------------------~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 151 (733)
|++|++++ .+|..+..+++|+.|++++|++++.+|..|.++++|+.|++++|++++
T Consensus 363 Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 442 (968)
T PLN00113 363 LSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQG 442 (968)
T ss_pred CCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccC
Confidence 55555544 444445555555555555555555555555566666666666666665
Q ss_pred CCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCC
Q 004732 152 PIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 231 (733)
Q Consensus 152 ~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 231 (733)
.+|..+..+++|+.|++++|.+....+..+...+|+.|++++|++++.+|..+.++++|+.|+|++|++.+.+|..+..+
T Consensus 443 ~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 522 (968)
T PLN00113 443 RINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSC 522 (968)
T ss_pred ccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCc
Confidence 55555556666666666666665555555555567888888888888888888888888888888888888888888888
Q ss_pred CCCCEEEecCCcccccCChhh--hcCCCeeecccCcCCCCCCccccccccccccccccccccc--CCceeeeeeeeCCCc
Q 004732 232 YDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQC--PKTYYSLHINCGGKQ 307 (733)
Q Consensus 232 ~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c--~~~~~~~~~~~~~~~ 307 (733)
++|+.|++++|.+++.+|..+ +++|+.|++++|++++..+........+..+-...+...+ +........ ..
T Consensus 523 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~----~~ 598 (968)
T PLN00113 523 KKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAI----NA 598 (968)
T ss_pred cCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhccc----Ch
Confidence 888888888888888888777 6778888888888877655544443333332222222211 100000000 00
Q ss_pred eeeCCCeeecc-CCCCCCCC-cccccCceEEE---ccchhhhh-cccccccceeccccccccccccc-hhhhcccccccc
Q 004732 308 VTANGNTTFEE-DTSEAGPS-TFSQSGTNWVL---SSTGHFLE-NGLKLGPYIQTNTSRLLMNDYQL-YTTARLSAISLT 380 (733)
Q Consensus 308 ~~~~g~~~~~~-~~~~~~~s-~~~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 380 (733)
....|+..... ....+.+. ........|.. ...+..+. ..+....+......+........ ..........-
T Consensus 599 ~~~~~n~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 677 (968)
T PLN00113 599 SAVAGNIDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDS- 677 (968)
T ss_pred hhhcCCccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhhhccccccccccccccccccccc-
Confidence 00011100000 00000000 00000011111 01111000 00000000000000000000000 00000000000
Q ss_pred eehhhhhHHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEE
Q 004732 381 YYGFYLQIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459 (733)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 459 (733)
..............|...++||+|+||.||+|+. .++..||||++...... ..+|++++++++|||||+++|+|.
T Consensus 678 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~ 753 (968)
T PLN00113 678 KVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCR 753 (968)
T ss_pred ccchhhhHHHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEE
Confidence 0000112223345678889999999999999995 68899999998653321 234688999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCc
Q 004732 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 539 (733)
Q Consensus 460 ~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 539 (733)
+++..++||||+++|+|.++++ .++|..+.+++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.
T Consensus 754 ~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 754 SEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred cCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 9999999999999999999985 48999999999999999999997766679999999999999999888875 665
Q ss_pred cccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCcc--chhhHHHHHHHHHhhCcccc
Q 004732 540 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE--DMFYLLDWALVLKEQGKLME 617 (733)
Q Consensus 540 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~ 617 (733)
+...... ....||++|+|||++.+..++.++|||||||++|||++|+.||... .......|++..........
T Consensus 829 ~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 829 PGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903 (968)
T ss_pred ccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh
Confidence 5432211 2236889999999999989999999999999999999999998432 23346667665544444444
Q ss_pred cccCCCCC--CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 618 LVDTNPGS--NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 618 ~~~~~~~~--~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.+++.... ....++...+.+++.+||+.+|++||+|.||++.|++...
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 45544322 3355667789999999999999999999999999986544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-56 Score=469.41 Aligned_cols=280 Identities=53% Similarity=0.883 Sum_probs=249.0
Q ss_pred hhhhHHhhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-
Q 004732 384 FYLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN- 462 (733)
Q Consensus 384 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~- 462 (733)
.|.+++.||++|...++||+|+||.||+|.+.+|+.||||++........++|.+|++++.+++|||+|+++|||.+.+
T Consensus 66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~ 145 (361)
T KOG1187|consen 66 SYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE 145 (361)
T ss_pred eHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc
Confidence 4899999999999999999999999999999999999999886653321567999999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRL-KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
+.+||||||++|+|.++|+.... .++|.+|++||.++|+||+|||+.+.++||||||||+|||||+++++||+|||+|+
T Consensus 146 ~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~ 225 (361)
T KOG1187|consen 146 HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAK 225 (361)
T ss_pred eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcc
Confidence 59999999999999999997665 89999999999999999999999998899999999999999999999999999997
Q ss_pred cCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCc---cchhhHHHHHHHHHhhCccccc
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK---EDMFYLLDWALVLKEQGKLMEL 618 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~---~~~~~~~~~~~~~~~~~~~~~~ 618 (733)
..........+...||.+|+|||++..+..+.|+|||||||+++|++||+.|... .....+.+|+......+.+.++
T Consensus 226 ~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~ei 305 (361)
T KOG1187|consen 226 LGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREI 305 (361)
T ss_pred cCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhe
Confidence 6554222222211899999999999999999999999999999999999988853 3455589999888888899999
Q ss_pred ccCCCC-CCCCH-HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 619 VDTNPG-SNFDK-EQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 619 ~~~~~~-~~~~~-~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
+|+.+. ..+.. ++..++..++.+|++.+|.+||+|.||+++|+..
T Consensus 306 iD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 306 VDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred eCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 999976 56664 6888899999999999999999999999999643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-48 Score=405.12 Aligned_cols=256 Identities=34% Similarity=0.529 Sum_probs=212.2
Q ss_pred cccCcccCCCcccEEEcccCCCcEEEEEEccccChhc--HHHHHHHHHHHHhCCCCceeeEeeEEEeCC-eEEEEEEccC
Q 004732 396 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQG--NREFINEIGMISALQHPNLVKLYGCCIEGN-QLLLIYEYLE 472 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~ 472 (733)
...+.||+|+||+||+|.+.....||||++....... .++|.+|+.+|++++|||||+++|+|.++. ..++|||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 3445699999999999999865569999997653222 468999999999999999999999999988 7999999999
Q ss_pred CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-CeEEcccCccccCcccCccc
Q 004732 473 NNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 473 ~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~~~~~~ 550 (733)
+|+|.++++. ....+++..+.+++.|||+||.|||++++ ||||||||+|||++.++ ++||+|||+++...... ..
T Consensus 124 ~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~ 200 (362)
T KOG0192|consen 124 GGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TS 200 (362)
T ss_pred CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-cc
Confidence 9999999987 47799999999999999999999999852 99999999999999997 99999999998655432 22
Q ss_pred ccccccCCCcccHHHHh--hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 551 STRVAGTIGYMAPEYAM--RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
.+...||+.|||||++. ...|+.|+|||||||++|||+||+.||.......... .....+.+..+...
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~---~v~~~~~Rp~~p~~------- 270 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS---AVVVGGLRPPIPKE------- 270 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH---HHHhcCCCCCCCcc-------
Confidence 33378999999999999 5689999999999999999999999997665532222 22222332222222
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 666 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 666 (733)
....+..++.+||+.||.+||++.+++..|+.+...
T Consensus 271 --~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 271 --CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred --CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 233488889999999999999999999999976553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=380.51 Aligned_cols=247 Identities=29% Similarity=0.474 Sum_probs=208.1
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-eEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN-QLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~ 470 (733)
++...+.||+|..|+||++++ .+++.+|+|++... .....+++.+|++++++.+||+||+++|+|..+. .+.++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 445678999999999999995 47889999999544 3344578999999999999999999999999998 59999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
|++|||++.+... +++++....+|+.+|++||.|||+.. +||||||||+|||++..|.+||||||.++..... .
T Consensus 160 MDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---~ 233 (364)
T KOG0581|consen 160 MDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---I 233 (364)
T ss_pred cCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---h
Confidence 9999999998755 57999999999999999999999642 5999999999999999999999999999876554 5
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCcc-----chhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE-----DMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
..++.||..|||||.+++..|+.++||||||++++|+.+|+.|+... +.+.+..++ ++..+ .
T Consensus 234 a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I------------v~~pp-P 300 (364)
T KOG0581|consen 234 ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI------------VDEPP-P 300 (364)
T ss_pred cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH------------hcCCC-C
Confidence 56789999999999999999999999999999999999999999664 333333322 22111 1
Q ss_pred CCCH-HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 626 NFDK-EQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 626 ~~~~-~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..+. ....++.+++..|+++||.+||++.|+++.
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1122 245569999999999999999999998764
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=377.97 Aligned_cols=208 Identities=30% Similarity=0.540 Sum_probs=187.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
..+|...+.||+|+||+||+|++ +++..||||.+..+ .+...+.+..|+.+|+.++|||||.+++++..++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35777888899999999999994 57899999999766 4555677889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC------CCeEEcccCcccc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD------LNSKISDFGLAKL 542 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~------~~~kl~DfGla~~ 542 (733)
|||.||+|.++++..+ .+++.++..++.|+|.||++||+++ ||||||||.||||+.. ..+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999998665 8999999999999999999999996 9999999999999865 4589999999998
Q ss_pred CcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHH
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDW 605 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~ 605 (733)
..+ .....+.+|++-|||||+++.++|+.|+|+||.|+++||+++|+.||......++..+
T Consensus 165 L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~ 225 (429)
T KOG0595|consen 165 LQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY 225 (429)
T ss_pred CCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence 774 3345678999999999999999999999999999999999999999988877776653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=390.40 Aligned_cols=252 Identities=31% Similarity=0.489 Sum_probs=216.9
Q ss_pred ccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCC
Q 004732 395 FATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 474 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 474 (733)
+...+.||+|-||+||.|.+.....||+|.++.. ......|.+|+++|++++|+|||+++|+|..++.++||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4456789999999999999988889999999764 334578999999999999999999999999999999999999999
Q ss_pred CHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 475 SLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 475 sL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
+|.++|.. .+..+...+.+.++.|||+||+||+++. +|||||.++|||++++..+||+|||+|+...++.......
T Consensus 287 sLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~ 363 (468)
T KOG0197|consen 287 SLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG 363 (468)
T ss_pred cHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence 99999985 6778999999999999999999999985 9999999999999999999999999999766655555554
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (733)
..-++.|.|||.+..+.++.|||||||||+||||+| |+.|+......+.+. ..+.+.++...+.++
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~----~le~GyRlp~P~~CP--------- 430 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE----LLERGYRLPRPEGCP--------- 430 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH----HHhccCcCCCCCCCC---------
Confidence 555789999999999999999999999999999999 888887665554443 234555544444333
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 633 MVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 633 ~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
..+.+++..||+.+|++|||+..+...|+..
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~ 461 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFETLREVLEDF 461 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence 3589999999999999999999988888754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=359.98 Aligned_cols=256 Identities=26% Similarity=0.448 Sum_probs=211.9
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEee-EEEeCCe-EEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYG-CCIEGNQ-LLLI 467 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lV 467 (733)
.+|.+.++||+|.||+||+++ +.+|..||.|.+.-. +....+....|+.+|++++|||||++++ .+.++.+ +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 367788999999999999998 789999999988643 4555678899999999999999999999 5666666 8999
Q ss_pred EEccCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCC-CeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 468 YEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYLHGESRI-KVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 468 ~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~-~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
||||+.|+|.+.++ +.++.+++.++|+++.|+++||.++|+.-+. -|+||||||.||+++.+|.+|++|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999986 4567899999999999999999999984321 2899999999999999999999999999987
Q ss_pred cccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
..... .....+|||.||+||.+....|+.|+||||+||++|||+.-+.||.+.+...+..-. .+++...+.
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI----~qgd~~~~p---- 249 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKI----EQGDYPPLP---- 249 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHH----HcCCCCCCc----
Confidence 65433 355688999999999999999999999999999999999999999888665554311 222221111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
..-.+..+..++..|+..||+.||+...+++.+.
T Consensus 250 ----~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 250 ----DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred ----HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1344567899999999999999998655554443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=386.54 Aligned_cols=248 Identities=27% Similarity=0.440 Sum_probs=212.4
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
..|...+.||+|||+.||+++. ..|..||+|++.+. .....+...+|+++.+.++|||||+++++|.+.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4678889999999999999995 89999999999763 3444567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
|+|++++|.+++. .++.+++.+++.++.||+.||.|||+.+ |||||||-.|++++++.++||+|||+|.....+.
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~- 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG- 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCcc-
Confidence 9999999999986 6679999999999999999999999996 9999999999999999999999999998766432
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
....+.+|||.|+|||++.+..++..+||||+|||||-|+.|++||...+..+...-+ ...+.. .+
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I---k~~~Y~-----------~P 238 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI---KLNEYS-----------MP 238 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH---HhcCcc-----------cc
Confidence 2345689999999999999999999999999999999999999999776554433321 111111 11
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
........+++.+.++.+|.+|||+++|++.
T Consensus 239 ~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 239 SHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred cccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 2233447889999999999999999999853
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=366.00 Aligned_cols=244 Identities=27% Similarity=0.401 Sum_probs=205.1
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
..++|+..++||+|+||+||.++ .++++.+|+|++++. .....+...+|..+|.+++||+||+++..|++++.+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35689999999999999999999 567899999999775 23345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
|+||+.||.|..+|.+++ .+++..+..++..|+.||.|||+.| |||||+||+|||||++|+++|+|||+++.....
T Consensus 103 Vld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 999999999999997654 7999999999999999999999997 999999999999999999999999999854433
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
. ....+++||+.|||||++.+..|+.++|.||+||++|||++|..||..++.....+- +.... + ..+
T Consensus 179 ~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~---I~~~k-~-----~~~--- 245 (357)
T KOG0598|consen 179 G-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDK---ILKGK-L-----PLP--- 245 (357)
T ss_pred C-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHH---HhcCc-C-----CCC---
Confidence 2 234558999999999999999999999999999999999999999988765443321 11111 0 011
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCC
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPS 652 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt 652 (733)
+.-......+++.+.+..||++|.-
T Consensus 246 -p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 246 -PGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred -CccCCHHHHHHHHHHhccCHHHhcC
Confidence 1112234788999999999999963
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=367.19 Aligned_cols=254 Identities=26% Similarity=0.396 Sum_probs=205.8
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChh-------cHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ-------GNREFINEIGMISALQHPNLVKLYGCCIEG 461 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 461 (733)
...+.|...+.||+|+||.|-+|. ..+|+.||||.+.+..-. ......+|+++|++++|||||++.++|..+
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 344567788999999999999998 678999999999754111 123457899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC---CCeEEcccC
Q 004732 462 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD---LNSKISDFG 538 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~---~~~kl~DfG 538 (733)
+..|+|||||+||+|.+.+..++ .+.+.....++.|++.|+.|||++| |+||||||+|||+..+ ..+||+|||
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred CceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999997654 6788888999999999999999997 9999999999999766 679999999
Q ss_pred ccccCcccCcccccccccCCCcccHHHHhhCC---CCccchhHhHHHHHHHHHhCCCCCCccchhh-HHHHHHHHHhhCc
Q 004732 539 LAKLDEEENTHISTRVAGTIGYMAPEYAMRGH---LTEKADVYSFGIVALEIVSGRSNVTKEDMFY-LLDWALVLKEQGK 614 (733)
Q Consensus 539 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~ 614 (733)
+|+..++ .....+.+||+.|.|||++.+.. +..++|+||+||+||-+++|..||..+.... +.+.+ ..+.
T Consensus 325 lAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI----~~G~ 398 (475)
T KOG0615|consen 325 LAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI----LKGR 398 (475)
T ss_pred hhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH----hcCc
Confidence 9998763 34456789999999999998654 3448899999999999999999996543221 22111 1111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. .......+..++..+++.+++..||++||++.|+++.
T Consensus 399 y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 399 YA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred cc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 10 0112233456678999999999999999999999875
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=343.98 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=205.3
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
+.|+....+|+|+||+||+++. .+|+.||||++.... +...+-.++|+++|++++|||+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 3466778999999999999995 569999999986542 3334567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
||+..-|++ |......++.....+++.|+++|+.|+|++. +|||||||+|||++.++.+||||||+|+..... ..
T Consensus 82 ~~dhTvL~e-Le~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-gd 156 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP-GD 156 (396)
T ss_pred ecchHHHHH-HHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-cc
Confidence 999865555 4455668899999999999999999999985 999999999999999999999999999987642 23
Q ss_pred cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHH------------HHhhCccc
Q 004732 550 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALV------------LKEQGKLM 616 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~------------~~~~~~~~ 616 (733)
..+..+.|.+|.|||.+.+ .+|+..+||||.||++.||++|..-|.+....+.+-.... +.......
T Consensus 157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~ 236 (396)
T KOG0593|consen 157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH 236 (396)
T ss_pred hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence 3455678999999999988 7899999999999999999999998876655443321111 11111111
Q ss_pred ccccCCCC-----CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004732 617 ELVDTNPG-----SNFDKEQVMVMINVALLCANASPTIRPSMSSVL 657 (733)
Q Consensus 617 ~~~~~~~~-----~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl 657 (733)
.+.-+.+. ....+....-++++++.|++.||.+|++-+|++
T Consensus 237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence 11111111 111122333688999999999999999999985
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=389.03 Aligned_cols=259 Identities=30% Similarity=0.504 Sum_probs=216.0
Q ss_pred hhcCccccCcccCCCcccEEEcccC------CCcEEEEEEccccChh-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 463 (733)
...+....+.||+|+||+||+|+.. +...||||.++.+... ..++|.+|++.++.++|||||+++|.|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3455666789999999999999832 3568999999887555 67899999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhc---------CC----CCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC
Q 004732 464 LLLIYEYLENNSLARALFEH---------RL----KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL 530 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~---------~~----~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 530 (733)
.++|+|||..|||.++|... +. .++..+.+.||.|||.||+||-++. +|||||..+|+|+.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccce
Confidence 99999999999999999721 22 3888999999999999999999885 99999999999999999
Q ss_pred CeEEcccCccccCcccCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHH
Q 004732 531 NSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALV 608 (733)
Q Consensus 531 ~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 608 (733)
.|||+|||+++..-..+.+. .....-.++|||||.++.++|+.+||||||||+|||+++ |+.|+.+.......+
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe---- 716 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIE---- 716 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHH----
Confidence 99999999998654444433 224455789999999999999999999999999999998 999997655444333
Q ss_pred HHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 609 LKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
...++.+....+.+| .+++.|+..||+..|.+||+++||-..|+.+..
T Consensus 717 ~i~~g~lL~~Pe~CP---------~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 717 CIRAGQLLSCPENCP---------TEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred HHHcCCcccCCCCCC---------HHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 224454444433333 359999999999999999999999999986544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=363.74 Aligned_cols=253 Identities=24% Similarity=0.373 Sum_probs=213.4
Q ss_pred HhhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCe
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 463 (733)
+...++|...++||+|+|++||+|+ ...++.||||++.+. .....+.+..|-++|.+| .||.||+++.-|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3445789999999999999999999 678999999998654 222335677899999999 89999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
+|+|+||+++|+|.++|...+ .+++...+.++.+|+.||+|||+.| ||||||||+|||||+||++||+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999997664 8999999999999999999999997 999999999999999999999999999977
Q ss_pred cccCcc----------c--ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh
Q 004732 544 EEENTH----------I--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE 611 (733)
Q Consensus 544 ~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 611 (733)
.+.... . ...++||-.|.+||++.....+..+|+|+||||+|+|+.|+.||...+++.+..-+. .-
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~--~l 302 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ--AL 302 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH--Hh
Confidence 643221 1 145899999999999999999999999999999999999999998887765554221 11
Q ss_pred hCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 612 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+ ..+++.....+.+|+.+.+..||.+|++..||-+.
T Consensus 303 --------~----y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 303 --------D----YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --------c----ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 1 11222223458899999999999999999988553
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=355.74 Aligned_cols=264 Identities=26% Similarity=0.392 Sum_probs=213.7
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 466 (733)
.+.|...+.||+|.||.||+|+ ..+|+.||+|++.... ........+|+.+|++++||||+++.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4567778899999999999999 7889999999987653 33345668999999999999999999999886 78999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
|+|||+. +|.-++.....+++..++..++.|++.||+|||++| |+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 196 VFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999987 888888888889999999999999999999999997 999999999999999999999999999988776
Q ss_pred CcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC---ccc--cccc
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG---KLM--ELVD 620 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~--~~~~ 620 (733)
.....+..+-|.+|.|||++.+. .|+.++|+||.||||.||+.|+..|.+.+....+..+....... .+. .+..
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~ 351 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH 351 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence 66555666779999999999885 69999999999999999999999998777655544333222111 011 1110
Q ss_pred ---CCCCCCCCHH-------HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 621 ---TNPGSNFDKE-------QVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 621 ---~~~~~~~~~~-------~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..+...+... .....++++..++..||.+|.|+.++++.
T Consensus 352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 0111111111 12257788999999999999999998753
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=354.28 Aligned_cols=254 Identities=30% Similarity=0.461 Sum_probs=203.9
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC--eEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN--QLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e~ 470 (733)
+|...+.||+|+||+||++.. ++|...|||.+........+.+.+|+.+|++++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 466778999999999999995 459999999986653333567899999999999999999999855544 68999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC-CCCeEEcccCccccCcc--cC
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLDEE--EN 547 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfGla~~~~~--~~ 547 (733)
+++|+|.+++...+.++++..+.++..||++||+|||++| ||||||||+|||++. ++.+||+|||+++.... ..
T Consensus 98 ~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 98 APGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 9999999999876658999999999999999999999987 999999999999999 79999999999986653 22
Q ss_pred cccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
......+.||+.|||||++..+ ....++||||+||++.||+||+.||... .....+........... .
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~~P---------~ 243 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDSLP---------E 243 (313)
T ss_pred ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCCCC---------C
Confidence 2223457899999999999864 3445999999999999999999999652 12222222222222111 1
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.+........+++.+|++.+|++|||+.++++..-
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 22223445888999999999999999999987643
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=362.55 Aligned_cols=251 Identities=27% Similarity=0.480 Sum_probs=212.9
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
...|+.-..||+|+.|.||.|+ ..+++.||||++........+-+.+|+.+|+..+|+|||++++.|..++++|.||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 3467777899999999999998 678899999999776555566788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
|++|+|.+.+... .+++.++..|+.++++||+|||.+| |+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus 352 m~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K 425 (550)
T KOG0578|consen 352 MEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K 425 (550)
T ss_pred cCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence 9999999998543 5899999999999999999999997 99999999999999999999999999987766544 4
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
..+++||+.|||||+.....|++|+||||||++++||+.|+.||..+++..-.. .+...+ .+....+..
T Consensus 426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly---LIa~ng--------~P~lk~~~k 494 (550)
T KOG0578|consen 426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIATNG--------TPKLKNPEK 494 (550)
T ss_pred cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH---HHhhcC--------CCCcCCccc
Confidence 456889999999999999999999999999999999999999997665432111 111111 122223334
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+.+++.+|++.||.+||++.|+++.
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 45569999999999999999999999764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=324.91 Aligned_cols=261 Identities=24% Similarity=0.350 Sum_probs=210.1
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh--hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|...+.||+|.||.||+|+ ..+|+.||||+++.... .-.....+|+..|+.++|+||+.++++|...+..-+|+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 56677899999999999999 77899999999876532 2245678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
|+. +|+..+......++...+..++.++++|++|||.+. |+||||||.|+|++++|.+||+|||+|+.+.......
T Consensus 83 m~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~ 158 (318)
T KOG0659|consen 83 MPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQ 158 (318)
T ss_pred ccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCccc
Confidence 976 899999888889999999999999999999999996 9999999999999999999999999999887655443
Q ss_pred ccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccc------cccc---
Q 004732 551 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM------ELVD--- 620 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~--- 620 (733)
... +-|.+|.|||.+.+. .|+..+|+||.|||+.||+-|..-|.+++..+.+............. .+.|
T Consensus 159 ~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 159 THQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred ccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 333 568899999999885 69999999999999999998877666665555444332222211111 1111
Q ss_pred ----CC-CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 621 ----TN-PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 621 ----~~-~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+. +....-........+++..++..||.+|++++|++++
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11 1111112233456899999999999999999998764
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=342.71 Aligned_cols=260 Identities=25% Similarity=0.385 Sum_probs=206.9
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
..+|.....||.|.-++||+|+ .+.+..||||++.... ....+.+.+|++.|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3577888999999999999999 6788999999997643 2335788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 470 YLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||.+||+.+++.. -...+++..+..|.+++++||.|||.+| .||||||+.|||++.+|.|||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 9999999999974 3446899999999999999999999997 99999999999999999999999999865543322
Q ss_pred c---cccccccCCCcccHHHHhh--CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 549 H---ISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 549 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
. ....+.||+.|||||+++. ..|+.|+|||||||+..|+.+|..||..-.+...+- ..-++......-...
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl----~tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL----LTLQNDPPTLLTSGL 257 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH----HHhcCCCCCcccccC
Confidence 1 1255789999999999654 469999999999999999999999996544433221 111111111110001
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...-.......+.+++..|++.||++|||++++++
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 11111122336889999999999999999999954
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=327.14 Aligned_cols=238 Identities=26% Similarity=0.381 Sum_probs=202.2
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
..++|...+.||.|+||+|..++ ..+|..+|+|.+.+.. -...+...+|..+|+.+.||+++++++.|.+.+.+++
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lym 121 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYM 121 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEE
Confidence 34688899999999999999999 4568899999997642 2234567789999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||++||.|..++++.+ ++++..++.++.||+.||+|||+.+ |++||+||+|||+|.+|.+||+|||+|+.....
T Consensus 122 vmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 122 VMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred EEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999999997654 8999999999999999999999996 999999999999999999999999999865543
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
.-+.+||+.|+|||+++...|..++|.|||||++|||+.|..||...+...+.+ +....+- .
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~--KI~~~~v------------~ 259 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE--KILEGKV------------K 259 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH--HHHhCcc------------c
Confidence 346899999999999999999999999999999999999999998777644332 2221111 1
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCC
Q 004732 627 FDKEQVMVMINVALLCANASPTIR 650 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~R 650 (733)
++.-....+.+++...++.|-++|
T Consensus 260 fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CCcccCHHHHHHHHHHHhhhhHhh
Confidence 222223347888999999999998
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=352.45 Aligned_cols=261 Identities=24% Similarity=0.347 Sum_probs=208.6
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhc-HHHHHHHHHHHHhCC-CCceeeEeeEEEeCC-eEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQG-NREFINEIGMISALQ-HPNLVKLYGCCIEGN-QLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lV 467 (733)
.++|...+.||.|.||.||+|+ ..+|..||||+++.+-... +-.=.+|+..|++++ |||||++.+++.+.+ .+++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4567788999999999999999 6789999999998763332 222368999999998 999999999999988 99999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
||||+. +|.+.+...+..+++.+++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+||......
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~Skp 164 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRSKP 164 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccccCC
Confidence 999976 899999888889999999999999999999999997 9999999999999998899999999999665433
Q ss_pred cccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHH-HHHhhCc--------ccc
Q 004732 548 THISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWAL-VLKEQGK--------LME 617 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~-~~~~~~~--------~~~ 617 (733)
. .+..+.|.+|.|||++.+ +.|+.+.|+||+|||++|+.+-+.-|.+.++.+..--+- +....++ +..
T Consensus 165 P--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~ 242 (538)
T KOG0661|consen 165 P--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS 242 (538)
T ss_pred C--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence 3 356778999999998865 679999999999999999999999897766554332111 1111100 000
Q ss_pred ccc--------CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 618 LVD--------TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 618 ~~~--------~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+. .... ..-+......++++.+|++.||.+|||+.|.++.
T Consensus 243 ~mnf~~P~~~~~~l~-~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 243 AMNFRFPQVKPSPLK-DLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HhccCCCcCCCCChH-HhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 000 0000 0111245578899999999999999999999876
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=362.54 Aligned_cols=261 Identities=31% Similarity=0.479 Sum_probs=213.7
Q ss_pred hhcCccccCcccCCCcccEEEcccCC--C--cE-EEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLAD--G--TA-IAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN 462 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 462 (733)
..++-...+.||+|+||.||+|++.. + .. ||||..+.. ......+|++|+++|++++|||||+++|++..+.
T Consensus 155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~ 234 (474)
T KOG0194|consen 155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE 234 (474)
T ss_pred eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 34455566899999999999999543 2 23 899998752 4566789999999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
.+++|||+|.||+|.++|......++..++.+++.+.|+||+|||++. +|||||.++|+|++.++.+||+|||+++.
T Consensus 235 Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 235 PLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred ccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 999999999999999999987778999999999999999999999985 99999999999999999999999999985
Q ss_pred CcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
........ ....-+..|+|||.+..+.|+.++|||||||++||+++ |..||.+........++. ..+..+....
T Consensus 312 ~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~---~~~~r~~~~~- 386 (474)
T KOG0194|consen 312 GSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV---KNGYRMPIPS- 386 (474)
T ss_pred Ccceeecc-ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH---hcCccCCCCC-
Confidence 44211111 11124679999999999999999999999999999999 888998877665554431 2222222222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
.....+..++.+||..+|++||+|.++.+.++......
T Consensus 387 --------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 387 --------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred --------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 22334777888999999999999999999998765544
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=354.04 Aligned_cols=250 Identities=23% Similarity=0.386 Sum_probs=207.9
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc----Ch-hcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCC
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK----SK-QGNREFINEIGMISALQ-HPNLVKLYGCCIEGN 462 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 462 (733)
...+.|...+.||+|+||+||.|. ..+|..||||.+... .. ...+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345678899999999999999998 567899999976553 11 23456678999999999 999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC-CCeEEcccCccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAK 541 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfGla~ 541 (733)
..++||||+.+|+|.+++.+ ..++.+..+.+++.|++.|++|||+.| |+||||||+|||+|.+ +++||+|||++.
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999988 668999999999999999999999997 9999999999999999 999999999999
Q ss_pred cCcccCcccccccccCCCcccHHHHhhCC-CC-ccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccc
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRGH-LT-EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 619 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (733)
... .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...+...+... .....-.+...
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k--i~~~~~~~p~~- 245 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK--IRKGEFKIPSY- 245 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH--HhcCCccCCCC-
Confidence 774 2233456689999999999999876 75 789999999999999999999977654443321 11111111111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004732 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 657 (733)
Q Consensus 620 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl 657 (733)
.. ...+..++.+|+..+|.+|+++.+|+
T Consensus 246 -------~~---S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 246 -------LL---SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred -------cC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 10 34588999999999999999999998
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=360.60 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=202.8
Q ss_pred hhcCccccCcccCCCcccEEEccc------CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC-
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG- 461 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 461 (733)
..++|...+.||+|+||.||+|.. .+++.||||.+.... ......+.+|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 456788999999999999999963 235789999986542 23346789999999999 899999999998765
Q ss_pred CeEEEEEEccCCCCHHHHHHhcC---------------------------------------------------------
Q 004732 462 NQLLLIYEYLENNSLARALFEHR--------------------------------------------------------- 484 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------------- 484 (733)
...++||||+++|+|.+++....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 45899999999999999987421
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc-cccccccCCC
Q 004732 485 ----LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIG 559 (733)
Q Consensus 485 ----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~ 559 (733)
..+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........ ......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 24788899999999999999999986 999999999999999999999999999865432222 1223456789
Q ss_pred cccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHH
Q 004732 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINV 638 (733)
Q Consensus 560 y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 638 (733)
|+|||++.+..++.++|||||||++|||++ |..||........ ..... ..+.... . +......+.++
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~~~-~~~~~~~-----~----~~~~~~~l~~l 309 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQRL-KDGTRMR-----A----PENATPEIYRI 309 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHHHH-hcCCCCC-----C----CCCCCHHHHHH
Confidence 999999999899999999999999999997 9999965332111 11111 1111111 1 11122358899
Q ss_pred HHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 639 ALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 639 ~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
+.+||+.||.+||++.|+++.|+..
T Consensus 310 i~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 310 MLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHH
Confidence 9999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=347.93 Aligned_cols=251 Identities=24% Similarity=0.316 Sum_probs=206.6
Q ss_pred hHHhhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004732 387 QIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN 462 (733)
Q Consensus 387 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 462 (733)
+.+...++|.....||+|+||.||.|+ ..+|..+|+|++++. .....+.+..|-.+|...++|.||+++..|.+.+
T Consensus 135 R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~ 214 (550)
T KOG0605|consen 135 RTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE 214 (550)
T ss_pred cccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence 345567899999999999999999999 567999999999875 3445567888999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
.+||||||++||++..+|...+ .|++..+..++.+++.||+-+|+.| +|||||||+|+|||..|++||+||||+.-
T Consensus 215 ~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 215 YLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred eeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 9999999999999999997654 8999999999999999999999997 99999999999999999999999999852
Q ss_pred Ccc-----------------------cCc----cc-------------------ccccccCCCcccHHHHhhCCCCccch
Q 004732 543 DEE-----------------------ENT----HI-------------------STRVAGTIGYMAPEYAMRGHLTEKAD 576 (733)
Q Consensus 543 ~~~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~D 576 (733)
... +.. .. ...++|||.|+|||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 110 000 00 01257999999999999999999999
Q ss_pred hHhHHHHHHHHHhCCCCCCccchhhH----HHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC
Q 004732 577 VYSFGIVALEIVSGRSNVTKEDMFYL----LDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPS 652 (733)
Q Consensus 577 v~s~Gvil~elltg~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt 652 (733)
.||+|||+|||+.|.+||..+++... ..|........+ . ....+..++|.+|+. ||..|.-
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~----------~----~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEE----------V----DLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCc----------C----cccHHHHHHHHHHhc-CHHHhcC
Confidence 99999999999999999987776543 333321111111 1 111457889999999 9999985
Q ss_pred ---HHHH
Q 004732 653 ---MSSV 656 (733)
Q Consensus 653 ---~~~v 656 (733)
+.||
T Consensus 436 ~~G~~EI 442 (550)
T KOG0605|consen 436 SKGAEEI 442 (550)
T ss_pred cccHHHH
Confidence 5555
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=358.89 Aligned_cols=260 Identities=28% Similarity=0.462 Sum_probs=207.4
Q ss_pred hhcCccccCcccCCCcccEEEcccCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
..+.+.....||+|.||+||+|+|. ..||||.+... .....+.|+.|+.++++-||.||+-+.|||..+.. .+|.
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 3455667889999999999999974 45999999765 34456789999999999999999999999999887 9999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc-C
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE-N 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~-~ 547 (733)
.||+|.+|..+++..+.+++..+.+.|++|||+|+.|||.++ |||||||+.||++.+++.|||+|||++..-..- .
T Consensus 467 qwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred hhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 999999999999988889999999999999999999999985 999999999999999999999999999643221 1
Q ss_pred cccccccccCCCcccHHHHhh---CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
......--|...|||||+++. .+|+..+|||||||++|||++|..||.......+ ......+..+.-.-
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI----ifmVGrG~l~pd~s---- 615 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI----IFMVGRGYLMPDLS---- 615 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe----EEEecccccCccch----
Confidence 111222347789999999975 4689999999999999999999999963322111 11112222211110
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.........|.+|+..||..++++||.+.+|+..|+....
T Consensus 616 -~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 616 -KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 1112234458889999999999999999999998885544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=349.25 Aligned_cols=246 Identities=27% Similarity=0.408 Sum_probs=210.6
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
++|...+.||+|+||+||||+. .+.+.||+|.+.+. .++..+.+.+|+++++.++|||||.++++|....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4566677899999999999994 56889999998654 33445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+.| +|..++... ..++++.+..++.++..||.|||+.+ |+|||+||.|||++..+.+|+||||+|+.+.. ++.
T Consensus 82 ~a~g-~L~~il~~d-~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQD-GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS 155 (808)
T ss_pred hhhh-hHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence 9988 999999654 58999999999999999999999986 99999999999999999999999999997665 344
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
..+.+.||+-|||||...++.|+..+|.||+||++||+++|+.||.......++..+ .. |+ ..++.
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I---~~--------d~---v~~p~ 221 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSI---LK--------DP---VKPPS 221 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHH---hc--------CC---CCCcc
Confidence 566788999999999999999999999999999999999999999877665555322 11 11 11233
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.....+.+++...+.+||.+|.+..+++.
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 45556889999999999999999999864
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=381.25 Aligned_cols=259 Identities=31% Similarity=0.479 Sum_probs=213.9
Q ss_pred cCccccCcccCCCcccEEEcccCC--Cc----EEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLAD--GT----AIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
......+.||+|+||.||+|+..+ |. .||||.++.. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 445567899999999999998543 43 4999999775 4556688999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCc
Q 004732 466 LIYEYLENNSLARALFEH------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 539 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 539 (733)
+++|||++|+|..+|++. ...++..+.+.++.|||+|+.|||+++ +|||||..+|+||++...|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999976 667999999999999999999999985 99999999999999999999999999
Q ss_pred cccCcccCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccc
Q 004732 540 AKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLME 617 (733)
Q Consensus 540 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 617 (733)
|+.+.....+. .....-...|||||.+..+.++.|+|||||||++||++| |..||...+.......+ .+.+ +.+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~---~~gg-RL~ 924 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDV---LEGG-RLD 924 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHH---HhCC-ccC
Confidence 99544333332 222234579999999999999999999999999999999 89999777665554422 1233 211
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 618 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
.. ......+++++..||+.+|++||++..|++.+.+..+..
T Consensus 925 ~P---------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 925 PP---------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred CC---------CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 11 122335889999999999999999999999888765543
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=342.05 Aligned_cols=255 Identities=25% Similarity=0.394 Sum_probs=206.7
Q ss_pred hcCccccCcccCCCcccEEEcccC----CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.++|+..+.||+|+||.||+|.+. .+..||+|.++... ......|.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356788899999999999999743 45689999987653 2334678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++|+|.+++......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+|++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999876668999999999999999999999986 999999999999999999999999987654322
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.........++..|+|||.+.+..++.++|||||||++||+++ |+.||............ ..+....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~----~~~~~~~-------- 228 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV----EDGFRLP-------- 228 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----HCCCCCC--------
Confidence 2221222345678999999999999999999999999999775 99999765544333221 1111111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
.+......+.+++.+||+.+|++||++.+|++.|+.
T Consensus 229 -~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 229 -APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred -CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 111223358889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=343.87 Aligned_cols=246 Identities=20% Similarity=0.296 Sum_probs=199.9
Q ss_pred cCcccCCCcccEEEcccCCCcEEEEEEccccChhc---HHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeEEEEEEc
Q 004732 398 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQG---NREFINEIGMISALQHPNLVKLYGCCIE----GNQLLLIYEY 470 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~ 470 (733)
...||+|++|.||+|.+ +|+.||||.+....... .+.|.+|++++++++|||||+++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999998 68999999987643322 4678899999999999999999999977 3578999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++|+|.+++... ..+++..+.+++.+++.||+|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--- 177 (283)
T PHA02988 104 CTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--- 177 (283)
T ss_pred CCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc---
Confidence 9999999999754 47899999999999999999999742 37899999999999999999999999998543321
Q ss_pred ccccccCCCcccHHHHhh--CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 551 STRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+........ ...+.... .+
T Consensus 178 -~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i---~~~~~~~~---------~~ 244 (283)
T PHA02988 178 -FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI---INKNNSLK---------LP 244 (283)
T ss_pred -ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH---HhcCCCCC---------CC
Confidence 23457899999999976 67999999999999999999999999765543332211 11111111 11
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
......+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 245 ~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 245 LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 12234588999999999999999999999999854
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=345.27 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=203.4
Q ss_pred cCccccCcccCCCcccEEEcccCC-----------------CcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLAD-----------------GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKL 454 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l 454 (733)
++|...+.||+|+||.||+|++.+ +..||+|.+.... .....+|.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788999999999999997432 3479999987542 3345679999999999999999999
Q ss_pred eeEEEeCCeEEEEEEccCCCCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeec
Q 004732 455 YGCCIEGNQLLLIYEYLENNSLARALFEHR------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516 (733)
Q Consensus 455 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 516 (733)
++++.+.+..++||||+++|+|.+++.... ..++|..+.+++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999986321 24788999999999999999999986 999
Q ss_pred CCCCCCcEEecCCCCeEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh--CCCC
Q 004732 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS--GRSN 593 (733)
Q Consensus 517 ~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt--g~~p 593 (733)
|||||+||+++.++.+||+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999976543322 12233456789999999998899999999999999999987 5667
Q ss_pred CCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 594 VTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
|..........+................ +......+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQVIENAGEFFRDQGRQVYLFR------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHHHHHHHHHHhhhccccccccC------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7554443333333222111111100000 1112235889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=337.40 Aligned_cols=255 Identities=25% Similarity=0.334 Sum_probs=205.5
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh--------------hcHHHHHHHHHHHHhCCCCceeeE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK--------------QGNREFINEIGMISALQHPNLVKL 454 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l 454 (733)
...+.|...+.||+|.||.|-+|+ ..+++.||||++.+... ...+...+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 345789999999999999999999 56899999999865411 112478899999999999999999
Q ss_pred eeEEEeC--CeEEEEEEccCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC
Q 004732 455 YGCCIEG--NQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 531 (733)
Q Consensus 455 ~~~~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 531 (733)
+.+..+. +.+|||+|||..|.+... ..... ++..++++++.++..||+|||.+| ||||||||+|+|++++|+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 9999874 679999999999976432 22334 899999999999999999999997 999999999999999999
Q ss_pred eEEcccCccccCccc----CcccccccccCCCcccHHHHhhCC----CCccchhHhHHHHHHHHHhCCCCCCccchhhHH
Q 004732 532 SKISDFGLAKLDEEE----NTHISTRVAGTIGYMAPEYAMRGH----LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL 603 (733)
Q Consensus 532 ~kl~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~ 603 (733)
+||+|||.+...... ....-...+||+.|+|||...++. .+.+.||||+||+||.|+.|+.||..+....+.
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~ 328 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELF 328 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHH
Confidence 999999999865322 111223478999999999987732 466899999999999999999999887766655
Q ss_pred HHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 604 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
+-+ +...+.....++..+.+.+++++++++||++|.+..+|.....
T Consensus 329 ~KI------------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpw 374 (576)
T KOG0585|consen 329 DKI------------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPW 374 (576)
T ss_pred HHH------------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecce
Confidence 421 2222222223345567899999999999999999999976654
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=362.10 Aligned_cols=256 Identities=28% Similarity=0.458 Sum_probs=216.5
Q ss_pred CccccCcccCCCcccEEEcccCC----CcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLAD----GTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
...++++||.|.||.||+|+++- ...||||.++.. ..+...+|+.|+.||.++.||||+++.|+.......++|.
T Consensus 630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 44578999999999999999642 357999999875 4556789999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
|||++|+|+.+|+.+..++++.+...++++||.|+.||-+.+ +|||||.++|||++.+..+||+|||+++...++..
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 999999999999988889999999999999999999999885 99999999999999999999999999997765543
Q ss_pred cccccccc--CCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 549 HISTRVAG--TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 549 ~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
...++.-| +++|.|||.+..++++.++|||||||+|||.++ |.+|+......+....+ +++ .+.
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI----e~g---------yRL 853 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI----EQG---------YRL 853 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH----Hhc---------cCC
Confidence 32332223 469999999999999999999999999999887 99999776655433211 111 222
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
..+++....|.+|++.||++|-.+||++.||+..|.++..
T Consensus 854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 854 PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 2344455569999999999999999999999999996544
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=347.84 Aligned_cols=241 Identities=28% Similarity=0.438 Sum_probs=199.2
Q ss_pred cccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCC
Q 004732 396 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNS 475 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 475 (733)
...+-||+|+.|.||.|++. ++.||||+++.-. ..++.-|++|+||||+.+.|+|.....+|+|||||..|-
T Consensus 127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq 198 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ 198 (904)
T ss_pred hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence 45677999999999999986 6889999875321 247788999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccccc
Q 004732 476 LARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 555 (733)
Q Consensus 476 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 555 (733)
|..+|... ..+.......+..+||.|+.|||.+ +|||||||+-||||..+..|||+|||-++...+. .....++
T Consensus 199 L~~VLka~-~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFa 272 (904)
T KOG4721|consen 199 LYEVLKAG-RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFA 272 (904)
T ss_pred HHHHHhcc-CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhh
Confidence 99999654 5788888999999999999999988 4999999999999999999999999999876554 2234589
Q ss_pred cCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHH
Q 004732 556 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVM 635 (733)
Q Consensus 556 gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 635 (733)
||..|||||++.+...++|+||||||||||||+||..||...+...+. | -+-...+....+.....-+
T Consensus 273 GTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-w-----------GVGsNsL~LpvPstcP~Gf 340 (904)
T KOG4721|consen 273 GTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-W-----------GVGSNSLHLPVPSTCPDGF 340 (904)
T ss_pred hhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-E-----------eccCCcccccCcccCchHH
Confidence 999999999999999999999999999999999999999544322110 0 0001111122233334457
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 636 INVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 636 ~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
.-+++.||+..|..||+|++|+..|+-
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 778999999999999999999999883
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=336.00 Aligned_cols=252 Identities=26% Similarity=0.474 Sum_probs=206.9
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
++|+..+.||+|+||.||+|.+.++..+|+|.+... ......|.+|++++++++||||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 357778899999999999999888889999988643 2335678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||.++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 83 NGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 99999999765557899999999999999999999986 999999999999999999999999999865433222222
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
...++..|+|||.+.+..++.++||||||+++|||++ |+.||...+......... . +... ..+ ...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~---~-~~~~--~~~-------~~~ 226 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS---R-GFRL--YRP-------KLA 226 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---C-CCCC--CCC-------CCC
Confidence 3345678999999988889999999999999999999 899997665444433221 1 1111 001 111
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
...+.+++.+||+.+|++||++.++++.|.
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 235889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=341.45 Aligned_cols=248 Identities=29% Similarity=0.456 Sum_probs=208.6
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
..|+..+.||+|+||.||+|. ...++.||+|++... .+....++.+|+.++..++++||.++++.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 356667899999999999999 567899999998764 344557888999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
|.||++.+.+... ..+++..+.-++.++..|+.|||.++ .+|||||+.||++..+|.+|++|||.+..........
T Consensus 93 ~~gGsv~~lL~~~-~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSG-NILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hcCcchhhhhccC-CCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 9999999998644 35588888999999999999999996 9999999999999999999999999997665543333
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
.+++||+.|||||++....|+.|+||||||++.+||++|..|+....++ ...-++...........
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm-------------rvlflIpk~~PP~L~~~ 234 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM-------------RVLFLIPKSAPPRLDGD 234 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc-------------eEEEeccCCCCCccccc
Confidence 6789999999999999889999999999999999999999999554332 22222332222333334
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
....+.+++..|++.+|+.||++.++++
T Consensus 235 ~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 235 FSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 4556999999999999999999999964
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=350.15 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=208.0
Q ss_pred HhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCe
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 463 (733)
+...++|...++||+|+||+|+.|.. .+++.+|||.+++. ..+..+..+.|.+++... +||.+++++.+|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 44567899999999999999999994 56889999999876 344556788899888877 59999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
+|+||||+.||++..+ .+...+++..+..++..|+.||.|||+++ |||||||-+|||||.+|.+||+|||+++..
T Consensus 444 l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~ 518 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG 518 (694)
T ss_pred EEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence 9999999999995443 34458999999999999999999999997 999999999999999999999999999853
Q ss_pred cccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
-.. ...+.+++||+.|||||++....|+.++|.|||||+||||+.|..||.++++..+.+... ..
T Consensus 519 m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~------------~d-- 583 (694)
T KOG0694|consen 519 MGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV------------ND-- 583 (694)
T ss_pred CCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh------------cC--
Confidence 322 224677999999999999999999999999999999999999999998888776665321 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSM 653 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 653 (733)
...|+.-...+.+.++.+.+..+|++|.-+
T Consensus 584 ~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 122344445568889999999999999977
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.06 Aligned_cols=249 Identities=24% Similarity=0.311 Sum_probs=199.2
Q ss_pred ccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 395 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
|+..+.||+|+||.||+|. ..+|+.||||.+.... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 5677899999999999998 4679999999986432 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++........
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence 9999999888643 346899999999999999999999986 99999999999999999999999999986543221
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....||..|+|||++.+..++.++|||||||++|||++|+.||..........-........ ...++.
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------~~~~~~ 226 (285)
T cd05631 158 -VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED----------QEEYSE 226 (285)
T ss_pred -ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc----------cccCCc
Confidence 234568999999999999999999999999999999999999996543221111010000000 011112
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004732 630 EQVMVMINVALLCANASPTIRPS-----MSSVLR 658 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 658 (733)
.....+.+++.+||+.||.+||+ ++++++
T Consensus 227 ~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 22345888999999999999997 677654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=333.01 Aligned_cols=254 Identities=29% Similarity=0.440 Sum_probs=208.9
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
.++|+..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35778889999999999999998888899999986543 33568899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 472 ENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 472 ~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
++|+|.+++.. ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (261)
T cd05072 84 AKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160 (261)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceec
Confidence 99999999974 3457899999999999999999999986 9999999999999999999999999998665433222
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....++..|+|||++....++.++|||||||++|||++ |+.||..........+.. ..... .....
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~----~~~~~-----~~~~~--- 228 (261)
T cd05072 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ----RGYRM-----PRMEN--- 228 (261)
T ss_pred cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH----cCCCC-----CCCCC---
Confidence 233446778999999988889999999999999999998 999996554433332221 11110 01111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 229 -~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 229 -CPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -CCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 22348889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=343.49 Aligned_cols=262 Identities=22% Similarity=0.345 Sum_probs=205.1
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|+..+.||+|+||.||+|+. .+|..||+|.+.... ......+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 46788999999999999999994 478899999986542 2334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 158 (331)
T cd06649 84 HMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-- 158 (331)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc--
Confidence 99999999998654 36899999999999999999999863 49999999999999999999999999987553321
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh---Cccc----------
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ---GKLM---------- 616 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~---------- 616 (733)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...+.......... +...
T Consensus 159 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (331)
T cd06649 159 -ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPG 237 (331)
T ss_pred -cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccc
Confidence 23456899999999999889999999999999999999999999654433322111000000 0000
Q ss_pred --------------------c-cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 --------------------E-LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 --------------------~-~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+ +................+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 238 RPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0 000000000011123458899999999999999999999765
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=319.07 Aligned_cols=263 Identities=23% Similarity=0.303 Sum_probs=208.3
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhc--HHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQG--NREFINEIGMISALQHPNLVKLYGCCIE--GNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 466 (733)
.+.|...+.|++|+||.||+|+ .++++.||+|+++...... --.-.+|+.+|.+.+|||||.+-.+..- -+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 4568889999999999999999 5678999999997653221 1345899999999999999999888654 467999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
|||||+. +|...+..-.+++...++..++.|+++|++|||..+ |+|||+|++|+|+...|.+||+|||+|+.++..
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9999987 899999888889999999999999999999999997 999999999999999999999999999987765
Q ss_pred CcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccc---------
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM--------- 616 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 616 (733)
.. ..+..+-|.+|.|||.+.+. .|+.+.|+||+|||+.|+++++.-|.+....+.++.+........-.
T Consensus 231 ~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 231 LK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred cc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 33 23456679999999999885 59999999999999999999999998777666555433322211000
Q ss_pred --------ccccCCCCCCCCHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 --------ELVDTNPGSNFDKE-QVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 --------~~~~~~~~~~~~~~-~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......+...+... ....-.+++...+..||.+|-|++|.++.
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00000111111111 22456688889999999999999998763
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=354.07 Aligned_cols=255 Identities=28% Similarity=0.454 Sum_probs=202.2
Q ss_pred hcCccccCcccCCCcccEEEccc------CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCe
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 463 (733)
.++|...+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+++++.+ +|||||+++++|.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999862 245689999986532 33446788999999999 89999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC-----------------------------------------------------------
Q 004732 464 LLLIYEYLENNSLARALFEHR----------------------------------------------------------- 484 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~----------------------------------------------------------- 484 (733)
.++||||+++|+|.+++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986422
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 485 ---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 485 ---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
..+++..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 24789999999999999999999986 999999999999999999999999999865433221
Q ss_pred -cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchh-hHHHHHHHHHhhCcccccccCCCCCC
Q 004732 550 -ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMF-YLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 550 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ....+ . ..+..... + ..
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~---~-~~~~~~~~----~-~~ 341 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKM---I-KEGYRMLS----P-EC 341 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHH---H-HhCccCCC----C-CC
Confidence 1222345678999999999999999999999999999998 88888543221 11111 1 11111100 0 11
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
....+.+++.+||+.||++||++.||++.|++
T Consensus 342 ----~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 342 ----APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred ----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 12358899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=307.13 Aligned_cols=250 Identities=25% Similarity=0.357 Sum_probs=210.1
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
.+.++|++.+.||+|-||.||.|+ .+++-.||+|++.+. ......++.+|+++-+.++||||++++++|.+....|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 356789999999999999999999 556788999998764 2334578899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 466 LIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
|++||..+|.+...|.+ ...++++.....++.|+|.|+.|+|... ||||||||+|+|++..+..||+|||-+...+
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999983 3456999999999999999999999885 9999999999999999999999999987433
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
.....+.+||..|.+||...+..++.++|+|++|++.||++.|..||.......... +...- +..+
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYk--rI~k~-----~~~~---- 241 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYK--RIRKV-----DLKF---- 241 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHH--HHHHc-----cccC----
Confidence 334567899999999999999999999999999999999999999997665333221 11111 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+........+++.+|+..+|.+|.+..|+++.
T Consensus 242 ---p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 242 ---PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 12223348899999999999999999998764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=351.17 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=203.3
Q ss_pred hhhcCccccCcccCCCcccEEEccc------CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 461 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 461 (733)
...++|...+.||+|+||.||+|+. .++..||||.+.... ......+.+|+++++.+ +|||||+++++|.+.
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 3456788999999999999999873 234579999997542 33345688999999999 899999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcC---------------------------------------------------------
Q 004732 462 NQLLLIYEYLENNSLARALFEHR--------------------------------------------------------- 484 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~--------------------------------------------------------- 484 (733)
+..++||||+++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999986321
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc-cc
Q 004732 485 ------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH-IS 551 (733)
Q Consensus 485 ------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~ 551 (733)
..+++..+++++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++........ ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 24788899999999999999999986 999999999999999999999999999755432221 12
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
....+++.|+|||++.+..++.++|||||||++|||++ |+.||......... .... ..+..... ...
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~--~~~~-~~~~~~~~-----~~~---- 339 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF--YKMV-KRGYQMSR-----PDF---- 339 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH--HHHH-HcccCccC-----CCC----
Confidence 22345678999999998899999999999999999997 99999544321111 1111 11110000 011
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
....+.+++.+||+.+|.+||++.+|+++|++.
T Consensus 340 ~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 340 APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 123588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=330.13 Aligned_cols=251 Identities=25% Similarity=0.437 Sum_probs=205.2
Q ss_pred CccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 394 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+|...+.||+|+||.||+|...++..||+|.+.... .....|.+|++++++++||||+++++++.+....++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 567778999999999999998777789999986542 3346799999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++......+++..+++++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||.++............
T Consensus 84 ~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (256)
T cd05113 84 GCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG 160 (256)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCC
Confidence 9999999765557899999999999999999999986 9999999999999999999999999988654432222223
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (733)
..++..|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+..... ... ..
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~-----~~~----~~ 227 (256)
T cd05113 161 SKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV----SQGLRLYR-----PHL----AS 227 (256)
T ss_pred CccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----hcCCCCCC-----CCC----CC
Confidence 346678999999988889999999999999999998 99998654433322211 11111100 011 13
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 633 MVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 633 ~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
..+.+++.+||+.+|.+||++.++++.|+
T Consensus 228 ~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 228 EKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 45889999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-40 Score=341.03 Aligned_cols=259 Identities=27% Similarity=0.446 Sum_probs=216.4
Q ss_pred hhhcCccccCcccCCCcccEEEcccC---CC--cEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLLA---DG--TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~~---~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 463 (733)
...+.....++||+|-||.||+|++. .| -.||||..+.+ .....+.|++|.-+|++++|||||+++|+|.+. .
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P 464 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P 464 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence 33445556789999999999999843 23 36899998874 344567899999999999999999999999864 6
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.|+|||.++-|.|..+|+.....++..+...++.||+.||+|||+. +.|||||..+|||+.....+|++|||+++..
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 7999999999999999998888999999999999999999999988 5999999999999999999999999999999
Q ss_pred cccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
.++..+..+...-++.|||||.+.-+.++.++|||.|||.+||++. |..||.+....+.. ...+++++.
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI----~~iEnGeRl------ 611 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI----GHIENGERL------ 611 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE----EEecCCCCC------
Confidence 8888777777777889999999999999999999999999999987 99999654322111 111233332
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
..++.+...++.++.+||+.+|.+||.+.++...|+.+..
T Consensus 612 ---P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 612 ---PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ---CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 3333444568899999999999999999999999985433
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=345.88 Aligned_cols=253 Identities=20% Similarity=0.234 Sum_probs=204.6
Q ss_pred cCccccCcccCCCcccEEEcccC-CCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||.||+|+.. +++.||||++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36788899999999999999954 68999999986532 223456888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999999654 47899999999999999999999986 99999999999999999999999999975443
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+........... ... ..........
T Consensus 154 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~~~---~~~~~~~~~~ 226 (333)
T cd05600 154 -YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW---KET---LQRPVYDDPR 226 (333)
T ss_pred -ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc---ccc---ccCCCCCccc
Confidence 223467999999999999989999999999999999999999999765543332211110 000 1000000000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......+.+++.+|++.+|.+||++.++++.
T Consensus 227 ~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 227 FNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1223457889999999999999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=343.61 Aligned_cols=242 Identities=26% Similarity=0.329 Sum_probs=198.0
Q ss_pred CcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCC
Q 004732 399 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 474 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 474 (733)
+.||+|+||.||+|+ ..+|+.||||.+.... ......+.+|++++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999998 4578999999986532 223456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccccc
Q 004732 475 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV 554 (733)
Q Consensus 475 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 554 (733)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccce
Confidence 999998654 47899999999999999999999986 9999999999999999999999999987532221 122346
Q ss_pred ccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHH
Q 004732 555 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 634 (733)
Q Consensus 555 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (733)
.||+.|+|||++.+..++.++||||+||++|||++|+.||...+......... .+.. .++......
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~----------~~p~~~~~~ 221 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL----MEEI----------RFPRTLSPE 221 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH----cCCC----------CCCCCCCHH
Confidence 79999999999999899999999999999999999999997655433332211 0100 111122345
Q ss_pred HHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004732 635 MINVALLCANASPTIRP-----SMSSVLRM 659 (733)
Q Consensus 635 l~~l~~~c~~~~P~~RP-----t~~~vl~~ 659 (733)
+.+++.+|++.||++|| ++.++++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 222 AKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred HHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 88899999999999999 78888653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=331.21 Aligned_cols=255 Identities=29% Similarity=0.469 Sum_probs=208.1
Q ss_pred hhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
..++|...+.||+|++|.||+|...+++.||+|.++... ...+++.+|++++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 345788889999999999999998778899999986543 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
+++++|.+++... ...+++..+..++.|++.|+.|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999999753 357899999999999999999999986 999999999999999999999999999866533222
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
......++..|+|||++.+..++.++||||||+++|||++ |+.||............ ...... ..+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~---------~~~ 226 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV----DQGYRM---------PCP 226 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCCC---------CCC
Confidence 1222233468999999988889999999999999999999 99999665433322211 111100 011
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
......+.+++.+|++.+|.+||++.++++.|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1223458899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=336.63 Aligned_cols=262 Identities=22% Similarity=0.285 Sum_probs=202.8
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 4688889999999999999995 468899999986532 2334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|++++.+..+. .....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccccc
Confidence 99998776554 44457899999999999999999999886 999999999999999999999999999865443333
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHH------------HhhCcccc
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVL------------KEQGKLME 617 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~------------~~~~~~~~ 617 (733)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+......-.... ........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07848 157 NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236 (287)
T ss_pred cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcc
Confidence 334467899999999999888999999999999999999999999655432221111000 00000000
Q ss_pred cccCCCCC------CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 618 LVDTNPGS------NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 618 ~~~~~~~~------~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+.... .+.......+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 237 LRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000 001112345899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=334.62 Aligned_cols=261 Identities=21% Similarity=0.318 Sum_probs=201.6
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++|...+.||+|+||+||+|+. .+++.||+|.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4688889999999999999984 578999999986542 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++ +|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 85 ~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-~ 159 (288)
T cd07871 85 LDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-T 159 (288)
T ss_pred CCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-c
Confidence 985 899988766667899999999999999999999986 99999999999999999999999999975433221 1
Q ss_pred ccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh------------Ccccc
Q 004732 551 STRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ------------GKLME 617 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~------------~~~~~ 617 (733)
.....|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.............. .....
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07871 160 YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239 (288)
T ss_pred ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhc
Confidence 233568999999999875 46899999999999999999999999665543333222111100 00000
Q ss_pred cccCCCCCC----CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 618 LVDTNPGSN----FDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 618 ~~~~~~~~~----~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+..... ........+.+++.+|++.||.+|||++|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred cccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000 00011235789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=338.38 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=201.3
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||.||+|+. .+|+.||+|.+.... ......+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 3678889999999999999995 478999999986432 223456888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-- 154 (291)
T cd05612 81 EYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-- 154 (291)
T ss_pred eCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC--
Confidence 999999999998754 47899999999999999999999986 999999999999999999999999999865432
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+........ . .+.. .++
T Consensus 155 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i---~-~~~~----------~~~ 218 (291)
T cd05612 155 --TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI---L-AGKL----------EFP 218 (291)
T ss_pred --cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-hCCc----------CCC
Confidence 12356899999999999888999999999999999999999999766544332211 1 1110 011
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPS-----MSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~~ 659 (733)
......+.+++.+|++.||.+||+ +.++++.
T Consensus 219 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 219 RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 111335789999999999999995 7776543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=333.49 Aligned_cols=254 Identities=30% Similarity=0.503 Sum_probs=205.9
Q ss_pred cCccccCcccCCCcccEEEcccCC------CcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLAD------GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
++|...+.||+|+||.||+|.... ...||+|.+.... ......|.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467888999999999999998432 2579999986543 333467899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC
Q 004732 466 LIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL 530 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 530 (733)
++|||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 9999999999999997431 45889999999999999999999986 99999999999999999
Q ss_pred CeEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHH
Q 004732 531 NSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALV 608 (733)
Q Consensus 531 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 608 (733)
.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||............
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i-- 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI-- 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 999999999976533222 12233456889999999988899999999999999999998 99999765443333221
Q ss_pred HHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 609 LKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
..+.... .+......+.+++.+||+.+|.+||++.||++.|++
T Consensus 240 --~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 --RSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred --HcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 1111111 112233458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=333.47 Aligned_cols=248 Identities=35% Similarity=0.589 Sum_probs=195.0
Q ss_pred ccCcccCCCcccEEEcccC-----CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 397 TDNNIGEGGFGPVYKGLLA-----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 397 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
..+.||.|+||.||+|.+. .+..|+||.++.. .....+.|.+|++.+++++||||++++|+|...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999865 3578999999654 333468899999999999999999999999988889999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc-Cc
Q 004732 471 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE-NT 548 (733)
Q Consensus 471 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~-~~ 548 (733)
+++|+|.+++... ...+++..+..|+.|||+||+|||+.+ ++||||+++||++++++.+||+|||++...... ..
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred ccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 668999999999999999999999985 999999999999999999999999999866322 12
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.......+...|+|||.+....++.++||||||+++||+++ |+.||........... . ..+......+ .
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~---~-~~~~~~~~~~-----~- 229 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK---L-KQGQRLPIPD-----N- 229 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH---H-HTTEETTSBT-----T-
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c-cccccceecc-----c-
Confidence 22233456789999999999999999999999999999999 6788855444333221 1 2222211111 1
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRML 660 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 660 (733)
....+.+++..||+.+|++||++.++++.|
T Consensus 230 ---~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 230 ---CPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---SBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---hhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 123488999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=343.76 Aligned_cols=245 Identities=21% Similarity=0.328 Sum_probs=201.1
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||.||+|+. .+++.||||.+... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5678889999999999999995 46899999998643 1223456889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+.+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 98 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~- 172 (329)
T PTZ00263 98 EFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT- 172 (329)
T ss_pred cCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-
Confidence 999999999999754 47899999999999999999999986 9999999999999999999999999998654322
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
....||+.|+|||++.+..++.++|||||||++|||++|+.||............ ..+.. .. ...
T Consensus 173 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i----~~~~~-~~-----p~~-- 237 (329)
T PTZ00263 173 ---FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKI----LAGRL-KF-----PNW-- 237 (329)
T ss_pred ---ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHH----hcCCc-CC-----CCC--
Confidence 2357999999999999988999999999999999999999999765543322111 11110 00 011
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPS-----MSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~~ 659 (733)
....+.+++.+||+.||++||+ +.++++.
T Consensus 238 --~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 238 --FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 2234788999999999999997 5666543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=330.15 Aligned_cols=253 Identities=26% Similarity=0.446 Sum_probs=205.9
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
.+|...+.||+|+||.||+|.. ..++.||+|.+... .....++.+|++++++++||||+++++++..+...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3577788999999999999995 46889999998654 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 472 ENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 472 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
++++|.+++... ...+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++..........
T Consensus 85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~ 161 (263)
T cd05052 85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 161 (263)
T ss_pred CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence 999999998753 346899999999999999999999986 9999999999999999999999999998655433222
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||...+....... .. ..... ..+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---~~-~~~~~---------~~~~ 228 (263)
T cd05052 162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LE-KGYRM---------ERPE 228 (263)
T ss_pred cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HH-CCCCC---------CCCC
Confidence 222334678999999998899999999999999999998 8999865544332211 11 11111 1111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
.....+.+++.+||+.+|++||++.+++++|+.
T Consensus 229 ~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 229 GCPPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 123458889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.17 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=207.7
Q ss_pred hcCccccCcccCCCcccEEEcccC----CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.++|+..+.||+|+||+||+|++. +...||||.+.... ......|.+|+.++++++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 357888999999999999999864 24589999986543 3344678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++++|.+++......+++..+++++.|++.|++|||+.+ |+||||||+||++++++.++|+|||+++.....
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999876668999999999999999999999986 999999999999999999999999999876522
Q ss_pred Cc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 547 NT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 547 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
.. .......+++.|+|||.+.+..++.++||||||+++||+++ |..||............ ...... +.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~----~~-- 229 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV----EDGYRL----PP-- 229 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHH----HcCCCC----CC--
Confidence 22 11222345678999999998899999999999999999998 99998654433332221 111110 00
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
+......+.+++.+||+.+|++||++.+|++.|+++
T Consensus 230 ---~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 ---PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111234588999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=340.61 Aligned_cols=247 Identities=24% Similarity=0.395 Sum_probs=209.6
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh---hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
+-|+..+.||+|+-|.|..|+ ..+|+.+|||.+.+..+ .....+.+|+.+|+.+.|||++++++++.+..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 457788999999999999999 56899999999866522 22356789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|-|++++...+ ++++.++.+++.||+.|+.|+|..+ |+|||+||+|+|||..+++||+|||+|.+..++.
T Consensus 92 Eyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk- 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK- 166 (786)
T ss_pred EecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence 9999999999997664 8999999999999999999999885 9999999999999999999999999998755433
Q ss_pred ccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.-.+.+|++.|.|||++++..| +.++||||+|||||.|+||+.||..++...++.-+ ..+.. ++.+
T Consensus 167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV----~~G~f-~MPs------- 233 (786)
T KOG0588|consen 167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKV----QRGVF-EMPS------- 233 (786)
T ss_pred -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHH----HcCcc-cCCC-------
Confidence 3356789999999999999886 56999999999999999999999877766655432 22221 2221
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+..+++.+++..||++|.|+.||++.
T Consensus 234 --~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 234 --NISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --cCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 122347889999999999999999999765
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=325.18 Aligned_cols=250 Identities=26% Similarity=0.442 Sum_probs=203.5
Q ss_pred CccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 394 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+|+..+.||+|+||.||+|...++..+|+|.+.... .....|.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 577888999999999999998777889999986432 2345788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++............
T Consensus 84 ~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~ 160 (256)
T cd05059 84 GCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG 160 (256)
T ss_pred CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence 9999999866567899999999999999999999986 9999999999999999999999999997654322222222
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (733)
..++..|+|||.+.+..++.++||||||+++||+++ |+.||............ ....... .+....
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~---------~~~~~~ 227 (256)
T cd05059 161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV----SAGYRLY---------RPKLAP 227 (256)
T ss_pred CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH----HcCCcCC---------CCCCCC
Confidence 234568999999998899999999999999999999 78998654433322211 1111000 011123
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004732 633 MVMINVALLCANASPTIRPSMSSVLRML 660 (733)
Q Consensus 633 ~~l~~l~~~c~~~~P~~RPt~~~vl~~L 660 (733)
..+.+++.+||+.+|++||++.|+++.|
T Consensus 228 ~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 228 TEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 3588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=336.87 Aligned_cols=250 Identities=27% Similarity=0.397 Sum_probs=213.3
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe-EEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ-LLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 468 (733)
++|...+.+|+|+||.++.++. .+++.|++|.+... .....+...+|+.++++++|||||.+.+.|.+++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 4677889999999999999984 47889999988654 33344577899999999999999999999999888 99999
Q ss_pred EccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 469 EYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
+||+||++.+.+... +..+++..+.+++.|++.|+.|||+.. |+|||||+.||+++.+..|||+|||+|+....+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999854 478899999999999999999999774 9999999999999999999999999999887765
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
. ...++.||+.|+.||.+.+.+|..|+||||+||++|||++-+.+|...+...+..-.. ... ....
T Consensus 161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~---------~~~----~~Pl 226 (426)
T KOG0589|consen 161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN---------RGL----YSPL 226 (426)
T ss_pred h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh---------hcc----CCCC
Confidence 3 3456889999999999999999999999999999999999999998887766654221 111 1122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+......+..++..|++.+|+.||++.+++.+
T Consensus 227 p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 227 PSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 23344458889999999999999999999876
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=329.13 Aligned_cols=256 Identities=29% Similarity=0.472 Sum_probs=212.0
Q ss_pred hhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
++..+|...+.||+|+||.||+|...++..+|+|.+..........+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567888999999999999999987799999999977655456788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 470 YLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
|+++++|.+++.. ....+++..+.+++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 9999999999975 3456899999999999999999999986 99999999999999999999999999976543322
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||............. .+.... .
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~----~~~~~~---------~ 225 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT----AGYRMP---------C 225 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH----hCCcCC---------C
Confidence 1 223346778999999988889999999999999999998 899996655433333221 111110 1
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11223458899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=338.46 Aligned_cols=241 Identities=22% Similarity=0.320 Sum_probs=194.7
Q ss_pred ccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCH
Q 004732 401 IGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 476 (733)
Q Consensus 401 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 476 (733)
||+|+||.||+|+. .+++.||+|.+... .......+.+|++++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999995 46889999998643 233345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccccccc
Q 004732 477 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG 556 (733)
Q Consensus 477 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 556 (733)
.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .......|
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~g 155 (312)
T cd05585 81 FHHLQRE-GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCG 155 (312)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccC
Confidence 9999754 47899999999999999999999986 9999999999999999999999999997543222 22334679
Q ss_pred CCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHH
Q 004732 557 TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMI 636 (733)
Q Consensus 557 t~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 636 (733)
|+.|+|||.+.+..++.++|||||||++|||++|+.||...+....... ... ... .++......+.
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~---~~~-~~~----------~~~~~~~~~~~ 221 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK---ILQ-EPL----------RFPDGFDRDAK 221 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHH---HHc-CCC----------CCCCcCCHHHH
Confidence 9999999999998999999999999999999999999976544332211 111 100 11112233578
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHh
Q 004732 637 NVALLCANASPTIRPSMSSVLRML 660 (733)
Q Consensus 637 ~l~~~c~~~~P~~RPt~~~vl~~L 660 (733)
+++.+||+.||.+||++.++.+.|
T Consensus 222 ~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 222 DLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred HHHHHHcCCCHHHcCCCCCHHHHH
Confidence 899999999999998654444433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=337.59 Aligned_cols=261 Identities=21% Similarity=0.359 Sum_probs=202.8
Q ss_pred hcCccccCcccCCCcccEEEcccC-CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|+..+.||+|+||.||+|... ++..+|+|.+... .......+.+|++++++++||||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468899999999999999999954 6889999988654 23334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++|+|.+++... ..+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 99999999999754 36899999999999999999999753 4999999999999999999999999998754332
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccc-------------
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM------------- 616 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------- 616 (733)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||............... ..+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCP-VEGDPAESETSPRPRPPGR 236 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCc-ccCCccccccCcccCCccc
Confidence 123356899999999999888999999999999999999999999654332221110000 000000
Q ss_pred -------------------ccccCCCCCCC-CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 -------------------ELVDTNPGSNF-DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 -------------------~~~~~~~~~~~-~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+.+........ .......+.+++.+||+.||++||++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00000000000 00122357899999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=342.15 Aligned_cols=252 Identities=25% Similarity=0.255 Sum_probs=197.8
Q ss_pred CccccCcccCCCcccEEEccc----CCCcEEEEEEccccC----hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeE
Q 004732 394 NFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 464 (733)
+|+..+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+++++.+ +||||+++++++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467788999999999999874 368899999986431 22335678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 9999999999999998754 46899999999999999999999986 9999999999999999999999999998654
Q ss_pred ccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
...........||+.|+|||.+.+. .++.++|||||||++|||++|+.||.................. .++..
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~------~~~~~ 230 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK------CDPPF 230 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc------CCCCC
Confidence 4333333456799999999999765 4789999999999999999999999543221111111100000 01111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRP-----SMSSVLRM 659 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~~ 659 (733)
+......+.+++.+|++.||++|| ++.++++.
T Consensus 231 ----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 231 ----PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ----CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 111233478899999999999999 67777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.48 Aligned_cols=244 Identities=29% Similarity=0.455 Sum_probs=205.7
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
-|...+.||.|+||.||-|+ ..+...||||++.-.. ...+.++..|+..|++++|||+|.+-|||..+...|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 35566789999999999999 5678899999986543 3345789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
||- ||-.|++.-..+++-+.++..|+.+.+.||+|||+.+ .||||||+.|||+++.|.||++|||.|.+..+.
T Consensus 107 YCl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA--- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA--- 179 (948)
T ss_pred HHh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch---
Confidence 995 4788888877889999999999999999999999986 899999999999999999999999999876553
Q ss_pred cccccccCCCcccHHHHh---hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 550 ISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
..++|||.|||||++. .+.|+-|+||||+||++.||...++|+...+.+.-+-.+ ...+. +.+
T Consensus 180 --nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI----AQNes-----PtL--- 245 (948)
T KOG0577|consen 180 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNES-----PTL--- 245 (948)
T ss_pred --hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH----HhcCC-----CCC---
Confidence 4588999999999985 478999999999999999999999999776655433211 11111 111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
-..+....+.+++..|++.-|.+|||..++++
T Consensus 246 qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 246 QSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 13456667999999999999999999999854
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=329.60 Aligned_cols=254 Identities=29% Similarity=0.509 Sum_probs=206.7
Q ss_pred hcCccccCcccCCCcccEEEcccC------CCcEEEEEEccccChh-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
.++|...+.||+|+||.||+|+.. +++.||||.+...... ....+.+|+++++.++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 346778899999999999999853 3478999998765433 457899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC
Q 004732 465 LLIYEYLENNSLARALFEHR-------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 531 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 531 (733)
++||||+++++|.+++...+ ..+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 99999999999999997432 35789999999999999999999986 999999999999999999
Q ss_pred eEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHH
Q 004732 532 SKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVL 609 (733)
Q Consensus 532 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 609 (733)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||...+.........
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-- 238 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-- 238 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH--
Confidence 99999999975432221 11233456788999999999999999999999999999998 999996555444333221
Q ss_pred HhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 610 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.+..... +......+.+++.+||+.+|.+||++.||++.|+
T Consensus 239 --~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 --QGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred --cCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111 1112235889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=334.22 Aligned_cols=262 Identities=28% Similarity=0.434 Sum_probs=211.8
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.....+.+.||+|-||.|..+....+..||||.++... +....+|.+|+++|.+++|||||+++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34556778999999999999999888999999998764 44458999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc-cCc
Q 004732 471 LENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE-ENT 548 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~-~~~ 548 (733)
|++|+|.+++.++..+ +.-....+|+.|||.||+||.+. ++|||||.++|+|+|.++++||+|||+++-.-. +..
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999866433 35566788999999999999987 599999999999999999999999999984433 333
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh--CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS--GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
....+.+-+++|||+|.+..++++.++|||+||+++||+++ ...||........++-.............+ .
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l-~----- 767 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL-S----- 767 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec-c-----
Confidence 33445667889999999999999999999999999999875 788885544444443322222222221111 1
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
.+......+++++.+||..+-.+||+++++...|.+
T Consensus 768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~ 803 (807)
T KOG1094|consen 768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE 803 (807)
T ss_pred CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence 122233458899999999999999999999988764
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=338.31 Aligned_cols=255 Identities=26% Similarity=0.451 Sum_probs=204.1
Q ss_pred cCccccCcccCCCcccEEEcccC-CCc----EEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGT----AIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.+|+..+.||+|+||.||+|++. ++. .||||.+.... ....+++.+|+.+++.++||||++++|+|..+ ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999843 343 48999986542 34456789999999999999999999999865 5679
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
|+||+++|+|.+++......+++..+++++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred eeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCC
Confidence 99999999999999876667999999999999999999999986 999999999999999999999999999866543
Q ss_pred Cccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 547 NTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 547 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
.... .....++..|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+..... +
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~----~- 233 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EKGERLPQ----P- 233 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----hCCCCCCC----C-
Confidence 3221 122334678999999999999999999999999999998 99999655433322211 11111100 0
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.. ....+.+++.+||+.+|.+||++.+++..+....
T Consensus 234 ~~----~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 234 PI----CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 1234788999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=353.25 Aligned_cols=249 Identities=21% Similarity=0.301 Sum_probs=203.5
Q ss_pred CccccCcccCCCcccEEEccc-CC-CcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-AD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
.|...+.||+|+||.||+|.. .+ +..||+|.+..........+.+|+++++.++|||||+++++|..++..++||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 377888999999999999984 34 6788999876555555567788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 472 ENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 472 ~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999998863 3446899999999999999999999986 99999999999999999999999999986544322
Q ss_pred -ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 549 -HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 549 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.......||++|+|||++.+..++.++|||||||++|||++|+.||...+......... .+... + .
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~----~~~~~----~-----~ 291 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL----YGKYD----P-----F 291 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCC----C-----C
Confidence 22345679999999999999899999999999999999999999996654433322111 11111 0 1
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+......+.+++.+||+.+|++||++.+++.
T Consensus 292 ~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 292 PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112235889999999999999999999864
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=344.88 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=203.5
Q ss_pred hhcCccccCcccCCCcccEEEcccC------CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCC
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQ-HPNLVKLYGCCIEGN 462 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 462 (733)
..++|.+.+.||+|+||.||+|+.. .+..||||++.... ....+.+.+|+++++++. |||||+++++|.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3567888999999999999999742 23479999996542 333467899999999996 999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcC----------------------------------------------------------
Q 004732 463 QLLLIYEYLENNSLARALFEHR---------------------------------------------------------- 484 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 484 (733)
..++|||||++|+|.+++....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999886421
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec
Q 004732 485 -------------------------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD 527 (733)
Q Consensus 485 -------------------------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~ 527 (733)
..+++..+..++.|+++||+|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 24788899999999999999999986 99999999999999
Q ss_pred CCCCeEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHH
Q 004732 528 KDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDW 605 (733)
Q Consensus 528 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~ 605 (733)
.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......... +
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~-~ 350 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF-Y 350 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH-H
Confidence 9999999999999865432222 1223457788999999998899999999999999999997 89998543221111 0
Q ss_pred HHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 606 ALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
. ....+.... .+......+.+++.+||+.+|++||++.+|.++|++.
T Consensus 351 ~--~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 351 N--KIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred H--HHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 0 111111110 1112234588999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=321.98 Aligned_cols=247 Identities=28% Similarity=0.432 Sum_probs=201.4
Q ss_pred CcccCCCcccEEEcccCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCHH
Q 004732 399 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLA 477 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 477 (733)
++||+|+||.||+|...+++.||+|.+.... ......+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3799999999999998889999999987543 233457889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccccccC
Q 004732 478 RALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT 557 (733)
Q Consensus 478 ~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 557 (733)
+++......+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 998766667899999999999999999999886 99999999999999999999999999875433222212223456
Q ss_pred CCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHH
Q 004732 558 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMI 636 (733)
Q Consensus 558 ~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 636 (733)
+.|+|||++.+..++.++||||||+++||+++ |..||............ ....... .+......+.
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~----~~~~~~~---------~~~~~~~~~~ 224 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV----EKGYRMS---------CPQKCPDDVY 224 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH----HcCCCCC---------CCCCCCHHHH
Confidence 78999999988889999999999999999998 99999655433322111 1111111 1111234588
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 637 NVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 637 ~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
+++.+|++.+|++||++.++++.|.
T Consensus 225 ~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 225 KVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHcccCcccCCCHHHHHHHhc
Confidence 9999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=320.12 Aligned_cols=248 Identities=23% Similarity=0.389 Sum_probs=208.8
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
..+|.+.+.||+|.||.|-+|. ...|+.||||.+++.. +++.-.+.+|++||+.++||||+.++.+|...+.+.+|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 3467788899999999999998 6889999999997653 33445578899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||..+|.|.+++.+. ..+++.+++.++.||..|+.|+|.++ ++|||+|.+|||+|.++++||+|||++-++....
T Consensus 132 MEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADKK 207 (668)
T ss_pred EEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence 9999999999999654 58999999999999999999999986 9999999999999999999999999998766543
Q ss_pred cccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
.-++++|++-|.+||++.+..| ++.+|-||+||+||-|+.|..||.+.+...++... . .+... .+
T Consensus 208 --fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQI---s-~GaYr---EP----- 273 (668)
T KOG0611|consen 208 --FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQI---S-RGAYR---EP----- 273 (668)
T ss_pred --HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHh---h-ccccc---CC-----
Confidence 3467999999999999998876 57899999999999999999999887765554322 1 11111 11
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRML 660 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 660 (733)
+..-...-++.|++..+|++|.|+.+|....
T Consensus 274 ---~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 274 ---ETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 1111255678899999999999999996553
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=324.42 Aligned_cols=252 Identities=29% Similarity=0.480 Sum_probs=205.3
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
++|+..+.||+|+||.||+|...++..||+|.+..... ....+.+|+.++++++|+|++++++++. ....++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46788899999999999999988888999999875432 3467999999999999999999999875 456899999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 473 NNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 473 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
+++|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++...........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 84 KGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 99999999753 346899999999999999999999986 99999999999999999999999999986544332222
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
....++..|+|||.+.+..++.++||||||+++|||++ |..||...+......+.. ..... ..+..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~----~~~~~---------~~~~~ 227 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE----RGYRM---------PCPQD 227 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH----cCCCC---------CCCCc
Confidence 23345678999999988889999999999999999999 888986655443333211 11000 11112
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
....+.+++.+|++.+|++|||+.++.+.|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 23458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=329.71 Aligned_cols=255 Identities=27% Similarity=0.452 Sum_probs=204.2
Q ss_pred cCccccCcccCCCcccEEEccc-----CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.+|+..+.||+|+||.||+|+. .++..||+|.+.... ......|.+|++++++++||||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4567778999999999999973 356789999987533 3334678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC
Q 004732 467 IYEYLENNSLARALFEH----------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL 530 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~----------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 530 (733)
||||+++++|.+++... ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 99999999999998632 235789999999999999999999986 99999999999999999
Q ss_pred CeEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHH
Q 004732 531 NSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALV 608 (733)
Q Consensus 531 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 608 (733)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||............
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~-- 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV-- 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 999999999976543221 22233446778999999988889999999999999999998 88898655433332211
Q ss_pred HHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 609 LKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
....... .... ....+.+++.+||+.+|.+||++.+|.+.|.++
T Consensus 240 --~~~~~~~-----~~~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05090 240 --RKRQLLP-----CSED----CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW 283 (283)
T ss_pred --HcCCcCC-----CCCC----CCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence 1111111 1111 223578899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=331.66 Aligned_cols=262 Identities=22% Similarity=0.329 Sum_probs=199.1
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh-hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|...+.||+|+||.||+|+. .+++.||||.+..... .....+.+|+++++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 46788999999999999999995 4789999999865422 223467889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|++ ++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 158 (303)
T cd07869 84 YVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH- 158 (303)
T ss_pred CCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCc-
Confidence 996 6788888766667899999999999999999999986 99999999999999999999999999875432221
Q ss_pred cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccch-hhHHHHHHHHHhhCc---cc---cc--c
Q 004732 550 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLDWALVLKEQGK---LM---EL--V 619 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~---~~---~~--~ 619 (733)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ............... .. .. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 2233568999999999875 4588999999999999999999999965322 111111111100000 00 00 0
Q ss_pred cCCCC---CCCCH-------HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 620 DTNPG---SNFDK-------EQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 620 ~~~~~---~~~~~-------~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.+... ..... .....+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00000 00000 01134778999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=336.83 Aligned_cols=242 Identities=25% Similarity=0.324 Sum_probs=197.3
Q ss_pred CcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCC
Q 004732 399 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 474 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 474 (733)
+.||+|+||.||+|+ ..+|+.||||.+... .......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999998 457899999998653 2233467888999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccccc
Q 004732 475 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV 554 (733)
Q Consensus 475 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 554 (733)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKTF 155 (328)
T ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccccc
Confidence 999888654 47899999999999999999999986 9999999999999999999999999987532221 122346
Q ss_pred ccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHH
Q 004732 555 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 634 (733)
Q Consensus 555 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (733)
.||+.|+|||.+.+..++.++|||||||++|||++|+.||...+........ .. .. . .++......
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~---~~-~~------~----~~p~~~~~~ 221 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI---LM-ED------I----KFPRTLSAD 221 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh---cc-CC------c----cCCCCCCHH
Confidence 7999999999999889999999999999999999999999665443322111 00 00 0 111122335
Q ss_pred HHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004732 635 MINVALLCANASPTIRP-----SMSSVLRM 659 (733)
Q Consensus 635 l~~l~~~c~~~~P~~RP-----t~~~vl~~ 659 (733)
+.+++.+|++.||++|| ++.|+++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 222 AKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred HHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 78899999999999997 88888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=349.39 Aligned_cols=262 Identities=21% Similarity=0.274 Sum_probs=212.7
Q ss_pred hhhcCccccCcccCCCcccEEEcccCCC-cEEEEEEccccChhcHHHHHHHHHHHHhCC-CCceeeEeeEE-Ee------
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLLADG-TAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCC-IE------ 460 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~------ 460 (733)
....+.++.++|.+|||+.||.|+...+ ..||+|++-...+...+...+|+++|++|. |+|||.+++.. ..
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3445667889999999999999996555 999999988777778888999999999996 99999999942 21
Q ss_pred CCeEEEEEEccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCc
Q 004732 461 GNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 539 (733)
Q Consensus 461 ~~~~~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 539 (733)
..+++|.||||.+|.|-+++.. -...|++.++++|+.++++|+++||.. .++|||||||-+||||+.++..||||||.
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 2468999999999999999973 234599999999999999999999988 57899999999999999999999999999
Q ss_pred cccCcccCccc--------ccccccCCCcccHHHHh---hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHH
Q 004732 540 AKLDEEENTHI--------STRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALV 608 (733)
Q Consensus 540 a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~ 608 (733)
|.-.-...... .-...-|+.|+|||.+. +..+++|+||||+||+||-|+....||......
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-------- 264 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-------- 264 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce--------
Confidence 86322211110 11234799999999984 567999999999999999999999999654322
Q ss_pred HHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccccc
Q 004732 609 LKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLD 668 (733)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~~ 668 (733)
.+++........+.+...|.+||..|++.+|.+||++.||+..+-.+....-
T Consensus 265 --------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~ 316 (738)
T KOG1989|consen 265 --------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC 316 (738)
T ss_pred --------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence 3333333333335677789999999999999999999999988877666543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=338.08 Aligned_cols=242 Identities=26% Similarity=0.337 Sum_probs=196.4
Q ss_pred CcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCC
Q 004732 399 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 474 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 474 (733)
+.||+|+||.||+|+ ..+|+.||+|.+... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999998 457899999998653 2233456778999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccccc
Q 004732 475 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV 554 (733)
Q Consensus 475 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 554 (733)
+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKTF 155 (323)
T ss_pred cHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccccc
Confidence 999888654 47899999999999999999999986 9999999999999999999999999987532221 112345
Q ss_pred ccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHH
Q 004732 555 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 634 (733)
Q Consensus 555 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (733)
.||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ . . ... . ++......
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~--~-~-~~~------~----~p~~~~~~ 221 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI--L-M-EEI------R----FPRTLSPE 221 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--h-c-CCC------C----CCCCCCHH
Confidence 7999999999999889999999999999999999999999665443322211 0 0 000 0 11112335
Q ss_pred HHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004732 635 MINVALLCANASPTIRP-----SMSSVLRM 659 (733)
Q Consensus 635 l~~l~~~c~~~~P~~RP-----t~~~vl~~ 659 (733)
+.+++.+|++.||++|| ++.++++.
T Consensus 222 ~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 222 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred HHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 78899999999999998 78887653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=321.54 Aligned_cols=256 Identities=26% Similarity=0.342 Sum_probs=196.4
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-----eEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN-----QLLLI 467 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~lV 467 (733)
.|...+++|.|+||.||+|. ..+++.||||+...+.+. --+|+++|+++.|||||+++.+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 45567899999999999999 456799999998654332 236999999999999999999887532 24689
Q ss_pred EEccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC-CCeEEcccCccccC
Q 004732 468 YEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAKLD 543 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfGla~~~ 543 (733)
||||+. +|.+.++. .+.+++.-.+.-+..||.+||+|||+.+ |+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999987 78888863 3567888899999999999999999986 9999999999999977 88999999999987
Q ss_pred cccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccc---
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV--- 619 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 619 (733)
....... ...-|..|.|||.+.+. .|+.+.||||.||++.||+-|+.-|.+++..+.+.............++.
T Consensus 177 ~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn 254 (364)
T KOG0658|consen 177 VKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMN 254 (364)
T ss_pred ccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcC
Confidence 6655443 24457889999999985 69999999999999999999999997766544333222222111111111
Q ss_pred -------cC----CCCCC-CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 620 -------DT----NPGSN-FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 620 -------~~----~~~~~-~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+ .+... +......+.++++.++++.+|.+|.++.|++..
T Consensus 255 ~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 255 PNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred cccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 01 11101 222233468899999999999999999998643
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=328.52 Aligned_cols=257 Identities=28% Similarity=0.498 Sum_probs=208.1
Q ss_pred hcCccccCcccCCCcccEEEccc------CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
.++|...+.||+|+||.||++.. .++..+|+|.+..........+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35788899999999999999973 234679999987665555678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeE
Q 004732 466 LIYEYLENNSLARALFEHR------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSK 533 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~k 533 (733)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999987432 25899999999999999999999986 99999999999999999999
Q ss_pred EcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHh
Q 004732 534 ISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKE 611 (733)
Q Consensus 534 l~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 611 (733)
|+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||............ .
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i----~ 236 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI----T 236 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----H
Confidence 9999999855432221 1223446788999999988889999999999999999998 89998655443332211 1
Q ss_pred hCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 612 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.+..... .... ...+.+++.+||+.+|.+||++.++++.|+...
T Consensus 237 ~~~~~~~-----~~~~----~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 237 QGRVLQR-----PRTC----PKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred cCCcCCC-----CCCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 1111111 1112 234889999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=342.53 Aligned_cols=253 Identities=22% Similarity=0.284 Sum_probs=203.5
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||+||+|+ ..+|+.||+|.+.... ......+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 367888999999999999998 4578999999987532 223456888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 999999999999876668999999999999999999999986 99999999999999999999999999986654433
Q ss_pred ccccccccCCCcccHHHHh------hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 549 HISTRVAGTIGYMAPEYAM------RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||.......... ............+
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~---~i~~~~~~~~~~~-- 232 (330)
T cd05601 158 VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN---NIMNFQRFLKFPE-- 232 (330)
T ss_pred eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH---HHHcCCCccCCCC--
Confidence 3334457899999999986 4567899999999999999999999996554332211 1111111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.......+.+++..|++ +|.+||++.++++.
T Consensus 233 -----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 233 -----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 01122347788899998 99999999998753
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=322.43 Aligned_cols=247 Identities=27% Similarity=0.419 Sum_probs=197.9
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCH
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 476 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 476 (733)
+.||+|+||.||+|+. .+++.||+|.+... .......+.+|++++++++||||++++++|..+...++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999995 57899999987643 233456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc-ccccc
Q 004732 477 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI-STRVA 555 (733)
Q Consensus 477 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~ 555 (733)
.+++......+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 9999766667899999999999999999999986 9999999999999999999999999987543221111 11112
Q ss_pred cCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHH
Q 004732 556 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 634 (733)
Q Consensus 556 gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (733)
++..|+|||.+.++.++.++|||||||++||+++ |..||............ ...... ..+......
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~----~~~~~~---------~~~~~~~~~ 224 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI----EQGVRL---------PCPELCPDA 224 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH----HcCCCC---------CCcccCCHH
Confidence 3457999999998889999999999999999998 88888544332221111 111000 111122345
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 635 MINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 635 l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
+.+++.+|++.+|++||++.++.++|.
T Consensus 225 ~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=339.17 Aligned_cols=246 Identities=23% Similarity=0.312 Sum_probs=200.4
Q ss_pred hcCccccCcccCCCcccEEEcccCC--CcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLAD--GTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.++|...+.||+|+||.||+|.... +..||+|.+... .......+.+|+++++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578888999999999999998432 368999998543 22334568889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999999754 47899999999999999999999986 999999999999999999999999999865432
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....... .. .+.. . ....
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~--i~--~~~~-~-----~p~~ 250 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK--IL--EGII-Y-----FPKF 250 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH--Hh--cCCC-C-----CCCC
Confidence 2345799999999999988899999999999999999999999976554322211 11 1110 0 0111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRP-----SMSSVLRM 659 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~~ 659 (733)
. ...+.+++.+|++.+|++|+ +++++++.
T Consensus 251 ~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 251 L----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred C----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 2 23477899999999999995 78887654
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=305.92 Aligned_cols=252 Identities=23% Similarity=0.345 Sum_probs=206.9
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++.|+..+.||+|+|+.||++. ..+|+.+|+|.+..+ +..+.+++.+|+.|-+.++|||||++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4567778899999999999998 568999999987543 3446678899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC---CCeEEcccCccccCcc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD---LNSKISDFGLAKLDEE 545 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~---~~~kl~DfGla~~~~~ 545 (733)
|+|.|++|..-+-.. ...++..+-.+++||++||.|+|.++ |||||+||+|+++... .-+|++|||+|....
T Consensus 90 e~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~- 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN- 164 (355)
T ss_pred ecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence 999999998777543 46788889999999999999999996 9999999999999543 348999999998766
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.......++|||+|||||++.+.+|+..+|||+.||+||-++.|..||.+++...+.+.... +.. -++.....
T Consensus 165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~----g~y--d~~~~~w~ 237 (355)
T KOG0033|consen 165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKA----GAY--DYPSPEWD 237 (355)
T ss_pred -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhc----ccc--CCCCcccC
Confidence 33344567899999999999999999999999999999999999999998776665543211 110 01111111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+...+++.+|+..||.+|.|+.|.++.
T Consensus 238 ----~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 238 ----TVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred ----cCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 223347789999999999999999998764
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=326.18 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=202.9
Q ss_pred cCccccCcccCCCcccEEEccc-CCCc----EEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGT----AIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
++|...+.||+|+||+||+|.+ .+++ .|++|.+.... .....++..|+.++++++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 4677889999999999999985 3454 47888875432 223356788888999999999999999875 455789
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
|+||+++|+|.+++......+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 86 i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred EEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 99999999999999877778999999999999999999999986 999999999999999999999999999865433
Q ss_pred Ccc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 547 NTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 547 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
... ......++..|+|||.+.++.++.++|||||||++||+++ |+.||.........+.. ..+..... +
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~--~--- 233 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL----EKGERLAQ--P--- 233 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HCCCcCCC--C---
Confidence 222 2234567789999999998899999999999999999998 99999665544333322 11211111 1
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
...+ ..+.+++.+||..+|.+||++.|+++.|+...
T Consensus 234 ~~~~----~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 234 QICT----IDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CCCC----HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111 24677889999999999999999999888543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=338.47 Aligned_cols=261 Identities=22% Similarity=0.377 Sum_probs=197.0
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----CeEE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQLL 465 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 465 (733)
+|...+.||+|+||.||+|+ ..+|+.||||++... .......+.+|++++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 46778899999999999999 457899999998643 223345688999999999999999999998643 2579
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||+. ++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 6898888654 46899999999999999999999986 99999999999999999999999999985432
Q ss_pred cCc--ccccccccCCCcccHHHHhh--CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh---------
Q 004732 546 ENT--HISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ--------- 612 (733)
Q Consensus 546 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 612 (733)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..............
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i 235 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV 235 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 221 11234578999999999876 57899999999999999999999999665433322211110000
Q ss_pred --Cc---ccccccCCCCCCCC---HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 613 --GK---LMELVDTNPGSNFD---KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 613 --~~---~~~~~~~~~~~~~~---~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. ....+......... +.....+.+++.+||+.+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 00000000000000 0112347899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=331.38 Aligned_cols=259 Identities=25% Similarity=0.390 Sum_probs=195.9
Q ss_pred CccccCcccCCCcccEEEccc-C-CCcEEEEEEccccC--hhcHHHHHHHHHHHHhC---CCCceeeEeeEEEe-----C
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-A-DGTAIAVKQLSSKS--KQGNREFINEIGMISAL---QHPNLVKLYGCCIE-----G 461 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~ 461 (733)
+|...+.||+|+||+||+|+. . +++.||||.+.... ......+.+|+++++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 678889999999999999984 3 46889999886432 22234566787777666 69999999999863 4
Q ss_pred CeEEEEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 462 NQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
...++||||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56899999997 5898888643 346899999999999999999999986 999999999999999999999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh---Cccc-
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ---GKLM- 616 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~- 616 (733)
+..... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.................. ....
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 765433 2233456899999999998889999999999999999999999999766544433322211100 0000
Q ss_pred ------ccccCCCCC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 617 ------ELVDTNPGS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 617 ------~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
......... .........+.+++.+|++.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000000000 000112335779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=329.31 Aligned_cols=256 Identities=27% Similarity=0.489 Sum_probs=208.3
Q ss_pred cCccccCcccCCCcccEEEccc------CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
++|...+.||+|+||.||+|.. .++..+++|.+........+.+.+|++++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 4577788999999999999973 2456799999876655556789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC
Q 004732 467 IYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 531 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 531 (733)
||||+++++|.+++.... ..+++..+++++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999997432 34899999999999999999999986 999999999999999999
Q ss_pred eEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHH
Q 004732 532 SKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVL 609 (733)
Q Consensus 532 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 609 (733)
++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |+.||............
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~--- 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI--- 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence 99999999975543221 12233456789999999998899999999999999999999 99998655443332211
Q ss_pred HhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 610 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
..+..... .......+.+++.+||+.+|++||++.+|+++|++..
T Consensus 239 -~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~ 283 (291)
T cd05094 239 -TQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG 283 (291)
T ss_pred -hCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 11111111 1112345889999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=327.29 Aligned_cols=255 Identities=25% Similarity=0.443 Sum_probs=203.7
Q ss_pred hhcCccccCcccCCCcccEEEcccC------CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 463 (733)
.+++|+..+.||+|+||.||+|... .+..||||.+.... .....+|.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999998642 35689999986432 2344678899999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEE
Q 004732 464 LLLIYEYLENNSLARALFEHR---------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKI 534 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 534 (733)
.++||||+++|+|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 999999999999999987432 24678899999999999999999986 999999999999999999999
Q ss_pred cccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhh
Q 004732 535 SDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQ 612 (733)
Q Consensus 535 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 612 (733)
+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||............ . .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~---~-~ 236 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV---M-E 236 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---H-c
Confidence 999998755432221 1122345778999999998889999999999999999999 68888655443333221 1 1
Q ss_pred CcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 613 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
...... +......+.+++.+||+.+|++||++.|+++.|+
T Consensus 237 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 237 GGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred CCcCCC---------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111111 1112235889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=323.63 Aligned_cols=254 Identities=29% Similarity=0.450 Sum_probs=204.9
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
.++|...+.||+|+||.||+|+..++..||+|.+.... .....|.+|++++++++||||+++++++. +...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35688899999999999999997777789999987532 23467899999999999999999999874 45679999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 472 ENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 472 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999753 346899999999999999999999986 9999999999999999999999999998655433322
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....++..|+|||...+..++.++|||||||++||+++ |+.||........... . ..... .....
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~---~-~~~~~---------~~~~~ 226 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---V-ERGYR---------MPCPP 226 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH---H-hcCCC---------CCCcc
Confidence 233456778999999988899999999999999999999 7888855433222110 0 11100 01122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
+....+.+++.+|++.+|++||++.++++.|+.+
T Consensus 227 ~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 3345688999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=301.90 Aligned_cols=261 Identities=23% Similarity=0.304 Sum_probs=209.1
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-----e
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN-----Q 463 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~ 463 (733)
...++|.+.+.||+|||+-||.++ ..+++.||+|++.-...++.+..++|++.-++++|||+++++++...+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345678899999999999999999 7889999999997777777788999999999999999999999976543 4
Q ss_pred EEEEEEccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 464 LLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
.|++++|...|+|.+.+.. .+..+++.++++|+.+|++||++||+.. ++++||||||.|||+.+++.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCc
Confidence 8999999999999999873 4457899999999999999999999985 57999999999999999999999999998
Q ss_pred ccCcccCccc--------ccccccCCCcccHHHHh---hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHH
Q 004732 541 KLDEEENTHI--------STRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVL 609 (733)
Q Consensus 541 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 609 (733)
....-..... -.....|..|.|||.+. +...++++|||||||++|+|+.|..||...-.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~---------- 246 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ---------- 246 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh----------
Confidence 7543211110 11234688999999985 35689999999999999999999999943211
Q ss_pred HhhCcccc-cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 610 KEQGKLME-LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 610 ~~~~~~~~-~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
..+.+.- +..............+.+.+++++|++.||.+||++.+++..++.
T Consensus 247 -~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 247 -QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred -cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 1222221 111111111122255679999999999999999999999988764
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=343.68 Aligned_cols=252 Identities=23% Similarity=0.323 Sum_probs=203.8
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||+||+|+. .+|+.||||++.... ......+.+|++++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 3678889999999999999994 478999999986531 233467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC-
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN- 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~- 547 (733)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999999765 57899999999999999999999986 9999999999999999999999999998654432
Q ss_pred ---------------------------cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchh
Q 004732 548 ---------------------------THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF 600 (733)
Q Consensus 548 ---------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~ 600 (733)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 11223456999999999999999999999999999999999999999665532
Q ss_pred hHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHHH
Q 004732 601 YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPS-MSSVLRM 659 (733)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-~~~vl~~ 659 (733)
.... ... ........ + .... ....+.+++.+|++ +|.+||+ +.++++.
T Consensus 237 ~~~~--~i~-~~~~~~~~--p-~~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ETYN--KII-NWKESLRF--P-PDPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH--HHh-ccCCcccC--C-CCCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 2211 111 10000000 0 0011 23457889999997 9999999 9999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=343.40 Aligned_cols=252 Identities=20% Similarity=0.291 Sum_probs=196.6
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.|...+.||+|+||+||+|+ ..+++.||||++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 47788899999999999998 5678999999986532 2334578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC--
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN-- 547 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~-- 547 (733)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 99999999998754 36899999999999999999999986 9999999999999999999999999976331100
Q ss_pred --------------------------------------------cccccccccCCCcccHHHHhhCCCCccchhHhHHHH
Q 004732 548 --------------------------------------------THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIV 583 (733)
Q Consensus 548 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvi 583 (733)
........||+.|+|||.+.+..++.++|||||||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 000123579999999999998889999999999999
Q ss_pred HHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHH--hhcCCCCCCCCHHHHHHH
Q 004732 584 ALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALL--CANASPTIRPSMSSVLRM 659 (733)
Q Consensus 584 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--c~~~~P~~RPt~~~vl~~ 659 (733)
+|||++|+.||...+........ ......... ......+ ..+.+++.+ |+..+|..||++.++++.
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i---~~~~~~~~~---~~~~~~s----~~~~dli~~ll~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 238 LFEMLVGQPPFLAPTPTETQLKV---INWENTLHI---PPQVKLS----PEAVDLITKLCCSAEERLGRNGADDIKAH 305 (381)
T ss_pred HHHHHhCCCCCcCCCHHHHHHHH---HccccccCC---CCCCCCC----HHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 99999999999655433221111 000000000 0111122 236667766 666677779999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.99 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=195.7
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|+..+.||+|+||+||+|+ ..+++.||||.+.... ......+.+|+.++.+++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 468889999999999999998 4568999999986532 223356788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 81 EFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred cCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccc
Confidence 999999999999754 47899999999999999999999986 99999999999999999999999999875432110
Q ss_pred ----------------------------------ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCC
Q 004732 549 ----------------------------------HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 594 (733)
Q Consensus 549 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~ 594 (733)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf 236 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCC
Confidence 0012357999999999999989999999999999999999999999
Q ss_pred CccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHH--hhcCCCCCCCCHHHHHHH
Q 004732 595 TKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALL--CANASPTIRPSMSSVLRM 659 (733)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~--c~~~~P~~RPt~~~vl~~ 659 (733)
...+......... ..... ...+ ....... .+.+++.+ |...++..||++.||++.
T Consensus 237 ~~~~~~~~~~~i~--~~~~~---~~~p-~~~~~s~----~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 237 CSETPQETYKKVM--NWKET---LIFP-PEVPISE----KAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCHHHHHHHHH--cCcCc---ccCC-CcCCCCH----HHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 7655433322111 00000 1011 0111222 24455554 333344567999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=322.99 Aligned_cols=253 Identities=32% Similarity=0.485 Sum_probs=206.3
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
.++|...+.||+|+||.||+|...+++.||+|.+.... .....+.+|++++++++||||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 35678889999999999999998889999999987543 33568899999999999999999999864 56789999999
Q ss_pred CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 472 ENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 472 ~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
.+++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05067 83 ENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence 99999999874 3457899999999999999999999886 9999999999999999999999999997655333222
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....++..|+|||.+....++.++||||||+++||+++ |+.||...+........ ..+..... ...
T Consensus 160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~~~~~-----~~~--- 227 (260)
T cd05067 160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL----ERGYRMPR-----PDN--- 227 (260)
T ss_pred ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH----HcCCCCCC-----CCC---
Confidence 233456788999999988889999999999999999999 99999655543333211 11111111 111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
....+.+++.+|++.+|++||+++++++.|+.
T Consensus 228 -~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 228 -CPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -CCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 22358899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=343.55 Aligned_cols=256 Identities=19% Similarity=0.266 Sum_probs=204.3
Q ss_pred HhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
....++|...+.||+|+||.||+|+. .+++.||+|.+... .......+.+|+.+++.++||||+++++++.++...
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 34567899999999999999999984 57899999998642 122335578899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||+++|+|.+++... .++...+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999988643 5788899999999999999999986 9999999999999999999999999998654
Q ss_pred ccCcccccccccCCCcccHHHHhhC----CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccccc
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRG----HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
...........||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+....... .. .........+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~--i~-~~~~~~~~~~ 270 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK--IM-DHKNSLTFPD 270 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHH--HH-cCCCcCCCCC
Confidence 4333233456799999999998653 478999999999999999999999976654332211 11 1110001110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTI--RPSMSSVLRM 659 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~~vl~~ 659 (733)
.......+.+++.+|++.+|.+ ||++.++++.
T Consensus 271 -------~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 271 -------DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -------cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0112345788999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=341.72 Aligned_cols=256 Identities=22% Similarity=0.283 Sum_probs=197.3
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.++|...+.||+|+||.||+|. ..+++.||+|... ...+.+|++++++++|||||++++++..+...++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 4679999999999999999998 5678999999753 23567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+. ++|..++... ..+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.........
T Consensus 165 ~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~ 239 (391)
T PHA03212 165 YK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239 (391)
T ss_pred CC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence 95 6888887654 47899999999999999999999986 9999999999999999999999999997543322223
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhh-----HHHHHHHHHhhCc-----------
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-----LLDWALVLKEQGK----------- 614 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~----------- 614 (733)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ...........+.
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~ 319 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA 319 (391)
T ss_pred cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence 344679999999999998899999999999999999999998874322100 0000000000000
Q ss_pred -cc-------ccccCCCCCCCC----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 615 -LM-------ELVDTNPGSNFD----KEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 615 -~~-------~~~~~~~~~~~~----~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.. ......+..... ......+.+++.+|++.||++|||+.|+++
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 000000000000 122346889999999999999999999975
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=328.41 Aligned_cols=264 Identities=29% Similarity=0.388 Sum_probs=200.5
Q ss_pred ccccCcccCCCcccEEEcc-----cCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEE
Q 004732 395 FATDNNIGEGGFGPVYKGL-----LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLL 466 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 466 (733)
|...+.||+|+||+||.+. ..+++.||+|.+.... ......|.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 3778899999999998754 3467899999987543 23456788999999999999999999998764 46899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999998653 5899999999999999999999986 999999999999999999999999999865443
Q ss_pred Cccc--ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccch--hhHHHHHHHHHhhCcccccccCC
Q 004732 547 NTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM--FYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 547 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
.... .....++..|+|||.+....++.++||||||+++|||++|..|+..... .....+...........+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence 2211 1223456679999999888899999999999999999999999843221 11111110000000111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.....+......+.+++..||+.+|++||++++|++.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 11111222334688999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=336.56 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=201.6
Q ss_pred hcCccccCcccCCCcccEEEcccC------CCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC-C
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG-N 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 462 (733)
.++|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|++++.++ +|+||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 347888999999999999999632 35789999986542 23345678899999999 899999999988754 5
Q ss_pred eEEEEEEccCCCCHHHHHHhcC----------------------------------------------------------
Q 004732 463 QLLLIYEYLENNSLARALFEHR---------------------------------------------------------- 484 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 484 (733)
..++||||+++|+|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6889999999999999986321
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc-ccccccCCCcc
Q 004732 485 --LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYM 561 (733)
Q Consensus 485 --~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~ 561 (733)
..++|..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......... .....++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 26899999999999999999999986 9999999999999999999999999998654332221 22345677899
Q ss_pred cHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHH
Q 004732 562 APEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVAL 640 (733)
Q Consensus 562 aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~ 640 (733)
|||++.+..++.++|||||||++|||++ |..||......... .... ..+..... +......+.+++.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~--~~~~-~~~~~~~~---------~~~~~~~~~~l~~ 310 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF--CRRL-KEGTRMRA---------PEYATPEIYSIML 310 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHH--HHHH-hccCCCCC---------CccCCHHHHHHHH
Confidence 9999999999999999999999999998 99998543221111 1111 11111110 1112345889999
Q ss_pred HhhcCCCCCCCCHHHHHHHhccC
Q 004732 641 LCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 641 ~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
+||+.+|++||++.||++.|+..
T Consensus 311 ~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 311 DCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHccCChhhCcCHHHHHHHHHHH
Confidence 99999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=340.87 Aligned_cols=258 Identities=19% Similarity=0.280 Sum_probs=202.8
Q ss_pred hHHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004732 387 QIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN 462 (733)
Q Consensus 387 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 462 (733)
.+....++|+..+.||+|+||.||+|+. .+++.||+|.+... .......+.+|+.+++.++||||+++++++.++.
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 3445567899999999999999999995 46889999998542 2223456788999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 117 YLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 999999999999999998643 5889999999999999999999986 99999999999999999999999999986
Q ss_pred CcccCcccccccccCCCcccHHHHhhC----CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccc
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRG----HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL 618 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (733)
.............||+.|+|||++.+. .++.++||||+||++|||++|+.||...+...... . ..........
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~--~-i~~~~~~~~~ 268 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS--K-IMDHKNSLNF 268 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH--H-HHhCCcccCC
Confidence 544333233456799999999999764 37889999999999999999999997655432221 1 1111111111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 004732 619 VDTNPGSNFDKEQVMVMINVALLCANASPTI--RPSMSSVLRM 659 (733)
Q Consensus 619 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~~vl~~ 659 (733)
. ........+.+++..|++.++.+ ||++.|+++.
T Consensus 269 p-------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 269 P-------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred C-------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 01112334677888888755544 8899999875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.73 Aligned_cols=256 Identities=28% Similarity=0.478 Sum_probs=206.0
Q ss_pred hcCccccCcccCCCcccEEEcccC-CC---cEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-DG---TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.++|+..+.||+|+||.||+|+.. ++ ..+|+|.+... .....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457788899999999999999854 33 37999998654 23345678999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++++|.+++......+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999876668999999999999999999999986 999999999999999999999999999765433
Q ss_pred Cccccc--ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 547 NTHIST--RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 547 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
...... ....++.|+|||++....++.++|||||||++||+++ |+.||...+....... ....... +
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~---i~~~~~~-------~ 230 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKA---INDGFRL-------P 230 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH---HhcCCCC-------C
Confidence 222111 1223457999999998889999999999999999997 9999965543332221 1111100 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
........+.+++.+||+.+|++||++.+|++.|+++
T Consensus 231 ---~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 231 ---APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111234588999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=335.28 Aligned_cols=242 Identities=28% Similarity=0.379 Sum_probs=195.3
Q ss_pred CcccCCCcccEEEccc----CCCcEEEEEEccccC----hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 399 NNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+.||+|+||.||+++. .+++.||||.+.... ......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999974 357899999986431 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... .
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (323)
T cd05584 82 LSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-V 156 (323)
T ss_pred CCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-c
Confidence 9999999998654 36788999999999999999999986 99999999999999999999999999874332221 2
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ . .+.. . .+..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~---~-~~~~-~---------~~~~ 222 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKI---L-KGKL-N---------LPPY 222 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHH---H-cCCC-C---------CCCC
Confidence 23457999999999999888999999999999999999999999765543222111 1 1110 0 1111
Q ss_pred HHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004732 631 QVMVMINVALLCANASPTIRP-----SMSSVLRM 659 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~~ 659 (733)
....+.+++.+|++.+|++|| ++.++++.
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 223478999999999999999 78887653
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=331.83 Aligned_cols=238 Identities=27% Similarity=0.375 Sum_probs=190.7
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|+. .+++.||||.++... ......+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 568899999986532 22334556677777654 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccc
Confidence 9999988654 47899999999999999999999986 9999999999999999999999999997543222 22334
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+........ .. .. + .++.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i---~~--~~-----~----~~~~~~~~ 221 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI---LN--DR-----P----HFPRWISK 221 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hc--CC-----C----CCCCCCCH
Confidence 67999999999999888999999999999999999999999766543332211 10 00 0 01111233
Q ss_pred HHHHHHHHhhcCCCCCCCCHHH
Q 004732 634 VMINVALLCANASPTIRPSMSS 655 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RPt~~~ 655 (733)
.+.+++.+||+.+|++||++.+
T Consensus 222 ~~~~ll~~~l~~~P~~R~~~~~ 243 (316)
T cd05592 222 EAKDCLSKLFERDPTKRLGVDG 243 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChH
Confidence 4778999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=340.00 Aligned_cols=248 Identities=26% Similarity=0.375 Sum_probs=193.2
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.+|...+.||+|+||.||+|+ ..+|+.||||.+.... ......+.+|+++++.++|+||+++++++.+++..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 456677899999999999998 4578999999986542 23346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++|+|.+. ...++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... .
T Consensus 154 ~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 224 (353)
T PLN00034 154 MDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P 224 (353)
T ss_pred CCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence 999998653 24567788899999999999999986 99999999999999999999999999986543221 1
Q ss_pred ccccccCCCcccHHHHhh-----CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 551 STRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.....||..|+|||.+.. ...+.++|||||||++|||++|+.||....... |......... .. . .
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~-~~--~----~ 294 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICM-SQ--P----P 294 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhc-cC--C----C
Confidence 234579999999998743 234568999999999999999999996332211 1111110000 00 0 0
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.........+.+++.+||+.||++||++.|+++.
T Consensus 295 ~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223458899999999999999999999874
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=326.73 Aligned_cols=264 Identities=28% Similarity=0.424 Sum_probs=203.1
Q ss_pred cCccccCcccCCCcccEEEccc-----CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLL 465 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 465 (733)
.+|...+.||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677889999999999999874 3578999999877666666789999999999999999999998764 34689
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred EEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 999999999999999876667999999999999999999999986 99999999999999999999999999986543
Q ss_pred cCccc--ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc-------cc
Q 004732 546 ENTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-------LM 616 (733)
Q Consensus 546 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~ 616 (733)
..... .....++..|+|||.+.+..++.++|||||||++|||++|..|+...... +......... ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVYHLI 236 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchHHHH
Confidence 32211 11223445699999998888999999999999999999987765322110 0000000000 00
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
+.+...............+.+++.+||+.+|++|||+.||++.|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00000000011112234588999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=342.74 Aligned_cols=252 Identities=22% Similarity=0.311 Sum_probs=199.7
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||+||+|+. .+|+.||||++.... ......+.+|+++++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688899999999999999994 578999999986431 223456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 81 EYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 9999999999987543 6899999999999999999999986 99999999999999999999999999875432110
Q ss_pred c-------------------------------------cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCC
Q 004732 549 H-------------------------------------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 591 (733)
Q Consensus 549 ~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~ 591 (733)
. ......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 0 011246999999999999989999999999999999999999
Q ss_pred CCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHHH
Q 004732 592 SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPS---MSSVLRM 659 (733)
Q Consensus 592 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt---~~~vl~~ 659 (733)
.||...+......... .......... .... ...+.+++.+|+. +|.+|++ +.|+++.
T Consensus 237 ~Pf~~~~~~~~~~~i~---~~~~~~~~~~---~~~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 237 PPFCSDNPQETYRKII---NWKETLQFPD---EVPL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCHHHHHHHHH---cCCCccCCCC---CCCC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 9997665433222111 1000001100 0111 2346788888886 9999998 8888663
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=319.93 Aligned_cols=247 Identities=27% Similarity=0.410 Sum_probs=197.0
Q ss_pred cccCCCcccEEEcccC---CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCC
Q 004732 400 NIGEGGFGPVYKGLLA---DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNS 475 (733)
Q Consensus 400 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 475 (733)
.||+|+||.||+|++. .+..||+|.+.... ....+.+.+|++++++++||||+++++++. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999753 45679999986653 233467899999999999999999999885 457899999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc--cc
Q 004732 476 LARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS--TR 553 (733)
Q Consensus 476 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~--~~ 553 (733)
|.+++......+++.++.+++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.......... ..
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99999866668999999999999999999999986 99999999999999999999999999975543322211 11
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (733)
..+++.|+|||.+.+..++.++|||||||++||+++ |..||............ ..+.... .+....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~~~~---------~~~~~~ 224 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI----EQGKRLD---------CPAECP 224 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH----HCCCCCC---------CCCCCC
Confidence 223578999999988889999999999999999996 99999655443322211 1111111 111223
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 633 MVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 633 ~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
..+.+++.+||+.+|++||++.+|.+.|+.+
T Consensus 225 ~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 225 PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 4588899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=326.81 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=200.0
Q ss_pred ccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 395 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
|+..+.||+|+||.||+|.. .+++.||||.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 66778999999999999984 578999999986532 12234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET- 157 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc-
Confidence 9999999988653 346899999999999999999999986 99999999999999999999999999986543222
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....|++.|+|||++.+..++.++||||+||++||+++|+.||................... ...++.
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------~~~~~~ 226 (285)
T cd05605 158 -IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED----------QEEYSE 226 (285)
T ss_pred -cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------ccccCc
Confidence 223468999999999998889999999999999999999999996554322211111111100 011122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004732 630 EQVMVMINVALLCANASPTIRP-----SMSSVLRM 659 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~~ 659 (733)
.....+.+++.+||+.||.+|| ++.++++.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 227 KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 2344588999999999999999 67776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=325.03 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=203.4
Q ss_pred hhcCccccCcccCCCcccEEEcccC------CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 463 (733)
.+++|...+.||+|+||.||+|... .+..||+|.+.... ......|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 4577889999999999999999864 35789999886543 3344678999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC---CeEE
Q 004732 464 LLLIYEYLENNSLARALFEHR------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSKI 534 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl 534 (733)
.++||||+++++|.+++...+ ..+++..+.+++.||+.||+|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 999999999999999997543 25899999999999999999999986 99999999999998754 5999
Q ss_pred cccCccccCcccCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhh
Q 004732 535 SDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQ 612 (733)
Q Consensus 535 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 612 (733)
+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||........... ....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~---~~~~ 237 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF---VTGG 237 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HHcC
Confidence 9999998653322111 112334568999999999999999999999999999997 9999966544333221 1111
Q ss_pred CcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 613 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.. . ..+......+.+++.+|++.+|++||++.+|++.|.
T Consensus 238 ~~-~---------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GR-L---------DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred Cc-C---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 11 0 111112345888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=322.50 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=205.7
Q ss_pred cCccccCcccCCCcccEEEcccC----CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
++|+..+.||+|+||.||+|+.. .+..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46788899999999999999853 23479999986542 33456789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++++|.+++......+++.++..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||++.......
T Consensus 84 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 84 TEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999876667899999999999999999999986 9999999999999999999999999998665433
Q ss_pred cccc--cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 548 THIS--TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 548 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
.... ....++..|+|||.+.+..++.++|||||||++||+++ |+.||..........+.. .+... +.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~----~~~~~----~~-- 230 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE----EGYRL----PA-- 230 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh----CCCcC----CC--
Confidence 2221 11223568999999998899999999999999999886 999996554433332221 11100 00
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.......+.+++.+|++.+|.+||++.++++.|++.
T Consensus 231 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 231 ---PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ---CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 111223578999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=351.05 Aligned_cols=256 Identities=21% Similarity=0.323 Sum_probs=205.9
Q ss_pred HHhhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC--
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN-- 462 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 462 (733)
.+...++|...+.||+|+||+||+|+ ..+|+.||||.+... .......+.+|+..+..++|+||+++.+.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 34456789999999999999999998 567999999998643 3344567889999999999999999988775432
Q ss_pred ------eEEEEEEccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeE
Q 004732 463 ------QLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSK 533 (733)
Q Consensus 463 ------~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~k 533 (733)
..++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 368999999999999998642 346899999999999999999999986 99999999999999999999
Q ss_pred EcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh
Q 004732 534 ISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 612 (733)
Q Consensus 534 l~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 612 (733)
|+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+......-. ..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~----~~ 259 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT----LA 259 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----hc
Confidence 999999986543222 2234567999999999999989999999999999999999999999765543332211 11
Q ss_pred CcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 613 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+... + .+......+.+++.+||+.+|.+||++.++++.
T Consensus 260 ~~~~----~-----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GRYD----P-----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCC----C-----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1111 1 111223458899999999999999999999764
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=321.42 Aligned_cols=257 Identities=23% Similarity=0.383 Sum_probs=206.4
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||.||+|+. .+++.||||.+... .......+.+|+++++.++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788899999999999999994 57899999987542 2333457889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 469 EYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 469 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
||+++|+|.+++.. ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988852 3345889999999999999999999986 99999999999999999999999999886543
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ...+...... .... .
T Consensus 159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~~~-~~~~--------~ 227 (267)
T cd08228 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKIEQ-CDYP--------P 227 (267)
T ss_pred hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHHhc-CCCC--------C
Confidence 3221 22346888999999998888999999999999999999999999544321 1122211111 1100 0
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.........+.+++.+||+.+|++||++.+|++.+++.
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 01112334588999999999999999999999998853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.70 Aligned_cols=253 Identities=28% Similarity=0.470 Sum_probs=204.3
Q ss_pred cCccccCcccCCCcccEEEccc------CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.+|...+.||+|+||.||+|.. .++..+|+|.+..........|.+|+++++.++|+||+++++++.++...++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4667788999999999999863 2467899999877666666789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCe
Q 004732 467 IYEYLENNSLARALFEHR--------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 532 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 532 (733)
||||+++|+|.+++.... ..+++..++.++.|++.|++|||+.+ ++||||||+||++++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 999999999999987543 35899999999999999999999986 9999999999999999999
Q ss_pred EEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHH
Q 004732 533 KISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLK 610 (733)
Q Consensus 533 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 610 (733)
||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||............
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI---- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH----
Confidence 9999999975433221 11223345788999999998899999999999999999998 89998554433322211
Q ss_pred hhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 611 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
..+...... ... ...+.+++.+||+.||.+||++.+|++.|+
T Consensus 238 ~~~~~~~~~-----~~~----~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 TQGRELERP-----RTC----PPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HcCccCCCC-----CCC----CHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111100 111 234789999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=329.28 Aligned_cols=260 Identities=25% Similarity=0.415 Sum_probs=207.7
Q ss_pred HHhhhcCccccCcccCCCcccEEEcccC------CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEE
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCI 459 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 459 (733)
++...++|+..+.||+|+||.||+|... ....+|+|.+... ......++.+|++++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3445567888999999999999999853 2368999998753 233446788999999999 8999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcE
Q 004732 460 EGNQLLLIYEYLENNSLARALFEH---------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNV 524 (733)
Q Consensus 460 ~~~~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Ni 524 (733)
.++..++||||+++|+|.+++... ...+++..+++++.|++.||+|||+.+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 999999999999999999998632 346899999999999999999999886 99999999999
Q ss_pred EecCCCCeEEcccCccccCcccCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhH
Q 004732 525 LLDKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYL 602 (733)
Q Consensus 525 ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~ 602 (733)
+++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++|||||||++||+++ |..||........
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 99999999999999998655432211 222345678999999988899999999999999999998 9999865543333
Q ss_pred HHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 603 LDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.... ..+... ..+......+.+++.+||+.+|.+|||+.|+++.|+.+
T Consensus 244 ~~~~----~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 244 FKLL----KEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred HHHH----HcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 2211 111111 11112234588999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=333.40 Aligned_cols=255 Identities=21% Similarity=0.247 Sum_probs=198.5
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||+||+|+ ..+++.||+|.+... .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468888999999999999999 456899999998642 2223456888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 157 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT 157 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCC
Confidence 999999999999766668999999999999999999999986 99999999999999999999999999876544333
Q ss_pred ccccccccCCCcccHHHHhh-----CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||.......... ..............
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~-- 232 (331)
T cd05597 158 VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG---KIMNHKEHFQFPPD-- 232 (331)
T ss_pred ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH---HHHcCCCcccCCCc--
Confidence 33334569999999999873 457889999999999999999999997654332221 11111111111110
Q ss_pred CCCCCHHHHHHHHHHHHHhhcC--CCCCCCCHHHHHHH
Q 004732 624 GSNFDKEQVMVMINVALLCANA--SPTIRPSMSSVLRM 659 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~--~P~~RPt~~~vl~~ 659 (733)
... ....+.+++.+|+.. ++..||++.++++.
T Consensus 233 ~~~----~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 233 VTD----VSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred cCC----CCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 011 223466777776654 33448899988765
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=324.29 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=205.8
Q ss_pred hcCccccCcccCCCcccEEEcccCC-----------------CcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceee
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLAD-----------------GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVK 453 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 453 (733)
..+|...+.||+|+||.||+|+..+ +..||+|.+.... ......+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578889999999999999987432 3468999987543 344568899999999999999999
Q ss_pred EeeEEEeCCeEEEEEEccCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCc
Q 004732 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHR----------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATN 523 (733)
Q Consensus 454 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~N 523 (733)
++++|..++..++|+||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999997543 26899999999999999999999986 9999999999
Q ss_pred EEecCCCCeEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh--CCCCCCccchh
Q 004732 524 VLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS--GRSNVTKEDMF 600 (733)
Q Consensus 524 ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt--g~~p~~~~~~~ 600 (733)
|+++.++.++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999975433221 12233456789999999988889999999999999999998 67787554433
Q ss_pred hHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 601 YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.................... .+......+.+++.+|++.+|.+||++.||++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 33333221111111111111 11112245899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=326.87 Aligned_cols=253 Identities=29% Similarity=0.430 Sum_probs=202.2
Q ss_pred CccccCcccCCCcccEEEcccC------CCcEEEEEEccccChh-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
+|...+.||+|+||.||+|... ++..||+|++...... ....+.+|+.+++.++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667789999999999999843 3578999999754332 34568899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC
Q 004732 467 IYEYLENNSLARALFEH---------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 531 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 531 (733)
++||+.+++|.+++... ...+++..+.+++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998521 235888999999999999999999986 999999999999999999
Q ss_pred eEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHH
Q 004732 532 SKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVL 609 (733)
Q Consensus 532 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 609 (733)
+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||............
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i--- 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI--- 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---
Confidence 99999999886543221 11233446789999999988889999999999999999998 88888655443332221
Q ss_pred HhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 610 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
. ...... .+......+.+++..||+.+|.+||++.+|++.|+.
T Consensus 240 ~-~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 R-NRQVLP---------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-cCCcCC---------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1 111111 111223448899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=312.23 Aligned_cols=272 Identities=24% Similarity=0.364 Sum_probs=206.7
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccc--cChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe-----CCe
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSS--KSKQGNREFINEIGMISALQHPNLVKLYGCCIE-----GNQ 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~ 463 (733)
...|...+.||+|+||.|+.|. ..+|+.||||++.. ......++..+|+..|+.++|+||+.+.+.+.. -..
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3455567899999999999998 56899999999873 344556788999999999999999999999875 357
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
+|+|+|+| +.+|...+... +.++...+..+++|+++||.|+|+.+ |+|||+||+|++++.+...||+|||+|+..
T Consensus 101 vYiV~elM-etDL~~iik~~-~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~ 175 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQ-QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYL 175 (359)
T ss_pred eEEehhHH-hhHHHHHHHcC-ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeec
Confidence 89999999 55888888543 45999999999999999999999986 999999999999999999999999999977
Q ss_pred cccC-cccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh----------
Q 004732 544 EEEN-THISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE---------- 611 (733)
Q Consensus 544 ~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~---------- 611 (733)
.... ....+..+-|.+|.|||++.. ..|+.+.||||.|||+.||++|+.-|.+.+......-......
T Consensus 176 ~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i 255 (359)
T KOG0660|consen 176 DKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKI 255 (359)
T ss_pred cccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHh
Confidence 5431 122345677999999999865 5799999999999999999999999976664433221111110
Q ss_pred -hCccccccc---CCCCCCCC---HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--hccCccccc
Q 004732 612 -QGKLMELVD---TNPGSNFD---KEQVMVMINVALLCANASPTIRPSMSSVLRM--LECGVDVLD 668 (733)
Q Consensus 612 -~~~~~~~~~---~~~~~~~~---~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~--L~~~~~~~~ 668 (733)
.......+. ..+...+. +......++++.+++..||.+|+|++|.++. |+.+.+..+
T Consensus 256 ~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~d 321 (359)
T KOG0660|consen 256 RSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPED 321 (359)
T ss_pred ccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCcc
Confidence 000000111 11111110 1122357899999999999999999999764 455544443
|
|
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.31 Aligned_cols=252 Identities=30% Similarity=0.468 Sum_probs=203.5
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
++|.....||+|+||.||+|...++..||+|.+.... ...+.+.+|++++++++|||++++++++. ....++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577888999999999999998777789999886533 33467899999999999999999999875 456889999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 473 NNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 473 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++..........
T Consensus 84 ~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 84 KGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred CCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999753 345899999999999999999999886 99999999999999999999999999976543322222
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
....++..|+|||...+..++.++|||||||++|||++ |+.||..........+. ...... ..+..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~---------~~~~~ 227 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV----ERGYRM---------PCPQG 227 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCC---------CCCcc
Confidence 23346778999999988889999999999999999999 89998655443332221 111100 11122
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
....+.+++.+||+.+|.+||++.+|++.|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 33458899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=314.22 Aligned_cols=261 Identities=24% Similarity=0.324 Sum_probs=203.3
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh--hcHHHHHHHHHHHHhCCCCc-eeeEeeEEEeCC------e
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPN-LVKLYGCCIEGN------Q 463 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------~ 463 (733)
.|...++||+|+||+||+|+ ..+|+.||+|++....+ ..-....+|+-+++.++|+| ||++++++.... .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 45566789999999999999 66889999999876533 23345689999999999999 999999999877 7
Q ss_pred EEEEEEccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 464 LLLIYEYLENNSLARALFEHR---LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
.++|+||++. +|..++.... ..++...+..++.||++||+|||+++ |+||||||.|||++++|.+||+|||+|
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 8999999966 8999998655 46788899999999999999999996 999999999999999999999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC---ccc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG---KLM 616 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~ 616 (733)
+...-+... .+..++|.+|.|||++.+. .|+...||||+|||++||++++.-|.+....+...-........ ...
T Consensus 168 ra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp 246 (323)
T KOG0594|consen 168 RAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP 246 (323)
T ss_pred HHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence 965533222 3446689999999999886 69999999999999999999998887665544433222222111 011
Q ss_pred ---ccccCCC-------CCCCCHHH---HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 ---ELVDTNP-------GSNFDKEQ---VMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 ---~~~~~~~-------~~~~~~~~---~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+-.. ........ .....+++.+|++.+|.+|.|++.++..
T Consensus 247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111110 00011111 1267899999999999999999998765
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.38 Aligned_cols=261 Identities=24% Similarity=0.384 Sum_probs=201.8
Q ss_pred hcCccccCcccCCCcccEEEcccCC---------------CcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEe
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLAD---------------GTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLY 455 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~ 455 (733)
.++|...+.||+|+||.||+|+... ...||+|.+... .......|.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578888999999999999987532 235899998754 233446789999999999999999999
Q ss_pred eEEEeCCeEEEEEEccCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcE
Q 004732 456 GCCIEGNQLLLIYEYLENNSLARALFEHR-----------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNV 524 (733)
Q Consensus 456 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Ni 524 (733)
+++..+...++||||+++++|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 99999999999999999999999986432 24789999999999999999999986 99999999999
Q ss_pred EecCCCCeEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh--CCCCCCccchhh
Q 004732 525 LLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS--GRSNVTKEDMFY 601 (733)
Q Consensus 525 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt--g~~p~~~~~~~~ 601 (733)
+++.++.+||+|||++......... ......++..|+|||.+..+.++.++|||||||++|||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999755432221 1222345778999999988889999999999999999998 567775443333
Q ss_pred HHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 602 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.................... ... ....+.+++.+||+.+|++||++.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~--~~~----~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQ--TPL----CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHhhhhccccccCCC--CCC----CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 22221111111111000100 011 1235899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.62 Aligned_cols=254 Identities=32% Similarity=0.468 Sum_probs=203.4
Q ss_pred CccccCcccCCCcccEEEcccC------CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
+|...+.||+|+||.||+|+.. ....+|+|.+.... ......+.+|+++++.++||||++++++|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4667889999999999999742 23578999886543 2334678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhc-----------------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCc
Q 004732 467 IYEYLENNSLARALFEH-----------------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATN 523 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~-----------------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~N 523 (733)
|+||+.+|+|.+++... ...+++.+++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 99999999999998632 135789999999999999999999886 9999999999
Q ss_pred EEecCCCCeEEcccCccccCcccCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhh
Q 004732 524 VLLDKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFY 601 (733)
Q Consensus 524 ill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~ 601 (733)
|++++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999998654332221 223345778999999988889999999999999999998 999996655444
Q ss_pred HHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 602 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
+..+.. ...... ... .....+.+++.+||+.+|++||++.++++.|++.
T Consensus 238 ~~~~~~----~~~~~~-----~~~----~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 LFNLLK----TGYRME-----RPE----NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred HHHHHh----CCCCCC-----CCC----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 333221 111000 111 1223588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=318.92 Aligned_cols=245 Identities=27% Similarity=0.398 Sum_probs=196.9
Q ss_pred cccCCCcccEEEccc---CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCC
Q 004732 400 NIGEGGFGPVYKGLL---ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 474 (733)
Q Consensus 400 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 474 (733)
.||+|+||.||+|.+ .++..||+|++.... ....+++.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 467899999986542 233567899999999999999999999885 45678999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc--cc
Q 004732 475 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI--ST 552 (733)
Q Consensus 475 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~--~~ 552 (733)
+|.+++... ..+++..+.+++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......... ..
T Consensus 81 ~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 999998654 47899999999999999999999986 9999999999999999999999999998654433221 12
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
...+++.|+|||.+....++.++|||||||++|||++ |+.||...+........ . .+..... +...
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i---~-~~~~~~~---------~~~~ 223 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI---E-SGERMEC---------PQRC 223 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H-CCCCCCC---------CCCC
Confidence 2334678999999988889999999999999999998 99999665444333221 1 1111111 1112
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
...+.+++.+||+.+|++||++.+|++.|+.
T Consensus 224 ~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 224 PPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2358899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=334.37 Aligned_cols=242 Identities=25% Similarity=0.323 Sum_probs=196.0
Q ss_pred CcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCC
Q 004732 399 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 474 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 474 (733)
+.||+|+||.||+|. ..+|+.||+|.+... .......+.+|+++++.++||||+++++++.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999998 457899999998653 2233456788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 475 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 475 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 ~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (325)
T cd05594 81 ELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMKT 155 (325)
T ss_pred cHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cccc
Confidence 999888654 478999999999999999999997 55 99999999999999999999999999875332221 1234
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... ... . ...... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~----~~~-~-----~~p~~~----~~ 221 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL----MEE-I-----RFPRTL----SP 221 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh----cCC-C-----CCCCCC----CH
Confidence 569999999999999899999999999999999999999996654433222110 000 0 011112 23
Q ss_pred HHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004732 634 VMINVALLCANASPTIRP-----SMSSVLRM 659 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RP-----t~~~vl~~ 659 (733)
.+.+++.+|++.||++|+ ++.++++.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 478899999999999997 89988754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=317.39 Aligned_cols=249 Identities=28% Similarity=0.426 Sum_probs=205.3
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|...+.||+|++|.||+|+. .+++.|++|.+... .......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 466778999999999999985 57899999988643 334557789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~ 157 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF 157 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence 9999999999764 467899999999999999999999886 999999999999999999999999998865443222
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....|++.|+|||+..+..++.++|||||||++|||++|+.||...+........ ..+.... ...
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~---------~~~ 223 (256)
T cd08529 158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKI----IRGVFPP---------VSQ 223 (256)
T ss_pred -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HcCCCCC---------Ccc
Confidence 23356889999999999988999999999999999999999999665543322211 1111111 111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.....+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 223458899999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=341.60 Aligned_cols=252 Identities=22% Similarity=0.276 Sum_probs=197.4
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||.||+|+ ..+++.||||++... .......+.+|++++++++|||||++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 467888999999999999998 567899999998543 1223456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 81 EFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred eCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999998754 47899999999999999999999986 99999999999999999999999999963221000
Q ss_pred c----------------------------------------------cccccccCCCcccHHHHhhCCCCccchhHhHHH
Q 004732 549 H----------------------------------------------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGI 582 (733)
Q Consensus 549 ~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gv 582 (733)
. ......||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 001246999999999999889999999999999
Q ss_pred HHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCC---CCHHHHHHH
Q 004732 583 VALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIR---PSMSSVLRM 659 (733)
Q Consensus 583 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R---Pt~~~vl~~ 659 (733)
++|||++|+.||............ ..........+ ... ....+.+++.+|+. +|.+| +++.|+++.
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i---~~~~~~~~~p~---~~~----~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h 305 (377)
T cd05629 237 IMFECLIGWPPFCSENSHETYRKI---INWRETLYFPD---DIH----LSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH 305 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHHHHHH---HccCCccCCCC---CCC----CCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence 999999999999665543322111 11000011111 011 12347788889997 66665 599998765
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=332.01 Aligned_cols=242 Identities=22% Similarity=0.359 Sum_probs=195.2
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|+. .+++.||||.+... .......+..|.+++..+ +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999985 46789999998653 223345677899998866 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|..++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~~ 155 (321)
T cd05591 81 GDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTTT 155 (321)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-cccc
Confidence 9999988654 47899999999999999999999986 99999999999999999999999999875332222 2234
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. +.. . ++.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i---~~-~~~---~-------~p~~~~~ 221 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI---LH-DDV---L-------YPVWLSK 221 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHH---Hc-CCC---C-------CCCCCCH
Confidence 67999999999999889999999999999999999999999766544433221 11 110 0 0111123
Q ss_pred HHHHHHHHhhcCCCCCCC-------CHHHHHHH
Q 004732 634 VMINVALLCANASPTIRP-------SMSSVLRM 659 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RP-------t~~~vl~~ 659 (733)
.+.+++.+|++.||++|| ++.++++.
T Consensus 222 ~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 222 EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 478899999999999999 67776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=317.25 Aligned_cols=251 Identities=28% Similarity=0.508 Sum_probs=205.2
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
.+|+..+.||+|+||.||+|.+.+++.+|+|.+.... .....|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3567788999999999999997778899999986542 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+++|.+++......+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++...........
T Consensus 83 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 83 HGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred CCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999876667899999999999999999999886 999999999999999999999999998755433222222
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
...++.+|+|||.+.++.++.++||||||+++||+++ |+.||............ ..+. ....+. . .
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~--~~~~~~---~----~ 226 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI----NAGF--RLYKPR---L----A 226 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH----hCCC--CCCCCC---C----C
Confidence 2345678999999998889999999999999999998 99999655443333211 1110 111111 1 1
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLRML 660 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 660 (733)
...+.+++.+||+.+|++||++.++++.|
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 24588999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=342.21 Aligned_cols=251 Identities=20% Similarity=0.277 Sum_probs=196.1
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
+|...+.||+|+||.||+|+ ..+++.||||.+.... ......+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68889999999999999998 4568999999986431 2234567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc---
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE--- 546 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~--- 546 (733)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|..+...
T Consensus 82 ~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 99999999999654 46889999999999999999999986 999999999999999999999999997532100
Q ss_pred ---------------------------------------CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHH
Q 004732 547 ---------------------------------------NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEI 587 (733)
Q Consensus 547 ---------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~el 587 (733)
.........||+.|+|||++.+..++.++|||||||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 00011235799999999999998999999999999999999
Q ss_pred HhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCC---CHHHHHHH
Q 004732 588 VSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRP---SMSSVLRM 659 (733)
Q Consensus 588 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP---t~~~vl~~ 659 (733)
++|+.||...+....... ...... .. ........+ ..+.+++.+|+ .+|.+|+ ++.++++.
T Consensus 238 l~G~~Pf~~~~~~~~~~~---i~~~~~--~~-~~~~~~~~s----~~~~~li~~l~-~~p~~R~~~~t~~ell~h 301 (376)
T cd05598 238 LVGQPPFLADTPAETQLK---VINWET--TL-HIPSQAKLS----REASDLILRLC-CGAEDRLGKNGADEIKAH 301 (376)
T ss_pred hhCCCCCCCCCHHHHHHH---HhccCc--cc-cCCCCCCCC----HHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence 999999976554322211 110000 00 000111122 23566677765 4999999 88888754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=319.14 Aligned_cols=255 Identities=31% Similarity=0.491 Sum_probs=208.7
Q ss_pred hhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
..++|.+.+.||+|+||.||+|...+++.||||.+.... ....++.+|+.++++++|+||+++++++..+...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 346788899999999999999998888899999987543 3456799999999999999999999999998999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
+++++|.+++.... ..+++.++..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 99999999997543 57899999999999999999999986 999999999999999999999999999866543222
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
......++..|+|||.+.+..++.++||||||+++||+++ |+.||............. . +.. . ..+
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~---~-~~~--~-------~~~ 226 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE---R-GYR--M-------PRP 226 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c-CCC--C-------CCC
Confidence 2223345678999999998889999999999999999998 999996554333222211 1 100 0 001
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
......+.+++.+|++.+|++||++.++++.|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1113458899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=331.63 Aligned_cols=237 Identities=24% Similarity=0.389 Sum_probs=192.4
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|+. .+++.||||.+... .......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 56899999998643 122345677888888876 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTST 155 (320)
T ss_pred chHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccccc
Confidence 9999988654 47899999999999999999999986 9999999999999999999999999987532221 12234
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+........ . .+.. . .+.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i---~-~~~~---~-------~~~~~~~ 221 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI---L-NDEV---V-------YPTWLSQ 221 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH---h-cCCC---C-------CCCCCCH
Confidence 67999999999999889999999999999999999999999766544433221 1 1110 0 0111223
Q ss_pred HHHHHHHHhhcCCCCCCCCHH
Q 004732 634 VMINVALLCANASPTIRPSMS 654 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RPt~~ 654 (733)
.+.+++.+|++.||.+||++.
T Consensus 222 ~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 222 DAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred HHHHHHHHHcccCHHHCCCCC
Confidence 478899999999999999983
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=323.05 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=192.6
Q ss_pred ccCCCcccEEEccc-CCCcEEEEEEccccCh---hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCH
Q 004732 401 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 476 (733)
Q Consensus 401 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 476 (733)
||+|+||+||+|.. .+|+.||+|.+..... .....+..|+++++.++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999984 5789999999864321 2235677899999999999999999999999999999999999999
Q ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 477 ARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 477 ~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 988753 3346899999999999999999999986 99999999999999999999999999976543322 2234
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||............. . ...... ..++.....
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~---~-----~~~~~~--~~~~~~~~~ 226 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---Q-----RILNDS--VTYPDKFSP 226 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHH---H-----hhcccC--CCCcccCCH
Confidence 578999999999999999999999999999999999999996543211110000 0 000000 111222334
Q ss_pred HHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004732 634 VMINVALLCANASPTIRP-----SMSSVLR 658 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RP-----t~~~vl~ 658 (733)
.+.+++.+|++.||++|| +++++++
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 588999999999999999 5566554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=320.83 Aligned_cols=251 Identities=25% Similarity=0.424 Sum_probs=197.5
Q ss_pred cccCcccCCCcccEEEcccCC-Cc--EEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------CeE
Q 004732 396 ATDNNIGEGGFGPVYKGLLAD-GT--AIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------NQL 464 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 464 (733)
...+.||+|+||.||+|+..+ +. .||+|.++.. .......+.+|+++++.++||||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456889999999999998644 33 6899988653 334456789999999999999999999987542 246
Q ss_pred EEEEEccCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCc
Q 004732 465 LLIYEYLENNSLARALFE-----HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 539 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 539 (733)
++||||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999998752 2345899999999999999999999986 99999999999999999999999999
Q ss_pred cccCcccCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccc
Q 004732 540 AKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLME 617 (733)
Q Consensus 540 a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 617 (733)
++......... .....+++.|+|||...+..++.++|||||||++|||++ |+.||............ ..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~----~~~~~~~ 234 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL----RQGNRLK 234 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HcCCCCC
Confidence 98654332211 122346778999999998899999999999999999999 78888654443332211 1111111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 618 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
. .......+.+++.+||+.+|++||++.++++.|+.
T Consensus 235 ~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 235 Q---------PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred C---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 11122348899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.76 Aligned_cols=254 Identities=27% Similarity=0.462 Sum_probs=204.7
Q ss_pred CccccCcccCCCcccEEEcccC-CC---cEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA-DG---TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
+|+..+.||+|+||.||+|... ++ ..||||.+... ......+|..|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677889999999999999854 33 36999998754 3334568999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++......+++.+++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 85 EFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred ecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 999999999999866667999999999999999999999986 99999999999999999999999999876543222
Q ss_pred cc--ccccc--cCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 549 HI--STRVA--GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 549 ~~--~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.. ..... .+..|+|||.+.+..++.++|||||||++||+++ |..||...+......+.. ..... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~----~~~~~-----~~ 232 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE----QDYRL-----PP 232 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH----cCCcC-----CC
Confidence 11 11111 2457999999998899999999999999999886 999997655444433321 11100 00
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
+.+....+.+++.+||+.+|.+||++.+|+..|++.
T Consensus 233 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 233 ----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 112234578899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=329.06 Aligned_cols=240 Identities=25% Similarity=0.378 Sum_probs=192.8
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|+. .+++.||||.+.... ......+..|..++... +||||+++++++.+++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999995 467899999986531 22335567788888764 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (316)
T cd05619 81 GDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTCT 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ceee
Confidence 9999998654 47899999999999999999999986 99999999999999999999999999874322111 2234
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... . .. +. ++.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~---~-~~------~~----~~~~~~~ 221 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR---M-DN------PC----YPRWLTR 221 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h-CC------CC----CCccCCH
Confidence 579999999999998899999999999999999999999997655443332211 0 00 00 1111223
Q ss_pred HHHHHHHHhhcCCCCCCCCHH-HHH
Q 004732 634 VMINVALLCANASPTIRPSMS-SVL 657 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RPt~~-~vl 657 (733)
.+.+++.+|++.+|++||++. ++.
T Consensus 222 ~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 222 EAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred HHHHHHHHHhccCHhhcCCChHHHH
Confidence 478899999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=331.60 Aligned_cols=244 Identities=24% Similarity=0.358 Sum_probs=193.6
Q ss_pred ccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHH---HhCCCCceeeEeeEEEeCCeEEEE
Q 004732 395 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMI---SALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
|+..+.||+|+||.||+|. ..+++.||||.+.... ....+.+.+|++++ +.++||||+++++++.+++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 4567899999999999998 4578999999986532 22234566666554 567899999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++|+|..++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05589 81 MEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG 155 (324)
T ss_pred EcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence 999999999988754 36899999999999999999999986 9999999999999999999999999987433221
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+........ .. ... . +
T Consensus 156 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i---~~-~~~------~----~ 220 (324)
T cd05589 156 -DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSI---VN-DEV------R----Y 220 (324)
T ss_pred -CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh-CCC------C----C
Confidence 1223467999999999999989999999999999999999999999765543332211 11 110 0 1
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPS-----MSSVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 658 (733)
+......+.+++.+|++.||.+||+ +.++++
T Consensus 221 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 221 PRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1112334788999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=320.53 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=201.6
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
..+|...+.||+|+||.||+|+ ..+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 3478889999999999999999 467899999998755444456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-~ 162 (267)
T cd06646 88 CGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-K 162 (267)
T ss_pred CCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-c
Confidence 9999999998654 47899999999999999999999986 99999999999999999999999999986543221 1
Q ss_pred ccccccCCCcccHHHHh---hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 551 STRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.....|++.|+|||.+. ...++.++|||||||++|||++|+.||.......... .. .... ...+.. ..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~---~~-~~~~---~~~~~~--~~ 233 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF---LM-SKSN---FQPPKL--KD 233 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe---ee-ecCC---CCCCCC--cc
Confidence 22356889999999884 3457889999999999999999999985432211100 00 0000 000000 01
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRML 660 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 660 (733)
.......+.+++.+||+.+|++||+++++++.|
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 112234588999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=330.42 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=217.1
Q ss_pred hHHhhhcCccccCcccCCCcccEEEcccCC-CcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 387 QIKAATNNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 387 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
..+....+....++||-|-||.||.|.|+. .-.||||.++.+ .-...+|+.|+.+|+.++|||+|+++|+|..+..+|
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 333444456677899999999999999764 568999999764 445689999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 466 LIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
+|.|||..|+|.++|.+. +..++.-..+.++.||+.|++||..+. +|||||..+|+|+.++..+||+|||+++++.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999999864 345677788999999999999999884 9999999999999999999999999999887
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.+.........-.+.|.|||.+....++.|+|||+|||+|||+.| |..|+.+-+... +....+.+..++....++
T Consensus 417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq----VY~LLEkgyRM~~PeGCP 492 (1157)
T KOG4278|consen 417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYGLLEKGYRMDGPEGCP 492 (1157)
T ss_pred CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH----HHHHHhccccccCCCCCC
Confidence 655443333334678999999999999999999999999999998 888886654332 333445566555544443
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
..+++++..||+.+|.+||++.|+.+.+|..
T Consensus 493 ---------pkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 493 ---------PKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred ---------HHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 3589999999999999999999999988854
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=325.61 Aligned_cols=257 Identities=30% Similarity=0.435 Sum_probs=202.6
Q ss_pred cCccccCcccCCCcccEEEcccC-CCc--EEEEEEcccc-ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGT--AIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 467 (733)
++|...+.||+|+||.||+|... ++. .+++|.++.. .....+.|.+|+++++++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 57888899999999999999854 343 4788888643 333456789999999999 799999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCe
Q 004732 468 YEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 532 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 532 (733)
+||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996432 35889999999999999999999986 9999999999999999999
Q ss_pred EEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHh
Q 004732 533 KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKE 611 (733)
Q Consensus 533 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 611 (733)
||+|||++........ ......+..|+|||.+....++.++|||||||++|||++ |..||............ .
T Consensus 159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~----~ 232 (297)
T cd05089 159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL----P 232 (297)
T ss_pred EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----h
Confidence 9999999864321111 111223567999999988889999999999999999997 99999665443332211 1
Q ss_pred hCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 612 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
.+... ..... ....+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 233 ~~~~~-----~~~~~----~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 233 QGYRM-----EKPRN----CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred cCCCC-----CCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11100 01111 2234889999999999999999999999998655433
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=330.98 Aligned_cols=241 Identities=24% Similarity=0.344 Sum_probs=194.3
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCC-ceeeEeeEEEeCCeEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHP-NLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~ 468 (733)
+|...+.||+|+||.||+|+. .+++.||||.+... .......+..|.+++..++|+ +|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 477889999999999999984 46789999998653 223345678899999999764 6888999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 156 (324)
T cd05587 81 EYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK 156 (324)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence 999999999998654 46899999999999999999999986 99999999999999999999999999874322111
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...+......... . .. . .++
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~---~-~~-~---------~~~ 221 (324)
T cd05587 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM---E-HN-V---------SYP 221 (324)
T ss_pred -ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---c-CC-C---------CCC
Confidence 1234579999999999999899999999999999999999999997655443332111 0 00 0 011
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSM 653 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~ 653 (733)
......+.+++.+|++.+|.+|++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 222 KSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1123357889999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=336.49 Aligned_cols=261 Identities=24% Similarity=0.360 Sum_probs=200.2
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-----eEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN-----QLL 465 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 465 (733)
+|...+.||+|+||.||+|.. .+|+.||||.+... .....+.+.+|+++++.++||||+++++++..+. ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 477889999999999999994 57899999998643 2233467889999999999999999999998776 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+|+||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999997 578777754 347899999999999999999999986 99999999999999999999999999986544
Q ss_pred cCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccc--------
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM-------- 616 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 616 (733)
..........+++.|+|||.+.+. .++.++||||+||++|||++|+.||...+..................
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 333333445688999999998774 47999999999999999999999996655433222111110000000
Q ss_pred --ccccCCCCC--------CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 --ELVDTNPGS--------NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 --~~~~~~~~~--------~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..+...... .........+.+++.+|++.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 0111123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=323.61 Aligned_cols=257 Identities=25% Similarity=0.428 Sum_probs=207.6
Q ss_pred hhcCccccCcccCCCcccEEEcccCC-----CcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCe
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLAD-----GTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIE-GNQ 463 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 463 (733)
..++|...+.||+|+||.||+|...+ +..|++|.+... .......+.+|+.++++++||||+++++++.+ +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678888999999999999999655 688999988654 23345678899999999999999999999876 467
Q ss_pred EEEEEEccCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcc
Q 004732 464 LLLIYEYLENNSLARALFEHR-------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 536 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 536 (733)
.++++||+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999987432 46899999999999999999999886 99999999999999999999999
Q ss_pred cCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCc
Q 004732 537 FGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGK 614 (733)
Q Consensus 537 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 614 (733)
||+++........ ......++..|+|||.+.+..++.++|||||||++||+++ |+.||...+...+..+.. . +.
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~-~~ 236 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK---D-GY 236 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH---c-CC
Confidence 9999865433222 1223446778999999988889999999999999999999 999997665544433221 1 11
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 615 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
... ..... ...+.+++.+||+.+|++||++.++++.|+..
T Consensus 237 ~~~-----~~~~~----~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~ 276 (280)
T cd05043 237 RLA-----QPINC----PDELFAVMACCWALDPEERPSFSQLVQCLTDF 276 (280)
T ss_pred CCC-----CCCcC----CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 000 00111 23478999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=330.44 Aligned_cols=241 Identities=23% Similarity=0.347 Sum_probs=195.1
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 468 (733)
+|...+.||+|+||.||+|+. .+++.||||.+.... ......+..|.+++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 477788999999999999984 467899999986532 22234567788888877 5899999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~ 156 (323)
T cd05616 81 EYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV 156 (323)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence 999999999988654 46899999999999999999999986 99999999999999999999999999975332221
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... . ... .++
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~---~-~~~----------~~p 221 (323)
T cd05616 157 -TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM---E-HNV----------AYP 221 (323)
T ss_pred -ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH---h-CCC----------CCC
Confidence 2234679999999999999999999999999999999999999997665544332211 1 110 111
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSM 653 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~ 653 (733)
......+.+++.+|++.+|++|++.
T Consensus 222 ~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 222 KSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CcCCHHHHHHHHHHcccCHHhcCCC
Confidence 1223457889999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.04 Aligned_cols=253 Identities=26% Similarity=0.446 Sum_probs=200.8
Q ss_pred ccccCcccCCCcccEEEcccC-C---CcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe-----
Q 004732 395 FATDNNIGEGGFGPVYKGLLA-D---GTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ----- 463 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 463 (733)
|...+.||+|+||.||+|... + +..||+|.++.. .......+.+|++.++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456789999999999999853 2 368999998754 23334678999999999999999999999876554
Q ss_pred -EEEEEEccCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEccc
Q 004732 464 -LLLIYEYLENNSLARALFEH-----RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 537 (733)
Q Consensus 464 -~~lV~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 537 (733)
.++|+||+++|+|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 79999999999999998632 246899999999999999999999986 999999999999999999999999
Q ss_pred CccccCcccCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcc
Q 004732 538 GLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKL 615 (733)
Q Consensus 538 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 615 (733)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.........++.. .+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~----~~~~ 233 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR----HGNR 233 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----cCCC
Confidence 9998654433221 122335678999999988889999999999999999999 888886554443333221 1111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.. .+......+.+++.+||+.||.+||++.|+++.|+..
T Consensus 234 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 LK---------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 1112234588999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.66 Aligned_cols=257 Identities=25% Similarity=0.417 Sum_probs=206.6
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||.||+|+ ..+++.||||.+... ......++.+|+.+++.++||||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 467788999999999999999 468999999987543 2233467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 469 EYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 469 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
||+++++|.+++.. ....+++..++.++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999998863 3456899999999999999999999986 99999999999999999999999999876543
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.... .....|+..|+|||.+.+..++.++||||||+++|||++|..||...... ...+..... ....+..
T Consensus 159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~------~~~~~~~-- 228 (267)
T cd08229 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE------QCDYPPL-- 228 (267)
T ss_pred CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhhh------cCCCCCC--
Confidence 3221 22356889999999998888999999999999999999999999543221 111111111 1111100
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
........+.+++.+||+.+|++||||.+|++++++.
T Consensus 229 -~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 229 -PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred -CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 0112334588999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=321.02 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=202.3
Q ss_pred hcCccccCcccCCCcccEEEcccC-----------------CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceee
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-----------------DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVK 453 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 453 (733)
.++|+..+.||+|+||.||+|... ++..||+|.+... .......|.+|+++++.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 356888999999999999998532 2457999998754 3334567899999999999999999
Q ss_pred EeeEEEeCCeEEEEEEccCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCc
Q 004732 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHR----------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATN 523 (733)
Q Consensus 454 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~N 523 (733)
+++++..++..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 9999999999999999999999999987432 24778899999999999999999986 9999999999
Q ss_pred EEecCCCCeEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh--CCCCCCccchh
Q 004732 524 VLLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS--GRSNVTKEDMF 600 (733)
Q Consensus 524 ill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt--g~~p~~~~~~~ 600 (733)
|+++.++.++|+|||+++........ ......+++.|+|||...++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999765432221 1222345678999999988889999999999999999998 77888544333
Q ss_pred hHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 601 YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
............... ....+.+ .. ....+.+++.+||+.||.+||++.+|++.|+
T Consensus 241 ~~~~~~~~~~~~~~~-~~~~~~~-~~----~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENTGEFFRDQGR-QVYLPKP-AL----CPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHHHHHHhhccc-cccCCCC-CC----CCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 322211111111100 0111111 11 2245889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=320.81 Aligned_cols=244 Identities=25% Similarity=0.321 Sum_probs=192.5
Q ss_pred ccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCH
Q 004732 401 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 476 (733)
Q Consensus 401 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 476 (733)
||+|+||.||+++. .+|+.||+|.+.... ......+..|++++++++||||+++++++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999984 568999999986431 12234566799999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccccc
Q 004732 477 ARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 555 (733)
Q Consensus 477 ~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 555 (733)
.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||++........ .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccC
Confidence 9888643 346899999999999999999999986 99999999999999999999999999876543221 23356
Q ss_pred cCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHhhCcccccccCCCCCCCCHHHHHH
Q 004732 556 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 634 (733)
Q Consensus 556 gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (733)
|+..|+|||++.+..++.++||||+||++|||++|+.||...... .......... ... +.. .... ....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~----~~~-~~~~----~~~~ 225 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTL-EDE----VKF-EHQN----FTEE 225 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhh-ccc----ccc-cccc----CCHH
Confidence 899999999999888999999999999999999999999543211 1111111100 000 000 0011 2334
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 635 MINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 635 l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+.+++.+||+.||++||++.|+++.
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccchhh
Confidence 7899999999999999999887643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=339.78 Aligned_cols=250 Identities=20% Similarity=0.301 Sum_probs=193.3
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.|...+.||+|+||+||+|+ ..+++.||+|.+.... ......+.+|++++++++|||||++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57788999999999999998 4578899999986532 2334578889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC--
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN-- 547 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~-- 547 (733)
||++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 99999999998754 46889999999999999999999986 9999999999999999999999999975321000
Q ss_pred --------------------------------------------cccccccccCCCcccHHHHhhCCCCccchhHhHHHH
Q 004732 548 --------------------------------------------THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIV 583 (733)
Q Consensus 548 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvi 583 (733)
........||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000123569999999999999899999999999999
Q ss_pred HHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHH
Q 004732 584 ALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPS---MSSVLR 658 (733)
Q Consensus 584 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt---~~~vl~ 658 (733)
+|||++|+.||...+........ ......... + .....+. .+.+++.+++ .+|.+|++ +.++++
T Consensus 238 l~elltG~~Pf~~~~~~~~~~~i---~~~~~~~~~--p-~~~~~s~----~~~~li~~l~-~~p~~R~~~~~~~ei~~ 304 (382)
T cd05625 238 LYEMLVGQPPFLAQTPLETQMKV---INWQTSLHI--P-PQAKLSP----EASDLIIKLC-RGPEDRLGKNGADEIKA 304 (382)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHH---HccCCCcCC--C-CcccCCH----HHHHHHHHHc-cCHhHcCCCCCHHHHhc
Confidence 99999999999765443222111 000000000 0 0111222 3555665554 49999997 776654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=321.76 Aligned_cols=256 Identities=25% Similarity=0.432 Sum_probs=204.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCc----EEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGT----AIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
.++|...+.||+|+||+||+|++ .+|+ .||+|.+... .......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 35678889999999999999984 4554 4899998654 333456788999999999999999999999754 578
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+++||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 999999999999999876667999999999999999999999986 99999999999999999999999999986643
Q ss_pred cCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 546 ENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 546 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
..... .....+++.|+|||...+..++.++|||||||++|||++ |..||.......+..+.. ...... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~----~~~~~~-----~ 232 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE----KGERLP-----Q 232 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH----CCCcCC-----C
Confidence 32221 122335678999999998899999999999999999998 899986554433333221 111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.. .....+.+++.+||+.||++||++.++++.|+...
T Consensus 233 ~~----~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 233 PP----ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred Cc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 11 12335788999999999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=320.52 Aligned_cols=254 Identities=26% Similarity=0.443 Sum_probs=205.7
Q ss_pred hcCccccCcccCCCcccEEEcccC------CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
.++|...+.||+|+||.||+|... .+..||+|.+.... ......+.+|+++++.++||||+++++++..+...
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357788899999999999999853 24689999986542 23346788999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEc
Q 004732 465 LLIYEYLENNSLARALFEH---------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKIS 535 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 535 (733)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999999642 224788999999999999999999886 9999999999999999999999
Q ss_pred ccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhC
Q 004732 536 DFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQG 613 (733)
Q Consensus 536 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 613 (733)
|||+++....... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||...+......+.. .+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~----~~ 237 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI----DG 237 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh----cC
Confidence 9999976543322 12233457889999999988889999999999999999998 899986555444433221 11
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
...... ... ...+.+++.+||+.+|++|||+.++++.|+
T Consensus 238 ~~~~~~-----~~~----~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 238 GHLDLP-----ENC----PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred CCCCCC-----CCC----CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111 111 345889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=331.22 Aligned_cols=240 Identities=23% Similarity=0.324 Sum_probs=189.7
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|+. .+++.||+|.+... .......+.+|+.++.++ +||||+++++++.++...++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999994 56889999998753 222335577888888776 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cccc
Confidence 9999888654 47999999999999999999999986 99999999999999999999999999875322211 2234
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccc-----hhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED-----MFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......+.......... ..+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~~p 225 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------RIP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------CCC
Confidence 679999999999999999999999999999999999999994211 11111121111111110 111
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSM 653 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~ 653 (733)
......+.+++.+|++.||++||+.
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 1223457889999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=316.05 Aligned_cols=251 Identities=27% Similarity=0.384 Sum_probs=192.8
Q ss_pred CcccCCCcccEEEcccC---CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCC
Q 004732 399 NNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 474 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 474 (733)
+.||+|+||.||+|... .+..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999754 34679999886543 233457889999999999999999999999999999999999999
Q ss_pred CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 475 SLARALFEH----RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 475 sL~~~l~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+|.+++... ....++..+..++.|+++|++|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 999999742 235678888999999999999999986 9999999999999999999999999997543332211
Q ss_pred -ccccccCCCcccHHHHhhC-------CCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 551 -STRVAGTIGYMAPEYAMRG-------HLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 551 -~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
.....|+..|+|||++... .++.++||||||+++|||++ |+.||............. .........+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~ 233 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV----REQQLKLPKP 233 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh----hcccCCCCCC
Confidence 2235578899999998642 35789999999999999996 999996544333222111 1111111222
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
..... ....+.+++..|| .+|++|||+.||++.|+
T Consensus 234 ~~~~~----~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 234 RLKLP----LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ccCCC----CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111 1224777889999 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=337.23 Aligned_cols=260 Identities=20% Similarity=0.289 Sum_probs=204.1
Q ss_pred hhHHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004732 386 LQIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEG 461 (733)
Q Consensus 386 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 461 (733)
.++....++|...+.||+|+||.||+|+. .+++.||+|.+... .......+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34555678999999999999999999995 46889999998542 222335678899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 462 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
...++||||+++|+|.+++... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999999988643 5788999999999999999999986 9999999999999999999999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhhC----CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccc
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRG----HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME 617 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 617 (733)
..............||+.|+|||++... .++.++|||||||++|||++|+.||...+...... . .........
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~--~-i~~~~~~~~ 267 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS--K-IMNHKNSLT 267 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHH--H-HHcCCCccc
Confidence 6654333333456799999999999753 37899999999999999999999997665433221 1 111111111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHHh
Q 004732 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTI--RPSMSSVLRML 660 (733)
Q Consensus 618 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~~vl~~L 660 (733)
..+ .......+.+++.+|+...+.+ ||++.++++..
T Consensus 268 ~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 268 FPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111 1112334778889999844433 77899888754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=318.82 Aligned_cols=257 Identities=26% Similarity=0.351 Sum_probs=205.3
Q ss_pred HHhhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
++.+++++.....||+|+||.||+|+ ..++..||+|.+........+.+.+|++++++++|+||+++++++..++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 45567788888899999999999998 45678999999877665566789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC-CCCeEEcccCccccC
Q 004732 467 IYEYLENNSLARALFEHRLKL--DWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLD 543 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfGla~~~ 543 (733)
|+||+++++|.+++......+ ++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999998654455 88899999999999999999886 999999999999986 678999999998755
Q ss_pred cccCcccccccccCCCcccHHHHhhCC--CCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGH--LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
..... ......|+..|+|||++.+.. ++.++||||||+++|+|++|+.||...+......+...... .
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~--~------- 229 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--I------- 229 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc--c-------
Confidence 43222 122345889999999987643 78999999999999999999999954332222211111000 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+......+.+++.+||+.+|.+||++.|+++.
T Consensus 230 --~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 230 --HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred --CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011122233458889999999999999999998763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=318.54 Aligned_cols=251 Identities=27% Similarity=0.367 Sum_probs=202.7
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-----hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-----KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
++|...+.||+|++|.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999984 578999999876432 1123568889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
|+||+++++|.+++... ..+++..+.+++.|++.||+|||+.+ |+||||+|+||++++++.++|+|||+++.....
T Consensus 82 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccc
Confidence 99999999999998654 36889999999999999999999986 999999999999999999999999999765432
Q ss_pred Ccccc--cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 547 NTHIS--TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 547 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
..... ....|+..|+|||.+.+..++.++||||+|+++||+++|+.||...+......+. .......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~~~-------- 226 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI---ATQPTNP-------- 226 (263)
T ss_pred ccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH---hccCCCC--------
Confidence 22111 3356788999999999888999999999999999999999999654433222111 1111110
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..+......+.+++.+||..+|.+||++.++++.
T Consensus 227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 227 -QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111223357889999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=333.37 Aligned_cols=246 Identities=29% Similarity=0.413 Sum_probs=205.3
Q ss_pred CcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCHH
Q 004732 399 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLA 477 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 477 (733)
-+||+|.||+||-|+ ..+...+|||.+........+.+.+|+..-+.++|.|||+++|.|.+++.+-+.||-++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999999 4556789999998776666677899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC-CCCeEEcccCccccCcccCccccccc
Q 004732 478 RALFEHRLKL--DWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLDEEENTHISTRV 554 (733)
Q Consensus 478 ~~l~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~ 554 (733)
+.|...-.++ .+.+.-.+..||++||.|||++. |||||||-+|||++. .|.+||+|||-++....- .....++
T Consensus 661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETF 736 (1226)
T KOG4279|consen 661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETF 736 (1226)
T ss_pred HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Ccccccc
Confidence 9999877777 78889999999999999999985 999999999999964 688999999999865432 3345678
Q ss_pred ccCCCcccHHHHhhC--CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHH
Q 004732 555 AGTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632 (733)
Q Consensus 555 ~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (733)
.||..|||||++..+ .|+.++|||||||.+.||.||+.||..-....-.-+ .- .+...+ ...+.+..
T Consensus 737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF-----kV----GmyKvH--P~iPeels 805 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF-----KV----GMYKVH--PPIPEELS 805 (1226)
T ss_pred ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh-----hh----cceecC--CCCcHHHH
Confidence 899999999999875 599999999999999999999999954332211100 00 111111 23466778
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 633 MVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 633 ~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+...++.+|+..||.+||++.++++.
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccC
Confidence 889999999999999999999998753
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=328.62 Aligned_cols=242 Identities=24% Similarity=0.360 Sum_probs=195.4
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||+||+|+. .+++.||||.+.... ......+..|.++++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999985 467899999987532 23345677888999888 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....... ....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 155 (318)
T cd05570 81 GDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTST 155 (318)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cccc
Confidence 9999988654 47999999999999999999999986 99999999999999999999999999874322211 2234
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. ... .++.....
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i---~~-~~~----------~~~~~~~~ 221 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI---LE-DEV----------RYPRWLSK 221 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHH---Hc-CCC----------CCCCcCCH
Confidence 56899999999999999999999999999999999999999765543332211 11 100 01111234
Q ss_pred HHHHHHHHhhcCCCCCCCCH-----HHHHHH
Q 004732 634 VMINVALLCANASPTIRPSM-----SSVLRM 659 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RPt~-----~~vl~~ 659 (733)
.+.+++.+||+.||.+||++ .++++.
T Consensus 222 ~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 222 EAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred HHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 57899999999999999999 777543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=325.48 Aligned_cols=257 Identities=27% Similarity=0.426 Sum_probs=204.3
Q ss_pred hhcCccccCcccCCCcccEEEccc------CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCC
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGN 462 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 462 (733)
..++|...+.||+|+||.||+|.. .++..||||.++... ....+.+.+|+++++++ +||||+++++++...+
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 345788899999999999999863 235589999987543 23345788999999999 7999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 463 QLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
..++||||+.+|+|.+++.... ..+++.++..++.|++.||+|||+.+ |+|+||||+||+++.++.++++|||+++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 9999999999999999997543 34899999999999999999999986 9999999999999999999999999998
Q ss_pred cCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccc
Q 004732 542 LDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELV 619 (733)
Q Consensus 542 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (733)
........ ......++..|+|||.+....++.++|||||||++|||++ |+.||.......... . ....+....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~--~-~~~~~~~~~-- 264 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY--K-LIKEGYRMA-- 264 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHH--H-HHHcCCcCC--
Confidence 65433221 1223346788999999998889999999999999999998 999985543221110 0 111111100
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 620 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
. +......+.+++.+|++.+|++||++.|+++.|++
T Consensus 265 ---~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 265 ---Q----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred ---C----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 0 11112358899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=320.36 Aligned_cols=239 Identities=23% Similarity=0.373 Sum_probs=190.1
Q ss_pred cccCCCcccEEEcccCC-------------------------CcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeE
Q 004732 400 NIGEGGFGPVYKGLLAD-------------------------GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL 454 (733)
Q Consensus 400 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 454 (733)
.||+|+||.||+|.+.. ...||+|.+..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13589999866544445678899999999999999999
Q ss_pred eeEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC----
Q 004732 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---- 530 (733)
Q Consensus 455 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---- 530 (733)
+++|.++...++||||+++|+|..++......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcccC
Confidence 99999999999999999999999999776668999999999999999999999886 99999999999997643
Q ss_pred ---CeEEcccCccccCcccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHH-hCCCCCCccchhhHHHH
Q 004732 531 ---NSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIV-SGRSNVTKEDMFYLLDW 605 (733)
Q Consensus 531 ---~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~ell-tg~~p~~~~~~~~~~~~ 605 (733)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++||++ +|+.||..........+
T Consensus 159 ~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 233 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF 233 (274)
T ss_pred ccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 3799999998643221 12357788999998865 56899999999999999985 68999865443322221
Q ss_pred HHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 606 ALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
. ..... . .... ...+.+++.+||+.+|++||++.+|++.|+
T Consensus 234 ~---~~~~~---~-----~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 234 Y---EKKHR---L-----PEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred H---HhccC---C-----CCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 1 00000 0 0111 124888999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=316.61 Aligned_cols=240 Identities=23% Similarity=0.402 Sum_probs=191.1
Q ss_pred CcccCCCcccEEEcccCC-------------CcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 399 NNIGEGGFGPVYKGLLAD-------------GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
+.||+|+||.||+|++.+ ...||+|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358999886654445567888999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC-------eEEcccC
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN-------SKISDFG 538 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~-------~kl~DfG 538 (733)
+||||+++|+|..++......+++..+.+++.||++||+|||+.+ |+||||||+|||++.++. ++++|||
T Consensus 81 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred EEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999998766667999999999999999999999986 999999999999987664 8999999
Q ss_pred ccccCcccCcccccccccCCCcccHHHHh-hCCCCccchhHhHHHHHHHHH-hCCCCCCccchhhHHHHHHHHHhhCccc
Q 004732 539 LAKLDEEENTHISTRVAGTIGYMAPEYAM-RGHLTEKADVYSFGIVALEIV-SGRSNVTKEDMFYLLDWALVLKEQGKLM 616 (733)
Q Consensus 539 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 616 (733)
++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+.......... .. ....
T Consensus 158 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~----~~-~~~~- 226 (262)
T cd05077 158 IPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER----FY-EGQC- 226 (262)
T ss_pred CCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH----HH-hcCc-
Confidence 98754322 2245788999999886 466899999999999999998 5888875443222111 00 0100
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
... .. ....+.+++.+||+.||++||++.+|++.++
T Consensus 227 ~~~-----~~----~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 227 MLV-----TP----SCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred cCC-----CC----ChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 000 11 1235789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=327.31 Aligned_cols=254 Identities=30% Similarity=0.432 Sum_probs=200.8
Q ss_pred hcCccccCcccCCCcccEEEcccC-CCc--EEEEEEcccc-ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-DGT--AIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 466 (733)
.++|...+.||+|+||.||+|... ++. .+|+|.+... .......+.+|++++.++ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 457888899999999999999853 454 4678877643 334456788999999999 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC
Q 004732 467 IYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 531 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 531 (733)
||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 999999999999997432 35789999999999999999999986 999999999999999999
Q ss_pred eEEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHH
Q 004732 532 SKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLK 610 (733)
Q Consensus 532 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 610 (733)
+||+|||+++..... .......++..|+|||.+.+..++.++|||||||++|||+| |..||...+........ .
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~---~ 237 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---P 237 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH---h
Confidence 999999998632211 11111234668999999988889999999999999999998 99999655443322211 1
Q ss_pred hhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 611 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
...... .+......+.+++.+||+.+|++||++.++++.|+..
T Consensus 238 -~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 238 -QGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred -cCCcCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 110000 0111223478999999999999999999999998844
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=323.09 Aligned_cols=251 Identities=27% Similarity=0.474 Sum_probs=204.9
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
..+|...+.||+|+||.||+|+ ..+++.||+|.+..........+.+|+.+++.++||||+++++++..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 3578888999999999999998 457899999998765555557788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++++|.+++.+. .+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ .
T Consensus 99 ~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~ 172 (296)
T cd06654 99 LAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K 172 (296)
T ss_pred cCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence 9999999998643 5799999999999999999999986 99999999999999999999999999875443221 1
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
.....|++.|+|||.+.+..++.++|||||||++|||++|+.||...+...... . ..... . +....+..
T Consensus 173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~--~-~~~~~-~-------~~~~~~~~ 241 (296)
T cd06654 173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY--L-IATNG-T-------PELQNPEK 241 (296)
T ss_pred cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH--H-HhcCC-C-------CCCCCccc
Confidence 233468899999999998889999999999999999999999996554322111 1 10000 0 00111222
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+.+++.+||..+|++||++.++++.
T Consensus 242 ~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 242 LSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred cCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 33458889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=308.17 Aligned_cols=248 Identities=27% Similarity=0.418 Sum_probs=210.9
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.+-|++...||+|+||.||+|.+ ..|..||||.+... .+.+++..|+.++++...|++|++||.|.....+|+||||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 34577889999999999999994 57999999998654 3458899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
|..|+..+.++..++.+++.++..++...++||+|||.. +-||||||+.|||++.+|.+|++|||.|....+. ...
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT-MAK 185 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT-MAK 185 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh-HHh
Confidence 999999999998888999999999999999999999976 4799999999999999999999999999754432 223
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC--CCC
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS--NFD 628 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 628 (733)
..++.||+.|||||++..-.|+.++||||+|+...||..|+.|+..-.+. +..-++...+.. ..+
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-------------RAIFMIPT~PPPTF~KP 252 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-------------RAIFMIPTKPPPTFKKP 252 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-------------ceeEeccCCCCCCCCCh
Confidence 45688999999999999999999999999999999999999998432211 111222222222 335
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
......+.++++.|+-..|++|-|+.++++
T Consensus 253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 566778999999999999999999988844
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=336.72 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=202.8
Q ss_pred hhcCccccCcccCCCcccEEEcccC------CCcEEEEEEccccCh-hcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCC
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSK-QGNREFINEIGMISALQ-HPNLVKLYGCCIEGN 462 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 462 (733)
..++|...+.||+|+||.||+|++. .++.||||++..... .....+.+|++++.++. |||||+++++|...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3456778899999999999999843 346899999975432 22357889999999997 999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcC----------------------------------------------------------
Q 004732 463 QLLLIYEYLENNSLARALFEHR---------------------------------------------------------- 484 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 484 (733)
..++||||+++|+|.++++...
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999996431
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEE
Q 004732 485 ---------------------------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL 525 (733)
Q Consensus 485 ---------------------------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nil 525 (733)
..+++..+..++.|++.||+|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 23677888999999999999999886 999999999999
Q ss_pred ecCCCCeEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHH
Q 004732 526 LDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLL 603 (733)
Q Consensus 526 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~ 603 (733)
+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.........
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 99999999999999986433221 11223457889999999998889999999999999999998 88898543322211
Q ss_pred HHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 604 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.. .. ..+.... .+......+.+++.+||+.+|.+||++++|++.|+..
T Consensus 352 ~~--~~-~~~~~~~---------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 352 YN--AI-KRGYRMA---------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HH--HH-HcCCCCC---------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 01 1111111 0111234588999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=332.80 Aligned_cols=238 Identities=25% Similarity=0.341 Sum_probs=193.8
Q ss_pred CcccCCCcccEEEccc----CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 399 NNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
+.||+|+||.||+++. .+|+.||+|++.... ......+.+|++++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999873 368899999986532 1233457789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ...
T Consensus 82 ~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~~ 156 (318)
T cd05582 82 GGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KAY 156 (318)
T ss_pred CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-cee
Confidence 99999998654 46899999999999999999999986 99999999999999999999999999976443322 223
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (733)
...||+.|+|||.+.+..++.++|||||||++|||++|+.||...+........ . .... . .+....
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i---~-~~~~-~---------~p~~~~ 222 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI---L-KAKL-G---------MPQFLS 222 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHH---H-cCCC-C---------CCCCCC
Confidence 467999999999999888999999999999999999999999765543332211 1 1110 0 111122
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHH
Q 004732 633 MVMINVALLCANASPTIRPSMSS 655 (733)
Q Consensus 633 ~~l~~l~~~c~~~~P~~RPt~~~ 655 (733)
..+.+++.+||+.||++||++.+
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCC
Confidence 34788999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=324.72 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=202.6
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++|...+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||++++++|.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688889999999999999984 468889999886542 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++++|.+++... ..+++..+..++.|+++||+|||+.. +++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (308)
T cd06615 81 MDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--- 154 (308)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc---
Confidence 9999999999755 57899999999999999999999742 49999999999999999999999999987543321
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccc--------------
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM-------------- 616 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------------- 616 (733)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||...+......+...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSP 234 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCcc
Confidence 234568999999999988889999999999999999999999996544332222111000000000
Q ss_pred ----------ccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 ----------ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 ----------~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..................+.+++.+||+.+|++||++.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 235 RPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred chhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000000000000123358899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=326.86 Aligned_cols=240 Identities=25% Similarity=0.338 Sum_probs=192.4
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|+. .+|+.||+|.++... ......+..|..++... +||||+++++++.+++..++||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999995 468899999986531 22335567788887754 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAST 155 (316)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceec
Confidence 9999988654 47899999999999999999999986 999999999999999999999999998743221 112344
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... . . .+..... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~---~-~------~~~~~~~----~~~ 221 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR---V-D------TPHYPRW----ITK 221 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---h-C------CCCCCCC----CCH
Confidence 679999999999999999999999999999999999999997665433322111 0 0 0011111 223
Q ss_pred HHHHHHHHhhcCCCCCCCCHH-HHH
Q 004732 634 VMINVALLCANASPTIRPSMS-SVL 657 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RPt~~-~vl 657 (733)
.+.+++.+|++.||++||++. ++.
T Consensus 222 ~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 222 ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred HHHHHHHHHccCCHHHcCCChHHHH
Confidence 478899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=315.70 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=206.0
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
.++|...+.||+|+||.||+|...++..+|+|.+... ......+.+|++++++++|+||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3577888999999999999999777888999988654 3345678999999999999999999999887 7789999999
Q ss_pred CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 472 ENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 472 ~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 159 (260)
T cd05073 83 AKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence 99999999975 3456899999999999999999999886 9999999999999999999999999997654332222
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....++..|+|||++....++.++|+|||||++|++++ |+.||...+......+.. .+..... ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~----~~~~~~~---------~~ 226 (260)
T cd05073 160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE----RGYRMPR---------PE 226 (260)
T ss_pred ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh----CCCCCCC---------cc
Confidence 223346678999999988889999999999999999999 899996655443333221 1111111 11
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
.....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 123358899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=321.19 Aligned_cols=255 Identities=29% Similarity=0.491 Sum_probs=204.4
Q ss_pred hhcCccccCcccCCCcccEEEcccC------CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 463 (733)
..++|+..+.||+|+||.||+|... ++..||+|.+.... ......+.+|++++++++||||+++++++.++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 3567889999999999999999843 46889999986542 3345678999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCC
Q 004732 464 LLLIYEYLENNSLARALFEHR---------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKAT 522 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~ 522 (733)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence 999999999999999996321 24788899999999999999999986 999999999
Q ss_pred cEEecCCCCeEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchh
Q 004732 523 NVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMF 600 (733)
Q Consensus 523 Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~ 600 (733)
||+++.++.++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875433221 11222345678999999988899999999999999999998 88898654443
Q ss_pred hHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 601 YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
...... ..+..... +......+.+++.+|++.+|++||++.|+++.|+
T Consensus 240 ~~~~~~----~~~~~~~~---------~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 240 EVIYYV----RDGNVLSC---------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHH----hcCCCCCC---------CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 322211 11111110 1112245888999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=325.12 Aligned_cols=261 Identities=22% Similarity=0.347 Sum_probs=200.0
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++|...+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 4678889999999999999984 467899999986542 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++ +|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 86 LDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence 985 888888766667899999999999999999999986 999999999999999999999999999754332221
Q ss_pred ccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC------------ccc-
Q 004732 551 STRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG------------KLM- 616 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------------~~~- 616 (733)
.....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+............... ...
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhh
Confidence 223467899999999865 468999999999999999999999996654333222111110000 000
Q ss_pred -ccccCCCCC--CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 617 -ELVDTNPGS--NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 617 -~~~~~~~~~--~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
......+.. .........+.+++.+|++.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 000000000 000112335789999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=314.69 Aligned_cols=250 Identities=27% Similarity=0.431 Sum_probs=206.0
Q ss_pred hcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.++|...+.||+|+||.||+|+.. +++.||+|.+..... .+.+.+|++++++++||||+++++++.++...++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 357888899999999999999965 488999999865432 57899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++++|.+++......+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.+||+|||++........ .
T Consensus 80 ~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-~ 155 (256)
T cd06612 80 CGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-K 155 (256)
T ss_pred CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-c
Confidence 9999999999876778999999999999999999999986 99999999999999999999999999986554322 2
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||............ ... .......+..
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-----~~~------~~~~~~~~~~ 224 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-----PNK------PPPTLSDPEK 224 (256)
T ss_pred cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-----ccC------CCCCCCchhh
Confidence 23355888999999999889999999999999999999999999654332211100 000 0001111222
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
....+.+++.+||+.+|++||++.||++
T Consensus 225 ~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 225 WSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 3345889999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.08 Aligned_cols=255 Identities=20% Similarity=0.242 Sum_probs=199.4
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||+||+|+. .+++.||+|.+... .......+.+|..++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688889999999999999994 46889999998642 1223345788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCc
Confidence 999999999999875668999999999999999999999986 99999999999999999999999999976554433
Q ss_pred ccccccccCCCcccHHHHhh-----CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.......||+.|+|||++.+ +.++.++|||||||++|||++|+.||...+....... ........... .
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~---i~~~~~~~~~p-~-- 231 (331)
T cd05624 158 VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK---IMNHEERFQFP-S-- 231 (331)
T ss_pred eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHH---HHcCCCcccCC-C--
Confidence 33344679999999999875 4688999999999999999999999976554332211 11111111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTI--RPSMSSVLRM 659 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~~vl~~ 659 (733)
........+.+++.+|+...+++ |+++.++++.
T Consensus 232 ---~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 232 ---HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00112345778888888865544 4678877654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.63 Aligned_cols=255 Identities=20% Similarity=0.246 Sum_probs=198.5
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||+||+++. .+++.||+|.+... .......+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 4678889999999999999995 45788999998542 1222345788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~ 157 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT 157 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCc
Confidence 999999999999876668999999999999999999999986 99999999999999999999999999975543333
Q ss_pred ccccccccCCCcccHHHHh-----hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 549 HISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.......||+.|+|||++. ...++.++|||||||++|||++|+.||...+....... ........... ..
T Consensus 158 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~---i~~~~~~~~~p--~~ 232 (332)
T cd05623 158 VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK---IMNHKERFQFP--AQ 232 (332)
T ss_pred ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH---HhCCCccccCC--Cc
Confidence 3334467999999999986 34688999999999999999999999976654332221 11111111110 00
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTI--RPSMSSVLRM 659 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~~vl~~ 659 (733)
.......+.+++.+|+..++.+ |+++.|+++.
T Consensus 233 ----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 233 ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0112334777888877554443 7889988765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=328.96 Aligned_cols=237 Identities=24% Similarity=0.364 Sum_probs=189.0
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHH-HHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIG-MISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
++||+|+||.||+|+. .+++.||+|.+.... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999995 568999999986432 222344555654 57889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|..++... ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (321)
T cd05603 81 GELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTST 155 (321)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccccc
Confidence 9999888643 46888999999999999999999986 9999999999999999999999999987532221 12334
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+........ .. .. . ..+.....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~-~~-~---------~~~~~~~~ 221 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI---LH-KP-L---------QLPGGKTV 221 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHH---hc-CC-C---------CCCCCCCH
Confidence 67999999999999888999999999999999999999999766543332211 11 10 0 01111233
Q ss_pred HHHHHHHHhhcCCCCCCCCHH
Q 004732 634 VMINVALLCANASPTIRPSMS 654 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RPt~~ 654 (733)
.+.+++.+|++.+|.+||+..
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 222 AACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred HHHHHHHHHccCCHhhcCCCC
Confidence 578899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=313.89 Aligned_cols=247 Identities=29% Similarity=0.439 Sum_probs=200.4
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEE-eCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI-EGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~ 471 (733)
.+|...+.||+|+||.||+|... |..||+|.+.... ..+.+.+|+.++++++|+|++++++++. ++...++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46778899999999999999764 7889999986432 3467899999999999999999999865 456789999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 472 ENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 472 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999997543 35899999999999999999999986 9999999999999999999999999987543221
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
....++..|+|||++.+..++.++|||||||++|||++ |+.||...+......+.. .+..... ..
T Consensus 157 -~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~----~~~~~~~---------~~ 222 (256)
T cd05082 157 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE----KGYKMDA---------PD 222 (256)
T ss_pred -CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh----cCCCCCC---------CC
Confidence 22345678999999988889999999999999999997 999986554433332211 1111111 11
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
.....+.+++.+||+.+|++|||+.++++.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 123458899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=314.04 Aligned_cols=247 Identities=28% Similarity=0.466 Sum_probs=198.3
Q ss_pred CcccCCCcccEEEcccC--C--CcEEEEEEccccCh-hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLLA--D--GTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|++. + +..||+|.+..... ...+++.+|+++++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999742 2 26899999875533 34567899999999999999999999876 5568999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc-
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST- 552 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~- 552 (733)
|+|.+++.... .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...........
T Consensus 80 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 80 GPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccccc
Confidence 99999997654 7899999999999999999999886 999999999999999999999999999866443322211
Q ss_pred -ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 553 -RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 553 -~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
...++..|+|||.+.+..++.++|||||||++||+++ |+.||...+......+.. ....... +..
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~----~~~~~~~---------~~~ 222 (257)
T cd05060 156 TAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE----SGERLPR---------PEE 222 (257)
T ss_pred cCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH----cCCcCCC---------CCC
Confidence 1224568999999988899999999999999999998 999996655444333321 1111111 111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
....+.+++.+||+.+|.+||++.++++.|++.
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 223588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=315.44 Aligned_cols=249 Identities=31% Similarity=0.500 Sum_probs=205.5
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
.++|...+.||+|+||.||+|... |+.||+|.+..... ..+++.+|+.+++.++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357788899999999999999865 78999999976544 4578999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 472 ENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 472 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-- 157 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-- 157 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc--
Confidence 9999999997543 36899999999999999999999986 99999999999999999999999999986533221
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
...++..|+|||.+..+.++.++||||||+++||+++ |+.||.......+.... ..+..... +.
T Consensus 158 --~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~---------~~ 222 (256)
T cd05039 158 --SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV----EKGYRMEA---------PE 222 (256)
T ss_pred --cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----hcCCCCCC---------cc
Confidence 2335678999999988889999999999999999997 99998655443332211 11111111 11
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
.....+.+++.+|++.+|++||++.+++++|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 123458899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=323.69 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=201.9
Q ss_pred CccccCcccCCCcccEEEccc-----CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLL 465 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 465 (733)
-|...+.||+|+||.||.|.. .++..||+|.+.... ......+.+|++++++++||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467788999999999999873 357899999986543 33346789999999999999999999999875 5689
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||+++++|.+++......+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 85 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred EEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccccc
Confidence 999999999999999766557899999999999999999999986 99999999999999999999999999986543
Q ss_pred cCcc--cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccc------------hhhHHHHHHHHHh
Q 004732 546 ENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED------------MFYLLDWALVLKE 611 (733)
Q Consensus 546 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~------------~~~~~~~~~~~~~ 611 (733)
.... ......|+..|+|||.+.+..++.++|||||||++||+++++.|..... ......+... ..
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 240 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-LE 240 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH-HH
Confidence 3221 1223456778999999988889999999999999999999877652210 0000111111 11
Q ss_pred hCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 612 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.+.... ........+.+++.+||+.+|++||++.++++.|+++
T Consensus 241 ~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 241 EGKRLP---------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred cCccCC---------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111110 0111234588999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=312.92 Aligned_cols=247 Identities=30% Similarity=0.460 Sum_probs=200.9
Q ss_pred CcccCCCcccEEEcccCCCcEEEEEEccccChh-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCHH
Q 004732 399 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLA 477 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 477 (733)
+.||+|+||.||+|...+++.||+|.+...... ....+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999766999999998765333 4567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc-ccccc
Q 004732 478 RALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS-TRVAG 556 (733)
Q Consensus 478 ~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~-~~~~g 556 (733)
+++......+++..+..++.+++.||+|||+.+ ++||||||+||+++.++.+||+|||++........... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 999766667899999999999999999999986 99999999999999999999999999975542211111 12234
Q ss_pred CCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHH
Q 004732 557 TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVM 635 (733)
Q Consensus 557 t~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 635 (733)
+..|+|||.+.++.++.++|||||||++|||++ |..||............ ..... ...+......+
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~----~~~~~---------~~~~~~~~~~~ 224 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI----ESGYR---------MPAPQLCPEEI 224 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH----hcCCC---------CCCCccCCHHH
Confidence 567999999988889999999999999999999 88888655433222211 11100 01111223458
Q ss_pred HHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 636 INVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 636 ~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.+++.+||+.+|.+||++.|+++.|.
T Consensus 225 ~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred HHHHHHHhccChhhCcCHHHHHHHhh
Confidence 89999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=342.15 Aligned_cols=259 Identities=21% Similarity=0.282 Sum_probs=193.6
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--------
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG-------- 461 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 461 (733)
..++|...+.||+|+||.||+|+. .+++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 356789999999999999999995 568999999885432 2345799999999999999999987532
Q ss_pred CeEEEEEEccCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-CeEEccc
Q 004732 462 NQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDF 537 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~Df 537 (733)
...++||||+++ +|.+++. .....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999985 6766664 34557999999999999999999999986 99999999999999765 6999999
Q ss_pred CccccCcccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc--
Q 004732 538 GLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-- 614 (733)
Q Consensus 538 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 614 (733)
|+|+....... .....||+.|+|||++.+. .++.++|||||||++|||++|..||....................
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 99986543222 2345689999999998764 689999999999999999999999976544332221111110000
Q ss_pred --------ccccccCC-----CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 --------LMELVDTN-----PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 --------~~~~~~~~-----~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.....-+. ....++......+.+++.+||+.||.+|||+.|+++.
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00000000 0000111123468899999999999999999999743
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=326.40 Aligned_cols=260 Identities=26% Similarity=0.427 Sum_probs=206.5
Q ss_pred hhhcCccccCcccCCCcccEEEccc--------CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL--------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCI 459 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 459 (733)
...++|...+.||+|+||.||+|+. .++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 3456778889999999999999963 134579999986542 33456789999999999 8999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcE
Q 004732 460 EGNQLLLIYEYLENNSLARALFEH---------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNV 524 (733)
Q Consensus 460 ~~~~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Ni 524 (733)
.....++||||+++|+|.+++... ...+++.++..++.||++||+|||+.+ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 999999999999999999999753 235789999999999999999999986 99999999999
Q ss_pred EecCCCCeEEcccCccccCcccCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhH
Q 004732 525 LLDKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYL 602 (733)
Q Consensus 525 ll~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~ 602 (733)
+++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++||+++ |..||........
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 99999999999999998664432221 222346678999999988889999999999999999998 7888865443332
Q ss_pred HHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 603 LDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
... .. .+..... +......+.+++.+||+.+|.+||++.|+++.|+++..
T Consensus 249 ~~~---~~-~~~~~~~---------~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 249 FKL---LK-EGHRMDK---------PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred HHH---HH-cCCcCCC---------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 221 11 1111110 11223458889999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=328.28 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=192.8
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|+. .+++.||||.++... ......+.+|..++..+ +||||+++++++.++...++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999984 578999999987532 22335678899999988 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTST 155 (329)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccccc
Confidence 9999988654 47999999999999999999999986 9999999999999999999999999987422211 12234
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccch-----hhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM-----FYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
..||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....++.......... . .+
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~---------~p 225 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI-R---------IP 225 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC-C---------CC
Confidence 6799999999999998999999999999999999999999942211 1111121111111110 0 11
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCC------HHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPS------MSSVLR 658 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt------~~~vl~ 658 (733)
......+.+++.+|++.||.+||+ +.++++
T Consensus 226 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 226 RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 112234788999999999999998 556543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=313.45 Aligned_cols=247 Identities=27% Similarity=0.443 Sum_probs=200.6
Q ss_pred CcccCCCcccEEEcccCC--C--cEEEEEEccccCh-hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLLAD--G--TAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|++++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998543 3 3699999977654 456789999999999999999999999988 889999999999
Q ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc--c
Q 004732 474 NSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH--I 550 (733)
Q Consensus 474 gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~--~ 550 (733)
|+|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++........ .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 99999997654 57899999999999999999999986 999999999999999999999999999866543221 1
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....++..|+|||.+.+..++.++|||||||++|||++ |+.||............. ....... .+.
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~~---------~~~ 224 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID---KEGERLE---------RPE 224 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---hcCCcCC---------CCc
Confidence 123457889999999988899999999999999999998 999996544433322211 1111100 011
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.....+.+++.+|++.+|++||++.++++.|.
T Consensus 225 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 225 ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 12345889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=318.47 Aligned_cols=255 Identities=27% Similarity=0.398 Sum_probs=205.1
Q ss_pred cCccccCcccCCCcccEEEcccCC----CcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLAD----GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
++|...+.||+|+||.||+|...+ ...||||...... ....+.+.+|++++++++||||+++++++.+ ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457788999999999999998543 3478999887654 4445689999999999999999999999875 457899
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++|+|.+++......+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 85 MELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 9999999999999876667899999999999999999999886 9999999999999999999999999998655443
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
........++..|+|||.+....++.++||||||+++||+++ |..||..........+. ..+.....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~----~~~~~~~~-------- 229 (270)
T cd05056 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI----ENGERLPM-------- 229 (270)
T ss_pred ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----HcCCcCCC--------
Confidence 222223345678999999988889999999999999999986 99999665543333221 11111111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
+......+.+++.+|+..+|.+|||+.++++.|++..
T Consensus 230 -~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 230 -PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred -CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1112235888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=317.38 Aligned_cols=247 Identities=30% Similarity=0.443 Sum_probs=195.1
Q ss_pred CcccCCCcccEEEcccC-CCc--EEEEEEcccc-ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLLA-DGT--AIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|+.. ++. .+|+|.++.. .......+.+|++++.++ +||||++++++|......++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 46999999999999864 444 4688888653 334456788999999999 799999999999999999999999999
Q ss_pred CCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccC
Q 004732 474 NSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFG 538 (733)
Q Consensus 474 gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 538 (733)
|+|.+++.... ..+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999987432 25789999999999999999999886 9999999999999999999999999
Q ss_pred ccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccc
Q 004732 539 LAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLME 617 (733)
Q Consensus 539 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 617 (733)
++...... ........+..|+|||++....++.++|||||||++|||++ |..||...+........ . .+...+
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~---~-~~~~~~ 231 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---P-QGYRLE 231 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH---h-CCCCCC
Confidence 98632211 11111234567999999988889999999999999999997 99999655433322211 1 111111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 618 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
. +......+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 232 ~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 232 K---------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred C---------CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 1 111223578999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=315.85 Aligned_cols=257 Identities=25% Similarity=0.431 Sum_probs=207.0
Q ss_pred cCccccCcccCCCcccEEEcccC-CCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||.||+|... +|+.||+|.++.. .....+.+.+|++++++++|+|++++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999955 8999999988532 2233567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 469 EYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 469 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
||+++|+|.+++.. ....+++..+..++.+++.||+|||+.+ |+||||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998863 3456899999999999999999999986 99999999999999999999999999876543
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||..... ...+...... .+... +.+
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~-~~~~~----~~~-- 229 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIE-KCDYP----PLP-- 229 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-cHHHHHhhhh-cCCCC----CCC--
Confidence 2221 2234688899999999888899999999999999999999999954431 1111111111 11111 111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.......+.+++.+||..+|++||++.+|+++|+.+
T Consensus 230 --~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 230 --ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 112334588999999999999999999999998854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=319.42 Aligned_cols=250 Identities=26% Similarity=0.404 Sum_probs=201.3
Q ss_pred ccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 395 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
|+..+.||+|+||.||+|.. .++..+|+|.+..........+.+|+++++.++||||+++++++..+...++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 45678899999999999995 45788999998766555567889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
++|..++......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 87 ~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~~ 162 (282)
T cd06643 87 GAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRDS 162 (282)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-ccccc
Confidence 9999988765668999999999999999999999986 9999999999999999999999999987543321 12234
Q ss_pred cccCCCcccHHHHh-----hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 554 VAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 554 ~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
..|+..|+|||++. +..++.++|||||||++|||++|+.||...+....... ... ....... .+
T Consensus 163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~-~~~~~~~-------~~ 231 (282)
T cd06643 163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK---IAK-SEPPTLA-------QP 231 (282)
T ss_pred ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH---Hhh-cCCCCCC-------Cc
Confidence 56899999999984 34578899999999999999999999965443222111 000 1000110 11
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......+.+++.+||+.+|.+||++.++++.
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 232 SRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1123458899999999999999999998765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=325.15 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=203.4
Q ss_pred hcCccccCcccCCCcccEEEcccC--------CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA--------DGTAIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 461 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 461 (733)
.++|...+.||+|+||.||+|... ++..||+|.+... ......++.+|+++++++ +||||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357888999999999999998742 2357999998754 233446788899999999 799999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe
Q 004732 462 NQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 526 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill 526 (733)
+..++||||+++|+|.+++.... ..+++.++.+++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 99999999999999999997532 35899999999999999999999886 9999999999999
Q ss_pred cCCCCeEEcccCccccCcccCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004732 527 DKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 604 (733)
Q Consensus 527 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~ 604 (733)
+.++.+||+|||+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||..........
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~ 253 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 253 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence 999999999999997654322111 112234568999999998889999999999999999998 888885544322222
Q ss_pred HHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 605 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
. . ......+ .+......+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 254 ~---~-~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~ 300 (307)
T cd05098 254 L---L-KEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 300 (307)
T ss_pred H---H-HcCCCCC---------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence 1 1 1111111 11112345788999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=297.94 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=204.3
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-----hh---cHHHHHHHHHHHHhC-CCCceeeEeeEEEe
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-----KQ---GNREFINEIGMISAL-QHPNLVKLYGCCIE 460 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 460 (733)
.-+.|...++||.|..++|.++. .++|+.+|+|++.... .. -.+.-.+|+.+|+++ .||+|+++.++|..
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34567788999999999999988 4578999999885431 11 123456799999998 69999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 461 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 461 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
+...++|+|.|+.|.|.|+|.+ ...+++....+|+.|+.+|++|||... |||||+||+|||+|++.++||+|||+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa 170 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFA 170 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEecccee
Confidence 9999999999999999999964 458999999999999999999999884 999999999999999999999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhh------CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMR------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 614 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 614 (733)
+...+... -...+||++|+|||.+.. ..|+..+|+||+||+||-++.|-.||+.....-.+.... .++
T Consensus 171 ~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Im----eGk 244 (411)
T KOG0599|consen 171 CQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIM----EGK 244 (411)
T ss_pred eccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHH----hcc
Confidence 87665433 356899999999999853 458899999999999999999999997665444333221 111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. .....-.+......+++.+|++.||++|.|.+|+++.
T Consensus 245 yq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 245 YQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 10 0011112334468899999999999999999998653
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=350.91 Aligned_cols=259 Identities=23% Similarity=0.367 Sum_probs=203.0
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||.||+|+. .+|+.||||++.... ....++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4788889999999999999984 468999999986532 223467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccC
Q 004732 469 EYLENNSLARALFEH----------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFG 538 (733)
Q Consensus 469 e~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 538 (733)
||+++|+|.+++... ....++..+++++.||++||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998631 134567888999999999999999986 9999999999999999999999999
Q ss_pred ccccCcccCc-----------------ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhh
Q 004732 539 LAKLDEEENT-----------------HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY 601 (733)
Q Consensus 539 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~ 601 (733)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 01123569999999999999999999999999999999999999996543322
Q ss_pred HHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHhccCcc
Q 004732 602 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRP-SMSSVLRMLECGVD 665 (733)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-t~~~vl~~L~~~~~ 665 (733)
.... ..........+. .+....+.+++.+|++.||++|| +++++.+.|+....
T Consensus 239 i~~~-------~~i~~P~~~~p~----~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ISYR-------DVILSPIEVAPY----REIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hhhh-------hhccChhhcccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 2110 000000000011 12233478899999999999996 56777777765533
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=320.31 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=203.4
Q ss_pred hhcCccccCcccCCCcccEEEcccC------CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 463 (733)
.+++|.+.+.||+|+||.||+|... .+..||+|.+.... ......+.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568889999999999999998643 24589999886442 2334568889999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEE
Q 004732 464 LLLIYEYLENNSLARALFEH---------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKI 534 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 534 (733)
.++||||+++|+|.+++... ...+++..+.+++.|++.||+|||+.+ |+||||||+||+++.++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999642 134567888999999999999999986 999999999999999999999
Q ss_pred cccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhh
Q 004732 535 SDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQ 612 (733)
Q Consensus 535 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 612 (733)
+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||............ ..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~---~~- 236 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV---MD- 236 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc-
Confidence 999999854432221 1222345778999999998899999999999999999998 78888654433322211 11
Q ss_pred CcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 613 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
+..... +......+.+++.+|++.+|++||++.++++.|+..
T Consensus 237 ~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 237 GGYLDQ---------PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CCCCCC---------CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 111110 111224588999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.12 Aligned_cols=237 Identities=27% Similarity=0.363 Sum_probs=189.7
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHH-HHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIG-MISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||+||+|+. .+|+.||||.+.... ......+..|.. +++.++||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999995 578999999986431 222344555554 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (323)
T cd05575 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTST 155 (323)
T ss_pred CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccccc
Confidence 9999988654 47899999999999999999999986 9999999999999999999999999987532221 12334
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+......-. .. ... . .... ...
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i---~~-~~~-~-----~~~~----~~~ 221 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI---LN-KPL-R-----LKPN----ISV 221 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHH---Hc-CCC-C-----CCCC----CCH
Confidence 67999999999999989999999999999999999999999765543322211 11 100 0 1111 233
Q ss_pred HHHHHHHHhhcCCCCCCCCHH
Q 004732 634 VMINVALLCANASPTIRPSMS 654 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RPt~~ 654 (733)
.+.+++.+|++.||.+||++.
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 222 SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred HHHHHHHHHhhcCHHhCCCCC
Confidence 588899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=326.27 Aligned_cols=242 Identities=23% Similarity=0.346 Sum_probs=194.7
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 468 (733)
+|+..+.||+|+||+||+|. ..+|+.||+|.+.... ......+..|.++++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36677899999999999998 4578999999986531 223356778999988885 577888999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++... ..+++.++..++.|++.||+|||+.| |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~ 156 (323)
T cd05615 81 EYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV 156 (323)
T ss_pred cCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence 999999999998654 46999999999999999999999986 99999999999999999999999999875432221
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... . ... .++
T Consensus 157 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~---~-~~~----------~~p 221 (323)
T cd05615 157 -TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM---E-HNV----------SYP 221 (323)
T ss_pred -cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---h-CCC----------CCC
Confidence 2234569999999999998889999999999999999999999997665443332211 1 100 011
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMS 654 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~ 654 (733)
......+.+++.+|++.+|.+|++..
T Consensus 222 ~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 222 KSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11233578899999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=317.37 Aligned_cols=252 Identities=27% Similarity=0.411 Sum_probs=199.9
Q ss_pred hhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC------
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG------ 461 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------ 461 (733)
.+++.|...+.||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 4667888899999999999999984 568899999986543 3446788999999998 799999999998763
Q ss_pred CeEEEEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 462 NQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
...++||||+.+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 4689999999999999998753 356899999999999999999999986 999999999999999999999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHh-----hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 615 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 615 (733)
........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||.......... .. . ....
T Consensus 159 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~--~~-~-~~~~ 233 (272)
T cd06637 159 AQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF--LI-P-RNPA 233 (272)
T ss_pred eecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH--HH-h-cCCC
Confidence 76543221 233467899999999986 3458889999999999999999999995443222111 00 0 0100
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
... ... .....+.+++.+||..+|.+||++.++++
T Consensus 234 ~~~----~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 234 PRL----KSK----KWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred CCC----CCC----CcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 000 011 12235889999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=312.27 Aligned_cols=247 Identities=33% Similarity=0.535 Sum_probs=203.6
Q ss_pred CcccCCCcccEEEcccCC----CcEEEEEEccccChh-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLLAD----GTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|.... +..||+|.+...... ..+.+.+|+++++.++|+||+++++++.++...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999543 789999998765333 357889999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 474 NSLARALFEH--------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 474 gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
++|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999865 468999999999999999999999986 99999999999999999999999999986654
Q ss_pred cCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 546 ENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 546 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
... .......+++.|+|||.+....++.++||||+||++|||++ |..||............. .+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~----~~~~~~------ 227 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR----KGYRLP------ 227 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH----cCCCCC------
Confidence 321 12334567889999999988889999999999999999999 699996654433332211 111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.+......+.+++.+||+.+|++||++.|+++.|+
T Consensus 228 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 ---KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112345889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=327.86 Aligned_cols=242 Identities=26% Similarity=0.341 Sum_probs=191.6
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHH-HHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIG-MISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|+. .+++.||+|++.... ......+..|.. +++.++||||+++++++.+++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999994 467889999986432 122234455544 56788999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++... ..+++..+..++.||++||+|||+.| |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~~ 155 (325)
T cd05602 81 GELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTST 155 (325)
T ss_pred CcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCccc
Confidence 9999998754 46788899999999999999999986 9999999999999999999999999997533221 12334
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... . ... . .......
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~---~-~~~-~---------~~~~~~~ 221 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL---N-KPL-Q---------LKPNITN 221 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH---h-CCc-C---------CCCCCCH
Confidence 679999999999999899999999999999999999999997665444332211 1 100 0 0111223
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 634 VMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+.+++.+|++.+|.+||++.+.+..
T Consensus 222 ~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 222 SARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred HHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 47889999999999999998765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=313.01 Aligned_cols=249 Identities=21% Similarity=0.313 Sum_probs=202.9
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
+|...+.||+|+||.||++.. .++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 467788999999999999984 47899999988543 3334567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 472 ENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 472 ~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.++++|||.+........ .
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence 99999998864 3446899999999999999999999986 99999999999999999999999999976543222 2
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+...... .. ..+..... +..
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~---~~-~~~~~~~~---------~~~ 223 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL---KV-CQGSYKPL---------PSH 223 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH---HH-hcCCCCCC---------Ccc
Confidence 234568899999999998889999999999999999999999997654332221 11 11111111 111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+.+++.+||+.+|++||++.+++..
T Consensus 224 ~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 224 YSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred cCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 23357889999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.73 Aligned_cols=245 Identities=24% Similarity=0.301 Sum_probs=194.9
Q ss_pred ccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 395 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
|...+.||+|+||+||+|.. .+++.||+|.+.... ......+.+|++++++++|+||+++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55667899999999999984 578999999986432 22234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 157 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES- 157 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence 9999999988753 346999999999999999999999986 99999999999999999999999999975433221
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....|+..|+|||.+.+..++.++|+|||||++|||++|+.||.................... ..+..
T Consensus 158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----------~~~~~ 226 (285)
T cd05632 158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----------EVYSA 226 (285)
T ss_pred -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----------cccCc
Confidence 2345789999999999988999999999999999999999999965433221111110001000 01111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHH
Q 004732 630 EQVMVMINVALLCANASPTIRPSMS 654 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~ 654 (733)
.....+.+++..|++.+|++||++.
T Consensus 227 ~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 227 KFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred cCCHHHHHHHHHHccCCHhHcCCCc
Confidence 2233478899999999999999944
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=328.90 Aligned_cols=258 Identities=27% Similarity=0.412 Sum_probs=199.9
Q ss_pred hcCccccCcccCCCcccEEEccc------CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC-C
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG-N 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 462 (733)
.++|...+.||+|+||.||+|+. .+++.||||.+.... ......+.+|+.++.++ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35788999999999999999962 357899999987543 23345788999999999 689999999988754 5
Q ss_pred eEEEEEEccCCCCHHHHHHhcC----------------------------------------------------------
Q 004732 463 QLLLIYEYLENNSLARALFEHR---------------------------------------------------------- 484 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~---------------------------------------------------------- 484 (733)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986421
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc-cccccc
Q 004732 485 --------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH-ISTRVA 555 (733)
Q Consensus 485 --------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~ 555 (733)
..+++..+.+++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 23688889999999999999999986 999999999999999999999999999765332211 122234
Q ss_pred cCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHH
Q 004732 556 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 634 (733)
Q Consensus 556 gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (733)
+++.|+|||.+.+..++.++||||||+++|||++ |..||......... .... ..+..... + ... ...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~--~~~~-~~~~~~~~----~-~~~----~~~ 310 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRL-KEGTRMRA----P-DYT----TPE 310 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHH--HHHH-hccCCCCC----C-CCC----CHH
Confidence 5678999999988899999999999999999997 89998543221111 1111 11111111 1 111 234
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 635 MINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 635 l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
+.+++..||+.+|.+||++.||++.|+...
T Consensus 311 ~~~~~~~cl~~~p~~Rps~~eil~~l~~~~ 340 (343)
T cd05103 311 MYQTMLDCWHGEPSQRPTFSELVEHLGNLL 340 (343)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 788999999999999999999999988543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-37 Score=314.42 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=195.0
Q ss_pred CcccCCCcccEEEcccC----CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCeEEEEEEccC
Q 004732 399 NNIGEGGFGPVYKGLLA----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIE-GNQLLLIYEYLE 472 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~ 472 (733)
+.||+|+||.||+|... ++..||+|.+... .......+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 47899999999999843 2457999998543 23345678899999999999999999998764 556899999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc---
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH--- 549 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~--- 549 (733)
+|+|.+++......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 81 HGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence 99999999866666788899999999999999999886 999999999999999999999999999754332111
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCC-CCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR-SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
......++..|+|||.+.+..++.++|||||||++|||++|+ .||...+........ .. +.... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~---~~-~~~~~-----~~~~-- 226 (262)
T cd05058 158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL---LQ-GRRLL-----QPEY-- 226 (262)
T ss_pred ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---hc-CCCCC-----CCCc--
Confidence 112344677899999998889999999999999999999964 555544443333221 11 11000 0011
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
....+.+++.+||+.+|++||++.+|++.|+..
T Consensus 227 --~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 227 --CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred --CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 123588999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=311.61 Aligned_cols=251 Identities=22% Similarity=0.263 Sum_probs=203.8
Q ss_pred hcCccccCcccCCCcccEEEcccC-CCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.+.|+..+.||+|.-|+||.++.. ++..+|+|++.+. ..+...+...|.+||+.+.||.++.+|+.+..+...|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 356778889999999999999965 4589999999764 233345677799999999999999999999999999999
Q ss_pred EEccCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc-
Q 004732 468 YEYLENNSLARALF-EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE- 545 (733)
Q Consensus 468 ~e~~~~gsL~~~l~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~- 545 (733)
||||+||+|....+ +.+..+++..++.++..|+-||+|||-.| ||+|||||+|||+-++|++-|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999999988 45667999999999999999999999997 99999999999999999999999999853210
Q ss_pred --------------------------------cCc----------------------ccccccccCCCcccHHHHhhCCC
Q 004732 546 --------------------------------ENT----------------------HISTRVAGTIGYMAPEYAMRGHL 571 (733)
Q Consensus 546 --------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 571 (733)
... ..+..++||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 01223679999999999999999
Q ss_pred CccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCC
Q 004732 572 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRP 651 (733)
Q Consensus 572 ~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP 651 (733)
+.++|+|+|||++|||+.|+.||.+.+....+. .++...+.-...++.+..+.++|.+.+.+||++|.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~------------NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRl 380 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR------------NIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRL 380 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH------------HHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhh
Confidence 999999999999999999999996654332221 11222222112224445688999999999999999
Q ss_pred C----HHHHH
Q 004732 652 S----MSSVL 657 (733)
Q Consensus 652 t----~~~vl 657 (733)
. +.||-
T Consensus 381 g~~rGA~eIK 390 (459)
T KOG0610|consen 381 GSKRGAAEIK 390 (459)
T ss_pred ccccchHHhh
Confidence 8 77764
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.66 Aligned_cols=241 Identities=24% Similarity=0.349 Sum_probs=191.6
Q ss_pred CcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHH-HHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIG-MISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|+ ..+|+.||+|++... .......+..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999998 457899999998653 1223345556655 56779999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|..++... ..+++..+..++.||++||+|||+.| |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~ 155 (325)
T cd05604 81 GELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTTT 155 (325)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCccc
Confidence 9999888654 47899999999999999999999986 9999999999999999999999999987432211 12234
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||.+.+..++.++|||||||++|||++|+.||...+........ .. ... .. .. ....
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~---~~-~~~--~~----~~----~~~~ 221 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI---LH-KPL--VL----RP----GASL 221 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHH---Hc-CCc--cC----CC----CCCH
Confidence 67999999999999999999999999999999999999999766543332211 11 110 00 01 1223
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 634 VMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.+.+++.+|++.+|.+||++.+.++
T Consensus 222 ~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 222 TAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred HHHHHHHHHhccCHHhcCCCCCCHH
Confidence 4778999999999999998864443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=334.76 Aligned_cols=258 Identities=20% Similarity=0.269 Sum_probs=196.6
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
...|.+.+.||+|+||.||+|+. ..++.||||.... ..+.+|++++++++|||||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 45788999999999999999995 4578999996422 3457899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc-
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH- 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~- 549 (733)
+. ++|.+++......++|..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 242 ~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~ 317 (461)
T PHA03211 242 YR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP 317 (461)
T ss_pred cC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence 95 6888888766668999999999999999999999986 999999999999999999999999999865432221
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccc--------hhhHHHHHHHHHh-hCcccccc-
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED--------MFYLLDWALVLKE-QGKLMELV- 619 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~--------~~~~~~~~~~~~~-~~~~~~~~- 619 (733)
......||+.|+|||++.+..++.++|||||||++|||++|..|+.... ...+......... ........
T Consensus 318 ~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~ 397 (461)
T PHA03211 318 FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAG 397 (461)
T ss_pred cccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcc
Confidence 2234679999999999999999999999999999999999887663211 0111111110000 00000000
Q ss_pred -------------cCCCC---CCCC--HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 620 -------------DTNPG---SNFD--KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 620 -------------~~~~~---~~~~--~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+. ..+. ......+.+++.+|++.||.+|||+.|+++.
T Consensus 398 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 398 SRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred hHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00000 0000 0112257889999999999999999999874
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=323.30 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=204.3
Q ss_pred hcCccccCcccCCCcccEEEccc--------CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL--------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 461 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 461 (733)
.++|.+.+.||+|+||.||+|+. .....||+|.+.... ......+.+|+++++++ +||||++++++|.++
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 45778889999999999999863 134579999987542 33456788999999999 699999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe
Q 004732 462 NQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 526 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill 526 (733)
...++||||+++|+|.+++.... ..+++.++.+++.|++.||+|||+.| |+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 99999999999999999996432 35899999999999999999999986 9999999999999
Q ss_pred cCCCCeEEcccCccccCcccCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004732 527 DKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 604 (733)
Q Consensus 527 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~ 604 (733)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998654322211 112234567999999998889999999999999999999 888986554433332
Q ss_pred HHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 605 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.. ........ +......+.+++.+||+.+|++||++.++++.|++...
T Consensus 248 ~~----~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 248 LL----REGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HH----HcCCCCCC---------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 21 11111111 11122357789999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.66 Aligned_cols=251 Identities=28% Similarity=0.456 Sum_probs=204.6
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
..+|...+.||+|+||.||+|. ..+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 3578889999999999999999 467999999998765444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++++|.+++.+ ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~- 171 (297)
T cd06656 98 LAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK- 171 (297)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccC-
Confidence 999999999864 35789999999999999999999986 999999999999999999999999998765433221
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
.....|++.|+|||.+.+..++.++|||||||++|++++|+.||...+....... ......+....+..
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~-----------~~~~~~~~~~~~~~ 240 (297)
T cd06656 172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL-----------IATNGTPELQNPER 240 (297)
T ss_pred cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee-----------eccCCCCCCCCccc
Confidence 2334688999999999988899999999999999999999999965433211100 00000111111222
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+.+++.+||+.+|++||++.++++.
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 241 LSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 33457889999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=323.69 Aligned_cols=251 Identities=24% Similarity=0.343 Sum_probs=209.5
Q ss_pred hcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccChh---cHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQ---GNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 466 (733)
...|...+.||+|.||.||+++.. +|+.+|+|.+.+.... ....+.+|+++|+++. |||||.+.++|.+....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 345677789999999999999954 5999999999765332 3458899999999998 9999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC----CCeEEcccCcccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD----LNSKISDFGLAKL 542 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~----~~~kl~DfGla~~ 542 (733)
|||++.||.|.+.+... .+++..+..++.|++.|+.|||+.| |+|||+||+|+|+... +.+|++|||+|..
T Consensus 114 vmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~ 188 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF 188 (382)
T ss_pred EEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence 99999999999999766 3999999999999999999999986 9999999999999643 4799999999998
Q ss_pred CcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
... .......+||++|+|||++....|+..+||||+||++|.|++|..||..+.......-+ ..++. -++
T Consensus 189 ~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i----~~~~~--~f~-- 258 (382)
T KOG0032|consen 189 IKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI----LRGDF--DFT-- 258 (382)
T ss_pred ccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH----HcCCC--CCC--
Confidence 766 33455688999999999999899999999999999999999999999877654433211 11111 111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...-......+.+++..++..||.+|+|+.++++.
T Consensus 259 --~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 259 --SEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred --CCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11222334568889999999999999999999985
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=317.59 Aligned_cols=253 Identities=26% Similarity=0.430 Sum_probs=205.4
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.++|.+.+.||+|+||.||+|.. .++..||+|.+........+.|.+|++++++++||||+++++++.++...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 45688889999999999999995 46899999998766655667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........ .
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-K 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-c
Confidence 9999999999876668999999999999999999999986 99999999999999999999999999875433222 1
Q ss_pred ccccccCCCcccHHHHhh-----CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 551 STRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.....|++.|+|||.+.. ..++.++|||||||++|||++|+.||...+...... .. ........
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~---~~-~~~~~~~~------- 228 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLL---KI-LKSEPPTL------- 228 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHH---HH-hcCCCCCc-------
Confidence 233568999999999853 447789999999999999999999996654332211 11 11111000
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..+......+.+++.+||+.+|.+||++.++++.
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0111123357889999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=329.50 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=203.9
Q ss_pred cccCcccCCCcccEEEcccC--CCc--EEEEEEccccChh-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 396 ATDNNIGEGGFGPVYKGLLA--DGT--AIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
...++||+|.||.|++|.|. .|+ .||||.+...... ...+|.+|+.+|.+|+|||+|++||+..+ ....+|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 34578999999999999975 454 6899999876544 56789999999999999999999999987 778999999
Q ss_pred cCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
++.|+|.+.|+. ....|-......++.|||.||.||..++ .||||+..+|+|+-..-.|||+|||+.+-.+.....
T Consensus 192 aplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 192 APLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred cccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999986 5557888999999999999999999986 999999999999999889999999999976654333
Q ss_pred c--ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 550 I--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 550 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
. .....-.+.|+|||.+....++.++|||+|||++|||+| |+.||.+.....++.-+ |......
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~i-------------D~~erLp 335 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNI-------------DAGERLP 335 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhc-------------cccccCC
Confidence 2 112223568999999999999999999999999999998 78999877766655322 1111112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVL 657 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl 657 (733)
-+..+.+.++++++.||..+|.+||||..|.
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair 366 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIR 366 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHH
Confidence 2333556799999999999999999999997
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=311.92 Aligned_cols=253 Identities=26% Similarity=0.419 Sum_probs=206.3
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
++|...+.||+|+||.||+|.. .+++.+|+|.+........+.+.+|++++++++||||+++++++.++...+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 5678889999999999999985 567899999987655555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ..
T Consensus 83 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 158 (262)
T cd06613 83 GGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-KR 158 (262)
T ss_pred CCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-cc
Confidence 999999998776568999999999999999999999986 99999999999999999999999999876543221 12
Q ss_pred cccccCCCcccHHHHhhC---CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 552 TRVAGTIGYMAPEYAMRG---HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
....++..|+|||.+.+. .++.++|||||||++|||++|+.||........... . ..... . .......
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~---~-~~~~~----~-~~~~~~~ 229 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL---I-SKSNF----P-PPKLKDK 229 (262)
T ss_pred ccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---H-HhccC----C-Cccccch
Confidence 335688899999999776 789999999999999999999999965433221110 0 00100 0 0011112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
......+.+++.+||+.+|.+||++.+|+.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 233456889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=316.35 Aligned_cols=240 Identities=25% Similarity=0.435 Sum_probs=191.4
Q ss_pred CcccCCCcccEEEcccCC--------CcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 399 NNIGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+.||+|+||.||+|.... ...||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998532 234888888655444556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC--------eEEcccCcccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN--------SKISDFGLAKL 542 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~--------~kl~DfGla~~ 542 (733)
+++|+|.+++......+++..+.+++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++..
T Consensus 81 ~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 81 VKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred CCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999876667999999999999999999999986 999999999999987765 69999999865
Q ss_pred CcccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCC-CCCCccchhhHHHHHHHHHhhCccccccc
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGR-SNVTKEDMFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
.... ....+++.|+|||.+.+. .++.++|||||||++|||++|. .|+...+...... ..... ...
T Consensus 158 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~---~~~~~---~~~-- 224 (258)
T cd05078 158 VLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ---FYEDR---HQL-- 224 (258)
T ss_pred cCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH---HHHcc---ccC--
Confidence 4321 235678899999999864 5899999999999999999995 5554333222111 11110 011
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
+......+.+++.+||+.+|++|||++++++.|+
T Consensus 225 -------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 225 -------PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred -------CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1111234889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=312.00 Aligned_cols=238 Identities=27% Similarity=0.453 Sum_probs=190.7
Q ss_pred CcccCCCcccEEEcccCCCc-----------EEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 399 NNIGEGGFGPVYKGLLADGT-----------AIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
+.||+|+||.||+|...+.. .|++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999965433 5788877654332 6788999999999999999999999988 778999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-------CeEEcccCcc
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-------NSKISDFGLA 540 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-------~~kl~DfGla 540 (733)
|||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++
T Consensus 79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 9999999999999866557999999999999999999999886 99999999999999887 7999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhhC--CCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLME 617 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 617 (733)
..... .....++..|+|||++... .++.++|||||||++|||++ |..||..........+ ... ....
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~---~~~-~~~~- 225 (259)
T cd05037 156 ITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF---YQD-QHRL- 225 (259)
T ss_pred ccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHH---Hhc-CCCC-
Confidence 75443 1224567789999999876 78999999999999999999 5777744332211111 111 1000
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 618 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
+.+. ...+.+++.+||..+|++||++.+|++.|+
T Consensus 226 ---~~~~-------~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 226 ---PMPD-------CAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ---CCCC-------chHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 145889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=315.39 Aligned_cols=253 Identities=30% Similarity=0.453 Sum_probs=199.3
Q ss_pred ccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcH--HHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 395 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
|+..+.||+|+||+||+|+. .+++.||+|.+........ ....+|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 45678999999999999994 5677999999977643322 23456999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
++++|.+++. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.++|+|||.+..... .....
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNENF 155 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSEB
T ss_pred cccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccccc
Confidence 9999999997 3457899999999999999999999986 99999999999999999999999999975421 22233
Q ss_pred cccccCCCcccHHHHh-hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 552 TRVAGTIGYMAPEYAM-RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
....++..|+|||.+. +..++.++||||+|+++|+|++|+.||................. .... ....... .
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~---~ 228 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK-RPLP---SSSQQSR---E 228 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH-THHH---HHTTSHT---T
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc-cccc---ccccccc---h
Confidence 4567899999999998 78899999999999999999999999976522221111111110 0000 0000000 0
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+.+++.+|++.||++||++.++++.
T Consensus 229 ~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 229 KSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp SHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred hHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01468999999999999999999999763
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=311.18 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=189.9
Q ss_pred CcccCCCcccEEEcccCC---CcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCC
Q 004732 399 NNIGEGGFGPVYKGLLAD---GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 474 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 474 (733)
+.||+|+||.||+|...+ ...+|+|.+.... ......|.+|+++++.++||||++++++|.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997433 3578888876442 233457889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc-
Q 004732 475 SLARALFEHR----LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH- 549 (733)
Q Consensus 475 sL~~~l~~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~- 549 (733)
+|.+++.... ...++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 9999997543 23567888999999999999999986 999999999999999999999999998754332211
Q ss_pred cccccccCCCcccHHHHhh-------CCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 550 ISTRVAGTIGYMAPEYAMR-------GHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
......+++.|+|||++.. ..++.++|||||||++|||++ |..||............ . . ........+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~-~-~~~~~~~~~ 233 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV--V-R-EQDIKLPKP 233 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH--h-h-ccCccCCCC
Confidence 1223446778999999753 356889999999999999999 77788554333222111 1 1 111111121
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.. +......+.+++..|| .||++||++++|++.|.
T Consensus 234 ~~----~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 234 QL----DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cc----cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11 1122334667888999 59999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.73 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=201.0
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.++|...+.||+|+||.||+|+ ..+++.||+|.++.........+.+|+.+++.++||||+++++++..++..++||||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 3577788899999999999998 457899999998765444456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++++|.+++... ..+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....... ..
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~ 162 (267)
T cd06645 88 CGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK 162 (267)
T ss_pred cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence 9999999988654 47899999999999999999999986 9999999999999999999999999987554321 12
Q ss_pred ccccccCCCcccHHHHh---hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 551 STRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.||.......... . ............. ...+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-~--~~~~~~~~~~~~~--~~~~ 237 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-L--MTKSNFQPPKLKD--KMKW 237 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-h--hhccCCCCCcccc--cCCC
Confidence 23456899999999985 4568899999999999999999999985443221110 0 0000000000000 0112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+.+++.+|++.+|++||++.+|++.
T Consensus 238 ----~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 238 ----SNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ----CHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 2347889999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=318.05 Aligned_cols=252 Identities=27% Similarity=0.427 Sum_probs=203.1
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
+.|++.+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+++++.++||||+++++++..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 5678889999999999999995 468999999997766666678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
++++|..++.+....+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 92 ~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~~~ 167 (292)
T cd06644 92 PGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-QRR 167 (292)
T ss_pred CCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-ccc
Confidence 999999988766668999999999999999999999986 9999999999999999999999999987533221 112
Q ss_pred cccccCCCcccHHHHh-----hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 552 TRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
....+++.|+|||++. ...++.++|||||||++|||++|+.||...+..... .... ....... .
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~-~~~~~~~-------~ 236 (292)
T cd06644 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL---LKIA-KSEPPTL-------S 236 (292)
T ss_pred ceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHH---HHHh-cCCCccC-------C
Confidence 3356888999999884 345788999999999999999999999654432211 1111 1111000 0
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+......+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 111223357889999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=323.70 Aligned_cols=241 Identities=23% Similarity=0.307 Sum_probs=190.1
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++.++ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999984 567899999997542 22345678899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTST 155 (327)
T ss_pred CcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cceec
Confidence 9999888654 47999999999999999999999986 9999999999999999999999999987432211 12234
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccc---hhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED---MFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
..||+.|+|||++.+..++.++|||||||++|||++|+.||.... .....++.......... ..+..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p~~ 225 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIPRF 225 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCCCC
Confidence 679999999999999999999999999999999999999994321 11111111111111110 01111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHH
Q 004732 631 QVMVMINVALLCANASPTIRPSMS 654 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~ 654 (733)
....+.+++.+|++.||.+|+++.
T Consensus 226 ~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 226 LSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCC
Confidence 223478899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=318.39 Aligned_cols=246 Identities=23% Similarity=0.388 Sum_probs=196.5
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
+|...+.||+|+||.||+|+ ..+++.||+|.+... .......+.+|++++++++||||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 56778899999999999998 467899999998654 2334467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
++++|..+ ..+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++...... ..
T Consensus 82 ~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~~ 150 (279)
T cd06619 82 DGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IA 150 (279)
T ss_pred CCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---cc
Confidence 99999755 25788999999999999999999986 999999999999999999999999999754332 12
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhh----HHHHHHHHHhhCcccccccCCCCCCC
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY----LLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||....... ...+........ ... .+...
T Consensus 151 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~- 224 (279)
T cd06619 151 KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-PPV----LPVGQ- 224 (279)
T ss_pred cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-CCC----CCCCc-
Confidence 33578999999999998889999999999999999999999995422110 011111110000 000 01111
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+.+++.+|++.+|++||++.|+++.
T Consensus 225 ---~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 225 ---FSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 22347899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=331.86 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=195.1
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|+..+.||+|+||.||+|+. .+++.||||.+... .......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3678889999999999999984 56899999998643 2223456788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 81 EFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred eCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999998654 46899999999999999999999986 99999999999999999999999999874422100
Q ss_pred ----------------------------------ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCC
Q 004732 549 ----------------------------------HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 594 (733)
Q Consensus 549 ----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~ 594 (733)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0012357999999999999999999999999999999999999999
Q ss_pred CccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC---HHHHHH
Q 004732 595 TKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPS---MSSVLR 658 (733)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt---~~~vl~ 658 (733)
...+......-. ......... + .....+ ..+.+++.+++ .+|.+|++ +.++++
T Consensus 237 ~~~~~~~~~~~i---~~~~~~~~~--p-~~~~~s----~~~~~li~~l~-~~p~~R~~~~~~~ei~~ 292 (360)
T cd05627 237 CSETPQETYRKV---MNWKETLVF--P-PEVPIS----EKAKDLILRFC-TDSENRIGSNGVEEIKS 292 (360)
T ss_pred CCCCHHHHHHHH---HcCCCceec--C-CCCCCC----HHHHHHHHHhc-cChhhcCCCCCHHHHhc
Confidence 765543322111 110000011 0 111122 23666666665 49999996 555543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=325.67 Aligned_cols=258 Identities=27% Similarity=0.434 Sum_probs=204.3
Q ss_pred hcCccccCcccCCCcccEEEcccC--------CCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA--------DGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 461 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 461 (733)
..+|.+.+.||+|+||.||+|+.. .+..||+|.+.... ....+++.+|+++++++ +||||++++++|.++
T Consensus 11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 346788899999999999999732 12368999887542 33456789999999999 799999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe
Q 004732 462 NQLLLIYEYLENNSLARALFEH---------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 526 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill 526 (733)
+..++|+||+++|+|.+++... ...+++.++..++.|++.||+|||+.+ |+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence 9999999999999999999742 235889999999999999999999986 9999999999999
Q ss_pred cCCCCeEEcccCccccCcccCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004732 527 DKDLNSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 604 (733)
Q Consensus 527 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~ 604 (733)
+.++.+||+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 247 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 247 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999998654322211 122234568999999999899999999999999999998 888886554333222
Q ss_pred HHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 605 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
. .. .+..... +......+.+++.+||+.+|.+||++.|+++.|+....
T Consensus 248 ~---~~-~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 248 L---LK-EGHRMDK---------PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred H---HH-cCCCCCC---------CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1 11 1111111 11122358899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=310.03 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=205.4
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|+..+.||+|+||.||.++ ..+++.+++|.+... .......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 46778999999999999998 567899999987643 344456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
+++++|.+++... ...+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999754 456899999999999999999999886 99999999999999999999999999986544332
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
......|++.|+|||...+..++.++||||||+++|||++|+.||........... .. .+..... ..
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~---~~-~~~~~~~---------~~ 223 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK---IV-QGNYTPV---------VS 223 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HH-cCCCCCC---------cc
Confidence 22345689999999999888899999999999999999999999966544332221 11 1111111 11
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRML 660 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 660 (733)
.....+.+++.+||+.+|.+||++.++++.+
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 2234588899999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=320.61 Aligned_cols=255 Identities=26% Similarity=0.454 Sum_probs=202.7
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCc----EEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGT----AIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
.++|+..+.||+|+||.||+|+. .+|. .||+|.+.... .....++.+|+.+++.++||||++++++|..+ ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 35678889999999999999984 3444 57889886542 23345788999999999999999999998754 467
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+|+||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999999876667899999999999999999999986 99999999999999999999999999986543
Q ss_pred cCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 546 ENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 546 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
..... .....++..|+|||.+.+..++.++|||||||++||+++ |+.||.........++.. .+.... .
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~----~~~~~~-----~ 232 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE----KGERLP-----Q 232 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH----CCCCCC-----C
Confidence 22211 222345778999999988899999999999999999997 899996554333333221 111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
... ....+.+++..||..+|++||++.++++.|+.+
T Consensus 233 ~~~----~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 233 PPI----CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 011 123578899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.33 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=196.6
Q ss_pred ccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 395 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
|+..+.||+|+||.||+|. ..+++.||||.+.... ......+.+|+.++++++|++|+++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 5667889999999999998 4578999999986432 22234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~- 157 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT- 157 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence 9999999988643 346899999999999999999999886 99999999999999999999999999875443222
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhH-HHHHHHHHhhCcccccccCCCCCCCC
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL-LDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
.....|+..|+|||.+.+..++.++|||||||++|||++|+.||........ ........ .... .....+
T Consensus 158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~---~~~~----~~~~~~- 228 (285)
T cd05630 158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK---EVQE----EYSEKF- 228 (285)
T ss_pred -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh---hhhh----hcCccC-
Confidence 1234689999999999998999999999999999999999999964322111 11110000 0000 011112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPS-----MSSVLR 658 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 658 (733)
...+.+++.+||+.||++||+ +.|+++
T Consensus 229 ---~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 229 ---SPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred ---CHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 234788999999999999999 777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=316.42 Aligned_cols=255 Identities=24% Similarity=0.384 Sum_probs=203.5
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|+..+.||+|+||+||+|. ..+|+.||+|.+.... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 3567788999999999999998 4568999999876542 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++++|.+++... ..+++..+..++.+++.||.|||+.. +++||||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 84 FMDCGSLDRIYKKG-GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred cCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999988654 46899999999999999999999742 49999999999999999999999999986543221
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchh--------hHHHHHHHHHhhCcccccccC
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF--------YLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~ 621 (733)
.....|+..|+|||.+.+..++.++|||||||++||+++|+.||...... ...++........
T Consensus 159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 229 (284)
T cd06620 159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-------- 229 (284)
T ss_pred -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc--------
Confidence 12356899999999998888999999999999999999999999643321 1112211111100
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
............+.+++.+|++.||++||++.|++++..
T Consensus 230 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 230 -PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred -CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 000001113345889999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.17 Aligned_cols=260 Identities=22% Similarity=0.299 Sum_probs=197.7
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------ 461 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 461 (733)
..++|...+.||+|+||.||+|.. ..++.||||.+... .......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 346888999999999999999984 56899999998653 223346778899999999999999999998643
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 462 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
...++||||+++ ++.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~ 167 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccc
Confidence 357999999976 5666654 25889999999999999999999986 9999999999999999999999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHH------------
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVL------------ 609 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~------------ 609 (733)
...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+...........
T Consensus 168 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (355)
T cd07874 168 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_pred cCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 644321 223457899999999999889999999999999999999999999665433221111000
Q ss_pred -------Hhh-CcccccccC-----CC---CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 610 -------KEQ-GKLMELVDT-----NP---GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 610 -------~~~-~~~~~~~~~-----~~---~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
... ........+ .. ...........+.+++.+|++.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000 000000000 00 000111123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=327.70 Aligned_cols=259 Identities=24% Similarity=0.326 Sum_probs=196.0
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC------
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN------ 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 462 (733)
.++|...+.||+|+||.||+|+. .+|..||||.+... .......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46788899999999999999984 56899999998643 2334467889999999999999999999986543
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~ 172 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 172 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccc
Confidence 57999999976 4655553 25788999999999999999999986 99999999999999999999999999975
Q ss_pred CcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHH--------------
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALV-------------- 608 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~-------------- 608 (733)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..........
T Consensus 173 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 173 ACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred cccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 43321 22345689999999999998999999999999999999999999965543221110000
Q ss_pred -----HHhhC-ccc-----ccccCC---CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 609 -----LKEQG-KLM-----ELVDTN---PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 609 -----~~~~~-~~~-----~~~~~~---~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..... ... +....- ............+.+++.+|++.||++|||+.|+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 000 000000 0000011123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=310.15 Aligned_cols=247 Identities=28% Similarity=0.438 Sum_probs=198.7
Q ss_pred ccccCcccCCCcccEEEccc-CCCcEEEEEEccccChh---------cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 395 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ---------GNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
|.....||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|++++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 56778999999999999984 56889999988654221 124678899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||+++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 9999999999999999654 46899999999999999999999986 9999999999999999999999999998654
Q ss_pred ccCcc-----cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccc
Q 004732 545 EENTH-----ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 619 (733)
Q Consensus 545 ~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (733)
..... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+....... . .. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~-~~-----~~ 228 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK---I-GE-----NA 228 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHH---H-hc-----cC
Confidence 22111 11234588999999999988899999999999999999999999965433221110 0 00 01
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 620 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.+.. +......+.+++.+||+.+|.+||++.+|++
T Consensus 229 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 229 SPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 1122345888999999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=314.34 Aligned_cols=255 Identities=27% Similarity=0.475 Sum_probs=204.5
Q ss_pred cCccccCcccCCCcccEEEcccC-CCc----EEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGT----AIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.+|...+.||+|+||.||+|... +|. .||+|.+.... ......+.+|++++++++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 46778899999999999999853 333 58999886553 3344678899999999999999999999987 78899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 86 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred EEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 99999999999999876667999999999999999999999986 999999999999999999999999999866533
Q ss_pred Cccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 547 NTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 547 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
.... .....++..|+|||.+....++.++|+|||||++||+++ |+.||............ . .+... +.+
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~-~~~~~----~~~- 233 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL---E-KGERL----PQP- 233 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---h-CCCCC----CCC-
Confidence 2221 112224568999999988889999999999999999998 99999665443333221 1 11110 000
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.. ....+.+++.+||..+|.+||++.++++.|+...
T Consensus 234 ~~----~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 234 PI----CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11 1234788999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=314.82 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=202.8
Q ss_pred cCccccCcccCCCcccEEEcccC------CCcEEEEEEccccChh-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
++|.....||+|+||.||+|+.. +.+.||+|.+...... ....+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778889999999999999853 3467999988654333 3467999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEccc
Q 004732 466 LIYEYLENNSLARALFEHR--------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 537 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 537 (733)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997433 25899999999999999999999986 999999999999999999999999
Q ss_pred CccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCccc
Q 004732 538 GLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLM 616 (733)
Q Consensus 538 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 616 (733)
|++...............++..|+|||.+.+..++.++||||||+++|++++ |..||............ ..+...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~----~~~~~~ 237 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL----QAGKLE 237 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH----HcCCcC
Confidence 9987543332222333456778999999988889999999999999999999 78888543332222211 111111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.. ....+ ...+.+++.+||+.+|++||++.|+++.|.
T Consensus 238 -~~---~~~~~----~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 238 -LP---VPEGC----PSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CC---CCCCC----CHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 01112 235889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=348.99 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=199.9
Q ss_pred hHHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe--C
Q 004732 387 QIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE--G 461 (733)
Q Consensus 387 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~ 461 (733)
......++|.+.+.||+|+||+||+|+. .++..||+|.+... .......|..|+.++++++|||||+++++|.+ .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3345567899999999999999999994 56788999988643 23345678999999999999999999999865 3
Q ss_pred CeEEEEEEccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCC----CCeecCCCCCCcEEecCC-----
Q 004732 462 NQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESR----IKVVHRDIKATNVLLDKD----- 529 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~ivH~Dik~~Nill~~~----- 529 (733)
..+++||||+++|+|.++|... ...+++..++.|+.||+.||+|||+.+. .+||||||||+|||++.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5689999999999999998642 3479999999999999999999998542 349999999999999642
Q ss_pred ------------CCeEEcccCccccCcccCcccccccccCCCcccHHHHhh--CCCCccchhHhHHHHHHHHHhCCCCCC
Q 004732 530 ------------LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVT 595 (733)
Q Consensus 530 ------------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~p~~ 595 (733)
+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 348999999998654322 2234579999999999864 458999999999999999999999996
Q ss_pred ccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 596 KEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
..+..... ...... .. .. +.... ...+.+++..||+.+|.+||++.|++.
T Consensus 245 ~~~~~~ql--i~~lk~-~p--~l----pi~~~----S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANNFSQL--ISELKR-GP--DL----PIKGK----SKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCcHHHH--HHHHhc-CC--CC----CcCCC----CHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 54332211 111111 10 00 00111 234888999999999999999999983
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.04 Aligned_cols=247 Identities=30% Similarity=0.492 Sum_probs=197.3
Q ss_pred CcccCCCcccEEEcccCC-------CcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 399 NNIGEGGFGPVYKGLLAD-------GTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+.||+|+||.||+|+..+ +..||||.+.... ......+.+|+++++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998542 2579999886542 23456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-----CeEEcccCc
Q 004732 471 LENNSLARALFEH------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-----NSKISDFGL 539 (733)
Q Consensus 471 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-----~~kl~DfGl 539 (733)
+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999999742 235789999999999999999999886 99999999999999877 899999999
Q ss_pred cccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccc
Q 004732 540 AKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLME 617 (733)
Q Consensus 540 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 617 (733)
++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||...+........ ..+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~----~~~~~~~ 233 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV----TAGGRLQ 233 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH----hcCCccC
Confidence 975533221 11223345778999999999999999999999999999998 99999655443333221 1111110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 618 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 234 ---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 234 ---------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ---------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 11122345789999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=316.31 Aligned_cols=259 Identities=24% Similarity=0.332 Sum_probs=193.4
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh--hcHHHHHHHHHHHHhC---CCCceeeEeeEEEe-----CC
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISAL---QHPNLVKLYGCCIE-----GN 462 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 462 (733)
+|...+.||+|+||+||+|+. .+++.||+|.+..... .....+.+|+++++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 467788999999999999984 5789999998865321 2224556777776665 79999999999864 34
Q ss_pred eEEEEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 463 QLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
..++||||+.+ +|.+++... ...+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccc
Confidence 57999999985 888888643 345899999999999999999999986 9999999999999999999999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh---Ccccc-
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ---GKLME- 617 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~- 617 (733)
....... .....||..|+|||++.+..++.++||||+||++|||++|+.||.................. .....
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 6543221 23456899999999999889999999999999999999999999655433222111111000 00000
Q ss_pred ------cccCCCC---CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 618 ------LVDTNPG---SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 618 ------~~~~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+... ....++....+.+++.+|++.||++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000 0001122345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=311.81 Aligned_cols=248 Identities=30% Similarity=0.460 Sum_probs=202.7
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
+|...+.||.|+||.||+|+. .+++.||+|.+.... ......+.+|+++++.++|+||+++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 577888999999999999994 478999999986543 333467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
++++|.+++... .+++..+..++.|++.|+.|||+.+ ++||||+|+||++++++.++|+|||+++....... ..
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 155 (274)
T cd06609 82 GGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-KR 155 (274)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-cc
Confidence 999999998654 7899999999999999999999986 99999999999999999999999999986654322 22
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
....|+..|+|||.+.+..++.++|||||||++|||++|+.||...+...... .. ......... .. ..
T Consensus 156 ~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~---~~-~~~~~~~~~-----~~---~~ 223 (274)
T cd06609 156 NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF---LI-PKNNPPSLE-----GN---KF 223 (274)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH---Hh-hhcCCCCCc-----cc---cc
Confidence 33568889999999998889999999999999999999999996544322111 00 111111111 11 02
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+.+++.+||..+|++||+++++++.
T Consensus 224 ~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 224 SKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 3348889999999999999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=315.20 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=204.5
Q ss_pred cCccccCcccCCCcccEEEcccC-----CCcEEEEEEccccChh-cHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-----DGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIE--GNQL 464 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 464 (733)
++|...+.||+|+||.||+|++. +++.||||.+...... ....|.+|+++++.++||||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35667789999999999999853 3689999998765442 45789999999999999999999999987 5678
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||+++++|.+++......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 9999999999999999876667999999999999999999999986 9999999999999999999999999998765
Q ss_pred ccCccc--ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhh------------HHHHHHHHH
Q 004732 545 EENTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY------------LLDWALVLK 610 (733)
Q Consensus 545 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~------------~~~~~~~~~ 610 (733)
...... .....++..|+|||.+....++.++||||||+++|||++|+.|+....... ...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 322211 112345667999999988889999999999999999999999984322111 111111111
Q ss_pred hhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 611 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
... ....+......+.+++.+||+.+|++||++.||+++|+.+
T Consensus 241 -~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 241 -EGE---------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred -cCC---------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 110 0011111224588999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=317.87 Aligned_cols=261 Identities=20% Similarity=0.328 Sum_probs=200.2
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++|...+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+++++.++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4678889999999999999985 468899999986442 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
++ ++|.+++......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 86 ~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~- 160 (301)
T cd07873 86 LD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT- 160 (301)
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCc-
Confidence 97 5899988776667899999999999999999999986 999999999999999999999999999754332221
Q ss_pred ccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh---Cccccccc------
Q 004732 551 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ---GKLMELVD------ 620 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~------ 620 (733)
.....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+.............. ........
T Consensus 161 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (301)
T cd07873 161 YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240 (301)
T ss_pred ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccc
Confidence 2234578899999998764 5888999999999999999999999665443322211111000 00000000
Q ss_pred ---CCCCCC----CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 621 ---TNPGSN----FDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 621 ---~~~~~~----~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+..... ........+.+++.+|++.||.+|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000 00112235788999999999999999999976
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=308.43 Aligned_cols=249 Identities=33% Similarity=0.553 Sum_probs=202.5
Q ss_pred cccCcccCCCcccEEEcccCC-----CcEEEEEEccccChh-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 396 ATDNNIGEGGFGPVYKGLLAD-----GTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
...+.||+|+||.||+|+..+ +..||+|.+...... ..+.+.+|++++..++|+||+++++++.+.+..++|||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999998543 388999999665332 46788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 470 YLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~-l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
|+++++|.+++...... +++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 82 YMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred ccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999754434 999999999999999999999986 99999999999999999999999999986654433
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.......+++.|+|||.+....++.++||||+|++++||++ |+.||...+........ ..+.....
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~~--------- 225 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYL----KKGYRLPK--------- 225 (258)
T ss_pred cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----hcCCCCCC---------
Confidence 22222347789999999988889999999999999999998 78888654443333322 11111111
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRML 660 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 660 (733)
.......+.+++.+|+..+|++|||+.|+++.|
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 226 PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111234588899999999999999999998864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=316.58 Aligned_cols=250 Identities=28% Similarity=0.473 Sum_probs=204.2
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
.+|...+.||.|+||.||+|+ ..+++.||+|.+..........+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 468888999999999999998 5678999999987655445677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
++++|.+++... .+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+||+|||++......... .
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~-~ 172 (296)
T cd06655 99 AGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK-R 172 (296)
T ss_pred CCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc-C
Confidence 999999988643 5899999999999999999999986 999999999999999999999999998755433221 2
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
....|+..|+|||.+.+..++.++|||||||++|++++|+.||...+........ .. ...... ..+...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~---~~-~~~~~~-------~~~~~~ 241 (296)
T cd06655 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---AT-NGTPEL-------QNPEKL 241 (296)
T ss_pred CCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh-cCCccc-------CCcccC
Confidence 3356889999999998888999999999999999999999999665443222111 11 111000 011112
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+.+++.+||+.+|++||++.++++.
T Consensus 242 ~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 242 SPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 2347789999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=309.07 Aligned_cols=250 Identities=27% Similarity=0.449 Sum_probs=200.5
Q ss_pred CccccCcccCCCcccEEEcccCCCcEEEEEEccccC------hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS------KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
+|...+.||+|+||+||+|...+++.+|||.+.... ......+.+|++++++++|+||++++++|.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 467788999999999999998889999999886432 12235688899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
+||+++++|.+++.+. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 9999999999999654 36899999999999999999999886 9999999999999999999999999987543211
Q ss_pred -----cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 548 -----THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 548 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
........|+..|+|||.+.+..++.++|||||||++||+++|+.||...+........ ....... +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~-----~~ 229 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI--GAHRGLM-----PR 229 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh--hhccCCC-----CC
Confidence 11123356899999999999888999999999999999999999999654332211110 0010111 11
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
... .....+.+++.+||+.+|.+||++.++++
T Consensus 230 ~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 230 LPD----SFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC----CCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 12344788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=326.43 Aligned_cols=259 Identities=20% Similarity=0.290 Sum_probs=197.1
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------C
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------N 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 462 (733)
.++|...+.||+|+||.||+|. ...++.||||++... .......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4678889999999999999998 456889999998653 233346788999999999999999999987643 3
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 103 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~ 175 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 175 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccc
Confidence 57999999976 6766664 25789999999999999999999986 99999999999999999999999999986
Q ss_pred CcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh-----------
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE----------- 611 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~----------- 611 (733)
..... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+.............
T Consensus 176 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 176 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred cCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 54322 22345689999999999999999999999999999999999999966544332211110000
Q ss_pred ---------hCcccc-----cccCCC---CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 612 ---------QGKLME-----LVDTNP---GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 612 ---------~~~~~~-----~~~~~~---~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...... ...... ...........+.+++.+|++.||.+|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 000000 000011122357899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=310.13 Aligned_cols=251 Identities=24% Similarity=0.405 Sum_probs=189.2
Q ss_pred CcccCCCcccEEEcccCCC---cEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCC
Q 004732 399 NNIGEGGFGPVYKGLLADG---TAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 474 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 474 (733)
+.||+|+||+||+|...++ ..+++|.+.... ......|.+|+.+++.++||||++++++|.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999975433 356677765432 334568999999999999999999999999999999999999999
Q ss_pred CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC-ccc
Q 004732 475 SLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN-THI 550 (733)
Q Consensus 475 sL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~-~~~ 550 (733)
+|.+++.+. ....++..+..++.||++||+|||+.+ ++||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999753 234677788899999999999999886 9999999999999999999999999986432211 112
Q ss_pred ccccccCCCcccHHHHhh-------CCCCccchhHhHHHHHHHHHhC-CCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 551 STRVAGTIGYMAPEYAMR-------GHLTEKADVYSFGIVALEIVSG-RSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
.....|+..|+|||++.. ..++.++|||||||++|||+++ ..||............ . .+......++.
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~--~--~~~~~~~~~~~ 233 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV--I--KDQQVKLFKPQ 233 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--H--hhcccccCCCc
Confidence 234567889999998753 2457899999999999999974 6677544433222211 1 11112223332
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
....+. ..+.+++..|| .+|++||++.+|++.|.
T Consensus 234 ~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 234 LELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred cCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222222 34777888999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=325.00 Aligned_cols=193 Identities=23% Similarity=0.340 Sum_probs=167.4
Q ss_pred hhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
....+|...+.||+|+||.||+|+. .+++.||+|..... ....|+.++++++||||+++++++.++...++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3456799999999999999999995 45788999975332 2356899999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+. ++|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 137 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 211 (357)
T PHA03209 137 PHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP- 211 (357)
T ss_pred EccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence 9995 5888888776678999999999999999999999986 9999999999999999999999999997533221
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 594 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~ 594 (733)
......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 123456899999999999989999999999999999999976665
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=310.08 Aligned_cols=252 Identities=27% Similarity=0.478 Sum_probs=201.1
Q ss_pred CccccCcccCCCcccEEEcccCC--CcEEEEEEcccc----------ChhcHHHHHHHHHHHHh-CCCCceeeEeeEEEe
Q 004732 394 NFATDNNIGEGGFGPVYKGLLAD--GTAIAVKQLSSK----------SKQGNREFINEIGMISA-LQHPNLVKLYGCCIE 460 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 460 (733)
+|+..+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999654 788999987532 12223557788888875 799999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEccc
Q 004732 461 GNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 537 (733)
Q Consensus 461 ~~~~~lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 537 (733)
++..++||||+++++|.+++. .....+++..+++++.|++.||.|||+.. +++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999999875 34557899999999999999999999632 4999999999999999999999999
Q ss_pred CccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccc
Q 004732 538 GLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME 617 (733)
Q Consensus 538 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 617 (733)
|.+....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...+....... ... ....
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~---~~~-~~~~- 231 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK---IVE-AVYE- 231 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHH---Hhh-ccCC-
Confidence 9998654432 23345689999999999988899999999999999999999999965543332221 111 1111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 618 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
+.....+ ...+.+++.+||+.||++||++.|+..+++
T Consensus 232 ---~~~~~~~----~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 232 ---PLPEGMY----SEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---cCCcccC----CHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 1111111 235888999999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=308.44 Aligned_cols=249 Identities=27% Similarity=0.394 Sum_probs=195.0
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-----hhcHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-----KQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQL 464 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 464 (733)
.+|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999984 568999999875431 1233568889999999999999999999876 3678
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++++||+++++|.+++.... .+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 89999999999999997543 6899999999999999999999886 9999999999999999999999999997543
Q ss_pred ccCc--ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 545 EENT--HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 545 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
.... .......++..|+|||.+.+..++.++|||||||++||+++|+.||...+...... ....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~---~~~~~~~-----~-- 227 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF---KIATQPT-----N-- 227 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH---HHhcCCC-----C--
Confidence 3211 11223558899999999998889999999999999999999999996543221111 0000000 1
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+......+.+++ +||..+|++||+++||++
T Consensus 228 --~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 228 --PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred --CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 111222233455665 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=328.65 Aligned_cols=258 Identities=18% Similarity=0.230 Sum_probs=197.1
Q ss_pred hcCccccCcccCCCcccEEEcccC---CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
..+|...+.||+|+||.||+|... .+..||+|.+... ..+.+|++++++++|||||++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357889999999999999999742 4578999987543 24568999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+. ++|.+++. ....+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 166 e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 166 PKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred hhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 9996 57888884 4457999999999999999999999986 99999999999999999999999999976544322
Q ss_pred c-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHH-HHHHHHhhCc-cccc-------
Q 004732 549 H-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD-WALVLKEQGK-LMEL------- 618 (733)
Q Consensus 549 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~-~~~~------- 618 (733)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... .......-+. ..+.
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~ 320 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN 320 (392)
T ss_pred cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence 2 2234679999999999998899999999999999999999999995543211100 0000000000 0000
Q ss_pred -------ccCCCCCCC-------CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 619 -------VDTNPGSNF-------DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 619 -------~~~~~~~~~-------~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
........+ .......+.+++.+|++.||++||++.|++..
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000000000 00122357789999999999999999999875
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=307.87 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=200.8
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCeEEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE-GNQLLLIYE 469 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e 469 (733)
+|...+.||+|++|.||+|.. .+++.||+|.+... .....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 467889999999999999984 46789999998643 23344678899999999999999999998764 446899999
Q ss_pred ccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 470 YLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
|+++++|.+++... ...+++.++..++.|++.|++|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD 157 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence 99999999999753 446899999999999999999999986 99999999999999999999999999976543222
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
......|++.|+|||.+.+..++.++||||||++++|+++|+.||...+..... .... .+.... .+
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~---~~~~-~~~~~~---------~~ 223 (257)
T cd08223 158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV---YRII-EGKLPP---------MP 223 (257)
T ss_pred -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHH-hcCCCC---------Cc
Confidence 223456889999999999989999999999999999999999999655432221 1111 111111 11
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......+.+++.+|++.+|++||++.++++.
T Consensus 224 ~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 2233458899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=309.68 Aligned_cols=247 Identities=30% Similarity=0.459 Sum_probs=203.1
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
.|+..+.||+|+||.||+|.. .++..||+|.+.... ......+.+|++++++++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 456678899999999999985 468899999886542 344567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
++|+|.+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 85 ~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~ 158 (277)
T cd06640 85 GGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KR 158 (277)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-cc
Confidence 99999998864 36889999999999999999999886 99999999999999999999999999976543322 12
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
....++..|+|||++.+..++.++|||||||++|||++|+.||........... .............
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------------~~~~~~~~~~~~~ 225 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-------------IPKNNPPTLTGEF 225 (277)
T ss_pred ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-------------hhcCCCCCCchhh
Confidence 334678899999999888899999999999999999999999965543322110 0000111223344
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+.+++.+||+.+|.+||++.++++.
T Consensus 226 ~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 226 SKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred hHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 5668899999999999999999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=318.97 Aligned_cols=256 Identities=20% Similarity=0.292 Sum_probs=193.6
Q ss_pred ccCcccCC--CcccEEEcc-cCCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 397 TDNNIGEG--GFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 397 ~~~~lg~G--~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
..++||+| +||+||+++ ..+|+.||+|++.... ......+.+|+++++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34689999 789999998 5678999999986542 223356778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc--
Q 004732 472 ENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-- 548 (733)
Q Consensus 472 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~-- 548 (733)
++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++|||.+........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999998643 346899999999999999999999986 99999999999999999999999986543221110
Q ss_pred ----ccccccccCCCcccHHHHhh--CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccC-
Q 004732 549 ----HISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT- 621 (733)
Q Consensus 549 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 621 (733)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||............ ..+......+.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~ 234 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK----LNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH----hcCCcccccccc
Confidence 01122346778999999976 45899999999999999999999999643322211100 00111000000
Q ss_pred -----------------------------------CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 622 -----------------------------------NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 622 -----------------------------------~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.............+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00001112233468899999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=312.86 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=200.8
Q ss_pred cCccccCcccCCCcccEEEcccC-CCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
++|+..+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|++++++++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36778899999999999999954 68999999886432 2233567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD- 155 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-
Confidence 9999988887643 346899999999999999999999986 99999999999999999999999999986544322
Q ss_pred cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHH-HHh----------hCc-cc
Q 004732 550 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALV-LKE----------QGK-LM 616 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~-~~~----------~~~-~~ 616 (733)
......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............. ... ... ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07847 156 DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFK 235 (286)
T ss_pred cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccc
Confidence 1223457889999999876 4588999999999999999999999965543322211110 000 000 00
Q ss_pred ccccCCCCCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 ELVDTNPGSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 ~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+.+....+ ......+.+++.+||+.+|++||++.|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 236 GLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000111111111 1123468899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=313.97 Aligned_cols=246 Identities=29% Similarity=0.462 Sum_probs=199.8
Q ss_pred ccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 395 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
|...+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 45567899999999999984 567899999986442 3344678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+++|.+++.. ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++........ ...
T Consensus 86 ~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06642 86 GGSALDLLKP--GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-hhh
Confidence 9999998854 46899999999999999999999986 99999999999999999999999999976543322 123
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (733)
...|+..|+|||++.+..++.++|||||||++|||++|+.|+..........+. .... .+ .......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~----~~~~-----~~----~~~~~~~ 226 (277)
T cd06642 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI----PKNS-----PP----TLEGQYS 226 (277)
T ss_pred cccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh----hcCC-----CC----CCCcccC
Confidence 356888999999999888999999999999999999999998544332221110 0010 01 1111233
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 633 MVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 633 ~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..+.+++.+||+.+|++||++.++++.
T Consensus 227 ~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 227 KPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 458899999999999999999999884
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=314.14 Aligned_cols=260 Identities=25% Similarity=0.330 Sum_probs=195.7
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|...+.||+|++|.||+|+. .++..||||.+.... ......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 467788999999999999995 578999999986432 22346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 471 LENNSLARALFEH--RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 471 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
++ ++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 6888888643 257899999999999999999999986 99999999999999999999999999975443221
Q ss_pred ccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHH-HHHHHHhh-----------Ccc
Q 004732 549 HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD-WALVLKEQ-----------GKL 615 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~-~~~~~~~~-----------~~~ 615 (733)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.......... ........ ...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY 235 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence 12234578899999988754 47899999999999999999999996544322111 00000000 000
Q ss_pred cccccCCCCC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 616 MELVDTNPGS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 616 ~~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.......... .........+.+++.+|++.||++|||+.+|+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000 000012235778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=313.65 Aligned_cols=262 Identities=24% Similarity=0.349 Sum_probs=204.0
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 467788999999999999994 578999999986543 33346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+ +++|.+++......+++..++.++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 99999999866678999999999999999999999986 9999999999999999999999999998665443222
Q ss_pred ccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc------ccc------
Q 004732 551 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK------LME------ 617 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~------ 617 (733)
.....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||..........+......... ..+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK 236 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence 3345689999999988654 468999999999999999999877765543333222211110000 000
Q ss_pred ccc-CCCCC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 618 LVD-TNPGS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 618 ~~~-~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
... ..... ....+....+.+++.+|++.+|++||+++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 237 ITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred ccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 00000 0001123568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=307.53 Aligned_cols=246 Identities=28% Similarity=0.470 Sum_probs=198.6
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
.+|...+.||+|+||.||+|.. +++.||+|.+.... ....+.+|+.++++++|||++++++++..+ ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577889999999999999975 57889999986532 346789999999999999999999998765 4799999999
Q ss_pred CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 473 NNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 473 ~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---- 154 (254)
T cd05083 82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---- 154 (254)
T ss_pred CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence 99999999754 346899999999999999999999886 9999999999999999999999999987543221
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
.....+..|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+..... ...
T Consensus 155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~~~~~---------~~~ 221 (254)
T cd05083 155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV----EKGYRMEP---------PEG 221 (254)
T ss_pred CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH----hCCCCCCC---------CCc
Confidence 12334568999999988899999999999999999998 99998665443322211 11111111 111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
....+.+++.+||+.+|++||++.+++..|+.
T Consensus 222 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 222 CPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 23457899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=334.72 Aligned_cols=264 Identities=18% Similarity=0.218 Sum_probs=195.5
Q ss_pred hhHHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCC------CceeeEeeEE
Q 004732 386 LQIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQH------PNLVKLYGCC 458 (733)
Q Consensus 386 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~ 458 (733)
.++...+++|.+.+.||+|+||+||+|.. ..++.||||++.... .....+..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 44556678999999999999999999984 568899999986432 223455667777777755 4588999998
Q ss_pred EeC-CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-------
Q 004732 459 IEG-NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL------- 530 (733)
Q Consensus 459 ~~~-~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~------- 530 (733)
..+ ...++|||++ +++|.+++... ..+++..+..|+.||+.||+|||++. +||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccccc
Confidence 765 5788999988 67888888654 47999999999999999999999741 399999999999998765
Q ss_pred ---------CeEEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhh
Q 004732 531 ---------NSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY 601 (733)
Q Consensus 531 ---------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~ 601 (733)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 499999998864322 2334679999999999999999999999999999999999999996654433
Q ss_pred HHHHHHHHHh---------------------hCcccccccCCC-----C-C-CCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004732 602 LLDWALVLKE---------------------QGKLMELVDTNP-----G-S-NFDKEQVMVMINVALLCANASPTIRPSM 653 (733)
Q Consensus 602 ~~~~~~~~~~---------------------~~~~~~~~~~~~-----~-~-~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 653 (733)
.......... .+......++.. . . .........+.+++.+|++.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 2221110000 000000000000 0 0 0000112357799999999999999999
Q ss_pred HHHHH
Q 004732 654 SSVLR 658 (733)
Q Consensus 654 ~~vl~ 658 (733)
.|+++
T Consensus 433 ~e~L~ 437 (467)
T PTZ00284 433 RQMTT 437 (467)
T ss_pred HHHhc
Confidence 99986
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.00 Aligned_cols=192 Identities=27% Similarity=0.449 Sum_probs=159.5
Q ss_pred cCcccCCCcccEEEcccC---CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEEEEEEccC
Q 004732 398 DNNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLLLIYEYLE 472 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~ 472 (733)
.+.||+|+||+||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 56789999986542 23567889999999999999999999864 456899999986
Q ss_pred CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe----cCCCCeEEcccCcc
Q 004732 473 NNSLARALFEH--------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL----DKDLNSKISDFGLA 540 (733)
Q Consensus 473 ~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill----~~~~~~kl~DfGla 540 (733)
+ +|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 787777521 235899999999999999999999986 9999999999999 45678999999999
Q ss_pred ccCcccCcc--cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCC
Q 004732 541 KLDEEENTH--ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVT 595 (733)
Q Consensus 541 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~ 595 (733)
+........ ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||.
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 865433221 2234678999999999977 458999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=314.54 Aligned_cols=258 Identities=26% Similarity=0.365 Sum_probs=201.7
Q ss_pred hhHHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEE----
Q 004732 386 LQIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCI---- 459 (733)
Q Consensus 386 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~---- 459 (733)
..+..++++|...+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 44567889999999999999999999984 568899999875432 2235688899999999 6999999999985
Q ss_pred -eCCeEEEEEEccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEc
Q 004732 460 -EGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKIS 535 (733)
Q Consensus 460 -~~~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 535 (733)
.++..++||||+++++|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~ 166 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLV 166 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEc
Confidence 34568999999999999998752 3456899999999999999999999986 9999999999999999999999
Q ss_pred ccCccccCcccCcccccccccCCCcccHHHHhh-----CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHH
Q 004732 536 DFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK 610 (733)
Q Consensus 536 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 610 (733)
|||+++....... ......|++.|+|||++.. ..++.++||||+||++|||++|+.||.......... . .
T Consensus 167 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~--~--~ 241 (286)
T cd06638 167 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF--K--I 241 (286)
T ss_pred cCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh--h--c
Confidence 9999876543221 2233468999999998753 457889999999999999999999996543322111 0 0
Q ss_pred hhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 611 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.........++ ......+.+++.+||+.+|++||++.|+++.
T Consensus 242 ~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 242 PRNPPPTLHQP-------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred cccCCCcccCC-------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 00000011111 1112348889999999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=316.50 Aligned_cols=256 Identities=25% Similarity=0.366 Sum_probs=205.0
Q ss_pred HHhhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccc--cChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeE
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSS--KSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 464 (733)
++.....|.+++.||+||.++||++...+.+.||+|++.. .+......|.+|++.|.++ .|.+||++++|-..++.+
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3455667889999999999999999998889999987643 3455567899999999999 499999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
|+|||| ...+|..+|.+.....+...++.+..|++.|+.+.|.+| |||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 436 YmvmE~-Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 436 YMVMEC-GDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred EEEeec-ccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 999996 456999999876655553489999999999999999997 999999999999975 589999999999877
Q ss_pred ccCccc-ccccccCCCcccHHHHhhC-----------CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh
Q 004732 545 EENTHI-STRVAGTIGYMAPEYAMRG-----------HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 612 (733)
Q Consensus 545 ~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 612 (733)
.+.+.. ....+||+.||+||.+... +.++++||||+|||||+|+.|+.||..- .-.|++
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~----~n~~aK----- 581 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI----INQIAK----- 581 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH----HHHHHH-----
Confidence 665544 4567899999999999643 2568999999999999999999999421 112332
Q ss_pred CcccccccCCCCCCCCHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 613 GKLMELVDTNPGSNFDKE-QVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+..+.++.....|+.- .-..++++++.|++.||.+||+..++++.
T Consensus 582 --l~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 582 --LHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 2233333222222111 11128999999999999999999999864
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=306.46 Aligned_cols=248 Identities=30% Similarity=0.468 Sum_probs=200.6
Q ss_pred CccccCcccCCCcccEEEcccC-CCcEEEEEEccccC-----hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS-----KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
+|...+.||+|+||.||+|... +++.|++|.+.... +...+.+.+|+++++.++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3567789999999999999965 78999999875432 23446789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
+||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 9999999999998754 36899999999999999999999986 9999999999999999999999999987654332
Q ss_pred cccccccccCCCcccHHHHhhCC-CCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
......|+..|+|||.+.... ++.++|+|||||++|++++|+.||......... ...........
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~--------- 222 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV---FKIGRSKELPP--------- 222 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH---HHHHhcccCCC---------
Confidence 223456889999999997766 899999999999999999999999554322111 11111111111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+......+.+++.+||+.+|.+||++.++++.
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111123457889999999999999999998763
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=315.81 Aligned_cols=249 Identities=26% Similarity=0.439 Sum_probs=200.3
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
.|.....||+|+||.||+|.. .++..||||.+........+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 344456799999999999984 5689999999866554555678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+++|.+++.. ..+++.++..++.||+.||+|||+.+ |+||||||+||+++.++.++|+|||++........ ...
T Consensus 103 ~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~ 176 (292)
T cd06658 103 GGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRK 176 (292)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCc
Confidence 9999998853 36899999999999999999999986 99999999999999999999999999875433222 123
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (733)
...|+..|+|||...+..++.++|||||||++||+++|+.||...+......-. . . .. ...... .....
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~---~-~-~~----~~~~~~--~~~~~ 245 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI---R-D-NL----PPRVKD--SHKVS 245 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-h-cC----CCcccc--ccccC
Confidence 356899999999998888999999999999999999999999665443222111 0 0 00 110000 11122
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 633 MVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 633 ~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..+.+++.+||..+|.+|||+.++++.
T Consensus 246 ~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 246 SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 347788999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.17 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=203.5
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|+..+.||+|+||.||+++ ..+|+.||+|.+... ......++.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 46778999999999999998 457899999998643 233446789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
+.+++|.+++... ...+++..+.+++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999998753 346899999999999999999999986 99999999999999999999999999976543222
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
......|++.|+|||+..+..++.++|||||||+++++++|+.||...+........ . .+.... .+.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~---~-~~~~~~---------~~~ 223 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI---I-RGSYPP---------VSS 223 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH---h-cCCCCC---------Ccc
Confidence 123356889999999998888999999999999999999999999665543332211 1 111111 111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.....+.+++.+||+.+|.+||++.+|++.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 224 HYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred cCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 223458899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.13 Aligned_cols=240 Identities=25% Similarity=0.332 Sum_probs=187.6
Q ss_pred ccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhC---CCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 401 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL---QHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 401 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
||+|+||+||+|+. .+++.||||++.... ......+..|..++... +||||+++++++.++...++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999984 568999999986432 12223455677777665 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 81 g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~~ 155 (330)
T cd05586 81 GELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNT 155 (330)
T ss_pred ChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-CccC
Confidence 9999988654 47899999999999999999999986 99999999999999999999999999875332221 2334
Q ss_pred cccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHH
Q 004732 554 VAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (733)
..||+.|+|||.+.+. .++.++|||||||++|||++|+.||...+........ ..+.. .. +... ..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i----~~~~~-~~----~~~~----~~ 222 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI----AFGKV-RF----PKNV----LS 222 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH----HcCCC-CC----CCcc----CC
Confidence 6799999999998764 4899999999999999999999999765543322111 11110 01 1111 12
Q ss_pred HHHHHHHHHhhcCCCCCCC----CHHHHHH
Q 004732 633 MVMINVALLCANASPTIRP----SMSSVLR 658 (733)
Q Consensus 633 ~~l~~l~~~c~~~~P~~RP----t~~~vl~ 658 (733)
..+.+++.+|++.+|.+|| ++.++++
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 3477899999999999999 4556554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=308.28 Aligned_cols=247 Identities=22% Similarity=0.350 Sum_probs=209.2
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.-|+.++.||+|.|..|-.|+ .-+|..||||++.+.. ......+.+|++.|+.++|||||++|.+...+..+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 346778899999999999999 4589999999996642 2334578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec-CCCCeEEcccCccccCcccCc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-KDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~~~kl~DfGla~~~~~~~~ 548 (733)
.-++|+|.+++..+...+.+.-+.+++.||+.|+.|+|+.. +||||+||+||.+- +-|-+|++|||++-.+.+..
T Consensus 98 LGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~- 173 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK- 173 (864)
T ss_pred ecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence 99999999999988889999999999999999999999885 99999999998875 45779999999997665543
Q ss_pred ccccccccCCCcccHHHHhhCCCCc-cchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTE-KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.-++.+|+..|-|||++.+..|+. ++||||+|||||-|++|+.||...+....+ ..++|-. ...
T Consensus 174 -kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL------------TmImDCK--Ytv 238 (864)
T KOG4717|consen 174 -KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL------------TMIMDCK--YTV 238 (864)
T ss_pred -hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh------------hhhhccc--ccC
Confidence 346689999999999999988765 899999999999999999999665443322 2222221 223
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+.....+..+++..|+..||.+|.+.++|+.
T Consensus 239 PshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 239 PSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred chhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 4456677999999999999999999999964
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=315.57 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=199.4
Q ss_pred cCccccCcccCCCcccEEEcccC-CCcEEEEEEccccCh--hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
++|...+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36778899999999999999964 689999998865322 234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++++|.++.... ..+++..+..++.|+++||+|||+.+ |+||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~- 155 (286)
T cd07846 81 FVDHTVLDDLEKYP-NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 155 (286)
T ss_pred cCCccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc-
Confidence 99999998876543 45899999999999999999999986 99999999999999999999999999986544332
Q ss_pred cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh-----------hCccc-
Q 004732 550 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE-----------QGKLM- 616 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~~- 616 (733)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||..........-...... .....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07846 156 VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235 (286)
T ss_pred ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhh
Confidence 2233557889999999875 4578899999999999999999999865443221111000000 00000
Q ss_pred ccccCCCCCC-----CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 617 ELVDTNPGSN-----FDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 617 ~~~~~~~~~~-----~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
....+..... ..+.....+.+++.+||+.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred ccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000000 01122346889999999999999999999876
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=313.59 Aligned_cols=252 Identities=25% Similarity=0.426 Sum_probs=200.0
Q ss_pred cCccccCcccCCCcccEEEcccC-CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++|+..+.||+|+||.||+|... ++..||+|.+... .......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 35778899999999999999954 7899999988653 233346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 471 LENNSLARALFEH--RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 471 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
+++++|.+++... ...+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 9999999988653 337899999999999999999999742 49999999999999999999999999987543221
Q ss_pred ccccccccCCCcccHHHHhhC------CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRG------HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
.....|+..|+|||.+.+. .++.++|||||||++|||++|+.||................ ....
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~------- 227 (286)
T cd06622 158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIV-DGDP------- 227 (286)
T ss_pred --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHh-hcCC-------
Confidence 2234578899999998553 35889999999999999999999996543322221111111 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 228 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 228 --PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred --CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11122234558899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.47 Aligned_cols=260 Identities=22% Similarity=0.318 Sum_probs=196.6
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|...+.||+|+||.||+|+. .+|+.||+|.+.... ......+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 367778999999999999995 578999999986432 22235678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
++ ++|.+++......+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~- 155 (284)
T cd07839 81 CD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC- 155 (284)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC-
Confidence 97 4788888765667999999999999999999999986 999999999999999999999999999855432221
Q ss_pred ccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCcc-chhhHHHHHHHHHhhC------cccccccCC
Q 004732 551 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKE-DMFYLLDWALVLKEQG------KLMELVDTN 622 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~ 622 (733)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.|+... +............... ......+..
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence 2234578899999998765 4789999999999999999999997432 2211111110000000 000000000
Q ss_pred CCCC---------CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 623 PGSN---------FDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 623 ~~~~---------~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.... ..+.....+.+++.+|++.||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 01112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.65 Aligned_cols=251 Identities=31% Similarity=0.500 Sum_probs=201.1
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh--hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|...+.||+|+||.||+|.. .+++.||+|.+..... ...+.+.+|+++++.++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 467788999999999999984 5789999999865533 3567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++..........
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 9999999998754 35899999999999999999999986 9999999999999999999999999998765433322
Q ss_pred cc---ccccCCCcccHHHHhhCC---CCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 551 ST---RVAGTIGYMAPEYAMRGH---LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 551 ~~---~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
.. ...++..|+|||++.... ++.++||||||+++||+++|+.||...+......+. ... +.......
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--~~~-~~~~~~~~---- 229 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGA-GHKPPIPD---- 229 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--Hhc-CCCCCCCc----
Confidence 21 356788999999998765 889999999999999999999999644321111111 111 11111100
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.......+.+++.+||+.+|.+||++.++++
T Consensus 230 ---~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 230 ---SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred ---ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111334778999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=307.50 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=201.5
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC------hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS------KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
+|+..+.||+|+||.||+|. ..+++.||+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 46778899999999999998 5678999999986432 1134678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-CeEEcccCccccCcc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEE 545 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~ 545 (733)
|+||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++ .+||+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 99999999999998654 37899999999999999999999986 99999999999998876 599999999876543
Q ss_pred cCcc---cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 546 ENTH---ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 546 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
.... ......|+..|+|||.+.+..++.++||||+|+++|++++|+.||...................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------- 227 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT--------- 227 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC---------
Confidence 3211 1233568899999999988889999999999999999999999995443222211111110000
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.....+......+.+++.+|++.+|.+||++.++++
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011122333456889999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=305.49 Aligned_cols=255 Identities=29% Similarity=0.459 Sum_probs=203.7
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++|+..+.||.|+||+||+|.. .++..+|+|++.... ......+.+|+++++.++|+||+++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688889999999999999994 568899999986532 23457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 471 LENNSLARALFEH--RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 471 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 9999999999753 246899999999999999999999986 99999999999999999999999999876544322
Q ss_pred c---cccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 549 H---ISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 549 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
. ......|+..|+|||.+... .++.++|||||||++|||++|+.||.......... ..... ... ....
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~--~~~~~--~~~-~~~~--- 229 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLM--LTLQN--DPP-SLET--- 229 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHH--HHhcC--CCC-CcCC---
Confidence 2 22345689999999999877 78999999999999999999999996543322111 10110 000 0000
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
..........+.+++.+||+.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 230 GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0001123345889999999999999999999876
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=304.55 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=197.2
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-----hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-----KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQL 464 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 464 (733)
++|...+.||+|+||.||+|.. .+|+.||||.+.... ......+.+|++++++++||||+++++++.++ ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4678889999999999999984 568999999875321 12245788899999999999999999998764 467
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||+++++|.+++... ..+++..+.+++.|++.||+|||+.+ |+||||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 8999999999999998754 36889999999999999999999986 9999999999999999999999999997543
Q ss_pred ccCcc--cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 545 EENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 545 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
..... ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~--------- 225 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF---KIATQP--------- 225 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH---HHhcCC---------
Confidence 32111 1223568899999999988889999999999999999999999996443221111 000000
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.....+......+.+++.+|+. +|.+||+++||++.
T Consensus 226 ~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0111223344557788889995 99999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=313.81 Aligned_cols=247 Identities=25% Similarity=0.392 Sum_probs=199.5
Q ss_pred cccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCC
Q 004732 396 ATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENN 474 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g 474 (733)
.....||+|+||.||+|.. .+++.||+|.+..........+.+|+.+++.++||||+++++++..++..++|+||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 3445799999999999984 578999999986554444567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccccc
Q 004732 475 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV 554 (733)
Q Consensus 475 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~ 554 (733)
+|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ .....
T Consensus 104 ~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~ 177 (297)
T cd06659 104 ALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKSL 177 (297)
T ss_pred CHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccce
Confidence 99987754 36899999999999999999999986 99999999999999999999999999875443222 12335
Q ss_pred ccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHH
Q 004732 555 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 634 (733)
Q Consensus 555 ~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (733)
.|+..|+|||++.+..++.++|||||||++|||++|+.||...+........ ....... .. ........
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~--~~-----~~~~~~~~ 246 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL----RDSPPPK--LK-----NAHKISPV 246 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hccCCCC--cc-----ccCCCCHH
Confidence 6899999999999888999999999999999999999999655433322211 1110000 00 00111234
Q ss_pred HHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 635 MINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 635 l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+.+++.+|++.+|.+||++.++++.
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhC
Confidence 7889999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.59 Aligned_cols=253 Identities=24% Similarity=0.419 Sum_probs=199.0
Q ss_pred ccccCcccCCCcccEEEcccC----CCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC------
Q 004732 395 FATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN------ 462 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 462 (733)
|...+.||+|+||.||+|.+. ++..||||.+... .....+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456789999999999999843 3688999998654 2334567889999999999999999999986542
Q ss_pred eEEEEEEccCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEccc
Q 004732 463 QLLLIYEYLENNSLARALFEH-----RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 537 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 537 (733)
..++++||+.+|+|.+++... ...+++..+.+++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 247899999999999887532 235789999999999999999999986 999999999999999999999999
Q ss_pred CccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcc
Q 004732 538 GLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKL 615 (733)
Q Consensus 538 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 615 (733)
|+++........ ......+++.|++||.+....++.++|||||||++|||++ |+.||...+......+.. .....
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~~~ 234 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI---KGNRL 234 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH---cCCcC
Confidence 999865432211 1223345678999999988889999999999999999999 888886555444333221 11110
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
. .+......+.+++.+||+.+|++||++.++++.|+++
T Consensus 235 -~---------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 235 -K---------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred -C---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0111234588999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.35 Aligned_cols=255 Identities=21% Similarity=0.294 Sum_probs=201.9
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+++++.++||||+++++++..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3678889999999999999994 467899999886542 223457889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC-
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN- 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~- 547 (733)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 81 EYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999999655 46899999999999999999999986 9999999999999999999999999987421100
Q ss_pred -------------cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc
Q 004732 548 -------------THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 614 (733)
Q Consensus 548 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 614 (733)
........|+..|+|||.+.+..++.++|+|||||++||+++|+.||.+......... ... +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~---~~~-~~ 232 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ---VIS-DD 232 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh-cc
Confidence 0011224578899999999888899999999999999999999999976544332211 111 11
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 615 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
. ..+..... ....+.+++.+||+.+|++||++.++.+.|+.
T Consensus 233 ~---~~~~~~~~----~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 233 I---EWPEGDEA----LPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred c---CCCCcccc----CCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 0 11111111 22347899999999999999998777777663
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=311.59 Aligned_cols=262 Identities=21% Similarity=0.322 Sum_probs=203.0
Q ss_pred CccccCcccCCCcccEEEcccC-CCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|+..+.||+|+||.||+|... +++.||||.+... .......+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5788899999999999999954 6889999988653 233346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
++++.+..+.. ....+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++..........
T Consensus 82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 82 VERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 99877766553 3456899999999999999999999986 9999999999999999999999999998765544323
Q ss_pred ccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh------------hCccc-
Q 004732 551 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE------------QGKLM- 616 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~------------~~~~~- 616 (733)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||................. .....
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG 237 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence 3446688999999999887 789999999999999999999999965543322211111000 00000
Q ss_pred -ccccCCCC----CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 -ELVDTNPG----SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 -~~~~~~~~----~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+....... ..++......+.+++.+||..+|++||+++++++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000000 00111124568999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.55 Aligned_cols=252 Identities=27% Similarity=0.442 Sum_probs=202.5
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLLLIY 468 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 468 (733)
+|...+.||.|+||.||+|. ..+++.||+|.+... .....+.+..|++++++++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 46778899999999999998 457889999988643 33345678899999999999999999998864 45679999
Q ss_pred EccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 469 EYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGES--RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 469 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
||+++++|.+++... ...+++..++.++.|++.||+|||..| ..+++||||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998643 467999999999999999999999332 335999999999999999999999999999866
Q ss_pred cccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
...... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+........ ..+..
T Consensus 161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~-------- 227 (265)
T cd08217 161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKI----KEGKF-------- 227 (265)
T ss_pred cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHH----hcCCC--------
Confidence 543321 23346899999999999888999999999999999999999999765533322211 11111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+......+.+++.+|++.+|++||++.+|++.
T Consensus 228 -~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 -RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11122334468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=309.41 Aligned_cols=258 Identities=27% Similarity=0.380 Sum_probs=202.8
Q ss_pred hhHHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC--
Q 004732 386 LQIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG-- 461 (733)
Q Consensus 386 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-- 461 (733)
.++..++++|...+.||+|+||.||+|.. .+++.+|+|.+.... .....+.+|+.+++++ +|||++++++++...
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~ 93 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADK 93 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc
Confidence 44556789999999999999999999994 578999999986532 2245678899999999 899999999998764
Q ss_pred ---CeEEEEEEccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEc
Q 004732 462 ---NQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKIS 535 (733)
Q Consensus 462 ---~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 535 (733)
...++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+
T Consensus 94 ~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 94 LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEe
Confidence 358999999999999998863 3457899999999999999999999886 9999999999999999999999
Q ss_pred ccCccccCcccCcccccccccCCCcccHHHHhhC-----CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHH
Q 004732 536 DFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-----HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK 610 (733)
Q Consensus 536 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~ 610 (733)
|||+++....... ......|+..|+|||.+... .++.++|||||||++|||++|+.||........... .
T Consensus 171 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~---~- 245 (291)
T cd06639 171 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFK---I- 245 (291)
T ss_pred ecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHH---H-
Confidence 9999876543221 12234688999999998643 368899999999999999999999965443222110 0
Q ss_pred hhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 611 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.........+ .......+.+++.+||+.+|++||++.|+++.
T Consensus 246 ~~~~~~~~~~-------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 246 PRNPPPTLLH-------PEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred hcCCCCCCCc-------ccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0111111111 11223358899999999999999999999763
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.54 Aligned_cols=254 Identities=27% Similarity=0.438 Sum_probs=198.7
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh----------hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK----------QGNREFINEIGMISALQHPNLVKLYGCCIEGN 462 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 462 (733)
+|...+.||+|+||.||+|. ..+|+.||+|.+..... ...+.+.+|+++++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 46677899999999999998 45789999998753211 11246788999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence 999999999999999999765 47899999999999999999999986 99999999999999999999999999976
Q ss_pred CcccCcc-cccccccCCCcccHHHHhhCC--CCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccc
Q 004732 543 DEEENTH-ISTRVAGTIGYMAPEYAMRGH--LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 619 (733)
Q Consensus 543 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (733)
....... ......|+..|+|||.+.... ++.++||||||+++||+++|+.||...+..... .. ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~-~~~~~~~~~~- 233 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM--FK-LGNKRSAPPI- 233 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH--HH-hhccccCCcC-
Confidence 4432211 123356889999999987654 889999999999999999999999544322111 00 0011101111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 620 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. .........+.+++.+||+.+|++||++.+|++.
T Consensus 234 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 234 PP----DVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred Cc----cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 11 1111223458889999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=311.88 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=200.1
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccChh-----cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ-----GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
+|...+.||+|+||.||+|.. .+|+.||||.+...... ....+..|++++++++|+||+++++++.++...++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 366778999999999999984 57899999998654322 235677899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+ +|+|.+++......+++..+..++.||++||+|||+.+ |+||||||+||+++.++.++|+|||+++......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 99999999765457999999999999999999999986 9999999999999999999999999998654432
Q ss_pred cccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh---------Ccccc
Q 004732 548 THISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ---------GKLME 617 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---------~~~~~ 617 (733)
.. .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||...+......-....... .....
T Consensus 157 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (298)
T cd07841 157 RK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235 (298)
T ss_pred cc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence 21 223356788999998865 45789999999999999999998777554433222111100000 00000
Q ss_pred cccCCCCCCC-----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 618 LVDTNPGSNF-----DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 618 ~~~~~~~~~~-----~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.......... .......+.+++.+||+.+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000001 11223568899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=306.97 Aligned_cols=251 Identities=24% Similarity=0.408 Sum_probs=203.2
Q ss_pred cCccccCcccCCCcccEEEcccC-CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++|+..+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++..+...++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35677889999999999999954 78999999986643 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
+++++|.+++......+++..+..++.|++.||+|||+ .+ ++||||||+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 157 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK 157 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh
Confidence 99999999997665688999999999999999999998 65 999999999999999999999999998755432221
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccch--hhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM--FYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||...+. ....+......... . ...
T Consensus 158 ---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~---------~~~ 224 (265)
T cd06605 158 ---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-P---------PRL 224 (265)
T ss_pred ---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-C---------CCC
Confidence 26688999999999988999999999999999999999999954421 11111111111110 0 001
Q ss_pred CHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 628 DKE-QVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 628 ~~~-~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+.. ....+.+++.+||..+|++||++.++++.
T Consensus 225 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111 33458899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=311.40 Aligned_cols=250 Identities=28% Similarity=0.469 Sum_probs=203.7
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
++|...+.||+|+||.||+|. ..+++.||+|.+........+.+.+|+.++++++||||++++++|..++..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 578888999999999999998 4578899999986554445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
++++|.+++.+. .+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++......... .
T Consensus 99 ~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-~ 172 (293)
T cd06647 99 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-R 172 (293)
T ss_pred CCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc-c
Confidence 999999998643 5789999999999999999999986 999999999999999999999999998755433222 2
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
....|++.|+|||.+.+..++.++|||||||++||+++|+.||...+........ .. ...+........
T Consensus 173 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~--------~~~~~~~~~~~~ 241 (293)
T cd06647 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---AT--------NGTPELQNPEKL 241 (293)
T ss_pred ccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hc--------CCCCCCCCcccc
Confidence 3346888999999998888999999999999999999999999655432211100 00 001111111223
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+.+++.+||+.+|++||++.+++..
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 3458889999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=314.16 Aligned_cols=251 Identities=24% Similarity=0.298 Sum_probs=200.2
Q ss_pred cCccccCcccCCCcccEEEcccC-CCcEEEEEEccccCh---hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+++++.++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999954 589999999865422 23457889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 469 EYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
||+.+++|.+++... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 157 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP 157 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence 999999999998743 457899999999999999999999986 9999999999999999999999999987543211
Q ss_pred cc----------------------------cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccch
Q 004732 548 TH----------------------------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM 599 (733)
Q Consensus 548 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~ 599 (733)
.. ......||..|+|||.+.+..++.++||||||+++|+|++|+.||...+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 10 11234688999999999988899999999999999999999999965543
Q ss_pred hhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC----HHHHHH
Q 004732 600 FYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPS----MSSVLR 658 (733)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt----~~~vl~ 658 (733)
..... ..... .............+.+++.+||+.+|++||+ +.|+++
T Consensus 238 ~~~~~--~~~~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 238 DETFS--NILKK----------EVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred HHHHH--HHhcC----------CccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 22211 11100 0000011113456899999999999999999 555544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=317.31 Aligned_cols=193 Identities=26% Similarity=0.436 Sum_probs=159.2
Q ss_pred cCcccCCCcccEEEcccC---CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEEEEEEccC
Q 004732 398 DNNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLLLIYEYLE 472 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~ 472 (733)
...||+|+||.||+|+.. ++..||+|.+.... ....+.+|++++++++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999854 45789999986542 23567889999999999999999999854 567899999987
Q ss_pred CCCHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe----cCCCCeEEcccCcc
Q 004732 473 NNSLARALFE--------HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL----DKDLNSKISDFGLA 540 (733)
Q Consensus 473 ~gsL~~~l~~--------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill----~~~~~~kl~DfGla 540 (733)
+ +|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 67776642 1235889999999999999999999986 9999999999999 56678999999999
Q ss_pred ccCcccCcc--cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCc
Q 004732 541 KLDEEENTH--ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTK 596 (733)
Q Consensus 541 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~ 596 (733)
+........ ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 865443221 1234568999999999876 4589999999999999999999999953
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=321.49 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=195.5
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------C
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEG------N 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 462 (733)
.++|...+.||+|+||.||+|. ..+++.||||.+.... ......+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 4678889999999999999998 4578899999986532 22345677899999999999999999988643 3
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~ 167 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQ 167 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcccee
Confidence 578999988 7789887743 46899999999999999999999986 99999999999999999999999999986
Q ss_pred CcccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc-------
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK------- 614 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------- 614 (733)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+................
T Consensus 168 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 168 ADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred cCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 5432 233568999999999877 5689999999999999999999999965543322211111000000
Q ss_pred -------ccccccCCCCCCC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 -------LMELVDTNPGSNF---DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 -------~~~~~~~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+...+.... .......+.+++.+|++.||.+|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000000 00011246789999999999999999999854
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.05 Aligned_cols=247 Identities=29% Similarity=0.455 Sum_probs=199.5
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
...|...+.||+|+||.||+|+. .+++.||+|.+.... ....+++.+|+++++.++||||++++++|.+++..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 45688889999999999999985 478999999886432 23345788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
+||+. |++.+.+......+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 99997 5777777655567999999999999999999999986 999999999999999999999999998754332
Q ss_pred cccccccccCCCcccHHHHh---hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
....|++.|+|||.+. ...++.++||||||+++|||++|+.||...+........ .. ... .
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~---~~-~~~--------~ 232 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI---AQ-NDS--------P 232 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH---hc-CCC--------C
Confidence 2346788999999874 356889999999999999999999999665443322111 00 000 0
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..........+.+++.+||+.+|++||++.+|++.
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 233 TLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred CCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 01111234458899999999999999999999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=306.61 Aligned_cols=254 Identities=26% Similarity=0.403 Sum_probs=200.4
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 468 (733)
++|...+.||.|++|.||+|.. .+++.+|+|.+.... ......+.+|++++++++||||++++++|.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3677888999999999999995 568899999986542 23456789999999999999999999998754 4689999
Q ss_pred EccCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 469 EYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 469 e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
||+++++|.+++. .....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999998875 23456899999999999999999999986 99999999999999999999999999875433
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccc-----hhhHHHHHHHHHhhCccccccc
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED-----MFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
... ....++..|+|||.+.+..++.++||||+||++|||++|+.||.... ......+. .. .....+ .
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~-~~~~~~-~ 229 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI---VN-MPNPEL-K 229 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH---hc-CCchhh-c
Confidence 221 23457889999999998899999999999999999999999996542 12222221 11 011111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..... .......+.+++.+||+.+|++|||+.|+++.
T Consensus 230 ~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 DEPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cCCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 11110 11234468899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=308.50 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=205.8
Q ss_pred HhhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
....+.|..-++||+||||.||-++ ..+|+.||.|++.++ .+.++...+.|-++|.+++.+.||.+-.+|..++.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~L 260 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDAL 260 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCce
Confidence 3345778999999999999999998 557999999988654 344566778899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 465 LLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
++|+..|.||+|.-+|++.+ ..+++..+..++.+|+.||++||... ||+||+||+|||+|+.|+++|+|.|+|..+
T Consensus 261 ClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 261 CLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 99999999999999998544 47899999999999999999999985 999999999999999999999999999877
Q ss_pred cccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
...... ...+||.||||||++.+..|+...|.||+||++|||+.|+.||....... .|. ++...+.. .
T Consensus 338 ~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv--k~e-------Evdrr~~~-~ 405 (591)
T KOG0986|consen 338 PEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV--KRE-------EVDRRTLE-D 405 (591)
T ss_pred CCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh--hHH-------HHHHHHhc-c
Confidence 665544 23489999999999999999999999999999999999999995332111 110 11111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMS 654 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ 654 (733)
...++........++....++.||.+|.--+
T Consensus 406 ~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 406 PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred hhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 1234444556688888899999999997443
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=307.42 Aligned_cols=247 Identities=26% Similarity=0.428 Sum_probs=201.1
Q ss_pred ccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 395 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
|...+.||+|++|.||+|. ..+++.||+|++........+.+.+|+.+++.++||||+++++++..++..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 4455799999999999998 457899999998655444556788999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||.+........ ....
T Consensus 101 ~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~~ 174 (285)
T cd06648 101 GALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRKS 174 (285)
T ss_pred CCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cccc
Confidence 999999866 46899999999999999999999986 99999999999999999999999998875443222 2233
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..|++.|+|||.+.+..++.++|||||||++|||++|+.||...+...... ..... .. +... .......
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~---~~~~~-~~-----~~~~--~~~~~~~ 243 (285)
T cd06648 175 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK---RIRDN-LP-----PKLK--NLHKVSP 243 (285)
T ss_pred ccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH---HHHhc-CC-----CCCc--ccccCCH
Confidence 568999999999988889999999999999999999999996654432221 11111 10 0000 0111224
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 634 VMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.+.+++.+||+.+|++||++.++++
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHcc
Confidence 5889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=319.07 Aligned_cols=257 Identities=23% Similarity=0.337 Sum_probs=202.7
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-C-----CceeeEeeEEEeCCeEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-H-----PNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 466 (733)
+|.+++.||+|+||.|.+|. ..+++.||||+++.. +.-..+-..|+.+|..++ | -|+|++++||...++.|+
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 67889999999999999998 677999999999764 333455677999999997 4 589999999999999999
Q ss_pred EEEccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC--CeEEcccCccccC
Q 004732 467 IYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL--NSKISDFGLAKLD 543 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~--~~kl~DfGla~~~ 543 (733)
|+|.++. +|.+++.. ....++...++.++.||+.||.+||+.+ |||+||||+||||..-. .+||+|||.|...
T Consensus 266 VfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9998855 89999984 4557999999999999999999999986 99999999999997544 5999999999865
Q ss_pred cccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh------------
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE------------ 611 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~------------ 611 (733)
...-. +..-+..|.|||++.+.+|+.+.||||||||++||++|..-|.++++.+..........
T Consensus 342 ~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~ 417 (586)
T KOG0667|consen 342 SQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK 417 (586)
T ss_pred CCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence 44322 45567789999999999999999999999999999999888877776665442222110
Q ss_pred ------h-Cccccc----------------------ccC--CC-----C-CCCCHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 004732 612 ------Q-GKLMEL----------------------VDT--NP-----G-SNFDKEQVMVMINVALLCANASPTIRPSMS 654 (733)
Q Consensus 612 ------~-~~~~~~----------------------~~~--~~-----~-~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ 654 (733)
. ...... .+. .+ . ..........+++++++|+..||.+|+|..
T Consensus 418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~ 497 (586)
T KOG0667|consen 418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA 497 (586)
T ss_pred cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence 0 000000 000 00 0 001113344689999999999999999999
Q ss_pred HHHHH
Q 004732 655 SVLRM 659 (733)
Q Consensus 655 ~vl~~ 659 (733)
|+++.
T Consensus 498 qal~H 502 (586)
T KOG0667|consen 498 QALNH 502 (586)
T ss_pred HHhcC
Confidence 99765
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=306.96 Aligned_cols=254 Identities=29% Similarity=0.492 Sum_probs=207.6
Q ss_pred hhhcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
..++.|...+.||+|++|.||+|... +++.||+|.+..... ....+.+|+++++.++|+|++++++++..+...++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888899999999999999965 789999999876544 4567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++++|.+++......+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 171 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS 171 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchh
Confidence 999999999999866558999999999999999999999986 99999999999999999999999999875443221
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||............ .. ....... ..
T Consensus 172 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~---~~-~~~~~~~-------~~ 239 (286)
T cd06614 172 -KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI---TT-KGIPPLK-------NP 239 (286)
T ss_pred -hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---Hh-cCCCCCc-------ch
Confidence 223345788999999998888999999999999999999999999655443222111 11 1111100 01
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......+.+++.+||+.+|.+||++.++++.
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred hhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1123458899999999999999999999763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=311.36 Aligned_cols=261 Identities=23% Similarity=0.351 Sum_probs=196.8
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh-hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++|...+.||+|++|.||+|.. .+++.||||.+..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5678889999999999999995 4789999999865422 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+.+ +|.+++......+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 85 ~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 159 (291)
T cd07844 85 LDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT- 159 (291)
T ss_pred CCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCcc-
Confidence 985 899998876668899999999999999999999986 999999999999999999999999998754322111
Q ss_pred ccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccc-hhhHHHHHHHHHhh---Cccccc-------
Q 004732 551 STRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKED-MFYLLDWALVLKEQ---GKLMEL------- 618 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~-~~~~~~~~~~~~~~---~~~~~~------- 618 (733)
.....++..|+|||.+.+ ..++.++||||+||++|||++|+.||.... .............. ......
T Consensus 160 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (291)
T cd07844 160 YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFK 239 (291)
T ss_pred ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccc
Confidence 122346889999999875 458999999999999999999999995443 11111100000000 000000
Q ss_pred ------ccCCC-CCCC-CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 619 ------VDTNP-GSNF-DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 619 ------~~~~~-~~~~-~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
..... .... .......+.+++.+|++.+|++||++.++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 240 PYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 0000 0001145778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=305.47 Aligned_cols=248 Identities=28% Similarity=0.462 Sum_probs=199.8
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCC---CCceeeEeeEEEeCCeEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQ---HPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 468 (733)
.|+..+.||+|+||.||+|.. .+++.||+|.+... ......++.+|++++++++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 466778999999999999994 67899999998654 3334567889999999997 999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence 999999999988543 7899999999999999999999986 99999999999999999999999999986654332
Q ss_pred ccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
. .....|+..|+|||.+.++ .++.++|||||||++|+|++|+.||..........+. ..... +.....
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~----~~~~~-----~~~~~~- 225 (277)
T cd06917 157 K-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI----PKSKP-----PRLEDN- 225 (277)
T ss_pred c-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc----ccCCC-----CCCCcc-
Confidence 2 2335689999999998754 4789999999999999999999999655432221110 00000 111110
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.....+.+++.+||+.+|++||++.++++.
T Consensus 226 --~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 226 --GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred --cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 123458899999999999999999999763
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=306.29 Aligned_cols=254 Identities=28% Similarity=0.394 Sum_probs=201.4
Q ss_pred hhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCC-----
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGN----- 462 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~----- 462 (733)
.++++|...+.||+|++|.||+|.. .+++.|++|.+..... ....+.+|+++++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 4678999999999999999999995 4678999999865433 346789999999999 7999999999997644
Q ss_pred -eEEEEEEccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccC
Q 004732 463 -QLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFG 538 (733)
Q Consensus 463 -~~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 538 (733)
..++||||+++++|.+++... ...+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 489999999999999988642 357899999999999999999999986 9999999999999999999999999
Q ss_pred ccccCcccCcccccccccCCCcccHHHHhh-----CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC
Q 004732 539 LAKLDEEENTHISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 613 (733)
Q Consensus 539 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 613 (733)
++........ ......|+..|+|||.+.. ..++.++|||||||++|++++|+.||.......... . . ...
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--~-~-~~~ 233 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF--K-I-PRN 233 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH--H-h-hcc
Confidence 9875443222 2233568899999998853 347889999999999999999999996443221111 0 0 001
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. ............+.+++.+||..||++|||+.++++.
T Consensus 234 ~~-------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 234 PP-------PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred CC-------CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 00 0111122234568899999999999999999999763
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=309.31 Aligned_cols=261 Identities=23% Similarity=0.322 Sum_probs=199.9
Q ss_pred cCccccCcccCCCcccEEEcccC-CCcEEEEEEccccCh--hcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLLI 467 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 467 (733)
++|...+.||+|+||.||+|... +++.||+|.++.... .....+.+|++++++++||||+++++++..+ ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46788899999999999999954 688999999865422 2234567899999999999999999999877 889999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++ +|.+++......+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999985 899988766667999999999999999999999986 9999999999999999999999999998655432
Q ss_pred cccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh---------------
Q 004732 548 THISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE--------------- 611 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--------------- 611 (733)
.. .....+++.|+|||.+.+. .++.++|+||||+++|||++|+.||..........-......
T Consensus 161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 KP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred cc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 21 2234578899999998764 468999999999999999999999965543322211100000
Q ss_pred --hCcccccccCCCCCCCCHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 612 --QGKLMELVDTNPGSNFDKE-QVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 612 --~~~~~~~~~~~~~~~~~~~-~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...............++.. ....+.+++.+||+.+|++||++.|++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000000000011111111 2445789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=302.62 Aligned_cols=248 Identities=26% Similarity=0.412 Sum_probs=201.3
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|...+.||+|+||.||+|.. .+++.+|||.+... .......+.+|+++++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 467788999999999999984 57889999998653 233456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-CeEEcccCccccCcccCc
Q 004732 471 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEENT 548 (733)
Q Consensus 471 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~~~~ 548 (733)
+++++|.+++... ...+++..+.+++.++++||+|||+.+ ++||||||+||+++.++ .+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 9999999999754 345899999999999999999999986 99999999999998654 589999999986543321
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+......... . .......+
T Consensus 158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~---~-~~~~~~~~-------- 223 (256)
T cd08220 158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM---S-GTFAPISD-------- 223 (256)
T ss_pred --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH---h-cCCCCCCC--------
Confidence 223568899999999988889999999999999999999999996655433332211 1 11111111
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.....+.+++.+||+.+|.+|||+.|+++.
T Consensus 224 -~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 -RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 122348899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=299.29 Aligned_cols=250 Identities=30% Similarity=0.484 Sum_probs=206.3
Q ss_pred CccccCcccCCCcccEEEcccC-CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
+|...+.||+|++|.||+|... +++.+++|++..........+.+|++++++++|+|++++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4667789999999999999954 789999999976654456789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+++|.+++......+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||.+........ ..
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~ 155 (253)
T cd05122 81 GGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--RN 155 (253)
T ss_pred CCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--cc
Confidence 99999998766568999999999999999999999986 99999999999999999999999999986654432 23
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (733)
...|+..|+|||.+....++.++||||||+++|+|++|+.||...+......... ......... .....
T Consensus 156 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~----~~~~~~~~~-------~~~~~ 224 (253)
T cd05122 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA----TNGPPGLRN-------PEKWS 224 (253)
T ss_pred ceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH----hcCCCCcCc-------ccccC
Confidence 4568899999999988889999999999999999999999996654322221111 111111111 11113
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 633 MVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 633 ~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..+.+++.+||+.+|++|||+.++++.
T Consensus 225 ~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 225 DEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 458899999999999999999998763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.40 Aligned_cols=256 Identities=27% Similarity=0.402 Sum_probs=200.3
Q ss_pred hhHHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEe---
Q 004732 386 LQIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIE--- 460 (733)
Q Consensus 386 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 460 (733)
.++..+.+.|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.+++++ +||||+++++++..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 87 (282)
T cd06636 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSP 87 (282)
T ss_pred hhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccc
Confidence 34455678899999999999999999994 578999999886543 3345688899999998 69999999999863
Q ss_pred ---CCeEEEEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcc
Q 004732 461 ---GNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 536 (733)
Q Consensus 461 ---~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 536 (733)
....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+|
T Consensus 88 ~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~d 164 (282)
T cd06636 88 PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVD 164 (282)
T ss_pred cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEee
Confidence 45789999999999999998753 346888999999999999999999986 99999999999999999999999
Q ss_pred cCccccCcccCcccccccccCCCcccHHHHh-----hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh
Q 004732 537 FGLAKLDEEENTHISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE 611 (733)
Q Consensus 537 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 611 (733)
||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|+.||.......... ....
T Consensus 165 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~---~~~~ 240 (282)
T cd06636 165 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---LIPR 240 (282)
T ss_pred Ccchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh---hHhh
Confidence 999875433221 123356899999999875 3468889999999999999999999995443221110 0000
Q ss_pred hCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 612 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
. ... ..........+.+++.+||+.+|.+||++.|+++
T Consensus 241 ~------~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 241 N------PPP---KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred C------CCC---CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0 000 0001122345889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.19 Aligned_cols=246 Identities=29% Similarity=0.466 Sum_probs=200.3
Q ss_pred ccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 395 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.++...++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 56778899999999999984 578999999876432 3334678899999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||||+||+++.++.++|+|||++........ ...
T Consensus 86 ~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~~~ 159 (277)
T cd06641 86 GGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-KRN 159 (277)
T ss_pred CCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-hhc
Confidence 9999998854 36899999999999999999999986 99999999999999999999999999876543221 123
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (733)
...|+..|+|||.+.+..++.++|||||||++|+|++|..||........... .. .... ........
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~-~~~~---------~~~~~~~~ 226 (277)
T cd06641 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL---IP-KNNP---------PTLEGNYS 226 (277)
T ss_pred cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH---Hh-cCCC---------CCCCcccC
Confidence 34688899999999888899999999999999999999999965443222211 11 1111 01111223
Q ss_pred HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 633 MVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 633 ~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..+.+++.+||+.+|.+||++.++++.
T Consensus 227 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 227 KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 458889999999999999999999884
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=308.03 Aligned_cols=244 Identities=27% Similarity=0.399 Sum_probs=199.8
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 3677889999999999999984 468999999986431 223467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999998755 47899999999999999999999986 999999999999999999999999999865443
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||...+........ . .+.. ..+
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--~--~~~~----------~~~ 218 (290)
T cd05580 155 --TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI--L--EGKV----------RFP 218 (290)
T ss_pred --CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--h--cCCc----------cCC
Confidence 23456899999999998888999999999999999999999999665532222111 1 1110 011
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRP-----SMSSVLR 658 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 658 (733)
......+.+++.+||+.+|.+|| ++.|+++
T Consensus 219 ~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 219 SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 11234588899999999999999 5666543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.16 Aligned_cols=263 Identities=24% Similarity=0.342 Sum_probs=197.4
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh-hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++++|...+.||+|+||.||+|. ..+|+.||+|.+..... .....+.+|+++++.++|+||+++.+++..++..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 45788899999999999999998 45789999999865432 22346788999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+. +++.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 158 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence 9996 6777777655557889999999999999999999986 99999999999999999999999999975433221
Q ss_pred ccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchh-hHHHHHHHH-------------HhhC
Q 004732 549 HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVL-------------KEQG 613 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~-~~~~~~~~~-------------~~~~ 613 (733)
. .....+++.|+|||.+.+. .++.++|||||||++|||++|+.||...... ......... ....
T Consensus 159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (291)
T cd07870 159 T-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN 237 (291)
T ss_pred C-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence 1 2234578899999998754 5788999999999999999999999543321 111100000 0000
Q ss_pred cccccccCCCCCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 614 KLMELVDTNPGSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 614 ~~~~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
............... ......+.+++.+|++.||++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000000000000 011235778999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=317.97 Aligned_cols=252 Identities=24% Similarity=0.406 Sum_probs=207.2
Q ss_pred cCccccCcccCCCcccEEEcccCCCc-EEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGT-AIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
+-|.+.-.||-|+||.||+|..++.. ..|.|.+...+.....+|+-|++||+...||+||++++.|+.++.+++..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 45667788999999999999966544 45678887777777789999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
.||-.+.++-+-+..|...++.-+++|++.||.|||++ +|||||||+.|||++-+|.++++|||.+..... .....
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~qkR 187 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQKR 187 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh-HHhhh
Confidence 99999999888888999999999999999999999998 499999999999999999999999999863221 12234
Q ss_pred cccccCCCcccHHHHh-----hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 552 TRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
..+.||+.|||||+.+ ..+|+.++||||||+.|.||..+..|-..-+++..+- .....+...++
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll----KiaKSePPTLl------- 256 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL----KIAKSEPPTLL------- 256 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH----HHhhcCCCccc-------
Confidence 5689999999999975 3679999999999999999999999976555443221 01111111111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
-+......+.+++.+|+..+|..||++.++++.
T Consensus 257 qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 123344568899999999999999999999654
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=308.47 Aligned_cols=249 Identities=25% Similarity=0.414 Sum_probs=192.1
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHH-HHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGM-ISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
++|...+.||+|+||.||+|+. .+|+.||+|++.... ......+..|+.. ++..+||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4678889999999999999995 579999999986542 2233456667665 666789999999999999999999999
Q ss_pred ccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 470 YLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 470 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
|++ |+|.+++.. ....+++..++.++.|++.||+|||++. +++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 678877753 3356899999999999999999999862 3999999999999999999999999999865432
Q ss_pred CcccccccccCCCcccHHHHhh----CCCCccchhHhHHHHHHHHHhCCCCCCccc-hhhHHHHHHHHHhhCcccccccC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMR----GHLTEKADVYSFGIVALEIVSGRSNVTKED-MFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
. ......|+..|+|||.+.+ ..++.++|+|||||++|||++|+.||.... ....... .. .......
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~-~~~~~~~--- 228 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ---VV-EEPSPQL--- 228 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH---HH-hcCCCCC---
Confidence 1 1233568889999998864 456889999999999999999999995321 1111110 00 1111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+... ....+.+++.+||..+|.+||++.++++
T Consensus 229 -~~~~----~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 229 -PAEK----FSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred -Cccc----cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0111 2345889999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=308.85 Aligned_cols=250 Identities=28% Similarity=0.436 Sum_probs=200.1
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.|...+.||+|+||.||+|+ ..++..||+|.+.... ......+.+|++++++++|||++++++++.++...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 36778899999999999999 4578999999986432 2234578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+. |++.+.+......+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--- 178 (317)
T cd06635 106 YCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--- 178 (317)
T ss_pred CCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc---
Confidence 997 4788887766667999999999999999999999986 999999999999999999999999998754332
Q ss_pred cccccccCCCcccHHHHh---hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 550 ISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
....|++.|+|||.+. .+.++.++|||||||++|||++|+.||...+....... ..... ... .
T Consensus 179 --~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~-~~~-----~--- 244 (317)
T cd06635 179 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQNE-SPT-----L--- 244 (317)
T ss_pred --ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH---HHhcc-CCC-----C---
Confidence 2346888999999984 35689999999999999999999999865433222111 11111 000 0
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
........+.+++.+||+.+|.+||++.++++.+....
T Consensus 245 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 245 QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 01122335889999999999999999999998765433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=302.72 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=205.1
Q ss_pred cCccccCcccCCCcccEEEcccC-CCcEEEEEEccccCh-hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++|...+.||+|++|.||+|+.. +++.||||.+..... .....+.+|++++.+++|+||+++++++..+...++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36778899999999999999955 599999999876543 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
+++++|.+++... ..+++..+..++.|+++|++|||+ .+ ++||||+|+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 81 MDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ 156 (264)
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence 9999999999755 578999999999999999999999 76 999999999999999999999999999865443322
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccc---hhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED---MFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
.....++..|+|||.+.+..++.++||||||+++|||++|+.||...+ ......+. .. ... ..
T Consensus 157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~-~~~---------~~ 222 (264)
T cd06623 157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---CD-GPP---------PS 222 (264)
T ss_pred -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH---hc-CCC---------CC
Confidence 223567889999999998889999999999999999999999995553 22222111 11 000 01
Q ss_pred CCHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 627 FDKE-QVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 627 ~~~~-~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+.. ....+.+++.+|++.+|++||++.++++.
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1111 33468899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=308.17 Aligned_cols=266 Identities=23% Similarity=0.313 Sum_probs=201.2
Q ss_pred hhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC----
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGN---- 462 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 462 (733)
.+.++|+..+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 4567889999999999999999995 468999999986542 223356788999999999999999999987655
Q ss_pred ------eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcc
Q 004732 463 ------QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 536 (733)
Q Consensus 463 ------~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 536 (733)
..++|+||+++ ++.+.+......+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~d 159 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLAD 159 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCc
Confidence 78999999986 677777655557999999999999999999999986 99999999999999999999999
Q ss_pred cCccccCcccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc-
Q 004732 537 FGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK- 614 (733)
Q Consensus 537 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~- 614 (733)
||++...............++..|+|||.+.+. .++.++|||||||++|||++|+.||...+................
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP 239 (302)
T ss_pred ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 999986654332222334567889999988653 578999999999999999999999965544333222211111000
Q ss_pred --cccccc--------CCCCC-----CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 --LMELVD--------TNPGS-----NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 --~~~~~~--------~~~~~-----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+.. ..... .........+.+++.+||+.+|.+||++.+++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000000 00000 0000123458899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=304.69 Aligned_cols=258 Identities=21% Similarity=0.263 Sum_probs=197.2
Q ss_pred ccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh-hcHHHHHHHHHHHHhCC-CCceeeEeeEEEeC--CeEEEEEE
Q 004732 395 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK-QGNREFINEIGMISALQ-HPNLVKLYGCCIEG--NQLLLIYE 469 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e 469 (733)
|...+.||+|+||.||+|. ..+++.||+|.++.... .......+|+.++.++. |+|++++++++.++ +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 4567889999999999998 45789999999865422 22234567889999885 99999999999987 88999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|++ |++.+.+......+++.++..++.|++.||+|||+.+ ++||||||+||+++. +.+||+|||+++.......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~- 154 (282)
T cd07831 81 LMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP- 154 (282)
T ss_pred cCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCC-
Confidence 997 5888888765567999999999999999999999986 999999999999999 9999999999986543322
Q ss_pred cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC-----------cccc
Q 004732 550 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG-----------KLME 617 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~~ 617 (733)
.....++..|+|||.+.. ..++.++|||||||++|||++|+.||...+......+........ ....
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 155 -YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred -cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 123457889999997654 557889999999999999999999997666554443332211100 0000
Q ss_pred cccCCCCC----CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 618 LVDTNPGS----NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 618 ~~~~~~~~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+.... .........+.+++.+|++.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000 0011234578999999999999999999999763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=307.67 Aligned_cols=261 Identities=24% Similarity=0.364 Sum_probs=200.5
Q ss_pred ccccCcccCCCcccEEEcccC-CCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEEEEE
Q 004732 395 FATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLLIYE 469 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e 469 (733)
|...+.||+|+||.||+|+.. +++.||+|.+.... ......+.+|++++++++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456788999999999999954 68999999997652 33346788999999999999999999999988 89999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++ +|.+++......+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 888888765568999999999999999999999986 999999999999999999999999999866544322
Q ss_pred cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC---ccccccc-----
Q 004732 550 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG---KLMELVD----- 620 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~----- 620 (733)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+............... ......+
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE 236 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence 2233456889999997765 457899999999999999999999996655443332221111000 0000000
Q ss_pred -CCCCCCC--------CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 621 -TNPGSNF--------DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 621 -~~~~~~~--------~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....... .......+.+++.+||+.+|++||++.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000 00014468899999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=293.81 Aligned_cols=242 Identities=26% Similarity=0.333 Sum_probs=201.3
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
..++|+..++||+|.||.|-.++ ...|+.+|+|++++.. +.....-..|-++|+..+||.+..+-..|...+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 45788999999999999999998 6689999999998753 3333445678899999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||..||.|.-+|... ..+++...+.+-..|..||.|||+++ ||+||+|.+|.|+|.+|++||+|||+++..- .
T Consensus 246 VMeyanGGeLf~HLsre-r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~ 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE-RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-K 320 (516)
T ss_pred EEEEccCceEeeehhhh-hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-c
Confidence 99999999999998654 47899999999999999999999985 9999999999999999999999999997422 2
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
......+++||+.|+|||++....|+.++|.|.+||+||||++|+.||...+...+...+. .++- .
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl--~ed~------------k 386 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL--MEDL------------K 386 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH--hhhc------------c
Confidence 2334567999999999999999999999999999999999999999998777655543221 1111 1
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCC
Q 004732 627 FDKEQVMVMINVALLCANASPTIRP 651 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RP 651 (733)
++.....+...++...+..||.+|.
T Consensus 387 FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 387 FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CCccCCHHHHHHHHHHhhcChHhhc
Confidence 2222223366777788999999997
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=313.44 Aligned_cols=259 Identities=22% Similarity=0.302 Sum_probs=197.4
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------C
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------N 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 462 (733)
.++|...+.||+|+||.||+|+ ..+|+.||||.+... .......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 4678889999999999999999 457899999998643 223345678899999999999999999998643 3
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++||||+.+ +|.+.+... +++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|||+++.
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 167 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 167 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcccee
Confidence 57999999965 788877532 889999999999999999999986 99999999999999999999999999986
Q ss_pred CcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHH------------
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK------------ 610 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~------------ 610 (733)
...... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+............
T Consensus 168 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 168 AGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred CCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 543221 233467889999999999999999999999999999999999996554322111110000
Q ss_pred -------hhCc------ccccccCCC----CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 611 -------EQGK------LMELVDTNP----GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 611 -------~~~~------~~~~~~~~~----~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.... ..+...... ...........+.+++.+|++.||++||++.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 000000000 000011234457899999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=299.09 Aligned_cols=249 Identities=23% Similarity=0.424 Sum_probs=200.1
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|...+.||+|+||.||+|.. .+|..||+|.+... .....+.+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 467788999999999999995 46889999998653 123345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC-eEEcccCccccCcccCc
Q 004732 471 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN-SKISDFGLAKLDEEENT 548 (733)
Q Consensus 471 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~-~kl~DfGla~~~~~~~~ 548 (733)
+++++|.+++... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++. +||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999998753 346899999999999999999999986 999999999999998864 69999999976543222
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
......|++.|+|||...+..++.++||||||+++||+++|+.||...+..... .... ....... .
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~-~~~~~~~---------~ 223 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV---LKIC-QGYFAPI---------S 223 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHh-cccCCCC---------C
Confidence 223346899999999998888999999999999999999999999654432221 1111 1111111 1
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......+.+++.+||+.+|++||++.++++.
T Consensus 224 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 224 PNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1122358889999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=315.73 Aligned_cols=245 Identities=25% Similarity=0.445 Sum_probs=193.3
Q ss_pred cccCcccCCCcccEEEccc-CCCcEEEEEEcc--c--cChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe--EEEEE
Q 004732 396 ATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLS--S--KSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ--LLLIY 468 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~--~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lV~ 468 (733)
+...+||+|+|-+||+|.. .+|..||=-.++ . .+....++|..|+++|+.|+|||||++++++.+... +-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 4456899999999999984 467777632222 1 133445789999999999999999999999987654 78999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC-CCeEEcccCccccCcccC
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfGla~~~~~~~ 547 (733)
|.+..|+|..++.+.+ +++......|+.||++||.|||++ .|||||||||-+||+++.+ |.|||+|.|+|.......
T Consensus 123 EL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 9999999999997654 788999999999999999999998 6899999999999999865 789999999998765432
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCcc-chhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE-DMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
...+.|||.|||||.+. ..|++.+||||||+.|+||+|+..||..- +...+.. ..-.+.....+..-
T Consensus 201 ---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYK----KV~SGiKP~sl~kV---- 268 (632)
T KOG0584|consen 201 ---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYK----KVTSGIKPAALSKV---- 268 (632)
T ss_pred ---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHH----HHHcCCCHHHhhcc----
Confidence 23378999999999887 68999999999999999999999999433 2222221 11122211111111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+.+++.+|+.. .++|||+.|+++.
T Consensus 269 ----~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 269 ----KDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ----CCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 112488899999998 9999999999753
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.68 Aligned_cols=253 Identities=27% Similarity=0.435 Sum_probs=193.3
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|...+.||+|+||.||++. ..+++.||+|.+.... ......+.+|+.++.++. ||||+++++++..+...++||||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45566789999999999998 4568999999986542 234567889999999996 99999999999999999999999
Q ss_pred cCCCCHHHH---HHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 471 LENNSLARA---LFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 471 ~~~gsL~~~---l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
+.. ++.++ +.. ....+++..+..++.|++.||+|||+.. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 875 55443 222 2357999999999999999999999752 4999999999999999999999999999754332
Q ss_pred CcccccccccCCCcccHHHHhhC---CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRG---HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.. .....|++.|+|||.+.+. .++.++|||||||++|||++|+.||..... ......... .+.. +..
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~-~~~~-----~~~ 231 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVV-KGDP-----PIL 231 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhc-CCCC-----CcC
Confidence 21 1334688999999999776 689999999999999999999999954431 111111000 0110 011
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...........+.+++.+||+.+|++||++.+|++.
T Consensus 232 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111112234458899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=306.98 Aligned_cols=259 Identities=25% Similarity=0.357 Sum_probs=196.3
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|+..+.||+|++|.||+|+. .+|+.||||.+.... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 477889999999999999984 578999999886542 22335788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
+. ++|.+++... ...+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.+||+|||++.........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 156 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 156 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccc
Confidence 96 6898888643 457899999999999999999999886 999999999999999999999999998755432221
Q ss_pred cccccccCCCcccHHHHhhCC-CCccchhHhHHHHHHHHHhCCCCCCccchhhHH-HHHHHHHhh---------------
Q 004732 550 ISTRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL-DWALVLKEQ--------------- 612 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~-~~~~~~~~~--------------- 612 (733)
.....+++.|+|||.+.+.. ++.++|||||||++|||+||+.||...+..... .........
T Consensus 157 -~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07860 157 -YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK 235 (284)
T ss_pred -cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence 22335688999999876644 688999999999999999999999655432211 111000000
Q ss_pred CcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 613 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
........... ..........+.+++.+|++.||++||++.++++
T Consensus 236 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 236 PSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 0000111234778999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=318.28 Aligned_cols=262 Identities=24% Similarity=0.388 Sum_probs=200.6
Q ss_pred ccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------CeEEE
Q 004732 395 FATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------NQLLL 466 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 466 (733)
|...+.||+||||.||+|+ ..+|+.||||.+... .....+...+|+++|++++|+|||+++++=.+. ....+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 4456789999999999999 678999999999764 334456778999999999999999999985543 35689
Q ss_pred EEEccCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec--CCCC--eEEcccCcc
Q 004732 467 IYEYLENNSLARALF--EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD--KDLN--SKISDFGLA 540 (733)
Q Consensus 467 V~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~--~~~~--~kl~DfGla 540 (733)
|||||.+|||...+. ++...|++.+.+.++.+++.||.|||+++ ||||||||.||++- ++|+ .||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 999999999999998 45668999999999999999999999986 99999999999993 3344 699999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchh---hHHHHHHHHHhhCccc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMF---YLLDWALVLKEQGKLM 616 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~ 616 (733)
+...+.. ....++||..|++||.+.. +.|+..+|.|||||++||++||..||.+.... .-..|.........+.
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~ 249 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA 249 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence 9766544 4566899999999999985 88999999999999999999999999543322 1233443332222211
Q ss_pred ccccCCC------------CCCCCHHHHHHHHHHHHHhhcCCCCCCC--CHHHHHHHhc
Q 004732 617 ELVDTNP------------GSNFDKEQVMVMINVALLCANASPTIRP--SMSSVLRMLE 661 (733)
Q Consensus 617 ~~~~~~~------------~~~~~~~~~~~l~~l~~~c~~~~P~~RP--t~~~vl~~L~ 661 (733)
-...+.. ...........+-......+..+|++|. .+.+....+.
T Consensus 250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~ 308 (732)
T KOG4250|consen 250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD 308 (732)
T ss_pred EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence 1111111 1112333444566777778888899998 5555554444
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=301.78 Aligned_cols=247 Identities=25% Similarity=0.336 Sum_probs=200.9
Q ss_pred CccccCcccCCCcccEEEcccC-CCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
+|...+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|++++++++||||+++++++.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4677889999999999999954 68999999986532 2345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+.+++|.+++... ..+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999998755 57899999999999999999999886 9999999999999999999999999988654432
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......... +....... .. ...+.
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~-~~---------~~~~~ 223 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRD-QIRAKQET-AD---------VLYPA 223 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHH-HHHHHhcc-cc---------ccCcc
Confidence 223456888999999998888999999999999999999999999655432111 11111110 00 11111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCH--HHHH
Q 004732 630 EQVMVMINVALLCANASPTIRPSM--SSVL 657 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~--~~vl 657 (733)
.....+.+++.+||+.+|.+||++ +|++
T Consensus 224 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 TWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 223568899999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=299.90 Aligned_cols=259 Identities=29% Similarity=0.417 Sum_probs=195.0
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHh--CCCCceeeEeeEEEeCC----eEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISA--LQHPNLVKLYGCCIEGN----QLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l 466 (733)
......++||+|.||.||||.+. ++.||||++.. ...+.|.+|-++.+. ++|+||++++++-.... +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34556778999999999999986 49999999954 345678888887765 47999999999976655 8899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC------CCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE------SRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
|++|.+.|+|.++|..+ .++|....+|+..+++||+|||+. ..++|+|||||++|||+..|+++.|+|||+|
T Consensus 286 Vt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred EeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 99999999999999765 789999999999999999999975 3567999999999999999999999999999
Q ss_pred ccCcccCcc-cccccccCCCcccHHHHhhCC-CC-----ccchhHhHHHHHHHHHhCCCCC------------Ccc--ch
Q 004732 541 KLDEEENTH-ISTRVAGTIGYMAPEYAMRGH-LT-----EKADVYSFGIVALEIVSGRSNV------------TKE--DM 599 (733)
Q Consensus 541 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~s~Gvil~elltg~~p~------------~~~--~~ 599 (733)
..+...... .....+||.+|||||++.+.- +. .+.||||+|.|+|||++.-.-+ ..+ ..
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 877643332 223478999999999998742 22 3789999999999999843222 100 01
Q ss_pred hhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 600 FYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
..+-+......+.+.+..+.+.=.. ...+..+.+.+..||+.||+.|.|+.=|-+.+.
T Consensus 444 Pt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~ 501 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMA 501 (534)
T ss_pred CCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence 1111111222222333333221111 023445888999999999999999987766555
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=311.97 Aligned_cols=268 Identities=25% Similarity=0.367 Sum_probs=200.8
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----CeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 464 (733)
+++|...+.||+|+||.||+|+ ..+|+.||||.+.... ......+.+|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 4688999999999999999998 5578999999986432 23345688899999999999999999987654 357
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++|+||+++ +|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 157 (336)
T cd07849 84 YIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD 157 (336)
T ss_pred EEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence 999999975 78777643 46899999999999999999999986 9999999999999999999999999997654
Q ss_pred ccCcc--cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc---cccc
Q 004732 545 EENTH--ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK---LMEL 618 (733)
Q Consensus 545 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~ 618 (733)
..... ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||...+......+......... ...+
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (336)
T cd07849 158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237 (336)
T ss_pred ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 32221 1233568999999998765 4689999999999999999999999965543332221111111000 0000
Q ss_pred c-----------cCCCCCCC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--hccCcc
Q 004732 619 V-----------DTNPGSNF---DKEQVMVMINVALLCANASPTIRPSMSSVLRM--LECGVD 665 (733)
Q Consensus 619 ~-----------~~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~--L~~~~~ 665 (733)
. ........ .+.....+.+++.+||+.+|++||++.|+++. ++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 0 00000000 01123458899999999999999999999876 554443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=306.03 Aligned_cols=263 Identities=25% Similarity=0.360 Sum_probs=199.7
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh--hcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 466 (733)
.++|+..+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 45788999999999999999994 5689999999864322 1223567899999999999999999998765 56899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++ +|.+++......+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 9999975 788888766668999999999999999999999986 999999999999999999999999999865443
Q ss_pred CcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC--ccc-------
Q 004732 547 NTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG--KLM------- 616 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~------- 616 (733)
... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+............... ...
T Consensus 162 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 211 222345788999999875 458999999999999999999999997665444332221111000 000
Q ss_pred --ccc--cCCCCCCCC---HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 --ELV--DTNPGSNFD---KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 --~~~--~~~~~~~~~---~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
... ......... ......+.+++.+|++.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000 000000000 0123457889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=294.88 Aligned_cols=251 Identities=30% Similarity=0.457 Sum_probs=204.5
Q ss_pred CccccCcccCCCcccEEEcccC-CCcEEEEEEccccCh--hcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLLIY 468 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 468 (733)
+|...+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|++++++++||||+++++++.+. ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999954 789999999865532 4457889999999999999999999999988 8999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++++|.+++.... .+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999987654 8999999999999999999999986 99999999999999999999999999986655432
Q ss_pred c-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 549 H-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 549 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
. ......++..|+|||.+.+...+.++||||||+++++|++|+.||...+......+. ........ ..
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~---------~~ 225 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK--IGSSGEPP---------EI 225 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHh--ccccCCCc---------CC
Confidence 1 123456888999999998888999999999999999999999999655411111111 00001111 11
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+......+.+++.+|++.+|++||++.++++.
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 12224468899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=301.59 Aligned_cols=260 Identities=26% Similarity=0.386 Sum_probs=198.0
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh-hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
+|+..+.||+|++|.||+|+. .+|+.||||.+..... .....+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 477889999999999999995 4689999999865432 23456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 472 ENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 472 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
++ +|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 8888886443 46899999999999999999999886 99999999999999999999999999975443221
Q ss_pred cccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC---------cccccc
Q 004732 550 ISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG---------KLMELV 619 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 619 (733)
......++..|++||.+.+. .++.++|||||||++||+++|+.||...+............... ......
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 12234578899999998664 57899999999999999999999996554332221111000000 000000
Q ss_pred cCCCCC------CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 620 DTNPGS------NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 620 ~~~~~~------~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+.. ...+.....+.+++.+|++.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000000 001112345789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=297.63 Aligned_cols=240 Identities=23% Similarity=0.342 Sum_probs=194.4
Q ss_pred ccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCH
Q 004732 401 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 476 (733)
Q Consensus 401 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 476 (733)
||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+++++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 79999999999995 458999999986532 23346789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccccccc
Q 004732 477 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG 556 (733)
Q Consensus 477 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 556 (733)
.+++... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||+++...... ......|
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDR-GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 9999754 36899999999999999999999986 9999999999999999999999999998665432 2233568
Q ss_pred CCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccc--hhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHH
Q 004732 557 TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED--MFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 634 (733)
Q Consensus 557 t~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (733)
+..|+|||.+.+..++.++|+||+|+++||+++|+.||.... ...... ....... ...++......
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~---------~~~~~~~~~~~ 222 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYN---DILKGNG---------KLEFPNYIDKA 222 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHH---HHhccCC---------CCCCCcccCHH
Confidence 899999999988889999999999999999999999996554 221111 1110000 01111112345
Q ss_pred HHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004732 635 MINVALLCANASPTIRPS-----MSSVLR 658 (733)
Q Consensus 635 l~~l~~~c~~~~P~~RPt-----~~~vl~ 658 (733)
+.+++.+||+.+|++||+ +.|+++
T Consensus 223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 223 AKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred HHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 899999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=299.48 Aligned_cols=242 Identities=26% Similarity=0.302 Sum_probs=186.0
Q ss_pred cccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHH---hCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 400 NIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMIS---ALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 400 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
+||+|+||.||+|.. .+++.||+|.+.... ......+.+|..+++ ..+||||+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999984 568999999885432 122233445554443 3479999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++....... ..
T Consensus 81 ~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~~ 153 (279)
T cd05633 81 GGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (279)
T ss_pred CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---cc
Confidence 99999988654 36999999999999999999999986 9999999999999999999999999987543321 12
Q ss_pred ccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 553 RVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
...|+..|+|||.+.+ ..++.++|||||||++|||++|+.||................ .... ..+...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-------~~~~----~~~~~~ 222 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-------TVNV----ELPDSF 222 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-------cCCc----CCcccc
Confidence 3468999999999874 558999999999999999999999995432211111111000 0011 112223
Q ss_pred HHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004732 632 VMVMINVALLCANASPTIRP-----SMSSVLRM 659 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RP-----t~~~vl~~ 659 (733)
...+.+++.+|++.+|.+|| +++++++.
T Consensus 223 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 223 SPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 34588899999999999999 58888664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=303.79 Aligned_cols=260 Identities=26% Similarity=0.360 Sum_probs=196.2
Q ss_pred ccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 395 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
|+..+.||.|++|.||+|.. .+|+.||+|++.... ......+.+|+++++.++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45678999999999999984 579999999986542 223357889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 472 ENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 472 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+ ++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++........
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~- 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT- 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence 5 68999887543 46899999999999999999999886 999999999999999999999999999755432221
Q ss_pred ccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhH-HHHHHHHHhhC--------ccccccc
Q 004732 551 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL-LDWALVLKEQG--------KLMELVD 620 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~--------~~~~~~~ 620 (733)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...+.... ........... ...+...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 1223468899999987654 578999999999999999999999965443221 11111000000 0000000
Q ss_pred CC------CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 621 TN------PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 621 ~~------~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. ............+.+++.+|++.+|++||++.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0000011122458899999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=303.00 Aligned_cols=262 Identities=23% Similarity=0.271 Sum_probs=194.8
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCe-----
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQ----- 463 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 463 (733)
++|+..+.||+|+||.||+|+. .+++.||+|.+.... ......+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3678889999999999999994 578999999876542 223357888999999995 6999999999987665
Q ss_pred EEEEEEccCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC-CCCeEEcccC
Q 004732 464 LLLIYEYLENNSLARALFEH----RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFG 538 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfG 538 (733)
.++||||+++ +|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999986 788887643 245899999999999999999999986 999999999999998 8899999999
Q ss_pred ccccCcccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc--
Q 004732 539 LAKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL-- 615 (733)
Q Consensus 539 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 615 (733)
+++........ .....+++.|+|||.+.+ ..++.++||||||+++|||++|..||...+......-..........
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV 235 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 98754332111 122356889999998865 45799999999999999999999999655433221111000000000
Q ss_pred -ccc---cc---CCCCC-----CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 616 -MEL---VD---TNPGS-----NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 616 -~~~---~~---~~~~~-----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
... .+ ..... ...+.....+.+++.+|++.+|.+||++.|++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00 00000 0001123458899999999999999999998753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.98 Aligned_cols=244 Identities=26% Similarity=0.432 Sum_probs=197.7
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCHH
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLA 477 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~ 477 (733)
..||+|+||.||+|.. .+++.||||++..........+.+|+.+++.++|+||+++++++..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999985 578999999986555455567899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccccccC
Q 004732 478 RALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT 557 (733)
Q Consensus 478 ~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 557 (733)
+++.. ..+++.....++.|++.|++|||+.+ ++||||+|+||++++++.++|+|||++........ ......|+
T Consensus 106 ~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~ 179 (292)
T cd06657 106 DIVTH--TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLVGT 179 (292)
T ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccccC
Confidence 98743 36899999999999999999999986 99999999999999999999999999875443221 12335688
Q ss_pred CCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHH
Q 004732 558 IGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMIN 637 (733)
Q Consensus 558 ~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 637 (733)
+.|+|||.+.+..++.++||||+|+++|||++|+.||............. .. ...... . .......+.+
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~---~~--~~~~~~-~-----~~~~~~~l~~ 248 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---DN--LPPKLK-N-----LHKVSPSLKG 248 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hh--CCcccC-C-----cccCCHHHHH
Confidence 99999999988889999999999999999999999997654433322111 10 000000 0 0111234778
Q ss_pred HHHHhhcCCCCCCCCHHHHHHH
Q 004732 638 VALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 638 l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
++.+||+.+|.+||++.++++.
T Consensus 249 li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 249 FLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHhCCcccCcCHHHHhcC
Confidence 8999999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=293.97 Aligned_cols=249 Identities=24% Similarity=0.426 Sum_probs=205.0
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|...+.||+|+||.||+|.. .++..||+|++.... ......+.+|+++++.++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 467788999999999999995 468999999986543 24556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 471 LENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 471 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
+++++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999754 368999999999999999999999986 9999999999999999999999999998654433
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||...+....... .. ......+
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~---~~-~~~~~~~--------- 223 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK---IL-KGQYPPI--------- 223 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH---Hh-cCCCCCC---------
Confidence 223345688999999999888899999999999999999999999966553332221 11 1111111
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+......+.+++.+||..+|++||++.++++.
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11223458889999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=283.57 Aligned_cols=254 Identities=25% Similarity=0.397 Sum_probs=200.5
Q ss_pred hhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 466 (733)
...++......||.|+-|.|++++. ..|..+|||.+... .+...+++...+.++.+-+ +|+||+.+|||..+...++
T Consensus 89 ~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 89 ADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred cChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 3445566677899999999999994 56899999998765 3445567777888766654 8999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
.||.|.. -++.++......+++.-+-++...+..||.||.++. .|+|||+||+|||+|+.|.+|+||||++...-+.
T Consensus 169 cMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 169 CMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence 9998854 466677666678999999999999999999998875 6999999999999999999999999999766553
Q ss_pred CcccccccccCCCcccHHHHhh---CCCCccchhHhHHHHHHHHHhCCCCCCccc-hhhHHHHHHHHHhhCcccccccCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKED-MFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
.. .+..+|-+.|||||.+.- ..|+-++|||||||.++||.||+.||...+ .+..+.-+. +.+. ..++..
T Consensus 246 kA--htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl----n~eP-P~L~~~ 318 (391)
T KOG0983|consen 246 KA--HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL----NEEP-PLLPGH 318 (391)
T ss_pred cc--cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH----hcCC-CCCCcc
Confidence 33 355678999999999864 468999999999999999999999996532 333332111 1111 111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......+.+++..|++.|+.+||.+.++++.
T Consensus 319 ------~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 319 ------MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ------cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1134458899999999999999999998764
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=321.09 Aligned_cols=252 Identities=29% Similarity=0.445 Sum_probs=207.9
Q ss_pred ccccCcccCCCcccEEEcc-cCCCc----EEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 395 FATDNNIGEGGFGPVYKGL-LADGT----AIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~-~~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++.+++||+|+||+||+|. .++|+ +||+|++... ..+...++.+|+-+|.+++|||+++++|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 4567899999999999998 45554 6889988654 3445678999999999999999999999998776 88999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
+||+.|+|.++++.++..+.....+.|+.|||+||.|||++. +|||||.++|||+.+-..+||+|||+|+....+..
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999999899999999999999999999999885 99999999999999999999999999998776554
Q ss_pred cccc-ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 549 HIST-RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 549 ~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
.... ...-.+.|||-|.+....|+.++|||||||.+||++| |..|+.+....++.+. .+.+++ ..
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl----le~geR---------Ls 920 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL----LEKGER---------LS 920 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH----Hhcccc---------CC
Confidence 4332 2233568999999999999999999999999999998 9999866544333321 122222 12
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
-++....+++-++.+||..|+..||+++++...+...
T Consensus 921 qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 921 QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 2233444588889999999999999999998777653
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=304.13 Aligned_cols=249 Identities=28% Similarity=0.434 Sum_probs=198.5
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.+.|...+.||+|+||.||+|+. .++..||+|.+... ......++.+|+++++.++|+|++++++++..+...++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 44577788999999999999994 56889999988542 223345788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+. |++.+++......+++.++..++.|++.|+.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 99996 6888887665667899999999999999999999986 999999999999999999999999998754432
Q ss_pred cccccccccCCCcccHHHHhh---CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
....|++.|+|||.+.+ ..++.++|||||||++|||++|+.||...+...... .. ........
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~-~~~~~~~~------ 234 (308)
T cd06634 169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HI-AQNESPAL------ 234 (308)
T ss_pred ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH---HH-hhcCCCCc------
Confidence 23467889999999853 467889999999999999999999986543322111 01 11111100
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
........+.+++.+||+.+|.+||++.++++...
T Consensus 235 --~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 235 --QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 01122345788999999999999999999987644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=295.70 Aligned_cols=247 Identities=27% Similarity=0.431 Sum_probs=204.0
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|+..+.||+|+||.||+|+ ..+++.+|+|.+... .......+.+|++++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 46778899999999999998 457889999998653 233346788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 471 LENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 471 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
+++++|.+++.. ....+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999864 2357899999999999999999999986 999999999999999999999999999866544
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
......|+..|+|||.+.+..++.++|+||+|+++||+++|+.||...+........ ..+... ..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~----~~~~~~---------~~ 221 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV----QRGKYP---------PI 221 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----hcCCCC---------CC
Confidence 122345788999999999888999999999999999999999999766544332211 111111 11
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+......+.+++.+|++.+|.+||++.++++.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12334558999999999999999999999764
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=298.88 Aligned_cols=240 Identities=25% Similarity=0.315 Sum_probs=189.3
Q ss_pred ccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCH
Q 004732 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 476 (733)
Q Consensus 401 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 476 (733)
||+|+||+||+|. ..+|+.||+|.+.... ......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999998 4578999999986432 22345677899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccccc
Q 004732 477 ARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 555 (733)
Q Consensus 477 ~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~ 555 (733)
.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++....... ......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence 99987543 46899999999999999999999986 9999999999999999999999999987654321 122345
Q ss_pred cCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHH
Q 004732 556 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVM 635 (733)
Q Consensus 556 gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 635 (733)
++..|+|||.+.+..++.++|||||||++|+|++|+.||............ .. ... .. . ...+......+
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~-~~~-~~-~----~~~~~~~~~~~ 225 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL---KR-RTL-EM-A----VEYPDKFSPEA 225 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH---Hh-ccc-cc-c----ccCCccCCHHH
Confidence 788999999998888999999999999999999999999554321111100 00 000 00 0 01111223458
Q ss_pred HHHHHHhhcCCCCCCCCHHH
Q 004732 636 INVALLCANASPTIRPSMSS 655 (733)
Q Consensus 636 ~~l~~~c~~~~P~~RPt~~~ 655 (733)
.+++.+||+.+|.+||++.+
T Consensus 226 ~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 226 KDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHccCChhHccCCCc
Confidence 89999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=304.16 Aligned_cols=263 Identities=22% Similarity=0.310 Sum_probs=196.7
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-------
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGN------- 462 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 462 (733)
++|...+.||+|+||.||+|.. .+++.||||.+.... ......+.+|++++++++||||++++++|....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 4688889999999999999994 578999999885432 222345678999999999999999999987654
Q ss_pred -eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 463 -QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 463 -~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
..++||||+.+ +|.+.+......+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 45999999975 788888766667999999999999999999999986 9999999999999999999999999997
Q ss_pred cCcccCcc---cccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh---Cc
Q 004732 542 LDEEENTH---ISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ---GK 614 (733)
Q Consensus 542 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~ 614 (733)
........ ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...+.............. ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV 247 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence 65432211 12234578899999988764 4788999999999999999999999665543332221111100 00
Q ss_pred cc-----ccccC--CCCC---CC-----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 LM-----ELVDT--NPGS---NF-----DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 ~~-----~~~~~--~~~~---~~-----~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. +..+. .+.. .. .......+.+++.+||+.+|.+||++.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 00 00000 0000 00 00012346789999999999999999998753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=293.27 Aligned_cols=247 Identities=30% Similarity=0.499 Sum_probs=202.7
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh--hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|...+.||+|++|.||+|+. .+++.||+|.+..... .....+.+|++++++++|||++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 466788999999999999984 4688999999876543 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 155 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD- 155 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence 9999999998655 57999999999999999999999986 999999999999999999999999999866543332
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||......... |... ...... .+..
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~-~~~~---~~~~~~---------~~~~ 222 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL-FRIV---QDDHPP---------LPEG 222 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH-HHHh---ccCCCC---------CCCC
Confidence 23356889999999998888899999999999999999999999654422211 1111 111111 1111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
....+.+++.+|+..+|++||++.+++.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 2345889999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=298.52 Aligned_cols=245 Identities=27% Similarity=0.402 Sum_probs=197.7
Q ss_pred ccCCCcccEEEcccC-CCcEEEEEEccccCh---hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCH
Q 004732 401 IGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 476 (733)
Q Consensus 401 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 476 (733)
||+|+||.||+|+.. +|+.||+|.+..... .....+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 589999999865432 3456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc-------c
Q 004732 477 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-------H 549 (733)
Q Consensus 477 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~-------~ 549 (733)
.+++.... .+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99997654 7899999999999999999999986 99999999999999999999999999875433211 1
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
......++..|+|||.......+.++||||||+++||+++|+.||............. . +.. .. + ...
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---~-~~~----~~-~-~~~-- 224 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL---N-GKI----EW-P-EDV-- 224 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---c-CCc----CC-C-ccc--
Confidence 2233567889999999988889999999999999999999999996655433322111 1 110 00 0 000
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.....+.+++.+||+.+|++||++.++.+.|+
T Consensus 225 ~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 225 EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01345889999999999999999966666655
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=305.64 Aligned_cols=200 Identities=28% Similarity=0.444 Sum_probs=167.2
Q ss_pred CccccCcccCCCcccEEEcccC---CCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLL 465 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 465 (733)
.|...+.||+|+||.||+|... +++.||+|.+.... ......+.+|++++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3667789999999999999954 57999999987632 33346678899999999999999999999988 8899
Q ss_pred EEEEccCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC----CCCeEEccc
Q 004732 466 LIYEYLENNSLARALFEH----RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK----DLNSKISDF 537 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~----~~~~kl~Df 537 (733)
+||||+++ ++.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 666666422 236889999999999999999999986 999999999999999 899999999
Q ss_pred CccccCcccCc--ccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCcc
Q 004732 538 GLAKLDEEENT--HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKE 597 (733)
Q Consensus 538 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~ 597 (733)
|+++....... .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 219 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGR 219 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 99986543322 112345688999999988764 5899999999999999999999999543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=294.64 Aligned_cols=249 Identities=26% Similarity=0.355 Sum_probs=197.2
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc-----ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-----SKQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQL 464 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 464 (733)
.+|...+.||+|+||.||+|+. .+++.||+|.+... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999984 56899999987432 122345788999999999999999999998764 468
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++|+||+++++|.+++.... .+++....+++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 89999999999999986543 5889999999999999999999986 9999999999999999999999999998543
Q ss_pred ccCc--ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 545 EENT--HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 545 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
.... .......|+..|+|||.+.+..++.++|||||||++||+++|+.||........... .....
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~--------- 225 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK---IATQP--------- 225 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHH---HHcCC---------
Confidence 2111 112235689999999999888899999999999999999999999965433221111 11011
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.....+......+.+++.+||+ +|..||+..+++.
T Consensus 226 ~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 0111222334458899999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=301.42 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=194.5
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh--hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
++|...+.||+|++|.||+|.. .+|+.||+|.+..... .....+.+|++++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4678889999999999999985 4789999999865322 233578899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC-CCCeEEcccCccccCcccC
Q 004732 470 YLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 470 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfGla~~~~~~~ 547 (733)
|++ ++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 996 4787777533 334688889999999999999999986 999999999999985 4579999999997654321
Q ss_pred cccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccc-------c
Q 004732 548 THISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL-------V 619 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------~ 619 (733)
. ......+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+......-...... ...... .
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 235 (294)
T PLN00009 158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILG-TPNEETWPGVTSLP 235 (294)
T ss_pred c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC-CCChhhccccccch
Confidence 1 12234578899999998764 578999999999999999999999965543322111100000 000000 0
Q ss_pred c---CCC--CC----CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 620 D---TNP--GS----NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 620 ~---~~~--~~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+ ..+ .. ...+.....+.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 000 00 001112335788999999999999999999986
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=300.08 Aligned_cols=258 Identities=19% Similarity=0.217 Sum_probs=183.3
Q ss_pred hcCccccCcccCCCcccEEEcccCC----CcEEEEEEccccChhc-----------HHHHHHHHHHHHhCCCCceeeEee
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLAD----GTAIAVKQLSSKSKQG-----------NREFINEIGMISALQHPNLVKLYG 456 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~l~~ 456 (733)
.++|.+.+.||+|+||.||+|...+ +..+|+|......... ......+...+..+.|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3578899999999999999999543 4566666543222111 011233444566778999999999
Q ss_pred EEEeCC----eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCe
Q 004732 457 CCIEGN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 532 (733)
Q Consensus 457 ~~~~~~----~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 532 (733)
++.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLVE-NTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeeEecCCceEEEEEEehhcc-CHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence 876543 44778887654 55555543 234678889999999999999999986 9999999999999999999
Q ss_pred EEcccCccccCcccCcc------cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccch-hhHHHH
Q 004732 533 KISDFGLAKLDEEENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLDW 605 (733)
Q Consensus 533 kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~-~~~~~~ 605 (733)
+|+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999865432211 11234699999999999999999999999999999999999999954421 111110
Q ss_pred HHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 606 ALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.... ....+....... ......+.+++..||+.+|++||++.++++.++
T Consensus 246 ~~~~----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 246 AKCD----FIKRLHEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred hHHH----HHHHhhhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0000 000000000000 011244889999999999999999999998763
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=299.99 Aligned_cols=260 Identities=22% Similarity=0.312 Sum_probs=201.7
Q ss_pred ccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh--hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 395 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
|...+.||+|++|.||+|.. .+++.+|+|.+..... .....+.+|++++++++|+||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45667899999999999985 5789999999865432 23467888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
++ ++.+++......+++..+..++.|+++||+|||+.+ |+|+||||+||+++.++.+||+|||.+........ ..
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~-~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR-PY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-cc
Confidence 75 888888765568999999999999999999999986 99999999999999999999999999976654431 12
Q ss_pred cccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC---cccccc--------
Q 004732 552 TRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG---KLMELV-------- 619 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~-------- 619 (733)
....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...+............... ......
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF 235 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence 234578899999998876 78999999999999999999999996655433221111110000 000000
Q ss_pred ---cCCCC--CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 620 ---DTNPG--SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 620 ---~~~~~--~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..... ..........+.+++.+||+.||.+||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000 00112234578899999999999999999999763
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=302.48 Aligned_cols=244 Identities=29% Similarity=0.463 Sum_probs=196.0
Q ss_pred ccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 395 FATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
|...+.||+|+||+||+|+. .+|+.||+|.+.... ......+.+|+++++.++|||++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999984 578999999986432 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+. |++.+.+......+++.++..++.|++.||+|||+.| ++||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP----- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC-----
Confidence 96 5788887766667999999999999999999999986 99999999999999999999999999864322
Q ss_pred ccccccCCCcccHHHHh---hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 551 STRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.....|+..|+|||.+. ...++.++|||||||++|||++|+.||...+......... . ...... ....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~---~-~~~~~~----~~~~- 244 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---Q-NDSPTL----QSNE- 244 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---h-cCCCCC----Cccc-
Confidence 22356889999999984 3568889999999999999999999996655433332211 1 111111 0111
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+.+++.+||+.+|.+||++.++++.
T Consensus 245 ---~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 245 ---WTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ---cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 12347889999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.98 Aligned_cols=263 Identities=20% Similarity=0.346 Sum_probs=199.8
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIE----GNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 464 (733)
.++|...+.||+|+||.||+|+ ..+|+.||+|++.... ......+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3678888999999999999998 4579999999987542 2334567889999999999999999998763 3568
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||+. |+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 158 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLS 158 (334)
T ss_pred EEEEehhh-hhHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeec
Confidence 99999996 5898888644 45999999999999999999999986 9999999999999999999999999997554
Q ss_pred ccCcc---cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh---------
Q 004732 545 EENTH---ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE--------- 611 (733)
Q Consensus 545 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--------- 611 (733)
..... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...+.............
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~ 238 (334)
T cd07855 159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238 (334)
T ss_pred ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence 32221 1234568999999999865 4689999999999999999999999966543332221111000
Q ss_pred --hCcccccccCCC-CCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 612 --QGKLMELVDTNP-GSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 612 --~~~~~~~~~~~~-~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+........ ..... ......+.+++.+|++.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000000000000 00111 1224568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=294.88 Aligned_cols=244 Identities=23% Similarity=0.299 Sum_probs=190.1
Q ss_pred CcccCCCcccEEEccc-CCCcEEEEEEccccCh---hcHHHHHHHHHHH-HhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIGMI-SALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||.||+|.. .+|+.||||.+..... .....+..|..++ ...+|+|++++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4699999999999984 5689999999865322 1223445555544 455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||+++.... ...
T Consensus 82 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 9999998654 46899999999999999999999986 99999999999999999999999999875432 233
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..|++.|+|||.+.+..++.++||||||+++|||++|..||...+......- .. ..... . . .........
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~-~~~~~-~-~----~~~~~~~~~ 222 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN---IL-SRRIN-W-P----EEVKEFCSP 222 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HH-hcccC-C-C----CcccccCCH
Confidence 5688899999999888899999999999999999999999966544332211 11 11100 0 0 000111234
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 634 VMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.+.+++.+||+.+|++||++.++.+.|+
T Consensus 223 ~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 223 EAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred HHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 5889999999999999998876655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=308.97 Aligned_cols=263 Identities=23% Similarity=0.386 Sum_probs=197.7
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC--CeE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG--NQL 464 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 464 (733)
..++|...+.||+|+||.||+|.. .+++.||||++... .......+.+|+.+++++ +||||++++++|... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 346788889999999999999995 46889999988542 223345677899999999 999999999998754 468
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||++ ++|..++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~ 158 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLS 158 (337)
T ss_pred EEEecccc-cCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence 99999997 5898888654 7899999999999999999999986 9999999999999999999999999998654
Q ss_pred ccCc----ccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh--------
Q 004732 545 EENT----HISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE-------- 611 (733)
Q Consensus 545 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-------- 611 (733)
.... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||.................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07852 159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE 238 (337)
T ss_pred cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 3322 12234568999999998765 4578999999999999999999999965433222111100000
Q ss_pred ------hCcccccccCCCC---CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 612 ------QGKLMELVDTNPG---SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 612 ------~~~~~~~~~~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
............. ..........+.+++.+||+.+|++||++.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000 00001123468899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=339.72 Aligned_cols=255 Identities=31% Similarity=0.451 Sum_probs=206.2
Q ss_pred HHhhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
+...+-+|.....||.|.||.||.|. ..+|.-.|||.++.. .....+...+|..++..++|||+|+++|+=.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 44455677888999999999999999 678999999987653 333446678899999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++.||||++|+|.+.+. .+...++.....+..|++.|++|||++| ||||||||.||+|+.+|.+|++|||.|..+.
T Consensus 1310 ~IFMEyC~~GsLa~ll~-~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLE-HGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHHhccCcHHHHHH-hcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 99999999999999885 4446777788889999999999999997 9999999999999999999999999998765
Q ss_pred ccCc---ccccccccCCCcccHHHHhhC---CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHH-HhhCcccc
Q 004732 545 EENT---HISTRVAGTIGYMAPEYAMRG---HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVL-KEQGKLME 617 (733)
Q Consensus 545 ~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 617 (733)
.... ......+||+.|||||++.+. ....+.||||+|||+.||+||++||..-+. .|+... ...+...+
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn----e~aIMy~V~~gh~Pq 1461 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN----EWAIMYHVAAGHKPQ 1461 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc----hhHHHhHHhccCCCC
Confidence 4421 123357899999999999764 367799999999999999999999954332 243322 22333322
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 618 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+ +......-.+++.+|++.||++|.++.|+++.
T Consensus 1462 ~---------P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1462 I---------PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred C---------chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 2 22244456788999999999999999877653
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=306.55 Aligned_cols=266 Identities=23% Similarity=0.353 Sum_probs=199.8
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----Ce
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQ 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 463 (733)
.++|...+.||+|+||+||+|+ ..+++.||||.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 3578888999999999999998 457899999998653 223345678899999999999999999988654 34
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.++|+||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 158 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTT 158 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence 799999996 6888888644 47999999999999999999999986 999999999999999999999999999865
Q ss_pred cccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh----------
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ---------- 612 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---------- 612 (733)
.... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+..............
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (337)
T cd07858 159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237 (337)
T ss_pred CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence 4332 22233467889999998875 46899999999999999999999999654432211111100000
Q ss_pred -Ccccccc---cCCCCC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--hccC
Q 004732 613 -GKLMELV---DTNPGS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM--LECG 663 (733)
Q Consensus 613 -~~~~~~~---~~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~--L~~~ 663 (733)
......+ ...... ...+.....+.+++.+|++.+|++||++.++++. ++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000000 000000 0011223458899999999999999999999876 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=304.17 Aligned_cols=263 Identities=25% Similarity=0.353 Sum_probs=196.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh--hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC------
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGN------ 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 462 (733)
.++|...+.||+|+||.||+|+. .+++.||||.+..... .....+.+|++++++++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 56888999999999999999994 5789999998854322 12346788999999999999999999876533
Q ss_pred --eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 463 --QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 463 --~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
..++|+||+.+ ++...+......+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~ 162 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLA 162 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccc
Confidence 46999999975 677777665668999999999999999999999986 999999999999999999999999999
Q ss_pred ccCcccCcc----------cccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHH
Q 004732 541 KLDEEENTH----------ISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVL 609 (733)
Q Consensus 541 ~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~ 609 (733)
+........ ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||...+...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~ 242 (311)
T cd07866 163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242 (311)
T ss_pred hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 755432211 11234678899999988654 5899999999999999999999999655443322211111
Q ss_pred HhhC---------cccccccCCCCCCCC-------HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 610 KEQG---------KLMELVDTNPGSNFD-------KEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 610 ~~~~---------~~~~~~~~~~~~~~~-------~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.... ......+.......+ ......+.+++.+|++.+|++|||+.|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 000000000000000 011245889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=324.44 Aligned_cols=264 Identities=20% Similarity=0.264 Sum_probs=187.0
Q ss_pred hhcCccccCcccCCCcccEEEcccCC--CcEEEEE------------------EccccChhcHHHHHHHHHHHHhCCCCc
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLAD--GTAIAVK------------------QLSSKSKQGNREFINEIGMISALQHPN 450 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~n 450 (733)
..++|.+.+.||+|+||+||+|.... +..+++| .+. ........+.+|++++++++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 35689999999999999999986432 2222222 111 11223456889999999999999
Q ss_pred eeeEeeEEEeCCeEEEEEEccCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe
Q 004732 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHR----LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 526 (733)
Q Consensus 451 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill 526 (733)
||++++++..++..++|++++. ++|.+++.... .......+..++.|++.||+|||+.+ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999985 46777665321 22345667889999999999999986 9999999999999
Q ss_pred cCCCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCc-cch---hhH
Q 004732 527 DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK-EDM---FYL 602 (733)
Q Consensus 527 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~-~~~---~~~ 602 (733)
+.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.++.. ... ..+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987655443334456799999999999998999999999999999999998865422 111 111
Q ss_pred HHHHHHHH-hhCcc-------cccccCC----CCCCCCH-----HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 603 LDWALVLK-EQGKL-------MELVDTN----PGSNFDK-----EQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 603 ~~~~~~~~-~~~~~-------~~~~~~~----~~~~~~~-----~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
........ ...+. .+.++.. ....... .....+.+++.+|++.||.+|||+.|+++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 11110000 00000 0000000 0000000 011246677889999999999999999864
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=292.69 Aligned_cols=263 Identities=27% Similarity=0.396 Sum_probs=199.1
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHh--CCCCceeeEeeEEEeC----CeEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISA--LQHPNLVKLYGCCIEG----NQLL 465 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~~ 465 (733)
.++....+.||+|.||.||+|.|. |..||||++... +++.+.+|.++.+. ++|+||+.+++.=..+ .+++
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw 285 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW 285 (513)
T ss_pred hheeEEEEEecCccccceeecccc-CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence 355667889999999999999996 889999999653 34567777777665 5999999999885543 3689
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-----CCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG-----ESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~-----~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
||.+|.+.|||.|+|.. ..++....++++..+|.||+|||- +|.|.|.|||||+.|||+..++.+.|+|+|+|
T Consensus 286 LvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 286 LVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 99999999999999976 479999999999999999999994 47888999999999999999999999999999
Q ss_pred ccCcccCcc---cccccccCCCcccHHHHhhC----CC--CccchhHhHHHHHHHHHh----C------CCCCCccchhh
Q 004732 541 KLDEEENTH---ISTRVAGTIGYMAPEYAMRG----HL--TEKADVYSFGIVALEIVS----G------RSNVTKEDMFY 601 (733)
Q Consensus 541 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~----~~--~~~~Dv~s~Gvil~ellt----g------~~p~~~~~~~~ 601 (733)
......... .....+||-+|||||++... .+ -..+||||||.|+||++. | +.||...-+.+
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 866544222 23456899999999999642 12 236899999999999975 2 24553211110
Q ss_pred --HHHHHHHHHhhCcccccccCCCCCC-CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 602 --LLDWALVLKEQGKLMELVDTNPGSN-FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 602 --~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.-+...++ -.+.+.+..... .+.+.+..+.++++.||..+|..|-|+--|-+.|.+..+
T Consensus 444 Ps~eeMrkVV-----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 444 PSFEEMRKVV-----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCHHHHhcce-----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 11100000 011112222222 234567789999999999999999999999888876544
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=295.99 Aligned_cols=258 Identities=26% Similarity=0.360 Sum_probs=194.6
Q ss_pred ccccCcccCCCcccEEEcccC-CCcEEEEEEccccCh--hcHHHHHHHHHHHHhC---CCCceeeEeeEEEeCCe-----
Q 004732 395 FATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK--QGNREFINEIGMISAL---QHPNLVKLYGCCIEGNQ----- 463 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 463 (733)
|+..+.||+|+||.||+|+.. +++.||+|.+..... .....+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456789999999999999965 589999999864322 2234566787777665 59999999999998776
Q ss_pred EEEEEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 464 LLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
.+++|||+.+ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCccee
Confidence 9999999975 7988886533 36899999999999999999999986 99999999999999999999999999976
Q ss_pred CcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHH-HHhhC--ccc---
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALV-LKEQG--KLM--- 616 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~-~~~~~--~~~--- 616 (733)
...... .....++..|+|||.+.+..++.++|||||||++|||++|+.||..........-... ..... ...
T Consensus 157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 543322 1234578899999999988899999999999999999999999865543322211110 00000 000
Q ss_pred ----ccccCCCC---CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 617 ----ELVDTNPG---SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 617 ----~~~~~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
........ .....+....+.+++.+||+.||.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 0111223456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=300.05 Aligned_cols=252 Identities=27% Similarity=0.420 Sum_probs=194.6
Q ss_pred hcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS-KQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 468 (733)
.++|...+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++.+.. ||||++++++|.++...++||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 457788899999999999999965 48999999986542 233456677887777764 999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+. +++.++.......+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||++........
T Consensus 94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~ 170 (296)
T cd06618 94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA 170 (296)
T ss_pred eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence 9985 4777777654558999999999999999999999742 499999999999999999999999999876543222
Q ss_pred ccccccccCCCcccHHHHhhCC----CCccchhHhHHHHHHHHHhCCCCCCccch-hhHHHHHHHHHhhCcccccccCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGH----LTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
. ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ...... .... .......
T Consensus 171 ~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~-~~~~~~~--- 241 (296)
T cd06618 171 K--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK---ILQE-EPPSLPP--- 241 (296)
T ss_pred c--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH---HhcC-CCCCCCC---
Confidence 1 2345788999999987543 78899999999999999999999954321 111111 1111 1101000
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. .....+.+++.+||+.+|.+||++.++++.
T Consensus 242 ~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 242 NE----GFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred CC----CCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 01 123358899999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=326.60 Aligned_cols=253 Identities=29% Similarity=0.456 Sum_probs=190.2
Q ss_pred hhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------ 461 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 461 (733)
+...+|.+.++||+||||.||+++. -||+.||||++... +......+.+|+..+++++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 3456899999999999999999994 48999999998654 333446788999999999999999988553210
Q ss_pred --------------------------------------------------------------------------------
Q 004732 462 -------------------------------------------------------------------------------- 461 (733)
Q Consensus 462 -------------------------------------------------------------------------------- 461 (733)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc
Q 004732 462 ---------------------------------NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 508 (733)
Q Consensus 462 ---------------------------------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~ 508 (733)
..+|+-||||+...+.+++.++...-.....++++.+|++||+|+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence 01578899999988877776544322567899999999999999999
Q ss_pred CCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc------c-----------cCcccccccccCCCcccHHHHhhC--
Q 004732 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE------E-----------ENTHISTRVAGTIGYMAPEYAMRG-- 569 (733)
Q Consensus 509 ~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~-- 569 (733)
+| ||||||||.||++|++..|||+|||+|.... . ......+..+||.-|+|||++.+.
T Consensus 716 ~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 QG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred Cc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 97 9999999999999999999999999998611 0 011123457899999999999765
Q ss_pred -CCCccchhHhHHHHHHHHHhCCCCCCc-cchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCC
Q 004732 570 -HLTEKADVYSFGIVALEIVSGRSNVTK-EDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASP 647 (733)
Q Consensus 570 -~~~~~~Dv~s~Gvil~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P 647 (733)
.|+.|+|+||+|||++||+. ||.. ++-...+. ..+.+.+.. + ..+.......=..++.++++.||
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~----~LR~g~iP~-----~-~~f~~~~~~~e~slI~~Ll~hdP 859 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILT----NLRKGSIPE-----P-ADFFDPEHPEEASLIRWLLSHDP 859 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHH----hcccCCCCC-----C-cccccccchHHHHHHHHHhcCCC
Confidence 49999999999999999995 4532 22111111 111222211 1 12222233345578889999999
Q ss_pred CCCCCHHHHHH
Q 004732 648 TIRPSMSSVLR 658 (733)
Q Consensus 648 ~~RPt~~~vl~ 658 (733)
.+|||+.|+++
T Consensus 860 ~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 860 SKRPTATELLN 870 (1351)
T ss_pred ccCCCHHHHhh
Confidence 99999999975
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=299.01 Aligned_cols=253 Identities=24% Similarity=0.300 Sum_probs=199.2
Q ss_pred CccccCcccCCCcccEEEccc----CCCcEEEEEEccccC----hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeE
Q 004732 394 NFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 464 (733)
+|...+.||+|+||.||+|+. .+++.||||.+.... ......+.+|++++.++ +||||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 366778999999999999873 357899999986432 12335678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||+++|+|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.++|+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred EEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 9999999999999998654 46899999999999999999999886 9999999999999999999999999988654
Q ss_pred ccCcccccccccCCCcccHHHHhhCC--CCccchhHhHHHHHHHHHhCCCCCCccchhh-HHHHHHHHHhhCcccccccC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGH--LTEKADVYSFGIVALEIVSGRSNVTKEDMFY-LLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 621 (733)
...........|+..|+|||...+.. .+.++||||||+++|||++|+.||...+... ........... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------~~ 229 (288)
T cd05583 157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-------KP 229 (288)
T ss_pred cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc-------CC
Confidence 43333333456899999999987654 7889999999999999999999995432211 11111111110 01
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.. +......+.+++.+||+.+|++|||+.++.+.|+
T Consensus 230 ~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 230 PF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 11 1112234788999999999999999998888776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=293.04 Aligned_cols=242 Identities=21% Similarity=0.282 Sum_probs=188.6
Q ss_pred hhcCccccCcc--cCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEE
Q 004732 391 ATNNFATDNNI--GEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 391 ~~~~~~~~~~l--g~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 466 (733)
..++|...+.+ |+|+||.||+++ ..++..+|+|.+...... .. |+.....+ +||||+++++++..++..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AI--EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hh--hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34566666666 999999999998 457889999998643211 11 22222222 79999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-CeEEcccCccccCcc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEE 545 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~ 545 (733)
||||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||||+||+++.++ .++|+|||+++....
T Consensus 87 v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred EEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 999999999999997654 8999999999999999999999986 99999999999999998 999999999875443
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchh--hHHHHHHHHHhhCcccccccCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF--YLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
. ....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ....+.... .....
T Consensus 163 ~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~------ 228 (267)
T PHA03390 163 P-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLP------ 228 (267)
T ss_pred C-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccCC------
Confidence 2 2246889999999999888999999999999999999999999643221 222222111 00000
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHH
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPS-MSSVLR 658 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-~~~vl~ 658 (733)
........+.+++.+|++.+|.+||+ ++|+++
T Consensus 229 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 ---FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11123345889999999999999996 688874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=325.71 Aligned_cols=255 Identities=33% Similarity=0.509 Sum_probs=207.9
Q ss_pred hcCccccCcccCCCcccEEEcccC----C----CcEEEEEEcccc-ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA----D----GTAIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 461 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~----~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 461 (733)
.++....+.||+|+||.|++|... . ...||||.++.. .....+.+..|+++|+.+ +|+||+.++|+|..+
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344556669999999999999732 1 457999998764 334567899999999999 599999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe
Q 004732 462 NQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 526 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill 526 (733)
+..++|+||+..|+|.+++...+ ..++..+.+.++.|||.|++||++.. +||||+..+|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999998766 34889999999999999999999884 9999999999999
Q ss_pred cCCCCeEEcccCccccCcccCccccccccc--CCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccc-hhhH
Q 004732 527 DKDLNSKISDFGLAKLDEEENTHISTRVAG--TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKED-MFYL 602 (733)
Q Consensus 527 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~-~~~~ 602 (733)
.++..+||+|||+|+..............| ...|||||.+....|+.|+|||||||+||||+| |..|+.+.. ..++
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l 531 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL 531 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH
Confidence 999999999999999765554443232233 457999999999999999999999999999999 788885532 2222
Q ss_pred HHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 603 LDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
.. ....+...+....+ ..+++++++.||+.+|++||++.++++.++.
T Consensus 532 ~~----~l~~G~r~~~P~~c---------~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 532 LE----FLKEGNRMEQPEHC---------SDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HH----HHhcCCCCCCCCCC---------CHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 22 23444444333322 2348899999999999999999999999985
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=297.55 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=202.1
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 467 (733)
++|...+.||+|+||.||+|+. .+|+.||+|.+... .....+.+.+|++++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 3678889999999999999995 47999999998653 2233467888999999998 99999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++++|.+++...+ .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++++|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 81 LEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred EcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 99999999999997654 7999999999999999999999986 9999999999999999999999999998654432
Q ss_pred c-------------------ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHH
Q 004732 548 T-------------------HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALV 608 (733)
Q Consensus 548 ~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~ 608 (733)
. .......|+..|+|||......++.++||||||++++++++|+.||...+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~- 235 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL- 235 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-
Confidence 2 12233567899999999988889999999999999999999999996554332221111
Q ss_pred HHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCH----HHHHH
Q 004732 609 LKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSM----SSVLR 658 (733)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~----~~vl~ 658 (733)
. . ....+......+.+++.+||+.+|.+||++ .++++
T Consensus 236 --~-~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 236 --K-L----------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --h-c----------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 0 0 001111223458899999999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=296.56 Aligned_cols=260 Identities=26% Similarity=0.366 Sum_probs=200.8
Q ss_pred ccccCcccCCCcccEEEcccC-CCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 395 FATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
|+..+.||+|++|.||+|+.. +++.||+|.+.... ....+.+..|++++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999954 58999999987653 333467788999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
+ ++|.+++......+++..+..++.|+++||+|||+.+ |+||||+|+||+++.++.+||+|||+++........ .
T Consensus 81 ~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~ 155 (282)
T cd07829 81 D-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT-Y 155 (282)
T ss_pred C-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc-c
Confidence 8 5899999866567999999999999999999999986 999999999999999999999999999865443221 2
Q ss_pred cccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC---------cc---ccc
Q 004732 552 TRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG---------KL---MEL 618 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---------~~---~~~ 618 (733)
....++..|+|||.+.+. .++.++|||||||++||+++|+.||................... .. ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT 235 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence 234467789999998776 78999999999999999999999996655433322211111000 00 000
Q ss_pred ccCCCCCCC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 619 VDTNPGSNF---DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 619 ~~~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......... .+.....+.+++.+||+.+|++||++.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000000 01113468999999999999999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=297.55 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=195.0
Q ss_pred CccccCcccCCCcccEEEccc----CCCcEEEEEEccccC----hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeE
Q 004732 394 NFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 464 (733)
+|+..+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999884 478999999986532 12335678899999999 599999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||+++++|.+++... ..+++..+..++.|+++||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 81 HLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred EEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 9999999999999998754 46889999999999999999999986 9999999999999999999999999998654
Q ss_pred ccCcccccccccCCCcccHHHHhhC--CCCccchhHhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHhhCcccccccC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 621 (733)
...........|+..|+|||.+... .++.++||||||+++|+|++|+.||...... ....+........ +
T Consensus 157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~-------~ 229 (290)
T cd05613 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE-------P 229 (290)
T ss_pred cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccC-------C
Confidence 4333323345689999999998753 4788999999999999999999999533211 1111111111100 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRP-----SMSSVLR 658 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 658 (733)
.++......+.+++.+||+.+|.+|| +..+++.
T Consensus 230 ----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 230 ----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11112234578899999999999997 5555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=300.88 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=191.1
Q ss_pred CcccCC--CcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEG--GFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
..||+| +||+||+|.. .+|+.||||.+.... ....+.+.+|+.+++.++||||++++++|..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356766 8999999984 579999999986432 23346788899999999999999999999999999999999999
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc--
Q 004732 474 NSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI-- 550 (733)
Q Consensus 474 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~-- 550 (733)
+++.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 9999998753 345899999999999999999999886 9999999999999999999999998654322111100
Q ss_pred ----ccccccCCCcccHHHHhhC--CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc----------
Q 004732 551 ----STRVAGTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK---------- 614 (733)
Q Consensus 551 ----~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------- 614 (733)
.....++..|+|||++.+. .++.++|||||||++|||++|+.||.......... ........
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL--QKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH--HHhcCCCCCCccccccch
Confidence 1112356679999999763 47899999999999999999999995543221110 00000000
Q ss_pred ---------------c----------cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 ---------------L----------MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 ---------------~----------~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
. ....+..............+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 00000001111122345578999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=298.27 Aligned_cols=257 Identities=21% Similarity=0.257 Sum_probs=191.0
Q ss_pred CcccCCCcccEEEcccCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCH
Q 004732 399 NNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 476 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 476 (733)
+.+|.|+++.||++.. +++.||||++... .......+.+|+++++.++||||+++++++.+++..+++|||+++|+|
T Consensus 8 ~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l 86 (314)
T cd08216 8 KCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86 (314)
T ss_pred HhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence 3455555655555554 7899999998654 334456889999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc------c
Q 004732 477 ARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT------H 549 (733)
Q Consensus 477 ~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~------~ 549 (733)
.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+........ .
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999753 446899999999999999999999986 99999999999999999999999999864432111 1
Q ss_pred cccccccCCCcccHHHHhh--CCCCccchhHhHHHHHHHHHhCCCCCCccchhhH-HHHHHHHH-----------hhCcc
Q 004732 550 ISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL-LDWALVLK-----------EQGKL 615 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~-~~~~~~~~-----------~~~~~ 615 (733)
......++..|+|||++.. ..++.++|||||||++|||++|+.||........ .+...... .....
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 1223457889999999876 3588999999999999999999999965432211 11000000 00000
Q ss_pred cc----cccCC----CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 616 ME----LVDTN----PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 616 ~~----~~~~~----~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. ..+.. ............+.+++.+||+.+|++|||+.++++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 00000 0111122334568899999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=304.75 Aligned_cols=250 Identities=24% Similarity=0.377 Sum_probs=206.3
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.....|.+...||+|.|+.|..|+ ..++..||||.+.+.. ......+.+|+++|..++|||||+++.+...+..+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 345678899999999999999999 4579999999987653 2233558899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+.+|.+.+++..++. ....++..++.|+.+|++|||+++ |||||||++||||+.++.+||+|||++..+..
T Consensus 133 V~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~- 207 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY- 207 (596)
T ss_pred EEEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc-
Confidence 9999999999999987764 445899999999999999999996 99999999999999999999999999987663
Q ss_pred CcccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.....+.+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||.+.+...+..- .+....+.
T Consensus 208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r------------vl~gk~rI 274 (596)
T KOG0586|consen 208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR------------VLRGKYRI 274 (596)
T ss_pred -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch------------heeeeecc
Confidence 334566899999999999998664 6799999999999999999999977654433221 11111111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+ -...+.-+++.+.+-.+|.+|++++++.+.
T Consensus 275 p~--~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 275 PF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred cc--eeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11 112246678889999999999999999654
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=325.22 Aligned_cols=257 Identities=22% Similarity=0.285 Sum_probs=210.8
Q ss_pred hhHHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccc---cChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004732 386 LQIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSS---KSKQGNREFINEIGMISALQHPNLVKLYGCCIEG 461 (733)
Q Consensus 386 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 461 (733)
.+++...++|.+.++||+|+||.|..++. .+++.||+|++.+ -......-|..|-.+|..-+.+=||++...|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 45566678999999999999999999995 5789999999876 2233446788899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 462 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
.++|+|||||+||+|-.++.... ++++..++.++..|.-||.-+|+.| +|||||||+|||+|..|++|++|||.+-
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHH
Confidence 99999999999999999997766 8999999999999999999999987 9999999999999999999999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhh-----CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccc
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM 616 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 616 (733)
.+..++.-.+...+|||.|++||++.. +.|++.+|.||+||++|||+.|..||+.+.......-+. ...+..
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm---~hk~~l 300 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIM---NHKESL 300 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHh---chhhhc
Confidence 888777777778899999999999963 579999999999999999999999998775443322111 111111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC---HHHHH
Q 004732 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPS---MSSVL 657 (733)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt---~~~vl 657 (733)
.+++ ..+.+....+++.+.+. +|+.|.. +.++-
T Consensus 301 ~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 301 SFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred CCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 1111 11233446677777665 7778877 77764
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=292.76 Aligned_cols=241 Identities=26% Similarity=0.293 Sum_probs=185.8
Q ss_pred cccCCCcccEEEccc-CCCcEEEEEEccccCh---hcHHHHHHHHH---HHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 400 NIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK---QGNREFINEIG---MISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 400 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
.||+|+||.||+|.. .+++.||+|.+..... .....+..|.. .++...||+|+++++++.+++..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999984 5689999998865321 11223444443 4445579999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+|+|.+++... ..+++..+..++.|+++|++|||+.+ |+||||||+||+++.++.+||+|||++....... ..
T Consensus 81 g~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~~ 153 (278)
T cd05606 81 GGDLHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---PH 153 (278)
T ss_pred CCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---Cc
Confidence 99999988654 47999999999999999999999986 9999999999999999999999999987543322 12
Q ss_pred ccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 553 RVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
...|+..|+|||.+.++ .++.++||||+||++|||++|+.||................ ...... +...
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~----~~~~ 222 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-------TMAVEL----PDSF 222 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh-------ccCCCC----CCcC
Confidence 34689999999999754 68999999999999999999999996542211111110000 001111 1112
Q ss_pred HHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004732 632 VMVMINVALLCANASPTIRP-----SMSSVLR 658 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 658 (733)
...+.+++.+|+..+|.+|| ++.++++
T Consensus 223 s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 223 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 34588899999999999999 8988875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=304.35 Aligned_cols=261 Identities=22% Similarity=0.339 Sum_probs=201.6
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-----eEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGN-----QLL 465 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 465 (733)
+|...+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+++++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 467788999999999999995 458999999987643 334567899999999999999999999998775 789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||++ ++|.+++.... .+++..+..++.|++.||+|||+.| |+||||||+||+++.++.++|+|||++.....
T Consensus 81 lv~e~~~-~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchh-hhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 9999998 48888886544 8999999999999999999999986 99999999999999999999999999986554
Q ss_pred cCc--ccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc--------
Q 004732 546 ENT--HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-------- 614 (733)
Q Consensus 546 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 614 (733)
... .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+................
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence 321 112334678899999999887 789999999999999999999999966554332221111100000
Q ss_pred ---cccccc---CCCCCC---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 ---LMELVD---TNPGSN---FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 ---~~~~~~---~~~~~~---~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+. ...... ........+.+++.+||+.+|.+||++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000 000000 011123457899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=304.31 Aligned_cols=263 Identities=22% Similarity=0.375 Sum_probs=196.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------C
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------N 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 462 (733)
.++|...+.||+|+||.||+|+. .+|+.||||.+... .......+.+|++++++++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 36888899999999999999994 57899999998653 222335688999999999999999999998754 3
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++|+||+.. +|.++. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 94 ~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~ 166 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARH 166 (342)
T ss_pred eEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence 46999999974 676654 236899999999999999999999986 99999999999999999999999999975
Q ss_pred CcccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh----------
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE---------- 611 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~---------- 611 (733)
.... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.............
T Consensus 167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (342)
T cd07879 167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL 242 (342)
T ss_pred CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 4322 123457889999999876 4689999999999999999999999976543322211110000
Q ss_pred -h---CcccccccCCCCCCC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--hccCcc
Q 004732 612 -Q---GKLMELVDTNPGSNF---DKEQVMVMINVALLCANASPTIRPSMSSVLRM--LECGVD 665 (733)
Q Consensus 612 -~---~~~~~~~~~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~--L~~~~~ 665 (733)
. ..........+.... .+.....+.+++.+||+.||.+||++.++++. ++...+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 0 000000000000000 00122357899999999999999999999844 555443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.91 Aligned_cols=259 Identities=25% Similarity=0.352 Sum_probs=196.3
Q ss_pred ccccCcccCCCcccEEEcccC-CCcEEEEEEccccCh-hcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEEcc
Q 004732 395 FATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK-QGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
|...+.||+|+||+||+|+.. +++.||||++..... .......+|+..+++++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999964 578999999865422 22334567999999999 999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 472 ENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 472 ~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+|+|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 889998887543 57899999999999999999999986 99999999999999999999999999976543222
Q ss_pred ccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHH-------------HHHHHHhhCccc
Q 004732 551 STRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD-------------WALVLKEQGKLM 616 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~-------------~~~~~~~~~~~~ 616 (733)
.....|+..|+|||.+.. ..++.++|+||||+++|||++|+.||.......... |...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 223457889999998754 458899999999999999999999995544322221 111110000110
Q ss_pred ccccCCCCC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 ELVDTNPGS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 ~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..+...... .........+.+++.+||+.+|++||++.|++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000 0000113468899999999999999999998763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=279.19 Aligned_cols=199 Identities=28% Similarity=0.454 Sum_probs=168.3
Q ss_pred cCccccCcccCCCcccEEEcccC---C--CcEEEEEEccccChh--cHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCeE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA---D--GTAIAVKQLSSKSKQ--GNREFINEIGMISALQHPNLVKLYGCCIE-GNQL 464 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 464 (733)
..|+....||+|.||.||+|.-. + .+.+|+|+++..++. ......+|+..++.++|||+|.+..++.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46778889999999999999632 2 237999999765332 23567899999999999999999999887 7889
Q ss_pred EEEEEccCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC----CCeEEcc
Q 004732 465 LLIYEYLENNSLARALF----EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD----LNSKISD 536 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~----~~~kl~D 536 (733)
++++||.+. +|...++ .....++......|+.||+.|+.|||++. |+|||+||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 999999987 7877776 23357899999999999999999999996 9999999999999887 8999999
Q ss_pred cCccccCcccCccc--ccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCC
Q 004732 537 FGLAKLDEEENTHI--STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVT 595 (733)
Q Consensus 537 fGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~ 595 (733)
||+++.+...-... ...++-|++|.|||.+.+. .|+.+.||||.|||+.||+|-+.-|.
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 99999877643332 3456779999999999885 59999999999999999999887773
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=300.76 Aligned_cols=258 Identities=22% Similarity=0.305 Sum_probs=194.6
Q ss_pred ccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhc--------------HHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004732 397 TDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQG--------------NREFINEIGMISALQHPNLVKLYGCCIEG 461 (733)
Q Consensus 397 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 461 (733)
..+.||+|+||.||+|. ..+++.||||.+....... ...+.+|+++++.++||||+++++++..+
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 45789999999999998 4578999999886432211 12577899999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 462 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
+..++||||+. |+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg~~~ 167 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcccee
Confidence 99999999997 589888854 346899999999999999999999986 9999999999999999999999999997
Q ss_pred cCcccC-------------cccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHH
Q 004732 542 LDEEEN-------------THISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWAL 607 (733)
Q Consensus 542 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~ 607 (733)
...... ........++..|+|||.+.+. .++.++|||||||++|||++|+.||...+.........
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~ 247 (335)
T PTZ00024 168 RYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIF 247 (335)
T ss_pred ecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 654111 1111223468899999998764 47899999999999999999999997665443332221
Q ss_pred HHHhhCcc---cccc--------cCCCCCC---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 608 VLKEQGKL---MELV--------DTNPGSN---FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 608 ~~~~~~~~---~~~~--------~~~~~~~---~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
........ .+.. ....... ........+.+++.+|++.+|++||++.|++..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111000 0000 0000000 001123457899999999999999999999864
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=304.05 Aligned_cols=260 Identities=23% Similarity=0.336 Sum_probs=193.5
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC----------
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG---------- 461 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------- 461 (733)
.+|...+.||+|+||.||+|+ ..+|+.||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 578888999999999999998 457899999998765555567788999999999999999999876543
Q ss_pred ----CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC-CCCeEEcc
Q 004732 462 ----NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISD 536 (733)
Q Consensus 462 ----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~D 536 (733)
...++||||++ ++|.+++.. ..+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+|++|
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECC
Confidence 35789999997 588887753 36899999999999999999999986 999999999999984 55789999
Q ss_pred cCccccCcccCcc--cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh--
Q 004732 537 FGLAKLDEEENTH--ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE-- 611 (733)
Q Consensus 537 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-- 611 (733)
||+++........ ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...+.............
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 9999765332211 1123457889999998755 5688899999999999999999999965543222111000000
Q ss_pred ----hC----ccccccc-CCCCCCC-----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 612 ----QG----KLMELVD-TNPGSNF-----DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 612 ----~~----~~~~~~~-~~~~~~~-----~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.. ....... ....... .......+.+++.+|++.||.+||++.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00 0000000 0000000 0112345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=291.67 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=199.4
Q ss_pred HhhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-------hhcHHHHHHHHHHHHhCCCCceeeEeeEEEe
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-------KQGNREFINEIGMISALQHPNLVKLYGCCIE 460 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 460 (733)
....++|-..++||+|||+.||+|. +...+.||||+-.... ....+...+|..|-+.+.||-||++|+||.-
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 3344567778999999999999998 6678999999854331 1122456789999999999999999999975
Q ss_pred -CCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC---CCCeEEcc
Q 004732 461 -GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISD 536 (733)
Q Consensus 461 -~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~D 536 (733)
.+.+|-|+|||+|.+|+.+|..++ .+++.+++.|+.||+.||.||.+. .++|||-||||.|||+-. -|.+||+|
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence 467899999999999999997654 789999999999999999999988 578999999999999953 46799999
Q ss_pred cCccccCcccCcc------cccccccCCCcccHHHHhh----CCCCccchhHhHHHHHHHHHhCCCCCCcc-chhhHHHH
Q 004732 537 FGLAKLDEEENTH------ISTRVAGTIGYMAPEYAMR----GHLTEKADVYSFGIVALEIVSGRSNVTKE-DMFYLLDW 605 (733)
Q Consensus 537 fGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~elltg~~p~~~~-~~~~~~~~ 605 (733)
||+++++..+... .....+||++|++||.+.- ...+.|+||||.|||+|+++.|+.||... ...+++..
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe 696 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE 696 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh
Confidence 9999988754332 3456789999999998753 35788999999999999999999999543 33444433
Q ss_pred HHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 004732 606 ALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSV 656 (733)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~v 656 (733)
...+...+ + .+ .+.. ........++.+|++..-++|.+..++
T Consensus 697 NTIlkAtE-V-qF---P~KP----vVsseAkaFIRRCLaYRKeDR~DV~qL 738 (775)
T KOG1151|consen 697 NTILKATE-V-QF---PPKP----VVSSEAKAFIRRCLAYRKEDRIDVQQL 738 (775)
T ss_pred hchhccee-c-cC---CCCC----ccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence 22221111 0 00 0111 112246678899999999999887775
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=289.91 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=194.4
Q ss_pred CccccCcccCCCcccEEEcccC-CCcEEEEEEcccc-----ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK-----SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
+|...+.||+|+||.||+|... .+..+++|.++.. .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3677789999999999999843 3445556655431 122334567899999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 468 YEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
|||+++++|.+++.. ....+++..++.++.|+++||.|||+.+ ++|+||||+||+++. +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998863 3457999999999999999999999986 999999999999975 569999999987654
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
.... ......|++.|+|||...+..++.++|+||||+++|+|++|..||........... .. .+..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~---~~-~~~~--------- 222 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLR---IV-EGPT--------- 222 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH---HH-cCCC---------
Confidence 3222 22345688899999999888899999999999999999999999965443222211 11 1111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+......+.+++.+||+.+|++||++.++++.
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11122334468899999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=300.21 Aligned_cols=264 Identities=23% Similarity=0.362 Sum_probs=198.7
Q ss_pred hhHHhhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC-
Q 004732 386 LQIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEG- 461 (733)
Q Consensus 386 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~- 461 (733)
.++...+++|...+.||+|+||.||+|. ..+++.||+|++.... ......+.+|++++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 3455677899999999999999999998 5678999999986532 22345678899999999999999999988643
Q ss_pred -----CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcc
Q 004732 462 -----NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 536 (733)
Q Consensus 462 -----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 536 (733)
...+++++++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~d 163 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD 163 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEec
Confidence 3467888876 7799887753 36899999999999999999999986 99999999999999999999999
Q ss_pred cCccccCcccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh---
Q 004732 537 FGLAKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ--- 612 (733)
Q Consensus 537 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~--- 612 (733)
||+++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..............
T Consensus 164 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T cd07877 164 FGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 239 (345)
T ss_pred cccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9998754322 233567889999999876 46889999999999999999999999654432221111000000
Q ss_pred --------C---cccccccCCCCCCCC---HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 613 --------G---KLMELVDTNPGSNFD---KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 613 --------~---~~~~~~~~~~~~~~~---~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
. .........+...+. ......+.+++.+|++.+|.+||++.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 240 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 000000000000000 0123357899999999999999999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=299.99 Aligned_cols=258 Identities=22% Similarity=0.352 Sum_probs=195.3
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-----
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN----- 462 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 462 (733)
..++|...+.||+|+||.||+|. ..+|+.||||++... .......+.+|++++++++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 46689999999999999999998 567999999998543 2223456889999999999999999999987653
Q ss_pred -eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 463 -QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 463 -~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.| |+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 468999999 6789888753 36899999999999999999999986 9999999999999999999999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh--------
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ-------- 612 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-------- 612 (733)
..... .....+++.|+|||.+.+ ..++.++|+||+||++|++++|+.||...+......-.......
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (343)
T cd07880 167 QTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQK 242 (343)
T ss_pred ccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 55332 123457889999999876 45889999999999999999999999655432211100000000
Q ss_pred ---CcccccccCCCCC------CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 613 ---GKLMELVDTNPGS------NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 613 ---~~~~~~~~~~~~~------~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
..........+.. .........+.+++.+|++.||++|||+.++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 243 LQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000 000112234789999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=297.88 Aligned_cols=260 Identities=24% Similarity=0.347 Sum_probs=197.6
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCeEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE-GNQLL 465 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 465 (733)
..+++|...+.||+|+||.||+|. ..+++.||||++... .....+.+.+|++++++++||||++++++|.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 467889999999999999999998 558999999987542 22334678899999999999999999999876 56789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 87 lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~ 160 (328)
T cd07856 87 FVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP 160 (328)
T ss_pred EEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC
Confidence 999998 5688888753 35788899999999999999999986 99999999999999999999999999875432
Q ss_pred cCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh-----------hC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE-----------QG 613 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~ 613 (733)
. .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+............. ..
T Consensus 161 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd07856 161 Q----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236 (328)
T ss_pred C----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccch
Confidence 2 123457889999998766 5689999999999999999999999965543222111110000 00
Q ss_pred cccccccCC-CCCCCCH-----HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 614 KLMELVDTN-PGSNFDK-----EQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 614 ~~~~~~~~~-~~~~~~~-----~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+.+... .....+. .....+.+++.+|++.+|++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000 0001111 123468899999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=297.38 Aligned_cols=260 Identities=25% Similarity=0.334 Sum_probs=192.2
Q ss_pred CccccCcccCCCcccEEEcccC-C--CcEEEEEEcccc--ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC----Ce
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA-D--GTAIAVKQLSSK--SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG----NQ 463 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 463 (733)
+|...+.||+|+||.||+|+.. . +..||+|++... .....+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3667789999999999999943 4 789999998643 222346788899999999 599999999976533 45
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.++++||+. ++|.+++.. ...+++..+..++.||+.||+|||+.| |+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 788899886 689888854 347899999999999999999999986 999999999999999999999999999865
Q ss_pred cccCcc---cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh--------
Q 004732 544 EEENTH---ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE-------- 611 (733)
Q Consensus 544 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-------- 611 (733)
...... ......||..|+|||.+.+ ..++.++||||+||++|++++|+.||...+.............
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 432211 1233568999999998766 4689999999999999999999999965543322221111000
Q ss_pred ----hC--cccccccCCCCCCC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 612 ----QG--KLMELVDTNPGSNF---DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 612 ----~~--~~~~~~~~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.. .............+ .+.....+.+++.+|++.+|++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00 00000000000000 0111345889999999999999999999864
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=300.96 Aligned_cols=259 Identities=23% Similarity=0.383 Sum_probs=197.8
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe----
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ---- 463 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 463 (733)
..++|...+.||+|+||.||+|+. .+++.||||++... .......+.+|+.++++++||||+++.+++..++.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 456888999999999999999995 46889999998643 22234567789999999999999999998876554
Q ss_pred --EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 464 --LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 464 --~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999998 5699988864 46899999999999999999999986 9999999999999999999999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc------
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK------ 614 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 614 (733)
..... .....++..|+|||.+.+ ..++.++|||||||++||+++|+.||...+................
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 242 (343)
T cd07851 167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK 242 (343)
T ss_pred ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence 65432 233467889999999875 3678999999999999999999999965544332221111100000
Q ss_pred --------ccccccCCCCCCCC---HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 --------LMELVDTNPGSNFD---KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 --------~~~~~~~~~~~~~~---~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+.......+. ......+.+++.+|++.+|++|||+.+|++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 00000000000000 0123468899999999999999999999763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=291.23 Aligned_cols=244 Identities=26% Similarity=0.370 Sum_probs=199.8
Q ss_pred ccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 397 TDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 397 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
.+++||+|-||+||-|. .++|+.||||++.+. .++.+..+.+|+.||++++||.||.+-..|...+.++.|||-+.|
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 35799999999999999 568999999998654 344567889999999999999999999999999999999999987
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC---CCCeEEcccCccccCcccCccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~DfGla~~~~~~~~~~ 550 (733)
.-|+-.|.....++++.....++.||+.||.|||.++ |+|+|+||+|||+.. -.++||||||+|+++++..-
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence 6666666677779999999999999999999999985 999999999999964 35699999999999887533
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
...++||+.|+|||++....|...-|+||.|||+|--++|..||..++... +.. + ...-+..+.++...
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn--dQI----Q--NAaFMyPp~PW~ei--- 791 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN--DQI----Q--NAAFMYPPNPWSEI--- 791 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh--HHh----h--ccccccCCCchhhc---
Confidence 355889999999999999999999999999999999999999996554321 111 1 11223333444333
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVL 657 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl 657 (733)
....++++...++..-++|-+...-+
T Consensus 792 -s~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 792 -SPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred -CHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 33467777788888888888887663
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=281.37 Aligned_cols=236 Identities=27% Similarity=0.358 Sum_probs=192.7
Q ss_pred ccCCCcccEEEcccC-CCcEEEEEEccccCh---hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCH
Q 004732 401 IGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK---QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL 476 (733)
Q Consensus 401 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL 476 (733)
||+|+||.||++... +++.||+|.+..... .....+..|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999954 689999999865422 2345788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccccccc
Q 004732 477 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG 556 (733)
Q Consensus 477 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 556 (733)
.+++.... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 99997553 6899999999999999999999986 9999999999999999999999999997654332 12234568
Q ss_pred CCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHH
Q 004732 557 TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMI 636 (733)
Q Consensus 557 t~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 636 (733)
+..|+|||...+...+.++|+||||+++||+++|+.||...+......... . .. ...+......+.
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~---~-~~----------~~~~~~~~~~l~ 221 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKIL---K-DP----------LRFPEFLSPEAR 221 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh---c-CC----------CCCCCCCCHHHH
Confidence 889999999988889999999999999999999999996555422222111 1 00 011111134588
Q ss_pred HHHHHhhcCCCCCCCCHHH
Q 004732 637 NVALLCANASPTIRPSMSS 655 (733)
Q Consensus 637 ~l~~~c~~~~P~~RPt~~~ 655 (733)
+++.+||..||++||++.+
T Consensus 222 ~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 222 DLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHHHHHhcCCHhhCCCccc
Confidence 9999999999999999943
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=284.46 Aligned_cols=242 Identities=24% Similarity=0.347 Sum_probs=200.9
Q ss_pred hcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccC---hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 466 (733)
..+|....+||+|+||.|..|..+ +.+.+|||+++++. ..+.+--+.|-++|+.. +-|.++++..+|..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357888899999999999999854 46789999998752 22223345677777766 57899999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+.||+|--++++-+ ++.++.+..+|..||-||-+||++| ||+||||..|||+|.+|++||+|||+++.---+
T Consensus 428 VMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred EEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccC
Confidence 999999999999987654 7889999999999999999999997 999999999999999999999999999743222
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
.....+++||+.|+|||++...+|+..+|.|||||+||||+.|+.||.+++...+...+. +. ...
T Consensus 504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~------------eh--nvs 568 (683)
T KOG0696|consen 504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM------------EH--NVS 568 (683)
T ss_pred -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH------------Hc--cCc
Confidence 223456899999999999999999999999999999999999999999888776654221 11 123
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCC
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPS 652 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt 652 (733)
|+...+.+...++...+...|.+|..
T Consensus 569 yPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 569 YPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred CcccccHHHHHHHHHHhhcCCccccC
Confidence 45555667888999999999999974
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=248.90 Aligned_cols=260 Identities=23% Similarity=0.351 Sum_probs=199.6
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+|+..+.||+|.||+||+|+ +.+++.||+|++..+ .+..-....+|+-+++.++|+|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35556789999999999999 667899999988654 333346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
|+. +|..+...-...++.+.+..++.|+++||.++|++. +.|||+||.|.+++.+|..|++|||+++.++-.-...
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcy 158 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY 158 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence 965 787777777778999999999999999999999984 9999999999999999999999999999777654443
Q ss_pred ccccccCCCcccHHHHhhCC-CCccchhHhHHHHHHHHHhCCCCC-CccchhhHHHHHHHHH---hhC---cccccccCC
Q 004732 551 STRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNV-TKEDMFYLLDWALVLK---EQG---KLMELVDTN 622 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~p~-~~~~~~~~~~~~~~~~---~~~---~~~~~~~~~ 622 (733)
+.. +-|.+|.+|.++.+.+ |+...|+||-||++.|+....+|. .+.+..+.+....... .++ ....+.|-.
T Consensus 159 sae-vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 159 SAE-VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred ece-eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 333 3589999999999865 899999999999999999855554 5544443332221111 111 122333433
Q ss_pred CCCCCCHHHHH---------HHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 623 PGSNFDKEQVM---------VMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 623 ~~~~~~~~~~~---------~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+...++....+ .=.++.+..+.-+|.+|.++++.++
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 33333332111 2346677777778888888887655
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=273.74 Aligned_cols=254 Identities=26% Similarity=0.365 Sum_probs=193.6
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh-hcHHHHHHHHHHHHh-CCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK-QGNREFINEIGMISA-LQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+......||.|+||+|+|-. .+.|+..|||++..... ...+++..|.+...+ -+.||||+++|++..++..|+.||.
T Consensus 65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL 144 (361)
T KOG1006|consen 65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL 144 (361)
T ss_pred hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence 44456789999999999998 46799999999976533 455778888886544 5799999999999999999999999
Q ss_pred cCCCCHHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 471 LENNSLARALF----EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 471 ~~~gsL~~~l~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
|+- |++.+-. -....+++.-.-+|...+.+||.||-+.- +|||||+||+|||+|..|.+|+||||++....+.
T Consensus 145 Md~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S 221 (361)
T KOG1006|consen 145 MDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS 221 (361)
T ss_pred Hhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence 965 5554322 23457889999999999999999998764 7999999999999999999999999998654432
Q ss_pred CcccccccccCCCcccHHHHhh--CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
...+.-+|-..|||||.+.. ..|+-++||||+|++|||+.||+.|+...+. ..+....... +....+....
T Consensus 222 --iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~-gdpp~l~~~~-- 294 (361)
T KOG1006|consen 222 --IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVI-GDPPILLFDK-- 294 (361)
T ss_pred --HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHc-CCCCeecCcc--
Confidence 22344578889999999864 3589999999999999999999999965432 2222211111 1111111111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+....+..++..|+.+|-++||.+.++.++
T Consensus 295 --~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 295 --ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred --cccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 112345568899999999999999999998654
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=316.67 Aligned_cols=145 Identities=28% Similarity=0.424 Sum_probs=130.2
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|.+.+.||+|+||.||+|.. .+++.||||++.... ......+.+|+.+++.++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 5788889999999999999995 478999999986532 223467888999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
||+.+++|.+++... ..+++..++.++.||+.||+|||..+ ||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999998654 36899999999999999999999986 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=275.43 Aligned_cols=255 Identities=21% Similarity=0.301 Sum_probs=195.0
Q ss_pred cCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEccCCCC
Q 004732 398 DNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLENNS 475 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gs 475 (733)
.++||+|+|++|--++ +.+|..||||++.+.......++.+|++++... .|+||+.++++|.++...|||||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 3689999999999988 789999999999877666778899999999998 59999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC---eEEcccCccccCccc--C---
Q 004732 476 LARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFGLAKLDEEE--N--- 547 (733)
Q Consensus 476 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~---~kl~DfGla~~~~~~--~--- 547 (733)
|..++++. ..+++.++.++..+||.||.+||.+| |.|||+||+|||...... +|||||.+..-+... -
T Consensus 163 lLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spa 238 (463)
T KOG0607|consen 163 LLSHIQKR-KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPA 238 (463)
T ss_pred HHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCC
Confidence 99999765 47899999999999999999999997 999999999999976554 799999987533211 1
Q ss_pred -cccccccccCCCcccHHHHh-----hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHH---hhCccccc
Q 004732 548 -THISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK---EQGKLMEL 618 (733)
Q Consensus 548 -~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~---~~~~~~~~ 618 (733)
+..-.+-+|+-.|||||+.. ...|+.+.|.||+|||+|-|++|..||.+.-..+ ..|.+... -+..+.+-
T Consensus 239 stP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d-CGWdrGe~Cr~CQ~~LFes 317 (463)
T KOG0607|consen 239 STPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD-CGWDRGEVCRVCQNKLFES 317 (463)
T ss_pred CCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc-CCccCCCccHHHHHHHHHH
Confidence 11122356888999999874 2468999999999999999999999995432111 01110000 00000000
Q ss_pred ccCCCCCCCCH----HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 619 VDTNPGSNFDK----EQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 619 ~~~~~~~~~~~----~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+-.. ...++. .......+++...+..++.+|.++.++++
T Consensus 318 IQEG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 318 IQEG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred Hhcc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 0000 011222 22335667888888899999999999977
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=265.55 Aligned_cols=252 Identities=20% Similarity=0.256 Sum_probs=191.7
Q ss_pred hcCccc-cCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHh-CCCCceeeEeeEEEe----CCeE
Q 004732 392 TNNFAT-DNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISA-LQHPNLVKLYGCCIE----GNQL 464 (733)
Q Consensus 392 ~~~~~~-~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 464 (733)
|++|.+ .++||-|-.|.|..+. ..+|+++|+|++... ....+|++.--. -.|||||.++++|.. ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 445544 2689999999999998 457899999998643 334678876433 479999999999864 3567
Q ss_pred EEEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC---CCCeEEcccCcc
Q 004732 465 LLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLA 540 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~DfGla 540 (733)
.+|||.|+||.|...+++. ...+++.++..|+.||+.|+.|||+. +|.||||||+|+|... +..+|++|||+|
T Consensus 135 LiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred EeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccc
Confidence 8999999999999999854 45799999999999999999999987 5999999999999975 445899999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccccc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
+....... ..+-+-|+.|.|||++...+|+...|+||+||++|-|++|..||+......+..-.+.....+.. ++
T Consensus 212 K~t~~~~~--L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy-~F-- 286 (400)
T KOG0604|consen 212 KETQEPGD--LMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQY-EF-- 286 (400)
T ss_pred cccCCCcc--ccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCc-cC--
Confidence 86544222 23346799999999999889999999999999999999999999665432221101100011100 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+.. .-...++...++++..+..+|++|.|+.+++..
T Consensus 287 --P~p-EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 287 --PEP-EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred --CCh-hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 000 112335567889999999999999999999754
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-34 Score=266.25 Aligned_cols=263 Identities=24% Similarity=0.362 Sum_probs=197.2
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--------
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG-------- 461 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 461 (733)
..|.....||+|.||.||+|+ -..|+.||+|++... ...-.....+|+.+|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345566789999999999999 456788999865432 222234568899999999999999999998642
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 462 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
..+|+||++|+. +|.-.|.....+++..++.+++.++..||.|+|.. .|+|||+||.|+|++.++.+||+|||+++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecccccc
Confidence 348999999977 78888877778899999999999999999999987 59999999999999999999999999997
Q ss_pred cCcccCcc---cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC----
Q 004732 542 LDEEENTH---ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG---- 613 (733)
Q Consensus 542 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---- 613 (733)
.+...... ..+..+-|.+|.+||.+.+ ..|+++.|||+-|||+.||.||..-+.+......+.........-
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev 252 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV 252 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence 65433221 1233445899999999887 569999999999999999999998887665544443333322210
Q ss_pred -------ccccccc--CCCCCCCC--HHHH------HHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 614 -------KLMELVD--TNPGSNFD--KEQV------MVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 614 -------~~~~~~~--~~~~~~~~--~~~~------~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+.+-+. +-+...+. .+.. ....+++...+..||.+|+++++++..
T Consensus 253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 0001110 00111110 0111 146788889999999999999998754
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-33 Score=286.67 Aligned_cols=244 Identities=22% Similarity=0.305 Sum_probs=201.7
Q ss_pred hhcCccccCcccCCCcccEEEcccCCCc-EEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLADGT-AIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
...++.....||-||||+|=.+...... .+|+|.+++. .....+.+..|-++|...+.|.||++|--|.+....|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 3456677788999999999998855433 4888887654 44455677889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
.||-|-||.+...+... ..++..+...++..+.+|++|||.++ ||+||+||+|.++|.+|-+||.|||+|+.+...
T Consensus 498 LmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 99999999999999654 47999999999999999999999996 999999999999999999999999999987664
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
... -+++||+.|.|||++.+...+.++|.||+|+++|||++|..||.+.+++...... ...- .. ..
T Consensus 574 ~KT--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I--LkGi-d~---------i~ 639 (732)
T KOG0614|consen 574 RKT--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI--LKGI-DK---------IE 639 (732)
T ss_pred Cce--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH--Hhhh-hh---------hh
Confidence 443 4589999999999999999999999999999999999999999887765443322 1111 11 11
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCC
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPS 652 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt 652 (733)
++........+++++....+|.+|.-
T Consensus 640 ~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cccccchhHHHHHHHHHhcCcHhhhc
Confidence 22233344778888888999999985
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.9e-32 Score=274.78 Aligned_cols=220 Identities=21% Similarity=0.212 Sum_probs=175.8
Q ss_pred CCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCHHHHHHh
Q 004732 404 GGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFE 482 (733)
Q Consensus 404 G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 482 (733)
|.+|.||+++ ..+++.||+|.+.... .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8999999999 5678999999986542 234455556666799999999999999999999999999999999865
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccccccCCCccc
Q 004732 483 HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 562 (733)
Q Consensus 483 ~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 562 (733)
. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.++++|||.+...... .....++..|+|
T Consensus 79 ~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~a 150 (237)
T cd05576 79 F-LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCA 150 (237)
T ss_pred h-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccccC
Confidence 4 36899999999999999999999986 999999999999999999999999987654332 122345778999
Q ss_pred HHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHh
Q 004732 563 PEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLC 642 (733)
Q Consensus 563 PE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 642 (733)
||.+.+..++.++||||+|+++|||++|+.|+...... . . .... ...+......+.+++.+|
T Consensus 151 PE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~--------~--~~~~-------~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 151 PEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I--------N--THTT-------LNIPEWVSEEARSLLQQL 212 (237)
T ss_pred CcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c--------c--cccc-------cCCcccCCHHHHHHHHHH
Confidence 99988888999999999999999999999876422100 0 0 0000 001111234578899999
Q ss_pred hcCCCCCCCCHH
Q 004732 643 ANASPTIRPSMS 654 (733)
Q Consensus 643 ~~~~P~~RPt~~ 654 (733)
++.||++||++.
T Consensus 213 l~~dp~~R~~~~ 224 (237)
T cd05576 213 LQFNPTERLGAG 224 (237)
T ss_pred ccCCHHHhcCCC
Confidence 999999999974
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=292.59 Aligned_cols=240 Identities=23% Similarity=0.318 Sum_probs=192.9
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 468 (733)
+++.|.....+|.|+|+.|-.+. ..+++..+||++.... .+-.+|+.++... .||||+++.+.+.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 46778888889999999999998 5678999999997652 2334577666665 6999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe-cCCCCeEEcccCccccCcccC
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL-DKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill-~~~~~~kl~DfGla~~~~~~~ 547 (733)
|.+.++-+.+.+.... .....+..|+.+|+.|+.|||++| +||||+||+|||+ +..++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~--~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP--EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred hhccccHHHHHHHhcc--hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 9999998888776443 222778889999999999999997 9999999999999 58899999999999876654
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
..+-+-|..|.|||+.....|++++|+||||++||+|++|+.||...... .+.. .+. ...
T Consensus 470 ---~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~-------------~i~---~~~ 530 (612)
T KOG0603|consen 470 ---CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHT-------------RIQ---MPK 530 (612)
T ss_pred ---hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHH-------------hhc---CCc
Confidence 12234578999999999999999999999999999999999999443221 1111 111 112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+....+....+++.+|++.||.+||+|.++...
T Consensus 531 ~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 531 FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 223344568899999999999999999999754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=294.85 Aligned_cols=257 Identities=28% Similarity=0.416 Sum_probs=209.9
Q ss_pred hhHHhhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEe---
Q 004732 386 LQIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIE--- 460 (733)
Q Consensus 386 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 460 (733)
..+.-.++-|.+.+.||.|.+|.||+++ .++++.+|||+..... ....++..|.++++.. .|||++.++|+|..
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 3444567788999999999999999999 6788999999886543 3456778899999988 69999999999874
Q ss_pred --CCeEEEEEEccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEccc
Q 004732 461 --GNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 537 (733)
Q Consensus 461 --~~~~~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 537 (733)
++++|||||||.+||..|++.. .+..+.|..+.-|++.+++|+.+||... ++|||||-.|||++.++.||++||
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeee
Confidence 5789999999999999999973 3668999999999999999999999884 999999999999999999999999
Q ss_pred CccccCcccCcccccccccCCCcccHHHHhh-----CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh
Q 004732 538 GLAKLDEEENTHISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 612 (733)
Q Consensus 538 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 612 (733)
|++...... .....+..||+.|||||++.. ..|+.++|+||+|++..||.-|..|+...-+.-.
T Consensus 168 GvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra---------- 236 (953)
T KOG0587|consen 168 GVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA---------- 236 (953)
T ss_pred eeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh----------
Confidence 998754332 223456789999999999864 3578899999999999999999999854432210
Q ss_pred Ccccccc-cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 613 GKLMELV-DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 613 ~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+..+. ++.+...-+.....++.+++..|+..|..+||++.++++.
T Consensus 237 --LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 237 --LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111 2223333456677889999999999999999999998653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-32 Score=270.15 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=210.4
Q ss_pred hhHHhhhcCccccCcccCCCcccEEEcccC------CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEE
Q 004732 386 LQIKAATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCC 458 (733)
Q Consensus 386 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 458 (733)
.++.....+++...++-+|.||+||+|.|. +.+.|.||.++.. +.-....+..|.-.+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 455556667888889999999999999654 3456778887653 444556788999999999999999999999
Q ss_pred EeC-CeEEEEEEccCCCCHHHHHH-------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC
Q 004732 459 IEG-NQLLLIYEYLENNSLARALF-------EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL 530 (733)
Q Consensus 459 ~~~-~~~~lV~e~~~~gsL~~~l~-------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 530 (733)
.++ ...+.+|.++.-|+|..+|. ...+.++..+...++.|++.|++|||+.+ |||.||..+|+++|+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 875 56789999999999999997 22345777788899999999999999997 99999999999999999
Q ss_pred CeEEcccCccccCcccCccc-ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHH
Q 004732 531 NSKISDFGLAKLDEEENTHI-STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALV 608 (733)
Q Consensus 531 ~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 608 (733)
++||+|=.+++..-+.+.+- ......+..||+||.+.+..|+.++|||||||+||||+| |+.|+..-+++....+.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-- 511 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-- 511 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH--
Confidence 99999999998665544432 233345678999999999999999999999999999998 99999777766655433
Q ss_pred HHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 609 LKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.++.+......+ +.++..++..||...|++||+++|++.-|.
T Consensus 512 --kdGyRlaQP~NC---------PDeLf~vMacCWallpeeRPsf~Qlv~cLs 553 (563)
T KOG1024|consen 512 --KDGYRLAQPFNC---------PDELFTVMACCWALLPEERPSFSQLVICLS 553 (563)
T ss_pred --hccceecCCCCC---------cHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 233333222222 234889999999999999999999998876
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=293.42 Aligned_cols=258 Identities=20% Similarity=0.244 Sum_probs=182.3
Q ss_pred HhhhcCccccCcccCCCcccEEEccc-----------------CCCcEEEEEEccccChhcHHH--------------HH
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGLL-----------------ADGTAIAVKQLSSKSKQGNRE--------------FI 437 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~ 437 (733)
+...++|++.++||+|+||+||+|.. .+++.||||++........++ +.
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 34578999999999999999999863 245689999986543322233 34
Q ss_pred HHHHHHHhCCCCce-----eeEeeEEEe--------CCeEEEEEEccCCCCHHHHHHhcC--------------------
Q 004732 438 NEIGMISALQHPNL-----VKLYGCCIE--------GNQLLLIYEYLENNSLARALFEHR-------------------- 484 (733)
Q Consensus 438 ~E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~-------------------- 484 (733)
.|+.++.+++|.++ ++++++|.. ++..++||||+++|+|.++++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 47777788876654 677888753 356899999999999999987421
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccccccCCCcc
Q 004732 485 ---LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYM 561 (733)
Q Consensus 485 ---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~ 561 (733)
..++|..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++..............+|+.|+
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 23567889999999999999999986 999999999999999999999999999755433222222234578999
Q ss_pred cHHHHhhCC----------------------CCccchhHhHHHHHHHHHhCCC-CCCccchh---------hHHHHHHHH
Q 004732 562 APEYAMRGH----------------------LTEKADVYSFGIVALEIVSGRS-NVTKEDMF---------YLLDWALVL 609 (733)
Q Consensus 562 aPE~~~~~~----------------------~~~~~Dv~s~Gvil~elltg~~-p~~~~~~~---------~~~~~~~~~ 609 (733)
|||.+.... ...+.||||+||+++||++|.. |+.....+ ....|....
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 999875432 1235799999999999999875 66322111 111121110
Q ss_pred HhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCC---CCCCCHHHHHHH
Q 004732 610 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASP---TIRPSMSSVLRM 659 (733)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P---~~RPt~~~vl~~ 659 (733)
.. ..+-.. .........+++.+++..+| .+|+|+.|+++.
T Consensus 458 ~~------~~~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 GQ------KYDFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cc------CCCccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00 001000 11123347788889998766 689999998764
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=267.97 Aligned_cols=237 Identities=27% Similarity=0.438 Sum_probs=193.8
Q ss_pred CcccEEEcccC-CCcEEEEEEccccChhc-HHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCHHHHHHh
Q 004732 405 GFGPVYKGLLA-DGTAIAVKQLSSKSKQG-NREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFE 482 (733)
Q Consensus 405 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~ 482 (733)
+||.||+|+.. +|+.+|+|.+....... .+.+.+|++.+++++|+||+++++++..+...++|+||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 58999999987654433 67899999999999999999999999999999999999999999999875
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccccccCCCccc
Q 004732 483 HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 562 (733)
Q Consensus 483 ~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 562 (733)
.. .+++..+..++.++++++.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|++
T Consensus 81 ~~-~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ 154 (244)
T smart00220 81 RG-RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA 154 (244)
T ss_pred cc-CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence 44 3899999999999999999999986 9999999999999999999999999998665432 2234568889999
Q ss_pred HHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCc-cchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHH
Q 004732 563 PEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK-EDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALL 641 (733)
Q Consensus 563 PE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 641 (733)
||.+....++.++||||||++++++++|..||.. .+.....++.. ...... ... .......+.+++.+
T Consensus 155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~----~~~~~~----~~~---~~~~~~~~~~~i~~ 223 (244)
T smart00220 155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIG----KPKPPF----PPP---EWKISPEAKDLIRK 223 (244)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHh----ccCCCC----ccc---cccCCHHHHHHHHH
Confidence 9999888899999999999999999999999965 33333332211 111000 000 00023458889999
Q ss_pred hhcCCCCCCCCHHHHHH
Q 004732 642 CANASPTIRPSMSSVLR 658 (733)
Q Consensus 642 c~~~~P~~RPt~~~vl~ 658 (733)
|+..+|++||++.++++
T Consensus 224 ~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 224 LLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HccCCchhccCHHHHhh
Confidence 99999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=300.51 Aligned_cols=259 Identities=20% Similarity=0.263 Sum_probs=172.0
Q ss_pred hhhcCccccCcccCCCcccEEEccc-CC----CcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeE------E
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL-AD----GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC------C 458 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~ 458 (733)
...++|...+.||+|+||.||+|+. .+ +..||||++...... +....| .+....+.+++.++.. +
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 4678999999999999999999995 45 789999987543211 111111 1222223333322221 2
Q ss_pred EeCCeEEEEEEccCCCCHHHHHHhcCCCC-------------------CHHHHHHHHHHHHHHHHHHHcCCCCCeecCCC
Q 004732 459 IEGNQLLLIYEYLENNSLARALFEHRLKL-------------------DWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519 (733)
Q Consensus 459 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~l-------------------~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Di 519 (733)
.++...++||||+++++|.+++....... ....+..++.|++.||+|||+.+ |+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcC
Confidence 45678999999999999999986432111 12345679999999999999986 999999
Q ss_pred CCCcEEecC-CCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhC----------------------CCCccch
Q 004732 520 KATNVLLDK-DLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG----------------------HLTEKAD 576 (733)
Q Consensus 520 k~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 576 (733)
||+|||++. ++.+||+|||+|+............+.||+.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57899999999986654444444567899999999976432 2345679
Q ss_pred hHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc-c---cccccCCCCCC----CC--HHHHHHHHHHHHHhhcCC
Q 004732 577 VYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-L---MELVDTNPGSN----FD--KEQVMVMINVALLCANAS 646 (733)
Q Consensus 577 v~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~---~~~~~~~~~~~----~~--~~~~~~l~~l~~~c~~~~ 646 (733)
||||||++|||+++..|+.... ..........+. . ........... +. ........+++.+|++.|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 9999999999999876653221 111111111000 0 00000000000 00 001123558999999999
Q ss_pred CCCCCCHHHHHHH
Q 004732 647 PTIRPSMSSVLRM 659 (733)
Q Consensus 647 P~~RPt~~~vl~~ 659 (733)
|++|||+.|+++.
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999874
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.9e-32 Score=261.88 Aligned_cols=246 Identities=22% Similarity=0.319 Sum_probs=193.8
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 465 (733)
..++|+..++||+|+|..|..+++ ++.+.||+|++++. ......-...|-.+..+. +||.+|-+..+|..+..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 457899999999999999999995 56788999998764 222334455666666655 7999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+|.||++||+|--++++.+ +++++.++.+...|.-||.|||+.| ||+||+|..|||+|.+|++|++|+|+++..-.
T Consensus 328 fvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 9999999999988886654 8999999999999999999999997 99999999999999999999999999985332
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccc----hhhHHHHHHHHHhhCcccccccC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED----MFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
+ .....+++||+.|+|||++.+..|+..+|.|++||+|+||+.|+.||.-.. ....-++...+.-+..+
T Consensus 404 ~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi------ 476 (593)
T KOG0695|consen 404 P-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI------ 476 (593)
T ss_pred C-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc------
Confidence 2 334567999999999999999999999999999999999999999993111 11111221111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCC
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRP 651 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP 651 (733)
..+.....+...+++..+..||.+|.
T Consensus 477 ----riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 ----RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----cccceeehhhHHHHHHhhcCCcHHhc
Confidence 11112223455678889999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=280.33 Aligned_cols=210 Identities=24% Similarity=0.410 Sum_probs=177.6
Q ss_pred hhhhHHhhh---cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEee
Q 004732 384 FYLQIKAAT---NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYG 456 (733)
Q Consensus 384 ~~~~~~~~~---~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~ 456 (733)
.|.+++.+. .-|..++.||-|+||+|.+++ .++...||+|.+.+++ ........+|-.||.....+-||+++.
T Consensus 617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy 696 (1034)
T KOG0608|consen 617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY 696 (1034)
T ss_pred hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence 355555553 458888999999999999998 4556789999997653 333456788999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcc
Q 004732 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 536 (733)
Q Consensus 457 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 536 (733)
.|.+++.+|+||||++||++-.+|.+.+ -+.+.-++.++..++.|+++.|..| +|||||||+|||||.+|++||+|
T Consensus 697 SFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTD 772 (1034)
T KOG0608|consen 697 SFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTD 772 (1034)
T ss_pred EeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeee
Confidence 9999999999999999999999998765 6888899999999999999999987 99999999999999999999999
Q ss_pred cCccccCc---c-----cCcc---------------------------------cccccccCCCcccHHHHhhCCCCccc
Q 004732 537 FGLAKLDE---E-----ENTH---------------------------------ISTRVAGTIGYMAPEYAMRGHLTEKA 575 (733)
Q Consensus 537 fGla~~~~---~-----~~~~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~ 575 (733)
|||+.-+. + ...+ .....+||+.|+|||++....|+.-+
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c 852 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC 852 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence 99985211 0 0000 00124699999999999999999999
Q ss_pred hhHhHHHHHHHHHhCCCCCCcc
Q 004732 576 DVYSFGIVALEIVSGRSNVTKE 597 (733)
Q Consensus 576 Dv~s~Gvil~elltg~~p~~~~ 597 (733)
|.||.|||||||+.|+.||...
T Consensus 853 dwws~gvil~em~~g~~pf~~~ 874 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLAD 874 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCC
Confidence 9999999999999999999433
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=242.12 Aligned_cols=202 Identities=26% Similarity=0.432 Sum_probs=166.7
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc-ChhcHHHHHHHHHHHHh-CCCCceeeEeeEEEeCCeEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK-SKQGNREFINEIGMISA-LQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~l 466 (733)
...++......||+|++|.|=+-+ ..+|+..|+|++... ..+..++..+|+.+..+ ..+|.+|.++|.+.+....++
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 344555667789999999999888 568999999998764 23334567788887554 479999999999999999999
Q ss_pred EEEccCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 467 IYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 467 V~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.||.|+. ||+.+-. ..+..+++...-+|+..+.+||.|||++- .+||||+||+|||++.+|++||||||++-+.
T Consensus 123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceee
Confidence 9999965 6655432 56778999999999999999999999974 7999999999999999999999999999865
Q ss_pred cccCcccccccccCCCcccHHHHhh----CCCCccchhHhHHHHHHHHHhCCCCCCc
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMR----GHLTEKADVYSFGIVALEIVSGRSNVTK 596 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~s~Gvil~elltg~~p~~~ 596 (733)
.+.-. .+...|--.|||||.+.. ..|+-|+||||+|+.+.||.+++.|+..
T Consensus 200 ~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 200 VDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred hhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 54322 222457778999999854 3689999999999999999999999943
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=261.17 Aligned_cols=262 Identities=23% Similarity=0.344 Sum_probs=197.3
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----CeEE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQLL 465 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 465 (733)
+...++.||.|+||.||.++ -++|+.||.|++... .-...+.+.+|+.+|..++|.|++..+++..-. +++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 45577899999999999998 468999999988543 223457889999999999999999988887643 3567
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
.|.|.|.. +|...+- ..+.++.+.+.-+.+||++||.|||+.+ |.||||||.|.|++.+...||||||+++....
T Consensus 134 V~TELmQS-DLHKIIV-SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIV-SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHh-hhhheec-cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 78887754 6666653 4567888899999999999999999986 99999999999999999999999999998776
Q ss_pred cCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh-----------C
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ-----------G 613 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~ 613 (733)
+.....+..+-|..|.|||++++. .|+.+.||||.|||+.|++..+.-|...++...++........ +
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 655555555568899999999985 6999999999999999999999888766655444433222211 1
Q ss_pred cccccccCCCCC-----CC----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004732 614 KLMELVDTNPGS-----NF----DKEQVMVMINVALLCANASPTIRPSMSSVLRML 660 (733)
Q Consensus 614 ~~~~~~~~~~~~-----~~----~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 660 (733)
....++...++. .| +...-.....+...++..||++|.+..+.+..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111111111110 00 111122355677788899999999999987654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=260.69 Aligned_cols=259 Identities=21% Similarity=0.314 Sum_probs=196.9
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCC--Cc----eeeEeeEEEeCCe
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH--PN----LVKLYGCCIEGNQ 463 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~n----iv~l~~~~~~~~~ 463 (733)
.+++|.+...+|+|.||.|-++. ...+..||||+++...+. .+..+-|++++.++.+ |+ +|.+.++|.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 47789999999999999999998 445789999998765333 3455679999999943 22 7888899999999
Q ss_pred EEEEEEccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC--------------
Q 004732 464 LLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-------------- 528 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-------------- 528 (733)
.++|+|.+ |-|+.+++.+ ....++...+..++.|+++++++||+.+ ++|-|+||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 99999987 5588999875 4567899999999999999999999985 999999999999941
Q ss_pred ------CCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhH
Q 004732 529 ------DLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL 602 (733)
Q Consensus 529 ------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~ 602 (733)
+..+||+|||.|....+.. ..++.|..|.|||++.+-..+..+||||+||||+|+.+|..-|...+....
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH 317 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH 317 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence 3348999999998755543 446678999999999999999999999999999999999999954442221
Q ss_pred HHHHHHH-----------------HhhCcc-----------cccccCCCC----CCCCHHHHHHHHHHHHHhhcCCCCCC
Q 004732 603 LDWALVL-----------------KEQGKL-----------MELVDTNPG----SNFDKEQVMVMINVALLCANASPTIR 650 (733)
Q Consensus 603 ~~~~~~~-----------------~~~~~~-----------~~~~~~~~~----~~~~~~~~~~l~~l~~~c~~~~P~~R 650 (733)
+.....+ ...+.+ ....+.+.. ......+...+.+++.+++..||.+|
T Consensus 318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence 1111100 011100 000000000 00122344579999999999999999
Q ss_pred CCHHHHHH
Q 004732 651 PSMSSVLR 658 (733)
Q Consensus 651 Pt~~~vl~ 658 (733)
+|+.|+++
T Consensus 398 iTl~EAL~ 405 (415)
T KOG0671|consen 398 ITLREALS 405 (415)
T ss_pred ccHHHHhc
Confidence 99999875
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-30 Score=237.66 Aligned_cols=255 Identities=18% Similarity=0.328 Sum_probs=193.1
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeC--CeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEG--NQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV 467 (733)
.++|.+.+.+|+|.++.||.|. ..+..+++||.++... .+.+.+|+.+|..++ ||||+++++...++ ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678889999999999999999 6678899999997543 357889999999997 99999999999875 456899
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-CeEEcccCccccCccc
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEE 546 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~~ 546 (733)
+||+.+.+....- ..++...+..++.+++.||.|+|+.| |+|||+||.|+|+|... ..+|+|+|+|.+..+.
T Consensus 114 FE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 9999998776543 36778889999999999999999997 99999999999999764 5999999999987765
Q ss_pred CcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCC-c-cchhhHHHHHHHHHh------------
Q 004732 547 NTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVT-K-EDMFYLLDWALVLKE------------ 611 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~-~-~~~~~~~~~~~~~~~------------ 611 (733)
.... ..+.+..|.-||.+.. ..|+..-|+|||||++..|+..+.||. + .+...++.-+++...
T Consensus 187 ~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i 264 (338)
T KOG0668|consen 187 KEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI 264 (338)
T ss_pred ceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence 4331 2234667889999876 458999999999999999999999993 2 233333332222211
Q ss_pred --hCcccccccCCCCCCC-------CHH-HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 612 --QGKLMELVDTNPGSNF-------DKE-QVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 612 --~~~~~~~~~~~~~~~~-------~~~-~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+.+...++....+..+ ... ...+.++++.+.+..|-++|||++|...
T Consensus 265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 1111111111111111 000 1235788888999999999999998643
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=308.22 Aligned_cols=260 Identities=30% Similarity=0.486 Sum_probs=171.7
Q ss_pred ceeeeecccce-----eeeeccccccccccCCccccCCCCCCeeeccccccccccchhcc-CCCCCCEEEcccccccccC
Q 004732 8 LVFHFWKQKTV-----NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLA-NISTLVNLTVQYNQFSGEL 81 (733)
Q Consensus 8 ~~~~~~~~~~~-----~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~ 81 (733)
..++.|.|++| ...|+|++|++++.++..|..+++|+.|+|++|++++.+|..+. ++++|++|+|++|++++.+
T Consensus 55 ~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~ 134 (968)
T PLN00113 55 ADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSI 134 (968)
T ss_pred CCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCcccccc
Confidence 35678888776 46788999999999999999999999999999999888887655 7888888888888877666
Q ss_pred CccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcC
Q 004732 82 PEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLE 161 (733)
Q Consensus 82 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~ 161 (733)
|. +.+++|++|+|++|.+++.+|..++++++|++|+|++|.+.+.+|..|+++++|++|+|++|++.+.+|..+++++
T Consensus 135 p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 212 (968)
T PLN00113 135 PR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMK 212 (968)
T ss_pred Cc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcC
Confidence 63 3456666666666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEec
Q 004732 162 NLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFA 240 (733)
Q Consensus 162 ~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 240 (733)
+|+.|++++|.+....+..++.+ +|+.|++++|.+++.+|..++++++|+.|+|++|.+++.+|..+..+++|+.|+++
T Consensus 213 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 292 (968)
T PLN00113 213 SLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLS 292 (968)
T ss_pred CccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECc
Confidence 66666666666655444444433 55566666666655555555555555555555555555555555555555555555
Q ss_pred CCcccccCChhh--hcCCCeeecccCcCCCC
Q 004732 241 GNLLTGAIPPWM--LERGDKIDLSYNNFTDG 269 (733)
Q Consensus 241 ~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~ 269 (733)
+|.+.+.+|..+ +++|+.|++++|.+.+.
T Consensus 293 ~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~ 323 (968)
T PLN00113 293 DNSLSGEIPELVIQLQNLEILHLFSNNFTGK 323 (968)
T ss_pred CCeeccCCChhHcCCCCCcEEECCCCccCCc
Confidence 555555555544 44455555555555443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=279.23 Aligned_cols=243 Identities=29% Similarity=0.399 Sum_probs=185.1
Q ss_pred ccccCcccCCCccc-EEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 395 FATDNNIGEGGFGP-VYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 395 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
|...+++|.|+.|+ ||+|..+ |+.||||++-... .....+|+..|+.- +|||||++++.-.++...|++.|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 45567899999764 7899885 7899999985432 24557899999888 69999999999888999999999996
Q ss_pred CCCHHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC---C--CCeEEcccCccccCc
Q 004732 473 NNSLARALFEHRLK---LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---D--LNSKISDFGLAKLDE 544 (733)
Q Consensus 473 ~gsL~~~l~~~~~~---l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~---~--~~~kl~DfGla~~~~ 544 (733)
. +|.+++...... ..-...+.+..|++.||++||+.+ ||||||||.||||+. + .+++|+|||+++...
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5 899999753111 111456788999999999999975 999999999999976 3 469999999999876
Q ss_pred ccCccc--ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhC-CCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 545 EENTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG-RSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 545 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
...... .....||-||+|||.+....-+.++||||+||++|+.++| ..||...-. ..+.+......+..+.
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~----R~~NIl~~~~~L~~L~-- 736 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE----RQANILTGNYTLVHLE-- 736 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH----hhhhhhcCccceeeec--
Confidence 554433 3457799999999999988888899999999999999996 899943211 1111111111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+ ..+. ...+++.++++.+|..||++.+|+.
T Consensus 737 -~----~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 737 -P----LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -c----CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0 0011 5788999999999999999999954
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-28 Score=240.55 Aligned_cols=210 Identities=37% Similarity=0.609 Sum_probs=183.7
Q ss_pred ccCCCcccEEEcccC-CCcEEEEEEccccChh-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCHHH
Q 004732 401 IGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLAR 478 (733)
Q Consensus 401 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~ 478 (733)
||+|++|.||++... +++.+++|.+...... ....+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999965 4899999998765332 34678999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC-CCCeEEcccCccccCcccCcccccccccC
Q 004732 479 ALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLDEEENTHISTRVAGT 557 (733)
Q Consensus 479 ~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt 557 (733)
++......+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~ 156 (215)
T cd00180 81 LLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVGT 156 (215)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccCC
Confidence 98765457899999999999999999999986 999999999999999 89999999999986544321 12234578
Q ss_pred CCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHH
Q 004732 558 IGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMI 636 (733)
Q Consensus 558 ~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 636 (733)
..|++||..... .++.+.|+|++|++++++ ..+.
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------~~~~ 191 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------PELK 191 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------HHHH
Confidence 899999999877 888999999999999998 3488
Q ss_pred HHHHHhhcCCCCCCCCHHHHHHH
Q 004732 637 NVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 637 ~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+++..|++.+|++||++.++++.
T Consensus 192 ~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred HHHHHHhhCCcccCcCHHHHhhC
Confidence 89999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-28 Score=247.54 Aligned_cols=260 Identities=22% Similarity=0.335 Sum_probs=192.9
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-----C---CceeeEeeEEEe--
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-----H---PNLVKLYGCCIE-- 460 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~-- 460 (733)
..+|-..++||.|.|++||.|. ....+.||+|+.+.... -.+..+.|+.+|++++ | .+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 4678889999999999999998 56788999999876432 3455688999999985 2 469999999975
Q ss_pred --CCeEEEEEEccCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC--------
Q 004732 461 --GNQLLLIYEYLENNSLARALF-EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-------- 529 (733)
Q Consensus 461 --~~~~~lV~e~~~~gsL~~~l~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~-------- 529 (733)
+.++++|+|++. -+|..+|. ...+.++...+.+|++||+.||.|||..| +|||-||||+|||+..+
T Consensus 156 pNG~HVCMVfEvLG-dnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~ 232 (590)
T KOG1290|consen 156 PNGQHVCMVFEVLG-DNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDA 232 (590)
T ss_pred CCCcEEEEEehhhh-hHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhh
Confidence 568999999984 46777776 44567999999999999999999999998 79999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 004732 530 -------------------------------------------------------------------------------- 529 (733)
Q Consensus 530 -------------------------------------------------------------------------------- 529 (733)
T Consensus 233 ~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~ 312 (590)
T KOG1290|consen 233 REAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGN 312 (590)
T ss_pred hhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCcc
Confidence
Q ss_pred ------------------------------------------------------------------------------CC
Q 004732 530 ------------------------------------------------------------------------------LN 531 (733)
Q Consensus 530 ------------------------------------------------------------------------------~~ 531 (733)
.+
T Consensus 313 ~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~ 392 (590)
T KOG1290|consen 313 ESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIR 392 (590)
T ss_pred ccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcccee
Confidence 01
Q ss_pred eEEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccc-------hhhHHH
Q 004732 532 SKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED-------MFYLLD 604 (733)
Q Consensus 532 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~-------~~~~~~ 604 (733)
+||+|||-|.+.....+ .-..|..|.|||++.+..|++.+||||++|++|||+||...|.+.. ...+..
T Consensus 393 vKIaDlGNACW~~khFT----~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~ 468 (590)
T KOG1290|consen 393 VKIADLGNACWVHKHFT----EDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIAL 468 (590)
T ss_pred EEEeeccchhhhhhhhc----hhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHH
Confidence 34444444443322211 1234778999999999999999999999999999999998884322 111110
Q ss_pred ------------------HHHHHHhhCcccccccCCC---------CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004732 605 ------------------WALVLKEQGKLMELVDTNP---------GSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 657 (733)
Q Consensus 605 ------------------~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl 657 (733)
+...+-+.+.+..+-.-.+ +..++.++...+.+++.-+++.+|++|||+.+.+
T Consensus 469 i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl 548 (590)
T KOG1290|consen 469 IMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCL 548 (590)
T ss_pred HHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHh
Confidence 1111112222222211111 1245778888999999999999999999999988
Q ss_pred HH
Q 004732 658 RM 659 (733)
Q Consensus 658 ~~ 659 (733)
+.
T Consensus 549 ~h 550 (590)
T KOG1290|consen 549 KH 550 (590)
T ss_pred cC
Confidence 64
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=239.07 Aligned_cols=199 Identities=34% Similarity=0.527 Sum_probs=173.2
Q ss_pred ccccCcccCCCcccEEEcccCC-CcEEEEEEccccChh-cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 395 FATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQ-GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
|...+.||+|++|.||+|...+ ++.+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566789999999999999654 899999999765443 56788999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+++|.+++......+++..+..++.++++++.+||+.+ ++|+||+|+||+++.++.++|+|||.+............
T Consensus 81 ~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (225)
T smart00221 81 GGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK 157 (225)
T ss_pred CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence 99999998765433899999999999999999999986 999999999999999999999999999876544311223
Q ss_pred ccccCCCcccHHHH-hhCCCCccchhHhHHHHHHHHHhCCCCCCc
Q 004732 553 RVAGTIGYMAPEYA-MRGHLTEKADVYSFGIVALEIVSGRSNVTK 596 (733)
Q Consensus 553 ~~~gt~~y~aPE~~-~~~~~~~~~Dv~s~Gvil~elltg~~p~~~ 596 (733)
...++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 45678899999998 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.7e-29 Score=257.13 Aligned_cols=196 Identities=24% Similarity=0.369 Sum_probs=166.1
Q ss_pred cCccccCcccCCCcccEEEcccC-CCcEEEEEEccccChh--------cHHHHHHHHHHHHhCC---CCceeeEeeEEEe
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQ--------GNREFINEIGMISALQ---HPNLVKLYGCCIE 460 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 460 (733)
.+|...+.+|+|+||.|+.|+++ +...|+||.+.+..-- ..-.+-.|++||+.++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 46888999999999999999954 5678899988654211 0112345999999997 9999999999999
Q ss_pred CCeEEEEEEccC-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCc
Q 004732 461 GNQLLLIYEYLE-NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 539 (733)
Q Consensus 461 ~~~~~lV~e~~~-~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 539 (733)
++.+||+||-.. +-+|.+++. -...+++.++.-|+.||+-|+++||++| |||||||-+||.++.+|-+||+|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE-~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIE-FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhh-ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeeccc
Confidence 999999999764 458888885 3457999999999999999999999997 99999999999999999999999999
Q ss_pred cccCcccCcccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCC
Q 004732 540 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVT 595 (733)
Q Consensus 540 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~ 595 (733)
|.+.... ....++||.+|.|||++.+..| +..-|||++|++||-++....||+
T Consensus 717 aa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9765432 2346889999999999998776 556899999999999999888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=264.65 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=201.4
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
..++|.....+|+|.||.||||+ ...++..|||.++.......+-..+|+-+++..+|||||.++|.+...+..+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 34678888999999999999999 56899999999987766666677889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
||.+|+|.+.-+.. ..+++.++..+++...+|++|||+.| -+|||||-.||++++.|.+|++|||.+..+...- .
T Consensus 93 ycgggslQdiy~~T-gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati-~ 167 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI-A 167 (829)
T ss_pred ecCCCcccceeeec-ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-h
Confidence 99999999876544 47899999999999999999999997 7899999999999999999999999987554322 2
Q ss_pred cccccccCCCcccHHHHh---hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 550 ISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
....+.||+.|||||+.. .+.|..++|||+.|+...|+-.-+.|....-+..-. ...-+..-....+-|
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l--~LmTkS~~qpp~lkD------ 239 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL--FLMTKSGFQPPTLKD------ 239 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH--HHhhccCCCCCcccC------
Confidence 244588999999999873 567999999999999999998777765332221110 111111111111112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVL 657 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl 657 (733)
.......+-++++.|+..+|.+||+++.++
T Consensus 240 -k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 240 -KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred -CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 222344588999999999999999988763
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=236.49 Aligned_cols=254 Identities=24% Similarity=0.381 Sum_probs=193.4
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------CeE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------NQL 464 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 464 (733)
+|...+.+|.|+- .|..|. .-.++.||+|++... .....++..+|...+..+.|+||++++.+|.-. .+.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 4556678888888 566665 446899999987543 233456778899999999999999999998743 357
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
|+|||||.. +|...+. ..++-.+...|+.|++.|++|||+.| |+||||||+||++..++.+||.|||+|+...
T Consensus 97 y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 97 YLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccC
Confidence 999999965 7888776 35778899999999999999999997 9999999999999999999999999998544
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc---------
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL--------- 615 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 615 (733)
.. ...+....|..|.|||++.+..+.+.+||||.||++.||++|+.-|.+.+..+ +|.+....-+..
T Consensus 170 ~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id--Q~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 170 TD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHID--QWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred cc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHH--HHHHHHHHhcCCCHHHHHHhh
Confidence 43 34456778889999999999889999999999999999999999887655332 233222211100
Q ss_pred ------------------cccc-cCCC--CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 616 ------------------MELV-DTNP--GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 616 ------------------~~~~-~~~~--~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+.+ |... ....+.-....+.+++.+++-.+|++|-+.+++++.
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0000 0000 000111123357889999999999999999999875
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.3e-27 Score=237.74 Aligned_cols=200 Identities=31% Similarity=0.479 Sum_probs=167.6
Q ss_pred hHHhhhcCccccCcccCCCcccEEEcccC----CCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004732 387 QIKAATNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 461 (733)
Q Consensus 387 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 461 (733)
.+....+.|...++||+|.|++||+|+.. ..+.||+|.+...+.. ..+.+|+++|..+ .+.||+++.+++...
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 34455678899999999999999999843 4678999998765443 5688999999999 599999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC-CCeEEcccCcc
Q 004732 462 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLA 540 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfGla 540 (733)
+...+|+||++.....++.. .++..++..+++.+..||+++|..| ||||||||+|+|.+.. ++-.|.|||+|
T Consensus 108 d~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred CeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 99999999999998888764 5678999999999999999999997 9999999999999854 56899999999
Q ss_pred ccCcccC-------------c------------------------------ccccccccCCCcccHHHHhh-CCCCccch
Q 004732 541 KLDEEEN-------------T------------------------------HISTRVAGTIGYMAPEYAMR-GHLTEKAD 576 (733)
Q Consensus 541 ~~~~~~~-------------~------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~~D 576 (733)
....... . ......+||+||.|||++.+ ...++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 7211000 0 00112569999999999987 45889999
Q ss_pred hHhHHHHHHHHHhCCCCCC
Q 004732 577 VYSFGIVALEIVSGRSNVT 595 (733)
Q Consensus 577 v~s~Gvil~elltg~~p~~ 595 (733)
|||.|||++.+++++.||.
T Consensus 261 iws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred eeeccceeehhhccccccc
Confidence 9999999999999999993
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=223.27 Aligned_cols=253 Identities=18% Similarity=0.284 Sum_probs=187.0
Q ss_pred hcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeE-EEeCCeEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGC-CIEGNQLLLIY 468 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lV~ 468 (733)
.+.|++.+.+|+|.||.+-.++++ ..+.+++|.+.... ...++|.+|..---.+ .|.||+.-++. |...+..++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 457889999999999999999954 67889999986542 3457899998764444 58999987765 67778889999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec--CCCCeEEcccCccccCccc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD--KDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~--~~~~~kl~DfGla~~~~~~ 546 (733)
||++.|+|.+-+.. ..+.+....+++.|++.||.|||++ ++||||||.+|||+- +..++|+||||+.+..+..
T Consensus 102 E~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred ccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 99999999987744 4578888999999999999999998 499999999999993 3457999999998743321
Q ss_pred CcccccccccCCCcccHHHHhhC-----CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRG-----HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
.....-+..|.+||..... ...+.+|||.||+++|.++||..||......+..-|.......+..+...+.
T Consensus 177 ----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~ 252 (378)
T KOG1345|consen 177 ----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK 252 (378)
T ss_pred ----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence 1122335579999987642 3577899999999999999999999644333333333333333433332221
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHh
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRML 660 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L 660 (733)
-..+. .++.++.++-+..+|++|=...++-++.
T Consensus 253 --F~~fs----~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 253 --FNPFS----EKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred --hcccC----HHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 11222 3466677788899999996555555443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.1e-27 Score=240.74 Aligned_cols=261 Identities=21% Similarity=0.267 Sum_probs=198.4
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC------CCceeeEeeEEEeCC
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ------HPNLVKLYGCCIEGN 462 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~ 462 (733)
....+|.+.-..|+|-|++|.+|. ...|..||||++.... ...+.=.+|+++|++|+ --|.++++-.|....
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 345678888899999999999998 4568899999997542 23344578999999996 358999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-CeEEcccCc
Q 004732 463 QLLLIYEYLENNSLARALFEH--RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGL 539 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGl 539 (733)
++|||+|.+.- +|.++|... ...|....+..++.|+.-||..|-..+ |+|.||||.|||+++.- .+||||||.
T Consensus 508 HLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcc
Confidence 99999998754 799998744 345778899999999999999999886 99999999999999865 479999999
Q ss_pred cccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh--------
Q 004732 540 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE-------- 611 (733)
Q Consensus 540 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-------- 611 (733)
|....+.... .+.-+..|.|||++.+-.|+...|+||.||.|||+.||+..|.+......+........
T Consensus 584 A~~~~eneit---PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 584 ASFASENEIT---PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred cccccccccc---HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 9866544332 22234569999999999999999999999999999999999966554444332211110
Q ss_pred -------------------------hCcccccccCCC-------------CCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004732 612 -------------------------QGKLMELVDTNP-------------GSNFDKEQVMVMINVALLCANASPTIRPSM 653 (733)
Q Consensus 612 -------------------------~~~~~~~~~~~~-------------~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 653 (733)
...+.-+..-.| ...........+.+|+..|+..||++|.|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 000000111111 011123345578899999999999999999
Q ss_pred HHHHH
Q 004732 654 SSVLR 658 (733)
Q Consensus 654 ~~vl~ 658 (733)
.+.++
T Consensus 741 nqAL~ 745 (752)
T KOG0670|consen 741 NQALK 745 (752)
T ss_pred HHHhc
Confidence 99865
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-28 Score=251.67 Aligned_cols=283 Identities=18% Similarity=0.199 Sum_probs=176.4
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
-++.+||+.|.|+.+--+.|..=.++++|+|++|+|+..-...|.++.+|..|.|++|+++...+..|.+|++|+.|+|.
T Consensus 150 alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLn 229 (873)
T KOG4194|consen 150 ALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLN 229 (873)
T ss_pred hhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcc
Confidence 35667777777776666667666777777777777776666777777777777777777774444566667777777777
Q ss_pred CccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCC
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT 177 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~ 177 (733)
.|+|.-.---.|.+|++|+.|.|..|.++..-.+.|..|.++++|+|+.|+++..-...+++|+.|+.|++|+|.+..+.
T Consensus 230 rN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih 309 (873)
T KOG4194|consen 230 RNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIH 309 (873)
T ss_pred ccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheee
Confidence 77776332445666777777777777776655666666677777777777766555556666666666666666666666
Q ss_pred ccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCccccc---------
Q 004732 178 FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGA--------- 247 (733)
Q Consensus 178 ~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--------- 247 (733)
...+... +|++|+|++|+|+...+..|..+..|+.|+|++|.++..-...|..+.+|+.|+|++|.+...
T Consensus 310 ~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~ 389 (873)
T KOG4194|consen 310 IDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFN 389 (873)
T ss_pred cchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhc
Confidence 6666655 566666666666655555555555555555555555543334444444444444444444322
Q ss_pred -----------------CCh-hh--hcCCCeeecccCcCCCCCCcccccccccccccccccccccCCceeeeee
Q 004732 248 -----------------IPP-WM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKTYYSLHI 301 (733)
Q Consensus 248 -----------------~p~-~~--l~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~ 301 (733)
+|. .+ +..|+.|||.+|.+....+.++-+. .+..++....++.|.+...|+..
T Consensus 390 gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDCql~Wl~q 462 (873)
T KOG4194|consen 390 GLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDCQLKWLAQ 462 (873)
T ss_pred cchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEeccHHHHHH
Confidence 222 22 4455556666666655555555555 44455555566777776555443
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-27 Score=248.57 Aligned_cols=250 Identities=20% Similarity=0.186 Sum_probs=225.5
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
++.|+|.+|-|+.+-.+++..++.|+.|||+.|.|+.+.-.+|..-.++++|+|++|.|+..--..|.++.+|..|.|++
T Consensus 127 l~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsr 206 (873)
T KOG4194|consen 127 LEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSR 206 (873)
T ss_pred eeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeeccc
Confidence 78899999999999999999999999999999999966556788888999999999999977778899999999999999
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCc
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATF 178 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~ 178 (733)
|+++-..+..|.+|++|+.|+|..|+|.-.---.|.++++|+.|.|..|++...-...|..|.+++.|+|..|++.....
T Consensus 207 NrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~ 286 (873)
T KOG4194|consen 207 NRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNE 286 (873)
T ss_pred CcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhc
Confidence 99997777888899999999999999993336689999999999999999997777789999999999999999999887
Q ss_pred cccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcC
Q 004732 179 PQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LER 255 (733)
Q Consensus 179 ~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~ 255 (733)
..+-++ +|+.|+||.|.|...-++.+...++|++|+||+|+|+...+++|..+..|+.|+|++|.++..--..+ +++
T Consensus 287 g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lss 366 (873)
T KOG4194|consen 287 GWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSS 366 (873)
T ss_pred ccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhh
Confidence 765554 89999999999999999999999999999999999998888999999999999999999974333333 788
Q ss_pred CCeeecccCcCCC
Q 004732 256 GDKIDLSYNNFTD 268 (733)
Q Consensus 256 l~~l~ls~N~l~~ 268 (733)
|+.|||+.|.++.
T Consensus 367 L~~LdLr~N~ls~ 379 (873)
T KOG4194|consen 367 LHKLDLRSNELSW 379 (873)
T ss_pred hhhhcCcCCeEEE
Confidence 9999999998764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-26 Score=273.74 Aligned_cols=195 Identities=17% Similarity=0.205 Sum_probs=140.8
Q ss_pred CCC-CceeeEeeEE-------EeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecC
Q 004732 446 LQH-PNLVKLYGCC-------IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 517 (733)
Q Consensus 446 l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~ 517 (733)
++| +||++++++| .+.+.+++++||+ +++|.+++......+++.++..++.||++||+|||++| |+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence 445 5788888887 2334577888987 56999999766667999999999999999999999986 9999
Q ss_pred CCCCCcEEecC-------------------CCCeEEcccCccccCcccC---------------cccccccccCCCcccH
Q 004732 518 DIKATNVLLDK-------------------DLNSKISDFGLAKLDEEEN---------------THISTRVAGTIGYMAP 563 (733)
Q Consensus 518 Dik~~Nill~~-------------------~~~~kl~DfGla~~~~~~~---------------~~~~~~~~gt~~y~aP 563 (733)
||||+|||++. ++.+|++|||+++...... ........||+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999954 4556777777776422100 0001124588999999
Q ss_pred HHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhh
Q 004732 564 EYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCA 643 (733)
Q Consensus 564 E~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~ 643 (733)
|++.+..++.++|||||||++|||++|..|+..... ...... . . ...+.. ........+++.+||
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~-~~~~~~----~-~----~~~~~~-----~~~~~~~~~~~~~~L 249 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR-TMSSLR----H-R----VLPPQI-----LLNWPKEASFCLWLL 249 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH-HHHHHH----H-h----hcChhh-----hhcCHHHHHHHHHhC
Confidence 999999999999999999999999999887643211 011100 0 0 001000 011223567888999
Q ss_pred cCCCCCCCCHHHHHHH
Q 004732 644 NASPTIRPSMSSVLRM 659 (733)
Q Consensus 644 ~~~P~~RPt~~~vl~~ 659 (733)
+.+|.+||++.|+++.
T Consensus 250 ~~~P~~Rps~~eil~h 265 (793)
T PLN00181 250 HPEPSCRPSMSELLQS 265 (793)
T ss_pred CCChhhCcChHHHhhc
Confidence 9999999999999764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=210.62 Aligned_cols=165 Identities=25% Similarity=0.224 Sum_probs=125.9
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++...+..+++.+++.++.|+++||+|||+.+ ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc------
Confidence 7899999876667999999999999999999999874 999999999999999 99998654322
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......... . .++. ..........
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~-~--~~~~-~~~~~~~~~~ 137 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMP-A--DDPR-DRSNLESVSA 137 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhc-c--CCcc-ccccHHHHHh
Confidence 2589999999999999999999999999999999999999954432111 1111111000 0 0000 0011112222
Q ss_pred --HHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 634 --VMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 634 --~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.+.+++.+||+.+|.+||++.|+++.+.
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~ 167 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCR 167 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence 5899999999999999999999998876
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.6e-23 Score=221.71 Aligned_cols=259 Identities=19% Similarity=0.182 Sum_probs=193.1
Q ss_pred CccccCcccCCCcccEEEcccCCC--cEEEEEEccccChhcHHHHHHHHHHHHhCCC----CceeeEeeEE-EeCCeEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLADG--TAIAVKQLSSKSKQGNREFINEIGMISALQH----PNLVKLYGCC-IEGNQLLL 466 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l 466 (733)
+|.+.+.||+|+||.||.|..... ..+|+|............+..|+.++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 788999999999999999995443 5788888765433322367889999888873 6899999999 47788999
Q ss_pred EEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC-----CCeEEcccCcc
Q 004732 467 IYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-----LNSKISDFGLA 540 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~-----~~~kl~DfGla 540 (733)
||+.+ |.+|.++..... ..++..+..+|+.|++.+|++||+.| ++||||||.|+++... ..++|.|||++
T Consensus 99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99976 779999875444 78999999999999999999999997 9999999999999865 35899999999
Q ss_pred ccCc--ccCc----cc---ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh
Q 004732 541 KLDE--EENT----HI---STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE 611 (733)
Q Consensus 541 ~~~~--~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 611 (733)
+... .... .. ...+.||..|+++....+.+.+++.|+||++.++.|++.|..||..........-......
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 8322 1111 11 2346699999999999999999999999999999999999999954332211111111111
Q ss_pred hCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 612 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
...... ..... ...+.++...+-..+..++|....+...+++...
T Consensus 255 ~~~~~~------~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 255 KLLTDR------FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred hhcccc------ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHH
Confidence 111110 01112 2235556666667899999999999888775544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-25 Score=209.81 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=187.5
Q ss_pred cccCcccCCCcccEEEcccCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 396 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
...-+|.+...|..|+|+|+.+. +++|++... .....++|..|.-.|+-+.||||++++|.|..+....++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 34457888999999999997544 555665432 333447899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEc--ccCccccCcccCccc
Q 004732 474 NSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKIS--DFGLAKLDEEENTHI 550 (733)
Q Consensus 474 gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~--DfGla~~~~~~~~~~ 550 (733)
|+|...+++. ...++..++.+++.++|+|++|||+.. +-|.---+.+..|++|++.+++|+ |--++. ..
T Consensus 272 gslynvlhe~t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf---qe---- 343 (448)
T KOG0195|consen 272 GSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF---QE---- 343 (448)
T ss_pred hHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee---ec----
Confidence 9999999853 446788899999999999999999985 224445689999999999988874 322221 11
Q ss_pred ccccccCCCcccHHHHhhCCC---CccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 551 STRVAGTIGYMAPEYAMRGHL---TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
....-.+.||+||.++..+- -.++|+|||++++||+.|...||..-.+....- .+.-..++...
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgm------------kialeglrv~i 410 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGM------------KIALEGLRVHI 410 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhh------------hhhhccccccC
Confidence 11234678999999987653 358999999999999999999996544333211 11111222333
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
++.....+.+++.-|+..||.+||.+..|+-.||+.
T Consensus 411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 444555688889999999999999999999998854
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.1e-24 Score=225.99 Aligned_cols=167 Identities=22% Similarity=0.210 Sum_probs=130.6
Q ss_pred HHhhhcCccccCcccCCCcccEEEcccC--CCcEEEEEEcccc-----ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGLLA--DGTAIAVKQLSSK-----SKQGNREFINEIGMISALQHPNLVKLYGCCIE 460 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 460 (733)
.....++|...+.||+|+||+||+|+.. +++.||||++... .......|.+|+++|++++|+|+++.+..
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~--- 89 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA--- 89 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence 3455678999999999999999999853 5788899986532 12234568999999999999999853322
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCC-CCCcEEecCCCCeEEcccCc
Q 004732 461 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI-KATNVLLDKDLNSKISDFGL 539 (733)
Q Consensus 461 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Di-k~~Nill~~~~~~kl~DfGl 539 (733)
.+..++||||+++++|... .. .. ...++.++++||+|||+.| |+|||| ||+|||++.++.+||+|||+
T Consensus 90 ~~~~~LVmE~~~G~~L~~~-~~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 90 TGKDGLVRGWTEGVPLHLA-RP----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred cCCcEEEEEccCCCCHHHh-Cc----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 2457999999999999632 11 11 2467899999999999986 999999 99999999999999999999
Q ss_pred cccCcccCccc-------ccccccCCCcccHHHHhh
Q 004732 540 AKLDEEENTHI-------STRVAGTIGYMAPEYAMR 568 (733)
Q Consensus 540 a~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~ 568 (733)
|+......... .....+++.|+|||++..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 98765433211 135678899999999854
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.3e-26 Score=236.61 Aligned_cols=244 Identities=23% Similarity=0.361 Sum_probs=179.1
Q ss_pred cceeeeeccccccccc-cCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCc-cccCCcCCce
Q 004732 16 KTVNQKRVLKEQNLTG-VLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE-ELGSLLNLEK 93 (733)
Q Consensus 16 ~~~~~~l~L~~n~l~~-~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~ 93 (733)
.++++.+++.+|++.. -+|..+..|..|+.|||++|+++ ..|..+..-+++-.|+||+|+|. .||. -|-+|+.|-.
T Consensus 77 Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLf 154 (1255)
T KOG0444|consen 77 LPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLF 154 (1255)
T ss_pred chhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhh
Confidence 5567777888888874 46778888888888888888888 78888888888888888888888 5554 4677888888
Q ss_pred eeccCccccccCCccccCCCCCCEEEeeCCccc-------------------------cCCCccccccCCCCEEEccCCC
Q 004732 94 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT-------------------------GQIPSFIQNWTKLEKLFIQPSG 148 (733)
Q Consensus 94 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-------------------------~~~~~~~~~l~~L~~L~l~~N~ 148 (733)
||||+|++. .+|..+..|.+|++|.|++|.+. ..+|..+..+.+|..++|+.|.
T Consensus 155 LDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~ 233 (1255)
T KOG0444|consen 155 LDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENN 233 (1255)
T ss_pred hccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccC
Confidence 888888887 77777777778888888777653 1345666777888888888888
Q ss_pred CccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCccc--C----
Q 004732 149 LAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLR--G---- 222 (733)
Q Consensus 149 l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~--~---- 222 (733)
|. .+|+++.++.+|+.|+||+|.++......-.-.+|++|+||+|+|+ .+|++++++++|+.|.+.+|+++ |
T Consensus 234 Lp-~vPecly~l~~LrrLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSG 311 (1255)
T KOG0444|consen 234 LP-IVPECLYKLRNLRRLNLSGNKITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSG 311 (1255)
T ss_pred CC-cchHHHhhhhhhheeccCcCceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccc
Confidence 87 7888888888888888888888877655433346677777777776 55666666666666666665543 1
Q ss_pred ------------------CCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCc
Q 004732 223 ------------------QIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNN 265 (733)
Q Consensus 223 ------------------~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~ 265 (733)
.+|+.++.|.+|+.|.|+.|.+. .+|..+ ++.++.||+..|+
T Consensus 312 IGKL~~Levf~aanN~LElVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 312 IGKLIQLEVFHAANNKLELVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred hhhhhhhHHHHhhccccccCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCc
Confidence 45556666666666667666665 566665 6777888888775
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-25 Score=234.97 Aligned_cols=255 Identities=26% Similarity=0.346 Sum_probs=221.3
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeecccccccc-ccchhccCCCCCCEEEcccccccccCCccccCCcCCceeec
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKG-PIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 96 (733)
.++.|.+++|++. .+-..+..|+.|+.+++..|++.. -+|..+.+|..|+.||||+|+++ +.|..+..-.++-.|+|
T Consensus 56 kLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNL 133 (1255)
T KOG0444|consen 56 KLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNL 133 (1255)
T ss_pred hhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEc
Confidence 3677889999999 556688999999999999999975 47888999999999999999999 99999999999999999
Q ss_pred cCccccccCCcc-ccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCc-------------------------
Q 004732 97 SSNNFTGELPKT-FAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA------------------------- 150 (733)
Q Consensus 97 s~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~------------------------- 150 (733)
|+|+|. .||.. |.+|+.|-.||||+|++. .+|..+..+.+|++|.|++|.|.
T Consensus 134 S~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl 211 (1255)
T KOG0444|consen 134 SYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTL 211 (1255)
T ss_pred ccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchh
Confidence 999999 66655 668999999999999999 78888999999999999999874
Q ss_pred cCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCC
Q 004732 151 GPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDD 230 (733)
Q Consensus 151 ~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~ 230 (733)
..+|.++-.|.||..+|+|.|+++..+.......+|..|+||+|+|+ .+....+...+|++|+||.|+++ .+|..+.+
T Consensus 212 ~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcK 289 (1255)
T KOG0444|consen 212 DNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCK 289 (1255)
T ss_pred hcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhh
Confidence 24788888999999999999999988877777779999999999999 66667788899999999999999 89999999
Q ss_pred CCCCCEEEecCCccc-ccCChhh--hcCCCeeecccCcCCCCCCcccccccc
Q 004732 231 LYDVDYIYFAGNLLT-GAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRS 279 (733)
Q Consensus 231 l~~L~~L~l~~N~l~-~~~p~~~--l~~l~~l~ls~N~l~~~~~~~~~~~~~ 279 (733)
+++|+.|++.+|+++ ..+|..+ +..|..+..++|.+. ..+++.|+...
T Consensus 290 L~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~k 340 (1255)
T KOG0444|consen 290 LTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVK 340 (1255)
T ss_pred hHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHH
Confidence 999999999999986 3467666 677777777777764 34555665443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=197.27 Aligned_cols=256 Identities=19% Similarity=0.245 Sum_probs=194.5
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEEcc
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
.|++.++||+|+||..|.|+ +-++..||||.-..++ ...++..|.+..+.|. .++|..++.+..++.+-.||+|.+
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 67889999999999999999 6789999999865443 3467788888888884 699999999989999999999987
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-----CeEEcccCccccCccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-----NSKISDFGLAKLDEEE 546 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-----~~kl~DfGla~~~~~~ 546 (733)
|.||+|+..=.+.+++..++.-+|.|++.-++|+|++. .|.|||||+|+||...+ .+.|+|||+|+.+.+.
T Consensus 107 -GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp 182 (449)
T KOG1165|consen 107 -GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDP 182 (449)
T ss_pred -CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcCc
Confidence 67999988878889999999999999999999999985 99999999999997543 3899999999977665
Q ss_pred Cccc------ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccccc
Q 004732 547 NTHI------STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 547 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
.+.. .....||-+||+--...+.+.+.+.|.-|+|-++++.+.|..||.+-.......-...+.+......+-+
T Consensus 183 ~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~ 262 (449)
T KOG1165|consen 183 KTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV 262 (449)
T ss_pred cccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH
Confidence 4433 2346799999999999999999999999999999999999999965432222211111111111111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
-+. .++. ++...+...-..+..+-|+.+-+...+.
T Consensus 263 Lc~--g~P~----efa~Yl~yvR~L~F~E~PDYdylr~Lf~ 297 (449)
T KOG1165|consen 263 LCE--GFPE----EFATYLRYVRRLDFFETPDYDYLRKLFD 297 (449)
T ss_pred HHh--cCHH----HHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence 111 1222 3444444455677788888766555444
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=193.00 Aligned_cols=264 Identities=20% Similarity=0.253 Sum_probs=198.9
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCC-CceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 469 (733)
.+.|...+.||+|+||.+|.|. ..+|..||||.-...... ..+..|..+.+.++| ..|..+.-|..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4678899999999999999999 788999999987554333 567789999999975 667777788888899999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC---CCeEEcccCccccCccc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD---LNSKISDFGLAKLDEEE 546 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~---~~~kl~DfGla~~~~~~ 546 (733)
.+ |.+|++...-....++..+.+-++-|++.-++|+|.++ .|||||||+|+|..-+ ..+.++|||+|+.+.+.
T Consensus 92 LL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~ 167 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDI 167 (341)
T ss_pred cc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccc
Confidence 87 77999988877778999999999999999999999987 9999999999999754 35899999999866543
Q ss_pred Cccc------ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccccc
Q 004732 547 NTHI------STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 547 ~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
.+.. .....||.+|.+--...+.+.+.+.|+-|+|.+|.++.-|..||.+-....-.+-...+.+. +....+
T Consensus 168 ~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek-K~s~~i- 245 (341)
T KOG1163|consen 168 RTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK-KMSTPI- 245 (341)
T ss_pred cccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh-hcCCCH-
Confidence 2221 23467999999988888888999999999999999999999999654332222111111111 111000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
..+=..++.+ +.-.+..|-....++-|+..-+-+.+.-....+
T Consensus 246 e~LC~G~P~E----F~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~l 288 (341)
T KOG1163|consen 246 EVLCKGFPAE----FAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTL 288 (341)
T ss_pred HHHhCCCcHH----HHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhc
Confidence 0011123333 555667899999999998877766665444433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-21 Score=204.22 Aligned_cols=255 Identities=30% Similarity=0.422 Sum_probs=197.2
Q ss_pred ccccCcccCCCcccEEEcccCCCcEEEEEEccccChh---cHHHHHHHHHHHHhCCCC-ceeeEeeEEEeCCeEEEEEEc
Q 004732 395 FATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ---GNREFINEIGMISALQHP-NLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~ 470 (733)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556678999999999999876 88999998765322 367899999999999988 799999999877778999999
Q ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-CeEEcccCccccCcccC
Q 004732 471 LENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEEN 547 (733)
Q Consensus 471 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~~~ 547 (733)
+.++++.+++.... ..+.......++.|++.+++|+|+.+ ++|||+||+||+++..+ .++++|||.++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997665443 27899999999999999999999997 99999999999999998 69999999998555433
Q ss_pred cc-----cccccccCCCcccHHHHhh---CCCCccchhHhHHHHHHHHHhCCCCCCccch----hhHHHHHHHHHhhCcc
Q 004732 548 TH-----ISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDM----FYLLDWALVLKEQGKL 615 (733)
Q Consensus 548 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~----~~~~~~~~~~~~~~~~ 615 (733)
.. ......||..|+|||.+.. ..++...|+||+|++++++++|..||..... ........ .....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIIL--ELPTP- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHH--hcCCc-
Confidence 22 2356789999999999987 5789999999999999999999999754432 12221111 11110
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.................+.+++..|+..+|..|.+..+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223457788999999999999999987654
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.9e-25 Score=218.75 Aligned_cols=246 Identities=28% Similarity=0.411 Sum_probs=143.5
Q ss_pred eeeecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCc
Q 004732 10 FHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLL 89 (733)
Q Consensus 10 ~~~~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 89 (733)
-.||..+. +++++|++|++. .+.+.+.++..|.+|++++|++. .+|++++.+..++.|+.++|+++ .+|.+++++.
T Consensus 39 e~wW~qv~-l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~ 114 (565)
T KOG0472|consen 39 ENWWEQVD-LQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLI 114 (565)
T ss_pred hhhhhhcc-hhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhh
Confidence 34565433 345667777766 44445666667777777777776 56666666666666666666666 6666666666
Q ss_pred CCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccC-----------------------CCCEEEccC
Q 004732 90 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWT-----------------------KLEKLFIQP 146 (733)
Q Consensus 90 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-----------------------~L~~L~l~~ 146 (733)
+|..|+++.|.+. .+|++++.+..|+.|+..+|+++ ..|+.+.++. .|++|++..
T Consensus 115 ~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~ 192 (565)
T KOG0472|consen 115 SLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNS 192 (565)
T ss_pred hhhhhhcccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccch
Confidence 6666666666666 55666666666666666666666 4454444444 455555555
Q ss_pred CCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCcccc-CCCCCcEEEccCCcccCCCC
Q 004732 147 SGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG-KMTKLKVLDLSFNRLRGQIP 225 (733)
Q Consensus 147 N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L~ls~N~l~~~~p 225 (733)
|.+. .+|..++.+.+|..|++.+|++...+ .+-+...|.+|+++.|+|. .+|.+.. ++.+|..|||..|+++ ..|
T Consensus 193 N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~P 268 (565)
T KOG0472|consen 193 NLLE-TLPPELGGLESLELLYLRRNKIRFLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVP 268 (565)
T ss_pred hhhh-cCChhhcchhhhHHHHhhhcccccCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCc
Confidence 5444 55555666666666666665555444 2222224556666666665 3344333 5666666666666666 556
Q ss_pred CCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCcCC
Q 004732 226 SNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFT 267 (733)
Q Consensus 226 ~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~ 267 (733)
+.+..+.+|..||+|+|.++ .+|..+ + .++.|.+.||++.
T Consensus 269 de~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 269 DEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred hHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchH
Confidence 66666666666666666665 333333 2 4555555565543
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-24 Score=217.96 Aligned_cols=231 Identities=24% Similarity=0.366 Sum_probs=195.8
Q ss_pred CCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEE
Q 004732 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 119 (733)
Q Consensus 40 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 119 (733)
-..|+.|.|++|.++ .+.+.+.++..|++|++.+|++. .+|++++.+..++.|+.++|+++ .+|..+..+.+|..|+
T Consensus 44 qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~ 120 (565)
T KOG0472|consen 44 QVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLD 120 (565)
T ss_pred hcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhh
Confidence 355899999999999 55557999999999999999999 89999999999999999999999 9999999999999999
Q ss_pred eeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCC
Q 004732 120 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGE 199 (733)
Q Consensus 120 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 199 (733)
++.|.+. .+|+.++.+-.|+.|+..+|+++ .+|..++++.+|..|++.+|++...++.......|++||+..|.+. .
T Consensus 121 ~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 121 CSSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIAMKRLKHLDCNSNLLE-T 197 (565)
T ss_pred cccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHHHHHHHhcccchhhhh-c
Confidence 9999999 88889999999999999999999 8899999999999999999999999988877557899999999888 7
Q ss_pred CCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh---hcCCCeeecccCcCCCCCCccccc
Q 004732 200 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM---LERGDKIDLSYNNFTDGSAESSCQ 276 (733)
Q Consensus 200 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~---l~~l~~l~ls~N~l~~~~~~~~~~ 276 (733)
+|..++.+.+|..|+|..|+|. ..| .|.+|..|++|+++.|.+. .+|... +.++..||+..|+++.. ++..|.
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklke~-Pde~cl 273 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLKEV-PDEICL 273 (565)
T ss_pred CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccccC-chHHHH
Confidence 8888999999999999999988 566 6777777777777777665 555554 44455666666666543 334444
Q ss_pred cccc
Q 004732 277 KRSV 280 (733)
Q Consensus 277 ~~~~ 280 (733)
.+++
T Consensus 274 LrsL 277 (565)
T KOG0472|consen 274 LRSL 277 (565)
T ss_pred hhhh
Confidence 4433
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-22 Score=227.31 Aligned_cols=254 Identities=22% Similarity=0.236 Sum_probs=187.9
Q ss_pred cccCcccCCCcccEEEcc-cCCCcEEEEEEcc----cc-Ch-hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 396 ATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS----SK-SK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~----~~-~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
...+++|.|++|.|+.+. ....+..+.|.+. .. .. .....+..|+.+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 466899999999888776 3444445555433 11 11 11122566888888899999999888888777777779
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC-
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN- 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~- 547 (733)
|||++ +|...+... ..+...++..++.|+..|++|+|+.| |.|||+|++|++++.+|.+||+|||.+..+.-+.
T Consensus 401 E~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 99999 999988644 47888999999999999999999997 9999999999999999999999999997654332
Q ss_pred --cccccccccCCCcccHHHHhhCCCCc-cchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 548 --THISTRVAGTIGYMAPEYAMRGHLTE-KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 548 --~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
......++|+-.|+|||.+.+.+|++ ..||||.|+++..|++|+.||......+-.- .........-.....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~~~~~~~~ 550 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQRNIFEGP 550 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccccccccCh
Confidence 24566788999999999999999887 5899999999999999999994322111000 000000011111111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.............++.++++.+|.+|-|+.+|++.
T Consensus 551 ~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 551 NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred HHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 11222344567889999999999999999999764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-21 Score=191.57 Aligned_cols=172 Identities=17% Similarity=0.164 Sum_probs=134.4
Q ss_pred hhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHH---H------HHHHHHHHHhCCCCceeeEeeEEEe
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNR---E------FINEIGMISALQHPNLVKLYGCCIE 460 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~l~~~~~~ 460 (733)
...++|+..+++|.|+||.||.+.. ++..+|||.+......... . +.+|++.+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3468899999999999999999765 5778999999754322222 2 6789999999999999999988664
Q ss_pred C--------CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCe
Q 004732 461 G--------NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 532 (733)
Q Consensus 461 ~--------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 532 (733)
. ...++||||++|.+|.++. .++. ....+++.++..+|+.| ++|||+||+||+++.++ +
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 3 3578999999999998873 2222 34569999999999997 99999999999999988 9
Q ss_pred EEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHH
Q 004732 533 KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIV 588 (733)
Q Consensus 533 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ell 588 (733)
+|+|||.......+... ..+.....+..++|+||||+.+..+.
T Consensus 174 ~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988754322111 11344556778999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.4e-21 Score=186.80 Aligned_cols=140 Identities=18% Similarity=0.210 Sum_probs=108.8
Q ss_pred cCcccCCCcccEEEcccCCCcEEEEEEccccChh--c-------HHH-----------------HHHHHHHHHhCCCCce
Q 004732 398 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ--G-------NRE-----------------FINEIGMISALQHPNL 451 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~h~ni 451 (733)
...||+|+||.||+|...+|+.||||+++..... . ... ...|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999879999999998654211 1 112 2349999999988776
Q ss_pred eeEeeEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeecCCCCCCcEEecCCC
Q 004732 452 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL-HGESRIKVVHRDIKATNVLLDKDL 530 (733)
Q Consensus 452 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~Dik~~Nill~~~~ 530 (733)
.....+.. ...++||||++++++...... ...+++.+...++.|++.+|.|+ |+.| |+||||||+|||++ ++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~ 154 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CC
Confidence 43333222 223899999999887655333 34789999999999999999999 6775 99999999999998 47
Q ss_pred CeEEcccCccccCc
Q 004732 531 NSKISDFGLAKLDE 544 (733)
Q Consensus 531 ~~kl~DfGla~~~~ 544 (733)
.++|+|||+|....
T Consensus 155 ~v~LiDFG~a~~~~ 168 (190)
T cd05147 155 KLYIIDVSQSVEHD 168 (190)
T ss_pred cEEEEEccccccCC
Confidence 89999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.9e-21 Score=206.66 Aligned_cols=210 Identities=28% Similarity=0.443 Sum_probs=158.6
Q ss_pred HHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCe-ecCCCCC
Q 004732 443 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV-VHRDIKA 521 (733)
Q Consensus 443 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i-vH~Dik~ 521 (733)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.....+++|.....++.+|+.||+|||+.. | .|+.+++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l~s 77 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGALKS 77 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeeecc
Confidence 35688999999999999999999999999999999999988889999999999999999999999873 4 8999999
Q ss_pred CcEEecCCCCeEEcccCccccCccc-CcccccccccCCCcccHHHHhhC-------CCCccchhHhHHHHHHHHHhCCCC
Q 004732 522 TNVLLDKDLNSKISDFGLAKLDEEE-NTHISTRVAGTIGYMAPEYAMRG-------HLTEKADVYSFGIVALEIVSGRSN 593 (733)
Q Consensus 522 ~Nill~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~s~Gvil~elltg~~p 593 (733)
+|+++|..+.+||+|||+....... .........-..-|.|||.+... ..+.+.||||||++++|+++.+.|
T Consensus 78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 9999999999999999998766421 00111112234469999999763 146789999999999999999999
Q ss_pred CCccchh----hHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 594 VTKEDMF----YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 594 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
|...... .+..+. ...+. ..+.+..... .+....+..++..||..+|.+||++.+|-..++.
T Consensus 158 ~~~~~~~~~~~eii~~~---~~~~~--~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~ 223 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRV---KKGGS--NPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLT 223 (484)
T ss_pred cccccccCChHHHHHHH---HhcCC--CCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhh
Confidence 9543211 122221 11011 1111111100 0223358889999999999999999999655553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-20 Score=176.84 Aligned_cols=187 Identities=17% Similarity=0.100 Sum_probs=142.8
Q ss_pred ccccCcccCCCcccEEEcccCCCcEEEEEEccccChh----cHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEE
Q 004732 395 FATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ----GNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 469 (733)
+.....|++|+||+||.+.. .+.+++.+.+...... ....|.+|+++|+++. |+++.+++++ ...+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34567899999999997766 6778888877654321 1225789999999995 5889999886 34699999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCC-CCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI-KATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Di-k~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
|+.|.+|.+.+.. ....++.|++++|+++|+.| |+|||| ||+|||++.++.++|+|||+|........
T Consensus 79 yI~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 79 YLAGAAMYQRPPR--------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred eecCccHHhhhhh--------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9999998754321 12357889999999999997 999999 79999999999999999999986554331
Q ss_pred c----c--------ccccccCCCcccHHHHhh-CCCC-ccchhHhHHHHHHHHHhCCCCCCcc
Q 004732 549 H----I--------STRVAGTIGYMAPEYAMR-GHLT-EKADVYSFGIVALEIVSGRSNVTKE 597 (733)
Q Consensus 549 ~----~--------~~~~~gt~~y~aPE~~~~-~~~~-~~~Dv~s~Gvil~elltg~~p~~~~ 597 (733)
. . ......++.|++|+...- ...+ ...+.++-|+.+|.++|++.+...+
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 0 112336888999986533 2333 5779999999999999999987544
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-21 Score=217.46 Aligned_cols=250 Identities=23% Similarity=0.260 Sum_probs=181.4
Q ss_pred CccccCcccCCCcccEEEcccCCCcEEEEEEccccC-hhcHHHHHHHHHH--HHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS-KQGNREFINEIGM--ISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++...+.||++.|=+|.+|+.+.|. |+||++-+.. .-..+.|.++++- ...++|||.+++.-.-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5667789999999999999998887 8899875543 3344555554433 4556899999998887777888999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc--cCcccCc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK--LDEEENT 548 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~--~~~~~~~ 548 (733)
+.. +|.|.+. .+..+...+...|+.|++.||..+|..| |+|||||.+|||++.-.-+.|+||.--+ +.++++.
T Consensus 103 vkh-nLyDRlS-TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 103 VKH-NLYDRLS-TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred Hhh-hhhhhhc-cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence 866 7888774 3446778888999999999999999997 9999999999999999999999997654 3333333
Q ss_pred ccccccccC----CCcccHHHHhhC----------C-CCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhh
Q 004732 549 HISTRVAGT----IGYMAPEYAMRG----------H-LTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQ 612 (733)
Q Consensus 549 ~~~~~~~gt----~~y~aPE~~~~~----------~-~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 612 (733)
...+-+..| .+|+|||.+... . .+++-||||.||+++||++ |+.||.-. .+..+.... .
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~aYr~~~--~ 252 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLAYRSGN--A 252 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHhHhccC--c
Confidence 322222222 379999987541 1 5778999999999999998 56666332 233322110 0
Q ss_pred CcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 613 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
......+.... ...+++++..|++.||++|-++++.++.-.+
T Consensus 253 ~~~e~~Le~Ie--------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 253 DDPEQLLEKIE--------DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred cCHHHHHHhCc--------CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 01111111100 0137889999999999999999999887554
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-21 Score=206.83 Aligned_cols=225 Identities=26% Similarity=0.305 Sum_probs=180.5
Q ss_pred cccCCCcccEEEcc----cCCCcEEEEEEccccChhc--HHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEEccC
Q 004732 400 NIGEGGFGPVYKGL----LADGTAIAVKQLSSKSKQG--NREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 400 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
.+|+|+||.|+.++ .+.|..+|+|.+++..... ......|..++...+ ||.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999876 3457889999887653221 124556888899987 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+|.|...+... ..++......+...+|-|++++|+.+ |+|||+|++||+++.+|++++.|||+++..-+....
T Consensus 81 gg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--- 153 (612)
T ss_pred cchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc---
Confidence 99999888544 36777788888889999999999997 999999999999999999999999999865443222
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (733)
+||..|||||++. ....++|.||||++++||+||-.||..+....+. . .....+.+..
T Consensus 154 --cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~~~~~Il----------------~--~~~~~p~~l~ 211 (612)
T KOG0603|consen 154 --CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGDTMKRIL----------------K--AELEMPRELS 211 (612)
T ss_pred --ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchHHHHHHh----------------h--hccCCchhhh
Confidence 8999999999987 6788999999999999999999999773221111 0 1122344555
Q ss_pred HHHHHHHHHhhcCCCCCCCCH
Q 004732 633 MVMINVALLCANASPTIRPSM 653 (733)
Q Consensus 633 ~~l~~l~~~c~~~~P~~RPt~ 653 (733)
....+++......+|..|--.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhcc
Confidence 567778888888888888755
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=178.77 Aligned_cols=141 Identities=17% Similarity=0.192 Sum_probs=110.9
Q ss_pred cCcccCCCcccEEEcccCCCcEEEEEEccccChh---------------------c-----HHHHHHHHHHHHhCCCCce
Q 004732 398 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ---------------------G-----NREFINEIGMISALQHPNL 451 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~ni 451 (733)
...||+|+||.||+|+..+|+.||||++...... . ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999778999999998654210 0 1123578999999999987
Q ss_pred eeEeeEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeecCCCCCCcEEecCCC
Q 004732 452 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKDL 530 (733)
Q Consensus 452 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dik~~Nill~~~~ 530 (733)
.....+.... .++||||++++++...... ...++.....+++.|++.++.++|+ .| |+||||||+||+++ ++
T Consensus 82 ~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~ 154 (190)
T cd05145 82 PVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CC
Confidence 5444433332 4899999999865443222 2367888999999999999999999 76 99999999999999 78
Q ss_pred CeEEcccCccccCcc
Q 004732 531 NSKISDFGLAKLDEE 545 (733)
Q Consensus 531 ~~kl~DfGla~~~~~ 545 (733)
.++|+|||++.....
T Consensus 155 ~~~liDFG~a~~~~~ 169 (190)
T cd05145 155 KPYIIDVSQAVELDH 169 (190)
T ss_pred CEEEEEcccceecCC
Confidence 999999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-22 Score=200.55 Aligned_cols=283 Identities=14% Similarity=0.155 Sum_probs=205.4
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEccc-ccccccCCccccCCcCCceeeccC
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQY-NQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
-++.|..|+|+.+-|.+|..+++|++|||++|+|+.+-|++|.++.+|..|-+.+ |+|+...-..|+.|..|+.|.+.-
T Consensus 70 veirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNa 149 (498)
T KOG4237|consen 70 VEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNA 149 (498)
T ss_pred eEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcCh
Confidence 4577999999988888999999999999999999988899999999888877666 899844446799999999999999
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCc------------cCCCCCCCCcCCcCee
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA------------GPIPSGIFSLENLTDL 166 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~------------~~~p~~l~~l~~L~~L 166 (733)
|++.-...+.|..+++|..|.+.+|.+...-...|..+..++.+.+..|.+. ...|.+++........
T Consensus 150 n~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~ 229 (498)
T KOG4237|consen 150 NHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPY 229 (498)
T ss_pred hhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchH
Confidence 9999788888999999999999999998444448899999999999988832 3345556666666555
Q ss_pred ecccccCCCCCccccccc--ccc-EEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCc
Q 004732 167 RISDLNGPEATFPQLGNM--KMT-KLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNL 243 (733)
Q Consensus 167 ~l~~n~~~~~~~~~~~~~--~L~-~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 243 (733)
.+.++.+.......+... .+. .+....+...-.....|..+++|++|+|++|+|+.+-+..|.++..|+.|+|..|+
T Consensus 230 rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~ 309 (498)
T KOG4237|consen 230 RLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNK 309 (498)
T ss_pred HHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcch
Confidence 666655555554443332 111 12222223332333457788888888888888887777788888888888888888
Q ss_pred ccccCChhh--hcCCCeeecccCcCCCCCCcccccccccccccccccccccCCceeeeeee
Q 004732 244 LTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKTYYSLHIN 302 (733)
Q Consensus 244 l~~~~p~~~--l~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~~~~~~ 302 (733)
+...-...+ +..|+.|+|.+|++++..+.++-....+..+-.-.+++.|.+...|+.-|
T Consensus 310 l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~W 370 (498)
T KOG4237|consen 310 LEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEW 370 (498)
T ss_pred HHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHH
Confidence 762222222 56677888888888877777776666666666666777777765555433
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-19 Score=205.96 Aligned_cols=224 Identities=22% Similarity=0.326 Sum_probs=183.4
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
..+|+|++++++ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++
T Consensus 180 ~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 180 KTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred ceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 456889999998 5676664 58999999999999 6776654 58999999999999 6787664 4799999999
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCc
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATF 178 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~ 178 (733)
|+++ .+|..+. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|.+...+.
T Consensus 251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~LP~ 321 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTALPE 321 (754)
T ss_pred CccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccccCCc
Confidence 9999 7887764 58999999999999 5777664 58999999999998 4666554 579999999999987543
Q ss_pred cccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCe
Q 004732 179 PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDK 258 (733)
Q Consensus 179 ~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~ 258 (733)
.. ..+|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|.++ .+|..+...++.
T Consensus 322 ~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~~sL~~ 392 (754)
T PRK15370 322 TL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLPAALQI 392 (754)
T ss_pred cc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHHHHHHH
Confidence 22 2479999999999985 676553 68999999999998 5776553 68999999999998 678777778899
Q ss_pred eecccCcCCCC
Q 004732 259 IDLSYNNFTDG 269 (733)
Q Consensus 259 l~ls~N~l~~~ 269 (733)
|++++|++...
T Consensus 393 LdLs~N~L~~L 403 (754)
T PRK15370 393 MQASRNNLVRL 403 (754)
T ss_pred HhhccCCcccC
Confidence 99999998754
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.2e-19 Score=171.55 Aligned_cols=137 Identities=15% Similarity=0.244 Sum_probs=106.7
Q ss_pred ccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhC-----CCCceeeEeeEEEeCC---e-EE
Q 004732 395 FATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-----QHPNLVKLYGCCIEGN---Q-LL 465 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~~ 465 (733)
....+.||+|+||.||. +++....+||++........+.+.+|+.+++.+ .||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567999999999996 433333479987654444557899999999999 5799999999998863 4 33
Q ss_pred EEEEc--cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHcCCCCCeecCCCCCCcEEecC----CCCeEEcccC
Q 004732 466 LIYEY--LENNSLARALFEHRLKLDWPTRRRICLGIARGL-AYLHGESRIKVVHRDIKATNVLLDK----DLNSKISDFG 538 (733)
Q Consensus 466 lV~e~--~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~ivH~Dik~~Nill~~----~~~~kl~DfG 538 (733)
+|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +++++|+||+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred EEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 78999 5589999999653 35555 35677888777 9999996 999999999999974 3479999954
Q ss_pred cc
Q 004732 539 LA 540 (733)
Q Consensus 539 la 540 (733)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 43
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.2e-19 Score=179.07 Aligned_cols=229 Identities=20% Similarity=0.209 Sum_probs=146.7
Q ss_pred cccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCC----------CceeeEeeEEE--
Q 004732 396 ATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQH----------PNLVKLYGCCI-- 459 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~-- 459 (733)
.....||.|+++.||.++. .+|+.+|||.+.... ....+++.+|.-....+.+ -.++-.++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 3457899999999999995 568999999875432 2344667777655555432 12222222222
Q ss_pred -------eCC--------eEEEEEEccCCCCHHHHHH---hcCC---CCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCC
Q 004732 460 -------EGN--------QLLLIYEYLENNSLARALF---EHRL---KLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518 (733)
Q Consensus 460 -------~~~--------~~~lV~e~~~~gsL~~~l~---~~~~---~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~D 518 (733)
... ..+++|+-+ .++|.+.+. .... .+....+..+..|+++.+++||+.| ++|+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 111 236677776 557877654 2221 2444566777899999999999997 99999
Q ss_pred CCCCcEEecCCCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhC--------CCCccchhHhHHHHHHHHHhC
Q 004732 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG--------HLTEKADVYSFGIVALEIVSG 590 (733)
Q Consensus 519 ik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~Dv~s~Gvil~elltg 590 (733)
|||+|++++.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|++|+++|.|.+|
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~ 246 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG 246 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence 9999999999999999999887654443221 2245789999987542 478899999999999999999
Q ss_pred CCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCC
Q 004732 591 RSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIR 650 (733)
Q Consensus 591 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R 650 (733)
+.||.........+| .+ ..+. +..+.+..++...++.+|.+|
T Consensus 247 ~lPf~~~~~~~~~~~------------~f-----~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 247 RLPFGLSSPEADPEW------------DF-----SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp S-STCCCGGGSTSGG------------GG-----TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cCCCCCCCccccccc------------cc-----hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999965433221111 11 1222 455668889999999999988
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=197.76 Aligned_cols=216 Identities=27% Similarity=0.336 Sum_probs=107.8
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
...|+|+.|+|+ .+|+.+. ++|+.|+|.+|+|+ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~---lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC---CCCCCcEEEecCCccC-cccCc---ccccceeeccC
Confidence 345677777777 5666554 36777777777777 4453 2456777777777776 44532 23444444444
Q ss_pred ccccccCCcccc-----------------CCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcC
Q 004732 99 NNFTGELPKTFA-----------------KLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLE 161 (733)
Q Consensus 99 N~l~~~~p~~~~-----------------~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~ 161 (733)
|.|+ .+|..+. .+++|+.|+|++|+|++ +|... .+|+.|++++|+|+ .+|.. ..
T Consensus 272 N~L~-~Lp~lp~~L~~L~Ls~N~Lt~LP~~p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~-~LP~l---p~ 342 (788)
T PRK15387 272 NPLT-HLPALPSGLCKLWIFGNQLTSLPVLPPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLT-SLPTL---PS 342 (788)
T ss_pred Cchh-hhhhchhhcCEEECcCCccccccccccccceeECCCCcccc-CCCCc---ccccccccccCccc-ccccc---cc
Confidence 4444 2222110 12456666666666653 33321 22334444444443 22321 13
Q ss_pred CcCeeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecC
Q 004732 162 NLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAG 241 (733)
Q Consensus 162 ~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 241 (733)
+|+.|+|++|++..++.. ..+|..|++++|+|++ +|.. ..+|+.|+|++|+|++ +|.. ..+|+.|++++
T Consensus 343 ~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~ 411 (788)
T PRK15387 343 GLQELSVSDNQLASLPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSG 411 (788)
T ss_pred ccceEecCCCccCCCCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCCEEEccC
Confidence 566777777766654321 1245555555555552 3332 2345555555555552 3332 13455555555
Q ss_pred CcccccCChhhhcCCCeeecccCcCC
Q 004732 242 NLLTGAIPPWMLERGDKIDLSYNNFT 267 (733)
Q Consensus 242 N~l~~~~p~~~l~~l~~l~ls~N~l~ 267 (733)
|.+.. +|. ...+++.|++++|+++
T Consensus 412 N~Lss-IP~-l~~~L~~L~Ls~NqLt 435 (788)
T PRK15387 412 NRLTS-LPM-LPSGLLSLSVYRNQLT 435 (788)
T ss_pred CcCCC-CCc-chhhhhhhhhccCccc
Confidence 55542 332 1233444555555544
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=4e-19 Score=203.36 Aligned_cols=224 Identities=24% Similarity=0.384 Sum_probs=182.4
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
.+..|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|++. .+|..+. .+|+.|+|+
T Consensus 200 ~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls 270 (754)
T PRK15370 200 QITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLF 270 (754)
T ss_pred CCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECc
Confidence 4778999999999 5676654 68999999999999 6776554 48999999999999 7888765 589999999
Q ss_pred CccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCC
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT 177 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~ 177 (733)
+|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|.+..++
T Consensus 271 ~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~LP 341 (754)
T PRK15370 271 HNKIS-CLPENLP--EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTSLP 341 (754)
T ss_pred CCccC-ccccccC--CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCccccCC
Confidence 99999 6787664 58999999999999 4666543 57999999999999 4666553 68999999999988754
Q ss_pred ccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh-----
Q 004732 178 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM----- 252 (733)
Q Consensus 178 ~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~----- 252 (733)
.. +. .+|+.|++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|++++|++. .+|..+
T Consensus 342 ~~-l~-~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~ 412 (754)
T PRK15370 342 AS-LP-PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRG 412 (754)
T ss_pred hh-hc-CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhh
Confidence 32 22 48999999999998 5676553 68999999999999 5666554 36999999999998 666654
Q ss_pred -hcCCCeeecccCcCCC
Q 004732 253 -LERGDKIDLSYNNFTD 268 (733)
Q Consensus 253 -l~~l~~l~ls~N~l~~ 268 (733)
.+.+..+++.+|+++.
T Consensus 413 ~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 413 EGPQPTRIIVEYNPFSE 429 (754)
T ss_pred cCCCccEEEeeCCCccH
Confidence 3567889999999874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.7e-18 Score=196.23 Aligned_cols=198 Identities=20% Similarity=0.255 Sum_probs=161.2
Q ss_pred hHHhhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC---CCceeeEeeEEEeCCe
Q 004732 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ---HPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 387 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~ 463 (733)
+.+...+.|.+.+.||+|+||+||+|...+|+.||+|.-+..... +|.--.+++.+|+ -+.|..+..++.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 445566789999999999999999999888999999987665544 2222334455554 3455666666667788
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC-------CCCeEEcc
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-------DLNSKISD 536 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-------~~~~kl~D 536 (733)
-+||+||.+-|+|.+++. .....+|.-.+.++.|+++-+++||..+ ||||||||+|+||.. ...++|+|
T Consensus 769 S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred ceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 899999999999999997 5568999999999999999999999986 999999999999942 34589999
Q ss_pred cCccccCcc-cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCC
Q 004732 537 FGLAKLDEE-ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 591 (733)
Q Consensus 537 fGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~ 591 (733)
||-+-.+.- .+......+++|-.+-.+|...++..+...|.|.++.+++-|+.|+
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 999864432 2223445578899999999999999999999999999999999986
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.9e-18 Score=166.60 Aligned_cols=134 Identities=19% Similarity=0.305 Sum_probs=113.9
Q ss_pred CcccCCCcccEEEcccCCCcEEEEEEccccChh--------cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 399 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ--------GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
+.||+|++|.||+|.. +|..|++|........ ....+.+|++++..++|+++.....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999976543211 124578899999999999998877787778888999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
++|++|.+++.... + .+..++.+++.+|.++|+.+ ++|||++|+||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 2 88999999999999999986 99999999999999 78899999999875
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.5e-20 Score=166.35 Aligned_cols=167 Identities=25% Similarity=0.469 Sum_probs=129.0
Q ss_pred cccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCC
Q 004732 36 KLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 115 (733)
Q Consensus 36 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 115 (733)
.+.++.+++.|.|++|+++ .+|+.+..+.+|+.|++++|+++ .+|..++.|++|+.|+++-|++. .+|..|+.+|.|
T Consensus 28 gLf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~l 104 (264)
T KOG0617|consen 28 GLFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPAL 104 (264)
T ss_pred cccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchh
Confidence 4456677788888888888 67777888888888888888888 78888888888888888888887 788888888888
Q ss_pred CEEEeeCCcccc-CCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccC
Q 004732 116 KDFRISDNQFTG-QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNC 194 (733)
Q Consensus 116 ~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n 194 (733)
++|||..|++.. .+|+.|..++.|+-|+|+.|.+. .+|..++++++|+.|.+. .|
T Consensus 105 evldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lr-----------------------dn 160 (264)
T KOG0617|consen 105 EVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLR-----------------------DN 160 (264)
T ss_pred hhhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeec-----------------------cC
Confidence 888888888763 56777777777777788888777 677777777777665554 45
Q ss_pred ccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCC
Q 004732 195 NITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 231 (733)
Q Consensus 195 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 231 (733)
.+- .+|.+++.++.|++|.+.+|+++ .+|..++.+
T Consensus 161 dll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 161 DLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANL 195 (264)
T ss_pred chh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhh
Confidence 555 67888889999999999999998 566555543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.3e-20 Score=204.11 Aligned_cols=240 Identities=24% Similarity=0.340 Sum_probs=162.1
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
++.+++++|+++ .+|+.++.+.+|+.|...+|+|+ .+|..+....+|+.|++.+|.++ -+|..++.+++|++|+|..
T Consensus 243 l~~~dis~n~l~-~lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~ 319 (1081)
T KOG0618|consen 243 LQYLDISHNNLS-NLPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQS 319 (1081)
T ss_pred ceeeecchhhhh-cchHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehh
Confidence 455566666666 33366666666666666666664 56666666666666666666666 5555556666666666666
Q ss_pred ccccccCCcccc-CCCC-CCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCC
Q 004732 99 NNFTGELPKTFA-KLTN-MKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEA 176 (733)
Q Consensus 99 N~l~~~~p~~~~-~l~~-L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~ 176 (733)
|+|. ..|+.+- -+.. |..|+.+.|++.......=..++.|+.|++.+|.|+...-..+.++.+|+.|+|++|.+..+
T Consensus 320 N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f 398 (1081)
T KOG0618|consen 320 NNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF 398 (1081)
T ss_pred cccc-ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence 6665 4443322 2222 44555555555522211122456678888888888877777788888888888888888877
Q ss_pred Cccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCccc-ccCChhhh-
Q 004732 177 TFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT-GAIPPWML- 253 (733)
Q Consensus 177 ~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~l- 253 (733)
+...+.+. .|+.|+||+|.|+ .+|+.+.++..|++|...+|+|. ..| .+.+++.|+.+|++.|.++ ..+|....
T Consensus 399 pas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~ 475 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS 475 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC
Confidence 77766666 6888888888888 77788888888888888888888 667 6888888888888888886 34455443
Q ss_pred cCCCeeecccCc
Q 004732 254 ERGDKIDLSYNN 265 (733)
Q Consensus 254 ~~l~~l~ls~N~ 265 (733)
++|+.||+++|.
T Consensus 476 p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 476 PNLKYLDLSGNT 487 (1081)
T ss_pred cccceeeccCCc
Confidence 788888888886
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.9e-18 Score=193.21 Aligned_cols=222 Identities=24% Similarity=0.297 Sum_probs=161.3
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccC-----------------CCCCCEEEccccccccc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLAN-----------------ISTLVNLTVQYNQFSGE 80 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~-----------------l~~L~~L~L~~N~l~~~ 80 (733)
.++.|+|.+|+|+. +|. .+++|++|+|++|+|+ .+|..+.+ ..+|+.|+|++|+++ .
T Consensus 223 ~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lt-sLP~lp~sL~~L~Ls~N~L~~Lp~lp~~L~~L~Ls~N~Lt-~ 296 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLT-S 296 (788)
T ss_pred CCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccC-cccCcccccceeeccCCchhhhhhchhhcCEEECcCCccc-c
Confidence 35667777777774 453 2467777777777777 34432111 123455556666555 3
Q ss_pred CCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCc
Q 004732 81 LPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSL 160 (733)
Q Consensus 81 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l 160 (733)
+|. .+++|+.|+|++|+|+ .+|... .+|+.|++++|+|+ .+|.. ..+|+.|+|++|+|+ .+|.. .
T Consensus 297 LP~---~p~~L~~LdLS~N~L~-~Lp~lp---~~L~~L~Ls~N~L~-~LP~l---p~~Lq~LdLS~N~Ls-~LP~l---p 361 (788)
T PRK15387 297 LPV---LPPGLQELSVSDNQLA-SLPALP---SELCKLWAYNNQLT-SLPTL---PSGLQELSVSDNQLA-SLPTL---P 361 (788)
T ss_pred ccc---cccccceeECCCCccc-cCCCCc---ccccccccccCccc-ccccc---ccccceEecCCCccC-CCCCC---C
Confidence 443 2367999999999999 456432 46888999999998 46652 258999999999999 46653 3
Q ss_pred CCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEec
Q 004732 161 ENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFA 240 (733)
Q Consensus 161 ~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 240 (733)
.+|+.|++++|.+..++. . ..+|+.|+|++|+|++ +|.. .++|+.|++++|+|++ +|..+ .+|+.|+++
T Consensus 362 ~~L~~L~Ls~N~L~~LP~-l--~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls 430 (788)
T PRK15387 362 SELYKLWAYNNRLTSLPA-L--PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVY 430 (788)
T ss_pred cccceehhhccccccCcc-c--ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhc
Confidence 578889999999886542 1 2378999999999995 5543 3689999999999994 67543 468889999
Q ss_pred CCcccccCChhh--hcCCCeeecccCcCCCCCCc
Q 004732 241 GNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAE 272 (733)
Q Consensus 241 ~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~~~~ 272 (733)
+|+++ .+|..+ ++.+..|++++|++++..+.
T Consensus 431 ~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 431 RNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred cCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 99998 788876 78899999999999876543
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.2e-17 Score=162.52 Aligned_cols=131 Identities=23% Similarity=0.314 Sum_probs=107.7
Q ss_pred cccCCCcccEEEcccCCCcEEEEEEccccCh--------hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 400 NIGEGGFGPVYKGLLADGTAIAVKQLSSKSK--------QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 400 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
.||+|+||.||+|.+ +|..|++|....... ....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 578899998644211 11256778999999999988766566666777789999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
+|++|.+.+..... .++.+++.+|.+||+.+ ++|||++|+||+++ ++.++++|||+++..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999988754321 88999999999999986 99999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=167.74 Aligned_cols=144 Identities=19% Similarity=0.182 Sum_probs=111.4
Q ss_pred CccccCcccCCCcccEEEcc--cCCCcEEEEEEccccChh------------------------cHHHHHHHHHHHHhCC
Q 004732 394 NFATDNNIGEGGFGPVYKGL--LADGTAIAVKQLSSKSKQ------------------------GNREFINEIGMISALQ 447 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 447 (733)
.|.+.+.||+|+||.||+|+ ..+|+.||||.+...... ....+..|++.+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46788899999999999998 578999999998643210 0123567999999997
Q ss_pred CCc--eeeEeeEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEE
Q 004732 448 HPN--LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL 525 (733)
Q Consensus 448 h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nil 525 (733)
+.. +.+++++ ...++||||+++++|....... ..+...+...++.|++.++++||+.+ .|+||||||+||+
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NIl 181 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNIL 181 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhEE
Confidence 533 3344443 2358999999999887654322 34556667899999999999999885 4999999999999
Q ss_pred ecCCCCeEEcccCccccCcc
Q 004732 526 LDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 526 l~~~~~~kl~DfGla~~~~~ 545 (733)
++ ++.++|+|||.+.....
T Consensus 182 i~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EE-CCCEEEEEChhhhccCC
Confidence 99 88999999999875443
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=9.6e-20 Score=162.61 Aligned_cols=163 Identities=29% Similarity=0.505 Sum_probs=116.1
Q ss_pred ccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCC
Q 004732 61 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE 140 (733)
Q Consensus 61 l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~ 140 (733)
+.++.+++.|-||+|+++ .+|..+..|.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 344556666666666666 56666666666666666666666 66666666666666666666666 5666666666666
Q ss_pred EEEccCCCCcc-CCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCc
Q 004732 141 KLFIQPSGLAG-PIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNR 219 (733)
Q Consensus 141 ~L~l~~N~l~~-~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~ 219 (733)
.|+|.+|++.. .+|..|+.++. |+.|+|++|.+. .+|..++++++|+.|.+..|.
T Consensus 106 vldltynnl~e~~lpgnff~m~t-----------------------lralyl~dndfe-~lp~dvg~lt~lqil~lrdnd 161 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTT-----------------------LRALYLGDNDFE-ILPPDVGKLTNLQILSLRDND 161 (264)
T ss_pred hhhccccccccccCCcchhHHHH-----------------------HHHHHhcCCCcc-cCChhhhhhcceeEEeeccCc
Confidence 66666666652 34444444444 455566667777 788899999999999999999
Q ss_pred ccCCCCCCcCCCCCCCEEEecCCcccccCChhh
Q 004732 220 LRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM 252 (733)
Q Consensus 220 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 252 (733)
+- .+|..++.+..|+.|.+.+|.++ .+|+.+
T Consensus 162 ll-~lpkeig~lt~lrelhiqgnrl~-vlppel 192 (264)
T KOG0617|consen 162 LL-SLPKEIGDLTRLRELHIQGNRLT-VLPPEL 192 (264)
T ss_pred hh-hCcHHHHHHHHHHHHhcccceee-ecChhh
Confidence 98 79999999999999999999998 555543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.2e-17 Score=197.52 Aligned_cols=220 Identities=20% Similarity=0.254 Sum_probs=105.5
Q ss_pred CCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEe
Q 004732 41 TFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 120 (733)
Q Consensus 41 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 120 (733)
.+|+.|+|.+|+|. .++..+..+++|+.|+|++|.....+|. ++.+++|+.|+|++|.....+|..+.++++|+.|++
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 44444444444444 3344444444444444444332223332 444444444444444333344444444444444444
Q ss_pred eCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccc--------------------
Q 004732 121 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ-------------------- 180 (733)
Q Consensus 121 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~-------------------- 180 (733)
++|...+.+|..+ ++++|+.|+|++|...+.+|.. ..+|+.|++++|.+...+...
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~lP~~~~l~~L~~L~l~~~~~~~l~~ 764 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEEFPSNLRLENLDELILCEMKSEKLWE 764 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccccccccccccccccccccccchhhccc
Confidence 4443222344333 3444444444444333333321 234444455544433322100
Q ss_pred ----------cccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCCh
Q 004732 181 ----------LGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP 250 (733)
Q Consensus 181 ----------~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 250 (733)
....+|+.|+|++|...+.+|..++++++|+.|+|++|..-+.+|..+ .+++|+.|++++|.....+|.
T Consensus 765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~ 843 (1153)
T PLN03210 765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD 843 (1153)
T ss_pred cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc
Confidence 001245666666666655666667777777777776664433555544 466666666666544434433
Q ss_pred hhhcCCCeeecccCcCCC
Q 004732 251 WMLERGDKIDLSYNNFTD 268 (733)
Q Consensus 251 ~~l~~l~~l~ls~N~l~~ 268 (733)
...+++.|++++|.+..
T Consensus 844 -~~~nL~~L~Ls~n~i~~ 860 (1153)
T PLN03210 844 -ISTNISDLNLSRTGIEE 860 (1153)
T ss_pred -cccccCEeECCCCCCcc
Confidence 23456666666666654
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.4e-17 Score=198.60 Aligned_cols=235 Identities=22% Similarity=0.259 Sum_probs=151.3
Q ss_pred ceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeec
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 96 (733)
..+.+|+|.+|++. .++..+..+++|+.|+|++|.....+| .++.+++|++|+|++|..-..+|..++++++|+.|+|
T Consensus 611 ~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L 688 (1153)
T PLN03210 611 ENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM 688 (1153)
T ss_pred cCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence 45677888888877 567778888999999998876544666 4888889999999887655688888888889999999
Q ss_pred cCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCC-------------------
Q 004732 97 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGI------------------- 157 (733)
Q Consensus 97 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l------------------- 157 (733)
++|.....+|..+ ++++|+.|+|++|...+.+|.. .++|+.|+|++|.+. .+|..+
T Consensus 689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~~l~~L~~L~l~~~~~~~l~ 763 (1153)
T PLN03210 689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNLRLENLDELILCEMKSEKLW 763 (1153)
T ss_pred CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccccccccccccccccchhhcc
Confidence 8865444777655 6777777777777654445432 345566666666654 333221
Q ss_pred -----------CCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCC
Q 004732 158 -----------FSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIP 225 (733)
Q Consensus 158 -----------~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 225 (733)
...++|+.|+|++|......+..++++ +|+.|++++|...+.+|..+ ++++|+.|+|++|..-..+|
T Consensus 764 ~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p 842 (1153)
T PLN03210 764 ERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFP 842 (1153)
T ss_pred ccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccc
Confidence 012355566666665444444444444 56677776665444555544 56666666666664443444
Q ss_pred CCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeeccc
Q 004732 226 SNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSY 263 (733)
Q Consensus 226 ~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~ 263 (733)
.. ..+|+.|++++|.+. .+|.++ +++|+.|++++
T Consensus 843 ~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~ 878 (1153)
T PLN03210 843 DI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNG 878 (1153)
T ss_pred cc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCC
Confidence 32 245666666666665 455554 56666666665
|
syringae 6; Provisional |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-17 Score=164.15 Aligned_cols=196 Identities=26% Similarity=0.362 Sum_probs=138.1
Q ss_pred CCCceeeEeeEEEe---------------------------CCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHH
Q 004732 447 QHPNLVKLYGCCIE---------------------------GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGI 499 (733)
Q Consensus 447 ~h~niv~l~~~~~~---------------------------~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~i 499 (733)
+|||||++.++|.+ +...|+||...+. +|.+++-.. ..+...+.-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence 59999999988753 2347899987754 788887543 45667778889999
Q ss_pred HHHHHHHHcCCCCCeecCCCCCCcEEec--CCC--CeEEcccCccccCcc-----cCcccccccccCCCcccHHHHhhCC
Q 004732 500 ARGLAYLHGESRIKVVHRDIKATNVLLD--KDL--NSKISDFGLAKLDEE-----ENTHISTRVAGTIGYMAPEYAMRGH 570 (733)
Q Consensus 500 a~~l~~LH~~~~~~ivH~Dik~~Nill~--~~~--~~kl~DfGla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~ 570 (733)
++|+.|||.+| |.|||+|++|||+. +|+ ...|+|||.+--... +.....-..-|.-.-||||+.....
T Consensus 351 LEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 99999999997 99999999999993 333 478999998742221 0111111234677889999986432
Q ss_pred ------CCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhc
Q 004732 571 ------LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCAN 644 (733)
Q Consensus 571 ------~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~ 644 (733)
--.|+|.|+.|.+.||+++...||+......+-... .++..+..+.+..+ ..+.+++...++
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---Yqe~qLPalp~~vp---------p~~rqlV~~lL~ 495 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---YQESQLPALPSRVP---------PVARQLVFDLLK 495 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh---hhhhhCCCCcccCC---------hHHHHHHHHHhc
Confidence 235899999999999999999999775544332111 22333333333322 237788888999
Q ss_pred CCCCCCCCHHHHHHHh
Q 004732 645 ASPTIRPSMSSVLRML 660 (733)
Q Consensus 645 ~~P~~RPt~~~vl~~L 660 (733)
.||++|++..-.-..|
T Consensus 496 r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 496 RDPSKRVSPNIAANVL 511 (598)
T ss_pred CCccccCCccHHHhHH
Confidence 9999999876554443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=160.54 Aligned_cols=139 Identities=21% Similarity=0.221 Sum_probs=109.4
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccCh----------------------hcHHHHHHHHHHHHhCCCCc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK----------------------QGNREFINEIGMISALQHPN 450 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~n 450 (733)
.-|...+.||+|+||.||+|...+|+.||||++..... .....+..|..++.++.|++
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 34777899999999999999988899999998653210 01123567888999998874
Q ss_pred --eeeEeeEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC
Q 004732 451 --LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK 528 (733)
Q Consensus 451 --iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~ 528 (733)
+.+.++ ....++||||+++++|.+.... .....++.+++.++.++|+.+ |+||||||+||++++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~ 160 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDD 160 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcC
Confidence 444443 2455899999999998765421 345678999999999999986 999999999999999
Q ss_pred CCCeEEcccCccccCcc
Q 004732 529 DLNSKISDFGLAKLDEE 545 (733)
Q Consensus 529 ~~~~kl~DfGla~~~~~ 545 (733)
++.++|+|||++.....
T Consensus 161 ~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 161 DEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCcEEEEECCccccCCC
Confidence 99999999999964443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.4e-17 Score=186.27 Aligned_cols=211 Identities=23% Similarity=0.321 Sum_probs=149.4
Q ss_pred hhcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
...+|+.++.|..|+||.||.++++ ..+++|+| +.+.. -+.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee-----------------
Confidence 4568999999999999999999865 46778884 32211 11110 44444555555
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc-
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT- 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~- 548 (733)
|+-...+... ..++. +++.+++|||+.| |+|||+||+|.+++.-|++|++|||+++.......
T Consensus 136 ----gDc~tllk~~-g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 ----GDCATLLKNI-GPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred ----chhhhhcccC-CCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 4444444322 23332 2378999999987 99999999999999999999999999985432110
Q ss_pred -----------c--cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc
Q 004732 549 -----------H--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 615 (733)
Q Consensus 549 -----------~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 615 (733)
+ ....++||+.|+|||++....|+..+|+|++|+|+||.+.|..||.++.+..++..+.. .....
T Consensus 200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis--d~i~w 277 (1205)
T KOG0606|consen 200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS--DDIEW 277 (1205)
T ss_pred hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh--hhccc
Confidence 0 12347899999999999999999999999999999999999999988877766653321 11111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSM 653 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 653 (733)
.+- | ...+ .+..+++.+.++.+|.+|--.
T Consensus 278 pE~-d----ea~p----~Ea~dli~~LL~qnp~~Rlgt 306 (1205)
T KOG0606|consen 278 PEE-D----EALP----PEAQDLIEQLLRQNPLCRLGT 306 (1205)
T ss_pred ccc-C----cCCC----HHHHHHHHHHHHhChHhhccc
Confidence 111 1 1122 237778888999999999733
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.8e-17 Score=184.81 Aligned_cols=138 Identities=19% Similarity=0.282 Sum_probs=112.4
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEcccc-C------hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK-S------KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
...|...+.||+|+||+||+|.+.+...++.+++... . ......+.+|+++++.++|++++....++..+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 4455678999999999999998755443332222221 1 11235688999999999999999888888887888
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
++||||+++++|.+++. .+..++.+++++|.|||+.+ ++||||||+||++ .++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999999874 45789999999999999986 9999999999999 577899999999975
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.1e-19 Score=189.44 Aligned_cols=249 Identities=22% Similarity=0.264 Sum_probs=155.0
Q ss_pred eecccccccc-ccCCccccCCCCCCeeecccccccc----ccchhccCCCCCCEEEccccccc------ccCCccccCCc
Q 004732 21 KRVLKEQNLT-GVLPPKLAELTFLQDISLIANRLKG----PIPKYLANISTLVNLTVQYNQFS------GELPEELGSLL 89 (733)
Q Consensus 21 ~l~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~------~~~p~~~~~l~ 89 (733)
.|+|..++++ +.....|..+.+|+.|+|++|.++. .++..+...++|++|+++++.+. ..++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4566777776 3445566667777777777777743 24555666677777777777665 22334566677
Q ss_pred CCceeeccCccccccCCccccCCCC---CCEEEeeCCcccc----CCCcccccc-CCCCEEEccCCCCccC----CCCCC
Q 004732 90 NLEKLHLSSNNFTGELPKTFAKLTN---MKDFRISDNQFTG----QIPSFIQNW-TKLEKLFIQPSGLAGP----IPSGI 157 (733)
Q Consensus 90 ~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~l~~N~l~~----~~~~~~~~l-~~L~~L~l~~N~l~~~----~p~~l 157 (733)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 7777777777776555555555544 7777777777763 223344555 7777777777777732 33345
Q ss_pred CCcCCcCeeecccccCCCCCcccc-----ccccccEEEcccCccCCC----CCccccCCCCCcEEEccCCcccCCCCCCc
Q 004732 158 FSLENLTDLRISDLNGPEATFPQL-----GNMKMTKLILRNCNITGE----LPRYLGKMTKLKVLDLSFNRLRGQIPSNF 228 (733)
Q Consensus 158 ~~l~~L~~L~l~~n~~~~~~~~~~-----~~~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~~ 228 (733)
..+++|+.|++++|.+.......+ ...+|+.|++++|.+++. +...+..+++|++|++++|.+++.....+
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l 241 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAAL 241 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHH
Confidence 556677777777777764332211 123677778887777643 23345566778888888887775322222
Q ss_pred C-----CCCCCCEEEecCCccccc----CChhh--hcCCCeeecccCcCCCC
Q 004732 229 D-----DLYDVDYIYFAGNLLTGA----IPPWM--LERGDKIDLSYNNFTDG 269 (733)
Q Consensus 229 ~-----~l~~L~~L~l~~N~l~~~----~p~~~--l~~l~~l~ls~N~l~~~ 269 (733)
. ..+.|+.|++++|.++.. +...+ .++++.+++++|.+...
T Consensus 242 ~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 242 ASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 2 136778888888877521 11111 35677788888877654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-17 Score=175.76 Aligned_cols=121 Identities=27% Similarity=0.453 Sum_probs=106.2
Q ss_pred eEEEEEEccCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 463 QLLLIYEYLENNSLARALF--EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
..++.|++|...+|.+|+. ......++.....++.|++.|++| ++ .+|||+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 5789999999999999996 344567899999999999999999 54 899999999999999999999999998
Q ss_pred ccCcccC-----cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh
Q 004732 541 KLDEEEN-----THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589 (733)
Q Consensus 541 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt 589 (733)
....... ....+...||..||+||.+.+..|+.|+||||+|++++|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7655443 223455779999999999999999999999999999999996
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.9e-19 Score=185.96 Aligned_cols=253 Identities=18% Similarity=0.204 Sum_probs=193.6
Q ss_pred cccceeeeeccccccccc----cCCccccCCCCCCeeeccccccc------cccchhccCCCCCCEEEcccccccccCCc
Q 004732 14 KQKTVNQKRVLKEQNLTG----VLPPKLAELTFLQDISLIANRLK------GPIPKYLANISTLVNLTVQYNQFSGELPE 83 (733)
Q Consensus 14 ~~~~~~~~l~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~------~~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 83 (733)
.....+++++|+++.++. .+++.+...+.|+.|+++++.+. ..++..+..+++|+.|+|++|.+.+..+.
T Consensus 20 ~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~ 99 (319)
T cd00116 20 PKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCG 99 (319)
T ss_pred HHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHH
Confidence 445668999999999964 36667778889999999999887 23456788899999999999999876777
Q ss_pred cccCCcC---CceeeccCccccc----cCCccccCC-CCCCEEEeeCCccccC----CCccccccCCCCEEEccCCCCcc
Q 004732 84 ELGSLLN---LEKLHLSSNNFTG----ELPKTFAKL-TNMKDFRISDNQFTGQ----IPSFIQNWTKLEKLFIQPSGLAG 151 (733)
Q Consensus 84 ~~~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~ 151 (733)
.+..+.+ |+.|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+..+++|++|++++|.+++
T Consensus 100 ~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~ 179 (319)
T cd00116 100 VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGD 179 (319)
T ss_pred HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCch
Confidence 7766666 9999999999983 344556677 8999999999999943 34456778899999999999985
Q ss_pred C----CCCCCCCcCCcCeeecccccCCCCCcccc----c-cccccEEEcccCccCCCCCccccC-----CCCCcEEEccC
Q 004732 152 P----IPSGIFSLENLTDLRISDLNGPEATFPQL----G-NMKMTKLILRNCNITGELPRYLGK-----MTKLKVLDLSF 217 (733)
Q Consensus 152 ~----~p~~l~~l~~L~~L~l~~n~~~~~~~~~~----~-~~~L~~L~l~~n~l~~~~p~~~~~-----l~~L~~L~ls~ 217 (733)
. ++..+..+++|+.|++++|.+.......+ . ..+|+.|++++|.+++.....+.. .+.|+.|++++
T Consensus 180 ~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~ 259 (319)
T cd00116 180 AGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSC 259 (319)
T ss_pred HHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccC
Confidence 3 34455667899999999999876543322 2 237999999999998643333332 37999999999
Q ss_pred CcccC----CCCCCcCCCCCCCEEEecCCcccccCChh----h--h-cCCCeeecccCcC
Q 004732 218 NRLRG----QIPSNFDDLYDVDYIYFAGNLLTGAIPPW----M--L-ERGDKIDLSYNNF 266 (733)
Q Consensus 218 N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~p~~----~--l-~~l~~l~ls~N~l 266 (733)
|.++. .+...+..+++|+++++++|.+...-... + . +.++.+++.+|++
T Consensus 260 n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 260 NDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred CCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 99972 23445666789999999999998542222 2 2 4677888877753
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-19 Score=181.15 Aligned_cols=260 Identities=19% Similarity=0.176 Sum_probs=169.2
Q ss_pred cceeeeecccceeeeeccccccccccCCccccCCCCCCeeeccc-cccccccchhccCCCCCCEEEcccccccccCCccc
Q 004732 7 FLVFHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIA-NRLKGPIPKYLANISTLVNLTVQYNQFSGELPEEL 85 (733)
Q Consensus 7 ~~~~~~~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 85 (733)
+++.+-|+....+++|+|++|+|+.+-|.+|..+++|..|-+.+ |+|+...-..|++|..|+.|.+.-|++.-+..++|
T Consensus 81 ~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al 160 (498)
T KOG4237|consen 81 SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDAL 160 (498)
T ss_pred cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHH
Confidence 45556677777899999999999999999999999988887776 99996666789999999999999999998888999
Q ss_pred cCCcCCceeeccCccccccCCc-cccCCCCCCEEEeeCCccc------------cCCCccccccCCCCEEEccCCCCccC
Q 004732 86 GSLLNLEKLHLSSNNFTGELPK-TFAKLTNMKDFRISDNQFT------------GQIPSFIQNWTKLEKLFIQPSGLAGP 152 (733)
Q Consensus 86 ~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~------------~~~~~~~~~l~~L~~L~l~~N~l~~~ 152 (733)
..|++|..|.|.+|.+. .+++ +|..+..++.+.+..|.+. ...|..++......-..+.++++...
T Consensus 161 ~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~ 239 (498)
T KOG4237|consen 161 RDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQE 239 (498)
T ss_pred HHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhccc
Confidence 99999999999999999 6665 8999999999999999833 22344444444444444555554422
Q ss_pred CCCCCCCcCCcCee--eccccc-CCCCCc-ccccc-ccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCC
Q 004732 153 IPSGIFSLENLTDL--RISDLN-GPEATF-PQLGN-MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN 227 (733)
Q Consensus 153 ~p~~l~~l~~L~~L--~l~~n~-~~~~~~-~~~~~-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 227 (733)
-+..|... ++.+ .++.+. .....+ .-|.. .+|++|+|++|+|+++-+.+|.++..|+.|.|..|+|...-...
T Consensus 240 ~a~kf~c~--~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~ 317 (498)
T KOG4237|consen 240 DARKFLCS--LESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGM 317 (498)
T ss_pred chhhhhhh--HHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHh
Confidence 22222211 1111 111111 111111 11222 24555555555555555555555555555555555555444445
Q ss_pred cCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCcCCCC
Q 004732 228 FDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDG 269 (733)
Q Consensus 228 ~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~ 269 (733)
|.++..|+.|+|.+|+|+...|..+ +..+..|++-.|++.|.
T Consensus 318 f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~Cn 361 (498)
T KOG4237|consen 318 FQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCN 361 (498)
T ss_pred hhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCc
Confidence 5555555555555555555555544 44455555555555443
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.4e-18 Score=191.46 Aligned_cols=244 Identities=23% Similarity=0.302 Sum_probs=175.8
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
++.+....|++... .-..++|+.|+.++|.++...+ .+. -.+|+++++++|+++ .+|.+++.+.+|+.|+.++
T Consensus 201 l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~-~p~-p~nl~~~dis~n~l~-~lp~wi~~~~nle~l~~n~ 273 (1081)
T KOG0618|consen 201 LEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDV-HPV-PLNLQYLDISHNNLS-NLPEWIGACANLEALNANH 273 (1081)
T ss_pred hhhhhhhhcccceE----EecCcchheeeeccCcceeecc-ccc-cccceeeecchhhhh-cchHHHHhcccceEecccc
Confidence 44444555555422 1233667777777777773222 121 246777777777777 5667777777777777777
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCC---------------------
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGI--------------------- 157 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l--------------------- 157 (733)
|+|+ .+|..+...++|+.|.+.+|.++ -+|.....++.|++|+|..|+|. .+|+.+
T Consensus 274 N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~l 350 (1081)
T KOG0618|consen 274 NRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTL 350 (1081)
T ss_pred hhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhcccccc
Confidence 7775 67777777777777777777777 66666667777777777777775 333211
Q ss_pred -----CCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCC
Q 004732 158 -----FSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 231 (733)
Q Consensus 158 -----~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 231 (733)
..+..|+.|++-+|.+++..++.+.+. +|+.|+|++|+|.......+.++..|+.|+||+|+|+ .+|.++..+
T Consensus 351 p~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~ 429 (1081)
T KOG0618|consen 351 PSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANL 429 (1081)
T ss_pred ccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhh
Confidence 124567788888888888888777766 7999999999998666667888999999999999999 788999999
Q ss_pred CCCCEEEecCCcccccCChhh-hcCCCeeecccCcCCCCCCccc
Q 004732 232 YDVDYIYFAGNLLTGAIPPWM-LERGDKIDLSYNNFTDGSAESS 274 (733)
Q Consensus 232 ~~L~~L~l~~N~l~~~~p~~~-l~~l~~l~ls~N~l~~~~~~~~ 274 (733)
..|+.|...+|.+. ..|... ++.++.+|++.|+++.......
T Consensus 430 ~~L~tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~~l~~~ 472 (1081)
T KOG0618|consen 430 GRLHTLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSEVTLPEA 472 (1081)
T ss_pred hhhHHHhhcCCcee-echhhhhcCcceEEecccchhhhhhhhhh
Confidence 99999999999987 556443 7889999999999986544333
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.1e-15 Score=140.93 Aligned_cols=135 Identities=21% Similarity=0.215 Sum_probs=115.0
Q ss_pred ccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCC--CceeeEeeEEEeCCeEEEEEEccCCC
Q 004732 397 TDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQH--PNLVKLYGCCIEGNQLLLIYEYLENN 474 (733)
Q Consensus 397 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~g 474 (733)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .++.++++++..++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 34679999999999999754 7899999865433 4678899999999976 58999999888888899999999998
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 475 SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 475 sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
.+... +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.++.
T Consensus 79 ~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77543 5677788999999999999986444699999999999999988999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2e-15 Score=146.87 Aligned_cols=136 Identities=24% Similarity=0.290 Sum_probs=97.5
Q ss_pred cCcccCCCcccEEEcccCCCcEEEEEEccccChh--cHHHH----------------------HHHHHHHHhCCCCc--e
Q 004732 398 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ--GNREF----------------------INEIGMISALQHPN--L 451 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~E~~~l~~l~h~n--i 451 (733)
.+.||+|+||+||+|...+|+.||||++...... ....+ ..|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999878999999987643211 11111 34566666665443 3
Q ss_pred eeEeeEEEeCCeEEEEEEccCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeecCCCCCCcEEecCC
Q 004732 452 VKLYGCCIEGNQLLLIYEYLENNSLAR-ALFEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKD 529 (733)
Q Consensus 452 v~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dik~~Nill~~~ 529 (733)
.+.+++ ...++||||++++.+.. .+.... .. .....++.+++.++.++|. .+ |+||||||+||+++ +
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~ 150 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-D 150 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-C
Confidence 344433 24589999999954321 111111 11 5678999999999999998 65 99999999999999 8
Q ss_pred CCeEEcccCccccCc
Q 004732 530 LNSKISDFGLAKLDE 544 (733)
Q Consensus 530 ~~~kl~DfGla~~~~ 544 (733)
+.++++|||.+....
T Consensus 151 ~~~~liDfg~a~~~~ 165 (187)
T cd05119 151 GKVYIIDVPQAVEID 165 (187)
T ss_pred CcEEEEECccccccc
Confidence 899999999997443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.2e-14 Score=146.30 Aligned_cols=135 Identities=21% Similarity=0.262 Sum_probs=105.3
Q ss_pred cCccc-CCCcccEEEcccCCCcEEEEEEccccC-------------hhcHHHHHHHHHHHHhCCCCce--eeEeeEEEeC
Q 004732 398 DNNIG-EGGFGPVYKGLLADGTAIAVKQLSSKS-------------KQGNREFINEIGMISALQHPNL--VKLYGCCIEG 461 (733)
Q Consensus 398 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 461 (733)
..+|| .||.|+||.+... +..++||.+.... ......+.+|++++.+++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 8999999998875 6789999875321 1123567889999999998885 6777765443
Q ss_pred C----eEEEEEEccCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcc
Q 004732 462 N----QLLLIYEYLEN-NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 536 (733)
Q Consensus 462 ~----~~~lV~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 536 (733)
. ..++|+||+++ .+|.+++... .++.. .+.+++.++.+||+.| |+||||||.|||++.++.++|+|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEE
Confidence 2 23599999997 6898887542 34433 3678999999999997 99999999999999988999999
Q ss_pred cCcccc
Q 004732 537 FGLAKL 542 (733)
Q Consensus 537 fGla~~ 542 (733)
||.++.
T Consensus 186 fg~~~~ 191 (239)
T PRK01723 186 FDRGEL 191 (239)
T ss_pred CCCccc
Confidence 999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.4e-16 Score=175.30 Aligned_cols=250 Identities=23% Similarity=0.286 Sum_probs=184.6
Q ss_pred CccccCcccCCCcccEEEcccC--CCcEEEEEEccccC--hhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA--DGTAIAVKQLSSKS--KQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 468 (733)
.|...+.||+|+|+.|-.+... ....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..+++.
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4556677999999999988753 34566777765543 222233344666666665 999999999999999999999
Q ss_pred EccCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeecCCCCCCcEEecCCC-CeEEcccCccccCcc
Q 004732 469 EYLENNSLARAL-FEHRLKLDWPTRRRICLGIARGLAYLH-GESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEE 545 (733)
Q Consensus 469 e~~~~gsL~~~l-~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~ 545 (733)
+|..++++.+-+ .......+....-.++.|+..++.|+| +.+ +.|||+||+|.+++..+ ..+++|||+|..+..
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999988 444336777888999999999999999 775 99999999999999999 999999999987665
Q ss_pred -c-Cccccccccc-CCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhh--HHHHHHHHHhhCcccccc
Q 004732 546 -E-NTHISTRVAG-TIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFY--LLDWALVLKEQGKLMELV 619 (733)
Q Consensus 546 -~-~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~ 619 (733)
. ........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+....... ...|... .+ ..
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~---~~----~~ 250 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN---KG----RF 250 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc---cc----cc
Confidence 2 2223344668 9999999998874 56778999999999999999999984332211 1112110 00 00
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004732 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 657 (733)
Q Consensus 620 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl 657 (733)
...+.... .....++..+++..+|..|.+.+++.
T Consensus 251 ~~~~~~~~----~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 251 TQLPWNSI----SDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred ccCccccC----ChhhhhcccccccCCchhcccccccc
Confidence 11111111 22355677788889999999998874
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=8.1e-16 Score=161.44 Aligned_cols=180 Identities=27% Similarity=0.393 Sum_probs=112.9
Q ss_pred CCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEE
Q 004732 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 119 (733)
Q Consensus 40 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 119 (733)
+..-...||+.|++. .+|..+..+-.|..|.|.+|.+. .+|..+.+|..|+.|||+.|+++ .+|..++.|+ |+.|-
T Consensus 74 ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli 149 (722)
T KOG0532|consen 74 LTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLI 149 (722)
T ss_pred ccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEE
Confidence 444555666677766 66666666666667777777766 66666667777777777777766 6666666654 66667
Q ss_pred eeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCC
Q 004732 120 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGE 199 (733)
Q Consensus 120 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 199 (733)
+++|+++ .+|..++.+..|..|+.+.|.+. .+|..++.+.+|+.|++.. |++. .
T Consensus 150 ~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrR-----------------------n~l~-~ 203 (722)
T KOG0532|consen 150 VSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRR-----------------------NHLE-D 203 (722)
T ss_pred EecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhh-----------------------hhhh-h
Confidence 7777766 66666666666666666666666 5565666666555555554 4444 3
Q ss_pred CCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh
Q 004732 200 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM 252 (733)
Q Consensus 200 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 252 (733)
+|.++. .-.|..||+|.|+++ .+|-.|..|..|++|-|.+|+++ ..|..+
T Consensus 204 lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI 253 (722)
T KOG0532|consen 204 LPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI 253 (722)
T ss_pred CCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence 444444 224566666666666 56666666666666666666665 334333
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.8e-15 Score=158.84 Aligned_cols=200 Identities=26% Similarity=0.414 Sum_probs=155.6
Q ss_pred eeeccccccccccch--hccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeC
Q 004732 45 DISLIANRLKGPIPK--YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD 122 (733)
Q Consensus 45 ~L~L~~n~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 122 (733)
.|.|++-+++ ..|. .=..+..-...||+.|++. ++|..+..+..|+.|.|+.|.|. .+|..++++..|+.|+|+.
T Consensus 54 ~l~Ls~rrlk-~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 54 RLLLSGRRLK-EFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred ccccccchhh-cCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 4556666665 3331 1134556677888888888 88888888888888888888888 8888888888888888888
Q ss_pred CccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCc
Q 004732 123 NQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPR 202 (733)
Q Consensus 123 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~ 202 (733)
|+++ .+|..++.|+ |+.|.+++|+++ .+|+.++.+..|. .|+.+.|++. .+|.
T Consensus 131 NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~-----------------------~ld~s~nei~-slps 183 (722)
T KOG0532|consen 131 NQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLA-----------------------HLDVSKNEIQ-SLPS 183 (722)
T ss_pred chhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHH-----------------------Hhhhhhhhhh-hchH
Confidence 8888 6777776654 778888888887 7777777555544 4556667777 7788
Q ss_pred cccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCcCCCCCCccccccc
Q 004732 203 YLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKR 278 (733)
Q Consensus 203 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~~~~~~~~~~ 278 (733)
.++++.+|+.|++..|++. .+|..+..| .|..||++.|++. .+|.++ |+.|+.|-|.+|++... +...|-+.
T Consensus 184 ql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSP-PAqIC~kG 257 (722)
T KOG0532|consen 184 QLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSP-PAQICEKG 257 (722)
T ss_pred HhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCC-hHHHHhcc
Confidence 9999999999999999999 677778755 5889999999998 788888 88999999999999753 44555544
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.2e-13 Score=151.09 Aligned_cols=146 Identities=21% Similarity=0.260 Sum_probs=104.1
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhc----------------------------------------
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQG---------------------------------------- 432 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------------------- 432 (733)
..|+ .+.||.|++|.||+|++.+|+.||||+........
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3444 36899999999999999999999999975431110
Q ss_pred HHHHHHHHHHHHhCC----CCceeeEeeEEE-eCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHH
Q 004732 433 NREFINEIGMISALQ----HPNLVKLYGCCI-EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR-GLAYL 506 (733)
Q Consensus 433 ~~~~~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~-~l~~L 506 (733)
+-+|.+|++.+.+++ |.+-+.+-.++. .....++||||++|++|.+......... .+.+++..+++ .+..+
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHH
Confidence 012455666555552 333334333332 2445799999999999988765322222 34567777766 47888
Q ss_pred HcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 507 H~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
|..| ++|+|+||.||+++.+++++++|||++....+
T Consensus 274 ~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 LRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9886 99999999999999999999999999976543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.6e-13 Score=148.36 Aligned_cols=199 Identities=28% Similarity=0.457 Sum_probs=137.0
Q ss_pred eeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCc-CCceeeccCccccccCCccccCCCCCCEEEeeCC
Q 004732 45 DISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLL-NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 123 (733)
Q Consensus 45 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 123 (733)
.|++..|.+. .....+..++.++.|++.+|.++ .++...+.+. +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 4677777764 23334555677778888888777 6776666664 7888888888777 66666777778888888888
Q ss_pred ccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCcc
Q 004732 124 QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRY 203 (733)
Q Consensus 124 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~ 203 (733)
+++ .+|...+.+++|+.|++++|++. .+|.....+..|+.|.++.|.........-...++..|.+.+|++. .++..
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~-~~~~~ 250 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLE-DLPES 250 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceee-eccch
Confidence 877 66666557777777888888877 6666655566677777777754444433333345666667777776 33566
Q ss_pred ccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChh
Q 004732 204 LGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 251 (733)
Q Consensus 204 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 251 (733)
++.+++|+.|++++|+++ .++. +..+.+++.|++++|.+....|..
T Consensus 251 ~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 251 IGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence 777777888888888877 3444 777777888888877777555543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.9e-13 Score=147.00 Aligned_cols=199 Identities=30% Similarity=0.447 Sum_probs=164.7
Q ss_pred eccccccccccCCccccCCCCCCeeeccccccccccchhccCCC-CCCEEEcccccccccCCccccCCcCCceeeccCcc
Q 004732 22 RVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANIS-TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNN 100 (733)
Q Consensus 22 l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 100 (733)
+.+..|.+...+ ..+..++.++.|++.+|.++ .++.....+. +|+.|++++|.+. .+|..++.+++|+.|++++|+
T Consensus 98 l~~~~~~~~~~~-~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~ 174 (394)
T COG4886 98 LDLNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFND 174 (394)
T ss_pred eeccccccccCc-hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCch
Confidence 556666664333 35556688999999999999 7777788885 9999999999999 787889999999999999999
Q ss_pred ccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccc
Q 004732 101 FTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ 180 (733)
Q Consensus 101 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~ 180 (733)
++ .+|...+.+++|+.|++++|+++ .+|........|++|.+++|++. ..+..+..+.++..|.+.+|.+.... ..
T Consensus 175 l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~~-~~ 250 (394)
T COG4886 175 LS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLP-ES 250 (394)
T ss_pred hh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeecc-ch
Confidence 99 88877778899999999999999 78887777788999999999654 57788889999999998888877642 22
Q ss_pred cccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcC
Q 004732 181 LGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFD 229 (733)
Q Consensus 181 ~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~ 229 (733)
+... .++.|++++|.++.. +. ++.+.+|+.|++++|.+....+....
T Consensus 251 ~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 251 IGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred hccccccceecccccccccc-cc-ccccCccCEEeccCccccccchhhhc
Confidence 3333 599999999999954 44 89999999999999999977666444
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=8.4e-13 Score=130.39 Aligned_cols=200 Identities=21% Similarity=0.298 Sum_probs=137.7
Q ss_pred HHHHhCCCCceeeEeeEEEeC-----CeEEEEEEccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 004732 441 GMISALQHPNLVKLYGCCIEG-----NQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRI 512 (733)
Q Consensus 441 ~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~ 512 (733)
.-|-++.|.|||++..|+.+. .+..++.|||+.|++..+|++ ....+......+++.||..||.|||+. .+
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence 345566799999999998754 457899999999999999983 344677788889999999999999987 68
Q ss_pred CeecCCCCCCcEEecCCCCeEEcccCccccCcccC---cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh
Q 004732 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN---THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS 589 (733)
Q Consensus 513 ~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt 589 (733)
+|+|+++.-+-|++..++-+||+----......-. ......-.|-++|.|||+-.....+.++|||+||...+||..
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai 277 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI 277 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence 89999999999999999988885322111100000 001122346789999998777778889999999999999988
Q ss_pred CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004732 590 GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 657 (733)
Q Consensus 590 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl 657 (733)
+..--...+........ ....+...-+. . =.+.+..|++..|..||+|++++
T Consensus 278 lEiq~tnseS~~~~ee~----ia~~i~~len~-l-----------qr~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 278 LEIQSTNSESKVEVEEN----IANVIIGLENG-L-----------QRGSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred heeccCCCcceeehhhh----hhhheeeccCc-c-----------ccCcCcccccCCCCCCcchhhhh
Confidence 76532111110000000 00000001111 1 12456689999999999999884
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=2.1e-12 Score=123.42 Aligned_cols=130 Identities=21% Similarity=0.152 Sum_probs=97.5
Q ss_pred CcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceee-EeeEEEeCCeEEEEEEccCCCCHH
Q 004732 399 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVK-LYGCCIEGNQLLLIYEYLENNSLA 477 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~~~~gsL~ 477 (733)
+.|+.|.++.||+++.. ++.|++|....... ....+..|+.+++.+.+.++++ ++.+. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56899999999999865 77899998755432 2235678999999987666554 44332 33458999999998875
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 478 RALFEHRLKLDWPTRRRICLGIARGLAYLHGES--RIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 478 ~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
+.. .....++.+++++|+.||..+ ...++|||++|+||+++ ++.++++|||.+..
T Consensus 80 ~~~---------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 80 TED---------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc---------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 430 112345679999999999885 22369999999999999 66899999998863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=2.1e-12 Score=138.86 Aligned_cols=248 Identities=22% Similarity=0.252 Sum_probs=180.5
Q ss_pred cCccccCcccC--CCcccEEEccc---CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeE
Q 004732 393 NNFATDNNIGE--GGFGPVYKGLL---ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 393 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 464 (733)
..|.....+|. |.+|.||.+.. .++..+|+|+=+.. .......=.+|+..-+.++ |+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 35667788999 99999999986 46788999873322 1122223345666666664 99999988899999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHcCCCCCeecCCCCCCcEEecCC-CCeEEcccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR----GLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGL 539 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfGl 539 (733)
++-+|++. .+|..+.+.....++....+.+..+... |+.++|... ++|-|+||.||+...+ ...+++|||+
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 99999886 6888887766666888889999999999 999999885 9999999999999999 8899999999
Q ss_pred cccCcccCccc----ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc
Q 004732 540 AKLDEEENTHI----STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 615 (733)
Q Consensus 540 a~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 615 (733)
...+....-.. ...-.|...|++||... +-++.++|+|++|.+..+...|......... ..|... +...+
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~---~~W~~~--r~~~i 343 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN---SSWSQL--RQGYI 343 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC---CCcccc--ccccC
Confidence 98776544221 22235788899999764 4688999999999999999988766532200 011100 00010
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+.......+...+..+++.+|..|++.+.+..
T Consensus 344 --------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 344 --------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred --------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 01111111223445788899999999999888754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=2.4e-12 Score=147.38 Aligned_cols=109 Identities=25% Similarity=0.508 Sum_probs=98.7
Q ss_pred CCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEee
Q 004732 42 FLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 121 (733)
Q Consensus 42 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 121 (733)
.++.|+|++|.++|.+|..++++++|+.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 47889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccCCCcccccc-CCCCEEEccCCCCc
Q 004732 122 DNQFTGQIPSFIQNW-TKLEKLFIQPSGLA 150 (733)
Q Consensus 122 ~N~l~~~~~~~~~~l-~~L~~L~l~~N~l~ 150 (733)
+|+++|.+|..++.+ .++..+++.+|...
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~l 528 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGL 528 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccc
Confidence 999999999988764 56788899988754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.27 E-value=2.3e-11 Score=134.46 Aligned_cols=143 Identities=14% Similarity=0.184 Sum_probs=95.8
Q ss_pred hcCccccCcccCCCcccEEEcccCC-CcEEEEEEccccChhc--------------------------------------
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQG-------------------------------------- 432 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-------------------------------------- 432 (733)
...|+. +.||+|++|.||+|++.+ |+.||||+........
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 446776 789999999999999877 9999999986431100
Q ss_pred --HHHHHHHHHHHHhCC----CCceeeEeeEEEe-CCeEEEEEEccCCCCHHHHHH--hcCC---CCCHHHHHHHHHHHH
Q 004732 433 --NREFINEIGMISALQ----HPNLVKLYGCCIE-GNQLLLIYEYLENNSLARALF--EHRL---KLDWPTRRRICLGIA 500 (733)
Q Consensus 433 --~~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~--~~~~---~l~~~~~~~i~~~ia 500 (733)
+-+|.+|+..+.+++ +...+.+-.++.+ ....++||||++|+.+.+... ..+. .+.......++.|
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-- 275 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-- 275 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence 012445555555543 4444444444433 456789999999999987532 2211 1222222233333
Q ss_pred HHHHHHHcCCCCCeecCCCCCCcEEecCCC----CeEEcccCccccCcc
Q 004732 501 RGLAYLHGESRIKVVHRDIKATNVLLDKDL----NSKISDFGLAKLDEE 545 (733)
Q Consensus 501 ~~l~~LH~~~~~~ivH~Dik~~Nill~~~~----~~kl~DfGla~~~~~ 545 (733)
++..| ++|+|+||.||+++.++ ++++.|||++....+
T Consensus 276 -----if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 -----VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34454 99999999999999988 899999999986654
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=5.8e-11 Score=128.86 Aligned_cols=228 Identities=17% Similarity=0.165 Sum_probs=150.3
Q ss_pred cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHH
Q 004732 414 LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR 493 (733)
Q Consensus 414 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~ 493 (733)
..++.+|.|...+...........+-++.|+.+|||||++++..+.+++..|+|+|-+.- |..++.+. +.....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~l----~~~~v~ 107 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKEL----GKEEVC 107 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHHh----HHHHHH
Confidence 567889999988766553345567778899999999999999999999999999998753 56666433 245566
Q ss_pred HHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCc
Q 004732 494 RICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573 (733)
Q Consensus 494 ~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 573 (733)
-.+.||+.||.|||+.| +++|++|.-+.|++++.|..||++|-++.....-.. ......--..|..|+.+.... -
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc--c
Confidence 67889999999999887 799999999999999999999999988754322111 001111122466676543222 3
Q ss_pred cchhHhHHHHHHHHHhCCCCCCcc--chhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCC
Q 004732 574 KADVYSFGIVALEIVSGRSNVTKE--DMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRP 651 (733)
Q Consensus 574 ~~Dv~s~Gvil~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP 651 (733)
..|.|-|||+++|++.|..+-..+ ....+........ ...+...... ... ..+++..|....+-.|=
T Consensus 183 s~D~~~Lg~li~el~ng~~~~~~~~~~~~~ipk~~~~~~----~k~~~~~~~~------r~n-~~~~~~~~~~~~gff~n 251 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNGSLLTKTDLSNTGKIPKALIELY----CKKLGATELK------RPN-KLRFILECRLLGGFFRN 251 (690)
T ss_pred chhhhhHHHHHHHHhCcccCcchhhhccCccchhHHHHH----HHHhcccccc------ccc-hhhHHHHHHhccccccc
Confidence 569999999999999983221110 0000000000000 0000000000 001 44566777777788888
Q ss_pred CHHHHHHHhccC
Q 004732 652 SMSSVLRMLECG 663 (733)
Q Consensus 652 t~~~vl~~L~~~ 663 (733)
.+-+++..|+.+
T Consensus 252 ~fvd~~~fLeel 263 (690)
T KOG1243|consen 252 DFVDTLLFLEEL 263 (690)
T ss_pred hHHHHHHHHHhc
Confidence 888888888754
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=9.4e-12 Score=142.53 Aligned_cols=110 Identities=23% Similarity=0.435 Sum_probs=102.6
Q ss_pred CCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEcc
Q 004732 66 TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 145 (733)
Q Consensus 66 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 145 (733)
.++.|+|++|.++|.+|..++.+++|+.|+|++|+|+|.+|..+..+++|+.|+|++|+|+|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 48899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCccCCCCCCCCc-CCcCeeecccccCCC
Q 004732 146 PSGLAGPIPSGIFSL-ENLTDLRISDLNGPE 175 (733)
Q Consensus 146 ~N~l~~~~p~~l~~l-~~L~~L~l~~n~~~~ 175 (733)
+|+++|.+|..+..+ .++..+++.+|....
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc 529 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLC 529 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCcccc
Confidence 999999999988774 567788998887544
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.7e-12 Score=133.05 Aligned_cols=182 Identities=21% Similarity=0.260 Sum_probs=96.2
Q ss_pred cCCCCCCeeeccccccccccc--hhccCCCCCCEEEcccccccccCC--ccccCCcCCceeeccCccccccCCccc-cCC
Q 004732 38 AELTFLQDISLIANRLKGPIP--KYLANISTLVNLTVQYNQFSGELP--EELGSLLNLEKLHLSSNNFTGELPKTF-AKL 112 (733)
Q Consensus 38 ~~l~~L~~L~L~~n~l~~~~p--~~l~~l~~L~~L~L~~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l 112 (733)
.++.+|+.+.|.+..+. ..+ .....+++++.|||+.|-|..-.+ .-...|++|+.|+|+.|++........ ..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 34666777777777766 333 355667777777777776653222 234567777777777777663222111 135
Q ss_pred CCCCEEEeeCCcccc-CCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCc--cccccccccEE
Q 004732 113 TNMKDFRISDNQFTG-QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATF--PQLGNMKMTKL 189 (733)
Q Consensus 113 ~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~--~~~~~~~L~~L 189 (733)
+.|+.|.|+.|.|+. .+...+..+++|+.|+|..|...+.-......++.|+.|+|++|++...+. .......|+.|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 667777777777762 122234456777777777764322323333345566666666665554431 11111244444
Q ss_pred EcccCccCCC-CCcc-----ccCCCCCcEEEccCCcc
Q 004732 190 ILRNCNITGE-LPRY-----LGKMTKLKVLDLSFNRL 220 (733)
Q Consensus 190 ~l~~n~l~~~-~p~~-----~~~l~~L~~L~ls~N~l 220 (733)
+++.|.+... +|+. ...+++|++|+++.|++
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I 313 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNI 313 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCcc
Confidence 4554444421 1111 23344555555555554
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.1e-10 Score=110.18 Aligned_cols=136 Identities=15% Similarity=0.139 Sum_probs=97.3
Q ss_pred CcccCCCcccEEEcccCC-------CcEEEEEEccccC----------------------hhcHHHHH----HHHHHHHh
Q 004732 399 NNIGEGGFGPVYKGLLAD-------GTAIAVKQLSSKS----------------------KQGNREFI----NEIGMISA 445 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~~ 445 (733)
..||.|--+.||.|.-.+ +..+|||..+... ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999998543 5799999874320 00112222 78999988
Q ss_pred CCC--CceeeEeeEEEeCCeEEEEEEccCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeecCCCCC
Q 004732 446 LQH--PNLVKLYGCCIEGNQLLLIYEYLENNSLAR-ALFEHRLKLDWPTRRRICLGIARGLAYL-HGESRIKVVHRDIKA 521 (733)
Q Consensus 446 l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~Dik~ 521 (733)
+.. -++.+++++ ...++||||+.++.+.. .+.. ..++..+...+..+++.+|..| |+.+ |||||+++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence 853 344455544 46689999998764422 2221 2345556778889999999999 7775 99999999
Q ss_pred CcEEecCCCCeEEcccCccccCc
Q 004732 522 TNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 522 ~Nill~~~~~~kl~DfGla~~~~ 544 (733)
.||+++ ++.++|+|||.+....
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4679999999887543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.6e-11 Score=115.49 Aligned_cols=124 Identities=23% Similarity=0.330 Sum_probs=40.2
Q ss_pred CCCCCeeeccccccccccchhcc-CCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccc-cCCCCCCE
Q 004732 40 LTFLQDISLIANRLKGPIPKYLA-NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTF-AKLTNMKD 117 (733)
Q Consensus 40 l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~~ 117 (733)
..+++.|+|++|.|+. +. .++ .+.+|+.|+|++|.|+ .++ .+..+++|+.|+|++|+|+ .+.+.+ ..+++|++
T Consensus 18 ~~~~~~L~L~~n~I~~-Ie-~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 18 PVKLRELNLRGNQIST-IE-NLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--E
T ss_pred cccccccccccccccc-cc-chhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCE
Confidence 3446667777777762 22 344 4566777777777776 333 3666677777777777776 444334 34677777
Q ss_pred EEeeCCccccCC-CccccccCCCCEEEccCCCCccCCCC----CCCCcCCcCeeecc
Q 004732 118 FRISDNQFTGQI-PSFIQNWTKLEKLFIQPSGLAGPIPS----GIFSLENLTDLRIS 169 (733)
Q Consensus 118 L~l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~l~~L~~L~l~ 169 (733)
|+|++|+|...- -..+..+++|+.|+|.+|.++.. +. .+..+++|+.||-.
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~~ 148 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDGQ 148 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETTE
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCCE
Confidence 777777776321 13456667777777777777632 22 34456777777643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.6e-10 Score=105.37 Aligned_cols=131 Identities=21% Similarity=0.290 Sum_probs=101.6
Q ss_pred CcccCCCcccEEEcccCCCcEEEEEEccccC---h-----hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 399 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKS---K-----QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
..+++|+-+.+|.+.+.+ ..+.+|.-..+. + -...+-.+|+.++++++--.|.-.+-+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 468899999999997753 346666432221 1 1123456799999998766666566677788888999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
++|..|.+.+... +..++..+-+-+.-||..| |||+|+.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA--------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888644 3567778888889999997 99999999999998764 99999999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.9e-10 Score=115.13 Aligned_cols=142 Identities=21% Similarity=0.300 Sum_probs=110.1
Q ss_pred CcccCCCcccEEEcccCCCcEEEEEEccccCh-hcHHHHHHHHHHHHhCCCCc--eeeEeeEEEeC---CeEEEEEEccC
Q 004732 399 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPN--LVKLYGCCIEG---NQLLLIYEYLE 472 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~---~~~~lV~e~~~ 472 (733)
+.|+.|..+.||+++..+|+.+++|....... .....+.+|+++++.+++.+ +.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987778999998754322 13457889999999997643 56677776653 25689999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------------
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES------------------------------------------ 510 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------------------------------------------ 510 (733)
|.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 84 GRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 9988765421 25677788888999999999998531
Q ss_pred -----------CCCeecCCCCCCcEEecC--CCCeEEcccCcccc
Q 004732 511 -----------RIKVVHRDIKATNVLLDK--DLNSKISDFGLAKL 542 (733)
Q Consensus 511 -----------~~~ivH~Dik~~Nill~~--~~~~kl~DfGla~~ 542 (733)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 234799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.9e-10 Score=103.47 Aligned_cols=142 Identities=18% Similarity=0.275 Sum_probs=106.5
Q ss_pred ccCcccCCCcccEEEcccCCCcEEEEEE-cccc-------ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 397 TDNNIGEGGFGPVYKGLLADGTAIAVKQ-LSSK-------SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 397 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
...+|-+|+-+.|+++.+. |+...||. +.+. .+-..++..+|++.|.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5578999999999999886 66666664 3222 1223356788999999987656655555677777778999
Q ss_pred EccCC-CCHHHHHHhcCCCCCHHHH-HHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC---eEEcccCcccc
Q 004732 469 EYLEN-NSLARALFEHRLKLDWPTR-RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFGLAKL 542 (733)
Q Consensus 469 e~~~~-gsL~~~l~~~~~~l~~~~~-~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~---~kl~DfGla~~ 542 (733)
||+++ .++.+++......-..+.. ..++..|-+.+.-||..+ ||||||..+||++..++. +.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 4777777644333333333 788999999999999986 999999999999976553 58999999864
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.14 E-value=2.9e-11 Score=113.84 Aligned_cols=138 Identities=20% Similarity=0.283 Sum_probs=45.3
Q ss_pred CCcccccceee--eecccceeeeeccccccccccCCcccc-CCCCCCeeeccccccccccchhccCCCCCCEEEcccccc
Q 004732 1 MVPLNTFLVFH--FWKQKTVNQKRVLKEQNLTGVLPPKLA-ELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQF 77 (733)
Q Consensus 1 ~~p~~~~~~~~--~~~~~~~~~~l~L~~n~l~~~~p~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l 77 (733)
||+++...+-. ...+....++|+|++|.|+.+ +.++ .+.+|+.|+|++|.|+. +. .+..+++|+.|+|++|.|
T Consensus 1 ~~~lt~~~i~~~~~~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I 76 (175)
T PF14580_consen 1 MVRLTANMIEQIAQYNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRI 76 (175)
T ss_dssp -------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS--
T ss_pred Cccccccccccccccccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCC
Confidence 45555444433 223344567788888888743 3455 46778888888888883 33 477778888888888888
Q ss_pred cccCCccc-cCCcCCceeeccCccccccC-CccccCCCCCCEEEeeCCccccCCCc----cccccCCCCEEEc
Q 004732 78 SGELPEEL-GSLLNLEKLHLSSNNFTGEL-PKTFAKLTNMKDFRISDNQFTGQIPS----FIQNWTKLEKLFI 144 (733)
Q Consensus 78 ~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~l 144 (733)
+ .+...+ ..+++|+.|+|++|+|...- -..++.+++|+.|+|.+|.++.. +. .+..+|+|+.||-
T Consensus 77 ~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD~ 147 (175)
T PF14580_consen 77 S-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLDG 147 (175)
T ss_dssp --S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEETT
T ss_pred C-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeCC
Confidence 7 455444 35778888888888876321 24466778888888888887733 32 3567778877764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.4e-09 Score=114.43 Aligned_cols=168 Identities=20% Similarity=0.324 Sum_probs=130.2
Q ss_pred CcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeEEEEEEccCC-CCHHH
Q 004732 405 GFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE----GNQLLLIYEYLEN-NSLAR 478 (733)
Q Consensus 405 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~-gsL~~ 478 (733)
--.+.|++. ..||..|+.|+++.........-..-+++++++.|+|||++.+++.. +..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 457889998 56899999999955433222223446789999999999999998873 4568999999987 46666
Q ss_pred HHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 479 ALFE--------------HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 479 ~l~~--------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
.-+. .+.+.++...|.++.|++.||.++|+.| ..-+-+.+++|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence 5441 2345788999999999999999999997 8889999999999999999999999887655
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSN 593 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p 593 (733)
.+... | + +--.+-|.-.||.+++.|.||...
T Consensus 445 ~d~~~-------------~--l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 445 EDPTE-------------P--L---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCCCc-------------c--h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 54311 0 1 112367888999999999999654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.09 E-value=8.7e-11 Score=126.57 Aligned_cols=246 Identities=21% Similarity=0.156 Sum_probs=174.3
Q ss_pred hhcCccccCcccCCCcccEEEccc--CCCcEEEEEEccccChhcH--HHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL--ADGTAIAVKQLSSKSKQGN--REFINEIGMISAL-QHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 465 (733)
.+.+|.....||.|.|+.||+... .++..|++|.+........ ..-..|+.+...+ .|.++++.+..+..-+..+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 356788899999999999999873 4678999998866432222 2234577666666 5899999888888888888
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC-CCeEEcccCccccCc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAKLDE 544 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfGla~~~~ 544 (733)
+--|||+++++...+ .....++...++++..|++.++.++|+.. ++|+|+||+||++..+ +..+++|||.+....
T Consensus 343 ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred CchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccc
Confidence 999999999887766 34456788899999999999999999875 9999999999999886 778999999986322
Q ss_pred ccCcccccccccCCCcc--cHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 545 EENTHISTRVAGTIGYM--APEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
-. .....++-+++ +++......+..+.|+||||.-+.|.++|..--.... .|.. +..-. .
T Consensus 419 ~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~-----~~~~-------i~~~~--~ 480 (524)
T KOG0601|consen 419 FS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV-----QSLT-------IRSGD--T 480 (524)
T ss_pred ee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc-----ccee-------eeccc--c
Confidence 11 11122233444 4555556678899999999999999998864322211 1110 11100 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
+.... ....+..+.+.....++..||.+.++....+
T Consensus 481 p~~~~---~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 481 PNLPG---LKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred cCCCc---hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11111 1133556677788899999999988766544
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.1e-11 Score=125.05 Aligned_cols=204 Identities=17% Similarity=0.141 Sum_probs=153.6
Q ss_pred cceeeeeccccccccccCC--ccccCCCCCCeeeccccccccc--cchhccCCCCCCEEEcccccccccCCcc-ccCCcC
Q 004732 16 KTVNQKRVLKEQNLTGVLP--PKLAELTFLQDISLIANRLKGP--IPKYLANISTLVNLTVQYNQFSGELPEE-LGSLLN 90 (733)
Q Consensus 16 ~~~~~~l~L~~n~l~~~~p--~~l~~l~~L~~L~L~~n~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~ 90 (733)
...++++.|+++.+. ..+ .-...+++++.|||+.|-+..- +..-...|++|+.|+|+.|++..-.... -..+++
T Consensus 120 ~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 120 LKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred HHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 455778888888776 333 3667889999999999999853 3455678999999999999997332222 346789
Q ss_pred CceeeccCccccccC-CccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCC--CCCCCcCCcCeee
Q 004732 91 LEKLHLSSNNFTGEL-PKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP--SGIFSLENLTDLR 167 (733)
Q Consensus 91 L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p--~~l~~l~~L~~L~ 167 (733)
|+.|.|+.|.|+... ...+..+|+|+.|+|..|...+.-......+..|+.|+|++|++- ..+ ...+.++.|+.|+
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCccc-ccccccccccccchhhhh
Confidence 999999999998533 333557899999999999644344555667889999999999987 344 5678899999999
Q ss_pred cccccCCCCCcccc-------ccccccEEEcccCccCCC-CCccccCCCCCcEEEccCCccc
Q 004732 168 ISDLNGPEATFPQL-------GNMKMTKLILRNCNITGE-LPRYLGKMTKLKVLDLSFNRLR 221 (733)
Q Consensus 168 l~~n~~~~~~~~~~-------~~~~L~~L~l~~n~l~~~-~p~~~~~l~~L~~L~ls~N~l~ 221 (733)
++.+.+.++..... ...+|++|+++.|++..- .-..+..+++|+.|.+..|.|+
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 99999988766554 123799999999999621 1133555667777777777776
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.4e-11 Score=118.50 Aligned_cols=128 Identities=23% Similarity=0.239 Sum_probs=68.1
Q ss_pred CCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEccc
Q 004732 114 NMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRN 193 (733)
Q Consensus 114 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~ 193 (733)
.|++|||++|.|+ .+..+..-++.++.|++++|.|.. + ..+..|++|+.||||+|.+....--....-+++.|.|+.
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL~La~ 361 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTLKLAQ 361 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceee-e-hhhhhcccceEeecccchhHhhhhhHhhhcCEeeeehhh
Confidence 3455555555555 444444444555555555555541 1 124444555555555544443322222222455666777
Q ss_pred CccCCCCCccccCCCCCcEEEccCCcccCCC-CCCcCCCCCCCEEEecCCcccc
Q 004732 194 CNITGELPRYLGKMTKLKVLDLSFNRLRGQI-PSNFDDLYDVDYIYFAGNLLTG 246 (733)
Q Consensus 194 n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~ 246 (733)
|.|... ..++++-+|..||+++|+|...- ...++++|-|+.+.|.+|++.+
T Consensus 362 N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 362 NKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 766522 34666667777777777776321 2356667777777777777763
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1e-11 Score=124.15 Aligned_cols=236 Identities=20% Similarity=0.229 Sum_probs=166.1
Q ss_pred cCCccccCCCCCCeeecccccccc----ccchhccCCCCCCEEEcccc---cccccCCcc-------ccCCcCCceeecc
Q 004732 32 VLPPKLAELTFLQDISLIANRLKG----PIPKYLANISTLVNLTVQYN---QFSGELPEE-------LGSLLNLEKLHLS 97 (733)
Q Consensus 32 ~~p~~l~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~N---~l~~~~p~~-------~~~l~~L~~L~Ls 97 (733)
.+-+.+..+..++.|+|++|-+.. .+...+.+.++|+..++++- .+...+|.+ +-.+++|++|+||
T Consensus 21 ~v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLS 100 (382)
T KOG1909|consen 21 DVEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLS 100 (382)
T ss_pred hHHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeecc
Confidence 344456677888899999998864 24556777888888888864 222344443 4556689999999
Q ss_pred CccccccCCcc----ccCCCCCCEEEeeCCccccCC-------------CccccccCCCCEEEccCCCCccC----CCCC
Q 004732 98 SNNFTGELPKT----FAKLTNMKDFRISDNQFTGQI-------------PSFIQNWTKLEKLFIQPSGLAGP----IPSG 156 (733)
Q Consensus 98 ~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~~~~-------------~~~~~~l~~L~~L~l~~N~l~~~----~p~~ 156 (733)
+|.|....+.. +++++.|+.|+|.||.+.-.- ....+.-+.|+.+...+|++... +...
T Consensus 101 DNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~ 180 (382)
T KOG1909|consen 101 DNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEA 180 (382)
T ss_pred ccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHH
Confidence 99887555443 456788999999999887211 12234567889999999998743 3345
Q ss_pred CCCcCCcCeeecccccCCCCCcc-----ccccccccEEEcccCccCCC----CCccccCCCCCcEEEccCCcccCCCCCC
Q 004732 157 IFSLENLTDLRISDLNGPEATFP-----QLGNMKMTKLILRNCNITGE----LPRYLGKMTKLKVLDLSFNRLRGQIPSN 227 (733)
Q Consensus 157 l~~l~~L~~L~l~~n~~~~~~~~-----~~~~~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 227 (733)
|...+.|+.+.+++|.+...... ...+.+|+.|||.+|-++.. +...+..+++|+.|+++.|.+.......
T Consensus 181 ~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a 260 (382)
T KOG1909|consen 181 FQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIA 260 (382)
T ss_pred HHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHH
Confidence 56678889999999888776552 12234788999999998743 3455777889999999999988655443
Q ss_pred c-----CCCCCCCEEEecCCcccccCC----hhh--hcCCCeeecccCcCC
Q 004732 228 F-----DDLYDVDYIYFAGNLLTGAIP----PWM--LERGDKIDLSYNNFT 267 (733)
Q Consensus 228 ~-----~~l~~L~~L~l~~N~l~~~~p----~~~--l~~l~~l~ls~N~l~ 267 (733)
| ...++|+.|.+.+|.++-.-- .++ .+.|..|++++|.+.
T Consensus 261 ~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 261 FVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 3 236889999999999863211 112 567888999999884
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.3e-11 Score=118.69 Aligned_cols=132 Identities=21% Similarity=0.226 Sum_probs=76.5
Q ss_pred cccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCC
Q 004732 36 KLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 115 (733)
Q Consensus 36 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 115 (733)
.+.....|+.|||++|.|+ .+..+..-++.++.|++|+|.|. .+.. +..|.+|+.||||+|.++ .+-.+-..+-|+
T Consensus 279 ~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~n-La~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 279 SADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQN-LAELPQLQLLDLSGNLLA-ECVGWHLKLGNI 354 (490)
T ss_pred ecchHhhhhhccccccchh-hhhhhhhhccceeEEecccccee-eehh-hhhcccceEeecccchhH-hhhhhHhhhcCE
Confidence 3444555666666666666 55555666666666666666666 3322 666666666666666666 555555556666
Q ss_pred CEEEeeCCccccCCCccccccCCCCEEEccCCCCccC-CCCCCCCcCCcCeeecccccC
Q 004732 116 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP-IPSGIFSLENLTDLRISDLNG 173 (733)
Q Consensus 116 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~l~~l~~L~~L~l~~n~~ 173 (733)
+.|.|+.|.|.. + ..++.+-+|..|++++|+|... --..+++|+.|+.|.|-+|.+
T Consensus 355 KtL~La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl 411 (490)
T KOG1259|consen 355 KTLKLAQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPL 411 (490)
T ss_pred eeeehhhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCc
Confidence 666666666652 1 2245555666666666666521 123455555555555444443
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.8e-11 Score=134.20 Aligned_cols=219 Identities=23% Similarity=0.251 Sum_probs=139.9
Q ss_pred cCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCE
Q 004732 38 AELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKD 117 (733)
Q Consensus 38 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 117 (733)
..+..++.+++..|.|. .+-..+..+++|..|++.+|+|. .+...+..+++|+.|+|++|.|+...+ +..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhh
Confidence 35566777778888887 33445777788888888888887 444447778888888888888874444 666777888
Q ss_pred EEeeCCccccCCCccccccCCCCEEEccCCCCccCCC-CCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCcc
Q 004732 118 FRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP-SGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNI 196 (733)
Q Consensus 118 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l 196 (733)
|++++|.|+ .+. .+..++.|+.+++++|++...-+ . +..+.+|+.+.+..|.+......... ..+..+++..|.+
T Consensus 145 L~l~~N~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i~~~~~~-~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 145 LNLSGNLIS-DIS-GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREIEGLDLL-KKLVLLSLLDNKI 220 (414)
T ss_pred heeccCcch-hcc-CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcccchHHH-HHHHHhhcccccc
Confidence 888888887 333 34557888888888888874333 1 46677777777777776654432111 1233446677777
Q ss_pred CCCCCccccCCC--CCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCeeecccCcCC
Q 004732 197 TGELPRYLGKMT--KLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFT 267 (733)
Q Consensus 197 ~~~~p~~~~~l~--~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~N~l~ 267 (733)
+..-+ +..+. .|+.+++++|++. .++..+..+.++..|++.+|.+...-.......+..+....|.+.
T Consensus 221 ~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 221 SKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEGLERLPKLSELWLNDNKLA 290 (414)
T ss_pred eeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhccccccccccccchHHHhccCcchhc
Confidence 63322 22223 2777888888777 344556667777777777777764433333344444455555443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.3e-10 Score=131.25 Aligned_cols=250 Identities=18% Similarity=0.217 Sum_probs=173.9
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
..-++|.+.+-+-+|+++.++.+. -..|...++|...... +...+...++-.++-..+||.++....-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 345677777888999999999887 3345445555443321 112223333444444456688887666666677889
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
||++|..+++|...++... ..+..-.......+..+.+|||.. .+.|||++|.|++...++..+++|||.....+.
T Consensus 881 L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~ 956 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL 956 (1205)
T ss_pred hhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccccc
Confidence 9999999999999998655 445555566677788999999987 389999999999999999999999984332110
Q ss_pred c------------------------------CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCC
Q 004732 546 E------------------------------NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVT 595 (733)
Q Consensus 546 ~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~ 595 (733)
. .........||+.|.+||...+......+|+|+.|++++|.++|..||.
T Consensus 957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 0 0001223569999999999999999999999999999999999999997
Q ss_pred ccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 004732 596 KEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMS 654 (733)
Q Consensus 596 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ 654 (733)
........+- .--.++ +....+.+......+++..-+..+|.+|-.+.
T Consensus 1037 a~tpq~~f~n-------i~~~~~----~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIFEN-------ILNRDI----PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred Ccchhhhhhc-------cccCCC----CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 7665544321 000111 11112223333466677778889999998877
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=9.9e-12 Score=124.24 Aligned_cols=227 Identities=21% Similarity=0.234 Sum_probs=167.5
Q ss_pred eeeeeccccccccc----cCCccccCCCCCCeeecccccccc----ccc-------hhccCCCCCCEEEcccccccccCC
Q 004732 18 VNQKRVLKEQNLTG----VLPPKLAELTFLQDISLIANRLKG----PIP-------KYLANISTLVNLTVQYNQFSGELP 82 (733)
Q Consensus 18 ~~~~l~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~----~~p-------~~l~~l~~L~~L~L~~N~l~~~~p 82 (733)
...+++|++|-+.. .+-+.+.+.++|+..++++ -++| .+| +.+...++|++||||+|-|.-..+
T Consensus 31 s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd-~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~g~ 109 (382)
T KOG1909|consen 31 SLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD-MFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPKGI 109 (382)
T ss_pred ceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh-hhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCccch
Confidence 35678899998874 4566777888999999876 3443 233 445667799999999999875555
Q ss_pred cc----ccCCcCCceeeccCccccccC-------------CccccCCCCCCEEEeeCCccccCC----CccccccCCCCE
Q 004732 83 EE----LGSLLNLEKLHLSSNNFTGEL-------------PKTFAKLTNMKDFRISDNQFTGQI----PSFIQNWTKLEK 141 (733)
Q Consensus 83 ~~----~~~l~~L~~L~Ls~N~l~~~~-------------p~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~~L~~ 141 (733)
.. +.++++|+.|+|.+|.+.-.- ..-.+.-++|+++...+|++.... ...|...+.|+.
T Consensus 110 ~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~lee 189 (382)
T KOG1909|consen 110 RGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTLEE 189 (382)
T ss_pred HHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhccccce
Confidence 44 466788999999999886211 122345678999999999988422 345677789999
Q ss_pred EEccCCCCccC----CCCCCCCcCCcCeeecccccCCCCCccccc----c-ccccEEEcccCccCCCCCcccc-----CC
Q 004732 142 LFIQPSGLAGP----IPSGIFSLENLTDLRISDLNGPEATFPQLG----N-MKMTKLILRNCNITGELPRYLG-----KM 207 (733)
Q Consensus 142 L~l~~N~l~~~----~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~----~-~~L~~L~l~~n~l~~~~p~~~~-----~l 207 (733)
+.+..|.|... +..++..+++|+.|||.+|-++...-..++ . .+|+.|++++|.+......+|. ..
T Consensus 190 vr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~ 269 (382)
T KOG1909|consen 190 VRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFVDALKESA 269 (382)
T ss_pred EEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHHHHHhccC
Confidence 99999998732 345677899999999999998876543332 1 2689999999999876554433 36
Q ss_pred CCCcEEEccCCcccCC----CCCCcCCCCCCCEEEecCCccc
Q 004732 208 TKLKVLDLSFNRLRGQ----IPSNFDDLYDVDYIYFAGNLLT 245 (733)
Q Consensus 208 ~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 245 (733)
++|+.|.+.+|.|+-. +..+....+.|..|+|++|.+.
T Consensus 270 p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 270 PSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred CCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 8999999999998732 2234455789999999999994
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=5.9e-11 Score=130.16 Aligned_cols=239 Identities=21% Similarity=0.239 Sum_probs=175.1
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
.+.+.+..|.+.. +-..+..+++|..|++.+|+|.. +...+..+++|++|+|++|.|+...+ +..++.|+.|++++
T Consensus 74 l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 74 LKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSG 149 (414)
T ss_pred HHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccccc--hhhccchhhheecc
Confidence 3445577777774 34468889999999999999994 44348889999999999999995544 77888899999999
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCcc-ccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCC
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSF-IQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT 177 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~ 177 (733)
|.|+ .+. .+..+++|+.+++++|++...-+ . ...+.+|+.+++.+|.+. ....+..+..+..+++..|.+....
T Consensus 150 N~i~-~~~-~~~~l~~L~~l~l~~n~i~~ie~-~~~~~~~~l~~l~l~~n~i~--~i~~~~~~~~l~~~~l~~n~i~~~~ 224 (414)
T KOG0531|consen 150 NLIS-DIS-GLESLKSLKLLDLSYNRIVDIEN-DELSELISLEELDLGGNSIR--EIEGLDLLKKLVLLSLLDNKISKLE 224 (414)
T ss_pred Ccch-hcc-CCccchhhhcccCCcchhhhhhh-hhhhhccchHHHhccCCchh--cccchHHHHHHHHhhcccccceecc
Confidence 9998 443 46669999999999999994433 2 578899999999999997 3344555566666688888777655
Q ss_pred ccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCccccc---CCh---
Q 004732 178 FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGA---IPP--- 250 (733)
Q Consensus 178 ~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~---~p~--- 250 (733)
....... +|+.+++++|.+. ..+..+..+..+..|+++.|++... ..+.....+..+....|.+... ...
T Consensus 225 ~l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (414)
T KOG0531|consen 225 GLNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYIT 301 (414)
T ss_pred CcccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccc
Confidence 4322211 4889999999998 4446677889999999999998842 3355566777778888877522 111
Q ss_pred hhhcCCCeeecccCcCCCC
Q 004732 251 WMLERGDKIDLSYNNFTDG 269 (733)
Q Consensus 251 ~~l~~l~~l~ls~N~l~~~ 269 (733)
.-...+..+.+.+|++...
T Consensus 302 ~~~~~~~~~~~~~~~~~~~ 320 (414)
T KOG0531|consen 302 SAAPTLVTLTLELNPIRKI 320 (414)
T ss_pred cccccccccccccCccccc
Confidence 1144556666667766543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=5e-08 Score=100.38 Aligned_cols=256 Identities=14% Similarity=0.179 Sum_probs=155.7
Q ss_pred ccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeE------E-EeCCeEEEEE
Q 004732 397 TDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGC------C-IEGNQLLLIY 468 (733)
Q Consensus 397 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~-~~~~~~~lV~ 468 (733)
..+.||+|+.+.+|-.--- +. -+.|++......... +.++.|.+. .||-+-.-+.+ . ..+....+.|
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d-~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RD-QVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecchh-hc-hhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 4578999999999953211 12 234555543322222 233444444 46654431222 1 1233367888
Q ss_pred EccCCCCHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 469 EYLENNSLARALF------EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 469 e~~~~gsL~~~l~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..+.+.-=-..++ ++....+|....+++..+|.+.+-||+.| .+-+|+.++|+|+.+++.+.+.|-..-.+
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 8887753222232 22335799999999999999999999998 88899999999999999999988655443
Q ss_pred CcccCcccccccccCCCcccHHHHh-----hCCCCccchhHhHHHHHHHHHhC-CCCCCccc-------hh--hHHH--H
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSG-RSNVTKED-------MF--YLLD--W 605 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg-~~p~~~~~-------~~--~~~~--~ 605 (733)
..+... ..--+|...|.+||.-. +..-+...|-|.+||++++++.| +.||.+-. .. .+.. +
T Consensus 167 ~~ng~~--~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f 244 (637)
T COG4248 167 NANGTL--HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRF 244 (637)
T ss_pred ccCCce--EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhccee
Confidence 322211 22235888999999764 33567789999999999999886 89983211 11 1110 0
Q ss_pred HHHHHhhCcccccccCCCCCCCCHHH-HHHHHHHHHHhhcCC--CCCCCCHHHHHHHhccCcccc
Q 004732 606 ALVLKEQGKLMELVDTNPGSNFDKEQ-VMVMINVALLCANAS--PTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~l~~~c~~~~--P~~RPt~~~vl~~L~~~~~~~ 667 (733)
+........ ..+.+ ...+.+. ...+..+..+|+... ++-||+.+.-+..|.+..+.+
T Consensus 245 ~ya~~~~~g----~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 245 AYASDQRRG----LKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred eechhccCC----CCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 000000000 01111 1122221 224566677888653 668999998887776554433
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.3e-08 Score=100.65 Aligned_cols=139 Identities=18% Similarity=0.077 Sum_probs=99.4
Q ss_pred cccCCCcccEEEcccCCCcEEEEEEccccChh-----------cHHHHHHHHHHHHhCCCCce--eeEeeEEEe-----C
Q 004732 400 NIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQ-----------GNREFINEIGMISALQHPNL--VKLYGCCIE-----G 461 (733)
Q Consensus 400 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~ 461 (733)
.+-......|++..+ +|+.|.||........ ....+.+|.+.+.++...+| .+++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 333344445667655 5778999977443211 11247789998888854333 344555543 2
Q ss_pred CeEEEEEEccCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC-------CCCe
Q 004732 462 NQLLLIYEYLENN-SLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-------DLNS 532 (733)
Q Consensus 462 ~~~~lV~e~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-------~~~~ 532 (733)
...++|+|++++. +|.+++... ....+...+..++.+++..+.-||..| |+|+|++++|||++. ++.+
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~ 184 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKL 184 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceE
Confidence 3578999999986 898887532 234556678899999999999999997 999999999999985 4679
Q ss_pred EEcccCcccc
Q 004732 533 KISDFGLAKL 542 (733)
Q Consensus 533 kl~DfGla~~ 542 (733)
.++||+.++.
T Consensus 185 ~LIDl~r~~~ 194 (268)
T PRK15123 185 SVIDLHRAQI 194 (268)
T ss_pred EEEECCcccc
Confidence 9999998853
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.4e-09 Score=82.86 Aligned_cols=59 Identities=34% Similarity=0.558 Sum_probs=28.6
Q ss_pred CCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCc
Q 004732 66 TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 124 (733)
Q Consensus 66 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 124 (733)
+|++|+|++|+++...+..|..+++|++|+|++|+|+...|..|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34455555555543333444455555555555555544444444555555555555544
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=1.5e-08 Score=97.11 Aligned_cols=125 Identities=23% Similarity=0.290 Sum_probs=82.6
Q ss_pred cEEEcccCCCcEEEEEEccccC-------------h--------h-----cHHHHHHHHHHHHhCCCCc--eeeEeeEEE
Q 004732 408 PVYKGLLADGTAIAVKQLSSKS-------------K--------Q-----GNREFINEIGMISALQHPN--LVKLYGCCI 459 (733)
Q Consensus 408 ~Vy~~~~~~~~~vavK~~~~~~-------------~--------~-----~~~~~~~E~~~l~~l~h~n--iv~l~~~~~ 459 (733)
.||.|...+|..+|||...... . . ......+|++.|.++..-+ +.+++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998889999999874320 0 0 0134567999999998664 44555442
Q ss_pred eCCeEEEEEEccC--CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HcCCCCCeecCCCCCCcEEecCCCCeEEcc
Q 004732 460 EGNQLLLIYEYLE--NNSLARALFEHRLKLDWPTRRRICLGIARGLAYL-HGESRIKVVHRDIKATNVLLDKDLNSKISD 536 (733)
Q Consensus 460 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~ivH~Dik~~Nill~~~~~~kl~D 536 (733)
...+||||++ |..+..+.... ++......++.+++..+..+ |..| |+|||+.+.||+++++ .+.|+|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 3479999999 65555443211 12455677888888866664 6775 9999999999999988 899999
Q ss_pred cCccccC
Q 004732 537 FGLAKLD 543 (733)
Q Consensus 537 fGla~~~ 543 (733)
||.+...
T Consensus 150 f~qav~~ 156 (188)
T PF01163_consen 150 FGQAVDS 156 (188)
T ss_dssp GTTEEET
T ss_pred cCcceec
Confidence 9988643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.81 E-value=3.2e-09 Score=82.19 Aligned_cols=61 Identities=30% Similarity=0.454 Sum_probs=52.1
Q ss_pred CCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccc
Q 004732 41 TFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNF 101 (733)
Q Consensus 41 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 101 (733)
++|++|+|++|+|+...+..|.++++|++|++++|.++...|..|..+++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 5788899999999866667888899999999999999877777889999999999998875
|
... |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.70 E-value=9.1e-08 Score=94.05 Aligned_cols=133 Identities=23% Similarity=0.254 Sum_probs=96.4
Q ss_pred cccCcccCCCcccEEEcccCCCcEEEEEEccccCh----------------------hcHHHHHHHHHHHHhCCCC--ce
Q 004732 396 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK----------------------QGNREFINEIGMISALQHP--NL 451 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~~l~~l~h~--ni 451 (733)
.+.+.||.|--+.||.|..+.|.++|||.-..... .......+|.++|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 45689999999999999999999999996432100 0113456789999998654 55
Q ss_pred eeEeeEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC
Q 004732 452 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 531 (733)
Q Consensus 452 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 531 (733)
.+.+++ +...+||||++|-.|... +++....-.++..|++-+.-+-..| |||+|+.+-||+++++|.
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCcccc----ccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecCCC
Confidence 555544 567899999999665442 2234444555555555555555555 999999999999999999
Q ss_pred eEEcccCccc
Q 004732 532 SKISDFGLAK 541 (733)
Q Consensus 532 ~kl~DfGla~ 541 (733)
+.++||-.+.
T Consensus 241 ~~vIDwPQ~v 250 (304)
T COG0478 241 IVVIDWPQAV 250 (304)
T ss_pred EEEEeCcccc
Confidence 9999997654
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=4.1e-08 Score=115.21 Aligned_cols=200 Identities=20% Similarity=0.247 Sum_probs=138.4
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccc--cccccchhccCCCCCCEEEcccccccccCCccccCCcCCceee
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANR--LKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 95 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~--l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 95 (733)
..+...+.+|++. .++.... .++|+.|-+..|. +.......|..++.|+.|||++|.=-+.+|..+++|-+|++|+
T Consensus 524 ~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~ 601 (889)
T KOG4658|consen 524 SVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLD 601 (889)
T ss_pred heeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccc
Confidence 3455666666665 3333332 3479999999996 5644455688899999999998876679999999999999999
Q ss_pred ccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCC--ccCCCCCCCCcCCcCeeecccccC
Q 004732 96 LSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL--AGPIPSGIFSLENLTDLRISDLNG 173 (733)
Q Consensus 96 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l--~~~~p~~l~~l~~L~~L~l~~n~~ 173 (733)
|++..++ .+|..+.+|..|.+|++..+.-...+|.....+++|++|.+..-.. ....-..+.++.+|+.|.......
T Consensus 602 L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~ 680 (889)
T KOG4658|consen 602 LSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV 680 (889)
T ss_pred ccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh
Confidence 9999999 9999999999999999998887666778788899999999876542 223344555566666665543332
Q ss_pred CCCCccccccccc----cEEEcccCccCCCCCccccCCCCCcEEEccCCcccC
Q 004732 174 PEATFPQLGNMKM----TKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG 222 (733)
Q Consensus 174 ~~~~~~~~~~~~L----~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 222 (733)
.......+..+| ..+.+..+... ..+..++.+.+|+.|.+.++.+..
T Consensus 681 -~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e 731 (889)
T KOG4658|consen 681 -LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISE 731 (889)
T ss_pred -HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCch
Confidence 111111111122 23333333333 445667888888999888888763
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=8e-10 Score=119.83 Aligned_cols=126 Identities=22% Similarity=0.198 Sum_probs=70.7
Q ss_pred CCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccC
Q 004732 115 MKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNC 194 (733)
Q Consensus 115 L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n 194 (733)
|.+.+++.|.+. ....++.-++.|+.|+|++|+++..- .+..|+.|+.|||++|.+...+--....++|..|.+++|
T Consensus 166 L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~lrnN 242 (1096)
T KOG1859|consen 166 LATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNLRNN 242 (1096)
T ss_pred HhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhhheeeeeccc
Confidence 344444444444 33334444444444444444444211 333344444444444444444333334456788888888
Q ss_pred ccCCCCCccccCCCCCcEEEccCCcccCCCC-CCcCCCCCCCEEEecCCccc
Q 004732 195 NITGELPRYLGKMTKLKVLDLSFNRLRGQIP-SNFDDLYDVDYIYFAGNLLT 245 (733)
Q Consensus 195 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~ 245 (733)
.++.. ..+.++.+|..||+++|-|.+--. ..+..+..|..|+|.+|++.
T Consensus 243 ~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 243 ALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred HHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 88743 347788889999999998875321 23445566777777777775
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.6e-08 Score=116.86 Aligned_cols=128 Identities=20% Similarity=0.293 Sum_probs=102.9
Q ss_pred eeeeecccccc--ccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceee
Q 004732 18 VNQKRVLKEQN--LTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 95 (733)
Q Consensus 18 ~~~~l~L~~n~--l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 95 (733)
.+..|.+.+|. +....++.|..++.|++|||++|.=-+.+|..+++|-+|++|+|++..++ .+|..|++|.+|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 46677788876 55555666888999999999998777799999999999999999999999 9999999999999999
Q ss_pred ccCccccccCCccccCCCCCCEEEeeCCccc--cCCCccccccCCCCEEEccC
Q 004732 96 LSSNNFTGELPKTFAKLTNMKDFRISDNQFT--GQIPSFIQNWTKLEKLFIQP 146 (733)
Q Consensus 96 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~L~l~~ 146 (733)
+..+.-...+|..+..+++|++|.+..-... ...-..+.++.+|+.|....
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~ 677 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITI 677 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeec
Confidence 9998876677888888999999999766522 22333445556666555533
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.8e-09 Score=93.89 Aligned_cols=104 Identities=20% Similarity=0.329 Sum_probs=46.7
Q ss_pred CCeeeccccccccccchh---ccCCCCCCEEEcccccccccCCccccCCc-CCceeeccCccccccCCccccCCCCCCEE
Q 004732 43 LQDISLIANRLKGPIPKY---LANISTLVNLTVQYNQFSGELPEELGSLL-NLEKLHLSSNNFTGELPKTFAKLTNMKDF 118 (733)
Q Consensus 43 L~~L~L~~n~l~~~~p~~---l~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 118 (733)
+..++|++|.|- -+++. +.....|+..+|++|.+. .+|..|.... .++.|+|++|.|+ .+|..++.++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 444555555544 22222 223333444455555554 4444443332 4445555555554 444445555555555
Q ss_pred EeeCCccccCCCccccccCCCCEEEccCCCCc
Q 004732 119 RISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 150 (733)
Q Consensus 119 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 150 (733)
+++.|.|. ..|.-+..+.+|..|+..+|.+.
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~ 136 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA 136 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccc
Confidence 55555544 33433444444444444444443
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=5.3e-07 Score=88.80 Aligned_cols=123 Identities=23% Similarity=0.233 Sum_probs=91.5
Q ss_pred CCcEEEEEEcccc-C------hhcHHHHHHHHHHHHhCCCCc--eeeEeeEEEeC----CeEEEEEEccCCC-CHHHHHH
Q 004732 416 DGTAIAVKQLSSK-S------KQGNREFINEIGMISALQHPN--LVKLYGCCIEG----NQLLLIYEYLENN-SLARALF 481 (733)
Q Consensus 416 ~~~~vavK~~~~~-~------~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~----~~~~lV~e~~~~g-sL~~~l~ 481 (733)
.++.+.+|..... . ........+|...+..+.... ..+.+++.... ...++|+|++++. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 3556666654321 1 123356788888888875433 34566665542 2458999999985 7998886
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC---CeEEcccCcccc
Q 004732 482 EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSKISDFGLAKL 542 (733)
Q Consensus 482 ~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl~DfGla~~ 542 (733)
... ..+......++.++++.++-||+.| |+|+|++++|||++.+. .+.++||+-++.
T Consensus 111 ~~~-~~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 111 QWE-QLDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred hhc-ccchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 533 2667788999999999999999997 99999999999999887 799999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.3e-06 Score=84.30 Aligned_cols=138 Identities=17% Similarity=0.183 Sum_probs=103.6
Q ss_pred CcccCCCcccEEEcccCCCcEEEEEEcccc---C---hhcHHHHHHHHHHHHhCCCCc--eeeEeeEEE-e----CCeEE
Q 004732 399 NNIGEGGFGPVYKGLLADGTAIAVKQLSSK---S---KQGNREFINEIGMISALQHPN--LVKLYGCCI-E----GNQLL 465 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---~---~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~----~~~~~ 465 (733)
---|+||.+.|++..+. |+.+-+|+-... + +.+...|.+|...|.++..-+ +.+++ ++. . ....+
T Consensus 24 pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 24 PNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred CCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 34577999999987765 446888876421 1 346688999999999986422 44444 332 1 12468
Q ss_pred EEEEccCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC--eEEcccCccc
Q 004732 466 LIYEYLEN-NSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN--SKISDFGLAK 541 (733)
Q Consensus 466 lV~e~~~~-gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~--~kl~DfGla~ 541 (733)
||+|-+++ -+|.+++.+. ..+.+...+..++.++++.++-||+.| +.|+|+.+.||+++.++. ++++||--++
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 99997764 5898888643 235677788999999999999999997 999999999999986666 9999997665
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.50 E-value=3.8e-08 Score=107.81 Aligned_cols=150 Identities=19% Similarity=0.337 Sum_probs=101.1
Q ss_pred HHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc--------ccccccCCCcccHHHHhh
Q 004732 497 LGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI--------STRVAGTIGYMAPEYAMR 568 (733)
Q Consensus 497 ~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 568 (733)
.+++.|+.|+|... ++||++|.|++|.+++.+..||+.|+++.......... ..-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 35569999999864 79999999999999999999999999886443311111 111223558999999999
Q ss_pred CCCCccchhHhHHHHHHHHHhCCCCC-CccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCC
Q 004732 569 GHLTEKADVYSFGIVALEIVSGRSNV-TKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASP 647 (733)
Q Consensus 569 ~~~~~~~Dv~s~Gvil~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P 647 (733)
...+.++|+||+||++|.+..|..+. ...+........ ...+......+..+...++.+-+.+.+..++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~----------~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~ 253 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS----------RNLLNAGAFGYSNNLPSELRESLKKLLNGDS 253 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh----------hcccccccccccccCcHHHHHHHHHHhcCCc
Confidence 88999999999999999998554444 332211111100 0011111111222233447777788999999
Q ss_pred CCCCCHHHHHH
Q 004732 648 TIRPSMSSVLR 658 (733)
Q Consensus 648 ~~RPt~~~vl~ 658 (733)
.-||++.++..
T Consensus 254 ~~rp~~~~l~~ 264 (700)
T KOG2137|consen 254 AVRPTLDLLLS 264 (700)
T ss_pred ccCcchhhhhc
Confidence 99998888744
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=7.3e-09 Score=90.13 Aligned_cols=131 Identities=20% Similarity=0.248 Sum_probs=66.5
Q ss_pred CCEEEcccccccccCCccc---cCCcCCceeeccCccccccCCccccC-CCCCCEEEeeCCccccCCCccccccCCCCEE
Q 004732 67 LVNLTVQYNQFSGELPEEL---GSLLNLEKLHLSSNNFTGELPKTFAK-LTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 142 (733)
Q Consensus 67 L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 142 (733)
+..|+|+++++. .+++.. ....+|+..+|++|.|. ..|+.|.. .+.++.|+|++|+|+ .+|..+..++.|+.|
T Consensus 29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l 105 (177)
T KOG4579|consen 29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL 105 (177)
T ss_pred hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence 445555555554 344332 22334455566666665 44444433 335566666666665 555556666666666
Q ss_pred EccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCC
Q 004732 143 FIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELP 201 (733)
Q Consensus 143 ~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p 201 (733)
+++.|.|. ..|..+..|.+|..|+..+|-...++...+-....-..++.++.+.+.-+
T Consensus 106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~eid~dl~~s~~~al~~lgnepl~~~~~ 163 (177)
T KOG4579|consen 106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARAEIDVDLFYSSLPALIKLGNEPLGDETK 163 (177)
T ss_pred ccccCccc-cchHHHHHHHhHHHhcCCCCccccCcHHHhccccHHHHHhcCCcccccCc
Confidence 66666665 45555555555555555555555554443322222222334444554443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.4e-06 Score=85.26 Aligned_cols=138 Identities=16% Similarity=0.227 Sum_probs=85.5
Q ss_pred CcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCce--eeEeeEEEeCCeEEEEEEccCCCC-
Q 004732 399 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL--VKLYGCCIEGNQLLLIYEYLENNS- 475 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~lV~e~~~~gs- 475 (733)
..||+|..+.||+. .|..+++|...... ......+|.++++.+..-.+ .+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47899999999984 25567888876533 23456889999998864444 567777777778889999999963
Q ss_pred HHHHH---------------------HhcC-CCCCHHHHHH-HHH----------HHHH-HHHHHHcC-CCCCeecCCCC
Q 004732 476 LARAL---------------------FEHR-LKLDWPTRRR-ICL----------GIAR-GLAYLHGE-SRIKVVHRDIK 520 (733)
Q Consensus 476 L~~~l---------------------~~~~-~~l~~~~~~~-i~~----------~ia~-~l~~LH~~-~~~~ivH~Dik 520 (733)
+...+ |.-. ...+...... +.. .+.+ ...+|... ....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 1100 0111111100 000 0001 12222211 12346899999
Q ss_pred CCcEEecCCCCeEEcccCcccc
Q 004732 521 ATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 521 ~~Nill~~~~~~kl~DfGla~~ 542 (733)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998763
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=9.9e-07 Score=97.32 Aligned_cols=141 Identities=16% Similarity=0.253 Sum_probs=94.1
Q ss_pred CcccCCCcccEEEcccCCCcEEEEEEccccChhc----------------------------------------HHHHHH
Q 004732 399 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQG----------------------------------------NREFIN 438 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~~ 438 (733)
+.|+.++-|.||+|++++|+.||||+....-... +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999875431100 012344
Q ss_pred HHHHHHhCC-----CCceeeEeeEE-EeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHH-HHHHHcCCC
Q 004732 439 EIGMISALQ-----HPNLVKLYGCC-IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARG-LAYLHGESR 511 (733)
Q Consensus 439 E~~~l~~l~-----h~niv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~-l~~LH~~~~ 511 (733)
|...+.+++ .+++ ++=.+| .-.....|+|||++|-.+.+...-.....+. ..++..++++ +..+=..|
T Consensus 211 EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~f~~q~~~dg- 285 (517)
T COG0661 211 EAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRAFLRQLLRDG- 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHHHHHHHHhcC-
Confidence 555555553 2333 222223 2346678999999999998875422234553 3333333332 22222233
Q ss_pred CCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 512 ~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
+.|.|.+|.||+++.++++.+.|||+.....+.
T Consensus 286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred --ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999998765543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 733 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-67 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-65 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 8e-56 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-55 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-41 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-41 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-40 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-38 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-26 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-26 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-26 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-25 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-25 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-24 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-24 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-23 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-23 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-23 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-23 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-23 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-23 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 5e-23 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-23 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-23 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-23 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-23 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-23 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-23 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-23 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 6e-23 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-23 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-23 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-23 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-23 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-23 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-23 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-23 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-22 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-22 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-22 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-22 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-22 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-22 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-22 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-22 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-22 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-22 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-22 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 9e-22 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-21 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-21 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-21 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-21 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-21 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-21 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-21 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-21 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-21 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-21 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-21 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 9e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-20 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 8e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 9e-20 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-19 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-19 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-19 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-19 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-19 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-19 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-19 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 4e-19 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-19 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-19 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-19 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-19 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-19 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-19 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-19 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-19 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 6e-19 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-19 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-19 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-19 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 6e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-19 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-19 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 6e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 7e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 8e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-19 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-18 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-18 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-18 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-18 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-18 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-18 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-18 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-18 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-18 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 2e-18 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-18 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-18 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-18 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-18 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 3e-18 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-18 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-18 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-18 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-18 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-18 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 6e-18 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-18 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-18 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-18 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-18 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-17 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-17 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-17 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-17 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-17 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-17 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-17 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-17 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-17 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-17 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 5e-17 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-17 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 5e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-17 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 6e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 6e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-17 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 8e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 8e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 9e-17 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 9e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-16 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-16 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-16 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-16 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-16 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-16 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-16 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-16 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-16 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 3e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-16 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-16 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-16 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-16 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 8e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-15 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-15 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-15 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-15 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-15 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-15 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-15 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 4e-15 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-15 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 5e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-15 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-15 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 5e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 6e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 6e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 6e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 6e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-15 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 8e-15 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-14 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-14 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-14 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-14 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-14 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 4e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-14 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-14 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 9e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-14 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 9e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 9e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 9e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-13 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-13 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-13 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-13 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-13 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 9e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-12 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-12 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-12 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-12 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-12 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-12 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-12 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 2e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-12 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-12 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-12 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 2e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-12 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-12 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-12 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-12 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 9e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-11 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-11 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-11 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 5e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 5e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 6e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 6e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 6e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 7e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 7e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 8e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 8e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 8e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-09 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-09 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-09 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-09 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-09 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 8e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 8e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 8e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 9e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-08 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-08 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-08 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-08 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 7e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 7e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 8e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 9e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-07 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 4e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 4e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-07 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 3e-06 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-06 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-06 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 6e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-05 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-05 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-05 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 2e-05 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 4e-05 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 4e-05 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 4e-05 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 4e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-05 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 5e-05 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-05 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 510 bits (1317), Expect = e-178
Identities = 131/293 (44%), Positives = 187/293 (63%), Gaps = 10/293 (3%)
Query: 385 YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN-REFINEIGMI 443
+++ A++NF+ N +G GGFG VYKG LADGT +AVK+L + QG +F E+ MI
Sbjct: 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI 81
Query: 444 SALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIA 500
S H NL++L G C+ + LL+Y Y+ N S+A L E + LDWP R+RI LG A
Sbjct: 82 SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 501 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 560
RGLAYLH K++HRD+KA N+LLD++ + + DFGLAKL + ++TH++T V GTIG+
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGH 201
Query: 561 MAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV-----TKEDMFYLLDWALVLKEQGKL 615
+APEY G +EK DV+ +G++ LE+++G+ +D LLDW L ++ KL
Sbjct: 202 IAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261
Query: 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLD 668
LVD + N+ E+V +I VALLC +SP RP MS V+RMLE G + +
Sbjct: 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE-GDGLAE 313
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 456 bits (1175), Expect = e-157
Identities = 120/284 (42%), Positives = 174/284 (61%), Gaps = 10/284 (3%)
Query: 385 YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMIS 444
+ ++ ATNNF IG G FG VYKG+L DG +A+K+ + +S QG EF EI +S
Sbjct: 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLS 90
Query: 445 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIAR 501
+HP+LV L G C E N+++LIY+Y+EN +L R L+ + + W R IC+G AR
Sbjct: 91 FCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 502 GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL-DEEENTHISTRVAGTIGY 560
GL YLH + ++HRD+K+ N+LLD++ KI+DFG++K E + TH+ST V GT+GY
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207
Query: 561 MAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK---EDMFYLLDWALVLKEQGKLME 617
+ PEY ++G LTEK+DVYSFG+V E++ RS + + +M L +WA+ G+L +
Sbjct: 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267
Query: 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+VD N E + + A+ C S RPSM VL LE
Sbjct: 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 451 bits (1162), Expect = e-155
Identities = 106/292 (36%), Positives = 164/292 (56%), Gaps = 21/292 (7%)
Query: 385 YLQIKAATNNF------ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSS----KSKQGNR 434
+ ++K TNNF N +GEGGFG VYKG + + T +AVK+L++ +++ +
Sbjct: 17 FYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQ 75
Query: 435 EFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALF--EHRLKLDWPTR 492
+F EI +++ QH NLV+L G +G+ L L+Y Y+ N SL L + L W R
Sbjct: 76 QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMR 135
Query: 493 RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL-DEEENTHIS 551
+I G A G+ +LH I HRDIK+ N+LLD+ +KISDFGLA+ ++ T ++
Sbjct: 136 CKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192
Query: 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV-TKEDMFYLLDWAL-VL 609
+R+ GT YMAPE +RG +T K+D+YSFG+V LEI++G V + LLD +
Sbjct: 193 SRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIE 251
Query: 610 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
E+ + + +D + D V M +VA C + RP + V ++L+
Sbjct: 252 DEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 5e-88
Identities = 69/300 (23%), Positives = 114/300 (38%), Gaps = 30/300 (10%)
Query: 388 IKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ 447
+ + G FG V+K L +AVK + KQ + E+ + ++
Sbjct: 19 LYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYSLPGMK 76
Query: 448 HPNLVKLYGCCIEGN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 503
H N+++ G G L LI + E SL+ L + W I +ARGL
Sbjct: 77 HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGL 134
Query: 504 AYLH-------GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVA 555
AYLH + + HRDIK+ NVLL +L + I+DFGLA + ++ +
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194
Query: 556 GTIGYMAPEYAMRGHL-----TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK 610
GT YMAPE + D+Y+ G+V E+ S + Y+L + +
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254
Query: 611 EQGKLMELVDTN---------PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ L ++ + + ++ C + R S V +
Sbjct: 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 1e-73
Identities = 73/310 (23%), Positives = 117/310 (37%), Gaps = 45/310 (14%)
Query: 391 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINE--IGMISALQH 448
+N IG G +G VYKG L D +AVK S ++Q FINE I + ++H
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEH 66
Query: 449 PNLVKLYGCCIEGN-----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 503
N+ + + LL+ EY N SL + L DW + R+ + RGL
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL--SLHTSDWVSSCRLAHSVTRGL 124
Query: 504 AYLHGE------SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL-------DEEENTHI 550
AYLH E + + HRD+ + NVL+ D ISDFGL+ E +
Sbjct: 125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNA 184
Query: 551 STRVAGTIGYMAPEYAM-------RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF--Y 601
+ GTI YMAPE ++ D+Y+ G++ EI +++ + Y
Sbjct: 185 AISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEY 244
Query: 602 LLDWALVLKEQGKLMELVDT----------NPGSNFDKEQVMVMINVALLCANASPTIRP 651
+ + + ++ + V + C + R
Sbjct: 245 QMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARL 304
Query: 652 SMSSVLRMLE 661
+ +
Sbjct: 305 TAQXAEERMA 314
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 3e-65
Identities = 77/268 (28%), Positives = 127/268 (47%), Gaps = 25/268 (9%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLYGCC 458
IG G FG V++ G+ +AVK L + EF+ E+ ++ L+HPN+V G
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 459 IEGNQLLLIYEYLENNSLARALFEH--RLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+ L ++ EYL SL R L + R +LD R + +A+G+ YLH + +VH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVH 162
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
R++K+ N+L+DK K+ DFGL++L + S AGT +MAPE EK+D
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 577 VYSFGIVALEIVSGR---SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633
VYSFG++ E+ + + N+ + + K +E+
Sbjct: 222 VYSFGVILWELATLQQPWGNLN------PAQVVAAVGFKCKRLEIPRNLNPQ-------- 267
Query: 634 VMINVALLCANASPTIRPSMSSVLRMLE 661
+ + C P RPS ++++ +L
Sbjct: 268 -VAAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 6e-65
Identities = 79/279 (28%), Positives = 136/279 (48%), Gaps = 38/279 (13%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGN-------REFINEIGMISALQHPNLV 452
IG+GGFG V+KG L+ D + +A+K L +G +EF E+ ++S L HPN+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
KLYG N ++ E++ L L + + W + R+ L IA G+ Y+ ++
Sbjct: 87 KLYGLMH--NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP- 143
Query: 513 KVVHRDIKATNVLLDK-----DLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE--Y 565
+VHRD+++ N+ L + +K++DFGL++ ++ H + + G +MAPE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAPETIG 199
Query: 566 AMRGHLTEKADVYSFGIVALEIVSGR---SNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622
A TEKAD YSF ++ I++G + + ++ + E+G + +
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI--NMIR--EEGLRPTIPEDC 255
Query: 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
P + NV LC + P RP S +++ L
Sbjct: 256 PPR---------LRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 1e-64
Identities = 74/276 (26%), Positives = 123/276 (44%), Gaps = 36/276 (13%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQL----SSKSKQGNREFINEIGMISALQHPNLVKLYG 456
IG GGFG VY+ G +AVK Q E + + L+HPN++ L G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
C++ L L+ E+ L R L ++ + IARG+ YLH E+ + ++H
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVL--SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131
Query: 517 RDIKATNVLLDKDLNS--------KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 568
RD+K++N+L+ + + + KI+DFGLA+ E T + AG +MAPE
Sbjct: 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSA-AGAYAWMAPEVIRA 188
Query: 569 GHLTEKADVYSFGIVALEIVSGR---SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625
++ +DV+S+G++ E+++G + L A + + + T P
Sbjct: 189 SMFSKGSDVWSYGVLLWELLTGEVPFRGID------GLAVAYGVAMNKLALPIPSTCPEP 242
Query: 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ C N P RPS +++L L
Sbjct: 243 ---------FAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-64
Identities = 76/264 (28%), Positives = 123/264 (46%), Gaps = 23/264 (8%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
+G G FG V K +A+KQ+ +S+ + FI E+ +S + HPN+VKLYG C+
Sbjct: 16 VGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGACL- 71
Query: 461 GNQLLLIYEYLENNSLARAL--FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
N + L+ EY E SL L E CL ++G+AYLH ++HRD
Sbjct: 72 -NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD 130
Query: 519 IKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 577
+K N+LL KI DFG A + T G+ +MAPE + +EK DV
Sbjct: 131 LKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDV 186
Query: 578 YSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMIN 637
+S+GI+ E+++ R +++ + G L+ P + +
Sbjct: 187 FSWGIILWEVITRR--KPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKP---------IES 235
Query: 638 VALLCANASPTIRPSMSSVLRMLE 661
+ C + P+ RPSM +++++
Sbjct: 236 LMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-64
Identities = 71/275 (25%), Positives = 113/275 (41%), Gaps = 28/275 (10%)
Query: 401 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G+G FG K G + +K+L ++ R F+ E+ ++ L+HPN++K G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
+ +L I EY++ +L + + W R IA G+AYLH + ++HRD+
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDL 134
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTH-------------ISTRVAGTIGYMAPEYA 566
+ N L+ ++ N ++DFGLA+L +E T V G +MAPE
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 567 MRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626
EK DV+SFGIV EI+ D + P
Sbjct: 195 NGRSYDEKVDVFSFGIVLCEIIGRV--NADPDYLPRTMDFGLNVRGFLDRYCPPNCP--- 249
Query: 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ + C + P RPS + LE
Sbjct: 250 ------PSFFPITVRCCDLDPEKRPSFVKLEHWLE 278
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-63
Identities = 76/268 (28%), Positives = 123/268 (45%), Gaps = 22/268 (8%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
IG G FG VYKG A+ + +++ + Q + F NE+G++ +H N++ G
Sbjct: 32 IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 461 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 520
L ++ ++ E +SL L K + I ARG+ YLH ++HRD+K
Sbjct: 92 PQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLK 147
Query: 521 ATNVLLDKDLNSKISDFGLAKL-DEEENTHISTRVAGTIGYMAPE---YAMRGHLTEKAD 576
+ N+ L +D KI DFGLA +H +++G+I +MAPE + ++D
Sbjct: 148 SNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSD 207
Query: 577 VYSFGIVALEIVSGR---SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633
VY+FGIV E+++G+ SN+ D + +G L + SN K
Sbjct: 208 VYAFGIVLYELMTGQLPYSNINNRDQII---EMV---GRGSLSPDLSKVR-SNCPKRMKR 260
Query: 634 VMINVALLCANASPTIRPSMSSVLRMLE 661
+M C RPS +L +E
Sbjct: 261 LM----AECLKKKRDERPSFPRILAEIE 284
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 4e-62
Identities = 70/290 (24%), Positives = 117/290 (40%), Gaps = 36/290 (12%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINE--IGMISALQHPNLVKLYGCC 458
+G+G +G V++G G +AVK SS + + + E + L+H N++
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 459 IEGN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE----- 509
+ QL LI Y E SL L LD + RI L IA GLA+LH E
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI---STRVAGTIGYMAPE-- 564
+ + HRD+K+ N+L+ K+ I+D GLA + + + + GT YMAPE
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVL 189
Query: 565 ----YAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620
++ D+++FG+V E+ R Y + V+ ++
Sbjct: 190 DETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248
Query: 621 ---------TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
P F + + + C +P+ R + + + L
Sbjct: 249 VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-61
Identities = 69/290 (23%), Positives = 111/290 (38%), Gaps = 36/290 (12%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINE--IGMISALQHPNLVKLYGCC 458
IG+G +G V+ G G +AVK + + E I ++H N++
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 459 IEGN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE----- 509
I+G QL LI +Y EN SL L LD + ++ GL +LH E
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI---STRVAGTIGYMAPE-- 564
+ + HRD+K+ N+L+ K+ I+D GLA + + GT YM PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 565 ----YAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620
AD+YSFG++ E+ R Y L + ++ ++ +
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYHDLVPSDPSYEDMRE 277
Query: 621 ---------TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ P E + M + C +P R + V + L
Sbjct: 278 IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 5e-61
Identities = 56/273 (20%), Positives = 113/273 (41%), Gaps = 36/273 (13%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCC 458
+ E G ++KG G I VK L + S + +R+F E + HPN++ + G C
Sbjct: 18 LNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 459 IE--GNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
LI ++ SL L E +D + L +ARG+A+LH + +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL-IP 135
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG----HL 571
+ + +V++D+D+ ++IS + + S ++APE A++
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPE-ALQKKPEDTN 188
Query: 572 TEKADVYSFGIVALEIVSGR---SNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628
AD++SF ++ E+V+ ++++ ++ + + +G +
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLS------NMEIGMKVALEGLRPTIPPGISPH--- 239
Query: 629 KEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ + +C N P RP ++ +LE
Sbjct: 240 ------VSKLMKICMNEDPAKRPKFDMIVPILE 266
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 5e-61
Identities = 60/279 (21%), Positives = 111/279 (39%), Gaps = 39/279 (13%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLYGCC 458
IG+G FG VY G G +A++ + + + + F E+ +H N+V G C
Sbjct: 41 IGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
+ L +I + +L + + ++ LD R+I I +G+ YLH + ++H+D
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKD 155
Query: 519 IKATNVLLDKDLNSKISDFGLAKL----DEEENTHISTRVAGTIGYMAPE---------Y 565
+K+ NV D I+DFGL + G + ++APE
Sbjct: 156 LKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTE 214
Query: 566 AMRGHLTEKADVYSFGIVALEIVSGR---SNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622
+ ++ +DV++ G + E+ + E + + + G L
Sbjct: 215 EDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-------GTGMKPNL---- 263
Query: 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
KE ++ L C RP+ + ++ MLE
Sbjct: 264 SQIGMGKEISDIL----LFCWAFEQEERPTFTKLMDMLE 298
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 3e-59
Identities = 76/291 (26%), Positives = 123/291 (42%), Gaps = 38/291 (13%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINE--IGMISALQHPNLVKLYGCC 458
IG+G FG V++G G +AVK SS + R + E I L+H N++
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 459 IEGN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE----- 509
+ N QL L+ +Y E+ SL L +R + ++ L A GLA+LH E
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI---STRVAGTIGYMAPEYA 566
+ + HRD+K+ N+L+ K+ I+D GLA + I GT YMAPE
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE-V 222
Query: 567 MRGHL-------TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 619
+ + ++AD+Y+ G+V EI R ++ Y L + ++ + E+
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281
Query: 620 D---------TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
P E + VM + C A+ R + + + L
Sbjct: 282 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-54
Identities = 83/253 (32%), Positives = 129/253 (50%), Gaps = 19/253 (7%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPK-YLANISTLVNLTVQYNQFSGELPEELG 86
+ G +PP + L+ ++L +N G +P L + L L + +N+FSGELPE L
Sbjct: 305 HFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLT 364
Query: 87 SLL-NLEKLHLSSNNFTGELPKTFAK--LTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 143
+L +L L LSSNNF+G + + +++ + +N FTG+IP + N ++L L
Sbjct: 365 NLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLH 424
Query: 144 IQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQ-LGNMK-MTKLILRNCNITGE 199
+ + L+G IPS + SL L DL++ L G PQ L +K + LIL ++TGE
Sbjct: 425 LSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEG---EIPQELMYVKTLETLILDFNDLTGE 481
Query: 200 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW-----MLE 254
+P L T L + LS NRL G+IP L ++ + + N +G IP L
Sbjct: 482 IPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLI 541
Query: 255 RGDKIDLSYNNFT 267
+DL+ N F
Sbjct: 542 W---LDLNTNLFN 551
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-51
Identities = 61/245 (24%), Positives = 109/245 (44%), Gaps = 9/245 (3%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
L+G +P L L+ L+D+ L N L+G IP+ L + TL L + +N +GE+P L +
Sbjct: 429 YLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 147
NL + LS+N TGE+PK +L N+ ++S+N F+G IP+ + + L L + +
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548
Query: 148 GLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKM 207
G IP+ +F G K G L ++
Sbjct: 549 LFNGTIPAAMFKQSGKIAANFIAGKRY-VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRL 607
Query: 208 TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-----LERGDKIDLS 262
+ +++ G FD+ + ++ + N+L+G IP + L ++L
Sbjct: 608 STRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLF---ILNLG 664
Query: 263 YNNFT 267
+N+ +
Sbjct: 665 HNDIS 669
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-50
Identities = 82/255 (32%), Positives = 118/255 (46%), Gaps = 22/255 (8%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLA-NISTLVNLTVQYNQFSGELPEELG 86
G +PP L LQ +SL N+ G IP +L+ TL L + N F G +P G
Sbjct: 258 QFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315
Query: 87 SLLNLEKLHLSSNNFTGELPK-TFAKLTNMKDFRISDNQFTGQIPSFIQN-WTKLEKLFI 144
S LE L LSSNNF+GELP T K+ +K +S N+F+G++P + N L L +
Sbjct: 316 SCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDL 375
Query: 145 QPSGLAGPIPSGIF--SLENLTDLRISD--LNGPEATFPQ-LGNMK-MTKLILRNCNITG 198
+ +GPI + L +L + + G P L N + L L ++G
Sbjct: 376 SSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGK---IPPTLSNCSELVSLHLSFNYLSG 432
Query: 199 ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-----L 253
+P LG ++KL+ L L N L G+IP + ++ + N LTG IP + L
Sbjct: 433 TIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNL 492
Query: 254 ERGDKIDLSYNNFTD 268
I LS N T
Sbjct: 493 NW---ISLSNNRLTG 504
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 3e-50
Identities = 63/247 (25%), Positives = 103/247 (41%), Gaps = 13/247 (5%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
TG +PP L+ + L + L N L G IP L ++S L +L + N GE+P+EL
Sbjct: 405 GFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 147
+ LE L L N+ TGE+P + TN+ +S+N+ TG+IP +I L L + +
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524
Query: 148 GLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQ-LGNMKMTKLILRNCNITGELPRYL 204
+G IP+ + +L L ++ NG P + + I G+ Y+
Sbjct: 525 SFSGNIPAELGDCRSLIWLDLNTNLFNGT---IPAAMFKQ---SGKIAANFIAGKRYVYI 578
Query: 205 GKMTKLKVLDLSFN--RLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKID 260
K + N +G + L + + G P +D
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 261 LSYNNFT 267
+SYN +
Sbjct: 639 MSYNMLS 645
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-50
Identities = 70/254 (27%), Positives = 113/254 (44%), Gaps = 22/254 (8%)
Query: 28 NLTGVLPPKLAE---LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEE 84
+++G L+ +++ N++ G + ++ L L V N FS +P
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF- 218
Query: 85 LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFI 144
LG L+ L +S N +G+ + + T +K IS NQF G IP L+ L +
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSL 276
Query: 145 QPSGLAGPIPSGIF-SLENLTDLRISD--LNGPEATFP-QLGNM-KMTKLILRNCNITGE 199
+ G IP + + + LT L +S G P G+ + L L + N +GE
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGA---VPPFFGSCSLLESLALSSNNFSGE 333
Query: 200 LPR-YLGKMTKLKVLDLSFNRLRGQIPSNFDDL-YDVDYIYFAGNLLTGAIPPWMLERG- 256
LP L KM LKVLDLSFN G++P + +L + + + N +G I P + +
Sbjct: 334 LPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPK 393
Query: 257 ---DKIDLSYNNFT 267
++ L N FT
Sbjct: 394 NTLQELYLQNNGFT 407
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 6e-49
Identities = 63/253 (24%), Positives = 108/253 (42%), Gaps = 18/253 (7%)
Query: 28 NLTGVLPPK--LAELTFLQDISLIANRLKGPIPK-YLANISTLVNLTVQYNQFSGELPEE 84
+L+G + L + L+ +++ +N L P +++L L + N SG
Sbjct: 111 SLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVG 170
Query: 85 L---GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEK 141
L+ L +S N +G++ ++ N++ +S N F+ IP + + + L+
Sbjct: 171 WVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQH 227
Query: 142 LFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQLGNMKMTKLILRNCNITGE 199
L I + L+G I + L L IS GP P L + L L TGE
Sbjct: 228 LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGP---IPPLPLKSLQYLSLAENKFTGE 284
Query: 200 LPRYL-GKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDK 258
+P +L G L LDLS N G +P F ++ + + N +G +P L +
Sbjct: 285 IPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRG 344
Query: 259 ---IDLSYNNFTD 268
+DLS+N F+
Sbjct: 345 LKVLDLSFNEFSG 357
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 1e-47
Identities = 74/245 (30%), Positives = 111/245 (45%), Gaps = 9/245 (3%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
+LTG +P L+ T L ISL NRL G IPK++ + L L + N FSG +P ELG
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 147
+L L L++N F G +P K + I+ N G+ +I+N ++ +
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGN 592
Query: 148 G--LAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMK-MTKLILRNCNITGELPRYL 204
G + L I+ T P N M L + ++G +P+ +
Sbjct: 593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
Query: 205 GKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLS 262
G M L +L+L N + G IP DL ++ + + N L G IP M L +IDLS
Sbjct: 653 GSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLS 712
Query: 263 YNNFT 267
NN +
Sbjct: 713 NNNLS 717
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 175 bits (445), Expect = 4e-46
Identities = 71/266 (26%), Positives = 104/266 (39%), Gaps = 49/266 (18%)
Query: 28 NLTGVLPPKLAE--LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEEL 85
N +G + P L + LQ++ L N G IP L+N S LV+L + +N SG +P L
Sbjct: 379 NFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 86 GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 145
GSL L L L N GE+P+ + ++ + N TG+IPS + N T L + +
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498
Query: 146 PSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 205
+ L G IP I LENL L L N + +G +P LG
Sbjct: 499 NNRLTGEIPKWIGRLENL-----------------------AILKLSNNSFSGNIPAELG 535
Query: 206 KMTKLKVLDLSFNRLRGQIPSNF--------------------DDLYDVDYIYFAGNL-- 243
L LDL+ N G IP+ + + AGNL
Sbjct: 536 DCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLE 595
Query: 244 LTGAIPP--WMLERGDKIDLSYNNFT 267
G L + +++ +
Sbjct: 596 FQGIRSEQLNRLSTRNPCNITSRVYG 621
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 1e-45
Identities = 61/254 (24%), Positives = 107/254 (42%), Gaps = 22/254 (8%)
Query: 27 QNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE--E 84
+ L LT L+ + L + + G + ++L +L + N SG +
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTS 121
Query: 85 LGSLLNLEKLHLSSNNFTGELPKT-FAKLTNMKDFRISDNQFTGQIPSFIQ---NWTKLE 140
LGS L+ L++SSN + KL +++ +S N +G +L+
Sbjct: 122 LGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181
Query: 141 KLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQLGNM-KMTKLILRNCNIT 197
L I + ++G + + NL L +S + P LG+ + L + ++
Sbjct: 182 HLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTG---IPFLGDCSALQHLDISGNKLS 236
Query: 198 GELPRYLGKMTKLKVLDLSFNRLRGQIP-SNFDDLYDVDYIYFAGNLLTGAIPPWMLERG 256
G+ R + T+LK+L++S N+ G IP L Y+ A N TG IP ++
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSL---QYLSLAENKFTGEIPDFLSGAC 293
Query: 257 DK---IDLSYNNFT 267
D +DLS N+F
Sbjct: 294 DTLTGLDLSGNHFY 307
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-32
Identities = 53/231 (22%), Positives = 89/231 (38%), Gaps = 33/231 (14%)
Query: 23 VLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELP 82
L + +G +P +L + L + L N G IP + S + N +G+
Sbjct: 520 KLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRY 575
Query: 83 EELGSLLNLEKLHLSSN--NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE 140
+ + ++ H + N F G + +L+ I+ + G N +
Sbjct: 576 VYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMM 635
Query: 141 KLFIQPSG--LAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITG 198
L + S L+G IP I S+ L L + N +I+G
Sbjct: 636 FLDM--SYNMLSGYIPKEIGSMPYLFILNLG----------------------HN-DISG 670
Query: 199 ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 249
+P +G + L +LDLS N+L G+IP L + I + N L+G IP
Sbjct: 671 SIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-32
Identities = 50/219 (22%), Positives = 81/219 (36%), Gaps = 34/219 (15%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYN--QFSGELPEEL 85
G +P + + + + AN + G Y+ N N +F G E+L
Sbjct: 549 LFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQL 604
Query: 86 GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 145
L +++S + G TF +M +S N +G IP I + L L +
Sbjct: 605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLG 664
Query: 146 PSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 205
+ ++G IP + +L L I DL+ N + G +P+ +
Sbjct: 665 HNDISGSIPD---EVGDLRGLNILDLS-------------------SN-KLDGRIPQAMS 701
Query: 206 KMTKLKVLDLSFNRLRGQIPSN--FDDLYDVDYIYFAGN 242
+T L +DLS N L G IP F+ F N
Sbjct: 702 ALTMLTEIDLSNNNLSGPIPEMGQFETF---PPAKFLNN 737
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-31
Identities = 44/208 (21%), Positives = 86/208 (41%), Gaps = 19/208 (9%)
Query: 72 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPS 131
N + L SL LE L LS+++ G + F ++ +S N +G + +
Sbjct: 60 KPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTT 118
Query: 132 F--IQNWTKLEKLFIQPSGLAGPIP-SGIFSLENLTDLRIS--DLNGP-EATFPQLGNM- 184
+ + + L+ L + + L P SG L +L L +S ++G +
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178
Query: 185 KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLL 244
++ L + I+G++ + + L+ LD+S N IP D + ++ +GN L
Sbjct: 179 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKL 235
Query: 245 TGAIPPWM-----LERGDKIDLSYNNFT 267
+G + L+ +++S N F
Sbjct: 236 SGDFSRAISTCTELKL---LNISSNQFV 260
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 4e-24
Identities = 37/191 (19%), Positives = 74/191 (38%), Gaps = 18/191 (9%)
Query: 90 NLEKLHLSSNNFT---GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 146
+ + LSS + + LT ++ +S++ G + F + L L +
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGF-KCSASLTSLDLSR 109
Query: 147 SGLAGPIPSG--IFSLENLTDLRISD--LNGPEATFPQLGNM-KMTKLILRNCNITGELP 201
+ L+GP+ + + S L L +S L+ P + + L L +I+G
Sbjct: 110 NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPG-KVSGGLKLNSLEVLDLSANSISGANV 168
Query: 202 ---RYLGKMTKLKVLDLSFNRLRGQIP-SNFDDLYDVDYIYFAGNLLTGAIPP-WMLERG 256
+LK L +S N++ G + S +L +++ + N + IP
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVDVSRCVNL---EFLDVSSNNFSTGIPFLGDCSAL 225
Query: 257 DKIDLSYNNFT 267
+D+S N +
Sbjct: 226 QHLDISGNKLS 236
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-54
Identities = 54/250 (21%), Positives = 100/250 (40%), Gaps = 15/250 (6%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKG--PIPKYLANISTLVNLTVQ-YNQFSGELPEE 84
GVL + + ++ L L PIP LAN+ L L + N G +P
Sbjct: 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPA 96
Query: 85 LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFI 144
+ L L L+++ N +G +P +++ + S N +G +P I + L +
Sbjct: 97 IAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITF 156
Query: 145 QPSGLAGPIPSGIFSLENL-TDLRISD--LNG--PEATFPQLGNMKMTKLILRNCNITGE 199
+ ++G IP S L T + IS L G P P N+ + + L + G+
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIP----PTFANLNLAFVDLSRNMLEGD 212
Query: 200 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGD 257
G + + L+ N L + +++ + N + G +P + L+
Sbjct: 213 ASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271
Query: 258 KIDLSYNNFT 267
+++S+NN
Sbjct: 272 SLNVSFNNLC 281
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-53
Identities = 72/230 (31%), Positives = 108/230 (46%), Gaps = 14/230 (6%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
NL G +PP +A+LT L + + + G IP +L+ I TLV L YN SG LP + S
Sbjct: 88 NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS 147
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNM-KDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 146
L NL + N +G +P ++ + + IS N+ TG+IP N L + +
Sbjct: 148 LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSR 206
Query: 147 SGLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQLGNMK-MTKLILRNCNITGELPRY 203
+ L G S +N + ++ L ++G K + L LRN I G LP+
Sbjct: 207 NMLEGDASVLFGSDKNTQKIHLAKNSLAFD---LGKVGLSKNLNGLDLRNNRIYGTLPQG 263
Query: 204 LGKMTKLKVLDLSFNRLRGQIPS--NFDDLYDVDYIYFAGN-LLTGAIPP 250
L ++ L L++SFN L G+IP N D +A N L G+ P
Sbjct: 264 LTQLKFLHSLNVSFNNLCGEIPQGGNLQRF---DVSAYANNKCLCGSPLP 310
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 2e-51
Identities = 74/262 (28%), Positives = 115/262 (43%), Gaps = 16/262 (6%)
Query: 24 LKEQNLTGV--LPPKLAELTFLQDISLI-ANRLKGPIPKYLANISTLVNLTVQYNQFSGE 80
L NL +P LA L +L + + N L GPIP +A ++ L L + + SG
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 81 LPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKL- 139
+P+ L + L L S N +G LP + + L N+ N+ +G IP +++KL
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 140 EKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG--PEATFPQLGNMKM-TKLILRNC 194
+ I + L G IP +L NL + +S L G G+ K K+ L
Sbjct: 177 TSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDAS----VLFGSDKNTQKIHLAKN 231
Query: 195 NITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP-WML 253
++ +L + +G L LDL NR+ G +P L + + + N L G IP L
Sbjct: 232 SLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL 290
Query: 254 ERGDKIDLSYNNFTDGSAESSC 275
+R D + N GS +C
Sbjct: 291 QRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 51/204 (25%), Positives = 87/204 (42%), Gaps = 16/204 (7%)
Query: 75 NQFSGELPEELGSLLNLEKLHLSSNNFTGE--LPKTFAKLTNMKDFRISD-NQFTGQIPS 131
+ G L + + L LS N +P + A L + I N G IP
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 132 FIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG--PEATFPQLGNM-KM 186
I T+L L+I + ++G IP + ++ L L S L+G P P + ++ +
Sbjct: 96 AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP----PSISSLPNL 151
Query: 187 TKLILRNCNITGELPRYLGKMTKL-KVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 245
+ I+G +P G +KL + +S NRL G+IP F +L ++ ++ + N+L
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLE 210
Query: 246 GAIPPWM--LERGDKIDLSYNNFT 267
G + KI L+ N+
Sbjct: 211 GDASVLFGSDKNTQKIHLAKNSLA 234
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 49/204 (24%), Positives = 78/204 (38%), Gaps = 22/204 (10%)
Query: 80 ELPEELGSLLNL----EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ--IPSFI 133
++ ++LG+ L + + G L T + + + +S IPS +
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 134 QNWTKLEKLFIQPS-GLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQ-LGNMK-MTK 188
N L L+I L GPIP I L L L I+ ++G P L +K +
Sbjct: 73 ANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA---IPDFLSQIKTLVT 129
Query: 189 LILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYD-VDYIYFAGNLLTGA 247
L ++G LP + + L + NR+ G IP ++ + + N LTG
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGK 189
Query: 248 IPPWMLERG----DKIDLSYNNFT 267
IPP +DLS N
Sbjct: 190 IPP---TFANLNLAFVDLSRNMLE 210
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-50
Identities = 70/274 (25%), Positives = 119/274 (43%), Gaps = 38/274 (13%)
Query: 401 IGEGGFGPVYKGLL-ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLYGCC 458
IG G FG V+ G L AD T +AVK + +F+ E ++ HPN+V+L G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
+ + ++ E ++ L +L T ++ A G+ YL +HRD
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHLTEKAD 576
+ A N L+ + KISDFG+++ +E + + ++ + + APE G + ++D
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSR-EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESD 297
Query: 577 VYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLK--EQGKLMELVDTNPGSNF 627
V+SFGI+ E S SN + E+G + + P + F
Sbjct: 298 VWSFGILLWETFSLGASPYPNLSN------------QQTREFVEKGGRLPCPELCPDAVF 345
Query: 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
++M C P RPS S++ + L+
Sbjct: 346 ---RLM------EQCWAYEPGQRPSFSTIYQELQ 370
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-47
Identities = 59/199 (29%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
IG G F VYKGL +A + +K + F E M+ LQHPN+V+ Y
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 93
Query: 458 CI----EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
++L+ E + + +L L + + R C I +GL +LH +
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTP-P 151
Query: 514 VVHRDIKATNVLLD-KDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
++HRD+K N+ + + KI D GLA L V GT +MAPE +
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEEKY-D 207
Query: 573 EKADVYSFGIVALEIVSGR 591
E DVY+FG+ LE+ +
Sbjct: 208 ESVDVYAFGMCMLEMATSE 226
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 5e-47
Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 12/198 (6%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G+G +G VY G L++ IA+K++ + + ++ EI + L+H N+V+ G
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 460 EGNQLLLIYEYLENNSLARALFEH--RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 517
E + + E + SL+ L LK + T I GL YLH ++VHR
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHR 146
Query: 518 DIKATNVLLD-KDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE---YAMRGHLTE 573
DIK NVL++ KISDFG +K N T GT+ YMAPE RG+ +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGY-GK 204
Query: 574 KADVYSFGIVALEIVSGR 591
AD++S G +E+ +G+
Sbjct: 205 AADIWSLGCTIIEMATGK 222
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 7e-47
Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 33/282 (11%)
Query: 401 IGEGGFGPVYKGLLA-----DGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 454
+GEG FG V G +AVK L + EI ++ L H N+VK
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 455 YGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
G C E GN + LI E+L + SL L +++ K++ + + + I +G+ YL SR
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYL--GSR- 145
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGH 570
+ VHRD+ A NVL++ + KI DFGL K E + + + + + + APE M+
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK 205
Query: 571 LTEKADVYSFGIVALEIVS-GRSNVTKEDMFYL--------LDWALVLK--EQGKLMELV 619
+DV+SFG+ E+++ S+ + +F + ++ ++GK +
Sbjct: 206 FYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP 265
Query: 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
P E +M C P+ R S +++ E
Sbjct: 266 PNCP-----DEVYQLM----RKCWEFQPSNRTSFQNLIEGFE 298
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 3e-46
Identities = 73/270 (27%), Positives = 118/270 (43%), Gaps = 34/270 (12%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGCC 458
+G G FG V G +AVK + S S+ EF E + L HP LVK YG C
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
+ + ++ EY+ N L L H L+ +C + G+A+L + +HRD
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFIHRD 129
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLTEKA 575
+ A N L+D+DL K+SDFG+ + ++ GT + + APE + K+
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 576 DVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631
DV++FGI+ E+ S G+ T ++ + QG + + + Q
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-------SQGHRLYRPHLASDTIY---Q 236
Query: 632 VMVMINVALLCANASPTIRPSMSSVLRMLE 661
+M C + P RP+ +L +E
Sbjct: 237 IM------YSCWHELPEKRPTFQQLLSSIE 260
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 4e-46
Identities = 65/275 (23%), Positives = 111/275 (40%), Gaps = 44/275 (16%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGCC 458
+G G FG V G +A+K + S S+ EFI E ++ L H LV+LYG C
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
+ + +I EY+ N L L E R + +C + + YL + +HRD
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRD 145
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLTEKA 575
+ A N L++ K+SDFGL++ ++ T G+ + + PE M + K+
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 576 DVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLK--EQGKLMELVDTNPGSN 626
D+++FG++ EI S +N + + QG +
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTN------------SETAEHIAQGLRLYRPHLASEKV 250
Query: 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ +M C + RP+ +L +
Sbjct: 251 Y---TIM------YSCWHEKADERPTFKILLSNIL 276
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-46
Identities = 74/292 (25%), Positives = 120/292 (41%), Gaps = 56/292 (19%)
Query: 401 IGEGGFGPVYKGLLADG------TAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL 454
+GEG FG V+ + +AVK L S+ ++F E +++ LQH ++V+
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR--------------ICLGIA 500
+G C EG LL+++EY+ + L R L H + +A
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 501 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--- 557
G+ YL + + VHRD+ N L+ + L KI DFG+++ + RV G
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTML 222
Query: 558 -IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVL 609
I +M PE + T ++DV+SFG+V EI + SN + +
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN---TEAIDCI------ 273
Query: 610 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
QG+ +E P + +M C P R S+ V L+
Sbjct: 274 -TQGRELERPRACPPEVY---AIM------RGCWQREPQQRHSIKDVHARLQ 315
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 5e-46
Identities = 70/283 (24%), Positives = 125/283 (44%), Gaps = 35/283 (12%)
Query: 401 IGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLY 455
+G+G FG V G +AVK+L +++ R+F EI ++ +LQH N+VK
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 456 GCCIEGNQ--LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
G C + L LI EYL SL L +H+ ++D + I +G+ YL ++ +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--GTK-R 134
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHL 571
+HRD+ N+L++ + KI DFGL K+ ++ + G I + APE
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 572 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWAL----------VLK--EQGKLMELV 619
+ +DV+SFG+V E+ + ++ +++ + +
Sbjct: 195 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 254
Query: 620 DTNPGSNFDKEQV-MVMINVALLCANASPTIRPSMSSVLRMLE 661
D P +++ M+M C N + RPS + ++
Sbjct: 255 DGCP------DEIYMIM----TECWNNNVNQRPSFRDLALRVD 287
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 6e-46
Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 34/270 (12%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGCC 458
IG G FG V+ G + +A+K + + S++ +FI E ++ L HP LV+LYG C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
+E + L+ E++E+ L+ L R T +CL + G+AYL V+HRD
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHRD 129
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLTEKA 575
+ A N L+ ++ K+SDFG+ + ++ T GT + + +PE + K+
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 576 DVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631
DV+SFG++ E+ S G+ N + ++ + G + + Q
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI-------STGFRLYKPRLASTHVY---Q 236
Query: 632 VMVMINVALLCANASPTIRPSMSSVLRMLE 661
+M C P RP+ S +LR L
Sbjct: 237 IM------NHCWRERPEDRPAFSRLLRQLA 260
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 7e-46
Identities = 70/283 (24%), Positives = 126/283 (44%), Gaps = 35/283 (12%)
Query: 401 IGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLY 455
+G+G FG V G +AVK+L +++ R+F EI ++ +LQH N+VK
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 456 GCCIEGNQ--LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
G C + L LI EYL SL L +H+ ++D + I +G+ YL ++ +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL--GTK-R 165
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHL 571
+HRD+ N+L++ + KI DFGL K+ ++ + + G I + APE
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 225
Query: 572 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWAL----------VLK--EQGKLMELV 619
+ +DV+SFG+V E+ + ++ +++ + +
Sbjct: 226 SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP 285
Query: 620 DTNPGSNFDKEQV-MVMINVALLCANASPTIRPSMSSVLRMLE 661
D P +++ M+M C N + RPS + ++
Sbjct: 286 DGCP------DEIYMIM----TECWNNNVNQRPSFRDLALRVD 318
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-46
Identities = 75/293 (25%), Positives = 127/293 (43%), Gaps = 57/293 (19%)
Query: 401 IGEGGFGPVYKGLLADG------TAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL 454
+GEG FG V+ + +AVK L + ++F E +++ LQH ++VK
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR---------------ICLGI 499
YG C +G+ L++++EY+++ L + L H + I I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 500 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT-- 557
A G+ YL + VHRD+ N L+ +L KI DFG+++ + + RV G
Sbjct: 143 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGGHTM 196
Query: 558 --IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALV 608
I +M PE M T ++DV+SFG++ EI + SN ++ +
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIECI----- 248
Query: 609 LKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
QG+++E P +D VM L C P R ++ + ++L
Sbjct: 249 --TQGRVLERPRVCPKEVYD---VM------LGCWQREPQQRLNIKEIYKILH 290
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 1e-45
Identities = 82/281 (29%), Positives = 125/281 (44%), Gaps = 32/281 (11%)
Query: 401 IGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLY 455
+G+G FG V G +AVKQL R+F EI ++ AL +VK
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 456 GCCIEGNQ--LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
G + L L+ EYL + L L HR +LD I +G+ YL SR +
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL--GSR-R 147
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHL 571
VHRD+ A N+L++ + + KI+DFGLAKL + + R G I + APE
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 572 TEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWAL--------VLK--EQGKLMELVD 620
+ ++DV+SFG+V E+ + + + F + +L+ E+G+ +
Sbjct: 208 SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPP 267
Query: 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
P E +M LC SP RPS S++ L+
Sbjct: 268 ACP-----AEVHELM----KLCWAPSPQDRPSFSALGPQLD 299
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 71/273 (26%), Positives = 126/273 (46%), Gaps = 33/273 (12%)
Query: 401 IGEGGFGPVYKGLLADG-----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 454
+G G FG VYKGL +A+K+L + S + N+E ++E +++++ +P++ +L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G C+ + + LI + + L + EH+ + C+ IA+G+ YL E R ++
Sbjct: 83 LGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL--EDR-RL 138
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT-IGYMAPEYAMRGHLTE 573
VHRD+ A NVL+ + KI+DFGLAKL E I +MA E + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 574 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629
++DV+S+G+ E+++ G + ++ +L E+G+ +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGERLPQPPICT------ 245
Query: 630 EQV-MVMINVALLCANASPTIRPSMSSVLRMLE 661
V M+M C RP ++
Sbjct: 246 IDVYMIM----RKCWMIDADSRPKFRELIIEFS 274
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-45
Identities = 74/274 (27%), Positives = 123/274 (44%), Gaps = 32/274 (11%)
Query: 401 IGEGGFGPVYKGLLADG----TAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLY 455
IG G FG VY G L D AVK L+ + G +F+ E ++ HPN++ L
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 456 GCCIEG-NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G C+ L++ Y+++ L + L +A+G+ YL S+ K
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL--ASK-KF 149
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHL 571
VHRD+ A N +LD+ K++DFGLA+ ++ + G + +MA E
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 209
Query: 572 TEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627
T K+DV+SFG++ E+++ G +V D+ L QG+ + + P +
Sbjct: 210 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------LQGRRLLQPEYCPDPLY 262
Query: 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+VM L C + +RPS S ++ +
Sbjct: 263 ---EVM------LKCWHPKAEMRPSFSELVSRIS 287
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-45
Identities = 70/274 (25%), Positives = 121/274 (44%), Gaps = 32/274 (11%)
Query: 401 IGEGGFGPVYKGLLADG----TAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVKLY 455
IG+G FG VY G D A+K LS ++ F+ E ++ L HPN++ L
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 456 GCCIEGN-QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G + ++ Y+ + L + + + L +ARG+ YL + K
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL---AEQKF 145
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHL 571
VHRD+ A N +LD+ K++DFGLA+ + + + + + A E
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF 205
Query: 572 TEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627
T K+DV+SFG++ E+++ G ++ D+ + L QG+ + + P S +
Sbjct: 206 TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL-------AQGRRLPQPEYCPDSLY 258
Query: 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
QVM C A P +RP+ ++ +E
Sbjct: 259 ---QVM------QQCWEADPAVRPTFRVLVGEVE 283
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 5e-45
Identities = 74/274 (27%), Positives = 131/274 (47%), Gaps = 34/274 (12%)
Query: 401 IGEGGFGPVYKGLL----ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 455
+G G FG V G L ++A+K L +++ R+F+ E ++ HPN+++L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLE 112
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G + ++++ EY+EN SL L +H + + GIA G+ YL S + V
Sbjct: 113 GVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYV 169
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
HRD+ A N+L++ +L K+SDFGL ++ D+ E + + I + +PE T
Sbjct: 170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTS 229
Query: 574 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLK--EQGKLMELVDTNPGSNF 627
+DV+S+GIV E++S G ++ +D V+K ++G + P + +
Sbjct: 230 ASDVWSYGIVLWEVMSYGERPYWEMSNQD---------VIKAVDEGYRLPPPMDCPAALY 280
Query: 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
Q+M L C RP ++ +L+
Sbjct: 281 ---QLM------LDCWQKDRNNRPKFEQIVSILD 305
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 7e-45
Identities = 76/272 (27%), Positives = 130/272 (47%), Gaps = 30/272 (11%)
Query: 401 IGEGGFGPVYKGLL----ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 455
IG G G V G L +A+K L + +++ R+F++E ++ HPN+++L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G G +++ EY+EN SL L H + + G+ G+ YL S + V
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYL---SDLGYV 173
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
HRD+ A NVL+D +L K+SDFGL+++ D+ + + +T I + APE +
Sbjct: 174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS 233
Query: 574 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629
+DV+SFG+V E+++ G N+T D+ + E+G + P +
Sbjct: 234 ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-------EEGYRLPAPMGCPHALH-- 284
Query: 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
Q+M L C + RP S ++ +L+
Sbjct: 285 -QLM------LDCWHKDRAQRPRFSQIVSVLD 309
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 8e-45
Identities = 75/275 (27%), Positives = 133/275 (48%), Gaps = 35/275 (12%)
Query: 401 IGEGGFGPVYKGLLADGTA-----IAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 454
IG G FG VYKG+L + +A+K L + +++ +F+ E G++ H N+++L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G + +++I EY+EN +L + L E + + GIA G+ YL + +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL---ANMNY 168
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHLT 572
VHRD+ A N+L++ +L K+SDFGL+++ E++ T G I + APE T
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
Query: 573 EKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLK--EQGKLMELVDTNPGSN 626
+DV+SFGIV E+++ G ++ + V+K G + P +
Sbjct: 229 SASDVWSFGIVMWEVMTYGERPYWELSNHE---------VMKAINDGFRLPTPMDCPSAI 279
Query: 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ Q+M + C RP + ++ +L+
Sbjct: 280 Y---QLM------MQCWQQERARRPKFADIVSILD 305
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 9e-45
Identities = 78/282 (27%), Positives = 119/282 (42%), Gaps = 35/282 (12%)
Query: 401 IGEGGFGPVYKGLL-----ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 454
+GEG FG V G +AVK L + Q + EI ++ L H +++K
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 455 YGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
GCC + L L+ EY+ SL L H + L I G+AYL ++
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGL--AQLLLFAQQICEGMAYL--HAQ- 153
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGH 570
+HRD+ A NVLLD D KI DFGLAK E + + R G + + APE
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK 213
Query: 571 LTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWA----------LVLKEQGKLMELV 619
+DV+SFG+ E+++ S+ + F L L E+G+ +
Sbjct: 214 FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRP 273
Query: 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
D P E +M C + RP+ +++ +L+
Sbjct: 274 DKCP-----AEVYHLM----KNCWETEASFRPTFENLIPILK 306
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 15/197 (7%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G G FG V++ G AVK++ + + + E+ + L P +V LYG
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVR 120
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
EG + + E LE SL L + L GL YLH +++H D+
Sbjct: 121 EGPWVNIFMELLEGGSLG-QLIKQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDV 176
Query: 520 KATNVLLDKD-LNSKISDFGLAKLDEEENTHISTR----VAGTIGYMAPEYAMRGHLTEK 574
KA NVLL D + + DFG A + + S + GT +MAPE M K
Sbjct: 177 KADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAK 236
Query: 575 ADVYSFGIVALEIVSGR 591
D++S + L +++G
Sbjct: 237 VDIWSSCCMMLHMLNGC 253
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 71/270 (26%), Positives = 115/270 (42%), Gaps = 29/270 (10%)
Query: 401 IGEGGFGPVYKGLLADG----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 455
IGEG FG V++G+ A+A+K + S +F+ E + HP++VKL
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G E N + +I E L L + LD + ++ LAYL + V
Sbjct: 83 GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL---ESKRFV 138
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 575
HRDI A NVL+ + K+ DFGL++ E+ + +++ I +MAPE T +
Sbjct: 139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 198
Query: 576 DVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631
DV+ FG+ EI+ G V D+ + E G+ + + P + +
Sbjct: 199 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGERLPMPPNCPPTLY---S 248
Query: 632 VMVMINVALLCANASPTIRPSMSSVLRMLE 661
+M C P+ RP + + L
Sbjct: 249 LM------TKCWAYDPSRRPRFTELKAQLS 272
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-44
Identities = 73/296 (24%), Positives = 131/296 (44%), Gaps = 38/296 (12%)
Query: 401 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYG 456
+G G +G VY+G+ +AVK L K+ EF+ E ++ ++HPNLV+L G
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
C +I E++ +L L E ++ + I+ + YL E + +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKK-NFI 340
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 575
HR++ A N L+ ++ K++DFGL++L + I + APE + K+
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 576 DVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631
DV++FG++ EI + G S + ++ LL E+ ME + P ++
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKDYRMERPEGCP-----EKV 448
Query: 632 VMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDETKAEAMR 687
+M C +P+ RPS + + + E + +SS+SD E +
Sbjct: 449 YELMRA----CWQWNPSDRPSFAEIHQAFE------TMFQESSISDEVEKELGKRG 494
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 72/274 (26%), Positives = 119/274 (43%), Gaps = 32/274 (11%)
Query: 401 IGEGGFGPVYKGLLADG----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 455
IG G FG VY G L D AVK L +F+ E ++ HPN++ L
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 456 GCCIEG-NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G C+ L++ Y+++ L + L +A+G+ +L S+ K
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL--ASK-KF 213
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHL 571
VHRD+ A N +LD+ K++DFGLA+ ++ G + +MA E
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273
Query: 572 TEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627
T K+DV+SFG++ E+++ G +V D+ L QG+ + + P +
Sbjct: 274 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------LQGRRLLQPEYCPDPLY 326
Query: 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+VM L C + +RPS S ++ +
Sbjct: 327 ---EVM------LKCWHPKAEMRPSFSELVSRIS 351
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 3e-44
Identities = 79/294 (26%), Positives = 120/294 (40%), Gaps = 58/294 (19%)
Query: 401 IGEGGFGPVYKGLLADG------TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVK 453
+GE FG VYKG L A+A+K L K EF +E + + LQHPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR---------------ICLG 498
L G + L +I+ Y + L L D + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT- 557
IA G+ YL S VVH+D+ NVL+ LN KISD GL + + ++ G
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY---YKLLGNS 190
Query: 558 ---IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWAL 607
I +MAPE M G + +D++S+G+V E+ S G SN +D+ ++
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVVEMI---- 243
Query: 608 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+++ D P + +M + C N P+ RP + L
Sbjct: 244 ---RNRQVLPCPDDCPAWVY---ALM------IECWNEFPSRRPRFKDIHSRLR 285
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 69/271 (25%), Positives = 117/271 (43%), Gaps = 30/271 (11%)
Query: 401 IGEGGFGPVYKGLLADG---TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLYG 456
+G G FG V +G+ +A+K L K E + E ++ L +P +V+L G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
C + L+L+ E L + L R ++ + ++ G+ YL VH
Sbjct: 78 VC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 133
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHLTEK 574
RD+ A NVLL +KISDFGL+K ++++ + R AG + + APE + +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 575 ADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630
+DV+S+G+ E +S G+ + ++ + EQGK ME P +
Sbjct: 194 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGKRMECPPECPPELY--- 243
Query: 631 QVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+M C RP +V + +
Sbjct: 244 ALM------SDCWIYKWEDRPDFLTVEQRMR 268
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-44
Identities = 86/315 (27%), Positives = 137/315 (43%), Gaps = 51/315 (16%)
Query: 401 IGEGGFGPVYKGLLADG---TAIAVKQL-SSKSKQGNREFINEIGMISAL-QHPNLVKLY 455
IGEG FG V K + A+K++ SK +R+F E+ ++ L HPN++ L
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---------------RICLGIA 500
G C L L EY + +L L + R+ P +A
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 501 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 560
RG+ YL S+ + +HRD+ A N+L+ ++ +KI+DFGL++ E R+ + +
Sbjct: 153 RGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP--VRW 207
Query: 561 MAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLM 616
MA E T +DV+S+G++ EIVS G + +T +++ L QG +
Sbjct: 208 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-------PQGYRL 260
Query: 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL----RMLECGVDVLDL--V 670
E N D E +M C P RPS + +L RMLE ++
Sbjct: 261 E-----KPLNCDDEVYDLM----RQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 311
Query: 671 SDSSVSDIDETKAEA 685
+ + ID + EA
Sbjct: 312 EKFTYAGIDCSAEEA 326
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 6e-44
Identities = 75/298 (25%), Positives = 133/298 (44%), Gaps = 42/298 (14%)
Query: 401 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYG 456
+G G +G VY+G+ +AVK L K+ EF+ E ++ ++HPNLV+L G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL----KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
C +I E++ +L L E ++ + I+ + YL E + +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKK-NFI 133
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
HRD+ A N L+ ++ K++DFGL++L + H + I + APE +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNKFSI 191
Query: 574 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629
K+DV++FG++ EI + G S + ++ LL E+ ME + P +
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EKDYRMERPEGCPEKVY-- 242
Query: 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSDIDETKAEAMR 687
++M C +P+ RPS + + + E + +SS+SD E +
Sbjct: 243 -ELM------RACWQWNPSDRPSFAEIHQAFE------TMFQESSISDEVEKELGKRG 287
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 68/274 (24%), Positives = 121/274 (44%), Gaps = 35/274 (12%)
Query: 401 IGEGGFGPVYKGLLADG-----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 454
+G G FG V+KG+ + +K + +Q + + + I +L H ++V+L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G C + L L+ +YL SL + +HR L + IA+G+ YL E +
Sbjct: 81 LGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL--EEH-GM 136
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIGYMAPEYAMRGHL 571
VHR++ A NVLL +++DFG+A L D+++ + + I +MA E G
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP--IKWMALESIHFGKY 194
Query: 572 TEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627
T ++DV+S+G+ E+++ G + ++ LL E+G+ +
Sbjct: 195 THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL-------EKGERLAQPQICT---- 243
Query: 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ MVM + C IRP+ +
Sbjct: 244 -IDVYMVM----VKCWMIDENIRPTFKELANEFT 272
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 76/288 (26%), Positives = 125/288 (43%), Gaps = 52/288 (18%)
Query: 401 IGEGGFGPVYKGLLADG------TAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVK 453
+G+G FG VY+G+ T +A+K ++ + R EF+NE ++ ++V+
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR---------ICLGIARGLA 504
L G +G L+I E + L L R + + IA G+A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT----IGY 560
YL + K VHRD+ A N ++ +D KI DFG+ + E + R G + +
Sbjct: 153 YL--NAN-KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRW 206
Query: 561 MAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLKEQG 613
M+PE G T +DV+SFG+V EI + G SN E + + +G
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRFV-------MEG 256
Query: 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
L++ D P F+ +M M C +P +RPS ++ ++
Sbjct: 257 GLLDKPDNCPDMLFE---LMRM------CWQYNPKMRPSFLEIISSIK 295
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 71/272 (26%), Positives = 130/272 (47%), Gaps = 31/272 (11%)
Query: 401 IGEGGFGPVYKGLLADG-----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKL 454
+G G FG VYKGL +A+K+L + S + N+E ++E +++++ +P++ +L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G C+ + + LI + + L + EH+ + C+ IA+G+ YL E R ++
Sbjct: 83 LGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL--EDR-RL 138
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
VHRD+ A NVL+ + KI+DFGLAK L EE + + I +MA E + T
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 198
Query: 574 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629
++DV+S+G+ E+++ G + ++ +L E+G+ +
Sbjct: 199 QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-------EKGERLPQPPICT-----I 246
Query: 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ M+M + C RP ++
Sbjct: 247 DVYMIM----VKCWMIDADSRPKFRELIIEFS 274
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-43
Identities = 72/275 (26%), Positives = 118/275 (42%), Gaps = 39/275 (14%)
Query: 401 IGEGGFGPVYKGLL----ADGTAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 455
+GEG FG VY+G+ + +AVK + +F++E ++ L HP++VKL
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G E +I E L L ++ L T L I + +AYL I V
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCV 135
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLT 572
HRDI N+L+ K+ DFGL++ E+E+ + + T I +M+PE T
Sbjct: 136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINFRRFT 192
Query: 573 EKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLK--EQGKLMELVDTNPGSN 626
+DV+ F + EI+S G+ + +D V+ E+G + D P
Sbjct: 193 TASDVWMFAVCMWEILSFGKQPFFWLENKD---------VIGVLEKGDRLPKPDLCPPVL 243
Query: 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ +M C + P+ RP + ++ L
Sbjct: 244 Y---TLM------TRCWDYDPSDRPRFTELVCSLS 269
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-43
Identities = 81/267 (30%), Positives = 126/267 (47%), Gaps = 32/267 (11%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
IG+G FG V G G +AVK + K+ + F+ E +++ L+H NLV+L G +E
Sbjct: 29 IGKGEFGDVMLGD-YRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 461 GN-QLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
L ++ EY+ SL L R L + L + + YL E VHRD
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NFVHRD 142
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
+ A NVL+ +D +K+SDFGL K E +T + ++ + + APE + K+DV+
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSDVW 198
Query: 579 SFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 634
SFGI+ EI S GR + +D+ + E+G M+ D P + + +VM
Sbjct: 199 SFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGYKMDAPDGCPPAVY---EVM- 247
Query: 635 MINVALLCANASPTIRPSMSSVLRMLE 661
C + +RPS + LE
Sbjct: 248 -----KNCWHLDAAMRPSFLQLREQLE 269
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-43
Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 48/286 (16%)
Query: 401 IGEGGFGPVYKGLLADG----TAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKL 454
+GEG FG V +G L +AVK + + S++ EF++E + HPN+++L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 455 YGCCIEGN-----QLLLIYEYLENNSLARALFEHRLKLD--WPTRR---RICLGIARGLA 504
G CIE + + ++I +++ L L RL+ + + + IA G+
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG----- 559
YL S +HRD+ A N +L D+ ++DFGL+K + + G I
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVK 214
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKL 615
++A E T K+DV++FG+ EI + G + V +M+ L G
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-------LHGHR 267
Query: 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
++ + + ++M C P RP+ S + LE
Sbjct: 268 LKQPEDCLDELY---EIM------YSCWRTDPLDRPTFSVLRLQLE 304
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 7e-43
Identities = 71/270 (26%), Positives = 115/270 (42%), Gaps = 29/270 (10%)
Query: 401 IGEGGFGPVYKGLLADG----TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLVKLY 455
IGEG FG V++G+ A+A+K + S +F+ E + HP++VKL
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G E N + +I E L L + LD + ++ LAYL + V
Sbjct: 458 GVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL---ESKRFV 513
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 575
HRDI A NVL+ + K+ DFGL++ E+ + +++ I +MAPE T +
Sbjct: 514 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 573
Query: 576 DVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631
DV+ FG+ EI+ G V D+ + E G+ + + P + +
Sbjct: 574 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-------ENGERLPMPPNCPPTLY---S 623
Query: 632 VMVMINVALLCANASPTIRPSMSSVLRMLE 661
+M C P+ RP + + L
Sbjct: 624 LM------TKCWAYDPSRRPRFTELKAQLS 647
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-43
Identities = 76/314 (24%), Positives = 124/314 (39%), Gaps = 55/314 (17%)
Query: 401 IGEGGFGPVYKGLLADG------TAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVK 453
+G G FG VY+G ++ +AVK L + + +F+ E +IS H N+V+
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR------RRICLGIARGLAYLH 507
G ++ ++ E + L L E R + P+ + IA G YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 508 GESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAKLDEEENTHISTRVAGT----IGY 560
+HRDI A N LL +KI DFG+A+ + R G + +
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRKGGCAMLPVKW 211
Query: 561 MAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLKEQG 613
M PE M G T K D +SFG++ EI S +SN +++ + G
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN---QEVLEFV-------TSG 261
Query: 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV---DVLDLV 670
M+ PG + ++M C P RP+ + +L +E DV++
Sbjct: 262 GRMDPPKNCPGPVY---RIM------TQCWQHQPEDRPNFAIILERIEYCTQDPDVINTA 312
Query: 671 SDSSVSDIDETKAE 684
+ E + +
Sbjct: 313 LPIEYGPLVEEEEK 326
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 8e-43
Identities = 66/286 (23%), Positives = 118/286 (41%), Gaps = 47/286 (16%)
Query: 401 IGEGGFGPVYKGLLADG----TAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKL 454
+G+G FG V + L +AVK L + EF+ E + HP++ KL
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 455 YGCCIEG------NQLLLIYEYLENNSLARALFEHRL-----KLDWPTRRRICLGIARGL 503
G + ++I ++++ L L R+ L T R + IA G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT----IG 559
YL SR +HRD+ A N +L +D+ ++DFGL++ + + R +
Sbjct: 151 EYL--SSR-NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY---RQGCASKLPVK 204
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKL 615
++A E T +DV++FG+ EI++ G++ + +++ L G
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL-------IGGNR 257
Query: 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
++ +D +M C +A P RPS + + LE
Sbjct: 258 LKQPPECMEEVYD---LM------YQCWSADPKQRPSFTCLRMELE 294
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-43
Identities = 71/272 (26%), Positives = 115/272 (42%), Gaps = 32/272 (11%)
Query: 401 IGEGGFGPVYKGLL---ADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLY 455
+G G FG V KG +AVK L + E + E ++ L +P +V++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G C E +L+ E E L + L ++R + + ++ G+ YL E V
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYL--EES-NFV 139
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHLTE 573
HRD+ A NVLL +KISDFGL+K + + + G + + APE +
Sbjct: 140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS 199
Query: 574 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629
K+DV+SFG++ E S G+ + ++ +L E+G+ M P +
Sbjct: 200 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML-------EKGERMGCPAGCPREMY-- 250
Query: 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+M LC RP ++V L
Sbjct: 251 -DLM------NLCWTYDVENRPGFAAVELRLR 275
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 8e-43
Identities = 91/272 (33%), Positives = 131/272 (48%), Gaps = 38/272 (13%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYGC 457
+G G FG V+ G T +AVK L KQG+ F+ E ++ LQH LV+LY
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL----KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+ + +I EY+EN SL L +KL + IA G+A++ E R +H
Sbjct: 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EER-NYIH 132
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLTE 573
RD++A N+L+ L+ KI+DFGLA+L E+ T G I + APE G T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDN---EYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 574 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629
K+DV+SFGI+ EIV+ GR +T ++ L E+G M D P +
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-------ERGYRMVRPDNCPEELY-- 240
Query: 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
Q+M LC P RP+ + +LE
Sbjct: 241 -QLM------RLCWKERPEDRPTFDYLRSVLE 265
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-42
Identities = 70/275 (25%), Positives = 120/275 (43%), Gaps = 30/275 (10%)
Query: 397 TDNNIGEGGFGPVYKGLLADG---TAIAVKQL-SSKSKQGNREFINEIGMISALQHPNLV 452
D +G G FG V +G+ +A+K L K E + E ++ L +P +V
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 399
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
+L G C + L+L+ E L + L R ++ + ++ G+ YL E +
Sbjct: 400 RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL--EEK- 455
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGH 570
VHR++ A NVLL +KISDFGL+K ++++ + R AG + + APE
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 571 LTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626
+ ++DV+S+G+ E +S G+ + ++ + EQGK ME P
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-------EQGKRMECPPECPPEL 568
Query: 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ +M C RP +V + +
Sbjct: 569 Y---ALM------SDCWIYKWEDRPDFLTVEQRMR 594
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-42
Identities = 82/269 (30%), Positives = 125/269 (46%), Gaps = 36/269 (13%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLYGCC 458
IG+G FG V G G +AVK + K + F+ E +++ L+H NLV+L G
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 459 IEGN-QLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+E L ++ EY+ SL L R L + L + + YL E VH
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NFVH 312
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
RD+ A NVL+ +D +K+SDFGL K E +T + ++ + + APE + K+D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKFSTKSD 368
Query: 577 VYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632
V+SFGI+ EI S GR + +D+ + E+G M+ D P + +D
Sbjct: 369 VWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-------EKGYKMDAPDGCPPAVYD---- 417
Query: 633 MVMINVALLCANASPTIRPSMSSVLRMLE 661
VM N C + RP+ + LE
Sbjct: 418 -VMKN----CWHLDAATRPTFLQLREQLE 441
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 3e-42
Identities = 70/267 (26%), Positives = 121/267 (45%), Gaps = 23/267 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQL---SSKSKQGNREFINEIGMISALQHPNLVKLYG 456
IG G F VY+ L DG +A+K++ + + I EI ++ L HPN++K Y
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGLAYLHGESRIK 513
IE N+L ++ E + L+R + + + + T + + + L ++H +
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---R 156
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
V+HRDIK NV + K+ D GL + + T + V GT YM+PE
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYNF 215
Query: 574 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMELVDTNPGSNFDKEQV 632
K+D++S G + E+ + +S + M +L K EQ L P ++ +E
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYGDKMNLY---SLCKKIEQCDYPPL----PSDHYSEE-- 266
Query: 633 MVMINVALLCANASPTIRPSMSSVLRM 659
+ + +C N P RP ++ V +
Sbjct: 267 --LRQLVNMCINPDPEKRPDVTYVYDV 291
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-42
Identities = 80/269 (29%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYGC 457
+G+G FG V+ G T +A+K L K G F+ E ++ L+H LV+LY
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
E + ++ EY+ SL L L P + IA G+AY+ E VH
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM-NYVH 303
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
RD++A N+L+ ++L K++DFGLA+L E+ I + APE A+ G T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 577 VYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632
V+SFGI+ E+ + GR + ++ + E+G M P S D
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERGYRMPCPPECPESLHD---- 412
Query: 633 MVMINVALLCANASPTIRPSMSSVLRMLE 661
+M C P RP+ + LE
Sbjct: 413 -LMCQ----CWRKEPEERPTFEYLQAFLE 436
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 4e-42
Identities = 75/311 (24%), Positives = 122/311 (39%), Gaps = 49/311 (15%)
Query: 401 IGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVK 453
+G G FG VY+G + +AVK L + + +F+ E +IS H N+V+
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR------RRICLGIARGLAYLH 507
G ++ ++ E + L L E R + P+ + IA G YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 508 GESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAKLDEEENTHISTRVAGT----IGY 560
+HRDI A N LL +KI DFG+A+ R G + +
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKGGCAMLPVKW 252
Query: 561 MAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLM 616
M PE M G T K D +SFG++ EI S G + + +++ + G M
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-------TSGGRM 305
Query: 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV---DVLDLVSDS 673
+ PG + ++M C P RP+ + +L +E DV++
Sbjct: 306 DPPKNCPGPVY---RIM------TQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPI 356
Query: 674 SVSDIDETKAE 684
+ E + +
Sbjct: 357 EYGPLVEEEEK 367
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 8e-42
Identities = 77/314 (24%), Positives = 133/314 (42%), Gaps = 60/314 (19%)
Query: 401 IGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSKQGNR-EFINEIGMISAL-QHPN 450
+GEG FG V +AVK L + + + + ++E+ M+ + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---------------RI 495
++ L G C + L +I EY +L L R +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 496 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 555
+ARG+ YL S+ K +HRD+ A NVL+ ++ KI+DFGLA+ + +
Sbjct: 163 TYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----KK 215
Query: 556 GTIG-----YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWA 606
T G +MAPE T ++DV+SFG++ EI + G S + E++F LL
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL--- 272
Query: 607 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 666
++G M+ + +M C +A P+ RP+ ++ L+ +
Sbjct: 273 ----KEGHRMDKPANCTNELYM---MM------RDCWHAVPSQRPTFKQLVEDLD---RI 316
Query: 667 LDLVSDSSVSDIDE 680
L L ++ D+ +
Sbjct: 317 LTLTTNEEYLDLSQ 330
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 9e-42
Identities = 54/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 401 IGEGGFGPVYKGLL----ADGTAIAVKQL---SSKSKQGNREFINEIGMISALQHPNLVK 453
+G+G FG V +G ++AVK L + +FI E+ + +L H NL++
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
LYG + + ++ E SL L +H+ T R + +A G+ YL ES+ +
Sbjct: 86 LYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL--ESK-R 141
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT--IGYMAPEYAMRGHL 571
+HRD+ A N+LL KI DFGL + + + H + + APE
Sbjct: 142 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 201
Query: 572 TEKADVYSFGIVALEIVS 589
+ +D + FG+ E+ +
Sbjct: 202 SHASDTWMFGVTLWEMFT 219
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 57/285 (20%), Positives = 113/285 (39%), Gaps = 53/285 (18%)
Query: 401 IGEGGFGPVYKGLL--------ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 452
+G+G F ++KG+ T + +K L + + F M+S L H +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
YG C+ G++ +L+ E+++ SL L +++ ++ + + +A + +L E
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL--EEN- 132
Query: 513 KVVHRDIKATNVLLDKDLNS--------KISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
++H ++ A N+LL ++ + K+SD G++ ++ + I ++ PE
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---ILQER--IPWVPPE 187
Query: 565 -YAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWALVLKEQGKLM 616
+L D +SFG EI S + K + E +
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY----------EDRHQL 237
Query: 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ N+ C + P RPS +++R L
Sbjct: 238 PAPKAAE-----------LANLINNCMDYEPDHRPSFRAIIRDLN 271
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-41
Identities = 60/192 (31%), Positives = 103/192 (53%), Gaps = 9/192 (4%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IG+G G VY + +A G +A++Q++ + + INEI ++ ++PN+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
G++L ++ EYL SL + E + +C + L +LH I HRDI
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIA--AVCRECLQALEFLHSNQVI---HRDI 142
Query: 520 KATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
K+ N+LL D + K++DFG A++ E++ + + GT +MAPE R K D++
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIW 200
Query: 579 SFGIVALEIVSG 590
S GI+A+E++ G
Sbjct: 201 SLGIMAIEMIEG 212
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 2e-41
Identities = 80/269 (29%), Positives = 122/269 (45%), Gaps = 32/269 (11%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYGC 457
+G+G FG V+ G T +A+K L K G F+ E ++ L+H LV+LY
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTL----KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
E + ++ EY+ SL L L P + IA G+AY+ E VH
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM-NYVH 386
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
RD++A N+L+ ++L K++DFGLA+L E+ I + APE A+ G T K+D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 577 VYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632
V+SFGI+ E+ + GR + ++ + E+G M P S D
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ERGYRMPCPPECPESLHD---- 495
Query: 633 MVMINVALLCANASPTIRPSMSSVLRMLE 661
+M C P RP+ + LE
Sbjct: 496 -LMCQ----CWRKEPEERPTFEYLQAFLE 519
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 61/192 (31%), Positives = 101/192 (52%), Gaps = 9/192 (4%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IGEG G V G +AVK + + +Q NE+ ++ QH N+V++Y +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
G +L ++ E+L+ +L + + RL + +C + + LAYLH + I HRDI
Sbjct: 113 VGEELWVLMEFLQGGALTDIVSQVRLNEEQIA--TVCEAVLQALAYLHAQGVI---HRDI 167
Query: 520 KATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
K+ ++LL D K+SDFG A++ ++ S + GT +MAPE R + D++
Sbjct: 168 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIW 225
Query: 579 SFGIVALEIVSG 590
S GI+ +E+V G
Sbjct: 226 SLGIMVIEMVDG 237
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-41
Identities = 75/303 (24%), Positives = 122/303 (40%), Gaps = 68/303 (22%)
Query: 401 IGEGGFGPVYKGLLADG------TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVK 453
IGEG FG V++ T +AVK L + S +F E +++ +PN+VK
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR-------------------- 493
L G C G + L++EY+ L L
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 494 ---RICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550
I +A G+AYL R K VHRD+ N L+ +++ KI+DFGL++ + +
Sbjct: 175 EQLCIARQVAAGMAYL--SER-KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 230
Query: 551 STRVAGTIGY-----MAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKED 598
A M PE T ++DV+++G+V EI S G ++ E+
Sbjct: 231 ---KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH---EE 284
Query: 599 MFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
+ Y + G ++ + P ++ +M LC + P RPS S+ R
Sbjct: 285 VIYYV-------RDGNILACPENCPLELYN---LM------RLCWSKLPADRPSFCSIHR 328
Query: 659 MLE 661
+L+
Sbjct: 329 ILQ 331
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 6e-41
Identities = 59/200 (29%), Positives = 101/200 (50%), Gaps = 18/200 (9%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G+G FG VYK G A K + +KS++ ++I EI +++ HP +VKL G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
+L ++ E+ ++ + E L P + +C + L +LH + I HRD+
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRII---HRDL 143
Query: 520 KATNVLLDKDLNSKISDFGL-AKLDEEE---NTHISTRVAGTIGYMAPEYAMRGHLTE-- 573
KA NVL+ + + +++DFG+ AK + ++ I GT +MAPE M + +
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEVVMCETMKDTP 198
Query: 574 ---KADVYSFGIVALEIVSG 590
KAD++S GI +E+
Sbjct: 199 YDYKADIWSLGITLIEMAQI 218
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 7/200 (3%)
Query: 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN 450
F +GEG +G VYK + G +A+KQ+ +S +E I EI ++ P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPH 85
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+VK YG + L ++ EY S++ + L I +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 570
+I HRDIKA N+LL+ + ++K++DFG+A + +T + GT +MAPE
Sbjct: 146 KI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQEIG 201
Query: 571 LTEKADVYSFGIVALEIVSG 590
AD++S GI A+E+ G
Sbjct: 202 YNCVADIWSLGITAIEMAEG 221
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 1e-40
Identities = 79/272 (29%), Positives = 125/272 (45%), Gaps = 38/272 (13%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYGC 457
+G G FG V+ T +AVK + K G+ F+ E ++ LQH LVKL+
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTM----KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+ + +I E++ SL L K P IA G+A++ E R +H
Sbjct: 252 VTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQR-NYIH 307
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGT---IGYMAPEYAMRGHLTE 573
RD++A N+L+ L KI+DFGLA++ E+ T G I + APE G T
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTI 364
Query: 574 KADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629
K+DV+SFGI+ +EIV+ GR ++ ++ L E+G M + P ++
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-------ERGYRMPRPENCPEELYN- 416
Query: 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+M+ C P RP+ + +L+
Sbjct: 417 ----IMMR----CWKNRPEERPTFEYIQSVLD 440
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-40
Identities = 83/300 (27%), Positives = 127/300 (42%), Gaps = 62/300 (20%)
Query: 401 IGEGGFGPVYKGLLADG------TAIAVKQLSSKSKQGNR-EFINEIGMISALQHPNLVK 453
+GEG FG V K T +AVK L + + ++E ++ + HP+++K
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR-------------------- 493
LYG C + LLLI EY + SL L E R
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 494 ---RICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550
I++G+ YL K+VHRD+ A N+L+ + KISDFGL++ EE+++
Sbjct: 151 DLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY- 206
Query: 551 STRVAGTIG-----YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFY 601
V + G +MA E T ++DV+SFG++ EIV+ G + + E +F
Sbjct: 207 ---VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFN 263
Query: 602 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
LL + G ME D + +M L C P RP + + + LE
Sbjct: 264 LL-------KTGHRMERPDNCSEEMYR---LM------LQCWKQEPDKRPVFADISKDLE 307
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 74/295 (25%), Positives = 125/295 (42%), Gaps = 57/295 (19%)
Query: 401 IGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSKQGNR-EFINEIGMISAL-QHPN 450
+GEG FG V +AVK L + + + + ++E+ M+ + +H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---------------RI 495
++ L G C + L +I EY +L L R +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 496 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 555
+ARG+ YL S+ K +HRD+ A NVL+ ++ KI+DFGLA+ + +
Sbjct: 209 TYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----KK 261
Query: 556 GTIG-----YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWA 606
T G +MAPE T ++DV+SFG++ EI + G S + E++F LL
Sbjct: 262 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL--- 318
Query: 607 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
++G M+ + +M C +A P+ RP+ ++ L+
Sbjct: 319 ----KEGHRMDKPANCTNELYM---MM------RDCWHAVPSQRPTFKQLVEDLD 360
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 66/265 (24%), Positives = 100/265 (37%), Gaps = 30/265 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISAL-QHPNLVKLY 455
+G G +G V+K DG AVK+ S +G ++ + E+G + QHP V+L
Sbjct: 65 LGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLE 123
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
EG L L E SL + L LA+LH + +V
Sbjct: 124 QAWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLV 179
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 574
H D+K N+ L K+ DFGL L + G YMAPE +
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--VQE-GDPRYMAPELLQGSY-GTA 235
Query: 575 ADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 634
ADV+S G+ LE+ E W + QG L S + +++
Sbjct: 236 ADVFSLGLTILEVACN-----MELPHGGEGWQQLR--QGYLPPEFTAGLSSEL-RSVLVM 287
Query: 635 MINVALLCANASPTIRPSMSSVLRM 659
M+ P +R + ++L +
Sbjct: 288 MLEP-------DPKLRATAEALLAL 305
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-40
Identities = 70/296 (23%), Positives = 127/296 (42%), Gaps = 46/296 (15%)
Query: 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN 450
++F +G+G FG V K D A+K++ +++ ++E+ ++++L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 451 LVKLYGCCIEGNQLLL----------IY---EYLENNSLARALFEHRLKLDWPTRRRICL 497
+V+ Y +E + ++ EY EN +L + L R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123
Query: 498 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL--------------D 543
I L+Y+H + ++HRD+K N+ +D+ N KI DFGLAK
Sbjct: 124 QILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 544 EEENTHISTRVAGTIGYMAPE-YAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL 602
+ ++++ + GT Y+A E GH EK D+YS GI+ E++
Sbjct: 181 PGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FSTG 231
Query: 603 LDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
++ +LK KL + P +FD ++ V + L + P RP ++L
Sbjct: 232 MERVNILK---KLRSVSIEFP-PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 74/288 (25%), Positives = 116/288 (40%), Gaps = 46/288 (15%)
Query: 401 IGEGGFGPVYKGLLAD------GTAIAVKQL-SSKSKQGNREFINEIGMISAL-QHPNLV 452
+G G FG V + +AVK L S+ ++E+ ++S L QH N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR-------------RICLGI 499
L G C G +L+I EY L L L+ +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 500 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTI 558
A+G+A+L S+ +HRD+ A NVLL +KI DFGLA + + N + +
Sbjct: 174 AQGMAFL--ASK-NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPV 230
Query: 559 GYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS----NVTKEDMFYLLDWALVLKEQG 613
+MAPE T ++DV+S+GI+ EI S G + + + L+ + G
Sbjct: 231 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV-------KDG 283
Query: 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
M P + + +M C PT RP+ + L+
Sbjct: 284 YQMAQPAFAPKNIYS---IM------QACWALEPTHRPTFQQICSFLQ 322
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-39
Identities = 81/313 (25%), Positives = 133/313 (42%), Gaps = 60/313 (19%)
Query: 401 IGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSKQGNR-EFINEIGMISAL-QHPN 450
+GEG FG V T +AVK L S + + + + I+E+ M+ + +H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---------------RI 495
++ L G C + L +I EY +L L R +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 496 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 555
+ARG+ YL S+ K +HRD+ A NVL+ +D KI+DFGLA+ + +
Sbjct: 197 AYQVARGMEYL--ASK-KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KK 249
Query: 556 GTIG-----YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS---NVTKEDMFYLLDWA 606
T G +MAPE T ++DV+SFG++ EI + G S V E++F LL
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL--- 306
Query: 607 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 666
++G M+ + +M C +A P+ RP+ ++ L+ +
Sbjct: 307 ----KEGHRMDKPSNCTNELYM---MMRD------CWHAVPSQRPTFKQLVEDLD---RI 350
Query: 667 LDLVSDSSVSDID 679
+ L S+ +
Sbjct: 351 VALTSNQEMGYYH 363
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 70/192 (36%), Positives = 99/192 (51%), Gaps = 8/192 (4%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 458
IG+G FG V+KG+ +A+K + + + E I EI ++S P + K YG
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
++ +L +I EYL S L E LD I I +GL YLH E +I HRD
Sbjct: 90 LKDTKLWIIMEYLGGGSA-LDLLEPG-PLDETQIATILREILKGLDYLHSEKKI---HRD 144
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
IKA NVLL + K++DFG+A + +T V GT +MAPE + KAD++
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSKADIW 203
Query: 579 SFGIVALEIVSG 590
S GI A+E+ G
Sbjct: 204 SLGITAIELARG 215
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 6e-39
Identities = 61/265 (23%), Positives = 115/265 (43%), Gaps = 25/265 (9%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
IGEG FG DG +K+ +S S + E E+ +++ ++HPN+V+
Sbjct: 32 IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
E L ++ +Y E L + + + + + I L ++H K++H
Sbjct: 92 FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILH 148
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTEKA 575
RDIK+ N+ L KD ++ DFG+A++ + GT Y++PE + + K+
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKPY-NNKS 206
Query: 576 DVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMELVDTNPGSNFDKEQVMV 634
D+++ G V E+ + + M LVLK G + ++ +
Sbjct: 207 DIWALGCVLYELCTLKHAFEAGSMK-----NLVLKIISGSFPPV----S-LHYSYD---- 252
Query: 635 MINVALLCANASPTIRPSMSSVLRM 659
+ ++ +P RPS++S+L
Sbjct: 253 LRSLVSQLFKRNPRDRPSVNSILEK 277
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 6e-39
Identities = 70/294 (23%), Positives = 118/294 (40%), Gaps = 54/294 (18%)
Query: 401 IGEGGFGPVYKGLLAD------GTAIAVKQLSSKSKQGNR-EFINEIGMISAL-QHPNLV 452
+G G FG V + +AVK L + R ++E+ ++S L H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR-----------------RI 495
L G C G L+I EY L L R
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 496 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 555
+A+G+A+L + +HRD+ A N+LL +KI DFGLA+ + ++ ++ A
Sbjct: 151 SYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 556 GT-IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-------GRSNVTKEDMFYLLDWAL 607
+ +MAPE T ++DV+S+GI E+ S G + ++
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP--VDSKFYKMI---- 261
Query: 608 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
++G M + P +D +M C +A P RP+ +++++E
Sbjct: 262 ---KEGFRMLSPEHAPAEMYD---IM------KTCWDADPLKRPTFKQIVQLIE 303
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 7e-39
Identities = 59/286 (20%), Positives = 106/286 (37%), Gaps = 53/286 (18%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISAL-QHPNLVKLYG 456
IG G FG V+K + DG A+K+ + + E+ + L QH ++V+ +
Sbjct: 19 IGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFS 78
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGLAYLHGESRIK 513
E + +L+ EY SLA A+ E+ + + L + RGL Y+H
Sbjct: 79 AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---S 135
Query: 514 VVHRDIKATNVLLDKD-------------------LNSKISDFGLAKLDEEENTHISTRV 554
+VH DIK +N+ + + + KI D G
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE---- 191
Query: 555 AGTIGYMAPEYAM--RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 612
G ++A E HL KAD+++ + + D ++ + Q
Sbjct: 192 -GDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPLPRNGDQWHEI-------RQ 242
Query: 613 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
G+L + P +E + + + P RPS ++++
Sbjct: 243 GRLPRI----P-QVLSQE----FTELLKVMIHPDPERRPSAMALVK 279
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 5e-38
Identities = 72/307 (23%), Positives = 124/307 (40%), Gaps = 55/307 (17%)
Query: 401 IGEGGFGPVYKGLLAD------GTAIAVKQLSSKSKQGNR-EFINEIGMISAL-QHPNLV 452
+G G FG V + +AVK L + ++E+ ++ + H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 453 KLYGCC-IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRR---------------IC 496
L G C G L++I E+ + +L+ L R +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 497 LGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAG 556
+A+G+ +L + K +HRD+ A N+LL + KI DFGLA+ ++ ++ A
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 557 T-IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS----NVTKEDMFYLLDWALVLK 610
+ +MAPE T ++DV+SFG++ EI S G S E+ L
Sbjct: 212 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL------- 264
Query: 611 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLV 670
++G M D + M L C + P+ RP+ S ++ L +L+
Sbjct: 265 KEGTRMRAPDYTTPEMYQ---TM------LDCWHGEPSQRPTFSELVEHLG------NLL 309
Query: 671 SDSSVSD 677
++ D
Sbjct: 310 QANAQQD 316
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-38
Identities = 64/197 (32%), Positives = 96/197 (48%), Gaps = 16/197 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREF---INEIGMISALQHPNLVKLYG 456
IG G FG VY + + +A+K++S KQ N ++ I E+ + L+HPN ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
C + + L+ EY S + L H+ L + G +GLAYLH + I H
Sbjct: 122 CYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI---H 177
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE---YAMRGHLTE 573
RD+KA N+LL + K+ DFG A + N+ + GT +MAPE G
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDG 232
Query: 574 KADVYSFGIVALEIVSG 590
K DV+S GI +E+
Sbjct: 233 KVDVWSLGITCIELAER 249
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-38
Identities = 74/301 (24%), Positives = 111/301 (36%), Gaps = 63/301 (20%)
Query: 401 IGEGGFGPVYKGLLADG------TAIAVKQLSSKSKQGNR-EFINEIGMISAL-QHPNLV 452
+G G FG V +AVK L K+ R ++E+ M++ L H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR------------------- 493
L G C + LI+EY L L R K
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 494 ---RICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550
+A+G+ +L VHRD+ A NVL+ KI DFGLA+ ++ +
Sbjct: 173 DLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY- 228
Query: 551 STRVAGTIG-----YMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS----NVTKEDMF 600
V +MAPE G T K+DV+S+GI+ EI S G + + +
Sbjct: 229 ---VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 285
Query: 601 YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRML 660
L+ + G M+ P +E ++M C RPS ++ L
Sbjct: 286 KLI-------QNGFKMD----QP-FYATEEIYIIM----QSCWAFDSRKRPSFPNLTSFL 329
Query: 661 E 661
Sbjct: 330 G 330
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 4e-37
Identities = 60/205 (29%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 458
IG G V +A+K+++ + Q + + + EI +S HPN+V Y
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 459 IEGNQLLLIYEYLENNSLA-------RALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
+ ++L L+ + L S+ LD T I + GL YLH +
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ 142
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGL-AKLDEEENTHISTR---VAGTIGYMAPEYAM 567
I HRD+KA N+LL +D + +I+DFG+ A L + + GT +MAPE
Sbjct: 143 I---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 568 RGHL-TEKADVYSFGIVALEIVSGR 591
+ KAD++SFGI A+E+ +G
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGA 224
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 22/215 (10%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPN 450
++ IG GG V++ L A+K L Q + NEI ++ LQ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 451 L--VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 508
++LY I + ++ E N L L + + +D R+ + + +H
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQ 145
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPE--- 564
+VH D+K N L+ K+ DFG+A + + + + GT+ YM PE
Sbjct: 146 H---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK 201
Query: 565 --------YAMRGHLTEKADVYSFGIVALEIVSGR 591
+ ++ K+DV+S G + + G+
Sbjct: 202 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 8e-37
Identities = 49/193 (25%), Positives = 98/193 (50%), Gaps = 8/193 (4%)
Query: 401 IGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 458
+G G G V+K G +A K + + K R I E+ ++ P +V YG
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
++ + E+++ SL + L + ++ ++ + + +GL YL + K++HRD
Sbjct: 101 YSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLR--EKHKIMHRD 157
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
+K +N+L++ K+ DFG++ + ++ ++ V GT YM+PE H + ++D++
Sbjct: 158 VKPSNILVNSRGEIKLCDFGVSG--QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIW 214
Query: 579 SFGIVALEIVSGR 591
S G+ +E+ GR
Sbjct: 215 SMGLSLVEMAVGR 227
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-36
Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL 451
+F IG GGFG V+K DG +K++ K N + E+ ++ L H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 452 VKLYGCCIE----------------GNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRR 494
V GC L + E+ + +L + + + R + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126
Query: 495 ICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRV 554
+ I +G+ Y+H + K+++RD+K +N+ L KI DFGL + + TR
Sbjct: 127 LFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--TRS 181
Query: 555 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG 590
GT+ YM+PE ++ D+Y+ G++ E++
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV 217
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-36
Identities = 41/205 (20%), Positives = 80/205 (39%), Gaps = 17/205 (8%)
Query: 401 IGEG--GFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLY 455
IG+G V G + V++ L + S + E+ + HPN+V
Sbjct: 33 IGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR 92
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKV 514
I N+L ++ ++ S + H + ++ I G+ + L Y+H +
Sbjct: 93 ATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYV-- 150
Query: 515 VHRDIKATNVLLDKDLNSKISDFG-LAKLDEE---ENTHISTR--VAGTIGYMAPEYAMR 568
HR +KA+++L+ D +S + + + +++PE +
Sbjct: 151 -HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 569 GHL--TEKADVYSFGIVALEIVSGR 591
K+D+YS GI A E+ +G
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGH 234
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 48/207 (23%), Positives = 85/207 (41%), Gaps = 22/207 (10%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNL--VKLYG 456
IG GG V++ L A+K L Q + NEI ++ LQ + ++LY
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
I + ++ E N L L + + +D R+ + + +H +VH
Sbjct: 77 YEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVH 131
Query: 517 RDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPE----------- 564
D+K N L+ K+ DFG+A + + + + GT+ YM PE
Sbjct: 132 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSREN 190
Query: 565 YAMRGHLTEKADVYSFGIVALEIVSGR 591
+ ++ K+DV+S G + + G+
Sbjct: 191 GKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 70/270 (25%), Positives = 115/270 (42%), Gaps = 26/270 (9%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
IG G +G K +DG + K+ S ++ + ++E+ ++ L+HPN+V+ Y
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 458 CIE--GNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGLAYLH--GES 510
I+ L ++ EY E LA + + + LD R+ + L H +
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 570
V+HRD+K NV LD N K+ DFGLA++ + + T V GT YM+PE R
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRMS 192
Query: 571 LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK-EQGKLMELVDTNPGSNFDK 629
EK+D++S G + E+ + T L K +GK + +
Sbjct: 193 YNEKSDIWSLGCLLYELCALMPPFTAFSQK-----ELAGKIREGKFRRI-----PYRYSD 242
Query: 630 EQVMVMINVALLCANASPTIRPSMSSVLRM 659
E + + N RPS+ +L
Sbjct: 243 E----LNEIITRMLNLKDYHRPSVEEILEN 268
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 54/211 (25%), Positives = 83/211 (39%), Gaps = 22/211 (10%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+GEGGF V L DG A+K++ +Q E E M HPN+++L C+
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 460 E----GNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGLAYLHGESRI 512
++ L+ + + +L + + K L + LGI RGL +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AK 153
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA--------GTIGYMAPE 564
HRD+K TN+LL + + D G + TI Y APE
Sbjct: 154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213
Query: 565 ---YAMRGHLTEKADVYSFGIVALEIVSGRS 592
+ E+ DV+S G V ++ G
Sbjct: 214 LFSVQSHCVIDERTDVWSLGCVLYAMMFGEG 244
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-36
Identities = 48/208 (23%), Positives = 85/208 (40%), Gaps = 24/208 (11%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHPNL--VKLYG 456
IG GG V++ L A+K L Q + NEI ++ LQ + ++LY
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
I + ++ E N L L + + +D R+ + + +H +VH
Sbjct: 124 YEITDQYIYMVMEC-GNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQH---GIVH 178
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPE---------- 564
D+K N L+ K+ DFG+A + + ++V G + YM PE
Sbjct: 179 SDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSSSRE 236
Query: 565 -YAMRGHLTEKADVYSFGIVALEIVSGR 591
+ ++ K+DV+S G + + G+
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 5e-36
Identities = 47/260 (18%), Positives = 88/260 (33%), Gaps = 19/260 (7%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
L+ + A T L ++ L++N ++ L+ L + +N S
Sbjct: 84 ELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ 143
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNM--KDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 145
L NL++L LS+N + N K +S NQ P +L LF+
Sbjct: 144 LENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLN 203
Query: 146 PSGLAGPIPSGIFSLENLTDLRISDLNG------PEATFPQLGNMKMTKLILRNCNITGE 199
L + + T +R L+ TF L +T L L N+
Sbjct: 204 NVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVV 263
Query: 200 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGD-- 257
+ +L+ L +N ++ + L++V Y+ + +I L + D
Sbjct: 264 GNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDF 323
Query: 258 ---------KIDLSYNNFTD 268
+++ N+
Sbjct: 324 SFQWLKCLEHLNMEDNDIPG 343
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 8e-33
Identities = 59/262 (22%), Positives = 95/262 (36%), Gaps = 14/262 (5%)
Query: 17 TVNQKRV-LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYN 75
TV+ + LT V P L T + ++L N+L+ S L +L V +N
Sbjct: 3 TVSHEVADCSHLKLTQV-PDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFN 59
Query: 76 QFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQN 135
S PE L L+ L+L N + KTFA TN+ + + N +
Sbjct: 60 TISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK 119
Query: 136 WTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG-PEATFPQLGNMKMTKLILR 192
L L + +GL+ LENL +L +S+ + N + KL L
Sbjct: 120 QKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELS 179
Query: 193 NCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNF---DDLYDVDYIYFAGNLLTGAIP 249
+ I P + +L L L+ +L + + + + + L+
Sbjct: 180 SNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSN 239
Query: 250 PWMLERGD----KIDLSYNNFT 267
L +DLSYNN
Sbjct: 240 TTFLGLKWTNLTMLDLSYNNLN 261
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-31
Identities = 45/246 (18%), Positives = 90/246 (36%), Gaps = 21/246 (8%)
Query: 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELP-EELGSLLNLEKLHLSS 98
+ L ++L N++ + + L L + N+ EL +E L N+ +++LS
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSY 439
Query: 99 NNFTGELPKTFAKLTNMKDFRISDNQFTG--QIPSFIQNWTKLEKLFIQPSGLAGPIPSG 156
N + +FA + +++ + PS Q L L + + +A
Sbjct: 440 NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
Query: 157 IFSLENLTDLRISD-----------LNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 205
+ LE L L + GP L ++ + L L +
Sbjct: 500 LEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI--LNLESNGFDEIPVEVFK 557
Query: 206 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDK----IDL 261
+ +LK++DL N L S F++ + + NL+T + + + +D+
Sbjct: 558 DLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTELDM 616
Query: 262 SYNNFT 267
+N F
Sbjct: 617 RFNPFD 622
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 45/263 (17%), Positives = 92/263 (34%), Gaps = 20/263 (7%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFS-GELP 82
+ +L + L L+ +++ N + G + L L++ + S L
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLT 371
Query: 83 EELGSLL---NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP-SFIQNWTK 138
E L L L+L+ N + F+ L +++ + N+ ++ +
Sbjct: 372 NETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 139 LEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQLGNM-KMTKLILRNCN 195
+ ++++ + + + +L L + L +++ + +T L L N N
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491
Query: 196 ITGELPRYLGKMTKLKVLDLSFNRL--------RGQIPSNFDDLYDVDYIYFAGNLLTGA 247
I L + KL++LDL N L G L + + N
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE- 550
Query: 248 IPPWMLERGDK---IDLSYNNFT 267
IP + + + IDL NN
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLN 573
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-27
Identities = 47/263 (17%), Positives = 88/263 (33%), Gaps = 25/263 (9%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGEL------ 81
NL V A L L+ L N ++ L + + L ++ + +
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 82 ---PEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQ---- 134
L LE L++ N+ G F L N+K +S++ + + +
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 135 NWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG--PEATFPQLGNMKMTKLI 190
+ L L + + ++ L +L L + + + L N+ +
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFE--IY 436
Query: 191 LRNCNITGELPRYLGKMTKLKVLDLSFNRLRG--QIPSNFDDLYDVDYIYFAGNLLTGAI 248
L + L+ L L L+ PS F L ++ + + N + I
Sbjct: 437 LSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIAN-I 495
Query: 249 PPWMLERGDK---IDLSYNNFTD 268
MLE +K +DL +NN
Sbjct: 496 NDDMLEGLEKLEILDLQHNNLAR 518
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-24
Identities = 43/226 (19%), Positives = 77/226 (34%), Gaps = 29/226 (12%)
Query: 65 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 124
+ + L + +NQ L L + N + P+ KL +K + N+
Sbjct: 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNE 84
Query: 125 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG-PEATFPQL 181
+ T L +L + + + + +NL L +S L+ T QL
Sbjct: 85 LSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 182 GNMKMTKLILRNCNITGELPRYLG--KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYF 239
N++ +L+L N I L + LK L+LS N+++ P F +
Sbjct: 145 ENLQ--ELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAI-------- 194
Query: 240 AGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRSVTGIVS 285
G L + L+ E C + + T I +
Sbjct: 195 -GRLFG-------------LFLNNVQLGPSLTEKLCLELANTSIRN 226
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-23
Identities = 42/214 (19%), Positives = 69/214 (32%), Gaps = 17/214 (7%)
Query: 28 NLTGVLPPK-LAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSG--ELPEE 84
+ L + L + +I L N+ A + +L L ++ P
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 85 LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT--------GQIPSFIQNW 136
L NL L LS+NN L ++ + N G F++
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL 535
Query: 137 TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG-PEATFPQLGNMKMTKLILRN 193
+ L L ++ +G L L + + LN P + F ++K L L+
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLK--SLNLQK 593
Query: 194 CNITGELPRYLGK-MTKLKVLDLSFNRLRGQIPS 226
IT + G L LD+ FN S
Sbjct: 594 NLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 3e-17
Identities = 37/209 (17%), Positives = 63/209 (30%), Gaps = 51/209 (24%)
Query: 68 VNLTV---QYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 124
V+ V + + + ++P++L + N+ L+L+ N F + + + + N
Sbjct: 4 VSHEVADCSHLKLT-QVPDDLPT--NITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 125 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM 184
+ P Q L+ L +Q + L+ NLT+L
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH----------------- 103
Query: 185 KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLL 244
L + +I K L LDLS N L L NL
Sbjct: 104 ------LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL---------ENLQ 148
Query: 245 TGAIPPWMLERGDKIDLSYNNFTDGSAES 273
+ LS N +E
Sbjct: 149 E-------------LLLSNNKIQALKSEE 164
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 3e-14
Identities = 35/189 (18%), Positives = 60/189 (31%), Gaps = 15/189 (7%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRL--------KGPIPKYLANISTLVNLTVQYNQFSG 79
N+ + L L L+ + L N L G +L +S L L ++ N F
Sbjct: 491 NIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
Query: 80 ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPS-FIQNWTK 138
E L L+ + L NN F ++K + N T F +
Sbjct: 551 IPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRN 610
Query: 139 LEKLFIQPSGLAGPIPSGIFSLE--NLTDLRISDL--NGPEATFPQLGNMKMTKLILRNC 194
L +L ++ + S + + N T I +L + T P + +C
Sbjct: 611 LTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNTPPHYHGFPVRLFDTSSC 670
Query: 195 NITGELPRY 203
+
Sbjct: 671 KD--SAHHH 677
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 7e-14
Identities = 22/155 (14%), Positives = 48/155 (30%), Gaps = 3/155 (1%)
Query: 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFS 78
N L + G L L+ L ++L +N + ++ L + + N +
Sbjct: 514 NNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLN 573
Query: 79 GELPEELGSLLNLEKLHLSSNNFTGELPKTFAK-LTNMKDFRISDNQFTGQIPSFIQNWT 137
+ ++L+ L+L N T K F N+ + + N F S
Sbjct: 574 TLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVN 633
Query: 138 KLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 172
+ + L+ + + + +
Sbjct: 634 WINETHTNIPELSSHYLCN--TPPHYHGFPVRLFD 666
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-35
Identities = 61/285 (21%), Positives = 113/285 (39%), Gaps = 45/285 (15%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLYGCC 458
+G GGFG V++ D A+K++ +++ RE + E+ ++ L+HP +V+ +
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 459 IEGNQ------------LLLIYEYLENNSLARALFEHRLK--LDWPTRRRICLGIARGLA 504
+E N L + + +L + + I L IA +
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA--------- 555
+LH + ++HRD+K +N+ D K+ DFGL +++ +
Sbjct: 133 FLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 556 --GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 613
GT YM+PE + K D++S G++ E++ S T+ + L
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFS--TQMERVRTLT----DVRNL 243
Query: 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
K L + E VMV +L + P RP +++
Sbjct: 244 KFPPL----FTQKYPCEYVMVQ---DMLSPS--PMERPEAINIIE 279
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 18/203 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMI-SALQHPNLVKLYGC 457
IG G +G V K + G +AVK++ S + ++ + ++ ++ + P +V+ YG
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR----RRICLGIARGLAYLHGESRIK 513
+ E + + S + LD +I L + L +L +K
Sbjct: 90 LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLK 146
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGL-AKLDEEENTHISTRVAGTIGYMAPE----YAMR 568
++HRDIK +N+LLD+ N K+ DFG+ +L ++ TR AG YMAPE A R
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 569 GHLTEKADVYSFGIVALEIVSGR 591
++DV+S GI E+ +GR
Sbjct: 204 QGYDVRSDVWSLGITLYELATGR 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-35
Identities = 49/215 (22%), Positives = 100/215 (46%), Gaps = 15/215 (6%)
Query: 386 LQIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQL-SSKSKQGNREFINEIGMI 443
+++KA ++ +G G +G V K + G +AVK++ ++ + Q + + ++ +
Sbjct: 2 MEVKA--DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS 59
Query: 444 -SALQHPNLVKLYGCCIEGNQLLLIYEYLE--NNSLARALFEHRLKLDWPTRRRICLGIA 500
+ P V YG + + E ++ + + + + + +I + I
Sbjct: 60 MRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119
Query: 501 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 560
+ L +LH S++ V+HRD+K +NVL++ K+ DFG++ + AG Y
Sbjct: 120 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPY 175
Query: 561 MAPE----YAMRGHLTEKADVYSFGIVALEIVSGR 591
MAPE + + K+D++S GI +E+ R
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 63/197 (31%), Positives = 89/197 (45%), Gaps = 12/197 (6%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVK----QLSSKSKQGNREFINEIGMISALQHPNLVKLY 455
+G GG VY +A+K K + R F E+ S L H N+V +
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKR-FEREVHNSSQLSHQNIVSMI 77
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
E + L+ EY+E +L E L T I G+ + H +++V
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTL-SEYIESHGPLSVDTAINFTNQILDGIKHAH---DMRIV 133
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 574
HRDIK N+L+D + KI DFG+AK L E T + V GT+ Y +PE A E
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAKGEATDEC 192
Query: 575 ADVYSFGIVALEIVSGR 591
D+YS GIV E++ G
Sbjct: 193 TDIYSIGIVLYEMLVGE 209
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-34
Identities = 41/265 (15%), Positives = 92/265 (34%), Gaps = 30/265 (11%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGP----IPKYLANISTLVNLTVQYNQFSG 79
L+ +G +P + +LT L+ ++L ++ K PK ++ + +
Sbjct: 88 LEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQK 147
Query: 80 ELPEELG--SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWT 137
+ +L K ++S+ + K+ N T + + T
Sbjct: 148 TFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLT 206
Query: 138 KLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMK-MTKLILRNCNI 196
KL + ++ S + EN + + N+K +T + + NC
Sbjct: 207 KLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLK-----WDNLKDLTDVEVYNCPN 261
Query: 197 TGELPRYLGKMTKLKVLDLSFNRLR--------GQIPSNFDDLYDVDYIYFAGN-LLTGA 247
+LP +L + ++++++++ NR Q ++ + IY N L T
Sbjct: 262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFP 321
Query: 248 IPPWM-----LERGDKIDLSYNNFT 267
+ + L ++ YN
Sbjct: 322 VETSLQKMKKLG---MLECLYNQLE 343
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-33
Identities = 45/279 (16%), Positives = 89/279 (31%), Gaps = 36/279 (12%)
Query: 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLK-GPIPKYLANISTLVNLTVQYNQF 77
N+ ++ +Q I + N LK P+ L + L L YNQ
Sbjct: 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQL 342
Query: 78 SGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPS--FIQN 135
G GS + L L+L+ N T +++ + N+ IP+ ++
Sbjct: 343 EG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKS 400
Query: 136 WTKLEKLFIQ-------PSGLAGPIPSGIFSLENLTDLRISD--LNG-PEATFPQLGNMK 185
+ + + P+ F N++ + +S+ ++ P+ F
Sbjct: 401 VSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP-- 458
Query: 186 MTKLILRNCNITG-------ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDD--LYDVDY 236
++ + L +T + L +DL FN+L + +F L +
Sbjct: 459 LSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVG 517
Query: 237 IYFAGNLLTGAIPPWM--------LERGDKIDLSYNNFT 267
I + N + P ++ D N
Sbjct: 518 IDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTL 555
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-32
Identities = 47/275 (17%), Positives = 92/275 (33%), Gaps = 36/275 (13%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQF------ 77
+ K L L D+ + +P +L + + + V N+
Sbjct: 232 SEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQL 291
Query: 78 --SGELPEELGSLLNLEKLHLSSNNF-TGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQ 134
+ + ++ +++ NN T + + K+ + NQ G++P+F
Sbjct: 292 KDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAF-G 350
Query: 135 NWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISD--LNG-PEATFPQLGNM-KMTKL 189
+ KL L + + + IP+ E + +L + L P ++ M+ +
Sbjct: 351 SEIKLASLNLAYNQITE-IPANFCGFTEQVENLSFAHNKLKYIPNIFD--AKSVSVMSAI 407
Query: 190 ILRNCNITG-------ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGN 242
I L K + ++LS N++ F + I GN
Sbjct: 408 DFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGN 467
Query: 243 LLTGAIPPWMLERGD----------KIDLSYNNFT 267
+LT IP L+ + IDL +N T
Sbjct: 468 MLTE-IPKNSLKDENENFKNTYLLTSIDLRFNKLT 501
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 7e-32
Identities = 46/266 (17%), Positives = 93/266 (34%), Gaps = 39/266 (14%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
N+T + + LT L+ + + +Y Q + +
Sbjct: 194 NITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDN 247
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT--------GQIPSFIQNWTKL 139
L +L + + + +LP L M+ ++ N+ Q + K+
Sbjct: 248 LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKI 307
Query: 140 EKLFIQPSGLA-GPIPSGIFSLENLTDLRISD--LNGPEATFPQLGNM-KMTKLILRNCN 195
+ ++I + L P+ + + ++ L L L G P G+ K+ L L
Sbjct: 308 QIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG---KLPAFGSEIKLASLNLAYNQ 364
Query: 196 ITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFD--DLYDVDYIYFAGNLLTG------- 246
IT + G +++ L + N+L+ IP+ FD + + I F+ N +
Sbjct: 365 ITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423
Query: 247 AIPPWM-----LERGDKIDLSYNNFT 267
+ P + I+LS N +
Sbjct: 424 PLDPTPFKGINVSS---INLSNNQIS 446
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-31
Identities = 34/267 (12%), Positives = 74/267 (27%), Gaps = 39/267 (14%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKG-PIPKYLANISTLVNLTVQYNQFSG------- 79
+T + ++++S N+LK P ++S + + YN+
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFD 423
Query: 80 ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKL 139
L +N+ ++LS+N + + F+ + + + N T
Sbjct: 424 PLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE------------ 471
Query: 140 EKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNG--PEATFPQLGNMKMTKLILRNCN 195
P + LT + + L + L + + L +
Sbjct: 472 -----IPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY--LVGIDLSYNS 524
Query: 196 ITGELPRYLGKMTKLKVL------DLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 249
+ P + LK D NR + P + + N + +
Sbjct: 525 FSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VN 582
Query: 250 PWMLERGDKIDLSYNNFTDGSAESSCQ 276
+ +D+ N C
Sbjct: 583 EKITPNISVLDIKDNPNISIDLSYVCP 609
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 35/212 (16%), Positives = 71/212 (33%), Gaps = 25/212 (11%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSG-------E 80
L P + + I+L N++ + + S L ++ + N + +
Sbjct: 420 KNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKD 479
Query: 81 LPEELGSLLNLEKLHLSSNNFTGELPKTFA--KLTNMKDFRISDNQFTGQIPSFIQNWTK 138
E + L + L N T L F L + +S N F+ P+ N +
Sbjct: 480 ENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSST 537
Query: 139 LEKLFIQPS------GLAGPIPSGIFSLENLTDLRISD--LNG-PEATFPQLGNMKMTKL 189
L+ I+ P GI +LT L+I + E P + + L
Sbjct: 538 LKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKITPNI-----SVL 592
Query: 190 ILRNCNITGELPRYLGKMTKLKVLDLSFNRLR 221
+++ Y+ + + L +++ +
Sbjct: 593 DIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 28/253 (11%), Positives = 75/253 (29%), Gaps = 36/253 (14%)
Query: 69 NLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ 128
N + + + + L S + L L +G +P +LT ++ + +
Sbjct: 61 NFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVN 120
Query: 129 ----IPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLE--NLTDLRISDLNGPEATFPQLG 182
P I E+ + +L I+ ++
Sbjct: 121 ERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSR 180
Query: 183 NM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDY----- 236
K T++ + NIT + + + ++TKL+ + + + + + +Y
Sbjct: 181 ITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYK 239
Query: 237 --------------IYFAGNLLTGAIPPWM-----LERGDKIDLSYNNFTDG-SAESSCQ 276
+ +P ++ ++ I+++ N G + Q
Sbjct: 240 TEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQ---LINVACNRGISGEQLKDDWQ 296
Query: 277 KRSVTGIVSCLRS 289
+ + ++
Sbjct: 297 ALADAPVGEKIQI 309
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-34
Identities = 66/208 (31%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGC- 457
+G G +G VYKG + G A+K + E EI M+ H N+ YG
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 458 -----CIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESR 511
+QL L+ E+ S+ + + L IC I RGL++LH
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 148
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGL-AKLDEEE---NTHISTRVAGTIGYMAPEYAM 567
KV+HRDIK NVLL ++ K+ DFG+ A+LD NT GT +MAPE
Sbjct: 149 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-----FIGTPYWMAPEVIA 202
Query: 568 RGHLTE-----KADVYSFGIVALEIVSG 590
+ K+D++S GI A+E+ G
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-33
Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 18/208 (8%)
Query: 394 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIG-MISALQHPNLV 452
+F + +G G G + + D +AVK++ + E+ + + +HPN++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVI 81
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
+ + + + E +L + + + GLA+LH +
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SL 137
Query: 513 KVVHRDIKATNVLL-----DKDLNSKISDFGLAKLDEEENTHISTR--VAGTIGYMAPEY 565
+VHRD+K N+L+ + + ISDFGL K S R V GT G++APE
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 566 ---AMRGHLTEKADVYSFGIVALEIVSG 590
+ + T D++S G V ++S
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 52/199 (26%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQL-SSKSKQGNREFINEIG-MISALQHPNLVKLYGC 457
+G G G V+K G IAVKQ+ S +K+ N+ + ++ ++ + P +V+ +G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 517
I + + E + + + ++ + I + L YL + V+HR
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQG-PIPERILGKMTVAIVKALYYLK--EKHGVIHR 149
Query: 518 DIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-----YAMRGHLT 572
D+K +N+LLD+ K+ DFG++ + R AG YMAPE +
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYD 207
Query: 573 EKADVYSFGIVALEIVSGR 591
+ADV+S GI +E+ +G+
Sbjct: 208 IRADVWSLGISLVELATGQ 226
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 54/197 (27%), Positives = 82/197 (41%), Gaps = 12/197 (6%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI----NEIGMISALQHPNLVKLY 455
+G GG G VY+ +A+K +S + + F E LQ P++V ++
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMSE-TLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
QL + + LA L L P I I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAH---AAGAT 156
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 574
HRD+K N+L+ D + + DFG+A +E+ T + GT+ YMAPE H T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSESHATYR 215
Query: 575 ADVYSFGIVALEIVSGR 591
AD+Y+ V E ++G
Sbjct: 216 ADIYALTCVLYECLTGS 232
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-32
Identities = 41/242 (16%), Positives = 79/242 (32%), Gaps = 13/242 (5%)
Query: 36 KLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQ--FSGELPEELGSLLNLEK 93
+ L L KG ++ +L L + N F G + +L+
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 94 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP-SFIQNWTKLEKLFIQPSGLAGP 152
L LS N + F L ++ + S + L L I +
Sbjct: 378 LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 153 IPSGIFSLENLTDLRISD----LNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMT 208
L +L L+++ N F +L N+ L L C + P ++
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF--LDLSQCQLEQLSPTAFNSLS 494
Query: 209 KLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDK---IDLSYNN 265
L+VL++S N + L + + ++ N + + + ++L+ N+
Sbjct: 495 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND 554
Query: 266 FT 267
F
Sbjct: 555 FA 556
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-26
Identities = 37/231 (16%), Positives = 67/231 (29%), Gaps = 17/231 (7%)
Query: 26 EQNLTGV---LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELP 82
E N + LP L L N L+ + L L + +
Sbjct: 16 ELNFYKIPDNLPFSTKNL------DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 83 EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 142
SL +L L L+ N F+ L++++ + I + L++L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 143 FIQPSGLAG-PIPSGIFSLENLTDLRISD--LNG-PEATFPQLGNMKMT--KLILRNCNI 196
+ + + +P +L NL L +S + L M + L L +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 197 TGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTG 246
+ K +L L L N + L ++
Sbjct: 190 NF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 39/233 (16%), Positives = 72/233 (30%), Gaps = 11/233 (4%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEE-LG 86
+ G T L+ + L N + + + L +L Q++
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 87 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI-PSFIQNWTKLEKLFIQ 145
SL NL L +S + F L++++ +++ N F P L L +
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 146 PSGLAGPIPSGIFSLENLTDLRISD--LNG-PEATFPQLGNMKMTKLILRNCNITGELPR 202
L P+ SL +L L +S + L ++ L +I +
Sbjct: 479 QCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL--QVLDYSLNHIMTSKKQ 536
Query: 203 YLGKM-TKLKVLDLSFNRLRGQIPSN--FDDLYDVDYIYFAGNLLTGAIPPWM 252
L + L L+L+ N + D + + A P
Sbjct: 537 ELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDK 589
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-23
Identities = 35/258 (13%), Positives = 81/258 (31%), Gaps = 24/258 (9%)
Query: 28 NLTGVLPPK-LAELTFLQDISLIANRLKGPIPKYLANIST---LVNLTVQYNQFS----- 78
+ + + L L+ L+ + + S L NLT++ + +
Sbjct: 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYY 270
Query: 79 -GELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWT 137
++ + L N+ L S F+ + + + +F +++
Sbjct: 271 LDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLK 328
Query: 138 KLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQLGNM-KMTKLILRNC 194
+L + G L +L L +S L+ + L L
Sbjct: 329 RLTFTSNK-----GGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFN 383
Query: 195 NITGELPRYLGKMTKLKVLDLSFNRLRGQIP-SNFDDLYDVDYIYFAGNLLTGAIPPWM- 252
+ + + +L+ LD + L+ S F L ++ Y+ + A
Sbjct: 384 GVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFN 442
Query: 253 -LERGDKIDLSYNNFTDG 269
L + + ++ N+F +
Sbjct: 443 GLSSLEVLKMAGNSFQEN 460
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-16
Identities = 29/193 (15%), Positives = 61/193 (31%), Gaps = 28/193 (14%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKY-LANISTLVNLTVQYNQFSGELPEELG 86
+ L+ L+ + + N + + L L + Q P
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 87 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNW-TKLEKLFIQ 145
SL +L+ L++S NNF + L +++ S N +Q++ + L L +
Sbjct: 492 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL- 550
Query: 146 PSG--LAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRY 203
+ A F L+ + D R L++ + P
Sbjct: 551 -TQNDFACTCEHQSF-LQWIKDQRQ--------------------LLVEVERMECATPSD 588
Query: 204 LGKMTKLKVLDLS 216
+ + L+++
Sbjct: 589 K-QGMPVLSLNIT 600
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-32
Identities = 45/199 (22%), Positives = 79/199 (39%), Gaps = 21/199 (10%)
Query: 401 IGEGGFGPVYKG--LLADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLY-- 455
I GG G +Y +G + +K L + + E ++ + HP++V+++
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 456 GCCIEGNQLLLIY---EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
+ + + Y EY+ SL R+ + L L I L+YLH I
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLH---SI 201
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
+V+ D+K N++L ++ K+ D G + GT G+ APE R T
Sbjct: 202 GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGY-----LYGTPGFQAPEIV-RTGPT 254
Query: 573 EKADVYSFGIVALEIVSGR 591
D+Y+ G +
Sbjct: 255 VATDIYTVGRTLAALTLDL 273
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVK----QLSSKSKQGNREFINEIGMISALQHPNLVKLY 455
+G GG V+ L D +AVK L+ R F E +AL HP +V +Y
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLR-FRREAQNAAALNHPAIVAVY 78
Query: 456 --GCCIEGNQLLLIY---EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
G E L Y EY++ +L + + + + L + H
Sbjct: 79 DTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSH--- 133
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHIST-RVAGTIGYMAPEYAMR 568
+ ++HRD+K N+++ K+ DFG+A+ + + N+ T V GT Y++PE A
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 569 GHLTEKADVYSFGIVALEIVSGR 591
+ ++DVYS G V E+++G
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGE 216
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 8/195 (4%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNRE-FINEIGMISALQHPNLVKLYG 456
+G+G F VY+ + G +A+K + K+ K G + NE+ + L+HP++++LY
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+ N + L+ E N + R L R I G+ YLH ++H
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILH 135
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
RD+ +N+LL +++N KI+DFGLA + + T + GT Y++PE A R ++D
Sbjct: 136 RDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLESD 194
Query: 577 VYSFGIVALEIVSGR 591
V+S G + ++ GR
Sbjct: 195 VWSLGCMFYTLLIGR 209
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 46/217 (21%), Positives = 84/217 (38%), Gaps = 23/217 (10%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPN 450
+ + + +G+G V++G G A+K ++ S + E ++ L H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 451 LVKLYGC--CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR--RRICLGIARGLAYL 506
+VKL+ +LI E+ SL L E P + + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 507 HGESRIKVVHRDIKATNVLL----DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 562
+VHR+IK N++ D K++DFG A+ E++ + GT Y+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLH 183
Query: 563 PE--------YAMRGHLTEKADVYSFGIVALEIVSGR 591
P+ + D++S G+ +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQLSSKS--KQGNRE-FINEIGMISALQHPNLVKLYG 456
+G+GGF ++ A K + K RE EI + +L H ++V +G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+ + + ++ E SL + L P R I G YLH R +V+H
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIH 138
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RGHLTEKA 575
RD+K N+ L++DL KI DFGLA E + + GT Y+APE +GH + +
Sbjct: 139 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH-SFEV 196
Query: 576 DVYSFGIVALEIVSGR 591
DV+S G + ++ G+
Sbjct: 197 DVWSIGCIMYTLLVGK 212
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 11/196 (5%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQLSSKS--KQGNRE-FINEIGMISALQHPNLVKLYG 456
+G+GGF ++ A K + K RE EI + +L H ++V +G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+ + + ++ E SL + L P R I G YLH R +V+H
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLRQIVLGCQYLH---RNRVIH 164
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RGHLTEKA 575
RD+K N+ L++DL KI DFGLA E + + GT Y+APE +GH + +
Sbjct: 165 RDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH-SFEV 222
Query: 576 DVYSFGIVALEIVSGR 591
DV+S G + ++ G+
Sbjct: 223 DVWSIGCIMYTLLVGK 238
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 57/196 (29%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQLS----SKSKQGNREFINEIGMISALQHPNLVKLY 455
+G+G FG VY +A+K L K+ ++ E+ + S L+HPN+++LY
Sbjct: 17 LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLRHPNILRLY 75
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G + ++ LI EY ++ R L + K D +A L+Y H +V+
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH---SKRVI 131
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 575
HRDIK N+LL KI+DFG + + GT+ Y+ PE EK
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT--D-LCGTLDYLPPEMIEGRMHDEKV 188
Query: 576 DVYSFGIVALEIVSGR 591
D++S G++ E + G+
Sbjct: 189 DLWSLGVLCYEFLVGK 204
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-31
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNL 451
+ +G GGFG V + + G +A+KQ + NRE EI ++ L HPN+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 452 VKLYGCCIE-------GNQLLLIYEYLENNSLARAL--FEHRLKLDWPTRRRICLGIARG 502
V + + LL EY E L + L FE+ L R + I+
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 503 LAYLHGESRIKVVHRDIKATNVLLDKDLNS---KISDFGLAKLDEEENTHISTRVAGTIG 559
L YLH +++HRD+K N++L KI D G AK + ++ + V GT+
Sbjct: 134 LRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK-ELDQGELCTEFV-GTLQ 188
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 591
Y+APE + T D +SFG +A E ++G
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-31
Identities = 46/217 (21%), Positives = 84/217 (38%), Gaps = 23/217 (10%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPN 450
+ + + +G+G V++G G A+K ++ S + E ++ L H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 451 LVKLYGC--CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR--RRICLGIARGLAYL 506
+VKL+ +LI E+ SL L E P + + G+ +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 507 HGESRIKVVHRDIKATNVLL----DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 562
+VHR+IK N++ D K++DFG A+ E++ + GT Y+
Sbjct: 129 R---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE-LEDDEQFVSLY-GTEEYLH 183
Query: 563 PE--------YAMRGHLTEKADVYSFGIVALEIVSGR 591
P+ + D++S G+ +G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 50/217 (23%), Positives = 82/217 (37%), Gaps = 26/217 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIG-MISALQHPNLVKLYGCC 458
+ EGGF VY+ + G A+K+L S ++ NR I E+ M HPN+V+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 459 I-------EGNQLLLIYEYLENNSLARALFEHRLK--LDWPTRRRICLGIARGLAYLHGE 509
G L+ L L L + + L T +I R + ++H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH-R 154
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA-----------GTI 558
+ ++HRD+K N+LL K+ DFG A + + T
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 559 GYMAPE---YAMRGHLTEKADVYSFGIVALEIVSGRS 592
Y PE + EK D+++ G + + +
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-30
Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 13/196 (6%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQLS----SKSKQGNREFINEIGMISALQHPNLVKLY 455
+G+G FG VY + +A+K L K ++ EI + S L+HPN++++Y
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ-LRREIEIQSHLRHPNILRMY 80
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
+ ++ L+ E+ L + L +H + D +A L Y H KV+
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCH---ERKVI 136
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 575
HRDIK N+L+ KI+DFG + T + GT+ Y+ PE EK
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR--T-MCGTLDYLPPEMIEGKTHDEKV 193
Query: 576 DVYSFGIVALEIVSGR 591
D++ G++ E + G
Sbjct: 194 DLWCAGVLCYEFLVGM 209
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-30
Identities = 43/264 (16%), Positives = 84/264 (31%), Gaps = 36/264 (13%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
N + + LT LQ I + + Y + +
Sbjct: 435 NRITFISKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSN 489
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTG---------QIPSFIQNWTK 138
L +L + L + +LP L ++ I+ N+ ++ K
Sbjct: 490 LKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPK 549
Query: 139 LEKLFIQPSGLAG-PIPSGIFSLENLTDLRISD--LNGPEATFPQLGNM-KMTKLILRNC 194
++ ++ + L P + + + L L + G K+T L L
Sbjct: 550 IQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVR----HLEAFGTNVKLTDLKLDYN 605
Query: 195 NITGELPRYLGK-MTKLKVLDLSFNRLRGQIPSNFD--DLYDVDYIYFAGNLLTGAIPPW 251
I E+P +++ L S N+L+ IP+ F+ +Y + + F+ N +
Sbjct: 606 QIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGS-EGRN 662
Query: 252 MLERGD--------KIDLSYNNFT 267
+ D + LSYN
Sbjct: 663 ISCSMDDYKGINASTVTLSYNEIQ 686
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-25
Identities = 36/263 (13%), Positives = 78/263 (29%), Gaps = 40/263 (15%)
Query: 33 LPPKL-AELTFLQDISLIANRLKG-PIPKYLANISTLVNLTVQYNQFSGELPEELGS--- 87
+P A ++ + N+LK P ++ + ++ YN+ +
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGS-EGRNISCSMD 668
Query: 88 ---LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFI 144
+N + LS N + FA + + +S+N T I
Sbjct: 669 DYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SI--------------- 712
Query: 145 QPSGLAGPIPSGIFSLENLTDLRISD--LNG--PEATFPQLGNMKMTKLILRNCNITGEL 200
P P + LT + + L + L ++ + + +
Sbjct: 713 -PENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPY--LSNMDVSYNCFS-SF 768
Query: 201 PRYLGKMTKLKVLDLSF------NRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLE 254
P ++LK + NR+ Q P+ + + N + + +
Sbjct: 769 PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIRK-VDEKLTP 827
Query: 255 RGDKIDLSYNNFTDGSAESSCQK 277
+ +D++ N S C
Sbjct: 828 QLYILDIADNPNISIDVTSVCPY 850
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 34/314 (10%), Positives = 90/314 (28%), Gaps = 38/314 (12%)
Query: 10 FHFWKQKTVNQKRV-LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLV 68
F K V ++ + + A + + R +
Sbjct: 244 FTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNW- 302
Query: 69 NLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ 128
N + + + + +L + + L L+ G +P +LT +K + T
Sbjct: 303 NFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVS 362
Query: 129 IPSFIQNWTKLEKLFIQPSGLAGPIPSGIF----SLENLTDLRISDLNGPEATFPQLG-- 182
F + + + L L+ + PE +
Sbjct: 363 GRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422
Query: 183 -NMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG------------------- 222
++K T++ IT + + + ++TKL+++ + +
Sbjct: 423 ISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYE 481
Query: 223 QIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-----LERGDKIDLSYNNFTDGSAESSCQK 277
++ +L D+ + +P ++ L+ ++++ N +A+
Sbjct: 482 NEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQS---LNIACNRGI-SAAQLKADW 537
Query: 278 RSVTGIVSCLRSVQ 291
+ +Q
Sbjct: 538 TRLADDEDTGPKIQ 551
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 20/126 (15%), Positives = 41/126 (32%), Gaps = 14/126 (11%)
Query: 28 NLTGVLPPKLA--ELTFLQDISLIANRLKGPIPKYLANISTLV------NLTVQYNQFSG 79
LT L L +L ++ + N P N S L + N+
Sbjct: 739 KLTS-LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILR 796
Query: 80 ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT-GQIPSFIQNWTK 138
+ P + + +L +L + SN+ ++ + + I+DN + S
Sbjct: 797 QWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIEA 853
Query: 139 LEKLFI 144
+ +
Sbjct: 854 GMYVLL 859
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-29
Identities = 55/228 (24%), Positives = 89/228 (39%), Gaps = 37/228 (16%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIG-MISALQHPNL 451
N ++ +G G G V G +AVK++ + EI + + HPN+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRML---IDFCDIALMEIKLLTESDDHPNV 71
Query: 452 VKLYGCCIEGNQLLLIYEYLENNSLA------RALFEHRLKLDWPTRRRICLGIARGLAY 505
++ Y L + E +L E+ + IA G+A+
Sbjct: 72 IRYYCSETTDRFLYIALELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 506 LHGESRIKVVHRDIKATNVLLD-------------KDLNSKISDFGLAKLDEEENTHIST 552
LH +K++HRD+K N+L+ ++L ISDFGL K + + T
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 553 R---VAGTIGYMAPE-------YAMRGHLTEKADVYSFGIVALEIVSG 590
+GT G+ APE + LT D++S G V I+S
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 47/228 (20%), Positives = 93/228 (40%), Gaps = 38/228 (16%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLA--DGTAIAVKQLSSKSKQGNREFI------------- 437
N++ + +G F + L D A+K+ + R+F
Sbjct: 31 NDYRIIRTLNQGKFNKII---LCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 438 ----NEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSL-------ARALFEHRLK 486
NE+ +I+ +++ + G +++ +IYEY+EN+S+ +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 487 LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546
+ + I + +Y+H + + HRD+K +N+L+DK+ K+SDFG ++ ++
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 547 NTHISTRVAGTIGYMAPEYAMRGHLT---EKADVYSFGIVALEIVSGR 591
S GT +M PE + K D++S GI +
Sbjct: 206 KIKGS---RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 37/295 (12%), Positives = 77/295 (26%), Gaps = 43/295 (14%)
Query: 386 LQIKAATNNFATDNNIGEGGFGPVYKG------LLADGTAIAVKQLSSKSKQGNREFINE 439
+ + + + +GEG F VY+ + +K +
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 440 IGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRL----KLDWPTRRRI 495
+ + +K Y + N +L+ E +L A+ ++ +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 496 CLGIARGLAYLHGESRIKVVHRDIKATNVLL-----------DKDLNSKISDFGLAK-LD 543
+ + + +H +++H DIK N +L D + D G + +
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL 603
I T T G+ E + D + ++ G M
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTY------MKVKN 288
Query: 604 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
+ E + +L N +LR
Sbjct: 289 EGGECKPEG----------LFRRLPHLDMWNEFFHVML--NIPDCHHLPSLDLLR 331
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-29
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 21/210 (10%)
Query: 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQ 447
+ + +G G +G V A+K + K+ + E+ ++ L
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIR-KTSVSTSSNSKLLEEVAVLKLLD 94
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLA 504
HPN++KLY + L+ E + LF+ + I + G+
Sbjct: 95 HPNIMKLYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAAVIIKQVLSGVT 150
Query: 505 YLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYM 561
YLH +VHRD+K N+LL +KD KI DFGL+ + E + GT Y+
Sbjct: 151 YLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KERLGTAYYI 205
Query: 562 APEYAMRGHLTEKADVYSFGIVALEIVSGR 591
APE +R EK DV+S G++ +++G
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVILFILLAGY 234
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 56/233 (24%), Positives = 96/233 (41%), Gaps = 17/233 (7%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
L+ L P + L+ LQ +++ A L +P + + L LT+ N LP
Sbjct: 88 LRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLARNPLR-ALPA 144
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAK---------LTNMKDFRISDNQFTGQIPSFIQ 134
+ SL L +L + + ELP+ A L N++ R+ +P+ I
Sbjct: 145 SIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIA 203
Query: 135 NWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ-LGNMK-MTKLILR 192
N L+ L I+ S L+ + I L L +L + +P G + +LIL+
Sbjct: 204 NLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALR-NYPPIFGGRAPLKRLILK 261
Query: 193 NCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 245
+C+ LP + ++T+L+ LDL ++PS L I +L
Sbjct: 262 DCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 47/209 (22%), Positives = 88/209 (42%), Gaps = 22/209 (10%)
Query: 33 LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS----- 87
LP + + L+ ++L N L+ +P +A+++ L L+++ ELPE L S
Sbjct: 119 LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 88 ----LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 143
L+NL+ L L LP + A L N+K +I ++ + + I + KLE+L
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELD 235
Query: 144 IQPSGLAGPIPSGIFSLENLTDLRISDLNG----PEATFPQLGNMKM-TKLILRNCNITG 198
++ P L L + D + P + + KL LR C
Sbjct: 236 LRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD----IHRLTQLEKLDLRGCVNLS 291
Query: 199 ELPRYLGKMTKLKVLDLSFNRLRGQIPSN 227
LP + ++ ++ + + L+ Q+ +
Sbjct: 292 RLPSLIAQLPANCIILVPPH-LQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 6e-10
Identities = 21/156 (13%), Positives = 44/156 (28%), Gaps = 11/156 (7%)
Query: 79 GELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTK 138
G E L+ + ++ + + + N
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQA----NSNN 57
Query: 139 LEKLFIQPSGL-AGPIPSGIFSLENLTDLRISDLNGPEATFP-QLGNMK-MTKLILRNCN 195
+ L A + L + + FP Q + + + +
Sbjct: 58 PQIETRTGRALKATADLLEDATQPGRVALELRSVPL--PQFPDQAFRLSHLQHMTIDAAG 115
Query: 196 ITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 231
+ ELP + + L+ L L+ N LR +P++ L
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASL 149
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 38/249 (15%), Positives = 76/249 (30%), Gaps = 13/249 (5%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
L + L+ L+ + I + L N TL +L + N S +
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP 151
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMK--DFRISDNQFTGQIPSFIQNWTKLEKLFIQ 145
L+ L +N + + L ++ N G I + + L
Sbjct: 152 TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNFG 210
Query: 146 PSGLAGPIPSGIF--SLENLTDLRISDLNG---PEATFPQLGNMKMTKLILRNCNITGEL 200
+ I G+ ++++L D++ A F L M + + L+
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270
Query: 201 PRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDK-- 258
+ L+ LDL+ L ++PS L + + + N +
Sbjct: 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFEN-LCQISASNFPSLT 328
Query: 259 -IDLSYNNF 266
+ + N
Sbjct: 329 HLSIKGNTK 337
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-26
Identities = 46/252 (18%), Positives = 90/252 (35%), Gaps = 15/252 (5%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKY-LANISTLVNLTVQYNQ--FSGELPEE 84
+ + L +S+ N + + L N+ L L + ++ S +
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 85 LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP-SFIQNWTKLEKLF 143
L +L +L+ L+LS N + F + ++ ++ + + S QN L+ L
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 144 IQPSGLAGPIPSGIFSLENLTDLRISD------LNGPEATFPQLGNMKMTKLILRNCNIT 197
+ S L L L L + + LG ++ L+L C+++
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLE--ILVLSFCDLS 489
Query: 198 GELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LER 255
+ + +DLS NRL L + Y+ A N ++ +P + L +
Sbjct: 490 SIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQ 548
Query: 256 GDKIDLSYNNFT 267
I+L N
Sbjct: 549 QRTINLRQNPLD 560
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-25
Identities = 38/274 (13%), Positives = 72/274 (26%), Gaps = 21/274 (7%)
Query: 11 HFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNL 70
KT N + L + P L + + N L + + L L
Sbjct: 10 EKEVNKTYN----CENLGLNEI-PGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTFL 62
Query: 71 TVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP 130
+ Q + S L+ L L++N + +K +
Sbjct: 63 DLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDF 122
Query: 131 SFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDL-----RISDLNGPEATFPQLGNMK 185
+ N LE L++ + ++ F E L L I L + L
Sbjct: 123 IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYL--SKEDMSSLQQAT 180
Query: 186 MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN--FDDLYDVDYIYFAGNL 243
L L +I + + L+ + I + + F
Sbjct: 181 NLSLNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239
Query: 244 LT----GAIPPWMLERGDKIDLSYNNFTDGSAES 273
+ I+L + F + S+ +
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNISSNT 273
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-23
Identities = 49/257 (19%), Positives = 97/257 (37%), Gaps = 18/257 (7%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
+ +++++ + L E++ ++ I+L + S L L + S ELP
Sbjct: 238 MDDEDISPAVFEGLCEMS-VESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPS 295
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPS-FIQNWTKLEKL 142
L L L+KL LS+N F + + ++ I N ++ + ++N L +L
Sbjct: 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLREL 355
Query: 143 FIQPSGLAGPIPSGIFSLENLTDLRISDLNG------PEATFPQLGNMKMTKLILRNCNI 196
+ + L NL+ L+ +L+ F + + L L +
Sbjct: 356 DLSHDDIET-SDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQ--LELLDLAFTRL 412
Query: 197 TGELPRY-LGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW---- 251
+ + + LKVL+LS + L FD L + ++ GN
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472
Query: 252 -MLERGDKIDLSYNNFT 267
L R + + LS+ + +
Sbjct: 473 QTLGRLEILVLSFCDLS 489
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 21/125 (16%), Positives = 43/125 (34%), Gaps = 4/125 (3%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTV---QYNQFSGE 80
L L L LQ ++L N + ++ TL L + + S
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 81 LPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE 140
SL + + LS N T + + L + ++ N + +PS + ++
Sbjct: 492 DQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQR 550
Query: 141 KLFIQ 145
+ ++
Sbjct: 551 TINLR 555
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 17/101 (16%), Positives = 36/101 (35%), Gaps = 1/101 (0%)
Query: 27 QNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELG 86
L L L+ + L L ++ + ++ + +N+ + E L
Sbjct: 462 PKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALS 521
Query: 87 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTG 127
L + L+L+SN+ + LP L+ + + N
Sbjct: 522 HLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 22/202 (10%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE----FINEIGMISALQHPNLVKLY 455
+G+G FG V G AVK +S K + + + E+ ++ L HPN++KLY
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVIS-KRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 92
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRI 512
+ L+ E LF+ + + RI + G+ Y+H +
Sbjct: 93 EFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAARIIRQVLSGITYMH---KN 145
Query: 513 KVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 569
K+VHRD+K N+LL KD N +I DFGL+ E GT Y+APE + G
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE-VLHG 202
Query: 570 HLTEKADVYSFGIVALEIVSGR 591
EK DV+S G++ ++SG
Sbjct: 203 TYDEKCDVWSTGVILYILLSGC 224
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-28
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQ 447
+ +G+G FG V K AVK ++ K+ N++ + E+ ++ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLD 79
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLA 504
HPN++KL+ + + ++ E LF+ +K + RI + G+
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 505 YLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYM 561
Y+H + +VHRD+K N+LL +KD + KI DFGL+ + GT Y+
Sbjct: 136 YMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--FQQNTKMKDRIGTAYYI 190
Query: 562 APEYAMRGHLTEKADVYSFGIVALEIVSGR 591
APE +RG EK DV+S G++ ++SG
Sbjct: 191 APE-VLRGTYDEKCDVWSAGVILYILLSGT 219
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 6e-28
Identities = 57/270 (21%), Positives = 100/270 (37%), Gaps = 39/270 (14%)
Query: 337 LSSTGHFLENGLKLGPYIQTNTSRLLMNDYQLYTTARLSAISLTYYGFYLQIKAATNNF- 395
S G F+ N +G R L N+ ++ + + + + +
Sbjct: 80 HSGNGTFV-NTELVG----KGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALR 134
Query: 396 ---ATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---------FINEIGM 442
+G G G V +A++ +S K K EI +
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS-KRKFAIGSAREADPALNVETEIEI 193
Query: 443 ISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGI 499
+ L HP ++K+ + ++ E +E LF+ +L T + +
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQM 248
Query: 500 ARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAG 556
+ YLH ++HRD+K NVLL ++D KI+DFG +K+ E + + T G
Sbjct: 249 LLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-G 303
Query: 557 TIGYMAPE---YAMRGHLTEKADVYSFGIV 583
T Y+APE D +S G++
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 333
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 48/194 (24%), Positives = 86/194 (44%), Gaps = 25/194 (12%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 458
+G G F V+ G A+K + KS + NEI ++ ++H N+V L
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIK-KSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 459 IEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRI 512
L+ + + E LF+ L+ T + + + + YLH
Sbjct: 76 ESTTHYYLVMQLVSGGE-------LFDRILERGVYTEKDASLVIQQVLSAVKYLH---EN 125
Query: 513 KVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 569
+VHRD+K N+L +++ I+DFGL+K+++ + GT GY+APE +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPEVLAQK 182
Query: 570 HLTEKADVYSFGIV 583
++ D +S G++
Sbjct: 183 PYSKAVDCWSIGVI 196
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 33/238 (13%), Positives = 70/238 (29%), Gaps = 55/238 (23%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE------------------------ 435
+G+ + G + V + +
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 436 ----FINEIGMISALQHPNLVKLYGCC--IEGNQLLLIYEYLENN--SLARALFEH---R 484
FI ++ Q ++++ + +Y +++N + L H
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 485 LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544
L R ++ L + R LA LH +VH ++ +++LD+ ++ F D
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
Query: 545 EENTHISTRVAGTIGYMAPEY-----------AMRGHLTEKADVYSFGIVALEIVSGR 591
+ + G+ PE R +T D ++ G+V I
Sbjct: 258 ARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 22/228 (9%), Positives = 50/228 (21%), Gaps = 44/228 (19%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLYG 456
+ G V+ + A+K + ++ E + L + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 457 CC--------------------------IEGNQLLLIYEYLENN-----SLARALFEHRL 485
LL+ + S ++ R
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 486 KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545
+ + R A L + +VH N+ + D + D
Sbjct: 190 DEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 546 ENTHISTRVAGTIGYMAPEYAMRGHL--TEKADVYSFGIVALEIVSGR 591
+ + Y E+ T + + G+ +
Sbjct: 247 ----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 28/233 (12%), Positives = 61/233 (26%), Gaps = 44/233 (18%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREF----------------------- 436
+G+ + G + V + +
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 437 --INEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL-------ENNSLARALFEHRLK- 486
+ I ++ P K+ ++ + ++ + + L H
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 487 --LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544
L R ++ L + R LA LH +VH ++ +++LD+ ++ F D
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 545 EENTHISTRVAGTIGYMAPE-----YAMRGHLTEKADVYSFGIVALEIVSGRS 592
R A +T D ++ G+ I
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 53/196 (27%), Positives = 89/196 (45%), Gaps = 24/196 (12%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQLS-SKSKQGNREFINEIGMISALQHPNLVKLYGCC 458
+G G FG V+ + G +K ++ +S+ + EI ++ +L HPN++K++
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTR--------RRICLGIARGLAYLHGES 510
+ + + ++ E E L E R+ + + LAY H
Sbjct: 90 EDYHNMYIVMETCEGGE----LLE-RIVSAQARGKALSEGYVAELMKQMMNALAYFH--- 141
Query: 511 RIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 567
VVH+D+K N+L KI DFGLA+L + + H + GT YMAPE
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL-FKSDEHSTNAA-GTALYMAPE-VF 198
Query: 568 RGHLTEKADVYSFGIV 583
+ +T K D++S G+V
Sbjct: 199 KRDVTFKCDIWSAGVV 214
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 5e-27
Identities = 46/248 (18%), Positives = 88/248 (35%), Gaps = 33/248 (13%)
Query: 426 SSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRL 485
S +I + N V L + + +L +
Sbjct: 98 PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157
Query: 486 KLDWPTR--RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543
D I + IA + +LH + ++HRD+K +N+ D K+ DFGL
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214
Query: 544 EEENTHIS-----------TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRS 592
+++ + T GT YM+PE + + K D++S G++ E++ S
Sbjct: 215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
Query: 593 NVTKEDMFYLLDWALVLKEQGKLMELV-DTNPGSNFDKEQVMVMINVALLCANASPTIRP 651
T+ + ++ + L + +E +MV +L + PT RP
Sbjct: 275 --TQMERVRIIT---------DVRNLKFPLLFTQKYPQEHMMVQ---DMLSPS--PTERP 318
Query: 652 SMSSVLRM 659
+ ++
Sbjct: 319 EATDIIEN 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 17/65 (26%), Positives = 35/65 (53%), Gaps = 2/65 (3%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 458
+G GGFG V++ D A+K++ +++ RE + E+ ++ L+HP +V+ +
Sbjct: 14 MGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 73
Query: 459 IEGNQ 463
+E
Sbjct: 74 LETPP 78
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-26
Identities = 58/212 (27%), Positives = 90/212 (42%), Gaps = 32/212 (15%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE--------------FINEIGMISA 445
+G G +G V + A+K + KS+ NEI ++ +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIK-KSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 446 LQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARG 502
L HPN++KL+ + L+ E+ E LFE + I I G
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAANIMKQILSG 158
Query: 503 LAYLHGESRIKVVHRDIKATNVLL-DKDLNS--KISDFGLAKLDEEENTHISTRVAGTIG 559
+ YLH + +VHRDIK N+LL +K+ KI DFGL+ + GT
Sbjct: 159 ICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKLRDRLGTAY 213
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 591
Y+APE ++ EK DV+S G++ ++ G
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 27/196 (13%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLYG 456
+G+G FG V K AVK ++ K+ N++ + E+ ++ L HPN++KL+
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVIN-KASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 457 CCIEGNQLLLIYEYL---ENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGES 510
+ + ++ E E LF+ R + RI + G+ Y+H
Sbjct: 89 ILEDSSSFYIVGELYTGGE-------LFDEIIKRKRFSEHDAARIIKQVFSGITYMH--- 138
Query: 511 RIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 567
+ +VHRD+K N+LL +KD + KI DFGL+ ++ GT Y+APE +
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VL 195
Query: 568 RGHLTEKADVYSFGIV 583
RG EK DV+S G++
Sbjct: 196 RGTYDEKCDVWSAGVI 211
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 68/191 (35%), Positives = 90/191 (47%), Gaps = 16/191 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-EIGMISALQHPNLVKLYGCC 458
+GEG +G V + A+AVK + K E I EI + L H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 459 IEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
EGN L EY L F+ + + P +R + G+ YLH I +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPE-YAMRGHLT 572
HRDIK N+LLD+ N KISDFGLA + ++ GT+ Y+APE R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHA 186
Query: 573 EKADVYSFGIV 583
E DV+S GIV
Sbjct: 187 EPVDVWSCGIV 197
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 48/190 (25%), Positives = 78/190 (41%), Gaps = 17/190 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IG G +G V + A K++ + F EI ++ +L HPN+++LY
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRIKVVH 516
+ + L+ E LFE + RI + +AY H ++ V H
Sbjct: 77 DNTDIYLVMELCTGGE----LFERVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAH 129
Query: 517 RDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
RD+K N L D K+ DFGLA + GT Y++P+ + G
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM--RTKVGTPYYVSPQ-VLEGLYGP 186
Query: 574 KADVYSFGIV 583
+ D +S G++
Sbjct: 187 ECDEWSAGVM 196
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 27/208 (12%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMI-----------SALQH 448
+G+GGFG V+ G L D +A+K + +++ +++ + H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIP-RNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAY 505
P +++L +L+ E A+ LF + L R + + +
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLP---AQDLFDYITEKGPLGEGPSRCFFGQVVAAIQH 154
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
H VVHRDIK N+L+D K+ DFG L +E GT Y PE
Sbjct: 155 CH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYSPPE 208
Query: 565 Y-AMRGHLTEKADVYSFGIVALEIVSGR 591
+ + + A V+S GI+ ++V G
Sbjct: 209 WISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-26
Identities = 68/191 (35%), Positives = 90/191 (47%), Gaps = 16/191 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-EIGMISALQHPNLVKLYGCC 458
+GEG +G V + A+AVK + K E I EI + L H N+VK YG
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 459 IEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
EGN L EY L F+ + + P +R + G+ YLH I +
Sbjct: 75 REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVVYLH---GIGIT 127
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPE-YAMRGHLT 572
HRDIK N+LLD+ N KISDFGLA + ++ GT+ Y+APE R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFHA 186
Query: 573 EKADVYSFGIV 583
E DV+S GIV
Sbjct: 187 EPVDVWSCGIV 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 47/195 (24%), Positives = 78/195 (40%), Gaps = 16/195 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVK-----QLSSKSKQGNREFINEIGMISALQHPNLVKL 454
IG+G F V + + G AVK + +S + E + L+HP++V+L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESR 511
L +++E+++ L + + + I L Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---D 148
Query: 512 IKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 568
++HRD+K VLL + K+ FG+A E RV GT +MAPE R
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKR 207
Query: 569 GHLTEKADVYSFGIV 583
+ DV+ G++
Sbjct: 208 EPYGKPVDVWGCGVI 222
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-26
Identities = 51/194 (26%), Positives = 94/194 (48%), Gaps = 22/194 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G G FG V+K A G +A K + ++ + E NEI +++ L H NL++LY
Sbjct: 97 LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 460 EGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRRRICLGIAR----GLAYLHGESRI 512
N ++L+ EY+ E LF+ + + + + G+ ++H ++
Sbjct: 157 SKNDIVLVMEYVDGGE-------LFDRIIDESYNLTELDTILFMKQICEGIRHMH---QM 206
Query: 513 KVVHRDIKATNVLL-DKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 570
++H D+K N+L ++D KI DFGLA+ + + GT ++APE
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARR-YKPREKLKVNF-GTPEFLAPEVVNYDF 264
Query: 571 LTEKADVYSFGIVA 584
++ D++S G++A
Sbjct: 265 VSFPTDMWSVGVIA 278
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 50/202 (24%), Positives = 82/202 (40%), Gaps = 30/202 (14%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---------FINEIGMISALQHPN 450
+G G G V +A+K +S K K EI ++ L HP
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIIS-KRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLH 507
++K+ + ++ E +E LF+ +L T + + + YLH
Sbjct: 77 IIKIKN-FFDAEDYYIVLELMEGGE----LFDKVVGNKRLKEATCKLYFYQMLLAVQYLH 131
Query: 508 GESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
++HRD+K NVLL ++D KI+DFG +K+ E + + T GT Y+APE
Sbjct: 132 ---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI-LGETSLMRTLC-GTPTYLAPE 186
Query: 565 ---YAMRGHLTEKADVYSFGIV 583
D +S G++
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVI 208
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 52/207 (25%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-------EIGMISALQH--PN 450
+G GGFG VY G+ ++D +A+K + K + + + E+ ++ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVE-KDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLH 507
+++L + +LI E E + LF+ R L R + + + H
Sbjct: 110 VIRLLDWFERPDSFVLILERPEP---VQDLFDFITERGALQEELARSFFWQVLEAVRHCH 166
Query: 508 GESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 566
V+HRDIK N+L+D + K+ DFG L ++ GT Y PE+
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEW- 219
Query: 567 MRGHLTE--KADVYSFGIVALEIVSGR 591
+R H A V+S GI+ ++V G
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 51/191 (26%), Positives = 85/191 (44%), Gaps = 19/191 (9%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IG G + + + A AVK + + E EI ++ QHPN++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPNIITLKDVYD 86
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRIKVVH 516
+G + ++ E ++ L + L+ + + R + I + + YLH VVH
Sbjct: 87 DGKYVYVVTELMKGGEL----LDKILRQKFFSEREASAVLFTITKTVEYLH---AQGVVH 139
Query: 517 RDIKATNVLL-DKDLNS---KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
RD+K +N+L D+ N +I DFG AK EN + T T ++APE R
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANFVAPEVLERQGYD 198
Query: 573 EKADVYSFGIV 583
D++S G++
Sbjct: 199 AACDIWSLGVL 209
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 56/195 (28%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREFIN-EIGMISALQHPNLVKLYGC 457
IG+G F V + G +A+K + ++ + + + E+ ++ L HPN+VKL+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 517
L LI EY + L H ++ R I + Y H + ++VHR
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCH---QKRIVHR 138
Query: 518 DIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTEKAD 576
D+KA N+LLD D+N KI+DFG + + G Y APE + + + + D
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNE-FTVGGKLDAFC-GAPPYAAPELFQGKKYDGPEVD 196
Query: 577 VYSFGIVALEIVSGR 591
V+S G++ +VSG
Sbjct: 197 VWSLGVILYTLVSGS 211
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 23/212 (10%)
Query: 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN---------EIGMI 443
++T + +G G FG V+ + + VK + K K +I EI ++
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIK-KEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 444 SALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIA 500
S ++H N++K+ E +E + LF +LD P I +
Sbjct: 84 SRVEHANIIKVLDI-FENQGF--FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV 140
Query: 501 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGY 560
+ YL ++HRDIK N+++ +D K+ DFG A E T GTI Y
Sbjct: 141 SAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY-LERGKLFYT-FCGTIEY 195
Query: 561 MAPE-YAMRGHLTEKADVYSFGIVALEIVSGR 591
APE + + +++S G+ +V
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 43/238 (18%), Positives = 80/238 (33%), Gaps = 16/238 (6%)
Query: 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFS--GELPEELGSLLNLEKLHLS 97
L FL+ ++L N+ + +L L + N S G +L L LS
Sbjct: 327 LPFLKSLTLTMNKGSISFK--KVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLS 384
Query: 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP-SFIQNWTKLEKLFIQPSGLAGPIPSG 156
N + F L ++ + S + KL L I +
Sbjct: 385 FNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGI 443
Query: 157 IFSLENLTDLRISD----LNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKV 212
L +L L+++ N F N+ T L L C + + +L++
Sbjct: 444 FLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL--TFLDLSKCQLEQISWGVFDTLHRLQL 501
Query: 213 LDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDK---IDLSYNNFT 267
L++S N L S+++ LY + + + N + + +L+ N+
Sbjct: 502 LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIET-SKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-24
Identities = 39/267 (14%), Positives = 79/267 (29%), Gaps = 23/267 (8%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSG-ELPEELG 86
+ P + LT L+++ + +L + + TL L V +N +LP
Sbjct: 91 PIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFS 150
Query: 87 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR----ISDNQFTGQIPSFIQNWTKLEKL 142
+L NL + LS N L +S N I KL +L
Sbjct: 151 NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHEL 209
Query: 143 FIQPSGLAGPIPSGIFSLENLTDLRISDLNG------------PEATFPQLGNMKMTKLI 190
++ + + I NL L + L + L ++ + +
Sbjct: 210 TLRGNFNSSNIMKTCLQ--NLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFR 267
Query: 191 LRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP 250
L N + + + + L+ ++ + + + L P
Sbjct: 268 LTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ-FPT 324
Query: 251 WMLERGDKIDLSYNNFTDGSAESSCQK 277
L + L+ N + + +
Sbjct: 325 LDLPFLKSLTLTMNKGSISFKKVALPS 351
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-21
Identities = 49/266 (18%), Positives = 82/266 (30%), Gaps = 31/266 (11%)
Query: 24 LKEQNLTGV---LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGE 80
+Q L+ V +P + L N LK +N S L L + +
Sbjct: 18 CMDQKLSKVPDDIPSSTKNI------DLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 81 LPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE 140
+ L +L L L+ N P +F+ LT++++ + + I L+
Sbjct: 72 EDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLK 131
Query: 141 KLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG------PEATFPQLGNMKMT--KLILR 192
KL + + + FS NLT+L DL+ L L +
Sbjct: 132 KLNVAHNFIHSCKLPAYFS--NLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189
Query: 193 NCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTG----- 246
I + + KL L L N I +L +
Sbjct: 190 LNPID-FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLE 248
Query: 247 AIPPWMLE-----RGDKIDLSYNNFT 267
P ++E D+ L+Y N
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDF 274
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 5e-20
Identities = 37/220 (16%), Positives = 71/220 (32%), Gaps = 31/220 (14%)
Query: 65 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 124
S+ N+ + +N + L+ L LS K + L ++ + ++ N
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 125 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM 184
P T LE L + LA I L L L ++
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVA--------------- 136
Query: 185 KMTKLILRNCNITG-ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL----YDVDYIYF 239
+ I +LP Y +T L +DLS+N ++ ++ L +
Sbjct: 137 --------HNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDM 188
Query: 240 AGNLLTGAIPPWMLE--RGDKIDLSYNNFTDGSAESSCQK 277
+ N + I + + ++ L N + ++ Q
Sbjct: 189 SLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQN 227
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 3e-11
Identities = 15/100 (15%), Positives = 28/100 (28%), Gaps = 1/100 (1%)
Query: 28 NLTGVLPPK-LAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELG 86
+ A T L + L +L+ + L L + +N
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 87 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT 126
L +L L S N ++ F +++N
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 52/196 (26%), Positives = 92/196 (46%), Gaps = 10/196 (5%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI-NEIGMISALQHPNLVKLYGCC 458
+G G FG V++ A G A K + + ++E + EI +S L+HP LV L+
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVM-TPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
+ N++++IYE++ L + + K+ + +GL ++H VH D
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLD 280
Query: 519 IKATNVLL-DKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
+K N++ K N K+ DFGL + + GT + APE A + D
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAH-LDPKQSVKVTT-GTAEFAAPEVAEGKPVGYYTD 338
Query: 577 VYSFGIVALEIVSGRS 592
++S G+++ ++SG S
Sbjct: 339 MWSVGVLSYILLSGLS 354
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 48/244 (19%), Positives = 81/244 (33%), Gaps = 57/244 (23%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVK-----QLSSKSKQGNREFINEIGMISALQHPNLVKL 454
IG+G +G V + A+K ++ + + E+ ++ L HPN+ +L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 455 YGCCIEGNQLLLIYEYLENNSL-----ARALFEHRLKLDWPTR----------------- 492
Y + + L+ E L +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 493 -----------------RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS--K 533
I I L YLH + HRDIK N L + + K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 534 ISDFGLAKL----DEEENTHISTRVAGTIGYMAPE--YAMRGHLTEKADVYSFGIVALEI 587
+ DFGL+K + E ++T+ GT ++APE K D +S G++ +
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLL 269
Query: 588 VSGR 591
+ G
Sbjct: 270 LMGA 273
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 57/191 (29%), Positives = 88/191 (46%), Gaps = 19/191 (9%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCC 458
+GEG F K + A AVK +S K + N + EI + + HPN+VKL+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQ--KEITALKLCEGHPNIVKLHEVF 75
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRIKVV 515
+ L+ E L L FE K + I + ++++H + VV
Sbjct: 76 HDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASYIMRKLVSAVSHMH---DVGVV 128
Query: 516 HRDIKATNVLL-DKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
HRD+K N+L D++ N KI DFG A+L +N + T T+ Y APE +
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNGYD 187
Query: 573 EKADVYSFGIV 583
E D++S G++
Sbjct: 188 ESCDLWSLGVI 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-25
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 42/217 (19%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN--------------------- 438
IG+G +G V D T A+K L SK K +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVL-SKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 439 ------EIGMISALQHPNLVKLYGCCIEG---NQLLLIYEYLENNSLARALFEHRLKLDW 489
EI ++ L HPN+VKL ++ + L +++E + + L D
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSED- 137
Query: 490 PTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549
R + +G+ YLH K++HRDIK +N+L+ +D + KI+DFG++ + +
Sbjct: 138 -QARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 550 ISTRVAGTIGYMAPE---YAMRGHLTEKADVYSFGIV 583
+S GT +MAPE + + DV++ G+
Sbjct: 194 LSN-TVGTPAFMAPESLSETRKIFSGKALDVWAMGVT 229
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 26/196 (13%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLYG 456
+G+G F V + + G A K ++ K R+ E + LQHPN+V+L+
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHD 72
Query: 457 CCIEGNQLLLIYEYL---ENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGES 510
E + L+++ + E LFE R I +AY H
Sbjct: 73 SIQEESFHYLVFDLVTGGE-------LFEDIVAREFYSEADASHCIQQILESIAYCH--- 122
Query: 511 RIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 567
+VHR++K N+LL K K++DFGLA ++ GT GY++PE
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE-VNDSEAWHGFA-GTPGYLSPEVLK 180
Query: 568 RGHLTEKADVYSFGIV 583
+ ++ D+++ G++
Sbjct: 181 KDPYSKPVDIWACGVI 196
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 29/201 (14%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVK-----QLSSKSKQGNREFI-NEIGMISALQHPNLVK 453
+G G F V K G A K +LSS + +RE I E+ ++ ++HPN++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 454 LYGCCIEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLH 507
L+ ++LI E + E LF+ + + T + I G+ YLH
Sbjct: 73 LHDIFENKTDVVLILELVSGGE-------LFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 508 GESRIKVVHRDIKATNVLL-DKDLNS---KISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
++ H D+K N++L DK++ + K+ DFG+A E GT ++AP
Sbjct: 126 ---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK-IEAGNEFKNIF-GTPEFVAP 180
Query: 564 EYAMRGHLTEKADVYSFGIVA 584
E L +AD++S G++
Sbjct: 181 EIVNYEPLGLEADMWSIGVIT 201
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 50/194 (25%), Positives = 84/194 (43%), Gaps = 22/194 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G G FG V++ + A G K +++ NEI +++ L HP L+ L+
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 460 EGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRRRICLGIAR----GLAYLHGESRI 512
+ +++LI E+L E LF+ D+ + R GL ++H
Sbjct: 119 DKYEMVLILEFLSGGE-------LFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EH 168
Query: 513 KVVHRDIKATNVLLDKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 570
+VH DIK N++ + S KI DFGLA + I T + APE R
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKVTTATAEFAAPEIVDREP 226
Query: 571 LTEKADVYSFGIVA 584
+ D+++ G++
Sbjct: 227 VGFYTDMWAIGVLG 240
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 55/236 (23%), Positives = 98/236 (41%), Gaps = 18/236 (7%)
Query: 35 PKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKL 94
LA LT + ++L AN L+N++ L LTV ++ + +L +L L
Sbjct: 126 SPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYSL 182
Query: 95 HLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP 154
L+ N P A LT++ F NQ T P + N T+L L I + + P
Sbjct: 183 SLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP 238
Query: 155 SGIFSLENLTDLRISD--LNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLK 211
+ +L LT L I ++ A + ++ K+ L + + I+ L +++L
Sbjct: 239 --LANLSQLTWLEIGTNQISDINA----VKDLTKLKMLNVGSNQISD--ISVLNNLSQLN 290
Query: 212 VLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFT 267
L L+ N+L + L ++ ++ + N +T P L + D D +
Sbjct: 291 SLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 49/243 (20%), Positives = 99/243 (40%), Gaps = 28/243 (11%)
Query: 34 PPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEK 93
L LT L+++ L + + P LAN++ + +L + N L ++ L
Sbjct: 103 ISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNY 159
Query: 94 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPI 153
L ++ + A LT++ ++ NQ P + + T L + +
Sbjct: 160 LTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDIT 215
Query: 154 PSGIFSLENLTDL-----RISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKM 207
P + ++ L L +I+DL+ L N+ ++T L + I+ + +
Sbjct: 216 P--VANMTRLNSLKIGNNKITDLSP-------LANLSQLTWLEIGTNQISD--INAVKDL 264
Query: 208 TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNN 265
TKLK+L++ N++ S ++L ++ ++ N L + L + LS N+
Sbjct: 265 TKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNH 322
Query: 266 FTD 268
TD
Sbjct: 323 ITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-17
Identities = 40/205 (19%), Positives = 73/205 (35%), Gaps = 18/205 (8%)
Query: 67 LVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT 126
L + P L + L + T T +L ++ ++ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTD--VVTQEELESITKLVVAGEKVA 57
Query: 127 GQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQLGNM 184
I+ T LE L + + + P + +L LT+L I + A L N+
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISA----LQNL 109
Query: 185 K-MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNL 243
+ +L L NI+ P L +TK+ L+L N S ++ ++Y+ +
Sbjct: 110 TNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESK 166
Query: 244 LTGAIPPWMLERGDKIDLSYNNFTD 268
+ P L + L+YN D
Sbjct: 167 VKDVTPIANLTDLYSLSLNYNQIED 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 2e-10
Identities = 28/117 (23%), Positives = 50/117 (42%), Gaps = 8/117 (6%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
+T + P LA L+ L + + N++ + +++ L L V NQ S L +
Sbjct: 232 KITDLSP--LANLSQLTWLEIGTNQISDINA--VKDLTKLKMLNVGSNQISD--ISVLNN 285
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFI 144
L L L L++N E + LTN+ +S N T P + + +K++
Sbjct: 286 LSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADF 340
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 47/203 (23%), Positives = 88/203 (43%), Gaps = 29/203 (14%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVK--------QLSSKSKQGNREFI-NEIGMISAL-QHP 449
+G G V + + AVK S++ Q RE E+ ++ + HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 450 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYL 506
N+++L L+++ ++ L F+ ++ L R+I + + L
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMRALLEVICAL 140
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-- 564
H ++ +VHRD+K N+LLD D+N K++DFG + + + GT Y+APE
Sbjct: 141 H---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ-LDPGEKLREVC-GTPSYLAPEII 195
Query: 565 ----YAMRGHLTEKADVYSFGIV 583
++ D++S G++
Sbjct: 196 ECSMNDNHPGYGKEVDMWSTGVI 218
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 49/174 (28%), Positives = 87/174 (50%), Gaps = 7/174 (4%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQG-NREFINEIGMISALQHPN 450
+ + +GEG + VYKG +A+K++ + ++G I E+ ++ L+H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+V L+ L L++EYL+ + L + L + ++ + + RGLAY H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH--- 117
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
R KV+HRD+K N+L+++ K++DFGLA+ V T+ Y P+
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPD 170
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 50/178 (28%), Positives = 89/178 (50%), Gaps = 7/178 (3%)
Query: 389 KAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLS-SKSKQG-NREFINEIGMISAL 446
+ + +GEG +G VYK + G +A+K++ +G I EI ++ L
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 506
HPN+V L L L++E++E + L + L E++ L + + RG+A+
Sbjct: 77 HHPNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
H + +++HRD+K N+L++ D K++DFGLA+ + V T+ Y AP+
Sbjct: 136 H---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPD 189
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 51/198 (25%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVK-----QLSSKSKQGNREFI-NEIGMISALQHPNLVK 453
+G G F V K + G A K Q + + +RE I E+ ++ + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGES 510
L+ ++LI E + LF+ + + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 511 RIKVVHRDIKATNVLL-DKDLNS---KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 566
K+ H D+K N++L DK++ K+ DFGLA E+ GT ++APE
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEFVAPEIV 190
Query: 567 MRGHLTEKADVYSFGIVA 584
L +AD++S G++
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 50/195 (25%), Positives = 86/195 (44%), Gaps = 24/195 (12%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLYG 456
+G+G F V + + G A K ++ K R+ E + LQHPN+V+L+
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIIN-TKKLSARDFQKLEREARICRKLQHPNIVRLHD 95
Query: 457 CCIEGNQLLLIYEYLENNSL-----ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
E + L+++ + L AR + I +AY H
Sbjct: 96 SIQEESFHYLVFDLVTGGELFEDIVAREFYSEA------DASHCIQQILESIAYCH---S 146
Query: 512 IKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 568
+VHR++K N+LL K K++DFGLA E ++ AGT GY++PE +
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI--EVNDSEAWHGFAGTPGYLSPEVLKK 204
Query: 569 GHLTEKADVYSFGIV 583
++ D+++ G++
Sbjct: 205 DPYSKPVDIWACGVI 219
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 6e-24
Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 23/198 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVK-----QLSSKSKQGNREFI-NEIGMISALQHPNLVK 453
+G G F V K + G A K Q + + RE I E+ ++ + HPN++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGES 510
L+ ++LI E + LF+ + + + I G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILDGVNYLH--- 132
Query: 511 RIKVVHRDIKATNVLL-DKDLNS---KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 566
K+ H D+K N++L DK++ K+ DFGLA E+ GT ++APE
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE-IEDGVEFKNIF-GTPEFVAPEIV 190
Query: 567 MRGHLTEKADVYSFGIVA 584
L +AD++S G++
Sbjct: 191 NYEPLGLEADMWSIGVIT 208
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-24
Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 21/194 (10%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE--FINEIGMISALQHPNLVKLYGC 457
+G+G F V + + + G A +++K E + L+HPN+V+L+
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 458 CIEGNQLLLIYEYLENNSL-----ARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
E LI++ + L AR + I + + H ++
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEA------DASHCIQQILEAVLHCH---QM 129
Query: 513 KVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 569
VVHR++K N+LL K K++DFGLA E E GT GY++PE +
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKD 188
Query: 570 HLTEKADVYSFGIV 583
+ D+++ G++
Sbjct: 189 PYGKPVDLWACGVI 202
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-24
Identities = 53/185 (28%), Positives = 93/185 (50%), Gaps = 11/185 (5%)
Query: 386 LQIKAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN-----E 439
L +K+ + + +GEG F VYK +A+K++ + ++ IN E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 440 IGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGI 499
I ++ L HPN++ L + + L+++++E + L + ++ L L + L
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMT 121
Query: 500 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG 559
+GL YLH + ++HRD+K N+LLD++ K++DFGLAK N + +V T
Sbjct: 122 LQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRW 177
Query: 560 YMAPE 564
Y APE
Sbjct: 178 YRAPE 182
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 54/174 (31%), Positives = 90/174 (51%), Gaps = 7/174 (4%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLS-SKSKQG-NREFINEIGMISALQHPN 450
+ IGEG +G VYK G A+K++ K +G I EI ++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+VKLY +L+L++E+L+ + L + L L+ T + L + G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH--- 117
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
+V+HRD+K N+L++++ KI+DFGLA+ + + T+ Y AP+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 35/187 (18%), Positives = 74/187 (39%), Gaps = 9/187 (4%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G G FG V++ + + K + EI +++ +H N++ L+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESFE 71
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
+L++I+E++ + + +L+ + L +LH + H DI
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128
Query: 520 KATNVLLDKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 577
+ N++ +S KI +FG A+ + + Y APE ++ D+
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQ-LKPGDNFRLLF-TAPEYYAPEVHQHDVVSTATDM 186
Query: 578 YSFGIVA 584
+S G +
Sbjct: 187 WSLGTLV 193
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 29/201 (14%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVK-----QLSSKSKQGNREFI-NEIGMISALQHPNLVK 453
+G G F V K + G A K + S + +RE I E+ ++ +QHPN++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 454 LYGCCIEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLH 507
L+ ++LI E + E LF+ + + T I G+ YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGE-------LFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 508 GESRIKVVHRDIKATNVLL-DKDLNS---KISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
+++ H D+K N++L D+++ KI DFGLA + N + GT ++AP
Sbjct: 132 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAP 186
Query: 564 EYAMRGHLTEKADVYSFGIVA 584
E L +AD++S G++
Sbjct: 187 EIVNYEPLGLEADMWSIGVIT 207
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 47/175 (26%), Positives = 79/175 (45%), Gaps = 8/175 (4%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHP 449
+ +GEG +G V K G +A+K+ S K + + EI ++ L+H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 450 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
NLV L C + + L++E++++ + L LD+ ++ I G+ + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDHT-ILDDLELFPNGLDYQVVQKYLFQIINGIGFCH-- 141
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
++HRDIK N+L+ + K+ DFG A+ VA T Y APE
Sbjct: 142 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 54/190 (28%), Positives = 84/190 (44%), Gaps = 18/190 (9%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G G VY+ A+K L + + EIG++ L HPN++KL
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRIKVVH 516
++ L+ E + LF+ ++ + + R I +AYLH +VH
Sbjct: 119 TPTEISLVLELVTGGE----LFDRIVEKGYYSERDAADAVKQILEAVAYLH---ENGIVH 171
Query: 517 RDIKATNVLL---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
RD+K N+L D KI+DFGL+K+ E + V GT GY APE
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM--KTVCGTPGYCAPEILRGCAYGP 229
Query: 574 KADVYSFGIV 583
+ D++S GI+
Sbjct: 230 EVDMWSVGII 239
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 45/202 (22%), Positives = 89/202 (44%), Gaps = 28/202 (13%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFI--------NEIGMISAL-QHPN 450
IG G V + + A G AVK + +++ + E + E ++ + HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLH 507
++ L + + L+++ + LF+ ++ L R I + +++LH
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGE----LFDYLTEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE--- 564
+VHRD+K N+LLD ++ ++SDFG + E + GT GY+APE
Sbjct: 218 ---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPEILK 272
Query: 565 ---YAMRGHLTEKADVYSFGIV 583
++ D+++ G++
Sbjct: 273 CSMDETHPGYGKEVDLWACGVI 294
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 8/175 (4%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQ--LSSKSKQGNREFINEIGMISALQHP 449
+ IGEG +G V+K G +A+K+ S + + EI M+ L+HP
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 450 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
NLV L +L L++EY ++ + L ++ + + I + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDHT-VLHELDRYQRGVPEHLVKSITWQTLQAVNFCH-- 119
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
+ +HRD+K N+L+ K K+ DFG A+L + + VA T Y +PE
Sbjct: 120 -KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPE 172
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 59/218 (27%), Positives = 96/218 (44%), Gaps = 28/218 (12%)
Query: 392 TNNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPN 450
+ F + G+G FG V G G ++A+K++ + NRE + + ++ L HPN
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 451 LVKLYGCCIEGNQ-------LLLIYEYLENN--SLARALFEHRLKLDWPTRRRICLGIAR 501
+V+L + L ++ EY+ + R + ++ + + R
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140
Query: 502 GLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAKL--DEEENTH-ISTRVA 555
+ LH S V HRDIK NVL+++ L K+ DFG AK E N I +R
Sbjct: 141 SIGCLHLPSV-NVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLSPSEPNVAYICSRY- 196
Query: 556 GTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVSGR 591
Y APE + G H T D++S G + E++ G
Sbjct: 197 ----YRAPEL-IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 43/175 (24%), Positives = 82/175 (46%), Gaps = 8/175 (4%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQG-NREFINEIGMISALQHP 449
+ IGEG +G V+K +A+K++ +G + EI ++ L+H
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 450 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
N+V+L+ +L L++E+ + + L + LD + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQD-LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-- 118
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
V+HRD+K N+L++++ K+++FGLA+ S V T+ Y P+
Sbjct: 119 -SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPD 171
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 50/200 (25%), Positives = 85/200 (42%), Gaps = 29/200 (14%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREFI-NEIGMISALQH-PNLVKLYG 456
+G G F V + + + G A K L + Q R I +EI ++ + P ++ L+
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 457 CCIEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTR------RRICLGIARGLAYLH 507
++++LI EY E +F + R+ I G+ YLH
Sbjct: 97 VYENTSEIILILEYAAGGE-------IFS-LCLPELAEMVSENDVIRLIKQILEGVYYLH 148
Query: 508 GESRIKVVHRDIKATNVLL-DKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
+ +VH D+K N+LL KI DFG+++ + + GT Y+APE
Sbjct: 149 ---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK-IGHACELREIM-GTPEYLAPE 203
Query: 565 YAMRGHLTEKADVYSFGIVA 584
+T D+++ GI+A
Sbjct: 204 ILNYDPITTATDMWNIGIIA 223
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-23
Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 27/205 (13%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
IG G FG V++ L + +A+K++ + NR E+ ++ ++HPN+V L
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----ELQIMRIVKHPNVVDLKAFFYS 103
Query: 461 GNQ------LLLIYEYLENN--SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
L L+ EY+ +R + + + + + R LAY+H I
Sbjct: 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---I 160
Query: 513 KVVHRDIKATNVLLDKDLNS-KISDFGLAK--LDEEENTH-ISTRVAGTIGYMAPEYAMR 568
+ HRDIK N+LLD K+ DFG AK + E N I +R Y APE +
Sbjct: 161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----YRAPE-LIF 214
Query: 569 G--HLTEKADVYSFGIVALEIVSGR 591
G + T D++S G V E++ G+
Sbjct: 215 GATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 50/206 (24%), Positives = 81/206 (39%), Gaps = 23/206 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS----SKSKQGNREFINEIGMISALQHPNLVKLY 455
+GEG +G V + L AVK L + G EI ++ L+H N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 456 G--CCIEGNQLLLIYEYLENNSLARALFEH----RLKLDWPTRRRICLGIARGLAYLHGE 509
E ++ ++ EY + + + R + + GL YLH
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEKRFPVC--QAHGYFCQLIDGLEYLH-- 126
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE--ENTHISTRVAGTIGYMAPEYAM 567
+VH+DIK N+LL KIS G+A+ + T G+ + PE A
Sbjct: 127 -SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPPEIAN 184
Query: 568 --RGHLTEKADVYSFGIVALEIVSGR 591
K D++S G+ I +G
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-23
Identities = 65/256 (25%), Positives = 115/256 (44%), Gaps = 36/256 (14%)
Query: 34 PPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEK 93
L+ LT LQ +S N++ P LAN++TL L + N+ S L L NLE
Sbjct: 149 ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLES 203
Query: 94 LHLSSNNFT-----GELPK---------------TFAKLTNMKDFRISDNQFTGQIPSFI 133
L ++N + G L T A LTN+ D +++NQ + P +
Sbjct: 204 LIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--L 261
Query: 134 QNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILR 192
TKL +L + + ++ P + L LT+L +++ N E + N+ +T L L
Sbjct: 262 SGLTKLTELKLGANQISNISP--LAGLTALTNLELNE-NQLE-DISPISNLKNLTYLTLY 317
Query: 193 NCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM 252
NI+ P + +TKL+ L N++ S+ +L +++++ N ++ P
Sbjct: 318 FNNISDISP--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTPLAN 373
Query: 253 LERGDKIDLSYNNFTD 268
L R ++ L+ +T+
Sbjct: 374 LTRITQLGLNDQAWTN 389
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-23
Identities = 67/257 (26%), Positives = 105/257 (40%), Gaps = 24/257 (9%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
+ + + P LA LT L ++L N++ P L N++ L L + N S
Sbjct: 97 MNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--IS 150
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 143
L L +L++L N T P A LT ++ IS N+ + S + T LE L
Sbjct: 151 ALSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLI 205
Query: 144 IQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQLGNMK-MTKLILRNCNITGEL 200
+ ++ P + L NL +L ++ L L ++ +T L L N I+
Sbjct: 206 ATNNQISDITP--LGILTNLDELSLNGNQLKDIGT----LASLTNLTDLDLANNQISNLA 259
Query: 201 PRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKID 260
P L +TKL L L N++ S L + + N L P L+ +
Sbjct: 260 P--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLEDISPISNLKNLTYLT 315
Query: 261 LSYNNFTDGSAESSCQK 277
L +NN +D S SS K
Sbjct: 316 LYFNNISDISPVSSLTK 332
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 48/255 (18%), Positives = 97/255 (38%), Gaps = 24/255 (9%)
Query: 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQ 76
+ + ++ + + L L + + ++ + L
Sbjct: 2 PLGSATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 77 FSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNW 136
+ + L NL +++ S+N T P LT + D +++NQ P + N
Sbjct: 58 IKS--IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANL 111
Query: 137 TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQLGNM-KMTKLILRN 193
T L L + + + P + +L NL L +S ++ A L + + +L N
Sbjct: 112 TNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA----LSGLTSLQQLSFGN 165
Query: 194 CNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWML 253
+T P L +T L+ LD+S N++ S L +++ + N ++ P +L
Sbjct: 166 -QVTDLKP--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGIL 220
Query: 254 ERGDKIDLSYNNFTD 268
D++ L+ N D
Sbjct: 221 TNLDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-20
Identities = 52/246 (21%), Positives = 95/246 (38%), Gaps = 17/246 (6%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
++ + P L LT L ++SL N+LK LA+++ L +L + NQ S
Sbjct: 206 ATNNQISDITP--LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISN--LA 259
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 143
L L L +L L +N + P A LT + + +++NQ S I N L L
Sbjct: 260 PLSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLT 315
Query: 144 IQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPR 202
+ + ++ P + SL L L + N L N+ + L + I+ P
Sbjct: 316 LYFNNISDISP--VSSLTKLQRLFFYN-NKVS-DVSSLANLTNINWLSAGHNQISDLTP- 370
Query: 203 YLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLS 262
L +T++ L L+ + ++ + + L + D++
Sbjct: 371 -LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDIT 429
Query: 263 YNNFTD 268
+N +
Sbjct: 430 WNLPSY 435
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 29/158 (18%), Positives = 62/158 (39%), Gaps = 11/158 (6%)
Query: 121 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ 180
D QI + + K + + + + L+ +T L+ L +
Sbjct: 10 QDTPIN-QIFT-DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDG 63
Query: 181 LGNMK-MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYF 239
+ + +T++ N +T P L +TKL + ++ N++ + +L ++ +
Sbjct: 64 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTL 119
Query: 240 AGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQK 277
N +T P L ++++LS N +D SA S
Sbjct: 120 FNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTS 157
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 9e-08
Identities = 24/145 (16%), Positives = 51/145 (35%), Gaps = 9/145 (6%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
N++ + P ++ LT LQ + N++ LAN++ + L+ +NQ S L +
Sbjct: 320 NISDISP--VSSLTKLQRLFFYNNKVSDVSS--LANLTNINWLSAGHNQISD--LTPLAN 373
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 147
L + +L L+ +T A ++ + P+ I + + I
Sbjct: 374 LTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDIT-W 430
Query: 148 GLAGPIPSGIFSLENLTDLRISDLN 172
L ++ +
Sbjct: 431 NLPSYTNEVSYTFSQPVTIGKGTTT 455
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 4e-23
Identities = 58/197 (29%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN----EIGMISALQHPNLVKLY 455
+G G FG V G G +AVK L+ + K + + + EI + +HP+++KLY
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILN-RQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
++ EY+ L + +H +++ RR+ I + Y H R VV
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCH---RHMVV 133
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTEK 574
HRD+K NVLLD +N+KI+DFGL+ + + + T G+ Y APE + R + +
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRT-SCGSPNYAAPEVISGRLYAGPE 191
Query: 575 ADVYSFGIVALEIVSGR 591
D++S G++ ++ G
Sbjct: 192 VDIWSCGVILYALLCGT 208
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-23
Identities = 55/248 (22%), Positives = 97/248 (39%), Gaps = 40/248 (16%)
Query: 381 YYGFYLQIKAATNNFATDNN------IGEGGFGPVYKGLLADGTAI-AVKQLSSK---SK 430
Y+ +LQ K ++ +G GGFG V+ + + A K+L+ K +
Sbjct: 167 YFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKR 226
Query: 431 QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL---ENNSLARALFEHRLKL 487
+G + + E +++ + +V L L L+ + + + H +
Sbjct: 227 KGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGD-------IRYH-IYN 278
Query: 488 DWPTRRRICLGIAR--------GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 539
A GL +LH +++RD+K NVLLD D N +ISD GL
Sbjct: 279 VDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 540 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRS------- 592
A + T GT G+MAPE + D ++ G+ E+++ R
Sbjct: 336 AVELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 593 NVTKEDMF 600
V +++
Sbjct: 395 KVENKELK 402
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 7e-23
Identities = 53/182 (29%), Positives = 96/182 (52%), Gaps = 12/182 (6%)
Query: 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQG-NREFINEIGMISALQ 447
++++ F +G G + VYKGL G +A+K++ S++G I EI ++ L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-----LDWPTRRRICLGIARG 502
H N+V+LY N+L L++E+++N+ L + + + L+ + + +G
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDND-LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQG 120
Query: 503 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMA 562
LA+ H K++HRD+K N+L++K K+ DFGLA+ S+ V T+ Y A
Sbjct: 121 LAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRA 176
Query: 563 PE 564
P+
Sbjct: 177 PD 178
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 7e-23
Identities = 48/196 (24%), Positives = 78/196 (39%), Gaps = 27/196 (13%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCC- 458
+G G G V + G A+K L S + +E + A P++V +
Sbjct: 37 LGLGVNGKVLECFHRRTGQKCALKLLY-DSPKARQEV--DH-HWQASGGPHIVCILDVYE 92
Query: 459 ---IEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTR--RRICLGIARGLAYLHGES 510
LL+I E +E L F R + R I I + +LH
Sbjct: 93 NMHHGKRCLLIIMECMEGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFLH--- 145
Query: 511 RIKVVHRDIKATNVLL-DKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 567
+ HRD+K N+L K+ ++ K++DFG AK + + T T Y+APE
Sbjct: 146 SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLG 202
Query: 568 RGHLTEKADVYSFGIV 583
+ D++S G++
Sbjct: 203 PEKYDKSCDMWSLGVI 218
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 48/205 (23%), Positives = 78/205 (38%), Gaps = 32/205 (15%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQ-HPNLVKLYGC 457
+GEG V + L AVK + K R E+ M+ Q H N+++L
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIE-KQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR---RICLGIARGLAYLHGESRIKV 514
E ++ L++E + S + H K + +A L +LH +
Sbjct: 80 FEEEDRFYLVFEKMRGGS----ILSHIHKRRHFNELEASVVVQDVASALDFLH---NKGI 132
Query: 515 VHRDIKATNVLL-DKDLNS--KISDFGLAK-------LDEEENTHISTRVAGTIGYMAPE 564
HRD+K N+L + S KI DF L + T G+ YMAPE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMAPE 191
Query: 565 ------YAMRGHLTEKADVYSFGIV 583
+ ++ D++S G++
Sbjct: 192 VVEAFSEEASIY-DKRCDLWSLGVI 215
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 2e-22
Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 401 IGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IG G FG VY+ L D G +A+K++ + NRE + ++ L H N+V+L
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIVRLRYFFY 117
Query: 460 EGNQ------LLLIYEYLENN--SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
+ L L+ +Y+ +AR + L + + R LAY+H
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS--- 174
Query: 512 IKVVHRDIKATNVLLDKDLNS-KISDFGLAK--LDEEENTH-ISTRVAGTIGYMAPEYAM 567
+ HRDIK N+LLD D K+ DFG AK + E N I +R Y APE +
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE-LI 228
Query: 568 RG--HLTEKADVYSFGIVALEIVSGR 591
G T DV+S G V E++ G+
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 3e-22
Identities = 55/176 (31%), Positives = 88/176 (50%), Gaps = 9/176 (5%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQG-NREFINEIGMISALQHP 449
NF IGEG +G VYK G +A+K++ +G I EI ++ L HP
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 450 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHG 508
N+VKL N+L L++E+L + L + + L + P + + +GLA+ H
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
+V+HRD+K N+L++ + K++DFGLA+ + V T+ Y APE
Sbjct: 122 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 80/286 (27%), Positives = 118/286 (41%), Gaps = 15/286 (5%)
Query: 315 TFEEDTSEAGPSTFSQSGTNWVLSSTGHFLENGLKLGPYIQTNTSRLLMNDYQLYTTARL 374
T+ A FS+S V PYI+ L + +Q + +
Sbjct: 111 TYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDK 170
Query: 375 SAISLTYYGFYLQIKAATNNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSK---SK 430
+ L I N+F+ IG GGFG VY AD G A+K L K K
Sbjct: 171 FTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK 230
Query: 431 QGNREFINE---IGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKL 487
QG +NE + ++S P +V + ++L I + + L L +H
Sbjct: 231 QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VF 289
Query: 488 DWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547
R I GL ++H VV+RD+K N+LLD+ + +ISD GLA ++
Sbjct: 290 SEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 346
Query: 548 THISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRS 592
H V GT GYMAPE +G AD +S G + +++ G S
Sbjct: 347 PH--ASV-GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 9e-22
Identities = 51/190 (26%), Positives = 80/190 (42%), Gaps = 17/190 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IG G FG +AVK + + + EI +L+HPN+V+ +
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIE-RGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86
Query: 460 EGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
L +I EY L +E + R + G++Y H +++ H
Sbjct: 87 TPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVSYCH---SMQICH 139
Query: 517 RDIKATNVLLDKD--LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTE 573
RD+K N LLD KI DFG +K ++ + V GT Y+APE + + +
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTV-GTPAYIAPEVLLRQEYDGK 197
Query: 574 KADVYSFGIV 583
ADV+S G+
Sbjct: 198 IADVWSCGVT 207
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 46/180 (25%), Positives = 82/180 (45%), Gaps = 14/180 (7%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQG-NREFINEIGMISALQHP 449
+ + +GEG +G VYK + +A+K++ ++G I E+ ++ LQH
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHR 93
Query: 450 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
N+++L ++L LI+EY EN+ L + + + + + G+ + H
Sbjct: 94 NIIELKSVIHHNHRLHLIFEYAEND-LKK-YMDKNPDVSMRVIKSFLYQLINGVNFCH-- 149
Query: 510 SRIKVVHRDIKATNVLLDKDLNS-----KISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
+ +HRD+K N+LL S KI DFGLA+ + + T+ Y PE
Sbjct: 150 -SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPE 207
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 24/202 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN----EIGMISALQHPNLVKLY 455
+GEG FG V +A+K +S + + EI + L+HP+++KLY
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFIS-RQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 456 GCCIEGNQLLLIYEYL--ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGES 510
++++ EY E LF++ + ++ RR I + Y H
Sbjct: 76 DVITTPTDIVMVIEYAGGE-------LFDYIVEKKRMTEDEGRRFFQQIICAIEYCH--- 125
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRG 569
R K+VHRD+K N+LLD +LN KI+DFGL+ + + + T G+ Y APE +
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI-MTDGNFLKT-SCGSPNYAAPEVINGKL 183
Query: 570 HLTEKADVYSFGIVALEIVSGR 591
+ + DV+S GIV ++ GR
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGR 205
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 53/199 (26%), Positives = 81/199 (40%), Gaps = 32/199 (16%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYG--- 456
+G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYE 125
Query: 457 -CCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTR--RRICLGIARGLAYLH 507
LL++ E L E LF R + R I I + YLH
Sbjct: 126 NLYAGRKCLLIVMECLDGGE-------LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 508 GESRIKVVHRDIKATNVLL-DKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
I + HRD+K N+L K N+ K++DFG AK N+ ++T T Y+APE
Sbjct: 179 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYYVAPE 233
Query: 565 YAMRGHLTEKADVYSFGIV 583
+ D++S G++
Sbjct: 234 VLGPEKYDKSCDMWSLGVI 252
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 33/219 (15%), Positives = 70/219 (31%), Gaps = 22/219 (10%)
Query: 57 IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMK 116
I + N + V + L S N+++L LS N + A T ++
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 117 DFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDL-----RISDL 171
+S N + ++ + L L + + + + ++ L IS +
Sbjct: 62 LLNLSSNVLY-ETLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV 114
Query: 172 NGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG-QIPSNFDD 230
+ + L N IT G ++++ LDL N +
Sbjct: 115 --SCSRGQGK-----KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAAS 167
Query: 231 LYDVDYIYFAGNLLTGAIPPWM-LERGDKIDLSYNNFTD 268
++++ N + + + + +DLS N
Sbjct: 168 SDTLEHLNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLAF 205
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 45/257 (17%), Positives = 84/257 (32%), Gaps = 24/257 (9%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
+ + +L L ++++ L N L LA + L L + N E
Sbjct: 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ETL- 74
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 143
+L SL L L L++N +++ ++N + ++ + ++
Sbjct: 75 DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSC--SRGQGKKNIY 126
Query: 144 IQPSGLAGPIPSGIFSLENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITG 198
+ + + + L I +N + L L+ I
Sbjct: 127 LANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFA-ELAASSDT--LEHLNLQYNFIY- 182
Query: 199 ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP--WMLERG 256
++ + KLK LDLS N+L + F V +I N L I +
Sbjct: 183 DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNL 239
Query: 257 DKIDLSYNNFTDGSAES 273
+ DL N F G+
Sbjct: 240 EHFDLRGNGFHCGTLRD 256
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 40/248 (16%), Positives = 90/248 (36%), Gaps = 25/248 (10%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
L+ + LA T L+ ++L +N L + L ++STL L + N EL
Sbjct: 45 PLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLV 97
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 147
++E LH ++NN + + ++ K+ +++N+ T ++++ L ++ +
Sbjct: 98 GPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154
Query: 148 GLAG-PIPSGIFSLENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELP 201
+ S + L L I D+ + F +L L L + + +
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKL-----KTLDLSSNKLA-FMG 207
Query: 202 RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKI-D 260
+ + L N+L I ++++ GN + ++
Sbjct: 208 PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266
Query: 261 LSYNNFTD 268
++
Sbjct: 267 VAKQTVKK 274
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 14/83 (16%), Positives = 28/83 (33%), Gaps = 2/83 (2%)
Query: 33 LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFS-GELPEELGSLLNL 91
+ P+ + ISL N+L I K L L + ++ N F G L + +
Sbjct: 206 MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV 264
Query: 92 EKLHLSSNNFTGELPKTFAKLTN 114
+ + + + +
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPT 287
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 3e-21
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 13/197 (6%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN----EIGMISALQHPNLVKLY 455
+G G FG V G G +AVK L+ + K + + + EI + +HP+++KLY
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILN-RQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
+ + ++ EY+ L + ++ +LD RR+ I G+ Y H R VV
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCH---RHMVV 138
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE-YAMRGHLTEK 574
HRD+K NVLLD +N+KI+DFGL+ + + + T G+ Y APE + R + +
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNM-MSDGEFLRTSC-GSPNYAAPEVISGRLYAGPE 196
Query: 575 ADVYSFGIVALEIVSGR 591
D++S G++ ++ G
Sbjct: 197 VDIWSSGVILYALLCGT 213
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 5e-21
Identities = 48/184 (26%), Positives = 81/184 (44%), Gaps = 27/184 (14%)
Query: 401 IGEGGFGPVYKG---LLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
+G G +G VYK D A+KQ+ + EI ++ L+HPN++ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 458 CIE--GNQLLLIYEYLENNSLARALFEHR--------LKLDWPTRRRICLGIARGLAYLH 507
+ ++ L+++Y E++ L + HR ++L + + I G+ YLH
Sbjct: 87 FLSHADRKVWLLFDYAEHD-LWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 508 GESRIKVVHRDIKATNVLLDKDLNS----KISDFGLAKL---DEEENTHISTRVAGTIGY 560
V+HRD+K N+L+ + KI+D G A+L + + V T Y
Sbjct: 146 ---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 561 MAPE 564
APE
Sbjct: 202 RAPE 205
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 6e-21
Identities = 24/197 (12%), Positives = 51/197 (25%), Gaps = 42/197 (21%)
Query: 401 IGEGGFGPVYKGLLAD---GTAIAVKQL---SSKSKQGNREFINEIGMISALQHPNLVKL 454
G ++ L D +A+ + +E ++ +S + P + ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
L++ E++ SL + + + R +A H R V
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSL-QEVADTSP--SPVGAIRAMQSLAAAADAAH---RAGV 150
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEK 574
+ V + D G L M +
Sbjct: 151 ALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDA-------NPQ 182
Query: 575 ADVYSFGIVALEIVSGR 591
D+ G ++ R
Sbjct: 183 DDIRGIGASLYALLVNR 199
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 7e-21
Identities = 64/242 (26%), Positives = 101/242 (41%), Gaps = 31/242 (12%)
Query: 381 YYGFYLQIKAATNNFATDNN------IGEGGFGPVYKGLLADGTAI-AVKQLSSK---SK 430
Y+ +LQ K T N +G+GGFG V + + A K+L K +
Sbjct: 166 YFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKR 225
Query: 431 QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEH-----RL 485
+G +NE ++ + +V L + L L+ + L H +
Sbjct: 226 KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL----KFHIYHMGQA 281
Query: 486 KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545
I GL LH E ++V+RD+K N+LLD + +ISD GLA
Sbjct: 282 GFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV-HVP 337
Query: 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRS-------NVTKED 598
E I RV GT+GYMAPE T D ++ G + E+++G+S + +E+
Sbjct: 338 EGQTIKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396
Query: 599 MF 600
+
Sbjct: 397 VE 398
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-20
Identities = 54/266 (20%), Positives = 88/266 (33%), Gaps = 33/266 (12%)
Query: 33 LPPK-LAELTFLQDISLIANRLKGPI--PKYLANISTLVNLTVQYNQFSG-ELPEELGSL 88
L P L L ++ L L + Y N+ L L + NQ L G L
Sbjct: 88 LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKL 147
Query: 89 LNLEKLHLSSNNFTGELPKTFAKLTNM--KDFRISDNQFTGQIPSFIQNWTK------LE 140
+L+ + SSN L F ++ N ++ LE
Sbjct: 148 NSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLE 207
Query: 141 KLFIQPSGLAGPIP---------SGIFSLENLTDLRISDLNG------PEATFPQLGNMK 185
L + +G I S FSL + + + TF L
Sbjct: 208 ILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSS 267
Query: 186 MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLL 244
+ L L + + R + LKVL+L++N++ +I F L ++ + + NLL
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLL 326
Query: 245 TGAIPPWM---LERGDKIDLSYNNFT 267
+ L + IDL N+
Sbjct: 327 G-ELYSSNFYGLPKVAYIDLQKNHIA 351
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 9e-19
Identities = 43/271 (15%), Positives = 85/271 (31%), Gaps = 39/271 (14%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
+ + L L+ ++L N++ + + L L + YN
Sbjct: 277 FVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG 336
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 147
L + + L N+ +TF L ++ + DN T I + +F+ +
Sbjct: 337 LPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGN 391
Query: 148 GLAGPIPSGIFSLE-------------------NLTDLRISDLNG-------PEATFPQL 181
L +P + + L+I LN + T +
Sbjct: 392 KLVT-LPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSEN 450
Query: 182 GNMKMTKLILRNCNITGE-----LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDY 236
+++ +L L + ++ L+VL L+ N L P F L +
Sbjct: 451 PSLE--QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRG 508
Query: 237 IYFAGNLLTGAIPPWMLERGDKIDLSYNNFT 267
+ N LT + + +D+S N
Sbjct: 509 LSLNSNRLTVLSHNDLPANLEILDISRNQLL 539
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 4e-17
Identities = 45/277 (16%), Positives = 86/277 (31%), Gaps = 39/277 (14%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
+ NLT V P L L +S N ++ + L L + + +
Sbjct: 11 YRFCNLTQV-PQVLNTTERL-LLS--FNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 84 E-LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI--PSFIQNWTKLE 140
E +L NL L L S+ P F L ++ + R+ + + + +N L
Sbjct: 67 EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT 126
Query: 141 KLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG------PEATFPQLGNMKMTKLILRNC 194
+L + + + F L L+ D + E L ++ L
Sbjct: 127 RLDLSKNQIRSLYLHPSFG--KLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAAN 184
Query: 195 NITGELPRYLG------KMTKLKVLDLSFNRLRGQIPSNFDD------------LYDVDY 236
++ + G + L++LD+S N I NF + + +
Sbjct: 185 SLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMG 244
Query: 237 IYFAGNLLTGAIPPWMLERGDK-----IDLSYNNFTD 268
F + + + +DLS+
Sbjct: 245 AGFGFHNIK-DPDQNTFAGLARSSVRHLDLSHGFVFS 280
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-15
Identities = 42/216 (19%), Positives = 72/216 (33%), Gaps = 21/216 (9%)
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI-PSFIQNWTKLEKLFIQP 146
L E+L LS N +F L ++ + I +N L L +
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 147 SGLAGPIPSGIFS-LENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITG-E 199
S + + F L +L +L +SD + F L + +L L I
Sbjct: 83 SKIYF-LHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALT--RLDLSKNQIRSLY 139
Query: 200 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLY--DVDYIYFAGNLLTGAIPPWMLERGD 257
L GK+ LK +D S N++ + L + + A N L + + +
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 258 --------KIDLSYNNFTDGSAESSCQKRSVTGIVS 285
+D+S N +T + S + S
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFS 235
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 39/238 (16%), Positives = 83/238 (34%), Gaps = 17/238 (7%)
Query: 39 ELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98
+ ++ + L + + + L L + YN+ + E L NL+ L+LS
Sbjct: 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF 158
N F L + + N + KL+ L ++ + L + I
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIH 378
Query: 159 SLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRY-LGKMTKLKVLDLSF 217
+ ++ D+ L+G + N+ + L + Y L ++ L++L L+
Sbjct: 379 FIPSIPDI---FLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQ 435
Query: 218 NRLRG-QIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-------LERGDKIDLSYNNFT 267
NR + ++ ++ N+L A + L + L++N
Sbjct: 436 NRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLN 493
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 5e-12
Identities = 48/251 (19%), Positives = 90/251 (35%), Gaps = 25/251 (9%)
Query: 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99
L LQ + L N L + I ++ ++ + N+ LP+ L +HLS N
Sbjct: 361 LEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKIN---LTANLIHLSEN 411
Query: 100 NFTG-ELPKTFAKLTNMKDFRISDNQFTG-QIPSFIQNWTKLEKLFIQPSGLAGPIPSGI 157
++ ++ +++ ++ N+F+ LE+LF+ + L + +
Sbjct: 412 RLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETEL 471
Query: 158 --FSLENLTDLRISDLNG------PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTK 209
E L+ L++ LN P F L ++ L L + +T L
Sbjct: 472 CWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR--GLSLNSNRLT-VLSHNDLP-AN 527
Query: 210 LKVLDLSFNRLRGQIPSNFDDL--YDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFT 267
L++LD+S N+L P F L D+ + F W+ I +
Sbjct: 528 LEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIY 587
Query: 268 DGSAESSCQKR 278
+S
Sbjct: 588 CVYPDSFSGVS 598
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 55/190 (28%), Positives = 92/190 (48%), Gaps = 26/190 (13%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREF----INEIGMISAL 446
+ + IG+G FG V+K G +A+K++ K+G F + EI ++ L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEG---FPITALREIKILQLL 73
Query: 447 QHPNLVKLYGCCIE--------GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG 498
+H N+V L C + L++++ E++ LA L +K +R+
Sbjct: 74 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTLSEIKRVMQM 132
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL----DEEENTHISTRV 554
+ GL Y+H R K++HRD+KA NVL+ +D K++DFGLA+ + + RV
Sbjct: 133 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189
Query: 555 AGTIGYMAPE 564
T+ Y PE
Sbjct: 190 V-TLWYRPPE 198
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 48/188 (25%), Positives = 80/188 (42%), Gaps = 25/188 (13%)
Query: 481 FEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540
++ L +A+G+ +L + K +HRD+ A N+LL + KI DFGLA
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 541 KLDEEENTHISTRVAGT-IGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRS----NV 594
+ ++ ++ A + +MAPE T ++DV+SFG++ EI S G S
Sbjct: 241 RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 300
Query: 595 TKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMS 654
E+ L ++G M D + M L C + P+ RP+ S
Sbjct: 301 IDEEFCRRL-------KEGTRMRAPDYTTPEMYQ---TM------LDCWHGEPSQRPTFS 344
Query: 655 SVLRMLEC 662
++ L
Sbjct: 345 ELVEHLGN 352
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 7e-11
Identities = 34/158 (21%), Positives = 59/158 (37%), Gaps = 17/158 (10%)
Query: 393 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQL-SSKSKQGNREFINEIG-MIS 444
+ +G G FG V + A +AVK L + +R ++E+ +I
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 445 ALQHPNLVKLYGCCI-EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 503
H N+V L G C G L++I E+ + +L+ L R +G
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK--------RNEFVPYKTKGA 133
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541
+ G+ + + D+K + +S S F K
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-19
Identities = 32/212 (15%), Positives = 68/212 (32%), Gaps = 22/212 (10%)
Query: 63 NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD 122
N + V + L S N+++L LS N + A T ++ +S
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 123 NQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDL-----RISDLNGPEAT 177
N + ++ + L L + + + + ++ L IS + +
Sbjct: 68 NVLY-ETLDL-ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISRV--SCSR 118
Query: 178 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG-QIPSNFDDLYDVDY 236
+ L N IT G ++++ LDL N + +++
Sbjct: 119 GQGK-----KNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEH 173
Query: 237 IYFAGNLLTGAIPPWM-LERGDKIDLSYNNFT 267
+ N + + + + +DLS N
Sbjct: 174 LNLQYNFIY-DVKGQVVFAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 40/247 (16%), Positives = 90/247 (36%), Gaps = 25/247 (10%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
L+ + LA T L+ ++L +N L + L ++STL L + N EL
Sbjct: 45 PLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLV 97
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 147
++E LH ++NN + + ++ K+ +++N+ T ++++ L ++ +
Sbjct: 98 GPSIETLHAANNNIS-RVS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLN 154
Query: 148 GLAG-PIPSGIFSLENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELP 201
+ S + L L I D+ + F +L L L + + +
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIYDVK-GQVVFAKL-----KTLDLSSNKLA-FMG 207
Query: 202 RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKI-D 260
+ + L N+L I ++++ GN + ++
Sbjct: 208 PEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQT 266
Query: 261 LSYNNFT 267
++
Sbjct: 267 VAKQTVK 273
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 32/223 (14%), Positives = 67/223 (30%), Gaps = 9/223 (4%)
Query: 28 NLTGVLPPKL-AELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELG 86
+ V +L A L+ ++L N + + + L L + N+ + + E
Sbjct: 155 EIDTVNFAELAASSDTLEHLNLQYNFIYD-VKG-QVVFAKLKTLDLSSNKLA-FMGPEFQ 211
Query: 87 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF-TGQIPSFIQNWTKLEKLFI- 144
S + + L +N + K N++ F + N F G + F +++ +
Sbjct: 212 SAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
Query: 145 QPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRN--CNITGELPR 202
L G + P +L +K + L + + T L
Sbjct: 271 TVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLEC 330
Query: 203 YLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 245
+ + +D + R I + L
Sbjct: 331 ERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 4e-18
Identities = 40/262 (15%), Positives = 78/262 (29%), Gaps = 42/262 (16%)
Query: 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99
+ + + LK + + + L + N S +L LE L+LSSN
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 100 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF- 158
E L+ ++ +++N + +E L + ++ +
Sbjct: 69 VLY-ETL-DLESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR-VSCSRGQ 120
Query: 159 SLENLTDL---RISDLNGPEATFPQLGNMKMTKLILRNCNITG-ELPRYLGKMTKLKVLD 214
+N+ L +I+ L + + L L+ I L+ L+
Sbjct: 121 GKKNI-YLANNKITML--RDLDEGCRSR--VQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 215 LSFNRLRG---------------------QIPSNFDDLYDVDYIYFAGNLLTGAIPPWM- 252
L +N + + F V +I N L I +
Sbjct: 176 LQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALR 234
Query: 253 -LERGDKIDLSYNNFTDGSAES 273
+ + DL N F G+
Sbjct: 235 FSQNLEHFDLRGNGFHCGTLRD 256
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 49/255 (19%), Positives = 99/255 (38%), Gaps = 26/255 (10%)
Query: 27 QNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQ--FSGELPEE 84
+ LT V P + + + L +N+L+ ++ L L++ N F G +
Sbjct: 17 KGLTSV-PTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQS 73
Query: 85 LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP--SFIQNWTKLEKL 142
+L+ L LS N + F L ++ + Q+ S + L L
Sbjct: 74 DFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYL 131
Query: 143 FIQPSGLAGPIPSGIFS-LENLTDLRISDLNG----PEATFPQLGNMKMTKLILRNCNIT 197
I + +GIF+ L +L L+++ + F +L N +T L L C +
Sbjct: 132 DISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN--LTFLDLSQCQLE 188
Query: 198 GELPRY-LGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPWMLER 255
+L ++ L+VL++S N + + + L + + ++ N + L+
Sbjct: 189 -QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQH 245
Query: 256 GDK----IDLSYNNF 266
++L+ N+F
Sbjct: 246 FPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 47/214 (21%), Positives = 78/214 (36%), Gaps = 16/214 (7%)
Query: 65 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT--GELPKTFAKLTNMKDFRISD 122
S+ L ++ N+ L L KL LSSN + G ++ T++K +S
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 123 NQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLN---GPEATF 178
N + S +LE L Q S L +F L NL L IS + F
Sbjct: 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIF 146
Query: 179 PQLGNMKMTKLILRNCNITGELPRY-LGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDY 236
L +++ L + + ++ L LDLS +L Q+ F+ L +
Sbjct: 147 NGLSSLE--VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQV 203
Query: 237 IYFAGNLLTGAIPP---WMLERGDKIDLSYNNFT 267
+ + N ++ L +D S N+
Sbjct: 204 LNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-19
Identities = 61/305 (20%), Positives = 105/305 (34%), Gaps = 43/305 (14%)
Query: 4 LNTFLVFHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLAN 63
+ F + + K + L LTF N+ +
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTS------NKGGNAFS--EVD 345
Query: 64 ISTLVNLTVQYNQ--FSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 121
+ +L L + N F G + +L+ L LS N + F L ++
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQ 404
Query: 122 DNQFTGQIP--SFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISD----LNGP 174
+ Q+ S + L L I + +GIF+ L +L L+++ N
Sbjct: 405 HSNLK-QMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFL 462
Query: 175 EATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDV 234
F +L N+ T L L C + P ++ L+VL+++ N+L+ FD L +
Sbjct: 463 PDIFTELRNL--TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSL 520
Query: 235 DYIYFAGNLLTGAIP------PWMLERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLR 288
I+ N + P W+ + K GSA+ S + V R
Sbjct: 521 QKIWLHTNPWDCSCPRIDYLSRWLNKNSQKE--------QGSAKCSGSGKPV-------R 565
Query: 289 SVQCP 293
S+ CP
Sbjct: 566 SIICP 570
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 2e-18
Identities = 46/310 (14%), Positives = 84/310 (27%), Gaps = 60/310 (19%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
L + LQ + L ++ ++S L L + N
Sbjct: 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSG 98
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT-GQIPSFIQNWTKLEKLF--- 143
L +L+KL N L +K+ ++ N ++P + N T LE L
Sbjct: 99 LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS 158
Query: 144 -----IQPSGLAG-------------------PIPSGIFSLENLTDLRISD----LNGPE 175
I + L I G F L L + + LN +
Sbjct: 159 NKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMK 218
Query: 176 ATFPQLGNMKMTKLIL----RNCNITGELPRYLGKMTKLKVLDLSFNRLRG---QIPSNF 228
L +++ +L+L N+ L + L + + L I F
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278
Query: 229 DDLYDVDYIYFAGNLLTG---------------------AIPPWMLERGDKIDLSYNNFT 267
+ L +V + P L+ ++ + N
Sbjct: 279 NCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG 338
Query: 268 DGSAESSCQK 277
+ +E
Sbjct: 339 NAFSEVDLPS 348
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 39/217 (17%), Positives = 72/217 (33%), Gaps = 18/217 (8%)
Query: 65 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 124
+ NL + +N S L+ L LS + L+++ ++ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 125 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDL-----RISDLNGPEATF 178
+ L+KL + LA + + L+ L +L I PE F
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEY-F 145
Query: 179 PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKV----LDLSFNRLRGQIPSNFDDLYDV 234
L N++ L L + I L + ++ + LDLS N + P F ++ +
Sbjct: 146 SNLTNLE--HLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-L 202
Query: 235 DYIYFAGNLLTGAIPP---WMLERGDKIDLSYNNFTD 268
+ N + + L + L F +
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN 239
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 37/213 (17%), Positives = 64/213 (30%), Gaps = 18/213 (8%)
Query: 26 EQNLTGV---LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELP 82
E N + LP L L N L+ + L L + +
Sbjct: 16 ELNFYKIPDNLPFSTKNL------DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 83 EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 142
SL +L L L+ N F+ L++++ + I + L++L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 143 FIQPSGLA-GPIPSGIFSLENLTDLRISDLNG----PEATFPQLGNMKM--TKLILRNCN 195
+ + + +P +L NL L +S N L M + L L
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSS-NKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 196 ITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNF 228
+ + K +L L L N +
Sbjct: 189 MN-FIQPGAFKEIRLHKLTLRNNFDSLNVMKTC 220
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 56/249 (22%), Positives = 99/249 (39%), Gaps = 14/249 (5%)
Query: 28 NLTGVLPPK-LAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELG 86
N+ + P L L+ + L +NRLK +S L L + N+ L
Sbjct: 66 NIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQ 125
Query: 87 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQ 145
L NL+ L + N+ + F+ L +++ + T IP+ + L L ++
Sbjct: 126 DLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLR 184
Query: 146 PSGLAGPIPSGIFS-LENLTDLRISDLNGPEATFPQ-LGNMKMTKLILRNCNITGELPRY 203
+ I F L L L IS + P L + +T L + +CN+T +P
Sbjct: 185 HLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYL 242
Query: 204 -LGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPWM---LERGDK 258
+ + L+ L+LS+N + I + +L + I G L + P+ L
Sbjct: 243 AVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRV 300
Query: 259 IDLSYNNFT 267
+++S N T
Sbjct: 301 LNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 41/225 (18%), Positives = 83/225 (36%), Gaps = 15/225 (6%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
+ +L +L L+ + + N L + + +++L LT++ + E L
Sbjct: 115 KIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSH 174
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 147
L L L L N +F +L +K IS + + L L I
Sbjct: 175 LHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHC 234
Query: 148 GLAGPIPSGIFSLENLTDLRISDLNG------PEATFPQLGNMKMTKLILRNCNITGELP 201
L +P +L LR +L+ + +L + ++ L + +
Sbjct: 235 NLTA-VPYLAVR--HLVYLRFLNLSYNPISTIEGSMLHELLR--LQEIQLVGGQLA-VVE 288
Query: 202 RY-LGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLL 244
Y + L+VL++S N+L + + F + +++ + N L
Sbjct: 289 PYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 59/254 (23%), Positives = 98/254 (38%), Gaps = 22/254 (8%)
Query: 26 EQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEEL 85
+ V P + T + + L NR+K A+ L L + N S P
Sbjct: 20 RKRFVAV-PEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAF 76
Query: 86 GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFI 144
+L NL L L SN F L+N+ IS+N+ + ++ Q+ L+ L +
Sbjct: 77 NNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEV 135
Query: 145 QPSGLAGPIPSGIFS-LENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITG 198
+ L I FS L +L L ++ + P L + L LR+ NI
Sbjct: 136 GDNDLVY-ISHRAFSGLNSLEQLTLEKCNLTSI--PTEALSHLHGLI--VLRLRHLNIN- 189
Query: 199 ELPRY-LGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM---LE 254
+ Y ++ +LKVL++S + N ++ + LT A+P L
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLV 248
Query: 255 RGDKIDLSYNNFTD 268
++LSYN +
Sbjct: 249 YLRFLNLSYNPIST 262
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-14
Identities = 31/193 (16%), Positives = 70/193 (36%), Gaps = 15/193 (7%)
Query: 37 LAELTFLQDISLIANRLKGPIPKY-LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 95
+ L L+ ++L L IP L+++ L+ L +++ + L L+ L
Sbjct: 148 FSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206
Query: 96 LSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSF-IQNWTKLEKLFIQPSGLAGPIP 154
+S + + N+ I+ T +P +++ L L + + ++ I
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIST-IE 264
Query: 155 SGIFS-LENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMT 208
+ L L ++ +++ + F L ++ L + +T +
Sbjct: 265 GSMLHELLRLQEIQLVGGQLAVV--EPYAFRGLNYLR--VLNVSGNQLTTLEESVFHSVG 320
Query: 209 KLKVLDLSFNRLR 221
L+ L L N L
Sbjct: 321 NLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 25/123 (20%), Positives = 42/123 (34%), Gaps = 2/123 (1%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
+ + P L +S+ L + ++ L L + YN S +
Sbjct: 207 ISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEG 265
Query: 84 E-LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 142
L LL L+++ L P F L ++ +S NQ T S + LE L
Sbjct: 266 SMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETL 325
Query: 143 FIQ 145
+
Sbjct: 326 ILD 328
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 33/208 (15%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKS--KQGNREFIN-EIGMISALQHPNLVK 453
+GEG F V LA A+K L + K+ ++ E ++S L HP VK
Sbjct: 38 LGEGSFSTVV---LARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR--------GLAY 505
LY + +L Y +N L ++ K R L Y
Sbjct: 95 LYFTFQDDEKLYFGLSYAKNGEL----LKYIRK-----IGSFDETCTRFYTAEIVSALEY 145
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR-VAGTIGYMAPE 564
LHG ++HRD+K N+LL++D++ +I+DFG AK+ E+ GT Y++PE
Sbjct: 146 LHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202
Query: 565 YAM-RGHLTEKADVYSFGIVALEIVSGR 591
+ + +D+++ G + ++V+G
Sbjct: 203 LLTEKSA-CKSSDLWALGCIIYQLVAGL 229
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 21/216 (9%)
Query: 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS-SKSKQGNREF----INEIG--- 441
AT+ + IG G +G VYK G +A+K + G + E+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 442 MISALQHPNLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRI 495
+ A +HPN+V+L C ++ L++E+++ + L L + L T + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQD-LRTYLDKAPPPGLPAETIKDL 125
Query: 496 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVA 555
RGL +LH +VHRD+K N+L+ K++DFGLA++ + ++ V
Sbjct: 126 MRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVVV 181
Query: 556 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 591
T+ Y APE ++ D++S G + E+ +
Sbjct: 182 -TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 2e-19
Identities = 43/201 (21%), Positives = 75/201 (37%), Gaps = 31/201 (15%)
Query: 33 LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92
LP L L S+ N+L +P A S L L NQ + LP L+
Sbjct: 136 LPVLPPGLQEL---SVSDNQLAS-LP---ALPSELCKLWAYNNQLT-SLPMLPS---GLQ 184
Query: 93 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP 152
+L +S N LP ++L + +N+ T +P+ L++L + + L
Sbjct: 185 ELSVSDNQLA-SLPTLPSELYKL---WAYNNRLT-SLPALPSG---LKELIVSGNRLTS- 235
Query: 153 IPSGIFSLENLT--DLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKL 210
+P L+ L R++ L P + L + +T LP L ++
Sbjct: 236 LPVLPSELKELMVSGNRLTSL--PM----LPSGL--LSLSVYRNQLT-RLPESLIHLSSE 286
Query: 211 KVLDLSFNRLRGQIPSNFDDL 231
++L N L + ++
Sbjct: 287 TTVNLEGNPLSERTLQALREI 307
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 50/249 (20%), Positives = 84/249 (33%), Gaps = 44/249 (17%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
+ E LT LP L + + + N L +P A L L V NQ + LP
Sbjct: 47 VGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LP---ALPPELRTLEVSGNQLT-SLPV 98
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 143
LL L + LP + + I NQ T +P +L
Sbjct: 99 LPPGLLELSIFSNPLTHLP-ALP------SGLCKLWIFGNQLT-SLPVLPPGLQELSVSD 150
Query: 144 IQPSGLAGPIPSGIFSLENLT--DLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELP 201
Q + L P+ L L + +++ L P + +L + + + LP
Sbjct: 151 NQLASL----PALPSELCKLWAYNNQLTSL--PM----LPSG--LQELSVSDNQLA-SLP 197
Query: 202 RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKI 259
++ KL + L + + +GN LT ++P L+ ++
Sbjct: 198 TLPSELYKLWAYNNRLTSLPALPSG-------LKELIVSGNRLT-SLPVLPSELK---EL 246
Query: 260 DLSYNNFTD 268
+S N T
Sbjct: 247 MVSGNRLTS 255
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 38/193 (19%), Positives = 71/193 (36%), Gaps = 30/193 (15%)
Query: 79 GELPEELGSLL--NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNW 136
+ +++ + L L++ + T LP ++ I DN T +P+
Sbjct: 28 AAVVQKMRACLNNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPALP--- 80
Query: 137 TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNI 196
+L L + + L +P L L+ L A L KL + +
Sbjct: 81 PELRTLEVSGNQLTS-LPVLPPGLLELSIFSNP-LTHLPALPSGL-----CKLWIFGNQL 133
Query: 197 TGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LE 254
T LP L+ L +S N+L +P+ +L ++ N LT ++P L+
Sbjct: 134 T-SLPVLPP---GLQELSVSDNQLA-SLPALPSEL---CKLWAYNNQLT-SLPMLPSGLQ 184
Query: 255 RGDKIDLSYNNFT 267
++ +S N
Sbjct: 185 ---ELSVSDNQLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 31/175 (17%), Positives = 62/175 (35%), Gaps = 12/175 (6%)
Query: 33 LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92
LP +EL L + NRL +P S L++L+V NQ + LPE L L +
Sbjct: 236 LPVLPSELKEL---MVSGNRLTS-LP---MLPSGLLSLSVYRNQLT-RLPESLIHLSSET 287
Query: 93 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP 152
++L N + + ++T+ + +F S + L L
Sbjct: 288 TVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLA--AADWLVPA 345
Query: 153 IPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKM 207
+ + +A L + T+ +++ ++ +L ++
Sbjct: 346 REGEPAPADRWHMFG--QEDNADAFSLFLDRLSETENFIKDAGFKAQISSWLAQL 398
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-18
Identities = 54/252 (21%), Positives = 92/252 (36%), Gaps = 50/252 (19%)
Query: 35 PKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKL 94
P+L L FL I N LK +P + L ++ N ELPE L +L L +
Sbjct: 189 PELQNLPFLTAIYADNNSLKK-LPDLPLS---LESIVAGNNILE-ELPE-LQNLPFLTTI 242
Query: 95 HLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP 154
+ +N LP +++ + DN T +P Q+ T L+ SGL+
Sbjct: 243 YADNNLLK-TLPDL---PPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGLSE--- 294
Query: 155 SGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTK----- 209
NL L S N + + + +L + N + ELP ++ +
Sbjct: 295 ----LPPNLYYLNASS-NEIRSLCDLPPS--LEELNVSNNKLI-ELPALPPRLERLIASF 346
Query: 210 ------------LKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LER 255
LK L + +N LR + P + + D+ + L +P L+
Sbjct: 347 NHLAEVPELPQNLKQLHVEYNPLR-EFPDIPESVEDLR----MNSHLA-EVPELPQNLK- 399
Query: 256 GDKIDLSYNNFT 267
++ + N
Sbjct: 400 --QLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 6e-15
Identities = 44/266 (16%), Positives = 85/266 (31%), Gaps = 69/266 (25%)
Query: 33 LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92
+ P+ TFLQ+ ++ L E+P E ++ +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-------------------------EMPVEAENVKSKT 37
Query: 93 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTG------------QIPSFIQNWTKLE 140
+ + + + + P + M R+ D +P + LE
Sbjct: 38 EYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPPH---LE 94
Query: 141 KLFIQPSGLAGPIPSGIFSLENLT--DLRISDLNG-PEA------------TFPQLGNMK 185
L + L +P SL++L + + L+ P P+L N
Sbjct: 95 SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSS 153
Query: 186 -MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLL 244
+ + + N ++ +LP L+ + N+L ++P +L + IY N L
Sbjct: 154 FLKIIDVDNNSLK-KLPDLPP---SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSL 207
Query: 245 TGAIPPWM--LERGDKIDLSYNNFTD 268
+P LE I N +
Sbjct: 208 K-KLPDLPLSLES---IVAGNNILEE 229
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 5e-12
Identities = 44/213 (20%), Positives = 77/213 (36%), Gaps = 31/213 (14%)
Query: 33 LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92
LP LTFL I + L P L L N+ L + +LE
Sbjct: 272 LPELPQSLTFLDVSENIFSGLSELPPN-------LYYLNASSNEIR-SLCDLPP---SLE 320
Query: 93 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP 152
+L++S+N ELP +L S N ++P QN L++L ++ + L
Sbjct: 321 ELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVPELPQN---LKQLHVEYNPLRE- 371
Query: 153 IPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKV 212
P S+E+L +N A P+L + +L + + E P ++
Sbjct: 372 FPDIPESVEDL------RMNSHLAEVPEL-PQNLKQLHVETNPLR-EFPDIPES---VED 420
Query: 213 LDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 245
L ++ R+ + ++ F +
Sbjct: 421 LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 52/211 (24%), Positives = 90/211 (42%), Gaps = 37/211 (17%)
Query: 401 IGEGGFGPVYKGLLADGTAI-AVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYG 456
IG+G FG V D + A+K ++ + + R E+ ++ L+HP LV L+
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 457 CCIEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRRRICLGIAR--------GLAY 505
+ + ++ + L + L H + + L Y
Sbjct: 83 SFQDEEDMFMVVDLLLGGD-------LRYHLQQ-----NVHFKEETVKLFICELVMALDY 130
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE- 564
L +++HRD+K N+LLD+ + I+DF +A + E + +AGT YMAPE
Sbjct: 131 LQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEM 185
Query: 565 ---YAMRGHLTEKADVYSFGIVALEIVSGRS 592
G+ + D +S G+ A E++ GR
Sbjct: 186 FSSRKGAGY-SFAVDWWSLGVTAYELLRGRR 215
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 89.3 bits (221), Expect = 1e-18
Identities = 45/236 (19%), Positives = 78/236 (33%), Gaps = 40/236 (16%)
Query: 33 LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92
LP A L +L NRL +P+ A+ L +L V NQ + LPE LE
Sbjct: 95 LPELPASLEYL---DACDNRLST-LPELPAS---LKHLDVDNNQLT-MLPELPA---LLE 143
Query: 93 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP 152
++ +N T LP T+++ + +NQ T +P ++ LE L + + L
Sbjct: 144 YINADNNQLT-MLP---ELPTSLEVLSVRNNQLT-FLPELPES---LEALDVSTNLLES- 194
Query: 153 IPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKV 212
+P+ + + I R IT +P + +
Sbjct: 195 LPAVPVRNHHSEETEIF-------------------FRCRENRIT-HIPENILSLDPTCT 234
Query: 213 LDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 268
+ L N L +I + + + + D F +
Sbjct: 235 IILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPE 290
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 61.5 bits (149), Expect = 6e-10
Identities = 45/212 (21%), Positives = 78/212 (36%), Gaps = 34/212 (16%)
Query: 63 NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS---NNFTGELPKTFAKLTNMKDFR 119
N +L + YN SG + + EK L N L + + + +
Sbjct: 9 NNFSLSQNS-FYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQ 65
Query: 120 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLE--NLTDLRISDLNGPEAT 177
++ + +P + ++ L I + L +P SLE + D R+S L PE
Sbjct: 66 LNRLNLS-SLPDNL--PPQITVLEITQNAL-ISLPELPASLEYLDACDNRLSTL--PE-- 117
Query: 178 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYI 237
++K L + N +T LP L+ ++ N+L +P L + +
Sbjct: 118 --LPASLK--HLDVDNNQLT-MLPELPA---LLEYINADNNQLT-MLPELPTSL---EVL 165
Query: 238 YFAGNLLTGAIPPWM--LERGDKIDLSYNNFT 267
N LT +P LE +D+S N
Sbjct: 166 SVRNNQLT-FLPELPESLE---ALDVSTNLLE 193
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 27/202 (13%), Positives = 58/202 (28%), Gaps = 15/202 (7%)
Query: 33 LPPKLAELTFLQDISLIANRLKGPIPKYLANI----STLVNLTVQYNQFSGELPEELGSL 88
LP L L + N L+ +P T + + N+ + +PE + SL
Sbjct: 175 LPELPESLEAL---DVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSL 229
Query: 89 LNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSG 148
+ L N + + ++ ++ T D+ F+ QN +
Sbjct: 230 DPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQ--QNTLHRPLADAVTAW 287
Query: 149 LAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMT 208
S + + + L + T ++ +L K++
Sbjct: 288 FPENKQSDVSQIWH----AFEHEEHANTFSAFLDRLSDTVSARNTSGFREQVAAWLEKLS 343
Query: 209 KLKVLDLSFNRLRGQIPSNFDD 230
L + + +D
Sbjct: 344 ASAELRQQSFAVAADATESCED 365
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 56/254 (22%), Positives = 89/254 (35%), Gaps = 49/254 (19%)
Query: 26 EQNLTGV---LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELP 82
+NL V + L L + N+++ ++ L L + N
Sbjct: 52 RKNLREVPDGISTNTRLL-NLHE-----NQIQIIKVNSFKHLRHLEILQLSRNHIRTIEI 105
Query: 83 EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 142
L NL L L N T F L+ +K+ + +N
Sbjct: 106 GAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIES--------------- 150
Query: 143 FIQPSGLAGPIPSGIFS-LENLTDLRISDLNG----PEATFPQLGNMKMTKLILRNCNIT 197
IPS F+ + +L L + +L E F L N + L L CN+
Sbjct: 151 ----------IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSN--LRYLNLAMCNLR 198
Query: 198 GELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPP---WML 253
E+P L + KL LDLS N L I F L + ++ + + I L
Sbjct: 199 -EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNL 254
Query: 254 ERGDKIDLSYNNFT 267
+ +I+L++NN T
Sbjct: 255 QSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 41/234 (17%), Positives = 85/234 (36%), Gaps = 27/234 (11%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEE-LG 86
+ + L L+ + L N ++ ++ L L + N+ + +P
Sbjct: 75 QIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFV 133
Query: 87 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD-NQFTGQIPSFI-QNWTKLEKLFI 144
L L++L L +N F ++ +++ + + + + I + + L L +
Sbjct: 134 YLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLS-YISEGAFEGLSNLRYLNL 192
Query: 145 QPSGLAGPIPSGIFSLENLTDLRISDLNG------PEATFPQLGNMKMTKLILRNCNITG 198
L I +L L L DL+G +F L +++ KL + I
Sbjct: 193 AMCNL-----REIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ--KLWMIQSQIQV 245
Query: 199 ELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPW 251
+ L ++L+ N L +P + F L+ ++ I+ N PW
Sbjct: 246 IERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN-------PW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 24/123 (19%), Positives = 45/123 (36%), Gaps = 3/123 (2%)
Query: 24 LKEQNLTGVLPPK-LAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELP 82
L E + L+ L+ ++L L+ IP L + L L + N S P
Sbjct: 167 LGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSGNHLSAIRP 224
Query: 83 EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 142
L++L+KL + + F L ++ + ++ N T LE++
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERI 284
Query: 143 FIQ 145
+
Sbjct: 285 HLH 287
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 3e-18
Identities = 55/213 (25%), Positives = 104/213 (48%), Gaps = 21/213 (9%)
Query: 393 NNFATDNNIGEGGFGPVYKG--LLADGTAIAVKQLS-SKSKQGN-----REFINEIGMIS 444
+ IGEG +G V+K L G +A+K++ ++G RE + + +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE-VAVLRHLE 69
Query: 445 ALQHPNLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLG 498
+HPN+V+L+ C +L L++E+++ + L L + + T + +
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQD-LTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTI 558
+ RGL +LH +VVHRD+K N+L+ K++DFGLA++ + +++ V T+
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV-TL 183
Query: 559 GYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 591
Y APE ++ D++S G + E+ +
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 20/205 (9%)
Query: 401 IGEGGFGPVY----KGLLADGTAIAVKQLSSKS--KQGNRE-FINEIGMISALQHPNLVK 453
IG G FG V K A+K L+ K+ F E ++ +
Sbjct: 82 IGRGAFGEVAVVKLKN---ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
L+ + N L L+ +Y L L + +L R + + +H ++
Sbjct: 139 LHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVH---QLH 195
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE------YAM 567
VHRDIK N+L+D + + +++DFG E+ T S+ GT Y++PE
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 568 RGHLTEKADVYSFGIVALEIVSGRS 592
+ + D +S G+ E++ G +
Sbjct: 256 GRY-GPECDWWSLGVCMYEMLYGET 279
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 53/238 (22%), Positives = 84/238 (35%), Gaps = 32/238 (13%)
Query: 26 EQNLTGV---LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELP 82
+Q L V +P + FL NR+ L L + N +
Sbjct: 20 QQGLQAVPVGIPAASQRI-FLHG-----NRISHVPAASFRACRNLTILWLHSNVLARIDA 73
Query: 83 EELGSLLNLEKLHLSSNNFTGELPK-TFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLE 140
L LE+L LS N + TF L + + ++ + + L+
Sbjct: 74 AAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQ 132
Query: 141 KLFIQPSGLAGPIPSGIFS-LENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNC 194
L++Q + L +P F L NLT L RIS + PE F L + + +L+L
Sbjct: 133 YLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRISSV--PERAFRGLHS--LDRLLLHQN 187
Query: 195 NITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPW 251
+ P + +L L L N L +P+ L + Y+ N PW
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN-------PW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 52/217 (23%), Positives = 80/217 (36%), Gaps = 19/217 (8%)
Query: 62 ANIST-LVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 120
I + + N+ S + NL L L SN F L ++ +
Sbjct: 28 VGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDL 87
Query: 121 SDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLNG----P 174
SDN + +L L + GL + G+F L L L + D N P
Sbjct: 88 SDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE-LGPGLFRGLAALQYLYLQD-NALQALP 145
Query: 175 EATFPQLGNMKMTKLILRNCNITGELPRY-LGKMTKLKVLDLSFNRLRGQIPSN-FDDLY 232
+ TF LGN +T L L I+ +P + L L L NR+ + + F DL
Sbjct: 146 DDTFRDLGN--LTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLG 201
Query: 233 DVDYIYFAGNLLTGAIPPWMLERGDK---IDLSYNNF 266
+ +Y N L+ A+P L + L+ N +
Sbjct: 202 RLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDNPW 237
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 50/268 (18%), Positives = 92/268 (34%), Gaps = 53/268 (19%)
Query: 12 FWKQKTVNQKRVLKEQNLTGV---LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLV 68
+ V + L+ V +P L L + N ++ ++ L
Sbjct: 53 SNQFSKVV----CTRRGLSEVPQGIPSNTRYL-NLME-----NNIQMIQADTFRHLHHLE 102
Query: 69 NLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ 128
L + N L +L L L N T F L+ +++ + +N
Sbjct: 103 VLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIES- 161
Query: 129 IPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLNG----PEATFPQLGN 183
IPS F+ + +L L + +L E F L N
Sbjct: 162 ------------------------IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFN 197
Query: 184 MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGN 242
+K L L CNI ++P L + L+ L++S N +I F L + ++ +
Sbjct: 198 LK--YLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNS 252
Query: 243 LLTGAIPPWM---LERGDKIDLSYNNFT 267
++ I L +++L++NN +
Sbjct: 253 QVS-LIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 39/234 (16%), Positives = 83/234 (35%), Gaps = 27/234 (11%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEE-LG 86
N+ + L L+ + L N ++ +++L L + N + +P
Sbjct: 86 NIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFE 144
Query: 87 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD-NQFTGQIPSFI-QNWTKLEKLFI 144
L L +L L +N F ++ ++ + + + I + L+ L +
Sbjct: 145 YLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNL 203
Query: 145 QPSGLAGPIPSGIFSLENLTDLRISDLNG------PEATFPQLGNMKMTKLILRNCNITG 198
+ + +L L L +++G +F L ++K KL + N ++
Sbjct: 204 GMCNI-----KDMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLK--KLWVMNSQVSL 256
Query: 199 ELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPW 251
+ L L+L+ N L +P + F L + ++ N PW
Sbjct: 257 IERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN-------PW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 22/123 (17%), Positives = 45/123 (36%), Gaps = 5/123 (4%)
Query: 24 LKEQNLTGVLPPK-LAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELP 82
L E + L L+ ++L +K +P L + L L + N F E+
Sbjct: 178 LGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFP-EIR 234
Query: 83 EE-LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEK 141
L +L+KL + ++ + F L ++ + ++ N + L +
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVE 294
Query: 142 LFI 144
L +
Sbjct: 295 LHL 297
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 62/216 (28%), Positives = 90/216 (41%), Gaps = 29/216 (13%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREF---INEIGMISALQHPNLVK 453
+G+G FG V +L G A+K L + E + E ++ +HP L
Sbjct: 156 LGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 454 LYGCCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLH 507
L ++L + EY E LF H R I L YLH
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGE-------LFFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 567
E + V+RD+K N++LDKD + KI+DFGL K ++ + T GT Y+APE
Sbjct: 266 SEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLE 322
Query: 568 RGHLTEKADVYSFGIVALEIVSGRS---NVTKEDMF 600
D + G+V E++ GR N E +F
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 358
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 42/252 (16%), Positives = 86/252 (34%), Gaps = 22/252 (8%)
Query: 33 LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92
+ L D+ + ++ +T + + L S +E
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 93 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAG 151
L+L+ FA ++ + N +P + QN L L ++ + L+
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSS 131
Query: 152 PIPSGIFS-LENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 205
+P GIF LT L + + + TF +++ L L + +T + L
Sbjct: 132 -LPRGIFHNTPKLTTLSMSNNNLERI--EDDTFQATTSLQ--NLQLSSNRLT-HVD--LS 183
Query: 206 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNN 265
+ L ++S+N L S V+ + + N + + + + L +NN
Sbjct: 184 LIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNN 237
Query: 266 FTDGSAESSCQK 277
TD + +
Sbjct: 238 LTDTAWLLNYPG 249
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 49/271 (18%), Positives = 98/271 (36%), Gaps = 39/271 (14%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
K + + L ++ ++L +++ A T+ L + +N LP
Sbjct: 52 FKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPP 110
Query: 84 E-LGSLLNLEKLHLSSNNFTGELPK-TFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLE 140
++ L L L N+ + LP+ F + +S+N +I Q T L+
Sbjct: 111 HVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQ 168
Query: 141 KLFIQPSGLAGPIPSGIF--------------SLENLTDLRISDLNG------PEATFPQ 180
L + + L + + +L + D + +
Sbjct: 169 NLQLSSNRLTH-VDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVE 227
Query: 181 LGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYF 239
L T L L++ N+T + +L L +DLS+N L +I + F + ++ +Y
Sbjct: 228 L-----TILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYI 279
Query: 240 AGNLLTGAIPP--WMLERGDKIDLSYNNFTD 268
+ N L A+ + +DLS+N+
Sbjct: 280 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH 309
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 36/198 (18%), Positives = 66/198 (33%), Gaps = 33/198 (16%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
L N++ L LA ++++ N + L L +Q+N + +
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVE---LTILKLQHNNLT-DTAW 243
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 143
L + L ++ LS N + F K+ ++ IS+N+ + + Q L+ L
Sbjct: 244 -LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 301
Query: 144 IQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRY 203
+ + L + + L +L L + +I L
Sbjct: 302 LSHNHLLH-VERNQPQFDRLENLY-----------------------LDHNSIV-TLK-- 334
Query: 204 LGKMTKLKVLDLSFNRLR 221
L LK L LS N
Sbjct: 335 LSTHHTLKNLTLSHNDWD 352
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 51/238 (21%), Positives = 87/238 (36%), Gaps = 60/238 (25%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKL----Y 455
+G G FG V + + G A+K++ + NRE + ++ L H N++KL Y
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIKLVDYFY 70
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRR-----------------RICLG 498
E + + + K ++
Sbjct: 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKS 130
Query: 499 -------------------IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS-KISDFG 538
+ R + ++H + + HRDIK N+L++ N+ K+ DFG
Sbjct: 131 FIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 539 LAK--LDEEENTH-ISTRVAGTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVSGR 591
AK + E + I +R Y APE M G T D++S G V E++ G+
Sbjct: 188 SAKKLIPSEPSVAYICSRF-----YRAPEL-MLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 50/207 (24%), Positives = 88/207 (42%), Gaps = 32/207 (15%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN---------EIGMISALQHPN 450
IG G G V +A+K+LS R F N E+ ++ + H N
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLS-------RPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 451 LVKLY------GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 504
++ L E + ++ E ++ N L + + +++LD + + G+
Sbjct: 86 IIGLLNVFTPQKSLEEFQDVYIVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIK 141
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
+LH ++HRD+K +N+++ D KI DFGLA+ + T T Y APE
Sbjct: 142 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPE 196
Query: 565 YAMRGHLTEKADVYSFGIVALEIVSGR 591
+ E D++S G + E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 4e-17
Identities = 44/262 (16%), Positives = 86/262 (32%), Gaps = 26/262 (9%)
Query: 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQ 76
T+N V E ++ + + L + + + + +TV+ ++
Sbjct: 262 TLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSK 321
Query: 77 FSGELPEELGSLLNLEKLHLSSNNFTGELPKT---FAKLTNMKDFRISDNQFT--GQIPS 131
L +LE L LS N E K +++ +S N +
Sbjct: 322 VFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381
Query: 132 FIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG----PEATFPQLGNMKMT 187
+ L L I + P+P E + L +S G L
Sbjct: 382 ILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSS-TGIRVVKTCIPQTL-----E 434
Query: 188 KLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGA 247
L + N N+ +L +L+ L +S N+L+ ++ + + + N L +
Sbjct: 435 VLDVSNNNLD-SFSLFL---PRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLK-S 487
Query: 248 IPPWMLERGDK---IDLSYNNF 266
+P + +R I L N +
Sbjct: 488 VPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-17
Identities = 40/214 (18%), Positives = 81/214 (37%), Gaps = 12/214 (5%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
+ ++ T + P L ++ + L N++ L + L L ++ ++ + +
Sbjct: 12 GRSRSFTSI-PSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRIN-TIEG 67
Query: 84 E-LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTG-QIPSFIQNWTKLEK 141
+ SL +LE L LS N+ + F L+++K + N + + S N T L+
Sbjct: 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127
Query: 142 LFIQPSGLAGPIPSGIFS-LENLTDLRISDLNG---PEATFPQLGNMKMTKLILRNCNIT 197
L I I F+ L +L +L I L+ + + ++ L L
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIH--HLTLHLSESA 185
Query: 198 GELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 231
L + ++ ++ L+L L S
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVD 219
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-17
Identities = 35/262 (13%), Positives = 89/262 (33%), Gaps = 27/262 (10%)
Query: 33 LPPKLAELTFLQDISLI-ANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNL 91
+ LT LQ + + A +++L L ++ + L S+ ++
Sbjct: 115 VTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDI 174
Query: 92 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFI---QNWTKLEKLFIQPSG 148
L L + L L++++ + D S + + + ++KL + S
Sbjct: 175 HHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSV 234
Query: 149 LAGPIPSGIFSLEN----LTDLRISDL---------NGPEATFPQLGNMKMTKLI---LR 192
L + + L L+++ D +LG ++ + +
Sbjct: 235 LTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIP 294
Query: 193 NCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPW 251
+ +L + K+K + + +++ +P + L ++++ + NL+
Sbjct: 295 QFYLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKN 353
Query: 252 MLERGD-----KIDLSYNNFTD 268
+G + LS N+
Sbjct: 354 SACKGAWPSLQTLVLSQNHLRS 375
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 47/233 (20%), Positives = 81/233 (34%), Gaps = 25/233 (10%)
Query: 66 TLVNLTVQYNQFSGELPEELGSLLN---LEKLHLSSNNFTGELPKTFAKLT--NMKDFRI 120
+L LTV+ + + +L L++L L + TG P + T ++ +
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 121 SDNQFTGQIPSF--IQNW--TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGP 174
+ + + +Q W L+ L I + + L+ L +SD G
Sbjct: 129 RNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGE 188
Query: 175 EATFPQLGNMKMTK---LILRNCNIT---GELPRYLGKMTKLKVLDLSFNRLRGQIP-SN 227
L +K L LRN + G +L+ LDLS N LR +
Sbjct: 189 RGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS 248
Query: 228 FDDLYDVDYIYFAGNLLTGAIP---PWMLERGDKIDLSYNNFTDGSAESSCQK 277
D ++ + + L +P P L +DLSYN + +
Sbjct: 249 CDWPSQLNSLNLSFTGLK-QVPKGLPAKLS---VLDLSYNRLDRNPSPDELPQ 297
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 46/267 (17%), Positives = 87/267 (32%), Gaps = 45/267 (16%)
Query: 20 QKRVLKEQNLTGVLPPKLAEL---TFLQDISLIANRLKGPIPKYLANIS--TLVNLTVQY 74
++ ++ + + + + LQ+++L + G P L + L L ++
Sbjct: 71 KRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRN 130
Query: 75 NQFSGELPE--ELGSLL--NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP 130
++ EL L L+ L ++ + + + +SDN G+
Sbjct: 131 VSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 131 ----SFIQNWTKLEKLFI---QPSGLAGPIPSGIFSLENLTDLRIS--DLNGPEATFPQL 181
+ L+ L + +G + + L L +S L
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
Query: 182 GNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAG 241
++ L L + ++P+ L KL VLDLS+NRL PS
Sbjct: 251 WPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPS--------------- 291
Query: 242 NLLTGAIPPWMLERGDKIDLSYNNFTD 268
P L + + L N F D
Sbjct: 292 --------PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 36/215 (16%), Positives = 70/215 (32%), Gaps = 22/215 (10%)
Query: 83 EELGSLLNLEKLHLSSNNFTGELPKT-FAKLTNMKDFRISDNQFTGQIPS---FIQNWTK 138
E G +LE L + T K ++K + + +I + +
Sbjct: 37 ELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISG 96
Query: 139 LEKLFIQPSGLAGPIPSGIFSL--ENLTDLRISDLNGPE-----ATFPQLGNMKMTKLIL 191
L++L ++ + G P + +L L + +++ A Q + L +
Sbjct: 97 LQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSI 156
Query: 192 RNCNITGELPRYLGKMTKLKVLDLSFNRLRGQI-------PSNFDDLYDVDYIYFAGNLL 244
+ + L LDLS N G+ P F L +
Sbjct: 157 AQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETP 216
Query: 245 TGAIPPWMLERGDK---IDLSYNNFTDGSAESSCQ 276
+G + + + +DLS+N+ D + SC
Sbjct: 217 SG-VCSALAAARVQLQGLDLSHNSLRDAAGAPSCD 250
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 6e-17
Identities = 60/208 (28%), Positives = 103/208 (49%), Gaps = 31/208 (14%)
Query: 401 IGEGGFGPVY---KGLLADGTAI-AVKQLSSKS-KQGNR-EFINEIGMISALQHPNLVKL 454
+G+G FG V+ K +D + A+K L + K +R E ++ + HP +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 455 YGCCIEGNQLLLIYEYL---ENNSLARALFEH-----RLKLDWPTRRRICLG-IARGLAY 505
+ +L LI ++L + LF + + L +A L +
Sbjct: 92 HYAFQTEGKLYLILDFLRGGD-------LFTRLSKEVMFTEE---DVKFYLAELALALDH 141
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 565
LH + +++RD+K N+LLD++ + K++DFGL+K + + GT+ YMAPE
Sbjct: 142 LH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEV 197
Query: 566 AMR-GHLTEKADVYSFGIVALEIVSGRS 592
R GH T+ AD +SFG++ E+++G
Sbjct: 198 VNRRGH-TQSADWWSFGVLMFEMLTGTL 224
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 9e-17
Identities = 50/208 (24%), Positives = 93/208 (44%), Gaps = 23/208 (11%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLS--SKSKQGNREFIN---------EIGMISALQHP 449
I G +G V G+ ++G +A+K++ + + EI +++ HP
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 450 NLVKLYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 504
N++ L + ++L L+ E + + LA+ + + R+ + + I GL
Sbjct: 90 NILGLRDIFVHFEEPAMHKLYLVTELMRTD-LAQVIHDQRIVISPQHIQYFMYHILLGLH 148
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPE 564
LH VVHRD+ N+LL + + I DF LA+ ++ + + + V Y APE
Sbjct: 149 VLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR-EDTADANKTHYVT-HRWYRAPE 203
Query: 565 YAM-RGHLTEKADVYSFGIVALEIVSGR 591
M T+ D++S G V E+ + +
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 1e-16
Identities = 49/201 (24%), Positives = 87/201 (43%), Gaps = 20/201 (9%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS---SKSKQGNREFINEIGMISALQHPNLVKLY- 455
IG G G V +A+K+LS R + E+ ++ + H N++ L
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY-RELVLMKCVNHKNIISLLN 128
Query: 456 -----GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
E + L+ E ++ N L + + +++LD + + G+ +LH
Sbjct: 129 VFTPQKTLEEFQDVYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKHLHSAG 184
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 570
++HRD+K +N+++ D KI DFGLA+ + T T Y APE +
Sbjct: 185 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMG 239
Query: 571 LTEKADVYSFGIVALEIVSGR 591
E D++S G + E+V +
Sbjct: 240 YKENVDIWSVGCIMGEMVRHK 260
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 36/213 (16%), Positives = 82/213 (38%), Gaps = 21/213 (9%)
Query: 65 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 124
L +Q N+ + + +L NL L L +N + P FA L ++ +S NQ
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 125 FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDL-----RISDLNGPEATF 178
++P + L++L + + + + +F+ L + + + F
Sbjct: 112 LK-ELPEKM--PKTLQELRVHENEITK-VRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 167
Query: 179 PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYI 237
+ + + + + NIT +P+ L L L L N++ ++ + L ++ +
Sbjct: 168 QGMKKLS--YIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKL 221
Query: 238 YFAGNLLTGAIPP---WMLERGDKIDLSYNNFT 267
+ N ++ A+ ++ L+ N
Sbjct: 222 GLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 53/253 (20%), Positives = 98/253 (38%), Gaps = 24/253 (9%)
Query: 41 TFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNN 100
+ L N++ N+ L L + N+ S P L+ LE+L+LS N
Sbjct: 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111
Query: 101 FTGELPK-TFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSGL-AGPIPSGI 157
ELP+ L + R+ +N+ T ++ + ++ + + + L + I +G
Sbjct: 112 LK-ELPEKMPKTLQEL---RVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGA 166
Query: 158 FS-LENLTDLRISDLNG----PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKV 212
F ++ L+ +RI+D P+ P L T+L L IT L + L
Sbjct: 167 FQGMKKLSYIRIAD-TNITTIPQGLPPSL-----TELHLDGNKITKVDAASLKGLNNLAK 220
Query: 213 LDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDG 269
L LSFN + + + + + ++ N L +P + + + L NN +
Sbjct: 221 LGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 278
Query: 270 SAESSCQKRSVTG 282
+ C T
Sbjct: 279 GSNDFCPPGYNTK 291
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 37/219 (16%), Positives = 71/219 (32%), Gaps = 25/219 (11%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLK-GPIPK-YLANISTLVNLTVQYNQFSGELPEEL 85
+T V L + + L N LK I + L + + + +P+
Sbjct: 132 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ-- 188
Query: 86 GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 145
G +L +LHL N T + L N+ +S N + + N L +L +
Sbjct: 189 GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 248
Query: 146 PSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 205
+ L +P G+ + + + L N ++ + P Y
Sbjct: 249 NNKLVK-VPGGLADHKYIQVVY-------------LHNNNISAIGSN----DFCPPGYNT 290
Query: 206 KMTKLKVLDLSFNRLR-GQIPSN-FDDLYDVDYIYFAGN 242
K + L N ++ +I + F +Y +
Sbjct: 291 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 82.7 bits (204), Expect = 2e-16
Identities = 44/252 (17%), Positives = 87/252 (34%), Gaps = 22/252 (8%)
Query: 33 LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEE-LGSLLNL 91
+ L D+ + ++ +T + + +LP L S +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 92 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 151
E L+L+ FA ++ + N P QN L L ++ + L+
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS 137
Query: 152 PIPSGIFS-LENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 205
+P GIF LT L + + + TF +++ L L + +T + L
Sbjct: 138 -LPRGIFHNTPKLTTLSMSNNNLERI--EDDTFQATTSLQ--NLQLSSNRLT-HVD--LS 189
Query: 206 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNN 265
+ L ++S+N L S V+ + + N + + + + L +NN
Sbjct: 190 LIPSLFHANVSYNLL-----STLAIPIAVEELDASHNSIN-VVRGPVNVELTILKLQHNN 243
Query: 266 FTDGSAESSCQK 277
TD + +
Sbjct: 244 LTDTAWLLNYPG 255
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 2e-15
Identities = 49/271 (18%), Positives = 99/271 (36%), Gaps = 39/271 (14%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
K + + L ++ ++L +++ A T+ L + +N LP
Sbjct: 58 FKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPP 116
Query: 84 EL-GSLLNLEKLHLSSNNFTGELPK-TFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLE 140
+ ++ L L L N+ + LP+ F + +S+N +I Q T L+
Sbjct: 117 HVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQ 174
Query: 141 KLFIQPSGLAGPIPSGIF--------------SLENLTDLRISDLNG------PEATFPQ 180
L + + L + + +L + D + +
Sbjct: 175 NLQLSSNRLTH-VDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVE 233
Query: 181 LGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYF 239
L T L L++ N+T + +L L +DLS+N L +I + F + ++ +Y
Sbjct: 234 L-----TILKLQHNNLT-DTA-WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYI 285
Query: 240 AGNLLTGAIPP--WMLERGDKIDLSYNNFTD 268
+ N L A+ + +DLS+N+
Sbjct: 286 SNNRLV-ALNLYGQPIPTLKVLDLSHNHLLH 315
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 3e-12
Identities = 36/198 (18%), Positives = 66/198 (33%), Gaps = 33/198 (16%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
L N++ L LA ++++ N + L L +Q+N + +
Sbjct: 194 LFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVE---LTILKLQHNNLT-DTAW 249
Query: 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLF 143
L + L ++ LS N + F K+ ++ IS+N+ + + Q L+ L
Sbjct: 250 -LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLD 307
Query: 144 IQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRY 203
+ + L + + L +L L + +I L
Sbjct: 308 LSHNHLLH-VERNQPQFDRLENLY-----------------------LDHNSIV-TLK-- 340
Query: 204 LGKMTKLKVLDLSFNRLR 221
L LK L LS N
Sbjct: 341 LSTHHTLKNLTLSHNDWD 358
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 46/198 (23%), Positives = 67/198 (33%), Gaps = 25/198 (12%)
Query: 62 ANI-STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 120
++ L + N L L +L+L T +L L + +
Sbjct: 27 PDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDL 84
Query: 121 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDL-----RISDLNGP 174
S NQ +P Q L L + + L +P G L L +L + L P
Sbjct: 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQELYLKGNELKTL--P 140
Query: 175 EATFPQLGNMKMTKLILRNCNITGELPRYL-GKMTKLKVLDLSFNRLRGQIPSNFDDLYD 233
+ KL L N N+T ELP L + L L L N L IP F +
Sbjct: 141 PGLLTPTPK--LEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHL 196
Query: 234 VDYIYFAGNLLTGAIPPW 251
+ + + GN PW
Sbjct: 197 LPFAFLHGN-------PW 207
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 54/213 (25%), Positives = 89/213 (41%), Gaps = 39/213 (18%)
Query: 401 IGEGGFGPVY----KGLLADGTAIAVKQLSSKSKQGNRE----FINEIGMISALQHPNLV 452
IG G FG V K A+K LS K + R F E +++ P +V
Sbjct: 77 IGRGAFGEVQLVRHKS---TRKVYAMKLLS-KFEMIKRSDSAFFWEERDIMAFANSPWVV 132
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR--------GLA 504
+L+ + L ++ EY+ L + + + W AR L
Sbjct: 133 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW----------ARFYTAEVVLALD 182
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAP 563
+H + +HRD+K N+LLDK + K++DFG +++E T V GT Y++P
Sbjct: 183 AIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 238
Query: 564 E----YAMRGHLTEKADVYSFGIVALEIVSGRS 592
E G+ + D +S G+ E++ G +
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 271
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 4e-16
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 33/210 (15%)
Query: 401 IGEGGFGPVY---KGLLADGTAI-AVKQLSSKSKQGNREFI----NEIGMISALQHPNLV 452
+G+GG+G V+ K A+ I A+K L N + E ++ ++HP +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 453 KLYGCCIEGNQLLLIYEYL---ENNSLARALFEH-----RLKLDWPTRRRICLG-IARGL 503
L G +L LI EYL E LF D L I+ L
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGE-------LFMQLEREGIFMED---TACFYLAEISMAL 134
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
+LH + +++RD+K N++L+ + K++DFGL K + T T GTI YMAP
Sbjct: 135 GHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT-FCGTIEYMAP 190
Query: 564 EYAMR-GHLTEKADVYSFGIVALEIVSGRS 592
E MR GH D +S G + ++++G
Sbjct: 191 EILMRSGH-NRAVDWWSLGALMYDMLTGAP 219
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 50/204 (24%), Positives = 90/204 (44%), Gaps = 28/204 (13%)
Query: 401 IGEGGFGPVYKGLLADGTAI-AVKQLSSKSKQGNREF---INEIGMISALQHPNLVKLYG 456
+G G FG V + A+K L + ++ +NE ++ A+ P LVKL
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 457 CCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGES 510
+ + L ++ EY+ E +F H + P R I YLH
Sbjct: 109 SFKDNSNLYMVMEYVAGGE-------MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE-NTHISTRVAGTIGYMAPEYAM-R 568
+++RD+K N+L+D+ +++DFG AK + T + GT +APE + +
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSK 213
Query: 569 GHLTEKADVYSFGIVALEIVSGRS 592
G+ + D ++ G++ E+ +G
Sbjct: 214 GY-NKAVDWWALGVLIYEMAAGYP 236
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 6e-16
Identities = 63/216 (29%), Positives = 88/216 (40%), Gaps = 30/216 (13%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREF---INEIGMISALQHPNLVK 453
+G+G FG V +L G A+K L + E + E ++ +HP L
Sbjct: 13 LGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69
Query: 454 LYGCCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLH 507
L ++L + EY E LF H R I L YLH
Sbjct: 70 LKYAFQTHDRLCFVMEYANGGE-------LFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 567
VV+RDIK N++LDKD + KI+DFGL K + + T GT Y+APE
Sbjct: 123 SR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLE 178
Query: 568 RGHLTEKADVYSFGIVALEIVSGRS---NVTKEDMF 600
D + G+V E++ GR N E +F
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 50/207 (24%), Positives = 80/207 (38%), Gaps = 22/207 (10%)
Query: 401 IGEGGFGPVY----KGLLADGTAIAVKQLSSKSKQGNRE----FINEIGMISALQHPNLV 452
IG G F V K G A+K ++ K R F E ++ +
Sbjct: 69 IGRGAFSEVAVVKMKQ---TGQVYAMKIMN-KWDMLKRGEVSCFREERDVLVNGDRRWIT 124
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
+L+ + N L L+ EY L L + ++ R I + +H R+
Sbjct: 125 QLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH---RL 181
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
VHRDIK N+LLD+ + +++DFG + T S GT Y++PE
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGG 241
Query: 573 EKADVY-------SFGIVALEIVSGRS 592
Y + G+ A E+ G++
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQT 268
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 7e-16
Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 25/214 (11%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 452
+G+G FG V +L+ AVK L + + + + + P L
Sbjct: 349 LGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGE 509
+L+ C ++L + EY+ L H + P IA GL +L +
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 569
+++RD+K NV+LD + + KI+DFG+ K + + T GT Y+APE
Sbjct: 462 ---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEIIAYQ 517
Query: 570 HLTEKADVYSFGIVALEIVSGRS---NVTKEDMF 600
+ D ++FG++ E+++G++ ++++F
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 551
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 7e-16
Identities = 49/237 (20%), Positives = 88/237 (37%), Gaps = 27/237 (11%)
Query: 42 FLQDISLIANRLKGPIPKYLANIST-LVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNN 100
L+ + LK +PK IS L +Q N S ++ L +L L L +N
Sbjct: 34 HLRVVQCSDLGLKA-VPK---EISPDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNK 89
Query: 101 FTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS- 159
+ K F+ L ++ IS N +IP + + L +L I + + +P G+FS
Sbjct: 90 ISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRK-VPKGVFSG 145
Query: 160 LENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLD 214
L N+ + + + F +K+ L + +T +P+ L L L
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAF---DGLKLNYLRISEAKLT-GIPKDL--PETLNELH 199
Query: 215 LSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPP---WMLERGDKIDLSYNNFT 267
L N+++ I + + N + I L ++ L N +
Sbjct: 200 LDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS 254
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 9e-15
Identities = 52/250 (20%), Positives = 93/250 (37%), Gaps = 22/250 (8%)
Query: 26 EQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEEL 85
+ L V P +++ + L N + + L L + N+ S +
Sbjct: 42 DLGLKAV-PKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAF 98
Query: 86 GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFI 144
L L+KL++S N+ P + L + RI DN+ ++P + + + +
Sbjct: 99 SPLRKLQKLYISKNHLVEIPPNLPSSLVEL---RIHDNRIR-KVPKGVFSGLRNMNCIEM 154
Query: 145 QPSGLA-GPIPSGIFSLENLTDLRISDLNG---PEATFPQLGNMKMTKLILRNCNITGEL 200
+ L G F L LRIS+ P+ L +L L + I
Sbjct: 155 GGNPLENSGFEPGAFDGLKLNYLRISEAKLTGIPKDLPETL-----NELHLDHNKIQAIE 209
Query: 201 PRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPWM--LERGD 257
L + +KL L L N++R I + L + ++ N L+ +P + L+
Sbjct: 210 LEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQ 267
Query: 258 KIDLSYNNFT 267
+ L NN T
Sbjct: 268 VVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 42/225 (18%), Positives = 82/225 (36%), Gaps = 26/225 (11%)
Query: 33 LPPKLAELTFLQDISLIANRLKGPIPKY-LANISTLVNLTVQYNQF-SGELPEELGSLLN 90
+PP L + L ++ + NR++ +PK + + + + + N + L
Sbjct: 117 IPPNL--PSSLVELRIHDNRIRK-VPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLK 173
Query: 91 LEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSGL 149
L L +S TG L + + N+ I ++KL +L + + +
Sbjct: 174 LNYLRISEAKLTGIPKDLPETLNEL---HLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQI 229
Query: 150 AGPIPSGIFS-LENLTDLRISD--LNGPEATFPQLGNMKMTKLILRNCNITGELP----- 201
I +G S L L +L + + L+ A P L ++ + L NIT ++
Sbjct: 230 RM-IENGSLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQ--VVYLHTNNIT-KVGVNDFC 285
Query: 202 --RYLGKMTKLKVLDLSFNRLR-GQIPSN-FDDLYDVDYIYFAGN 242
+ K + L N + ++ F + D I F
Sbjct: 286 PVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 7e-16
Identities = 45/247 (18%), Positives = 91/247 (36%), Gaps = 20/247 (8%)
Query: 34 PPKLAELTFLQDISLIANRLKGPIPKYLANIS-----TLVNLTVQYNQFSGELPEELGSL 88
+L T + S+ +L+G + + S L V + F
Sbjct: 240 ILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIF 299
Query: 89 LNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSG 148
N+ + + + +K++ S+N T + + T+LE L +Q +
Sbjct: 300 SNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQ 359
Query: 149 LAG-PIPSGIF-SLENLTDLRISD----LNGPEATFPQLGNMKMTKLILRNCNITGELPR 202
L + + +++L L IS + + + + L + + +T + R
Sbjct: 360 LKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS--LLSLNMSSNILTDTIFR 417
Query: 203 YLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDK---I 259
L ++KVLDL N+++ IP L + + A N L ++P + +R I
Sbjct: 418 CL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKI 473
Query: 260 DLSYNNF 266
L N +
Sbjct: 474 WLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 39/265 (14%), Positives = 87/265 (32%), Gaps = 22/265 (8%)
Query: 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFS 78
+ + + ++ V +L+ + + + + + L I L L NLT+ + +
Sbjct: 176 KEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS--ILAKLQTNPKLSNLTLNNIETT 233
Query: 79 GELPEELGSLL---NLEKLHLSSNNFTG-----ELPKTFAKLTNMKDFRISDNQFTGQIP 130
+ L+ + +S+ G + + L + ++ + F
Sbjct: 234 WNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQS 293
Query: 131 SFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDLRISD---LNGPEATFPQLGNMKM 186
+ ++ + SG + S + L S+ + L +
Sbjct: 294 YIYEIFSNMNIKNFTVSGT-RMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTEL-- 350
Query: 187 TKLILRNCNITGELPRYLG---KMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGN 242
LIL+ + EL + +M L+ LD+S N + + + + N
Sbjct: 351 ETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSN 409
Query: 243 LLTGAIPPWMLERGDKIDLSYNNFT 267
+LT I + R +DL N
Sbjct: 410 ILTDTIFRCLPPRIKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 30/184 (16%), Positives = 50/184 (27%), Gaps = 31/184 (16%)
Query: 90 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL 149
L++S N + L+ ++ IS N+
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY---------------------- 59
Query: 150 AGPIPSGIF-SLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPR--YLGK 206
+ +F + L L +S + + N+ L L LP G
Sbjct: 60 ---LDISVFKFNQELEYLDLSHNKLVKISCHPTVNL--KHLDLSFNAFD-ALPICKEFGN 113
Query: 207 MTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNF 266
M++LK L LS L L + G P L+ + L
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173
Query: 267 TDGS 270
T+
Sbjct: 174 TNKE 177
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 37/226 (16%), Positives = 66/226 (29%), Gaps = 17/226 (7%)
Query: 26 EQNLTGV---LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELP 82
+ L V L K L +IS N + + ++S L L + +N+
Sbjct: 9 KNGLIHVPKDLSQKTTIL----NISQ--NYISELWTSDILSLSKLRILIISHNRIQYLDI 62
Query: 83 EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTG-QIPSFIQNWTKLEK 141
LE L LS N ++ N+K +S N F I N ++L+
Sbjct: 63 SVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKF 119
Query: 142 LFIQPSGLAGPIPSGIFSLENLTDLRISDLN----GPEATFPQLGNMKMTKLILRNCNIT 197
L + + L I L L + + + N
Sbjct: 120 LGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFH 179
Query: 198 GELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNL 243
L + + L++ ++ + L + NL
Sbjct: 180 FILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL 225
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 30/236 (12%), Positives = 76/236 (32%), Gaps = 18/236 (7%)
Query: 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99
++ L+ + L L+ +A+++ L V + E+ L + L
Sbjct: 114 MSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYG--EKEDPEGLQDFNTESLHIV 171
Query: 100 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS 159
T K F + ++ +++ + + I+ + K S LA + S
Sbjct: 172 FPTN---KEFHFILDVSVKTVANLELSN-----IKCVLEDNKCSYFLSILAKLQTNPKLS 223
Query: 160 LENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITG-----ELPRYLGKMTKLKVLD 214
L ++ + N + + + + N + G + + L +
Sbjct: 224 NLTLNNIETTW-NSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQ 282
Query: 215 LSFNRLRGQIPSNFDDLYDVDY--IYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 268
+ + ++ +++ +G + + P + +D S N TD
Sbjct: 283 VVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD 338
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 7e-16
Identities = 58/229 (25%), Positives = 100/229 (43%), Gaps = 44/229 (19%)
Query: 401 IGEGGFGPVY---KGLLADGTAI-AVKQLSSKSKQGNREFI------NEIGMISALQHPN 450
+G G +G V+ K D + A+K L + + ++ + Q P
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQSPF 120
Query: 451 LVKLYGCCIEGNQLLLIYEYL---ENNSLARALFEH-----RLKLDWPTRRRICLG-IAR 501
LV L+ +L LI +Y+ E LF H R +I +G I
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGE-------LFTHLSQRERFTEH---EVQIYVGEIVL 170
Query: 502 GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYM 561
L +LH ++ +++RDIK N+LLD + + ++DFGL+K + T + GTI YM
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 562 APE---YAMRGHLTEKADVYSFGIVALEIVSGRS-------NVTKEDMF 600
AP+ GH + D +S G++ E+++G S ++ ++
Sbjct: 228 APDIVRGGDSGH-DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS 275
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 7e-16
Identities = 40/234 (17%), Positives = 84/234 (35%), Gaps = 19/234 (8%)
Query: 37 LAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96
L I+ + + + A++ + L+ + E + L NL L L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLEL 70
Query: 97 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSG 156
N T P LT + + +S N S I ++ L + + + +
Sbjct: 71 KDNQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQI-----TD 121
Query: 157 IFSLENLTDLRISDLNGPEAT-FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLD 214
+ L L++L++ L+ + T L + + L + N ++ P L ++KL L
Sbjct: 122 VTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLK 179
Query: 215 LSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 268
N++ S L ++ ++ N ++ P + L+ T+
Sbjct: 180 ADDNKISD--ISPLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITN 231
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 41/197 (20%), Positives = 81/197 (41%), Gaps = 17/197 (8%)
Query: 37 LAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96
+ L L + L N++ P L N++ + L + N + L +++ L L
Sbjct: 59 VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDL 114
Query: 97 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSG 156
+S T P A L+N++ + NQ T I + T L+ L I + + S
Sbjct: 115 TSTQITDVTP--LAGLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQV-----SD 165
Query: 157 IFSLENLTDLRISDLNGPEAT-FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLD 214
+ L NL+ L + + + L ++ + ++ L+N I+ P L + L ++
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 215 LSFNRLRGQIPSNFDDL 231
L+ + Q ++L
Sbjct: 224 LTNQTITNQPVFYNNNL 240
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 20/114 (17%), Positives = 39/114 (34%), Gaps = 6/114 (5%)
Query: 157 IFSLENLTDLRISDLNGPEAT-FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLD 214
IF L + T ++ +T L +T + + + L L+
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLE 69
Query: 215 LSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 268
L N++ + +L + + +GN L L+ +DL+ TD
Sbjct: 70 LKDNQITD--LAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITD 121
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 8e-16
Identities = 52/203 (25%), Positives = 94/203 (46%), Gaps = 25/203 (12%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS---SKSKQGNREFINEIGMISALQHPNLVKLY- 455
+G G +G V + G +A+K+LS R + E+ ++ +QH N++ L
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY-RELLLLKHMQHENVIGLLD 90
Query: 456 -----GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
L+ +++ + L + + LK + + + +GL Y+H
Sbjct: 91 VFTPASSLRNFYDFYLVMPFMQTD-LQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSAG 146
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAM-R 568
VVHRD+K N+ +++D KI DFGLA+ + E T + TR Y APE +
Sbjct: 147 ---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPEVILSW 198
Query: 569 GHLTEKADVYSFGIVALEIVSGR 591
H + D++S G + E+++G+
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 48/199 (24%), Positives = 80/199 (40%), Gaps = 23/199 (11%)
Query: 62 ANI-STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 120
+NI + L +Q N+ S + L L L+L+ N F +L N++ +
Sbjct: 33 SNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWV 92
Query: 121 SDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISDLNG----- 173
+DN+ +P + L +L + + L +P +F SL LT L L
Sbjct: 93 TDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYL---SLGYNELQS 147
Query: 174 -PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLY 232
P+ F +L + + +L L N + K+T+LK L L N+L+ FD L
Sbjct: 148 LPKGVFDKLTS--LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLE 205
Query: 233 DVDYIYFAGNLLTGAIPPW 251
+ + N PW
Sbjct: 206 KLKMLQLQEN-------PW 217
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 31/217 (14%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 452
+G+G FG V LA A+K L + + + + A +HP L
Sbjct: 25 LGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81
Query: 453 KLYGCCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYL 506
++ L + EYL + L H K D I GL +L
Sbjct: 82 HMFCTFQTKENLFFVMEYLNGGD-------LMYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 566
H + +V+RD+K N+LLDKD + KI+DFG+ K + + +T GT Y+APE
Sbjct: 135 HSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEIL 190
Query: 567 MRGHLTEKADVYSFGIVALEIVSGRS---NVTKEDMF 600
+ D +SFG++ E++ G+S +E++F
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 227
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 3e-15
Identities = 30/186 (16%), Positives = 59/186 (31%), Gaps = 36/186 (19%)
Query: 38 AELTFLQDISLIANRLKGPIPKYLANISTLVNLT---VQYNQFSGELPEELGSLLNLEKL 94
A++ L I+L + L I N+ + + + L NLE+L
Sbjct: 41 AQMNSLTYITLANINVTD-----LTGIEYAHNIKDLTINNIHATN--YNPISGLSNLERL 93
Query: 95 HLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP 154
+ + T + + LT++ IS + I + I K+ + + +G I
Sbjct: 94 RIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA---I- 149
Query: 155 SGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLD 214
+ I L+ L +L L ++ + + KL L
Sbjct: 150 TDIMPLKTLPEL--------------------KSLNIQFDGVHDYRG--IEDFPKLNQLY 187
Query: 215 LSFNRL 220
+
Sbjct: 188 AFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 7e-11
Identities = 24/186 (12%), Positives = 67/186 (36%), Gaps = 37/186 (19%)
Query: 87 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 146
+ L ++ T A++ ++ +++ T + + I+ ++ L
Sbjct: 21 TFKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDL---- 71
Query: 147 SGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLG 205
+ ++ ++ N + + + +L + ++T + L
Sbjct: 72 ---------------TINNIHATNYNP-------ISGLSNLERLRIMGKDVTSDKIPNLS 109
Query: 206 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKI---DLS 262
+T L +LD+S + I + + L V+ I + N I P L+ ++ ++
Sbjct: 110 GLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP--LKTLPELKSLNIQ 167
Query: 263 YNNFTD 268
++ D
Sbjct: 168 FDGVHD 173
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 14/100 (14%), Positives = 34/100 (34%), Gaps = 3/100 (3%)
Query: 28 NLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGS 87
++T P L+ LT L + + + I + + + ++ + YN ++ L +
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKT 157
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTG 127
L L+ L++ + + G
Sbjct: 158 LPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 48/203 (23%), Positives = 94/203 (46%), Gaps = 24/203 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS---SKSKQGNREFINEIGMISALQHPNLVKLY- 455
+G G +G V + G +A+K+L R + E+ ++ ++H N++ L
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMRHENVIGLLD 91
Query: 456 -----GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+ L+ ++ + L + + KL + + + +GL Y+H
Sbjct: 92 VFTPDETLDDFTDFYLVMPFMGTD-LGKLM--KHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAM-R 568
++HRD+K N+ +++D KI DFGLA+ + E T ++ TR Y APE +
Sbjct: 149 ---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW-----YRAPEVILNW 200
Query: 569 GHLTEKADVYSFGIVALEIVSGR 591
T+ D++S G + E+++G+
Sbjct: 201 MRYTQTVDIWSVGCIMAEMITGK 223
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 3e-15
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 44/212 (20%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREF---INEIGMISALQHPNLVK 453
+G G FG V+ L +G A+K L + ++ +E M+S + HP +++
Sbjct: 14 LGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIR 70
Query: 454 LYGCCIEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRRRICLGIAR--------G 502
++G + Q+ +I +Y+ E LF K +R +A+
Sbjct: 71 MWGTFQDAQQIFMIMDYIEGGE-------LFSLLRK-----SQRFPNPVAKFYAAEVCLA 118
Query: 503 LAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE-NTHISTRVAGTIGYM 561
L YLH + +++RD+K N+LLDK+ + KI+DFG AK + T + GT Y+
Sbjct: 119 LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYI 170
Query: 562 APEYAMR-GHLTEKADVYSFGIVALEIVSGRS 592
APE + + D +SFGI+ E+++G +
Sbjct: 171 APEVVSTKPY-NKSIDWWSFGILIYEMLAGYT 201
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 34/209 (16%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 452
IG+G FG V LLA + AVK L K+ +E + + ++ ++HP LV
Sbjct: 46 IGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102
Query: 453 KLYGCCIEGNQLLLIYEYL---ENNSLARALFEH-----RLKLDWPTRRRICLG-IARGL 503
L+ ++L + +Y+ E LF H R R IA L
Sbjct: 103 GLHFSFQTADKLYFVLDYINGGE-------LFYHLQRERCFLEP---RARFYAAEIASAL 152
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
YLH + +V+RD+K N+LLD + ++DFGL K + E N+ ST GT Y+AP
Sbjct: 153 GYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST-FCGTPEYLAP 208
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGRS 592
E + D + G V E++ G
Sbjct: 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLP 237
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 45/214 (21%), Positives = 86/214 (40%), Gaps = 52/214 (24%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSS-KSKQGNREFINEIGMISALQ----HPNLVKL 454
+G G + V++ + + + + VK L K K+ RE I L+ PN++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKRE-------IKILENLRGGPNIITL 96
Query: 455 YGCCI--EGNQLLLIYEYLENNSLARALFEHRL--KLDWPTRRRICLGIARGLAYLHGES 510
L++E++ N +L L R I + L Y H
Sbjct: 97 ADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEILKALDYCHSMG 150
Query: 511 RIKVVHRDIKATNVLLDKDLNS-KISDFGLAKL---DEEENTHISTRVAGTIGYMAPE-- 564
++HRD+K NV++D + ++ D+GLA+ +E N +++R + PE
Sbjct: 151 ---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPELL 202
Query: 565 -------YAMRGHLTEKADVYSFGIVALEIVSGR 591
Y++ D++S G + ++ +
Sbjct: 203 VDYQMYDYSL--------DMWSLGCMLASMIFRK 228
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 54/217 (24%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 452
+G+G FG V +LA G AVK L + + + + A HP L
Sbjct: 31 LGKGSFGKV---MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87
Query: 453 KLYGCCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYL 506
+L+ C ++L + E++ + L H + D R I L +L
Sbjct: 88 QLFCCFQTPDRLFFVMEFVNGGD-------LMFHIQKSRRFDEARARFYAAEIISALMFL 140
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 566
H + +++RD+K NVLLD + + K++DFG+ K +T GT Y+APE
Sbjct: 141 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT-FCGTPDYIAPEIL 196
Query: 567 MRGHLTEKADVYSFGIVALEIVSGRS---NVTKEDMF 600
D ++ G++ E++ G + ++D+F
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF 233
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-15
Identities = 51/217 (23%), Positives = 96/217 (44%), Gaps = 31/217 (14%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 452
+G+G FG V +L+ AVK L + + + + + P L
Sbjct: 28 LGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 453 KLYGCCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYL 506
+L+ C ++L + EY+ + L H + P IA GL +L
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGD-------LMYHIQQVGRFKEPHAVFYAAEIAIGLFFL 137
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 566
+ +++RD+K NV+LD + + KI+DFG+ K + + T GT Y+APE
Sbjct: 138 QSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT-FCGTPDYIAPEII 193
Query: 567 MRGHLTEKADVYSFGIVALEIVSGRS---NVTKEDMF 600
+ D ++FG++ E+++G++ ++++F
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF 230
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 8e-15
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG-----MISALQHPNL 451
IG G + V LL A+K + K + E I+ + A HP L
Sbjct: 17 IGRGSYAKV---LLVRLKKTDRIYAMKVVK-KELVNDDEDIDWVQTEKHVFEQASNHPFL 72
Query: 452 VKLYGCCIEGNQLLLIYEYL---ENNSLARALFEH---RLKLDWPTRRRICLGIARGLAY 505
V L+ C ++L + EY+ + L H + KL R I+ L Y
Sbjct: 73 VGLHSCFQTESRLFFVIEYVNGGD-------LMFHMQRQRKLPEEHARFYSAEISLALNY 125
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 565
LH +++RD+K NVLLD + + K++D+G+ K ST GT Y+APE
Sbjct: 126 LHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEI 181
Query: 566 AMRGHLTEKADVYSFGIVALEIVSGRS 592
D ++ G++ E+++GRS
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGRS 208
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 43/157 (27%), Positives = 62/157 (39%), Gaps = 30/157 (19%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCC- 458
+G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYE 81
Query: 459 ---IEGNQLLLIYEYL---ENNSLARALFE---HRLKLDWPTR--RRICLGIARGLAYLH 507
LL++ E L E LF R + R I I + YLH
Sbjct: 82 NLYAGRKCLLIVMECLDGGE-------LFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 508 GESRIKVVHRDIKATNVLL-DKDLNS--KISDFGLAK 541
I + HRD+K N+L K N+ K++DFG AK
Sbjct: 135 ---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 50/206 (24%), Positives = 83/206 (40%), Gaps = 28/206 (13%)
Query: 401 IGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQGNREFINEIG----MISALQHPNLV 452
IG G + V LL A++ + + + + A HP LV
Sbjct: 60 IGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116
Query: 453 KLYGCCIEGNQLLLIYEYL---ENNSLARALFEHRLKLDWPTRRRICL---GIARGLAYL 506
L+ C ++L + EY+ + L H + I+ L YL
Sbjct: 117 GLHSCFQTESRLFFVIEYVNGGD-------LMFHMQRQRKLPEEHARFYSAEISLALNYL 169
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA 566
H +++RD+K NVLLD + + K++D+G+ K ST GT Y+APE
Sbjct: 170 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST-FCGTPNYIAPEIL 225
Query: 567 MRGHLTEKADVYSFGIVALEIVSGRS 592
D ++ G++ E+++GRS
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRS 251
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 74.5 bits (182), Expect = 1e-14
Identities = 35/198 (17%), Positives = 60/198 (30%), Gaps = 52/198 (26%)
Query: 391 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQL--------SSKSKQGNREFINEIGM 442
T IGEG FG V++ + AD T +A+K + + ++ E + EI +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 443 ISALQ---------HPNLVKLYGCCI------------------------------EGNQ 463
L + L + +Q
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATN 523
L ++ E+ + T + I + LA + ++ HRD+ N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGN 192
Query: 524 VLLDKDLNSKISDFGLAK 541
VLL K K+ K
Sbjct: 193 VLLKKTSLKKLHYTLNGK 210
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 2e-14
Identities = 43/233 (18%), Positives = 71/233 (30%), Gaps = 29/233 (12%)
Query: 26 EQNLTGV--LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
+ L V LP + + L N + + + L L V+ +
Sbjct: 19 NRGLHQVPELPAHVNYV------DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN 72
Query: 84 EL-GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTG-QIPSFI-QNWTKLE 140
L +L L L N F F L N++ ++ G + + T LE
Sbjct: 73 NTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLE 132
Query: 141 KLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG------PEATFPQLGNMKMTKLILRNC 194
L ++ + + P+ F N+ + DL E T L L +
Sbjct: 133 MLVLRDNNIKKIQPASFFL--NMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS- 189
Query: 195 NITGELPRYLG---------KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 238
++ Y K T + LDLS N + + F D I
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 39/255 (15%), Positives = 71/255 (27%), Gaps = 59/255 (23%)
Query: 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNL-------- 70
+ + E L + T + + L N K + K + +
Sbjct: 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249
Query: 71 -----TVQYNQFSGELPEELGSLL--NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 123
+ + F L ++ LS + L F+ T+++ ++ N
Sbjct: 250 YNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQN 309
Query: 124 QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDL-----RISDLNGPEAT 177
+ I F L +L L + +
Sbjct: 310 EIN-------------------------KIDDNAFWGLTHLLKLNLSQNFLGSI--DSRM 342
Query: 178 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDY 236
F L + L L +I + + LK L L N+L+ +P FD L +
Sbjct: 343 FENLDK--LEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQK 399
Query: 237 IYFAGNLLTGAIPPW 251
I+ N PW
Sbjct: 400 IWLHTN-------PW 407
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 56/206 (27%), Positives = 97/206 (47%), Gaps = 26/206 (12%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS--SKSKQGNREFINEIGMISALQHPNLVKLYGC 457
IGEG +G V + +A+K++S R EI ++ +H N++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL-REIKILLRFRHENIIGINDI 93
Query: 458 CI-----EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG---IARGLAYLHGE 509
+ + ++ + +E + L + L L + IC I RGL Y+H
Sbjct: 94 IRAPTIEQMKDVYIVQDLMETD-LYKLLKTQHL-----SNDHICYFLYQILRGLKYIHSA 147
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIGYMAPEYA 566
+ V+HRD+K +N+LL+ + KI DFGLA++ D + ++ VA T Y APE
Sbjct: 148 N---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRWYRAPEIM 203
Query: 567 M-RGHLTEKADVYSFGIVALEIVSGR 591
+ T+ D++S G + E++S R
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 3e-14
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS---SKSKQGNREFINEIGMISALQHPNLVKLY- 455
+G G +G V G +AVK+LS R + E+ ++ ++H N++ L
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY-RELRLLKHMKHENVIGLLD 95
Query: 456 -----GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
E N + L+ + + L + +L D + + I RGL Y+H
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGAD-LNNIVKCQKLTDD--HVQFLIYQILRGLKYIHSAD 152
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAM-R 568
++HRD+K +N+ +++D KI DFGLA+ +E T +++TR Y APE +
Sbjct: 153 ---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRAPEIMLNW 204
Query: 569 GHLTEKADVYSFGIVALEIVSGR 591
H + D++S G + E+++GR
Sbjct: 205 MHYNQTVDIWSVGCIMAELLTGR 227
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 4e-14
Identities = 43/219 (19%), Positives = 76/219 (34%), Gaps = 24/219 (10%)
Query: 62 ANIST-LVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 120
N+ NL + +N S L+ L LS + L+++ +
Sbjct: 24 DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLIL 83
Query: 121 SDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDL-----RISDLNG 173
+ N + + L+KL + LA + + L+ L +L I
Sbjct: 84 TGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKL 141
Query: 174 PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKV----LDLSFNRLRGQIPSN-F 228
PE F L N + L L + I L + ++ + LDLS N + I F
Sbjct: 142 PEY-FSNLTN--LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAF 197
Query: 229 DDLYDVDYIYFAGNLLTGAIPPWMLERGDK---IDLSYN 264
++ + + N L ++P + +R I L N
Sbjct: 198 KEI-RLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 4e-14
Identities = 43/248 (17%), Positives = 87/248 (35%), Gaps = 14/248 (5%)
Query: 27 QNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELG 86
+ P + L + ++++ + + +L+ V+ F
Sbjct: 268 KLFQFFWPRPVEYLN-IYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYS 326
Query: 87 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 146
+ LS ++ ++ + N FT + +L+ L +Q
Sbjct: 327 VFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386
Query: 147 SGLAGPIPSGIFSLENLTDLRISDLNG---PEATFPQL--GNMKMTKLILRNCNITGELP 201
+GL +N++ L D++ + + + L L + +TG +
Sbjct: 387 NGLKN-FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVF 445
Query: 202 RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDK--- 258
R L K+KVLDL NR+ IP + L + + A N L ++P + +R
Sbjct: 446 RCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQY 501
Query: 259 IDLSYNNF 266
I L N +
Sbjct: 502 IWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 3e-05
Identities = 26/175 (14%), Positives = 54/175 (30%), Gaps = 10/175 (5%)
Query: 62 ANI-STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 120
++ L++ N S ++ L L L LS N F +++ +
Sbjct: 48 KDLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDV 107
Query: 121 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE---AT 177
S N+ I L L + + F NLT L L+ +
Sbjct: 108 SHNRLQN-ISC--CPMASLRHLDLSFNDFDVLPVCKEFG--NLTKLTFLGLSAAKFRQLD 162
Query: 178 FPQLGNMKMTKLILRNCNITGE-LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 231
+ ++ ++ ++L + + ++ VL L F+ +
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSV 217
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 6e-14
Identities = 37/242 (15%), Positives = 73/242 (30%), Gaps = 39/242 (16%)
Query: 41 TFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSN 99
++ + L NR+ L L L + N + + E+ SL +LE L LS N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 100 NFTGELPKTFAKLTNMKDFRISDNQFTGQIP--SFIQNWTKLEKLFIQPSGLAGPIPSGI 157
+ F L+++ + N + + S + TKL+ L + I
Sbjct: 111 YLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 158 FSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSF 217
F+ LT L +L + ++ P+ L + + L L
Sbjct: 170 FA--GLTFLE--------------------ELEIDASDLQSYEPKSLKSIQNVSHLILHM 207
Query: 218 NRLRGQIPSN-FDDLYDVDYIYFAGNLLTG----AIPP------WMLERGDKIDLSYNNF 266
+ + D V+ + L + + ++ +
Sbjct: 208 KQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESL 266
Query: 267 TD 268
Sbjct: 267 FQ 268
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 9e-10
Identities = 38/168 (22%), Positives = 64/168 (38%), Gaps = 11/168 (6%)
Query: 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLT 71
F + RV T + A LTFL+++ + A+ L+ PK L +I + +L
Sbjct: 145 FSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLI 204
Query: 72 VQYNQFSGELPEELGSLLNLEKLHLSSNNFTG----ELPK-TFAKLTNMKDFR---ISDN 123
+ Q L + ++E L L + EL L FR I+D
Sbjct: 205 LHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264
Query: 124 QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISD 170
Q+ + + L +L + L +P GIF L +L + +
Sbjct: 265 SLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHT 310
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 37/224 (16%), Positives = 67/224 (29%), Gaps = 54/224 (24%)
Query: 33 LPPK--LAELTFLQDISLIANRLKGPIPKY-LANISTLVNLTVQYNQFSGELPEELGSLL 89
L + LT LQ + + I + A ++ L L + + P+ L S+
Sbjct: 139 LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQ 198
Query: 90 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL 149
N+ L L L ++++ + D S L
Sbjct: 199 NVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDT----------------FHFSEL 242
Query: 150 AGPIPSGIF-SLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMT 208
+G SL R + ++ + L +++
Sbjct: 243 ----STGETNSLIKKFTFRNVKITD---------------------ESLFQVMKLLNQIS 277
Query: 209 KLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPW 251
L L+ S N+L+ +P FD L + I+ N PW
Sbjct: 278 GLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN-------PW 313
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 9e-14
Identities = 57/214 (26%), Positives = 101/214 (47%), Gaps = 33/214 (15%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLY---- 455
+G GG G V+ + +A+K++ Q + + EI +I L H N+VK++
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 456 ----------GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL---GIARG 502
G E N + ++ EY+E + LA L + L L + RG
Sbjct: 79 PSGSQLTDDVGSLTELNSVYIVQEYMETD-LANVLEQGPL-----LEEHARLFMYQLLRG 132
Query: 503 LAYLHGESRIKVVHRDIKATNVLLD-KDLNSKISDFGLAKL---DEEENTHISTRVAGTI 558
L Y+H + V+HRD+K N+ ++ +DL KI DFGLA++ H+S + T
Sbjct: 133 LKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLV-TK 188
Query: 559 GYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGR 591
Y +P + + T+ D+++ G + E+++G+
Sbjct: 189 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 1e-13
Identities = 42/199 (21%), Positives = 76/199 (38%), Gaps = 12/199 (6%)
Query: 65 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELP-KTFAKLTNMKDFRISDN 123
+ L + +L N+ ++++S + +L +F L+ + I +
Sbjct: 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90
Query: 124 QFTGQIPSFI-QNWTKLEKLFIQPSGLAG-PIPSGIFSLENLTDLRISDLNG----PEAT 177
+ I + L+ L I +GL P + ++S + L I+D P
Sbjct: 91 RNLTYIDPDALKELPLLKFLGIFNTGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 178 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDV-D 235
F L N +T L L N T + Y TKL + L+ N+ I + F +Y
Sbjct: 151 FQGLCNETLT-LKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 236 YIYFAGNLLTGAIPPWMLE 254
+ + +T A+P LE
Sbjct: 209 LLDVSQTSVT-ALPSKGLE 226
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 34/190 (17%), Positives = 61/190 (32%), Gaps = 15/190 (7%)
Query: 90 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSG 148
+ + L L + F+ L N+ +S + Q+ S N +K+ + I+ +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 149 LAGPIPSGIFS-LENLTDLRISDLNG----PEATFPQLGNMKMTKLILRNCNITGELPRY 203
I L L L I + G P+ T ++ I N +T
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFN-TGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 204 LGKMTK-LKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPWM---LERG-D 257
+ L L N + F+ +D +Y N I + G
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTK-LDAVYLNKNKYLTVIDKDAFGGVYSGPS 208
Query: 258 KIDLSYNNFT 267
+D+S + T
Sbjct: 209 LLDVSQTSVT 218
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 4e-13
Identities = 44/189 (23%), Positives = 88/189 (46%), Gaps = 28/189 (14%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN---------EIGMISALQHPN 450
IG G +G VY +A+K+++ R F + EI +++ L+
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVN-------RMFEDLIDCKRILREITILNRLKSDY 86
Query: 451 LVKLYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 505
+++LY I + ++L ++ E +++ L + LF+ + L + I + G +
Sbjct: 87 IIRLYDLIIPDDLLKFDELYIVLEIADSD-LKK-LFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA-KLDEEENTHISTRVAGTIGYMAPE 564
+H ++HRD+K N LL++D + K+ DFGLA ++ E++T+I +
Sbjct: 145 IHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 565 YAMRGHLTE 573
++ LT
Sbjct: 202 KNLKKQLTS 210
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 42/210 (20%), Positives = 71/210 (33%), Gaps = 56/210 (26%)
Query: 57 IPKYLANIST-LVNLTVQYNQFSGELPEE--LGSLLNLEKLHLSSNNFTGELPKTFAKLT 113
+P ++ + L + +N S L E L NL L LS N+ + F +
Sbjct: 33 VP---QSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVP 88
Query: 114 NMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS-LENLTDL-----R 167
N++ +S N + +FS L+ L L
Sbjct: 89 NLRYLDLSSNHLHT-------------------------LDEFLFSDLQALEVLLLYNNH 123
Query: 168 ISDLNGPEATFPQLGNMKMTKLILRNCNITGELP----RYLGKMTKLKVLDLSFNRLRGQ 223
I + F + + KL L I+ P + K+ KL +LDLS N+L+
Sbjct: 124 IVVV--DRNAFEDMAQL--QKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKL 178
Query: 224 IPSNFDDL--YDVDYIYFAGNLLTGAIPPW 251
++ L + + +Y N P
Sbjct: 179 PLTDLQKLPAWVKNGLYLHNN-------PL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 33/172 (19%), Positives = 48/172 (27%), Gaps = 38/172 (22%)
Query: 33 LPPK--LAELTFLQDISLIANRLKGPIPKY-LANISTLVNLTVQYNQFSGELPEE-LGSL 88
L + LT L + L N L I + L L + N L E L
Sbjct: 54 LRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDL 111
Query: 89 LNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSG 148
LE L L +N+ F + ++ +S NQ +
Sbjct: 112 QALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR--------------------- 150
Query: 149 LAGPIPSGIFS-LENLTDLRISDLNG------PEATFPQLGNMKMTKLILRN 193
P + L L + DL+ P +L L L N
Sbjct: 151 ----FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-12
Identities = 39/194 (20%), Positives = 81/194 (41%), Gaps = 33/194 (17%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN---------EIGMISALQHPN 450
IG G +G V + + +A+K++ R F + EI +++ L H +
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKIL-------RVFEDLIDCKRILREIAILNRLNHDH 113
Query: 451 LVKLYGCCI-----EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 505
+VK+ I + ++L ++ E +++ + LF + L + + + G+ Y
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEIADSD-FKK-LFRTPVYLTELHIKTLLYNLLVGVKY 171
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA------KLDEEENTHISTRVAGTIG 559
+H ++HRD+K N L+++D + K+ DFGLA + + +
Sbjct: 172 VHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 560 YMAPEYAMRGHLTE 573
++ LT
Sbjct: 229 TFPHTKNLKRQLTG 242
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 34/198 (17%), Positives = 62/198 (31%), Gaps = 12/198 (6%)
Query: 65 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPK-TFAKLTNMKDFRISD- 122
+ L + +LEK+ +S N+ + F+ L + + RI
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 123 NQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISDLNG----PEAT 177
N P QN L+ L I +G+ +P L I D +
Sbjct: 90 NNLLYINPEAFQNLPNLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 178 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDY 236
F L + L L I ++ N L ++P++ F
Sbjct: 149 FVGLSF-ESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVI 206
Query: 237 IYFAGNLLTGAIPPWMLE 254
+ + + ++P + LE
Sbjct: 207 LDISRTRIH-SLPSYGLE 223
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 36/190 (18%), Positives = 65/190 (34%), Gaps = 17/190 (8%)
Query: 90 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSG 148
N +L F+ +++ IS N I + + N KL ++ I+ +
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 90
Query: 149 LAGPIPSGIFS-LENLTDLRISDLNG----PEATFPQLGNMKMTKLILRNCNITGELPRY 203
I F L NL L IS+ G P+ + + N NI + R
Sbjct: 91 NLLYINPEAFQNLPNLQYLLISN-TGIKHLPDVHKIHSLQKVLLDI-QDNINIH-TIERN 147
Query: 204 L--GKMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPP---WMLERGD 257
G + +L L+ N ++ +I ++ F+ + N L +P
Sbjct: 148 SFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPV 205
Query: 258 KIDLSYNNFT 267
+D+S
Sbjct: 206 ILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 5e-11
Identities = 42/210 (20%), Positives = 74/210 (35%), Gaps = 18/210 (8%)
Query: 32 VLPPK-LAELTFLQDISLIANRLKGPIPKY-LANISTLVNLTVQ-YNQFSGELPEELGSL 88
V+ + L+ I + N + I +N+ L + ++ N PE +L
Sbjct: 44 VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNL 103
Query: 89 LNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP--SFIQNWTKLEKLFIQP 146
NL+ L +S+ I DN I SF+ + L++
Sbjct: 104 PNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163
Query: 147 SGLAGPIPSGIFSLENLTDLRISDLNG----PEATFPQLGNMKMTKLILRNCNITGELPR 202
+G+ I + F+ L +L +SD N P F L + I LP
Sbjct: 164 NGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASG--PVILDISRTRIH-SLPS 219
Query: 203 Y-LGKMTKLKVLDLSFNRLRGQIPSNFDDL 231
Y L + KL+ + ++P+ + L
Sbjct: 220 YGLENLKKLRARSTYNLK---KLPT-LEKL 245
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 41/234 (17%), Positives = 89/234 (38%), Gaps = 31/234 (13%)
Query: 43 LQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFT 102
+ + ++ +K P + + ++ + + L +++++ ++++
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 103 GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLEN 162
+ + L N+ ++ N+ T I + N L LF+ + + + SL++
Sbjct: 57 -SV-QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKI-----KDLSSLKD 107
Query: 163 LTDL--------RISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLD 214
L L ISD+NG L + L L N IT L ++TKL L
Sbjct: 108 LKKLKSLSLEHNGISDING----LVHLPQL--ESLYLGNNKITD--ITVLSRLTKLDTLS 159
Query: 215 LSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 268
L N++ I L + +Y + N ++ L+ D ++L +
Sbjct: 160 LEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLN 211
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 46/228 (20%), Positives = 91/228 (39%), Gaps = 33/228 (14%)
Query: 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLT---VQYNQ 76
K LK++++T + EL + I + +K + I L N+T + N+
Sbjct: 24 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-----SVQGIQYLPNVTKLFLNGNK 76
Query: 77 FSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNW 136
+ + L +L NL L L N +L + L +K + N + I + + +
Sbjct: 77 LTDI--KPLTNLKNLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHL 130
Query: 137 TKLEKLFIQPSGLAGPIPSGIFSLENLTDL-----RISDLNGPEATFPQLGNM-KMTKLI 190
+LE L++ + + + + L L L +ISD+ L + K+ L
Sbjct: 131 PQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP-------LAGLTKLQNLY 181
Query: 191 LRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 238
L +I+ +L L + L VL+L + ++ +L + +
Sbjct: 182 LSKNHIS-DLR-ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVK 227
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 29/108 (26%), Positives = 45/108 (41%), Gaps = 6/108 (5%)
Query: 37 LAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96
L+ LT L +SL N++ +P LA ++ L NL + N S +L L L NL+ L L
Sbjct: 149 LSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLEL 204
Query: 97 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFI 144
S + + L + +D P I + EK +
Sbjct: 205 FSQECLNKPINHQSNLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNV 250
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 1e-12
Identities = 49/270 (18%), Positives = 80/270 (29%), Gaps = 43/270 (15%)
Query: 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLT---VQYNQ 76
V + +L L + + + + I L LT N
Sbjct: 21 ASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-----MTGIEKLTGLTKLICTSNN 75
Query: 77 FSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTG--------- 127
+ L L NL L SN T L LT + N+ T
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLL 129
Query: 128 --------QIPSF-IQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATF 178
+ + + T+L +L + + + LT L S E
Sbjct: 130 TYLNCARNTLTEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDV 187
Query: 179 PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 238
Q + +L NIT +L L + +L LD S N+L +I L + Y
Sbjct: 188 SQNKL--LNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFD 239
Query: 239 FAGNLLTGAIPPWMLERGDKIDLSYNNFTD 268
+ N LT + L + + + +
Sbjct: 240 CSVNPLT-ELDVSTLSKLTTLHCIQTDLLE 268
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 45/307 (14%), Positives = 92/307 (29%), Gaps = 45/307 (14%)
Query: 37 LAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96
+++ L ++ N + + L L L N+ + E+ + L L
Sbjct: 187 VSQNKLLNRLNCDTNNITK-LD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDC 240
Query: 97 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSG 156
S N T EL + L+ + +I + + T+L
Sbjct: 241 SVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYF-------------- 280
Query: 157 IFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLS 216
E ++ D+ N ++ L + IT EL L + KL L L+
Sbjct: 281 --QAEGCRKIKELDVT---------HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLN 326
Query: 217 FNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQ 276
L ++ + + + + + + E +
Sbjct: 327 NTELT-ELD--VSHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEGQTITMPKE-TLT 382
Query: 277 KRSVTGIVSCLRSVQCPKTYYSLHINCGGKQVTANGNTTFEEDTSEAGPSTFSQSGTNWV 336
S+T VS + ++ GG A T+E +++ T++ + N
Sbjct: 383 NNSLTIAVS-PDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSENGA 441
Query: 337 LSSTGHF 343
+ T
Sbjct: 442 IVGTVTT 448
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 29/179 (16%), Positives = 56/179 (31%), Gaps = 13/179 (7%)
Query: 90 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL 149
N ++ + +L + ++ T + I+ T L KL + +
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNI 76
Query: 150 AGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTK 209
+ + NLT L N K+T L +T +L + +
Sbjct: 77 TT-LD--LSQNTNLTYLACDS-NKLT-NLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPL 128
Query: 210 LKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 268
L L+ + N L S+ L + N + + +D S+N T+
Sbjct: 129 LTYLNCARNTLTEIDVSHNTQLT---ELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE 184
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 51/212 (24%), Positives = 91/212 (42%), Gaps = 31/212 (14%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS--SKSKQGNREFINEIGMISALQHPNLVKLY-- 455
+GEG +G V G +A+K++ K R EI ++ +H N++ ++
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL-REIKILKHFKHENIITIFNI 77
Query: 456 ---GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICL---GIARGLAYLHGE 509
N++ +I E ++ + L R + L + I R + LHG
Sbjct: 78 QRPDSFENFNEVYIIQELMQTD-LHRVISTQML-----SDDHIQYFIYQTLRAVKVLHGS 131
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIG---------Y 560
+ V+HRD+K +N+L++ + + K+ DFGLA++ +E S G Y
Sbjct: 132 N---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWY 188
Query: 561 MAPEYAM-RGHLTEKADVYSFGIVALEIVSGR 591
APE + + DV+S G + E+ R
Sbjct: 189 RAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 47/180 (26%), Positives = 72/180 (40%), Gaps = 17/180 (9%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PN 450
N + IG G FG +Y G +A G +A+K K+K E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVG 66
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+ + C EG+ +++ E L SL K T + + + Y+H ++
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125
Query: 511 RIKVVHRDIKATNVLLDKDLNSK---ISDFGLAK--LDEEENTHISTR----VAGTIGYM 561
+HRD+K N L+ I DFGLAK D + HI R + GT Y
Sbjct: 126 ---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 48/215 (22%), Positives = 87/215 (40%), Gaps = 33/215 (15%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNRE-----FINEIGMI--SALQHP 449
+G G F V+ + + T +A+K + E +N+ ++
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86
Query: 450 NLVKLYGC----CIEGNQLLLIYEYLENN--SLARALFEHRLKLDWPTRRRICLGIARGL 503
+++KL G +++++E L N +L + + L ++I + GL
Sbjct: 87 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL--IYVKQISKQLLLGL 144
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNS------KISDFGLA-KLDEEENTHISTRVAG 556
Y+H I +H DIK NVL++ + KI+D G A DE I TR
Sbjct: 145 DYMHRRCGI--IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE-- 200
Query: 557 TIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 591
Y +PE + AD++S + E+++G
Sbjct: 201 ---YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 3e-11
Identities = 46/182 (25%), Positives = 69/182 (37%), Gaps = 19/182 (10%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PN 450
NF IG G FG + G L +A+K KS+ E L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+ ++Y G ++ E L SL T I + + + Y+H ++
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125
Query: 511 RIKVVHRDIKATNVLLDKDLNSK-----ISDFGLAK--LDEEENTHISTR----VAGTIG 559
+++RD+K N L+ + N I DF LAK +D E HI R + GT
Sbjct: 126 ---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTAR 182
Query: 560 YM 561
YM
Sbjct: 183 YM 184
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 44/182 (24%), Positives = 73/182 (40%), Gaps = 19/182 (10%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PN 450
++ IGEG FG +++G L + +A+K +S + +E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTG 67
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+ +Y EG +L+ + L SL L K T + + +H +S
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 511 RIKVVHRDIKATNVLLDKDLNSK-----ISDFGLAK--LDEEENTHISTR----VAGTIG 559
+V+RDIK N L+ + + + DFG+ K D HI R ++GT
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183
Query: 560 YM 561
YM
Sbjct: 184 YM 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 34/187 (18%), Positives = 78/187 (41%), Gaps = 14/187 (7%)
Query: 83 EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 142
L N K +L + T + +L+ +++F ++ + + +Q +T L++L
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68
Query: 143 FIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE-ATFPQLGNMKMTKLILRNCNITGELP 201
+ + + S + L++LT L +N + + +++L L N +
Sbjct: 69 HLSHNQI-----SDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNELRDTDS 123
Query: 202 RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDL 261
L + L++L + N+L+ I L ++ + GN +T L++ + IDL
Sbjct: 124 --LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDL 179
Query: 262 SYNNFTD 268
+ +
Sbjct: 180 TGQKCVN 186
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 36/202 (17%), Positives = 72/202 (35%), Gaps = 26/202 (12%)
Query: 37 LAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96
L +L + + +S + N + + NL++LHL
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS--LAGMQFFTNLKELHL 70
Query: 97 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSG 156
S N + +L LT +++ ++ N+ + L +LF+ + L
Sbjct: 71 SHNQIS-DL-SPLKDLTKLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNELRDT--DS 123
Query: 157 IFSLENLTDL-----RISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKL 210
+ L+NL L ++ + LG + K+ L L IT L ++ K+
Sbjct: 124 LIHLKNLEILSIRNNKLKSIVM-------LGFLSKLEVLDLHGNEITNTGG--LTRLKKV 174
Query: 211 KVLDLSFNRLRGQIPSNFDDLY 232
+DL+ + + +LY
Sbjct: 175 NWIDLTGQKCVNEPVKYQPELY 196
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 48/180 (26%), Positives = 76/180 (42%), Gaps = 17/180 (9%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPN 450
N F IG G FG +Y G + +A+K + K+K + + + E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTG 64
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+ + +EG+ +L+ + L SL KL T + + + ++H +S
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123
Query: 511 RIKVVHRDIKATNVLLDKDLNSK---ISDFGLAKL--DEEENTHISTR----VAGTIGYM 561
+HRDIK N L+ + I DFGLAK D + HI R + GT Y
Sbjct: 124 ---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 6e-11
Identities = 48/235 (20%), Positives = 95/235 (40%), Gaps = 33/235 (14%)
Query: 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLT---VQYNQ 76
K LK++++T + EL + I + +K + I L N+T + N+
Sbjct: 27 IKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-----SVQGIQYLPNVTKLFLNGNK 79
Query: 77 FSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNW 136
+ ++ + L +L NL L L N +L + L +K + N + I + + +
Sbjct: 80 LT-DI-KPLANLKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGIS-DI-NGLVHL 133
Query: 137 TKLEKLFIQPSGLAGPIPSGIFSLENLTDL-----RISDLNGPEATFPQLGNM-KMTKLI 190
+LE L++ + + + + L L L +ISD+ L + K+ L
Sbjct: 134 PQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP-------LAGLTKLQNLY 184
Query: 191 LRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 245
L +I+ +L R L + L VL+L + ++ +L + + L
Sbjct: 185 LSKNHIS-DL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 2e-10
Identities = 39/217 (17%), Positives = 85/217 (39%), Gaps = 31/217 (14%)
Query: 61 LANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 120
+ + ++ + + L +++++ ++++ + + L N+ +
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 121 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDL--------RISDLN 172
+ N+ T I + N L LF+ + + + SL++L L ISD+N
Sbjct: 76 NGNKLT-DI-KPLANLKNLGWLFLDENKV-----KDLSSLKDLKKLKSLSLEHNGISDIN 128
Query: 173 GPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 231
G L ++ ++ L L N IT L ++TKL L L N++ I L
Sbjct: 129 G-------LVHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS-DI-VPLAGL 177
Query: 232 YDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 268
+ +Y + N ++ L+ D ++L +
Sbjct: 178 TKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLN 214
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 36/195 (18%), Positives = 76/195 (38%), Gaps = 29/195 (14%)
Query: 83 EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 142
+ K +L + T + +L ++ +++ + IQ + KL
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 73
Query: 143 FIQPSGLAGPIPSGIFSLENLTDLR--------ISDLNGPEATFPQLGNM-KMTKLILRN 193
F+ + L + I L NL +L + DL+ L ++ K+ L L +
Sbjct: 74 FLNGNKL-----TDIKPLANLKNLGWLFLDENKVKDLSS-------LKDLKKLKSLSLEH 121
Query: 194 CNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWML 253
I+ ++ L + +L+ L L N++ + L +D + N ++ +P L
Sbjct: 122 NGIS-DIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLAGL 177
Query: 254 ERGDKIDLSYNNFTD 268
+ + LS N+ +D
Sbjct: 178 TKLQNLYLSKNHISD 192
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 19/114 (16%), Positives = 44/114 (38%), Gaps = 6/114 (5%)
Query: 157 IFSLENLTDLRISDLNGPEAT-FPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLD 214
IFS + + +L T + + ++I N +I + + + L
Sbjct: 17 IFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLF 74
Query: 215 LSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 268
L+ N+L I +L ++ +++ N + L++ + L +N +D
Sbjct: 75 LNGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISD 126
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 7e-11
Identities = 50/210 (23%), Positives = 90/210 (42%), Gaps = 37/210 (17%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQH------PN 450
IG+G FG V K +A+K + ++ + Q EI ++ L+ N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDNTMN 160
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK------LDWPTRRRICLGIARGLA 504
++ + N + + +E L N L+E +K P R+ I + L
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMN-----LYEL-IKKNKFQGFSLPLVRKFAHSILQCLD 214
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNS--KISDFGLAKLDEEE-NTHISTRVAGTIGYM 561
LH + +++H D+K N+LL + S K+ DFG + + + T+I +R Y
Sbjct: 215 ALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YR 266
Query: 562 APEYAMRGHLTEKADVYSFGIVALEIVSGR 591
APE + D++S G + E+++G
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 8e-11
Identities = 40/186 (21%), Positives = 82/186 (44%), Gaps = 26/186 (13%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFIN---------EIGMISALQ-HP 449
+G+G +G V+K + G +AVK++ F N EI +++ L H
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIF-------DAFQNSTDAQRTFREIMILTELSGHE 69
Query: 450 NLVKLYGCCI--EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 507
N+V L + L+++Y+E + L + + L+ ++ + + + + YLH
Sbjct: 70 NIVNLLNVLRADNDRDVYLVFDYMETD-LHAVIRANILEPV--HKQYVVYQLIKVIKYLH 126
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 567
++HRD+K +N+LL+ + + K++DFGL++ +
Sbjct: 127 SGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 568 RGHLTE 573
+ LT+
Sbjct: 184 QPILTD 189
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 35/212 (16%)
Query: 399 NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHP----- 449
+ IG+G FG V K + +A+K + +K Q E+ ++ +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEMK 115
Query: 450 -NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK------LDWPTRRRICLGIARG 502
+V L + N L L++E L N L++ L+ + R+ +
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLSYN-----LYDL-LRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 503 LAYLHGESRIKVVHRDIKATNVLLDKDLNS--KISDFGLA-KLDEEENTHISTRVAGTIG 559
L +L + ++H D+K N+LL S KI DFG + +L + +I +R
Sbjct: 170 LLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF----- 223
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGR 591
Y +PE + D++S G + +E+ +G
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 3e-10
Identities = 40/190 (21%), Positives = 70/190 (36%), Gaps = 33/190 (17%)
Query: 401 IGEGGFGPVYKGLLADGTAI------AVKQLSSKSKQ-----------GNREFINEIGMI 443
IG+GGFG +Y + ++ VK S + E I +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 444 SALQHPNLVKLYGCCIEGNQLL----LIYEYLENNSLARALFEHRLKLDWPTRRRICLGI 499
L++ + K +G + +I + + L + + + T ++ L I
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRI 161
Query: 500 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKI--SDFGLAK--LDEEENTHISTR-- 553
L Y+H VH DIKA+N+LL+ ++ D+GLA E + +
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218
Query: 554 --VAGTIGYM 561
GTI +
Sbjct: 219 RCHDGTIEFT 228
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 8e-10
Identities = 62/243 (25%), Positives = 96/243 (39%), Gaps = 66/243 (27%)
Query: 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLK--GPIPKYLANISTLVNLTVQYNQFSGEL 81
LK++++T EL + I + +K I + + L + N+
Sbjct: 26 LKKKSVTDA--VTQNELNSIDQIIANNSDIKSVQGIQY----LPNVRYLALGGNKLH--- 76
Query: 82 PEELG---SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTK 138
++ L NL L L+ N F KLTN+K+ + +NQ
Sbjct: 77 --DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQ-------------- 120
Query: 139 LEKLFIQPSGLAGPIPSGIF-SLENLTDLRISD-----LNGPEATFPQLGNMKMTKLILR 192
L+ L P G+F L NLT L ++ L P+ F +L +T+L L
Sbjct: 121 LQSL-----------PDGVFDKLTNLTYLNLAHNQLQSL--PKGVFDKL--TNLTELDL- 164
Query: 193 NCNITGELPRYLG---KMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAI 248
+ N LP G K+T+LK L L N+L+ +P FD L + YI+ N
Sbjct: 165 SYNQLQSLPE--GVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN------ 215
Query: 249 PPW 251
PW
Sbjct: 216 -PW 217
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 28/130 (21%), Positives = 49/130 (37%), Gaps = 6/130 (4%)
Query: 44 QDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFT 102
+I L N +K P + L + + NQ S EL + L +L L L N T
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 103 GELPKTFAKLTNMKDFRISDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIF-SL 160
F L +++ ++ N+ + Q+ L L + + L I G F L
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQT-IAKGTFSPL 151
Query: 161 ENLTDLRISD 170
+ + ++
Sbjct: 152 RAIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 31/169 (18%), Positives = 56/169 (33%), Gaps = 44/169 (26%)
Query: 90 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL 149
+ ++ L N P F+ ++ +S+NQ I
Sbjct: 33 TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQ--------ISE-------------- 70
Query: 150 AGPIPSGIF-SLENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRY 203
+ F L +L L +I++L P++ F L + L+L I L
Sbjct: 71 ---LAPDAFQGLRSLNSLVLYGNKITEL--PKSLFEGLF--SLQLLLLNANKIN-CLRVD 122
Query: 204 L-GKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 251
+ L +L L N+L+ F L + ++ A N P+
Sbjct: 123 AFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN-------PF 164
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 27/147 (18%), Positives = 56/147 (38%), Gaps = 16/147 (10%)
Query: 62 ANI-STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 120
N+ T+ + ++ N P L ++ LS+N + P F L ++ +
Sbjct: 28 TNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVL 87
Query: 121 SDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISDLN---GPE 175
N+ T ++P + + L+ L + + + + F L NL L + D +
Sbjct: 88 YGNKIT-ELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAK 145
Query: 176 ATFPQLGNMKMTKLILRN------CNI 196
TF L ++ + L C++
Sbjct: 146 GTFSPLRAIQT--MHLAQNPFICDCHL 170
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 45/171 (26%), Positives = 67/171 (39%), Gaps = 28/171 (16%)
Query: 92 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNW-TKLEKLFIQPSGLA 150
EKL L S TF LT + + NQ + + + + T+L L + + LA
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 151 GPIPSGIF-SLENLTDLRISDLNG------PEATFPQLGNMKMTKLILRNCNITGELPRY 203
+P G+F L L L L G P F +L + +L L + +P
Sbjct: 97 S-LPLGVFDHLTQLDKL---YLGGNQLKSLPSGVFDRLTK--LKELRLNTNQLQ-SIPA- 148
Query: 204 LG---KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 251
G K+T L+ L LS N+L+ FD L + I GN +
Sbjct: 149 -GAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN-------QF 191
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 6e-09
Identities = 64/396 (16%), Positives = 123/396 (31%), Gaps = 121/396 (30%)
Query: 335 WVLSSTG-----HFLENGLKL--------------GP------YIQTNTSRLLMNDYQLY 369
W L S F+E L++ P YI+ L ND Q++
Sbjct: 69 WTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR--LYNDNQVF 126
Query: 370 TTARLSAISLTYYGFYLQIKAATNNFATDNNI---GEGGFGPVYKGLLADGTAIAVKQLS 426
+S + YL+++ A N+ G G G K +A
Sbjct: 127 AKYNVSRLQP-----YLKLRQALLELRPAKNVLIDGVLGSG---KTWVA---LDVCLSYK 175
Query: 427 SKSKQGNREF-INEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRL 485
+ K + F +N C +L E L+ +++
Sbjct: 176 VQCKMDFKIFWLN----------------LKNCNSPETVL---EMLQK-------LLYQI 209
Query: 486 KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL--LDKDLNSK--ISDFGL-A 540
+W +R I + + E R + + + N L L ++ + + F L
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE--NCLLVLL-NVQNAKAWNAFNLSC 266
Query: 541 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF 600
K ++TR +++ H++ + T +++
Sbjct: 267 K------ILLTTRFKQVTDFLSAAT--TTHISLDHHSMTL--------------TPDEVK 304
Query: 601 YLLDWALVLK-EQGKL-MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
LL L L E++ TNP + + +I A + + +
Sbjct: 305 SLL--LKYLDCRPQDLPREVLTTNP-------RRLSII--AESIRD-----GLATWDNWK 348
Query: 659 MLECGVDVLDLVSDSSVSDIDETKAEAMRKYYQFCV 694
+ C D L + +SS++ ++ AE RK +
Sbjct: 349 HVNC--DKLTTIIESSLNVLEP--AE-YRKMFDRLS 379
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 56.4 bits (135), Expect = 3e-08
Identities = 87/600 (14%), Positives = 156/600 (26%), Gaps = 201/600 (33%)
Query: 117 DFRISDNQFTGQ--IPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGP 174
DF ++Q+ + + F + + D+
Sbjct: 8 DFETGEHQYQYKDILSVFEDAFVD--------------------------NFDCKDV--- 38
Query: 175 EATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN-----FD 229
M K IL E+ + + F L + +
Sbjct: 39 ---------QDMPKSILSK----EEIDHIIMSKDAVSGTLRLFWTLLSK-QEEMVQKFVE 84
Query: 230 DLYDVDYIYFAGNLLTGAIPPWMLERG--DKIDLSYNN---FTDGSAESSCQKRSVTGIV 284
++ ++Y + + T P M+ R ++ D YN+ F + + + +
Sbjct: 85 EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV---SRLQPYLKLR 141
Query: 285 SCLRSVQCPKTYYSLHINCG----GKQVTAN---------------------GNTTFEED 319
L ++ P + G GK A N E
Sbjct: 142 QALLELR-PAKNVLID---GVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPET 197
Query: 320 TSEAGPSTFSQSGTNWV------------LSSTGHFLENGLKLGPYIQTNTSRLLMNDYQ 367
E Q NW + S L LK PY L++ + Q
Sbjct: 198 VLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY---ENCLLVLLNVQ 254
Query: 368 --------------LYTTARLSAISLTYYGFYLQIKAATNNFATDNNIGEGGFGPVY-KG 412
L TT R ++ +L T+ + P K
Sbjct: 255 NAKAWNAFNLSCKILLTT-RFKQVT-----DFLSAATTTHISLDHH---SMTLTPDEVKS 305
Query: 413 LLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV-----KLYGCCIEGNQLLLI 467
LL + L + N + +I+ L K C ++L I
Sbjct: 306 LLLKYLDCRPQDLPREVLTTN-PRR--LSIIAESIRDGLATWDNWKHVNC----DKLTTI 358
Query: 468 ----YEYLENNSLARALFE-------------HRLKLDWPTRRRICLGIARGLAYLHGES 510
LE R +F+ L L W +
Sbjct: 359 IESSLNVLEPAEY-RKMFDRLSVFPPSAHIPTILLSLIW--------------FDVIKSD 403
Query: 511 RIKVVHRDIKATNVLLDKDLN-SKISDFGL-----AKLDEEENTH--ISTRVAGTIGYMA 562
+ VV++ K + L++K S IS + KL+ E H I Y
Sbjct: 404 VMVVVNKLHKYS--LVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH------YNI 455
Query: 563 PE-YAMRGHLTEKADVYSFGIVA--LEIVSGRSNVTKEDMF---YL-LDWALVLKEQGKL 615
P+ + + D Y + + L + + +F +L + + K+
Sbjct: 456 PKTFDSDDLIPPYLDQYFYSHIGHHL---KNIEHPERMTLFRMVFLDFRFL-----EQKI 507
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 51/256 (19%), Positives = 91/256 (35%), Gaps = 73/256 (28%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-----HPN---L 451
+G G F V+ + +A+K + S ++EI ++ +++ PN +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREMV 103
Query: 452 VKLYGC----CIEGNQLLLIYEYL-ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 506
V+L + G + +++E L + ++ L P ++I + +GL YL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG-LPLPCVKKIIQQVLQGLDYL 162
Query: 507 HGESRIKVVHRDIKATNVLL---------------------------------------- 526
H + RI +H DIK N+LL
Sbjct: 163 HTKCRI--IHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNF 220
Query: 527 ---------DKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKAD 576
+ L KI+D G A + T I TR Y + E + AD
Sbjct: 221 LVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNTPAD 275
Query: 577 VYSFGIVALEIVSGRS 592
++S +A E+ +G
Sbjct: 276 IWSTACMAFELATGDY 291
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 34/188 (18%), Positives = 62/188 (32%), Gaps = 32/188 (17%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ--------------GNREFINEIGMISA 445
IG GGFG +Y A + + ++ ++ I +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 446 LQHPNLVKLYGC----CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIAR 501
L + + YG + ++ E L L + + T ++ + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQK-ISGQNGTFKKSTVLQLGIRMLD 162
Query: 502 GLAYLHGESRIKVVHRDIKATNVLLDKDLNSKI--SDFGLAK--LDEEENTHISTRVA-- 555
L Y+H VH DIKA N+LL ++ +D+GL+ +
Sbjct: 163 VLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219
Query: 556 --GTIGYM 561
GTI +
Sbjct: 220 HNGTIEFT 227
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 47/166 (28%), Positives = 65/166 (39%), Gaps = 43/166 (25%)
Query: 92 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 151
+ L+L N T P F L N+K+ + NQ L L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQ--------------LGAL--------- 79
Query: 152 PIPSGIF-SLENLTDLRISD-----LNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG 205
P G+F SL LT L + L P A F +L + +L + CN ELPR +
Sbjct: 80 --PVGVFDSLTQLTVLDLGTNQLTVL--PSAVFDRLV--HLKELFM-CCNKLTELPRGIE 132
Query: 206 KMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 251
++T L L L N+L+ FD L + + Y GN PW
Sbjct: 133 RLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN-------PW 171
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 1e-07
Identities = 35/125 (28%), Positives = 54/125 (43%), Gaps = 5/125 (4%)
Query: 44 QDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFT 102
Q + L N++ P ++ L L + NQ LP + SL L L L +N T
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 103 GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF-SLE 161
F +L ++K+ + N+ T +P I+ T L L + + L IP G F L
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLS 159
Query: 162 NLTDL 166
+LT
Sbjct: 160 SLTHA 164
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 26/200 (13%), Positives = 63/200 (31%), Gaps = 37/200 (18%)
Query: 393 NNFATDNNIGEGGFGPVYKGL---------LADGTAIAVK------QLSSKSKQGNREF- 436
+ + G +Y+ ++K +L ++ R
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 437 ---INEIGMISALQHPNLVKLYGCCIEGNQL-LLIYEYLENNSLARALFEHRLKLDWPTR 492
+N+ + + + G + ++ L+ L SL + K R
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVLSER 159
Query: 493 RRICLG---IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKI--SDFGLAKLDEEEN 547
+ + + L +LH VH ++ A N+ +D + S++ + +G A
Sbjct: 160 SVLQVACRLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 548 THISTR------VAGTIGYM 561
H++ G + ++
Sbjct: 216 KHVAYVEGSRSPHEGDLEFI 235
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 31/170 (18%), Positives = 60/170 (35%), Gaps = 45/170 (26%)
Query: 90 NLEKLHLSSNNFTGELPK-TFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSG 148
+L L++N FT F KL ++ S+N+ T
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD--------------------- 71
Query: 149 LAGPIPSGIF-SLENLTDL-----RISDLNGPEATFPQLGNMKMTKLILRNCNITGELPR 202
I G F + ++ R+ ++ F L ++ L+LR+ IT +
Sbjct: 72 ----IEEGAFEGASGVNEILLTSNRLENV--QHKMFKGLESL--KTLMLRSNRIT-CVGN 122
Query: 203 YL-GKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 251
++ +++L L N++ P FD L+ + + N P+
Sbjct: 123 DSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN-------PF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 27/149 (18%), Positives = 52/149 (34%), Gaps = 30/149 (20%)
Query: 26 EQNLTGVLPPK--LAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE 83
N VL +L L+ I+ N++ S + + + N+ +
Sbjct: 40 NNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQH 98
Query: 84 EL-GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 142
++ L +L+ L L SN T +F L++++ + DNQ T
Sbjct: 99 KMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT---------------- 142
Query: 143 FIQPSGLAGPIPSGIF-SLENLTDLRISD 170
+ G F +L +L+ L +
Sbjct: 143 ---------TVAPGAFDTLHSLSTLNLLA 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 19/95 (20%), Positives = 38/95 (40%), Gaps = 3/95 (3%)
Query: 33 LPPK-LAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEEL-GSLLN 90
+ + + +I L +NRL+ K + +L L ++ N+ + + + L +
Sbjct: 72 IEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSS 130
Query: 91 LEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF 125
+ L L N T P F L ++ + N F
Sbjct: 131 VRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 36/188 (19%), Positives = 65/188 (34%), Gaps = 28/188 (14%)
Query: 61 LANISTLVNLTVQYNQFSGELPEELGSLL-----NLEKLHLSSNNFTGE----LPKTFAK 111
L LTV N + L L LE L L S T + L A
Sbjct: 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVAS 225
Query: 112 LTNMKDFRISDNQFTGQ-----IPSFIQNWTKLEKLFIQPSGL----AGPIPSGIFSLEN 162
++++ + N+ P + ++L L+I G+ G + + + E+
Sbjct: 226 KASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKES 285
Query: 163 LTDLRISDLN-GPE-----ATFPQLGNMKMTKLILRNCNITGELPRYLGKM----TKLKV 212
L +L ++ G E ++ L +++C+ T + + L
Sbjct: 286 LKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLE 345
Query: 213 LDLSFNRL 220
L +S NRL
Sbjct: 346 LQISNNRL 353
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 32/181 (17%), Positives = 60/181 (33%), Gaps = 26/181 (14%)
Query: 65 STLVNLTVQYNQFSGELPEELGSLL-NLEKLHLSSNNFTGE----LPKTFAKLTNMKDFR 119
+ +L +Q + S EL LL + + L T + + +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 120 ISDNQFTGQ-----IPSFIQNWTKLEKLFIQPSGL----AGPIPSGIFSLENLTDLRISD 170
+ N+ + K++KL +Q L G + S + +L L +L +SD
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 171 LNGPE-------ATFPQLGNMKMTKLILRNCNITGELPRYLGKM----TKLKVLDLSFNR 219
N ++ KL L C+++ L + K L +S N
Sbjct: 123 -NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNND 181
Query: 220 L 220
+
Sbjct: 182 I 182
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 6e-05
Identities = 34/189 (17%), Positives = 67/189 (35%), Gaps = 30/189 (15%)
Query: 61 LANISTLVNLTVQYNQFSGELPEELGSLL-----NLEKLHLSSNNFTGE----LPKTFAK 111
+A+ ++L L + N+ EL L L L + T + L +
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 112 LTNMKDFRISDNQFTGQ-----IPSFIQNWTKLEKLFIQPSGL----AGPIPSGIFSLEN 162
++K+ ++ N+ + + ++ +LE L+++ S +
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 163 LTDLRISDLNGPE-------ATFPQLGNMKMTKLILRNCNITGELPRYLGKM----TKLK 211
L +L+IS+ N E + L L +C+++ L L+
Sbjct: 343 LLELQISN-NRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLR 401
Query: 212 VLDLSFNRL 220
LDLS N L
Sbjct: 402 ELDLSNNCL 410
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 39/226 (17%), Positives = 74/226 (32%), Gaps = 42/226 (18%)
Query: 37 LAELTFLQDISLIANRL--KG--PIPKYLANISTLVNLTVQYNQFSGELPEELGSLL--- 89
L + L + L N P+ +L+ + L +L + N + ++ L
Sbjct: 90 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 90 ----------NLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFTGQ-----IP 130
L + N KTF + ++ N + +
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLL 209
Query: 131 SFIQNWTKLEKLFIQPSGL----AGPIPSGIFSLENLTDLRISDLN-GPE------ATFP 179
+ +L+ L +Q + + + + S NL +L ++D F
Sbjct: 210 EGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFS 269
Query: 180 QLGNMKMTKLILRNCNITGELPRYLG-----KMTKLKVLDLSFNRL 220
+L N+ + L L+ I + R L KM L L+L+ NR
Sbjct: 270 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 38/234 (16%), Positives = 69/234 (29%), Gaps = 51/234 (21%)
Query: 37 LAELTFLQDISL---IANRLKGPIP-------KYLANISTLVNLTVQYNQFSGELPEELG 86
+A L+ R+K IP + L L + + N F E L
Sbjct: 56 IASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLI 115
Query: 87 SLL----NLEKLHLSSNNFTGE-------------LPKTFAKLTNMKDFRISDNQFTGQ- 128
L LE L+L +N + + K ++ N+
Sbjct: 116 DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGS 175
Query: 129 ---IPSFIQNWTKLEKLF-----IQPSGLAGPIPSGIFSLENLTDLRISDLN--GPEATF 178
Q+ L + I+P G+ + G+ + L L + D N +
Sbjct: 176 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD-NTFTHLGS- 233
Query: 179 PQLG-----NMKMTKLILRNCNITGELPRYLGKM------TKLKVLDLSFNRLR 221
L + +L L +C ++ + L+ L L +N +
Sbjct: 234 SALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 43/231 (18%), Positives = 73/231 (31%), Gaps = 50/231 (21%)
Query: 37 LAELTFLQDISLIANRLKG----PIPKYLANISTLVNLTVQYNQFSGE----LPEELGSL 88
+A + ++ SL + + + L ++ + + N E L E + S
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 89 LNLEKLHLSSNNFTGE-----------LPKTFAKLTNMKDFRISDNQFTGQ----IPSFI 133
+LE S + FTG L + K + R+SDN F + F+
Sbjct: 60 KDLEIAEFS-DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFL 118
Query: 134 QNWTKLEKLF-----IQPSG---LAG--PIPSGIFSLENLTDLRISDLN----GPEATFP 179
T LE L+ + P +A + +N LR +
Sbjct: 119 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSM-K 177
Query: 180 QLGNM-----KMTKLILRNCNITGE-----LPRYLGKMTKLKVLDLSFNRL 220
+ + + + I E L L +LKVLDL N
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 36/240 (15%), Positives = 73/240 (30%), Gaps = 30/240 (12%)
Query: 4 LNTFLVFHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLAN 63
L W ++ VL + A L L + + L +
Sbjct: 313 LPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRDSATDEQLFRCELSVEKST-VLQSELES 370
Query: 64 ISTLVNLTVQYN-------------QFSGELPEELGSLLNLEKL--------HLSSNNFT 102
L L + E L L+ + + F
Sbjct: 371 CKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFL 430
Query: 103 GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLEN 162
E + +++ ++ T + ++ + L + + L +P + +L
Sbjct: 431 LENSVLKMEYADVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRC 487
Query: 163 LTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITG-ELPRYLGKMTKLKVLDLSFNRL 220
L L+ SD N E + N+ ++ +L+L N + + L +L +L+L N L
Sbjct: 488 LEVLQASD-NALE-NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 39/238 (16%), Positives = 72/238 (30%), Gaps = 15/238 (6%)
Query: 11 HFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNL 70
L +Q ++ L+ +R + + A L
Sbjct: 296 PSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW-CRDSATDEQLFRC 354
Query: 71 TVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGEL---PKTFAKLTNMKDFRISDNQFTG 127
+ + S L EL S L++L + + + L K+ +
Sbjct: 355 ELSVEK-STVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKA 413
Query: 128 QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMT 187
P L F+ + + + + L +L ++ L E QL + T
Sbjct: 414 VDPMRAAYLDDLRSKFLLENSVLKMEYADVRVL-HLAHKDLTVLCHLE----QLLLV--T 466
Query: 188 KLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 245
L L + + LP L + L+VL S N L + +L + + N L
Sbjct: 467 HLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 4e-04
Identities = 18/74 (24%), Positives = 28/74 (37%), Gaps = 9/74 (12%)
Query: 33 LPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTV---QYNQFSG-ELPEELGSL 88
LPP LA L L+ + N L+ + ++ L L N+ + L S
Sbjct: 478 LPPALAALRCLEVLQASDNALE-----NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSC 532
Query: 89 LNLEKLHLSSNNFT 102
L L+L N+
Sbjct: 533 PRLVLLNLQGNSLC 546
|
| >2jwp_A Malectin, MGC80075; sugar binding, sugar binding protein; NMR {Xenopus laevis} PDB: 2k46_A* 2kr2_A* Length = 174 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 9e-07
Identities = 16/83 (19%), Positives = 24/83 (28%), Gaps = 21/83 (25%)
Query: 301 INCGGKQVTANGNTTFEEDTSEAGPSTFSQSGTNWVLSSTGHFLENGLKLGPYIQTNTSR 360
+N GG+ + +D E S G P +++N
Sbjct: 10 VNAGGESHVDVHGIHYRKDPLEGRVGRASDYGMK----------------LPILRSNP-- 51
Query: 361 LLMNDYQLYTTARLSAISLTYYG 383
D LY T R + S Y
Sbjct: 52 ---EDQVLYQTERYNEDSFGYDI 71
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 1e-06
Identities = 41/188 (21%), Positives = 62/188 (32%), Gaps = 64/188 (34%)
Query: 69 NLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ 128
L ++ N L +L +L+L N F KLT++ +S NQ
Sbjct: 32 YLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS- 90
Query: 129 IPSFIQNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISDLNGPEATFPQLGNMKMT 187
+P+G+F L L +L L ++
Sbjct: 91 ------------------------LPNGVFDKLTQLKEL-------------ALNTNQLQ 113
Query: 188 KLILRNCNITGELPRYLG---KMTKLKVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNL 243
LP G K+T+LK L L N+L+ +P FD L + YI+ N
Sbjct: 114 -----------SLPD--GVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN- 158
Query: 244 LTGAIPPW 251
PW
Sbjct: 159 ------PW 160
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 5e-06
Identities = 27/112 (24%), Positives = 50/112 (44%), Gaps = 6/112 (5%)
Query: 62 ANI-STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 120
I + L + NQF+ +P+EL + +L + LS+N + ++F+ +T + +
Sbjct: 27 KGIPRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLIL 85
Query: 121 SDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISD 170
S N+ IP L L + + ++ +P G F L L+ L I
Sbjct: 86 SYNRLR-CIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGA 135
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 29/162 (17%), Positives = 53/162 (32%), Gaps = 59/162 (36%)
Query: 92 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 151
+L+L N FT +PK + ++ +S+N+ +
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIST------------------------ 68
Query: 152 PIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYL-GKMTKL 210
+ + FS N+T L LIL + N +P + L
Sbjct: 69 -LSNQSFS--NMTQL--------------------LTLIL-SYNRLRCIPPRTFDGLKSL 104
Query: 211 KVLDLSFNRLRGQIPSN-FDDLYDVDYIYFAGNLLTGAIPPW 251
++L L N + +P F+DL + ++ N P
Sbjct: 105 RLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN-------PL 138
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 6e-06
Identities = 46/230 (20%), Positives = 80/230 (34%), Gaps = 61/230 (26%)
Query: 401 IGEGGFGPVYKG--LLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHP------NLV 452
+GEG FG V + + +A+K + + K + EI ++ ++ V
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-EINVLKKIKEKDKENKFLCV 85
Query: 453 KLYGC-------CI--EGNQLLL---IYEYLENNSLARALFEHRLKLDWPTRRRICLGIA 500
+ CI E LL +E+L+ N+ + R + +
Sbjct: 86 LMSDWFNFHGHMCIAFE----LLGKNTFEFLKENNFQP--YPLPHV------RHMAYQLC 133
Query: 501 RGLAYLHGESRIKVVHRDIKATNVLLDKDLNS-------------------KISDFGLA- 540
L +LH ++ H D+K N+L +++DFG A
Sbjct: 134 HALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 541 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG 590
E T ++TR Y PE + + DV+S G + E G
Sbjct: 191 FDHEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 8e-06
Identities = 27/108 (25%), Positives = 46/108 (42%), Gaps = 5/108 (4%)
Query: 62 ANI-STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 120
I S+ L ++ N+ L L KL LS N F KLT + +
Sbjct: 24 TGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYL 83
Query: 121 SDNQFTGQIPSFI-QNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDL 166
+N+ +P+ + T+L++L + + L +P GIF L +L +
Sbjct: 84 HENKLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKI 129
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 38/164 (23%), Positives = 50/164 (30%), Gaps = 62/164 (37%)
Query: 92 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 151
+L L SN F KLT + +S NQ
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS------------------------ 66
Query: 152 PIPSGIF-SLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLG---KM 207
+P G+F L LT L L K+ LP G K+
Sbjct: 67 -LPDGVFDKLTKLTILY-------------LHENKLQ-----------SLPN--GVFDKL 99
Query: 208 TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 251
T+LK L L N+L+ FD L + I+ N PW
Sbjct: 100 TQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN-------PW 136
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 1e-05
Identities = 18/83 (21%), Positives = 26/83 (31%), Gaps = 6/83 (7%)
Query: 153 IPSGIFSLENLTDLRISDLNG----PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMT 208
+ ENLT+L I + LG + L + + P
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGEL--RNLTIVKSGLRFVAPDAFHFTP 80
Query: 209 KLKVLDLSFNRLRGQIPSNFDDL 231
+L L+LSFN L L
Sbjct: 81 RLSRLNLSFNALESLSWKTVQGL 103
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 15/90 (16%), Positives = 26/90 (28%), Gaps = 2/90 (2%)
Query: 57 IPKYLANISTLVNLTVQYNQFSGELPEE-LGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 115
+L L L ++ Q L L L L L + + P F +
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 116 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQ 145
+S N + L++L +
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLS 111
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 14/94 (14%), Positives = 33/94 (35%), Gaps = 6/94 (6%)
Query: 80 ELPEELGSLLNLEKLHLSSNNFTGELPK-TFAKLTNMKDFRISDNQFTGQIP--SFIQNW 136
+ L NL +L++ + L L +++ I + + +F
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAF-HFT 79
Query: 137 TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD 170
+L +L + + L + +L +L +S
Sbjct: 80 PRLSRLNLSFNALES-LSWKTVQGLSLQELVLSG 112
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.9 bits (112), Expect = 1e-05
Identities = 55/239 (23%), Positives = 89/239 (37%), Gaps = 79/239 (33%)
Query: 401 IGEGGFGPVYKG--LLADGTAIAVKQLSSKSK---QGNREFINEIGMISALQHP------ 449
+GEG FG V + A G +AVK + + + +EI ++ L
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPNSTF 77
Query: 450 NLVKLYGC-------CI--EGNQLLL---IYEYLENNSLARALFEHRLKLDWPTRRRICL 497
V++ CI E LL Y++++ N +LD R++
Sbjct: 78 RCVQMLEWFEHHGHICIVFE----LLGLSTYDFIKENG------FLPFRLD--HIRKMAY 125
Query: 498 GIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS-------------------KISDFG 538
I + + +LH K+ H D+K N+L + + K+ DFG
Sbjct: 126 QICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
Query: 539 LA-KLDEEENTHISTRVAGTIGYMAPE------YAMRGHLTEKADVYSFGIVALEIVSG 590
A DE +T +STR Y APE ++ DV+S G + +E G
Sbjct: 183 SATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCILIEYYLG 230
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 5e-05
Identities = 53/243 (21%), Positives = 88/243 (36%), Gaps = 83/243 (34%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQH-----PNL 451
+G+G FG V + + AVK + + K E ++ +Q+ N+
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINNNNI 98
Query: 452 VKLYGC-------CI--EGNQLLL---IYEYLENNSLARALFEHRLKLDWPTRRRICLGI 499
VK +G C+ E L +YE + N+ F + C+ I
Sbjct: 99 VKYHGKFMYYDHMCLIFE----PLGPSLYEIITRNNYNG--FHIEDI------KLYCIEI 146
Query: 500 ARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS-------------------------KI 534
+ L YL ++ + H D+K N+LLD K+
Sbjct: 147 LKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 535 SDFGLAKLDEEE-NTHISTRVAGTIGYMAPE------YAMRGHLTEKADVYSFGIVALEI 587
DFG A + + I+TR Y APE + + +D++SFG V E+
Sbjct: 204 IDFGCATFKSDYHGSIINTRQ-----YRAPEVILNLGWDV------SSDMWSFGCVLAEL 252
Query: 588 VSG 590
+G
Sbjct: 253 YTG 255
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 26/110 (23%), Positives = 50/110 (45%), Gaps = 8/110 (7%)
Query: 62 ANI-STLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 119
+I L + N+ + L G L +L KL L N TG P F +++++ +
Sbjct: 25 RDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84
Query: 120 ISDNQFTGQIPS--FIQNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDL 166
+ +N+ +I + F +L+ L + + ++ + G F L +LT L
Sbjct: 85 LGENKIK-EISNKMF-LGLHQLKTLNLYDNQISC-VMPGSFEHLNSLTSL 131
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 1e-04
Identities = 28/191 (14%), Positives = 55/191 (28%), Gaps = 36/191 (18%)
Query: 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGI 157
S +L + + + +I + L+ L I GL + I
Sbjct: 157 SWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGK---KPRPNLKSLEIISGGLPDSVVEDI 213
Query: 158 FS--LENLTDLRI---SDLNGPEATFPQLGNM-------KMTKLILRNCNITGELPRYLG 205
L NL L + + G + + + L + + +
Sbjct: 214 LGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFL 273
Query: 206 K---MTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLS 262
+ + +L+ +D+S L D A LL L+ I++
Sbjct: 274 ESDILPQLETMDISAGVLT-----------DEG----ARLLLDHVDKIKHLKF---INMK 315
Query: 263 YNNFTDGSAES 273
YN +D +
Sbjct: 316 YNYLSDEMKKE 326
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 4e-04
Identities = 28/204 (13%), Positives = 58/204 (28%), Gaps = 47/204 (23%)
Query: 64 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAK-----LTNMKDF 118
+ + L + + L NL+ L + S + + L + +
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 119 RISDNQFTGQIPSFI------QNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 172
++ + + L+ L I + + + L L D++
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287
Query: 173 GPEATFPQLGNMKMTKLILRNCNITGE----LPRYLGKMTKLKVLDLSFN--------RL 220
+T E L ++ K+ LK +++ +N L
Sbjct: 288 --------------------AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327
Query: 221 RGQIPSNFD----DLYDVDYIYFA 240
+ +P D YD DY Y
Sbjct: 328 QKSLPMKIDVSDSQEYDDDYSYPM 351
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 31/159 (19%), Positives = 53/159 (33%), Gaps = 34/159 (21%)
Query: 63 NISTLVNLTVQYNQFSGELPEELGSLL-NLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 121
+ + L + + + E L + NLE L L + + KL +K +S
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 122 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG--PEATFP 179
+N+ G + + L L NL+ ++ D++ P
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHL-------------------NLSGNKLKDISTLEPLKKLE 120
Query: 180 QLGNMKMTKLILRNCNITGELPRY----LGKMTKLKVLD 214
L L L NC +T L Y + +L LD
Sbjct: 121 CL-----KSLDLFNCEVT-NLNDYRESVFKLLPQLTYLD 153
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 26/189 (13%), Positives = 61/189 (32%), Gaps = 42/189 (22%)
Query: 65 STLVNLTVQYNQFSGELPEELGSLL-----NLEKLHLSSNNFTGELPKTFAK-LTNMKDF 118
S+L L + + + + ++L L++++L+S +T +
Sbjct: 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKL 131
Query: 119 RISDNQFTGQ----IPSFIQ-NWTKLEKLF-----IQPSGLAGPIPSGIFSLENLTDLRI 168
+ N + + + + ++ L + +G + G+ ++T L +
Sbjct: 132 GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAG-VAVLMEGLAGNTSVTHLSL 190
Query: 169 SDLNGPEATFPQLG-------------NMKMTKLILRNCNITGE----LPRYLGKMTKLK 211
LG N ++ +L + L R + L+
Sbjct: 191 LH-T-------GLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLE 242
Query: 212 VLDLSFNRL 220
+L L FN L
Sbjct: 243 LLHLYFNEL 251
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 733 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.97 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 99.97 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.97 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.96 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 99.96 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 99.96 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.96 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.95 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.95 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.95 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.95 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.95 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.95 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 99.95 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.95 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.95 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 99.95 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 99.95 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.94 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 99.94 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 99.94 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.94 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.93 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 99.93 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.92 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.92 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.92 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.92 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.92 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.92 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.91 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.89 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.89 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.88 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.86 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.86 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.85 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.85 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.85 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.83 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.8 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.8 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.79 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.79 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.78 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.77 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.76 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.74 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.7 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.69 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.68 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.67 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.66 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.66 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.65 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.64 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.63 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.61 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.6 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.59 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.58 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.58 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.56 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.56 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.52 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.5 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.5 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.49 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.49 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.48 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.47 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.46 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.32 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.31 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.3 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.29 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.28 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.01 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.94 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.92 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.88 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.82 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.76 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.65 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.61 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.58 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.54 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.52 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.44 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.43 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.41 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.37 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.35 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.18 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.06 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.04 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.91 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.85 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.81 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.72 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.59 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.49 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.26 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.23 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.22 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.18 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.16 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.02 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.99 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.71 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.67 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.63 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.46 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.42 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.23 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.93 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.18 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 90.82 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.95 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.55 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 82.4 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-55 Score=453.54 Aligned_cols=256 Identities=28% Similarity=0.499 Sum_probs=214.3
Q ss_pred cCccccCcccCCCcccEEEcccC------CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
++|...+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999853 478899999987777777889999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEE
Q 004732 467 IYEYLENNSLARALFEH------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKI 534 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 534 (733)
|||||++|+|.++|+.. ...++|.++.+|+.|||+||+|||+++ ||||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999753 247999999999999999999999986 999999999999999999999
Q ss_pred cccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhh
Q 004732 535 SDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQ 612 (733)
Q Consensus 535 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 612 (733)
+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||...+...+.... ..
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i----~~ 245 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI----TQ 245 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----Hc
Confidence 999999865443322 2344679999999999999999999999999999999999 89999776655444322 12
Q ss_pred CcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 613 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
+...... ..+ ...+.+++.+||+.||++||||.||++.|+...
T Consensus 246 ~~~~~~p-----~~~----~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~ 288 (299)
T 4asz_A 246 GRVLQRP-----RTC----PQEVYELMLGCWQREPHMRKNIKGIHTLLQNLA 288 (299)
T ss_dssp TCCCCCC-----TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCC-----ccc----hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2221111 122 235889999999999999999999999998643
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=452.60 Aligned_cols=256 Identities=28% Similarity=0.415 Sum_probs=212.4
Q ss_pred CccccCcccCCCcccEEEcccC------CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
+++..+.||+|+||+||+|++. +++.||||+++.. .....++|.+|+.++++++|||||+++|+|.+++..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3455678999999999999852 4688999999754 33345789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC
Q 004732 467 IYEYLENNSLARALFEH---------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 531 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 531 (733)
|||||++|+|.++|... ...++|.++.+|+.|||+||+|||+.+ ||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 99999999999999643 236999999999999999999999986 999999999999999999
Q ss_pred eEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHH
Q 004732 532 SKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVL 609 (733)
Q Consensus 532 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 609 (733)
+||+|||+|+....... .......||+.|||||++.++.|+.++|||||||++|||+| |+.||...+...+...+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i--- 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMI--- 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHH---
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---
Confidence 99999999986654332 23445689999999999999999999999999999999998 89999776655544332
Q ss_pred HhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 610 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
..+...... ......+.+++.+||+.||++||||.||++.|+++.+
T Consensus 261 -~~~~~~~~p---------~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n 306 (308)
T 4gt4_A 261 -RNRQVLPCP---------DDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 306 (308)
T ss_dssp -HTTCCCCCC---------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred -HcCCCCCCc---------ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence 222222211 1223458899999999999999999999999997654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=455.90 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=208.6
Q ss_pred cCccccCcccCCCcccEEEcccC------CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
++|...+.||+|+||+||+|++. +++.||||+++.......++|.+|+++|++++|||||+++|+|.+++..++
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46677789999999999999853 478999999987777777889999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCe
Q 004732 467 IYEYLENNSLARALFEHR--------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 532 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 532 (733)
|||||++|+|.++++... ..++|.++++|+.|||+||+|||+.+ ||||||||+|||+++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997432 35999999999999999999999986 9999999999999999999
Q ss_pred EEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHH
Q 004732 533 KISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLK 610 (733)
Q Consensus 533 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 610 (733)
||+|||+|+....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||...+.......+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i---- 273 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---- 273 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH----
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH----
Confidence 9999999986654332 23445789999999999999999999999999999999999 89999776655444322
Q ss_pred hhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 611 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
..+...... ..++ ..+.+++.+||+.||++||||.||++.|+.+..
T Consensus 274 ~~g~~~~~p-----~~~~----~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 274 TQGRELERP-----RACP----PEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHTCCCCCC-----TTCC----HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCc-----cccc----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 122211111 1222 358899999999999999999999999987644
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-54 Score=445.62 Aligned_cols=258 Identities=26% Similarity=0.422 Sum_probs=203.9
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.+++...+.||+|+||+||+|++.+ .||||+++.. .....+.|.+|++++++++|||||+++|+|.+ +..++|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3567778899999999999998753 5999998653 34455789999999999999999999999865 56899999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC-c
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN-T 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~-~ 548 (733)
||++|+|.++++.....++|.++.+|+.|||+||+|||+.+ ||||||||+|||+++++.+||+|||+|+...... .
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 188 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGS 188 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCcc
Confidence 99999999999877778999999999999999999999986 9999999999999999999999999998765432 2
Q ss_pred ccccccccCCCcccHHHHhh---CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.......||+.|||||++.+ +.|+.++|||||||++|||+||+.||...+........ ...+.....+.
T Consensus 189 ~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~---~~~~~~~p~~~----- 260 (307)
T 3omv_A 189 QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM---VGRGYASPDLS----- 260 (307)
T ss_dssp -----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH---HHTTCCCCCST-----
T ss_pred eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH---HhcCCCCCCcc-----
Confidence 33455789999999999974 35899999999999999999999999655433222211 11111111000
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
..+......+.+++.+||+.||++||||.||++.|+.+
T Consensus 261 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l 298 (307)
T 3omv_A 261 KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL 298 (307)
T ss_dssp TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11112234588999999999999999999999998854
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=439.34 Aligned_cols=249 Identities=22% Similarity=0.375 Sum_probs=204.6
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
++|...+.||+|+||+||+|+ ..+|+.||||++... .....+.|.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 578899999999999999999 567999999998654 33445689999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 470 YLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+||+|.+++... ...+++.+++.|+.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999754 446799999999999999999999996 9999999999999999999999999998765422
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||...+...+.... . .+.... ....+
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i---~-~~~~~~-----~~~~~- 249 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI---I-SGSFPP-----VSLHY- 249 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---H-HTCCCC-----CCTTS-
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---H-cCCCCC-----CCccC-
Confidence 2234568999999999999999999999999999999999999999877655443321 1 111111 11122
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+.+++.+||+.||++|||+.|+++
T Consensus 250 ---s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 250 ---SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 234889999999999999999999976
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=438.56 Aligned_cols=249 Identities=25% Similarity=0.396 Sum_probs=210.2
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
..|+..+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|++++|||||+++++|.+++..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 4688889999999999999994 579999999997654445567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
++|+|.+++.. ..+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....... ..
T Consensus 154 ~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~~ 227 (346)
T 4fih_A 154 EGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RR 227 (346)
T ss_dssp TTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CB
T ss_pred CCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-cc
Confidence 99999999865 36999999999999999999999996 99999999999999999999999999987654332 23
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
...+||+.|||||++.+..|+.++||||+||++|||++|+.||...+......... . .... ........
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~---~-~~~~-------~~~~~~~~ 296 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---D-NLPP-------RLKNLHKV 296 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---H-SSCC-------CCSCGGGS
T ss_pred cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---c-CCCC-------CCCccccC
Confidence 45789999999999999999999999999999999999999997766554433221 1 1100 01111122
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+.+++.+||+.||++|||+.|+++
T Consensus 297 s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 297 SPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 345889999999999999999999876
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-52 Score=435.63 Aligned_cols=253 Identities=25% Similarity=0.257 Sum_probs=205.3
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.+.|...+.||+|+||+||+|+ ..+|+.||||+++.... +.+|++++++++|||||+++++|.+++..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 3567788899999999999999 45799999999965322 24799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-CeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~~~~~ 549 (733)
|+||+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+|+........
T Consensus 132 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 132 LEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp CTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 9999999999765 47999999999999999999999986 99999999999999987 6999999999876543221
Q ss_pred ----cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 550 ----ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 550 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
....++||+.|||||++.+..|+.++|||||||++|||++|+.||...+...+.... ........+
T Consensus 208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i--~~~~~~~~~-------- 277 (336)
T 4g3f_A 208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKI--ASEPPPIRE-------- 277 (336)
T ss_dssp ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHH--HHSCCGGGG--------
T ss_pred cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH--HcCCCCchh--------
Confidence 123468999999999999999999999999999999999999999665443332211 111111111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.+......+.+++.+||+.||.+|||+.|+++.|....
T Consensus 278 -~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 278 -IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp -SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 11122345888999999999999999999999887543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-52 Score=428.46 Aligned_cols=247 Identities=24% Similarity=0.352 Sum_probs=209.8
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|+..+.||+|+||+||+|+ ..+|+.||||++.+. .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 468889999999999999999 567999999998653 2334577999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC-
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN- 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~- 547 (733)
|||+||+|.+++.+. ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 112 Ey~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 999999999999754 47999999999999999999999996 9999999999999999999999999999765433
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
......++||+.|||||++.+..|+.++||||+||++|||++|+.||...+...+..... . +.. . ....+
T Consensus 188 ~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~---~-~~~-~-----~p~~~ 257 (311)
T 4aw0_A 188 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII---K-LEY-D-----FPEKF 257 (311)
T ss_dssp CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H-TCC-C-----CCTTC
T ss_pred cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---c-CCC-C-----CCccc
Confidence 233456789999999999999999999999999999999999999998776554443221 1 111 1 11122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVL 657 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl 657 (733)
+ ..+.+++.+|++.||++|||+.|+.
T Consensus 258 s----~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 258 F----PKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp C----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred C----HHHHHHHHHHccCCHhHCcChHHHc
Confidence 2 3478999999999999999999863
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=423.87 Aligned_cols=245 Identities=27% Similarity=0.430 Sum_probs=197.4
Q ss_pred cccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeEEEEE
Q 004732 396 ATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE----GNQLLLIY 468 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 468 (733)
+..+.||+|+||+||+|+ ..++..||||.+... .....+.|.+|++++++++|||||+++++|.+ +...++||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 456689999999999999 457899999998643 34445779999999999999999999999875 34589999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC-CCCeEEcccCccccCcccC
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfGla~~~~~~~ 547 (733)
|||++|+|.+++.+. ..+++..+..++.||+.||+|||+++ ++||||||||+|||++. ++.+||+|||+|+.....
T Consensus 109 Ey~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~- 185 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 185 (290)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC-
Confidence 999999999999754 47999999999999999999999884 35999999999999984 789999999999864332
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
.....+||+.|||||++.+ .|+.++|||||||++|||+||+.||...... .+.. .. ..+......+ ..
T Consensus 186 --~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~---~i-~~~~~~~~~~----~~ 254 (290)
T 3fpq_A 186 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RV-TSGVKPASFD----KV 254 (290)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HH-TTTCCCGGGG----GC
T ss_pred --ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHH---HH-HcCCCCCCCC----cc
Confidence 2345789999999998864 6999999999999999999999999654322 2211 11 1111111111 11
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.+ ..+.+++.+||+.||++|||+.|+++
T Consensus 255 ~~----~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 255 AI----PEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 22 24788999999999999999999976
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=440.00 Aligned_cols=250 Identities=25% Similarity=0.403 Sum_probs=211.1
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.+.|+..+.||+|+||+||+|+ ..+|+.||||++........+.+.+|+++|+.++|||||+++++|.+++.+|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 3568899999999999999999 457999999999765555556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
|+||+|.+++... .+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....... .
T Consensus 230 ~~gG~L~~~i~~~--~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~ 303 (423)
T 4fie_A 230 LEGGALTDIVTHT--RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 303 (423)
T ss_dssp CTTEEHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred CCCCcHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence 9999999998653 6999999999999999999999997 99999999999999999999999999987654332 2
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||...+......... . ...... ......
T Consensus 304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~---~-~~~~~~---~~~~~~--- 373 (423)
T 4fie_A 304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---D-NLPPRL---KNLHKV--- 373 (423)
T ss_dssp BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---H-SCCCCC---SCTTSS---
T ss_pred ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---c-CCCCCC---cccccC---
Confidence 345789999999999999999999999999999999999999997776554433221 1 111010 001112
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+.+++.+||+.||++|||+.|+++
T Consensus 374 -s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 374 -SPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp -CHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 235889999999999999999999876
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=413.65 Aligned_cols=245 Identities=26% Similarity=0.416 Sum_probs=192.6
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|+..+.||+|+||+||+|+ ..+|+.||||++... .......+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 578999999999999999998 467999999998654 2234567999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||| +|+|.+++.+. ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 93 Ey~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~- 166 (275)
T 3hyh_A 93 EYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN- 166 (275)
T ss_dssp ECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC--------
T ss_pred eCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCC-
Confidence 999 68999998765 47999999999999999999999996 9999999999999999999999999998654432
Q ss_pred ccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.....+||+.|||||++.+..+ +.++||||+||++|||++|+.||...+...+.... . .+.. . .....
T Consensus 167 -~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i---~-~~~~-~-----~p~~~ 235 (275)
T 3hyh_A 167 -FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI---S-NGVY-T-----LPKFL 235 (275)
T ss_dssp ---------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H-HTCC-C-----CCTTS
T ss_pred -ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---H-cCCC-C-----CCCCC
Confidence 2345789999999999988775 57999999999999999999999776554433211 1 1111 0 11122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+.+++.+|++.||++|||+.|+++
T Consensus 236 ----s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 236 ----SPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 234789999999999999999999987
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=435.92 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=209.8
Q ss_pred hhcCccccCcccCCCcccEEEcccC------CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCC-CceeeEeeEEEeC-
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQH-PNLVKLYGCCIEG- 461 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~- 461 (733)
..++|...+.||+|+||+||+|++. .++.||||.+.... ....+.|.+|+++|++++| ||||+++|+|.++
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~ 141 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 141 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence 4567889999999999999999743 24689999997643 3345679999999999965 8999999999775
Q ss_pred CeEEEEEEccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe
Q 004732 462 NQLLLIYEYLENNSLARALFEH---------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 526 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill 526 (733)
+..++|||||++|+|.++|+.. ...++|.++..++.|||+||+|||+++ ||||||||+|||+
T Consensus 142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl 218 (353)
T 4ase_A 142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILL 218 (353)
T ss_dssp SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceee
Confidence 5689999999999999999743 235899999999999999999999986 9999999999999
Q ss_pred cCCCCeEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004732 527 DKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 604 (733)
Q Consensus 527 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~ 604 (733)
++++.+||+|||+|+........ ......||+.|||||++.+..|+.++|||||||++|||+| |+.||.........
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~- 297 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF- 297 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH-
T ss_pred CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 99999999999999876544332 3445789999999999999999999999999999999998 99999654322211
Q ss_pred HHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 605 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
......+......+ ..+ ..+.+++.+||+.||++||||.||++.|+.+
T Consensus 298 --~~~i~~g~~~~~p~-----~~~----~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 298 --CRRLKEGTRMRAPD-----YTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp --HHHHHHTCCCCCCT-----TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHHHcCCCCCCCc-----cCC----HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 11112222222211 122 3488899999999999999999999998854
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=426.72 Aligned_cols=262 Identities=28% Similarity=0.340 Sum_probs=197.8
Q ss_pred CccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC----eEEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN----QLLLIYE 469 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV~e 469 (733)
+|...+.||+|+||+||+|++ +|+.||||++..... ....+.+|+..+.+++|||||+++|+|.+++ ..++|||
T Consensus 4 ~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~E 81 (303)
T 3hmm_A 4 TIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSD 81 (303)
T ss_dssp GEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred EEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEec
Confidence 466778999999999999997 589999999865322 1222344566667889999999999998754 6899999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES-----RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
||++|+|.++++.. .++|..+.+++.|+|+||+|||+++ .++||||||||+|||++.++.+||+|||+|+...
T Consensus 82 y~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 159 (303)
T 3hmm_A 82 YHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159 (303)
T ss_dssp CCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEE
T ss_pred CCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcccc
Confidence 99999999999754 6899999999999999999999862 3469999999999999999999999999998665
Q ss_pred ccCcc---cccccccCCCcccHHHHhhC------CCCccchhHhHHHHHHHHHhCCCCCCccchh------------hHH
Q 004732 545 EENTH---ISTRVAGTIGYMAPEYAMRG------HLTEKADVYSFGIVALEIVSGRSNVTKEDMF------------YLL 603 (733)
Q Consensus 545 ~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~------------~~~ 603 (733)
..... .....+||+.|||||++.+. .++.++|||||||++|||+||+.|+...... ...
T Consensus 160 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~ 239 (303)
T 3hmm_A 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239 (303)
T ss_dssp TTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHH
T ss_pred CCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHH
Confidence 43322 12346799999999999764 3678999999999999999998776322110 011
Q ss_pred HHHHHHHhhCcccccccCCCC-CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 604 DWALVLKEQGKLMELVDTNPG-SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.........+ .++... .....+....+.+++.+||+.||++||||.||++.|+++.
T Consensus 240 ~~~~~~~~~~-----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~ 296 (303)
T 3hmm_A 240 EMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp HHHHHHTTSC-----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccc-----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111111111 111111 1112345567889999999999999999999999998643
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-51 Score=420.42 Aligned_cols=242 Identities=25% Similarity=0.336 Sum_probs=195.3
Q ss_pred cCccccCcccCCCcccEEEccc----CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
++|+..+.||+|+||+||+|+. ..++.||||++.... ......+.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5688999999999999999974 247899999986542 2233468899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
|||||+||+|.+++.+. ..+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 104 vmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp EECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred EEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 99999999999999764 47999999999999999999999996 999999999999999999999999999865433
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
.. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+......... . ... . ....
T Consensus 180 ~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~---~-~~~-~-----~p~~ 248 (304)
T 3ubd_A 180 EK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL---K-AKL-G-----MPQF 248 (304)
T ss_dssp -C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H-CCC-C-----CCTT
T ss_pred Cc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHH---c-CCC-C-----CCCc
Confidence 22 2345789999999999999999999999999999999999999998776554433221 1 111 0 1112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSM 653 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~ 653 (733)
. ...+.+++.+||+.||++|||+
T Consensus 249 ~----s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 249 L----SPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSTTC
T ss_pred C----CHHHHHHHHHHcccCHHHCCCC
Confidence 2 2348899999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=407.72 Aligned_cols=248 Identities=21% Similarity=0.362 Sum_probs=188.2
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC--------
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGN-------- 462 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 462 (733)
++|+..+.||+|+||+||+|+ ..+|+.||||++.... ....+.+.+|+++|++++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 368888999999999999999 4579999999986543 334567899999999999999999999987644
Q ss_pred ----eEEEEEEccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcc
Q 004732 463 ----QLLLIYEYLENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 536 (733)
Q Consensus 463 ----~~~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 536 (733)
..|+|||||++|+|.+++.... ...++..++.++.||++||+|||+++ ||||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 3799999999999999997543 23566778999999999999999996 99999999999999999999999
Q ss_pred cCccccCcccCcc-----------cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHH
Q 004732 537 FGLAKLDEEENTH-----------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDW 605 (733)
Q Consensus 537 fGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~ 605 (733)
||+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||...... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--~~~ 236 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--VRT 236 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--HHH
Confidence 9999876543221 1234679999999999999999999999999999999996 77543211 110
Q ss_pred HHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 606 ALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.. ......... ........+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~-~~~~~~~p~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 237 LT-DVRNLKFPP---------LFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHHTTCCCH---------HHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHhcCCCCC---------CCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 10 111111111 01122234678999999999999999999987
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=406.12 Aligned_cols=262 Identities=20% Similarity=0.324 Sum_probs=204.9
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe------CCe
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE------GNQ 463 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 463 (733)
++|...+.||+|+||+||+|+ ..+|+.||||++... .....+.+.+|+++|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 578999999999999999999 467999999999654 23345678899999999999999999999764 367
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.|+|||||+ |+|.+++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+..
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~-~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~ 208 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSS-QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGL 208 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSS-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred EEEEEeCCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeec
Confidence 899999996 6799988654 58999999999999999999999997 999999999999999999999999999866
Q ss_pred cccC---cccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccc--
Q 004732 544 EEEN---THISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME-- 617 (733)
Q Consensus 544 ~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 617 (733)
.... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+...................
T Consensus 209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 4322 2234457899999999998875 579999999999999999999999987766554433222211110000
Q ss_pred ---------cccCC-CCCCCCHH-----HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 618 ---------LVDTN-PGSNFDKE-----QVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 618 ---------~~~~~-~~~~~~~~-----~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+... .....+.. ....+.+++.+|++.||++|||+.|+++.
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000 00011111 12357899999999999999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=395.69 Aligned_cols=203 Identities=28% Similarity=0.448 Sum_probs=173.4
Q ss_pred hhhHHhhhcCccccCcccCCCcccEEEccc----CCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEE
Q 004732 385 YLQIKAATNNFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCI 459 (733)
Q Consensus 385 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 459 (733)
|..+....+.|++.+.||+|+||+||+|+. ..++.||||.+.... ...++.+|+++|+.+ +|||||++++++.
T Consensus 13 ~~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~ 90 (361)
T 4f9c_A 13 YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR 90 (361)
T ss_dssp HHHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE
T ss_pred HHhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE
Confidence 334445568899999999999999999974 246889999986543 346788999999998 6999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC-CCeEEcccC
Q 004732 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFG 538 (733)
Q Consensus 460 ~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfG 538 (733)
+++..++|||||++|+|.+++. .+++.++..++.|++.||+|||++| ||||||||+|||++.+ +.+||+|||
T Consensus 91 ~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 91 KNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp ETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred ECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999999999883 5899999999999999999999997 9999999999999877 789999999
Q ss_pred ccccCcccCc---------------------------ccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhC
Q 004732 539 LAKLDEEENT---------------------------HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSG 590 (733)
Q Consensus 539 la~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg 590 (733)
+|+....... ......+||+.|+|||++.+. .|+.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9985543211 112345799999999999875 589999999999999999999
Q ss_pred CCCCCc
Q 004732 591 RSNVTK 596 (733)
Q Consensus 591 ~~p~~~ 596 (733)
+.||..
T Consensus 244 ~~Pf~~ 249 (361)
T 4f9c_A 244 RYPFYK 249 (361)
T ss_dssp CSSSSC
T ss_pred CCCCCC
Confidence 999954
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=390.80 Aligned_cols=278 Identities=43% Similarity=0.766 Sum_probs=239.6
Q ss_pred hhHHhhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 386 LQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 386 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
.++..++++|+..+.||+|+||.||+|+..+|+.||||++........+.+.+|+++++.++||||+++++++.+++..+
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34567889999999999999999999998889999999987766666678999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 466 LIYEYLENNSLARALFEHR---LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
+||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999986432 35899999999999999999999986 99999999999999999999999999986
Q ss_pred CcccC-cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccc---hhhHHHHHHHHHhhCccccc
Q 004732 543 DEEEN-THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED---MFYLLDWALVLKEQGKLMEL 618 (733)
Q Consensus 543 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~---~~~~~~~~~~~~~~~~~~~~ 618 (733)
..... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.... ......|.......+.....
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI 268 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHh
Confidence 54322 222344568999999999999999999999999999999999999995432 33445565555556666677
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004732 619 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 666 (733)
Q Consensus 619 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 666 (733)
+++........+....+.+++.+||+.||++|||+.|+++.|+.....
T Consensus 269 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 269 VDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp SSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred cChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 777776677888889999999999999999999999999999865543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=389.57 Aligned_cols=279 Identities=46% Similarity=0.801 Sum_probs=239.6
Q ss_pred hhhHHhhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccCh-hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004732 385 YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK-QGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 385 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 463 (733)
+.++..++++|...+.||+|+||.||+|+..+|+.||||++..... .....+.+|+++++.++||||++++++|.++..
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 5678889999999999999999999999988899999999876432 223468999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 464 LLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+..+|+||||||+||+++.++.+||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence 99999999999999999743 235999999999999999999999983334999999999999999999999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCc-----cchhhHHHHHHHHHhhCcc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK-----EDMFYLLDWALVLKEQGKL 615 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~-----~~~~~~~~~~~~~~~~~~~ 615 (733)
+..............||+.|+|||.+.+..++.++|||||||++|||++|+.||.. .......+|..........
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred cccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence 87765555555566799999999999999999999999999999999999999942 2233445565555555566
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
....+......+..+....+.+++.+||+.||.+|||+.||++.|++.
T Consensus 262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 666677677778888899999999999999999999999999999863
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=414.26 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=212.8
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.++|.+.+.||+|+||+||+|+ ..+|+.||||.+........+.+.+|+++|+.++|||||+++++|.++...++||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 3689999999999999999999 467999999999776655667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC--CCeEEcccCccccCcccCc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD--LNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~--~~~kl~DfGla~~~~~~~~ 548 (733)
|+||+|.+++......+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+.......
T Consensus 236 ~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~ 312 (573)
T 3uto_A 236 MSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 312 (573)
T ss_dssp CCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE
T ss_pred cCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCc
Confidence 9999999999766668999999999999999999999996 9999999999999854 7899999999987654332
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
....+||+.|||||++.+..|+.++||||+||++|||++|+.||...+......... ...... ........
T Consensus 313 --~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~--~~~~~~----~~~~~~~~- 383 (573)
T 3uto_A 313 --VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK--SCDWNM----DDSAFSGI- 383 (573)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--TTCCCC----CSGGGTTS-
T ss_pred --eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH--hCCCCC----CcccccCC-
Confidence 344689999999999999999999999999999999999999997766554433211 111111 00011112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+.+++.+||+.||.+|||+.|+++.
T Consensus 384 ---s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 384 ---SEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2347889999999999999999999873
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=411.36 Aligned_cols=250 Identities=26% Similarity=0.313 Sum_probs=200.3
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHH---HHHHHHhCCCCceeeEeeEEEeCCe
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFIN---EIGMISALQHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~ 463 (733)
..++|...++||+|+||+||+|+ ..+|+.||||++.+.. ......+.+ ++.+++.++|||||+++++|.+++.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 35789999999999999999999 5579999999986431 122233334 4566777899999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
+|+|||||+||+|.+++... ..+++..+..++.||+.||+|||++| ||||||||+|||++.+|.+||+|||+|+..
T Consensus 267 lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999999765 47999999999999999999999997 999999999999999999999999999866
Q ss_pred cccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
.... ....+||+.|||||++.+ ..|+.++||||+||++|||++|+.||...+............. ... .
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~-~~~------~ 412 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MAV------E 412 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-CCC------C
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-CCC------C
Confidence 5432 345789999999999975 5799999999999999999999999965443222211111111 110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPS-----MSSVLR 658 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 658 (733)
....+ ...+.+++.+|++.||.+|++ +.||.+
T Consensus 413 ~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 413 LPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp CCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred CCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 11122 334889999999999999998 577643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=375.95 Aligned_cols=262 Identities=27% Similarity=0.431 Sum_probs=212.5
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.++|...+.||+|+||+||+|+. .+++.||+|.+........+.|.+|++++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35677889999999999999994 57899999998776666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++|+|.+++......+++.++..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (310)
T 3s95_A 89 IKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165 (310)
T ss_dssp CTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred cCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence 9999999999887778999999999999999999999996 9999999999999999999999999998654432211
Q ss_pred -------------ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccc
Q 004732 551 -------------STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME 617 (733)
Q Consensus 551 -------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 617 (733)
.....||+.|+|||.+.+..++.++|||||||++|||++|..|+.......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-------~~~~~~ 238 (310)
T 3s95_A 166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-------GLNVRG 238 (310)
T ss_dssp --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-------SBCHHH
T ss_pred cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-------hhhhhc
Confidence 124679999999999999999999999999999999999999984321110000 000000
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 618 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
..+.......+ ..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 239 ~~~~~~~~~~~----~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 239 FLDRYCPPNCP----PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp HHHHTCCTTCC----TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cccccCCCCCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 00000001111 23888999999999999999999999999765543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=365.10 Aligned_cols=252 Identities=27% Similarity=0.455 Sum_probs=210.6
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
..++|...+.||+|+||+||+|+ ..+|+.||||.+........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 34678999999999999999998 56799999999876655556788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 171 (297)
T 3fxz_A 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (297)
T ss_dssp CCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence 99999999999754 6899999999999999999999996 99999999999999999999999999986554332
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+........ ...... . ...+.
T Consensus 172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~---~~~~~~-~-------~~~~~ 240 (297)
T 3fxz_A 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTP-E-------LQNPE 240 (297)
T ss_dssp CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHHCSC-C-------CSCGG
T ss_pred ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhCCCC-C-------CCCcc
Confidence 234467999999999999999999999999999999999999999766543322211 111110 0 01111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.....+.+++.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 241 KLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 223458899999999999999999999863
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=362.37 Aligned_cols=255 Identities=27% Similarity=0.453 Sum_probs=214.8
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
++|...+.||+|+||.||+|+..+++.||||++.... ...+.+.+|++++++++||||+++++++.++...++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 5678889999999999999998888999999997543 345679999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+|+|.+++......+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 89 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 99999999877778999999999999999999999996 999999999999999999999999999866554333344
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
...||+.|+|||.+.+..++.++||||+|+++|||++ |+.||............ . ... ........
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~---~-~~~-----~~~~~~~~---- 232 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---S-TGF-----RLYKPRLA---- 232 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---H-TTC-----CCCCCTTS----
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---h-cCc-----cCCCCCcC----
Confidence 5567889999999999999999999999999999999 99999766544433221 1 110 00111112
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
...+.+++.+||+.+|++||++.++++.|+++.
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~ 265 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 265 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHH
Confidence 234888999999999999999999999998643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=371.81 Aligned_cols=258 Identities=27% Similarity=0.440 Sum_probs=210.7
Q ss_pred hcCccccCcccCCCcccEEEcccC----CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.++|...+.||+|+||.||+|+.. .+..||||.+... .....+.|.+|++++++++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 456788899999999999999853 3456999999764 34445789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999999877678999999999999999999999996 999999999999999999999999999876543
Q ss_pred Ccc--cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 547 NTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 547 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+... .
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----~~~~~~-----~- 274 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV----EEGYRL-----P- 274 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH----HTTCCC-----C-
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH----HcCCCC-----C-
Confidence 222 1223456788999999999999999999999999999999 99999766554433221 111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.+......+.+++.+||+.||.+||++.+|++.|+++..
T Consensus 275 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~ 313 (325)
T 3kul_A 275 ---APMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR 313 (325)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111123358899999999999999999999999996544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=370.74 Aligned_cols=263 Identities=29% Similarity=0.460 Sum_probs=206.2
Q ss_pred HHhhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
.....++|...+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..+
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 110 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLS 110 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCE
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceE
Confidence 344567889999999999999999986 58899999986543 334467899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 466 LIYEYLENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
+||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 111 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 111 IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 9999999999999997543 23899999999999999999999884 24999999999999999999999999999854
Q ss_pred cccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+......... ....... .
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~~-----~ 260 (309)
T 3p86_A 190 ASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG---FKCKRLE-----I 260 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---HSCCCCC-----C
T ss_pred cccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCC-----C
Confidence 4322 22334679999999999999999999999999999999999999997665444332221 1111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
...++ ..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 261 ~~~~~----~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~ 298 (309)
T 3p86_A 261 PRNLN----PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK 298 (309)
T ss_dssp CTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred CccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11222 348899999999999999999999999986654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=378.17 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=211.6
Q ss_pred hcCccccCcccCCCcccEEEccc--------CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL--------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 461 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 461 (733)
.++|...+.||+|+||.||+|+. .++..||||.+.... ....+.+.+|+++++++ +||||++++++|.++
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 46788899999999999999974 245679999997643 33456799999999999 899999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe
Q 004732 462 NQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 526 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill 526 (733)
+..++||||+++|+|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999997543 35899999999999999999999996 9999999999999
Q ss_pred cCCCCeEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004732 527 DKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 604 (733)
Q Consensus 527 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~ 604 (733)
+.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||..........
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986554322 22334567889999999999999999999999999999999 999996655444332
Q ss_pred HHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 605 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.. ..+.... .+......+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 317 ~~----~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 317 LL----KEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HH----HTTCCCC---------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----hcCCCCC---------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 21 1111111 111122358899999999999999999999999986544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=359.29 Aligned_cols=258 Identities=26% Similarity=0.417 Sum_probs=216.2
Q ss_pred hhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
..++|...+.||+|+||.||+|...++..||||.+.... ...+++.+|++++++++||||+++++++.++...++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 346788899999999999999998888899999997543 3456799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 85 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 161 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS 161 (268)
T ss_dssp CTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred cCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence 9999999999877667999999999999999999999996 9999999999999999999999999998766554444
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||............ ..+... . .....
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~--~---~~~~~-- 230 (268)
T 3sxs_A 162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV----SQGHRL--Y---RPHLA-- 230 (268)
T ss_dssp CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----HTTCCC--C---CCTTS--
T ss_pred ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH----HcCCCC--C---CCCcC--
Confidence 444567788999999999899999999999999999999 99999655443322211 111110 0 01112
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
...+.+++.+||+.+|++|||+.++++.|+.+.+
T Consensus 231 --~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 231 --SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp --CHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred --hHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 2348889999999999999999999999997654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=367.50 Aligned_cols=249 Identities=26% Similarity=0.382 Sum_probs=208.5
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
..++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356788999999999999999994 68999999998654 334456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 93 ~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 168 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG 168 (328)
T ss_dssp ECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred EECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence 9999999999999755 47999999999999999999999996 9999999999999999999999999998654432
Q ss_pred cccccccccCCCcccHHHHhhCCCC-ccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLT-EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
......||+.|+|||++.+..+. .++||||+||++|||++|+.||...+......... .+.. .....
T Consensus 169 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~----~~~~------~~p~~ 236 (328)
T 3fe3_A 169 --KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL----RGKY------RIPFY 236 (328)
T ss_dssp --GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCC------CCCTT
T ss_pred --ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCC------CCCCC
Confidence 23456799999999999988765 79999999999999999999997766544333211 1111 00111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+.+++.+|++.||.+|||+.|+++.
T Consensus 237 ----~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 237 ----MSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ----SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 22347889999999999999999999864
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-43 Score=377.52 Aligned_cols=258 Identities=27% Similarity=0.477 Sum_probs=201.7
Q ss_pred hcCccccCcccCCCcccEEEcccC----CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.++|...+.||+|+||.||+|+.. ++..||||.++.. .....+.|.+|++++++++||||+++++++.+++..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 457889999999999999999854 5778999999764 33445689999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++|+|.+++......+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999999877778999999999999999999999986 999999999999999999999999999876543
Q ss_pred Cccc--ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 547 NTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 547 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||............ ..+... ..
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i----~~~~~~-----~~ 271 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV----DEGYRL-----PP 271 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH----HTTEEC-----CC
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCC-----CC
Confidence 2221 122345788999999999999999999999999999998 99999765544333221 111110 01
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.. .....+.+++.+||+.||.+||++.+|++.|+....
T Consensus 272 ~~----~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 309 (373)
T 2qol_A 272 PM----DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR 309 (373)
T ss_dssp CT----TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred Cc----cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence 11 123458899999999999999999999999987644
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=360.23 Aligned_cols=274 Identities=37% Similarity=0.629 Sum_probs=223.1
Q ss_pred hhhhHHhhhcCcccc------CcccCCCcccEEEcccCCCcEEEEEEcccc----ChhcHHHHHHHHHHHHhCCCCceee
Q 004732 384 FYLQIKAATNNFATD------NNIGEGGFGPVYKGLLADGTAIAVKQLSSK----SKQGNREFINEIGMISALQHPNLVK 453 (733)
Q Consensus 384 ~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~ 453 (733)
.+.++..++++|... +.||+|+||.||+|+. +++.||||++... .....+.+.+|++++++++||||++
T Consensus 16 ~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 94 (307)
T 2nru_A 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94 (307)
T ss_dssp CHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEE
Confidence 367788899999888 8999999999999987 5889999998653 2234567899999999999999999
Q ss_pred EeeEEEeCCeEEEEEEccCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC
Q 004732 454 LYGCCIEGNQLLLIYEYLENNSLARALFE--HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 531 (733)
Q Consensus 454 l~~~~~~~~~~~lV~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 531 (733)
+++++.+++..++||||+++|+|.+++.. ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 95 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~ 171 (307)
T 2nru_A 95 LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFT 171 (307)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCC
T ss_pred EEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCc
Confidence 99999999999999999999999999973 3346999999999999999999999986 999999999999999999
Q ss_pred eEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhh-HHHHHHHH
Q 004732 532 SKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-LLDWALVL 609 (733)
Q Consensus 532 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~-~~~~~~~~ 609 (733)
+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... ...+....
T Consensus 172 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (307)
T 2nru_A 172 AKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEI 250 (307)
T ss_dssp EEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHH
T ss_pred EEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHh
Confidence 99999999986554322 22334679999999998864 58999999999999999999999996443222 22222222
Q ss_pred Hh-hCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 610 KE-QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 610 ~~-~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.. ...+.+.++... ..........+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 251 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 251 EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred hhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 22 222233333332 334566778899999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=361.23 Aligned_cols=261 Identities=26% Similarity=0.348 Sum_probs=207.1
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+ ..+++.||+|.+... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 4578889999999999999998 457899999998543 233446789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 90 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999999754 37999999999999999999999996 9999999999999999999999999998766544
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
........||+.|+|||.+.+..++.++|||||||++|||++|+.||........... .. ........ .......
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~---~~-~~~~~~~~-~~~~~~~ 240 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIK---HI-QDSVPNVT-TDVRKDI 240 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHH---HH-SSCCCCHH-HHSCTTS
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---Hh-hccCCCcc-hhcccCC
Confidence 4444556799999999999999999999999999999999999999976654332211 11 11111110 0011112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHhccCcc
Q 004732 628 DKEQVMVMINVALLCANASPTIRP-SMSSVLRMLECGVD 665 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RP-t~~~vl~~L~~~~~ 665 (733)
...+.+++.+|++.||.+|| ++.++.+.|+....
T Consensus 241 ----~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 241 ----PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp ----CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred ----CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 23488899999999999999 99999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=359.86 Aligned_cols=257 Identities=24% Similarity=0.391 Sum_probs=211.7
Q ss_pred hhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
..++|...+.||+|+||.||+|...++..||||.+.... ...+++.+|++++++++||||+++++++.+++..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 345778889999999999999998888899999997543 2357799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 101 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 177 (283)
T 3gen_A 101 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 177 (283)
T ss_dssp CTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHS
T ss_pred cCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccccc
Confidence 9999999999876668999999999999999999999996 9999999999999999999999999998665443333
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+........ .. +. ........
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~---~~-~~-----~~~~~~~~-- 246 (283)
T 3gen_A 178 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---AQ-GL-----RLYRPHLA-- 246 (283)
T ss_dssp TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---HT-TC-----CCCCCTTC--
T ss_pred ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHH---hc-cc-----CCCCCCcC--
Confidence 344567889999999999999999999999999999998 99999665543332211 11 11 01111112
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
...+.+++.+||+.+|.+|||+.++++.|++..
T Consensus 247 --~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~ 279 (283)
T 3gen_A 247 --SEKVYTIMYSCWHEKADERPTFKILLSNILDVM 279 (283)
T ss_dssp --CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence 235888999999999999999999999998654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=362.81 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=207.0
Q ss_pred ccccCcccCCCcccEEEcccC-CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 395 FATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++..++..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 666779999999999999954 7999999999766556667899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|+|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....... ....
T Consensus 127 ~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~~~~ 200 (321)
T 2c30_A 127 GALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 200 (321)
T ss_dssp CBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-CBCC
T ss_pred CCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCcc-cccc
Confidence 999998854 36999999999999999999999986 99999999999999999999999999986554322 2344
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||++.+..++.++|||||||++|||++|+.||............. ....... ........
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~----~~~~~~~-------~~~~~~~~ 269 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR----DSPPPKL-------KNSHKVSP 269 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH----HSSCCCC-------TTGGGSCH
T ss_pred ccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh----cCCCCCc-------CccccCCH
Confidence 679999999999999999999999999999999999999997665443332211 1111000 00111223
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 634 VMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+.+++.+||+.||++|||+.|+++.
T Consensus 270 ~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 270 VLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 58889999999999999999999874
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=381.85 Aligned_cols=263 Identities=20% Similarity=0.245 Sum_probs=215.0
Q ss_pred hhhHHhhhcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEe
Q 004732 385 YLQIKAATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIE 460 (733)
Q Consensus 385 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 460 (733)
+.+++..+++|...+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++..++||||++++++|.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 4566778899999999999999999999954 57899999986421 1122348899999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 461 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 461 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
++..++|||||++|+|.+++......+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999999876678999999999999999999999986 999999999999999999999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHh-----hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 615 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 615 (733)
+.............+||++|+|||++. ...++.++|||||||++|||++|+.||...+..............-..
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 302 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF 302 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCC
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccC
Confidence 876655544455578999999999997 456899999999999999999999999776655443322111111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTI--RPSMSSVLRM 659 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~~vl~~ 659 (733)
. ......+ ..+.+++.+|+..+|++ ||++.|+++.
T Consensus 303 p-----~~~~~~s----~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 303 P-----TQVTDVS----ENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp C-----SSCCCSC----HHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred C-----cccccCC----HHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1 1111122 34788999999888888 9999999764
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=380.61 Aligned_cols=257 Identities=26% Similarity=0.410 Sum_probs=211.4
Q ss_pred hhcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
..++|...+.||+|+||.||+|+.. +++.||||.+.... ......|.+|++++++++|||||+++++|.+++..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 4567888999999999999999964 78999999987542 333457889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++......+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 192 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp ECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred EcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999999876667999999999999999999999996 99999999999999999999999999986443222
Q ss_pred ccc-cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 549 HIS-TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 549 ~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
... ....+++.|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+..... ...
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~-----~~~ 339 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV----EKGGRLPC-----PEL 339 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH----HTTCCCCC-----CTT
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCC-----CCC
Confidence 111 12335778999999999999999999999999999998 99999765544333221 12211111 111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
. ...+.+++.+||+.||++|||+.+|++.|+.+
T Consensus 340 ~----~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 340 C----PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 2 23488899999999999999999999999854
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=364.68 Aligned_cols=260 Identities=20% Similarity=0.230 Sum_probs=210.8
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|...+.||+|+||.||+|+ ..+|+.||||.+..... ...+.+|+++++++ +||||+++++++.+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 4678899999999999999999 46789999999865432 24688999999999 99999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC-----eEEcccCccccCc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN-----SKISDFGLAKLDE 544 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~-----~kl~DfGla~~~~ 544 (733)
|+ +++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~ 161 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence 99 99999999876678999999999999999999999996 999999999999998887 9999999998654
Q ss_pred ccCcc------cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHH---HhhCcc
Q 004732 545 EENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVL---KEQGKL 615 (733)
Q Consensus 545 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~---~~~~~~ 615 (733)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||............... ......
T Consensus 162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 241 (330)
T 2izr_A 162 DPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI 241 (330)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH
T ss_pred cCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH
Confidence 43221 124567999999999999999999999999999999999999999654322222211111 111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
.... ..+ . .+.+++..||+.+|.+||++.+|++.|+......
T Consensus 242 ~~~~-----~~~----p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 242 EVLC-----ENF----P-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp HHHT-----TTC----H-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHh-----ccC----h-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 0000 001 1 5889999999999999999999999998654433
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=385.34 Aligned_cols=261 Identities=28% Similarity=0.420 Sum_probs=215.6
Q ss_pred HhhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
....++|...+.||+|+||.||+|++.++..||||.++... ...+.|.+|++++++++|||||++++++. ++..++||
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~ 261 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT 261 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence 44567888999999999999999998888999999997643 34678999999999999999999999986 66789999
Q ss_pred EccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 469 EYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~ 338 (454)
T 1qcf_A 262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 338 (454)
T ss_dssp CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence 999999999999743 347899999999999999999999986 9999999999999999999999999998765433
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
........+|+.|+|||.+....++.++|||||||++|||++ |+.||............ ..+..... ...
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~~~~~~~~-----~~~ 409 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL----ERGYRMPR-----PEN 409 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HHTCCCCC-----CTT
T ss_pred eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCC-----CCC
Confidence 222334457889999999999999999999999999999999 99999766544433221 11111111 111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
+ ...+.+++.+||+.||++|||+.+|++.|+.+....
T Consensus 410 ~----~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 410 C----PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred C----CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 2 235889999999999999999999999999765543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=366.43 Aligned_cols=262 Identities=26% Similarity=0.389 Sum_probs=207.2
Q ss_pred hcCccccCcccCCCcccEEEccc-----CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 464 (733)
.++|+..+.||+|+||+||+|++ .+++.||||++........+.+.+|++++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 45778889999999999999973 36889999999877666667899999999999999999999998654 558
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~ 165 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 165 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred EEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence 9999999999999999877767999999999999999999999986 9999999999999999999999999998765
Q ss_pred ccCcc--cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhH------------HHHHHHHH
Q 004732 545 EENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL------------LDWALVLK 610 (733)
Q Consensus 545 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~------------~~~~~~~~ 610 (733)
..... ......|+..|+|||.+.+..++.++||||||+++|||++|..|+........ ........
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHH
Confidence 43221 22334577889999999999999999999999999999999999854321100 00000011
Q ss_pred hhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 611 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.... ....+......+.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 246 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~ 291 (295)
T 3ugc_A 246 KNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 291 (295)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 1111 111112223458899999999999999999999999986543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=371.25 Aligned_cols=270 Identities=19% Similarity=0.214 Sum_probs=209.0
Q ss_pred hhcCccccCcccCCCcccEEEcccCC------CcEEEEEEccccChhc-----------HHHHHHHHHHHHhCCCCceee
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLAD------GTAIAVKQLSSKSKQG-----------NREFINEIGMISALQHPNLVK 453 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~ 453 (733)
..++|...+.||+|+||.||+|+... ++.||||.+....... ...+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45678899999999999999998643 4789999986543211 123445666778888999999
Q ss_pred EeeEEEeC----CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec--
Q 004732 454 LYGCCIEG----NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-- 527 (733)
Q Consensus 454 l~~~~~~~----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~-- 527 (733)
+++++... ...++||||+ +++|.+++......+++..++.++.||+.||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESS
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecC
Confidence 99999875 4589999999 99999999877678999999999999999999999996 99999999999999
Q ss_pred CCCCeEEcccCccccCcccCccc------ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccch-h
Q 004732 528 KDLNSKISDFGLAKLDEEENTHI------STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM-F 600 (733)
Q Consensus 528 ~~~~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~-~ 600 (733)
.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~ 268 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP 268 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence 88999999999998665432221 1335699999999999999999999999999999999999999964321 1
Q ss_pred hHHHHHHHHHhhCcccccccCCCC-CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccccc
Q 004732 601 YLLDWALVLKEQGKLMELVDTNPG-SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDL 669 (733)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~~~ 669 (733)
....+.... ....+..+++.... ...+ ..+.+++..||+.+|.+||++.+|++.|+........
T Consensus 269 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~----~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~ 333 (364)
T 3op5_A 269 KYVRDSKIR-YRENIASLMDKCFPAANAP----GEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGS 333 (364)
T ss_dssp HHHHHHHHH-HHHCHHHHHHHHSCTTCCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHH-hhhhHHHHHHHhcccccCH----HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 222212111 11223333333221 1222 3488899999999999999999999999876655443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=371.10 Aligned_cols=264 Identities=27% Similarity=0.335 Sum_probs=204.4
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC----eEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN----QLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV 467 (733)
.++|...+.||+|+||+||+|+.. ++.||||++.... .....+.+|+.++++++|||||++++++.++. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 457888899999999999999865 7999999986543 23345667899999999999999999998743 47999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC-------CCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE-------SRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
|||+++|+|.+++... .+++..+..++.|+++||+|||+. ...+|+||||||+|||++.++.+||+|||++
T Consensus 101 ~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a 178 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178 (322)
T ss_dssp EECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence 9999999999999754 589999999999999999999987 0113999999999999999999999999999
Q ss_pred ccCcccCcc-cccccccCCCcccHHHHhhC-----CCCccchhHhHHHHHHHHHhCCCCCCccchhh-------------
Q 004732 541 KLDEEENTH-ISTRVAGTIGYMAPEYAMRG-----HLTEKADVYSFGIVALEIVSGRSNVTKEDMFY------------- 601 (733)
Q Consensus 541 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~------------- 601 (733)
+........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 258 (322)
T 3soc_A 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258 (322)
T ss_dssp EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence 765543322 23346799999999999863 45678899999999999999999995432111
Q ss_pred HHHHHHHHHhhCcccccccCCCCCC-CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 602 LLDWALVLKEQGKLMELVDTNPGSN-FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
...+.......... +..... ........+.+++.+||+.||++|||+.||++.|+++.
T Consensus 259 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~ 317 (322)
T 3soc_A 259 LEDMQEVVVHKKKR-----PVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQ 317 (322)
T ss_dssp HHHHHHHHTTSCCC-----CCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhhhhhhhcccCC-----CCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11111111111111 111110 12234556899999999999999999999999998643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=363.77 Aligned_cols=252 Identities=17% Similarity=0.257 Sum_probs=208.7
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.++|...+.||+|+||.||+|+. .+++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 46788999999999999999994 568899999987543 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC--CCCeEEcccCccccCcccCc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK--DLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~--~~~~kl~DfGla~~~~~~~~ 548 (733)
+++|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.......
T Consensus 83 ~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999999776668999999999999999999999996 999999999999987 78999999999987654322
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||............. ... .. .+......
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~~-~~--~~~~~~~~-- 229 (321)
T 1tki_A 160 --FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM---NAE-YT--FDEEAFKE-- 229 (321)
T ss_dssp --EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---HTC-CC--CCHHHHTT--
T ss_pred --cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH---cCC-CC--CChhhhcc--
Confidence 234679999999999998889999999999999999999999997665544332211 111 00 00000001
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+.+++.+|++.||.+|||+.|+++.
T Consensus 230 --~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 230 --ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp --SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --CCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 12358899999999999999999999874
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=374.67 Aligned_cols=259 Identities=28% Similarity=0.414 Sum_probs=210.8
Q ss_pred hcCccccCcccCCCcccEEEcccC------CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
.++|...+.||+|+||+||+|++. +++.||||++... .......+.+|+.++++++|||||++++++.++...
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 457888899999999999999843 4678999999654 344556789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC---CeEEc
Q 004732 465 LLIYEYLENNSLARALFEHR------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSKIS 535 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl~ 535 (733)
++||||+++|+|.+++.... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997543 45899999999999999999999996 99999999999999555 59999
Q ss_pred ccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhC
Q 004732 536 DFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQG 613 (733)
Q Consensus 536 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 613 (733)
|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i----~~~ 302 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV----TSG 302 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH----HTT
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcC
Confidence 9999975433222 22334568999999999999999999999999999999998 99999766554443322 111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004732 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 666 (733)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 666 (733)
.... ..... ...+.+++.+||+.||.+||++.+|++.|+.....
T Consensus 303 ~~~~-----~~~~~----~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 303 GRMD-----PPKNC----PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp CCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCC-----CCccC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111 11122 23488999999999999999999999999865443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=387.80 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=215.6
Q ss_pred HhhhcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
+....+|...+.||+|+||.||+|++. ++..||||.+.... ...+.|.+|++++++++|||||+++++|.+++..++|
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 344567888999999999999999965 48899999997643 3467899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 468 YEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
|||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 9999999999999853 456899999999999999999999986 999999999999999999999999999876544
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.........+++.|+|||.+....++.++|||||||++|||++ |+.||...+........ ..+....
T Consensus 372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~-------- 439 (495)
T 1opk_A 372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL----EKDYRME-------- 439 (495)
T ss_dssp CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH----HTTCCCC--------
T ss_pred ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCC--------
Confidence 3333344557889999999999999999999999999999999 99999765544433221 1111111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.+......+.+++.+||+.||.+|||+.+|++.|+...
T Consensus 440 -~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 440 -RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 11112245889999999999999999999999999654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=355.51 Aligned_cols=261 Identities=20% Similarity=0.255 Sum_probs=211.8
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|...+.||+|+||.||+|+ ..+|+.||||.+..... ...+.+|+++++.+ +|+|++++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 4578899999999999999999 46799999999865432 24678899999999 79999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC-----eEEcccCccccCc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN-----SKISDFGLAKLDE 544 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~-----~kl~DfGla~~~~ 544 (733)
|+ +++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+++...
T Consensus 87 ~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~ 162 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 162 (298)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccc
Confidence 99 99999999877778999999999999999999999986 999999999999987776 9999999998665
Q ss_pred ccCcc------cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccch---hhHHHHHHHHHhhCcc
Q 004732 545 EENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM---FYLLDWALVLKEQGKL 615 (733)
Q Consensus 545 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~ 615 (733)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ................
T Consensus 163 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 163 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 43221 23456799999999999999999999999999999999999999965322 1111111111111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
.... ..++ ..+.+++.+||+.||++||++.+|++.|+.+....
T Consensus 243 ~~~~-----~~~~----~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 243 RELC-----AGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp HHHT-----TTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHH-----hhCc----HHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 1111 1122 34889999999999999999999999999765544
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-42 Score=375.86 Aligned_cols=262 Identities=20% Similarity=0.227 Sum_probs=212.4
Q ss_pred hhhHHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEe
Q 004732 385 YLQIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIE 460 (733)
Q Consensus 385 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 460 (733)
+.+.+...++|...+.||+|+||+||+|+. .+|+.||||++.+.. ......+.+|..++..++||||++++++|.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 445667789999999999999999999995 579999999986431 1223457889999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 461 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 461 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
++..++||||+++|+|.+++...+..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999999876668999999999999999999999986 999999999999999999999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhh-------CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMR-------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 613 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 613 (733)
+.............+||+.|+|||++.. ..++.++|||||||++|||++|+.||...+...............
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~ 289 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHL 289 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCc
Confidence 8766544444445789999999999973 568999999999999999999999997765544332221111111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCC---CCHHHHHHH
Q 004732 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIR---PSMSSVLRM 659 (733)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R---Pt~~~vl~~ 659 (733)
.. +...... ...+.+++.+|++ +|.+| |++.|+++.
T Consensus 290 ~~-----p~~~~~~----s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 290 SL-----PLVDEGV----PEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp CC-----C----CC----CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred CC-----CccccCC----CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 11 1001122 2348899999999 99998 589998653
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=367.63 Aligned_cols=256 Identities=26% Similarity=0.438 Sum_probs=203.0
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCc----EEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGT----AIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
.++|+..+.||+|+||+||+|+. .+++ +||+|.+... .....+.|.+|++++++++||||++++++|.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 35678889999999999999984 4454 3688887543 3345678999999999999999999999998765 78
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+|+||+.+|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999999887778999999999999999999999996 99999999999999999999999999986544
Q ss_pred cCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 546 ENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 546 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.... ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~----~~~~~~------- 238 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EKGERL------- 238 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTCCC-------
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH----HcCCCC-------
Confidence 3322 2334557889999999999999999999999999999999 99999665544433221 111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
..+......+.+++.+||+.+|.+||++.++++.|+...
T Consensus 239 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 239 --PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp --CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred --CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 111122335889999999999999999999999988543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=365.95 Aligned_cols=253 Identities=23% Similarity=0.308 Sum_probs=210.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.++|...+.||+|+||.||+|+. .+|+.||+|.+..........+.+|+++++.++||||+++++++.++...++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 46788999999999999999984 57899999999766555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC--CCCeEEcccCccccCcccCc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK--DLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~--~~~~kl~DfGla~~~~~~~~ 548 (733)
+++|+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.......
T Consensus 130 ~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 130 LSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp CCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred CCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 9999999999766668999999999999999999999986 999999999999974 46799999999987654322
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... ... .. .+.......
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~---~~~-~~--~~~~~~~~~- 277 (387)
T 1kob_A 207 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK---RCD-WE--FDEDAFSSV- 277 (387)
T ss_dssp --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---HCC-CC--CCSSTTTTS-
T ss_pred --eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH---hCC-CC--CCccccccC-
Confidence 233579999999999999899999999999999999999999997765443332211 111 00 111111122
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+.+++.+||+.||++|||+.|+++.
T Consensus 278 ---s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 278 ---SPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ---CHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 2348899999999999999999999874
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-42 Score=360.82 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=204.7
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|...+.||+|+||+||+|+..+|+.||||++.... ......+.+|++++++++||||+++++++.++...++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 46788889999999999999998889999999986542 2224678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++ +|.+.+......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 100 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~- 174 (311)
T 3niz_A 100 FMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR- 174 (311)
T ss_dssp CCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred CCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcc-
Confidence 9985 888888777777999999999999999999999996 99999999999999999999999999986543322
Q ss_pred cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccc----------
Q 004732 550 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL---------- 618 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------- 618 (733)
......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||........................
T Consensus 175 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 254 (311)
T 3niz_A 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK 254 (311)
T ss_dssp ---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence 2234578999999999976 56899999999999999999999999655444433322221111110000
Q ss_pred ------ccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 619 ------VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 619 ------~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
................+.+++.+|++.||++|||+.|+++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000000000111235789999999999999999999987
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=366.86 Aligned_cols=263 Identities=29% Similarity=0.462 Sum_probs=215.2
Q ss_pred hHHhhhcCccccCcccCCCcccEEEcccC------CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEE
Q 004732 387 QIKAATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCI 459 (733)
Q Consensus 387 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 459 (733)
.+....++|...+.||+|+||.||+|+.. +++.||||.+... .....+.+.+|++++++++||||++++++|.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34456688999999999999999999853 4588999999764 3334567999999999999999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeec
Q 004732 460 EGNQLLLIYEYLENNSLARALFEHR-----------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516 (733)
Q Consensus 460 ~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH 516 (733)
+++..++||||+++|+|.+++.... ..+++.+++.++.||++||+|||+.+ |+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence 9999999999999999999997532 57999999999999999999999996 999
Q ss_pred CCCCCCcEEecCCCCeEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCC
Q 004732 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNV 594 (733)
Q Consensus 517 ~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~ 594 (733)
|||||+||+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999976543322 22334568899999999999999999999999999999999 99999
Q ss_pred CccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 595 TKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 595 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
............ ..+..... ...+ ...+.+++.+||+.||++||++.++++.|+++.+
T Consensus 278 ~~~~~~~~~~~~----~~~~~~~~-----~~~~----~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 278 YGMAHEEVIYYV----RDGNILAC-----PENC----PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTSCHHHHHHHH----HTTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCChHHHHHHH----hCCCcCCC-----CCCC----CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 765544333221 12221111 1122 2358899999999999999999999999997655
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=363.05 Aligned_cols=249 Identities=26% Similarity=0.312 Sum_probs=206.8
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||+||+|+. .+|+.||||.+... .......+.+|+++++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 35788899999999999999994 57899999998653 233456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence 9999999999998754 47899999999999999999999996 9999999999999999999999999998543222
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ .. ... ......
T Consensus 160 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---~~-~~~------~~p~~~ 228 (337)
T 1o6l_A 160 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI---LM-EEI------RFPRTL 228 (337)
T ss_dssp -CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-CCC------CCCTTS
T ss_pred -CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHH---Hc-CCC------CCCCCC
Confidence 2234567999999999999989999999999999999999999999766544333211 11 111 011112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRP-----SMSSVLRM 659 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~~ 659 (733)
...+.+++.+||+.||++|| ++.|+++.
T Consensus 229 ----s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 229 ----SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 23588999999999999999 89998653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=381.77 Aligned_cols=261 Identities=29% Similarity=0.449 Sum_probs=209.0
Q ss_pred hhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
...++|...+.||+|+||.||+|++.++..||||.+.... ...+.|.+|++++++++||||+++++++.+ +..++|||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3456788899999999999999998888889999997643 345789999999999999999999999876 67899999
Q ss_pred ccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 470 YLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
|+++|+|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 335 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 335 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCce
Confidence 9999999999974 3356999999999999999999999986 99999999999999999999999999987654333
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.......+++.|+|||.+....++.++|||||||++|||++ |+.||............ ..+.... .
T Consensus 336 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~~~~~~~---------~ 402 (452)
T 1fmk_A 336 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV----ERGYRMP---------C 402 (452)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTTCCCC---------C
T ss_pred ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCC---------C
Confidence 33334557889999999999999999999999999999999 99999765544333221 1121111 1
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccccc
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLD 668 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~~ 668 (733)
+......+.+++.+||+.||++|||+.+|++.|+.+....+
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~ 443 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 443 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence 11223458899999999999999999999999997765443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=374.71 Aligned_cols=259 Identities=20% Similarity=0.276 Sum_probs=212.2
Q ss_pred hhHHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004732 386 LQIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEG 461 (733)
Q Consensus 386 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 461 (733)
.+++...++|...+.||+|+||+||+|+. .+++.||+|++.... ......+.+|+.+++.++|||||+++++|.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 45666788999999999999999999995 468999999986421 12224578999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 462 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
+..++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999999998653 6899999999999999999999996 9999999999999999999999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhhCC----CCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccc
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRGH----LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME 617 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 617 (733)
.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..............-.
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~--- 293 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT--- 293 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC---
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcccccc---
Confidence 76655444445678999999999998755 78999999999999999999999977665444332211111111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCC--CCCHHHHHHH
Q 004732 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTI--RPSMSSVLRM 659 (733)
Q Consensus 618 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~--RPt~~~vl~~ 659 (733)
... ....+ ..+.+++.+|++.+|.+ ||++.||++.
T Consensus 294 ~p~---~~~~s----~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 294 FPD---DNDIS----KEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp CCT---TCCCC----HHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred CCC---ccccc----HHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 100 11222 34888999999999988 9999999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-42 Score=355.06 Aligned_cols=257 Identities=26% Similarity=0.374 Sum_probs=198.6
Q ss_pred hhcCccccCcccCCCcccEEEcccC----CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
..++|...+.||+|+||.||+|+.. .+..||+|.+... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 3457888899999999999999853 2457999998654 3334567899999999999999999999984 56789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||+++|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999999877778999999999999999999999986 99999999999999999999999999987655
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
..........+|+.|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+.... ..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----~~~~~~~-----~~ 239 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGERLP-----MP 239 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTCCCC-----CC
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH----HcCCCCC-----CC
Confidence 44333344567889999999999999999999999999999997 99999665544433221 1111111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
... ...+.+++.+||+.||++||++.|+++.|+.+.
T Consensus 240 ~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 275 (281)
T 1mp8_A 240 PNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 275 (281)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 122 235888999999999999999999999998543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=352.50 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=213.4
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
++|...+.||+|+||.||+|+..+++.||+|.+.... ...+.+.+|++++++++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5678889999999999999998888999999997643 234689999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+++|.+++......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...........
T Consensus 87 ~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 87 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp TCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99999999877678999999999999999999999996 999999999999999999999999999866543333333
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
...|++.|+|||.+.+..++.++||||||+++|||++ |+.||............ . .+.. .......
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i---~-~~~~-----~~~~~~~---- 230 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---S-TGFR-----LYKPRLA---- 230 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---H-TTCC-----CCCCTTS----
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH---h-cCCc-----CCCCccC----
Confidence 4567889999999999999999999999999999999 89999765544333211 1 1111 0011112
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
...+.+++.+||+.+|++||++.++++.|+++.
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~ 263 (267)
T 3t9t_A 231 STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIA 263 (267)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 234888999999999999999999999998643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=364.34 Aligned_cols=252 Identities=22% Similarity=0.286 Sum_probs=206.9
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChh------cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ------GNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
.+.|...+.||+|+||.||+|+. .+|+.||||.+...... ..+.+.+|+.++++++||||+++++++.++...
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 45788999999999999999994 57899999998654221 346789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC----CeEEcccCcc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL----NSKISDFGLA 540 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~----~~kl~DfGla 540 (733)
++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999654 47999999999999999999999986 99999999999998877 7999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccccc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... . ... . .+
T Consensus 167 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~---~-~~~-~-~~ 238 (361)
T 2yab_A 167 HEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT---A-VSY-D-FD 238 (361)
T ss_dssp EECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH---T-TCC-C-CC
T ss_pred eEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h-cCC-C-CC
Confidence 8665432 2244679999999999999899999999999999999999999997765544332111 1 100 0 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...... ....+.+++.+|+..||.+|||+.|+++.
T Consensus 239 ~~~~~~----~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 239 EEFFSQ----TSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp HHHHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhccC----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000011 12358899999999999999999999863
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=365.93 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=201.2
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 465 (733)
..++|...+.||+|+||+||+|+. .+|+.||||++... .......+.+|.++++.+ +||||+++++++.+++..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 346888999999999999999994 57899999998653 223446688899999988 6999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 101 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999999754 47999999999999999999999996 99999999999999999999999999985332
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... . +..
T Consensus 177 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~---~-~~~---------- 241 (353)
T 3txo_A 177 NG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL---N-DEV---------- 241 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H-CCC----------
T ss_pred CC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH---c-CCC----------
Confidence 22 22345689999999999999899999999999999999999999997766544432211 1 111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCH------HHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSM------SSVLR 658 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~------~~vl~ 658 (733)
.++......+.+++.+|++.||.+||++ .|+++
T Consensus 242 ~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 0111122347889999999999999998 66654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=370.69 Aligned_cols=262 Identities=26% Similarity=0.380 Sum_probs=209.7
Q ss_pred HHhhhcCccccCcccCCCcccEEEcc------cCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEE
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGL------LADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCI 459 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 459 (733)
.....++|...+.||+|+||.||+|+ ..+++.||||++.... ....+.+.+|+++++++ +|||||+++++|.
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 34556789999999999999999996 3456899999997643 33456799999999999 7999999999998
Q ss_pred eCC-eEEEEEEccCCCCHHHHHHhcCC-----------------------------------------------------
Q 004732 460 EGN-QLLLIYEYLENNSLARALFEHRL----------------------------------------------------- 485 (733)
Q Consensus 460 ~~~-~~~lV~e~~~~gsL~~~l~~~~~----------------------------------------------------- 485 (733)
+.+ ..++||||+++|+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 765 48999999999999999975432
Q ss_pred ------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc-cccc
Q 004732 486 ------------KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-HIST 552 (733)
Q Consensus 486 ------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~ 552 (733)
.+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ....
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 2899999999999999999999996 99999999999999999999999999986543322 2334
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
...||+.|+|||++.+..++.++|||||||++|||++ |+.||.......... ... ..+..... ....+
T Consensus 254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--~~~-~~~~~~~~-----~~~~~--- 322 (359)
T 3vhe_A 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--RRL-KEGTRMRA-----PDYTT--- 322 (359)
T ss_dssp -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH--HHH-HHTCCCCC-----CTTCC---
T ss_pred ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH--HHH-HcCCCCCC-----CCCCC---
Confidence 5678999999999999999999999999999999998 999996543222111 111 11111111 11122
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
..+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 323 -~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 354 (359)
T 3vhe_A 323 -PEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 354 (359)
T ss_dssp -HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 34888999999999999999999999998643
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=370.57 Aligned_cols=262 Identities=29% Similarity=0.430 Sum_probs=214.5
Q ss_pred hhhcCccccCcccCCCcccEEEccc--------CCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL--------ADGTAIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCI 459 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 459 (733)
...++|...+.||+|+||.||+|+. ..+..||||++... .......+.+|+++++++ +|||||+++++|.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 3456788899999999999999974 23467999998764 334457789999999999 9999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcE
Q 004732 460 EGNQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNV 524 (733)
Q Consensus 460 ~~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Ni 524 (733)
+++..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 9999999999999999999998543 35999999999999999999999996 99999999999
Q ss_pred EecCCCCeEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhH
Q 004732 525 LLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYL 602 (733)
Q Consensus 525 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~ 602 (733)
|++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||........
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999986654332 22334567889999999999999999999999999999999 9999976654443
Q ss_pred HHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 603 LDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
.... ..+..... .... ...+.+++.+||+.||++||++.||++.|+++....
T Consensus 303 ~~~~----~~~~~~~~-----~~~~----~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 303 FKLL----KEGHRMDK-----PSNC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp HHHH----HTTCCCCC-----CSSC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred HHHH----HcCCCCCC-----CccC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 3222 11111111 1122 234889999999999999999999999999766544
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-42 Score=352.11 Aligned_cols=253 Identities=28% Similarity=0.458 Sum_probs=197.3
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccCh----hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK----QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+.. |+.||||.+..... ...+.+.+|+++++.++||||+++++++.+++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 457888999999999999999875 88999999865422 2346789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC--------CCCeEEcccCc
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK--------DLNSKISDFGL 539 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~--------~~~~kl~DfGl 539 (733)
|||+++++|.+++. ...+++..++.++.|+++||+|||+.+..+|+||||||+||+++. ++.+||+|||+
T Consensus 85 ~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 85 MEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 99999999999885 347999999999999999999999986555999999999999986 67899999999
Q ss_pred cccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccc
Q 004732 540 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 619 (733)
Q Consensus 540 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (733)
++....... ....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+........ .......
T Consensus 163 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~--- 233 (271)
T 3dtc_A 163 AREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV---AMNKLAL--- 233 (271)
T ss_dssp ----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH---HTSCCCC---
T ss_pred ccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh---hcCCCCC---
Confidence 986543322 2456899999999999999999999999999999999999999765443322111 1111111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 620 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
...... ...+.+++.+||+.||.+|||+.|+++.|+.
T Consensus 234 --~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 234 --PIPSTC----PEPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp --CCCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred --CCCccc----CHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 111122 2358899999999999999999999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=354.53 Aligned_cols=262 Identities=27% Similarity=0.356 Sum_probs=203.1
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccCh--hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++|...+.||+|+||+||+|+..+|+.||||++..... .....+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 46788899999999999999988899999999865432 2236788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+++ +|.+++......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 156 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc-c
Confidence 986 899998876678999999999999999999999996 99999999999999999999999999976543221 2
Q ss_pred ccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc------ccc--ccC
Q 004732 551 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL------MEL--VDT 621 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~--~~~ 621 (733)
.....||+.|+|||.+.+. .++.++||||+||++|||++|+.||..................... .+. .++
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 1ob3_A 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (288)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence 2345689999999999764 5899999999999999999999999765544333222211111000 000 000
Q ss_pred CCC-------CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 622 NPG-------SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 622 ~~~-------~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00011123457899999999999999999999763
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=358.60 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=206.1
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh------hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK------QGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
.++|...+.||+|+||.||+|+. .+|+.||||.+..... ...+.+.+|+.++++++||||+++++++.++...
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 35678889999999999999994 5789999999865422 1357899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC----CeEEcccCcc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL----NSKISDFGLA 540 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~----~~kl~DfGla 540 (733)
++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999999643 57999999999999999999999986 99999999999999887 7999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccccc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
+....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||............. ..........
T Consensus 166 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~--~~~~~~~~~~- 240 (326)
T 2y0a_A 166 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVNYEFEDEY- 240 (326)
T ss_dssp EECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--HTCCCCCHHH-
T ss_pred eECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH--hcCCCcCccc-
Confidence 86643322 234679999999999998899999999999999999999999997655443332111 0000000000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
... ....+.+++.+||+.||++|||+.|+++.
T Consensus 241 ---~~~----~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 241 ---FSN----TSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp ---HTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---ccc----CCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001 12347899999999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=365.73 Aligned_cols=248 Identities=24% Similarity=0.312 Sum_probs=200.8
Q ss_pred ccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCCCC
Q 004732 397 TDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNS 475 (733)
Q Consensus 397 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs 475 (733)
..+.||+|+||.||+|+ ..+|+.||+|++........+.+.+|++++++++||||+++++++.+++..++||||+++|+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~ 172 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE 172 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence 35689999999999998 46799999999987665666789999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe--cCCCCeEEcccCccccCcccCcccccc
Q 004732 476 LARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL--DKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 476 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill--~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
|.+++......+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++....... ...
T Consensus 173 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~ 247 (373)
T 2x4f_A 173 LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV 247 (373)
T ss_dssp EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence 99999877678999999999999999999999996 9999999999999 5677899999999987654332 234
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHH
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (733)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ ...... ... .....+ ..
T Consensus 248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i---~~~~~~--~~~-~~~~~~----~~ 317 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI---LACRWD--LED-EEFQDI----SE 317 (373)
T ss_dssp CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HHTCCC--SCS-GGGTTS----CH
T ss_pred ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HhccCC--CCh-hhhccC----CH
Confidence 56999999999999888999999999999999999999999766544332211 111110 000 000112 23
Q ss_pred HHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 634 VMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 634 ~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+.+++.+|++.||.+||++.|+++.
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 58899999999999999999999873
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=353.65 Aligned_cols=265 Identities=19% Similarity=0.241 Sum_probs=209.8
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC--eEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGN--QLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 467 (733)
.++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.... ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 35678889999999999999995 468999999987543 334577889999999999999999999998765 78999
Q ss_pred EEccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe----cCCCCeEEcccCccc
Q 004732 468 YEYLENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL----DKDLNSKISDFGLAK 541 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill----~~~~~~kl~DfGla~ 541 (733)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999997533 34999999999999999999999996 9999999999999 788889999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHh--------hCCCCccchhHhHHHHHHHHHhCCCCCCccch-hhHHHHHHHHHhh
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAM--------RGHLTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLDWALVLKEQ 612 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~-~~~~~~~~~~~~~ 612 (733)
....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||..... .............
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 6654332 23457999999999987 46789999999999999999999999943221 1111111111111
Q ss_pred Cc---ccccc-----------cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 613 GK---LMELV-----------DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 613 ~~---~~~~~-----------~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
.. ..... ...............+.+++.+|++.||++|||+.|+++...
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 11 00000 011122445677778999999999999999999999998876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=355.58 Aligned_cols=261 Identities=24% Similarity=0.412 Sum_probs=217.2
Q ss_pred hHHhhhcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 387 QIKAATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 387 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
+.....++|...+.||+|+||.||+|+.. ++..||||.+.... ...+.+.+|++++++++||||+++++++.+++..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 33456678899999999999999999954 58899999987543 34578899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 466 LIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999753 456999999999999999999999986 9999999999999999999999999998766
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
...........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+......... ..... ..
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~----~~~~~-----~~ 233 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE----KDYRM-----ER 233 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH----TTCCC-----CC
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh----ccCCC-----CC
Confidence 554444455667889999999999999999999999999999999 999996655444332211 11111 11
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.... ...+.+++.+|++.||.+||++.++++.|+...
T Consensus 234 ~~~~----~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~ 270 (288)
T 3kfa_A 234 PEGC----PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270 (288)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence 1122 245889999999999999999999999998543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=355.27 Aligned_cols=259 Identities=26% Similarity=0.405 Sum_probs=201.1
Q ss_pred hhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHh--CCCCceeeEeeEEEeC----CeE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISA--LQHPNLVKLYGCCIEG----NQL 464 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~----~~~ 464 (733)
..++|...+.||+|+||+||+|+. +|+.||||++... ....+.+|.+++.. ++||||+++++++.+. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 346788999999999999999987 6899999998643 34566777777776 7999999999997653 458
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeecCCCCCCcEEecCCCCeEEcc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH--------GESRIKVVHRDIKATNVLLDKDLNSKISD 536 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~Dik~~Nill~~~~~~kl~D 536 (733)
++||||+++|+|.+++.. ..+++..+++++.|++.||+||| +.+ |+||||||+|||++.++.+||+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D 156 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD 156 (301)
T ss_dssp EEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred EEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence 999999999999999953 47999999999999999999999 664 99999999999999999999999
Q ss_pred cCccccCcccCccc---ccccccCCCcccHHHHhhC------CCCccchhHhHHHHHHHHHhC----------CCCCCcc
Q 004732 537 FGLAKLDEEENTHI---STRVAGTIGYMAPEYAMRG------HLTEKADVYSFGIVALEIVSG----------RSNVTKE 597 (733)
Q Consensus 537 fGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gvil~elltg----------~~p~~~~ 597 (733)
||+++......... .....||+.|+|||.+.+. .++.++|||||||++|||++| +.||...
T Consensus 157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 99997654433221 2335799999999999876 455799999999999999999 8888432
Q ss_pred ch--hhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 598 DM--FYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 598 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
.. ................... +...........+.+++.+||+.||++|||+.||++.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~ 299 (301)
T 3q4u_A 237 VPNDPSFEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299 (301)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred CCCCcchhhhhHHHhccCCCCCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence 11 1111111111111111111 1111233456679999999999999999999999999984
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=366.22 Aligned_cols=270 Identities=28% Similarity=0.385 Sum_probs=211.9
Q ss_pred cCccccCcccCCCcccEEEccc-----CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEE--eCCeEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI--EGNQLL 465 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~ 465 (733)
++|+..+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5678889999999999999983 468899999998776666678999999999999999999999987 456789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 179 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPL 179 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred EEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence 999999999999999876667999999999999999999999986 99999999999999999999999999987654
Q ss_pred cCcc--cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHH--HHHHhhCcccccccC
Q 004732 546 ENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWA--LVLKEQGKLMELVDT 621 (733)
Q Consensus 546 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 621 (733)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........+. ..........+.+..
T Consensus 180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (327)
T 3lxl_A 180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259 (327)
T ss_dssp TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHT
T ss_pred CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhc
Confidence 3322 233456888999999999999999999999999999999999998544322111000 000000000011111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
......+......+.+++.+||+.||++|||+.|+++.|+....
T Consensus 260 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 260 GQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred ccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 11111122233458899999999999999999999999986544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=363.44 Aligned_cols=252 Identities=22% Similarity=0.348 Sum_probs=206.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
.++|...+.||+|+||.||+|+. .+|+.||||.+... .....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45788899999999999999984 57899999998654 2334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC---CeEEcccCccccCcc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSKISDFGLAKLDEE 545 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl~DfGla~~~~~ 545 (733)
||+++|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+++....
T Consensus 108 e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 108 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp CCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred ecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999998654 47899999999999999999999996 99999999999998654 599999999986654
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... . +... ... .
T Consensus 184 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~---~-~~~~-~~~--~-- 252 (362)
T 2bdw_A 184 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK---A-GAYD-YPS--P-- 252 (362)
T ss_dssp CCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H-TCCC-CCT--T--
T ss_pred Ccc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---h-CCCC-CCc--c--
Confidence 322 234679999999999999899999999999999999999999997765544332221 1 1110 000 0
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
........+.+++.+||+.||++||++.|+++.
T Consensus 253 -~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 253 -EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 001122358899999999999999999999764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.55 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=204.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcE----EEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTA----IAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
.++|...+.||+|+||+||+|+. .+++. ||+|.+.... ......+.+|+.++++++||||++++++|. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 35788889999999999999984 44554 7888775432 223356788999999999999999999986 56689
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||+.+|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999999876668999999999999999999999996 99999999999999999999999999987654
Q ss_pred cCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 546 ENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 546 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.... ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+........
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~-- 241 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL----EKGERLAQPQI-- 241 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHH----HTTCBCCCCTT--
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHH----HcCCCCCCCCc--
Confidence 4332 2344668889999999999999999999999999999999 99999765444333221 11111111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
....+.+++.+||+.||.+||++.++++.|+...
T Consensus 242 -------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 242 -------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp -------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred -------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1113778999999999999999999999998543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=371.18 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=206.8
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
..++|...+.||+|+||.||+|+ ..+|+.||+|.+.... ....+.+.+|+++++.++|||||++++++.+++..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 35678889999999999999998 5678999999986543 23346789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec---CCCCeEEcccCccccCc
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD---KDLNSKISDFGLAKLDE 544 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~---~~~~~kl~DfGla~~~~ 544 (733)
|||+++|+|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++...
T Consensus 89 ~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~ 164 (444)
T 3soa_A 89 FDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE 164 (444)
T ss_dssp ECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred EEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence 9999999999999765 47999999999999999999999996 99999999999998 45789999999998665
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
.... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+......... .+.. .... ...
T Consensus 165 ~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~----~~~~-~~~~-~~~ 237 (444)
T 3soa_A 165 GEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK----AGAY-DFPS-PEW 237 (444)
T ss_dssp TTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HTCC-CCCT-TTT
T ss_pred CCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH----hCCC-CCCc-ccc
Confidence 4322 2234679999999999999899999999999999999999999997766544433221 1111 0000 011
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
... ...+.+++.+|++.||.+|||+.|+++.
T Consensus 238 ~~~----s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 238 DTV----TPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp TTS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ccC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 122 2348899999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=353.99 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=204.7
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+. .+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 35788889999999999999994 579999999986531 23456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~- 159 (318)
T 1fot_A 85 MDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV- 159 (318)
T ss_dssp ECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred EeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence 9999999999999754 47999999999999999999999986 999999999999999999999999999865432
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ . . ... . ....+
T Consensus 160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i--~-~-~~~-~-----~p~~~ 226 (318)
T 1fot_A 160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI--L-N-AEL-R-----FPPFF 226 (318)
T ss_dssp ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--H-H-CCC-C-----CCTTS
T ss_pred ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--H-h-CCC-C-----CCCCC
Confidence 23467999999999999999999999999999999999999999766544332211 1 1 110 0 11112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRP-----SMSSVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 658 (733)
...+.+++.+|++.||++|| ++.|+++
T Consensus 227 ----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 227 ----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp ----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 23488999999999999999 8888864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=361.72 Aligned_cols=250 Identities=24% Similarity=0.345 Sum_probs=205.1
Q ss_pred HhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCe
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 463 (733)
+...++|...+.||+|+||.||+|+. .+|+.||||.+.... ......+..|.+++..+ +||||+++++++.+++.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34567899999999999999999995 578999999986531 23456678899999877 99999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999999754 47999999999999999999999996 999999999999999999999999999854
Q ss_pred cccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... . ... ..
T Consensus 169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~---~-~~~------~~ 237 (345)
T 1xjd_A 169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR---M-DNP------FY 237 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H-CCC------CC
T ss_pred ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---h-CCC------CC
Confidence 3222 22345789999999999999999999999999999999999999997765544332211 1 110 01
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHH-HHH
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMS-SVL 657 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~-~vl 657 (733)
.... ...+.+++.+|++.||++||++. +|.
T Consensus 238 p~~~----s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 238 PRWL----EKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp CTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred Cccc----CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1112 23588999999999999999997 654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=349.12 Aligned_cols=262 Identities=21% Similarity=0.299 Sum_probs=203.3
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
++|...+.||+|+||+||+|+. .+++.||||++.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 4688889999999999999994 578999999986542 3334678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++ ++.+.+......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 156 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR- 156 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS-
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCccc-
Confidence 9986 566666666678999999999999999999999996 99999999999999999999999999986543322
Q ss_pred cccccccCCCcccHHHHhhCC-CCccchhHhHHHHHHHHHhCCCCCC-ccchhhHHHHHHHHHhhCc---c---cccccC
Q 004732 550 ISTRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNVT-KEDMFYLLDWALVLKEQGK---L---MELVDT 621 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~p~~-~~~~~~~~~~~~~~~~~~~---~---~~~~~~ 621 (733)
......||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+. ..+................ . ....+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 233457899999999998765 8999999999999999999998863 3333332222211111100 0 000000
Q ss_pred C---------CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 622 N---------PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 622 ~---------~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
. ............+.+++.+|++.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 0001111233457899999999999999999999863
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=361.19 Aligned_cols=264 Identities=24% Similarity=0.410 Sum_probs=198.2
Q ss_pred HHhhhcCccccCcccCCCcccEEEcccCC-Cc---EEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGLLAD-GT---AIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG 461 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 461 (733)
.....++|...+.||+|+||.||+|+... +. .||||.+... .....+.+.+|++++++++||||+++++++...
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence 34556789999999999999999998543 32 7999998754 334457899999999999999999999999887
Q ss_pred CeE------EEEEEccCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC
Q 004732 462 NQL------LLIYEYLENNSLARALFEHR-----LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL 530 (733)
Q Consensus 462 ~~~------~lV~e~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 530 (733)
... ++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM 174 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence 665 99999999999999996322 26899999999999999999999996 99999999999999999
Q ss_pred CeEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHH
Q 004732 531 NSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALV 608 (733)
Q Consensus 531 ~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~ 608 (733)
.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||...+........
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~-- 252 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL-- 252 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH--
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH--
Confidence 9999999999865443222 2234557889999999999999999999999999999999 89999765544433221
Q ss_pred HHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 609 LKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
.. +.... .+......+.+++.+||+.||++|||+.++++.|+++....
T Consensus 253 -~~-~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 253 -IG-GNRLK---------QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -HT-TCCCC---------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -hc-CCCCC---------CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 11 11110 11112245889999999999999999999999999766544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=376.21 Aligned_cols=252 Identities=29% Similarity=0.430 Sum_probs=207.2
Q ss_pred hhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-eEEEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN-QLLLIY 468 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~ 468 (733)
...++|...+.||+|+||.||+|.+. |+.||||.++... ..+.|.+|++++++++|||||++++++.+.+ ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 34567888999999999999999875 7899999997643 3478999999999999999999999988765 799999
Q ss_pred EccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 469 EYLENNSLARALFEHRL-KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
||+++|+|.+++..... .+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 99999999999986543 4799999999999999999999996 999999999999999999999999999854322
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
.....+++.|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+...... ..
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i----~~~~~~~~p-----~~ 410 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKGYKMDAP-----DG 410 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH----HTTCCCCCC-----TT
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCCC-----Cc
Confidence 122357889999999999999999999999999999998 99999665444333211 122111111 11
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
+ ...+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 411 ~----~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~ 444 (450)
T 1k9a_A 411 C----PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444 (450)
T ss_dssp C----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 2 235889999999999999999999999998643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=353.50 Aligned_cols=262 Identities=24% Similarity=0.378 Sum_probs=191.4
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|...+.||+|+||.||+|+. .+|+.||||.+.... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 45788999999999999999984 578999999986543 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 470 YLENNSLARALFEHR-----LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~-----~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
|++ |+|.+++.... ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 59999887432 46899999999999999999999986 9999999999999999999999999998654
Q ss_pred ccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc---ccc---
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK---LME--- 617 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~--- 617 (733)
.... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...+................ ...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3322 22345789999999999764 689999999999999999999999976655444332222111100 000
Q ss_pred cc--cCCC----CCCC--------CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 618 LV--DTNP----GSNF--------DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 618 ~~--~~~~----~~~~--------~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.. .+.. .... .......+.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00 0000 0000 0011235889999999999999999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=361.21 Aligned_cols=251 Identities=30% Similarity=0.451 Sum_probs=201.9
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|...+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 46788999999999999999984 478999999986542 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc-
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT- 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~- 548 (733)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 86 YCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999988543 46999999999999999999999986 99999999999999999999999999986543322
Q ss_pred ccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCCccchh--hHHHHHHHHHhhCcccccccCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMF--YLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.......||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... ....|. ...... ...
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~----~~~~~~-----~~~- 231 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKKTYL-----NPW- 231 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHH----TTCTTS-----TTG-
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh----cccccC-----Ccc-
Confidence 22345679999999999988765 77999999999999999999999654332 111111 111100 000
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......+.+++.+||+.||++|||+.|+++.
T Consensus 232 ---~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 232 ---KKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---ccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1122347889999999999999999999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=359.61 Aligned_cols=258 Identities=32% Similarity=0.465 Sum_probs=211.6
Q ss_pred hhcCccccCcccCCCcccEEEccc------CCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 463 (733)
..++|...+.||+|+||.||+|+. .+++.||||.+... .....+.+.+|++++++++||||+++++++.+++.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 456788899999999999999974 34588999999754 33445778999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCC
Q 004732 464 LLLIYEYLENNSLARALFEHR-----------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIK 520 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik 520 (733)
.++||||+++|+|.+++.... ..+++.+++.++.|+++||+|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 999999999999999997543 24899999999999999999999996 9999999
Q ss_pred CCcEEecCCCCeEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccc
Q 004732 521 ATNVLLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKED 598 (733)
Q Consensus 521 ~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~ 598 (733)
|+||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999866543322 2334567889999999999999999999999999999999 999996655
Q ss_pred hhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 599 MFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
........ ..+.... ....+ ...+.+++.+||+.||++||++.++++.|+++.
T Consensus 258 ~~~~~~~~----~~~~~~~-----~~~~~----~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~ 310 (314)
T 2ivs_A 258 PERLFNLL----KTGHRME-----RPDNC----SEEMYRLMLQCWKQEPDKRPVFADISKDLEKMM 310 (314)
T ss_dssp GGGHHHHH----HTTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHh----hcCCcCC-----CCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 44333221 1111111 11122 235889999999999999999999999998653
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=350.91 Aligned_cols=258 Identities=31% Similarity=0.458 Sum_probs=211.8
Q ss_pred hhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
...++|...+.||+|+||.||+|...++..||||.+.... ...+.+.+|++++++++||||+++++++. ++..++|||
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 3456788999999999999999998888899999986543 34578999999999999999999999986 456899999
Q ss_pred ccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 470 YLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
|+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCccc
Confidence 99999999998643 236999999999999999999999996 99999999999999999999999999987655443
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.......+++.|+|||.+.+..++.++||||||+++|||++ |+.||............ ..+... ......
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~----~~~~~~-----~~~~~~ 235 (279)
T 1qpc_A 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRM-----VRPDNC 235 (279)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTTCCC-----CCCTTC
T ss_pred ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH----hcccCC-----CCcccc
Confidence 33344567889999999998899999999999999999999 89999665543332211 111111 111122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
...+.+++.+|++.+|++|||+.++++.|+....
T Consensus 236 ----~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 236 ----PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 2358899999999999999999999999986544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=359.35 Aligned_cols=251 Identities=22% Similarity=0.331 Sum_probs=202.3
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-----hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-----KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
+.|...+.||+|+||.||+|+ ..+|+.||||++.... ....+.+.+|+++++.++||||+++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 467888999999999999998 4578999999985421 1235789999999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC---eEEcccCcc
Q 004732 467 IYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFGLA 540 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~---~kl~DfGla 540 (733)
||||+++|+|.+.+.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 9999999999988863 2346899999999999999999999996 999999999999987655 999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccccc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
+....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ... . ... +... ..
T Consensus 181 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~--~-i~~-~~~~--~~ 252 (351)
T 3c0i_A 181 IQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFE--G-IIK-GKYK--MN 252 (351)
T ss_dssp EECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-HHH--H-HHH-TCCC--CC
T ss_pred eEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-HHH--H-HHc-CCCC--CC
Confidence 86654322 233467999999999999989999999999999999999999999764321 111 1 111 1110 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+...... ...+.+++.+||+.||++|||+.|+++
T Consensus 253 ~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 253 PRQWSHI----SESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp HHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccC----CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0000111 235889999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=358.09 Aligned_cols=263 Identities=19% Similarity=0.242 Sum_probs=200.2
Q ss_pred hcCccccCcccCCCcccEEEcccC----CCcEEEEEEccccChh-----------cHHHHHHHHHHHHhCCCCceeeEee
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSKSKQ-----------GNREFINEIGMISALQHPNLVKLYG 456 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~ 456 (733)
.++|...+.||+|+||.||+|+.. ++..||||.+...... ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 357888999999999999999954 6789999998654321 1134677889999999999999999
Q ss_pred EEEe----CCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC--
Q 004732 457 CCIE----GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-- 530 (733)
Q Consensus 457 ~~~~----~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-- 530 (733)
++.+ +...++||||+ +++|.+++.... .+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence 9988 78899999999 999999987554 8999999999999999999999986 99999999999999887
Q ss_pred CeEEcccCccccCcccCcc------cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCcc--chhhH
Q 004732 531 NSKISDFGLAKLDEEENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE--DMFYL 602 (733)
Q Consensus 531 ~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~--~~~~~ 602 (733)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||... +....
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~ 270 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV 270 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence 9999999999866433211 124467999999999999999999999999999999999999999542 22212
Q ss_pred HHHHHHHHhhCcccccc-cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 603 LDWALVLKEQGKLMELV-DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 603 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
........ . .....+ .......++ ..+.+++.+||+.||++||++.+|++.|+...-
T Consensus 271 ~~~~~~~~-~-~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 271 QTAKTNLL-D-ELPQSVLKWAPSGSSC----CEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHHHHHHH-H-TTTHHHHHHSCTTSCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHHHHhhc-c-cccHHHHhhccccccH----HHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 11111111 1 111111 101111222 348899999999999999999999999996543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=363.94 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=209.2
Q ss_pred HhhhcCccccCcccCCCcccEEEccc------CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEe
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIE 460 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 460 (733)
....++|...+.||+|+||.||+|+. .++..||||.+.... ......+.+|+.+++++ +||||+++++++.+
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 120 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 120 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence 34567889999999999999999984 245689999987542 23346789999999999 89999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCC
Q 004732 461 GNQLLLIYEYLENNSLARALFEHRL----------------------KLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518 (733)
Q Consensus 461 ~~~~~lV~e~~~~gsL~~~l~~~~~----------------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~D 518 (733)
++..++||||+++|+|.+++..... .+++..++.++.||++||+|||+.+ |+|||
T Consensus 121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D 197 (344)
T 1rjb_A 121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 197 (344)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence 9999999999999999999975432 3799999999999999999999986 99999
Q ss_pred CCCCcEEecCCCCeEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCc
Q 004732 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTK 596 (733)
Q Consensus 519 ik~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~ 596 (733)
|||+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 9999999999999999999999866543322 2334567889999999999999999999999999999998 9999965
Q ss_pred cchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 597 EDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
........ .....+.... ..... ...+.+++.+||+.||.+||++.++++.|+....
T Consensus 278 ~~~~~~~~---~~~~~~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 334 (344)
T 1rjb_A 278 IPVDANFY---KLIQNGFKMD-----QPFYA----TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA 334 (344)
T ss_dssp CCCSHHHH---HHHHTTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred CCcHHHHH---HHHhcCCCCC-----CCCCC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 43222111 1111111110 11112 2358889999999999999999999999986544
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=349.78 Aligned_cols=257 Identities=26% Similarity=0.376 Sum_probs=206.3
Q ss_pred hhcCccccCcccCCCcccEEEcccCC----CcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLAD----GTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
..++|...+.||+|+||.||+|+... +..||||.+... .....+.+.+|++++++++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45678889999999999999998432 346999998765 33445789999999999999999999999765 4568
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||+++++|.+++......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999999877677999999999999999999999986 99999999999999999999999999987655
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||............ . .+.... ..
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~---~-~~~~~~-----~~ 236 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL---E-KGDRLP-----KP 236 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH---H-HTCCCC-----CC
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHH---h-cCCCCC-----CC
Confidence 44333445567889999999999999999999999999999998 99999654443333211 1 111111 11
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
... ...+.+++.+||+.||++||++.|+++.|+...
T Consensus 237 ~~~----~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~ 272 (281)
T 3cc6_A 237 DLC----PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY 272 (281)
T ss_dssp TTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCC----CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence 112 234889999999999999999999999998543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=384.65 Aligned_cols=261 Identities=29% Similarity=0.448 Sum_probs=215.0
Q ss_pred hhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
...++|...+.||+|+||.||+|++.++..||||+++... ...+.|.+|+++|++++|||||++++++.+ +..++|||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 4456788899999999999999998888889999997643 345789999999999999999999999876 67899999
Q ss_pred ccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 470 YLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
|+++|+|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 418 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 418 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence 9999999999974 3356999999999999999999999986 99999999999999999999999999987654322
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.......+++.|+|||.+....++.++|||||||++|||++ |+.||............ ..+.....
T Consensus 419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i----~~~~~~~~--------- 485 (535)
T 2h8h_A 419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV----ERGYRMPC--------- 485 (535)
T ss_dssp HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH----HTTCCCCC---------
T ss_pred ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCC---------
Confidence 22334457889999999999999999999999999999999 99999765544333221 11211111
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccccc
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLD 668 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~~ 668 (733)
+......+.+++.+||+.||++|||+.+|++.|+.+....+
T Consensus 486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~ 526 (535)
T 2h8h_A 486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 526 (535)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence 11123358899999999999999999999999997765443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=360.03 Aligned_cols=258 Identities=26% Similarity=0.395 Sum_probs=205.9
Q ss_pred cCccccCcccCCCcccEEEcc-----cCCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-----LADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQL 464 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 464 (733)
+.|+..+.||+|+||.||+|+ ..+++.||||++... .......+.+|++++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 357788899999999999998 346899999998754 233457889999999999999999999999876 668
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||+++|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 177 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccccc
Confidence 9999999999999999777678999999999999999999999996 9999999999999999999999999998765
Q ss_pred ccCc--ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchh------------hHHHHHHHHH
Q 004732 545 EENT--HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF------------YLLDWALVLK 610 (733)
Q Consensus 545 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~------------~~~~~~~~~~ 610 (733)
.... .......||..|+|||.+.+..++.++||||||+++|||++|+.|+...... .........
T Consensus 178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 256 (302)
T 4e5w_A 178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL- 256 (302)
T ss_dssp TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHH-
T ss_pred CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHH-
Confidence 4432 2233456888999999999999999999999999999999999886322110 001111111
Q ss_pred hhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 611 EQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
..+. ....+......+.+++.+||+.||.+|||+.++++.|+++
T Consensus 257 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 300 (302)
T 4e5w_A 257 KEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300 (302)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred hccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence 1111 1111122234588999999999999999999999999854
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=358.24 Aligned_cols=245 Identities=22% Similarity=0.319 Sum_probs=205.5
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+++++.++||||+++++++.++...++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 46788999999999999999994 578999999986431 23456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 120 ~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999999754 36999999999999999999999986 999999999999999999999999999865432
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ . .+.. . ....+
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i---~-~~~~-~-----~p~~~ 261 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI---V-SGKV-R-----FPSHF 261 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H-HCCC-C-----CCTTC
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHH---H-cCCC-C-----CCCCC
Confidence 23467999999999999999999999999999999999999999766554333211 1 1111 0 11122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPS-----MSSVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 658 (733)
...+.+++.+||+.||.+||+ +.||++
T Consensus 262 ----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 262 ----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 234889999999999999998 777754
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=363.08 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=202.7
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+ ..+++.||+|.+... .......+.+|+++++.++|||||+++++|.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 3578888999999999999998 456899999998643 223456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+.+|+|.+++... ..+++..+..++.||+.||+|||+.| |+||||||+|||++.++.+||+|||+++......
T Consensus 94 ~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169 (384)
T ss_dssp ECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence 9999999999999654 47999999999999999999999997 9999999999999999999999999998654332
Q ss_pred cccccccccCCCcccHHHHhh---CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
......||+.|+|||++.. ..++.++|||||||++|||++|+.||.................. .
T Consensus 170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-~---------- 236 (384)
T 4fr4_A 170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-V---------- 236 (384)
T ss_dssp --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-C----------
T ss_pred --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-c----------
Confidence 2345789999999999864 45899999999999999999999999644332222211111111 0
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPS-MSSVLR 658 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt-~~~vl~ 658 (733)
..++......+.+++.+||+.||.+||+ +.++.+
T Consensus 237 ~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0111112345889999999999999998 666653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=351.40 Aligned_cols=255 Identities=30% Similarity=0.509 Sum_probs=204.2
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhc-------HHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQG-------NREFINEIGMISALQHPNLVKLYGCCIEGN 462 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 462 (733)
..++|...+.||+|+||+||+|+. .+++.||||.+....... .+.+.+|++++++++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 346788899999999999999994 678999999986542211 167899999999999999999999987655
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC-----eEEccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN-----SKISDF 537 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~-----~kl~Df 537 (733)
++||||+++|+|.+.+......+++..++.++.|++.||+|||+.+ .+|+||||||+||+++.++. +||+||
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 6999999999999999877778999999999999999999999884 24999999999999988776 999999
Q ss_pred CccccCcccCcccccccccCCCcccHHHHh--hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc
Q 004732 538 GLAKLDEEENTHISTRVAGTIGYMAPEYAM--RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 615 (733)
Q Consensus 538 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 615 (733)
|+++.... ......||+.|+|||.+. ...++.++|||||||++|||++|+.||.......... ..........
T Consensus 174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~ 248 (287)
T 4f0f_A 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF-INMIREEGLR 248 (287)
T ss_dssp TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHH-HHHHHHSCCC
T ss_pred Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHH-HHHHhccCCC
Confidence 99975433 233467999999999984 4557899999999999999999999996543322211 1111111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
.. ..... ...+.+++.+||+.||.+|||+.|+++.|++
T Consensus 249 ~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 249 PT-----IPEDC----PPRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp CC-----CCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred CC-----CCccc----CHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11 11122 3458899999999999999999999999874
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=355.88 Aligned_cols=245 Identities=26% Similarity=0.318 Sum_probs=195.4
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||+||+|+. .+|+.||||++.... ......+..|+..+.++ +||||++++++|.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 5788899999999999999995 479999999986532 23334556666666555 8999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+ +++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 137 e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~- 211 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG- 211 (311)
T ss_dssp ECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred ecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCC-
Confidence 999 67999998877778999999999999999999999986 9999999999999999999999999998654432
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
......||++|+|||++.+ .++.++|||||||++|||++|..|+......... ..+....... .
T Consensus 212 -~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-------~~~~~~~~~~----~--- 275 (311)
T 3p1a_A 212 -AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL-------RQGYLPPEFT----A--- 275 (311)
T ss_dssp ----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHHH-------TTTCCCHHHH----T---
T ss_pred -CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-------hccCCCcccc----c---
Confidence 2334569999999998875 7999999999999999999998777544321110 1111110000 1
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.....+.+++.+||+.||++|||+.|+++.
T Consensus 276 -~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 276 -GLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp -TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 112458899999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=351.30 Aligned_cols=260 Identities=29% Similarity=0.451 Sum_probs=196.1
Q ss_pred hhcCccccCcccCCCcccEEEcccCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
..++|...+.||+|+||+||+|+.. ..||||.+... .....+.|.+|++++++++||||+++++++ .....++||
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~ 98 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT 98 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence 3467888999999999999999864 35999998654 334457799999999999999999999965 556689999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC-
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN- 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~- 547 (733)
||+++++|.+++......+++.+++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 99 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 99 QWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp ECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999999877778999999999999999999999986 9999999999999999999999999997654322
Q ss_pred cccccccccCCCcccHHHHh---hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
........||+.|+|||.+. ...++.++||||||+++|||++|+.||.......... .....+.......
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~---- 248 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII---EMVGRGSLSPDLS---- 248 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHH---HHHHHTSCCCCTT----
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHH---HHhcccccCcchh----
Confidence 22234467999999999986 5678899999999999999999999996543322111 1111111111111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.........+.+++.+||+.+|.+||++.++++.|+++.
T Consensus 249 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 249 -KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp -SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 111122345889999999999999999999999998654
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=357.52 Aligned_cols=259 Identities=26% Similarity=0.454 Sum_probs=204.8
Q ss_pred hcCccccCcccCCCcccEEEcccCC-----CcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLAD-----GTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
..+|...+.||+|+||.||+|+... +..||||.+... .......+.+|++++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567778999999999999998542 236999998754 3334567899999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||+++|+|.+++......+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999999877778999999999999999999999996 99999999999999999999999999986654
Q ss_pred cCcc--cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 546 ENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 546 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
.... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+....
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~----~~~~~~~----- 270 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI----NDGFRLP----- 270 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HTTCCCC-----
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH----HCCCcCC-----
Confidence 3221 1223456789999999999999999999999999999999 99999665544333211 1111110
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 666 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 666 (733)
.+......+.+++.+||+.+|.+||++.++++.|++....
T Consensus 271 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 271 ----TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ----CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1111233588999999999999999999999999865543
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=360.82 Aligned_cols=266 Identities=27% Similarity=0.400 Sum_probs=204.5
Q ss_pred ccccCcccCCCcccEEEccc-----CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEE
Q 004732 395 FATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLL 466 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 466 (733)
|...+.||+|+||+||+|.+ .+++.||||++.... ......+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 47788999999999987753 368899999997643 34456789999999999999999999999984 67899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred EEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 99999999999998654 5899999999999999999999996 999999999999999999999999999876543
Q ss_pred Ccc--cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHH--HHHHHHHhhCcccccccCC
Q 004732 547 NTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL--DWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 547 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 622 (733)
... ......||..|+|||.+.+..++.++|||||||++|||++|+.||......... .+...........+.+...
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 321 233456888999999999999999999999999999999999998543211100 0000000000001111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.....+......+.+++.+||+.||.+|||+.|+++.|+.+.+
T Consensus 268 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 268 ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111122223458899999999999999999999999986543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=357.65 Aligned_cols=260 Identities=27% Similarity=0.421 Sum_probs=211.0
Q ss_pred hhhcCccccCcccCCCcccEEEccc------CCCcEEEEEEccccCh-hcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSK-QGNREFINEIGMISAL-QHPNLVKLYGCCIEG 461 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 461 (733)
...++|...+.||+|+||.||+|+. .+++.||||.+..... ...+.+.+|+++++++ +||||+++++++.++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3456788999999999999999973 3568999999975432 3457789999999999 999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcE
Q 004732 462 NQLLLIYEYLENNSLARALFEHRL-----------------KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNV 524 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~~-----------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Ni 524 (733)
+..++||||+++|+|.+++..... .+++..++.++.|+++||+|||+.+ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999975432 4899999999999999999999996 99999999999
Q ss_pred EecCCCCeEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhH
Q 004732 525 LLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYL 602 (733)
Q Consensus 525 ll~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~ 602 (733)
+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 9999999999999999876544332 2334567889999999999999999999999999999999 9999965432221
Q ss_pred HHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 603 LDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.. ... ..... ....... ...+.+++.+||+.||.+|||+.|+++.|++..
T Consensus 257 ~~--~~~-~~~~~-----~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 306 (313)
T 1t46_A 257 FY--KMI-KEGFR-----MLSPEHA----PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (313)
T ss_dssp HH--HHH-HHTCC-----CCCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH--HHh-ccCCC-----CCCcccC----CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence 11 111 11111 0011112 235889999999999999999999999998543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=349.99 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=205.4
Q ss_pred hcCccccCcccCCCcccEEEcccC-CC-------cEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-DG-------TAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 463 (733)
.++|...+.||+|+||+||+|+.. ++ ..||+|.+........+.+.+|++++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 457888899999999999999854 33 4799999977666667889999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC--------eEEc
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN--------SKIS 535 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~--------~kl~ 535 (733)
.++||||+++|+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~ 163 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLS 163 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeec
Confidence 99999999999999999877667999999999999999999999996 999999999999998887 9999
Q ss_pred ccCccccCcccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCC-CccchhhHHHHHHHHHhhC
Q 004732 536 DFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNV-TKEDMFYLLDWALVLKEQG 613 (733)
Q Consensus 536 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~-~~~~~~~~~~~~~~~~~~~ 613 (733)
|||++...... ....||+.|+|||.+.+ ..++.++|||||||++|||++|..|+ ...+....... .....
T Consensus 164 Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~---~~~~~ 235 (289)
T 4fvq_A 164 DPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF---YEDRH 235 (289)
T ss_dssp CCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---HHTTC
T ss_pred cCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH---hhccC
Confidence 99999754332 23457899999999987 67999999999999999999966555 33332222111 11111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.. .... ...+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 236 ~~---~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 236 QL---PAPK---------AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp CC---CCCS---------SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred CC---CCCC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 1111 1237889999999999999999999999996544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=359.84 Aligned_cols=246 Identities=28% Similarity=0.467 Sum_probs=202.5
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
+.|...+.||+|+||+||+|+ ..+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 457888999999999999998 4689999999986532 223457899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+. |+|.+.+......+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB--
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC--
Confidence 9997 6888888766678999999999999999999999996 999999999999999999999999999865432
Q ss_pred ccccccccCCCcccHHHHh---hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...+...... ...... .... ...
T Consensus 208 ---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~---~~~~~~-~~~~----~~~ 276 (348)
T 1u5q_A 208 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY---HIAQNE-SPAL----QSG 276 (348)
T ss_dssp ---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHHSC-CCCC----CCT
T ss_pred ---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhcC-CCCC----CCC
Confidence 3457999999999985 4678999999999999999999999996654433221 111111 1111 111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.++ ..+.+++.+||+.||++|||+.++++.
T Consensus 277 ~~~----~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 277 HWS----EYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCC----HHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 222 347889999999999999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=358.17 Aligned_cols=249 Identities=22% Similarity=0.325 Sum_probs=204.6
Q ss_pred hhcCccccCcccCCCcccEEEcccC-CCcEEEEEEcccc---ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 465 (733)
..++|...+.||+|+||.||+|+.. +|+.||||++... .......+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468889999999999999999954 5889999998653 223456788999999988 8999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 98 lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 173 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 173 (353)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence 999999999999999754 36999999999999999999999996 99999999999999999999999999985332
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+...+..... . ...
T Consensus 174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~---~-~~~---------- 238 (353)
T 2i0e_A 174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM---E-HNV---------- 238 (353)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H-CCC----------
T ss_pred CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH---h-CCC----------
Confidence 22 22345689999999999999999999999999999999999999997765544332211 1 111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPS-----MSSVLR 658 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 658 (733)
.++......+.+++.+|++.||.+||+ +.+|++
T Consensus 239 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 239 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 011122345889999999999999995 466654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=358.10 Aligned_cols=257 Identities=26% Similarity=0.431 Sum_probs=203.1
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcE----EEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTA----IAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
.++|...+.||+|+||.||+|+. .+++. ||+|.+... .....+.+.+|+.++++++||||++++++|..+. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 45788999999999999999984 45554 577777543 3445678999999999999999999999998765 78
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+|+||+.+|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999999887778999999999999999999999996 99999999999999999999999999987654
Q ss_pred cCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 546 ENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 546 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.... ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||............ ..+....
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----~~~~~~~------ 239 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EKGERLP------ 239 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTCCCC------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCCCC------
Confidence 3222 2233457889999999999999999999999999999999 99999765544433221 1111110
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.+......+.+++.+||+.||.+||++.|+++.|+....
T Consensus 240 ---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 240 ---QPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp ---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred ---CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111122348889999999999999999999999987654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=362.24 Aligned_cols=247 Identities=22% Similarity=0.316 Sum_probs=197.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 466 (733)
.++|...+.||+|+||+||+|+. .+++.||||+++... ......+.+|..++.++ +|||||++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 45788899999999999999994 568899999987542 22234578899999887 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 131 V~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC
Confidence 99999999999999754 47999999999999999999999996 999999999999999999999999999853322
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhh-----HHHHHHHHHhhCcccccccC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-----LLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 621 (733)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+..........
T Consensus 207 ~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 279 (396)
T 4dc2_A 207 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 279 (396)
T ss_dssp T-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC------
T ss_pred C-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc------
Confidence 2 22445789999999999999999999999999999999999999995321110 01111111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSM 653 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 653 (733)
.++......+.+++.+||+.||.+||++
T Consensus 280 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 280 ----RIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred ----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 1111123358899999999999999995
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=359.19 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=190.2
Q ss_pred hhhcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
...++|...+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|++++++++||||++++++|.+++..++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 34567889999999999999999954 68899999987543 3467889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC---CCCeEEcccCccccCcc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAKLDEE 545 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~DfGla~~~~~ 545 (733)
||+++|+|.+++... ..+++.++..++.|+++||+|||+.+ |+||||||+||+++. ++.+||+|||+++....
T Consensus 128 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 128 ELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999998654 46899999999999999999999986 999999999999975 88999999999986543
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... +.. ... ... ....
T Consensus 204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~-i~~-~~~-~~~~----- 272 (349)
T 2w4o_A 204 QV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM-FRR-ILN-CEY-YFIS----- 272 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH-HHH-HHT-TCC-CCCT-----
T ss_pred cc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH-HHH-HHh-CCC-ccCC-----
Confidence 22 223467999999999999989999999999999999999999999654332211 111 111 111 0000
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.........+.+++.+|++.||++|||+.|+++.
T Consensus 273 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 273 PWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred chhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223358899999999999999999999874
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=355.89 Aligned_cols=262 Identities=25% Similarity=0.437 Sum_probs=213.5
Q ss_pred HHhhhcCccccCcccCCCcccEEEcccC------CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEe
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIE 460 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 460 (733)
.....++|...+.||+|+||.||+|+.. +++.||||.+.... ......+.+|++++++++||||+++++++.+
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 20 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred hcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 3455678899999999999999999753 47889999997543 3344678999999999999999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC
Q 004732 461 GNQLLLIYEYLENNSLARALFEHR---------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 531 (733)
Q Consensus 461 ~~~~~lV~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 531 (733)
++..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCe
Confidence 999999999999999999997422 46799999999999999999999996 999999999999999999
Q ss_pred eEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHH
Q 004732 532 SKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVL 609 (733)
Q Consensus 532 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 609 (733)
+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||............
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~--- 253 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV--- 253 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH---
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH---
Confidence 99999999986544322 22334567889999999999999999999999999999999 88999665544333221
Q ss_pred HhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 610 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
..+..... .... ...+.+++.+||+.||.+||++.|+++.|++...
T Consensus 254 -~~~~~~~~-----~~~~----~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 254 -MEGGLLDK-----PDNC----PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -HTTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HcCCcCCC-----CCCC----CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111 1122 2348889999999999999999999999986544
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=348.74 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=208.1
Q ss_pred cCccccC-cccCCCcccEEEcccC---CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 393 NNFATDN-NIGEGGFGPVYKGLLA---DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 393 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
++|.... .||+|+||.||+|+.. ++..||||.+... .....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3444554 8999999999999743 5788999999764 334457799999999999999999999999 56678999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++++|.+++......+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 9999999999999877678999999999999999999999996 9999999999999999999999999998765433
Q ss_pred ccc--ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 548 THI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 548 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
... .....||+.|+|||.+.+..++.++||||||+++|||++ |+.||............ ..+....
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i----~~~~~~~------- 233 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI----EQGKRME------- 233 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH----HTTCCCC-------
T ss_pred ceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH----hcCCcCC-------
Confidence 222 223457889999999998899999999999999999998 99999665544333221 1111111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.+......+.+++.+||+.+|++||++.++++.|++..
T Consensus 234 --~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 271 (287)
T 1u59_A 234 --CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 271 (287)
T ss_dssp --CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11122345889999999999999999999999998543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=350.37 Aligned_cols=263 Identities=24% Similarity=0.331 Sum_probs=201.4
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-----hhcHHHHHHHHHHHHhCC---CCceeeEeeEEEeC
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-----KQGNREFINEIGMISALQ---HPNLVKLYGCCIEG 461 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 461 (733)
.+++|...+.||+|+||+||+|+ ..+++.||||++.... ......+.+|++++++++ ||||++++++|...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 46789999999999999999999 4678999999986432 111245677777776664 99999999999876
Q ss_pred C-----eEEEEEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEc
Q 004732 462 N-----QLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKIS 535 (733)
Q Consensus 462 ~-----~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 535 (733)
. ..++||||+. |+|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEe
Confidence 5 5899999997 59999987543 34999999999999999999999997 9999999999999999999999
Q ss_pred ccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc
Q 004732 536 DFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 615 (733)
Q Consensus 536 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 615 (733)
|||+++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.................
T Consensus 163 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 163 DFGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred eCccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9999986543322 34567999999999999999999999999999999999999999766655443322221111100
Q ss_pred ccccc------CC--CCCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 616 MELVD------TN--PGSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 616 ~~~~~------~~--~~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..... .. ...... .+....+.+++.+|++.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000 00 000000 1123458899999999999999999999763
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-41 Score=355.89 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=210.5
Q ss_pred hhcCccccCcccCCCcccEEEccc--------CCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEe
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL--------ADGTAIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIE 460 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 460 (733)
..++|...+.||+|+||.||+|+. .++..||||++... .......+.+|+++++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 346788899999999999999974 35678999999754 333456789999999999 89999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEE
Q 004732 461 GNQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL 525 (733)
Q Consensus 461 ~~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nil 525 (733)
++..++||||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 999999999999999999997543 24899999999999999999999996 999999999999
Q ss_pred ecCCCCeEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHH
Q 004732 526 LDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLL 603 (733)
Q Consensus 526 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~ 603 (733)
++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.........
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 999999999999999866543322 2233457889999999999899999999999999999999 99999765544333
Q ss_pred HHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 604 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
... . .+.... ....+ ...+.+++.+||+.+|.+||++.|+++.|+.+..
T Consensus 270 ~~~---~-~~~~~~-----~~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 270 KLL---K-EGHRMD-----KPANC----TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp HHH---H-HTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH---h-cCCCCC-----CCccC----CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 221 1 111111 11122 2348889999999999999999999999997654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=359.88 Aligned_cols=252 Identities=23% Similarity=0.344 Sum_probs=196.9
Q ss_pred hhcCccccCcccCCCcccEEEcccCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCC--CceeeEeeEEEeCCeEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQH--PNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~l 466 (733)
..++|...+.||+|+||.||+|...+++.||||++... .....+.+.+|++++++++| |||+++++++.++...++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 45678899999999999999999888999999998643 33345678999999999986 999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||| +.+|+|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+|||++ ++.+||+|||+++.....
T Consensus 87 v~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEC-CCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEe-CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 999 5688999999764 47999999999999999999999996 99999999999997 578999999999876543
Q ss_pred Ccc-cccccccCCCcccHHHHhh-----------CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc
Q 004732 547 NTH-ISTRVAGTIGYMAPEYAMR-----------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 614 (733)
Q Consensus 547 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 614 (733)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ..... ...
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~-~~~---- 234 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-ISKLH-AII---- 234 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-HHHHH-HHH----
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-HHHHH-HHh----
Confidence 332 2345679999999999975 67899999999999999999999999543211 11111 111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+......++......+.+++.+||+.||.+|||+.|+++.
T Consensus 235 -----~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 235 -----DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -----CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 1111111111112357899999999999999999999865
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=359.11 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=201.9
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+ ..+++.||||.+.... ......+.+|+++++.++||||+++++++.++...++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3578899999999999999999 4678999999986431 12235788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+ +|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 88 ~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~ 162 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN 162 (336)
T ss_dssp ECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB
T ss_pred EECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCc
Confidence 9999 78899988654 47999999999999999999999996 9999999999999999999999999998655432
Q ss_pred cccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.......+ ...+.... ..
T Consensus 163 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------------~~~i~~~~-~~ 226 (336)
T 3h4j_B 163 --FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------------FKKVNSCV-YV 226 (336)
T ss_dssp --TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------------BCCCCSSC-CC
T ss_pred --ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------------HHHHHcCC-CC
Confidence 2344679999999999987765 7899999999999999999999965432111 11111100 11
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+......+.+++.+|++.||.+|||+.|+++.
T Consensus 227 ~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 227 MPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred CcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 112223458899999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=353.12 Aligned_cols=249 Identities=25% Similarity=0.339 Sum_probs=195.7
Q ss_pred hcCccccCcccCCCcccEEEccc----CCCcEEEEEEccccC----hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 463 (733)
.++|...+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+++++.++||||+++++++.+++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 45788889999999999999985 478999999987542 2234567889999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999754 36899999999999999999999996 999999999999999999999999999754
Q ss_pred cccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+........ .. ... .
T Consensus 172 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i---~~-~~~------~- 239 (327)
T 3a62_A 172 IHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI---LK-CKL------N- 239 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HH-TCC------C-
T ss_pred ccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHH---Hh-CCC------C-
Confidence 33222 233467999999999999989999999999999999999999999766544333211 11 110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRP-----SMSSVLRM 659 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~~ 659 (733)
.+......+.+++.+||+.||.+|| ++.|+++.
T Consensus 240 ---~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 240 ---LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 1111223588999999999999999 67787653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=351.65 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=196.8
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh--------------------------hcHHHHHHHHHHHH
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK--------------------------QGNREFINEIGMIS 444 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 444 (733)
.++|...+.||+|+||.||+|+ ..+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 3578888999999999999998 45789999999865421 11246889999999
Q ss_pred hCCCCceeeEeeEEEe--CCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCC
Q 004732 445 ALQHPNLVKLYGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKAT 522 (733)
Q Consensus 445 ~l~h~niv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~ 522 (733)
+++||||+++++++.+ +...++||||+++++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~ 166 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPS 166 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHH
Confidence 9999999999999987 578999999999999987643 347999999999999999999999996 999999999
Q ss_pred cEEecCCCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhCC---CCccchhHhHHHHHHHHHhCCCCCCccch
Q 004732 523 NVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH---LTEKADVYSFGIVALEIVSGRSNVTKEDM 599 (733)
Q Consensus 523 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gvil~elltg~~p~~~~~~ 599 (733)
||+++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++|||||||++|||++|+.||.....
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 245 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence 99999999999999999986554322 223467999999999987654 47889999999999999999999976654
Q ss_pred hhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 600 FYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...... ... ... ... .....+ ..+.+++.+||+.||++||++.|+++
T Consensus 246 ~~~~~~---~~~-~~~-~~~---~~~~~~----~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 246 MCLHSK---IKS-QAL-EFP---DQPDIA----EDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp HHHHHH---HHH-CCC-CCC---SSSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred HHHHHH---Hhc-ccC-CCC---CccccC----HHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 332221 111 111 000 011222 34889999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-41 Score=384.15 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=203.5
Q ss_pred CccccC-cccCCCcccEEEcccC---CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 394 NFATDN-NIGEGGFGPVYKGLLA---DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 394 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++...+ .||+|+||.||+|.+. ++..||||+++... ....+.|.+|++++++++|||||+++++|.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 333334 7999999999999853 46679999997643 3456789999999999999999999999976 5689999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++|+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 999999999999877778999999999999999999999986 99999999999999999999999999987654332
Q ss_pred cc--ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 549 HI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 549 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.. .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...+........ ..+.....
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i----~~~~~~~~------- 560 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI----EQGKRMEC------- 560 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH----HTTCCCCC-------
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCCCCC-------
Confidence 22 122345789999999999999999999999999999998 99999766554433322 12221111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
+......+.+++.+||+.+|++||++.+|++.|+...
T Consensus 561 --p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 561 --PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp --CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred --CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1112345889999999999999999999999998643
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=354.32 Aligned_cols=252 Identities=22% Similarity=0.286 Sum_probs=193.2
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.++|...+.||+|+||+||+|+. .+++.||||++..... ....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 46788999999999999999994 4789999999865432 336788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC--eEEcccCccccCcccCc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN--SKISDFGLAKLDEEENT 548 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~--~kl~DfGla~~~~~~~~ 548 (733)
+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+++......
T Consensus 98 ~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~- 172 (361)
T 3uc3_A 98 ASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 172 (361)
T ss_dssp CCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC--------
T ss_pred CCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccC-
Confidence 9999999998654 37999999999999999999999986 999999999999987765 9999999997433221
Q ss_pred ccccccccCCCcccHHHHhhCCCCcc-chhHhHHHHHHHHHhCCCCCCccchhh-HHHHHHHHHhhCcccccccCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEK-ADVYSFGIVALEIVSGRSNVTKEDMFY-LLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~s~Gvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
......||+.|+|||++.+..++.+ +|||||||++|||++|+.||....... ............ . ... ....
T Consensus 173 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~-~-~~~---~~~~ 246 (361)
T 3uc3_A 173 -QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK-Y-SIP---DDIR 246 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC-C-CCC---TTSC
T ss_pred -CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC-C-CCC---CcCC
Confidence 2234579999999999988887665 899999999999999999996543221 111111111110 0 000 0111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+ ..+.+++.+||+.||.+|||+.|+++.
T Consensus 247 ~s----~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 247 IS----PECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CC----HHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CC----HHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 22 347899999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=354.20 Aligned_cols=247 Identities=23% Similarity=0.323 Sum_probs=198.6
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 466 (733)
.++|...+.||+|+||.||+|+. .+++.||||++... .......+.+|..+++++ +||||+++++++.++...++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 35688889999999999999995 56899999998654 233345688899999988 89999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 88 v~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999999754 47999999999999999999999996 999999999999999999999999999854322
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchh-----hHHHHHHHHHhhCcccccccC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-----YLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~ 621 (733)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...............
T Consensus 164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~------ 236 (345)
T 3a8x_A 164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------ 236 (345)
T ss_dssp T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC------
T ss_pred C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC------
Confidence 2 2234568999999999999999999999999999999999999999542111 001111111111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSM 653 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 653 (733)
.++......+.+++.+||+.||++||++
T Consensus 237 ----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 237 ----RIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 0111123358889999999999999996
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=356.46 Aligned_cols=250 Identities=21% Similarity=0.359 Sum_probs=196.9
Q ss_pred hcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC-------
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGN------- 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 462 (733)
.++|...+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||+++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356888899999999999999954 89999999986543 334578999999999999999999999987653
Q ss_pred --------------------------------------------------eEEEEEEccCCCCHHHHHHhcC--CCCCHH
Q 004732 463 --------------------------------------------------QLLLIYEYLENNSLARALFEHR--LKLDWP 490 (733)
Q Consensus 463 --------------------------------------------------~~~lV~e~~~~gsL~~~l~~~~--~~l~~~ 490 (733)
..++||||+++|+|.+++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 3899999999999999997532 245677
Q ss_pred HHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc-----------ccccccccCCC
Q 004732 491 TRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT-----------HISTRVAGTIG 559 (733)
Q Consensus 491 ~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~gt~~ 559 (733)
.++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 79999999999999999986 99999999999999999999999999987654321 12234579999
Q ss_pred cccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHH
Q 004732 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVA 639 (733)
Q Consensus 560 y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~ 639 (733)
|+|||.+.+..++.++|||||||++|||++|..|+.... ... . ........ .........+.+++
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--~~~---~-~~~~~~~~---------~~~~~~~~~~~~li 306 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--RII---T-DVRNLKFP---------LLFTQKYPQEHMMV 306 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--HHH---H-HHHTTCCC---------HHHHHHCHHHHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--HHH---H-HhhccCCC---------cccccCChhHHHHH
Confidence 999999999999999999999999999999876642111 110 0 01111110 01122334578899
Q ss_pred HHhhcCCCCCCCCHHHHHHH
Q 004732 640 LLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 640 ~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+||+.||++|||+.|+++.
T Consensus 307 ~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 307 QDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHCSSGGGSCCHHHHHHS
T ss_pred HHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999873
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=343.23 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=205.9
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
.++|...+.||+|+||.||+|.. .+|+.||+|++... .......+.+|++++++++||||+++++++.++...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46889999999999999999984 56899999998654 3334567889999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC---eEEcccCccccCcc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFGLAKLDEE 545 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~---~kl~DfGla~~~~~ 545 (733)
||+++++|.+.+... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++.....
T Consensus 85 e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 85 DLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred ecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999988654 47999999999999999999999996 999999999999987655 99999999976554
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+......... .+... ...+ ...
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~~-~~~~-~~~ 232 (284)
T 3kk8_A 161 SEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK----AGAYD-YPSP-EWD 232 (284)
T ss_dssp SCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HTCCC-CCTT-TTT
T ss_pred Ccc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH----hcccc-CCch-hhc
Confidence 322 234679999999999999999999999999999999999999997665444332211 11110 0000 011
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
..+ ..+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~----~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 233 TVT----PEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TSC----HHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccC----HHHHHHHHHHcccChhhCCCHHHHhc
Confidence 222 34889999999999999999999976
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=345.86 Aligned_cols=261 Identities=21% Similarity=0.274 Sum_probs=207.4
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEE-EeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCC-IEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e 469 (733)
.++|...+.||+|+||.||+|+ ..+|+.||||++...... ..+.+|+.+++.++|+++++.+.++ .++...++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 4688999999999999999999 468999999998654332 4688999999999998877666655 56788899999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe---cCCCCeEEcccCccccCccc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfGla~~~~~~ 546 (733)
|+ +++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++.....
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99 99999999866678999999999999999999999996 9999999999999 48889999999999866543
Q ss_pred Ccc------cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccch---hhHHHHHHHHHhhCcccc
Q 004732 547 NTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM---FYLLDWALVLKEQGKLME 617 (733)
Q Consensus 547 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 617 (733)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..................
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (296)
T 3uzp_A 162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEV 241 (296)
T ss_dssp TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHH
Confidence 321 12456799999999999999999999999999999999999999954321 111111111111111110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 618 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
.. ..++ ..+.+++.+||+.||++||++.+|++.|+......
T Consensus 242 ~~-----~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 282 (296)
T 3uzp_A 242 LC-----KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HT-----TTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HH-----hhCC----HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence 10 1122 34889999999999999999999999999765544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=343.24 Aligned_cols=250 Identities=21% Similarity=0.298 Sum_probs=204.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.++|...+.||+|+||.||+|+. .++..||+|++........+.+.+|++++++++||||+++++++.++...++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 35688889999999999999994 46789999998766555667899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe---cCCCCeEEcccCccccCcccC
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfGla~~~~~~~ 547 (733)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~ 163 (277)
T 3f3z_A 88 CTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK 163 (277)
T ss_dssp CCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred cCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence 9999999988754 46899999999999999999999996 9999999999999 788899999999998655432
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
. .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||............ . .+... .... ....
T Consensus 164 ~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~-~~~~~-~~~~-~~~~- 233 (277)
T 3f3z_A 164 M--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKI---R-EGTFT-FPEK-DWLN- 233 (277)
T ss_dssp C--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H-HCCCC-CCHH-HHTT-
T ss_pred c--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHH---H-hCCCC-CCch-hhhc-
Confidence 2 234579999999998865 4899999999999999999999999765543322211 1 11110 0000 0001
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
....+.+++.+|++.||.+||++.++++
T Consensus 234 ---~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 234 ---VSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---SCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1235889999999999999999999865
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=365.97 Aligned_cols=261 Identities=22% Similarity=0.279 Sum_probs=209.3
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCC-CceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|...+.||+|+||.||+|+ ..+++.||||++...... ..+.+|+++++.++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4688999999999999999999 467999999987654332 457899999999987 566667777788899999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe---cCCCCeEEcccCccccCccc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfGla~~~~~~ 546 (733)
|+ +++|.+++......+++.+++.++.||+.||+|||+.+ ||||||||+|||+ +.++.+||+|||+++.....
T Consensus 84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99 99999999876778999999999999999999999996 9999999999999 68899999999999876543
Q ss_pred Ccc------cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccch---hhHHHHHHHHHhhCcccc
Q 004732 547 NTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDM---FYLLDWALVLKEQGKLME 617 (733)
Q Consensus 547 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~---~~~~~~~~~~~~~~~~~~ 617 (733)
... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..... ..................
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA 239 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH
Confidence 322 12356799999999999999999999999999999999999999965332 111111111111111111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 618 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
+.. .++ ..+.+++..||+.+|++||++.+|+++|+.+....
T Consensus 240 l~~-----~~p----~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 240 LCR-----GYP----TEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HHT-----TSC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred Hhc-----CCc----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 111 112 34889999999999999999999999999765544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=342.04 Aligned_cols=249 Identities=26% Similarity=0.358 Sum_probs=198.3
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++|...+.||+|+||.||+|+ ..++..||+|++.... ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 467788999999999999998 4578999999986542 33457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe---cCCCCeEEcccCccccCc
Q 004732 471 LENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 471 ~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfGla~~~~ 544 (733)
+++|+|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||++ +.++.+||+|||+++...
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 999999999863 3467999999999999999999999986 9999999999999 456789999999998654
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
.... .....||+.|+|||.+. +.++.++|||||||++|||++|+.||............. . ....... ..
T Consensus 179 ~~~~--~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~---~-~~~~~~~---~~ 248 (285)
T 3is5_A 179 SDEH--STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT---Y-KEPNYAV---EC 248 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H-CCCCCCC-----
T ss_pred Cccc--CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc---c-CCccccc---cc
Confidence 4322 34467999999999875 578999999999999999999999997665443332211 1 1110000 00
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 249 ~~~~----~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 249 RPLT----PQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp CCCC----HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred CcCC----HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1122 34778999999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=345.26 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=204.6
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC--CeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG--NQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 467 (733)
.++|...+.||+|+||.||+|+.. ++.||||++... .....+.|.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 356788899999999999999975 889999998754 234456799999999999999999999999887 788999
Q ss_pred EEccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 468 YEYLENNSLARALFEHRL-KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
|||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~- 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS- 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred ecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence 999999999999975443 5899999999999999999999873 3499999999999999999999999988754222
Q ss_pred CcccccccccCCCcccHHHHhhCCCCc---cchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTE---KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
....||+.|+|||.+.+..++. ++|||||||++|||++|+.||........... ......... .
T Consensus 166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~-----~ 232 (271)
T 3kmu_A 166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK---VALEGLRPT-----I 232 (271)
T ss_dssp -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH---HHHSCCCCC-----C
T ss_pred -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH---HHhcCCCCC-----C
Confidence 2346899999999998765444 89999999999999999999976544333221 111111111 1
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.... ...+.+++.+||+.||++|||+.++++.|+...
T Consensus 233 ~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 233 PPGI----SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 1122 234889999999999999999999999998643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=348.11 Aligned_cols=261 Identities=21% Similarity=0.256 Sum_probs=200.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 46788999999999999999994 478999999986542 22346788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEK 188 (309)
T ss_dssp EECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred EEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence 9999999999999754 47999999999999999999999996 9999999999999999999999999998665544
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
........||+.|+|||.+.+..++.++||||||+++|||++|+.||........... ........... ...+
T Consensus 189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~----~~~~ 261 (309)
T 2h34_A 189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAH---INQAIPRPSTV----RPGI 261 (309)
T ss_dssp --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHH---HHSCCCCGGGT----STTC
T ss_pred cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHH---hccCCCCcccc----CCCC
Confidence 3334456799999999999888899999999999999999999999976554322111 11111110000 1112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHhccCcccc
Q 004732 628 DKEQVMVMINVALLCANASPTIRP-SMSSVLRMLECGVDVL 667 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RP-t~~~vl~~L~~~~~~~ 667 (733)
+ ..+.+++.+||+.||++|| ++.++++.|+......
T Consensus 262 ~----~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 262 P----VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp C----THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred C----HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 2 2488899999999999999 9999999999765533
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=346.02 Aligned_cols=262 Identities=21% Similarity=0.274 Sum_probs=204.1
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEE-EeCCeEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCC-IEGNQLLLIY 468 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV~ 468 (733)
..++|...+.||+|+||.||+|+ ..+++.||||.+...... ..+.+|+++++.++|++++..++++ .+++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 35689999999999999999999 467899999987544322 4578899999999988877766665 6678889999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe---cCCCCeEEcccCccccCcc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfGla~~~~~ 545 (733)
||+ +++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++....
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 999 99999999876778999999999999999999999996 9999999999999 7889999999999987654
Q ss_pred cCcc------cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchh---hHHHHHHHHHhhCccc
Q 004732 546 ENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF---YLLDWALVLKEQGKLM 616 (733)
Q Consensus 546 ~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~ 616 (733)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ................
T Consensus 161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 3321 223467999999999999999999999999999999999999999543211 1111111111111110
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 617 ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
... ..++ ..+.+++.+||+.||++||++.+|++.|+......
T Consensus 241 ~~~-----~~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 241 VLC-----KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHT-----TTSC----HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhh-----ccCC----HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHh
Confidence 000 1112 34889999999999999999999999999765543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=363.07 Aligned_cols=257 Identities=26% Similarity=0.423 Sum_probs=196.8
Q ss_pred CccccCcccCCCcccEEEcccC--CC--cEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCeEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA--DG--TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIE-GNQLLLI 467 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV 467 (733)
.|...+.||+|+||.||+|+.. ++ ..||||.+... .....+.|.+|+.++++++||||++++++|.+ ++..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4567789999999999999853 22 36899998654 33445789999999999999999999999765 4578999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++|+|.+++......+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 170 ~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999877778999999999999999999999996 9999999999999999999999999998654332
Q ss_pred cc---cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 548 TH---ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 548 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||...+........ ..+.... .
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~~~~~~~-----~ 317 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGRRLL-----Q 317 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----HTTCCCC-----C
T ss_pred cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----HcCCCCC-----C
Confidence 21 1233567889999999999999999999999999999999 56677544433332221 1111110 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 666 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 666 (733)
....+ ..+.+++.+||+.||++||++.|+++.|+++...
T Consensus 318 p~~~~----~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 318 PEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp CTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11122 3488899999999999999999999999876543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=348.78 Aligned_cols=254 Identities=30% Similarity=0.500 Sum_probs=197.4
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
++|...+.||+|+||.||+|+.. ++.||||.+... ...+.|.+|++++++++||||+++++++.+ ..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence 46778899999999999999875 788999998643 345789999999999999999999998863 4789999999
Q ss_pred CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC-eEEcccCccccCcccCcc
Q 004732 473 NNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN-SKISDFGLAKLDEEENTH 549 (733)
Q Consensus 473 ~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~-~kl~DfGla~~~~~~~~~ 549 (733)
+|+|.+++.... ..+++..++.++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 999999997543 24789999999999999999999943235999999999999998887 799999999754332
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhh-HHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-LLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||....... ...|. ...+...... ...+
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~-----~~~~ 230 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA---VHNGTRPPLI-----KNLP 230 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH---HHTTCCCCCB-----TTCC
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH---HhcCCCCCcc-----cccC
Confidence 223468999999999999899999999999999999999999995432211 11111 1111111111 1122
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
..+.+++.+||+.||++|||+.++++.|+......
T Consensus 231 ----~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 231 ----KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp ----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred ----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 34888999999999999999999999998765443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=354.66 Aligned_cols=253 Identities=21% Similarity=0.329 Sum_probs=195.5
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC----e
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGN----Q 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 463 (733)
.++|...+.||+|+||.||+|+ ..+++.||||++.... ......+.+|++++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 4678899999999999999999 4678999999997642 233457889999999999999999999987654 3
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.++||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred cEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence 49999999999999999754 37999999999999999999999996 999999999999999999999999999866
Q ss_pred cccCcc--cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 544 EEENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 544 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ...........
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~-- 241 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ---HVREDPIPPSA-- 241 (311)
T ss_dssp ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHCCCCCHHH--
T ss_pred cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HhcCCCCCccc--
Confidence 543222 23346799999999999999999999999999999999999999976654332211 11111111000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
..... ...+.+++.+||+.||.+||+..++++
T Consensus 242 -~~~~~----~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 242 -RHEGL----SADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp -HSTTC----CHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred -ccCCC----CHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 00111 234889999999999999998777654
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=342.72 Aligned_cols=248 Identities=26% Similarity=0.389 Sum_probs=202.8
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
+.++|...+.||+|+||.||+|+ ..++..||||.+.... ......+.+|++++++++||||+++++++.++...++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 45688899999999999999998 4567899999985432 2234678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 87 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~ 162 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 162 (279)
T ss_dssp EECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence 99999999999999754 46999999999999999999999986 999999999999999999999999998654332
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...+........ .. .. ......
T Consensus 163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~-~~------~~~~~~ 229 (279)
T 3fdn_A 163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI---SR-VE------FTFPDF 229 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---HH-TC------CCCCTT
T ss_pred c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH---Hh-CC------CCCCCc
Confidence 2 23457899999999999999999999999999999999999999766544332211 11 10 001111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
. ...+.+++.+||+.||.+||++.|+++.
T Consensus 230 ~----~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 230 V----TEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp S----CHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred C----CHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 2 2347889999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=359.08 Aligned_cols=247 Identities=26% Similarity=0.345 Sum_probs=194.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHH-HHhCCCCceeeEeeEEEeCCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGM-ISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.++|...+.||+|+||.||+|+. .+++.||||++.... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 35788889999999999999995 568899999986542 2233456677776 577899999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 117 v~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999754 47899999999999999999999996 999999999999999999999999999853322
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ . . ... . ....
T Consensus 193 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i--~-~-~~~-~-----~~~~ 261 (373)
T 2r5t_A 193 N-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI--L-N-KPL-Q-----LKPN 261 (373)
T ss_dssp C-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHH--H-H-SCC-C-----CCSS
T ss_pred C-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--H-h-ccc-C-----CCCC
Confidence 2 2234578999999999999999999999999999999999999999776654433211 1 1 110 0 1111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVL 657 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl 657 (733)
. ...+.+++.+|++.||.+||++.+.+
T Consensus 262 ~----~~~~~~li~~lL~~dp~~R~~~~~~~ 288 (373)
T 2r5t_A 262 I----TNSARHLLEGLLQKDRTKRLGAKDDF 288 (373)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred C----CHHHHHHHHHHcccCHHhCCCCCCCH
Confidence 2 23488899999999999999986433
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=369.89 Aligned_cols=250 Identities=25% Similarity=0.317 Sum_probs=197.7
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
..++|...+.||+|+||.||+|+ ..+|+.||||++... .......+.+|+++++.++||||++++++|.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 34678899999999999999998 567899999998653 23334567889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....
T Consensus 226 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999998754 479999999999999999999997 75 99999999999999999999999999985433
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... . ... . ...
T Consensus 302 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~---~-~~~-~-----~p~ 370 (446)
T 4ejn_A 302 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL---M-EEI-R-----FPR 370 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H-CCC-C-----CCT
T ss_pred CCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHH---h-CCC-C-----CCc
Confidence 222 2345789999999999999999999999999999999999999997665544333221 1 110 0 111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRP-----SMSSVLRM 659 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~~ 659 (733)
.. ...+.+++.+||+.||.+|| ++.|+++.
T Consensus 371 ~~----~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 371 TL----GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp TS----CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred cC----CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 12 23588999999999999999 99998763
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=359.98 Aligned_cols=262 Identities=20% Similarity=0.306 Sum_probs=204.0
Q ss_pred hhcCccccCcccCC--CcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 391 ATNNFATDNNIGEG--GFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 391 ~~~~~~~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
..++|...+.||+| +||.||+|+. .+|+.||||++.... ....+.+.+|+++++.++|||||++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 34678899999999 9999999995 479999999986542 334467888999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 466 LIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
+|||||++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||.+....
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999754 357999999999999999999999996 9999999999999999999999999986543
Q ss_pred ccCc------ccccccccCCCcccHHHHhh--CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccc
Q 004732 545 EENT------HISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM 616 (733)
Q Consensus 545 ~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 616 (733)
.... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+......... .+...
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~----~~~~~ 255 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL----NGTVP 255 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh----cCCCC
Confidence 2211 11223478999999999987 579999999999999999999999996543322211000 00000
Q ss_pred cccc------------------------------C------CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 ELVD------------------------------T------NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 ~~~~------------------------------~------~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+ . .....+.......+.+++.+||+.||++|||+.|+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000 0 00001112223468899999999999999999999754
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.70 Aligned_cols=262 Identities=15% Similarity=0.163 Sum_probs=206.9
Q ss_pred hcCccccCcccCCCcccEEEcccC---------CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceee---------
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA---------DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVK--------- 453 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 453 (733)
.++|...+.||+|+||.||+|+.. +++.||||.+... ..+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 367889999999999999999855 3789999998643 36789999999999999987
Q ss_pred ------EeeEEEe-CCeEEEEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEE
Q 004732 454 ------LYGCCIE-GNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL 525 (733)
Q Consensus 454 ------l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nil 525 (733)
+++++.. +...++||||+ +++|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6778877 78899999999 99999999864 467999999999999999999999996 999999999999
Q ss_pred ecCCC--CeEEcccCccccCcccCcc------cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCcc
Q 004732 526 LDKDL--NSKISDFGLAKLDEEENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE 597 (733)
Q Consensus 526 l~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~ 597 (733)
++.++ .+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999866543221 123457999999999999999999999999999999999999999654
Q ss_pred c--hhhHHHHHHHHHhhCcccccccCCCC-CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccccc
Q 004732 598 D--MFYLLDWALVLKEQGKLMELVDTNPG-SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLD 668 (733)
Q Consensus 598 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~~ 668 (733)
. ............. ........... ..++ ..+.+++.+||+.||++||++.+|++.|+++.....
T Consensus 272 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 272 LPNTEDIMKQKQKFVD--KPGPFVGPCGHWIRPS----ETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp TTCHHHHHHHHHHHHH--SCCCEECTTSCEECCC----HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CcCHHHHHHHHHhccC--ChhhhhhhccccCCCc----HHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 2 2222222211111 11122221111 1122 348889999999999999999999999997655443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=359.73 Aligned_cols=263 Identities=22% Similarity=0.369 Sum_probs=194.1
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCC--eE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGN--QL 464 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~ 464 (733)
..++|...+.||+|+||.||+|+ ..+|+.||||++... .......+.+|+.+++++. ||||+++++++..++ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 35688999999999999999998 567899999998643 3344567889999999997 999999999998654 78
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++|||||+ |+|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 87 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 160 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160 (388)
T ss_dssp EEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESS
T ss_pred EEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCccccccc
Confidence 99999998 589998865 37899999999999999999999996 9999999999999999999999999998653
Q ss_pred cc--------------------CcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHH
Q 004732 545 EE--------------------NTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL 603 (733)
Q Consensus 545 ~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~ 603 (733)
.. .........||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~ 240 (388)
T 3oz6_A 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQL 240 (388)
T ss_dssp SCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 21 1112334679999999999987 67999999999999999999999999766554433
Q ss_pred HHHHHHHhhCcccccc---------------------cCCCCCCCC------------HHHHHHHHHHHHHhhcCCCCCC
Q 004732 604 DWALVLKEQGKLMELV---------------------DTNPGSNFD------------KEQVMVMINVALLCANASPTIR 650 (733)
Q Consensus 604 ~~~~~~~~~~~~~~~~---------------------~~~~~~~~~------------~~~~~~l~~l~~~c~~~~P~~R 650 (733)
..............+. .......++ ......+.+++.+||+.||++|
T Consensus 241 ~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R 320 (388)
T 3oz6_A 241 ERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKR 320 (388)
T ss_dssp HHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccC
Confidence 2221111100000000 000000000 0112358899999999999999
Q ss_pred CCHHHHHHH
Q 004732 651 PSMSSVLRM 659 (733)
Q Consensus 651 Pt~~~vl~~ 659 (733)
||+.|+++.
T Consensus 321 ~t~~e~l~H 329 (388)
T 3oz6_A 321 ISANDALKH 329 (388)
T ss_dssp CCHHHHTTS
T ss_pred CCHHHHhCC
Confidence 999999865
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=348.19 Aligned_cols=262 Identities=22% Similarity=0.299 Sum_probs=200.3
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 5788899999999999999995 568999999886543 2234678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~~~~l~~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 158 (311)
T 4agu_A 83 YCDHTVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY 158 (311)
T ss_dssp CCSEEHHHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred eCCCchHHHHHhhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc
Confidence 99999999887543 57999999999999999999999996 999999999999999999999999999865533222
Q ss_pred cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh-----------hCc-cc
Q 004732 550 ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE-----------QGK-LM 616 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~-~~ 616 (733)
.....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||................. ... ..
T Consensus 159 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 159 -YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred -cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 234578999999999976 5689999999999999999999999976554433322211110 000 00
Q ss_pred ccccCCCCCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 ELVDTNPGSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 ~~~~~~~~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+.+..... ......+.+++.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000011100000 1123358899999999999999999999864
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=361.82 Aligned_cols=250 Identities=22% Similarity=0.347 Sum_probs=196.9
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCC--CCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQ--HPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|...+++.||||++... .......+.+|++++++++ |||||++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3468889999999999999999877999999998653 3344577899999999996 59999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|| +.+++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++......
T Consensus 135 ~E-~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EE-CCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred Ee-cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 99 67889999997654 7899999999999999999999986 99999999999996 5789999999998765433
Q ss_pred cc-cccccccCCCcccHHHHhh-----------CCCCccchhHhHHHHHHHHHhCCCCCCccch-hhHHHHHHHHHhhCc
Q 004732 548 TH-ISTRVAGTIGYMAPEYAMR-----------GHLTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLDWALVLKEQGK 614 (733)
Q Consensus 548 ~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~ 614 (733)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .... ........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~---~~~~~~~~ 285 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKL---HAIIDPNH 285 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH---HHHHCTTS
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHH---HHHhCccc
Confidence 22 2345679999999999875 3689999999999999999999999964321 1111 11111111
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...++......+.+++.+||+.||.+||++.|+++.
T Consensus 286 ---------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 286 ---------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ---------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111111112358889999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=349.11 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=205.7
Q ss_pred CccccCcccCCCcccEEEcccC-CC---cEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE-EEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLLA-DG---TAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL-LLI 467 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV 467 (733)
.|...+.||+|+||+||+|+.. ++ ..||+|.+.... ....+.+.+|++++++++||||+++++++.+++.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4556689999999999999843 23 379999987543 34457889999999999999999999999876655 999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+.+|+|.+++......+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 102 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp ECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 9999999999999876778999999999999999999999996 9999999999999999999999999998654332
Q ss_pred c---ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCC-CccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 548 T---HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV-TKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 548 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
. .......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+ ...+......... ..... ..
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~----~~~~~-----~~ 249 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA----QGRRL-----PQ 249 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH----TTCCC-----CC
T ss_pred ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh----cCCCC-----CC
Confidence 1 1223456889999999999999999999999999999999966665 4333333332211 11110 01
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 666 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 666 (733)
.... ...+.+++.+||+.||.+|||+.++++.|++....
T Consensus 250 ~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~ 288 (298)
T 3pls_A 250 PEYC----PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSA 288 (298)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Cccc----hHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1112 23588999999999999999999999999876543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=362.92 Aligned_cols=269 Identities=19% Similarity=0.233 Sum_probs=211.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC--eEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGN--QLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV 467 (733)
.++|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 35688889999999999999995 468999999987543 234577889999999999999999999998765 78999
Q ss_pred EEccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe----cCCCCeEEcccCccc
Q 004732 468 YEYLENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL----DKDLNSKISDFGLAK 541 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill----~~~~~~kl~DfGla~ 541 (733)
|||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999997432 34999999999999999999999996 9999999999999 777889999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhh--------CCCCccchhHhHHHHHHHHHhCCCCCCccch-hhHHHHHHHHHhh
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMR--------GHLTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLDWALVLKEQ 612 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~-~~~~~~~~~~~~~ 612 (733)
....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .............
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 6554322 234679999999999875 4678899999999999999999999943221 1111111111111
Q ss_pred Ccc--cccc------------cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 613 GKL--MELV------------DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 613 ~~~--~~~~------------~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
... ...+ +..............+.+++.+||+.||++||++.|+++.++.+.+
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 110 0000 0111223456777789999999999999999999999999886544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=350.47 Aligned_cols=262 Identities=25% Similarity=0.417 Sum_probs=200.6
Q ss_pred HHhhhcCccccCcccCCCcccEEEcccC----CCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG 461 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 461 (733)
+....++|...+.||+|+||.||+|+.. .+..||||.+... .....+.+.+|++++++++||||+++++++.+.
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence 3445678889999999999999999743 3458999998654 333456789999999999999999999999875
Q ss_pred C-----eEEEEEEccCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC
Q 004732 462 N-----QLLLIYEYLENNSLARALFE-----HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 531 (733)
Q Consensus 462 ~-----~~~lV~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 531 (733)
. ..++||||+++|+|.+++.. ....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~ 185 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMT 185 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSC
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCc
Confidence 5 35999999999999999853 3356999999999999999999999986 999999999999999999
Q ss_pred eEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHH
Q 004732 532 SKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVL 609 (733)
Q Consensus 532 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~ 609 (733)
+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.............
T Consensus 186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-- 263 (313)
T 3brb_A 186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-- 263 (313)
T ss_dssp EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH--
T ss_pred EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH--
Confidence 999999999865443222 2233567889999999999999999999999999999999 888986655444333211
Q ss_pred HhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 610 KEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.+..... ...+ ...+.+++.+||+.||.+||++.++++.|+....
T Consensus 264 --~~~~~~~-----~~~~----~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 264 --HGHRLKQ-----PEDC----LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp --TTCCCCC-----BTTC----CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --cCCCCCC-----Cccc----cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111 1112 2358899999999999999999999999986544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=342.87 Aligned_cols=249 Identities=27% Similarity=0.425 Sum_probs=184.5
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+. .+|+.||||.+.... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35788899999999999999984 679999999986432 12346789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++++|.+++......+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence 9999999999999877678999999999999999999999996 9999999999999999999999999998654322
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... ....... ..
T Consensus 167 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------------~~~~~~~--~~ 231 (278)
T 3cok_A 167 EK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------------KVVLADY--EM 231 (278)
T ss_dssp --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------------CCSSCC--CC
T ss_pred Cc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------------HHhhccc--CC
Confidence 21 234568999999999998889999999999999999999999996543322111 0000000 01
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+......+.+++.+||+.||++||++.++++
T Consensus 232 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 PSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 1112335889999999999999999999876
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=356.08 Aligned_cols=260 Identities=28% Similarity=0.399 Sum_probs=208.8
Q ss_pred HhhhcCccccCcccCCCcccEEEcccC-CC-----cEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEe
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGLLA-DG-----TAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIE 460 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 460 (733)
....++|...+.||+|+||.||+|+.. ++ ..||+|.+.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 121 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH 121 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence 345678899999999999999999843 22 479999987643 33456789999999999 89999999999999
Q ss_pred CCeEEEEEEccCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec
Q 004732 461 GNQLLLIYEYLENNSLARALFEH-------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD 527 (733)
Q Consensus 461 ~~~~~lV~e~~~~gsL~~~l~~~-------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~ 527 (733)
++..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~ 198 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLT 198 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEE
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEEC
Confidence 99999999999999999999743 346899999999999999999999986 99999999999999
Q ss_pred CCCCeEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHH
Q 004732 528 KDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDW 605 (733)
Q Consensus 528 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~ 605 (733)
.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |..||..........
T Consensus 199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~- 277 (333)
T 2i1m_A 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY- 277 (333)
T ss_dssp GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH-
T ss_pred CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH-
Confidence 9999999999999865443322 2334567889999999999999999999999999999999 899996543222111
Q ss_pred HHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 606 ALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.......... ..... ...+.+++.+||+.||.+|||+.|+++.|+..
T Consensus 278 --~~~~~~~~~~-----~~~~~----~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 278 --KLVKDGYQMA-----QPAFA----PKNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp --HHHHHTCCCC-----CCTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHhcCCCCC-----CCCCC----CHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111111110 01111 23588899999999999999999999999854
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=355.72 Aligned_cols=259 Identities=20% Similarity=0.240 Sum_probs=201.4
Q ss_pred HHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc-----ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-----SKQGNREFINEIGMISALQHPNLVKLYGCCIEG 461 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 461 (733)
+....++|...+.||+|+||.||+|+. .+++.||+|++... .....+.+.+|++++++++||||+++++++.++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 345567899999999999999999984 57889999998643 233456889999999999999999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHH
Q 004732 462 NQLLLIYEYLENNSLARALFEH---------------------------------------RLKLDWPTRRRICLGIARG 502 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~---------------------------------------~~~l~~~~~~~i~~~ia~~ 502 (733)
+..++||||+++|+|.+++... ...+++..++.++.|++.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988410 1123567788999999999
Q ss_pred HHHHHcCCCCCeecCCCCCCcEEecCCC--CeEEcccCccccCcccCc---ccccccccCCCcccHHHHhh--CCCCccc
Q 004732 503 LAYLHGESRIKVVHRDIKATNVLLDKDL--NSKISDFGLAKLDEEENT---HISTRVAGTIGYMAPEYAMR--GHLTEKA 575 (733)
Q Consensus 503 l~~LH~~~~~~ivH~Dik~~Nill~~~~--~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 575 (733)
|+|||+.+ |+||||||+||+++.++ .+||+|||+++....... .......||+.|+|||.+.+ ..++.++
T Consensus 181 l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 99999996 99999999999998776 899999999986543221 12345679999999999975 6789999
Q ss_pred hhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHH
Q 004732 576 DVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSS 655 (733)
Q Consensus 576 Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~ 655 (733)
|||||||++|||++|+.||............ ....... ..+ ........+.+++.+||+.||.+||++.|
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~---~~~~~~~--~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQV---LNKKLCF--ENP-----NYNVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHCCCCT--TSG-----GGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---Hhccccc--CCc-----ccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 9999999999999999999765544332211 1111100 000 00012235889999999999999999999
Q ss_pred HHHH
Q 004732 656 VLRM 659 (733)
Q Consensus 656 vl~~ 659 (733)
+++.
T Consensus 328 ~l~h 331 (345)
T 3hko_A 328 ALQH 331 (345)
T ss_dssp HHHS
T ss_pred HhcC
Confidence 9873
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=346.15 Aligned_cols=259 Identities=26% Similarity=0.449 Sum_probs=197.9
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||.||+|. ..+|+.||||++... .......+.+|++++++++||||+++++++.+++..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 468888999999999999998 467999999998653 2344567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 469 EYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 469 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
||+++|+|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999863 3557899999999999999999999996 99999999999999999999999999986544
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ......... ....... ...
T Consensus 189 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~-~~~~~~~----~~~ 261 (310)
T 2wqm_A 189 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIE-QCDYPPL----PSD 261 (310)
T ss_dssp -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHHHHH-TTCSCCC----CTT
T ss_pred CCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHHHhh-cccCCCC----ccc
Confidence 322 223456899999999999999999999999999999999999999644221 111111111 1111111 111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.++ ..+.+++.+||+.||++||++.+|++.|+.+..
T Consensus 262 ~~~----~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 262 HYS----EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp TSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccC----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 222 348889999999999999999999999986544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=348.66 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=206.0
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChh------cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ------GNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
.++|...+.||+|+||.||+|+. .+|+.||||.+...... ..+.+.+|+.++++++||||+++++++.++...
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 45688889999999999999994 57899999998654221 357799999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC----CeEEcccCcc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL----NSKISDFGLA 540 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~----~~kl~DfGla 540 (733)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred EEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 9999999999999999653 47899999999999999999999996 99999999999999887 7999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccccc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
+....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||............ .. ... . .+
T Consensus 167 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i---~~-~~~-~-~~ 238 (321)
T 2a2a_A 167 HEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI---TS-VSY-D-FD 238 (321)
T ss_dssp EECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH---HT-TCC-C-CC
T ss_pred eecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---Hh-ccc-c-cC
Confidence 86554322 23457999999999999999999999999999999999999999765544332211 11 000 0 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....... ...+.+++.+|++.||++|||+.|+++.
T Consensus 239 ~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 239 EEFFSHT----SELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp HHHHTTC----CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred hhhhccc----CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000111 2348899999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=347.59 Aligned_cols=258 Identities=26% Similarity=0.400 Sum_probs=204.5
Q ss_pred hcCccccCcccCCCcccEEEcccCC----CcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCeEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLAD----GTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIE-GNQLL 465 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 465 (733)
...|...+.||+|+||.||+|+..+ +..||+|.+... .....+.+.+|+.++++++||||++++++|.+ ++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 3467788999999999999998532 236899998754 33445778999999999999999999999754 56789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||+++|+|.+++......+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999999876778999999999999999999999996 99999999999999999999999999986654
Q ss_pred cCcc---cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhC-CCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 546 ENTH---ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSG-RSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 546 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
.... ......||+.|+|||.+.+..++.++||||||+++|||++| ..||...+........ ..+...
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----~~~~~~----- 251 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGRRL----- 251 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH----HTTCCC-----
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH----hcCCCC-----
Confidence 3221 23345678899999999999999999999999999999995 4555444433332211 111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
......+ ..+.+++.+||+.+|.+||++.|+++.|++...
T Consensus 252 ~~~~~~~----~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 291 (298)
T 3f66_A 252 LQPEYCP----DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291 (298)
T ss_dssp CCCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCC----HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0011122 348889999999999999999999999987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=364.67 Aligned_cols=247 Identities=25% Similarity=0.419 Sum_probs=204.9
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35788889999999999999995 479999999986432 12346789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 95 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 95 MEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp EECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 9999999999998643 47999999999999999999999986 9999999999999999999999999998655432
Q ss_pred cccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+........ . .+.. . ....
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i---~-~~~~-~-----~p~~ 238 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI---C-DGIF-Y-----TPQY 238 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH---H-TTCC-C-----CCTT
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH---h-cCCc-C-----CCcc
Confidence 2344679999999999988765 78999999999999999999999766544333211 1 1110 0 0111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.+ ..+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~s----~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 239 LN----PSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp CC----HHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC----HHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 22 34888999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=352.80 Aligned_cols=260 Identities=28% Similarity=0.416 Sum_probs=206.5
Q ss_pred hhcCccccCcccCCCcccEEEccc------CCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 463 (733)
..++|...+.||+|+||.||+|+. .++..||||.+... .......+.+|+.++++++||||+++++++.++..
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 346788899999999999999984 35778999999654 34455678999999999999999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC---CCCeEE
Q 004732 464 LLLIYEYLENNSLARALFEHR------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKI 534 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl 534 (733)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 999999999999999998543 45899999999999999999999996 999999999999984 446999
Q ss_pred cccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhh
Q 004732 535 SDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQ 612 (733)
Q Consensus 535 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 612 (733)
+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||..........+.. .
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~----~ 260 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT----S 260 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH----T
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHh----c
Confidence 99999975433222 22234568899999999999999999999999999999998 999997655444333221 1
Q ss_pred CcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004732 613 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 666 (733)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 666 (733)
+.... .....+ ..+.+++.+||+.||.+||++.++++.|+.....
T Consensus 261 ~~~~~-----~~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 261 GGRMD-----PPKNCP----GPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp TCCCC-----CCTTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCC-----CCCCCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 11111 111222 3488899999999999999999999999865443
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=349.12 Aligned_cols=255 Identities=30% Similarity=0.442 Sum_probs=203.9
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEE--EEEEcccc-ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAI--AVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 467 (733)
++|...+.||+|+||.||+|+. .++..+ |||.+... .....+.+.+|+++++++ +||||+++++++.+++..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5778889999999999999995 456644 99988653 233456789999999999 899999999999999999999
Q ss_pred EEccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCe
Q 004732 468 YEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 532 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 532 (733)
|||+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997543 47999999999999999999999986 9999999999999999999
Q ss_pred EEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHh
Q 004732 533 KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKE 611 (733)
Q Consensus 533 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 611 (733)
||+|||+++...... ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||............ .
T Consensus 182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~----~ 255 (327)
T 1fvr_A 182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL----P 255 (327)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG----G
T ss_pred EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh----h
Confidence 999999997433221 1233457889999999999889999999999999999998 99999766544332211 1
Q ss_pred hCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 612 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.+.. ...... ....+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 256 ~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 300 (327)
T 1fvr_A 256 QGYR-----LEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 300 (327)
T ss_dssp GTCC-----CCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCC-----CCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1110 111112 22458899999999999999999999999986544
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.49 Aligned_cols=266 Identities=26% Similarity=0.398 Sum_probs=208.8
Q ss_pred hcCccccCcccCCCcccEEEccc-----CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC--eE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-----ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGN--QL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 464 (733)
.++|...+.||+|+||.||+|++ .+|+.||||++........+.+.+|++++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35678889999999999999973 468899999998766666678999999999999999999999987654 67
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||+++++|.+++......+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~ 196 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLP 196 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence 9999999999999999877778999999999999999999999986 9999999999999999999999999998765
Q ss_pred ccCcc--cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC-------cc
Q 004732 545 EENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG-------KL 615 (733)
Q Consensus 545 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-------~~ 615 (733)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .... ..... .+
T Consensus 197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~-~~~~---~~~~~~~~~~~~~~ 272 (326)
T 2w1i_A 197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-FMRM---IGNDKQGQMIVFHL 272 (326)
T ss_dssp SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-HHHH---HCTTCCTHHHHHHH
T ss_pred ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-HHHh---hccccchhhhHHHH
Confidence 43322 123345778899999999988999999999999999999999988432110 0000 00000 00
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.+.+........+......+.+++.+||+.||++||++.|+++.|+++.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~ 321 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 321 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 0001100001111122345889999999999999999999999998643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=352.87 Aligned_cols=266 Identities=23% Similarity=0.313 Sum_probs=202.1
Q ss_pred HhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChh-----cHHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ-----GNREFINEIGMISALQHPNLVKLYGCCIEGN 462 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 462 (733)
....++|...+.||+|+||.||+|+. .+|+.||||.+...... ..+.+.+|+++++.++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 34457899999999999999999995 46899999998653221 1246789999999999999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++||||+++ +|.+++......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred ceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 99999999986 899988777678999999999999999999999997 99999999999999999999999999986
Q ss_pred CcccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
...... ......||+.|+|||.+.+. .++.++|||||||++|||++|..||...+.....................+.
T Consensus 162 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 162 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred ccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 644322 23346789999999999764 5899999999999999999999999766554433322211111110000000
Q ss_pred ---------CCCCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 622 ---------NPGSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 622 ---------~~~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......+ ......+.+++.+|++.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000011 1122468899999999999999999999875
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.25 Aligned_cols=260 Identities=24% Similarity=0.327 Sum_probs=205.6
Q ss_pred hhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-----CCceeeEeeEEEeCCe
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-----HPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~ 463 (733)
...++|...+.||+|+||+||+|+. .+++.||||++... ......+..|+++++.++ ||||+++++++...+.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~ 110 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDH 110 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTE
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCe
Confidence 4567899999999999999999994 67899999998643 344567788999999997 9999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC--------------
Q 004732 464 LLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-------------- 528 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-------------- 528 (733)
.++||||+ +++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 111 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 111 MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccc
Confidence 99999999 999999997543 46999999999999999999999986 999999999999975
Q ss_pred -----------CCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCcc
Q 004732 529 -----------DLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE 597 (733)
Q Consensus 529 -----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~ 597 (733)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 262 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTH 262 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCC
Confidence 788999999999864432 23467899999999999999999999999999999999999999766
Q ss_pred chhhHHHHHHHHHhhC-----------cccccccC------CCCCCCCHH---------------HHHHHHHHHHHhhcC
Q 004732 598 DMFYLLDWALVLKEQG-----------KLMELVDT------NPGSNFDKE---------------QVMVMINVALLCANA 645 (733)
Q Consensus 598 ~~~~~~~~~~~~~~~~-----------~~~~~~~~------~~~~~~~~~---------------~~~~l~~l~~~c~~~ 645 (733)
+............... .....++. -+....... ....+.+++.+||+.
T Consensus 263 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 263 EHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp SHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred cHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 5444332221111000 00000000 000000111 014577999999999
Q ss_pred CCCCCCCHHHHHH
Q 004732 646 SPTIRPSMSSVLR 658 (733)
Q Consensus 646 ~P~~RPt~~~vl~ 658 (733)
||++|||+.|+++
T Consensus 343 dP~~Rpta~elL~ 355 (360)
T 3llt_A 343 DPTLRPSPAELLK 355 (360)
T ss_dssp SGGGSCCHHHHTT
T ss_pred ChhhCCCHHHHhc
Confidence 9999999999875
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=372.54 Aligned_cols=253 Identities=25% Similarity=0.331 Sum_probs=206.5
Q ss_pred hhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
...++|...+.||+|+||.||+|+. .+|+.||||++... .......+.+|+++++.++|||||++++++.+++..+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 4567899999999999999999995 57999999998653 2234567889999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 466 LIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
+||||+++|+|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999999997543 35999999999999999999999996 9999999999999999999999999998665
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhH-HHHHHHHHhhCcccccccCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL-LDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 623 (733)
.... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......... ..
T Consensus 338 ~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~-~~--------- 405 (576)
T 2acx_A 338 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VP--------- 405 (576)
T ss_dssp TTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH-CC---------
T ss_pred cCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc-cc---------
Confidence 4322 2345799999999999998899999999999999999999999965432111 111111111 10
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRP-----SMSSVLR 658 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 658 (733)
..++......+.+++.+|++.||.+|| ++.||++
T Consensus 406 -~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 406 -EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred -ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 011111234588999999999999999 7788864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=345.17 Aligned_cols=256 Identities=20% Similarity=0.283 Sum_probs=197.0
Q ss_pred cCccc-cCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFAT-DNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~-~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 469 (733)
+.|.+ .+.||+|+||.||+|+ ..+++.||||++..........+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 45666 4789999999999998 557999999999766555667899999999985 79999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC---eEEcccCccccCccc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFGLAKLDEEE 546 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~---~kl~DfGla~~~~~~ 546 (733)
|+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+++.....
T Consensus 92 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 92 KMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred cCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999754 47899999999999999999999996 999999999999998776 999999999765422
Q ss_pred Cc------ccccccccCCCcccHHHHhh-----CCCCccchhHhHHHHHHHHHhCCCCCCccchhh------------HH
Q 004732 547 NT------HISTRVAGTIGYMAPEYAMR-----GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY------------LL 603 (733)
Q Consensus 547 ~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~------------~~ 603 (733)
.. .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... ..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 247 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN 247 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence 11 11223569999999999975 558899999999999999999999995442110 00
Q ss_pred HHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 604 DWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...... ..+.. ..... .... ....+.+++.+|++.||.+|||+.|+++.
T Consensus 248 ~~~~~i-~~~~~-~~~~~-~~~~----~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 248 MLFESI-QEGKY-EFPDK-DWAH----ISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHH-HHCCC-CCCHH-HHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHH-hccCc-ccCch-hccc----CCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 001111 11110 00000 0001 12358899999999999999999999874
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=350.09 Aligned_cols=258 Identities=23% Similarity=0.309 Sum_probs=203.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE----GNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 466 (733)
.++|...+.||+|+||.||+|+. .+|+.||||++........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 45788889999999999999994 6799999999876666667789999999999999999999999873 347899
Q ss_pred EEEccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 467 IYEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
||||+++|+|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999975 4567999999999999999999999996 999999999999999999999999998755
Q ss_pred cccCcc--------cccccccCCCcccHHHHhhCC---CCccchhHhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHh
Q 004732 544 EEENTH--------ISTRVAGTIGYMAPEYAMRGH---LTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKE 611 (733)
Q Consensus 544 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~s~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~ 611 (733)
...... ......||+.|+|||.+.... ++.++|||||||++|||++|+.||...... ..... .. .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~-~ 261 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL--AV-Q 261 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH--HH-H
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH--Hh-h
Confidence 322111 112345799999999987543 688999999999999999999999432110 00000 00 0
Q ss_pred hCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 612 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
. .. .. .....+ ...+.+++.+||+.||.+||++.++++.|+...
T Consensus 262 ~-~~-~~---~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~ 305 (317)
T 2buj_A 262 N-QL-SI---PQSPRH----SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305 (317)
T ss_dssp C-C---C---CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred c-cC-CC---CccccC----CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence 0 00 00 011112 235889999999999999999999999998654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=350.89 Aligned_cols=261 Identities=26% Similarity=0.389 Sum_probs=209.0
Q ss_pred HhhhcCccccCcccCCCcccEEEccc------CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEe
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIE 460 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 460 (733)
....++|...+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+++++++ +||||+++++++.+
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 102 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 102 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec
Confidence 34567899999999999999999963 456899999997643 33446789999999999 79999999999987
Q ss_pred CC-eEEEEEEccCCCCHHHHHHhcCC---------------CCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcE
Q 004732 461 GN-QLLLIYEYLENNSLARALFEHRL---------------KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNV 524 (733)
Q Consensus 461 ~~-~~~lV~e~~~~gsL~~~l~~~~~---------------~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Ni 524 (733)
.+ ..++||||+++|+|.+++..... .+++..++.++.|+++||+|||+.+ |+||||||+||
T Consensus 103 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Ni 179 (316)
T 2xir_A 103 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 179 (316)
T ss_dssp TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceE
Confidence 54 58999999999999999975433 2899999999999999999999986 99999999999
Q ss_pred EecCCCCeEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhH
Q 004732 525 LLDKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYL 602 (733)
Q Consensus 525 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~ 602 (733)
+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||........
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~ 259 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 259 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence 999999999999999986544322 22334568899999999999999999999999999999998 9999955432211
Q ss_pred HHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 603 LDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
. .... ..+..... .... ...+.+++.+||+.||.+|||+.|+++.|+.+.
T Consensus 260 ~--~~~~-~~~~~~~~-----~~~~----~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 309 (316)
T 2xir_A 260 F--CRRL-KEGTRMRA-----PDYT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309 (316)
T ss_dssp H--HHHH-HHTCCCCC-----CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H--HHHh-ccCccCCC-----CCCC----CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1111 11111111 1112 234888999999999999999999999998643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=351.43 Aligned_cols=261 Identities=21% Similarity=0.333 Sum_probs=199.1
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhc-HHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQG-NREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++|...+.||+|+||+||+|+. .+++.||||++....... ...+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 4688889999999999999995 478999999986543221 12456799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
++ |+|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....... .
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~ 156 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-T 156 (324)
T ss_dssp CS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-c
Confidence 98 5899999877778999999999999999999999996 99999999999999999999999999986543322 2
Q ss_pred ccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccc---cccc------
Q 004732 551 STRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM---ELVD------ 620 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~------ 620 (733)
.....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+.................. ....
T Consensus 157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (324)
T 3mtl_A 157 YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKT 236 (324)
T ss_dssp ------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHH
T ss_pred cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcc
Confidence 234568999999999987 568999999999999999999999997766555444333222111100 0000
Q ss_pred ---CCCCCCC----CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 621 ---TNPGSNF----DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 621 ---~~~~~~~----~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+...... .......+.+++.+|++.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 237 YNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp TCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0000000 0011235789999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=349.03 Aligned_cols=265 Identities=25% Similarity=0.331 Sum_probs=201.7
Q ss_pred hhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhC--CCCceeeEeeEEEeC----Ce
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL--QHPNLVKLYGCCIEG----NQ 463 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~----~~ 463 (733)
...++|...+.||+|+||.||+|+.. ++.||||++... ....+.+|.+++... +||||+++++++.+. ..
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 34568999999999999999999875 899999998543 234556666666655 899999999999987 78
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeecCCCCCCcEEecCCCCeEEcccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES-----RIKVVHRDIKATNVLLDKDLNSKISDFG 538 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dik~~Nill~~~~~~kl~DfG 538 (733)
.++||||+++|+|.+++... .+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 99999999999999999654 6899999999999999999999871 1139999999999999999999999999
Q ss_pred ccccCcccCccc---ccccccCCCcccHHHHhhCCCCcc------chhHhHHHHHHHHHhC----------CCCCCccch
Q 004732 539 LAKLDEEENTHI---STRVAGTIGYMAPEYAMRGHLTEK------ADVYSFGIVALEIVSG----------RSNVTKEDM 599 (733)
Q Consensus 539 la~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~s~Gvil~elltg----------~~p~~~~~~ 599 (733)
+++......... .....||+.|+|||.+.+...+.+ +|||||||++|||++| +.||.....
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~ 267 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcC
Confidence 997654432221 234579999999999988766665 9999999999999999 666632211
Q ss_pred --hhHHHHHHHHHhhCcccccccCCCCC-CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 600 --FYLLDWALVLKEQGKLMELVDTNPGS-NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 600 --~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
............ .. ..+.... ....+....+.+++.+||+.||.+|||+.||++.|+++.+
T Consensus 268 ~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 331 (337)
T 3mdy_A 268 SDPSYEDMREIVCI-KK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331 (337)
T ss_dssp SSCCHHHHHHHHTT-SC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCchhhhHHHHhh-hc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence 111111111111 11 1111111 1122556779999999999999999999999999986554
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=345.25 Aligned_cols=255 Identities=26% Similarity=0.373 Sum_probs=204.6
Q ss_pred hcCccccC-cccCCCcccEEEccc---CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 392 TNNFATDN-NIGEGGFGPVYKGLL---ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 392 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
.++|...+ .||+|+||.||+|.. .+++.||||.+.... ....+.+.+|+++++.++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 34666766 999999999999953 357899999987542 22356799999999999999999999999 667789
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 94 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 169 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRA 169 (291)
T ss_dssp EEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred EEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeecc
Confidence 999999999999999764 46999999999999999999999996 99999999999999999999999999986654
Q ss_pred cCccc--ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 546 ENTHI--STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 546 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
..... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||............ ..+....
T Consensus 170 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----~~~~~~~----- 240 (291)
T 1xbb_A 170 DENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML----EKGERMG----- 240 (291)
T ss_dssp TCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTTCCCC-----
T ss_pred CCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCCCC-----
Confidence 33322 223446789999999999889999999999999999999 99999766544433221 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.+......+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 241 ----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 278 (291)
T 1xbb_A 241 ----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278 (291)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11112335889999999999999999999999998543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=363.80 Aligned_cols=259 Identities=22% Similarity=0.321 Sum_probs=197.4
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------C
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------N 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 462 (733)
.++|...+.||+|+||+||+|+ ..+|+.||||++... .....+.+.+|+.+++.++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 4678899999999999999998 557899999998654 334456788999999999999999999999754 4
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++||||++++ |.+.+. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 141 ~~~lv~E~~~~~-l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred eEEEEEeCCCCC-HHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 679999999875 655553 35899999999999999999999996 99999999999999999999999999986
Q ss_pred CcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC------c--
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG------K-- 614 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------~-- 614 (733)
..... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+............... .
T Consensus 214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 54422 2345679999999999999999999999999999999999999997765443332211111000 0
Q ss_pred --ccccccCCCC-CC-----------------CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 --LMELVDTNPG-SN-----------------FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 --~~~~~~~~~~-~~-----------------~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+...+. .. ........+.+++.+|++.||++|||+.|+++.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000000 00 001124568999999999999999999999874
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=347.23 Aligned_cols=261 Identities=26% Similarity=0.424 Sum_probs=187.5
Q ss_pred hhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
...++|...+.||+|+||.||+|+. .+++.||||.+.... ......+.+|++++++++||||+++++++..++..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 3456888999999999999999984 578999999986542 33456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 468 YEYLENNSLARALFE-------HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~-------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 999999999999863 2446899999999999999999999986 999999999999999999999999999
Q ss_pred ccCcccCc----ccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC-c
Q 004732 541 KLDEEENT----HISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG-K 614 (733)
Q Consensus 541 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-~ 614 (733)
........ .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||............ ..... .
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~ 246 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT--LQNDPPS 246 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--HTSSCCC
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH--hccCCCc
Confidence 76543221 11234579999999999876 56899999999999999999999999655443322111 11110 0
Q ss_pred cc-ccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 LM-ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 ~~-~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. ...+......++ ..+.+++.+||+.||.+||++.++++.
T Consensus 247 ~~~~~~~~~~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 247 LETGVQDKEMLKKYG----KSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp TTC-----CCCCCCC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cccccccchhhhhhh----HHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00 011111112222 348889999999999999999999863
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=350.33 Aligned_cols=243 Identities=21% Similarity=0.332 Sum_probs=201.9
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh--------hcHHHHHHHHHHHHhCCCCceeeEeeEEEeC
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK--------QGNREFINEIGMISALQHPNLVKLYGCCIEG 461 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 461 (733)
..++|...+.||+|+||.||+|+ ..+++.||||.+..... .....+.+|++++++++||||+++++++.++
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 35678899999999999999998 56789999999865421 1224577899999999999999999999999
Q ss_pred CeEEEEEEccCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 462 NQLLLIYEYLENN-SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 462 ~~~~lV~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
+..++||||+.+| +|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRH-PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccc
Confidence 9999999999777 999988654 47999999999999999999999996 999999999999999999999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 619 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (733)
+....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... .....
T Consensus 178 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--------------~~~~~ 241 (335)
T 3dls_A 178 AYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--------------VEAAI 241 (335)
T ss_dssp EECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------------TTTCC
T ss_pred eECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------------Hhhcc
Confidence 86654332 234679999999999988776 88999999999999999999999543210 00001
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 620 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
. ....++ ..+.+++.+||+.||++|||+.++++.
T Consensus 242 ~--~~~~~~----~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 242 H--PPYLVS----KELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp C--CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred C--CCcccC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1 111122 348899999999999999999999885
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=350.48 Aligned_cols=262 Identities=22% Similarity=0.366 Sum_probs=200.1
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
++|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 4688889999999999999995 568999999985542 2334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 105 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 179 (331)
T 4aaa_A 105 FVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE- 179 (331)
T ss_dssp CCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred cCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcc-
Confidence 9999999887653 347999999999999999999999996 99999999999999999999999999986544322
Q ss_pred cccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHH------------HhhCccc
Q 004732 550 ISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVL------------KEQGKLM 616 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~------------~~~~~~~ 616 (733)
......||+.|+|||.+.+. .++.++|||||||++|||++|+.||............... .......
T Consensus 180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (331)
T 4aaa_A 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259 (331)
T ss_dssp ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence 22345689999999999875 6899999999999999999999999765543332211111 0000000
Q ss_pred ccccCCCCCCCCH-----HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 ELVDTNPGSNFDK-----EQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 ~~~~~~~~~~~~~-----~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+........ .....+.+++.+||+.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1111111111111 123468899999999999999999998763
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=350.20 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=204.5
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEe--------C
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIE--------G 461 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 461 (733)
++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+++++.++||||+++++++.+ .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5788899999999999999995 679999999986542 2234578899999999999999999999987 4
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 462 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
+..++||||+++ +|.+.+......+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 468999999985 788888766678999999999999999999999996 9999999999999999999999999998
Q ss_pred cCcccC---cccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccc-
Q 004732 542 LDEEEN---THISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM- 616 (733)
Q Consensus 542 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~- 616 (733)
...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......................
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 252 (351)
T 3mi9_A 173 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252 (351)
T ss_dssp ECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence 654322 122344678999999999976 458999999999999999999999997766554443332221111000
Q ss_pred --cc--------ccCCCCCCCCH-HH------HHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 --EL--------VDTNPGSNFDK-EQ------VMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 --~~--------~~~~~~~~~~~-~~------~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. ........... +. ...+.+++.+|++.||.+|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 00000000011 11 2347899999999999999999999874
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=351.02 Aligned_cols=247 Identities=24% Similarity=0.320 Sum_probs=178.9
Q ss_pred cCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEEccCCCC
Q 004732 398 DNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYLENNS 475 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gs 475 (733)
.+.||+|+||.||+|+. .+++.||||++... ....+.+|+.+++.+. ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999995 57899999998543 3467789999999997 9999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC---CeEEcccCccccCcccCccccc
Q 004732 476 LARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 476 L~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl~DfGla~~~~~~~~~~~~ 552 (733)
|.+++... ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||+++....... ...
T Consensus 93 L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~ 167 (325)
T 3kn6_A 93 LFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PLK 167 (325)
T ss_dssp HHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------
T ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-ccc
Confidence 99999765 47999999999999999999999986 99999999999998765 799999999986544322 233
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhh----HHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY----LLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+... ........ ..+... ......
T Consensus 168 ~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i-~~~~~~------~~~~~~ 240 (325)
T 3kn6_A 168 TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI-KKGDFS------FEGEAW 240 (325)
T ss_dssp ----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHH-TTTCCC------CCSHHH
T ss_pred ccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHH-HcCCCC------CCcccc
Confidence 4568999999999999999999999999999999999999996543210 11111111 111100 000000
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......+.+++.+|++.||.+|||+.|+++.
T Consensus 241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred cCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 1123458899999999999999999998754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=338.70 Aligned_cols=252 Identities=27% Similarity=0.377 Sum_probs=199.7
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
+.|....+||+|+||.||+|+ ..+++.||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 345566799999999999999 4678999999987665555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC-CCCeEEcccCccccCcccCc
Q 004732 472 ENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 472 ~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfGla~~~~~~~~ 548 (733)
++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 9999999997543 35678899999999999999999986 999999999999987 89999999999986543222
Q ss_pred ccccccccCCCcccHHHHhhCC--CCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGH--LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||..........+.... ... .+.....
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~-----~~~~~~~ 250 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM--FKV-----HPEIPES 250 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH--HCC-----CCCCCTT
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc--ccc-----ccccccc
Confidence 223457899999999997653 899999999999999999999999544322211111111 011 1111112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
. ...+.+++.+||+.||++||++.++++.
T Consensus 251 ~----~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 251 M----SAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp S----CHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred C----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 2 2358889999999999999999999763
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=341.03 Aligned_cols=250 Identities=29% Similarity=0.441 Sum_probs=198.4
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC-CeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG-NQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~ 470 (733)
.++|+..+.||+|+||.||+|+.. |+.||||.+.... ..+.+.+|++++++++||||+++++++.+. +..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 457888899999999999999874 8899999987543 446789999999999999999999997655 478999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 471 LENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 471 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
+++|+|.+++.... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 171 (278)
T 1byg_A 97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 171 (278)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc--
Confidence 99999999997543 23899999999999999999999986 9999999999999999999999999997544321
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
....+++.|+|||.+.+..++.++||||||+++|||++ |+.||............ ..+... ......
T Consensus 172 --~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~----~~~~~~-----~~~~~~- 239 (278)
T 1byg_A 172 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKGYKM-----DAPDGC- 239 (278)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH----TTTCCC-----CCCTTC-
T ss_pred --cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----hcCCCC-----CCcccC-
Confidence 23457889999999999999999999999999999998 99999665443332211 111111 111122
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
...+.+++.+||+.||.+||++.|+++.|+.+.
T Consensus 240 ---~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~ 272 (278)
T 1byg_A 240 ---PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272 (278)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHH
Confidence 235888999999999999999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-40 Score=355.06 Aligned_cols=254 Identities=23% Similarity=0.297 Sum_probs=203.3
Q ss_pred hcCccccCcccCCCcccEEEccc----CCCcEEEEEEccccC----hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCC
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGN 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 462 (733)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+++++++ +||||+++++++.++.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 46788999999999999999985 478999999986532 12335677899999999 6999999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++||||+++|+|.+++... ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999999754 47999999999999999999999986 99999999999999999999999999987
Q ss_pred CcccCcccccccccCCCcccHHHHhh--CCCCccchhHhHHHHHHHHHhCCCCCCccchhh-HHHHHHHHHhhCcccccc
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-LLDWALVLKEQGKLMELV 619 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 619 (733)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ............
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~------ 282 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE------ 282 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCC------
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccC------
Confidence 65544444455789999999999986 347899999999999999999999995432211 111111111110
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHHHh
Q 004732 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRP-----SMSSVLRML 660 (733)
Q Consensus 620 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~~L 660 (733)
+ .++......+.+++.+||+.||.+|| ++.|+++..
T Consensus 283 -~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 283 -P----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp -C----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred -C----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0 11112234578899999999999999 888887653
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=378.93 Aligned_cols=247 Identities=27% Similarity=0.373 Sum_probs=199.0
Q ss_pred CcccCCCcccEEEccc---CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLL---ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||+||+|.+ ..++.||||+++... ....++|.+|++++++++|||||+++++|. .+..++|||||++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 4799999999999964 356789999997642 334578999999999999999999999996 4568999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc--cc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH--IS 551 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~--~~ 551 (733)
|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........ ..
T Consensus 454 g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~ 529 (635)
T 4fl3_A 454 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 529 (635)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred CCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence 9999999654 47999999999999999999999996 999999999999999999999999999876543322 22
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
....||+.|+|||++.+..++.++|||||||++|||++ |+.||............ ..+..... +..
T Consensus 530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i----~~~~~~~~---------p~~ 596 (635)
T 4fl3_A 530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML----EKGERMGC---------PAG 596 (635)
T ss_dssp -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTTCCCCC---------CTT
T ss_pred cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCC---------CCC
Confidence 33457889999999999999999999999999999998 99999766554433221 12221111 111
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
....+.+++..||+.||++||++.+|++.|+..
T Consensus 597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 629 (635)
T 4fl3_A 597 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 629 (635)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 224588999999999999999999999999853
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=344.01 Aligned_cols=254 Identities=24% Similarity=0.419 Sum_probs=201.9
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
..++|...+.||+|+||.||+|+. .+++.||+|.+..........+.+|+++++.++||||+++++++.+++..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 346788999999999999999995 4689999999977666667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++++|.+++......+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 172 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-Q 172 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-H
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc-c
Confidence 99999999999876678999999999999999999999986 9999999999999999999999999976432211 1
Q ss_pred cccccccCCCcccHHHHh-----hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 550 ISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
......||+.|+|||.+. ...++.++||||||+++|||++|+.||...+....... .... ......
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~-~~~~~~----- 243 (302)
T 2j7t_A 173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK---IAKS-DPPTLL----- 243 (302)
T ss_dssp C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHHS-CCCCCS-----
T ss_pred ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHH---Hhcc-CCcccC-----
Confidence 123356899999999984 56789999999999999999999999966544332211 1111 111110
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+......+.+++.+||+.||.+|||+.++++.
T Consensus 244 --~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 244 --TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --CccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 111123358899999999999999999998763
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=344.83 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=198.7
Q ss_pred hcCccccCcccCCCcccEEEcccC--CCc--EEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA--DGT--AIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
.++|...+.||+|+||.||+|++. +++ .||||.+... .....+.+.+|++++++++||||+++++++.++. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 356788899999999999999843 333 6899988654 2334578899999999999999999999998765 8
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++|+||+++|+|.+++......+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccc
Confidence 8999999999999999876667999999999999999999999996 9999999999999999999999999998765
Q ss_pred ccCcc--cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 545 EENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 545 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
..... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...+........ ........
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~~~~~~~---- 245 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI---DKEGERLP---- 245 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---HTSCCCCC----
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH---HccCCCCC----
Confidence 43322 2234567889999999999889999999999999999999 99999766544333211 11111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.... ....+.+++.+||+.||.+||++.++++.|++.
T Consensus 246 -~~~~----~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 282 (291)
T 1u46_A 246 -RPED----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 282 (291)
T ss_dssp -CCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCcC----cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHh
Confidence 1112 234588999999999999999999999999854
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=338.94 Aligned_cols=250 Identities=24% Similarity=0.321 Sum_probs=201.3
Q ss_pred cCccccCcccCCCcccEEEcccC-CCcEEEEEEccccCh------hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK------QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
++|...+.||+|+||.||+|+.. +|+.||+|.+..... ...+.+.+|++++++++||||+++++++.++...+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46788899999999999999954 789999999865421 13578999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC----CeEEcccCccc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL----NSKISDFGLAK 541 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~----~~kl~DfGla~ 541 (733)
+||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++ .+||+|||++.
T Consensus 85 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 999999999999999654 47999999999999999999999986 99999999999998877 79999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
....... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||............ . .... . ...
T Consensus 161 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~-~~~~-~-~~~ 232 (283)
T 3bhy_A 161 KIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI---S-AVNY-D-FDE 232 (283)
T ss_dssp ECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---H-TTCC-C-CCH
T ss_pred eccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh---H-hccc-C-Ccc
Confidence 6544322 23456899999999999889999999999999999999999999765543332211 0 0000 0 000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
..... ....+.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 233 EYFSN----TSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp HHHTT----CCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccc----CCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 00001 1235889999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=353.40 Aligned_cols=254 Identities=15% Similarity=0.138 Sum_probs=206.0
Q ss_pred HHhhhcCccccCcccCCCcccEEEcc------cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC---CCceeeEeeEE
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGL------LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ---HPNLVKLYGCC 458 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~ 458 (733)
++...++|...+.||+|+||+||+|+ ..+++.||||++... ...++.+|+++++.++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 44556789999999999999999993 557899999999654 3457788888888887 99999999999
Q ss_pred EeCCeEEEEEEccCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC------
Q 004732 459 IEGNQLLLIYEYLENNSLARALFE----HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK------ 528 (733)
Q Consensus 459 ~~~~~~~lV~e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~------ 528 (733)
..++..++||||+++|+|.+++.. ....+++..++.++.||++||+|||+.+ ||||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 999999999999999999999974 3457999999999999999999999986 999999999999998
Q ss_pred -----CCCeEEcccCccccCcc-cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhH
Q 004732 529 -----DLNSKISDFGLAKLDEE-ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL 602 (733)
Q Consensus 529 -----~~~~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~ 602 (733)
++.+||+|||+|+.... ..........||++|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-- 291 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG-- 291 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT--
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC--
Confidence 89999999999975432 2222345567999999999999999999999999999999999999999543221
Q ss_pred HHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCC-CCHHHHHHHhccCcc
Q 004732 603 LDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIR-PSMSSVLRMLECGVD 665 (733)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~R-Pt~~~vl~~L~~~~~ 665 (733)
. ..+......... ...+.+++..|++.+|.+| |++.++.+.|+.+..
T Consensus 292 -----------~--~~~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~ 339 (365)
T 3e7e_A 292 -----------E--CKPEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQ 339 (365)
T ss_dssp -----------E--EEECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHH
T ss_pred -----------c--eeechhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHH
Confidence 0 001111111112 3346778889999999998 578888888885543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-40 Score=350.98 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=198.6
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|...+.||+|+||.||+|+. .+|+.||||.+..... .+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 45788889999999999999994 5789999999965432 245688888887 79999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC----CCeEEcccCccccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD----LNSKISDFGLAKLDEE 545 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~----~~~kl~DfGla~~~~~ 545 (733)
|+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+..+ +.+||+|||+++....
T Consensus 97 ~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~ 172 (342)
T 2qr7_A 97 LMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172 (342)
T ss_dssp CCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred CCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence 99999999999654 47999999999999999999999996 9999999999998543 3499999999986554
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||................ .+... . ..
T Consensus 173 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~-~~~~~-~-~~---- 244 (342)
T 2qr7_A 173 ENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG-SGKFS-L-SG---- 244 (342)
T ss_dssp TTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH-HCCCC-C-CS----
T ss_pred CCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc-cCCcc-c-Cc----
Confidence 322 2334678999999999988889999999999999999999999996532211111111111 11111 0 00
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.+.......+.+++.+|++.||++||++.|+++
T Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111112335889999999999999999999975
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=338.28 Aligned_cols=257 Identities=26% Similarity=0.393 Sum_probs=205.1
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 466 (733)
.++|...+.||+|+||.||+|+. .+|+.||+|.+... .....+.+.+|++++++++||||+++++++.+ +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 45788899999999999999995 57899999998654 23445678999999999999999999999865 568999
Q ss_pred EEEccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 467 IYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGES--RIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ..+|+||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999743 345999999999999999999999874 1239999999999999999999999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...+........ ..+.....
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i----~~~~~~~~--- 236 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI----REGKFRRI--- 236 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHTCCCCC---
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHH----hhcccccC---
Confidence 6544322 223456899999999999989999999999999999999999999766543332211 11221111
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
...+ ...+.+++.+||+.||++||++.||++.+..
T Consensus 237 --~~~~----~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~ 271 (279)
T 2w5a_A 237 --PYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLI 271 (279)
T ss_dssp --CTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred --Cccc----CHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence 1122 2358899999999999999999999987763
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=348.84 Aligned_cols=261 Identities=21% Similarity=0.300 Sum_probs=194.5
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh--hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK--QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
.++|...+.||+|+||+||+|+ ..+++.||||++..... .....+.+|++++++++||||+++++++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 4578888999999999999998 55789999999965432 22456789999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec-----CCCCeEEcccCccccC
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-----KDLNSKISDFGLAKLD 543 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~-----~~~~~kl~DfGla~~~ 543 (733)
||+++ +|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++..
T Consensus 113 e~~~~-~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp ECCSE-EHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred ecCCC-CHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99985 9999987553 6999999999999999999999996 99999999999994 4556999999999865
Q ss_pred cccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccc---cc-
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM---EL- 618 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~- 618 (733)
..... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...................... ..
T Consensus 188 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (329)
T 3gbz_A 188 GIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVT 266 (329)
T ss_dssp C------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred CCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhh
Confidence 43322 23345689999999999875 48999999999999999999999997665444332221111100000 00
Q ss_pred -----ccCCCC-CCCCHH------HHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 619 -----VDTNPG-SNFDKE------QVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 619 -----~~~~~~-~~~~~~------~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
....+. ...... ....+.+++.+|++.||++|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp GSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000 000000 1245789999999999999999999986
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=349.80 Aligned_cols=256 Identities=21% Similarity=0.374 Sum_probs=206.3
Q ss_pred HHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh--------hcHHHHHHHHHHHHhC-CCCceeeEeeE
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--------QGNREFINEIGMISAL-QHPNLVKLYGC 457 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~l~~~ 457 (733)
.....++|...+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+.+++++ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 344557899999999999999999996 4799999999865421 1135678899999999 79999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEccc
Q 004732 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 537 (733)
Q Consensus 458 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 537 (733)
+......++||||+++++|.+++... ..+++..+..++.||+.||.|||+.| |+||||||+||+++.++.+||+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~Df 244 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDF 244 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEec
Confidence 99999999999999999999999754 47999999999999999999999986 999999999999999999999999
Q ss_pred CccccCcccCcccccccccCCCcccHHHHhhC------CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh
Q 004732 538 GLAKLDEEENTHISTRVAGTIGYMAPEYAMRG------HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE 611 (733)
Q Consensus 538 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 611 (733)
|++........ .....||+.|+|||++.+. .++.++|||||||++|||++|+.||............. .
T Consensus 245 G~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~---~ 319 (365)
T 2y7j_A 245 GFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM---E 319 (365)
T ss_dssp TTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---H
T ss_pred CcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH---h
Confidence 99986654322 2446799999999998743 58889999999999999999999997655443332211 1
Q ss_pred hCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 612 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+... ...+. .... ...+.+++.+|++.||++||++.|+++.
T Consensus 320 -~~~~-~~~~~-~~~~----~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 320 -GQYQ-FSSPE-WDDR----SSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -TCCC-CCHHH-HSSS----CHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -CCCC-CCCcc-cccC----CHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1100 00000 0011 2348899999999999999999999873
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=353.27 Aligned_cols=261 Identities=21% Similarity=0.360 Sum_probs=203.7
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|...+.||+|+||.||+|+. .+++.||+|.+... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 46788999999999999999995 47899999998764 33445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
|+++|+|.+++... ..+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++.....
T Consensus 112 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp CCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 99999999999754 3689999999999999999999985 5 999999999999999999999999999754322
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh----------------
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ---------------- 612 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~---------------- 612 (733)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..............
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------------
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcc
Confidence 123457999999999999999999999999999999999999999655433221110000000
Q ss_pred ----------Ccccc----cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 613 ----------GKLME----LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 613 ----------~~~~~----~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+ .................+.+++.+||+.||++|||+.|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp ---------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000 000000000011123358899999999999999999999763
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=349.07 Aligned_cols=267 Identities=27% Similarity=0.401 Sum_probs=198.1
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHH--HHhCCCCceeeEeeEEEe-----CCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGM--ISALQHPNLVKLYGCCIE-----GNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~~~ 464 (733)
.++|...+.||+|+||.||+|+. +++.||||++.... ...+..|.++ +..++||||+++++++.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 46788899999999999999976 68999999986432 3445555555 445899999999987653 2357
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC------CCCeecCCCCCCcEEecCCCCeEEcccC
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES------RIKVVHRDIKATNVLLDKDLNSKISDFG 538 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~ivH~Dik~~Nill~~~~~~kl~DfG 538 (733)
++||||+++|+|.+++... ..++..+..++.|+++||+|||+.. ..+|+||||||+|||++.++.+||+|||
T Consensus 88 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 8999999999999999754 4589999999999999999999881 1139999999999999999999999999
Q ss_pred ccccCcccC-------cccccccccCCCcccHHHHhh-------CCCCccchhHhHHHHHHHHHhCCCCCCccchh----
Q 004732 539 LAKLDEEEN-------THISTRVAGTIGYMAPEYAMR-------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMF---- 600 (733)
Q Consensus 539 la~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~---- 600 (733)
+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 998654322 112234579999999999976 35677999999999999999998877332110
Q ss_pred -----------hHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 601 -----------YLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 601 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
...++............+.. ...........+.+++.+||+.||++|||+.|+++.|+++....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~ 320 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPE---AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW 320 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT---TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCc---ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence 00111111111111111111 11112335567999999999999999999999999999765543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=354.64 Aligned_cols=269 Identities=23% Similarity=0.352 Sum_probs=203.9
Q ss_pred hhhHHhhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccCh-----------hcHHHHHHHHHHHHhCCCCceee
Q 004732 385 YLQIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK-----------QGNREFINEIGMISALQHPNLVK 453 (733)
Q Consensus 385 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~ 453 (733)
..++....++|...+.||+|+||.||+|+..+|+.||||++..... ...+.+.+|++++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 4567888999999999999999999999987899999999854321 12367899999999999999999
Q ss_pred EeeEEEeC-----CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC
Q 004732 454 LYGCCIEG-----NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK 528 (733)
Q Consensus 454 l~~~~~~~-----~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~ 528 (733)
+++++... ...++||||++ |+|.+++......+++..+..++.||+.||+|||+.+ |+||||||+||+++.
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 169 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLAD 169 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECT
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcC
Confidence 99998653 36899999998 6888888876678999999999999999999999996 999999999999999
Q ss_pred CCCeEEcccCccccCcccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHH
Q 004732 529 DLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWAL 607 (733)
Q Consensus 529 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~ 607 (733)
++.+||+|||+++...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus 170 ~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~ 247 (362)
T 3pg1_A 170 NNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247 (362)
T ss_dssp TCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999997543322 2234578999999999987 679999999999999999999999997665444333222
Q ss_pred HHHhhCccc---------------ccccCCCCCC---CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 608 VLKEQGKLM---------------ELVDTNPGSN---FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 608 ~~~~~~~~~---------------~~~~~~~~~~---~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......... ......+... ........+.+++.+|++.||.+|||+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 248 EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111100 0000000000 001112358899999999999999999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=339.15 Aligned_cols=249 Identities=23% Similarity=0.342 Sum_probs=204.8
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 35678889999999999999995 46889999998653 233456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 94 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 169 (294)
T ss_dssp EECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCc
Confidence 9999999999988654 47999999999999999999999996 9999999999999999999999999998654322
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... . .. .... . .....
T Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--~-~~-~~~~-~-----~~~~~ 238 (294)
T 2rku_A 170 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL--R-IK-KNEY-S-----IPKHI 238 (294)
T ss_dssp C-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--H-HH-TTCC-C-----CCTTS
T ss_pred c-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-Hh-hccC-C-----Ccccc
Confidence 2 2234678999999999998889999999999999999999999997654432221 1 11 1110 0 11112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+.+++.+||+.||++||++.|+++.
T Consensus 239 ----~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 239 ----NPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 2347889999999999999999998753
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=339.04 Aligned_cols=247 Identities=26% Similarity=0.419 Sum_probs=203.5
Q ss_pred hcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe----------
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE---------- 460 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 460 (733)
.++|...+.||+|+||.||+|+.. +|+.||+|.+.... ..+.+|++++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 457888999999999999999954 79999999986543 356789999999999999999999864
Q ss_pred ------CCeEEEEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeE
Q 004732 461 ------GNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSK 533 (733)
Q Consensus 461 ------~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~k 533 (733)
....++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+|
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~k 162 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVK 162 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEE
Confidence 44589999999999999999743 457999999999999999999999986 99999999999999999999
Q ss_pred EcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC
Q 004732 534 ISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 613 (733)
Q Consensus 534 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 613 (733)
|+|||+++....... .....||+.|+|||.+.+..++.++||||||+++|||++|..|+..... +.... ...
T Consensus 163 l~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----~~~~~-~~~ 234 (284)
T 2a19_B 163 IGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK-----FFTDL-RDG 234 (284)
T ss_dssp ECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH-----HHHHH-HTT
T ss_pred ECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH-----HHHHh-hcc
Confidence 999999986654322 2345689999999999998999999999999999999999988732211 11111 111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
. ....++ ..+.+++.+||+.||.+||++.|+++.|+.+..
T Consensus 235 ~--------~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 235 I--------ISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp C--------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred c--------ccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 1 111222 247889999999999999999999999986544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=365.65 Aligned_cols=249 Identities=23% Similarity=0.325 Sum_probs=203.0
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
..++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|++++++++||||+++++++.+....++
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 262 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL 262 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence 457899999999999999999995 579999999986532 2345678899999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 467 IYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
||||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999999753 346999999999999999999999996 999999999999999999999999999865
Q ss_pred cccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHhhCcccccccCC
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ........... ...
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~-~~~------- 410 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE-QAV------- 410 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH-CCC-------
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh-ccc-------
Confidence 54322 233468999999999999999999999999999999999999999654221 11111111111 110
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHH
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMS 654 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~ 654 (733)
.++......+.+++.+|++.||++||++.
T Consensus 411 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 411 ---TYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred ---CCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 11112234588899999999999999763
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=341.16 Aligned_cols=251 Identities=27% Similarity=0.406 Sum_probs=201.9
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
..++|...+.||+|+||.||+|+. .+|+.||||.+.... ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 456788999999999999999985 468999999986543 34678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++++|.+++......+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 99999999999766678999999999999999999999986 99999999999999999999999999976544322
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......... .... ...... ..+.
T Consensus 181 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~-~~~~~~-------~~~~ 249 (314)
T 3com_A 181 KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF---MIPT-NPPPTF-------RKPE 249 (314)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHHH-SCCCCC-------SSGG
T ss_pred ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHhc-CCCccc-------CCcc
Confidence 2234578999999999998899999999999999999999999996554332211 1111 111000 0111
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.....+.+++.+||+.||.+||++.++++
T Consensus 250 ~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 250 LWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp GSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 12235889999999999999999999976
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=338.50 Aligned_cols=249 Identities=29% Similarity=0.456 Sum_probs=206.9
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.+.|...+.||+|+||.||+|+ ..+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 3467888999999999999998 4578999999986542 3445789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 101 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 174 (303)
T 3a7i_A 101 YLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 174 (303)
T ss_dssp CCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC-
T ss_pred eCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcccc-
Confidence 9999999999854 47899999999999999999999996 99999999999999999999999999986554322
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||............ ...... .....++
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~-----~~~~~~~- 244 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI----PKNNPP-----TLEGNYS- 244 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----HHSCCC-----CCCSSCC-
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh----hcCCCC-----CCccccC-
Confidence 223467899999999999999999999999999999999999999665443332211 111111 1112222
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..+.+++.+||+.||.+|||+.++++.
T Consensus 245 ---~~l~~li~~~l~~dp~~Rps~~~ll~~ 271 (303)
T 3a7i_A 245 ---KPLKEFVEACLNKEPSFRPTAKELLKH 271 (303)
T ss_dssp ---HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred ---HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 348899999999999999999999764
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=350.64 Aligned_cols=262 Identities=21% Similarity=0.327 Sum_probs=198.6
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC------
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN------ 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 462 (733)
.++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+++++.++||||+++++++..+.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35788889999999999999994 67999999998553 2334567889999999999999999999998653
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 177 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 177 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence 469999999 8899999875 46899999999999999999999996 99999999999999999999999999986
Q ss_pred CcccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc------
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL------ 615 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 615 (733)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.................
T Consensus 178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~ 253 (367)
T 1cm8_A 178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 253 (367)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 5432 234678999999999987 67999999999999999999999999766544433222111100000
Q ss_pred --------cccccCCCC---CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--hccC
Q 004732 616 --------MELVDTNPG---SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM--LECG 663 (733)
Q Consensus 616 --------~~~~~~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~--L~~~ 663 (733)
...+..... ..........+.+++.+|++.||++|||+.|+++. ++..
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~ 314 (367)
T 1cm8_A 254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 314 (367)
T ss_dssp SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence 000000000 00011123458899999999999999999999873 4443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=356.35 Aligned_cols=251 Identities=20% Similarity=0.263 Sum_probs=189.7
Q ss_pred cCcccc-CcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHH-hCCCCceeeEeeEEEe----CCeEE
Q 004732 393 NNFATD-NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMIS-ALQHPNLVKLYGCCIE----GNQLL 465 (733)
Q Consensus 393 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~~ 465 (733)
++|... +.||+|+||+||+|+. .+|+.||||++... ..+.+|++++. ..+||||++++++|.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 455554 6899999999999984 57899999998532 45678888874 4589999999999876 56789
Q ss_pred EEEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC---CCCeEEcccCccc
Q 004732 466 LIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAK 541 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~DfGla~ 541 (733)
+|||||++|+|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 9999999999999997543 46999999999999999999999986 999999999999998 7889999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..................+.. ....+
T Consensus 213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~-~~~~~ 289 (400)
T 1nxk_A 213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY-EFPNP 289 (400)
T ss_dssp ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC-CCCTT
T ss_pred ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc-cCCCc
Confidence 654322 224567899999999998889999999999999999999999999654322110000000011111 00000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..... ...+.+++.+||+.||++|||+.|+++.
T Consensus 290 -~~~~~----s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 290 -EWSEV----SEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp -TTTTS----CHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred -ccccC----CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01112 2358899999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=345.87 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=205.0
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+. .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 35678889999999999999995 46889999998653 233456788999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 120 ~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG 195 (335)
T ss_dssp ECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred EecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCc
Confidence 9999999999988654 47999999999999999999999996 9999999999999999999999999998654332
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........... ... ... ......
T Consensus 196 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~-~~~------~~~~~~ 264 (335)
T 2owb_A 196 E-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR---IKK-NEY------SIPKHI 264 (335)
T ss_dssp C-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHH-TCC------CCCTTS
T ss_pred c-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---Hhc-CCC------CCCccC
Confidence 2 22346799999999999998999999999999999999999999976543332211 111 110 011112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+ ..+.+++.+||+.||++||++.|+++
T Consensus 265 ~----~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 265 N----PVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp C----HHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred C----HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 2 34788999999999999999999876
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=342.52 Aligned_cols=251 Identities=22% Similarity=0.361 Sum_probs=203.4
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.++|...+.||+|+||.||+|+. .+|+.||+|.+..........+.+|++++++++||||+++++++.++...++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 35678889999999999999994 57899999999765444456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe---cCCCCeEEcccCccccCcccC
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfGla~~~~~~~ 547 (733)
+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||++ +.++.+||+|||+++.....
T Consensus 88 ~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~- 162 (304)
T 2jam_A 88 VSGGELFDRILER-GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG- 162 (304)
T ss_dssp CCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-
T ss_pred CCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-
Confidence 9999999998654 37899999999999999999999986 9999999999999 78889999999999754432
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ .. +.. .. ... .
T Consensus 163 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i---~~-~~~-~~-~~~----~ 230 (304)
T 2jam_A 163 --IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI---KE-GYY-EF-ESP----F 230 (304)
T ss_dssp --TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HH-CCC-CC-CTT----T
T ss_pred --ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH---Hc-CCC-CC-Ccc----c
Confidence 223356899999999999888999999999999999999999999765544333211 11 111 00 001 1
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.......+.+++.+|++.||++||++.|+++.
T Consensus 231 ~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 231 WDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11123458899999999999999999999863
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=337.16 Aligned_cols=246 Identities=22% Similarity=0.342 Sum_probs=203.8
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+. .+++.||||.+.... ......+.+|++++++++||||+++++++.+++..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 35788889999999999999985 467899999985431 22346789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++|+|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 93 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 168 (284)
T 2vgo_A 93 LEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR 168 (284)
T ss_dssp ECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred EEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence 9999999999999754 36899999999999999999999986 9999999999999999999999999987544322
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||........... ... .. .......
T Consensus 169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~-~~------~~~~~~~ 235 (284)
T 2vgo_A 169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR---IVN-VD------LKFPPFL 235 (284)
T ss_dssp ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH---HHT-TC------CCCCTTS
T ss_pred ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH---Hhc-cc------cCCCCcC
Confidence 2345789999999999998999999999999999999999999966544332211 111 10 0111112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+.+++.+|++.||.+||++.++++
T Consensus 236 ----~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 236 ----SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp ----CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ----CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 235889999999999999999999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=353.73 Aligned_cols=260 Identities=21% Similarity=0.306 Sum_probs=197.7
Q ss_pred HhhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG------ 461 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 461 (733)
....++|...+.||+|+||+||+|+ ..+|+.||||++..... ...+|+++++.++|||||+++++|...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 3456789999999999999999998 56899999999865422 234799999999999999999998543
Q ss_pred --------------------------------CeEEEEEEccCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHH
Q 004732 462 --------------------------------NQLLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYL 506 (733)
Q Consensus 462 --------------------------------~~~~lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~l~~L 506 (733)
...++||||++ |+|.+.+. .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34889999998 58877775 3456899999999999999999999
Q ss_pred HcCCCCCeecCCCCCCcEEec-CCCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHH
Q 004732 507 HGESRIKVVHRDIKATNVLLD-KDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVA 584 (733)
Q Consensus 507 H~~~~~~ivH~Dik~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil 584 (733)
|+.| |+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+||++
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 9986 99999999999998 688999999999986544332 2345789999999998875 499999999999999
Q ss_pred HHHHhCCCCCCccchhhHHHHHHHHHhhCcc----------cccccCCCCCC-----CCHHHHHHHHHHHHHhhcCCCCC
Q 004732 585 LEIVSGRSNVTKEDMFYLLDWALVLKEQGKL----------MELVDTNPGSN-----FDKEQVMVMINVALLCANASPTI 649 (733)
Q Consensus 585 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~-----~~~~~~~~l~~l~~~c~~~~P~~ 649 (733)
|||++|+.||...+................. .+..-+..... ++......+.+++.+||+.||++
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 9999999999766554433322211111100 00000000000 11112335889999999999999
Q ss_pred CCCHHHHHH
Q 004732 650 RPSMSSVLR 658 (733)
Q Consensus 650 RPt~~~vl~ 658 (733)
|||+.|+++
T Consensus 313 R~t~~e~l~ 321 (383)
T 3eb0_A 313 RINPYEAMA 321 (383)
T ss_dssp SCCHHHHHT
T ss_pred CCCHHHHhc
Confidence 999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=335.49 Aligned_cols=244 Identities=24% Similarity=0.386 Sum_probs=198.7
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+. .+++.||||.+... .......+.+|+..+..+ +||||+++++++.+++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 46788999999999999999995 47999999998753 233456788999999999 999999999999999999999
Q ss_pred EEccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC---------------
Q 004732 468 YEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD--------------- 529 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~--------------- 529 (733)
|||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999743 256899999999999999999999996 9999999999999844
Q ss_pred ----CCeEEcccCccccCcccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHH
Q 004732 530 ----LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD 604 (733)
Q Consensus 530 ----~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~ 604 (733)
..+||+|||.+....... ...||+.|+|||.+.+. .++.++|||||||++|||++|..|+.......
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~--- 238 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH--- 238 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---
T ss_pred cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---
Confidence 479999999998654432 23589999999999876 56789999999999999999988775443211
Q ss_pred HHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 605 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. ..+.... ....++ ..+.+++.+||+.||++|||+.|+++.
T Consensus 239 --~~--~~~~~~~-----~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 239 --EI--RQGRLPR-----IPQVLS----QEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp --HH--HTTCCCC-----CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --HH--HcCCCCC-----CCcccC----HHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 11 1111111 111222 348899999999999999999999764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=347.70 Aligned_cols=262 Identities=27% Similarity=0.353 Sum_probs=206.5
Q ss_pred hhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHh--CCCCceeeEeeEEEeCC----e
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISA--LQHPNLVKLYGCCIEGN----Q 463 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~ 463 (733)
...++|...+.||+|+||.||+|+. +|+.||||.+... ....+.+|++++.. ++||||+++++++.... .
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred cccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3456889999999999999999987 4899999998643 34678889999887 78999999999998876 7
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------cCCCCCeecCCCCCCcEEecCCCCeEEc
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH--------GESRIKVVHRDIKATNVLLDKDLNSKIS 535 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~ivH~Dik~~Nill~~~~~~kl~ 535 (733)
.++||||+++|+|.+++... .+++..++.++.|++.||+||| +.+ |+||||||+||+++.++.+||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEEC
T ss_pred eEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEE
Confidence 89999999999999999753 6899999999999999999999 664 9999999999999999999999
Q ss_pred ccCccccCcccCcc---cccccccCCCcccHHHHhhCC------CCccchhHhHHHHHHHHHhC----------CCCCCc
Q 004732 536 DFGLAKLDEEENTH---ISTRVAGTIGYMAPEYAMRGH------LTEKADVYSFGIVALEIVSG----------RSNVTK 596 (733)
Q Consensus 536 DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gvil~elltg----------~~p~~~ 596 (733)
|||+++........ ......||+.|+|||.+.+.. ++.++|||||||++|||++| +.||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 99999865543322 234457999999999997652 33689999999999999999 778844
Q ss_pred cch--hhHHHHHHHHHhhCcccccccCCCCC-CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 597 EDM--FYLLDWALVLKEQGKLMELVDTNPGS-NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 597 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
... .....+......... .+.... ....+....+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 270 LVPSDPSVEEMRKVVCEQKL-----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp TSCSSCCHHHHHHHHTTSCC-----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCcCcccHHHHHHHHHHHHh-----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 321 111222221111111 111111 1123556679999999999999999999999999986543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=362.80 Aligned_cols=250 Identities=24% Similarity=0.370 Sum_probs=199.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
.++|...+.||+|+||+||+|+. .++..||||++.... ......+.+|+++++.++|||||+++++|.++...++||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 34688889999999999999994 578999999986542 233567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC---CCeEEcccCccccCcc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD---LNSKISDFGLAKLDEE 545 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~---~~~kl~DfGla~~~~~ 545 (733)
|||++|+|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.. +.+||+|||+++....
T Consensus 116 e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 116 ECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred ecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999988654 47999999999999999999999996 9999999999999764 4599999999987654
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.. ......||+.|+|||++. ..++.++||||+||++|+|++|+.||............. .+... .......
T Consensus 192 ~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~----~~~~~--~~~~~~~ 262 (494)
T 3lij_A 192 QK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE----KGKYT--FDSPEWK 262 (494)
T ss_dssp TB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HTCCC--CCSGGGT
T ss_pred Cc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCC--CCchhcc
Confidence 32 234467999999999886 569999999999999999999999997765544432221 11110 0000011
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.. ...+.+++.+||+.||.+|||+.|+++
T Consensus 263 ~~----s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 263 NV----SEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp TS----CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cC----CHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 12 234889999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=351.18 Aligned_cols=260 Identities=23% Similarity=0.317 Sum_probs=191.2
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEe--------
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIE-------- 460 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~-------- 460 (733)
...+|...+.||+|+||.||+|+ ..+++.||||++........+.+.+|+.+++++. ||||+++++++..
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 34578889999999999999999 4578999999987666666678999999999996 9999999999953
Q ss_pred CCeEEEEEEccCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccC
Q 004732 461 GNQLLLIYEYLENNSLARALFE--HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFG 538 (733)
Q Consensus 461 ~~~~~lV~e~~~~gsL~~~l~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 538 (733)
....++||||+. |+|.+++.. ....+++.+++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg 183 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFG 183 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCc
Confidence 345899999996 789998864 4457999999999999999999999874 349999999999999999999999999
Q ss_pred ccccCcccCccc-----------ccccccCCCcccHHHH---hhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHH
Q 004732 539 LAKLDEEENTHI-----------STRVAGTIGYMAPEYA---MRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD 604 (733)
Q Consensus 539 la~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~ 604 (733)
+++......... .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||..........
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 263 (337)
T 3ll6_A 184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263 (337)
T ss_dssp TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence 998765432211 1135689999999998 56678999999999999999999999996543322111
Q ss_pred HHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccccc
Q 004732 605 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLD 668 (733)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~~ 668 (733)
. . ......... ...+.+++.+||+.||.+||++.|+++.|+.......
T Consensus 264 -------~-~----~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 264 -------G-K----YSIPPHDTQ----YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp --------------CCCCTTCCS----SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred -------C-c----ccCCccccc----chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 0 0 000011111 1237789999999999999999999999997665443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=346.82 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=202.1
Q ss_pred HhhhcCcccc-CcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCe
Q 004732 389 KAATNNFATD-NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 389 ~~~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 463 (733)
+...+.|... +.||+|+||.||+|+. .+|+.||||++... .......+.+|+.+++.++ ||||+++++++.+++.
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~ 103 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE 103 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe
Confidence 3444556665 8899999999999984 57899999998654 2334578899999999994 6999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC---CCCeEEcccCc
Q 004732 464 LLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGL 539 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~DfGl 539 (733)
.++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 104 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 99999999999999988633 457999999999999999999999996 999999999999998 78999999999
Q ss_pred cccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccc
Q 004732 540 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 619 (733)
Q Consensus 540 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (733)
++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+......... ......
T Consensus 181 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~--~~~~~~---- 252 (327)
T 3lm5_A 181 SRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS--QVNVDY---- 252 (327)
T ss_dssp CEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--HTCCCC----
T ss_pred ccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH--hccccc----
Confidence 986644322 234679999999999999999999999999999999999999997665433322111 100000
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 620 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
. ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 253 ~----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 253 S----EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C----TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred C----chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 01111123348889999999999999999999764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=375.52 Aligned_cols=258 Identities=26% Similarity=0.374 Sum_probs=207.6
Q ss_pred hhhcCccccCcccCCCcccEEEcccC----CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
...++|...+.||+|+||.||+|+.. .+..||||.+... .....+.|.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 34567889999999999999999853 2467999998754 3334467999999999999999999999985 4568
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||+++|+|.+++......+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999999877778999999999999999999999986 9999999999999999999999999998765
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
...........+|+.|+|||.+.+..++.++|||||||++|||++ |..||............. .+.....
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~----~~~~~~~----- 613 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE----NGERLPM----- 613 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH----HTCCCCC-----
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----cCCCCCC-----
Confidence 544333444567889999999999999999999999999999997 999997665444333221 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.... ...+.+++.+||+.||.+||++.++++.|+.+.
T Consensus 614 ~~~~----~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il 650 (656)
T 2j0j_A 614 PPNC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650 (656)
T ss_dssp CTTC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred Cccc----cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1112 235889999999999999999999999998643
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=363.08 Aligned_cols=251 Identities=24% Similarity=0.379 Sum_probs=203.4
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
.++|...+.||+|+||+||+|+. .+++.||||++... .......+.+|++++++++|||||++++++.++...++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 35688889999999999999994 57899999998543 2334578899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec---CCCCeEEcccCccccCcc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD---KDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~---~~~~~kl~DfGla~~~~~ 545 (733)
||+.+|+|.+.+... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++ .++.+||+|||+++....
T Consensus 101 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 176 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176 (486)
T ss_dssp CCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred EcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence 999999999988754 47999999999999999999999996 99999999999995 456799999999986544
Q ss_pred cCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.. ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||...+......... .+.... +...
T Consensus 177 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~----~~~~~~--~~~~-- 245 (486)
T 3mwu_A 177 NT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE----TGKYAF--DLPQ-- 245 (486)
T ss_dssp C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HTCCCS--CSGG--
T ss_pred CC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCCC--CCcc--
Confidence 32 2334579999999999865 69999999999999999999999997766554433221 111110 0000
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.......+.+++.+||+.||.+|||+.|+++.
T Consensus 246 --~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 246 --WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp --GGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred --cCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 01122358899999999999999999999874
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=360.54 Aligned_cols=253 Identities=22% Similarity=0.347 Sum_probs=191.5
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC--------hhcHHHHHHHHHHHHhCCCCceeeEeeEEEe
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--------KQGNREFINEIGMISALQHPNLVKLYGCCIE 460 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 460 (733)
...++|...+.||+|+||.||+|. ..+++.||||.+.... ......+.+|++++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 456789999999999999999998 4578999999986431 111235789999999999999999999975
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC---CeEEccc
Q 004732 461 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSKISDF 537 (733)
Q Consensus 461 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl~Df 537 (733)
.+..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DF 286 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 286 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred cCceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeec
Confidence 55689999999999999988543 47999999999999999999999986 99999999999997544 5999999
Q ss_pred CccccCcccCcccccccccCCCcccHHHHhh---CCCCccchhHhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHhhC
Q 004732 538 GLAKLDEEENTHISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKEQG 613 (733)
Q Consensus 538 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~ 613 (733)
|+++...... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ...... ..+
T Consensus 287 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i----~~~ 360 (419)
T 3i6u_A 287 GHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----TSG 360 (419)
T ss_dssp STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH----HTT
T ss_pred ccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH----hcC
Confidence 9998765432 2345679999999999853 56889999999999999999999999543221 111111 111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....... ... .....+.+++.+||+.||++||++.|+++.
T Consensus 361 ~~~~~~~--~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 361 KYNFIPE--VWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp CCCCCHH--HHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCCCch--hhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 1100000 000 112358899999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=356.96 Aligned_cols=241 Identities=14% Similarity=0.129 Sum_probs=189.9
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHH---HHHHhCCCCceeeEe-------e
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEI---GMISALQHPNLVKLY-------G 456 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~ 456 (733)
..++|...+.||+|+||.||+|+. .+|+.||||++... .....+.+.+|+ +++++++|||||+++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 456788899999999999999995 67999999998642 333457889999 555666899999998 6
Q ss_pred EEEeCC-----------------eEEEEEEccCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHcCCCCC
Q 004732 457 CCIEGN-----------------QLLLIYEYLENNSLARALFEHR------LKLDWPTRRRICLGIARGLAYLHGESRIK 513 (733)
Q Consensus 457 ~~~~~~-----------------~~~lV~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ 513 (733)
++.+++ ..++||||+ +|+|.+++.... ..+++..++.++.||++||+|||+.+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 666553 278999999 689999997532 12335888999999999999999996
Q ss_pred eecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhC-----------CCCccchhHhHHH
Q 004732 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-----------HLTEKADVYSFGI 582 (733)
Q Consensus 514 ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~s~Gv 582 (733)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999985332 2334567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 583 VALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 583 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
++|||++|+.||........ ...+.. .. ...+ ..+.+++.+||+.||++||++.|+++
T Consensus 302 il~elltg~~Pf~~~~~~~~------------~~~~~~-~~-~~~~----~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG------------SEWIFR-SC-KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CC------------SGGGGS-SC-CCCC----HHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccc------------hhhhhh-hc-cCCC----HHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 99999999999955432111 111111 11 1222 34888999999999999999999976
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=361.72 Aligned_cols=252 Identities=26% Similarity=0.368 Sum_probs=202.5
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh-------------hcHHHHHHHHHHHHhCCCCceeeEee
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK-------------QGNREFINEIGMISALQHPNLVKLYG 456 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~ 456 (733)
..++|...+.||+|+||+||+|+. .+++.||||++..... ...+.+.+|++++++++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 356788999999999999999994 5688999999865321 23467899999999999999999999
Q ss_pred EEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC---CeE
Q 004732 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL---NSK 533 (733)
Q Consensus 457 ~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~k 533 (733)
+|.++...++|||||++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+|
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEE
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999998754 47999999999999999999999996 99999999999998776 699
Q ss_pred EcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC
Q 004732 534 ISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 613 (733)
Q Consensus 534 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 613 (733)
|+|||+++...... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||...+......... .+
T Consensus 190 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~----~~ 262 (504)
T 3q5i_A 190 IVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE----KG 262 (504)
T ss_dssp ECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HC
T ss_pred EEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----cC
Confidence 99999998665432 234467999999999986 469999999999999999999999997766544433221 11
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.... ........ ...+.+++.+|++.||.+|||+.|+++.
T Consensus 263 ~~~~--~~~~~~~~----s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 263 KYYF--DFNDWKNI----SDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp CCCC--CHHHHTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCC--CccccCCC----CHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 1100 00000111 2358899999999999999999999753
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-40 Score=342.56 Aligned_cols=250 Identities=24% Similarity=0.386 Sum_probs=185.7
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-hhcH-HHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGN-REFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
..++|+..+.||+|+||.||+|+ ..+|+.||||++.... .... +.+.++...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 45678899999999999999999 4678999999986542 2222 3344455568888999999999999999999999
Q ss_pred EEccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 468 YEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
|||+++ +|.+++.. ....+++..+..++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999985 88777753 556899999999999999999999987 6 999999999999999999999999999865
Q ss_pred cccCcccccccccCCCcccHHHH----hhCCCCccchhHhHHHHHHHHHhCCCCCCccc-hhhHHHHHHHHHhhCccccc
Q 004732 544 EEENTHISTRVAGTIGYMAPEYA----MRGHLTEKADVYSFGIVALEIVSGRSNVTKED-MFYLLDWALVLKEQGKLMEL 618 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~ 618 (733)
..... .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||.... ..... .... ... ....
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~-~~~-~~~~ 234 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQL--KQVV-EEP-SPQL 234 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHH--HHHH-HSC-CCCC
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHH--HHHh-ccC-CCCc
Confidence 44322 2334699999999997 45678999999999999999999999996422 11111 1111 111 1111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 619 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 619 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+...+ ...+.+++.+||+.||++|||+.|+++
T Consensus 235 ----~~~~~----~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 235 ----PADKF----SAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ----CTTTS----CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----ccccC----CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11122 234889999999999999999999976
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=357.14 Aligned_cols=194 Identities=24% Similarity=0.424 Sum_probs=154.4
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----Ce
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQ 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 463 (733)
.++|...+.||+|+||+||+|+ ..+++.||||++... .....+.+.+|+++++.++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 3678999999999999999998 457899999998653 333457789999999999999999999999543 56
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.|+||||++ |+|.+++.. ...+++..+..++.||++||+|||+.+ ||||||||+|||++.++.+||+|||+|+..
T Consensus 132 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEEECCCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEEeccc-cchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhc
Confidence 899999985 689988864 457999999999999999999999996 999999999999999999999999999865
Q ss_pred cccCc--------------------------ccccccccCCCcccHHHHh-hCCCCccchhHhHHHHHHHHHhC
Q 004732 544 EEENT--------------------------HISTRVAGTIGYMAPEYAM-RGHLTEKADVYSFGIVALEIVSG 590 (733)
Q Consensus 544 ~~~~~--------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~elltg 590 (733)
..... ......+||+.|+|||++. ...++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 43211 1223467899999999874 56699999999999999999993
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=374.14 Aligned_cols=250 Identities=22% Similarity=0.316 Sum_probs=206.2
Q ss_pred hhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 464 (733)
...++|...+.||+|+||.||+|+. .+++.||||++... .......+..|.+++..+ +||||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 3457899999999999999999994 56889999998653 223346678899999988 799999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+...
T Consensus 418 ~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999999765 37999999999999999999999996 9999999999999999999999999998543
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...+.... .. ..
T Consensus 494 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i---~~-~~---------- 558 (674)
T 3pfq_A 494 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI---ME-HN---------- 558 (674)
T ss_dssp CTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HS-SC----------
T ss_pred cCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH---Hh-CC----------
Confidence 322 2244578999999999999999999999999999999999999999776654443321 11 11
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCH-----HHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSM-----SSVLR 658 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~-----~~vl~ 658 (733)
..++......+.+++.+|++.||++||++ .||.+
T Consensus 559 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 559 VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 01112223458899999999999999998 66653
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=338.42 Aligned_cols=251 Identities=29% Similarity=0.446 Sum_probs=203.0
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|...+.||+|+||.||+|+. .+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 35788889999999999999995 478999999986432 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc-
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT- 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~- 548 (733)
|+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 161 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence 9999999998854 346899999999999999999999986 99999999999999999999999999986543322
Q ss_pred ccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCCccchh--hHHHHHHHHHhhCcccccccCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMF--YLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ....|. ...... ....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~-----~~~~ 232 (276)
T 2yex_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK----EKKTYL-----NPWK 232 (276)
T ss_dssp CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHH----TTCTTS-----TTGG
T ss_pred hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhh----hccccc-----Cchh
Confidence 22345679999999999987664 77999999999999999999999654322 111111 111000 0001
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.....+.+++.+||+.||++|||+.|+++.
T Consensus 233 ----~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 233 ----KIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp ----GSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ----hcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 122347889999999999999999998763
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=364.45 Aligned_cols=251 Identities=26% Similarity=0.399 Sum_probs=205.8
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+. .+|+.||||++... .......+.+|++++++++|||||++++++.+....++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 35678889999999999999994 57899999998543 234567899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe---cCCCCeEEcccCccccCc
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---DKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfGla~~~~ 544 (733)
|||+.+|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 105 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp ECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred EecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999998654 47999999999999999999999996 9999999999999 567889999999998655
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
.... .....||+.|+|||++.+ .++.++||||+||++|+|++|+.||...+......... .+.... ....
T Consensus 181 ~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~----~~~~~~--~~~~- 250 (484)
T 3nyv_A 181 ASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE----KGKYTF--ELPQ- 250 (484)
T ss_dssp CCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCCCC--CSGG-
T ss_pred cccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH----cCCCCC--CCcc-
Confidence 4322 234579999999999865 79999999999999999999999997766554443221 111110 0000
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.......+.+++.+|++.+|.+|||+.|+++.
T Consensus 251 ---~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 251 ---WKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp ---GGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ---cccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 01122358899999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=342.44 Aligned_cols=256 Identities=16% Similarity=0.266 Sum_probs=198.9
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEe--CCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIE--GNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV 467 (733)
.++|...+.||+|+||+||+|+ ..+++.||||.+... ..+.+.+|++++++++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 3578889999999999999998 567899999998643 3467899999999997 9999999999998 6678999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-CeEEcccCccccCccc
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEE 546 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~~ 546 (733)
|||+++++|.+++. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 112 ~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred EeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 99999999999874 4889999999999999999999996 99999999999999777 7999999999865543
Q ss_pred CcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCcc-chhhHHHHHHHHHhhCcccc-------
Q 004732 547 NTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKE-DMFYLLDWALVLKEQGKLME------- 617 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~------- 617 (733)
.. .....||..|+|||.+.+ ..++.++|||||||++|||++|+.||... ...................+
T Consensus 185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 32 234578999999999987 67999999999999999999999999432 21111111000000000000
Q ss_pred --------ccc--------CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 618 --------LVD--------TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 618 --------~~~--------~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
... ..............+.+++.+|++.||++|||+.|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 000001111123458899999999999999999999873
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=335.01 Aligned_cols=252 Identities=21% Similarity=0.334 Sum_probs=204.0
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---------hhcHHHHHHHHHHHHhCC-CCceeeEeeEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---------KQGNREFINEIGMISALQ-HPNLVKLYGCCI 459 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 459 (733)
..++|...+.||+|+||.||+|+. .+|+.||||.+.... ....+.+.+|+++++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 346888999999999999999995 578999999986432 122356789999999996 999999999999
Q ss_pred eCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCc
Q 004732 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGL 539 (733)
Q Consensus 460 ~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 539 (733)
++...++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 170 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 170 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccc
Confidence 999999999999999999999754 47999999999999999999999996 99999999999999999999999999
Q ss_pred cccCcccCcccccccccCCCcccHHHHh------hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC
Q 004732 540 AKLDEEENTHISTRVAGTIGYMAPEYAM------RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 613 (733)
Q Consensus 540 a~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 613 (733)
+........ .....||+.|+|||.+. ...++.++||||||+++|||++|+.||............ .. +
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~-~ 244 (298)
T 1phk_A 171 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI---MS-G 244 (298)
T ss_dssp CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-T
T ss_pred hhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH---hc-C
Confidence 986544322 23457899999999986 346889999999999999999999999765543332211 11 1
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
... ... .........+.+++.+||+.||++||++.|+++
T Consensus 245 ~~~-~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 245 NYQ-FGS-----PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp CCC-CCT-----TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Ccc-cCc-----ccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 110 000 001122345889999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.53 Aligned_cols=202 Identities=23% Similarity=0.341 Sum_probs=174.7
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhC------CCCceeeEeeEEEeCCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISAL------QHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~ 464 (733)
..+|...+.||+|+||.||+|+ ..+++.||||++... ......+.+|+++++.+ +|+||+++++++......
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 4578899999999999999998 456899999999653 33446778888888877 577999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC--eEEcccCccc
Q 004732 465 LLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN--SKISDFGLAK 541 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~--~kl~DfGla~ 541 (733)
++||||+. ++|.+++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++. +||+|||+++
T Consensus 175 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp EEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred EEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999996 68999887543 45999999999999999999999986 999999999999999987 9999999997
Q ss_pred cCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhH
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL 602 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~ 602 (733)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+....
T Consensus 251 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~ 307 (429)
T 3kvw_A 251 YEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQ 307 (429)
T ss_dssp ETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred ecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence 54432 2346789999999999999999999999999999999999999976655443
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-40 Score=345.58 Aligned_cols=260 Identities=22% Similarity=0.372 Sum_probs=203.0
Q ss_pred HhhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
....++|...+.||+|+||.||+|+... .||+|.+.... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~i 106 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAI 106 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEE
Confidence 3456788999999999999999998653 59999986542 2233567889999999999999999999999999999
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++++|.+++......+++..++.++.|++.||+|||+.+ |+||||||+||+++ ++.+||+|||+++.....
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 99999999999999876668999999999999999999999996 99999999999998 679999999998754322
Q ss_pred C----cccccccccCCCcccHHHHhh---------CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC
Q 004732 547 N----THISTRVAGTIGYMAPEYAMR---------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG 613 (733)
Q Consensus 547 ~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 613 (733)
. ........||+.|+|||.+.. ..++.++|||||||++|||++|+.||........... . ..+
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~---~-~~~ 258 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ---M-GTG 258 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH---H-HTT
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---h-ccC
Confidence 1 112233568999999999874 3578999999999999999999999976554333211 1 111
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCccc
Q 004732 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDV 666 (733)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~ 666 (733)
........ ..+ ..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 259 ~~~~~~~~----~~~----~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 259 MKPNLSQI----GMG----KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp CCCCCCCS----SCC----TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred CCCCCCcC----CCC----HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 11111110 111 2388999999999999999999999999976553
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=333.01 Aligned_cols=248 Identities=24% Similarity=0.399 Sum_probs=196.6
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|...+.||+|+||.||+|+. .+|+.||||.+.... ......+.+|+++++.++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 35788889999999999999995 479999999986432 23346789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 9999999999999754 36899999999999999999999986 9999999999999999999999999998654432
Q ss_pred cccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
. .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||............ . .+.. . ....
T Consensus 166 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~-~~~~-~-----~~~~ 233 (276)
T 2h6d_A 166 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI---R-GGVF-Y-----IPEY 233 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H-HCCC-C-----CCTT
T ss_pred c--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh---h-cCcc-c-----Cchh
Confidence 2 234568999999999987665 68999999999999999999999765543332211 1 1110 0 1111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
. ...+.+++.+|++.||++|||+.|+++.
T Consensus 234 ~----~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 234 L----NRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp S----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred c----CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 2 2348889999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-39 Score=333.62 Aligned_cols=250 Identities=27% Similarity=0.414 Sum_probs=198.4
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE----GNQLL 465 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 465 (733)
+.|...+.||+|+||.||+|. ..++..||+|.+... .....+.+.+|+.++++++||||+++++++.. +...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 346777899999999999998 457889999998653 34445678999999999999999999999876 45689
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec-CCCCeEEcccCccccCc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-KDLNSKISDFGLAKLDE 544 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~~~kl~DfGla~~~~ 544 (733)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||+.+ .+|+||||||+||+++ .++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 999999999999999754 47899999999999999999999884 3499999999999998 78899999999997544
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
... .....||+.|+|||.+. +.++.++|||||||++|+|++|+.||......... ..... .+......+.
T Consensus 184 ~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~-~~~~~~~~~~--- 253 (290)
T 1t4h_A 184 ASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVT-SGVKPASFDK--- 253 (290)
T ss_dssp TTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHT-TTCCCGGGGG---
T ss_pred ccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HHHHh-ccCCccccCC---
Confidence 322 23456999999999876 46999999999999999999999999653322111 11111 1111111111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. ...+.+++.+||+.||.+|||+.|+++.
T Consensus 254 -~~----~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 254 -VA----IPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -CC----CHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -CC----CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 11 1348899999999999999999999863
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=354.30 Aligned_cols=254 Identities=10% Similarity=0.016 Sum_probs=183.1
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh---hcHHHHHHHHHHHHhC--CCCceeeEe-------eEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISAL--QHPNLVKLY-------GCC 458 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~ 458 (733)
..+|...+.||+|+||.||+|+ ..+|+.||||++..... ...+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 4458889999999999999999 45789999999976432 2345677785544444 699988755 455
Q ss_pred EeC-----------------CeEEEEEEccCCCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHcCCCCCee
Q 004732 459 IEG-----------------NQLLLIYEYLENNSLARALFEHRLKLDWPTR------RRICLGIARGLAYLHGESRIKVV 515 (733)
Q Consensus 459 ~~~-----------------~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~iv 515 (733)
..+ ...++||||++ |+|.+++......+++..+ ..++.||++||+|||+.+ |+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv 216 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV 216 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence 443 33899999999 8999999865556677777 888899999999999996 99
Q ss_pred cCCCCCCcEEecCCCCeEEcccCccccCcccCcccccccccCCCcccHHHHhh--CCCCccchhHhHHHHHHHHHhCCCC
Q 004732 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSN 593 (733)
Q Consensus 516 H~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~p 593 (733)
||||||+|||++.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P 292 (371)
T 3q60_A 217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292 (371)
T ss_dssp ETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence 99999999999999999999999998654322 13457799999999987 6799999999999999999999999
Q ss_pred CCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 594 VTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
|..........|. .......................+.+++.+||+.||++|||+.|+++
T Consensus 293 f~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 293 FGLVTPGIKGSWK-----RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp TTBCCTTCTTCCC-----BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCcCcccccchh-----hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9655321100000 00000000001111111122345889999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=352.95 Aligned_cols=198 Identities=24% Similarity=0.424 Sum_probs=166.5
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----Ce
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQ 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 463 (733)
.++|...+.||+|+||.||+|+ ..+++.||||++... .....+.+.+|++++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4578899999999999999998 457889999999653 333457889999999999999999999999876 57
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.|+||||++ |+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~ 179 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI 179 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence 899999987 599998864 457999999999999999999999996 999999999999999999999999999876
Q ss_pred cccCcc---------------------cccccccCCCcccHHHHh-hCCCCccchhHhHHHHHHHHHhCCCCC
Q 004732 544 EEENTH---------------------ISTRVAGTIGYMAPEYAM-RGHLTEKADVYSFGIVALEIVSGRSNV 594 (733)
Q Consensus 544 ~~~~~~---------------------~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~s~Gvil~elltg~~p~ 594 (733)
...... ......||+.|+|||++. ...++.++||||+||++|||++|..||
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 443211 134567999999999874 556999999999999999999865444
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=336.57 Aligned_cols=251 Identities=27% Similarity=0.442 Sum_probs=194.9
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe----------
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE---------- 460 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------- 460 (733)
.++|...+.||+|+||.||+|+. .+|+.||||.+... ....+.+.+|++++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 45788899999999999999994 57999999998643 3445778999999999999999999999875
Q ss_pred ---CCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEccc
Q 004732 461 ---GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 537 (733)
Q Consensus 461 ---~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 537 (733)
....++||||+++|+|.+++......+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeC
Confidence 35689999999999999999877777899999999999999999999996 999999999999999999999999
Q ss_pred CccccCcccC-------------cccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccc-hhhH
Q 004732 538 GLAKLDEEEN-------------THISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKED-MFYL 602 (733)
Q Consensus 538 Gla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~-~~~~ 602 (733)
|+++...... ........||+.|+|||.+.+. .++.++|||||||++|||++ ||.... ....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~ 237 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI 237 (303)
T ss_dssp CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence 9998654321 1122345689999999999864 68999999999999999998 554321 1111
Q ss_pred HHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 603 LDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
. ..... .. ......++......+.+++.+||+.||.+|||+.++++.
T Consensus 238 ~---~~~~~-~~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 238 L---KKLRS-VS------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp H---HHHHS-TT------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred H---Hhccc-cc------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 1 11111 00 011111222333457899999999999999999999874
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=346.45 Aligned_cols=262 Identities=22% Similarity=0.340 Sum_probs=203.4
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----CeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 464 (733)
.++|...+.||+|+||.||+|+ ..+++.||||++.... ......+.+|++++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 4578899999999999999998 4578899999987533 33446789999999999999999999999765 468
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||++ |+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 106 ~iv~e~~~-~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp EEEEECCS-EEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEcccC-cCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 99999998 4899988653 6999999999999999999999996 9999999999999999999999999998765
Q ss_pred ccCccc--ccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccc----
Q 004732 545 EENTHI--STRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME---- 617 (733)
Q Consensus 545 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 617 (733)
...... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+...................
T Consensus 180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 259 (364)
T 3qyz_A 180 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI 259 (364)
T ss_dssp GGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred CCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence 433221 344679999999998765 4589999999999999999999999976654444332221111100000
Q ss_pred -------cccCCC-CCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 618 -------LVDTNP-GSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 618 -------~~~~~~-~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.....+ ....+ ......+.+++.+|++.||++|||+.|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00011 1112358899999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=345.86 Aligned_cols=257 Identities=21% Similarity=0.325 Sum_probs=193.3
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC------
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN------ 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 462 (733)
.++|...+.||+|+||.||+|+ ..+++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 3578889999999999999998 457899999998653 2334567889999999999999999999998654
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++||||+++ +|.+.+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 78999999985 6877774 35899999999999999999999996 99999999999999999999999999986
Q ss_pred CcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc-c-----
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL-M----- 616 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~----- 616 (733)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...... ......+.. .
T Consensus 177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~ 252 (371)
T 2xrw_A 177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN--KVIEQLGTPCPEFMKK 252 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHC-CCCCCHHHHTT
T ss_pred ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHHHHHH
Confidence 54322 2334679999999999999999999999999999999999999997665433221 111100000 0
Q ss_pred ------ccccCCCC---------------C---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 ------ELVDTNPG---------------S---NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 ------~~~~~~~~---------------~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......+. . .........+.+++.+|++.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 253 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp SCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred hhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 00000000 0 0011224578999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=346.05 Aligned_cols=258 Identities=24% Similarity=0.370 Sum_probs=185.9
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------C
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG------N 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 462 (733)
.++|...+.||+|+||.||+|+ ..+|+.||||++... .....+.+.+|+++++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 3678889999999999999998 567899999998653 333456788999999999999999999999754 5
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~ 181 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARH 181 (367)
T ss_dssp CCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC------
T ss_pred eEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccc
Confidence 679999999 6899998864 47999999999999999999999986 99999999999999999999999999986
Q ss_pred CcccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc------
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL------ 615 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 615 (733)
.... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+.................
T Consensus 182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~ 257 (367)
T 2fst_X 182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 257 (367)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence 5432 234678999999999987 67999999999999999999999999776554433322211111000
Q ss_pred --------cccccCCCCCCCC---HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 616 --------MELVDTNPGSNFD---KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 616 --------~~~~~~~~~~~~~---~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+...+...+. ......+.+++.+|++.||.+|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0000000000000 0112357899999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=342.31 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=200.1
Q ss_pred hHHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEe----
Q 004732 387 QIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIE---- 460 (733)
Q Consensus 387 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 460 (733)
++....++|...+.||+|+||.||+|+. .+|+.||||.+.... .....+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3445678899999999999999999994 578999999986543 2346789999999999 89999999999987
Q ss_pred --CCeEEEEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEccc
Q 004732 461 --GNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 537 (733)
Q Consensus 461 --~~~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 537 (733)
....++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeC
Confidence 46889999999999999999754 357899999999999999999999996 999999999999999999999999
Q ss_pred CccccCcccCcccccccccCCCcccHHHHh-----hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh
Q 004732 538 GLAKLDEEENTHISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 612 (733)
Q Consensus 538 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 612 (733)
|++........ ......||+.|+|||.+. +..++.++|||||||++|||++|+.||........... ...
T Consensus 174 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~- 248 (326)
T 2x7f_A 174 GVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---IPR- 248 (326)
T ss_dssp TTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHH-
T ss_pred cCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH---hhc-
Confidence 99986543221 223457899999999987 56789999999999999999999999966544332211 111
Q ss_pred CcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 613 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....... ...++ ..+.+++.+||+.||.+||++.++++.
T Consensus 249 ~~~~~~~----~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 249 NPAPRLK----SKKWS----KKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp SCCCCCS----CSCSC----HHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CccccCC----ccccC----HHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111111 11222 348899999999999999999999873
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=349.55 Aligned_cols=258 Identities=21% Similarity=0.328 Sum_probs=200.4
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC--------CCceeeEeeEEE---
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ--------HPNLVKLYGCCI--- 459 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~--- 459 (733)
.++|...+.||+|+||+||+|+ ..+++.||||++... ......+.+|+++++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 3678899999999999999998 567899999999653 344567889999999986 788999999988
Q ss_pred -eCCeEEEEEEccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeecCCCCCCcEEecCCC------
Q 004732 460 -EGNQLLLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDL------ 530 (733)
Q Consensus 460 -~~~~~~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dik~~Nill~~~~------ 530 (733)
++...++||||+ +++|.+++.. ....+++..++.++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhh
Confidence 456789999999 5566665553 346799999999999999999999997 6 99999999999999775
Q ss_pred -------------------------------------------CeEEcccCccccCcccCcccccccccCCCcccHHHHh
Q 004732 531 -------------------------------------------NSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 567 (733)
Q Consensus 531 -------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~ 567 (733)
.+||+|||+++..... .....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999865433 23357899999999999
Q ss_pred hCCCCccchhHhHHHHHHHHHhCCCCCCccchh------hHHHHHHHHHhh--------C-ccccccc----------CC
Q 004732 568 RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF------YLLDWALVLKEQ--------G-KLMELVD----------TN 622 (733)
Q Consensus 568 ~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~------~~~~~~~~~~~~--------~-~~~~~~~----------~~ 622 (733)
+..++.++|||||||++|||++|+.||...... ............ + ....... ..
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 346 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK 346 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence 999999999999999999999999999543311 111111100000 0 0000000 00
Q ss_pred C---------CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 623 P---------GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 623 ~---------~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
+ ....+......+.+++.+||+.||++|||+.|+++
T Consensus 347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0 01235566778999999999999999999999986
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=341.59 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=195.4
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh--------hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK--------QGNREFINEIGMISALQHPNLVKLYGCCIEGN 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 462 (733)
.++|...+.||+|+||.||+|+. .+++.||||.+..... .....+.+|++++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 45788999999999999999984 5689999999865321 12245889999999999999999999987655
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC---eEEcccCc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFGL 539 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~---~kl~DfGl 539 (733)
.++||||+++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred -eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 89999999999999988643 47999999999999999999999986 999999999999987664 99999999
Q ss_pred cccCcccCcccccccccCCCcccHHHHh---hCCCCccchhHhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHhhCcc
Q 004732 540 AKLDEEENTHISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKEQGKL 615 (733)
Q Consensus 540 a~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~ 615 (733)
++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...... .+.... ..+..
T Consensus 164 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~~~~ 237 (322)
T 2ycf_A 164 SKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----TSGKY 237 (322)
T ss_dssp CEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH----HHTCC
T ss_pred ceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH----HhCcc
Confidence 98654322 223457999999999985 456899999999999999999999999543321 111111 11111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..... .... ....+.+++.+||+.||++||++.++++.
T Consensus 238 ~~~~~--~~~~----~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 238 NFIPE--VWAE----VSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp CCCHH--HHTT----SCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ccCch--hhhh----cCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 00000 0001 12358899999999999999999999763
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=339.26 Aligned_cols=263 Identities=25% Similarity=0.387 Sum_probs=202.5
Q ss_pred hhhcCccccCcccCCCcccEEEccc--CCCcEEEEEEccccC--hhcHHHHHHHHHHHHhC---CCCceeeEeeEEE---
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL--ADGTAIAVKQLSSKS--KQGNREFINEIGMISAL---QHPNLVKLYGCCI--- 459 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~--- 459 (733)
.+.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4567899999999999999999985 468899999986432 11223566777777666 8999999999987
Q ss_pred --eCCeEEEEEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcc
Q 004732 460 --EGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISD 536 (733)
Q Consensus 460 --~~~~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 536 (733)
.....++||||++ |+|.+++.... ..+++..+..++.|++.||+|||+.| |+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567899999998 69999997543 35999999999999999999999996 99999999999999999999999
Q ss_pred cCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccc
Q 004732 537 FGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM 616 (733)
Q Consensus 537 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 616 (733)
||+++...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......................
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 99998655332 2344678999999999999999999999999999999999999997665544333222111100000
Q ss_pred cc----------ccC---CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 617 EL----------VDT---NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 617 ~~----------~~~---~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.. ... .....+.......+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00 000 0000011122345789999999999999999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=352.47 Aligned_cols=256 Identities=24% Similarity=0.297 Sum_probs=193.4
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------CeEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG------NQLL 465 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 465 (733)
.+|...+.||+|+||.||+|+. .+|+.||||++..... .+.+|+++++.++|||||+++++|... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 3577889999999999999995 5689999999865322 234799999999999999999998642 2367
Q ss_pred EEEEccCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC-CCeEEcccCccc
Q 004732 466 LIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAK 541 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfGla~ 541 (733)
+||||+++ ++.+.+. .....+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999986 5655554 34568999999999999999999999986 9999999999999965 568999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh---------
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE--------- 611 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~--------- 611 (733)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+.............
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~ 283 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6543322 2346789999999999765 799999999999999999999999976654332221111100
Q ss_pred -hCcccccccCCCCCC-----CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 612 -QGKLMELVDTNPGSN-----FDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 612 -~~~~~~~~~~~~~~~-----~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.....+...+..... +.......+.+++.+||+.||.+||++.|+++
T Consensus 284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000011100000000 11112346889999999999999999999985
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=351.60 Aligned_cols=258 Identities=23% Similarity=0.300 Sum_probs=195.5
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe------EEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ------LLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~l 466 (733)
.+|...+.||+|+||+||+|+...+..||+|++..... ...+|+++++.++||||++++++|..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46788899999999999999987777799998854322 22369999999999999999999975433 789
Q ss_pred EEEccCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec-CCCCeEEcccCccccC
Q 004732 467 IYEYLENNSLARALF--EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-KDLNSKISDFGLAKLD 543 (733)
Q Consensus 467 V~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~~~kl~DfGla~~~ 543 (733)
||||++++.+..... .....+++..+..++.||++||+|||+.+ |+||||||+|||++ .++.+||+|||+|+..
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 999999865544332 34568999999999999999999999996 99999999999999 7899999999999865
Q ss_pred cccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC---------
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG--------- 613 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------- 613 (733)
..... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||...+...............
T Consensus 193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 44322 2345789999999999765 59999999999999999999999997665443322211111000
Q ss_pred -cccccccCCCC-C----CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 614 -KLMELVDTNPG-S----NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 614 -~~~~~~~~~~~-~----~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+..-+... . .+.......+.+++.+||+.||.+|||+.|+++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000000 0 0111123468899999999999999999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=333.15 Aligned_cols=250 Identities=22% Similarity=0.308 Sum_probs=199.1
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC----hhcHHHHHHHHHHHHhCCCCceeeEeeEEE--eCCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS----KQGNREFINEIGMISALQHPNLVKLYGCCI--EGNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 464 (733)
.++|...+.||+|+||.||+|.. .+++.||||.+.... ......+.+|++++++++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 36889999999999999999995 578999999986542 234577899999999999999999999985 44678
Q ss_pred EEEEEccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 465 LLIYEYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
++||||++++ |.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999987 7676654 3457999999999999999999999996 999999999999999999999999999865
Q ss_pred cccC-cccccccccCCCcccHHHHhhCC--CCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccccc
Q 004732 544 EEEN-THISTRVAGTIGYMAPEYAMRGH--LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 544 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
.... ........||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...+........ ..+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i----~~~~~-~--- 231 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI----GKGSY-A--- 231 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHCCC-C---
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHH----hcCCC-C---
Confidence 4322 22233456999999999997644 478999999999999999999999766544332211 11111 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+ ...+.+++.+||+.||.+||++.|+++.
T Consensus 232 --~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 232 --IPGDC----GPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --CCSSS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --CCCcc----CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11122 2347889999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=342.33 Aligned_cols=266 Identities=21% Similarity=0.273 Sum_probs=191.7
Q ss_pred hHHhhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe--
Q 004732 387 QIKAATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ-- 463 (733)
Q Consensus 387 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-- 463 (733)
+.....++|...+.||+|+||.||+|+. .+|+.||||++.... .....+.+|++.++.++||||++++++|.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3455678999999999999999999995 578999999886542 223456788889999999999999999976433
Q ss_pred -----EEEEEEccCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH--cCCCCCeecCCCCCCcEEecC-CCCe
Q 004732 464 -----LLLIYEYLENNSLARALF---EHRLKLDWPTRRRICLGIARGLAYLH--GESRIKVVHRDIKATNVLLDK-DLNS 532 (733)
Q Consensus 464 -----~~lV~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~ivH~Dik~~Nill~~-~~~~ 532 (733)
.++||||++++ |.+.+. .....+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 78999999874 544443 34567899999999999999999999 775 999999999999997 8999
Q ss_pred EEcccCccccCcccCcccccccccCCCcccHHHHhhCC-CCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh
Q 004732 533 KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE 611 (733)
Q Consensus 533 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 611 (733)
||+|||+++....... .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+.............
T Consensus 172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 9999999986654332 23457899999999997654 89999999999999999999999976654443322211110
Q ss_pred hC------------cccccccCCC------CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 612 QG------------KLMELVDTNP------GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 612 ~~------------~~~~~~~~~~------~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. ......+... ...........+.+++.+||+.||.+|||+.|+++.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 0000000000 001111134568899999999999999999999763
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=338.41 Aligned_cols=262 Identities=21% Similarity=0.308 Sum_probs=201.0
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----CeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 464 (733)
.++|...+.||+|+||.||+|+. .+|+.||||.+... .......+.+|++++++++||||+++++++..+ ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 46888999999999999999995 57899999998653 233456788999999999999999999998764 678
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDE 544 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 544 (733)
++||||++ |+|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 90 ~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp EEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 99999998 589998865 36899999999999999999999996 9999999999999999999999999998655
Q ss_pred ccCcc---------cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc
Q 004732 545 EENTH---------ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 614 (733)
Q Consensus 545 ~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 614 (733)
..... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+................
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 32211 1223578999999998865 6799999999999999999999999976654433222211111100
Q ss_pred cc------------ccccCCCC-CCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 LM------------ELVDTNPG-SNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 ~~------------~~~~~~~~-~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. +.....+. .... ......+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00 00000000 0000 1123357899999999999999999999873
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.05 Aligned_cols=261 Identities=23% Similarity=0.333 Sum_probs=194.4
Q ss_pred hcCccccCcccCCCcccEEEcccC-CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEE-----------
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI----------- 459 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----------- 459 (733)
.++|...+.||+|+||.||+|+.. +++.||||++........+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 357888999999999999999954 58999999987766666778999999999999999999999873
Q ss_pred ---eCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec-CCCCeEEc
Q 004732 460 ---EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-KDLNSKIS 535 (733)
Q Consensus 460 ---~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~~~kl~ 535 (733)
+....++||||++ |+|.+++.. ..+++..++.++.|+++||+|||+.+ |+||||||+||+++ +++.+||+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 163 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ--GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIG 163 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEEC
T ss_pred cccccCceeEEeeccC-CCHHHHhhc--CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEc
Confidence 4467899999998 699998854 46899999999999999999999996 99999999999997 56789999
Q ss_pred ccCccccCcccCcc--cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh
Q 004732 536 DFGLAKLDEEENTH--ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 612 (733)
Q Consensus 536 DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 612 (733)
|||+++........ ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||..................
T Consensus 164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 243 (320)
T 2i6l_A 164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243 (320)
T ss_dssp CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCC
T ss_pred cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence 99999876432221 1234567999999998876 67999999999999999999999999766543322211110000
Q ss_pred ----------CcccccccCC-CCCCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 613 ----------GKLMELVDTN-PGSNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 613 ----------~~~~~~~~~~-~~~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.......... .....+ ......+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp CCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 0000000000 000000 012345889999999999999999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=339.58 Aligned_cols=262 Identities=20% Similarity=0.256 Sum_probs=203.9
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-CC-----ceeeEeeEEEeCC
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HP-----NLVKLYGCCIEGN 462 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~ 462 (733)
...++|...+.||+|+||+||+|+ ..+++.||||++... ......+..|+++++.++ |+ +|+++++++...+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 346789999999999999999998 457889999999743 333567788999988885 55 4999999999999
Q ss_pred eEEEEEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec--CCCCeEEcccCc
Q 004732 463 QLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD--KDLNSKISDFGL 539 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~--~~~~~kl~DfGl 539 (733)
..++||||++ |+|.+++.... ..+++..+..++.|++.||+|||.+ ..+|+||||||+|||++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999996 59999997543 5699999999999999999999953 12599999999999995 477899999999
Q ss_pred cccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC------
Q 004732 540 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG------ 613 (733)
Q Consensus 540 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------ 613 (733)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+...............
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 283 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILD 283 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred ceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 9865432 234678999999999999999999999999999999999999997665544433222111100
Q ss_pred ---cccccccCC-----------------------------------------CCCCCCHHHHHHHHHHHHHhhcCCCCC
Q 004732 614 ---KLMELVDTN-----------------------------------------PGSNFDKEQVMVMINVALLCANASPTI 649 (733)
Q Consensus 614 ---~~~~~~~~~-----------------------------------------~~~~~~~~~~~~l~~l~~~c~~~~P~~ 649 (733)
.....++.. ............+.+++.+||+.||++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 363 (382)
T 2vx3_A 284 QAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKT 363 (382)
T ss_dssp TCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTT
T ss_pred hhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhh
Confidence 000000000 000112234457899999999999999
Q ss_pred CCCHHHHHH
Q 004732 650 RPSMSSVLR 658 (733)
Q Consensus 650 RPt~~~vl~ 658 (733)
|||+.|+++
T Consensus 364 Rpta~e~L~ 372 (382)
T 2vx3_A 364 RIQPYYALQ 372 (382)
T ss_dssp SCCHHHHTT
T ss_pred CCCHHHHhc
Confidence 999999876
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=334.90 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=203.7
Q ss_pred hcCccccCcccCCCcccEEEccc--CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCc------eeeEeeEEEeCCe
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL--ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN------LVKLYGCCIEGNQ 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 463 (733)
.++|...+.||+|+||.||+|.. .+++.||||++... ......+.+|+++++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 45788999999999999999984 46889999998653 334567889999999887654 9999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC--------------
Q 004732 464 LLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-------------- 528 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-------------- 528 (733)
.++||||+ +++|.+++.... ..+++..+..++.|+++||+|||+.+ |+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 889999987543 46899999999999999999999996 999999999999987
Q ss_pred -----CCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHH
Q 004732 529 -----DLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL 603 (733)
Q Consensus 529 -----~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~ 603 (733)
++.+||+|||+++..... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+.....
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 668999999999864432 23457899999999999989999999999999999999999999765544332
Q ss_pred HHHHHHHhhCc--------cccccc---------------------C-CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004732 604 DWALVLKEQGK--------LMELVD---------------------T-NPGSNFDKEQVMVMINVALLCANASPTIRPSM 653 (733)
Q Consensus 604 ~~~~~~~~~~~--------~~~~~~---------------------~-~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 653 (733)
........... ...... + .............+.+++.+||+.||.+|||+
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 323 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence 22111110000 000000 0 00011123445678999999999999999999
Q ss_pred HHHHHH
Q 004732 654 SSVLRM 659 (733)
Q Consensus 654 ~~vl~~ 659 (733)
.|+++.
T Consensus 324 ~ell~h 329 (339)
T 1z57_A 324 REALKH 329 (339)
T ss_dssp HHHTTS
T ss_pred HHHhcC
Confidence 998753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=353.47 Aligned_cols=199 Identities=27% Similarity=0.444 Sum_probs=154.8
Q ss_pred cCccc-cCcccCCCcccEEEcccC---CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEEE
Q 004732 393 NNFAT-DNNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLLL 466 (733)
Q Consensus 393 ~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 466 (733)
+.|.. .++||+|+||+||+|+.. +++.||||++..... ...+.+|++++++++|||||++++++.. +...++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 34554 468999999999999854 578999999975432 3578899999999999999999999965 678999
Q ss_pred EEEccCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe----cCCCCeEE
Q 004732 467 IYEYLENNSLARALFEH--------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL----DKDLNSKI 534 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~--------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill----~~~~~~kl 534 (733)
||||+++ +|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||
T Consensus 98 v~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEE
Confidence 9999975 787777521 224999999999999999999999997 9999999999999 77789999
Q ss_pred cccCccccCcccCc--ccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCcc
Q 004732 535 SDFGLAKLDEEENT--HISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKE 597 (733)
Q Consensus 535 ~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~ 597 (733)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 239 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 239 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence 99999987654322 223456799999999999874 5999999999999999999999999543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-39 Score=338.19 Aligned_cols=255 Identities=22% Similarity=0.327 Sum_probs=197.0
Q ss_pred HHhhhcCccccCcccCCCcccEEEcccCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCC--CCceeeEeeEEEeCCe
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQ--HPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 463 (733)
+....++|...+.||+|+||.||+|+..+++.||||.+... .......+.+|++++++++ ||||+++++++.+++.
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 102 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 102 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence 34456778999999999999999999888999999998643 3344577899999999997 5999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.++||| +.+++|.+++... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++ +.+||+|||+++..
T Consensus 103 ~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 103 IYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 999999 6788999999764 47899999999999999999999996 999999999999975 78999999999866
Q ss_pred cccCcc-cccccccCCCcccHHHHhh-----------CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh
Q 004732 544 EEENTH-ISTRVAGTIGYMAPEYAMR-----------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE 611 (733)
Q Consensus 544 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~ 611 (733)
...... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .. ......
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~-~~~~~~ 254 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-SK-LHAIID 254 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-HH-HHHHHC
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-HH-HHHHHh
Confidence 543322 2234579999999999875 468889999999999999999999995432111 11 111111
Q ss_pred hCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 612 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..... .++......+.+++.+||+.||++||++.|+++.
T Consensus 255 ~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 255 PNHEI---------EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp TTSCC---------CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccc---------CCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 11111 1111112358889999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=345.22 Aligned_cols=256 Identities=20% Similarity=0.312 Sum_probs=203.8
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhc-----------------HHHHHHHHHHHHhCCCCceeeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQG-----------------NREFINEIGMISALQHPNLVKL 454 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l 454 (733)
.++|...+.||+|+||.||+|+. +|+.||||.+....... ...+.+|++++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46889999999999999999998 89999999986432111 1789999999999999999999
Q ss_pred eeEEEeCCeEEEEEEccCCCCHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeecCCCCCCcEEe
Q 004732 455 YGCCIEGNQLLLIYEYLENNSLARA------LFEH-RLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLL 526 (733)
Q Consensus 455 ~~~~~~~~~~~lV~e~~~~gsL~~~------l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dik~~Nill 526 (733)
++++.+++..++||||+++|+|.++ +... ...+++..++.++.|++.||+|||+ .+ |+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEE
Confidence 9999999999999999999999998 5432 5679999999999999999999998 75 9999999999999
Q ss_pred cCCCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhC-CCCc-cchhHhHHHHHHHHHhCCCCCCccch-hhHH
Q 004732 527 DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG-HLTE-KADVYSFGIVALEIVSGRSNVTKEDM-FYLL 603 (733)
Q Consensus 527 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~s~Gvil~elltg~~p~~~~~~-~~~~ 603 (733)
+.++.+||+|||++...... ......||+.|+|||.+.+. .++. ++|||||||++|||++|+.||..... ....
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~ 262 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELF 262 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHH
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 99999999999999865443 23446799999999999877 5666 99999999999999999999965543 2222
Q ss_pred HHHHHHHhhCcccccccCC-------C---CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 604 DWALVLKEQGKLMELVDTN-------P---GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~-------~---~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
... ..+.. ...... . ...........+.+++.+||+.||.+||++.|+++.
T Consensus 263 ~~i----~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 263 NNI----RTKNI-EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHH----TSCCC-CCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHH----hccCc-CCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 211 11111 000000 0 000001223458899999999999999999999873
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=329.65 Aligned_cols=251 Identities=23% Similarity=0.372 Sum_probs=203.0
Q ss_pred hhcCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
..++|...+.||+|+||.||+|+. .+++.||||++... .......+.+|++++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 99 (287)
T 2wei_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (287)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence 346788999999999999999995 47899999998643 233467899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC---CCeEEcccCccccCc
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD---LNSKISDFGLAKLDE 544 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~---~~~kl~DfGla~~~~ 544 (733)
|||+++++|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.+ +.+||+|||++....
T Consensus 100 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 100 GELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp ECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999988654 37899999999999999999999996 9999999999999764 469999999998654
Q ss_pred ccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 545 EENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 545 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
.... .....||+.|+|||.+.+ .++.++||||||+++|+|++|+.||...+........ . .+....... ..
T Consensus 176 ~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~-~~~~~~~~~--~~ 246 (287)
T 2wei_A 176 QNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV---E-TGKYAFDLP--QW 246 (287)
T ss_dssp CCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H-HCCCCCCSG--GG
T ss_pred CCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH---H-cCCCCCCch--hh
Confidence 4322 223458899999998865 5899999999999999999999999766544333211 1 111110000 00
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
..+ ...+.+++.+||+.||++|||+.|+++
T Consensus 247 ~~~----~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 247 RTI----SDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp TTS----CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhc----CHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 112 234889999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=340.15 Aligned_cols=257 Identities=22% Similarity=0.381 Sum_probs=197.5
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE----
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL---- 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 464 (733)
.++|...+.||+|+||.||+|+ ..+|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 3578888999999999999998 457899999998754 233356788999999999999999999999877654
Q ss_pred --EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 465 --LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 465 --~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
++||||+. ++|.+.+ ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 121 ~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred eEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999998 5787776 335999999999999999999999996 99999999999999999999999999985
Q ss_pred CcccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc------
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL------ 615 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 615 (733)
.... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+.................
T Consensus 194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 269 (371)
T 4exu_A 194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL 269 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence 5432 234578999999999987 67999999999999999999999999766544433222111100000
Q ss_pred --------cccccCCCCCCC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 616 --------MELVDTNPGSNF---DKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 616 --------~~~~~~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+.......+ .......+.+++.+|++.||++|||+.|+++.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000000000000 01113458899999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.87 Aligned_cols=258 Identities=20% Similarity=0.279 Sum_probs=200.3
Q ss_pred hcCccccCcccCCCcccEEEccc-CCC-cEEEEEEccccChhcHHHHHHHHHHHHhCCCCc------eeeEeeEEEeCCe
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADG-TAIAVKQLSSKSKQGNREFINEIGMISALQHPN------LVKLYGCCIEGNQ 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~ 463 (733)
.++|...+.||+|+||.||+|+. .++ +.||||++... ......+.+|++++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 35788999999999999999984 344 68999998653 334567888999999997766 9999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe----------------
Q 004732 464 LLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL---------------- 526 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill---------------- 526 (733)
.++||||+ ++++.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccc
Confidence 99999999 56676666644 357999999999999999999999986 9999999999999
Q ss_pred ---cCCCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHH
Q 004732 527 ---DKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLL 603 (733)
Q Consensus 527 ---~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~ 603 (733)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||...+.....
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~ 248 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHL 248 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 66789999999999864432 23457999999999999999999999999999999999999999765544333
Q ss_pred HHHHHHHhhC--------cccccc-cC---------------------CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCH
Q 004732 604 DWALVLKEQG--------KLMELV-DT---------------------NPGSNFDKEQVMVMINVALLCANASPTIRPSM 653 (733)
Q Consensus 604 ~~~~~~~~~~--------~~~~~~-~~---------------------~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~ 653 (733)
.......... ...... .. .............+.+++.+||+.||++|||+
T Consensus 249 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 328 (355)
T 2eu9_A 249 VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITL 328 (355)
T ss_dssp HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCH
Confidence 2221111000 000000 00 00001122334578899999999999999999
Q ss_pred HHHHH
Q 004732 654 SSVLR 658 (733)
Q Consensus 654 ~~vl~ 658 (733)
.|+++
T Consensus 329 ~e~l~ 333 (355)
T 2eu9_A 329 AEALL 333 (355)
T ss_dssp HHHTT
T ss_pred HHHhc
Confidence 99875
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=341.91 Aligned_cols=260 Identities=19% Similarity=0.299 Sum_probs=200.3
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-----------CCceeeEeeEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-----------HPNLVKLYGCC 458 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 458 (733)
..++|...+.||+|+||+||+|+ ..+++.||||++... ......+.+|+.++++++ ||||+++++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 34678999999999999999999 467899999998643 334567889999998886 89999999999
Q ss_pred EeCC----eEEEEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeecCCCCCCcEEec-----
Q 004732 459 IEGN----QLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLD----- 527 (733)
Q Consensus 459 ~~~~----~~~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dik~~Nill~----- 527 (733)
...+ ..++||||+ +++|.+++... ...+++..+..++.||+.||+|||+. + |+||||||+|||++
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 8654 789999999 89999999753 34699999999999999999999997 6 99999999999995
Q ss_pred -CCCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhH----
Q 004732 528 -KDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYL---- 602 (733)
Q Consensus 528 -~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~---- 602 (733)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 3447999999999865432 2335789999999999999999999999999999999999999964432110
Q ss_pred HHHHHHHHhhCcccc-----------ccc------C-------------CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC
Q 004732 603 LDWALVLKEQGKLME-----------LVD------T-------------NPGSNFDKEQVMVMINVALLCANASPTIRPS 652 (733)
Q Consensus 603 ~~~~~~~~~~~~~~~-----------~~~------~-------------~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt 652 (733)
.........-+.... ... . .....++......+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 000000000000000 000 0 0011245566778999999999999999999
Q ss_pred HHHHHHH
Q 004732 653 MSSVLRM 659 (733)
Q Consensus 653 ~~~vl~~ 659 (733)
+.|+++.
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999873
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=334.62 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=177.7
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHH-HHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIG-MISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
.++|...+.||+|+||.||+|+. .+|+.||||++.... ......+..|+. +++.++||||+++++++.+++..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 46788899999999999999995 578999999986542 333455666666 677789999999999999999999999
Q ss_pred EccCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 469 EYLENNSLARALFE----HRLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 469 e~~~~gsL~~~l~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
||+++ +|.+++.. ....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99986 78777652 256789999999999999999999997 6 999999999999999999999999999865
Q ss_pred cccCcccccccccCCCcccHHHH----hhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccc
Q 004732 544 EEENTHISTRVAGTIGYMAPEYA----MRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 619 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 619 (733)
..... .....||+.|+|||.+ .+..++.++|||||||++|||++|+.||....... +. ........
T Consensus 177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~------~~~~~~~~ 246 (327)
T 3aln_A 177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--DQ------LTQVVKGD 246 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------CCCCCSC
T ss_pred ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--HH------HHHHhcCC
Confidence 44322 2334689999999998 45678999999999999999999999996432110 00 00010000
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 620 ~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.+.............+.+++.+||+.||++||++.++++
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000111011112335889999999999999999999975
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=330.33 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=179.9
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccCh-hcH-HHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSK-QGN-REFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
.++|...+.||+|+||.||+|+. .+|+.||||.+..... ... +.+.++..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 45778889999999999999995 5789999999865432 222 33444556788889999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
||+ ++.+..+.......+++..+..++.|+++||+|||+. + |+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK 179 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCc
Confidence 999 5566666555556899999999999999999999984 5 9999999999999999999999999997654432
Q ss_pred cccccccccCCCcccHHHHh-----hCCCCccchhHhHHHHHHHHHhCCCCCCccc-hhhHHHHHHHHHhhCcccccccC
Q 004732 548 THISTRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKED-MFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
. .....||+.|+|||.+. ...++.++|||||||++|||++|+.||.... ...... ... . +.......
T Consensus 180 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~-~-~~~~~~~~- 252 (318)
T 2dyl_A 180 A--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT--KVL-Q-EEPPLLPG- 252 (318)
T ss_dssp ---------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH--HHH-H-SCCCCCCS-
T ss_pred c--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH--HHh-c-cCCCCCCc-
Confidence 2 23456899999999994 4568999999999999999999999996532 222111 111 1 11111100
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...++ ..+.+++.+||+.||.+||++.++++
T Consensus 253 --~~~~~----~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 253 --HMGFS----GDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --SSCCC----HHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --cCCCC----HHHHHHHHHHccCChhHCcCHHHHhh
Confidence 01122 34888999999999999999999975
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=337.35 Aligned_cols=256 Identities=22% Similarity=0.371 Sum_probs=196.2
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe------
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ------ 463 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 463 (733)
++|...+.||+|+||.||+|+. .+|+.||||++... .......+.+|+.+++.++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 5788889999999999999984 57899999998653 23335678899999999999999999999987653
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.++||||++ |+|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 104 ~~lv~e~~~-~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CEEEEECCS-EEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred EEEEecccc-CCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999998 58877653 35899999999999999999999996 999999999999999999999999999864
Q ss_pred cccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc--------
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-------- 614 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 614 (733)
... .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...+................
T Consensus 177 ~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 177 DAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred CCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 432 234578999999999987 6789999999999999999999999976654433222111110000
Q ss_pred ------ccccccCCCC---CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 ------LMELVDTNPG---SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 ------~~~~~~~~~~---~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
....+..... ..........+.+++.+|++.||++|||+.|+++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000000 01111223458899999999999999999999863
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=343.51 Aligned_cols=251 Identities=24% Similarity=0.313 Sum_probs=188.2
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+++++++ +|||||++++++.+++..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 344556889999999998776667999999998643 235678899999886 8999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC-------------CCe
Q 004732 472 ENNSLARALFEHRLK------LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-------------LNS 532 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~------l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~-------------~~~ 532 (733)
+ |+|.+++...... .++..++.++.||+.||+|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 6 6999999744321 133456789999999999999986 9999999999999754 479
Q ss_pred EEcccCccccCcccCcc---cccccccCCCcccHHHHhh-------CCCCccchhHhHHHHHHHHHh-CCCCCCccchhh
Q 004732 533 KISDFGLAKLDEEENTH---ISTRVAGTIGYMAPEYAMR-------GHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFY 601 (733)
Q Consensus 533 kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~ 601 (733)
||+|||+++........ ......||++|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543322 1234579999999999975 568999999999999999999 999995443221
Q ss_pred HHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 602 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.. ........ +.............+.+++.+||+.||.+|||+.||++.
T Consensus 248 -~~---i~~~~~~~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 -SN---IIRGIFSL-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp -HH---HHHTCCCC-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HH---HhcCCCCc-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 11 11111011 111122244566779999999999999999999999763
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=334.94 Aligned_cols=252 Identities=21% Similarity=0.239 Sum_probs=171.0
Q ss_pred hcCcccc-CcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeEE
Q 004732 392 TNNFATD-NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE----GNQLL 465 (733)
Q Consensus 392 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 465 (733)
.++|... ++||+|+||.||+|+. .+|+.||||++... . ....+....++.++||||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4567774 4699999999999995 47999999998643 1 122223334677799999999999976 45589
Q ss_pred EEEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC---CCCeEEcccCccc
Q 004732 466 LIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAK 541 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~DfGla~ 541 (733)
+||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||+++
T Consensus 103 lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 9999999999999998543 46999999999999999999999996 999999999999986 4559999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.................... ...+
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~ 253 (336)
T 3fhr_A 180 ETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ---YGFP 253 (336)
T ss_dssp EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------CCC
T ss_pred eccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccc---cccC
Confidence 654322 2345689999999999888899999999999999999999999965433222110000000000 0000
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.+ ........+.+++.+||+.||.+|||+.|+++.
T Consensus 254 ~~---~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 254 NP---EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp TT---TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ch---hhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 011123358899999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=331.95 Aligned_cols=244 Identities=26% Similarity=0.393 Sum_probs=191.7
Q ss_pred HhhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChh------cHHHHHHHHHHHHhC----CCCceeeEeeE
Q 004732 389 KAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ------GNREFINEIGMISAL----QHPNLVKLYGC 457 (733)
Q Consensus 389 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~l~~~ 457 (733)
....++|...+.||+|+||.||+|+ ..+++.||||.+...... ....+.+|+.++.++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 3445789999999999999999998 467899999999654321 223456799999998 89999999999
Q ss_pred EEeCCeEEEEEEc-cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec-CCCCeEEc
Q 004732 458 CIEGNQLLLIYEY-LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-KDLNSKIS 535 (733)
Q Consensus 458 ~~~~~~~~lV~e~-~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~~~kl~ 535 (733)
+.+++..++|+|| +.+++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++ .++.+||+
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~ 182 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLI 182 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEE
Confidence 9999999999999 8999999999764 36999999999999999999999986 99999999999999 88999999
Q ss_pred ccCccccCcccCcccccccccCCCcccHHHHhhCCCC-ccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc
Q 004732 536 DFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT-EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 614 (733)
Q Consensus 536 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 614 (733)
|||+++...... .....||..|+|||++.+..+. .++|||||||++|||++|+.||...... . . ..
T Consensus 183 dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--~-------~-~~ 249 (312)
T 2iwi_A 183 DFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--L-------E-AE 249 (312)
T ss_dssp CCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--H-------H-TC
T ss_pred EcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH--h-------h-hc
Confidence 999998665432 2345689999999999877664 5999999999999999999999654211 0 0 00
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
. . ..... ...+.+++.+||+.||++||++.|+++.
T Consensus 250 ~-~-----~~~~~----~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 250 L-H-----FPAHV----SPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp C-C-----CCTTS----CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred c-C-----CcccC----CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0 11112 2348889999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=335.06 Aligned_cols=243 Identities=22% Similarity=0.380 Sum_probs=199.7
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChh------cHHHHHHHHHHHHhCC--CCceeeEeeEEEe
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQ------GNREFINEIGMISALQ--HPNLVKLYGCCIE 460 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~~~~~ 460 (733)
...++|...+.||+|+||.||+|+ ..+++.||||.+...... ....+.+|+.++++++ ||||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 445688999999999999999998 567899999998654211 2245678999999996 5999999999999
Q ss_pred CCeEEEEEEccCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec-CCCCeEEcccC
Q 004732 461 GNQLLLIYEYLEN-NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-KDLNSKISDFG 538 (733)
Q Consensus 461 ~~~~~lV~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~~~kl~DfG 538 (733)
++..++|+||+.+ ++|.+++... ..+++..++.++.|+++||+|||+.+ |+||||||+||+++ .++.+||+|||
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 9999999999986 8999998754 47899999999999999999999986 99999999999999 77899999999
Q ss_pred ccccCcccCcccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccc
Q 004732 539 LAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLME 617 (733)
Q Consensus 539 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 617 (733)
+++...... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||...... . .....
T Consensus 196 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--~--------~~~~~- 261 (320)
T 3a99_A 196 SGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--I--------RGQVF- 261 (320)
T ss_dssp TCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--H--------HCCCC-
T ss_pred ccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--h--------ccccc-
Confidence 998655432 234569999999999987765 78899999999999999999999654211 0 01100
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 618 LVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 618 ~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.....+ ..+.+++.+||+.||++||++.|+++.
T Consensus 262 -----~~~~~~----~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 262 -----FRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -----CSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----ccccCC----HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111222 348899999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=342.25 Aligned_cols=250 Identities=22% Similarity=0.297 Sum_probs=190.0
Q ss_pred hhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e 469 (733)
...+|...+.||+|+||+||.....+|+.||||++..... ..+.+|+++++++ +|||||++++++.++...++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 3446788899999999997655566789999999865432 2356899999999 79999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC-----CCCeEEcccCccccCc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-----DLNSKISDFGLAKLDE 544 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-----~~~~kl~DfGla~~~~ 544 (733)
||+ |+|.+++........+..+..++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+++...
T Consensus 99 ~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 997 5999999876666777788899999999999999996 999999999999953 3358899999998765
Q ss_pred ccCc--ccccccccCCCcccHHHHh---hCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCccccc
Q 004732 545 EENT--HISTRVAGTIGYMAPEYAM---RGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMEL 618 (733)
Q Consensus 545 ~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (733)
.... .......||++|+|||++. ...++.++|||||||++|||++ |+.||......... ....... ...
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~----~~~~~~~-~~~ 249 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN----ILLGACS-LDC 249 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH----HHTTCCC-CTT
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH----HHhccCC-ccc
Confidence 4322 2234467999999999997 4567889999999999999999 88888443221111 0111000 000
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 619 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 619 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
..........+.+++.+||+.||.+|||+.||++
T Consensus 250 ------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 250 ------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp ------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0111233445789999999999999999999975
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=353.27 Aligned_cols=257 Identities=24% Similarity=0.344 Sum_probs=198.5
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe------CCeE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIE------GNQL 464 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~~ 464 (733)
++|...+.||+|+||.||+|.. .+|+.||||++... .......+.+|++++++++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6789999999999999999995 57899999998654 34445778999999999999999999998765 6778
Q ss_pred EEEEEccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC---eEEcccCc
Q 004732 465 LLIYEYLENNSLARALFEHR--LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN---SKISDFGL 539 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~---~kl~DfGl 539 (733)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 99999999999999997533 36899999999999999999999986 999999999999997765 89999999
Q ss_pred cccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc----c
Q 004732 540 AKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK----L 615 (733)
Q Consensus 540 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~ 615 (733)
++....... .....||+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..|......... .
T Consensus 171 a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~--~~~~~~i~~~~~~~~~~ 246 (676)
T 3qa8_A 171 AKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP--VQWHGKVREKSNEHIVV 246 (676)
T ss_dssp CCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH--HHSSTTCC------CCS
T ss_pred ccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch--hhhhhhhhcccchhhhh
Confidence 986654322 24467999999999999889999999999999999999999999654321 112111000000 0
Q ss_pred cccccC--------CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 004732 616 MELVDT--------NPGSNFDKEQVMVMINVALLCANASPTIRPSMSSV 656 (733)
Q Consensus 616 ~~~~~~--------~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~v 656 (733)
.+.... .............+.+++.+|++.||++|||+.|+
T Consensus 247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el 295 (676)
T 3qa8_A 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295 (676)
T ss_dssp CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence 000000 01122344456779999999999999999999774
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-36 Score=332.12 Aligned_cols=242 Identities=14% Similarity=0.121 Sum_probs=181.9
Q ss_pred hhhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh---hcHHHHHHHHHHHHhCCC-Ccee------------
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---QGNREFINEIGMISALQH-PNLV------------ 452 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv------------ 452 (733)
..+..|...++||+|+||+||+|+ ..+|+.||||++..... ...+.|.+|+.+++.++| +|..
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 345567788999999999999999 66899999999874322 234678999999999987 2211
Q ss_pred ---e------EeeEEEe-----CCeEEEEEEccCCCCHHHHHH------hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCC
Q 004732 453 ---K------LYGCCIE-----GNQLLLIYEYLENNSLARALF------EHRLKLDWPTRRRICLGIARGLAYLHGESRI 512 (733)
Q Consensus 453 ---~------l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~ 512 (733)
. ++.++.. ....+++|+++ +++|.+++. .....+++..++.++.|+++||+|||+.+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-- 231 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG-- 231 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence 1 1111111 12356777755 679998884 22445788999999999999999999986
Q ss_pred CeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccccccCCCcccHHHH----------hhCCCCccchhHhHHH
Q 004732 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYA----------MRGHLTEKADVYSFGI 582 (733)
Q Consensus 513 ~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~s~Gv 582 (733)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||
T Consensus 232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred -cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 999999999999999999999999999865443 344567 999999999 4445888999999999
Q ss_pred HHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 583 VALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 583 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
++|||++|+.||...+.... ....+... ...+ ..+.+++.+||+.||++||++.++++
T Consensus 306 il~elltg~~Pf~~~~~~~~------------~~~~~~~~--~~~~----~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAALGG------------SEWIFRSC--KNIP----QPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHHSSCCCCTTGGGSC------------SGGGGSSC--CCCC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCcchhhh------------HHHHHhhc--ccCC----HHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999965543211 11111111 1222 34889999999999999999998854
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=352.51 Aligned_cols=237 Identities=21% Similarity=0.313 Sum_probs=190.8
Q ss_pred hcCccccCcccCCCcccEEEcccC--CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCe-----
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA--DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQ----- 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 463 (733)
.++|.+.+.||+|+||+||+|+.. +|+.||||.+... .......+.+|++++++++|||||+++++|.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 367889999999999999999854 6899999998654 33445678999999999999999999999987655
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.|+||||+++++|.+++.. .+++..++.++.||++||.|||+.+ |+||||||+|||++.+ .+||+|||+++..
T Consensus 159 ~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred eEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999987743 7999999999999999999999996 9999999999999986 8999999999865
Q ss_pred cccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCC
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (733)
... ....||++|+|||++.+.. +.++|||||||++|||++|..||...... .+ +
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~----------------~~----~ 285 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD----------------GL----P 285 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS----------------SC----C
T ss_pred ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc----------------cc----c
Confidence 433 3467999999999987754 89999999999999999998887542110 00 0
Q ss_pred CCCCCHHHHHHHHHHHHHhhcCCCCCCCC-HHHHHHHhc
Q 004732 624 GSNFDKEQVMVMINVALLCANASPTIRPS-MSSVLRMLE 661 (733)
Q Consensus 624 ~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-~~~vl~~L~ 661 (733)
...........+.+++.+||+.||.+||+ +.++...|.
T Consensus 286 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 286 EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 00011122346889999999999999996 455555554
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.85 Aligned_cols=229 Identities=14% Similarity=0.099 Sum_probs=181.7
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||.||+|+. .+|+.||||.+.... ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 5688889999999999999995 468999999997643 233467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+++++|.+++.. .....++.+++.|++.||+|||+.| |+||||||+|||++.++.+||+++|
T Consensus 111 e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~---------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA---------- 174 (286)
T ss_dssp ECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred EecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc----------
Confidence 99999999999853 2356678999999999999999997 9999999999999999999998554
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC--C
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS--N 626 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 626 (733)
|++ .++.++|||||||++|||++|+.||...+...... ............ .
T Consensus 175 -----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~ 227 (286)
T 3uqc_A 175 -----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA---------PAERDTAGQPIEPAD 227 (286)
T ss_dssp -----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE---------ECCBCTTSCBCCHHH
T ss_pred -----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH---------HHHHHhccCCCChhh
Confidence 333 36889999999999999999999996543211000 000000000000 0
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
........+.+++.+||+.||++| |+.|+++.|++...
T Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 228 IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 011122358899999999999999 99999999986543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=308.21 Aligned_cols=226 Identities=19% Similarity=0.290 Sum_probs=177.0
Q ss_pred cCcccc-CcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHH-HhCCCCceeeEeeEEEe----CCeEE
Q 004732 393 NNFATD-NNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMI-SALQHPNLVKLYGCCIE----GNQLL 465 (733)
Q Consensus 393 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~ 465 (733)
++|... +.||+|+||.||+|+. .+++.||||.+... ..+.+|++++ +..+||||+++++++.. +...+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 345555 7899999999999984 67899999998542 4567888887 66699999999999987 67789
Q ss_pred EEEEccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC---CCCeEEcccCccc
Q 004732 466 LIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLAK 541 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~DfGla~ 541 (733)
+||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++.
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 9999999999999998643 46999999999999999999999996 999999999999998 7889999999986
Q ss_pred cCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
.... ..++.++|||||||++|||++|+.||......... ......+..
T Consensus 169 ~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~---------~~~~~~~~~ 216 (299)
T 3m2w_A 169 ETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---------PGMKTRIRM 216 (299)
T ss_dssp ECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC----------------CCSCCSSCT
T ss_pred cccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh---------HHHHHHHhh
Confidence 4321 34677999999999999999999999654322110 001111110
Q ss_pred CCCCCCCH----HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 622 NPGSNFDK----EQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 622 ~~~~~~~~----~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
. ....+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 217 ~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 217 G-QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp T-CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred c-cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0 011111 123458899999999999999999999863
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=312.37 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=241.6
Q ss_pred ecccce--------eeeeccccccccc--cCCccccCCCCCCeeeccc-cccccccchhccCCCCCCEEEcccccccccC
Q 004732 13 WKQKTV--------NQKRVLKEQNLTG--VLPPKLAELTFLQDISLIA-NRLKGPIPKYLANISTLVNLTVQYNQFSGEL 81 (733)
Q Consensus 13 ~~~~~~--------~~~l~L~~n~l~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 81 (733)
|.|++| .+.|+|++|++++ .+|..|..+++|++|+|++ |.+.+.+|..|+++++|++|+|++|.+++.+
T Consensus 38 w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~ 117 (313)
T 1ogq_A 38 WLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI 117 (313)
T ss_dssp STTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEEC
T ss_pred CcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcC
Confidence 888766 4568899999999 9999999999999999995 9999999999999999999999999999999
Q ss_pred CccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccC-CCCEEEccCCCCccCCCCCCCCc
Q 004732 82 PEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWT-KLEKLFIQPSGLAGPIPSGIFSL 160 (733)
Q Consensus 82 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~l~~l 160 (733)
|..|..+++|++|+|++|.|++.+|..|..+++|++|+|++|++++.+|..+..++ +|+.|+|++|++++.+|..+..+
T Consensus 118 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l 197 (313)
T 1ogq_A 118 PDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL 197 (313)
T ss_dssp CGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC
T ss_pred CHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCC
Confidence 99999999999999999999999999999999999999999999999999999998 99999999999999999999999
Q ss_pred CCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEe
Q 004732 161 ENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYF 239 (733)
Q Consensus 161 ~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 239 (733)
+ |+.|++++|.+....+..+... +|+.|+|++|.+++.+|. +..+++|++|+|++|++++.+|..+..+++|+.|++
T Consensus 198 ~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 275 (313)
T 1ogq_A 198 N-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275 (313)
T ss_dssp C-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEEC
T ss_pred c-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEEC
Confidence 7 9999999999998877777766 899999999999977766 889999999999999999999999999999999999
Q ss_pred cCCcccccCChhh-hcCCCeeecccCcCCCCCCcccc
Q 004732 240 AGNLLTGAIPPWM-LERGDKIDLSYNNFTDGSAESSC 275 (733)
Q Consensus 240 ~~N~l~~~~p~~~-l~~l~~l~ls~N~l~~~~~~~~~ 275 (733)
++|.++|.+|... +++++.+++++|+..++.+...|
T Consensus 276 s~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~~C 312 (313)
T 1ogq_A 276 SFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp CSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred cCCcccccCCCCccccccChHHhcCCCCccCCCCCCC
Confidence 9999999999865 78899999999985544443344
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-36 Score=319.64 Aligned_cols=242 Identities=20% Similarity=0.200 Sum_probs=183.6
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccC--------hhcHHHHHHHHHHHHhCC---------CCceeeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--------KQGNREFINEIGMISALQ---------HPNLVKL 454 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l 454 (733)
.++|...+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+++++.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 45678889999999999999987 68999999986542 223477889999998886 7777777
Q ss_pred eeEEE------------------------------eCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Q 004732 455 YGCCI------------------------------EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 504 (733)
Q Consensus 455 ~~~~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~ 504 (733)
.+++. +++..++||||+++|++.+.+.+ ..+++..+..++.||+.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL~ 175 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASLA 175 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence 77643 26789999999999976666543 46899999999999999999
Q ss_pred HHH-cCCCCCeecCCCCCCcEEecCCC--------------------CeEEcccCccccCcccCcccccccccCCCcccH
Q 004732 505 YLH-GESRIKVVHRDIKATNVLLDKDL--------------------NSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563 (733)
Q Consensus 505 ~LH-~~~~~~ivH~Dik~~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aP 563 (733)
||| +.+ |+||||||+|||++.++ .+||+|||+|+..... ...||+.|+||
T Consensus 176 ~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP 246 (336)
T 2vuw_A 176 VAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred HHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence 999 886 99999999999999887 8999999999865432 34799999999
Q ss_pred HHHhhCCCCccchhHhHHHH-HHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHh
Q 004732 564 EYAMRGHLTEKADVYSFGIV-ALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLC 642 (733)
Q Consensus 564 E~~~~~~~~~~~Dv~s~Gvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c 642 (733)
|++.+.. +.++||||+|++ .+++++|..||... .|.............................+.+++.+|
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV------LWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH------HHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcch------hhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 9998655 899999998777 77788899887332 121111000000000011111112334567899999999
Q ss_pred hcCCCCCCCCHHHHH
Q 004732 643 ANASPTIRPSMSSVL 657 (733)
Q Consensus 643 ~~~~P~~RPt~~~vl 657 (733)
++.| |+.|++
T Consensus 320 L~~d-----sa~e~l 329 (336)
T 2vuw_A 320 LNFS-----SATDLL 329 (336)
T ss_dssp GGSS-----SHHHHH
T ss_pred hccC-----CHHHHH
Confidence 9965 888887
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=334.02 Aligned_cols=258 Identities=31% Similarity=0.457 Sum_probs=236.3
Q ss_pred cceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceee
Q 004732 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 95 (733)
Q Consensus 16 ~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 95 (733)
.+.+++|+|++|++++.+|..|..+++|+.|+|++|++++.+|..|+++++|++|+|++|.+++.+|..|+.+++|++|+
T Consensus 393 ~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 472 (768)
T 3rgz_A 393 KNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLI 472 (768)
T ss_dssp TCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEE
T ss_pred cCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEE
Confidence 45688899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCC
Q 004732 96 LSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE 175 (733)
Q Consensus 96 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~ 175 (733)
|++|++++.+|..+.++++|++|+|++|++++.+|..|+++++|+.|+|++|++++.+|..+..+++|+.|++++|.+..
T Consensus 473 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g 552 (768)
T 3rgz_A 473 LDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552 (768)
T ss_dssp CCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEES
T ss_pred ecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998764
Q ss_pred CCcccc----------------------------------------------------------------------cc-c
Q 004732 176 ATFPQL----------------------------------------------------------------------GN-M 184 (733)
Q Consensus 176 ~~~~~~----------------------------------------------------------------------~~-~ 184 (733)
..+..+ .. .
T Consensus 553 ~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~ 632 (768)
T 3rgz_A 553 TIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNG 632 (768)
T ss_dssp BCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSB
T ss_pred cCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccc
Confidence 433221 11 2
Q ss_pred cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecc
Q 004732 185 KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLS 262 (733)
Q Consensus 185 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls 262 (733)
+|+.|+|++|+++|.+|..|+++++|+.|+|++|+++|.+|..++.+++|+.|++++|+++|.+|..+ ++.|+.||++
T Consensus 633 ~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls 712 (768)
T 3rgz_A 633 SMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLS 712 (768)
T ss_dssp CCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECC
T ss_pred cccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECc
Confidence 58899999999999999999999999999999999999999999999999999999999999999988 7889999999
Q ss_pred cCcCCCCCCcc
Q 004732 263 YNNFTDGSAES 273 (733)
Q Consensus 263 ~N~l~~~~~~~ 273 (733)
+|+++|..|..
T Consensus 713 ~N~l~g~iP~~ 723 (768)
T 3rgz_A 713 NNNLSGPIPEM 723 (768)
T ss_dssp SSEEEEECCSS
T ss_pred CCcccccCCCc
Confidence 99998866543
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=329.54 Aligned_cols=266 Identities=29% Similarity=0.410 Sum_probs=242.1
Q ss_pred eeeecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCc
Q 004732 10 FHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLL 89 (733)
Q Consensus 10 ~~~~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 89 (733)
+..+.+.+.++.|+|++|++++.+|..|..+++|+.|+|++|.+++.+|..+..+++|++|+|++|++++.+|..|+.++
T Consensus 411 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 490 (768)
T 3rgz_A 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCT 490 (768)
T ss_dssp CGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCT
T ss_pred CHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCcccCcCCHHHhcCC
Confidence 34456677899999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCC------------
Q 004732 90 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGI------------ 157 (733)
Q Consensus 90 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l------------ 157 (733)
+|++|+|++|++++.+|.++..+++|++|+|++|+++|.+|..++++++|+.|++++|+++|.+|..+
T Consensus 491 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~ 570 (768)
T 3rgz_A 491 NLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFI 570 (768)
T ss_dssp TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTT
T ss_pred CCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcc
Confidence 99999999999999999999999999999999999999999999999999999999999988777543
Q ss_pred ----------------------------------------------------------CCcCCcCeeecccccCCCCCcc
Q 004732 158 ----------------------------------------------------------FSLENLTDLRISDLNGPEATFP 179 (733)
Q Consensus 158 ----------------------------------------------------------~~l~~L~~L~l~~n~~~~~~~~ 179 (733)
..+++|+.|++++|.+....+.
T Consensus 571 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~ 650 (768)
T 3rgz_A 571 AGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPK 650 (768)
T ss_dssp CSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCG
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCH
Confidence 3457899999999999998888
Q ss_pred ccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh-hcCCC
Q 004732 180 QLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-LERGD 257 (733)
Q Consensus 180 ~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-l~~l~ 257 (733)
.++.+ +|+.|+|++|+++|.+|..|+++++|+.|||++|+++|.+|..+..+++|+.|++++|+++|.+|... +..+.
T Consensus 651 ~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~ 730 (768)
T 3rgz_A 651 EIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFP 730 (768)
T ss_dssp GGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSC
T ss_pred HHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCC
Confidence 88877 89999999999999999999999999999999999999999999999999999999999999999864 55666
Q ss_pred eeecccCcCCCCCCcccc
Q 004732 258 KIDLSYNNFTDGSAESSC 275 (733)
Q Consensus 258 ~l~ls~N~l~~~~~~~~~ 275 (733)
...+.+|+.-|+.+...|
T Consensus 731 ~~~~~gN~~Lcg~~l~~C 748 (768)
T 3rgz_A 731 PAKFLNNPGLCGYPLPRC 748 (768)
T ss_dssp GGGGCSCTEEESTTSCCC
T ss_pred HHHhcCCchhcCCCCcCC
Confidence 667778864444333333
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-32 Score=284.11 Aligned_cols=251 Identities=19% Similarity=0.297 Sum_probs=228.5
Q ss_pred CCCCeeecccccccc--ccchhccCCCCCCEEEccc-ccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCE
Q 004732 41 TFLQDISLIANRLKG--PIPKYLANISTLVNLTVQY-NQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKD 117 (733)
Q Consensus 41 ~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 117 (733)
.+++.|+|++|.+++ .+|..|.++++|++|+|++ |.+.+.+|..|+++++|++|+|++|++++.+|..|.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 679999999999999 8999999999999999995 9999999999999999999999999999999999999999999
Q ss_pred EEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcC-CcCeeecccccCCCCCccccccccccEEEcccCcc
Q 004732 118 FRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLE-NLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNI 196 (733)
Q Consensus 118 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~-~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l 196 (733)
|+|++|++++.+|..|.++++|++|+|++|++++.+|..++.++ +|+.|++++|.+....+..+...+|+.|++++|.+
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~L~~L~Ls~N~l 209 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML 209 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCcccEEECcCCcc
Confidence 99999999999999999999999999999999999999999998 99999999999998888888888899999999999
Q ss_pred CCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCcCCCCCCccc
Q 004732 197 TGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESS 274 (733)
Q Consensus 197 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~~~~~~ 274 (733)
++.+|..|..+++|+.|+|++|.+++.+|. +..+++|+.|++++|.+++.+|.++ +++|+.|++++|++++..+..
T Consensus 210 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~- 287 (313)
T 1ogq_A 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG- 287 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-
T ss_pred cCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-
Confidence 999999999999999999999999987776 8889999999999999999999987 788999999999998765544
Q ss_pred ccccccccccccccccccC
Q 004732 275 CQKRSVTGIVSCLRSVQCP 293 (733)
Q Consensus 275 ~~~~~~~~~~~~~~~~~c~ 293 (733)
.....+..+....++..|+
T Consensus 288 ~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 288 GNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp TTGGGSCGGGTCSSSEEES
T ss_pred ccccccChHHhcCCCCccC
Confidence 3344444444444544443
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.5e-31 Score=290.96 Aligned_cols=144 Identities=19% Similarity=0.226 Sum_probs=127.7
Q ss_pred ceeeeeccccccccccCCccccCCCCCCeeecccccccccc-chhccCCCCCCEEEcccccccccCCccccCCcCCceee
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPI-PKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 95 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 95 (733)
..++.|+|++|++++..|..|..+++|++|+|++|.+.+.+ +..|.++++|++|+|++|.+++..|..|+.+++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 34788999999999999999999999999999999997555 56799999999999999999988899999999999999
Q ss_pred ccCccccccCCcc--ccCCCCCCEEEeeCCccccCCCcc-ccccCCCCEEEccCCCCccCCCCCCCCc
Q 004732 96 LSSNNFTGELPKT--FAKLTNMKDFRISDNQFTGQIPSF-IQNWTKLEKLFIQPSGLAGPIPSGIFSL 160 (733)
Q Consensus 96 Ls~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~~~~-~~~l~~L~~L~l~~N~l~~~~p~~l~~l 160 (733)
|++|++++.+|.. |..+++|++|+|++|++++..|.. +.++++|++|++++|++++..+..+..+
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l 177 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNF 177 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGG
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcc
Confidence 9999999766555 889999999999999999887776 8999999999999999998877766544
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=294.01 Aligned_cols=279 Identities=20% Similarity=0.206 Sum_probs=185.0
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
.+.|+|++|+|++..+..|..+++|++|+|++|.|++..|..|.++++|++|+|++|.++...+..|.++++|++|+|++
T Consensus 34 l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 113 (477)
T 2id5_A 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISE 113 (477)
T ss_dssp CSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTT
T ss_pred CcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCC
Confidence 45556666666665555666666666666666666655555666666666666666666643334455666666666666
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCcc------------------------CCC
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG------------------------PIP 154 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~------------------------~~p 154 (733)
|++++..|..|.++++|++|+|++|++++..+..|.++++|+.|+|++|++++ ..+
T Consensus 114 n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~ 193 (477)
T 2id5_A 114 NKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRD 193 (477)
T ss_dssp SCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECT
T ss_pred CccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeCh
Confidence 66665555555555566666666665555555555555555555555555554 333
Q ss_pred CCCCCcCCcCeeecccccCCCCCc-cccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCC
Q 004732 155 SGIFSLENLTDLRISDLNGPEATF-PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYD 233 (733)
Q Consensus 155 ~~l~~l~~L~~L~l~~n~~~~~~~-~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~ 233 (733)
..|..+++|+.|++++|......+ ..+...+|+.|++++|.+++..+..|..+++|+.|+|++|.+++..+..|..+++
T Consensus 194 ~~~~~l~~L~~L~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~ 273 (477)
T 2id5_A 194 YSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLR 273 (477)
T ss_dssp TCSCSCTTCCEEEEECCTTCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTT
T ss_pred hhcccCcccceeeCCCCccccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhcccccc
Confidence 444445555555555444333222 2223337888888889998665577899999999999999999888888999999
Q ss_pred CCEEEecCCcccccCChhh--hcCCCeeecccCcCCCCCCcccccccccccccccccccccCCcee
Q 004732 234 VDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKTYY 297 (733)
Q Consensus 234 L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c~~~~~ 297 (733)
|+.|++++|.+.+..|..+ +++|+.|++++|.+++...........+..+....+++.|.+...
T Consensus 274 L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~~~ 339 (477)
T 2id5_A 274 LQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCRLL 339 (477)
T ss_dssp CCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGGGH
T ss_pred CCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccchH
Confidence 9999999999998878776 688999999999998877665555566666666777777766543
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=290.06 Aligned_cols=282 Identities=16% Similarity=0.140 Sum_probs=186.8
Q ss_pred eecccceeeeeccccccccccC-CccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCcc--ccCC
Q 004732 12 FWKQKTVNQKRVLKEQNLTGVL-PPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEE--LGSL 88 (733)
Q Consensus 12 ~~~~~~~~~~l~L~~n~l~~~~-p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~--~~~l 88 (733)
.+.+.+.++.|+|++|.+.+.+ +..|..+++|++|+|++|++++..|..|+++++|++|+|++|.+++.++.. |+.+
T Consensus 49 ~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l 128 (455)
T 3v47_A 49 SFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPL 128 (455)
T ss_dssp TTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTC
T ss_pred HhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCc
Confidence 3455667888888888887554 557888888888888888888777888888888888888888888655554 8888
Q ss_pred cCCceeeccCccccccCCcc-ccCCCCCCEEEeeCCccccCCCcccccc-------------------------------
Q 004732 89 LNLEKLHLSSNNFTGELPKT-FAKLTNMKDFRISDNQFTGQIPSFIQNW------------------------------- 136 (733)
Q Consensus 89 ~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~l~~N~l~~~~~~~~~~l------------------------------- 136 (733)
++|++|+|++|++++..|.. +.++++|++|++++|++++..+..+..+
T Consensus 129 ~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~ 208 (455)
T 3v47_A 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNP 208 (455)
T ss_dssp TTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCT
T ss_pred ccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhccccccccccccccCcccccchhhccccccccc
Confidence 88888888888888776765 7788888888888888887766655543
Q ss_pred ---CCCCEEEccCCCCccCCCCCCCC---------------------------------------cCCcCeeecccccCC
Q 004732 137 ---TKLEKLFIQPSGLAGPIPSGIFS---------------------------------------LENLTDLRISDLNGP 174 (733)
Q Consensus 137 ---~~L~~L~l~~N~l~~~~p~~l~~---------------------------------------l~~L~~L~l~~n~~~ 174 (733)
++|+.|++++|++++..|..+.. .++|+.|++++|.+.
T Consensus 209 ~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 288 (455)
T 3v47_A 209 FKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF 288 (455)
T ss_dssp TTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCC
T ss_pred cccceeeeEecCCCcccccchhhhhccccccceeeEeeccccccccccchhhhccCcccccccccccCceEEEecCcccc
Confidence 45667777777665433221111 145666666666666
Q ss_pred CCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh-
Q 004732 175 EATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM- 252 (733)
Q Consensus 175 ~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~- 252 (733)
...+..+... +|+.|++++|.+++..|..|+++++|+.|+|++|.+++..|..|..+++|+.|++++|.+.+..|..+
T Consensus 289 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 368 (455)
T 3v47_A 289 ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFL 368 (455)
T ss_dssp EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred ccchhhcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhcc
Confidence 5555555444 56666666666666656666666666666666666665556666666666666666666665555544
Q ss_pred -hcCCCeeecccCcCCCCCCcccccccccccccccccccccC
Q 004732 253 -LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCP 293 (733)
Q Consensus 253 -l~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c~ 293 (733)
+++|+.|++++|++++...........+..+....+++.|.
T Consensus 369 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 410 (455)
T 3v47_A 369 GLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 410 (455)
T ss_dssp TCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred ccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccC
Confidence 45666666666666655444333334444444444444444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=300.83 Aligned_cols=259 Identities=20% Similarity=0.261 Sum_probs=225.0
Q ss_pred ceeeee---cccce-----eeeeccccccccccCCccccCCCCCCeeecccc----------------------------
Q 004732 8 LVFHFW---KQKTV-----NQKRVLKEQNLTGVLPPKLAELTFLQDISLIAN---------------------------- 51 (733)
Q Consensus 8 ~~~~~~---~~~~~-----~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n---------------------------- 51 (733)
..++.| .|++| ...|+|++|+++|.+|+.|+.|++|++|+|++|
T Consensus 64 ~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l 143 (636)
T 4eco_A 64 KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRM 143 (636)
T ss_dssp SCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHT
T ss_pred CCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHHHHHHHh
Confidence 346778 89888 467899999999999999999999999999988
Q ss_pred --------------------------------------------------ccccccchhccCCCCCCEEEccccccccc-
Q 004732 52 --------------------------------------------------RLKGPIPKYLANISTLVNLTVQYNQFSGE- 80 (733)
Q Consensus 52 --------------------------------------------------~l~~~~p~~l~~l~~L~~L~L~~N~l~~~- 80 (733)
++++ +|..|+++++|++|+|++|.+++.
T Consensus 144 ~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~ 222 (636)
T 4eco_A 144 HYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAEN 222 (636)
T ss_dssp HHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGG
T ss_pred hHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCcccccc
Confidence 4555 888999999999999999999986
Q ss_pred ----------------CCcccc--CCcCCceeeccCccccccCCccccCCCCCCEEEeeCCc-ccc-CCCcccccc----
Q 004732 81 ----------------LPEELG--SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ-FTG-QIPSFIQNW---- 136 (733)
Q Consensus 81 ----------------~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~~~~~~~l---- 136 (733)
+|..++ ++++|++|+|++|++.+.+|..|+++++|++|+|++|+ ++| .+|..++++
T Consensus 223 ~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~ 302 (636)
T 4eco_A 223 ICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302 (636)
T ss_dssp BSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSG
T ss_pred ccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccc
Confidence 999999 99999999999999999999999999999999999998 998 899988887
Q ss_pred --CCCCEEEccCCCCccCCCC--CCCCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCC-C
Q 004732 137 --TKLEKLFIQPSGLAGPIPS--GIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTK-L 210 (733)
Q Consensus 137 --~~L~~L~l~~N~l~~~~p~--~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~-L 210 (733)
++|+.|+|++|+++ .+|. .++.+++|+.|++++|.+....+ .+... +|+.|++++|.++ .+|..+..+++ |
T Consensus 303 ~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~~L 379 (636)
T 4eco_A 303 VGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQIT-EIPANFCGFTEQV 379 (636)
T ss_dssp GGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECCSSEEE-ECCTTSEEECTTC
T ss_pred cCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECCCCccc-cccHhhhhhcccC
Confidence 99999999999999 8898 89999999999999999984444 45444 7999999999998 77888889988 9
Q ss_pred cEEEccCCcccCCCCCCcCCCC--CCCEEEecCCcccccCChhhh---------cCCCeeecccCcCCCCCC
Q 004732 211 KVLDLSFNRLRGQIPSNFDDLY--DVDYIYFAGNLLTGAIPPWML---------ERGDKIDLSYNNFTDGSA 271 (733)
Q Consensus 211 ~~L~ls~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~p~~~l---------~~l~~l~ls~N~l~~~~~ 271 (733)
+.|++++|+++ .+|..+..+. +|+.|++++|.+.+..|..+. .+++.|++++|.++..+.
T Consensus 380 ~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~ 450 (636)
T 4eco_A 380 ENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPK 450 (636)
T ss_dssp CEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEEECCSSCCCSCCT
T ss_pred cEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEEECcCCccCcCCH
Confidence 99999999998 7888777654 888999999998887776542 467888888888875443
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=288.44 Aligned_cols=281 Identities=19% Similarity=0.169 Sum_probs=192.9
Q ss_pred ecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCcc-ccCCcCC
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEE-LGSLLNL 91 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~-~~~l~~L 91 (733)
+.+.+.++.|+|++|+++ .+|..+..+++|++|+|++|.+++..|..+.++++|++|++++|.+.+.+|.. +..+++|
T Consensus 274 ~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L 352 (606)
T 3t6q_A 274 FHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352 (606)
T ss_dssp TTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTC
T ss_pred hccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcC
Confidence 344455666666666666 55666666666666666666666655666666666666666666666555543 6667777
Q ss_pred ceeeccCccccccC--CccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCC-CCCcCCcCeeec
Q 004732 92 EKLHLSSNNFTGEL--PKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSG-IFSLENLTDLRI 168 (733)
Q Consensus 92 ~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-l~~l~~L~~L~l 168 (733)
++|+|++|.+++.. +..+..+++|++|++++|++++..|..|..+++|+.|++++|++.+..+.. +..+++|+.|++
T Consensus 353 ~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l 432 (606)
T 3t6q_A 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432 (606)
T ss_dssp CEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEEC
T ss_pred CEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEEC
Confidence 77777777776554 566777777777777777777666777777777777777777777655443 667777777777
Q ss_pred ccccCCCCCccccccc-cccEEEcccCccCC---CCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcc
Q 004732 169 SDLNGPEATFPQLGNM-KMTKLILRNCNITG---ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLL 244 (733)
Q Consensus 169 ~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~---~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 244 (733)
++|.+....+..+... +|+.|++++|.+++ ..+..+..+++|+.|++++|++++..|..|..+++|+.|++++|.+
T Consensus 433 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l 512 (606)
T 3t6q_A 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512 (606)
T ss_dssp TTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred CCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCcc
Confidence 7777776666655544 67778888877765 2335577777888888888888877777788888888888888888
Q ss_pred cccCChhh--hcCCCeeecccCcCCCCCCcccccccccccccccccccccCCc
Q 004732 245 TGAIPPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKT 295 (733)
Q Consensus 245 ~~~~p~~~--l~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c~~~ 295 (733)
++..|..+ ++.+ .|++++|++++..+........+..+....+++.|.+.
T Consensus 513 ~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 564 (606)
T 3t6q_A 513 TSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCS 564 (606)
T ss_dssp CGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGG
T ss_pred CcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCC
Confidence 77777666 5667 78888888877666555555555555555666666543
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-29 Score=281.26 Aligned_cols=258 Identities=19% Similarity=0.180 Sum_probs=193.8
Q ss_pred ecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCc
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 92 (733)
+.+.+.+++|+|++|++++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|..+++|+
T Consensus 52 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 131 (477)
T 2id5_A 52 FASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLK 131 (477)
T ss_dssp TTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred ccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCC
Confidence 44455566666666666666666666666666666666666644444556666666666666666655555555555555
Q ss_pred eeeccCccccccCCccccCCCCCCE------------------------EEeeCCccccCCCccccccCCCCEEEccCCC
Q 004732 93 KLHLSSNNFTGELPKTFAKLTNMKD------------------------FRISDNQFTGQIPSFIQNWTKLEKLFIQPSG 148 (733)
Q Consensus 93 ~L~Ls~N~l~~~~p~~~~~l~~L~~------------------------L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 148 (733)
.|+|++|.+++..+..|.++++|+. |+|++|++.+..+..|..+++|+.|++++|.
T Consensus 132 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~ 211 (477)
T 2id5_A 132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWP 211 (477)
T ss_dssp EEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCT
T ss_pred EEECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCc
Confidence 5555555555544545555445554 4555555554445567778888888888888
Q ss_pred CccCCCCCCCCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCC
Q 004732 149 LAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN 227 (733)
Q Consensus 149 l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 227 (733)
+.+.+|..+....+|+.|++++|.+.......+... +|+.|+|++|.+++..+..|.++++|+.|+|++|++++..|..
T Consensus 212 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 291 (477)
T 2id5_A 212 YLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYA 291 (477)
T ss_dssp TCCEECTTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTT
T ss_pred cccccCcccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccChhhccccccCCEEECCCCccceECHHH
Confidence 888888888888899999999999998876666655 8999999999999888889999999999999999999999999
Q ss_pred cCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCcCCCCC
Q 004732 228 FDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 228 ~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~~ 270 (733)
|..+++|+.|++++|.+++..+..+ +++|+.|++++|++.|..
T Consensus 292 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c 336 (477)
T 2id5_A 292 FRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDC 336 (477)
T ss_dssp BTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSG
T ss_pred hcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCcc
Confidence 9999999999999999996655554 788999999999998653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.3e-30 Score=300.68 Aligned_cols=252 Identities=20% Similarity=0.244 Sum_probs=220.2
Q ss_pred cccce-----eeeeccccccccccCCccccCCCCCCeeec-cccccccc-------------------------------
Q 004732 14 KQKTV-----NQKRVLKEQNLTGVLPPKLAELTFLQDISL-IANRLKGP------------------------------- 56 (733)
Q Consensus 14 ~~~~~-----~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L-~~n~l~~~------------------------------- 56 (733)
.|++| ...|+|++|+++|.+|+.|++|++|+.|+| ++|.+.|.
T Consensus 315 ~GV~C~~~~~V~~L~Ls~~~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~ 394 (876)
T 4ecn_A 315 PGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDY 394 (876)
T ss_dssp TTEEECTTSCEEEEECTTTCCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCC
T ss_pred CceEecCCCCEEEEECccCCCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhcc
Confidence 88887 567899999999999999999999999999 77766554
Q ss_pred ---------------------------------------------cchhccCCCCCCEEEcccccccc------------
Q 004732 57 ---------------------------------------------IPKYLANISTLVNLTVQYNQFSG------------ 79 (733)
Q Consensus 57 ---------------------------------------------~p~~l~~l~~L~~L~L~~N~l~~------------ 79 (733)
+|..|+++++|++|+|++|.|++
T Consensus 395 ~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~ 474 (876)
T 4ecn_A 395 DQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANS 474 (876)
T ss_dssp CGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTS
T ss_pred CcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCccccccccccc
Confidence 78889999999999999999998
Q ss_pred -----cCCcccc--CCcCCceeeccCccccccCCccccCCCCCCEEEeeCCc-ccc-CCCccccccC-------CCCEEE
Q 004732 80 -----ELPEELG--SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ-FTG-QIPSFIQNWT-------KLEKLF 143 (733)
Q Consensus 80 -----~~p~~~~--~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~-~~~~~~~~l~-------~L~~L~ 143 (733)
.+|..++ ++++|+.|+|++|++.+.+|..|.++++|+.|+|++|+ |+| .+|..+++++ +|+.|+
T Consensus 475 n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~ 554 (876)
T 4ecn_A 475 DYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFY 554 (876)
T ss_dssp HHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEE
T ss_pred ccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEE
Confidence 3899988 99999999999999999999999999999999999998 998 8888777776 999999
Q ss_pred ccCCCCccCCCC--CCCCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCC-CcEEEccCCc
Q 004732 144 IQPSGLAGPIPS--GIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTK-LKVLDLSFNR 219 (733)
Q Consensus 144 l~~N~l~~~~p~--~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~-L~~L~ls~N~ 219 (733)
|++|+++ .+|. .++++++|+.|+|++|.+..++ .++.+ +|+.|+|++|.++ .+|..+.++++ |+.|+|++|+
T Consensus 555 Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~~lp--~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~ 630 (876)
T 4ecn_A 555 MGYNNLE-EFPASASLQKMVKLGLLDCVHNKVRHLE--AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNK 630 (876)
T ss_dssp CCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCCBCC--CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSC
T ss_pred eeCCcCC-ccCChhhhhcCCCCCEEECCCCCcccch--hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCC
Confidence 9999999 8898 8999999999999999998444 55554 8999999999999 88888999999 9999999999
Q ss_pred ccCCCCCCcCCCCC--CCEEEecCCcccccCChhh-------hcCCCeeecccCcCCCCC
Q 004732 220 LRGQIPSNFDDLYD--VDYIYFAGNLLTGAIPPWM-------LERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 220 l~~~~p~~~~~l~~--L~~L~l~~N~l~~~~p~~~-------l~~l~~l~ls~N~l~~~~ 270 (733)
++ .+|..+..+.. |+.|++++|.+.+.+|... ..+|+.|++++|++...+
T Consensus 631 L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp 689 (876)
T 4ecn_A 631 LK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFP 689 (876)
T ss_dssp CC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCC
T ss_pred CC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCCccC
Confidence 99 78888877654 9999999999988766432 246788888888887443
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.9e-29 Score=262.20 Aligned_cols=258 Identities=19% Similarity=0.226 Sum_probs=228.3
Q ss_pred eeecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcC
Q 004732 11 HFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLN 90 (733)
Q Consensus 11 ~~~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 90 (733)
+.+.+.+..+.+++++++++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|.+++..|..|+.+++
T Consensus 25 cp~~c~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 101 (330)
T 1xku_A 25 CPFRCQCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 101 (330)
T ss_dssp CCTTCEEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTT
T ss_pred CCCCCcCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCC
Confidence 34444556788899999998 5666554 78999999999999877778999999999999999999888999999999
Q ss_pred CceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCcc--CCCCCCCCcCCcCeeec
Q 004732 91 LEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG--PIPSGIFSLENLTDLRI 168 (733)
Q Consensus 91 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~p~~l~~l~~L~~L~l 168 (733)
|++|+|++|+|+ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|++.. ..+..+..+++|+.|++
T Consensus 102 L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l 178 (330)
T 1xku_A 102 LERLYLSKNQLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178 (330)
T ss_dssp CCEEECCSSCCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEEC
T ss_pred CCEEECCCCcCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEEC
Confidence 999999999999 6776654 799999999999998778889999999999999999964 67888999999999999
Q ss_pred ccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccC
Q 004732 169 SDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAI 248 (733)
Q Consensus 169 ~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 248 (733)
++|.+...+.... .+|+.|++++|.+++..+..|..+++|+.|+|++|.+++..+..+..+++|+.|++++|.+. .+
T Consensus 179 ~~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~l 255 (330)
T 1xku_A 179 ADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KV 255 (330)
T ss_dssp CSSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SC
T ss_pred CCCccccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cC
Confidence 9999987654433 58999999999999988999999999999999999999888889999999999999999998 77
Q ss_pred Chhh--hcCCCeeecccCcCCCCCCcccccc
Q 004732 249 PPWM--LERGDKIDLSYNNFTDGSAESSCQK 277 (733)
Q Consensus 249 p~~~--l~~l~~l~ls~N~l~~~~~~~~~~~ 277 (733)
|.++ +++|+.|++++|++++.+...+|..
T Consensus 256 p~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~ 286 (330)
T 1xku_A 256 PGGLADHKYIQVVYLHNNNISAIGSNDFCPP 286 (330)
T ss_dssp CTTTTTCSSCCEEECCSSCCCCCCTTSSSCS
T ss_pred ChhhccCCCcCEEECCCCcCCccChhhcCCc
Confidence 7766 7889999999999998877777643
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-31 Score=299.29 Aligned_cols=214 Identities=17% Similarity=0.102 Sum_probs=95.5
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
++.|+|++|++++..|..|..+++|++|+|++|.|++..| |+.+++|++|+|++|.|++. | ..++|+.|+|++
T Consensus 36 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~l-~----~~~~L~~L~L~~ 108 (487)
T 3oja_A 36 VKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQEL-L----VGPSIETLHAAN 108 (487)
T ss_dssp CCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEEE-E----ECTTCCEEECCS
T ss_pred ccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCCC-C----CCCCcCEEECcC
Confidence 4444444444444444444444444444444444443333 44444444444444444421 1 114444444444
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCC-CcCCcCeeecccccCCCCC
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISDLNGPEAT 177 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~L~l~~n~~~~~~ 177 (733)
|.|++..+. .+++|+.|+|++|+|++..|..|+++++|+.|+|++|.+++..|..+. .+++|+.|+|++|.+....
T Consensus 109 N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~ 185 (487)
T 3oja_A 109 NNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVK 185 (487)
T ss_dssp SCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEE
T ss_pred CcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCcccccc
Confidence 444433322 234444444444444444444444444444444444444444444443 3444444444444444331
Q ss_pred ccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCccc
Q 004732 178 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 245 (733)
Q Consensus 178 ~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 245 (733)
.. ....+|+.|+|++|.|++.+| .+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|++.
T Consensus 186 ~~-~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 186 GQ-VVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp CC-CCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred cc-ccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 11 112244444444444443222 24444444444444444442 3444444444444444444444
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=264.23 Aligned_cols=223 Identities=21% Similarity=0.283 Sum_probs=139.9
Q ss_pred CCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEe
Q 004732 41 TFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 120 (733)
Q Consensus 41 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 120 (733)
++++.|+|++|.|+ .+|..++++++|++|+|++|.++ .+|..|+.+++|++|+|++|.|+ .+|..+.++++|++|+|
T Consensus 81 ~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L 157 (328)
T 4fcg_A 81 PGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSI 157 (328)
T ss_dssp TTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEE
T ss_pred cceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEEC
Confidence 45566666666665 55555555666666666666665 55555666666666666666665 55555666666666666
Q ss_pred eCCccccCCCccccc---------cCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEc
Q 004732 121 SDNQFTGQIPSFIQN---------WTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLIL 191 (733)
Q Consensus 121 ~~N~l~~~~~~~~~~---------l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l 191 (733)
++|++.+.+|..+.. +++|+.|+|++|+++ .+|..+..+++|+.|++++|.+...........+|+.|+|
T Consensus 158 ~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~l~~~l~~l~~L~~L~L 236 (328)
T 4fcg_A 158 RACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSALGPAIHHLPKLEELDL 236 (328)
T ss_dssp EEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCCCCGGGGGCTTCCEEEC
T ss_pred CCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCcCchhhccCCCCCEEEC
Confidence 665555555554443 666666666666665 5555566666666666666666554333222235666667
Q ss_pred ccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCcCC
Q 004732 192 RNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFT 267 (733)
Q Consensus 192 ~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~ 267 (733)
++|++.+.+|..++.+++|+.|+|++|++.+.+|..+..+++|+.|++++|++.+.+|.++ +++++.+++..|.+.
T Consensus 237 s~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred cCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 7777777777777777777777777777777777777777777777777777777777766 566677776666544
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=291.42 Aligned_cols=253 Identities=19% Similarity=0.250 Sum_probs=176.2
Q ss_pred eeecccceeeeecccccccccc-----------------CCcccc--CCCCCCeeeccccccccccchhccCCCCCCEEE
Q 004732 11 HFWKQKTVNQKRVLKEQNLTGV-----------------LPPKLA--ELTFLQDISLIANRLKGPIPKYLANISTLVNLT 71 (733)
Q Consensus 11 ~~~~~~~~~~~l~L~~n~l~~~-----------------~p~~l~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 71 (733)
..+.+.+.++.|+|++|++++. +|+.+. ++++|++|+|++|++.+.+|..|+++++|++|+
T Consensus 200 ~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 279 (636)
T 4eco_A 200 KAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLIN 279 (636)
T ss_dssp GGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEE
T ss_pred HHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEE
Confidence 3455566677777777777775 777777 777777777777777777777777777777777
Q ss_pred ccccc-ccc-cCCccccCC------cCCceeeccCccccccCCc--cccCCCCCCEEEeeCCccccCCCccccccCCCCE
Q 004732 72 VQYNQ-FSG-ELPEELGSL------LNLEKLHLSSNNFTGELPK--TFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEK 141 (733)
Q Consensus 72 L~~N~-l~~-~~p~~~~~l------~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~ 141 (733)
|++|+ ++| .+|..++.+ ++|+.|+|++|+++ .+|. .++++++|++|+|++|+++|.+| .|+++++|+.
T Consensus 280 Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~ 357 (636)
T 4eco_A 280 VACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLAS 357 (636)
T ss_dssp CTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESE
T ss_pred CcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCE
Confidence 77776 776 677776665 77777777777777 6776 77777777777777777777777 6777777777
Q ss_pred EEccCCCCccCCCCCCCCcCC-cCeeecccccCCCCCccccccc---cccEEEcccCccCCCCCcccc-------CCCCC
Q 004732 142 LFIQPSGLAGPIPSGIFSLEN-LTDLRISDLNGPEATFPQLGNM---KMTKLILRNCNITGELPRYLG-------KMTKL 210 (733)
Q Consensus 142 L~l~~N~l~~~~p~~l~~l~~-L~~L~l~~n~~~~~~~~~~~~~---~L~~L~l~~n~l~~~~p~~~~-------~l~~L 210 (733)
|+|++|+++ .+|..+..+++ |+.|++++|.+...+ ..+... +|+.|++++|.+++.+|..|. .+++|
T Consensus 358 L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~lp-~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L 435 (636)
T 4eco_A 358 LNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLKYIP-NIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV 435 (636)
T ss_dssp EECCSSEEE-ECCTTSEEECTTCCEEECCSSCCSSCC-SCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCE
T ss_pred EECCCCccc-cccHhhhhhcccCcEEEccCCcCcccc-hhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCC
Confidence 777777777 66777777777 777777777776433 333332 577777777777777777666 66677
Q ss_pred cEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhc----------CCCeeecccCcCCC
Q 004732 211 KVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLE----------RGDKIDLSYNNFTD 268 (733)
Q Consensus 211 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~----------~l~~l~ls~N~l~~ 268 (733)
+.|+|++|+++...+..+..+++|+.|++++|.++ .+|..... +|+.|++++|+++.
T Consensus 436 ~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 502 (636)
T 4eco_A 436 SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502 (636)
T ss_dssp EEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCCB
T ss_pred CEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCCc
Confidence 77777777777333333445677777777777776 55554422 67777777777763
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-28 Score=260.13 Aligned_cols=254 Identities=19% Similarity=0.214 Sum_probs=225.2
Q ss_pred ecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCc
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 92 (733)
+.+.+..+.+++++++++ .+|..+. ++|+.|+|++|.|++..+..|.++++|++|+|++|.+++..|.+|+.+++|+
T Consensus 29 ~~c~c~l~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 105 (332)
T 2ft3_A 29 FGCHCHLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQ 105 (332)
T ss_dssp SSCEEETTEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCC
T ss_pred CCCcccCCEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCC
Confidence 334456788999999998 6777664 7999999999999988888999999999999999999988899999999999
Q ss_pred eeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCc--cCCCCCCCCcCCcCeeeccc
Q 004732 93 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA--GPIPSGIFSLENLTDLRISD 170 (733)
Q Consensus 93 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~p~~l~~l~~L~~L~l~~ 170 (733)
+|+|++|+++ .+|..+. ++|++|++++|++++..+..|.++++|+.|++++|.++ +..+..+..+ +|+.|++++
T Consensus 106 ~L~L~~n~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~ 181 (332)
T 2ft3_A 106 KLYISKNHLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISE 181 (332)
T ss_dssp EEECCSSCCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCS
T ss_pred EEECCCCcCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcC
Confidence 9999999999 7776665 89999999999999777778999999999999999996 4778888888 999999999
Q ss_pred ccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCCh
Q 004732 171 LNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP 250 (733)
Q Consensus 171 n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 250 (733)
|.+...+.... .+|+.|++++|.+++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|.+. .+|.
T Consensus 182 n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~ 258 (332)
T 2ft3_A 182 AKLTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPA 258 (332)
T ss_dssp SBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCT
T ss_pred CCCCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecCh
Confidence 99988655433 58999999999999988899999999999999999999888889999999999999999998 7777
Q ss_pred hh--hcCCCeeecccCcCCCCCCccccc
Q 004732 251 WM--LERGDKIDLSYNNFTDGSAESSCQ 276 (733)
Q Consensus 251 ~~--l~~l~~l~ls~N~l~~~~~~~~~~ 276 (733)
.+ +++|+.|++++|++++......+.
T Consensus 259 ~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 286 (332)
T 2ft3_A 259 GLPDLKLLQVVYLHTNNITKVGVNDFCP 286 (332)
T ss_dssp TGGGCTTCCEEECCSSCCCBCCTTSSSC
T ss_pred hhhcCccCCEEECCCCCCCccChhHccc
Confidence 66 788999999999998876655543
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.4e-29 Score=259.79 Aligned_cols=245 Identities=16% Similarity=0.176 Sum_probs=150.3
Q ss_pred eeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccc--cCCccccCCcCCceeeccC
Q 004732 21 KRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSG--ELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 21 ~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~ 98 (733)
.++.++++++ .+|..+. ++|++|+|++|+++...+..|.++++|++|+|++|.++. ..+..+..+++|++|+|++
T Consensus 11 ~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~ 87 (306)
T 2z66_A 11 EIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87 (306)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCS
T ss_pred EEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCC
Confidence 4555566665 3444332 466666666666663333345666666666666666652 2245555666666666666
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCC-ccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCC-C
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIP-SFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE-A 176 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~-~ 176 (733)
|.++ .+|..+..+++|++|++++|++++..+ ..+..+++|++|++++|++.+..+..+..+++|+.|++++|.+.. .
T Consensus 88 n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 166 (306)
T 2z66_A 88 NGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166 (306)
T ss_dssp CSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGE
T ss_pred Cccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCcccccc
Confidence 6666 455556666666666666666664433 456666666666666666666666666666666666666666654 2
Q ss_pred Cccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--h
Q 004732 177 TFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--L 253 (733)
Q Consensus 177 ~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l 253 (733)
.+..+... +|+.|++++|.+++..|..|..+++|+.|+|++|++++..+..+..+++|+.|++++|.+.+..|..+ +
T Consensus 167 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~ 246 (306)
T 2z66_A 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 246 (306)
T ss_dssp ECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCC
T ss_pred chhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhh
Confidence 33333333 56666666666666666666666666666666666665555566666666666666666666655554 2
Q ss_pred -cCCCeeecccCcCCCC
Q 004732 254 -ERGDKIDLSYNNFTDG 269 (733)
Q Consensus 254 -~~l~~l~ls~N~l~~~ 269 (733)
++++.|++++|++.+.
T Consensus 247 ~~~L~~L~L~~N~~~~~ 263 (306)
T 2z66_A 247 PSSLAFLNLTQNDFACT 263 (306)
T ss_dssp CTTCCEEECTTCCEECS
T ss_pred hccCCEEEccCCCeecc
Confidence 3566666666666554
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=260.25 Aligned_cols=223 Identities=25% Similarity=0.350 Sum_probs=209.4
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
....|+|++|+++ .+|+.+..+++|++|+|++|.|+ .+|..|+++++|++|+|++|.++ .+|..|+.+++|++|+|+
T Consensus 82 ~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~ 158 (328)
T 4fcg_A 82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR 158 (328)
T ss_dssp TCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEE
T ss_pred ceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECC
Confidence 3578899999999 78889999999999999999999 89999999999999999999999 899999999999999999
Q ss_pred CccccccCCccccC---------CCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeec
Q 004732 98 SNNFTGELPKTFAK---------LTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRI 168 (733)
Q Consensus 98 ~N~l~~~~p~~~~~---------l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l 168 (733)
+|++.+.+|..+.. +++|++|+|++|+|+ .+|..++++++|+.|+|++|+++ .+|..+..+++|+.|++
T Consensus 159 ~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~L 236 (328)
T 4fcg_A 159 ACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDL 236 (328)
T ss_dssp EETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEEC
T ss_pred CCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEEC
Confidence 99999999988765 999999999999999 89999999999999999999999 47778999999999999
Q ss_pred ccccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCccc
Q 004732 169 SDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 245 (733)
Q Consensus 169 ~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 245 (733)
++|++....+..+... +|+.|+|++|++.+.+|..+.++++|+.|+|++|++.+.+|..+..+++|+.+++..|.+.
T Consensus 237 s~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 237 RGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred cCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 9999998888777766 8999999999999999999999999999999999999999999999999999999988765
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=290.59 Aligned_cols=186 Identities=17% Similarity=0.123 Sum_probs=132.2
Q ss_pred cccCCCcccEEEcc-cCCCcEEEEEEccccC----------hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEE
Q 004732 400 NIGEGGFGPVYKGL-LADGTAIAVKQLSSKS----------KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 400 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 467 (733)
..+.|++|.+..++ .-.|+.||||.+.... ....++|.+|+++|+++ .|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 56778888777766 4468999999986531 22346799999999999 799999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||++|++|.++|.+. ..++.. +|+.||+.||+|+|++| ||||||||+|||++.++.+||+|||+|+......
T Consensus 321 MEyv~G~~L~d~i~~~-~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAG-EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp EECCCSEEHHHHHHTT-CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred EecCCCCcHHHHHHhC-CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 9999999999999754 356643 58999999999999997 9999999999999999999999999998765443
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 594 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~ 594 (733)
. .....+||++|+|||++.+ .+..++|+||+|++++++.++..++
T Consensus 394 ~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 394 S-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred c-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 3 2345679999999999865 5677899999999988877665443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-28 Score=254.50 Aligned_cols=250 Identities=18% Similarity=0.185 Sum_probs=216.5
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCc
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 99 (733)
..++.++++++ .+|..+ .++|++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|..+++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 45788889998 456544 479999999999999887788999999999999999999888999999999999999999
Q ss_pred c-ccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCc
Q 004732 100 N-FTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATF 178 (733)
Q Consensus 100 ~-l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~ 178 (733)
. ++...|..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..+..+++|+.|++++|.+.....
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 170 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCH
Confidence 7 886668899999999999999999998889999999999999999999997777789999999999999999998777
Q ss_pred cccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChh-hhcCC
Q 004732 179 PQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW-MLERG 256 (733)
Q Consensus 179 ~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~-~l~~l 256 (733)
..+... +|+.|++++|.+++..|..|..+++|+.|++++|++++..+..+..+++|+.|++++|++.+..+.. +...+
T Consensus 171 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l 250 (285)
T 1ozn_A 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWL 250 (285)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHH
T ss_pred HHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHH
Confidence 666655 8999999999999988999999999999999999999877777999999999999999998776643 23344
Q ss_pred CeeecccCcCCCCCCc
Q 004732 257 DKIDLSYNNFTDGSAE 272 (733)
Q Consensus 257 ~~l~ls~N~l~~~~~~ 272 (733)
+.+..+.+.+.|..+.
T Consensus 251 ~~~~~~~~~~~c~~p~ 266 (285)
T 1ozn_A 251 QKFRGSSSEVPCSLPQ 266 (285)
T ss_dssp HHCCSEECCCBEEESG
T ss_pred HhcccccCccccCCch
Confidence 4555666666554443
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-28 Score=268.62 Aligned_cols=248 Identities=16% Similarity=0.124 Sum_probs=216.8
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCc
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 99 (733)
..++..+++++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|
T Consensus 57 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n 133 (452)
T 3zyi_A 57 SKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133 (452)
T ss_dssp CEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred cEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence 46777888888 5676665 78999999999999888999999999999999999999888899999999999999999
Q ss_pred cccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCC-CCccCCCCCCCCcCCcCeeecccccCCCCCc
Q 004732 100 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS-GLAGPIPSGIFSLENLTDLRISDLNGPEATF 178 (733)
Q Consensus 100 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~ 178 (733)
+|++..+..|..+++|++|+|++|+|+...+..|.++++|+.|+|++| .+....+..|.++++|+.|++++|.+....
T Consensus 134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~- 212 (452)
T 3zyi_A 134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMP- 212 (452)
T ss_dssp CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSCC-
T ss_pred cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccccc-
Confidence 999777777999999999999999999777778999999999999994 555444457889999999999999998763
Q ss_pred cccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCC
Q 004732 179 PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERG 256 (733)
Q Consensus 179 ~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l 256 (733)
......+|+.|+|++|.+++..|..|.++++|+.|+|++|++++..+..|..+++|+.|++++|.+++..+..+ +++|
T Consensus 213 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 292 (452)
T 3zyi_A 213 NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYL 292 (452)
T ss_dssp CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTC
T ss_pred cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCC
Confidence 22333489999999999999999999999999999999999999999999999999999999999996555544 6889
Q ss_pred CeeecccCcCCCCCC
Q 004732 257 DKIDLSYNNFTDGSA 271 (733)
Q Consensus 257 ~~l~ls~N~l~~~~~ 271 (733)
+.|++++|++.|...
T Consensus 293 ~~L~L~~Np~~CdC~ 307 (452)
T 3zyi_A 293 VELHLHHNPWNCDCD 307 (452)
T ss_dssp CEEECCSSCEECSTT
T ss_pred CEEEccCCCcCCCCC
Confidence 999999999876543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.6e-28 Score=254.55 Aligned_cols=245 Identities=21% Similarity=0.264 Sum_probs=220.2
Q ss_pred ceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeec
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 96 (733)
..++.|+|++|++++..+..|..+++|++|+|++|++++..|..|+++++|++|+|++|.++ .+|..+. ++|++|+|
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 34678999999999988889999999999999999999888999999999999999999999 7787665 79999999
Q ss_pred cCccccccCCccccCCCCCCEEEeeCCcccc--CCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCC
Q 004732 97 SSNNFTGELPKTFAKLTNMKDFRISDNQFTG--QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGP 174 (733)
Q Consensus 97 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~ 174 (733)
++|++++..+..|.++++|++|++++|+++. ..+..|.++++|+.|++++|+++ .+|..+. ++|+.|++++|.+.
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l~ 205 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKIT 205 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCCC
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcCC
Confidence 9999998778889999999999999999963 77889999999999999999998 5676665 89999999999999
Q ss_pred CCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh-
Q 004732 175 EATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM- 252 (733)
Q Consensus 175 ~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~- 252 (733)
...+..+... +|+.|++++|.+++..+..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|.+++..+..+
T Consensus 206 ~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~ 284 (330)
T 1xku_A 206 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284 (330)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred ccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcC
Confidence 9877777665 8999999999999888889999999999999999999 788899999999999999999986555444
Q ss_pred -------hcCCCeeecccCcCCC
Q 004732 253 -------LERGDKIDLSYNNFTD 268 (733)
Q Consensus 253 -------l~~l~~l~ls~N~l~~ 268 (733)
...+..+++++|++..
T Consensus 285 ~~~~~~~~~~l~~l~l~~N~~~~ 307 (330)
T 1xku_A 285 PPGYNTKKASYSGVSLFSNPVQY 307 (330)
T ss_dssp CSSCCTTSCCCSEEECCSSSSCG
T ss_pred CcccccccccccceEeecCcccc
Confidence 2567789999999864
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=281.25 Aligned_cols=258 Identities=18% Similarity=0.217 Sum_probs=234.8
Q ss_pred eecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccch-hccCCCCCCEEEcccccccccC--CccccCC
Q 004732 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPK-YLANISTLVNLTVQYNQFSGEL--PEELGSL 88 (733)
Q Consensus 12 ~~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l 88 (733)
.+.+.+.++.|+|++|.+++..|..+..+++|+.|+|++|.+.+.+|. .+.++++|++|+|++|.+++.. +..+..+
T Consensus 296 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l 375 (606)
T 3t6q_A 296 GLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNL 375 (606)
T ss_dssp SCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTC
T ss_pred hhcccccCCEEECccCCcCcCchhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccC
Confidence 455667899999999999999899999999999999999999977765 4999999999999999999766 7889999
Q ss_pred cCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCc-cccccCCCCEEEccCCCCccCCCCCCCCcCCcCeee
Q 004732 89 LNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPS-FIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLR 167 (733)
Q Consensus 89 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~-~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~ 167 (733)
++|++|+|++|++++..|..|..+++|+.|++++|++++..+. .|.++++|+.|++++|.+.+..|..+..+++|+.|+
T Consensus 376 ~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~ 455 (606)
T 3t6q_A 376 SHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLN 455 (606)
T ss_dssp TTCCEEECCSCSCEEECTTTTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEE
T ss_pred CCCCEEECCCCcCCcCCHHHhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEE
Confidence 9999999999999989999999999999999999999987665 489999999999999999998999999999999999
Q ss_pred cccccCCCCCc---cccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCc
Q 004732 168 ISDLNGPEATF---PQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNL 243 (733)
Q Consensus 168 l~~n~~~~~~~---~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 243 (733)
+++|.+..... ..+... +|+.|++++|.+++..|..|..+++|+.|+|++|++++..|..+..+++| .|++++|.
T Consensus 456 L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~ 534 (606)
T 3t6q_A 456 LQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNH 534 (606)
T ss_dssp CTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSC
T ss_pred CCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCc
Confidence 99999876322 334444 89999999999999999999999999999999999999999999999999 99999999
Q ss_pred ccccCChhh--hcCCCeeecccCcCCCCC
Q 004732 244 LTGAIPPWM--LERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 244 l~~~~p~~~--l~~l~~l~ls~N~l~~~~ 270 (733)
+++..|..+ +++++.+++++|++.|..
T Consensus 535 l~~~~~~~~~~l~~L~~L~l~~N~~~c~c 563 (606)
T 3t6q_A 535 ISIILPSLLPILSQQRTINLRQNPLDCTC 563 (606)
T ss_dssp CCCCCGGGHHHHHTSSEEECTTCCEECSG
T ss_pred ccccCHhhcccCCCCCEEeCCCCCccccC
Confidence 998777765 789999999999998753
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=255.99 Aligned_cols=252 Identities=16% Similarity=0.181 Sum_probs=219.7
Q ss_pred ceeeeeccccccccccCCccccCCCCCCeeeccccccccc--cchhccCCCCCCEEEcccccccccCCccccCCcCCcee
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGP--IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKL 94 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~--~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 94 (733)
+.+++|+|++|+++...+..|..+++|++|+|++|.++.. .+..+..+++|++|+|++|.++ .+|..+..+++|++|
T Consensus 28 ~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~L 106 (306)
T 2z66_A 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHL 106 (306)
T ss_dssp TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCEE
T ss_pred CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCEE
Confidence 3578899999999966666689999999999999999843 4778889999999999999999 688889999999999
Q ss_pred eccCccccccCC-ccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCcc-CCCCCCCCcCCcCeeeccccc
Q 004732 95 HLSSNNFTGELP-KTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAG-PIPSGIFSLENLTDLRISDLN 172 (733)
Q Consensus 95 ~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~p~~l~~l~~L~~L~l~~n~ 172 (733)
+|++|++++..+ ..+..+++|++|++++|++++..+..|..+++|++|++++|.+++ .+|..+..+++|+.|++++|.
T Consensus 107 ~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~ 186 (306)
T 2z66_A 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQ 186 (306)
T ss_dssp ECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSC
T ss_pred ECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCEEECCCCC
Confidence 999999996554 579999999999999999999999999999999999999999987 589999999999999999999
Q ss_pred CCCCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCC-CCCEEEecCCcccccCCh
Q 004732 173 GPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLY-DVDYIYFAGNLLTGAIPP 250 (733)
Q Consensus 173 ~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~-~L~~L~l~~N~l~~~~p~ 250 (733)
+....+..+... +|+.|+|++|.+++..+..+..+++|+.|+|++|++++..|..+..++ +|+.|++++|++.+..+.
T Consensus 187 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~ 266 (306)
T 2z66_A 187 LEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEH 266 (306)
T ss_dssp CCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGG
T ss_pred cCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccCh
Confidence 999877777665 899999999999988888899999999999999999999999999985 999999999999877553
Q ss_pred h-h---hcCCCeeecccCcCCCC
Q 004732 251 W-M---LERGDKIDLSYNNFTDG 269 (733)
Q Consensus 251 ~-~---l~~l~~l~ls~N~l~~~ 269 (733)
. + +...+.+.+..+.+.|.
T Consensus 267 ~~~~~~l~~~~~~~~~~~~~~C~ 289 (306)
T 2z66_A 267 QSFLQWIKDQRQLLVEVERMECA 289 (306)
T ss_dssp HHHHHHHHHTGGGBSCGGGCBEE
T ss_pred HHHHHHHHhhhhhhccccccccC
Confidence 2 1 34444444444544443
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.2e-28 Score=265.58 Aligned_cols=247 Identities=19% Similarity=0.171 Sum_probs=212.9
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCc
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 99 (733)
..++..+++++ .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|
T Consensus 46 ~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n 122 (440)
T 3zyj_A 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN 122 (440)
T ss_dssp CEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence 45677888888 6676665 78999999999999888889999999999999999999877788999999999999999
Q ss_pred cccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCC-CCccCCCCCCCCcCCcCeeecccccCCCCCc
Q 004732 100 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS-GLAGPIPSGIFSLENLTDLRISDLNGPEATF 178 (733)
Q Consensus 100 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~ 178 (733)
+|++..+..|..+++|++|+|++|+|+...+..|.++++|+.|+|++| .+....+..|.++++|+.|++++|.+...+
T Consensus 123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~- 201 (440)
T 3zyj_A 123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIP- 201 (440)
T ss_dssp CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSCC-
T ss_pred cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcccc-
Confidence 999666678999999999999999999777778999999999999985 455444457888999999999999988664
Q ss_pred cccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCC
Q 004732 179 PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERG 256 (733)
Q Consensus 179 ~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l 256 (733)
......+|+.|+|++|.+++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|.+++..+..+ +++|
T Consensus 202 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L 281 (440)
T 3zyj_A 202 NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHL 281 (440)
T ss_dssp CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTC
T ss_pred ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCC
Confidence 22233489999999999998889999999999999999999999889999999999999999999996655554 6889
Q ss_pred CeeecccCcCCCCC
Q 004732 257 DKIDLSYNNFTDGS 270 (733)
Q Consensus 257 ~~l~ls~N~l~~~~ 270 (733)
+.|++++|++.|..
T Consensus 282 ~~L~L~~Np~~CdC 295 (440)
T 3zyj_A 282 ERIHLHHNPWNCNC 295 (440)
T ss_dssp CEEECCSSCEECSS
T ss_pred CEEEcCCCCccCCC
Confidence 99999999987654
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=254.57 Aligned_cols=242 Identities=22% Similarity=0.270 Sum_probs=218.0
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
.++.|+|++|++++..|..|..+++|++|+|++|+|++..|..|+++++|++|+|++|.++ .+|..+. ++|++|+|+
T Consensus 55 ~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l~ 131 (332)
T 2ft3_A 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRIH 131 (332)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEECC
T ss_pred CCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEECC
Confidence 4688999999999988999999999999999999999888999999999999999999999 7787665 899999999
Q ss_pred CccccccCCccccCCCCCCEEEeeCCccc--cCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCC
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFT--GQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE 175 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~ 175 (733)
+|++++..+..|.++++|+.|++++|.++ +..+..+..+ +|+.|++++|++++ +|..+. ++|+.|++++|.+..
T Consensus 132 ~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~ 207 (332)
T 2ft3_A 132 DNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQA 207 (332)
T ss_dssp SSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCC
T ss_pred CCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCc
Confidence 99999777778999999999999999996 4778888888 99999999999994 777665 799999999999999
Q ss_pred CCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--
Q 004732 176 ATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-- 252 (733)
Q Consensus 176 ~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-- 252 (733)
..+..+... +|+.|++++|.+++..+..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|.+++..+..+
T Consensus 208 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l~~~~~~~~~~ 286 (332)
T 2ft3_A 208 IELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFCP 286 (332)
T ss_dssp CCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCCCBCCTTSSSC
T ss_pred cCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCCCccChhHccc
Confidence 887777665 8999999999999988889999999999999999999 788889999999999999999986555443
Q ss_pred ------hcCCCeeecccCcCC
Q 004732 253 ------LERGDKIDLSYNNFT 267 (733)
Q Consensus 253 ------l~~l~~l~ls~N~l~ 267 (733)
...++.+++++|++.
T Consensus 287 ~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 287 VGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp SSCCSSSCCBSEEECCSSSSC
T ss_pred cccccccccccceEeecCccc
Confidence 245788999999986
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=278.90 Aligned_cols=122 Identities=16% Similarity=0.157 Sum_probs=75.0
Q ss_pred CCCCCCcCCcCeeecccccCCCCCc-cccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccC-CCCCCcCC
Q 004732 154 PSGIFSLENLTDLRISDLNGPEATF-PQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG-QIPSNFDD 230 (733)
Q Consensus 154 p~~l~~l~~L~~L~l~~n~~~~~~~-~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~ 230 (733)
|..+..+++|+.|++++|.+....+ ..+... +|+.|++++|.+++..|..+.++++|+.|++++|.+++ .+|..+..
T Consensus 392 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~ 471 (606)
T 3vq2_A 392 SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFAN 471 (606)
T ss_dssp CCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred hhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhcc
Confidence 4556667777777777777666554 334333 56666666666666666666666666666666666665 25666666
Q ss_pred CCCCCEEEecCCcccccCChhh--hcCCCeeecccCcCCCCCCcccc
Q 004732 231 LYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSC 275 (733)
Q Consensus 231 l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~~~~~~~ 275 (733)
+++|+.|++++|.+++..|..+ +++|+.|++++|++++..+...+
T Consensus 472 l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 518 (606)
T 3vq2_A 472 TTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518 (606)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTT
T ss_pred CCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHcc
Confidence 6666666666666665555544 45566666666666554444333
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=1e-27 Score=260.51 Aligned_cols=249 Identities=17% Similarity=0.125 Sum_probs=157.9
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
.++.+++++|.++...+..|..+++|++|+|++|.+++..+..|.++++|++|+|++|.+++..|..|+.+++|++|+|+
T Consensus 46 ~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 125 (390)
T 3o6n_A 46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125 (390)
T ss_dssp CCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECC
Confidence 34556666666665444455666666666666666665555566666666666666666665555566666666666666
Q ss_pred CccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCC------------------
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS------------------ 159 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~------------------ 159 (733)
+|+++...+..|.++++|++|++++|++++..+..|.++++|+.|++++|++++.....+..
T Consensus 126 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 205 (390)
T 3o6n_A 126 RNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPI 205 (390)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCS
T ss_pred CCccCcCCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCC
Confidence 66666333333566666666666666666655666666666666666666665431111111
Q ss_pred -------------------cCCcCeeecccccCCCCCcccccc-ccccEEEcccCccCCCCCccccCCCCCcEEEccCCc
Q 004732 160 -------------------LENLTDLRISDLNGPEATFPQLGN-MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNR 219 (733)
Q Consensus 160 -------------------l~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~ 219 (733)
.++|+.|++++|.+... ..+.. .+|+.|++++|.+++..|..|..+++|+.|+|++|+
T Consensus 206 ~L~~L~l~~n~l~~~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~ 283 (390)
T 3o6n_A 206 AVEELDASHNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 283 (390)
T ss_dssp SCSEEECCSSCCCEEECCCCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSC
T ss_pred cceEEECCCCeeeeccccccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCc
Confidence 12455555555555543 22333 267777777777777777777777788888888887
Q ss_pred ccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCcCCCCC
Q 004732 220 LRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 220 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~~ 270 (733)
+++ +|..+..+++|+.|++++|.+. .+|..+ +++|+.|++++|+++...
T Consensus 284 l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~ 334 (390)
T 3o6n_A 284 LVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK 334 (390)
T ss_dssp CCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC
T ss_pred Ccc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeC
Confidence 774 4555667777888888888777 444444 677788888888776553
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.4e-28 Score=276.24 Aligned_cols=248 Identities=18% Similarity=0.138 Sum_probs=171.4
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
++.+++.+|.++...+..|..+++|++|+|++|.|++..|..|+.+++|++|+|++|.+++..|..|+++++|++|+|++
T Consensus 53 l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 132 (597)
T 3oja_B 53 QKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLER 132 (597)
T ss_dssp CSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred ceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeC
Confidence 45566777777766555667777777777777777766666777777777777777777766666677777777777777
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCc------------------
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSL------------------ 160 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l------------------ 160 (733)
|.|++..+..|.++++|++|+|++|.|++..|..|+++++|+.|+|++|++++..+..+..+
T Consensus 133 n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~ 212 (597)
T 3oja_B 133 NDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIA 212 (597)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTT
T ss_pred CCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCch
Confidence 77774444456777777777777777777667777777777777777777765322211111
Q ss_pred -------------------CCcCeeecccccCCCCCcccccc-ccccEEEcccCccCCCCCccccCCCCCcEEEccCCcc
Q 004732 161 -------------------ENLTDLRISDLNGPEATFPQLGN-MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRL 220 (733)
Q Consensus 161 -------------------~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l 220 (733)
++|+.|+|++|.+... ..+.. .+|+.|+|++|.+++.+|..|+.+++|+.|+|++|.+
T Consensus 213 L~~L~ls~n~l~~~~~~~~~~L~~L~L~~n~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l 290 (597)
T 3oja_B 213 VEELDASHNSINVVRGPVNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 290 (597)
T ss_dssp CSEEECCSSCCCEEECSCCSCCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCC
T ss_pred hheeeccCCcccccccccCCCCCEEECCCCCCCCC--hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCC
Confidence 2344555555554442 22333 3677888888888877777888888888888888888
Q ss_pred cCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCcCCCCC
Q 004732 221 RGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 221 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~~ 270 (733)
++ +|..+..+++|+.|++++|.+. .+|..+ +++|+.|++++|++++.+
T Consensus 291 ~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~ 340 (597)
T 3oja_B 291 VA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLK 340 (597)
T ss_dssp CE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCC
T ss_pred CC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcC
Confidence 75 5666677788888888888887 455554 677888888888877653
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=272.99 Aligned_cols=248 Identities=18% Similarity=0.220 Sum_probs=150.2
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
.++.|+|++|++++..|..|..+++|++|+|++|+|++..|..|+++++|++|+|++|+++ .+|.. .+++|++|+|+
T Consensus 22 ~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L~ 98 (520)
T 2z7x_B 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLS 98 (520)
T ss_dssp TCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEECC
T ss_pred cccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEecc
Confidence 4556666666666555556666666666666666666555666666666666666666665 34443 55566666666
Q ss_pred Cccccc-cCCccccCCCCCCEEEeeCCccc-------------------------cCCCccccccC--------------
Q 004732 98 SNNFTG-ELPKTFAKLTNMKDFRISDNQFT-------------------------GQIPSFIQNWT-------------- 137 (733)
Q Consensus 98 ~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~-------------------------~~~~~~~~~l~-------------- 137 (733)
+|.+++ .+|..|+++++|++|++++|+|+ +..|..+..+.
T Consensus 99 ~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~ 178 (520)
T 2z7x_B 99 FNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEF 178 (520)
T ss_dssp SSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCC
T ss_pred CCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcch
Confidence 666654 34555555555555555555443 22233333211
Q ss_pred ---------------------------------------------------------------------CCCEEEccCCC
Q 004732 138 ---------------------------------------------------------------------KLEKLFIQPSG 148 (733)
Q Consensus 138 ---------------------------------------------------------------------~L~~L~l~~N~ 148 (733)
+|++|++++|+
T Consensus 179 ~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~ 258 (520)
T 2z7x_B 179 HFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258 (520)
T ss_dssp CCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEE
T ss_pred hhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeeccc
Confidence 45566666666
Q ss_pred CccCCCCCC-----------------------------------------------------CCcCCcCeeecccccCCC
Q 004732 149 LAGPIPSGI-----------------------------------------------------FSLENLTDLRISDLNGPE 175 (733)
Q Consensus 149 l~~~~p~~l-----------------------------------------------------~~l~~L~~L~l~~n~~~~ 175 (733)
++|.+|..+ ..+++|+.|++++|.+..
T Consensus 259 l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~Ls~n~l~~ 338 (520)
T 2z7x_B 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD 338 (520)
T ss_dssp EESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEECCSSCCCT
T ss_pred ccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEeECCccCh
Confidence 665555544 456677777777777777
Q ss_pred CCccccccc-cccEEEcccCccCC--CCCccccCCCCCcEEEccCCcccCCCCC-CcCCCCCCCEEEecCCcccccCChh
Q 004732 176 ATFPQLGNM-KMTKLILRNCNITG--ELPRYLGKMTKLKVLDLSFNRLRGQIPS-NFDDLYDVDYIYFAGNLLTGAIPPW 251 (733)
Q Consensus 176 ~~~~~~~~~-~L~~L~l~~n~l~~--~~p~~~~~l~~L~~L~ls~N~l~~~~p~-~~~~l~~L~~L~l~~N~l~~~~p~~ 251 (733)
..+..+... +|+.|++++|++++ .+|..++.+++|+.|++++|++++.+|. .+..+++|+.|++++|.+++..|..
T Consensus 339 ~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 418 (520)
T 2z7x_B 339 TVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRC 418 (520)
T ss_dssp TTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCGGGGGS
T ss_pred hhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCcchhhh
Confidence 555555544 67777777777775 4456677777777777777777764444 3666666777777777666555555
Q ss_pred hhcCCCeeecccCcCCC
Q 004732 252 MLERGDKIDLSYNNFTD 268 (733)
Q Consensus 252 ~l~~l~~l~ls~N~l~~ 268 (733)
+.++++.|++++|+++.
T Consensus 419 l~~~L~~L~Ls~N~l~~ 435 (520)
T 2z7x_B 419 LPPRIKVLDLHSNKIKS 435 (520)
T ss_dssp CCTTCCEEECCSSCCCC
T ss_pred hcccCCEEECCCCcccc
Confidence 44556666666666653
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-28 Score=261.90 Aligned_cols=252 Identities=19% Similarity=0.235 Sum_probs=213.0
Q ss_pred ecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCc
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 92 (733)
+.+.+.++.|+|++|++++..+..|..+++|++|+|++|.+++..|..|+++++|++|+|++|.++...+..|+.+++|+
T Consensus 65 ~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~ 144 (390)
T 3o6n_A 65 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 144 (390)
T ss_dssp HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCc
Confidence 44567789999999999988888999999999999999999988888899999999999999999944444479999999
Q ss_pred eeeccCccccccCCccccCCCCCCEEEeeCCccccCCCcccccc------------------------------------
Q 004732 93 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNW------------------------------------ 136 (733)
Q Consensus 93 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l------------------------------------ 136 (733)
+|+|++|.+++..|..|..+++|++|++++|++++.....+.++
T Consensus 145 ~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~~~~~~~L~~L~l~~n~l~~~~~~~ 224 (390)
T 3o6n_A 145 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPV 224 (390)
T ss_dssp EEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSEEECCSSCSEEECCSSCCCEEECCC
T ss_pred EEECCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccccCCCCcceEEECCCCeeeeccccc
Confidence 99999999998888889999999999999999986432222222
Q ss_pred -CCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEE
Q 004732 137 -TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLD 214 (733)
Q Consensus 137 -~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 214 (733)
++|+.|++++|++++. ..+..+++|+.|++++|.+....+..+... +|+.|+|++|.+++ +|..+..+++|+.|+
T Consensus 225 ~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~ 301 (390)
T 3o6n_A 225 NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD 301 (390)
T ss_dssp CSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEE
T ss_pred cccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEE
Confidence 2456666666666642 568889999999999999998877777665 89999999999995 566778899999999
Q ss_pred ccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCeeecccCcCCCC
Q 004732 215 LSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDG 269 (733)
Q Consensus 215 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~N~l~~~ 269 (733)
|++|+++ .+|..+..+++|+.|++++|.++. +|...+++++.|++++|++.+.
T Consensus 302 L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~-~~~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIVT-LKLSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp CCSSCCC-CCGGGHHHHTTCSEEECCSSCCCC-CCCCTTCCCSEEECCSSCEEHH
T ss_pred CCCCcce-ecCccccccCcCCEEECCCCccce-eCchhhccCCEEEcCCCCccch
Confidence 9999999 577778899999999999999984 4555688999999999998764
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=270.03 Aligned_cols=107 Identities=21% Similarity=0.270 Sum_probs=77.7
Q ss_pred ceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeec
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 96 (733)
+.+++|+|++|+|++..|..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+++ .+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEEC
Confidence 34677778888777777777777788888888888877777777777777777777777777 56655 6777777777
Q ss_pred cCccccc-cCCccccCCCCCCEEEeeCCccc
Q 004732 97 SSNNFTG-ELPKTFAKLTNMKDFRISDNQFT 126 (733)
Q Consensus 97 s~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~ 126 (733)
++|++++ .+|..|+++++|++|+|++|+++
T Consensus 129 s~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~ 159 (562)
T 3a79_B 129 SFNDFDVLPVCKEFGNLTKLTFLGLSAAKFR 159 (562)
T ss_dssp CSSCCSBCCCCGGGGGCTTCCEEEEECSBCC
T ss_pred CCCCccccCchHhhcccCcccEEecCCCccc
Confidence 7777775 23566777777777777766654
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-27 Score=263.52 Aligned_cols=231 Identities=16% Similarity=0.147 Sum_probs=211.3
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
..+.|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 76 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 155 (452)
T 3zyi_A 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155 (452)
T ss_dssp TCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSSCTTCCEEECC
T ss_pred CccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcccCCCCEEECC
Confidence 46889999999999999999999999999999999998888999999999999999999997667779999999999999
Q ss_pred CccccccCCccccCCCCCCEEEeeCC-ccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCC
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDN-QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEA 176 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~ 176 (733)
+|+|+...+..|.++++|+.|+|++| .+....+..|.++++|+.|+|++|++++ +| .+..+++|+.|+|++|.+...
T Consensus 156 ~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L~Ls~N~l~~~ 233 (452)
T 3zyi_A 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEELEMSGNHFPEI 233 (452)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEEECTTSCCSEE
T ss_pred CCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEEECcCCcCccc
Confidence 99999777778999999999999995 5554445579999999999999999995 44 588999999999999999998
Q ss_pred Cccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCCh
Q 004732 177 TFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP 250 (733)
Q Consensus 177 ~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 250 (733)
.+..+... +|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|++.+....
T Consensus 234 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~~ 308 (452)
T 3zyi_A 234 RPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDCDI 308 (452)
T ss_dssp CGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECSTTT
T ss_pred CcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCCCc
Confidence 88877766 899999999999999999999999999999999999988888899999999999999999877654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-27 Score=283.54 Aligned_cols=263 Identities=17% Similarity=0.156 Sum_probs=181.8
Q ss_pred ceeeeeccccccccccCCccccCCCCCCeeecccccccccc-chhccCCCCCCEEEcccccccccCCccccCCcCCceee
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPI-PKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 95 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 95 (733)
+.++.|+|++|.|++..|..|..+++|++|+|++|.+.+.+ |..|.++++|++|+|++|.+++..|.+|+++++|++|+
T Consensus 24 ~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 103 (844)
T 3j0a_A 24 NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELR 103 (844)
T ss_dssp TTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEE
T ss_pred CCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEee
Confidence 34677788888888777778888888888888888555444 66778888888888888888777777788888888888
Q ss_pred ccCccccccCCcc--ccCCCCCCEEEeeCCccccCCC-ccccccCCCCEEEccCCCCccCCCCCCCCc--CC--------
Q 004732 96 LSSNNFTGELPKT--FAKLTNMKDFRISDNQFTGQIP-SFIQNWTKLEKLFIQPSGLAGPIPSGIFSL--EN-------- 162 (733)
Q Consensus 96 Ls~N~l~~~~p~~--~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l--~~-------- 162 (733)
|++|.+++.+|.. |.++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..+..+..+ ++
T Consensus 104 Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~ 183 (844)
T 3j0a_A 104 LYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183 (844)
T ss_dssp CTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECC
T ss_pred CcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCC
Confidence 8888887656554 7778888888888888776544 467778888888888777776655555444 33
Q ss_pred ----------------------cCeeecccccCCCCCcccc---------------------------------------
Q 004732 163 ----------------------LTDLRISDLNGPEATFPQL--------------------------------------- 181 (733)
Q Consensus 163 ----------------------L~~L~l~~n~~~~~~~~~~--------------------------------------- 181 (733)
|+.|++++|.+....+..+
T Consensus 184 n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l 263 (844)
T 3j0a_A 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGL 263 (844)
T ss_dssp SBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTT
T ss_pred CccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhcc
Confidence 4555555553332211111
Q ss_pred ccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCee
Q 004732 182 GNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKI 259 (733)
Q Consensus 182 ~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l 259 (733)
...+|+.|++++|.+++..+..|..+++|+.|+|++|++++..|..|..+++|+.|++++|.+.+..|..+ +++|+.|
T Consensus 264 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 343 (844)
T 3j0a_A 264 ARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYI 343 (844)
T ss_dssp TTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEE
T ss_pred ccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEE
Confidence 01246677777777776667777777777777777777777777777777777777777777776666555 6677777
Q ss_pred ecccCcCCCCCCcccccccc
Q 004732 260 DLSYNNFTDGSAESSCQKRS 279 (733)
Q Consensus 260 ~ls~N~l~~~~~~~~~~~~~ 279 (733)
++++|++....+........
T Consensus 344 ~L~~N~i~~~~~~~~~~l~~ 363 (844)
T 3j0a_A 344 DLQKNHIAIIQDQTFKFLEK 363 (844)
T ss_dssp ECCSCCCCCCCSSCSCSCCC
T ss_pred ECCCCCCCccChhhhcCCCC
Confidence 77777776655544433333
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-27 Score=262.13 Aligned_cols=231 Identities=15% Similarity=0.155 Sum_probs=211.0
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
..+.|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|+++...+..|..+++|++|+|+
T Consensus 65 ~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 144 (440)
T 3zyj_A 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144 (440)
T ss_dssp TCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTSCSCSSCCEEECC
T ss_pred CCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHhhccccCceeeCC
Confidence 46789999999999999999999999999999999998888999999999999999999996666689999999999999
Q ss_pred CccccccCCccccCCCCCCEEEeeCC-ccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCC
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDN-QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEA 176 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~ 176 (733)
+|.|+...+..|.++++|++|+|++| .+....+..|.++++|+.|+|++|+++ .+| .+..+++|+.|+|++|.+...
T Consensus 145 ~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L~Ls~N~l~~~ 222 (440)
T 3zyj_A 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAI 222 (440)
T ss_dssp SCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEEECTTSCCCEE
T ss_pred CCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEEECCCCccCcc
Confidence 99999777788999999999999995 455444558999999999999999998 556 588999999999999999998
Q ss_pred Cccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCCh
Q 004732 177 TFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP 250 (733)
Q Consensus 177 ~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 250 (733)
.+..+... +|+.|+|++|++++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|++++|++.+....
T Consensus 223 ~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC~l 297 (440)
T 3zyj_A 223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCNCDI 297 (440)
T ss_dssp CTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECSSTT
T ss_pred ChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCCCCc
Confidence 88777766 899999999999999999999999999999999999988888899999999999999999876653
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-28 Score=277.68 Aligned_cols=252 Identities=19% Similarity=0.229 Sum_probs=216.7
Q ss_pred ecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCc
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 92 (733)
+.+.+.++.|+|++|+|++..|..|..+++|+.|+|++|.|++..|..|+++++|++|+|++|.|++..+..|+++++|+
T Consensus 71 ~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~ 150 (597)
T 3oja_B 71 LDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLT 150 (597)
T ss_dssp HHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred HccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCC
Confidence 44567789999999999999999999999999999999999988888899999999999999999955555679999999
Q ss_pred eeeccCccccccCCccccCCCCCCEEEeeCCccccCCCcccccc------------------------------------
Q 004732 93 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNW------------------------------------ 136 (733)
Q Consensus 93 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l------------------------------------ 136 (733)
+|+|++|.|++..|..|.++++|++|+|++|+|++.....+.++
T Consensus 151 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~l~~~~~L~~L~ls~n~l~~~~~~~ 230 (597)
T 3oja_B 151 TLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPV 230 (597)
T ss_dssp EEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSEEECCTTCSEEECCSSCCCEEECSC
T ss_pred EEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCccccccCCchhheeeccCCccccccccc
Confidence 99999999998888899999999999999999986533332222
Q ss_pred -CCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEE
Q 004732 137 -TKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLD 214 (733)
Q Consensus 137 -~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 214 (733)
++|+.|+|++|.+++ +..+..+++|+.|+|++|.+....+..+..+ +|+.|+|++|.+++ +|..+..+++|+.|+
T Consensus 231 ~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~ 307 (597)
T 3oja_B 231 NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLD 307 (597)
T ss_dssp CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEE
T ss_pred CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEE
Confidence 235566666666654 3678889999999999999999888777766 89999999999996 577778899999999
Q ss_pred ccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCeeecccCcCCCC
Q 004732 215 LSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDG 269 (733)
Q Consensus 215 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~N~l~~~ 269 (733)
|++|.++ .+|..+..+++|+.|++++|.+.+. |...+++|+.|++++|++.|.
T Consensus 308 Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 308 LSHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-KLSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-CCCTTCCCSEEECCSSCEEHH
T ss_pred CCCCCCC-ccCcccccCCCCCEEECCCCCCCCc-ChhhcCCCCEEEeeCCCCCCh
Confidence 9999999 6888889999999999999999854 555578999999999998754
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=269.85 Aligned_cols=245 Identities=18% Similarity=0.134 Sum_probs=173.6
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCc
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 99 (733)
+.+++++|+++ .+|..+. ++|++|+|++|.|++..|..|.++++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 45778888888 4666665 78888888888888777777888888888888888888777778888888888888888
Q ss_pred cccccCCccccCCCCCCEEEeeCCcccc-CCCccccccCCCCEEEccCCCCc-------------------------cCC
Q 004732 100 NFTGELPKTFAKLTNMKDFRISDNQFTG-QIPSFIQNWTKLEKLFIQPSGLA-------------------------GPI 153 (733)
Q Consensus 100 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~-------------------------~~~ 153 (733)
+|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|++++|+++ +..
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l~~~~~~ 156 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED 156 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTTTTSSCC
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccccccccc
Confidence 887 56655 77888888888888876 46777777777777777777663 223
Q ss_pred CCCCCCcC------------------------------------------------------------------------
Q 004732 154 PSGIFSLE------------------------------------------------------------------------ 161 (733)
Q Consensus 154 p~~l~~l~------------------------------------------------------------------------ 161 (733)
|..+..+.
T Consensus 157 ~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~ 236 (520)
T 2z7x_B 157 PEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236 (520)
T ss_dssp TTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHH
T ss_pred cccccccccceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHH
Confidence 44443322
Q ss_pred -----------CcCeeecccccCCCCCcccc-------------------------------------------------
Q 004732 162 -----------NLTDLRISDLNGPEATFPQL------------------------------------------------- 181 (733)
Q Consensus 162 -----------~L~~L~l~~n~~~~~~~~~~------------------------------------------------- 181 (733)
+|+.|++++|.+....+..+
T Consensus 237 ~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~~~p~~~~~~~~~~~~L~~L~l~~n~l~~ 316 (520)
T 2z7x_B 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316 (520)
T ss_dssp HHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCCCSCTHHHHHHHHTCCCSEEEEESSCCCC
T ss_pred HHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccceecchhhhhcccccCceeEEEcCCCcccc
Confidence 45556666555442221111
Q ss_pred ----cc-ccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccC--CCCCCcCCCCCCCEEEecCCcccccCChhh--
Q 004732 182 ----GN-MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG--QIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-- 252 (733)
Q Consensus 182 ----~~-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~--~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-- 252 (733)
.. .+|+.|++++|.+++.+|..++++++|+.|+|++|++++ .+|..+..+++|+.|++++|.+.+.+|...
T Consensus 317 ~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~ 396 (520)
T 2z7x_B 317 MLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS 396 (520)
T ss_dssp CCCCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCC
T ss_pred ccchhhCCcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhc
Confidence 12 267788888888887777778888888888888888875 455667778888888888888876566542
Q ss_pred -hcCCCeeecccCcCCCCC
Q 004732 253 -LERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 253 -l~~l~~l~ls~N~l~~~~ 270 (733)
+++|+.|++++|.+++..
T Consensus 397 ~l~~L~~L~Ls~N~l~~~~ 415 (520)
T 2z7x_B 397 WTKSLLSLNMSSNILTDTI 415 (520)
T ss_dssp CCTTCCEEECCSSCCCGGG
T ss_pred cCccCCEEECcCCCCCcch
Confidence 567788888888776543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.3e-28 Score=258.95 Aligned_cols=245 Identities=18% Similarity=0.217 Sum_probs=209.1
Q ss_pred cceeeeeccccccccccCCccccCCCCCCeeeccccccc-cccchhcc-------CCCCCCEEEcccccccccCCccc--
Q 004732 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLK-GPIPKYLA-------NISTLVNLTVQYNQFSGELPEEL-- 85 (733)
Q Consensus 16 ~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~-~~~p~~l~-------~l~~L~~L~L~~N~l~~~~p~~~-- 85 (733)
...++.+++++|++ .+|..+... |+.|+|++|.++ +.+|..+. ++++|++|+|++|++++.+|..+
T Consensus 42 ~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 117 (312)
T 1wwl_A 42 GRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLE 117 (312)
T ss_dssp EEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSS
T ss_pred CCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHH
Confidence 44577888999999 788877755 999999999994 56777666 79999999999999999999986
Q ss_pred cCCcCCceeeccCccccccCCccccCC-----CCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccC--CCCCC-
Q 004732 86 GSLLNLEKLHLSSNNFTGELPKTFAKL-----TNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP--IPSGI- 157 (733)
Q Consensus 86 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l-----~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~p~~l- 157 (733)
+.+++|++|+|++|+|++. |..+..+ ++|++|+|++|+|++..+..|+++++|++|+|++|++.+. ++..+
T Consensus 118 ~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~ 196 (312)
T 1wwl_A 118 ATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALC 196 (312)
T ss_dssp CCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSC
T ss_pred hcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHH
Confidence 9999999999999999976 8888887 9999999999999988889999999999999999998765 33344
Q ss_pred -CCcCCcCeeecccccCCCCCc---ccccc-ccccEEEcccCccCCCCC-ccccCCCCCcEEEccCCcccCCCCCCcCCC
Q 004732 158 -FSLENLTDLRISDLNGPEATF---PQLGN-MKMTKLILRNCNITGELP-RYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 231 (733)
Q Consensus 158 -~~l~~L~~L~l~~n~~~~~~~---~~~~~-~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 231 (733)
..+++|+.|++++|.+..... ..+.. .+|+.|++++|.+++.+| ..+..+++|+.|+|++|+|+ .+|..+.
T Consensus 197 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~-- 273 (312)
T 1wwl_A 197 PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP-- 273 (312)
T ss_dssp TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--
T ss_pred hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--
Confidence 889999999999999984321 22223 489999999999998775 55677899999999999999 7888776
Q ss_pred CCCCEEEecCCcccccCChh-hhcCCCeeecccCcCCCC
Q 004732 232 YDVDYIYFAGNLLTGAIPPW-MLERGDKIDLSYNNFTDG 269 (733)
Q Consensus 232 ~~L~~L~l~~N~l~~~~p~~-~l~~l~~l~ls~N~l~~~ 269 (733)
++|+.|++++|++++. |.. .+++|+.|++++|++++.
T Consensus 274 ~~L~~L~Ls~N~l~~~-p~~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 274 AKLSVLDLSYNRLDRN-PSPDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp SEEEEEECCSSCCCSC-CCTTTSCEEEEEECTTCTTTCC
T ss_pred CCceEEECCCCCCCCC-hhHhhCCCCCEEeccCCCCCCC
Confidence 8999999999999976 552 278899999999999763
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.5e-27 Score=272.87 Aligned_cols=282 Identities=17% Similarity=0.156 Sum_probs=222.5
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
..++|+|++|+|+++.+..|..+++|++|+|++|+|+++.+..|.++++|++|+|++|+|++..+.+|.++++|++|+|+
T Consensus 53 ~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls 132 (635)
T 4g8a_A 53 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 132 (635)
T ss_dssp TCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECT
T ss_pred CCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECC
Confidence 46889999999998888899999999999999999998778889999999999999999997666789999999999999
Q ss_pred CccccccCCccccCCCCCCEEEeeCCcccc-CCCccccccCCCCEEEccCCCCccCCCCCCC------------------
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTG-QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF------------------ 158 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~------------------ 158 (733)
+|+|++..+..|+++++|++|+|++|++++ .+|..++.+++|++|+|++|+|++..+..+.
T Consensus 133 ~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~ 212 (635)
T 4g8a_A 133 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 212 (635)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred CCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCc
Confidence 999997777789999999999999999975 4678889999999999999887643221110
Q ss_pred --------------------------------------------------------------------------------
Q 004732 159 -------------------------------------------------------------------------------- 158 (733)
Q Consensus 159 -------------------------------------------------------------------------------- 158 (733)
T Consensus 213 l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~ 292 (635)
T 4g8a_A 213 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 292 (635)
T ss_dssp CCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCC
T ss_pred ccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhc
Confidence
Q ss_pred ----------------------------------------------------------------------------CcCC
Q 004732 159 ----------------------------------------------------------------------------SLEN 162 (733)
Q Consensus 159 ----------------------------------------------------------------------------~l~~ 162 (733)
.+++
T Consensus 293 ~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~ 372 (635)
T 4g8a_A 293 YYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPS 372 (635)
T ss_dssp SCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTT
T ss_pred ccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccc
Confidence 1223
Q ss_pred cCeeecccccCCCCC-----------------------------------------------------------------
Q 004732 163 LTDLRISDLNGPEAT----------------------------------------------------------------- 177 (733)
Q Consensus 163 L~~L~l~~n~~~~~~----------------------------------------------------------------- 177 (733)
|+.|++++|.+....
T Consensus 373 L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~l 452 (635)
T 4g8a_A 373 LEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 452 (635)
T ss_dssp CCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEEC
T ss_pred cccchhhccccccccccccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccc
Confidence 334444443321100
Q ss_pred ---------cccccc-ccccEEEcccCcc-CCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccc
Q 004732 178 ---------FPQLGN-MKMTKLILRNCNI-TGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTG 246 (733)
Q Consensus 178 ---------~~~~~~-~~L~~L~l~~n~l-~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 246 (733)
+..+.. .+++.|++++|.+ .+.+|..|..+++|+.|+|++|+|++..|..|.++++|+.|++++|.+++
T Consensus 453 s~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~ 532 (635)
T 4g8a_A 453 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 532 (635)
T ss_dssp TTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCB
T ss_pred cccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCC
Confidence 000000 1356677777764 44577889999999999999999999999999999999999999999998
Q ss_pred cCChhh--hcCCCeeecccCcCCCCCCcccccc-cccccccccccccccCCceeee
Q 004732 247 AIPPWM--LERGDKIDLSYNNFTDGSAESSCQK-RSVTGIVSCLRSVQCPKTYYSL 299 (733)
Q Consensus 247 ~~p~~~--l~~l~~l~ls~N~l~~~~~~~~~~~-~~~~~~~~~~~~~~c~~~~~~~ 299 (733)
..|..+ +++|+.||+++|++++..+...... ..+..+-...+++.|.+...++
T Consensus 533 l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~ 588 (635)
T 4g8a_A 533 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSF 588 (635)
T ss_dssp CCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHH
T ss_pred CChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHH
Confidence 777766 7899999999999998877766554 4566666778899998765444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.5e-27 Score=273.18 Aligned_cols=283 Identities=20% Similarity=0.214 Sum_probs=225.5
Q ss_pred ecccceeeeeccccccccccCCccccCCCCCCeeeccccccccc--cchhccCC--CCCCEEEcccccccccCCccccCC
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGP--IPKYLANI--STLVNLTVQYNQFSGELPEELGSL 88 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~--~p~~l~~l--~~L~~L~L~~N~l~~~~p~~~~~l 88 (733)
+...+.++.|+|++|++++..+..|..+++|++|+|++|.+++. ....|..+ ++|+.|+|++|++++..|.+|..+
T Consensus 325 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~~~~~~l 404 (680)
T 1ziw_A 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWL 404 (680)
T ss_dssp TTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECTTTTTTC
T ss_pred cccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeEChhhhhCC
Confidence 34566788888888999888888888888888888888875432 22334433 578888888899988888889999
Q ss_pred cCCceeeccCccccccCC-ccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCc--cCCCCCCCCcCCcCe
Q 004732 89 LNLEKLHLSSNNFTGELP-KTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA--GPIPSGIFSLENLTD 165 (733)
Q Consensus 89 ~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~p~~l~~l~~L~~ 165 (733)
++|+.|+|++|.+++.+| ..|.++++|++|++++|++++..+..|..+++|+.|++++|.+. +.+|..+..+++|+.
T Consensus 405 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~ 484 (680)
T 1ziw_A 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI 484 (680)
T ss_dssp TTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCE
T ss_pred CCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCE
Confidence 999999999999987666 67888999999999999999888888999999999999999887 567888999999999
Q ss_pred eecccccCCCCCccccccc-cccEEEcccCccCCCCC--------ccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCE
Q 004732 166 LRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELP--------RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDY 236 (733)
Q Consensus 166 L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p--------~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~ 236 (733)
|++++|.+....+..+... +|+.|++++|.+++..+ ..|.++++|+.|+|++|+++...+..|..+++|+.
T Consensus 485 L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~ 564 (680)
T 1ziw_A 485 LDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI 564 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred EECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcce
Confidence 9999999988877766655 79999999999886422 23788899999999999999555567889999999
Q ss_pred EEecCCcccccCChhh--hcCCCeeecccCcCCCCCCcccc-cccccccccccccccccCCc
Q 004732 237 IYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAESSC-QKRSVTGIVSCLRSVQCPKT 295 (733)
Q Consensus 237 L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~~~~~~~-~~~~~~~~~~~~~~~~c~~~ 295 (733)
|++++|.+++..+..+ +++|+.|++++|++++..+.... ....+..+....+++.|.+.
T Consensus 565 L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~ 626 (680)
T 1ziw_A 565 IDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE 626 (680)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred eECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence 9999999985544443 57889999999998877655433 33445555566678888765
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.4e-27 Score=268.17 Aligned_cols=245 Identities=18% Similarity=0.112 Sum_probs=185.9
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCc
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 99 (733)
+.+++++|++++ +|..+. ++|++|+|++|.|++..+..|.++++|++|+|++|++++..|..|+.+++|++|+|++|
T Consensus 34 ~~l~ls~~~L~~-ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 110 (562)
T 3a79_B 34 SMVDYSNRNLTH-VPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHN 110 (562)
T ss_dssp CEEECTTSCCCS-CCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTS
T ss_pred cEEEcCCCCCcc-CCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCC
Confidence 578899999885 676554 78899999999998777788999999999999999998877888999999999999999
Q ss_pred cccccCCccccCCCCCCEEEeeCCcccc-CCCccccccCCCCEEEccCCCCccC-------------------------C
Q 004732 100 NFTGELPKTFAKLTNMKDFRISDNQFTG-QIPSFIQNWTKLEKLFIQPSGLAGP-------------------------I 153 (733)
Q Consensus 100 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~-------------------------~ 153 (733)
+|+ .+|.. .+++|++|+|++|++++ .+|..|+++++|++|+|++|++++. .
T Consensus 111 ~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l~~~~~~ 187 (562)
T 3a79_B 111 RLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGE 187 (562)
T ss_dssp CCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSCCCCSSS
T ss_pred cCC-ccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccccccccC
Confidence 988 67765 78899999999999886 3467888888888888888876531 2
Q ss_pred CCCCCCcC------------------------------------------------------------------------
Q 004732 154 PSGIFSLE------------------------------------------------------------------------ 161 (733)
Q Consensus 154 p~~l~~l~------------------------------------------------------------------------ 161 (733)
|..+..+.
T Consensus 188 ~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~ 267 (562)
T 3a79_B 188 TESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSV 267 (562)
T ss_dssp CCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHH
T ss_pred cccccccCcceEEEEecCccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHH
Confidence 22222211
Q ss_pred ---------CcCeeecccccCCCCCcccc---------------------------------------------------
Q 004732 162 ---------NLTDLRISDLNGPEATFPQL--------------------------------------------------- 181 (733)
Q Consensus 162 ---------~L~~L~l~~n~~~~~~~~~~--------------------------------------------------- 181 (733)
+|+.|++++|.+....+..+
T Consensus 268 ~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~ 347 (562)
T 3a79_B 268 KLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV 347 (562)
T ss_dssp HHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC
T ss_pred HHHHhhhcccccEEEEeccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc
Confidence 45566666665553222211
Q ss_pred --cc-ccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCC--CCCCcCCCCCCCEEEecCCcccccCChhh---h
Q 004732 182 --GN-MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQ--IPSNFDDLYDVDYIYFAGNLLTGAIPPWM---L 253 (733)
Q Consensus 182 --~~-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~p~~~---l 253 (733)
.. .+|+.|++++|.+++.+|..++++++|+.|+|++|++++. +|..+..+++|+.|++++|.+.+.+|... +
T Consensus 348 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l 427 (562)
T 3a79_B 348 CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427 (562)
T ss_dssp CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCC
T ss_pred CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCc
Confidence 22 3688888888888888888888888888888888888863 34668888888888888888887666543 5
Q ss_pred cCCCeeecccCcCCCCC
Q 004732 254 ERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 254 ~~l~~l~ls~N~l~~~~ 270 (733)
++++.|++++|++++..
T Consensus 428 ~~L~~L~l~~n~l~~~~ 444 (562)
T 3a79_B 428 ESILVLNLSSNMLTGSV 444 (562)
T ss_dssp TTCCEEECCSSCCCGGG
T ss_pred ccCCEEECCCCCCCcch
Confidence 77888888888876543
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-27 Score=277.89 Aligned_cols=247 Identities=21% Similarity=0.235 Sum_probs=216.5
Q ss_pred ccceeeeeccccccccccCCccccCCCCCCeeeccccc-ccc-ccchhccCCC-------CCCEEEcccccccccCCc--
Q 004732 15 QKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANR-LKG-PIPKYLANIS-------TLVNLTVQYNQFSGELPE-- 83 (733)
Q Consensus 15 ~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~-l~~-~~p~~l~~l~-------~L~~L~L~~N~l~~~~p~-- 83 (733)
+.+.++.|+|++|++.+.+|..|.++++|+.|+|++|+ ++| .+|..+++++ +|++|+|++|+++ .+|.
T Consensus 489 ~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~ 567 (876)
T 4ecn_A 489 NLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASA 567 (876)
T ss_dssp GCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHH
T ss_pred cCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChh
Confidence 78889999999999999999999999999999999998 998 8998777766 9999999999999 8998
Q ss_pred cccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCC-CCEEEccCCCCccCCCCCCCCcCC
Q 004732 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTK-LEKLFIQPSGLAGPIPSGIFSLEN 162 (733)
Q Consensus 84 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~-L~~L~l~~N~l~~~~p~~l~~l~~ 162 (733)
.|+++++|+.|+|++|+|+ .+| .|..+++|+.|+|++|+|+ .+|..+.++++ |+.|+|++|+|+ .+|..+..++.
T Consensus 568 ~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~ 643 (876)
T 4ecn_A 568 SLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSV 643 (876)
T ss_dssp HHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCS
T ss_pred hhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-cCchhhhcccc
Confidence 9999999999999999999 888 8999999999999999999 89999999999 999999999999 88988887755
Q ss_pred --cCeeecccccCCCCCccc------cccccccEEEcccCccCCCCCcc-ccCCCCCcEEEccCCcccCCCCCCcCCC--
Q 004732 163 --LTDLRISDLNGPEATFPQ------LGNMKMTKLILRNCNITGELPRY-LGKMTKLKVLDLSFNRLRGQIPSNFDDL-- 231 (733)
Q Consensus 163 --L~~L~l~~n~~~~~~~~~------~~~~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~L~ls~N~l~~~~p~~~~~l-- 231 (733)
|+.|++++|.+....+.. +...+|+.|+|++|.++ .+|.. +..+++|+.|+|++|+|+ .+|..+...
T Consensus 644 ~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~~~~~ 721 (876)
T 4ecn_A 644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQ-KFPTELFATGSPISTIILSNNLMT-SIPENSLKPKD 721 (876)
T ss_dssp SCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCSEEECCSCCCS-CCCTTSSSCTT
T ss_pred CCCCEEECcCCcCCCccccchhhhccccCCCcCEEEccCCcCC-ccCHHHHccCCCCCEEECCCCcCC-ccChHHhcccc
Confidence 999999999997754322 23347999999999999 55555 458999999999999999 566654432
Q ss_pred ------CCCCEEEecCCcccccCChhh----hcCCCeeecccCcCCCC
Q 004732 232 ------YDVDYIYFAGNLLTGAIPPWM----LERGDKIDLSYNNFTDG 269 (733)
Q Consensus 232 ------~~L~~L~l~~N~l~~~~p~~~----l~~l~~l~ls~N~l~~~ 269 (733)
++|+.|++++|.++ .+|..+ +++|+.|++++|++++.
T Consensus 722 ~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~l 768 (876)
T 4ecn_A 722 GNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSSF 768 (876)
T ss_dssp SCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSSC
T ss_pred ccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCcc
Confidence 38999999999998 677765 47899999999999874
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6e-27 Score=279.40 Aligned_cols=259 Identities=17% Similarity=0.141 Sum_probs=214.4
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccC-CccccCCcCCceeeccC
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGEL-PEELGSLLNLEKLHLSS 98 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~ 98 (733)
+..+.++++++ .+|. -.++|++|+|++|.|++..|..|.++++|++|+|++|.+.+.+ |.+|+++++|++|+|++
T Consensus 7 ~~~dcs~~~L~-~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~ 82 (844)
T 3j0a_A 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82 (844)
T ss_dssp EEEEESCCCSS-CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTT
T ss_pred eEEEccCCCCC-CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCC
Confidence 45678889999 4565 4589999999999999999999999999999999999666566 78899999999999999
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCcc--ccccCCCCEEEccCCCCccCCC-CCCCCcCCcCeeecccccCCC
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSF--IQNWTKLEKLFIQPSGLAGPIP-SGIFSLENLTDLRISDLNGPE 175 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~--~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~l~~n~~~~ 175 (733)
|.|++..|..|.++++|++|+|++|++++.+|.. |+++++|++|+|++|.+++..+ ..|+++++|+.|++++|.+..
T Consensus 83 N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~ 162 (844)
T 3j0a_A 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFL 162 (844)
T ss_dssp CCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCC
T ss_pred CcCcccCHhHccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCe
Confidence 9999889999999999999999999999866655 9999999999999999997655 579999999999999999877
Q ss_pred CCcccccc---------------------------------ccccEEEcccCccCCCCCccccC----------------
Q 004732 176 ATFPQLGN---------------------------------MKMTKLILRNCNITGELPRYLGK---------------- 206 (733)
Q Consensus 176 ~~~~~~~~---------------------------------~~L~~L~l~~n~l~~~~p~~~~~---------------- 206 (733)
..+..+.. .+|+.|++++|.+++.++..+..
T Consensus 163 ~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~ 242 (844)
T 3j0a_A 163 VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHI 242 (844)
T ss_dssp CCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSC
T ss_pred eCHHHcccccCCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccc
Confidence 65443322 12677777777666555544332
Q ss_pred ----------------------CCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecc
Q 004732 207 ----------------------MTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLS 262 (733)
Q Consensus 207 ----------------------l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls 262 (733)
.++|+.|+|++|.+.+..+..|..+++|+.|++++|.+.+..|..+ +++|+.|+++
T Consensus 243 ~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls 322 (844)
T 3j0a_A 243 MGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLS 322 (844)
T ss_dssp CBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEE
T ss_pred ccccccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECC
Confidence 1578888999998888888889999999999999999988877766 7889999999
Q ss_pred cCcCCCCCCccccccccccc
Q 004732 263 YNNFTDGSAESSCQKRSVTG 282 (733)
Q Consensus 263 ~N~l~~~~~~~~~~~~~~~~ 282 (733)
+|.+.+..+........+..
T Consensus 323 ~N~l~~~~~~~~~~l~~L~~ 342 (844)
T 3j0a_A 323 YNLLGELYSSNFYGLPKVAY 342 (844)
T ss_dssp SCCCSCCCSCSCSSCTTCCE
T ss_pred CCCCCccCHHHhcCCCCCCE
Confidence 99988776655554444433
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-28 Score=257.13 Aligned_cols=243 Identities=20% Similarity=0.175 Sum_probs=153.6
Q ss_pred eccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccc
Q 004732 22 RVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNF 101 (733)
Q Consensus 22 l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 101 (733)
.++++++++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.+++..|..|+++++|++|+|++|+|
T Consensus 36 c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l 112 (353)
T 2z80_A 36 CKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYL 112 (353)
T ss_dssp EECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred eeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcC
Confidence 455666666 4455443 4677777777777755555677777777777777777766666677777777777777777
Q ss_pred cccCCccccCCCCCCEEEeeCCccccCCC-ccccccCCCCEEEccCC-CCccCCCCCCCCcCCcCeeecccccCCCCCcc
Q 004732 102 TGELPKTFAKLTNMKDFRISDNQFTGQIP-SFIQNWTKLEKLFIQPS-GLAGPIPSGIFSLENLTDLRISDLNGPEATFP 179 (733)
Q Consensus 102 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N-~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~ 179 (733)
++..+..|.++++|++|+|++|++++..+ ..|.++++|+.|++++| .+....+..+.++++|+.|++++|.+....+.
T Consensus 113 ~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 192 (353)
T 2z80_A 113 SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPK 192 (353)
T ss_dssp SSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTT
T ss_pred CcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHH
Confidence 74444446677777777777777773322 36667777777777776 35555556667777777777777777666555
Q ss_pred ccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCC-------------------------------C
Q 004732 180 QLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPS-------------------------------N 227 (733)
Q Consensus 180 ~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~-------------------------------~ 227 (733)
.+... +|+.|++++|.++...+..+..+++|+.|++++|.+++..+. .
T Consensus 193 ~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~ 272 (353)
T 2z80_A 193 SLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKL 272 (353)
T ss_dssp TTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHH
T ss_pred HHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHH
Confidence 55554 677777777776533333344566777777777777654333 3
Q ss_pred cCCCCCCCEEEecCCcccccCChhh---hcCCCeeecccCcCCC
Q 004732 228 FDDLYDVDYIYFAGNLLTGAIPPWM---LERGDKIDLSYNNFTD 268 (733)
Q Consensus 228 ~~~l~~L~~L~l~~N~l~~~~p~~~---l~~l~~l~ls~N~l~~ 268 (733)
+..+++|+.|++++|.++ .+|... +++|+.|++++|++.+
T Consensus 273 l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 273 LNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp HHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred HhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccC
Confidence 445566666666666666 344432 4556666666666554
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.8e-27 Score=267.71 Aligned_cols=114 Identities=19% Similarity=0.260 Sum_probs=67.6
Q ss_pred ecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCc
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 92 (733)
+.+.+.++.|+|++|++++..+..|..+++|++|+|++|++++..|..|+++++|++|+|++|++++..+..|+++++|+
T Consensus 48 ~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~ 127 (570)
T 2z63_A 48 FFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLK 127 (570)
T ss_dssp TTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCC
T ss_pred hhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCcccccccccc
Confidence 34455566666666666666566666666666666666666655555566666666666666665533333455666666
Q ss_pred eeeccCccccc-cCCccccCCCCCCEEEeeCCccc
Q 004732 93 KLHLSSNNFTG-ELPKTFAKLTNMKDFRISDNQFT 126 (733)
Q Consensus 93 ~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~ 126 (733)
+|+|++|.+++ .+|..|.++++|++|++++|+++
T Consensus 128 ~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~ 162 (570)
T 2z63_A 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162 (570)
T ss_dssp EEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCC
T ss_pred EEecCCCccceecChhhhcccCCCCEEeCcCCccc
Confidence 66666666554 24555666666666666555544
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=265.13 Aligned_cols=120 Identities=18% Similarity=0.244 Sum_probs=63.8
Q ss_pred cccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccc-cCCccccCCcCCc
Q 004732 14 KQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSG-ELPEELGSLLNLE 92 (733)
Q Consensus 14 ~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~ 92 (733)
.+.+.+++|+|++|++++..|..|..+++|++|+|++|++++..|..|+++++|++|+|++|.+++ ..|..|+++++|+
T Consensus 47 ~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~ 126 (549)
T 2z81_A 47 RACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126 (549)
T ss_dssp SSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCC
T ss_pred hcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCcc
Confidence 344455555566666655555555556666666666666655544455556666666666665553 2344455555555
Q ss_pred eeeccCccccccCC-ccccCCCCCCEEEeeCCccccCCCccc
Q 004732 93 KLHLSSNNFTGELP-KTFAKLTNMKDFRISDNQFTGQIPSFI 133 (733)
Q Consensus 93 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~ 133 (733)
+|+|++|.+.+.+| ..|.++++|++|++++|++++..|..+
T Consensus 127 ~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l 168 (549)
T 2z81_A 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL 168 (549)
T ss_dssp EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTT
T ss_pred EEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhh
Confidence 55555555222332 345555555555555555554444433
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=238.21 Aligned_cols=224 Identities=21% Similarity=0.206 Sum_probs=203.6
Q ss_pred CCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeC
Q 004732 43 LQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD 122 (733)
Q Consensus 43 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 122 (733)
-+.++.+++.++ .+|..+ .++|++|+|++|.+++..+..|..+++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 13 ~~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 89 (285)
T 1ozn_A 13 KVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSD 89 (285)
T ss_dssp SCEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CeEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCC
Confidence 368999999999 667544 47999999999999987778899999999999999999988899999999999999999
Q ss_pred Cc-cccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCC
Q 004732 123 NQ-FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGEL 200 (733)
Q Consensus 123 N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~ 200 (733)
|+ ++...+..|..+++|++|+|++|++++..|..+..+++|+.|++++|.+.......+... +|+.|++++|.+++..
T Consensus 90 n~~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 169 (285)
T 1ozn_A 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVP 169 (285)
T ss_dssp CTTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEEC
T ss_pred CCCccccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccC
Confidence 98 886668899999999999999999998888999999999999999999998887777655 8999999999999877
Q ss_pred CccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCcCCCC
Q 004732 201 PRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDG 269 (733)
Q Consensus 201 p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~ 269 (733)
+..|..+++|+.|++++|.+++..|..|..+++|+.|++++|.+.+..+..+ +++|+.|++++|++.+.
T Consensus 170 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 240 (285)
T 1ozn_A 170 ERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred HHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCC
Confidence 7789999999999999999999999999999999999999999997555545 78899999999998764
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.5e-26 Score=270.12 Aligned_cols=247 Identities=18% Similarity=0.183 Sum_probs=180.5
Q ss_pred ceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeec
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 96 (733)
..++.|+|++|++++..+..|..+++|++|+|++|.+++..|..|+++++|++|+|++|.+++..+..|+++++|++|+|
T Consensus 25 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 104 (680)
T 1ziw_A 25 TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHL 104 (680)
T ss_dssp TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEEC
T ss_pred CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEEC
Confidence 34677888888888877778888888888888888888888888888888888888888888544456888888888888
Q ss_pred cCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCC--CcCCcCeeecccccCC
Q 004732 97 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF--SLENLTDLRISDLNGP 174 (733)
Q Consensus 97 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~--~l~~L~~L~l~~n~~~ 174 (733)
++|++++..|..|+++++|++|+|++|++++..+..++++++|++|++++|++++..+..+. .+++|+.|++++|.+.
T Consensus 105 ~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~ 184 (680)
T 1ziw_A 105 MSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIK 184 (680)
T ss_dssp CSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCC
T ss_pred CCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCccc
Confidence 88888876677888888888888888888888788888888888888888888866665443 4577888888888777
Q ss_pred CCCcccccc----------------------------ccccEEEcccCccCCCCCccccCCCC--CcEEEccCCcccCCC
Q 004732 175 EATFPQLGN----------------------------MKMTKLILRNCNITGELPRYLGKMTK--LKVLDLSFNRLRGQI 224 (733)
Q Consensus 175 ~~~~~~~~~----------------------------~~L~~L~l~~n~l~~~~p~~~~~l~~--L~~L~ls~N~l~~~~ 224 (733)
...+..+.. .+|+.|++++|.+++..|..|.+++. |+.|+|++|++++..
T Consensus 185 ~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~ 264 (680)
T 1ziw_A 185 EFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVG 264 (680)
T ss_dssp CBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEEC
T ss_pred ccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccC
Confidence 655443321 24566666666666666666666543 666666666666666
Q ss_pred CCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeeccc
Q 004732 225 PSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSY 263 (733)
Q Consensus 225 p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~ 263 (733)
|..|..+++|+.|++++|.+.+..|..+ +++++.|++++
T Consensus 265 ~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 305 (680)
T 1ziw_A 265 NDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKR 305 (680)
T ss_dssp TTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTT
T ss_pred cccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccc
Confidence 6666666666666666666665555443 34444444444
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=9.4e-27 Score=268.08 Aligned_cols=275 Identities=21% Similarity=0.143 Sum_probs=208.7
Q ss_pred ecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCc
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 92 (733)
+...+.++.+++++|.++ .+| .+..+++|+.|++++|.+ +.+| .+ .+++|++|++++|...+.+ .++.+++|+
T Consensus 281 ~~~l~~L~~L~l~~~~~~-~l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~L~~L~l~~n~~~~~~--~~~~l~~L~ 353 (606)
T 3vq2_A 281 FHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPFLKSLTLTMNKGSISF--KKVALPSLS 353 (606)
T ss_dssp CGGGTTCSEEEEESCCCC-CCC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSSCCEEEEESCSSCEEC--CCCCCTTCC
T ss_pred cccCCCCCEEEecCccch-hhh-hccccccCCEEEcccccC-cccc-cC-CCCccceeeccCCcCccch--hhccCCCCC
Confidence 455667788888888886 455 788888888888888888 4777 45 8888888888888555444 567888888
Q ss_pred eeeccCcccccc--CCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCC-CCCCCcCCcCeeecc
Q 004732 93 KLHLSSNNFTGE--LPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP-SGIFSLENLTDLRIS 169 (733)
Q Consensus 93 ~L~Ls~N~l~~~--~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~l~ 169 (733)
+|+|++|++++. +|..+..+++|++|++++|.+++ +|..|..+++|+.|++++|++.+..| ..+..+++|+.|+++
T Consensus 354 ~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~ 432 (606)
T 3vq2_A 354 YLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432 (606)
T ss_dssp EEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECT
T ss_pred EEECcCCccCCCcchhhhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECc
Confidence 888888888765 37778888888888888888884 66778888888888888888887766 577788888888888
Q ss_pred cccCCCCCccccccc-cccEEEcccCccCC-CCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCccccc
Q 004732 170 DLNGPEATFPQLGNM-KMTKLILRNCNITG-ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGA 247 (733)
Q Consensus 170 ~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~-~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 247 (733)
+|.+....+..+... +|+.|++++|.+++ .+|..|+.+++|+.|+|++|++++..|..+..+++|+.|++++|.+++.
T Consensus 433 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 512 (606)
T 3vq2_A 433 YTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512 (606)
T ss_dssp TSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCE
T ss_pred CCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCc
Confidence 888877766666554 78888888888887 4677788888888888888888888888888888888888888888877
Q ss_pred CChhh--hcCCCeeecccCcCCCCCCccccccc-ccccccccccccccCCce
Q 004732 248 IPPWM--LERGDKIDLSYNNFTDGSAESSCQKR-SVTGIVSCLRSVQCPKTY 296 (733)
Q Consensus 248 ~p~~~--l~~l~~l~ls~N~l~~~~~~~~~~~~-~~~~~~~~~~~~~c~~~~ 296 (733)
.|..+ +++|+.|++++|+++..+.. ..... .+..+....+++.|.+..
T Consensus 513 ~~~~~~~l~~L~~L~l~~N~l~~~p~~-~~~l~~~L~~l~l~~N~~~c~c~~ 563 (606)
T 3vq2_A 513 DSSHYNQLYSLSTLDCSFNRIETSKGI-LQHFPKSLAFFNLTNNSVACICEH 563 (606)
T ss_dssp EGGGTTTCTTCCEEECTTSCCCCEESC-GGGSCTTCCEEECCSCCCCCSSTT
T ss_pred CHHHccCCCcCCEEECCCCcCcccCHh-HhhhcccCcEEEccCCCcccCCcc
Confidence 77766 67788888888888754433 32222 345555556666665543
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-26 Score=248.29 Aligned_cols=256 Identities=15% Similarity=0.114 Sum_probs=209.1
Q ss_pred cccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCC
Q 004732 36 KLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 115 (733)
Q Consensus 36 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 115 (733)
.-..++.....++++|.++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|++++..|..|.++++|
T Consensus 26 ~~~~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 102 (353)
T 2z80_A 26 ASLSCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102 (353)
T ss_dssp -CCEECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred cCCCCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCC
Confidence 3344566677899999999 7787665 599999999999997666789999999999999999998888899999999
Q ss_pred CEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCC-CCCCCcCCcCeeeccccc-CCCCCccccccc-cccEEEcc
Q 004732 116 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP-SGIFSLENLTDLRISDLN-GPEATFPQLGNM-KMTKLILR 192 (733)
Q Consensus 116 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~l~~l~~L~~L~l~~n~-~~~~~~~~~~~~-~L~~L~l~ 192 (733)
++|+|++|++++..+..|+++++|++|+|++|++++..+ ..+..+++|+.|++++|+ +....+..+... +|+.|+++
T Consensus 103 ~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~ 182 (353)
T 2z80_A 103 EHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEID 182 (353)
T ss_dssp CEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEE
T ss_pred CEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECC
Confidence 999999999996555569999999999999999995433 478899999999999994 666666666655 89999999
Q ss_pred cCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccC------------------------
Q 004732 193 NCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAI------------------------ 248 (733)
Q Consensus 193 ~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~------------------------ 248 (733)
+|.+++..|..+..+++|++|++++|.++......+..+++|+.|++++|.+.+..
T Consensus 183 ~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~ 262 (353)
T 2z80_A 183 ASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKIT 262 (353)
T ss_dssp ETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCC
T ss_pred CCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhcccccccccc
Confidence 99999999999999999999999999997544334556899999999999998643
Q ss_pred -------Chhh--hcCCCeeecccCcCCCCCCcccccccccccccccccccccCC
Q 004732 249 -------PPWM--LERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPK 294 (733)
Q Consensus 249 -------p~~~--l~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~~~~~~~~~c~~ 294 (733)
|.++ +++|+.|++++|+++..+.........+..+....+++.|.+
T Consensus 263 ~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~~~ 317 (353)
T 2z80_A 263 DESLFQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSC 317 (353)
T ss_dssp HHHHHHHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred CcchhhhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccCcC
Confidence 2223 568999999999998665443344455555555556666543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.3e-27 Score=252.03 Aligned_cols=236 Identities=17% Similarity=0.106 Sum_probs=155.2
Q ss_pred cceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceee
Q 004732 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 95 (733)
Q Consensus 16 ~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 95 (733)
.+.+++|+|++|++++..|..|..+++|+.|+|++|.+++..+ |..+++|++|+|++|.+++ ++ .+++|+.|+
T Consensus 33 ~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~n~l~~-l~----~~~~L~~L~ 105 (317)
T 3o53_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL----VGPSIETLH 105 (317)
T ss_dssp GGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCSSEEEE-EE----ECTTCCEEE
T ss_pred CCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcCCcccc-cc----CCCCcCEEE
Confidence 3456677777777776666677777777777777777775444 7777777777777777763 22 236777777
Q ss_pred ccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCC-CcCCcCeeecccccCC
Q 004732 96 LSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIF-SLENLTDLRISDLNGP 174 (733)
Q Consensus 96 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~-~l~~L~~L~l~~n~~~ 174 (733)
|++|++++..+. .+++|++|++++|++++..+..++.+++|+.|+|++|++++..+..+. .+++|+.|++++|.+.
T Consensus 106 l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~ 182 (317)
T 3o53_A 106 AANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY 182 (317)
T ss_dssp CCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCC
T ss_pred CCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCc
Confidence 777777754433 256677777777777766666677777777777777777765555553 5677777777777766
Q ss_pred CCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCccc-ccCChhh-
Q 004732 175 EATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT-GAIPPWM- 252 (733)
Q Consensus 175 ~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-~~~p~~~- 252 (733)
..... ....+|+.|+|++|.+++. |..+..+++|+.|+|++|+|+ .+|..+..+++|+.|++++|++. +.+|.++
T Consensus 183 ~~~~~-~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~ 259 (317)
T 3o53_A 183 DVKGQ-VVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259 (317)
T ss_dssp EEECC-CCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHH
T ss_pred ccccc-cccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHh
Confidence 65222 2234677777777777743 444677777777777777777 45666777777777777777776 4444443
Q ss_pred -hcCCCeeecccC
Q 004732 253 -LERGDKIDLSYN 264 (733)
Q Consensus 253 -l~~l~~l~ls~N 264 (733)
+++++.++++++
T Consensus 260 ~~~~L~~l~l~~~ 272 (317)
T 3o53_A 260 KNQRVQTVAKQTV 272 (317)
T ss_dssp TCHHHHHHHHHHH
T ss_pred ccccceEEECCCc
Confidence 445556666633
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.9e-26 Score=234.32 Aligned_cols=224 Identities=19% Similarity=0.172 Sum_probs=192.8
Q ss_pred eccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccc
Q 004732 22 RVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNF 101 (733)
Q Consensus 22 l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 101 (733)
++-.+.+++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|++|.+
T Consensus 12 ~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l 88 (276)
T 2z62_A 12 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88 (276)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCcc
Confidence 344555665 5666554 6799999999999987777899999999999999999977777899999999999999999
Q ss_pred cccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccC-CCCCCCCcCCcCeeecccccCCCCCccc
Q 004732 102 TGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP-IPSGIFSLENLTDLRISDLNGPEATFPQ 180 (733)
Q Consensus 102 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~-~p~~l~~l~~L~~L~l~~n~~~~~~~~~ 180 (733)
++..+..|.++++|++|++++|++++..+..++++++|++|++++|++++. +|..+..+++|+.|++++|.+.......
T Consensus 89 ~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~ 168 (276)
T 2z62_A 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168 (276)
T ss_dssp CEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGG
T ss_pred CccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHH
Confidence 988888999999999999999999977777899999999999999999863 6899999999999999999998877666
Q ss_pred cccc-ccc----EEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCC
Q 004732 181 LGNM-KMT----KLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 249 (733)
Q Consensus 181 ~~~~-~L~----~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 249 (733)
+... +|+ .|++++|.+++..+..+. ..+|+.|+|++|++++..+..|..+++|+.|++++|++.+..|
T Consensus 169 ~~~l~~L~~l~l~L~ls~n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 169 LRVLHQMPLLNLSLDLSLNPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp GHHHHTCTTCCEEEECCSSCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred hhhhhhccccceeeecCCCcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 6544 455 899999999976665554 4589999999999998777778999999999999999998776
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-26 Score=261.83 Aligned_cols=260 Identities=18% Similarity=0.209 Sum_probs=210.5
Q ss_pred eeecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcC
Q 004732 11 HFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLN 90 (733)
Q Consensus 11 ~~~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 90 (733)
..|.+.+.++.|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|+++++
T Consensus 70 ~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~ 149 (635)
T 4g8a_A 70 YSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 149 (635)
T ss_dssp TTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTT
T ss_pred HHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcc
Confidence 45677888999999999999988889999999999999999999777788999999999999999999766678999999
Q ss_pred CceeeccCccccc-cCCccccCCCCCCEEEeeCCccccCCCcccc-----------------------------------
Q 004732 91 LEKLHLSSNNFTG-ELPKTFAKLTNMKDFRISDNQFTGQIPSFIQ----------------------------------- 134 (733)
Q Consensus 91 L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~----------------------------------- 134 (733)
|++|+|++|.|++ .+|..+..+++|++|+|++|+|++..+..|.
T Consensus 150 L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l 229 (635)
T 4g8a_A 150 LKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKL 229 (635)
T ss_dssp CCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEE
T ss_pred cCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhh
Confidence 9999999999985 4678889999999999999987643221110
Q ss_pred --------------------------------------------------------------------------------
Q 004732 135 -------------------------------------------------------------------------------- 134 (733)
Q Consensus 135 -------------------------------------------------------------------------------- 134 (733)
T Consensus 230 ~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~ 309 (635)
T 4g8a_A 230 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVS 309 (635)
T ss_dssp EEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCS
T ss_pred hhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccc
Confidence
Q ss_pred -----------------------------------------------------------ccCCCCEEEccCCCCc-----
Q 004732 135 -----------------------------------------------------------NWTKLEKLFIQPSGLA----- 150 (733)
Q Consensus 135 -----------------------------------------------------------~l~~L~~L~l~~N~l~----- 150 (733)
.+++|+.|++++|.+.
T Consensus 310 ~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~ 389 (635)
T 4g8a_A 310 SFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 389 (635)
T ss_dssp EEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEEC
T ss_pred cccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhcccccccccc
Confidence 1233444454444432
Q ss_pred ---------------------------------------------------------------------cCCCCCCCCcC
Q 004732 151 ---------------------------------------------------------------------GPIPSGIFSLE 161 (733)
Q Consensus 151 ---------------------------------------------------------------------~~~p~~l~~l~ 161 (733)
+..+..+..++
T Consensus 390 ~~~~~~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~ 469 (635)
T 4g8a_A 390 SQSDFGTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 469 (635)
T ss_dssp CHHHHSCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred ccchhhhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccch
Confidence 11222334455
Q ss_pred CcCeeecccccCCC-CCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEe
Q 004732 162 NLTDLRISDLNGPE-ATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYF 239 (733)
Q Consensus 162 ~L~~L~l~~n~~~~-~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 239 (733)
+|+.|++++|.+.. ..+..+... +|+.|+|++|+|++.+|..|.++++|++|+|++|+|++..|..|..+++|+.|++
T Consensus 470 ~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 549 (635)
T 4g8a_A 470 SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDY 549 (635)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEEC
T ss_pred hhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEEC
Confidence 66667777665433 334445544 7999999999999999999999999999999999999999999999999999999
Q ss_pred cCCcccccCChhh--h-cCCCeeecccCcCCCCC
Q 004732 240 AGNLLTGAIPPWM--L-ERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 240 ~~N~l~~~~p~~~--l-~~l~~l~ls~N~l~~~~ 270 (733)
++|++++..|..+ + ++|+.|++++|++.|..
T Consensus 550 s~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C 583 (635)
T 4g8a_A 550 SLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 583 (635)
T ss_dssp TTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred CCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence 9999998888876 3 68999999999998753
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-27 Score=247.59 Aligned_cols=222 Identities=23% Similarity=0.284 Sum_probs=193.0
Q ss_pred eeeecccccccc-ccCCcccc-------CCCCCCeeeccccccccccchhc--cCCCCCCEEEcccccccccCCccccCC
Q 004732 19 NQKRVLKEQNLT-GVLPPKLA-------ELTFLQDISLIANRLKGPIPKYL--ANISTLVNLTVQYNQFSGELPEELGSL 88 (733)
Q Consensus 19 ~~~l~L~~n~l~-~~~p~~l~-------~l~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p~~~~~l 88 (733)
++.|+|++|+++ ..+|..+. .+++|++|+|++|++++.+|..+ ..+++|++|+|++|++++. |..++.+
T Consensus 65 L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l 143 (312)
T 1wwl_A 65 IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAEL 143 (312)
T ss_dssp HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHH
T ss_pred HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHH
Confidence 778899999994 56777776 79999999999999999999886 8999999999999999976 8888888
Q ss_pred -----cCCceeeccCccccccCCccccCCCCCCEEEeeCCccccC--CCccc--cccCCCCEEEccCCCCcc--CCC-CC
Q 004732 89 -----LNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ--IPSFI--QNWTKLEKLFIQPSGLAG--PIP-SG 156 (733)
Q Consensus 89 -----~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~~~~~--~~l~~L~~L~l~~N~l~~--~~p-~~ 156 (733)
++|++|+|++|+|++..|..|+++++|++|+|++|++.+. .+..+ ..+++|++|+|++|+|++ .++ ..
T Consensus 144 ~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 223 (312)
T 1wwl_A 144 QQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSAL 223 (312)
T ss_dssp HTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHH
T ss_pred HHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHH
Confidence 8999999999999988889999999999999999998865 33444 899999999999999983 223 33
Q ss_pred CCCcCCcCeeecccccCCCCCc-ccccc-ccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCC
Q 004732 157 IFSLENLTDLRISDLNGPEATF-PQLGN-MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDV 234 (733)
Q Consensus 157 l~~l~~L~~L~l~~n~~~~~~~-~~~~~-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 234 (733)
+..+++|+.|++++|.+....+ ..+.. .+|+.|+|++|.|+ .+|..+. ++|+.|||++|+|++. |. +..+++|
T Consensus 224 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L 298 (312)
T 1wwl_A 224 AAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQV 298 (312)
T ss_dssp HHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEE
T ss_pred HhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCC
Confidence 4578999999999999998763 34443 48999999999999 7787776 8999999999999976 66 9999999
Q ss_pred CEEEecCCcccc
Q 004732 235 DYIYFAGNLLTG 246 (733)
Q Consensus 235 ~~L~l~~N~l~~ 246 (733)
+.|++++|++++
T Consensus 299 ~~L~L~~N~l~~ 310 (312)
T 1wwl_A 299 GNLSLKGNPFLD 310 (312)
T ss_dssp EEEECTTCTTTC
T ss_pred CEEeccCCCCCC
Confidence 999999999975
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-26 Score=264.43 Aligned_cols=153 Identities=20% Similarity=0.217 Sum_probs=134.2
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
.++.|+|++|++++..|..|..+++|++|+|++|++++..|..|+++++|++|+|++|.+++..|..|+.+++|++|+|+
T Consensus 27 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls 106 (549)
T 2z81_A 27 AMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM 106 (549)
T ss_dssp TCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECT
T ss_pred CccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECC
Confidence 57889999999999999999999999999999999998888999999999999999999997777779999999999999
Q ss_pred Cccccc-cCCccccCCCCCCEEEeeCCccccCCC-ccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeeccc
Q 004732 98 SNNFTG-ELPKTFAKLTNMKDFRISDNQFTGQIP-SFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD 170 (733)
Q Consensus 98 ~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~ 170 (733)
+|.+++ ..|..+.++++|++|++++|++.+.+| ..|.++++|++|++++|++++..|..+..+++|+.|+++.
T Consensus 107 ~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~l~~ 181 (549)
T 2z81_A 107 GNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHL 181 (549)
T ss_dssp TCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEEC
T ss_pred CCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCceEeccc
Confidence 999996 457789999999999999999554555 6899999999999999999998888887654444444333
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.1e-25 Score=257.14 Aligned_cols=250 Identities=14% Similarity=0.149 Sum_probs=221.4
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
..+.|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|.+++..|.+|+.+++|++|+|+
T Consensus 29 ~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 108 (570)
T 2z63_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (570)
T ss_dssp SCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred cccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccccc
Confidence 46889999999999999999999999999999999998888899999999999999999998888899999999999999
Q ss_pred CccccccCCccccCCCCCCEEEeeCCcccc-CCCccccccCCCCEEEccCCCCccCCCCCCCCcCCc----Ceeeccccc
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTG-QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENL----TDLRISDLN 172 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L----~~L~l~~n~ 172 (733)
+|++++..+..|+++++|++|++++|++++ .+|..|+++++|++|++++|++++..+..+..+++| ..|++++|.
T Consensus 109 ~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~ 188 (570)
T 2z63_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (570)
T ss_dssp TSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCC
T ss_pred ccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCC
Confidence 999996666679999999999999999997 479999999999999999999998888889999888 899999999
Q ss_pred CCCCCccccccccccEEEcccC----------------------------------------------------------
Q 004732 173 GPEATFPQLGNMKMTKLILRNC---------------------------------------------------------- 194 (733)
Q Consensus 173 ~~~~~~~~~~~~~L~~L~l~~n---------------------------------------------------------- 194 (733)
+....+..+...+|+.|++++|
T Consensus 189 l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~ 268 (570)
T 2z63_A 189 MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268 (570)
T ss_dssp CCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETT
T ss_pred ceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcch
Confidence 9988877777777888887776
Q ss_pred ccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCeeecccCcCCCCC
Q 004732 195 NITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 195 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~N~l~~~~ 270 (733)
.+.+.+|..+..+++|+.|++++|.++ .+|..+..+ +|+.|++++|.+. .+|...+++++.|++++|.+.+..
T Consensus 269 ~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~-~l~~~~l~~L~~L~l~~n~~~~~~ 341 (570)
T 2z63_A 269 YYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFG-QFPTLKLKSLKRLTFTSNKGGNAF 341 (570)
T ss_dssp EEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCS-SCCBCBCSSCCEEEEESCBSCCBC
T ss_pred hhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCccc-ccCcccccccCEEeCcCCcccccc
Confidence 445566777888899999999999998 588888888 9999999999988 677767888889999888876543
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.2e-27 Score=262.96 Aligned_cols=184 Identities=17% Similarity=0.211 Sum_probs=146.2
Q ss_pred cccCcccCCCcccEEEcccCCCcEEEEEEccccCh--------hcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 396 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK--------QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
...+.||+|+||.||+|.. .++.+++|+...... ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 468889987643311 1134589999999999999999777777788888999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||+++++|.+++.. +..++.|+++||+|||+++ |+||||||+|||++. .+||+|||+++......
T Consensus 418 mE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~ 483 (540)
T 3en9_A 418 MSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDE 483 (540)
T ss_dssp EECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHH
T ss_pred EECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCcc
Confidence 999999999999854 5689999999999999986 999999999999999 99999999999765532
Q ss_pred ccc------ccccccCCCcccHHHHhh--CCCCccchhHhHHHHHHHHHhCCCCC
Q 004732 548 THI------STRVAGTIGYMAPEYAMR--GHLTEKADVYSFGIVALEIVSGRSNV 594 (733)
Q Consensus 548 ~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~elltg~~p~ 594 (733)
... ...+.||+.|+|||++.. ..|+..+|+||..+-..+-+.++.++
T Consensus 484 ~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 484 DKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 221 235789999999999987 56888999999999888888777665
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-25 Score=230.17 Aligned_cols=208 Identities=16% Similarity=0.156 Sum_probs=191.7
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
.++.|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|++|+|+
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 47889999999999888899999999999999999998888899999999999999999998888899999999999999
Q ss_pred CccccccCCccccCCCCCCEEEeeCCccccC-CCccccccCCCCEEEccCCCCccCCCCCCCCcCCcC----eeeccccc
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQ-IPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLT----DLRISDLN 172 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~----~L~l~~n~ 172 (733)
+|++++..+..+..+++|++|++++|++++. +|..|.++++|+.|+|++|++++..+..+..+.+|+ .|++++|.
T Consensus 109 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~ 188 (276)
T 2z62_A 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188 (276)
T ss_dssp TSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSC
T ss_pred CCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCc
Confidence 9999977777899999999999999999963 699999999999999999999988778888888887 89999999
Q ss_pred CCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCC
Q 004732 173 GPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIP 225 (733)
Q Consensus 173 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 225 (733)
+.......+...+|+.|++++|.+++..+..|..+++|+.|+|++|.+++..+
T Consensus 189 l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 189 MNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp CCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 99988888888899999999999998877788999999999999999996543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.1e-26 Score=239.13 Aligned_cols=237 Identities=19% Similarity=0.140 Sum_probs=205.5
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
..+..+++.+++.......+..+++|++|+|++|+|++..|..|.++++|++|+|++|.+++..+ |..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 45567888899987777777788999999999999998888899999999999999999997655 9999999999999
Q ss_pred CccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCC
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT 177 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~ 177 (733)
+|+|++. + ..++|++|++++|++++..+. .+++|+.|++++|++++..+..+..+++|+.|++++|.+....
T Consensus 89 ~n~l~~l-~----~~~~L~~L~l~~n~l~~~~~~---~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (317)
T 3o53_A 89 NNYVQEL-L----VGPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (317)
T ss_dssp SSEEEEE-E----ECTTCCEEECCSSCCSEEEEC---CCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred CCccccc-c----CCCCcCEEECCCCccCCcCcc---ccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence 9999943 3 348999999999999976554 3688999999999999888889999999999999999999987
Q ss_pred ccccc--cccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--h
Q 004732 178 FPQLG--NMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--L 253 (733)
Q Consensus 178 ~~~~~--~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l 253 (733)
+..+. ..+|+.|+|++|.+++. + ....+++|+.|+|++|++++. |..+..+++|+.|++++|.++ .+|..+ +
T Consensus 161 ~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~~l-~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l 236 (317)
T 3o53_A 161 FAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLAFM-GPEFQSAAGVTWISLRNNKLV-LIEKALRFS 236 (317)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCCEE-CGGGGGGTTCSEEECTTSCCC-EECTTCCCC
T ss_pred HHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCCcc-hhhhcccCcccEEECcCCccc-chhhHhhcC
Confidence 77664 34899999999999966 3 344599999999999999964 555999999999999999998 466665 6
Q ss_pred cCCCeeecccCcCCC
Q 004732 254 ERGDKIDLSYNNFTD 268 (733)
Q Consensus 254 ~~l~~l~ls~N~l~~ 268 (733)
++++.|++++|++.+
T Consensus 237 ~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 237 QNLEHFDLRGNGFHC 251 (317)
T ss_dssp TTCCEEECTTCCCBH
T ss_pred CCCCEEEccCCCccC
Confidence 889999999999974
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-25 Score=235.51 Aligned_cols=243 Identities=19% Similarity=0.256 Sum_probs=204.5
Q ss_pred ecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCc
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 92 (733)
+.+.+.++.|+|++|+++.. +.|..+++|++|+|++|.+++. +. +..+++|++|++++|..... +..+..+++|+
T Consensus 84 ~~~l~~L~~L~L~~n~i~~~--~~~~~l~~L~~L~l~~n~i~~~-~~-~~~l~~L~~L~l~~n~~~~~-~~~~~~l~~L~ 158 (347)
T 4fmz_A 84 LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDI-SP-LANLTKMYSLNLGANHNLSD-LSPLSNMTGLN 158 (347)
T ss_dssp GTTCTTCCEEECCSSCCCCC--GGGTTCTTCSEEECTTSCCCCC-GG-GTTCTTCCEEECTTCTTCCC-CGGGTTCTTCC
T ss_pred hhcCCcCCEEEccCCcccCc--hHHcCCCcCCEEECcCCcccCc-hh-hccCCceeEEECCCCCCccc-ccchhhCCCCc
Confidence 55677899999999999964 4799999999999999999954 43 99999999999999976634 44599999999
Q ss_pred eeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeeccccc
Q 004732 93 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 172 (733)
Q Consensus 93 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 172 (733)
+|++++|.+++..+ +..+++|+.|++++|++.+ ++. +..+++|+.|++++|.+.+..+ +..+++|+.|++++|.
T Consensus 159 ~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~-~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~ 232 (347)
T 4fmz_A 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIED-ISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNK 232 (347)
T ss_dssp EEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCC-CGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSC
T ss_pred EEEecCCCcCCchh--hccCCCCCEEEccCCcccc-ccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCc
Confidence 99999999985444 8899999999999999985 443 8899999999999999985544 8889999999999999
Q ss_pred CCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh
Q 004732 173 GPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM 252 (733)
Q Consensus 173 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 252 (733)
+..... .....+|+.|++++|.+++. ..+..+++|+.|++++|++++. ..+..+++|+.|++++|.+.+..|..+
T Consensus 233 l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l 307 (347)
T 4fmz_A 233 ITDLSP-LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVI 307 (347)
T ss_dssp CCCCGG-GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHH
T ss_pred cCCCcc-hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHh
Confidence 887765 22334899999999999864 5688999999999999999864 458889999999999999988777766
Q ss_pred --hcCCCeeecccCcCCCCCC
Q 004732 253 --LERGDKIDLSYNNFTDGSA 271 (733)
Q Consensus 253 --l~~l~~l~ls~N~l~~~~~ 271 (733)
+++|+.|++++|++++..+
T Consensus 308 ~~l~~L~~L~L~~n~l~~~~~ 328 (347)
T 4fmz_A 308 GGLTNLTTLFLSQNHITDIRP 328 (347)
T ss_dssp HTCTTCSEEECCSSSCCCCGG
T ss_pred hccccCCEEEccCCccccccC
Confidence 6889999999999887655
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-24 Score=221.04 Aligned_cols=214 Identities=21% Similarity=0.235 Sum_probs=160.2
Q ss_pred eeeecccce-----eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCcc
Q 004732 10 FHFWKQKTV-----NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEE 84 (733)
Q Consensus 10 ~~~~~~~~~-----~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 84 (733)
++.|.+..| .+.+++++++++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|.++...+..
T Consensus 4 ~C~~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~ 80 (270)
T 2o6q_A 4 LCKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGI 80 (270)
T ss_dssp CBGGGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTT
T ss_pred cCCCCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhh
Confidence 345655333 346778888888 4565554 57888888888888666667888888888888888887544455
Q ss_pred ccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcC
Q 004732 85 LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLT 164 (733)
Q Consensus 85 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~ 164 (733)
|..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|+
T Consensus 81 ~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~ 160 (270)
T 2o6q_A 81 FKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLK 160 (270)
T ss_dssp TSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCC
T ss_pred hcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccc
Confidence 67788888888888888866666677788888888888888876667777778888888888877754444455555555
Q ss_pred eeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcc
Q 004732 165 DLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLL 244 (733)
Q Consensus 165 ~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l 244 (733)
.|+|++|.+++..+..|.++++|+.|+|++|++++..+..|..+++|+.|++++|++
T Consensus 161 -----------------------~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 217 (270)
T 2o6q_A 161 -----------------------ELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPW 217 (270)
T ss_dssp -----------------------EEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred -----------------------eeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCCe
Confidence 555666777766667788899999999999999977777788999999999999999
Q ss_pred cccCC
Q 004732 245 TGAIP 249 (733)
Q Consensus 245 ~~~~p 249 (733)
.+..+
T Consensus 218 ~c~c~ 222 (270)
T 2o6q_A 218 DCTCN 222 (270)
T ss_dssp CCSSS
T ss_pred eCCCc
Confidence 87654
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=8e-26 Score=252.19 Aligned_cols=232 Identities=21% Similarity=0.171 Sum_probs=197.3
Q ss_pred cccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccc
Q 004732 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTG 103 (733)
Q Consensus 24 L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 103 (733)
+...++...+......+++|+.|+|++|.|++..|..|+.+++|++|+|++|.+++..| |+.+++|++|+|++|.|++
T Consensus 17 ~~~~~l~~~l~~l~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~ 94 (487)
T 3oja_A 17 VTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE 94 (487)
T ss_dssp CCTTTHHHHHHTTSTTGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE
T ss_pred CchhhhHHHHHHhcccCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC
Confidence 44444443333334445599999999999998888999999999999999999997666 9999999999999999995
Q ss_pred cCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccc-
Q 004732 104 ELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLG- 182 (733)
Q Consensus 104 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~- 182 (733)
..+ .++|++|+|++|+|++..+. .+++|+.|+|++|++++..|..++.+++|+.|+|++|.+....+..+.
T Consensus 95 l~~-----~~~L~~L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~ 166 (487)
T 3oja_A 95 LLV-----GPSIETLHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAA 166 (487)
T ss_dssp EEE-----CTTCCEEECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGG
T ss_pred CCC-----CCCcCEEECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhh
Confidence 433 38999999999999976554 468999999999999998899999999999999999999998777765
Q ss_pred -cccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCee
Q 004732 183 -NMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKI 259 (733)
Q Consensus 183 -~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l 259 (733)
..+|+.|+|++|.+++..+ +..+++|+.|+|++|.|++..| .+..+++|+.|++++|.+++ +|..+ +++++.|
T Consensus 167 ~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L 242 (487)
T 3oja_A 167 SSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHF 242 (487)
T ss_dssp GTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEE
T ss_pred hCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEE
Confidence 3489999999999997733 4469999999999999997555 59999999999999999995 66665 6889999
Q ss_pred ecccCcCCCC
Q 004732 260 DLSYNNFTDG 269 (733)
Q Consensus 260 ~ls~N~l~~~ 269 (733)
++++|++.|.
T Consensus 243 ~l~~N~l~c~ 252 (487)
T 3oja_A 243 DLRGNGFHCG 252 (487)
T ss_dssp ECTTCCBCHH
T ss_pred EcCCCCCcCc
Confidence 9999998743
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.4e-24 Score=229.99 Aligned_cols=254 Identities=19% Similarity=0.258 Sum_probs=211.7
Q ss_pred ecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCc
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 92 (733)
+...+.++.|+|++|++++..+ +..+++|++|+|++|.++. ++ .|.++++|++|+|++|.+++ ++. +..+++|+
T Consensus 62 ~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~~L~l~~n~i~~-~~~-~~~l~~L~ 135 (347)
T 4fmz_A 62 IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLRELYLNEDNISD-ISP-LANLTKMY 135 (347)
T ss_dssp GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEECTTSCCCC-CGG-GTTCTTCC
T ss_pred hhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC-ch-HHcCCCcCCEEECcCCcccC-chh-hccCCcee
Confidence 4556779999999999996543 9999999999999999995 44 69999999999999999994 444 99999999
Q ss_pred eeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeeccccc
Q 004732 93 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 172 (733)
Q Consensus 93 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 172 (733)
.|++++|.....++ .+..+++|++|++++|.+.+..+ +..+++|+.|++++|++.+. +. +..+++|+.|++++|.
T Consensus 136 ~L~l~~n~~~~~~~-~~~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~l~~n~ 210 (347)
T 4fmz_A 136 SLNLGANHNLSDLS-PLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI-SP-LASLTSLHYFTAYVNQ 210 (347)
T ss_dssp EEECTTCTTCCCCG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCSEEECTTSCCCCC-GG-GGGCTTCCEEECCSSC
T ss_pred EEECCCCCCccccc-chhhCCCCcEEEecCCCcCCchh--hccCCCCCEEEccCCccccc-cc-ccCCCccceeecccCC
Confidence 99999997664444 49999999999999999995444 88999999999999999854 33 8889999999999999
Q ss_pred CCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCCh-h
Q 004732 173 GPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP-W 251 (733)
Q Consensus 173 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~ 251 (733)
+..... .....+|+.|++++|.+++..+ +..+++|+.|++++|.+++. ..+..+++|+.|++++|.+.+. +. .
T Consensus 211 l~~~~~-~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~~~ 284 (347)
T 4fmz_A 211 ITDITP-VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-SVLN 284 (347)
T ss_dssp CCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGG
T ss_pred CCCCch-hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCC--hhHhcCCCcCEEEccCCccCCC-hhhc
Confidence 988765 2233489999999999996654 89999999999999999963 5688999999999999999865 33 2
Q ss_pred hhcCCCeeecccCcCCCCCCcccccccccccc
Q 004732 252 MLERGDKIDLSYNNFTDGSAESSCQKRSVTGI 283 (733)
Q Consensus 252 ~l~~l~~l~ls~N~l~~~~~~~~~~~~~~~~~ 283 (733)
.+++++.|++++|++++..+........+..+
T Consensus 285 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L 316 (347)
T 4fmz_A 285 NLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316 (347)
T ss_dssp GCTTCSEEECCSSCCCGGGHHHHHTCTTCSEE
T ss_pred CCCCCCEEECcCCcCCCcChhHhhccccCCEE
Confidence 37899999999999987665544444444433
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.7e-24 Score=223.25 Aligned_cols=205 Identities=20% Similarity=0.172 Sum_probs=124.8
Q ss_pred ccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCC
Q 004732 37 LAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMK 116 (733)
Q Consensus 37 l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 116 (733)
+.++++|+.|++++|.|+ .+|..+. ++|+.|+|++|.+++..+..|..+++|+.|+|++|.|++..+ ...+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCcCC
Confidence 344555555555555555 3443332 455555555555554444555555555555555555553222 14455555
Q ss_pred EEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccc-cccEEEcccCc
Q 004732 117 DFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCN 195 (733)
Q Consensus 117 ~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~ 195 (733)
+|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|.+.......+... +|+.|+|++|+
T Consensus 81 ~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~ 159 (290)
T 1p9a_G 81 TLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNN 159 (290)
T ss_dssp EEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSC
T ss_pred EEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCc
Confidence 5555555555 445555555555555555555554444455555555555555555554444444333 56677777888
Q ss_pred cCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccC
Q 004732 196 ITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAI 248 (733)
Q Consensus 196 l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 248 (733)
|++..+..|..+++|+.|+|++|+|+ .+|..+..+.+|+.|++++|++.+..
T Consensus 160 l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C~c 211 (290)
T 1p9a_G 160 LTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (290)
T ss_dssp CSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred CCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccCcC
Confidence 88666667788999999999999998 67888888889999999999987654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.5e-24 Score=220.27 Aligned_cols=183 Identities=21% Similarity=0.243 Sum_probs=160.2
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
.+++|+|++|++++..+..|..+++|++|+|++|+|+...+..|.++++|++|+|++|.+++..+..|..+++|++|+|+
T Consensus 38 ~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 117 (270)
T 2o6q_A 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD 117 (270)
T ss_dssp TCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred CCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence 47889999999998888899999999999999999996666678999999999999999997666778999999999999
Q ss_pred CccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCC
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT 177 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~ 177 (733)
+|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+..|..+++|+.|+
T Consensus 118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~---------- 187 (270)
T 2o6q_A 118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLK---------- 187 (270)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE----------
T ss_pred CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEE----------
Confidence 9999988888899999999999999999977777799999999999999999976666677776666554
Q ss_pred ccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCC
Q 004732 178 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQ 223 (733)
Q Consensus 178 ~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 223 (733)
|++|.+++..+..|..+++|+.|+|++|.+...
T Consensus 188 -------------L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 220 (270)
T 2o6q_A 188 -------------LDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCT 220 (270)
T ss_dssp -------------CCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCS
T ss_pred -------------CCCCcCCcCCHHHhccccCCCEEEecCCCeeCC
Confidence 555667666666788899999999999988754
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-24 Score=239.30 Aligned_cols=240 Identities=29% Similarity=0.371 Sum_probs=136.6
Q ss_pred cccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCce
Q 004732 14 KQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEK 93 (733)
Q Consensus 14 ~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 93 (733)
...+.++.|+|++|++++..+ +..+++|++|+|++|.+++..+ ++++++|++|+|++|.+++. +. +..+++|++
T Consensus 65 ~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~-~~-~~~l~~L~~ 138 (466)
T 1o6v_A 65 EYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDI-DP-LKNLTNLNR 138 (466)
T ss_dssp GGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC-GG-GTTCTTCSE
T ss_pred hhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCC-hH-HcCCCCCCE
Confidence 334556666777777665433 6667777777777777764433 66677777777777766633 32 666666777
Q ss_pred eeccCccccccCCc--------------------cccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCC
Q 004732 94 LHLSSNNFTGELPK--------------------TFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPI 153 (733)
Q Consensus 94 L~Ls~N~l~~~~p~--------------------~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~ 153 (733)
|+|++|.+++ ++. .+.++++|++|++++|++++. ..+..+++|+.|++++|++.+..
T Consensus 139 L~l~~n~l~~-~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~ 215 (466)
T 1o6v_A 139 LELSSNTISD-ISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDIT 215 (466)
T ss_dssp EEEEEEEECC-CGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG
T ss_pred EECCCCccCC-ChhhccCCcccEeecCCcccCchhhccCCCCCEEECcCCcCCCC--hhhccCCCCCEEEecCCcccccc
Confidence 7776666653 221 134445555555555555532 23555566666666666655433
Q ss_pred CCCCCCcCCcCeeecccccCCCCCcccccc-ccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCC
Q 004732 154 PSGIFSLENLTDLRISDLNGPEATFPQLGN-MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLY 232 (733)
Q Consensus 154 p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 232 (733)
| ++.+++|+.|++++|.+.... .+.. .+|+.|++++|.+++..+ +..+++|+.|++++|.+++..+ +..++
T Consensus 216 ~--~~~l~~L~~L~l~~n~l~~~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~ 287 (466)
T 1o6v_A 216 P--LGILTNLDELSLNGNQLKDIG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLT 287 (466)
T ss_dssp G--GGGCTTCCEEECCSSCCCCCG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCT
T ss_pred c--ccccCCCCEEECCCCCcccch--hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCC
Confidence 3 445555666666665555431 2222 256666666666664433 5566666666666666664332 55566
Q ss_pred CCCEEEecCCcccccCChhhhcCCCeeecccCcCCCCC
Q 004732 233 DVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 233 ~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~N~l~~~~ 270 (733)
+|+.|++++|.+.+..|-..+++|+.|++++|++++..
T Consensus 288 ~L~~L~L~~n~l~~~~~~~~l~~L~~L~L~~n~l~~~~ 325 (466)
T 1o6v_A 288 ALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS 325 (466)
T ss_dssp TCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCG
T ss_pred ccCeEEcCCCcccCchhhcCCCCCCEEECcCCcCCCch
Confidence 66666666666655444333555666666666665543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.4e-24 Score=236.00 Aligned_cols=231 Identities=20% Similarity=0.170 Sum_probs=189.0
Q ss_pred eecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCC
Q 004732 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNL 91 (733)
Q Consensus 12 ~~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 91 (733)
.+...+.++.|+|++|++++. | .|..+++|++|+|++|+|++. | ++.+++|++|+|++|.+++ ++ ++.+++|
T Consensus 37 ~~~~l~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L 108 (457)
T 3bz5_A 37 SEEQLATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKL 108 (457)
T ss_dssp EHHHHTTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTC
T ss_pred ChhHcCCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcC
Confidence 344567788999999999975 5 789999999999999999964 4 8899999999999999996 44 8899999
Q ss_pred ceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccc
Q 004732 92 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDL 171 (733)
Q Consensus 92 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n 171 (733)
++|+|++|++++ +| +..+++|++|++++|+|++ ++ ++++++|+.|++++|+..+.+ .+..+++|+.|++++|
T Consensus 109 ~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n 180 (457)
T 3bz5_A 109 TYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFN 180 (457)
T ss_dssp CEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSS
T ss_pred CEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCC
Confidence 999999999995 55 8899999999999999996 33 888999999999999766566 5788899999999999
Q ss_pred cCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChh
Q 004732 172 NGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPW 251 (733)
Q Consensus 172 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~ 251 (733)
.+...+. ....+|+.|++++|.+++. .++.+++|+.|++++|++++ +| +..+++|+.|++++|.+++. |..
T Consensus 181 ~l~~l~l--~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~-~~~ 251 (457)
T 3bz5_A 181 KITELDV--SQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTEL-DVS 251 (457)
T ss_dssp CCCCCCC--TTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-CCT
T ss_pred ccceecc--ccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCc-CHH
Confidence 9888652 2234789999999999865 38889999999999999997 55 88889999999999999865 444
Q ss_pred hhcCCCeeecccCcCC
Q 004732 252 MLERGDKIDLSYNNFT 267 (733)
Q Consensus 252 ~l~~l~~l~ls~N~l~ 267 (733)
.+++++.|++++|++.
T Consensus 252 ~l~~L~~L~l~~n~L~ 267 (457)
T 3bz5_A 252 TLSKLTTLHCIQTDLL 267 (457)
T ss_dssp TCTTCCEEECTTCCCS
T ss_pred HCCCCCEEeccCCCCC
Confidence 4556666665555544
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.92 E-value=4.5e-24 Score=237.37 Aligned_cols=241 Identities=27% Similarity=0.377 Sum_probs=186.8
Q ss_pred ecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCC----------
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELP---------- 82 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p---------- 82 (733)
+.+.+.++.|+|++|++++..+ +..+++|++|+|++|.+++..+ +.++++|++|+|++|.+++ ++
T Consensus 86 ~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~ 160 (466)
T 1o6v_A 86 LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-ISALSGLTSLQQ 160 (466)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CGGGTTCTTCSE
T ss_pred hhccccCCEEECCCCccccChh--hcCCCCCCEEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-ChhhccCCcccE
Confidence 4456678888888888886654 8888888888888888885433 8888888888888888774 22
Q ss_pred ----------ccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccC
Q 004732 83 ----------EELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP 152 (733)
Q Consensus 83 ----------~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 152 (733)
..+.++++|+.|+|++|.+++ ++ .+..+++|+.|++++|++++..+ ++.+++|+.|++++|++++.
T Consensus 161 L~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~ 236 (466)
T 1o6v_A 161 LSFGNQVTDLKPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI 236 (466)
T ss_dssp EEEEESCCCCGGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC
T ss_pred eecCCcccCchhhccCCCCCEEECcCCcCCC-Ch-hhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccc
Confidence 126677888999999999884 33 48889999999999999986555 77888999999999988743
Q ss_pred CCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCC
Q 004732 153 IPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLY 232 (733)
Q Consensus 153 ~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 232 (733)
..+..+++|+.|++++|.+....+ .....+|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..++
T Consensus 237 --~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~ 309 (466)
T 1o6v_A 237 --GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLK 309 (466)
T ss_dssp --GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCT
T ss_pred --hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCC
Confidence 457778888888888888877654 2223378888888888886544 7788888888888888886544 77888
Q ss_pred CCCEEEecCCcccccCChhhhcCCCeeecccCcCCCC
Q 004732 233 DVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDG 269 (733)
Q Consensus 233 ~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~N~l~~~ 269 (733)
+|+.|++++|.+.+..|...+++|+.|++++|++++.
T Consensus 310 ~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~ 346 (466)
T 1o6v_A 310 NLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV 346 (466)
T ss_dssp TCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred CCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc
Confidence 8888888888888776655577888888888888765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=224.43 Aligned_cols=221 Identities=23% Similarity=0.262 Sum_probs=154.6
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCc
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 99 (733)
..+.+..+.+... ..+..+++|+.|++++|.++ .++ .+..+++|++|+|++|.+++ + ..+..+++|++|+|++|
T Consensus 22 ~~l~l~~~~~~~~--~~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n 95 (272)
T 3rfs_A 22 IKANLKKKSVTDA--VTQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGN 95 (272)
T ss_dssp HHHHHTCSCTTSE--ECHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTS
T ss_pred HHHHhcCcccccc--cccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCC
Confidence 3455666666654 34567788888888888877 333 47778888888888888874 3 46778888888888888
Q ss_pred cccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCcc
Q 004732 100 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFP 179 (733)
Q Consensus 100 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~ 179 (733)
.+++..+..|.++++|++|+|++|++++..+..|+++++|++|+|++|++++..+..+..+++|+.|++
T Consensus 96 ~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l----------- 164 (272)
T 3rfs_A 96 QLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDL----------- 164 (272)
T ss_dssp CCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC-----------
T ss_pred ccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEEC-----------
Confidence 888666666778888888888888888766667778888888888888887655555666666665555
Q ss_pred ccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCee
Q 004732 180 QLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKI 259 (733)
Q Consensus 180 ~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~l 259 (733)
++|.+++..+..|+.+++|+.|++++|++++..+..+..+++|+.|++++|++.|.+| .++.+
T Consensus 165 ------------~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~-----~l~~l 227 (272)
T 3rfs_A 165 ------------SYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP-----GIRYL 227 (272)
T ss_dssp ------------CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT-----TTHHH
T ss_pred ------------CCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc-----HHHHH
Confidence 4555555555556667777777777777776666666777777777777777766555 35556
Q ss_pred ecccCcCCCCCCccc
Q 004732 260 DLSYNNFTDGSAESS 274 (733)
Q Consensus 260 ~ls~N~l~~~~~~~~ 274 (733)
++..|.++|..+...
T Consensus 228 ~~~~n~~~g~ip~~~ 242 (272)
T 3rfs_A 228 SEWINKHSGVVRNSA 242 (272)
T ss_dssp HHHHHHTGGGBBCTT
T ss_pred HHHHHhCCCcccCcc
Confidence 666666665544433
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-24 Score=235.38 Aligned_cols=234 Identities=18% Similarity=0.137 Sum_probs=198.3
Q ss_pred ecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCc
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 92 (733)
+...+.++.|+|++|++++. | +..+++|++|+|++|+|++. + ++++++|++|+|++|++++ +| ++.+++|+
T Consensus 60 l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~~-~--~~~l~~L~~L~L~~N~l~~-l~--~~~l~~L~ 130 (457)
T 3bz5_A 60 IEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTNL-D--VTPLTKLTYLNCDTNKLTK-LD--VSQNPLLT 130 (457)
T ss_dssp GGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSCC-C--CTTCTTCCEEECCSSCCSC-CC--CTTCTTCC
T ss_pred hcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCcee-e--cCCCCcCCEEECCCCcCCe-ec--CCCCCcCC
Confidence 45567789999999999985 3 89999999999999999964 4 9999999999999999996 55 89999999
Q ss_pred eeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeeccccc
Q 004732 93 KLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 172 (733)
Q Consensus 93 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 172 (733)
+|+|++|+|++ ++ ++.+++|++|++++|+..+.+ .++.+++|+.|++++|++++ +| +..+++|+.|++++|.
T Consensus 131 ~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~ 202 (457)
T 3bz5_A 131 YLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTNN 202 (457)
T ss_dssp EEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSSC
T ss_pred EEECCCCccce-ec--cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEEECcCCc
Confidence 99999999996 44 889999999999999766666 48899999999999999996 55 8889999999999999
Q ss_pred CCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCC-------CCCEEEecCCccc
Q 004732 173 GPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLY-------DVDYIYFAGNLLT 245 (733)
Q Consensus 173 ~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~-------~L~~L~l~~N~l~ 245 (733)
+..... ....+|+.|++++|++++ +| ++.+++|+.|++++|++++..+..+..+. +|+.|++++|.+.
T Consensus 203 l~~~~l--~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~L~~L~l~~n~L~~L~l~~n~~~ 277 (457)
T 3bz5_A 203 ITKLDL--NQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTHNTQL 277 (457)
T ss_dssp CSCCCC--TTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTTCCEEECTTCCCSCCCCTTCTTC
T ss_pred CCeecc--ccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCCCCEEeccCCCCCEEECCCCccC
Confidence 988742 223489999999999997 55 88999999999999999987666665554 5667777777777
Q ss_pred ccCChhhhcCCCeeecccCcCCC
Q 004732 246 GAIPPWMLERGDKIDLSYNNFTD 268 (733)
Q Consensus 246 ~~~p~~~l~~l~~l~ls~N~l~~ 268 (733)
+.+|...+++|+.|++++|...+
T Consensus 278 ~~~~~~~l~~L~~L~Ls~n~~l~ 300 (457)
T 3bz5_A 278 IYFQAEGCRKIKELDVTHNTQLY 300 (457)
T ss_dssp CEEECTTCTTCCCCCCTTCTTCC
T ss_pred CcccccccccCCEEECCCCcccc
Confidence 77776557888888888887554
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.2e-24 Score=223.94 Aligned_cols=203 Identities=19% Similarity=0.218 Sum_probs=165.5
Q ss_pred CCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEE
Q 004732 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 119 (733)
Q Consensus 40 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 119 (733)
+.++..+++..+.+.... .+..+++|+.|++++|.++ .++ .+..+++|++|+|++|.+++ + ..+..+++|++|+
T Consensus 18 ~~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~ 91 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLI 91 (272)
T ss_dssp HHHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEE
T ss_pred HHHHHHHHhcCccccccc--ccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEE
Confidence 355667778888777543 3677888999999999887 343 58888999999999999885 3 4688888999999
Q ss_pred eeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCC
Q 004732 120 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGE 199 (733)
Q Consensus 120 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 199 (733)
|++|++++..+..|.++++|++|+|++|++++..+..+..+++|+. |++++|.+++.
T Consensus 92 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~-----------------------L~L~~n~l~~~ 148 (272)
T 3rfs_A 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTY-----------------------LNLAHNQLQSL 148 (272)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCE-----------------------EECCSSCCCCC
T ss_pred CCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCE-----------------------EECCCCccCcc
Confidence 9999998777777888888988888888888666666666666654 55566777777
Q ss_pred CCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCcCCCCCC
Q 004732 200 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSA 271 (733)
Q Consensus 200 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~~~ 271 (733)
.+..|..+++|+.|++++|++++..+..+..+++|+.|++++|.+.+..|..+ +++|+.|++++|++.|..+
T Consensus 149 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 222 (272)
T 3rfs_A 149 PKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP 222 (272)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred CHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccCc
Confidence 77778999999999999999998888889999999999999999998777655 7899999999999987543
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=215.52 Aligned_cols=213 Identities=15% Similarity=0.170 Sum_probs=175.9
Q ss_pred eeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEccccc-ccccCCccccCCcCCceeeccC-
Q 004732 21 KRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQ-FSGELPEELGSLLNLEKLHLSS- 98 (733)
Q Consensus 21 ~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l~~L~~L~Ls~- 98 (733)
.+.+..++++ .+|. +. ++|+.|+|++|+|++..+..|.++++|++|+|++|+ ++...+..|..+++|++|+|++
T Consensus 15 ~~~v~c~~l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~ 90 (239)
T 2xwt_C 15 DFRVTCKDIQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNT 90 (239)
T ss_dssp TTEEEECSCS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEE
T ss_pred cceeEccCcc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCC
Confidence 3444444555 5666 44 489999999999998777789999999999999997 8866667899999999999998
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCC---EEEccCC-CCccCCCCCCCCcCCcC-eeecccccC
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE---KLFIQPS-GLAGPIPSGIFSLENLT-DLRISDLNG 173 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~---~L~l~~N-~l~~~~p~~l~~l~~L~-~L~l~~n~~ 173 (733)
|+|++..+..|.++++|++|++++|++++ +|. |..+++|+ .|++++| ++++..+..|.++++|+ .|++++|.+
T Consensus 91 n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l 168 (239)
T 2xwt_C 91 RNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGF 168 (239)
T ss_dssp TTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCC
T ss_pred CCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCC
Confidence 99997777889999999999999999995 776 88899998 9999999 99977777899999999 999999888
Q ss_pred CCCCccccccccccEEEcccCc-cCCCCCccccCC-CCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCC
Q 004732 174 PEATFPQLGNMKMTKLILRNCN-ITGELPRYLGKM-TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGN 242 (733)
Q Consensus 174 ~~~~~~~~~~~~L~~L~l~~n~-l~~~~p~~~~~l-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N 242 (733)
.......+...+|+.|++++|. +++..+..|.++ ++|+.|++++|++++ +|.. .+++|+.|+++++
T Consensus 169 ~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~-l~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 169 TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTA-LPSK--GLEHLKELIARNT 236 (239)
T ss_dssp CEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCC-CCCT--TCTTCSEEECTTC
T ss_pred cccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCcccc-CChh--HhccCceeeccCc
Confidence 8766666666678888888884 886667778888 888888888888884 4433 5667777777765
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.9e-23 Score=216.77 Aligned_cols=205 Identities=20% Similarity=0.180 Sum_probs=183.8
Q ss_pred eeecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcC
Q 004732 11 HFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLN 90 (733)
Q Consensus 11 ~~~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 90 (733)
+...+.+..+++++++|+++ .+|..+. ++|+.|+|++|.|++..+..|.++++|++|+|++|.+++..+ .+.+++
T Consensus 4 C~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~--~~~l~~ 78 (290)
T 1p9a_G 4 CEVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPV 78 (290)
T ss_dssp SEEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTT
T ss_pred ccccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccC--CCCCCc
Confidence 44556667889999999999 5666664 789999999999998888999999999999999999995433 388999
Q ss_pred CceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeeccc
Q 004732 91 LEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD 170 (733)
Q Consensus 91 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~ 170 (733)
|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+.|++++
T Consensus 79 L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 157 (290)
T 1p9a_G 79 LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157 (290)
T ss_dssp CCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCC
Confidence 999999999999 8898999999999999999999987788999999999999999999977777888999999999999
Q ss_pred ccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccC
Q 004732 171 LNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG 222 (733)
Q Consensus 171 n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 222 (733)
|.+.......+... +|+.|+|++|+|+ .+|..+..+.+|+.|+|++|.+..
T Consensus 158 N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 99998888777654 8999999999999 778888889999999999999873
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-23 Score=211.99 Aligned_cols=215 Identities=20% Similarity=0.270 Sum_probs=113.7
Q ss_pred ecccce---eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCc
Q 004732 13 WKQKTV---NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLL 89 (733)
Q Consensus 13 ~~~~~~---~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 89 (733)
|.+++| .+.+++++++++ .+|..+. ++|+.|+|++|+|++..+..|.++++|++|+|++|.+++..+..|..++
T Consensus 7 ~~gC~C~~~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~ 83 (251)
T 3m19_A 7 VTGCTCNEGKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLT 83 (251)
T ss_dssp HHSSEEEGGGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCT
T ss_pred CCceEcCCCCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCC
Confidence 444444 234555555555 3444333 4555555555555555555555555555555555555544444455555
Q ss_pred CCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecc
Q 004732 90 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRIS 169 (733)
Q Consensus 90 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~ 169 (733)
+|++|+|++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 84 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L------------------------- 138 (251)
T 3m19_A 84 ELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRL------------------------- 138 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC-------------------------
T ss_pred cCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEEC-------------------------
Confidence 5555555555555444444445555555555555554333333344444443333
Q ss_pred cccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCC
Q 004732 170 DLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 249 (733)
Q Consensus 170 ~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 249 (733)
++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.+...
T Consensus 139 ----------------------s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~ 196 (251)
T 3m19_A 139 ----------------------NTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCSRC 196 (251)
T ss_dssp ----------------------CSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTTST
T ss_pred ----------------------cCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCCcc
Confidence 4444444445566777778888888888887666777788888888888888876632
Q ss_pred ------hhhhcC-CCeeecccCcCCCCCCcccccc
Q 004732 250 ------PWMLER-GDKIDLSYNNFTDGSAESSCQK 277 (733)
Q Consensus 250 ------~~~l~~-l~~l~ls~N~l~~~~~~~~~~~ 277 (733)
.|+..+ .+..+..++.+.+.+....|..
T Consensus 197 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~C~~ 231 (251)
T 3m19_A 197 EILYLSQWIRENSNKVKDGTGQNLHESPDGVTCSD 231 (251)
T ss_dssp THHHHHHHHHHSGGGBCC-------CCGGGCBBTT
T ss_pred ccHHHHHHHHhcccceeeccCcccccCCCcCccCC
Confidence 233222 2334555666655555555543
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.5e-23 Score=229.83 Aligned_cols=228 Identities=18% Similarity=0.180 Sum_probs=154.9
Q ss_pred ceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCC-------------CEEEcccccccccCCc
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTL-------------VNLTVQYNQFSGELPE 83 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L-------------~~L~L~~N~l~~~~p~ 83 (733)
+.++++++++|++ +.+|+.|+++++|++|++++|.++|.+|..++++++| ++|++++|.+++ +|.
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-lp~ 88 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-LPE 88 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-CCS
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-CCC
Confidence 5678899999999 7999999999999999999999999999999988764 999999999984 554
Q ss_pred cccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCc
Q 004732 84 ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENL 163 (733)
Q Consensus 84 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L 163 (733)
. .++|+.|+|++|.+++ +|.. +++|++|++++|++++ ++.. .++|++|++++|++++ +| .++++++|
T Consensus 89 ~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L 155 (454)
T 1jl5_A 89 L---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFL 155 (454)
T ss_dssp C---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTC
T ss_pred C---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCC
Confidence 2 3688999999999985 6653 3678888888888884 3332 2688888888888885 66 58888888
Q ss_pred CeeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCc
Q 004732 164 TDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNL 243 (733)
Q Consensus 164 ~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 243 (733)
+.|++++|.+...+. .. .+|+.|++++|.+++ +| .++++++|+.|++++|++++ +|... ++|+.|++++|.
T Consensus 156 ~~L~l~~N~l~~lp~-~~--~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~l~~-l~~~~---~~L~~L~l~~n~ 226 (454)
T 1jl5_A 156 KIIDVDNNSLKKLPD-LP--PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNI 226 (454)
T ss_dssp CEEECCSSCCSCCCC-CC--TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSS-CCCCC---TTCCEEECCSSC
T ss_pred CEEECCCCcCcccCC-Cc--ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCcCCc-CCCCc---CcccEEECcCCc
Confidence 888888888776432 11 378888888888886 45 57888888888888888875 44432 477778888887
Q ss_pred ccccCChhh-hcCCCeeecccCcCCCC
Q 004732 244 LTGAIPPWM-LERGDKIDLSYNNFTDG 269 (733)
Q Consensus 244 l~~~~p~~~-l~~l~~l~ls~N~l~~~ 269 (733)
+. .+|... +++++.|++++|++++.
T Consensus 227 l~-~lp~~~~l~~L~~L~l~~N~l~~l 252 (454)
T 1jl5_A 227 LE-ELPELQNLPFLTTIYADNNLLKTL 252 (454)
T ss_dssp CS-SCCCCTTCTTCCEEECCSSCCSSC
T ss_pred CC-cccccCCCCCCCEEECCCCcCCcc
Confidence 77 555422 66777777777777653
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.8e-23 Score=218.10 Aligned_cols=226 Identities=16% Similarity=0.162 Sum_probs=186.2
Q ss_pred CCCCeeeccccccccccch---hccCCCCCCEEEcccccccccCCccc--cCCcCCceeeccCccccccCC----ccccC
Q 004732 41 TFLQDISLIANRLKGPIPK---YLANISTLVNLTVQYNQFSGELPEEL--GSLLNLEKLHLSSNNFTGELP----KTFAK 111 (733)
Q Consensus 41 ~~L~~L~L~~n~l~~~~p~---~l~~l~~L~~L~L~~N~l~~~~p~~~--~~l~~L~~L~Ls~N~l~~~~p----~~~~~ 111 (733)
..++.|.+.++.++..... .+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..
T Consensus 64 ~~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~ 143 (310)
T 4glp_A 64 LRVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWL 143 (310)
T ss_dssp CCCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTB
T ss_pred cceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhh
Confidence 4478888888887642111 23345789999999999999999988 999999999999999997655 44567
Q ss_pred CCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccC--C--CCCCCCcCCcCeeecccccCCCCCcc---cccc-
Q 004732 112 LTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP--I--PSGIFSLENLTDLRISDLNGPEATFP---QLGN- 183 (733)
Q Consensus 112 l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~--~--p~~l~~l~~L~~L~l~~n~~~~~~~~---~~~~- 183 (733)
+++|++|+|++|++++..+..|+++++|++|+|++|++.+. + +..+..+++|+.|++++|.+...... .+..
T Consensus 144 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~l~~~l 223 (310)
T 4glp_A 144 KPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMETPTGVCAALAAAG 223 (310)
T ss_dssp CSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCCHHHHHHHHHHHT
T ss_pred ccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCchHHHHHHHHhcC
Confidence 99999999999999988889999999999999999998753 2 33457899999999999999754332 2233
Q ss_pred ccccEEEcccCccCCCCCccccCC---CCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCeee
Q 004732 184 MKMTKLILRNCNITGELPRYLGKM---TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKID 260 (733)
Q Consensus 184 ~~L~~L~l~~n~l~~~~p~~~~~l---~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~l~ 260 (733)
.+|+.|+|++|.+++..|..+..+ ++|++|+|++|+|+ .+|..+. ++|+.|++++|.+++......+++++.|+
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~~~~~~l~~L~~L~ 300 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRAPQPDELPEVDNLT 300 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSCCCTTSCCCCSCEE
T ss_pred CCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCCchhhhCCCccEEE
Confidence 489999999999999888888877 69999999999999 6787764 79999999999999742233478999999
Q ss_pred cccCcCCCC
Q 004732 261 LSYNNFTDG 269 (733)
Q Consensus 261 ls~N~l~~~ 269 (733)
+++|++++.
T Consensus 301 L~~N~l~~~ 309 (310)
T 4glp_A 301 LDGNPFLVP 309 (310)
T ss_dssp CSSTTTSCC
T ss_pred CcCCCCCCC
Confidence 999998753
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1e-24 Score=231.69 Aligned_cols=263 Identities=14% Similarity=0.165 Sum_probs=212.7
Q ss_pred eeeeecccce----eeeeccccccccccCCccccCC--CCCCeeeccccccccccchhccCCCCCCEEEccccccccc-C
Q 004732 9 VFHFWKQKTV----NQKRVLKEQNLTGVLPPKLAEL--TFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGE-L 81 (733)
Q Consensus 9 ~~~~~~~~~~----~~~l~L~~n~l~~~~p~~l~~l--~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~ 81 (733)
+...|....+ .+.+++++|++. +..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.+++. +
T Consensus 35 vc~~W~~~~~~~~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 35 VCKRWYRLASDESLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp SCHHHHHHHTCSTTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHHHHhcCchhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHH
Confidence 4445655432 567899998887 5667777 8999999999999977665 67899999999999999866 8
Q ss_pred CccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCC-ccccC-CCccccccCCCCEEEccCC-CCccC-CCCCC
Q 004732 82 PEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN-QFTGQ-IPSFIQNWTKLEKLFIQPS-GLAGP-IPSGI 157 (733)
Q Consensus 82 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~-~p~~l 157 (733)
+..+..+++|++|+|++|.+++..+..++.+++|++|+|++| .+++. ++..+.++++|++|++++| .+++. ++..+
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~ 190 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAV 190 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHH
T ss_pred HHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHH
Confidence 888999999999999999999889999999999999999999 68763 6777899999999999999 99864 56778
Q ss_pred CCcC-CcCeeecccc--cCCCCC-ccccc-cccccEEEcccCc-cCCCCCccccCCCCCcEEEccCCc-ccCCCCCCcCC
Q 004732 158 FSLE-NLTDLRISDL--NGPEAT-FPQLG-NMKMTKLILRNCN-ITGELPRYLGKMTKLKVLDLSFNR-LRGQIPSNFDD 230 (733)
Q Consensus 158 ~~l~-~L~~L~l~~n--~~~~~~-~~~~~-~~~L~~L~l~~n~-l~~~~p~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~ 230 (733)
..++ +|+.|++++| .+.... +..+. ..+|+.|++++|. +++..+..+..+++|+.|++++|. +.......+..
T Consensus 191 ~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~ 270 (336)
T 2ast_B 191 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGE 270 (336)
T ss_dssp HHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGG
T ss_pred HhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhc
Confidence 8899 9999999999 454222 22333 3389999999999 787888899999999999999995 33222236888
Q ss_pred CCCCCEEEecCCcccccCChhhhcCCCeeecccCcCCCCCCccccc
Q 004732 231 LYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQ 276 (733)
Q Consensus 231 l~~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~N~l~~~~~~~~~~ 276 (733)
+++|+.|++++| ++...-..+...+..|++++|++++..+.....
T Consensus 271 ~~~L~~L~l~~~-i~~~~~~~l~~~l~~L~l~~n~l~~~~~~~~~~ 315 (336)
T 2ast_B 271 IPTLKTLQVFGI-VPDGTLQLLKEALPHLQINCSHFTTIARPTIGN 315 (336)
T ss_dssp CTTCCEEECTTS-SCTTCHHHHHHHSTTSEESCCCSCCTTCSSCSS
T ss_pred CCCCCEEeccCc-cCHHHHHHHHhhCcceEEecccCccccCCcccc
Confidence 999999999999 443322333456889999999999877655543
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=9.9e-25 Score=234.35 Aligned_cols=248 Identities=15% Similarity=0.135 Sum_probs=200.5
Q ss_pred eccccccccccCCccccCCCCCCeeeccccccccccc----hhccCCC-CCCEEEcccccccccCCccccCC-----cCC
Q 004732 22 RVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIP----KYLANIS-TLVNLTVQYNQFSGELPEELGSL-----LNL 91 (733)
Q Consensus 22 l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p----~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l-----~~L 91 (733)
..|++|++++.+|..+...++|++|+|++|.|++..+ ..|.+++ +|++|+|++|.+++..+..|..+ ++|
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L 82 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTC
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCc
Confidence 4688999999999888877889999999999997777 7888998 99999999999998778777776 999
Q ss_pred ceeeccCccccccCCccccC----C-CCCCEEEeeCCccccCCCccccc-----cCCCCEEEccCCCCccCCC----CCC
Q 004732 92 EKLHLSSNNFTGELPKTFAK----L-TNMKDFRISDNQFTGQIPSFIQN-----WTKLEKLFIQPSGLAGPIP----SGI 157 (733)
Q Consensus 92 ~~L~Ls~N~l~~~~p~~~~~----l-~~L~~L~l~~N~l~~~~~~~~~~-----l~~L~~L~l~~N~l~~~~p----~~l 157 (733)
++|+|++|.+++..+..++. + ++|++|+|++|+|++..+..+.. .++|++|+|++|++++..+ ..+
T Consensus 83 ~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l 162 (362)
T 3goz_A 83 TSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQIL 162 (362)
T ss_dssp CEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHH
T ss_pred cEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHH
Confidence 99999999999777765444 4 89999999999999776655543 3699999999999996443 334
Q ss_pred CCcC-CcCeeecccccCCCCCccccc-----c-ccccEEEcccCccCCC----CCccccC-CCCCcEEEccCCcccCCCC
Q 004732 158 FSLE-NLTDLRISDLNGPEATFPQLG-----N-MKMTKLILRNCNITGE----LPRYLGK-MTKLKVLDLSFNRLRGQIP 225 (733)
Q Consensus 158 ~~l~-~L~~L~l~~n~~~~~~~~~~~-----~-~~L~~L~l~~n~l~~~----~p~~~~~-l~~L~~L~ls~N~l~~~~p 225 (733)
..++ +|+.|+|++|.+.......+. . .+|+.|+|++|.+++. ++..+.. .++|+.|+|++|.+++..+
T Consensus 163 ~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~ 242 (362)
T 3goz_A 163 AAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSL 242 (362)
T ss_dssp HTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCH
T ss_pred hcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHH
Confidence 4555 999999999999887765433 2 3899999999999964 4455655 4599999999999997655
Q ss_pred ----CCcCCCCCCCEEEecCCcccccCChhh---------hcCCCeeecccCcCCCC
Q 004732 226 ----SNFDDLYDVDYIYFAGNLLTGAIPPWM---------LERGDKIDLSYNNFTDG 269 (733)
Q Consensus 226 ----~~~~~l~~L~~L~l~~N~l~~~~p~~~---------l~~l~~l~ls~N~l~~~ 269 (733)
..+..+++|+.|++++|.+.+..+... +++++.||+++|++.+.
T Consensus 243 ~~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~ 299 (362)
T 3goz_A 243 ENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299 (362)
T ss_dssp HHHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGG
T ss_pred HHHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCc
Confidence 345778999999999999664433322 45678899999998654
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.7e-23 Score=218.21 Aligned_cols=221 Identities=18% Similarity=0.229 Sum_probs=163.8
Q ss_pred eeeccccccccccCC---ccccCCCCCCeeeccccccccccchhc--cCCCCCCEEEcccccccccCC----ccccCCcC
Q 004732 20 QKRVLKEQNLTGVLP---PKLAELTFLQDISLIANRLKGPIPKYL--ANISTLVNLTVQYNQFSGELP----EELGSLLN 90 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p---~~l~~l~~L~~L~L~~n~l~~~~p~~l--~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~ 90 (733)
+.+.+.++.++...- ..+..+++|++|+|++|.+++..|..+ ..+++|++|+|++|.+++..+ ..+..+++
T Consensus 67 ~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~ 146 (310)
T 4glp_A 67 RRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPG 146 (310)
T ss_dssp CEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSC
T ss_pred eEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccC
Confidence 445555555543111 112234668888888888888888777 788888888888888886555 34567888
Q ss_pred CceeeccCccccccCCccccCCCCCCEEEeeCCccccC--C--CccccccCCCCEEEccCCCCccCCCC----CCCCcCC
Q 004732 91 LEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQ--I--PSFIQNWTKLEKLFIQPSGLAGPIPS----GIFSLEN 162 (733)
Q Consensus 91 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~--~--~~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~l~~ 162 (733)
|++|+|++|++++..|..|..+++|++|+|++|++.+. + +..+..+++|++|+|++|+++ .++. .+..+++
T Consensus 147 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~ 225 (310)
T 4glp_A 147 LKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQ 225 (310)
T ss_dssp CCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCC
T ss_pred CCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCC
Confidence 88888888888877778888888888888888887642 1 233467888888888888886 2222 2456788
Q ss_pred cCeeecccccCCCCCcccccc----ccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEE
Q 004732 163 LTDLRISDLNGPEATFPQLGN----MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 238 (733)
Q Consensus 163 L~~L~l~~n~~~~~~~~~~~~----~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 238 (733)
|+.|+|++|.+....+..+.. .+|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|+
T Consensus 226 L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~ 300 (310)
T 4glp_A 226 PHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLT 300 (310)
T ss_dssp CSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEE
T ss_pred CCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEE
Confidence 888888888888775544443 37889999999999 6677664 7999999999999964 44 67889999999
Q ss_pred ecCCcccc
Q 004732 239 FAGNLLTG 246 (733)
Q Consensus 239 l~~N~l~~ 246 (733)
+++|+++.
T Consensus 301 L~~N~l~~ 308 (310)
T 4glp_A 301 LDGNPFLV 308 (310)
T ss_dssp CSSTTTSC
T ss_pred CcCCCCCC
Confidence 99999864
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.89 E-value=7e-23 Score=206.47 Aligned_cols=211 Identities=18% Similarity=0.190 Sum_probs=178.8
Q ss_pred eeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCcc-ccccCCccccCCCCCCEEEeeC-C
Q 004732 46 ISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNN-FTGELPKTFAKLTNMKDFRISD-N 123 (733)
Q Consensus 46 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~~L~l~~-N 123 (733)
+++..+.++ .+|. +. ++|++|+|++|++++..+..|..+++|++|+|++|+ +++..+..|.++++|++|+|++ |
T Consensus 16 ~~v~c~~l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n 91 (239)
T 2xwt_C 16 FRVTCKDIQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91 (239)
T ss_dssp TEEEECSCS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEET
T ss_pred ceeEccCcc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCC
Confidence 333333466 5666 43 489999999999997777789999999999999997 9866777899999999999999 9
Q ss_pred ccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcC---eeecccc-cCCCCCccccccc-ccc-EEEcccCccC
Q 004732 124 QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLT---DLRISDL-NGPEATFPQLGNM-KMT-KLILRNCNIT 197 (733)
Q Consensus 124 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~---~L~l~~n-~~~~~~~~~~~~~-~L~-~L~l~~n~l~ 197 (733)
++++..+..|.++++|+.|++++|++++ +|. +..+++|+ .|++++| .+.......+... +|+ .|++++|.++
T Consensus 92 ~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~ 169 (239)
T 2xwt_C 92 NLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169 (239)
T ss_dssp TCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC
T ss_pred CeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc
Confidence 9997777899999999999999999996 776 88888888 9999999 8888877767665 899 9999999999
Q ss_pred CCCCccccCCCCCcEEEccCCc-ccCCCCCCcCCC-CCCCEEEecCCcccccCChhhhcCCCeeecccC
Q 004732 198 GELPRYLGKMTKLKVLDLSFNR-LRGQIPSNFDDL-YDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYN 264 (733)
Q Consensus 198 ~~~p~~~~~l~~L~~L~ls~N~-l~~~~p~~~~~l-~~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~N 264 (733)
...+..|.. ++|+.|+|++|+ +++..+..|..+ ++|+.|++++|.++ .+|...+++++.|+++++
T Consensus 170 ~i~~~~~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 170 SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236 (239)
T ss_dssp EECTTTTTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCTTCTTCSEEECTTC
T ss_pred ccCHhhcCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChhHhccCceeeccCc
Confidence 444444554 899999999995 997778889999 99999999999998 566667788999988765
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=2.1e-22 Score=204.62 Aligned_cols=154 Identities=21% Similarity=0.242 Sum_probs=135.0
Q ss_pred ceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeec
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 96 (733)
..++.|+|++|++++..+..|..+++|++|+|++|.|++..+..|.++++|++|+|++|++++..+..|..+++|++|+|
T Consensus 35 ~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 114 (251)
T 3m19_A 35 ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYL 114 (251)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEc
Confidence 34788999999999999999999999999999999999888888999999999999999999777788999999999999
Q ss_pred cCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeeccc
Q 004732 97 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD 170 (733)
Q Consensus 97 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~ 170 (733)
++|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..+..+++|+.|++++
T Consensus 115 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 188 (251)
T 3m19_A 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFG 188 (251)
T ss_dssp CSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS
T ss_pred CCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeC
Confidence 99999977777789999999999999999977777889999999999999888865555666555555544443
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=215.97 Aligned_cols=151 Identities=19% Similarity=0.100 Sum_probs=121.9
Q ss_pred HHhhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccCh------------------hcHHHHHHHHHHHHhCCCC
Q 004732 388 IKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK------------------QGNREFINEIGMISALQHP 449 (733)
Q Consensus 388 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~ 449 (733)
+......|...+.||+|+||.||+|+..+|+.||||.+..... .....+.+|++++++++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344556777799999999999999997799999999864321 12456899999999999
Q ss_pred ceeeEeeEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC
Q 004732 450 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD 529 (733)
Q Consensus 450 niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~ 529 (733)
| +++.+++.. +..++||||+++|+|.+ +. ......++.|+++||+|||+.| |+||||||+|||++ +
T Consensus 163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~ 228 (282)
T 1zar_A 163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-E 228 (282)
T ss_dssp T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-T
T ss_pred C-CCcCeEEec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-C
Confidence 5 677776544 45699999999999987 31 1335579999999999999986 99999999999999 9
Q ss_pred CCeEEcccCccccCcccCcccccccccCCCcccHHHHhh
Q 004732 530 LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 568 (733)
Q Consensus 530 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 568 (733)
+.+||+|||+|+. +..|+|||++.+
T Consensus 229 ~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 229 EGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp TEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred CcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 9999999999863 345789998853
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-24 Score=235.74 Aligned_cols=249 Identities=18% Similarity=0.181 Sum_probs=201.4
Q ss_pred eccccccccc----cCCccccCCCCCCeeeccccccccccc----hhccCCCCCCEEEcccc---cccccCCccc-----
Q 004732 22 RVLKEQNLTG----VLPPKLAELTFLQDISLIANRLKGPIP----KYLANISTLVNLTVQYN---QFSGELPEEL----- 85 (733)
Q Consensus 22 l~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p----~~l~~l~~L~~L~L~~N---~l~~~~p~~~----- 85 (733)
..|..++++. .++..+..+++|+.|+|++|.|++..+ ..|..+++|++|+|++| .+++.+|..+
T Consensus 9 ~~L~~~~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~ 88 (386)
T 2ca6_A 9 KSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQ 88 (386)
T ss_dssp CCCEESSCCSHHHHTTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHH
T ss_pred cccccCCCCHHHHHHHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHH
Confidence 3444554442 577788899999999999999997644 44778999999999995 5556667655
Q ss_pred --cCCcCCceeeccCccccc----cCCccccCCCCCCEEEeeCCccccCCCcccc----cc---------CCCCEEEccC
Q 004732 86 --GSLLNLEKLHLSSNNFTG----ELPKTFAKLTNMKDFRISDNQFTGQIPSFIQ----NW---------TKLEKLFIQP 146 (733)
Q Consensus 86 --~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~----~l---------~~L~~L~l~~ 146 (733)
..+++|++|+|++|.|++ .+|..+..+++|++|+|++|+|++..+..+. .+ ++|++|+|++
T Consensus 89 ~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~ 168 (386)
T 2ca6_A 89 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168 (386)
T ss_dssp HHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCS
T ss_pred HHhhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCC
Confidence 789999999999999997 4788899999999999999999854444443 44 9999999999
Q ss_pred CCCc-cCCC---CCCCCcCCcCeeecccccCCCC-----Ccccccc-ccccEEEcccCccC----CCCCccccCCCCCcE
Q 004732 147 SGLA-GPIP---SGIFSLENLTDLRISDLNGPEA-----TFPQLGN-MKMTKLILRNCNIT----GELPRYLGKMTKLKV 212 (733)
Q Consensus 147 N~l~-~~~p---~~l~~l~~L~~L~l~~n~~~~~-----~~~~~~~-~~L~~L~l~~n~l~----~~~p~~~~~l~~L~~ 212 (733)
|+++ +.++ ..+..+++|+.|++++|.+... .+..+.. .+|+.|+|++|.++ +.+|..+..+++|+.
T Consensus 169 n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~ 248 (386)
T 2ca6_A 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 248 (386)
T ss_dssp SCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCE
T ss_pred CCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCE
Confidence 9997 3444 4677889999999999988743 2213333 48999999999996 678888999999999
Q ss_pred EEccCCcccCC----CCCCc--CCCCCCCEEEecCCcccc----cCChhh---hcCCCeeecccCcCCCCC
Q 004732 213 LDLSFNRLRGQ----IPSNF--DDLYDVDYIYFAGNLLTG----AIPPWM---LERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 213 L~ls~N~l~~~----~p~~~--~~l~~L~~L~l~~N~l~~----~~p~~~---l~~l~~l~ls~N~l~~~~ 270 (733)
|+|++|.+++. ++..+ ..+++|+.|++++|.+++ .+|..+ +++|+.|++++|++++..
T Consensus 249 L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 249 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp EECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred EECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 99999999876 45666 348999999999999997 477776 588999999999998654
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.88 E-value=7.4e-22 Score=218.00 Aligned_cols=206 Identities=23% Similarity=0.329 Sum_probs=111.5
Q ss_pred CCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEe
Q 004732 41 TFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRI 120 (733)
Q Consensus 41 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 120 (733)
++|++|+|++|++++ +| .|+++++|++|++++|++++ +|..+ .+|++|+|++|++++ +| .+.++++|+.|++
T Consensus 131 ~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l 202 (454)
T 1jl5_A 131 PLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA 202 (454)
T ss_dssp TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred CCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence 466667777776664 55 46666667777777666663 45432 366666666666664 44 4666666666666
Q ss_pred eCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCC
Q 004732 121 SDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGEL 200 (733)
Q Consensus 121 ~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~ 200 (733)
++|++++ +|... ++|+.|++++|+++ .+| .++.+++|+.|++++|.+...+.. ..+|+.|++++|.+++ +
T Consensus 203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~-l 272 (454)
T 1jl5_A 203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTD-L 272 (454)
T ss_dssp CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSC-C
T ss_pred CCCcCCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccc-c
Confidence 6666663 33322 35666666666665 445 255566666666666655543211 1244455555555543 2
Q ss_pred CccccCCCCCcEEEccCCcccC--CCCCCcC-------------CC-CCCCEEEecCCcccccCChhhhcCCCeeecccC
Q 004732 201 PRYLGKMTKLKVLDLSFNRLRG--QIPSNFD-------------DL-YDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYN 264 (733)
Q Consensus 201 p~~~~~l~~L~~L~ls~N~l~~--~~p~~~~-------------~l-~~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~N 264 (733)
|.. +++|+.|++++|++++ .+|..+. .+ ++|+.|++++|.+.+ +|.. +++++.|++++|
T Consensus 273 ~~~---~~~L~~L~ls~N~l~~l~~~~~~L~~L~l~~N~l~~i~~~~~~L~~L~Ls~N~l~~-lp~~-~~~L~~L~L~~N 347 (454)
T 1jl5_A 273 PEL---PQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPAL-PPRLERLIASFN 347 (454)
T ss_dssp CCC---CTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTTCCEEECCSSCCSC-CCCC-CTTCCEEECCSS
T ss_pred Ccc---cCcCCEEECcCCccCcccCcCCcCCEEECcCCcCCcccCCcCcCCEEECCCCcccc-cccc-CCcCCEEECCCC
Confidence 221 1344444444444443 1221111 12 356666666666664 4433 356666777766
Q ss_pred cCCCC
Q 004732 265 NFTDG 269 (733)
Q Consensus 265 ~l~~~ 269 (733)
.++..
T Consensus 348 ~l~~l 352 (454)
T 1jl5_A 348 HLAEV 352 (454)
T ss_dssp CCSCC
T ss_pred ccccc
Confidence 66643
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=212.40 Aligned_cols=208 Identities=21% Similarity=0.328 Sum_probs=168.1
Q ss_pred eeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCcc
Q 004732 21 KRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNN 100 (733)
Q Consensus 21 ~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 100 (733)
.+.+..++++..+ .+..+++|+.|++++|.++ .++ .+..+++|++|+|++|.+++ ++. +..+++|++|+|++|+
T Consensus 23 ~~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~ 96 (308)
T 1h6u_A 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNP 96 (308)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCcee--cHHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCc
Confidence 3456677777653 3557899999999999998 455 68999999999999999995 444 9999999999999999
Q ss_pred ccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccc
Q 004732 101 FTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ 180 (733)
Q Consensus 101 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~ 180 (733)
+++ ++ .+..+++|++|+|++|++++ ++. +..+++|+.|++++|++++..+ +..+++|+.|++++|.+.....
T Consensus 97 l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-- 168 (308)
T 1h6u_A 97 LKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-- 168 (308)
T ss_dssp CSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred CCC-ch-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--
Confidence 984 44 68899999999999999995 443 8899999999999999985433 8888999999999888877554
Q ss_pred ccc-ccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccc
Q 004732 181 LGN-MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTG 246 (733)
Q Consensus 181 ~~~-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 246 (733)
+.. .+|+.|++++|.+++..+ +..+++|+.|+|++|++++.. .+..+++|+.|++++|++++
T Consensus 169 l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i~~ 231 (308)
T 1h6u_A 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTITN 231 (308)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEEEC
T ss_pred hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCeeec
Confidence 443 378888888888886543 788888888888888888654 37888888888888888864
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.88 E-value=9.3e-22 Score=224.00 Aligned_cols=216 Identities=27% Similarity=0.313 Sum_probs=125.9
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
.+.+++++|+|+ .+|..+. ++|+.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|++
T Consensus 42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~ 110 (622)
T 3g06_A 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFS 110 (622)
T ss_dssp CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECS
T ss_pred CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcC
Confidence 456778888887 6666665 67888888888877 4554 4677888888888777 4555 567777777777
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCC---CCC--------------cC
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSG---IFS--------------LE 161 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~---l~~--------------l~ 161 (733)
|+|+ .+|. .+++|+.|++++|+|++ +|.. +++|++|+|++|++++ +|.. +.. ++
T Consensus 111 N~l~-~l~~---~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~ 181 (622)
T 3g06_A 111 NPLT-HLPA---LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPS 181 (622)
T ss_dssp CCCC-CCCC---CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCT
T ss_pred CcCC-CCCC---CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCC
Confidence 7777 3443 45566666666666663 4432 3566666666666653 2221 111 25
Q ss_pred CcCeeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecC
Q 004732 162 NLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAG 241 (733)
Q Consensus 162 ~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 241 (733)
+|+.|++++|.+...+.. ..+|+.|++++|.++ .+|. .+++|+.|+|++|+|++ +| ..+++|+.|++++
T Consensus 182 ~L~~L~Ls~N~l~~l~~~---~~~L~~L~L~~N~l~-~l~~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~ 250 (622)
T 3g06_A 182 GLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPA---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSG 250 (622)
T ss_dssp TCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCS-SCCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCS
T ss_pred CCcEEECCCCCCCCCCCc---cchhhEEECcCCccc-ccCC---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCC
Confidence 666666666666553321 124445555555554 2222 12456666666666653 33 2345556666666
Q ss_pred CcccccCChhhhcCCCeeecccCcCC
Q 004732 242 NLLTGAIPPWMLERGDKIDLSYNNFT 267 (733)
Q Consensus 242 N~l~~~~p~~~l~~l~~l~ls~N~l~ 267 (733)
|.++ .+|. .+++|+.|++++|+++
T Consensus 251 N~L~-~lp~-~~~~L~~L~Ls~N~L~ 274 (622)
T 3g06_A 251 NRLT-SLPM-LPSGLLSLSVYRNQLT 274 (622)
T ss_dssp SCCS-CCCC-CCTTCCEEECCSSCCC
T ss_pred CCCC-cCCc-ccccCcEEeCCCCCCC
Confidence 6555 3333 4455556666666555
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=1.8e-24 Score=234.54 Aligned_cols=250 Identities=17% Similarity=0.221 Sum_probs=199.9
Q ss_pred cccceeeeeccccccccccCC----ccccCCCCCCeeecccc---ccccccchhc-------cCCCCCCEEEcccccccc
Q 004732 14 KQKTVNQKRVLKEQNLTGVLP----PKLAELTFLQDISLIAN---RLKGPIPKYL-------ANISTLVNLTVQYNQFSG 79 (733)
Q Consensus 14 ~~~~~~~~l~L~~n~l~~~~p----~~l~~l~~L~~L~L~~n---~l~~~~p~~l-------~~l~~L~~L~L~~N~l~~ 79 (733)
...+.++.|+|++|+++...+ ..|..+++|++|+|++| ++++.+|..+ ..+++|++|+|++|.+++
T Consensus 29 ~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 108 (386)
T 2ca6_A 29 LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 108 (386)
T ss_dssp HHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCT
T ss_pred hcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECCCCcCCH
Confidence 345668999999999998644 45778999999999996 5556666555 789999999999999997
Q ss_pred ----cCCccccCCcCCceeeccCccccccCCcccc----CC---------CCCCEEEeeCCccc-cCCC---ccccccCC
Q 004732 80 ----ELPEELGSLLNLEKLHLSSNNFTGELPKTFA----KL---------TNMKDFRISDNQFT-GQIP---SFIQNWTK 138 (733)
Q Consensus 80 ----~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~----~l---------~~L~~L~l~~N~l~-~~~~---~~~~~l~~ 138 (733)
.+|..+..+++|++|+|++|.|++..+..+. .+ ++|++|+|++|+++ +.++ ..+..+++
T Consensus 109 ~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~ 188 (386)
T 2ca6_A 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 188 (386)
T ss_dssp TTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTT
T ss_pred HHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHHHHhCCC
Confidence 4788899999999999999999865544444 34 99999999999998 4455 46778999
Q ss_pred CCEEEccCCCCcc-----CCCCCCCCcCCcCeeecccccCCC----CCcccccc-ccccEEEcccCccCCC----CCccc
Q 004732 139 LEKLFIQPSGLAG-----PIPSGIFSLENLTDLRISDLNGPE----ATFPQLGN-MKMTKLILRNCNITGE----LPRYL 204 (733)
Q Consensus 139 L~~L~l~~N~l~~-----~~p~~l~~l~~L~~L~l~~n~~~~----~~~~~~~~-~~L~~L~l~~n~l~~~----~p~~~ 204 (733)
|+.|+|++|+++. ..+..+..+++|+.|+|++|.+.. ..+..+.. .+|+.|+|++|.+++. ++..+
T Consensus 189 L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l 268 (386)
T 2ca6_A 189 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF 268 (386)
T ss_dssp CCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHH
T ss_pred cCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHH
Confidence 9999999999983 345588899999999999999852 22333333 4899999999999876 56666
Q ss_pred c--CCCCCcEEEccCCcccC----CCCCCc-CCCCCCCEEEecCCcccccCC--hhh---hcCCCeeeccc
Q 004732 205 G--KMTKLKVLDLSFNRLRG----QIPSNF-DDLYDVDYIYFAGNLLTGAIP--PWM---LERGDKIDLSY 263 (733)
Q Consensus 205 ~--~l~~L~~L~ls~N~l~~----~~p~~~-~~l~~L~~L~l~~N~l~~~~p--~~~---l~~l~~l~ls~ 263 (733)
. .+++|+.|+|++|.+++ .+|..+ .++++|+.|++++|.+++..+ ..+ +++++.+++..
T Consensus 269 ~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~~~~~l~~~l~~~~~~~l~~ 339 (386)
T 2ca6_A 269 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELDE 339 (386)
T ss_dssp HTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSHHHHHHHHHHHHHTCCEECC
T ss_pred hhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchhHHHHHHHHhhhcCcchhhh
Confidence 4 49999999999999997 477777 668999999999999997775 333 45555455433
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-21 Score=207.97 Aligned_cols=240 Identities=15% Similarity=0.132 Sum_probs=193.0
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCC-ccccCCcCCce-eec
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELP-EELGSLLNLEK-LHL 96 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~-L~L 96 (733)
.+.++-++++++ .+|..+ .++|++|+|++|+|+.+.+..|.++++|++|+|++|++.+.+| .+|.++++|++ +.+
T Consensus 11 ~~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 11 NRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TTEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEE
T ss_pred CCEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcc
Confidence 355677888999 677766 3789999999999996666689999999999999999876666 46899999775 677
Q ss_pred cCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccC-CCCccCCCCCCCCcC-CcCeeecccccCC
Q 004732 97 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP-SGLAGPIPSGIFSLE-NLTDLRISDLNGP 174 (733)
Q Consensus 97 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p~~l~~l~-~L~~L~l~~n~~~ 174 (733)
+.|+|+...|..|..+++|++|++++|+|++..+..+....++..|++.+ |++....+..|..+. .++.|++++|.+.
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 78999988889999999999999999999977777788888899999865 677755566777765 6889999999999
Q ss_pred CCCccccccccccEEEccc-CccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh-
Q 004732 175 EATFPQLGNMKMTKLILRN-CNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM- 252 (733)
Q Consensus 175 ~~~~~~~~~~~L~~L~l~~-n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~- 252 (733)
.+....+...+|+.|++++ |.++...+..|.++++|+.|||++|+|+...+.. +.+|+.|.+.++.-...+|..-
T Consensus 168 ~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~---~~~L~~L~~l~~~~l~~lP~l~~ 244 (350)
T 4ay9_X 168 EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYG---LENLKKLRARSTYNLKKLPTLEK 244 (350)
T ss_dssp EECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSS---CTTCCEEECTTCTTCCCCCCTTT
T ss_pred CCChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcCccChhh---hccchHhhhccCCCcCcCCCchh
Confidence 9888888888999999985 6677555567899999999999999999544444 4556666666554444666432
Q ss_pred hcCCCeeecccC
Q 004732 253 LERGDKIDLSYN 264 (733)
Q Consensus 253 l~~l~~l~ls~N 264 (733)
+++|+.++++++
T Consensus 245 l~~L~~l~l~~~ 256 (350)
T 4ay9_X 245 LVALMEASLTYP 256 (350)
T ss_dssp CCSCCEEECSCH
T ss_pred CcChhhCcCCCC
Confidence 778888888654
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=3.4e-22 Score=209.36 Aligned_cols=215 Identities=17% Similarity=0.233 Sum_probs=181.6
Q ss_pred CCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEE
Q 004732 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 119 (733)
Q Consensus 40 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 119 (733)
+.++..+.+..+.+++.+. +..+++|++|++++|.++ .+| .+..+++|++|+|++|.+++ ++. +..+++|++|+
T Consensus 18 l~~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~ 91 (308)
T 1h6u_A 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELE 91 (308)
T ss_dssp HHHHHHHHTTCSSTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEE
T ss_pred HHHHHHHHhCCCCcCceec--HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEE
Confidence 3445556677777775443 567889999999999998 566 69999999999999999995 444 99999999999
Q ss_pred eeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCcccccc-ccccEEEcccCccCC
Q 004732 120 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGN-MKMTKLILRNCNITG 198 (733)
Q Consensus 120 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~-~~L~~L~l~~n~l~~ 198 (733)
|++|++++ ++ .+..+++|+.|+|++|++++ ++ .+..+++|+.|++++|.+..... +.. .+|+.|++++|.+++
T Consensus 92 L~~n~l~~-~~-~~~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 165 (308)
T 1h6u_A 92 LSGNPLKN-VS-AIAGLQSIKTLDLTSTQITD-VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD 165 (308)
T ss_dssp CCSCCCSC-CG-GGTTCTTCCEEECTTSCCCC-CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC
T ss_pred ccCCcCCC-ch-hhcCCCCCCEEECCCCCCCC-ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC
Confidence 99999995 33 68999999999999999986 44 38999999999999999988765 444 489999999999996
Q ss_pred CCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCeeecccCcCCCCC
Q 004732 199 ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 199 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~N~l~~~~ 270 (733)
..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|.+.+..|-..+++|+.|++++|++++.+
T Consensus 166 ~~~--l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~l~~N~i~~~~ 233 (308)
T 1h6u_A 166 LTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQP 233 (308)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEEEEEECCC
T ss_pred Chh--hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCccccccCCCCCCEEEccCCeeecCC
Confidence 544 8999999999999999996543 8899999999999999997765444889999999999987643
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-23 Score=224.07 Aligned_cols=239 Identities=14% Similarity=0.169 Sum_probs=192.8
Q ss_pred cceeeeeccccccccccCC----ccccCCC-CCCeeeccccccccccchhccCC-----CCCCEEEcccccccccCCccc
Q 004732 16 KTVNQKRVLKEQNLTGVLP----PKLAELT-FLQDISLIANRLKGPIPKYLANI-----STLVNLTVQYNQFSGELPEEL 85 (733)
Q Consensus 16 ~~~~~~l~L~~n~l~~~~p----~~l~~l~-~L~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~~ 85 (733)
...+++|+|++|++++..+ ..|..++ +|++|+|++|+|++..+..|..+ ++|++|+|++|.+++..+..+
T Consensus 21 ~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l 100 (362)
T 3goz_A 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL 100 (362)
T ss_dssp CTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred CCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence 4458999999999998877 7888898 99999999999998888888876 999999999999997766654
Q ss_pred c----CC-cCCceeeccCccccccCCcccc----C-CCCCCEEEeeCCccccCCC----ccccccC-CCCEEEccCCCCc
Q 004732 86 G----SL-LNLEKLHLSSNNFTGELPKTFA----K-LTNMKDFRISDNQFTGQIP----SFIQNWT-KLEKLFIQPSGLA 150 (733)
Q Consensus 86 ~----~l-~~L~~L~Ls~N~l~~~~p~~~~----~-l~~L~~L~l~~N~l~~~~~----~~~~~l~-~L~~L~l~~N~l~ 150 (733)
. .+ ++|++|+|++|+|++..+..+. . .++|++|+|++|+|++... ..+..++ +|+.|+|++|+++
T Consensus 101 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~ 180 (362)
T 3goz_A 101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180 (362)
T ss_dssp HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence 4 44 8999999999999976665554 3 3699999999999996444 3445565 9999999999999
Q ss_pred cCCCCCCCC----c-CCcCeeecccccCCCCCccccc------cccccEEEcccCccCCCCC----ccccCCCCCcEEEc
Q 004732 151 GPIPSGIFS----L-ENLTDLRISDLNGPEATFPQLG------NMKMTKLILRNCNITGELP----RYLGKMTKLKVLDL 215 (733)
Q Consensus 151 ~~~p~~l~~----l-~~L~~L~l~~n~~~~~~~~~~~------~~~L~~L~l~~n~l~~~~p----~~~~~l~~L~~L~l 215 (733)
+..+..+.. + ++|+.|+|++|.+.......+. ..+|+.|+|++|.+++..+ ..+..+++|+.|+|
T Consensus 181 ~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~~~~l~~L~~L~L 260 (362)
T 3goz_A 181 SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYL 260 (362)
T ss_dssp GSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHHSCTTCCEEECCSSCCCCCCHHHHHHTTTTTTTCSEEEE
T ss_pred hhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHHHhcCCCCceEEECcCCCCCcHHHHHHHHHHhcCCCccEEEe
Confidence 777655444 4 6999999999999885443222 2379999999999997655 34567899999999
Q ss_pred cCCcccCC-------CCCCcCCCCCCCEEEecCCcccccCChhhhc
Q 004732 216 SFNRLRGQ-------IPSNFDDLYDVDYIYFAGNLLTGAIPPWMLE 254 (733)
Q Consensus 216 s~N~l~~~-------~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~ 254 (733)
++|.+.+. ++..+..+++|+.|++++|.+.+..+.....
T Consensus 261 ~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~~~~~~ 306 (362)
T 3goz_A 261 DYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHSIPISN 306 (362)
T ss_dssp EHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGCHHHHH
T ss_pred ccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcchHHHHH
Confidence 99995543 3346778899999999999998776665533
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.86 E-value=1.3e-21 Score=220.01 Aligned_cols=184 Identities=21% Similarity=0.256 Sum_probs=138.7
Q ss_pred CCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEee
Q 004732 42 FLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 121 (733)
Q Consensus 42 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 121 (733)
+|+.|+|++|+|++ +|..+. ++|++|+|++|+|+ .+| ..+++|+.|+|++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 77888888888875 665553 67888888888887 666 446778888888888875 666 554 78888888
Q ss_pred CCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCC
Q 004732 122 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELP 201 (733)
Q Consensus 122 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p 201 (733)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|.+..++. +. .+|+.|+|++|.|+ .+|
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~lp~--l~-~~L~~L~Ls~N~L~-~lp 196 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTFLPE--LP-ESLEALDVSTNLLE-SLP 196 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSCCCC--CC-TTCCEEECCSSCCS-SCC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCCcch--hh-CCCCEEECcCCCCC-chh
Confidence 888875 555 57788888888888875 555 46778888888888777444 44 67888888888888 556
Q ss_pred ccccCCCCC-------cEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh
Q 004732 202 RYLGKMTKL-------KVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM 252 (733)
Q Consensus 202 ~~~~~l~~L-------~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 252 (733)
. |.. +| +.|+|++|+|+ .+|..+..+++|+.|++++|++++.+|..+
T Consensus 197 ~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l 250 (571)
T 3cvr_A 197 A-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250 (571)
T ss_dssp C-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHH
T ss_pred h-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHH
Confidence 5 554 67 99999999998 578878889999999999999998888776
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.85 E-value=4.4e-24 Score=237.17 Aligned_cols=250 Identities=18% Similarity=0.159 Sum_probs=163.7
Q ss_pred eeeeeccccccccc----cCCccccCCCCCCeeeccccccccccchhccC-----CCCCCEEEccccccccc----CCcc
Q 004732 18 VNQKRVLKEQNLTG----VLPPKLAELTFLQDISLIANRLKGPIPKYLAN-----ISTLVNLTVQYNQFSGE----LPEE 84 (733)
Q Consensus 18 ~~~~l~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~-----l~~L~~L~L~~N~l~~~----~p~~ 84 (733)
.+++|+|++|+++. .++..|..+++|++|+|++|.+++..+..+.. +++|++|+|++|.+++. ++..
T Consensus 86 ~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 165 (461)
T 1z7x_W 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASV 165 (461)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred ceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHH
Confidence 58899999999984 56888999999999999999998655544433 56788888888888863 3555
Q ss_pred ccCCcCCceeeccCccccccCCcccc-----CCCCCCEEEeeCCccccC----CCccccccCCCCEEEccCCCCccCC--
Q 004732 85 LGSLLNLEKLHLSSNNFTGELPKTFA-----KLTNMKDFRISDNQFTGQ----IPSFIQNWTKLEKLFIQPSGLAGPI-- 153 (733)
Q Consensus 85 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-----~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~-- 153 (733)
+..+++|++|+|++|.++...+..+. .+++|++|+|++|++++. ++..+..+++|++|++++|++++..
T Consensus 166 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~ 245 (461)
T 1z7x_W 166 LRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA 245 (461)
T ss_dssp HHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred HhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHH
Confidence 66778888888888888755444443 256788888888887753 4666667777888888877776432
Q ss_pred ---CCCCCCcCCcCeeecccccCCCCCcc----ccc-cccccEEEcccCccCCCCCccccCC-----CCCcEEEccCCcc
Q 004732 154 ---PSGIFSLENLTDLRISDLNGPEATFP----QLG-NMKMTKLILRNCNITGELPRYLGKM-----TKLKVLDLSFNRL 220 (733)
Q Consensus 154 ---p~~l~~l~~L~~L~l~~n~~~~~~~~----~~~-~~~L~~L~l~~n~l~~~~p~~~~~l-----~~L~~L~ls~N~l 220 (733)
+..+..+++|+.|++++|.+...... .+. ..+|+.|++++|.+++..+..+... ++|+.|++++|.+
T Consensus 246 ~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l 325 (461)
T 1z7x_W 246 ELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325 (461)
T ss_dssp HHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred HHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCC
Confidence 11222466777777777766654221 122 2356677777776654433333322 4666666666666
Q ss_pred cCC----CCCCcCCCCCCCEEEecCCcccccCChhh-------hcCCCeeecccCcCC
Q 004732 221 RGQ----IPSNFDDLYDVDYIYFAGNLLTGAIPPWM-------LERGDKIDLSYNNFT 267 (733)
Q Consensus 221 ~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-------l~~l~~l~ls~N~l~ 267 (733)
++. ++..+..+++|+.|++++|.+.+..+..+ .++++.|++++|.++
T Consensus 326 ~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~ 383 (461)
T 1z7x_W 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383 (461)
T ss_dssp BGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred chHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence 644 33444555666666666666654433332 135666666666655
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.5e-21 Score=217.65 Aligned_cols=223 Identities=24% Similarity=0.312 Sum_probs=169.2
Q ss_pred ceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeec
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 96 (733)
+.++.|+|++|+|+ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|++|+++ .+|. .+++|+.|+|
T Consensus 61 ~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~l~~---~l~~L~~L~L 128 (622)
T 3g06_A 61 AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFSNPLT-HLPA---LPSGLCKLWI 128 (622)
T ss_dssp TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECSCCCC-CCCC---CCTTCCEEEC
T ss_pred CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcCCcCC-CCCC---CCCCcCEEEC
Confidence 45778888888888 4554 5688888888888888 4554 6678888888888887 4554 4566777777
Q ss_pred cCccccccCCccccCCCCCCEEEeeCCccccCCCcc---ccc--------------cCCCCEEEccCCCCccCCCCCCCC
Q 004732 97 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSF---IQN--------------WTKLEKLFIQPSGLAGPIPSGIFS 159 (733)
Q Consensus 97 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~---~~~--------------l~~L~~L~l~~N~l~~~~p~~l~~ 159 (733)
++|+|+ .+|.. +++|++|+|++|+|++ +|.. +.. +++|+.|+|++|+|++ +|..
T Consensus 129 ~~N~l~-~lp~~---l~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~~~~~~L~~L~Ls~N~l~~-l~~~--- 199 (622)
T 3g06_A 129 FGNQLT-SLPVL---PPGLQELSVSDNQLAS-LPALPSELCKLWAYNNQLTSLPMLPSGLQELSVSDNQLAS-LPTL--- 199 (622)
T ss_dssp CSSCCS-CCCCC---CTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSC-CCCC---
T ss_pred CCCCCC-cCCCC---CCCCCEEECcCCcCCC-cCCccCCCCEEECCCCCCCCCcccCCCCcEEECCCCCCCC-CCCc---
Confidence 777777 35543 3667777777776664 2222 222 3889999999999984 5543
Q ss_pred cCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEe
Q 004732 160 LENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYF 239 (733)
Q Consensus 160 l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l 239 (733)
+++|+.|++++|.+...+.. ..+|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|. .+++|+.|++
T Consensus 200 ~~~L~~L~L~~N~l~~l~~~---~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp~---~~~~L~~L~L 268 (622)
T 3g06_A 200 PSELYKLWAYNNRLTSLPAL---PSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLPM---LPSGLLSLSV 268 (622)
T ss_dssp CTTCCEEECCSSCCSSCCCC---CTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCCC---CCTTCCEEEC
T ss_pred cchhhEEECcCCcccccCCC---CCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCCc---ccccCcEEeC
Confidence 47899999999999876532 2579999999999996 55 56789999999999999 5665 6789999999
Q ss_pred cCCcccccCChhh--hcCCCeeecccCcCCCCCCc
Q 004732 240 AGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSAE 272 (733)
Q Consensus 240 ~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~~~~ 272 (733)
++|.++ .+|..+ +++|+.|++++|++++..+.
T Consensus 269 s~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 269 YRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp CSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred CCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 999999 778776 78899999999999865443
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.85 E-value=9.9e-23 Score=216.40 Aligned_cols=231 Identities=18% Similarity=0.182 Sum_probs=193.1
Q ss_pred ceeeeeccccccccccCCccccCCCCCCeeeccccccccc-cchhccCCCCCCEEEcccccccccCCccccCCcCCceee
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGP-IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 95 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 95 (733)
...+.+++++|.+++..+. +..+++|++|+|++|.+++. ++..+..+++|++|+|++|.+++..+..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 4578889999999988775 56899999999999999876 888899999999999999999988999999999999999
Q ss_pred ccCc-cccc-cCCccccCCCCCCEEEeeCC-ccccC-CCccccccC-CCCEEEccCC--CCc-cCCCCCCCCcCCcCeee
Q 004732 96 LSSN-NFTG-ELPKTFAKLTNMKDFRISDN-QFTGQ-IPSFIQNWT-KLEKLFIQPS--GLA-GPIPSGIFSLENLTDLR 167 (733)
Q Consensus 96 Ls~N-~l~~-~~p~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~l~-~L~~L~l~~N--~l~-~~~p~~l~~l~~L~~L~ 167 (733)
|++| .+++ .++..+.++++|++|++++| .+++. ++..+..++ +|++|+|++| .++ +.++..+..+++|+.|+
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~ 228 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLD 228 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEe
Confidence 9999 7886 37777889999999999999 99864 677889999 9999999999 555 45677778899999999
Q ss_pred ccccc-CCCCCccccccc-cccEEEcccCc-cCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCC-CCCCEEEecCCc
Q 004732 168 ISDLN-GPEATFPQLGNM-KMTKLILRNCN-ITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL-YDVDYIYFAGNL 243 (733)
Q Consensus 168 l~~n~-~~~~~~~~~~~~-~L~~L~l~~n~-l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l-~~L~~L~l~~N~ 243 (733)
+++|. ++...+..+... +|+.|++++|. +.......++++++|+.|++++| ++ ...+..+ .+++.|++++|.
T Consensus 229 l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~~-i~---~~~~~~l~~~l~~L~l~~n~ 304 (336)
T 2ast_B 229 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VP---DGTLQLLKEALPHLQINCSH 304 (336)
T ss_dssp CTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SC---TTCHHHHHHHSTTSEESCCC
T ss_pred CCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccCc-cC---HHHHHHHHhhCcceEEeccc
Confidence 99999 666666666554 89999999995 33222236889999999999999 44 2234444 247777899999
Q ss_pred ccccCChhh
Q 004732 244 LTGAIPPWM 252 (733)
Q Consensus 244 l~~~~p~~~ 252 (733)
+++..|...
T Consensus 305 l~~~~~~~~ 313 (336)
T 2ast_B 305 FTTIARPTI 313 (336)
T ss_dssp SCCTTCSSC
T ss_pred CccccCCcc
Confidence 999888764
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.8e-21 Score=214.25 Aligned_cols=187 Identities=24% Similarity=0.274 Sum_probs=122.8
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
.++.|+|++|+|++ +|..+. ++|+.|+|++|+|+ .+| ..+++|++|+|++|+|++ +|. |.. +|+.|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 45667777777775 555442 66777777777777 555 445677777777777774 565 554 67777777
Q ss_pred CccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCC
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT 177 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~ 177 (733)
+|+|++ +|. .+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|++ +|. |. ++|+.|+|++|.+..++
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~lp 196 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLESLP 196 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSSCC
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCchh
Confidence 777774 554 56677777777777774 554 45677777777777775 555 44 67777777777776544
Q ss_pred ccccccccc-------cEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCC
Q 004732 178 FPQLGNMKM-------TKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDL 231 (733)
Q Consensus 178 ~~~~~~~~L-------~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l 231 (733)
. +.. +| +.|+|++|.|+ .+|..+..+++|+.|+|++|.|++.+|..+..+
T Consensus 197 ~--~~~-~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 253 (571)
T 3cvr_A 197 A--VPV-RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQ 253 (571)
T ss_dssp C--CC---------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHH
T ss_pred h--HHH-hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHh
Confidence 4 333 55 77777777777 456666667777777777777777666665554
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.85 E-value=4.4e-21 Score=188.87 Aligned_cols=151 Identities=20% Similarity=0.191 Sum_probs=124.5
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCc
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 99 (733)
..++.++++++ .+|..+ .++|++|+|++|++++..+..|.++++|++|+|++|++++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 45667788887 445444 368999999999999777777899999999999999999666667889999999999999
Q ss_pred cccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccC
Q 004732 100 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG 173 (733)
Q Consensus 100 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~ 173 (733)
+|++..+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|.+
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 160 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPW 160 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCB
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCe
Confidence 99966667788999999999999999977777788999999999999999866666677788887777766543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.84 E-value=4.1e-23 Score=229.35 Aligned_cols=258 Identities=19% Similarity=0.218 Sum_probs=205.4
Q ss_pred cccceeeeeccccccccccCCcccc-CCC----CCCeeecccccccc----ccchhccCCCCCCEEEcccccccccCCcc
Q 004732 14 KQKTVNQKRVLKEQNLTGVLPPKLA-ELT----FLQDISLIANRLKG----PIPKYLANISTLVNLTVQYNQFSGELPEE 84 (733)
Q Consensus 14 ~~~~~~~~l~L~~n~l~~~~p~~l~-~l~----~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 84 (733)
...+.+++|+|++|+++...+..+. .++ +|++|+|++|+|+. .++..|..+++|++|+|++|.+++..+..
T Consensus 53 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~ 132 (461)
T 1z7x_W 53 RVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQL 132 (461)
T ss_dssp HTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHH
T ss_pred HhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHH
Confidence 3457789999999999875554443 355 79999999999994 56889999999999999999998655544
Q ss_pred cc-----CCcCCceeeccCcccccc----CCccccCCCCCCEEEeeCCccccCCCcccc-----ccCCCCEEEccCCCCc
Q 004732 85 LG-----SLLNLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFTGQIPSFIQ-----NWTKLEKLFIQPSGLA 150 (733)
Q Consensus 85 ~~-----~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~-----~l~~L~~L~l~~N~l~ 150 (733)
+. .+++|++|+|++|++++. ++..+..+++|++|++++|.++...+..+. ..++|+.|+|++|+++
T Consensus 133 l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~ 212 (461)
T 1z7x_W 133 LCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVT 212 (461)
T ss_dssp HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCB
T ss_pred HHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCc
Confidence 33 356899999999999974 366677889999999999999865555444 3679999999999998
Q ss_pred cC----CCCCCCCcCCcCeeecccccCCCCCcccc------ccccccEEEcccCccCCC----CCccccCCCCCcEEEcc
Q 004732 151 GP----IPSGIFSLENLTDLRISDLNGPEATFPQL------GNMKMTKLILRNCNITGE----LPRYLGKMTKLKVLDLS 216 (733)
Q Consensus 151 ~~----~p~~l~~l~~L~~L~l~~n~~~~~~~~~~------~~~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~ls 216 (733)
+. ++..+..+++|+.|++++|.+.......+ ...+|+.|++++|.++.. ++..+..+++|++|+|+
T Consensus 213 ~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls 292 (461)
T 1z7x_W 213 SDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLA 292 (461)
T ss_dssp TTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECT
T ss_pred HHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECC
Confidence 64 57777889999999999998876543222 234899999999999864 67778889999999999
Q ss_pred CCcccCCCCCCcCC-----CCCCCEEEecCCcccccC----Chhh--hcCCCeeecccCcCCCCCC
Q 004732 217 FNRLRGQIPSNFDD-----LYDVDYIYFAGNLLTGAI----PPWM--LERGDKIDLSYNNFTDGSA 271 (733)
Q Consensus 217 ~N~l~~~~p~~~~~-----l~~L~~L~l~~N~l~~~~----p~~~--l~~l~~l~ls~N~l~~~~~ 271 (733)
+|.+++..+..+.. .++|+.|++++|.+++.. +..+ .++++.|++++|.+.+...
T Consensus 293 ~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~ 358 (461)
T 1z7x_W 293 GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGV 358 (461)
T ss_dssp TCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHH
T ss_pred CCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccH
Confidence 99998655544433 269999999999998653 3333 5789999999999876433
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.6e-20 Score=184.83 Aligned_cols=176 Identities=18% Similarity=0.185 Sum_probs=127.4
Q ss_pred CeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCC
Q 004732 44 QDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 123 (733)
Q Consensus 44 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 123 (733)
+.++++++.++ .+|..+ .++|++|+|++|++++..+..|+.+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 57788888888 556444 468899999999998666667888899999999999998666666788889999999999
Q ss_pred ccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCcc
Q 004732 124 QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRY 203 (733)
Q Consensus 124 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~ 203 (733)
+|++..+..|.++++|+.|+|++|+|++..+..+..+++|+.|++++ |.+++..+..
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~-----------------------N~l~~~~~~~ 143 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQ-----------------------NQLKSVPDGV 143 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS-----------------------SCCSCCCTTT
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCC-----------------------CccceeCHHH
Confidence 98876666788888888888888888866666667777766665555 5555444444
Q ss_pred ccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh
Q 004732 204 LGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM 252 (733)
Q Consensus 204 ~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 252 (733)
|..+++|+.|++++|.+.+. +++|+.|+++.|.++|.+|.++
T Consensus 144 ~~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~g~ip~~~ 185 (208)
T 2o6s_A 144 FDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVVRNSA 185 (208)
T ss_dssp TTTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCTTTBBCTT
T ss_pred hccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCCceeeccC
Confidence 56666666666666655532 3456666666666666666543
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=4.5e-20 Score=196.99 Aligned_cols=216 Identities=18% Similarity=0.154 Sum_probs=178.2
Q ss_pred CeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCC-ccccCCCCCCE-EEee
Q 004732 44 QDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELP-KTFAKLTNMKD-FRIS 121 (733)
Q Consensus 44 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~-L~l~ 121 (733)
+.++.++++|+ .+|..+ .++|++|+|++|+|+.+.+.+|.++++|++|+|++|++.+.+| ..|.++++|.+ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 57899999999 788766 3689999999999995555679999999999999999876665 56889998875 6777
Q ss_pred CCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeeccc-ccCCCCCccccccc--cccEEEcccCccCC
Q 004732 122 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD-LNGPEATFPQLGNM--KMTKLILRNCNITG 198 (733)
Q Consensus 122 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~-n~~~~~~~~~~~~~--~L~~L~l~~n~l~~ 198 (733)
+|+|+...|+.|.++++|++|++++|+|+...+..+....++..|++.+ +.+.......+... .++.|+|++|+|+.
T Consensus 89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~~ 168 (350)
T 4ay9_X 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE 168 (350)
T ss_dssp ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE
T ss_pred CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhccccccccC
Confidence 8999988889999999999999999999977777777888889999976 56666666655554 58899999999995
Q ss_pred CCCccccCCCCCcEEEccC-CcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCeeecccC
Q 004732 199 ELPRYLGKMTKLKVLDLSF-NRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYN 264 (733)
Q Consensus 199 ~~p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~N 264 (733)
. +.......+|+.|++++ |.++...+..|..+++|+.|++++|.|+ .+|...+.+++.|.+.++
T Consensus 169 i-~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~LdLs~N~l~-~lp~~~~~~L~~L~~l~~ 233 (350)
T 4ay9_X 169 I-HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST 233 (350)
T ss_dssp E-CTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSEEECTTSCCC-CCCSSSCTTCCEEECTTC
T ss_pred C-ChhhccccchhHHhhccCCcccCCCHHHhccCcccchhhcCCCCcC-ccChhhhccchHhhhccC
Confidence 4 54444667899999985 6677544567899999999999999998 677777788888876554
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-19 Score=179.34 Aligned_cols=153 Identities=19% Similarity=0.196 Sum_probs=131.9
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
.+.+++++++++ .+|..+. ++|+.|+|++|+|++..+..|..+++|++|+|++|++++..|..|..+++|++|+|++
T Consensus 13 ~~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 13 NNIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TTEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CCEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 456788899988 5666654 7899999999999987777899999999999999999988899999999999999999
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCC
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGP 174 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~ 174 (733)
|+|+...+..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 165 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI 165 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence 9999666666788999999999999999888889999999999999999999777777888888887777776543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=4.8e-20 Score=191.33 Aligned_cols=186 Identities=21% Similarity=0.308 Sum_probs=129.4
Q ss_pred eccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccc
Q 004732 22 RVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNF 101 (733)
Q Consensus 22 l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 101 (733)
+.+..+.+++.. .+..+++|+.|++++|.++. ++ .+..+++|++|+|++|++++. +. +..+++|+.|+|++|++
T Consensus 29 ~~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~~n~l 102 (291)
T 1h6t_A 29 DNLKKKSVTDAV--TQNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLDENKV 102 (291)
T ss_dssp HHTTCSCTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCC
T ss_pred HHhcCCCccccc--chhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEECCCCcC
Confidence 346666666543 34567888888888888874 33 477788888888888888753 33 77888888888888888
Q ss_pred cccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCcccc
Q 004732 102 TGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQL 181 (733)
Q Consensus 102 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~ 181 (733)
++ +| .+..+++|++|+|++|++++. ..+..+++|+.|++++|++++. ..+..+++|
T Consensus 103 ~~-~~-~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L------------------ 158 (291)
T 1h6t_A 103 KD-LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKL------------------ 158 (291)
T ss_dssp CC-GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTC------------------
T ss_pred CC-Ch-hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCC------------------
Confidence 74 33 377788888888888887753 4577777788887777777643 344444444
Q ss_pred ccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccc
Q 004732 182 GNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTG 246 (733)
Q Consensus 182 ~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 246 (733)
+.|++++|.+++..+ +..+++|+.|+|++|.+++ ++ .+..+++|+.|++++|++..
T Consensus 159 -----~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 159 -----DTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp -----SEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEEC
T ss_pred -----CEEEccCCccccchh--hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccC
Confidence 455556666665444 7777788888888888774 33 37777788888888887763
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=6.9e-20 Score=208.36 Aligned_cols=189 Identities=22% Similarity=0.302 Sum_probs=132.1
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
...+.|..++++..++ +..|++|+.|+|++|.|.. ++ .|..+++|+.|+|++|.|++..| |..+++|+.|+|++
T Consensus 23 l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~ 96 (605)
T 1m9s_A 23 TIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDE 96 (605)
T ss_dssp HHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCC-CT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCS
T ss_pred HHHHhccCCCcccccc--hhcCCCCCEEECcCCCCCC-Ch-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcC
Confidence 3445677777776544 5678889999999999884 44 58889999999999999985444 88899999999999
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCc
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATF 178 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~ 178 (733)
|.|++ +| .+..+++|+.|+|++|+|++ + ..+..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.+....+
T Consensus 97 N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~ 170 (605)
T 1m9s_A 97 NKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP 170 (605)
T ss_dssp SCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGG
T ss_pred CCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCCchh
Confidence 99884 44 68888999999999999885 3 4588888999999999888854 566667777766666655554433
Q ss_pred cccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccC
Q 004732 179 PQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG 222 (733)
Q Consensus 179 ~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 222 (733)
.....+|+.|+|++|.|++. ..+..+++|+.|+|++|++++
T Consensus 171 -l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 171 -LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp -GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEEC
T ss_pred -hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcC
Confidence 11122455555555555432 234455555555555555543
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=4.1e-20 Score=191.78 Aligned_cols=171 Identities=21% Similarity=0.333 Sum_probs=143.2
Q ss_pred ccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCcee
Q 004732 15 QKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKL 94 (733)
Q Consensus 15 ~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 94 (733)
..+.++.|++++|+++.. + .+..+++|+.|+|++|++++..+ +.++++|++|+|++|.+++ ++ .+..+++|+.|
T Consensus 44 ~l~~L~~L~l~~~~i~~~-~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~~L 117 (291)
T 1h6t_A 44 ELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSL 117 (291)
T ss_dssp HHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEE
T ss_pred hcCcccEEEccCCCcccC-h-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCCEE
Confidence 355678999999999965 3 58999999999999999996554 9999999999999999995 44 49999999999
Q ss_pred eccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCC
Q 004732 95 HLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGP 174 (733)
Q Consensus 95 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~ 174 (733)
+|++|++++ + ..+..+++|+.|++++|++++. ..+..+++|+.|+|++|++++..+ +..+++|+.|++
T Consensus 118 ~L~~n~i~~-~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L------ 185 (291)
T 1h6t_A 118 SLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYL------ 185 (291)
T ss_dssp ECTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCCEEEC------
T ss_pred ECCCCcCCC-C-hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccchh--hcCCCccCEEEC------
Confidence 999999995 4 5689999999999999999964 679999999999999999986544 666666665554
Q ss_pred CCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccC
Q 004732 175 EATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG 222 (733)
Q Consensus 175 ~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 222 (733)
++|.+++. + .+..+++|+.|++++|+++.
T Consensus 186 -----------------~~N~i~~l-~-~l~~l~~L~~L~l~~n~i~~ 214 (291)
T 1h6t_A 186 -----------------SKNHISDL-R-ALAGLKNLDVLELFSQECLN 214 (291)
T ss_dssp -----------------CSSCCCBC-G-GGTTCTTCSEEEEEEEEEEC
T ss_pred -----------------CCCcCCCC-h-hhccCCCCCEEECcCCcccC
Confidence 55556543 3 37888999999999999885
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.80 E-value=8e-19 Score=175.31 Aligned_cols=51 Identities=31% Similarity=0.425 Sum_probs=34.2
Q ss_pred CCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCC
Q 004732 199 ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 249 (733)
Q Consensus 199 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 249 (733)
.+|..+..+++|+.|+|++|+|++..+..|..+++|+.|++++|++.+..+
T Consensus 126 ~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 176 (229)
T 3e6j_A 126 ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDCECR 176 (229)
T ss_dssp SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCTTBG
T ss_pred ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccCCcc
Confidence 344455666667777777777775555667777777777777777776654
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.80 E-value=2.7e-19 Score=177.56 Aligned_cols=153 Identities=14% Similarity=0.177 Sum_probs=131.7
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccc-hhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIP-KYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
.+.+++++|+++. +|..+. +.++.|+|++|+|++..+ ..|.++++|++|+|++|.|++..+.+|..+++|++|+|+
T Consensus 13 ~~~l~~s~n~l~~-iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 13 GTTVDCSNQKLNK-IPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TTEEECCSSCCSS-CCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CCEeEeCCCCccc-CccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 4678899999984 676654 457899999999997755 458899999999999999998777789999999999999
Q ss_pred CccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCC
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGP 174 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~ 174 (733)
+|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+|++|.+.
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 166 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN 166 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence 99999888888999999999999999999888899999999999999999999888888888888887777766544
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.1e-19 Score=206.59 Aligned_cols=192 Identities=19% Similarity=0.316 Sum_probs=164.6
Q ss_pred CCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEE
Q 004732 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 119 (733)
Q Consensus 40 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 119 (733)
+..+..+.|..+.+....+ +..|++|+.|+|++|.+. .++ .|..|++|+.|+|++|+|++..| +..+++|+.|+
T Consensus 20 l~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~ 93 (605)
T 1m9s_A 20 FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLF 93 (605)
T ss_dssp HHHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEE
T ss_pred HHHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEE
Confidence 4557778888888886554 678899999999999998 555 59999999999999999996555 99999999999
Q ss_pred eeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCC
Q 004732 120 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITG 198 (733)
Q Consensus 120 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~ 198 (733)
|++|+|++ ++ .+..+++|+.|+|++|+|.+ + ..+..+++|+.|+|++|.+... ..+..+ +|+.|+|++|.|++
T Consensus 94 Ls~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 94 LDENKIKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp CCSSCCCC-CT-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred CcCCCCCC-Ch-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence 99999995 44 68999999999999999985 3 5688999999999999999887 344444 89999999999997
Q ss_pred CCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCccccc
Q 004732 199 ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGA 247 (733)
Q Consensus 199 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 247 (733)
..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++.+.
T Consensus 168 ~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 168 IVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred chh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 766 89999999999999999963 4588899999999999999753
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.2e-19 Score=192.42 Aligned_cols=179 Identities=21% Similarity=0.289 Sum_probs=93.4
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhcc-CCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLA-NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
+.+++++++|+. +|..+. +.++.|+|++|+|++..+..|. ++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 21 ~~l~c~~~~l~~-iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLPN-VPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCSS-CCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 345555555552 343332 3355555555555544444444 555555555555555544444555555555555555
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCc
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATF 178 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~ 178 (733)
|+|++..+..|.++++|++|+|++|+|++..+..|.++++|+.|+|++|+|++ +|
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~-l~------------------------ 152 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FP------------------------ 152 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCS-CC------------------------
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCe-eC------------------------
Confidence 55554444445555555555555555554444444444555444444444442 11
Q ss_pred cccccccccEEEcccCccCCCCCccc---cCCCCCcEEEccCCcccCCCCCCcCCCCC--CCEEEecCCcccccC
Q 004732 179 PQLGNMKMTKLILRNCNITGELPRYL---GKMTKLKVLDLSFNRLRGQIPSNFDDLYD--VDYIYFAGNLLTGAI 248 (733)
Q Consensus 179 ~~~~~~~L~~L~l~~n~l~~~~p~~~---~~l~~L~~L~ls~N~l~~~~p~~~~~l~~--L~~L~l~~N~l~~~~ 248 (733)
+..| ..+++|+.|+|++|+|++..+..+..++. |+.|++++|++.+..
T Consensus 153 ----------------------~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C 205 (361)
T 2xot_A 153 ----------------------VELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC 205 (361)
T ss_dssp ----------------------GGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred ----------------------HHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCc
Confidence 1112 44666667777777766544455555555 367777888776554
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.79 E-value=2.5e-19 Score=192.01 Aligned_cols=156 Identities=20% Similarity=0.113 Sum_probs=91.9
Q ss_pred CceeeccCccccccCCcccc-CCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecc
Q 004732 91 LEKLHLSSNNFTGELPKTFA-KLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRIS 169 (733)
Q Consensus 91 L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~ 169 (733)
|+.|+|++|+|++..+..|. ++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..+..|..+++|+
T Consensus 41 l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~----- 115 (361)
T 2xot_A 41 TALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALE----- 115 (361)
T ss_dssp CSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC-----
T ss_pred CCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCC-----
Confidence 44444444444433333333 444444444444444443334444444444444444444433333344443333
Q ss_pred cccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCc---CCCCCCCEEEecCCcccc
Q 004732 170 DLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNF---DDLYDVDYIYFAGNLLTG 246 (733)
Q Consensus 170 ~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~---~~l~~L~~L~l~~N~l~~ 246 (733)
.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..| ..+++|+.|+|++|.+.+
T Consensus 116 ------------------~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 177 (361)
T 2xot_A 116 ------------------VLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKK 177 (361)
T ss_dssp ------------------EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCC
T ss_pred ------------------EEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCc
Confidence 33344455555567778889999999999999996555555 579999999999999995
Q ss_pred cCChhh--hcC--CCeeecccCcCCCC
Q 004732 247 AIPPWM--LER--GDKIDLSYNNFTDG 269 (733)
Q Consensus 247 ~~p~~~--l~~--l~~l~ls~N~l~~~ 269 (733)
..+..+ ++. ++.|++++|++.|.
T Consensus 178 l~~~~~~~l~~~~l~~l~l~~N~~~C~ 204 (361)
T 2xot_A 178 LPLTDLQKLPAWVKNGLYLHNNPLECD 204 (361)
T ss_dssp CCHHHHHHSCHHHHTTEECCSSCEECC
T ss_pred cCHHHhhhccHhhcceEEecCCCccCC
Confidence 433333 332 36799999999875
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.79 E-value=9.4e-19 Score=174.82 Aligned_cols=153 Identities=20% Similarity=0.203 Sum_probs=130.7
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
...++.++++++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|+...+..|..+++|+.|+|++
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEeEccCCCcC-ccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCC
Confidence 456778888887 6666554 8999999999999988899999999999999999999865556789999999999999
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCC
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE 175 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~ 175 (733)
|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|++++|.+..
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c 173 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPWDC 173 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCBCT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCccC
Confidence 9999777777899999999999999999 788889999999999999999996666678888888877777665543
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=4.4e-20 Score=187.94 Aligned_cols=136 Identities=18% Similarity=0.153 Sum_probs=106.3
Q ss_pred ccccCcccCCCcccEEEccc-CCCcE--EEEEEccccChh------------------------cHHHHHHHHHHHHhCC
Q 004732 395 FATDNNIGEGGFGPVYKGLL-ADGTA--IAVKQLSSKSKQ------------------------GNREFINEIGMISALQ 447 (733)
Q Consensus 395 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~ 447 (733)
|...+.||+|+||.||+|.. .+|+. ||||.+...... ....+.+|++++.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999997 78989 999987543111 1136788999999998
Q ss_pred CCce--eeEeeEEEeCCeEEEEEEccCC-C----CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-cCCCCCeecCCC
Q 004732 448 HPNL--VKLYGCCIEGNQLLLIYEYLEN-N----SLARALFEHRLKLDWPTRRRICLGIARGLAYLH-GESRIKVVHRDI 519 (733)
Q Consensus 448 h~ni--v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~ivH~Di 519 (733)
|+++ ..++++ ...++||||+.+ | +|.++... .++..+..++.|++.||.||| +.| |+||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDl 197 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAE---LVHADL 197 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCC
Confidence 8764 333332 356899999943 4 67665432 235678899999999999999 886 999999
Q ss_pred CCCcEEecCCCCeEEcccCccccC
Q 004732 520 KATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 520 k~~Nill~~~~~~kl~DfGla~~~ 543 (733)
||+|||++. .++|+|||+|...
T Consensus 198 kp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 198 SEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp STTSEEESS--SEEECCCTTCEET
T ss_pred CHHHEEEcC--cEEEEECcccccC
Confidence 999999998 9999999999754
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.78 E-value=1.4e-18 Score=172.49 Aligned_cols=156 Identities=19% Similarity=0.229 Sum_probs=123.6
Q ss_pred CEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCC
Q 004732 68 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 147 (733)
Q Consensus 68 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N 147 (733)
+.+++++|.++ .+|..+. ++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N 90 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN 90 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSS
T ss_pred CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCC
Confidence 57888888888 6776554 57888888888888666667888888888888888888777788888888888888888
Q ss_pred CCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCC
Q 004732 148 GLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSN 227 (733)
Q Consensus 148 ~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~ 227 (733)
+|+...+..|.++++|+ .|+|++|.|++..|..|..+++|+.|+|++|+|++..+..
T Consensus 91 ~l~~l~~~~f~~l~~L~-----------------------~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 147 (220)
T 2v9t_B 91 KITELPKSLFEGLFSLQ-----------------------LLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGT 147 (220)
T ss_dssp CCCCCCTTTTTTCTTCC-----------------------EEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred cCCccCHhHccCCCCCC-----------------------EEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHH
Confidence 88744444455555554 5566677788777888999999999999999999888888
Q ss_pred cCCCCCCCEEEecCCcccccCC
Q 004732 228 FDDLYDVDYIYFAGNLLTGAIP 249 (733)
Q Consensus 228 ~~~l~~L~~L~l~~N~l~~~~p 249 (733)
|..+++|+.|++++|++.+...
T Consensus 148 ~~~l~~L~~L~L~~N~~~c~c~ 169 (220)
T 2v9t_B 148 FSPLRAIQTMHLAQNPFICDCH 169 (220)
T ss_dssp TTTCTTCCEEECCSSCEECSGG
T ss_pred HhCCCCCCEEEeCCCCcCCCCc
Confidence 9999999999999999986544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-18 Score=172.55 Aligned_cols=157 Identities=19% Similarity=0.272 Sum_probs=124.9
Q ss_pred CEEEcccccccccCCccccCCcCCceeeccCccccccCC-ccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccC
Q 004732 68 VNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELP-KTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 146 (733)
Q Consensus 68 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 146 (733)
+.|++++|.++ .+|..+.. .++.|+|++|+|++..| ..|..+++|++|+|++|+|++..+..|.++++|++|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~~--~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 90 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTS 90 (220)
T ss_dssp TEEECCSSCCS-SCCSCCCT--TCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCCC--CCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCC
Confidence 57888888887 57765543 46788888888886644 4477888888888888888877677788888888888888
Q ss_pred CCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCC
Q 004732 147 SGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPS 226 (733)
Q Consensus 147 N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 226 (733)
|+|++..+..|..+++|+ .|+|++|.|++..|..|..+++|+.|+|++|+|++..|.
T Consensus 91 N~l~~~~~~~~~~l~~L~-----------------------~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 147 (220)
T 2v70_A 91 NRLENVQHKMFKGLESLK-----------------------TLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPG 147 (220)
T ss_dssp SCCCCCCGGGGTTCSSCC-----------------------EEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTT
T ss_pred CccCccCHhHhcCCcCCC-----------------------EEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHH
Confidence 888766665666665555 555667778878888899999999999999999988899
Q ss_pred CcCCCCCCCEEEecCCcccccCCh
Q 004732 227 NFDDLYDVDYIYFAGNLLTGAIPP 250 (733)
Q Consensus 227 ~~~~l~~L~~L~l~~N~l~~~~p~ 250 (733)
.|..+++|+.|++++|++.+..+.
T Consensus 148 ~~~~l~~L~~L~L~~N~l~c~c~l 171 (220)
T 2v70_A 148 AFDTLHSLSTLNLLANPFNCNCYL 171 (220)
T ss_dssp TTTTCTTCCEEECCSCCEECSGGG
T ss_pred HhcCCCCCCEEEecCcCCcCCCch
Confidence 999999999999999999887664
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.4e-20 Score=212.78 Aligned_cols=182 Identities=16% Similarity=0.164 Sum_probs=122.8
Q ss_pred cCCCCCCeeeccccccccccchhccCCCCCCEEEccccc-------------ccccCCccccCCcCCceee-ccCccccc
Q 004732 38 AELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQ-------------FSGELPEELGSLLNLEKLH-LSSNNFTG 103 (733)
Q Consensus 38 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~-------------l~~~~p~~~~~l~~L~~L~-Ls~N~l~~ 103 (733)
..+++|+.|+|++|+|+ .+|..++++++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 56788999999999998 789999999999999987775 5667777888888888888 6666543
Q ss_pred cCCc------cccC--CCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCC
Q 004732 104 ELPK------TFAK--LTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE 175 (733)
Q Consensus 104 ~~p~------~~~~--l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~ 175 (733)
.++. .+.. ...|+.|+|++|+|++ +|. |+++++|+.|+|++|+|+ .+|..++.+++|+.|+|++
T Consensus 424 ~L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~----- 495 (567)
T 1dce_A 424 DLRSKFLLENSVLKMEYADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASD----- 495 (567)
T ss_dssp HHHHHHHHHHHHHHHHHTTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCS-----
T ss_pred hhhhhhhhcccccccCccCceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCC-----
Confidence 1111 0111 1247777777777774 565 777777777777777777 6677777776666665555
Q ss_pred CCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCC-CCCcCCCCCCCEEEecCCcccccCC
Q 004732 176 ATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQI-PSNFDDLYDVDYIYFAGNLLTGAIP 249 (733)
Q Consensus 176 ~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~p 249 (733)
|.|++ +| .++++++|+.|+|++|+|++.. |..+..+++|+.|++++|++++..|
T Consensus 496 ------------------N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 496 ------------------NALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp ------------------SCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred ------------------CCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 44553 33 4555666666666666666554 5556666666666666666654443
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.76 E-value=2.1e-19 Score=209.54 Aligned_cols=188 Identities=18% Similarity=0.174 Sum_probs=121.5
Q ss_pred eeeeccccccccccCCccccCCCCCCee-----eccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCce
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDI-----SLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEK 93 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L-----~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 93 (733)
...+.|.+|++... +..+.....|..+ ++..|++. ..+..|..++.|+.|+|++|.+. .+|..+..+++|++
T Consensus 175 ~~~l~L~~n~~~~~-~~~~l~~l~Ls~~~i~~~~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~ 251 (727)
T 4b8c_D 175 TPKIELFANGKDEA-NQALLQHKKLSQYSIDEDDDIENRMV-MPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTR 251 (727)
T ss_dssp -------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSC
T ss_pred cceEEeeCCCCCcc-hhhHhhcCccCcccccCcccccccee-cChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCE
Confidence 45678888888863 4444333333332 33344444 56788999999999999999998 88888889999999
Q ss_pred eeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccC
Q 004732 94 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG 173 (733)
Q Consensus 94 L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~ 173 (733)
|+|++|.|+ .+|..|.++++|++|+|++|+|+ .+|..|+++++|++|+|++|.|+ .+|..|+.|++|+.|+|++|.+
T Consensus 252 L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l 328 (727)
T 4b8c_D 252 LYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPL 328 (727)
T ss_dssp CBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCC
T ss_pred EEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCcc
Confidence 999999999 89999999999999999999999 78999999999999999999997 7898999999999999999998
Q ss_pred CCCCcccccccc--ccEEEcccCccCCCCCccccCCCCCcEEEccCC
Q 004732 174 PEATFPQLGNMK--MTKLILRNCNITGELPRYLGKMTKLKVLDLSFN 218 (733)
Q Consensus 174 ~~~~~~~~~~~~--L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N 218 (733)
....+..+...+ +..|+|++|.+++.+|.. |+.|++++|
T Consensus 329 ~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p~~------l~~l~l~~n 369 (727)
T 4b8c_D 329 EKQFLKILTEKSVTGLIFYLRDNRPEIPLPHE------RRFIEINTD 369 (727)
T ss_dssp CSHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC---------------
T ss_pred CCCChHHHhhcchhhhHHhhccCcccCcCccc------cceeEeecc
Confidence 887776665542 335678888888887764 445666666
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=6.8e-19 Score=179.70 Aligned_cols=170 Identities=23% Similarity=0.354 Sum_probs=95.3
Q ss_pred CCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEE
Q 004732 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 119 (733)
Q Consensus 40 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 119 (733)
+.++..+++++|.+++. + .+..+++|++|++++|.++ .++ .+..+++|+.|+|++|+|++..+ +.++++|++|+
T Consensus 18 l~~l~~l~l~~~~i~~~-~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~ 91 (263)
T 1xeu_A 18 LANAVKQNLGKQSVTDL-V-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELS 91 (263)
T ss_dssp HHHHHHHHHTCSCTTSE-E-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEE
T ss_pred HHHHHHHHhcCCCcccc-c-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEE
Confidence 44455556666666532 2 3555666666666666665 344 45566666666666666663322 55666666666
Q ss_pred eeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCC
Q 004732 120 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGE 199 (733)
Q Consensus 120 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~ 199 (733)
|++|++++ ++... . ++|+.|+|++|++++. ..+..+++|+. |++++|++++.
T Consensus 92 L~~N~l~~-l~~~~-~-~~L~~L~L~~N~l~~~--~~l~~l~~L~~-----------------------L~Ls~N~i~~~ 143 (263)
T 1xeu_A 92 VNRNRLKN-LNGIP-S-ACLSRLFLDNNELRDT--DSLIHLKNLEI-----------------------LSIRNNKLKSI 143 (263)
T ss_dssp CCSSCCSC-CTTCC-C-SSCCEEECCSSCCSBS--GGGTTCTTCCE-----------------------EECTTSCCCBC
T ss_pred CCCCccCC-cCccc-c-CcccEEEccCCccCCC--hhhcCcccccE-----------------------EECCCCcCCCC
Confidence 66666663 33222 2 5666666666666532 12444444443 33444444433
Q ss_pred CCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCccccc
Q 004732 200 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGA 247 (733)
Q Consensus 200 ~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 247 (733)
+ .+..+++|+.|+|++|++++. ..+..+++|+.|++++|++.+.
T Consensus 144 -~-~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 144 -V-MLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp -G-GGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred -h-HHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCC
Confidence 2 456666777777777777654 5566677777777777777644
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=3.4e-18 Score=166.55 Aligned_cols=156 Identities=17% Similarity=0.211 Sum_probs=105.9
Q ss_pred cccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCC
Q 004732 36 KLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 115 (733)
Q Consensus 36 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 115 (733)
....+++|+.|++++|.|+ .+| .+..+++|++|++++|.++ .+..+..+++|++|+|++|++++..|..++.+++|
T Consensus 39 ~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L 114 (197)
T 4ezg_A 39 TEAQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSL 114 (197)
T ss_dssp BHHHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTC
T ss_pred ChhhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCC
Confidence 3456677777777777777 455 5777777777777777655 23467777777777777777776667777777777
Q ss_pred CEEEeeCCccccCCCccccccCCCCEEEccCCC-CccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccC
Q 004732 116 KDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSG-LAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNC 194 (733)
Q Consensus 116 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~-l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n 194 (733)
++|+|++|++++..+..++.+++|+.|++++|+ ++ .+| .+..+++ |+.|++++|
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~-----------------------L~~L~l~~n 169 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPE-----------------------LKSLNIQFD 169 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSS-----------------------CCEEECTTB
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCC-----------------------CCEEECCCC
Confidence 777777777776666777777777777777776 44 333 3444444 445556666
Q ss_pred ccCCCCCccccCCCCCcEEEccCCcccC
Q 004732 195 NITGELPRYLGKMTKLKVLDLSFNRLRG 222 (733)
Q Consensus 195 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 222 (733)
.+++. + .+..+++|+.|++++|++.+
T Consensus 170 ~i~~~-~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 170 GVHDY-R-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCCCC-T-TGGGCSSCCEEEECBC----
T ss_pred CCcCh-H-HhccCCCCCEEEeeCcccCC
Confidence 66643 3 67788889999999988764
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=4.2e-18 Score=165.87 Aligned_cols=152 Identities=18% Similarity=0.187 Sum_probs=132.8
Q ss_pred ccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCcee
Q 004732 15 QKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKL 94 (733)
Q Consensus 15 ~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 94 (733)
....++.++|++|+++ .+| .+..+++|++|+|++|.++ . +..+..+++|++|+|++|.+++..+..|+.+++|++|
T Consensus 42 ~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~-~-~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L 117 (197)
T 4ezg_A 42 QMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT-N-YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117 (197)
T ss_dssp HHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS-C-CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEE
T ss_pred hcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC-c-chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEE
Confidence 3556889999999999 556 7999999999999999877 3 3479999999999999999998889999999999999
Q ss_pred eccCccccccCCccccCCCCCCEEEeeCCc-cccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccC
Q 004732 95 HLSSNNFTGELPKTFAKLTNMKDFRISDNQ-FTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNG 173 (733)
Q Consensus 95 ~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~-l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~ 173 (733)
+|++|++++..|..+..+++|++|+|++|+ ++ .++ .+..+++|+.|++++|++++ ++ .+..+++|+.|++++|++
T Consensus 118 ~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~~-~~-~l~~l~~L~~L~l~~N~i 193 (197)
T 4ezg_A 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVHD-YR-GIEDFPKLNQLYAFSQTI 193 (197)
T ss_dssp ECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCCC-CT-TGGGCSSCCEEEECBC--
T ss_pred EecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCcC-hH-HhccCCCCCEEEeeCccc
Confidence 999999998889999999999999999998 55 566 68999999999999999985 44 788888888888888775
Q ss_pred C
Q 004732 174 P 174 (733)
Q Consensus 174 ~ 174 (733)
.
T Consensus 194 ~ 194 (197)
T 4ezg_A 194 G 194 (197)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=4.4e-20 Score=208.68 Aligned_cols=187 Identities=17% Similarity=0.157 Sum_probs=139.4
Q ss_pred cCCCCCCEEEcccccccccCCccccCCcCCceeeccCcc-------------ccccCCccccCCCCCCEEE-eeCCcccc
Q 004732 62 ANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNN-------------FTGELPKTFAKLTNMKDFR-ISDNQFTG 127 (733)
Q Consensus 62 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-------------l~~~~p~~~~~l~~L~~L~-l~~N~l~~ 127 (733)
..+++|+.|+|++|+++ .+|.++++|++|+.|++++|. +.+.+|..+.++++|+.|+ ++.|.+.
T Consensus 346 ~~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~- 423 (567)
T 1dce_A 346 ATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD- 423 (567)
T ss_dssp STTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH-
T ss_pred ccCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc-
Confidence 56789999999999998 889999999999999998776 5566777777777887777 5655443
Q ss_pred CCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccC
Q 004732 128 QIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGK 206 (733)
Q Consensus 128 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~ 206 (733)
.|..+.+++|.++...+ ..|+.|+|++|.+...+. ++.+ +|+.|+|++|.|+ .+|..|++
T Consensus 424 ----------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTVLCH--LEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSSCCC--GGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ----------hhhhhhhhcccccccCc------cCceEEEecCCCCCCCcC--ccccccCcEeecCccccc-ccchhhhc
Confidence 12222223333321111 124445555554444321 2322 5667778888888 78899999
Q ss_pred CCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccC-Chhh--hcCCCeeecccCcCCCCCC
Q 004732 207 MTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAI-PPWM--LERGDKIDLSYNNFTDGSA 271 (733)
Q Consensus 207 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~-p~~~--l~~l~~l~ls~N~l~~~~~ 271 (733)
+++|+.|+|++|+|++ +| .+..+++|+.|++++|.+++.. |..+ +++|+.|++++|++++.++
T Consensus 485 l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~ 550 (567)
T 1dce_A 485 LRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEG 550 (567)
T ss_dssp CTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSS
T ss_pred CCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCcc
Confidence 9999999999999996 67 8999999999999999999876 8877 7899999999999987654
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=1.9e-18 Score=176.47 Aligned_cols=172 Identities=20% Similarity=0.287 Sum_probs=125.0
Q ss_pred CCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEE
Q 004732 63 NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 142 (733)
Q Consensus 63 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 142 (733)
.+.++..|++++|.+++ ++ .+..+++|+.|+|++|.|+ .++ .+..+++|+.|+|++|+|++..+ +.++++|+.|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEE
Confidence 34556667777777763 33 4667777777777777776 455 56677777777777777774333 6677777777
Q ss_pred EccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccC
Q 004732 143 FIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG 222 (733)
Q Consensus 143 ~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 222 (733)
+|++|++++ +|.. . ..+|+.|++++|.+++. ..+..+++|+.|+|++|++++
T Consensus 91 ~L~~N~l~~-l~~~-----------------------~--~~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~ 142 (263)
T 1xeu_A 91 SVNRNRLKN-LNGI-----------------------P--SACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS 142 (263)
T ss_dssp ECCSSCCSC-CTTC-----------------------C--CSSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB
T ss_pred ECCCCccCC-cCcc-----------------------c--cCcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC
Confidence 777777663 2211 1 14567788888888864 358999999999999999996
Q ss_pred CCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCeeecccCcCCCCC
Q 004732 223 QIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 223 ~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~N~l~~~~ 270 (733)
. + .+..+++|+.|++++|.+.+...-.-+++|+.|++++|++.+.+
T Consensus 143 ~-~-~l~~l~~L~~L~L~~N~i~~~~~l~~l~~L~~L~l~~N~~~~~~ 188 (263)
T 1xeu_A 143 I-V-MLGFLSKLEVLDLHGNEITNTGGLTRLKKVNWIDLTGQKCVNEP 188 (263)
T ss_dssp C-G-GGGGCTTCCEEECTTSCCCBCTTSTTCCCCCEEEEEEEEEECCC
T ss_pred C-h-HHccCCCCCEEECCCCcCcchHHhccCCCCCEEeCCCCcccCCc
Confidence 4 4 68999999999999999997722223788999999999998764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.1e-18 Score=203.56 Aligned_cols=167 Identities=19% Similarity=0.164 Sum_probs=125.8
Q ss_pred eeeeccccccccc---------cCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCc
Q 004732 19 NQKRVLKEQNLTG---------VLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLL 89 (733)
Q Consensus 19 ~~~l~L~~n~l~~---------~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 89 (733)
++.++|+.|+|.+ ..+..|..++.|+.|+|++|.|. .+|..+.++++|++|+|++|.|+ .+|..|+.|+
T Consensus 193 l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~ 270 (727)
T 4b8c_D 193 LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLS 270 (727)
T ss_dssp -----------------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGT
T ss_pred hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCC
Confidence 4555666666554 44778999999999999999999 78888889999999999999999 8999999999
Q ss_pred CCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCC-cCeeec
Q 004732 90 NLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLEN-LTDLRI 168 (733)
Q Consensus 90 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~-L~~L~l 168 (733)
+|+.|+|++|+|+ .+|..|.+|++|++|+|++|.|+ .+|..|+++++|+.|+|++|.|++.+|..+..+.. +..|+|
T Consensus 271 ~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l 348 (727)
T 4b8c_D 271 NLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYL 348 (727)
T ss_dssp TCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHH
T ss_pred CCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhh
Confidence 9999999999999 88999999999999999999998 78988999999999999999999988888766433 235789
Q ss_pred ccccCCCCCccccccccccEEEcccC
Q 004732 169 SDLNGPEATFPQLGNMKMTKLILRNC 194 (733)
Q Consensus 169 ~~n~~~~~~~~~~~~~~L~~L~l~~n 194 (733)
++|.+....+.. |..|+++.|
T Consensus 349 ~~N~l~~~~p~~-----l~~l~l~~n 369 (727)
T 4b8c_D 349 RDNRPEIPLPHE-----RRFIEINTD 369 (727)
T ss_dssp HHCCCCCCCCCC--------------
T ss_pred ccCcccCcCccc-----cceeEeecc
Confidence 999988766653 556777766
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=3.1e-17 Score=158.95 Aligned_cols=130 Identities=19% Similarity=0.295 Sum_probs=103.9
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccch-hccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPK-YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
+.+++++|+++ .+|..+.. +|+.|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 56788888886 56665543 788888888888865554 478888888888888888877788888888888888888
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccC
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP 152 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 152 (733)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|.+.+.
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 888877777788888888888888888887788888888888888888888744
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.70 E-value=2.2e-17 Score=160.10 Aligned_cols=130 Identities=19% Similarity=0.301 Sum_probs=115.8
Q ss_pred CeeeccccccccccchhccCCCCCCEEEcccccccccCCc-cccCCcCCceeeccCccccccCCccccCCCCCCEEEeeC
Q 004732 44 QDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPE-ELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD 122 (733)
Q Consensus 44 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 122 (733)
+.|++++|+|+ .+|..+.. +|++|+|++|++++..+. .|+.+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 11 ~~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 87 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCC
Confidence 78999999997 77876654 899999999999966554 489999999999999999988899999999999999999
Q ss_pred CccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCC
Q 004732 123 NQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEA 176 (733)
Q Consensus 123 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~ 176 (733)
|+|++..+..|.++++|++|+|++|+|++..|..+..+++|+.|++++|.+...
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 141 (192)
T 1w8a_A 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN 141 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred CcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCc
Confidence 999988888899999999999999999998899999999998888888776643
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.69 E-value=8.2e-19 Score=201.08 Aligned_cols=190 Identities=14% Similarity=0.081 Sum_probs=104.1
Q ss_pred CCccccCCcCCceeeccCccccccCC-ccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEcc--------------
Q 004732 81 LPEELGSLLNLEKLHLSSNNFTGELP-KTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQ-------------- 145 (733)
Q Consensus 81 ~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~-------------- 145 (733)
+|..+..+++|++|+|++|.+++... ..+..+++|++|++++|...+.++..+..+++|++|+|+
T Consensus 285 l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~ 364 (592)
T 3ogk_B 285 MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGL 364 (592)
T ss_dssp GGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCCEEEEEGGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCC
T ss_pred HHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCCEEeccCccCHHHHHHHHHhCCCCCEEEeecCccccccccccCc
Confidence 34455667788888888888765433 335566777777776332222233333455555555555
Q ss_pred ----------------------CCCCccCCCCCCCC-cCCcCeeecc----cccCCCCCcc-----ccc-cccccEEEcc
Q 004732 146 ----------------------PSGLAGPIPSGIFS-LENLTDLRIS----DLNGPEATFP-----QLG-NMKMTKLILR 192 (733)
Q Consensus 146 ----------------------~N~l~~~~p~~l~~-l~~L~~L~l~----~n~~~~~~~~-----~~~-~~~L~~L~l~ 192 (733)
.|++++..+..++. +++|+.|+++ .|.++..+.. .+. ..+|+.|+++
T Consensus 365 ~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~ 444 (592)
T 3ogk_B 365 VSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFY 444 (592)
T ss_dssp CCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred cCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEe
Confidence 33333333333332 4445555553 2333322110 011 1245556655
Q ss_pred cCc--cCCCCCcccc-CCCCCcEEEccCCcccCC-CCCCcCCCCCCCEEEecCCcccccCChhh---hcCCCeeecccCc
Q 004732 193 NCN--ITGELPRYLG-KMTKLKVLDLSFNRLRGQ-IPSNFDDLYDVDYIYFAGNLLTGAIPPWM---LERGDKIDLSYNN 265 (733)
Q Consensus 193 ~n~--l~~~~p~~~~-~l~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~p~~~---l~~l~~l~ls~N~ 265 (733)
.|. +++.....+. .+++|+.|+|++|++++. ++..+..+++|+.|++++|.+++.....+ +++|+.|++++|+
T Consensus 445 ~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 445 LRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp CCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred cCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 322 4443333333 367777778877777652 34445667788888888888764433333 5678888888888
Q ss_pred CCCCC
Q 004732 266 FTDGS 270 (733)
Q Consensus 266 l~~~~ 270 (733)
+++..
T Consensus 525 it~~~ 529 (592)
T 3ogk_B 525 ASMTG 529 (592)
T ss_dssp CCTTC
T ss_pred CCHHH
Confidence 76543
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.68 E-value=6.5e-17 Score=153.09 Aligned_cols=134 Identities=23% Similarity=0.196 Sum_probs=92.8
Q ss_pred CCCCeeeccccccc-cccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEE
Q 004732 41 TFLQDISLIANRLK-GPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 119 (733)
Q Consensus 41 ~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 119 (733)
++|+.|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..|..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 66777777777776 56666677777777777777777744 6677777777777777777765666666677777777
Q ss_pred eeCCccccCC-CccccccCCCCEEEccCCCCccCCC---CCCCCcCCcCeeecccccCCCC
Q 004732 120 ISDNQFTGQI-PSFIQNWTKLEKLFIQPSGLAGPIP---SGIFSLENLTDLRISDLNGPEA 176 (733)
Q Consensus 120 l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p---~~l~~l~~L~~L~l~~n~~~~~ 176 (733)
|++|+|++.. +..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+...
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 7777777432 2567777777777777777774433 3666677777777666655443
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.67 E-value=8e-17 Score=152.46 Aligned_cols=138 Identities=22% Similarity=0.192 Sum_probs=123.2
Q ss_pred cceeeeecccccccc-ccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCcee
Q 004732 16 KTVNQKRVLKEQNLT-GVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKL 94 (733)
Q Consensus 16 ~~~~~~l~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 94 (733)
.+.++.|+|++|+++ +.+|..+..+++|++|+|++|.|++. ..|..+++|++|+|++|.+++.+|..+..+++|+.|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 356889999999999 78899999999999999999999966 789999999999999999997788888889999999
Q ss_pred eccCccccccC-CccccCCCCCCEEEeeCCccccCCC---ccccccCCCCEEEccCCCCccCCCCC
Q 004732 95 HLSSNNFTGEL-PKTFAKLTNMKDFRISDNQFTGQIP---SFIQNWTKLEKLFIQPSGLAGPIPSG 156 (733)
Q Consensus 95 ~Ls~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~l~~N~l~~~~p~~ 156 (733)
+|++|+|++.. +..+..+++|+.|++++|.+++..+ ..+..+++|+.|++++|.+. .+|.+
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 99999999532 2789999999999999999996555 48999999999999999997 45543
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.66 E-value=2.8e-16 Score=152.27 Aligned_cols=128 Identities=21% Similarity=0.277 Sum_probs=97.0
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
...+++++|+++ .+|..+. ++|+.|+|++|+|+ .+|..|.++++|++|+|++|.|++..+..|..+++|++|+|++
T Consensus 12 ~~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 12 DTVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 345677788877 5565543 57888888888887 6667788888888888888888866667788888888888888
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCc
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 150 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 150 (733)
|+|++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 8888777777778888888888888888655556777777777777777775
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.66 E-value=5.3e-17 Score=150.37 Aligned_cols=127 Identities=20% Similarity=0.182 Sum_probs=80.4
Q ss_pred CCCCeeeccccccc-cccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEE
Q 004732 41 TFLQDISLIANRLK-GPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 119 (733)
Q Consensus 41 ~~L~~L~L~~n~l~-~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 119 (733)
++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|.+++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 55666666666666 55666666666666666666666643 5566666666666666666655666666666666666
Q ss_pred eeCCccccC-CCccccccCCCCEEEccCCCCccCCC---CCCCCcCCcCeeecc
Q 004732 120 ISDNQFTGQ-IPSFIQNWTKLEKLFIQPSGLAGPIP---SGIFSLENLTDLRIS 169 (733)
Q Consensus 120 l~~N~l~~~-~~~~~~~l~~L~~L~l~~N~l~~~~p---~~l~~l~~L~~L~l~ 169 (733)
+++|++++. .+..++.+++|+.|++++|++++..+ ..+..+++|+.|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 666666642 23556666666666666666664433 355566666666654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.65 E-value=5.9e-16 Score=149.94 Aligned_cols=127 Identities=20% Similarity=0.254 Sum_probs=107.8
Q ss_pred CeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCC
Q 004732 44 QDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 123 (733)
Q Consensus 44 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 123 (733)
+.+++++|.|+ .+|..+. ++|++|+|++|.|+ .+|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 67899999998 6776554 68999999999998 78888999999999999999999877888999999999999999
Q ss_pred ccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCC
Q 004732 124 QFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGP 174 (733)
Q Consensus 124 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~ 174 (733)
+|++..+..|..+++|+.|+|++|+|+...+..|..+++|+.|++++|.+.
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~ 139 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLY 139 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEE
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCee
Confidence 999888888999999999999999998655566777888887777766543
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.65 E-value=2.8e-17 Score=173.59 Aligned_cols=137 Identities=12% Similarity=0.149 Sum_probs=99.6
Q ss_pred CccccCcccCCCcccEEEcccCCCcEEEEEEccccCh--------------hcHHH--------HHHHHHHHHhCCCCce
Q 004732 394 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK--------------QGNRE--------FINEIGMISALQHPNL 451 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~~~--------~~~E~~~l~~l~h~ni 451 (733)
-|.+.+.||+|+||.||+|...+|+.||||+++.... ..... ..+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3888999999999999999988999999998753200 00111 2346666777654443
Q ss_pred eeEeeEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCC
Q 004732 452 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLN 531 (733)
Q Consensus 452 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 531 (733)
.-..-+... ..++||||++|++|.++. .......++.|++.+|.|||+.| ||||||||.|||+++++.
T Consensus 176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 176 PVPEPIAQS--RHTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD 243 (397)
T ss_dssp SCCCEEEEE--TTEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred CCCeeeecc--CceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence 211111111 237999999998886542 22345678899999999999987 999999999999988763
Q ss_pred ----------eEEcccCcccc
Q 004732 532 ----------SKISDFGLAKL 542 (733)
Q Consensus 532 ----------~kl~DfGla~~ 542 (733)
+.|+||+-+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 89999998763
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1.6e-16 Score=147.20 Aligned_cols=129 Identities=22% Similarity=0.190 Sum_probs=117.1
Q ss_pred cceeeeecccccccc-ccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCcee
Q 004732 16 KTVNQKRVLKEQNLT-GVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKL 94 (733)
Q Consensus 16 ~~~~~~l~L~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 94 (733)
.+.++.|++++|+++ +.+|..+..+++|+.|+|++|.+++. ..++++++|++|+|++|.+++.+|..+..+++|++|
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L 93 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL 93 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence 356889999999999 88999999999999999999999966 789999999999999999997788888889999999
Q ss_pred eccCcccccc-CCccccCCCCCCEEEeeCCccccCCC---ccccccCCCCEEEccC
Q 004732 95 HLSSNNFTGE-LPKTFAKLTNMKDFRISDNQFTGQIP---SFIQNWTKLEKLFIQP 146 (733)
Q Consensus 95 ~Ls~N~l~~~-~p~~~~~l~~L~~L~l~~N~l~~~~~---~~~~~l~~L~~L~l~~ 146 (733)
+|++|.+++. .+..+..+++|++|++++|++++..+ ..+..+++|+.|++++
T Consensus 94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 9999999963 34889999999999999999997666 5899999999999864
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.64 E-value=1.3e-17 Score=191.06 Aligned_cols=130 Identities=13% Similarity=0.134 Sum_probs=55.3
Q ss_pred CCCCCCeeeccccccccccchhccCC--CCCCEEEccccc-ccc-cCCccccCCcCCceeeccCcccccc----CCcccc
Q 004732 39 ELTFLQDISLIANRLKGPIPKYLANI--STLVNLTVQYNQ-FSG-ELPEELGSLLNLEKLHLSSNNFTGE----LPKTFA 110 (733)
Q Consensus 39 ~l~~L~~L~L~~n~l~~~~p~~l~~l--~~L~~L~L~~N~-l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~ 110 (733)
.+++|++|+|++|.+++..+..+..+ .+|++|+|++|. ++. .++.....+++|++|+|++|.+++. ++..+.
T Consensus 110 ~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~ 189 (592)
T 3ogk_B 110 NLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQ 189 (592)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHHGGGCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHH
T ss_pred hCCCCCeEEeeccEecHHHHHHHHHhccccCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHh
Confidence 34455555555555444444444332 225555554443 110 1111122444555555555544433 222233
Q ss_pred CCCCCCEEEeeCCccc----cCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecc
Q 004732 111 KLTNMKDFRISDNQFT----GQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRIS 169 (733)
Q Consensus 111 ~l~~L~~L~l~~N~l~----~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~ 169 (733)
.+++|++|++++|.++ +.++..+.++++|+.|++++|.+.+ ++..+..+++|+.|+++
T Consensus 190 ~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~ 251 (592)
T 3ogk_B 190 HNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGG 251 (592)
T ss_dssp HCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEEC
T ss_pred cCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHH-HHHHHhhhhHHHhhccc
Confidence 4445555555555544 1222333444555555555554442 33444444444444444
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.63 E-value=1e-15 Score=146.24 Aligned_cols=131 Identities=19% Similarity=0.282 Sum_probs=97.3
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
.+.+++++|+++. +|..+. ++|+.|+|++|++++..+..|.++++|++|+|++|.+++..+..|..+++|+.|+|++
T Consensus 9 ~~~l~~~~~~l~~-~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLTS-VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCSS-CCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCcc-CCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 3556777777773 444333 6788888888888866666678888888888888888865556677888888888888
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccC
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGP 152 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 152 (733)
|+|++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|.+.+.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 888866666677788888888888888865555667788888888888877643
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.61 E-value=3.7e-15 Score=142.25 Aligned_cols=130 Identities=18% Similarity=0.201 Sum_probs=105.4
Q ss_pred CCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeC
Q 004732 43 LQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD 122 (733)
Q Consensus 43 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~ 122 (733)
.+.+++++|+++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 9 ~~~l~~~~~~l~-~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 9 GTEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TTEEECCSSCCS-SCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEecCCCCc-cCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 578899999998 5665443 6899999999999966666788999999999999999966667788899999999999
Q ss_pred CccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCC
Q 004732 123 NQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPE 175 (733)
Q Consensus 123 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~ 175 (733)
|+|++..+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|.+..
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~ 138 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 138 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeec
Confidence 99997777778889999999999999986555556777777777776665543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.60 E-value=1.2e-17 Score=162.87 Aligned_cols=151 Identities=23% Similarity=0.323 Sum_probs=130.6
Q ss_pred eecccceeeeeccccccccccCCc------cccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccc
Q 004732 12 FWKQKTVNQKRVLKEQNLTGVLPP------KLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEEL 85 (733)
Q Consensus 12 ~~~~~~~~~~l~L~~n~l~~~~p~------~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~ 85 (733)
.|........++|+.+++++.+|. .|..+++|++|+|++|.|++ +| .+.++++|++|+|++|.++ .+|..+
T Consensus 13 ~~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~ 89 (198)
T 1ds9_A 13 IFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLD 89 (198)
T ss_dssp HHHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHH
T ss_pred HHHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchh
Confidence 466667778889999999999887 89999999999999999996 66 8999999999999999999 788888
Q ss_pred cCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCC-ccccccCCCCEEEccCCCCccCCCCC--------
Q 004732 86 GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP-SFIQNWTKLEKLFIQPSGLAGPIPSG-------- 156 (733)
Q Consensus 86 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~-------- 156 (733)
..+++|+.|+|++|+|++ +| .+..+++|++|+|++|+|++..+ ..+..+++|+.|++++|.+.+..|..
T Consensus 90 ~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~ 167 (198)
T 1ds9_A 90 AVADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRI 167 (198)
T ss_dssp HHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHH
T ss_pred hcCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHH
Confidence 888999999999999995 55 68889999999999999985332 47889999999999999998776653
Q ss_pred --CCCcCCcCeee
Q 004732 157 --IFSLENLTDLR 167 (733)
Q Consensus 157 --l~~l~~L~~L~ 167 (733)
+..+++|+.|+
T Consensus 168 ~~~~~l~~L~~Ld 180 (198)
T 1ds9_A 168 EVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHHCSSCSEEC
T ss_pred HHHHhCCCcEEEC
Confidence 67788888776
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.59 E-value=2.3e-15 Score=158.98 Aligned_cols=88 Identities=13% Similarity=-0.004 Sum_probs=51.1
Q ss_pred cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCC-EEEecCCcccccCChhh--hcCCCeeec
Q 004732 185 KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVD-YIYFAGNLLTGAIPPWM--LERGDKIDL 261 (733)
Q Consensus 185 ~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~-~L~l~~N~l~~~~p~~~--l~~l~~l~l 261 (733)
+|+.|+|++|+++...+..|.++.+|+.|+|.+| ++...+.+|.++.+|+ .+++.+ .++..-+..+ ..+|+.+++
T Consensus 227 ~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l 304 (329)
T 3sb4_A 227 NLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLA 304 (329)
T ss_dssp TCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEE
T ss_pred CCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEe
Confidence 5666666666666555556666666666666666 5545555666666666 666665 4443333333 455666666
Q ss_pred ccCcCCCCCCccc
Q 004732 262 SYNNFTDGSAESS 274 (733)
Q Consensus 262 s~N~l~~~~~~~~ 274 (733)
++|+++......+
T Consensus 305 ~~n~i~~I~~~aF 317 (329)
T 3sb4_A 305 TGDKITTLGDELF 317 (329)
T ss_dssp CSSCCCEECTTTT
T ss_pred CCCccCccchhhh
Confidence 6666654444333
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.58 E-value=4.5e-15 Score=156.75 Aligned_cols=214 Identities=10% Similarity=-0.009 Sum_probs=125.4
Q ss_pred cceeeeecccccccc--ccCCccccCCCCCCeeeccccccccccchhccC--------CCCCCEEEcccccccccCCccc
Q 004732 16 KTVNQKRVLKEQNLT--GVLPPKLAELTFLQDISLIANRLKGPIPKYLAN--------ISTLVNLTVQYNQFSGELPEEL 85 (733)
Q Consensus 16 ~~~~~~l~L~~n~l~--~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~--------l~~L~~L~L~~N~l~~~~p~~~ 85 (733)
.+.++.|+|++|+|. ......+ +.++.+.+..|.|. ...|.+ +++|+.|+|.+ .++.+-+.+|
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~~~~---~~~~~~~~~~~~I~---~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~I~~~aF 120 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKAGTY---PNGKFYIYMANFVP---AYAFSNVVNGVTKGKQTLEKVILSE-KIKNIEDAAF 120 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESSSSS---GGGCCEEECTTEEC---TTTTEEEETTEEEECTTCCC-CBCT-TCCEECTTTT
T ss_pred hccCeEEecCcceeEEecCccccc---cccccccccccccC---HHHhcccccccccccCCCcEEECCc-cccchhHHHh
Confidence 455888999999988 3222222 22344444444332 344555 67777777766 6664555567
Q ss_pred cCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCcc----ccCCCcccc---------------------------
Q 004732 86 GSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQF----TGQIPSFIQ--------------------------- 134 (733)
Q Consensus 86 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l----~~~~~~~~~--------------------------- 134 (733)
.+|++|+.|+|++|.++...+..|.++.++..+.+..+.. .......|.
T Consensus 121 ~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~~ 200 (329)
T 3sb4_A 121 KGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGLQ 200 (329)
T ss_dssp TTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTCC
T ss_pred hcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhcccC
Confidence 7777777777777766655556666655555554443221 000111111
Q ss_pred -----------------------ccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccc-ccc-EE
Q 004732 135 -----------------------NWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMT-KL 189 (733)
Q Consensus 135 -----------------------~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~-~L 189 (733)
.+++|+.|+|++|+++...+.+|.++.+|+.|++.+| +..+....|.++ +|+ .+
T Consensus 201 ~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l 279 (329)
T 3sb4_A 201 PRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTL 279 (329)
T ss_dssp GGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEE
T ss_pred ccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEE
Confidence 2566777777766666544556666667777776665 555555555555 466 66
Q ss_pred EcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEE
Q 004732 190 ILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 238 (733)
Q Consensus 190 ~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 238 (733)
++.+ .++...+.+|.++++|+.|++++|+++...+..|.++++|+.++
T Consensus 280 ~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 280 ELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhc
Confidence 6666 55555556666666777777666666655556666666666665
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.58 E-value=2.2e-15 Score=143.71 Aligned_cols=132 Identities=11% Similarity=0.142 Sum_probs=86.4
Q ss_pred cccCCCCCCeeeccccccccccchhccCCC-CCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCC
Q 004732 36 KLAELTFLQDISLIANRLKGPIPKYLANIS-TLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTN 114 (733)
Q Consensus 36 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 114 (733)
.+..+.+|+.|+|++|+++ .++. +..+. +|++|+|++|.+++. ..|..+++|++|+|++|+|++..+..+..+++
T Consensus 14 ~~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 89 (176)
T 1a9n_A 14 QYTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 89 (176)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred hcCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCC
Confidence 4556667777777777777 3343 44444 777777777777743 56777777777777777777444444567777
Q ss_pred CCEEEeeCCccccCCCc--cccccCCCCEEEccCCCCccCCCCC----CCCcCCcCeeecccccC
Q 004732 115 MKDFRISDNQFTGQIPS--FIQNWTKLEKLFIQPSGLAGPIPSG----IFSLENLTDLRISDLNG 173 (733)
Q Consensus 115 L~~L~l~~N~l~~~~~~--~~~~l~~L~~L~l~~N~l~~~~p~~----l~~l~~L~~L~l~~n~~ 173 (733)
|++|+|++|+|+ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|+.|++++|..
T Consensus 90 L~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~ 152 (176)
T 1a9n_A 90 LTELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL 152 (176)
T ss_dssp CCEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred CCEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence 777777777775 4554 6667777777777777776 44543 66666666666666543
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.56 E-value=5.5e-17 Score=158.10 Aligned_cols=109 Identities=20% Similarity=0.282 Sum_probs=59.8
Q ss_pred ccCCCCCCeeeccccccccccch------hccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCcccc
Q 004732 37 LAELTFLQDISLIANRLKGPIPK------YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFA 110 (733)
Q Consensus 37 l~~l~~L~~L~L~~n~l~~~~p~------~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 110 (733)
+.....++.++++.|.++|..|. .|..+++|++|+|++|.+++ +| .+..+++|+.|+|++|.|+ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 34445666666666666665554 55566666666666666653 44 5555556666666666555 4555555
Q ss_pred CCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCc
Q 004732 111 KLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 150 (733)
Q Consensus 111 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 150 (733)
.+++|++|+|++|+|++ +| .+..+++|+.|+|++|+++
T Consensus 91 ~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~ 128 (198)
T 1ds9_A 91 VADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKIT 128 (198)
T ss_dssp HHHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECC
T ss_pred cCCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCC
Confidence 55555555555555553 22 3444444444444444443
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.56 E-value=3.6e-15 Score=142.23 Aligned_cols=132 Identities=18% Similarity=0.192 Sum_probs=114.8
Q ss_pred ecccceeeeeccccccccccCCccccCCC-CCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCC
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELT-FLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNL 91 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 91 (733)
+.+...++.|+|++|+++.. |. +..+. +|+.|+|++|.|++. ..|..+++|++|+|++|.|++..+..|..+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 45567789999999999954 54 55555 999999999999965 679999999999999999996544556999999
Q ss_pred ceeeccCccccccCCc--cccCCCCCCEEEeeCCccccCCCcc----ccccCCCCEEEccCCCCc
Q 004732 92 EKLHLSSNNFTGELPK--TFAKLTNMKDFRISDNQFTGQIPSF----IQNWTKLEKLFIQPSGLA 150 (733)
Q Consensus 92 ~~L~Ls~N~l~~~~p~--~~~~l~~L~~L~l~~N~l~~~~~~~----~~~l~~L~~L~l~~N~l~ 150 (733)
++|+|++|+|+ .+|. .+..+++|+.|++++|.++ .+|.. +..+++|+.|++++|.+.
T Consensus 91 ~~L~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CEEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CEEECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 99999999997 6776 8999999999999999999 56764 899999999999999876
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.52 E-value=2.3e-16 Score=180.78 Aligned_cols=249 Identities=14% Similarity=0.064 Sum_probs=123.0
Q ss_pred ccceeeeecccccc--ccc-cCCccccCCCCCCeeecccc-ccccccchhccCCCCCCEEEccccc--------------
Q 004732 15 QKTVNQKRVLKEQN--LTG-VLPPKLAELTFLQDISLIAN-RLKGPIPKYLANISTLVNLTVQYNQ-------------- 76 (733)
Q Consensus 15 ~~~~~~~l~L~~n~--l~~-~~p~~l~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L~~L~L~~N~-------------- 76 (733)
..+.++.|+|++|+ ++. .++..+..+++|++|+|++| .+++ ++..+.++++|+.|+++.+.
T Consensus 182 ~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~ 260 (594)
T 2p1m_B 182 TYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVA 260 (594)
T ss_dssp TCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHH
T ss_pred cCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHH
Confidence 45578888888886 221 11222344688888888888 4443 66666666777777644331
Q ss_pred ------------cc----ccCCccccCCcCCceeeccCccccccCC-ccccCCCCCCEEEeeCCcccc-CCCccccccCC
Q 004732 77 ------------FS----GELPEELGSLLNLEKLHLSSNNFTGELP-KTFAKLTNMKDFRISDNQFTG-QIPSFIQNWTK 138 (733)
Q Consensus 77 ------------l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~l~~ 138 (733)
+. +.++..+..+++|+.|+|++|.+++... ..+..+++|+.|++++| ++. .++.....+++
T Consensus 261 l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~ 339 (594)
T 2p1m_B 261 LSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKD 339 (594)
T ss_dssp HHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTT
T ss_pred HhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCC
Confidence 11 1223333356778888888877664332 22456777777777777 332 12222334666
Q ss_pred CCEEEcc---------CCCCccCCCCCCC-CcCCcCeeecccccCCCCCccccc--cccccEEEcc--c----CccCCCC
Q 004732 139 LEKLFIQ---------PSGLAGPIPSGIF-SLENLTDLRISDLNGPEATFPQLG--NMKMTKLILR--N----CNITGEL 200 (733)
Q Consensus 139 L~~L~l~---------~N~l~~~~p~~l~-~l~~L~~L~l~~n~~~~~~~~~~~--~~~L~~L~l~--~----n~l~~~~ 200 (733)
|+.|++. .|.+++.....+. .+++|+.|.++.|.++......+. ..+|+.|+++ + |.++...
T Consensus 340 L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~ 419 (594)
T 2p1m_B 340 LRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEP 419 (594)
T ss_dssp CCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCC
T ss_pred CCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCc
Confidence 6666662 2334322211222 245555555555555443333222 1245555555 2 3333111
Q ss_pred -----CccccCCCCCcEEEccCCcccCCCCCCcCC-CCCCCEEEecCCcccccCChhh---hcCCCeeecccCcC
Q 004732 201 -----PRYLGKMTKLKVLDLSFNRLRGQIPSNFDD-LYDVDYIYFAGNLLTGAIPPWM---LERGDKIDLSYNNF 266 (733)
Q Consensus 201 -----p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-l~~L~~L~l~~N~l~~~~p~~~---l~~l~~l~ls~N~l 266 (733)
+..+..+++|+.|+|++ .+++..+..+.. +++|+.|++++|.+++..+..+ +++|+.|++++|++
T Consensus 420 ~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~ 493 (594)
T 2p1m_B 420 LDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF 493 (594)
T ss_dssp THHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred hhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence 11133444555555544 333332222322 4445555555554433322222 34445555555544
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.50 E-value=2.7e-13 Score=146.42 Aligned_cols=239 Identities=11% Similarity=0.055 Sum_probs=164.7
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
+..+.+.. +++.+-..+|.+. +|+.+.|.+| ++.+...+|.+ .+|+.+.|.+ .++.+-+.+|.++.+|+.++|++
T Consensus 115 l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~ 189 (401)
T 4fdw_A 115 YNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSK 189 (401)
T ss_dssp CSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTT
T ss_pred ccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCC
Confidence 44445543 5666666677764 6888888766 66566667777 4688888875 66656667788888888888888
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCc
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATF 178 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~ 178 (733)
|+++......|. .++|+.+.|.+| ++......|.++++|+.+.|..| ++..-..+|.+ .+|+.+.+. +++..+..
T Consensus 190 n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~lp-~~i~~I~~ 264 (401)
T 4fdw_A 190 TKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKLP-NGVTNIAS 264 (401)
T ss_dssp SCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEEE-TTCCEECT
T ss_pred CcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEeC-CCccEECh
Confidence 888844444454 578888888744 66556677888888888888764 55344555655 778888883 45666666
Q ss_pred cccccc-cccEEEcccCccC-----CCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh
Q 004732 179 PQLGNM-KMTKLILRNCNIT-----GELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM 252 (733)
Q Consensus 179 ~~~~~~-~L~~L~l~~n~l~-----~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 252 (733)
..|..+ +|+.+.+.+|.+. ...+..|.++++|+.++|. |.++......|.+|.+|+.+.+..| +...-+..+
T Consensus 265 ~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF 342 (401)
T 4fdw_A 265 RAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAF 342 (401)
T ss_dssp TTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSS
T ss_pred hHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhC
Confidence 666665 7888888777665 3556678888888888888 4477666677888888888888655 442333333
Q ss_pred --hcCCCeeecccCcCCCCC
Q 004732 253 --LERGDKIDLSYNNFTDGS 270 (733)
Q Consensus 253 --l~~l~~l~ls~N~l~~~~ 270 (733)
. +|+.+++.+|.+....
T Consensus 343 ~~~-~L~~l~l~~n~~~~l~ 361 (401)
T 4fdw_A 343 NNT-GIKEVKVEGTTPPQVF 361 (401)
T ss_dssp SSS-CCCEEEECCSSCCBCC
T ss_pred CCC-CCCEEEEcCCCCcccc
Confidence 3 6788888887765443
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.50 E-value=1.3e-15 Score=174.48 Aligned_cols=159 Identities=11% Similarity=0.157 Sum_probs=112.3
Q ss_pred ccCCCCCCEEEeeCCccccCC-CccccccCCCCEEEccCCCCccCCCCC-CCCcCCcCeeeccc---------ccCCCCC
Q 004732 109 FAKLTNMKDFRISDNQFTGQI-PSFIQNWTKLEKLFIQPSGLAGPIPSG-IFSLENLTDLRISD---------LNGPEAT 177 (733)
Q Consensus 109 ~~~l~~L~~L~l~~N~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~~-l~~l~~L~~L~l~~---------n~~~~~~ 177 (733)
+..+++|+.|+|++|.+++.. ...+.++++|+.|++++| +....... ...+++|+.|++++ +.++...
T Consensus 285 ~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~ 363 (594)
T 2p1m_B 285 YSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQG 363 (594)
T ss_dssp HHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHH
T ss_pred HHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHH
Confidence 346789999999999977543 334668999999999998 54322222 23478999999944 3343333
Q ss_pred ccccc--cccccEEEcccCccCCCCCcccc-CCCCCcEEEcc--C----CcccCCC-----CCCcCCCCCCCEEEecCCc
Q 004732 178 FPQLG--NMKMTKLILRNCNITGELPRYLG-KMTKLKVLDLS--F----NRLRGQI-----PSNFDDLYDVDYIYFAGNL 243 (733)
Q Consensus 178 ~~~~~--~~~L~~L~l~~n~l~~~~p~~~~-~l~~L~~L~ls--~----N~l~~~~-----p~~~~~l~~L~~L~l~~N~ 243 (733)
...+. ..+|+.|.+..|.+++.....+. .+++|+.|+|+ + |.+++.. +..+..+++|+.|++++ .
T Consensus 364 l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~ 442 (594)
T 2p1m_B 364 LVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-L 442 (594)
T ss_dssp HHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-S
T ss_pred HHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-c
Confidence 22222 34799999999999877666665 58999999999 4 5565221 12256789999999987 6
Q ss_pred ccccCChhh---hcCCCeeecccCcCCCC
Q 004732 244 LTGAIPPWM---LERGDKIDLSYNNFTDG 269 (733)
Q Consensus 244 l~~~~p~~~---l~~l~~l~ls~N~l~~~ 269 (733)
+++..+..+ +++|+.|++++|.+++.
T Consensus 443 l~~~~~~~l~~~~~~L~~L~L~~~~i~~~ 471 (594)
T 2p1m_B 443 LTDKVFEYIGTYAKKMEMLSVAFAGDSDL 471 (594)
T ss_dssp CCHHHHHHHHHHCTTCCEEEEESCCSSHH
T ss_pred ccHHHHHHHHHhchhccEeeccCCCCcHH
Confidence 665544444 67899999999998653
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.49 E-value=3.8e-13 Score=145.30 Aligned_cols=242 Identities=13% Similarity=0.116 Sum_probs=187.8
Q ss_pred eecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCC
Q 004732 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNL 91 (733)
Q Consensus 12 ~~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 91 (733)
.|.++ .++.+.|..+ ++.+-..+|.+ .+|+.+.|.+ .++.+-...|.++++|+.++|++|+++.+...+|. +.+|
T Consensus 131 aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L 205 (401)
T 4fdw_A 131 AFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGI 205 (401)
T ss_dssp TTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCC
T ss_pred hcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcceEechhhEe-eccc
Confidence 34443 5777888765 88777778888 4799999986 77767778899999999999999999954445565 6899
Q ss_pred ceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccc
Q 004732 92 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDL 171 (733)
Q Consensus 92 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n 171 (733)
+.+.|.+| ++.....+|.++++|+.+++.+| ++..-...|.+ .+|+.+.| .|.++.....+|.++++|+.+++.+|
T Consensus 206 ~~l~lp~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~ 281 (401)
T 4fdw_A 206 EEVLLPVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGS 281 (401)
T ss_dssp SEEECCTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESS
T ss_pred CEEEeCCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCc
Confidence 99999855 77677788999999999999875 56455677777 78999999 56677566788999999999999887
Q ss_pred cCC-----CCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCccc
Q 004732 172 NGP-----EATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLT 245 (733)
Q Consensus 172 ~~~-----~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 245 (733)
.+. .+....|..+ +|+.+.|. +.++.....+|.++++|+.|+|..| ++......|.++ +|+.|++.+|.+.
T Consensus 282 ~~~~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~ 358 (401)
T 4fdw_A 282 TFNDDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPP 358 (401)
T ss_dssp CCCCCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCC
T ss_pred cccCCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCc
Confidence 765 3455556655 89999999 4587777888999999999999655 776777899999 9999999999876
Q ss_pred ccCChhh---hcCCCeeecccCc
Q 004732 246 GAIPPWM---LERGDKIDLSYNN 265 (733)
Q Consensus 246 ~~~p~~~---l~~l~~l~ls~N~ 265 (733)
...+..+ ...+..|.+..+.
T Consensus 359 ~l~~~~F~~~~~~l~~l~vp~~~ 381 (401)
T 4fdw_A 359 QVFEKVWYGFPDDITVIRVPAES 381 (401)
T ss_dssp BCCCSSCCCSCTTCCEEEECGGG
T ss_pred ccccccccCCCCCccEEEeCHHH
Confidence 4333333 2345667666554
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.49 E-value=7e-14 Score=132.35 Aligned_cols=104 Identities=18% Similarity=0.269 Sum_probs=45.6
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCc
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 99 (733)
+.+++++|+++. +|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|
T Consensus 12 ~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N 88 (170)
T 3g39_A 12 TTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLNDN 88 (170)
T ss_dssp TEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCCC
Confidence 344455554442 333332 44444444444444444444444444444444444444333333444444444444444
Q ss_pred cccccCCccccCCCCCCEEEeeCCccc
Q 004732 100 NFTGELPKTFAKLTNMKDFRISDNQFT 126 (733)
Q Consensus 100 ~l~~~~p~~~~~l~~L~~L~l~~N~l~ 126 (733)
+|++..+..|..+++|++|+|++|.++
T Consensus 89 ~l~~~~~~~~~~l~~L~~L~L~~N~~~ 115 (170)
T 3g39_A 89 QLKSIPRGAFDNLKSLTHIWLLNNPWD 115 (170)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred ccCEeCHHHhcCCCCCCEEEeCCCCCC
Confidence 444333333444444444444444443
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.48 E-value=8.8e-14 Score=131.65 Aligned_cols=107 Identities=21% Similarity=0.253 Sum_probs=97.7
Q ss_pred CCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEee
Q 004732 42 FLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 121 (733)
Q Consensus 42 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 121 (733)
..+.|++++|.|+ .+|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|.++++|++|+|+
T Consensus 10 ~~~~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 10 SGTTVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp ETTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 3578999999999 6776664 899999999999998888999999999999999999997777778999999999999
Q ss_pred CCccccCCCccccccCCCCEEEccCCCCcc
Q 004732 122 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 151 (733)
Q Consensus 122 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 151 (733)
+|+|++..+..|.++++|+.|+|++|.+..
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 999998777789999999999999999984
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.47 E-value=1.1e-13 Score=131.38 Aligned_cols=103 Identities=21% Similarity=0.309 Sum_probs=46.6
Q ss_pred eeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCc
Q 004732 45 DISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 124 (733)
Q Consensus 45 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 124 (733)
.|++++|+|+ .+|..+. ++|++|+|++|+|++..|..|+.+++|++|+|++|+|++..+..|.++++|++|+|++|+
T Consensus 16 ~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~ 92 (174)
T 2r9u_A 16 LVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNH 92 (174)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCc
Confidence 4444444443 3333332 444444444444444444444444444444444444443333334444445555555554
Q ss_pred cccCCCccccccCCCCEEEccCCCCc
Q 004732 125 FTGQIPSFIQNWTKLEKLFIQPSGLA 150 (733)
Q Consensus 125 l~~~~~~~~~~l~~L~~L~l~~N~l~ 150 (733)
|++..+..|..+++|+.|+|++|.+.
T Consensus 93 l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 93 LKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp CCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred cceeCHHHhccccCCCEEEeCCCCcc
Confidence 44333333444444555555544444
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.46 E-value=1.5e-13 Score=130.62 Aligned_cols=106 Identities=17% Similarity=0.227 Sum_probs=95.2
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
...+++++|+++ .+|..+. ++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 467889999997 6777665 8999999999999988899999999999999999999976566689999999999999
Q ss_pred ccccccCCccccCCCCCCEEEeeCCcccc
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFTG 127 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 127 (733)
|+|++..+..|..+++|+.|+|++|.|..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccc
Confidence 99996666679999999999999999984
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.4e-14 Score=153.16 Aligned_cols=182 Identities=19% Similarity=0.220 Sum_probs=92.1
Q ss_pred CCCCeeeccccccccccchhccCC-----CCCCEEEcccccccccCCccc-cCCcCCceeeccCccccccCCcccc----
Q 004732 41 TFLQDISLIANRLKGPIPKYLANI-----STLVNLTVQYNQFSGELPEEL-GSLLNLEKLHLSSNNFTGELPKTFA---- 110 (733)
Q Consensus 41 ~~L~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~~p~~~~---- 110 (733)
++|+.|+|++|.|+......|..+ ++|++|+|++|.++......+ ..+++|+.|+|++|.|+......++
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 455666666666654333333222 456666666666543222222 2344566666666666543333331
Q ss_pred -CCCCCCEEEeeCCccccC----CCccccccCCCCEEEccCCCCccC----CCCCCCCcCCcCeeecccccCCCCCcccc
Q 004732 111 -KLTNMKDFRISDNQFTGQ----IPSFIQNWTKLEKLFIQPSGLAGP----IPSGIFSLENLTDLRISDLNGPEATFPQL 181 (733)
Q Consensus 111 -~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p~~l~~l~~L~~L~l~~n~~~~~~~~~~ 181 (733)
..++|++|+|++|.|+.. ++..+..+++|++|+|++|+|+.. ++..+...+
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~-------------------- 211 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNR-------------------- 211 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCS--------------------
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCC--------------------
Confidence 245566666666665431 223334455555566655555421 122222223
Q ss_pred ccccccEEEcccCccCCC----CCccccCCCCCcEEEccCCcccCCCCCCcCCCC-----CCCEEE--ecCCccc
Q 004732 182 GNMKMTKLILRNCNITGE----LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLY-----DVDYIY--FAGNLLT 245 (733)
Q Consensus 182 ~~~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~-----~L~~L~--l~~N~l~ 245 (733)
+|+.|+|++|.|+.. ++..+...++|++|||++|.|+......+..+. .|+.+. +..|.+.
T Consensus 212 ---~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~~~~~~~~~~L~~l~~ll~~~~~~ 283 (372)
T 3un9_A 212 ---QLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGTAVS 283 (372)
T ss_dssp ---CCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHHHCC------CEEECCCC----CH
T ss_pred ---CcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHHHHhcCCCccchhhHhhhcCCccC
Confidence 466666666766642 334455668888888888888765444443332 155665 5556554
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.31 E-value=3.4e-12 Score=135.64 Aligned_cols=103 Identities=20% Similarity=0.198 Sum_probs=68.5
Q ss_pred eeccccc-cccccCCccccCCCCCCeeeccc-cccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 21 KRVLKEQ-NLTGVLPPKLAELTFLQDISLIA-NRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 21 ~l~L~~n-~l~~~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
.++++++ +|++ +|. |..+++|+.|+|++ |+|++..+..|++|++|++|+|++|+|++..|..|.+|++|+.|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 4556665 6663 555 77777777777774 777766666677777777777777777766666677777777777777
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccc
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFT 126 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 126 (733)
|+|++..+..|..++ |+.|+|.+|.|.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 777744444454444 777777777666
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.30 E-value=9.3e-12 Score=126.63 Aligned_cols=144 Identities=15% Similarity=0.102 Sum_probs=113.0
Q ss_pred hhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e 469 (733)
....|.....++.|+.+.||++... ++.+++|............+.+|+++++.+. |..+.++++++.+.+..++|||
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 3456777788898999999999754 6889999986432122346889999999985 6677889999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC----------------------------------------
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE---------------------------------------- 509 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------------- 509 (733)
|++|.+|.+.+. +......++.+++++|+.||+.
T Consensus 91 ~i~G~~l~~~~~------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 91 EADGVLCSEEYE------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp CCSSEEHHHHCC------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred ecCCeehhhccC------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 999999987531 1233457889999999999981
Q ss_pred ----------------CCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 510 ----------------SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 510 ----------------~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
.+..++|+|++|.||+++++..+.|+||+.+.
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 11348999999999999876556799999775
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.29 E-value=4.6e-12 Score=134.61 Aligned_cols=105 Identities=15% Similarity=0.201 Sum_probs=95.4
Q ss_pred Ceeecccc-ccccccchhccCCCCCCEEEccc-ccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEee
Q 004732 44 QDISLIAN-RLKGPIPKYLANISTLVNLTVQY-NQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 121 (733)
Q Consensus 44 ~~L~L~~n-~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 121 (733)
..++++++ +|+ .+|. |..+++|++|+|++ |.|++..+..|+.|++|+.|+|++|+|++..|..|.++++|+.|+|+
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~ 88 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CEEEcCCCCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence 45789998 899 5888 99999999999996 99998777899999999999999999999999999999999999999
Q ss_pred CCccccCCCccccccCCCCEEEccCCCCcc
Q 004732 122 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAG 151 (733)
Q Consensus 122 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~ 151 (733)
+|+|++..+..|..++ |+.|+|.+|.|..
T Consensus 89 ~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 89 FNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp SSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 9999976667777666 9999999999983
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.28 E-value=3.4e-14 Score=151.98 Aligned_cols=159 Identities=16% Similarity=0.151 Sum_probs=118.5
Q ss_pred ceeeeeccccccccccCCccccCC-----CCCCeeeccccccccccchhcc-CCCCCCEEEcccccccccCCccc-----
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAEL-----TFLQDISLIANRLKGPIPKYLA-NISTLVNLTVQYNQFSGELPEEL----- 85 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l-----~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~N~l~~~~p~~~----- 85 (733)
..++.++|++|+|+......|..+ ++|+.|+|++|.|+......+. .+++|++|+|++|.|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~ 151 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLL 151 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHH
Confidence 457889999999987544444443 7999999999999865444443 46789999999999985544444
Q ss_pred cCCcCCceeeccCccccc----cCCccccCCCCCCEEEeeCCccccC----CCccccccCCCCEEEccCCCCccC----C
Q 004732 86 GSLLNLEKLHLSSNNFTG----ELPKTFAKLTNMKDFRISDNQFTGQ----IPSFIQNWTKLEKLFIQPSGLAGP----I 153 (733)
Q Consensus 86 ~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~ 153 (733)
...++|++|+|++|.|+. .++..+..+++|++|+|++|+|+.. ++..+...++|+.|+|++|.|+.. +
T Consensus 152 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l 231 (372)
T 3un9_A 152 HDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALAL 231 (372)
T ss_dssp STTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHH
T ss_pred hcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHH
Confidence 346789999999999975 3455567899999999999999853 356677889999999999999853 2
Q ss_pred CCCCCCcCCcCeeecccccCCC
Q 004732 154 PSGIFSLENLTDLRISDLNGPE 175 (733)
Q Consensus 154 p~~l~~l~~L~~L~l~~n~~~~ 175 (733)
+..+...++|+.|+|++|.+..
T Consensus 232 ~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 232 ARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp HHHHHHCSSCCEEECTTSSCCH
T ss_pred HHHHHhCCCCCEEeccCCCCCH
Confidence 3333345566666665555443
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.22 E-value=1.5e-11 Score=124.77 Aligned_cols=137 Identities=16% Similarity=0.111 Sum_probs=102.0
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCce--eeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL--VKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~~~~~lV~e~ 470 (733)
.++....+.+.|..+.||++...+|+.+++|..... ....+.+|+++++.+.+.++ .++++++..++..++||||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 344443344466679999998777888999997543 22457889999999865454 4588888888889999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC----------------------------------------
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES---------------------------------------- 510 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~---------------------------------------- 510 (733)
++|.++. .. .. ....++.++++.|+.||+..
T Consensus 97 i~G~~l~--~~----~~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (264)
T 1nd4_A 97 VPGQDLL--SS----HL---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 167 (264)
T ss_dssp CSSEETT--TS----CC---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cCCcccC--cC----cC---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccH
Confidence 9998884 11 11 13367788888888888742
Q ss_pred ---------------CCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 511 ---------------RIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 511 ---------------~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
+..++|+|++|.||+++.+..+.|+|||.+.
T Consensus 168 ~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 168 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1228999999999999877666799999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.02 E-value=2.7e-10 Score=118.47 Aligned_cols=185 Identities=17% Similarity=0.200 Sum_probs=123.2
Q ss_pred cCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-CCce--eeEeeEEEeCC---eEEEEEEcc
Q 004732 398 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNL--VKLYGCCIEGN---QLLLIYEYL 471 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~~---~~~lV~e~~ 471 (733)
.+.++.|....||+.. ..+++|..... .....+.+|+++++.+. +..+ .+++.....+. ..|+||+|+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999875 45889886432 34567889999998884 3332 33444433332 348899999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------------------
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE------------------------------------------ 509 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------------ 509 (733)
+|.++.+... ..++..++..++.++++.++.||+.
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9998875432 2467778888899999999999861
Q ss_pred -------------CCCCeecCCCCCCcEEecC--CCCeEEcccCccccCcccCcccccc--------------cccCCCc
Q 004732 510 -------------SRIKVVHRDIKATNVLLDK--DLNSKISDFGLAKLDEEENTHISTR--------------VAGTIGY 560 (733)
Q Consensus 510 -------------~~~~ivH~Dik~~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~~--------------~~gt~~y 560 (733)
..+.++|+|++|.||+++. ...+.|+||+.+....... ..... +...++.
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-Dl~~~~~~~~~~~~~~~~~~l~~Y~~ 254 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-DFISLMEDDEEYGMEFVSKILNHYKH 254 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-HHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-HHHHHHhhccccCHHHHHHHHHHcCC
Confidence 1234799999999999998 4557899999987533211 11000 0001111
Q ss_pred cc-HHHHhhCCCCccchhHhHHHHHHHHHhCCCCC
Q 004732 561 MA-PEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 594 (733)
Q Consensus 561 ~a-PE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~ 594 (733)
.. |+..... ....+.|+++.++|++.+|..+|
T Consensus 255 ~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 255 KDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp SCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 22 2222111 12358999999999999998776
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.01 E-value=6.4e-10 Score=118.56 Aligned_cols=143 Identities=17% Similarity=0.257 Sum_probs=107.1
Q ss_pred ccCcccCCCcccEEEcccCCCcEEEEEEcc--ccC-hhcHHHHHHHHHHHHhCCC--CceeeEeeEEEeC---CeEEEEE
Q 004732 397 TDNNIGEGGFGPVYKGLLADGTAIAVKQLS--SKS-KQGNREFINEIGMISALQH--PNLVKLYGCCIEG---NQLLLIY 468 (733)
Q Consensus 397 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lV~ 468 (733)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+++++.+.+ ..+.+++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999988764 678888765 321 1223567889999999974 4577888888776 4579999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC--------------------------------------
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES-------------------------------------- 510 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------- 510 (733)
||++|..+.+. ....++...+..++.++++.|+.||...
T Consensus 121 e~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (359)
T 3dxp_A 121 EFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM 197 (359)
T ss_dssp ECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred EecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence 99999877431 1234678889999999999999999731
Q ss_pred -----------------CCCeecCCCCCCcEEecCCCC--eEEcccCccccC
Q 004732 511 -----------------RIKVVHRDIKATNVLLDKDLN--SKISDFGLAKLD 543 (733)
Q Consensus 511 -----------------~~~ivH~Dik~~Nill~~~~~--~kl~DfGla~~~ 543 (733)
+..++|||+++.||+++.++. +.|.||+.+...
T Consensus 198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 246899999999999997753 689999998753
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.94 E-value=5.8e-09 Score=112.64 Aligned_cols=60 Identities=8% Similarity=-0.061 Sum_probs=33.0
Q ss_pred cccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccC
Q 004732 203 YLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYN 264 (733)
Q Consensus 203 ~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N 264 (733)
.|..+.+|+.+.+..+ ++......|.++.+|+.+++.++ ++..-..++ ..+|+.+++..|
T Consensus 292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~ 353 (394)
T 4fs7_A 292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS 353 (394)
T ss_dssp TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT
T ss_pred cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc
Confidence 4556666777766544 44444556666777777766543 332222333 345666666544
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.92 E-value=1.7e-10 Score=122.35 Aligned_cols=206 Identities=17% Similarity=0.172 Sum_probs=107.4
Q ss_pred CCCCeeecccccccc-c-------cchhccCCCCCCEEEccccccc---------ccCCccccCCcCCceeeccCccccc
Q 004732 41 TFLQDISLIANRLKG-P-------IPKYLANISTLVNLTVQYNQFS---------GELPEELGSLLNLEKLHLSSNNFTG 103 (733)
Q Consensus 41 ~~L~~L~L~~n~l~~-~-------~p~~l~~l~~L~~L~L~~N~l~---------~~~p~~~~~l~~L~~L~Ls~N~l~~ 103 (733)
..++.|.+......+ . +..++.++++|+.|.+.++... +.+...+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 346677776555432 1 2334556778888877654321 112333455566666666655211
Q ss_pred cCCccccCCCCCCEEEeeCCccccCCCcccc--ccCCCCEEEccC--CCCccCCCCCCCCcCCcCeeecccccCCCCCcc
Q 004732 104 ELPKTFAKLTNMKDFRISDNQFTGQIPSFIQ--NWTKLEKLFIQP--SGLAGPIPSGIFSLENLTDLRISDLNGPEATFP 179 (733)
Q Consensus 104 ~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~--~l~~L~~L~l~~--N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~ 179 (733)
.++. +. +++|+.|+|..|.+.......++ .+++|+.|+|+. |...+.. .+ ..|.. ...
T Consensus 186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~--~~---~~l~~-----------~l~ 247 (362)
T 2ra8_A 186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDG--DM---NVFRP-----------LFS 247 (362)
T ss_dssp BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCS--CG---GGTGG-----------GSC
T ss_pred eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccch--hH---HHHHH-----------HHh
Confidence 1222 22 55666666666655433222332 456666665542 1111100 00 00000 000
Q ss_pred ccccccccEEEcccCccCCCCCcccc---CCCCCcEEEccCCcccCC----CCCCcCCCCCCCEEEecCCcccccCChhh
Q 004732 180 QLGNMKMTKLILRNCNITGELPRYLG---KMTKLKVLDLSFNRLRGQ----IPSNFDDLYDVDYIYFAGNLLTGAIPPWM 252 (733)
Q Consensus 180 ~~~~~~L~~L~l~~n~l~~~~p~~~~---~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~p~~~ 252 (733)
.....+|+.|+|.+|.+....+..+. .+++|++|+|+.|.|++. ++..+..+++|+.|++++|.++...-..+
T Consensus 248 ~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l 327 (362)
T 2ra8_A 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKEL 327 (362)
T ss_dssp TTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHH
T ss_pred cCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHH
Confidence 01123677777777777644333333 477888888888888764 33344556888888888888764433333
Q ss_pred hc-CCCeeecccCc
Q 004732 253 LE-RGDKIDLSYNN 265 (733)
Q Consensus 253 l~-~l~~l~ls~N~ 265 (733)
.. ....++++.|+
T Consensus 328 ~~alg~~~~~~~~~ 341 (362)
T 2ra8_A 328 QKSLPMKIDVSDSQ 341 (362)
T ss_dssp HHHCCSEEECCSBC
T ss_pred HHHcCCEEEecCCc
Confidence 22 23567777765
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.88 E-value=2.6e-10 Score=120.88 Aligned_cols=181 Identities=13% Similarity=0.182 Sum_probs=112.2
Q ss_pred ccccCCCCCCeeeccccccc---------cccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccC
Q 004732 35 PKLAELTFLQDISLIANRLK---------GPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGEL 105 (733)
Q Consensus 35 ~~l~~l~~L~~L~L~~n~l~---------~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 105 (733)
.++..+++|+.|.|..+... +.+...+..+++|+.|+|++|.-. .++. +. +++|+.|+|..|.++...
T Consensus 133 ~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~~-~~~L~~L~L~~~~l~~~~ 209 (362)
T 2ra8_A 133 ENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-KP-RPNLKSLEIISGGLPDSV 209 (362)
T ss_dssp TTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-CB-CTTCSEEEEECSBCCHHH
T ss_pred HhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-cc-CCCCcEEEEecCCCChHH
Confidence 34667899999999765431 235566788899999999988311 2443 43 889999999999887555
Q ss_pred Ccccc--CCCCCCEEEeeC--CccccC-----CCccc--cccCCCCEEEccCCCCccCCCCCCC---CcCCcCeeecccc
Q 004732 106 PKTFA--KLTNMKDFRISD--NQFTGQ-----IPSFI--QNWTKLEKLFIQPSGLAGPIPSGIF---SLENLTDLRISDL 171 (733)
Q Consensus 106 p~~~~--~l~~L~~L~l~~--N~l~~~-----~~~~~--~~l~~L~~L~l~~N~l~~~~p~~l~---~l~~L~~L~l~~n 171 (733)
...++ .+|+|+.|+|+. |...+. +...+ ..+++|+.|+|++|.+....+..+. .++
T Consensus 210 l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~---------- 279 (362)
T 2ra8_A 210 VEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILP---------- 279 (362)
T ss_dssp HHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGG----------
T ss_pred HHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCC----------
Confidence 55555 789999999964 332221 11122 2467788888877777643222222 233
Q ss_pred cCCCCCccccccccccEEEcccCccCCC----CCccccCCCCCcEEEccCCcccCCCCCCcCC-CCCCCEEEecCCc
Q 004732 172 NGPEATFPQLGNMKMTKLILRNCNITGE----LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDD-LYDVDYIYFAGNL 243 (733)
Q Consensus 172 ~~~~~~~~~~~~~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-l~~L~~L~l~~N~ 243 (733)
+|+.|+|+.|.|++. ++..+..+++|+.|+|++|.|+...-..+.. + ...+++++|.
T Consensus 280 -------------~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~~~~~l~~al--g~~~~~~~~~ 341 (362)
T 2ra8_A 280 -------------QLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSL--PMKIDVSDSQ 341 (362)
T ss_dssp -------------GCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHHHHHHHHHHC--CSEEECCSBC
T ss_pred -------------CCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHHHHHHHHHHc--CCEEEecCCc
Confidence 455566666666543 2333345677777777777776443333332 2 3456777665
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.82 E-value=2.8e-08 Score=107.27 Aligned_cols=227 Identities=18% Similarity=0.124 Sum_probs=153.9
Q ss_pred ccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCC
Q 004732 27 QNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELP 106 (733)
Q Consensus 27 n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 106 (733)
+++..+-..+|..+++|+.+.|.++..+ +....|.++.+|+.+++..| ++.+...+|.++..|+.+.+..+... +.
T Consensus 148 ~~~~~i~~~aF~~c~~L~~i~l~~~~~~-I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~~~~~--i~ 223 (394)
T 4fs7_A 148 EGVTVIGDEAFATCESLEYVSLPDSMET-LHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPNSLYY--LG 223 (394)
T ss_dssp TTCCEECTTTTTTCTTCCEEECCTTCCE-ECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCTTCCE--EC
T ss_pred ccccccchhhhcccCCCcEEecCCccce-eccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCCCceE--ee
Confidence 3444455668899999999999866443 66678999999999999877 55466678999999999998877544 34
Q ss_pred ccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccc
Q 004732 107 KTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKM 186 (733)
Q Consensus 107 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L 186 (733)
+......+|+.+.+..+. +......|.++..|+.+.+..+... .....|..+..|+.+.+..+.+....+ ....+|
T Consensus 224 ~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~F--~~~~~L 299 (394)
T 4fs7_A 224 DFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKTF--YGCSSL 299 (394)
T ss_dssp TTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTTT--TTCTTC
T ss_pred hhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeeccccc--cccccc
Confidence 444556788888886543 3344567778888888888776554 455667777777777766544333222 122367
Q ss_pred cEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccC
Q 004732 187 TKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYN 264 (733)
Q Consensus 187 ~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N 264 (733)
+.+.+.++ ++.....+|.++.+|+.++|..+ ++.....+|.+|.+|+.+.+..| +...-..++ ..+|+.+++..+
T Consensus 300 ~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 300 TEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred cccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 77777654 55455667788888888888644 66555677888888888888766 442223333 356777776543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.76 E-value=2.4e-07 Score=99.90 Aligned_cols=108 Identities=12% Similarity=0.120 Sum_probs=72.0
Q ss_pred eccc-ceeeeeccccccccccCCccccCCCCCCeeeccccc---cccccchhccCCCCCCEEEcccccccccCCccccCC
Q 004732 13 WKQK-TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANR---LKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSL 88 (733)
Q Consensus 13 ~~~~-~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~---l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 88 (733)
|.++ ..++++.|.. +++.+-..+|.++++|+.+.+..|. ++.+-..+|.++.+|+.+.+.++ ++.+...+|..+
T Consensus 59 F~~~~~~L~sI~iP~-svt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c 136 (394)
T 4gt6_A 59 FCNYKYVLTSVQIPD-TVTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHC 136 (394)
T ss_dssp TTTCCSCCCEEEECT-TCCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTC
T ss_pred ccCCCCcCEEEEECC-CeeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhh
Confidence 4443 3467777765 5777777788888899998888764 66455667777788887777655 443555667777
Q ss_pred cCCceeeccCccccccCCccccCCCCCCEEEeeCC
Q 004732 89 LNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDN 123 (733)
Q Consensus 89 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N 123 (733)
.+|+.+.+..+. +......|..+.+|+.+.+.++
T Consensus 137 ~~L~~i~lp~~~-~~I~~~~F~~c~~L~~i~~~~~ 170 (394)
T 4gt6_A 137 EELDTVTIPEGV-TSVADGMFSYCYSLHTVTLPDS 170 (394)
T ss_dssp TTCCEEECCTTC-CEECTTTTTTCTTCCEEECCTT
T ss_pred ccccccccccee-eeecccceecccccccccccce
Confidence 777777776443 3244455666666666666543
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.65 E-value=5.9e-07 Score=96.76 Aligned_cols=249 Identities=12% Similarity=0.087 Sum_probs=163.3
Q ss_pred ceeeeecccceeeeecccccc---ccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCcc
Q 004732 8 LVFHFWKQKTVNQKRVLKEQN---LTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEE 84 (733)
Q Consensus 8 ~~~~~~~~~~~~~~l~L~~n~---l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 84 (733)
+...-|.+++.++++.+..|. ++.+-..+|..+.+|+.+.+..+ ++.+....|.++.+|+.+.+..+.-. +....
T Consensus 78 Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~I~~~aF~~c~~L~~i~lp~~~~~-I~~~~ 155 (394)
T 4gt6_A 78 IGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTEIDSEAFHHCEELDTVTIPEGVTS-VADGM 155 (394)
T ss_dssp ECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSEECTTTTTTCTTCCEEECCTTCCE-ECTTT
T ss_pred EhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cceehhhhhhhhcccccccccceeee-ecccc
Confidence 334456778888889887764 66666778888999999888765 55466678899999999999765433 66677
Q ss_pred ccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCC----------------
Q 004732 85 LGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSG---------------- 148 (733)
Q Consensus 85 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~---------------- 148 (733)
|..+.+|+.+.+.++ ++......|.. .+|+.+.+..+-.. .....|.++..|.......+.
T Consensus 156 F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip~~~~~-i~~~af~~c~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (394)
T 4gt6_A 156 FSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIPAKVTR-IGTNAFSECFALSTITSDSESYPAIDNVLYEKSANGD 232 (394)
T ss_dssp TTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEECTTCCE-ECTTTTTTCTTCCEEEECCSSSCBSSSCEEEECTTSC
T ss_pred eecccccccccccce-eeEeccccccc-cceeEEEECCcccc-cccchhhhccccceecccccccccccceeeccccccc
Confidence 888889999988765 44244444543 56777777655433 444555556555555433221
Q ss_pred --------------------CccCCCCCCCCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccCC
Q 004732 149 --------------------LAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKM 207 (733)
Q Consensus 149 --------------------l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l 207 (733)
+......+|.++.+|+.+.+.++. ..+....+.+. +|+.+.+. +.++......|.++
T Consensus 233 ~~~~~~~~~~~~~~~~ip~~v~~i~~~aF~~c~~L~~i~lp~~~-~~I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c 310 (394)
T 4gt6_A 233 YALIRYPSQREDPAFKIPNGVARIETHAFDSCAYLASVKMPDSV-VSIGTGAFMNCPALQDIEFS-SRITELPESVFAGC 310 (394)
T ss_dssp EEEEECCTTCCCSEEECCTTEEEECTTTTTTCSSCCEEECCTTC-CEECTTTTTTCTTCCEEECC-TTCCEECTTTTTTC
T ss_pred ccccccccccccceEEcCCcceEcccceeeecccccEEeccccc-ceecCcccccccccccccCC-CcccccCceeecCC
Confidence 111223456677888888876533 33333344443 67888875 45655666778888
Q ss_pred CCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCc
Q 004732 208 TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNN 265 (733)
Q Consensus 208 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~ 265 (733)
.+|+.++|..+ ++.....+|.+|.+|+.+.+..+ ++..-...+ ..+|+.+++.+|.
T Consensus 311 ~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~ 368 (394)
T 4gt6_A 311 ISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSR 368 (394)
T ss_dssp TTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCH
T ss_pred CCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCce
Confidence 88888888754 55556678888888888888654 442223333 4567888877664
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.61 E-value=6e-09 Score=104.72 Aligned_cols=121 Identities=21% Similarity=0.210 Sum_probs=76.0
Q ss_pred eeeccccccccccch-hccCCCCCCE--EEccccccc---ccCCccccCCcCCceeeccCccccc--cCCccccCCCCCC
Q 004732 45 DISLIANRLKGPIPK-YLANISTLVN--LTVQYNQFS---GELPEELGSLLNLEKLHLSSNNFTG--ELPKTFAKLTNMK 116 (733)
Q Consensus 45 ~L~L~~n~l~~~~p~-~l~~l~~L~~--L~L~~N~l~---~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~ 116 (733)
.|..++|..++.+.- .|...+.|+. ++++.|... +.++....++++|+.|+|++|+|++ .+|..+..+++|+
T Consensus 120 ~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~ 199 (267)
T 3rw6_A 120 IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 199 (267)
T ss_dssp HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCC
T ss_pred HHHhccchhccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCC
Confidence 344555555544442 2555555555 666777433 2222223567778888888888876 4456667788888
Q ss_pred EEEeeCCccccCCCccccccC--CCCEEEccCCCCccCCCC-------CCCCcCCcCeee
Q 004732 117 DFRISDNQFTGQIPSFIQNWT--KLEKLFIQPSGLAGPIPS-------GIFSLENLTDLR 167 (733)
Q Consensus 117 ~L~l~~N~l~~~~~~~~~~l~--~L~~L~l~~N~l~~~~p~-------~l~~l~~L~~L~ 167 (733)
.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|. .+..+++|+.||
T Consensus 200 ~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LD 257 (267)
T 3rw6_A 200 ILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLD 257 (267)
T ss_dssp EEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEES
T ss_pred EEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeEC
Confidence 888888888754 3344444 788888888888766653 355677777776
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.58 E-value=1e-08 Score=97.93 Aligned_cols=119 Identities=18% Similarity=0.193 Sum_probs=78.6
Q ss_pred cCCccccCCCCCCeeecccc-ccccc----cchhccCCCCCCEEEccccccccc----CCccccCCcCCceeeccCcccc
Q 004732 32 VLPPKLAELTFLQDISLIAN-RLKGP----IPKYLANISTLVNLTVQYNQFSGE----LPEELGSLLNLEKLHLSSNNFT 102 (733)
Q Consensus 32 ~~p~~l~~l~~L~~L~L~~n-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~ 102 (733)
.+...+...+.|+.|+|++| .|... +...+...++|++|+|++|.|+.. +...+...++|++|+|++|.|+
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34445666778888888888 77642 345566677888888888887632 2334555567888888888877
Q ss_pred cc----CCccccCCCCCCEEEe--eCCccccC----CCccccccCCCCEEEccCCCCc
Q 004732 103 GE----LPKTFAKLTNMKDFRI--SDNQFTGQ----IPSFIQNWTKLEKLFIQPSGLA 150 (733)
Q Consensus 103 ~~----~p~~~~~l~~L~~L~l--~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~ 150 (733)
.. +...+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 43 3455666677888888 67777643 2334445577777777777764
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.56 E-value=4.8e-09 Score=105.44 Aligned_cols=80 Identities=21% Similarity=0.390 Sum_probs=43.0
Q ss_pred cCCCCCCEEEcccccccc--cCCccccCCcCCceeeccCccccccCCccccCCC--CCCEEEeeCCccccCCCc------
Q 004732 62 ANISTLVNLTVQYNQFSG--ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLT--NMKDFRISDNQFTGQIPS------ 131 (733)
Q Consensus 62 ~~l~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~--~L~~L~l~~N~l~~~~~~------ 131 (733)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+.+.+|+
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~ 244 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS 244 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence 445566666666666654 3334455566666666666666533 2233333 566666666666554442
Q ss_pred -cccccCCCCEEE
Q 004732 132 -FIQNWTKLEKLF 143 (733)
Q Consensus 132 -~~~~l~~L~~L~ 143 (733)
.+..+++|+.|+
T Consensus 245 ~il~~~P~L~~LD 257 (267)
T 3rw6_A 245 AIRERFPKLLRLD 257 (267)
T ss_dssp HHHHHCTTCCEES
T ss_pred HHHHHCcccCeEC
Confidence 245556665554
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.44 E-value=7.3e-06 Score=87.62 Aligned_cols=240 Identities=11% Similarity=0.060 Sum_probs=122.1
Q ss_pred eecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCC
Q 004732 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNL 91 (733)
Q Consensus 12 ~~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 91 (733)
|+.....++++.+.. +++.+-..+|.++.+|+.++|..+ ++.+-..+|.+. +|+.+.+..+ ++.+-..+|... +|
T Consensus 41 ~~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~~-~L 115 (379)
T 4h09_A 41 WYKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQGT-DL 115 (379)
T ss_dssp TGGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTTC-CC
T ss_pred ccccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCce-eeEeccceeccC-Cc
Confidence 344556677777764 688777778888999999999754 665666677776 6777777654 443444556553 78
Q ss_pred ceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCc---------------------
Q 004732 92 EKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA--------------------- 150 (733)
Q Consensus 92 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--------------------- 150 (733)
+.+.+..+-.. .....|.+ .+|+.+.+..+ ++......|..+.+|+.+.+..+...
T Consensus 116 ~~i~lp~~~~~-i~~~~F~~-~~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (379)
T 4h09_A 116 DDFEFPGATTE-IGNYIFYN-SSVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPA 192 (379)
T ss_dssp SEEECCTTCCE-ECTTTTTT-CCCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCT
T ss_pred ccccCCCcccc-cccccccc-ceeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccc
Confidence 88888654322 22233333 24444444332 22222333444444444443322110
Q ss_pred --------------cCCCCCCCCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEc
Q 004732 151 --------------GPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDL 215 (733)
Q Consensus 151 --------------~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~l 215 (733)
......+....+|+.+.+..+ +..+....+... .|+.+.+..+ ++.....+|.++.+|+.+.+
T Consensus 193 ~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l 270 (379)
T 4h09_A 193 AKTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNF 270 (379)
T ss_dssp TCCCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEE
T ss_pred cccccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhccccc
Confidence 011223333444554444332 222222222222 4555555543 44344455555666666665
Q ss_pred cCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecc
Q 004732 216 SFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLS 262 (733)
Q Consensus 216 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls 262 (733)
..+ ++......|.++.+|+.+.+.++.+...-...+ ..+|+.+++.
T Consensus 271 ~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp 318 (379)
T 4h09_A 271 YAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLP 318 (379)
T ss_dssp CCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECC
T ss_pred ccc-ceeccccccccccccccccccccccceehhhhhcCCCCCCEEEcC
Confidence 433 333344455566666666665555542222333 2345555554
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=1.5e-06 Score=90.14 Aligned_cols=137 Identities=19% Similarity=0.181 Sum_probs=95.6
Q ss_pred cCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCC---ceeeEeeEEE-eCCeEEEEEEccCC
Q 004732 398 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHP---NLVKLYGCCI-EGNQLLLIYEYLEN 473 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~~ 473 (733)
.+.++.|....||+. |..+++|... .......+.+|+++|+.+.+. .+.+++.++. ..+..++||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 346788888899987 5678888853 233456788999999999753 2445666664 34567899999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC--------------------------------------------
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE-------------------------------------------- 509 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------------------------------------------- 509 (733)
..+.+... ..++...+..++.++++.|+.||+.
T Consensus 98 ~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 174 (306)
T 3tdw_A 98 QILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTL 174 (306)
T ss_dssp EECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHH
T ss_pred eECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHH
Confidence 88876321 1234455555566666666655542
Q ss_pred -------------CCCCeecCCCCCCcEEecC---CCCe-EEcccCccccC
Q 004732 510 -------------SRIKVVHRDIKATNVLLDK---DLNS-KISDFGLAKLD 543 (733)
Q Consensus 510 -------------~~~~ivH~Dik~~Nill~~---~~~~-kl~DfGla~~~ 543 (733)
.++.++|+|+++.||+++. ++.+ .|+||+.+...
T Consensus 175 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 175 RFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2234699999999999997 4554 89999988753
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.41 E-value=4e-08 Score=93.81 Aligned_cols=113 Identities=23% Similarity=0.276 Sum_probs=91.3
Q ss_pred cccceeeeeccccc-cccc----cCCccccCCCCCCeeeccccccccc----cchhccCCCCCCEEEccccccccc----
Q 004732 14 KQKTVNQKRVLKEQ-NLTG----VLPPKLAELTFLQDISLIANRLKGP----IPKYLANISTLVNLTVQYNQFSGE---- 80 (733)
Q Consensus 14 ~~~~~~~~l~L~~n-~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~---- 80 (733)
...+.+++|+|++| +|+. .+...+...++|++|+|++|.|... +...+...++|++|+|++|.|+..
T Consensus 33 ~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~ 112 (185)
T 1io0_A 33 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 112 (185)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHH
Confidence 33566889999999 8875 3455677789999999999999753 455667778999999999999853
Q ss_pred CCccccCCcCCceeec--cCcccccc----CCccccCCCCCCEEEeeCCccc
Q 004732 81 LPEELGSLLNLEKLHL--SSNNFTGE----LPKTFAKLTNMKDFRISDNQFT 126 (733)
Q Consensus 81 ~p~~~~~l~~L~~L~L--s~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~ 126 (733)
+...+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 113 l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 113 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 4566788889999999 88999854 3455666799999999999987
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.37 E-value=3.2e-06 Score=85.80 Aligned_cols=135 Identities=16% Similarity=0.130 Sum_probs=97.6
Q ss_pred cccCCCcc-cEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEEEEEEccCCCCH
Q 004732 400 NIGEGGFG-PVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLLLIYEYLENNSL 476 (733)
Q Consensus 400 ~lg~G~~g-~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL 476 (733)
.+..|..| .||+... .++..+++|+-.. .....+.+|...|+.+. +--+.++++++.+++..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455555 6898764 3567889998643 23457888999998884 22356788899999999999999999988
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC-----------------------------------------------
Q 004732 477 ARALFEHRLKLDWPTRRRICLGIARGLAYLHGE----------------------------------------------- 509 (733)
Q Consensus 477 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------------------------------------------- 509 (733)
.+..... ......++.++++.|+.||..
T Consensus 108 ~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 108 FQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 7765321 233455667777777777741
Q ss_pred --------CCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 510 --------SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 510 --------~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
.++.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 112278999999999999877677999998763
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.35 E-value=6.1e-06 Score=88.20 Aligned_cols=244 Identities=11% Similarity=0.002 Sum_probs=155.9
Q ss_pred eeeeecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCC
Q 004732 9 VFHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSL 88 (733)
Q Consensus 9 ~~~~~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l 88 (733)
...-|.+++.++++.|.. +++.+-..+|.+. +|+.+.+..+ ++.+...+|.. .+|+.+.+..+-.. .....|.+.
T Consensus 61 g~~aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~~I~~~aF~~-~~L~~i~lp~~~~~-i~~~~F~~~ 135 (379)
T 4h09_A 61 GEANFNSCYNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VKKFGDYVFQG-TDLDDFEFPGATTE-IGNYIFYNS 135 (379)
T ss_dssp CTTTTTTCTTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CCEECTTTTTT-CCCSEEECCTTCCE-ECTTTTTTC
T ss_pred HHHHhhCCCCCCEEEeCC-cceEechhhhcCC-CCceEECCce-eeEeccceecc-CCcccccCCCcccc-ccccccccc
Confidence 334567778888999875 5876767788776 6888877654 55344455655 47888888765332 333444443
Q ss_pred cCCceeeccCccccccCCccccCCCCCCEEEeeCCccc-----------------------------------cCCCccc
Q 004732 89 LNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT-----------------------------------GQIPSFI 133 (733)
Q Consensus 89 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~-----------------------------------~~~~~~~ 133 (733)
+|+.+.+..+ ++......|..+.+|+.+.+..+... ......+
T Consensus 136 -~l~~~~~~~~-v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~f 213 (379)
T 4h09_A 136 -SVKRIVIPKS-VTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKTVTAYGF 213 (379)
T ss_dssp -CCCEEEECTT-CCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCEECTTTT
T ss_pred -eeeeeeccce-eeccccchhcccccccccccccccceeecccceecccccceeccccccccccccccccceeEEeeccc
Confidence 4555555433 33234444555555555554433211 1223345
Q ss_pred cccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCCCcE
Q 004732 134 QNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKV 212 (733)
Q Consensus 134 ~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~ 212 (733)
..+.+|+.+.+..+ +.......+.++.+|+.+.+..+ +..+....+.+. +|+.+.+..+ ++......|.++.+|+.
T Consensus 214 ~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~ 290 (379)
T 4h09_A 214 SYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTK 290 (379)
T ss_dssp TTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCE
T ss_pred ccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceecccccccccccccc
Confidence 56677888777654 44355667788889999888764 555555555554 6888888654 55466677888999999
Q ss_pred EEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeeccc
Q 004732 213 LDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSY 263 (733)
Q Consensus 213 L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~ 263 (733)
+.+.++.++......|.++.+|+.+.+..+ ++..-..++ ..+|+.+.+..
T Consensus 291 i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~ 342 (379)
T 4h09_A 291 VVMDNSAIETLEPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPK 342 (379)
T ss_dssp EEECCTTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCT
T ss_pred ccccccccceehhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECC
Confidence 999988888777788999999999998755 442223333 35567666643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.18 E-value=8.3e-07 Score=94.18 Aligned_cols=80 Identities=6% Similarity=0.034 Sum_probs=54.5
Q ss_pred cCcc-cCCCcccEEEcccC-------CCcEEEEEEccccC---hhcHHHHHHHHHHHHhCC-C--CceeeEeeEEEeC--
Q 004732 398 DNNI-GEGGFGPVYKGLLA-------DGTAIAVKQLSSKS---KQGNREFINEIGMISALQ-H--PNLVKLYGCCIEG-- 461 (733)
Q Consensus 398 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 461 (733)
.+.| +.|....+|+.... +++.+++|...... ......+.+|+.+++.+. + -.+.+++.++.++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88889999988754 26788899864322 001245678888888884 2 2456677777654
Q ss_pred -CeEEEEEEccCCCCHH
Q 004732 462 -NQLLLIYEYLENNSLA 477 (733)
Q Consensus 462 -~~~~lV~e~~~~gsL~ 477 (733)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999986653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.06 E-value=9.4e-06 Score=87.37 Aligned_cols=75 Identities=19% Similarity=0.216 Sum_probs=49.4
Q ss_pred cCcccCCCcccEEEcccC-CCcEEEEEEccccCh-------hcHHHHHHHHHHHHhCCC--Ccee-eEeeEEEeCCeEEE
Q 004732 398 DNNIGEGGFGPVYKGLLA-DGTAIAVKQLSSKSK-------QGNREFINEIGMISALQH--PNLV-KLYGCCIEGNQLLL 466 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~niv-~l~~~~~~~~~~~l 466 (733)
.+.||.|.++.||+++.. +++.|+||....... .....+..|.++++.+.. +..+ +++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457999999999999754 468899997643211 122456778888887742 4444 44433 4455689
Q ss_pred EEEccCCC
Q 004732 467 IYEYLENN 474 (733)
Q Consensus 467 V~e~~~~g 474 (733)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.04 E-value=1.8e-05 Score=83.07 Aligned_cols=138 Identities=17% Similarity=0.249 Sum_probs=80.1
Q ss_pred CcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-----CCceeeEe-e--EEEeCCeEEEEEEc
Q 004732 399 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-----HPNLVKLY-G--CCIEGNQLLLIYEY 470 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lV~e~ 470 (733)
+.|+.|..+.||+....+| .+++|..... ...+..|+++++.+. .|.++... | +...++..++||+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566677899999887655 4889988642 133344555555443 34444311 1 22356778999999
Q ss_pred cCCCCHH--------------HHHHh--cCC-----------CCCHHHHH------------------------------
Q 004732 471 LENNSLA--------------RALFE--HRL-----------KLDWPTRR------------------------------ 493 (733)
Q Consensus 471 ~~~gsL~--------------~~l~~--~~~-----------~l~~~~~~------------------------------ 493 (733)
++|..+. ..+|. ... .-.|....
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11221 110 01232210
Q ss_pred -HHHHHHHHHHHHHHc----------CCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 494 -RICLGIARGLAYLHG----------ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 494 -~i~~~ia~~l~~LH~----------~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
.+...+.+++++|++ ..+..++|||+++.||+++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 111224446667763 023459999999999999888889999999875
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.91 E-value=4.4e-06 Score=77.76 Aligned_cols=84 Identities=13% Similarity=0.082 Sum_probs=58.8
Q ss_pred CCCCeeeccccccccccchhccCCCCCCEEEccccc-ccccCCccccCC----cCCceeeccCcc-ccccCCccccCCCC
Q 004732 41 TFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQ-FSGELPEELGSL----LNLEKLHLSSNN-FTGELPKTFAKLTN 114 (733)
Q Consensus 41 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~~~~p~~~~~l----~~L~~L~Ls~N~-l~~~~p~~~~~l~~ 114 (733)
-+|+.|||+++.|+..--..+.++++|++|+|++|. |+..--..+..+ ++|++|+|++|. ||..--..++++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 468888888888877666677788888888888874 664433445554 367888887763 66544455667777
Q ss_pred CCEEEeeCCc
Q 004732 115 MKDFRISDNQ 124 (733)
Q Consensus 115 L~~L~l~~N~ 124 (733)
|+.|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 7777777774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.85 E-value=7e-05 Score=77.26 Aligned_cols=137 Identities=16% Similarity=0.140 Sum_probs=92.3
Q ss_pred ccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC---CCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 397 TDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ---HPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 397 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
..+.|+.|....+|+... ++..+++|..... ....+.+|++.|+.+. ...+.++++++..++..++||||+++
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 446789999999999876 4678889986532 3467888999988884 25677888888888899999999999
Q ss_pred CCHH--------H---HHHhcCC--C-------------------CCHHHHH---HHH----------------HHHHHH
Q 004732 474 NSLA--------R---ALFEHRL--K-------------------LDWPTRR---RIC----------------LGIARG 502 (733)
Q Consensus 474 gsL~--------~---~l~~~~~--~-------------------l~~~~~~---~i~----------------~~ia~~ 502 (733)
..+. + .++.... . -+|.+.. ++. ..+.+.
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 8642 1 2232111 1 1354321 111 111111
Q ss_pred -HHHHHc-CCCCCeecCCCCCCcEEecCCCCeEEcccC
Q 004732 503 -LAYLHG-ESRIKVVHRDIKATNVLLDKDLNSKISDFG 538 (733)
Q Consensus 503 -l~~LH~-~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 538 (733)
...|.. ..++.++|+|+.+.|++++.++ +.|.||+
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223432 2345689999999999999887 8899984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.81 E-value=5.1e-05 Score=77.61 Aligned_cols=79 Identities=22% Similarity=0.225 Sum_probs=57.1
Q ss_pred CccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCC---ceeeEeeEEEeCCeEEEEEEc
Q 004732 394 NFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHP---NLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~~~~~lV~e~ 470 (733)
.......+|.|..+.||+.++.||+.|++|+...........|.+|++.|+.+.-. -+.+++++ .. .++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence 44556789999999999999999999999987554333345688899999988532 23344443 22 3789999
Q ss_pred cCCCCH
Q 004732 471 LENNSL 476 (733)
Q Consensus 471 ~~~gsL 476 (733)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 988753
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.72 E-value=9.9e-06 Score=75.39 Aligned_cols=83 Identities=13% Similarity=0.161 Sum_probs=48.2
Q ss_pred CCCCEEEcccccccccCCccccCCcCCceeeccCcc-ccccCCccccCC----CCCCEEEeeCCc-cccCCCccccccCC
Q 004732 65 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNN-FTGELPKTFAKL----TNMKDFRISDNQ-FTGQIPSFIQNWTK 138 (733)
Q Consensus 65 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~-l~~~~p~~~~~l----~~L~~L~l~~N~-l~~~~~~~~~~l~~ 138 (733)
-+|+.|||+++.++..--..+..+++|+.|+|++|. |+..--..++.+ ++|++|+|++|. ++..--..+.++++
T Consensus 61 ~~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 61 YKIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp CCEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred ceEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 357777777777665444556666677777777663 554333444443 356666666663 55333334555666
Q ss_pred CCEEEccCC
Q 004732 139 LEKLFIQPS 147 (733)
Q Consensus 139 L~~L~l~~N 147 (733)
|+.|+|+++
T Consensus 141 L~~L~L~~c 149 (176)
T 3e4g_A 141 LKYLFLSDL 149 (176)
T ss_dssp CCEEEEESC
T ss_pred CCEEECCCC
Confidence 666666654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00023 Score=77.07 Aligned_cols=74 Identities=16% Similarity=0.170 Sum_probs=44.9
Q ss_pred ccCcccCCCcccEEEcccCCCcEEEEEEcccc------C-h--hcHHHHHHHHHHHH-hCCCCceeeEeeEEEeCCeEEE
Q 004732 397 TDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK------S-K--QGNREFINEIGMIS-ALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 397 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~------~-~--~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~l 466 (733)
..+.||.|..+.||++.. +++.++||..... . . .....+..|+..+. ......+.+++.+. .+..++
T Consensus 38 ~i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l 114 (420)
T 2pyw_A 38 VIKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI 114 (420)
T ss_dssp EEEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred EEEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence 346789999999999864 4678999943211 0 0 12233444443332 22234455666554 566799
Q ss_pred EEEcc-CC
Q 004732 467 IYEYL-EN 473 (733)
Q Consensus 467 V~e~~-~~ 473 (733)
||||+ ++
T Consensus 115 v~e~l~~g 122 (420)
T 2pyw_A 115 GMRYLEPP 122 (420)
T ss_dssp EECCCCTT
T ss_pred EEeecCCc
Confidence 99999 76
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.49 E-value=3.1e-05 Score=73.42 Aligned_cols=113 Identities=15% Similarity=0.184 Sum_probs=64.2
Q ss_pred ccCCCCCCeeecccc-cccc----ccchhccCCCCCCEEEcccccccccCC----ccccCCcCCceeeccCccccccC--
Q 004732 37 LAELTFLQDISLIAN-RLKG----PIPKYLANISTLVNLTVQYNQFSGELP----EELGSLLNLEKLHLSSNNFTGEL-- 105 (733)
Q Consensus 37 l~~l~~L~~L~L~~n-~l~~----~~p~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~~-- 105 (733)
+.+-+.|+.|+|++| +|.. .+...+...+.|+.|+|++|.|....- ..+..-+.|+.|+|++|.|+...
T Consensus 37 l~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~ 116 (197)
T 1pgv_A 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLA 116 (197)
T ss_dssp HTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHH
T ss_pred HhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHH
Confidence 334466777777774 6653 244556666777777777777763322 22344566777777777776432
Q ss_pred --CccccCCCCCCEEEeeCCc---ccc----CCCccccccCCCCEEEccCCCC
Q 004732 106 --PKTFAKLTNMKDFRISDNQ---FTG----QIPSFIQNWTKLEKLFIQPSGL 149 (733)
Q Consensus 106 --p~~~~~l~~L~~L~l~~N~---l~~----~~~~~~~~l~~L~~L~l~~N~l 149 (733)
-+.+..-+.|++|+|++|. +.. .+...+..-+.|..|+++.|.+
T Consensus 117 ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 117 RLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 2334445567777776542 221 1223344445666666665544
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.26 E-value=0.0006 Score=70.02 Aligned_cols=136 Identities=11% Similarity=0.108 Sum_probs=74.5
Q ss_pred cCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCce-eeEeeEEEeCCeEEEEEEcc-CCCC
Q 004732 398 DNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL-VKLYGCCIEGNQLLLIYEYL-ENNS 475 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~-~~gs 475 (733)
.+.|+.|....+|+. ..+++|......... ....+|+.+++.+....+ .+++++ +++.-++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 567889999999998 568888875432111 123467777777643333 344443 344457899999 6544
Q ss_pred HHHH------------------HHhcCCCCC-----HHHHHHHHH--------------HHHHHH----HHHHc-CCCCC
Q 004732 476 LARA------------------LFEHRLKLD-----WPTRRRICL--------------GIARGL----AYLHG-ESRIK 513 (733)
Q Consensus 476 L~~~------------------l~~~~~~l~-----~~~~~~i~~--------------~ia~~l----~~LH~-~~~~~ 513 (733)
+... +|.....++ +.....+.. .+.+.+ +.+.. ..+..
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 4211 111111111 111111100 011111 11111 12334
Q ss_pred eecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 514 VVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 514 ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
++|+|+.+.||+ ..++.+.++||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 799999999999 5667889999998864
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0018 Score=67.33 Aligned_cols=140 Identities=13% Similarity=0.134 Sum_probs=82.0
Q ss_pred CcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCc--eeeEeeE-----EEeCCeEEEEEEcc
Q 004732 399 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN--LVKLYGC-----CIEGNQLLLIYEYL 471 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~lV~e~~ 471 (733)
..++ |....||+....+|+.+++|...... .....+..|..+++.+.... +.+++.. ...++..++||+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 88889999888778889999985321 23456677888877774222 3334432 23356678999999
Q ss_pred CCCCHH-----H------H---HHh--c------CCCCCHHHH----HHH---------------HHHHHHHHHHHHc--
Q 004732 472 ENNSLA-----R------A---LFE--H------RLKLDWPTR----RRI---------------CLGIARGLAYLHG-- 508 (733)
Q Consensus 472 ~~gsL~-----~------~---l~~--~------~~~l~~~~~----~~i---------------~~~ia~~l~~LH~-- 508 (733)
+|..+. . . ++. . ....++... ..+ ...+.+.++.+..
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 885431 1 1 121 1 011222211 001 1111122233321
Q ss_pred --CCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 509 --ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 509 --~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..+..++|||+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 1233579999999999999 4 899999988763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0018 Score=67.37 Aligned_cols=140 Identities=18% Similarity=0.159 Sum_probs=72.1
Q ss_pred CcccCCCccc-EEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCc--eeeEeeEEEeCCeEEEEEEccCCCC
Q 004732 399 NNIGEGGFGP-VYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN--LVKLYGCCIEGNQLLLIYEYLENNS 475 (733)
Q Consensus 399 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gs 475 (733)
+.|+.|+... +|+....+|+.+++|....... ..+..|+.+++.+.... +.+++.+..+.+ ++|||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcc
Confidence 4566665554 6677654467777776543221 23345666666663222 345555533333 78999998777
Q ss_pred HHHHHHhcC-------------------------CCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 004732 476 LARALFEHR-------------------------LKLDWPTRR-------R-------------ICLGIARGLAYLH--- 507 (733)
Q Consensus 476 L~~~l~~~~-------------------------~~l~~~~~~-------~-------------i~~~ia~~l~~LH--- 507 (733)
+.+++.... ..++..... . ....+.+.++.+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 654442110 011111100 0 0001112222221
Q ss_pred cCCCCCeecCCCCCCcEEecCC----CCeEEcccCccccC
Q 004732 508 GESRIKVVHRDIKATNVLLDKD----LNSKISDFGLAKLD 543 (733)
Q Consensus 508 ~~~~~~ivH~Dik~~Nill~~~----~~~kl~DfGla~~~ 543 (733)
...+..++|||+.+.|||++.+ ..+.|+||+.+...
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1123458999999999999875 67899999988753
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.18 E-value=8.9e-05 Score=70.31 Aligned_cols=112 Identities=11% Similarity=0.111 Sum_probs=84.6
Q ss_pred ccceeeeeccccc-cccc----cCCccccCCCCCCeeeccccccccc----cchhccCCCCCCEEEcccccccccC----
Q 004732 15 QKTVNQKRVLKEQ-NLTG----VLPPKLAELTFLQDISLIANRLKGP----IPKYLANISTLVNLTVQYNQFSGEL---- 81 (733)
Q Consensus 15 ~~~~~~~l~L~~n-~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~---- 81 (733)
+-+.+++|+|++| +|.. .+-+.+..-+.|+.|+|++|.|... +...+...+.|++|+|++|.|+...
T Consensus 39 ~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al 118 (197)
T 1pgv_A 39 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 118 (197)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred cCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence 3455788899985 7763 3556677789999999999999853 4455667899999999999998433
Q ss_pred CccccCCcCCceeeccCc---cccc----cCCccccCCCCCCEEEeeCCccc
Q 004732 82 PEELGSLLNLEKLHLSSN---NFTG----ELPKTFAKLTNMKDFRISDNQFT 126 (733)
Q Consensus 82 p~~~~~l~~L~~L~Ls~N---~l~~----~~p~~~~~l~~L~~L~l~~N~l~ 126 (733)
-.++..-+.|++|+|++| .+.. .+...+..-+.|+.|+++.|.+.
T Consensus 119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~g 170 (197)
T 1pgv_A 119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASME 170 (197)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCHH
T ss_pred HHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCcc
Confidence 234666678999999875 3442 24455667789999999988765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00052 Score=74.31 Aligned_cols=72 Identities=17% Similarity=0.234 Sum_probs=49.0
Q ss_pred cCcccCCCcccEEEcccCC--------CcEEEEEEccccChhcHHHHHHHHHHHHhCCCCce-eeEeeEEEeCCeEEEEE
Q 004732 398 DNNIGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL-VKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~ 468 (733)
.+.|+.|-...||++...+ ++.+++|+.... .....+.+|..+++.+...++ .++++.+. + .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEE
Confidence 3567888889999998653 578999987432 112456689998888854344 45666543 2 3899
Q ss_pred EccCCCC
Q 004732 469 EYLENNS 475 (733)
Q Consensus 469 e~~~~gs 475 (733)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0014 Score=67.80 Aligned_cols=140 Identities=17% Similarity=0.163 Sum_probs=79.0
Q ss_pred CcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCc--eeeEee------EEEeCCeEEEEEEc
Q 004732 399 NNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN--LVKLYG------CCIEGNQLLLIYEY 470 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~~~lV~e~ 470 (733)
+.|+.|....+|+....+| .+++|...... ....+..|+.+++.+.... +.+++. +....+..++|++|
T Consensus 28 ~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~ 104 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISF 104 (322)
T ss_dssp EEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEEC
T ss_pred eccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEe
Confidence 4577888899999887665 68889876521 1234556777776664222 222331 12234677999999
Q ss_pred cCCCCHHH--------------HHHhcCCC--------C---CHHHHHH------------HHHHHHHHHHHHHcC----
Q 004732 471 LENNSLAR--------------ALFEHRLK--------L---DWPTRRR------------ICLGIARGLAYLHGE---- 509 (733)
Q Consensus 471 ~~~gsL~~--------------~l~~~~~~--------l---~~~~~~~------------i~~~ia~~l~~LH~~---- 509 (733)
++|..+.. .++..... . .|..... +...+.+.++++++.
T Consensus 105 l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~ 184 (322)
T 2ppq_A 105 LEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKD 184 (322)
T ss_dssp CCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCS
T ss_pred CCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCccc
Confidence 99865310 12211000 1 1322111 001244455555531
Q ss_pred CCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 510 ~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
.+..++|+|+++.||+++.+..+.|+||+.+.
T Consensus 185 ~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 185 LPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred CCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 23458999999999999987556899999775
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0022 Score=67.80 Aligned_cols=138 Identities=19% Similarity=0.258 Sum_probs=81.2
Q ss_pred CcccCCCcccEEEcccC--------CCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCce-eeEeeEEEeCCeEEEEEE
Q 004732 399 NNIGEGGFGPVYKGLLA--------DGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL-VKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e 469 (733)
+.|..|-...+|+.... +++.|++|+.... ......+.+|.++++.+.-..+ .++++++. + .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~--~--g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP--E--GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC--C--ccEEE
Confidence 46777888899998764 3578999986432 2234566789999888853233 45665543 2 39999
Q ss_pred ccCCCCHHH--------------H---HHhcC----CCCC--HHHHHHHHHHHHH-------------------HHHH--
Q 004732 470 YLENNSLAR--------------A---LFEHR----LKLD--WPTRRRICLGIAR-------------------GLAY-- 505 (733)
Q Consensus 470 ~~~~gsL~~--------------~---l~~~~----~~l~--~~~~~~i~~~ia~-------------------~l~~-- 505 (733)
|++|..|.. . +|... .... |.+..++..++.. .+.+
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 999865421 1 11111 1122 3444445443321 2233
Q ss_pred --HHcC-CCCCeecCCCCCCcEEecCC----CCeEEcccCccc
Q 004732 506 --LHGE-SRIKVVHRDIKATNVLLDKD----LNSKISDFGLAK 541 (733)
Q Consensus 506 --LH~~-~~~~ivH~Dik~~Nill~~~----~~~kl~DfGla~ 541 (733)
|... .+..++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3222 23357999999999999876 689999999875
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0038 Score=67.85 Aligned_cols=74 Identities=18% Similarity=0.099 Sum_probs=47.5
Q ss_pred cCcccCCCcccEEEcccCC-CcEEEEEEccccChhcHHHHHHHHHHHHhCCCCcee-eEeeEEEeCCeEEEEEEccCCCC
Q 004732 398 DNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV-KLYGCCIEGNQLLLIYEYLENNS 475 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~~~gs 475 (733)
.+.|+.|-...+|+....+ +..+++|+........ .+-.+|..+++.+...++. ++++++ .+ .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCcc
Confidence 4568888889999998765 5788899874432111 1125788899988655554 566665 22 35999998754
Q ss_pred H
Q 004732 476 L 476 (733)
Q Consensus 476 L 476 (733)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.67 E-value=0.012 Score=61.24 Aligned_cols=31 Identities=32% Similarity=0.402 Sum_probs=27.6
Q ss_pred CCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 512 ~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4589999999999999888899999988764
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.003 Score=55.70 Aligned_cols=60 Identities=20% Similarity=0.119 Sum_probs=47.6
Q ss_pred cEEEcccCccC-CCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccC
Q 004732 187 TKLILRNCNIT-GELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAI 248 (733)
Q Consensus 187 ~~L~l~~n~l~-~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 248 (733)
..++.+++.|+ ..+|..+ -++|+.|+|++|+|+...+..|..+++|+.|+|++|++.+..
T Consensus 11 ~~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~CdC 71 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWRCDC 71 (130)
T ss_dssp TEEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCBCSG
T ss_pred CEEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCeeccC
Confidence 46788888887 3455433 236999999999999777778899999999999999997643
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.0037 Score=55.12 Aligned_cols=56 Identities=14% Similarity=0.323 Sum_probs=26.7
Q ss_pred eeeccCcccc-ccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCc
Q 004732 93 KLHLSSNNFT-GELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 150 (733)
Q Consensus 93 ~L~Ls~N~l~-~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 150 (733)
.++.+++.|+ ..+|..+. ++|+.|+|++|+|+...++.|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 4445555543 23332221 24555555555555444444555555555555555543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0031 Score=66.75 Aligned_cols=72 Identities=14% Similarity=0.154 Sum_probs=42.8
Q ss_pred CcccCCCcccEEEcccCC---------CcEEEEEEccccChhcHHHHHHHHHHHHhCCCCce-eeEeeEEEeCCeEEEEE
Q 004732 399 NNIGEGGFGPVYKGLLAD---------GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL-VKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~ 468 (733)
..|+.|....+|+....+ ++.+++|........ ..+...|.++++.+...++ .++++.. .+ ++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence 467778888999987654 268888887543221 1123568888877753333 3555443 22 6899
Q ss_pred EccCCCC
Q 004732 469 EYLENNS 475 (733)
Q Consensus 469 e~~~~gs 475 (733)
||++|..
T Consensus 114 e~i~G~~ 120 (369)
T 3c5i_A 114 EWLYGDP 120 (369)
T ss_dssp ECCCSEE
T ss_pred EEecCCc
Confidence 9998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.23 E-value=0.017 Score=55.04 Aligned_cols=103 Identities=16% Similarity=0.114 Sum_probs=69.0
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccccc
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR 553 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~ 553 (733)
-+|.++|...+.+++++++|.++.|.+++|.-+-.... + ..+=+.|..|++..+|.|...+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc------------
Confidence 38999999888899999999999999999877621100 1 1333457999999999988764 2211
Q ss_pred cccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCC
Q 004732 554 VAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSN 593 (733)
Q Consensus 554 ~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p 593 (733)
.....+.|||... ...+.+.=|||+|+++|.-+--..|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0112356777542 3456788999999999998865444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.18 E-value=0.019 Score=61.50 Aligned_cols=73 Identities=12% Similarity=0.122 Sum_probs=46.7
Q ss_pred CcccCCCcccEEEcccCC--------CcEEEEEEccccChhcHHHHHHHHHHHHhCCCCce-eeEeeEEEeCCeEEEEEE
Q 004732 399 NNIGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL-VKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e 469 (733)
+.+..|-...+|+....+ ++.|++++....... .-+..+|.++++.+.-.++ .++++.+ .+ ++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEE
Confidence 456678888999988653 578999986543221 1123568888887753333 3455432 22 78999
Q ss_pred ccCCCCH
Q 004732 470 YLENNSL 476 (733)
Q Consensus 470 ~~~~gsL 476 (733)
|++|..|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=90.82 E-value=0.43 Score=50.68 Aligned_cols=29 Identities=24% Similarity=0.418 Sum_probs=24.6
Q ss_pred eecCCCCCCcEEe------cCCCCeEEcccCcccc
Q 004732 514 VVHRDIKATNVLL------DKDLNSKISDFGLAKL 542 (733)
Q Consensus 514 ivH~Dik~~Nill------~~~~~~kl~DfGla~~ 542 (733)
++|+|+.+.|||+ +++..++++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4566799999998863
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.95 E-value=2 Score=40.65 Aligned_cols=114 Identities=8% Similarity=0.079 Sum_probs=79.3
Q ss_pred CCCceeeEeeEEEeCCeEEEEEEccCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEE
Q 004732 447 QHPNLVKLYGCCIEGNQLLLIYEYLENN-SLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVL 525 (733)
Q Consensus 447 ~h~niv~l~~~~~~~~~~~lV~e~~~~g-sL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nil 525 (733)
.||++++. .+-.+++.+.+.|+.-+.+ ++.. -...+...+++++..|+....+++.. +|--+.|+||+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-----ik~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~NL~ 111 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-----IKSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDELF 111 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-----GGGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGGEE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-----HHhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecceEE
Confidence 68998876 4555667666666654422 2222 24678899999999999988776643 78899999999
Q ss_pred ecCCCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCC
Q 004732 526 LDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 594 (733)
Q Consensus 526 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~ 594 (733)
++.++.+++.-.|+...+.+.. +.+| .=.-.+=+++..+++++..|
T Consensus 112 f~~~~~p~i~~RGik~~l~P~~-------------~~ee----------~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 112 FTRDGLPIAKTRGLQNVVDPLP-------------VSEA----------EFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp ECTTSCEEESCCEETTTBSCCC-------------CCHH----------HHHHHHHHHHHHHHCTTCCH
T ss_pred EcCCCCEEEEEccCccCCCCCC-------------CCHH----------HHHHHHHHHHHHHHcCCCCH
Confidence 9999999999888654322210 1122 22235677888899998776
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.55 E-value=4 Score=38.76 Aligned_cols=114 Identities=10% Similarity=0.097 Sum_probs=78.2
Q ss_pred CCCceeeEeeEEEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHcCCCCCeecCCCCCCcEE
Q 004732 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA-YLHGESRIKVVHRDIKATNVL 525 (733)
Q Consensus 447 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~ivH~Dik~~Nil 525 (733)
.||++ -..+-.+++.+.+.|+.-+++-=...+ ..++...+++++..|+.... +++. -+|--+.|+||+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~ 116 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM 116 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence 68888 334446677777778765444323333 36788999999999988777 6654 478889999999
Q ss_pred ecCCCCeEEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCC
Q 004732 526 LDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV 594 (733)
Q Consensus 526 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~ 594 (733)
+|.++.++|.-.|+-..+.+.. +.+|-+ .-.+=+++..++.++..|
T Consensus 117 f~~~~~p~i~hRGi~~~lpP~e-------------~~ee~f----------l~qyKali~all~~K~~F 162 (219)
T 4ano_A 117 FNRALEPFFLHVGVKESLPPDE-------------WDDERL----------LREVKATVLALTEGEYRF 162 (219)
T ss_dssp ECTTCCEEESCCEETTTBSSCS-------------CCHHHH----------HHHHHHHHHHHTTCSSCH
T ss_pred EeCCCcEEEEEcCCcccCCCCC-------------CCHHHH----------HHHHHHHHHHHHcCCCCH
Confidence 9999999999888754322211 222322 225667888888887655
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=82.40 E-value=0.23 Score=53.87 Aligned_cols=62 Identities=8% Similarity=0.124 Sum_probs=18.8
Q ss_pred cccCcccCCCcccEEEcccCC-CcEEEE------EEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe
Q 004732 396 ATDNNIGEGGFGPVYKGLLAD-GTAIAV------KQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE 460 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 460 (733)
...+.|| ||.||+|.+.. ..+||| |..+.. .......|.+|..+++.++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3445676 99999999754 367888 766542 22333568889999999999999999888653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 733 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-75 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-64 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-63 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 9e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-61 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-57 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-56 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-51 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-44 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-44 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-43 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-41 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-41 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-31 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-19 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-14 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-04 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-06 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 9e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 7e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 241 bits (615), Expect = 9e-75
Identities = 74/273 (27%), Positives = 127/273 (46%), Gaps = 16/273 (5%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 452
IG G FG VYKG A+ + +++ + Q + F NE+G++ +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
G QL ++ ++ E +SL L K + I A+G+ YLH +
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK--- 123
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKL-DEEENTHISTRVAGTIGYMAPEYAM---R 568
++HRD+K+ N+ L +DL KI DFGLA + +H +++G+I +MAPE +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 569 GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628
+ ++DVY+FGIV E+++G+ + + D + + +G L + SN
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNIN---NRDQIIFMVGRGYLSPDLSKVR-SNCP 239
Query: 629 KEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
K M + C RP +L +E
Sbjct: 240 KA----MKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 1e-68
Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 16/269 (5%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 452
+ IG G FG V+ G + +A+K + + +FI E ++ L HP LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
+LYG C+E + L++E++E+ L+ L R T +CL + G+AYL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE---EA 120
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
V+HRD+ A N L+ ++ K+SDFG+ + ++ ST + + +PE +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 573 EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632
K+DV+SFG++ E+ S + + +++E + T +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYEN------------RSNSEVVEDISTGFRLYKPRLAS 228
Query: 633 MVMINVALLCANASPTIRPSMSSVLRMLE 661
+ + C P RP+ S +LR L
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 5e-68
Identities = 77/270 (28%), Positives = 120/270 (44%), Gaps = 18/270 (6%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 452
+G G FG V+ G T +AVK L + F+ E ++ LQH LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHR-LKLDWPTRRRICLGIARGLAYLHGESR 511
+LY + + +I EY+EN SL L +KL + IA G+A++
Sbjct: 72 RLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---E 127
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 571
+HRD++A N+L+ L+ KI+DFGLA+L E+ I + APE G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 572 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631
T K+DV+SFGI+ EIV+ + + V++ + +V N +E
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRI-----PYPGMTNPEVIQNLERGYRMVRP---DNCPEE- 238
Query: 632 VMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ + LC P RP+ + +LE
Sbjct: 239 ---LYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 4e-67
Identities = 59/269 (21%), Positives = 105/269 (39%), Gaps = 16/269 (5%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 452
+ +G G FG V G +A+K + + EFI E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
+LYG C + + +I EY+ N L L E R + +C + + YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK--- 119
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
+ +HRD+ A N L++ K+SDFGL++ ++ S + + PE M +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 573 EKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQV 632
K+D+++FG++ EI S + + E +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERF------------TNSETAEHIAQGLRLYRPHLAS 227
Query: 633 MVMINVALLCANASPTIRPSMSSVLRMLE 661
+ + C + RP+ +L +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 214 bits (547), Expect = 7e-65
Identities = 65/287 (22%), Positives = 126/287 (43%), Gaps = 24/287 (8%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL 451
+ + +G G +G VY+G+ +AVK L + + EF+ E ++ ++HPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 452 VKLYGCCIEGNQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGES 510
V+L G C +I E++ +L L E R ++ + I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 132
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 570
+ +HRD+ A N L+ ++ K++DFGL++L + I + APE
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 571 LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630
+ K+DV++FG++ EI + + + ++ EL++ + +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPG------------IDLSQVYELLEKDYRMERPEG 240
Query: 631 QVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSSVSD 677
+ + C +P+ RPS + + + E + +SS+SD
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFE------TMFQESSISD 281
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 5e-64
Identities = 70/270 (25%), Positives = 117/270 (43%), Gaps = 18/270 (6%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 452
+ + +G+G FG V+ G T +A+K L F+ E ++ L+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLD-WPTRRRICLGIARGLAYLHGESR 511
+LY + ++ EY+ SL L K P + IA G+AY+ R
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---R 131
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 571
+ VHRD++A N+L+ ++L K++DFGLA+L E+ I + APE A+ G
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 572 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631
T K+DV+SFGI+ E+ + ++++ V+ E
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPG------------MVNREVLDQVERGYRMPCPPEC 239
Query: 632 VMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ ++ C P RP+ + LE
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 6e-64
Identities = 70/295 (23%), Positives = 127/295 (43%), Gaps = 33/295 (11%)
Query: 385 YLQIKAATNNFATDNN---------IGEGGFGPVYKGLLA----DGTAIAVKQL-SSKSK 430
+ A FA + + IG G FG V G L +A+K L S ++
Sbjct: 9 FEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE 68
Query: 431 QGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWP 490
+ R+F++E ++ HPN++ L G + +++I E++EN SL L ++ +
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 128
Query: 491 TRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550
+ GIA G+ YL + VHRD+ A N+L++ +L K+SDFGL++ E++ +
Sbjct: 129 QLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 551 STRVA----GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWA 606
+ A I + APE T +DV+S+GIV E++S +
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-------- 237
Query: 607 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
++ ++ + + + + L C RP ++ L+
Sbjct: 238 ----TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLD 288
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (542), Expect = 1e-63
Identities = 50/208 (24%), Positives = 101/208 (48%), Gaps = 10/208 (4%)
Query: 386 LQIKAATNNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNRE-FINEIGMI 443
+++K ++F + +G G G V+K G +A K + + K R I E+ ++
Sbjct: 1 MELK--DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 58
Query: 444 SALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 503
P +V YG ++ + E+++ SL + L + ++ ++ + + +GL
Sbjct: 59 HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGL 117
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
YL + K++HRD+K +N+L++ K+ DFG++ + GT YM+P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGR 591
E H + ++D++S G+ +E+ GR
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-63
Identities = 67/271 (24%), Positives = 119/271 (43%), Gaps = 24/271 (8%)
Query: 398 DNNIGEGGFGPVYKGLLA---DGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVK 453
D +G G FG V +G+ +A+K L +++ + E + E ++ L +P +V+
Sbjct: 14 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 73
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
L G C + L+L+ E L + L R ++ + ++ G+ YL +
Sbjct: 74 LIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---N 129
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR--VAGTIGYMAPEYAMRGHL 571
VHRD+ A NVLL +KISDFGL+K ++++ + R + + APE
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 572 TEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630
+ ++DV+S+G+ E +S G+ K ++ + EQGK ME P
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI----EQGKRMECPPECPPE----- 240
Query: 631 QVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ + C RP +V + +
Sbjct: 241 ----LYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 4e-63
Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 30/287 (10%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
IG+G FG V++G G +AVK SS+ ++ + EI L+H N++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 461 GN----QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE-----SR 511
N QL L+ +Y E+ SL L +R + ++ L A GLA+LH E +
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS---TRVAGTIGYMAPEY--- 565
+ HRD+K+ N+L+ K+ I+D GLA + I GT YMAPE
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 566 ---AMRGHLTEKADVYSFGIVALEIVSGR--SNVTKEDMFYLLDWALVLKEQGKLMELVD 620
++AD+Y+ G+V EI + ++ D ++ ++V
Sbjct: 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVC 246
Query: 621 TN------PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
P E + VM + C A+ R + + + L
Sbjct: 247 EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 9e-63
Identities = 71/277 (25%), Positives = 129/277 (46%), Gaps = 23/277 (8%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADGT-----AIAVKQLSSKSKQGNR-EFINEIGMISAL 446
+ IG G FG VYKG+L + +A+K L + + R +F+ E G++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 447 QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYL 506
H N+++L G + +++I EY+EN +L + L E + + GIA G+ YL
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 507 HGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPE 564
+ VHRD+ A N+L++ +L K+SDFGL+++ D+ E T+ ++ I + APE
Sbjct: 127 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 565 YAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624
T +DV+SFGIV E+++ E ++M+ ++
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL------------SNHEVMKAINDGFR 231
Query: 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ + + + C RP + ++ +L+
Sbjct: 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 6e-62
Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 24/271 (8%)
Query: 398 DNNIGEGGFGPVYKGLLAD---GTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLV 452
D +G G FG V KG +AVK L +++ E + E ++ L +P +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
++ G C E +L+ E E L + L ++R + + ++ G+ YL
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTR--VAGTIGYMAPEYAMRGH 570
VHRD+ A NVLL +KISDFGL+K + + + + + APE
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 571 LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630
+ K+DV+SFG++ E S + + + ++ +++
Sbjct: 187 FSSKSDVWSFGVLMWEAFS-----YGQKPYRGMK-------GSEVTAMLEKGERMGCPAG 234
Query: 631 QVMVMINVALLCANASPTIRPSMSSVLRMLE 661
M ++ LC RP ++V L
Sbjct: 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 1e-61
Identities = 76/264 (28%), Positives = 117/264 (44%), Gaps = 26/264 (9%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIE 460
IG+G FG V G G +AVK + + + + F+ E +++ L+H NLV+L G +E
Sbjct: 15 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 461 G-NQLLLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
L ++ EY+ SL L R L + L + + YL G VHRD
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRD 128
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
+ A NVL+ +D +K+SDFGL K + + APE + K+DV+
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKKFSTKSDVW 184
Query: 579 SFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMIN 637
SFGI+ EI S GR + + ++ E+G M+ D P + +
Sbjct: 185 SFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKGYKMDAPDGCPPA---------VYE 231
Query: 638 VALLCANASPTIRPSMSSVLRMLE 661
V C + +RPS + LE
Sbjct: 232 VMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 6e-61
Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 46/300 (15%)
Query: 401 IGEGGFGPVYKGLLA------DGTAIAVKQLSSKSKQGNRE-FINEIGMISAL-QHPNLV 452
+G G FG V + +AVK L + RE ++E+ ++S L H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 453 KLYGCCIEGNQLLLIYEYLENNSLARALFEHR-----------------LKLDWPTRRRI 495
L G C G L+I EY L L R L LD
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 496 CLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRV 554
+A+G+A+L + +HRD+ A N+LL +KI DFGLA+ + + N +
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 555 AGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK 614
+ +MAPE T ++DV+S+GI E+ S S+ + K
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS-----------PYPGMPVDSK 256
Query: 615 LMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVLDLVSDSS 674
+++ + M ++ C +A P RP+ +++++E +S+S+
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE------KQISEST 310
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-60
Identities = 70/277 (25%), Positives = 121/277 (43%), Gaps = 26/277 (9%)
Query: 394 NFATDNNIGEGGFGPVYKGLLAD----GTAIAVKQLSSKSKQGN-REFINEIGMISALQH 448
+F + IG G FG VY G L D AVK L+ + G +F+ E ++ H
Sbjct: 30 HF--NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87
Query: 449 PNLVKLYGCCIEG-NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 507
PN++ L G C+ L++ Y+++ L + L +A+G+ +L
Sbjct: 88 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL---DEEENTHISTRVAGTIGYMAPE 564
+ K VHRD+ A N +LD+ K++DFGLA+ E ++ H T + +MA E
Sbjct: 148 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 565 YAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624
T K+DV+SFG++ E+++ + + D + L + +L+
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGRRLL------QP 256
Query: 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ V L C + +RPS S ++ +
Sbjct: 257 EYCPDP----LYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 203 bits (518), Expect = 2e-60
Identities = 76/304 (25%), Positives = 126/304 (41%), Gaps = 54/304 (17%)
Query: 393 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNR-EFINEIGMISA 445
NN +IGEG FG V++ T +AVK L ++ + +F E +++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 446 LQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRL-------------------- 485
+PN+VKL G C G + L++EY+ L L
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 132
Query: 486 ---KLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK- 541
L + I +A G+AYL K VHRD+ N L+ +++ KI+DFGL++
Sbjct: 133 GPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRN 189
Query: 542 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR----SNVTKE 597
+ + A I +M PE T ++DV+++G+V EI S + E
Sbjct: 190 IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249
Query: 598 DMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVL 657
++ Y + G ++ + P + N+ LC + P RPS S+
Sbjct: 250 EVIYYV-------RDGNILACPENCPLE---------LYNLMRLCWSKLPADRPSFCSIH 293
Query: 658 RMLE 661
R+L+
Sbjct: 294 RILQ 297
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 5e-60
Identities = 72/291 (24%), Positives = 119/291 (40%), Gaps = 34/291 (11%)
Query: 376 AISLTYYGFYLQIKAATNNFATDNNIGEGGFGPVYKGLLAD-GTAIAVKQLSSK--SKQG 432
A+ ++ G +L+ D IG G F VYKGL + +A +L + +K
Sbjct: 1 AVGMSNDGRFLKF---------DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE 51
Query: 433 NREFINEIGMISALQHPNLVKLYGCCIE----GNQLLLIYEYLENNSLARALFEHRLKLD 488
+ F E M+ LQHPN+V+ Y ++L+ E + + +L L + +
Sbjct: 52 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMK 110
Query: 489 WPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS-KISDFGLAKLDEEEN 547
R C I +GL +LH ++HRD+K N+ + S KI D GLA L
Sbjct: 111 IKVLRSWCRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166
Query: 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWAL 607
+ V GT +MAPE E DVY+FG+ LE+ + ++ +
Sbjct: 167 ASFAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---- 221
Query: 608 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
+ ++FDK + + + C + R S+ +L
Sbjct: 222 -------YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-59
Identities = 73/301 (24%), Positives = 108/301 (35%), Gaps = 45/301 (14%)
Query: 393 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKSKQGNRE-FINEIGMISA 445
N +G G FG V +AVK L K+ RE ++E+ M++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 446 L-QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLK------------------ 486
L H N+V L G C + LI+EY L L R K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 487 ----LDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK- 541
L + +A+G+ +L VHRD+ A NVL+ KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 542 LDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY 601
+ + N + + +MAPE G T K+DV+S+GI+ EI S N
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI--- 270
Query: 602 LLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+L+ + + + C RPS ++ L
Sbjct: 271 --------PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
Query: 662 C 662
C
Sbjct: 323 C 323
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 5e-59
Identities = 63/264 (23%), Positives = 113/264 (42%), Gaps = 21/264 (7%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G+G FG VYK A K + +KS++ +++ EI ++++ HPN+VKL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
N L ++ E+ ++ + E L + +C L YLH K++HRD+
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 136
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-----RGHLTEK 574
KA N+L D + K++DFG++ + + + GT +MAPE M K
Sbjct: 137 KAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRPYDYK 195
Query: 575 ADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 634
ADV+S GI +E+ + + +L + K + + +
Sbjct: 196 ADVWSLGITLIEMAEIEPPHHELNPMRVLL--KIAKSEPPTLAQPS-----RWSSN---- 244
Query: 635 MINVALLCANASPTIRPSMSSVLR 658
+ C + R + S +L+
Sbjct: 245 FKDFLKKCLEKNVDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-58
Identities = 70/268 (26%), Positives = 113/268 (42%), Gaps = 24/268 (8%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
IG G +G K +DG + K+L S ++ + ++E+ ++ L+HPN+V+ Y
Sbjct: 12 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 71
Query: 458 CIE--GNQLLLIYEYLENNSLARALFEH---RLKLDWPTRRRICLGIARGLAYLH--GES 510
I+ L ++ EY E LA + + R LD R+ + L H +
Sbjct: 72 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 131
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 570
V+HRD+K NV LD N K+ DFGLA++ +T + GT YM+PE R
Sbjct: 132 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKAFVGTPYYMSPEQMNRMS 190
Query: 571 LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630
EK+D++S G + E+ + T L K+ E + E
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG---------KIREGKFRRIPYRYSDE 241
Query: 631 QVMVMINVALLCANASPTIRPSMSSVLR 658
+ + N RPS+ +L
Sbjct: 242 ----LNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 197 bits (502), Expect = 5e-58
Identities = 76/302 (25%), Positives = 129/302 (42%), Gaps = 35/302 (11%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGN---REFINEIGMISALQHPNLVKLYG 456
IG G FG VY + + +A+K++S KQ N ++ I E+ + L+HPN ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
C + + L+ EY ++ H+ L + G +GLAYLH ++H
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEV-HKKPLQEVEIAAVTHGALQGLAYLH---SHNMIH 138
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM---RGHLTE 573
RD+KA N+LL + K+ DFG A + N+ + GT +MAPE + G
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVILAMDEGQYDG 193
Query: 574 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633
K DV+S GI +E+ + + + L Q + L ++ +
Sbjct: 194 KVDVWSLGITCIELAERKPPLFNMNAMSALYHIA----QNESPAL----QSGHWSEY--- 242
Query: 634 VMINVALLCANASPTIRPSMSSVLRM-----LECGVDVLDLVS--DSSVSDIDETKAEAM 686
N C P RP+ +L+ ++DL+ +V ++D + M
Sbjct: 243 -FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKM 301
Query: 687 RK 688
+K
Sbjct: 302 KK 303
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 9e-58
Identities = 64/268 (23%), Positives = 121/268 (45%), Gaps = 23/268 (8%)
Query: 401 IGEGGFGPVYKGLLAD-----GTAIAVKQLS-SKSKQGNREFINEIGMISALQHPNLVKL 454
+G G FG VYKGL +A+K+L + S + N+E ++E +++++ +P++ +L
Sbjct: 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 76
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
G C+ + LI + + L + EH+ + C+ IA+G+ YL ++
Sbjct: 77 LGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RL 132
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRGHLTE 573
VHRD+ A NVL+ + KI+DFGLAK L EE + + I +MA E + T
Sbjct: 133 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 192
Query: 574 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633
++DV+S+G+ E+++ S ++ +++ +
Sbjct: 193 QSDVWSYGVTVWELMTFGSKPYDGI------------PASEISSILEKGERLPQPPICTI 240
Query: 634 VMINVALLCANASPTIRPSMSSVLRMLE 661
+ + + C RP ++
Sbjct: 241 DVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-57
Identities = 76/270 (28%), Positives = 113/270 (41%), Gaps = 19/270 (7%)
Query: 393 NNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPN 450
++ +GEG +G V A+AVK + K E EI + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+VK YG EGN L EY L + + P +R + G+ YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLH--- 120
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVAGTIGYMAPEYAMRG 569
I + HRDIK N+LLD+ N KISDFGLA + ++ GT+ Y+APE R
Sbjct: 121 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 570 HL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628
E DV+S GIV +++G + KE+ + NP D
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYL-----NPWKKID 233
Query: 629 KEQVMVMINVALLCANASPTIRPSMSSVLR 658
+ ++ +L N P+ R ++ + +
Sbjct: 234 SAPLALLH--KILVEN--PSARITIPDIKK 259
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 2e-57
Identities = 69/267 (25%), Positives = 113/267 (42%), Gaps = 23/267 (8%)
Query: 401 IGEGGFGPVYKGLLAD----GTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLY 455
IGEG FG V++G+ A+A+K + + RE F+ E + HP++VKL
Sbjct: 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 456 GCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVV 515
G E N + +I E L L + LD + ++ LAYL + V
Sbjct: 75 GVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFV 130
Query: 516 HRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKA 575
HRDI A NVL+ + K+ DFGL++ E+ + +++ I +MAPE T +
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSAS 190
Query: 576 DVYSFGIVALEI-VSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMV 634
DV+ FG+ EI + G ++ E G+ + + N
Sbjct: 191 DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGERLPMPP-----NCPPT---- 237
Query: 635 MINVALLCANASPTIRPSMSSVLRMLE 661
+ ++ C P+ RP + + L
Sbjct: 238 LYSLMTKCWAYDPSRRPRFTELKAQLS 264
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-56
Identities = 63/270 (23%), Positives = 106/270 (39%), Gaps = 25/270 (9%)
Query: 393 NNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQH 448
+F +G+G FG VY +A+K L + E+ + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 508
PN+++LYG + ++ LI EY ++ R L + K D +A L+Y H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCH- 123
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 568
+V+HRDIK N+LL KI+DFG + + GT+ Y+ PE
Sbjct: 124 --SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEG 178
Query: 569 GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628
EK D++S G++ E + G+ + + + + V
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK--RISRVEFTFPDFVTEG------ 230
Query: 629 KEQVMVMINVALLCANASPTIRPSMSSVLR 658
++ +P+ RP + VL
Sbjct: 231 ------ARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-56
Identities = 63/271 (23%), Positives = 113/271 (41%), Gaps = 26/271 (9%)
Query: 401 IGEGGFGPVYKGLL----ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVK 453
+G+G FG V +G ++AVK L + +FI E+ + +L H NL++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
LYG + + ++ E SL L +H+ T R + +A G+ YL +
Sbjct: 76 LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKR 131
Query: 514 VVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH--ISTRVAGTIGYMAPEYAMRGHL 571
+HRD+ A N+LL KI DFGL + + + H + + APE
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 572 TEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630
+ +D + FG+ E+ + G+ + +L + ++G+ + + P
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK---IDKEGERLPRPEDCPQD----- 243
Query: 631 QVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ NV + C P RP+ ++ L
Sbjct: 244 ----IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 2e-56
Identities = 72/289 (24%), Positives = 119/289 (41%), Gaps = 37/289 (12%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADG---TAIAVKQLS-SKSKQGNREFINEIGMISAL-Q 447
N+ + IGEG FG V K + A+K++ SK +R+F E+ ++ L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRL---------------KLDWPTR 492
HPN++ L G C L L EY + +L L + R+ L
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 493 RRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552
+ARG+ YL + + +HRD+ A N+L+ ++ +KI+DFGL++ E T
Sbjct: 130 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--T 184
Query: 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ 612
+ +MA E T +DV+S+G++ EIVS + + A
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLG-----GTPYCGMTCA------ 233
Query: 613 GKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+L E + + ++ C P RPS + +L L
Sbjct: 234 -ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 8e-56
Identities = 70/259 (27%), Positives = 116/259 (44%), Gaps = 18/259 (6%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IG+G G VY + +A G +A++Q++ + + INEI ++ ++PN+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
G++L ++ EYL SL + E +D +C + L +LH +V+HRDI
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLH---SNQVIHRDI 142
Query: 520 KATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYS 579
K+ N+LL D + K++DFG E + ST V GT +MAPE R K D++S
Sbjct: 143 KSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 580 FGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVA 639
GI+A+E++ G + + L NP +
Sbjct: 202 LGIMAIEMIEGEP------PYLNENPLRALYLIATNGTPELQNP-EKLSAI----FRDFL 250
Query: 640 LLCANASPTIRPSMSSVLR 658
C + R S +L+
Sbjct: 251 NRCLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 187 bits (475), Expect = 9e-54
Identities = 58/269 (21%), Positives = 111/269 (41%), Gaps = 18/269 (6%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL 451
+++ +G G FG V++ A G A K + + + EI +S L+HP L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 452 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
V L+ + N++++IYE++ L + + K+ + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---E 142
Query: 512 IKVVHRDIKATNVLLDKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 569
VH D+K N++ ++ K+ DFGL + + + T GT + APE A
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGK 200
Query: 570 HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629
+ D++S G+++ ++SG S F + L+ +D + S +
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLS------PFGGENDDETLRNVKSCDWNMDDSAFSGISE 254
Query: 630 EQVMVMINVALLCANASPTIRPSMSSVLR 658
+ + A P R ++ L
Sbjct: 255 D----GKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 2e-53
Identities = 71/288 (24%), Positives = 124/288 (43%), Gaps = 36/288 (12%)
Query: 393 NNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLS-SKSKQGNREFINEIGMISA 445
+G+G FG VY+G+ T +A+K ++ + S + EF+NE ++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 446 LQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHR---------LKLDWPTRRRIC 496
++V+L G +G L+I E + L L R ++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 497 LGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEENTHISTRVA 555
IA G+AYL+ K VHRD+ A N ++ +D KI DFG+ + + E + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 556 GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK--EQG 613
+ +M+PE G T +DV+SFG+V EI + E + L VL+ +G
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA-----EQPYQGLSNEQVLRFVMEG 251
Query: 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
L++ D P + + +C +P +RPS ++ ++
Sbjct: 252 GLLDKPDNCPDM---------LFELMRMCWQYNPKMRPSFLEIISSIK 290
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 181 bits (461), Expect = 8e-52
Identities = 60/261 (22%), Positives = 102/261 (39%), Gaps = 18/261 (6%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G G FG V++ + A G K +++ NEI +++ L HP L+ L+
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
+ +++LI E+L L + K+ GL ++H +VH DI
Sbjct: 97 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDI 153
Query: 520 KATNVLLDKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 577
K N++ + S KI DFGLA + T T + APE R + D+
Sbjct: 154 KPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYTDM 211
Query: 578 YSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMIN 637
++ G++ ++SG S ED L V + + D + S+ E +
Sbjct: 212 WAIGVLGYVLLSGLSPFAGEDDLETLQ--NVKRCDWEF----DEDAFSSVSPE----AKD 261
Query: 638 VALLCANASPTIRPSMSSVLR 658
P R ++ L
Sbjct: 262 FIKNLLQKEPRKRLTVHDALE 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-51
Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 39/294 (13%)
Query: 393 NNFATDNNIGEGGFGPVYKGL------LADGTAIAVKQLSSKSKQG-NREFINEIGMISA 445
+ +G G FG V + A +AVK L + +R ++E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 446 -LQHPNLVKLYGCCIE-GNQLLLIYEYLENNSLARALFEHRLK---------------LD 488
H N+V L G C + G L++I E+ + +L+ L R + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 489 WPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK-LDEEEN 547
+A+G+ +L K +HRD+ A N+LL + KI DFGLA+ + ++ +
Sbjct: 133 LEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWAL 607
+ +MAPE T ++DV+SFG++ EI S + + + +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA--SPYPGVKIDEEFC 247
Query: 608 VLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
++G M D M L C + P+ RP+ S ++ L
Sbjct: 248 RRLKEGTRMRAPDYTTPE---------MYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-51
Identities = 70/295 (23%), Positives = 120/295 (40%), Gaps = 41/295 (13%)
Query: 393 NNFATDNNIGEGGFGPVYKGLL--------ADGTAIAVKQLSSKSKQGN-REFINEIGMI 443
+ +GEG FG V T +AVK L S + + + + I+E+ M+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 444 SAL-QHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRL---------------KL 487
+ +H N++ L G C + L +I EY +L L R +L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 488 DWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547
+ARG+ YL K +HRD+ A NVL+ +D KI+DFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 548 THISTRVA-GTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWA 606
+ T + +MAPE T ++DV+SFG++ EI + + +
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-----GSPYPGVPVE 244
Query: 607 LVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+L +L+ + + + C +A P+ RP+ ++ L+
Sbjct: 245 -------ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 9e-50
Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 9/208 (4%)
Query: 389 KAATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMIS 444
K +F +GEG F V LA A+K L + + E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 445 ALQHPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 504
L HP VKLY + +L Y +N L + + + D R I L
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALE 122
Query: 505 YLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL-DEEENTHISTRVAGTIGYMAP 563
YLH ++HRD+K N+LL++D++ +I+DFG AK+ E + GT Y++P
Sbjct: 123 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGR 591
E + +D+++ G + ++V+G
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (418), Expect = 2e-46
Identities = 57/260 (21%), Positives = 102/260 (39%), Gaps = 15/260 (5%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHPNLVKLYGCC 458
+G G F V +A+K ++ K+ +G NEI ++ ++HPN+V L
Sbjct: 17 LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY 76
Query: 459 IEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRD 518
G L LI + + L + E R+ + + YLH + +
Sbjct: 77 ESGGHLYLIMQLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKP 135
Query: 519 IKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVY 578
LD+D ISDFGL+K+ E+ + + GT GY+APE + ++ D +
Sbjct: 136 ENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCW 193
Query: 579 SFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINV 638
S G++A ++ G E+ L + +LK + + D+ + +
Sbjct: 194 SIGVIAYILLCGYPPFYDENDAKLFE--QILKAEYEF----DSPYWDDISDS----AKDF 243
Query: 639 ALLCANASPTIRPSMSSVLR 658
P R + L+
Sbjct: 244 IRHLMEKDPEKRFTCEQALQ 263
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-46
Identities = 44/261 (16%), Positives = 96/261 (36%), Gaps = 19/261 (7%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G G FG V++ + + K + K EI +++ +H N++ L+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFE 71
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
+L++I+E++ + + +L+ + L +LH + H DI
Sbjct: 72 SMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHFDI 128
Query: 520 KATNVLLDKDLNS--KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 577
+ N++ +S KI +FG A+ + + Y APE ++ D+
Sbjct: 129 RPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTATDM 186
Query: 578 YSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMIN 637
+S G + ++SG + E +++ ++ + D E ++
Sbjct: 187 WSLGTLVYVLLSGINPFLAETNQQIIE--NIMNAEYTF----DEEAFKEISIE----AMD 236
Query: 638 VALLCANASPTIRPSMSSVLR 658
R + S L+
Sbjct: 237 FVDRLLVKERKSRMTASEALQ 257
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 165 bits (419), Expect = 6e-46
Identities = 65/207 (31%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 393 NNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQ- 447
N+F+ IG GGFG VY G A+K L K KQG +NE M+S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 448 --HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAY 505
P +V + ++L I + + L L +H + R I GL +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-SEADMRFYAAEIILGLEH 122
Query: 506 LHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEY 565
+H VV+RD+K N+LLD+ + +ISD GLA ++ H S GT GYMAPE
Sbjct: 123 MH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 176
Query: 566 AMRG-HLTEKADVYSFGIVALEIVSGR 591
+G AD +S G + +++ G
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (409), Expect = 3e-45
Identities = 53/271 (19%), Positives = 88/271 (32%), Gaps = 21/271 (7%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
IG G FG +Y G +A G +A+K K+K + E + +Q + C
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 460 EGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDI 519
++ L SL K T + + + Y+H +HRD+
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDV 129
Query: 520 KATNVL---LDKDLNSKISDFGLAKLDEEENTHI------STRVAGTIGYMAPEYAMRGH 570
K N L K I DFGLAK + TH + + GT Y + +
Sbjct: 130 KPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE 189
Query: 571 LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630
+ + D+ S G V + G + + + K M + E
Sbjct: 190 QSRRDDLESLGYVLMYFNLGSLPW--QGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247
Query: 631 QVMVMINVALLCANASPTIRPSMSSVLRMLE 661
C + +P S + ++
Sbjct: 248 ----FATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 7e-45
Identities = 63/291 (21%), Positives = 110/291 (37%), Gaps = 27/291 (9%)
Query: 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE-FINEIGMISALQHP 449
+ + IGEG +G V + +A+K++S Q + + EI ++ +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 450 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFE--HRLKLDWPTRRRICLGIARGLAYLH 507
N++ + + YL + + L++ L I RGL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYMAPEY 565
V+HRD+K +N+LL+ + KI DFGLA++ + ++T T T Y APE
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 566 AMRGHL-TEKADVYSFGIVALEIVSGRS---NVTKEDMFYLLDWALVLKEQGKLMELVDT 621
+ T+ D++S G + E++S R D + L Q L +++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 622 NPGSNFDKEQVMVMINVALLCANAS--------------PTIRPSMSSVLR 658
+ + L NA P R + L
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-44
Identities = 59/218 (27%), Positives = 94/218 (43%), Gaps = 10/218 (4%)
Query: 393 NNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNRE---FINEIGMIS-ALQ 447
+F +G+G FG V+ A+K L + + + E ++S A +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 448 HPNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLH 507
HP L ++ L + EYL L + K D I GL +LH
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLH 120
Query: 508 GESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 567
+V+RD+K N+LLDKD + KI+DFG+ K + + +T GT Y+APE +
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILL 176
Query: 568 RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDW 605
D +SFG++ E++ G+S +D L
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS 214
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 160 bits (405), Expect = 2e-44
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 393 NNFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSK---SKQGNREFINEIGMISALQH 448
+F +G G FG V+ +G A+K L + + +E M+S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 508
P +++++G + Q+ +I +Y+E L +L + P + + L YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGEL-FSLLRKSQRFPNPVAKFYAAEVCLALEYLH- 121
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 568
+++RD+K N+LLDK+ + KI+DFG AK + + GT Y+APE
Sbjct: 122 --SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVVST 175
Query: 569 GHLTEKADVYSFGIVALEIVSGRS 592
+ D +SFGI+ E+++G +
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 2e-44
Identities = 67/293 (22%), Positives = 122/293 (41%), Gaps = 30/293 (10%)
Query: 391 ATNNFATDNNIGEGGFGPVYKG--LLADGTAIAVKQLSSKSKQGN--REFINEIGMISAL 446
A + IGEG +G V+K L G +A+K++ ++ + I E+ ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 447 ---QHPNLVKLYGCCIEG-----NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLG 498
+HPN+V+L+ C +L L++E+++ + + T + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 499 IARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTI 558
+ RGL +LH +VVHRD+K N+L+ K++DFGLA++ + T V T+
Sbjct: 125 LLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTL 179
Query: 559 GYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR---SNVTKEDMFYLL----------DW 605
Y APE ++ D++S G + E+ + + D + DW
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 606 ALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
+ + P F + + ++ L C +P R S S L
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 158 bits (400), Expect = 4e-44
Identities = 64/283 (22%), Positives = 115/283 (40%), Gaps = 21/283 (7%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPN 450
+ IGEG +G VYK G A+K++ + + I EI ++ L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+VKLY +L+L++E+L+ + L+ T + L + G+AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCH--- 117
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 570
+V+HRD+K N+L++++ KI+DFGLA+ + +
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 571 LTEKADVYSFGIVALEIVSGR---SNVTKEDMFYLL----------DWALV--LKEQGKL 615
+ D++S G + E+V+G V++ D + +W V L +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237
Query: 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
+ + P +F K I++ P R + L
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 157 bits (398), Expect = 6e-44
Identities = 56/281 (19%), Positives = 107/281 (38%), Gaps = 25/281 (8%)
Query: 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLS---SKSKQGNREFINEIGMISALQ 447
++ + +G GG V+ L +AVK L ++ F E +AL
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 448 HPNLVKLYGCCIE----GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 503
HP +V +Y G ++ EY++ +L + + + + L
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQAL 124
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL--DEEENTHISTRVAGTIGYM 561
+ H + ++HRD+K N+++ K+ DFG+A+ D + + V GT Y+
Sbjct: 125 NFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 562 APEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621
+PE A + ++DVYS G V E+++G F V + + + +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEP------PFTGDSPVSVAYQHVREDPIPPS 235
Query: 622 NPGSNFDKEQVMVMINVALLCANASPTIRP-SMSSVLRMLE 661
+ + V L +P R + + + L
Sbjct: 236 ARHEGLSAD----LDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 7e-44
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 6/201 (2%)
Query: 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPN 450
NF IGEG +G VYK G +A+K++ ++++ I EI ++ L HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+VKL N+L L++E+L + + P + + +GLA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 119
Query: 511 RIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGH 570
+V+HRD+K N+L++ + K++DFGLA+ + V +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 571 LTEKADVYSFGIVALEIVSGR 591
+ D++S G + E+V+ R
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRR 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 157 bits (397), Expect = 7e-44
Identities = 50/275 (18%), Positives = 105/275 (38%), Gaps = 33/275 (12%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS---------SKSKQGNREFINEIGMISALQ-HP 449
+G G V + + AVK + + ++ + E+ ++ + HP
Sbjct: 11 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 70
Query: 450 NLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
N+++L L+++ ++ L L E L R+I + + LH
Sbjct: 71 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALH-- 127
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-- 567
++ +VHRD+K N+LLD D+N K++DFG + + V GT Y+APE
Sbjct: 128 -KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGTPSYLAPEIIECS 184
Query: 568 ----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNP 623
++ D++S G++ +++G +L +++ + +
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR--MIMSGNYQF----GSPE 238
Query: 624 GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658
++ + ++ P R + L
Sbjct: 239 WDDYSDT----VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 155 bits (393), Expect = 3e-43
Identities = 48/282 (17%), Positives = 95/282 (33%), Gaps = 25/282 (8%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PN 450
++ IGEG FG +++G L + +A+K +S + +E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES 510
+ +Y EG +L+ + L + L K T + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDL-LDLCGRKFSVKTVAMAAKQMLARVQSIH--- 118
Query: 511 RIKVVHRDIKATNVLLDKDLNS-----KISDFGLAKLDEEENTHI------STRVAGTIG 559
+V+RDIK N L+ + + + DFG+ K + T ++GT
Sbjct: 119 EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 178
Query: 560 YMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELV 619
YM+ + + + D+ + G V + + G + L A ++ ++ E
Sbjct: 179 YMSINTHLGREQSRRDDLEALGHVFMYFLRGS------LPWQGLKAATNKQKYERIGEKK 232
Query: 620 DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661
+ P N + P + +
Sbjct: 233 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-42
Identities = 61/280 (21%), Positives = 115/280 (41%), Gaps = 26/280 (9%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQG-----NREFINEIGMISALQHPNLVKL 454
+GEG F VYK +A+K++ + NR + EI ++ L HPN++ L
Sbjct: 6 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65
Query: 455 YGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKV 514
+ + L+++++E + + ++ L L + L +GL YLH + +
Sbjct: 66 LDAFGHKSNISLVFDFMETDLE-VIIKDNSLVLTPSHIKAYMLMTLQGLEYLH---QHWI 121
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL-TE 573
+HRD+K N+LLD++ K++DFGLAK N + +V T Y APE +
Sbjct: 122 LHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGARMYGV 180
Query: 574 KADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVM 633
D+++ G + E++ + + L + D ++ +
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 634 VMINVALLCANAS--------------PTIRPSMSSVLRM 659
I + + + A P R + + L+M
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 4e-41
Identities = 49/203 (24%), Positives = 81/203 (39%), Gaps = 17/203 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE------FINEIGMISALQ--HPNL 451
+G GGFG VY G+ ++D +A+K + E E+ ++ + +
Sbjct: 12 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 452 VKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESR 511
++L + +LI E E R L R + + + H
Sbjct: 72 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCH---N 128
Query: 512 IKVVHRDIKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RG 569
V+HRDIK N+L+D + K+ DFG L ++ T GT Y PE+
Sbjct: 129 CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRYHR 185
Query: 570 HLTEKADVYSFGIVALEIVSGRS 592
+ A V+S GI+ ++V G
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDI 208
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 6e-41
Identities = 59/269 (21%), Positives = 100/269 (37%), Gaps = 27/269 (10%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNR------EFINEIGMISALQHPNLVK 453
+G G F V K + G A K + + + +R + E+ ++ +QHPN++
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 454 LYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIK 513
L+ ++LI E + L L E L I G+ YLH ++
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLH---SLQ 133
Query: 514 VVHRDIKATNVLLDKD----LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRG 569
+ H D+K N++L KI DFGLA + N + GT ++APE
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNIFGTPEFVAPEIVNYE 191
Query: 570 HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629
L +AD++S G++ ++SG F L + + SN
Sbjct: 192 PLGLEADMWSIGVITYILLSGA------SPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 630 EQVMVMINVALLCANASPTIRPSMSSVLR 658
+ P R ++ L+
Sbjct: 246 L----AKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 1e-39
Identities = 53/267 (19%), Positives = 94/267 (35%), Gaps = 24/267 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCC- 458
+G G G V + A+K L + RE E+ A Q P++V++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREV--EL-HWRASQCPHIVRIVDVYE 75
Query: 459 ---IEGNQLLLIYEYLENNSLARALFEHRLK-LDWPTRRRICLGIARGLAYLHGESRIKV 514
LL++ E L+ L + + + I I + YLH I +
Sbjct: 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINI 132
Query: 515 VHRDIKATNVLLDKDLNS---KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHL 571
HRD+K N+L + K++DFG AK N+ + T Y+APE
Sbjct: 133 AHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGPEKY 190
Query: 572 TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631
+ D++S G++ ++ G + G+ S +E
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE--FPNPEWSEVSEE- 247
Query: 632 VMVMINVALLCANASPTIRPSMSSVLR 658
+ + PT R +++ +
Sbjct: 248 ---VKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 55/208 (26%), Positives = 84/208 (40%), Gaps = 18/208 (8%)
Query: 394 NFATDNNIGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV 452
++ IG G FG VY+ L G +A+K++ + NRE + ++ L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRE----LQIMRKLDHCNIV 76
Query: 453 KLYGCCIEGNQ------LLLIYEYLENNSLARALFEHRLK--LDWPTRRRICLGIARGLA 504
+L + L L+ +Y+ A R K L + + R LA
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 505 YLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
Y+H + HRDIK N+LLD D K+ DFG AK + +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ-LVRGEPNVSYICSRYYRAPE 192
Query: 564 EYAMRGHLTEKADVYSFGIVALEIVSGR 591
T DV+S G V E++ G+
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 7e-38
Identities = 52/206 (25%), Positives = 96/206 (46%), Gaps = 19/206 (9%)
Query: 401 IGEGGFGPVYKG-LLADGTAIAVKQLSSKSKQGN--REFINEIGMISALQHPNLVKLYGC 457
IG+G FG V+K G +A+K++ ++++ + EI ++ L+H N+V L
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 458 CIEG--------NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
C + L++++ E++ +K +R+ + GL Y+H
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIH-- 134
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK---LDEEENTHISTRVAGTIGYMAPEYA 566
R K++HRD+KA NVL+ +D K++DFGLA+ L + + T T+ Y PE
Sbjct: 135 -RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELL 193
Query: 567 MRGHL-TEKADVYSFGIVALEIVSGR 591
+ D++ G + E+ +
Sbjct: 194 LGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-37
Identities = 63/216 (29%), Positives = 90/216 (41%), Gaps = 9/216 (4%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQH 448
N+F +G+G FG V A G A+K L + +K + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 449 PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 508
P L L ++L + EY L L R R I L YLH
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLH- 122
Query: 509 ESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMR 568
VV+RDIK N++LDKD + KI+DFGL K + + T GT Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLED 179
Query: 569 GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD 604
D + G+V E++ GR +D L +
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-37
Identities = 41/195 (21%), Positives = 83/195 (42%), Gaps = 7/195 (3%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
IGEG +G V+K +A+K++ + + EI ++ L+H N+V+L+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHR 517
+L L++E+ + + + D + + +GL + H V+HR
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDL-DPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 518 DIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADV 577
D+K N+L++++ K+++FGLA+ S V + D+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 578 YSFGIVALEIVSGRS 592
+S G + E+ +
Sbjct: 186 WSAGCIFAELANAGR 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (350), Expect = 9e-37
Identities = 47/209 (22%), Positives = 88/209 (42%), Gaps = 12/209 (5%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNRE---FINEIGMISALQHPNLVKLYG 456
+G G FG V G A+K L + ++ +NE ++ A+ P LVKL
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 457 CCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVH 516
+ + L ++ EY+ + L + P R I YLH + +++
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH---SLDLIY 164
Query: 517 RDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKAD 576
RD+K N+L+D+ +++DFG AK + + GT +APE + + D
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPEIILSKGYNKAVD 220
Query: 577 VYSFGIVALEIVSGRSNVTKEDMFYLLDW 605
++ G++ E+ +G + + +
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQIYEK 249
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 1e-35
Identities = 46/198 (23%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQL--SSKSKQGNREFINEIGMISALQHPNLVKLYGC 457
+G G +G V + G +A+K+L +S+ + E+ ++ ++H N++ L
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 458 CIEGNQLLLIYEYLENNSLARALFEHRLK---LDWPTRRRICLGIARGLAYLHGESRIKV 514
L ++ +K L + + + +GL Y+H +
Sbjct: 86 FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIH---AAGI 142
Query: 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM-RGHLTE 573
+HRD+K N+ +++D KI DFGLA+ + E T T Y APE + T+
Sbjct: 143 IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGY----VVTRWYRAPEVILNWMRYTQ 198
Query: 574 KADVYSFGIVALEIVSGR 591
D++S G + E+++G+
Sbjct: 199 TVDIWSVGCIMAEMITGK 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (326), Expect = 1e-33
Identities = 49/235 (20%), Positives = 92/235 (39%), Gaps = 24/235 (10%)
Query: 385 YLQIKAATNNFATDNN------IGEGGFGPVYKGL-LADGTAIAVKQLS--SKSKQGNRE 435
+ ++ + F IG G G V +A+K+LS +++ +
Sbjct: 3 FYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR 62
Query: 436 FINEIGMISALQHPNLVKLYGCCI------EGNQLLLIYEYLENNSLARALFEHRLKLDW 489
E+ ++ + H N++ L E + L+ E ++ N +++LD
Sbjct: 63 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC----QVIQMELDH 118
Query: 490 PTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549
+ + G+ +LH ++HRD+K +N+++ D KI DFGLA+
Sbjct: 119 ERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
Query: 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLD 604
T T Y APE + E D++S G + E+V + D +
Sbjct: 176 --TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 2e-32
Identities = 38/206 (18%), Positives = 84/206 (40%), Gaps = 18/206 (8%)
Query: 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPN 450
+++ +G G + V++ + + + + VK L K+ + EI ++ L+ PN
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPN 91
Query: 451 LVKLYGCCIE--GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHG 508
++ L + L++E++ N + L R I + L Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTD----FKQLYQTLTDYDIRFYMYEILKALDYCH- 146
Query: 509 ESRIKVVHRDIKATNVLLDKDLNS-KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAM 567
+ ++HRD+K NV++D + ++ D+GLA+ + + + PE +
Sbjct: 147 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLV 202
Query: 568 R-GHLTEKADVYSFGIVALEIVSGRS 592
D++S G + ++ +
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 1e-31
Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 393 NNFATDNNIGEGGFGPVYKGLLA----DGTAIAVKQLS----SKSKQGNREFINEIGMIS 444
NF +G G +G V+ G A+K L + + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 445 ALQH-PNLVKLYGCCIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGL 503
++ P LV L+ +L LI +Y+ L L + + + I L
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLAL 142
Query: 504 AYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAP 563
+LH ++ +++RDIK N+LLD + + ++DFGL+K + T + GTI YMAP
Sbjct: 143 EHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 564 EYAMRGH--LTEKADVYSFGIVALEIVSGR 591
+ G + D +S G++ E+++G
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 5e-31
Identities = 48/199 (24%), Positives = 86/199 (43%), Gaps = 16/199 (8%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLS--SKSKQGNREFINEIGMISALQHPNLVKLYGC 457
+G G +G V G +AVK+LS +S + E+ ++ ++H N++ L
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 458 CIEGNQL-----LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRI 512
L + + +L L KL + + I RGL Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIH---SA 140
Query: 513 KVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLT 572
++HRD+K +N+ +++D KI DFGLA+ + ++ VA H
Sbjct: 141 DIIHRDLKPSNLAVNEDCELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWMHYN 197
Query: 573 EKADVYSFGIVALEIVSGR 591
+ D++S G + E+++GR
Sbjct: 198 QTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 110 bits (276), Expect = 5e-27
Identities = 43/209 (20%), Positives = 79/209 (37%), Gaps = 21/209 (10%)
Query: 401 IGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCI 459
+G G F V+ + + T +A+K + K +EI ++ + + K
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 460 E---------------GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLA 504
G +++++E L N LA + ++I + GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 505 YLHGESRIKVVHRDIKATNVLLDK-DLNSKISDFGLAKL-DEEENTHISTRVAGTIGYMA 562
Y+H I +H DIK NVL++ D + +A L + T T Y +
Sbjct: 140 YMHRRCGI--IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197
Query: 563 PEYAMRGHLTEKADVYSFGIVALEIVSGR 591
PE + AD++S + E+++G
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 1e-21
Identities = 29/158 (18%), Positives = 49/158 (31%), Gaps = 20/158 (12%)
Query: 401 IGEGGFGPVYKGLLADGTAIAVK----------QLSSKSKQGNREFINEIGMISALQHPN 450
+GEG V+ VK ++ K G+ F + +
Sbjct: 8 MGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRA 67
Query: 451 LVKLYGCCIEGNQLLLIYEYLENNSL-ARALFEHRLKLDWPTRRRICLGIARGLAYLHGE 509
L KL G + Y + N L + ++ + I +A +
Sbjct: 68 LQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY-- 120
Query: 510 SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547
+VH D+ NVL+ + I DF + EE
Sbjct: 121 -HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG 156
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 87.0 bits (214), Expect = 6e-19
Identities = 46/195 (23%), Positives = 84/195 (43%), Gaps = 13/195 (6%)
Query: 70 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI 129
L NQ S P + + NL++L L+ N T A LTN+ D +++NQ +
Sbjct: 202 LIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLA 257
Query: 130 PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKL 189
P + TKL +L + + ++ P + +L N E P +T L
Sbjct: 258 P--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNE---NQLEDISPISNLKNLTYL 312
Query: 190 ILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 249
L NI+ P + +TKL+ L + N++ S+ +L +++++ N ++ P
Sbjct: 313 TLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP 368
Query: 250 PWMLERGDKIDLSYN 264
L R ++ L+
Sbjct: 369 LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 72.7 bits (177), Expect = 3e-14
Identities = 39/188 (20%), Positives = 72/188 (38%), Gaps = 17/188 (9%)
Query: 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99
LT L+ + N++ P ++ L L++ NQ L SL NL L L++N
Sbjct: 196 LTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANN 251
Query: 100 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSF-IQNWTKLEKLFIQPSGLAGPIPSGIF 158
+ P + LT + + ++ NQ + P + T LE Q ++
Sbjct: 252 QISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 159 SLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSF 217
+ L ISD+ + ++ K+ +L N ++ L +T + L
Sbjct: 310 TYLTLYFNNISDI-------SPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 218 NRLRGQIP 225
N++ P
Sbjct: 361 NQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 60.0 bits (144), Expect = 4e-10
Identities = 19/84 (22%), Positives = 34/84 (40%), Gaps = 6/84 (7%)
Query: 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99
L L ++L N + P +++++ L L N+ S L +L N+ L N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHN 361
Query: 100 NFTGELPKTFAKLTNMKDFRISDN 123
+ P A LT + ++D
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 48.5 bits (114), Expect = 2e-06
Identities = 46/283 (16%), Positives = 86/283 (30%), Gaps = 51/283 (18%)
Query: 35 PKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKL 94
LAE L + + + ++ + L + + L NL ++
Sbjct: 19 TALAEKMKTV---LGKTNVTDTVSQ--TDLDQVTTLQADRLGIKS--IDGVEYLNNLTQI 71
Query: 95 HLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSF---------------------- 132
+ S+N T P LT + D +++NQ P
Sbjct: 72 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLK 129
Query: 133 --------------IQNWTKLEKLFIQPSGLAGPIPSGIFSLENLT--DLRISDLNGPEA 176
I + + L L G + + L NLT + N
Sbjct: 130 NLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD 189
Query: 177 TFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDY 236
+ LI N I+ P + +T L L L+ N+L+ L ++
Sbjct: 190 ISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTD 245
Query: 237 IYFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRS 279
+ A N ++ P L + ++ L N ++ S + +
Sbjct: 246 LDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALT 288
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 3e-04
Identities = 16/76 (21%), Positives = 27/76 (35%), Gaps = 5/76 (6%)
Query: 152 PIPSGIFSLENLTDLRISDLNGPEAT--FPQLGNMKMTKLILRNCNITGELPRYLGKMTK 209
PI IF+ L + + L T Q ++T L I + + +
Sbjct: 11 PINQ-IFTDTALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIK-SIDG-VEYLNN 67
Query: 210 LKVLDLSFNRLRGQIP 225
L ++ S N+L P
Sbjct: 68 LTQINFSNNQLTDITP 83
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.5 bits (192), Expect = 2e-16
Identities = 42/260 (16%), Positives = 87/260 (33%), Gaps = 10/260 (3%)
Query: 80 ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKL 139
++P++L + L L +N T F L N+ + +N+ + P KL
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 140 EKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGE 199
E+L++ + L +L+ L ++ F L M + +L +G
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGI 141
Query: 200 LPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKI 259
M KL + ++ + L ++ GN +T + +
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITTIPQGLPPSL---TELHLDGNKITKVDAASLKGLNNLA 198
Query: 260 DLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKTYYSLHINCGGKQVTANGNTTFEED 319
L + + + ++ + L + + K L + + V + N +
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNN-----N 253
Query: 320 TSEAGPSTFSQSGTNWVLSS 339
S G + F G N +S
Sbjct: 254 ISAIGSNDFCPPGYNTKKAS 273
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.2 bits (191), Expect = 2e-16
Identities = 46/239 (19%), Positives = 82/239 (34%), Gaps = 10/239 (4%)
Query: 41 TFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNN 100
+ L N++ N+ L L + N+ S P L+ LE+L+LS N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 101 FTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSL 160
K L ++ + + + + +E L P +G +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQGM 149
Query: 161 ENLTDLRISDLNG---PEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSF 217
+ L+ +RI+D N P+ P L T+L L IT L + L L LSF
Sbjct: 150 KKLSYIRIADTNITTIPQGLPPSL-----TELHLDGNKITKVDAASLKGLNNLAKLGLSF 204
Query: 218 NRLRGQIPSNFDDLYDVDYIYFAG-NLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSC 275
N + + + + ++ L+ + + L NN + + C
Sbjct: 205 NSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 70.9 bits (172), Expect = 6e-14
Identities = 67/255 (26%), Positives = 102/255 (40%), Gaps = 29/255 (11%)
Query: 24 LKEQNLTGV--LPPKLAELTFLQDISLIAN-RLKGPIPKYLANISTLVNLTVQYNQFSGE 80
L NL +P LA L +L + + L GPIP +A ++ L L + + SG
Sbjct: 57 LSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 81 LPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLE 140
+P+ L + L L S N +G LP + + L N+ N+ +G IP +++KL
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 141 KLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLI---------- 190
F+ NL + +S G+ K T+ I
Sbjct: 177 TSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236
Query: 191 --------------LRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDY 236
LRN I G LP+ L ++ L L++SFN L G+IP +L D
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDV 295
Query: 237 IYFAGN-LLTGAIPP 250
+A N L G+ P
Sbjct: 296 SAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 46.7 bits (109), Expect = 5e-06
Identities = 16/73 (21%), Positives = 25/73 (34%), Gaps = 1/73 (1%)
Query: 10 FHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVN 69
L+ + G LP L +L FL +++ N L G IP+ N+
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDV 295
Query: 70 LTVQYNQFSGELP 82
N+ P
Sbjct: 296 SAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 40.5 bits (93), Expect = 4e-04
Identities = 45/235 (19%), Positives = 74/235 (31%), Gaps = 53/235 (22%)
Query: 86 GSLLNLEKLHLSSNNFTG--ELPKTFAKLTNMKDFRISDN-QFTGQIPSFIQNWTKLEKL 142
+ L LS N +P + A L + I G IP I T+L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 143 FIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLI-LRNCNITGELP 201
+I + ++G IP + ++ L L S P + ++ I I+G +P
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 202 RYLGKMTKLKVLDLSF-NRLRGQIPSNFDDLYDVD------------------------- 235
G +KL NRL G+IP F +L
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKI 226
Query: 236 ---------------------YIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFT 267
+ N + G +P + L+ +++S+NN
Sbjct: 227 HLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (148), Expect = 5e-11
Identities = 32/192 (16%), Positives = 60/192 (31%), Gaps = 6/192 (3%)
Query: 80 ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKL 139
+P + + +++ L N + +F N+ + N + L
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 140 EKLFIQPSGLAGPIPSGIFS-LENLTDLRISDLNGPEATFP-QLGNMKMTKLILRNCNIT 197
E+L + + + F L L L + E G + L L++ +
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 198 GELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP--WMLER 255
+ L L L NR+ F L+ +D + N + P L R
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 256 GDKIDLSYNNFT 267
+ L NN +
Sbjct: 203 LMTLYLFANNLS 214
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.8 bits (148), Expect = 6e-11
Identities = 41/218 (18%), Positives = 73/218 (33%), Gaps = 7/218 (3%)
Query: 7 FLVFHFWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANIST 66
F + Q + L V P L L + L L+ P ++
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130
Query: 67 LVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFT 126
L L +Q N + L NL L L N + + F L ++ + N+
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 127 GQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD--LNGPEATFPQLGNM 184
P ++ +L L++ + L+ + L L LR++D P +
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWL 250
Query: 185 KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRG 222
+ K + + LP+ L + L+ N L+G
Sbjct: 251 Q--KFRGSSSEVPCSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.5 bits (124), Expect = 7e-08
Identities = 47/209 (22%), Positives = 73/209 (34%), Gaps = 8/209 (3%)
Query: 65 STLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 124
+ + + N+ S + NL L L SN F L ++ +SDN
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 125 FTGQI-PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENL--TDLRISDLNG-PEATFPQ 180
+ P+ +L L + GL P L L L+ + L P+ TF
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 181 LGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFA 240
LGN+ L L I+ R + L L L NR+ P F DL + +Y
Sbjct: 152 LGNLTH--LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 241 GNLLTGAIPPWMLERGD--KIDLSYNNFT 267
N L+ + + L+ N +
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 1e-08
Identities = 27/272 (9%), Positives = 85/272 (31%), Gaps = 39/272 (14%)
Query: 44 QDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTG 103
Q + L L + L + ++ + L E S ++ + LS++
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 104 E-LPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL--AGPIPSGIFSL 160
L ++ + +++ + + + I + + + L +L + + + + S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 161 ENLT--------------------------------DLRISDLNGPEATFPQLGNMKMTK 188
L R + +T + +
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 189 LILRNCNITGELPRYLGKMTKLKVLDLSF-NRLRGQIPSNFDDLYDVDYIYFAGNLLTGA 247
+ + + + + ++ L+ L LS + + ++ + + G + G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 248 IPPWMLERGDKIDLSYNNFTDGSAESSCQKRS 279
+ + E + ++ ++FT + + K++
Sbjct: 241 L-QLLKEALPHLQINCSHFTTIARPTIGNKKN 271
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 2e-07
Identities = 34/202 (16%), Positives = 55/202 (27%), Gaps = 26/202 (12%)
Query: 63 NISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISD 122
+++ + + + LP +L + LHLS N T T + +
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 123 NQFTGQIPSFI--------------------QNWTKLEKLFIQPSGLAGPIPSGIFSLEN 162
+ T + +P G
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 163 LTDLRISDLNGPEATFPQL--GNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRL 220
N + P L K+ KL L N N+T L + L L L N L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 221 RGQIPSNFDDLYDVDYIYFAGN 242
IP F + + + + GN
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (104), Expect = 2e-05
Identities = 27/205 (13%), Positives = 54/205 (26%), Gaps = 26/205 (12%)
Query: 39 ELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98
++ +++ L +P L L + N L L +L+L
Sbjct: 8 KVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 99 NNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGL--------- 149
T + D + Q + + T L+ F + + L
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 150 -----------AGPIPSGIFSLENLTDLRISDLNGPEATFPQL--GNMKMTKLILRNCNI 196
+P G+ + + N L G + L+L+ ++
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 197 TGELPRYLGKMTKLKVLDLSFNRLR 221
+P+ L L N
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 3e-07
Identities = 13/84 (15%), Positives = 27/84 (32%), Gaps = 9/84 (10%)
Query: 60 YLANISTLVNLTVQYNQFSGE----LPEELGSLLNLEKLHLSSNNFTGELPKTFAK---- 111
S L L + S L L + +L +L LS+N +
Sbjct: 364 LGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQ 423
Query: 112 -LTNMKDFRISDNQFTGQIPSFIQ 134
++ + D ++ ++ +Q
Sbjct: 424 PGCLLEQLVLYDIYWSEEMEDRLQ 447
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 3e-06
Identities = 16/74 (21%), Positives = 25/74 (33%), Gaps = 12/74 (16%)
Query: 159 SLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGE----LPRYLGKMTKLKVLD 214
E L+D R ++L P L + + L +C +T + L L L+
Sbjct: 10 QCEELSDARWAEL------LPLLQQCQ--VVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 215 LSFNRLRGQIPSNF 228
L N L
Sbjct: 62 LRSNELGDVGVHCV 75
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 5e-06
Identities = 16/115 (13%), Positives = 34/115 (29%), Gaps = 7/115 (6%)
Query: 89 LNLEKLHLSSNNFTGE-LPKTFAKLTNMKDFRISDNQFTGQ----IPSFIQNWTKLEKLF 143
L+++ L + + + L + R+ D T I S ++ L +L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 144 IQPSGLAGPIPSGIFSL--ENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNI 196
++ + L + ++ L T G + T L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQE 116
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.0 bits (104), Expect = 3e-05
Identities = 14/89 (15%), Positives = 33/89 (37%), Gaps = 10/89 (11%)
Query: 90 NLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFTGQIPSFI-----QNWTKLE 140
L L L+ + + L T ++++ +S+N + Q LE
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 141 KLFIQPSGLAGPIPSGIFSL-ENLTDLRI 168
+L + + + + +L ++ LR+
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 6e-05
Identities = 13/81 (16%), Positives = 26/81 (32%), Gaps = 9/81 (11%)
Query: 41 TFLQDISLIANRLKG----PIPKYLANISTLVNLTVQYNQFSGELPEELGSLL-----NL 91
+ L+ + L + + L +L L + N +L + L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428
Query: 92 EKLHLSSNNFTGELPKTFAKL 112
E+L L ++ E+ L
Sbjct: 429 EQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 2e-04
Identities = 12/106 (11%), Positives = 33/106 (31%), Gaps = 10/106 (9%)
Query: 43 LQDISLIANRLK-GPIPKYLANISTLVNLTVQYNQFSGELPEELGSLL----NLEKLHLS 97
+Q + + L + L + + + + +++ S L L +L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 98 SNNFTGELPKTFAKL-----TNMKDFRISDNQFTGQIPSFIQNWTK 138
SN + ++ + + TG + + +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR 109
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 12/51 (23%), Positives = 18/51 (35%), Gaps = 4/51 (7%)
Query: 182 GNMKMTKLILRNCNITGE----LPRYLGKMTKLKVLDLSFNRLRGQIPSNF 228
+ L L +C+++ L L L+ LDLS N L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQL 417
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 2e-06
Identities = 21/89 (23%), Positives = 32/89 (35%), Gaps = 9/89 (10%)
Query: 51 NRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFA 110
N I +L L V N+ ELP LE+L S N+ E+P+
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA-EVPEL-- 322
Query: 111 KLTNMKDFRISDNQFTGQIPSFIQNWTKL 139
N+K + N + P ++ L
Sbjct: 323 -PQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 6e-06
Identities = 24/91 (26%), Positives = 41/91 (45%), Gaps = 9/91 (9%)
Query: 73 QYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSF 132
N S E+ +LE+L++S+N ELP +L + S N ++P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPEL 322
Query: 133 IQNWTKLEKLFIQPSGLAGPIPSGIFSLENL 163
QN L++L ++ + L P S+E+L
Sbjct: 323 PQN---LKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 4e-05
Identities = 24/130 (18%), Positives = 42/130 (32%), Gaps = 29/130 (22%)
Query: 94 LHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPI 153
LHL+ + T +L + +S N+ P+
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPAL--------------------- 39
Query: 154 PSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITG-ELPRYLGKMTKLKV 212
+L L L+ SD N E ++ +L+L N + + L +L +
Sbjct: 40 ----AALRCLEVLQASD-NALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 94
Query: 213 LDLSFNRLRG 222
L+L N L
Sbjct: 95 LNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.2 bits (96), Expect = 6e-05
Identities = 21/86 (24%), Positives = 36/86 (41%), Gaps = 3/86 (3%)
Query: 189 LILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAI 248
L L + ++T +L ++ + LDLS NRLR P+ L ++ + + N L
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVD 59
Query: 249 PPWMLERGDKIDLSYNNFTDGSAESS 274
L R ++ L N +A
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQP 85
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.001
Identities = 19/101 (18%), Positives = 29/101 (28%), Gaps = 4/101 (3%)
Query: 70 LTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI 129
L + + + L LL + L LS N P A L ++ + SDN +
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE-NV 58
Query: 130 PSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISD 170
E L + S L L +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 99
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 9e-05
Identities = 27/216 (12%), Positives = 56/216 (25%), Gaps = 13/216 (6%)
Query: 62 ANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 121
++ + + + + + + L + L T + L N+ +
Sbjct: 16 PALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELK 71
Query: 122 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQL 181
DNQ T + L K+ + P
Sbjct: 72 DNQIT-----DLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 182 GNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAG 241
G + L L IT P + S + + +L + +
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYL----SIGNAQVSDLTPLANLSKLTTLKADD 182
Query: 242 NLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQK 277
N ++ P L ++ L N +D S ++
Sbjct: 183 NKISDISPLASLPNLIEVHLKNNQISDVSPLANTSN 218
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 21/65 (32%), Positives = 31/65 (47%), Gaps = 5/65 (7%)
Query: 60 YLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFR 119
LAN+S L L N+ S L SL NL ++HL +N + P A +N+
Sbjct: 168 PLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVT 223
Query: 120 ISDNQ 124
++ NQ
Sbjct: 224 LT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 34/212 (16%), Positives = 61/212 (28%), Gaps = 22/212 (10%)
Query: 40 LTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99
L I+ + + + A++ + L+ + E + L NL L L N
Sbjct: 18 LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 100 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFS 159
T P + + + I T S +
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 160 L--------------ENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYL 204
L +S N + L N+ K+T L + I+ P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 205 GKMTKLKVLDLSFNRLRGQIP-SNFDDLYDVD 235
+ L + L N++ P +N +L+ V
Sbjct: 192 ASLPNLIEVHLKNNQISDVSPLANTSNLFIVT 223
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.9 bits (97), Expect = 1e-04
Identities = 31/188 (16%), Positives = 56/188 (29%), Gaps = 16/188 (8%)
Query: 35 PKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKL 94
AE L + + + ++++ + + + L N+ KL
Sbjct: 21 DAFAETIKDN---LKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKL 73
Query: 95 HLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIP 154
L+ N T K A L N+ + +N+ K L +
Sbjct: 74 FLNGNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 155 SGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLD 214
+ N K+ L L + I+ +P L +TKL+ L
Sbjct: 132 HLPQ-----LESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLY 184
Query: 215 LSFNRLRG 222
LS N +
Sbjct: 185 LSKNHISD 192
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 32/191 (16%), Positives = 67/191 (35%), Gaps = 11/191 (5%)
Query: 87 SLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQP 146
+ K +L + T + + +L ++ +++ IQ + KLF+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 147 SGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGK 206
+ L + I L NL +L L+ + L + L
Sbjct: 78 NKL-----TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 207 MTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNF 266
+ +L+ L L N++ L +D + N ++ +P L + + LS N+
Sbjct: 133 LPQLESLYLGNNKITDIT--VLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHI 190
Query: 267 TDGSAESSCQK 277
+D A + +
Sbjct: 191 SDLRALAGLKN 201
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 39.3 bits (90), Expect = 7e-04
Identities = 21/178 (11%), Positives = 46/178 (25%), Gaps = 23/178 (12%)
Query: 62 ANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 121
++ + + + + + L + L L N+ S
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFS 70
Query: 122 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQL 181
+NQ T P + P+ + P L
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 182 GNMKMTKLILR-----------------NCNITGELPRYLGKMTKLKVLDLSFNRLRG 222
++++ + + +T P L +T L+ LD+S N++
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSD 186
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 35/190 (18%), Positives = 61/190 (32%), Gaps = 11/190 (5%)
Query: 88 LLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPS 147
L K L N T + + L + + ++ L ++ +
Sbjct: 17 LAEKMKTVLGKTNVTDTV--SQTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 72
Query: 148 GLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELPRYLGKM 207
+ I L+NLT L +N + L N L +
Sbjct: 73 -----QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 127
Query: 208 TKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFT 267
T L L+LS N + S L + + F+ N +T P L +++D+S N +
Sbjct: 128 TNLNRLELSSNTI--SDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVS 185
Query: 268 DGSAESSCQK 277
D S +
Sbjct: 186 DISVLAKLTN 195
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.9 bits (91), Expect = 8e-04
Identities = 11/74 (14%), Positives = 25/74 (33%), Gaps = 4/74 (5%)
Query: 80 ELPEELGSLLNLEKLHLSSNNFTGE----LPKTFAKLTNMKDFRISDNQFTGQIPSFIQN 135
+ L +++++ LS N E L + A +++ SD +
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 136 WTKLEKLFIQPSGL 149
L + ++ L
Sbjct: 82 LRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.5 bits (90), Expect = 0.001
Identities = 16/59 (27%), Positives = 26/59 (44%), Gaps = 6/59 (10%)
Query: 178 FPQLGNMKMTKLILRNCNITGELPRYL-----GKMTKLKVLDLSFNRLRGQIPSNFDDL 231
F +L N+ + L L+ I + R L KM L L+L+ NR + D++
Sbjct: 267 FSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEI 324
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 23/147 (15%), Positives = 44/147 (29%), Gaps = 3/147 (2%)
Query: 179 PQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYI 237
Q N + +L LR I + + + +D S N +R +
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLLRRLKTLLV 70
Query: 238 YFAGNLLTGAIPPWMLERGDKIDLSYNNFTDGSAESSCQKRSVTGIVSCLRSVQCPKTYY 297
G L ++ L+ N+ + + LR+ K +Y
Sbjct: 71 NNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHY 130
Query: 298 SLHINCGGKQVTA-NGNTTFEEDTSEA 323
L++ QV + ++ EA
Sbjct: 131 RLYVIYKVPQVRVLDFQKVKLKERQEA 157
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (86), Expect = 0.002
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 7/96 (7%)
Query: 156 GIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITG--ELPRYLGKMTKLKVL 213
I + N + L E P+L L L N + ++ + K LK+L
Sbjct: 42 NIDVVLNRRSSMAATLRIIEENIPEL-----LSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96
Query: 214 DLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 249
+LS N L+ + + ++ ++ GN L+
Sbjct: 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.7 bits (84), Expect = 0.003
Identities = 19/134 (14%), Positives = 46/134 (34%), Gaps = 5/134 (3%)
Query: 12 FWKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLT 71
++ ++ L + L P L ++ ++ + NI L++L
Sbjct: 15 IMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAAT-LRIIEENIPELLSLN 71
Query: 72 VQYNQFSG--ELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQI 129
+ N+ ++ + NL+ L+LS N E K +++ + N +
Sbjct: 72 LSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131
Query: 130 PSFIQNWTKLEKLF 143
+ + + F
Sbjct: 132 RDQSTYISAIRERF 145
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 733 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.98 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.95 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.9 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.89 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.88 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.78 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.75 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.75 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.74 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.73 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.67 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.56 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.56 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.56 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.55 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.54 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.51 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.48 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.42 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.4 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.37 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.36 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.36 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.32 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.53 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.5 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.01 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.82 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.61 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.46 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.29 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.11 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.79 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.26 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.62 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=428.19 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=202.5
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
++|+..+.||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 467788999999999999999888899999999754 3345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+|+|.+++......++|..+..++.|||+||+|||+.+ |+||||||+|||+++++.+||+|||+|+...........
T Consensus 84 ~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 84 HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 99999999877778999999999999999999999986 999999999999999999999999999876655444445
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCC-CCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSN-VTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
...||+.|+|||++.+..++.++|||||||++|||+|++.| +............ . .+.... .+ ...
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i---~-~~~~~~--~p---~~~---- 227 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---S-TGFRLY--KP---RLA---- 227 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH---H-HTCCCC--CC---TTS----
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH---H-hcCCCC--Cc---ccc----
Confidence 56799999999999999999999999999999999996444 5444433333221 1 111111 11 112
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
...+.+++.+||+.||++||||+||++.|+++.
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~ 260 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 235889999999999999999999999998643
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=420.59 Aligned_cols=259 Identities=29% Similarity=0.455 Sum_probs=204.6
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|...+.||+|+||+||+|++. ..||||+++.. .....+.|.+|++++++++|||||++++++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467888999999999999999864 35999998654 34456789999999999999999999998754 56899999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc-
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT- 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~- 548 (733)
||++|+|.+++......+++..+..++.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCc
Confidence 99999999999877778999999999999999999999986 99999999999999999999999999987654322
Q ss_pred ccccccccCCCcccHHHHhh---CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.......||+.|+|||++.+ ..++.++|||||||++|||+||+.||............ ...+....... ....
T Consensus 161 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~---~~~~~~~p~~~-~~~~ 236 (276)
T d1uwha_ 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM---VGRGYLSPDLS-KVRS 236 (276)
T ss_dssp -----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH---HHHTSCCCCGG-GSCT
T ss_pred ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH---HhcCCCCCcch-hccc
Confidence 23455789999999999975 35899999999999999999999999654433222111 11121111111 1111
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.++ ..+.+++.+||+.||++|||+.||++.|+.+.
T Consensus 237 ~~~----~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 237 NCP----KAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp TCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cch----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 222 34889999999999999999999999998654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.5e-52 Score=426.42 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=214.4
Q ss_pred hhhcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 390 AATNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 390 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
...++|...+.||+|+||+||+|++ .+|+.||||+++.. ....++|.+|++++++++|||||+++++|.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 3456788889999999999999995 46889999998754 334678999999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 469 EYLENNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||++|+|.+++.. ....+++..+..++.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999999975 4567899999999999999999999986 9999999999999999999999999999776655
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCcc-chhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKE-DMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+... +...+... ...+....
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~----i~~~~~~~--------- 236 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----LEKDYRME--------- 236 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----HHTTCCCC---------
T ss_pred ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHH----HhcCCCCC---------
Confidence 55455567899999999999999999999999999999999987776433 33222221 11121111
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.+......+.+++.+||+.||++|||+.||++.|+.+
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~ 273 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111234588999999999999999999999999854
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.9e-52 Score=428.55 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=201.4
Q ss_pred cCccccCcccCCCcccEEEcccC-CC---cEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DG---TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
++|+..+.||+|+||+||+|++. ++ ..||||.+... .....++|.+|+++|++++|||||+++|+|.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 45667789999999999999854 33 36899998654 444557899999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
||||++|+|.+++......++|.++.+++.|||+||+|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 9999999999999877778999999999999999999999986 9999999999999999999999999998765433
Q ss_pred ccc----ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 548 THI----STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 548 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
... .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||.......+.... ..+....
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i----~~~~~~~----- 253 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI----EQDYRLP----- 253 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HTTCCCC-----
T ss_pred CcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCC-----
Confidence 221 223468999999999999999999999999999999998 89999766555444322 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.+.+....+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 254 ----~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 254 ----PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111223458899999999999999999999999986543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-51 Score=414.66 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=216.6
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5788999999999999999999888899999997643 345789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccccc
Q 004732 473 NNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIST 552 (733)
Q Consensus 473 ~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 552 (733)
+|+|.+++......+++..+++++.|+|+||+|||+.+ |+||||||+|||++.++.+||+|||+++...........
T Consensus 83 ~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 83 NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp TEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred CCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 99999998877778999999999999999999999986 999999999999999999999999999876655554455
Q ss_pred ccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 553 RVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 553 ~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
...||+.|+|||.+.+..++.++|||||||++|||+| |+.||........... . ..+..... ....
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~---i-~~~~~~~~-----p~~~---- 226 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---I-AQGLRLYR-----PHLA---- 226 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH---H-HTTCCCCC-----CTTC----
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH---H-HhCCCCCC-----cccc----
Confidence 5679999999999999999999999999999999998 8999976654443321 1 11211111 1122
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
...+.+++.+||+.||++|||+++|++.|..
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 2358899999999999999999999998853
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=422.29 Aligned_cols=253 Identities=31% Similarity=0.459 Sum_probs=209.3
Q ss_pred hcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
.++|...+.||+|+||+||+|++++++.||||++.... ...+.|.+|++++++++|||||+++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 45788889999999999999999888999999997543 345789999999999999999999998754 5679999999
Q ss_pred CCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 472 ENNSLARALF-EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 472 ~~gsL~~~l~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
++|+|.+++. .....++|..+.+++.|||+||+|||+.+ |+||||||+|||+++++.+||+|||+|+.........
T Consensus 90 ~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~ 166 (272)
T d1qpca_ 90 ENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA 166 (272)
T ss_dssp TTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred CCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccc
Confidence 9999999876 33346999999999999999999999986 9999999999999999999999999999876655555
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCC-CccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV-TKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....||+.|+|||++.++.++.++|||||||++|||+||+.|+ ............ ..+..... ....+
T Consensus 167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i----~~~~~~~~-----p~~~~- 236 (272)
T d1qpca_ 167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL----ERGYRMVR-----PDNCP- 236 (272)
T ss_dssp CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTTCCCCC-----CTTCC-
T ss_pred ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCCCC-----cccCh-
Confidence 55677999999999999999999999999999999999976665 333333332221 11111111 11222
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
..+.+++.+||+.||++||||+||++.|+.
T Consensus 237 ---~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 237 ---EELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 348899999999999999999999999884
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=414.75 Aligned_cols=249 Identities=27% Similarity=0.462 Sum_probs=209.5
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
++|...+.||+|+||+||+|+ ..+|+.||||++........+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 479999999999999999998 5679999999987655555678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
++|+|.+++... .+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+....... ..
T Consensus 100 ~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~~ 173 (293)
T d1yhwa1 100 AGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-KR 173 (293)
T ss_dssp TTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-CB
T ss_pred CCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-cc
Confidence 999999987653 6999999999999999999999996 99999999999999999999999999987654332 23
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHH
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQ 631 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (733)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...+......... ..... . ...+...
T Consensus 174 ~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~~~~-~-------~~~~~~~ 242 (293)
T d1yhwa1 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA---TNGTP-E-------LQNPEKL 242 (293)
T ss_dssp CCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH---HHCSC-C-------CSSGGGS
T ss_pred cccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHH---hCCCC-C-------CCCcccC
Confidence 45679999999999999999999999999999999999999997665443332111 11110 0 0111122
Q ss_pred HHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 632 VMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 632 ~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+.+++.+||+.||++|||+.|+++
T Consensus 243 s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 345889999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-50 Score=416.83 Aligned_cols=253 Identities=26% Similarity=0.405 Sum_probs=208.0
Q ss_pred cCccccCc-ccCCCcccEEEcccC---CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 393 NNFATDNN-IGEGGFGPVYKGLLA---DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 393 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
++|...+. ||+|+||+||+|++. ++..||||+++.. .....++|.+|+++|++++|||||+++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 34555564 999999999999753 3557999999754 34455789999999999999999999999864 568999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
||||++|+|.+++...+..+++.++.+++.|||+||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 87 mE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 163 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163 (285)
T ss_dssp EECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccc
Confidence 9999999999998877778999999999999999999999986 9999999999999999999999999998765443
Q ss_pred cc--cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 548 TH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 548 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
.. ......||+.|+|||++.+..++.++|||||||++|||+| |+.||............ ..+...+..
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i----~~~~~~~~p----- 234 (285)
T d1u59a_ 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI----EQGKRMECP----- 234 (285)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH----HTTCCCCCC-----
T ss_pred cccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH----HcCCCCCCC-----
Confidence 32 2334568999999999999999999999999999999998 89999765544333221 222222211
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
...+ ..+.+++.+||+.||++||||.+|++.|+.
T Consensus 235 ~~~~----~~l~~li~~cl~~~p~~RPs~~~i~~~L~~ 268 (285)
T d1u59a_ 235 PECP----PELYALMSDCWIYKWEDRPDFLTVEQRMRA 268 (285)
T ss_dssp TTCC----HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred CcCC----HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1222 358899999999999999999999998874
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-50 Score=409.63 Aligned_cols=245 Identities=26% Similarity=0.400 Sum_probs=206.8
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|...+.||+|+||+||+|+. .+|+.||||++... .......+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5788899999999999999995 57899999998643 2234567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
|||++|+|.+++... ..+++..+..++.||++||+|||+++ ||||||||+|||++.++.+||+|||+|+......
T Consensus 86 Ey~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~- 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR- 160 (263)
T ss_dssp ECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC-
T ss_pred eecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCc-
Confidence 999999999999754 47999999999999999999999986 9999999999999999999999999998654332
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ ..... ......
T Consensus 161 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i----~~~~~------~~p~~~- 227 (263)
T d2j4za1 161 --RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI----SRVEF------TFPDFV- 227 (263)
T ss_dssp --CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HTTCC------CCCTTS-
T ss_pred --ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCC------CCCccC-
Confidence 23467999999999999999999999999999999999999999766554433211 11110 011112
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+.+++.+||+.||++|||+.|+++
T Consensus 228 ---s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 228 ---TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp ---CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 235888999999999999999999976
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=418.19 Aligned_cols=258 Identities=26% Similarity=0.436 Sum_probs=203.9
Q ss_pred hcCccccCcccCCCcccEEEcccCCC-----cEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLADG-----TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
..+|+..++||+|+||+||+|.+... ..||||++... ......+|.+|++++++++|||||+++|+|.+++..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35678889999999999999986532 37999998654 3344567999999999999999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+|||||.+|++.+.+......++|.++.+++.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999998877778999999999999999999999986 99999999999999999999999999987654
Q ss_pred cCc--ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCc-cchhhHHHHHHHHHhhCcccccccCC
Q 004732 546 ENT--HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTK-EDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 546 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.. .......... ..+...
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i----~~~~~~------ 232 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI----NDGFRL------ 232 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH----HTTCCC------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH----hccCCC------
Confidence 322 223345689999999999999999999999999999999997766633 3333222211 111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
..+......+.+++.+||+.||++||||.||++.|+++..
T Consensus 233 ---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 233 ---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp ---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 1111223458899999999999999999999999986544
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-50 Score=415.98 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=209.4
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
+.|+..+.||+|+||+||+|+ ..+|+.||||++........+.|.+|++++++++|||||++++++.+++..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 467888999999999999999 4578999999997766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
++|+|.+++.+....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...... ...
T Consensus 92 ~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~~ 167 (288)
T d2jfla1 92 AGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 167 (288)
T ss_dssp TTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HHH
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-ccc
Confidence 999999998776678999999999999999999999996 9999999999999999999999999997654322 123
Q ss_pred cccccCCCcccHHHHh-----hCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 552 TRVAGTIGYMAPEYAM-----RGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
....||+.|+|||++. ...|+.++|||||||++|||++|+.||...+........ . ...... ..
T Consensus 168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i--~--~~~~~~-------~~ 236 (288)
T d2jfla1 168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI--A--KSEPPT-------LA 236 (288)
T ss_dssp TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH--H--HSCCCC-------CS
T ss_pred cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH--H--cCCCCC-------CC
Confidence 4567999999999984 456899999999999999999999999766554433211 1 111111 11
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.+......+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 237 QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122345889999999999999999999876
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=412.58 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=196.1
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe--CCeEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE--GNQLLLI 467 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 467 (733)
++|+..+.||+|+||+||+|+ ..+|+.||||.+... .....+.+.+|++++++++|||||++++++.+ +...++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 578899999999999999998 467999999998654 33345678999999999999999999999975 4568999
Q ss_pred EEccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC--CCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 468 YEYLENNSLARALFE---HRLKLDWPTRRRICLGIARGLAYLHGES--RIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
||||++|+|.+++.. ....+++..++.++.|++.||+|||+.+ ..+||||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999999863 3457999999999999999999999864 23599999999999999999999999999987
Q ss_pred CcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+...+.... ..+....
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i----~~~~~~~----- 233 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI----REGKFRR----- 233 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH----HHTCCCC-----
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH----HcCCCCC-----
Confidence 654322 234578999999999999999999999999999999999999999776554433221 1122111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
....++ ..+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 IPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 112223 34889999999999999999999875
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-51 Score=415.13 Aligned_cols=252 Identities=29% Similarity=0.429 Sum_probs=202.6
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 35788899999999999999994 579999999986542 2334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc-
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT- 548 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~- 548 (733)
||++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.......
T Consensus 84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999854 347999999999999999999999986 99999999999999999999999999987654332
Q ss_pred ccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||......... +.. ........ .+..
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~-~~~~~~~~-----~~~~-- 230 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD-WKEKKTYL-----NPWK-- 230 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHH-HHTTCTTS-----TTGG--
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHH-HhcCCCCC-----Cccc--
Confidence 23445789999999999988775 67899999999999999999999544322111 111 11111110 0011
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.....+.+++.+||+.||++|||+.|+++
T Consensus 231 --~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 231 --KIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --GSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11234778999999999999999999865
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=413.94 Aligned_cols=257 Identities=28% Similarity=0.418 Sum_probs=204.8
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccC
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLE 472 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~ 472 (733)
++|+..+.||+|+||.||+|++.+++.||||++... ....+.|.+|+.++++++|||||+++|+|. ++..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 568888999999999999999888889999999654 334578999999999999999999999985 456799999999
Q ss_pred CCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 473 NNSLARALFE-HRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 473 ~gsL~~~l~~-~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
+|+|...+.. ....++|.++..++.|||.||+|||+.+ |+||||||+|||+|.++.+||+|||+|+..........
T Consensus 95 ~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 95 KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp TCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 9999998874 3456999999999999999999999986 99999999999999999999999999987655544444
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCC-CccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNV-TKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
....||+.|+|||++..+.++.++|||||||++|||++|+.|+ ..........+.. .+.... .+..
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~----~~~~~~---------~~~~ 238 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE----RGYRMP---------CPPE 238 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH----TTCCCC---------CCTT
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH----hcCCCC---------CCcc
Confidence 5567999999999999999999999999999999999977766 3333333333221 111111 1112
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcccc
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLRMLECGVDVL 667 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~~~ 667 (733)
....+.+++.+||+.||++||+|++|+++|+.+....
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred cCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 2345889999999999999999999999999765543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=409.52 Aligned_cols=246 Identities=27% Similarity=0.383 Sum_probs=199.1
Q ss_pred CcccCCCcccEEEcccC---CCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEccCC
Q 004732 399 NNIGEGGFGPVYKGLLA---DGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYLEN 473 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~ 473 (733)
+.||+|+||+||+|.+. .++.||||+++.. .....++|.+|++++++++|||||+++|+|.. +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999854 3568999998653 22335679999999999999999999999864 567899999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc--c
Q 004732 474 NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI--S 551 (733)
Q Consensus 474 gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~--~ 551 (733)
|+|.+++... ..+++..+.+++.|||+||+|||+.+ ||||||||+|||++.++.+||+|||+|+......... .
T Consensus 92 g~L~~~l~~~-~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CcHHHHHhhc-cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence 9999998754 47999999999999999999999986 9999999999999999999999999998765433322 3
Q ss_pred cccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHH
Q 004732 552 TRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKE 630 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (733)
....||+.|+|||.+.+..++.++|||||||++|||+| |+.||...+...+.... ..+...... ...
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i----~~~~~~~~p-----~~~--- 235 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML----EKGERMGCP-----AGC--- 235 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH----HTTCCCCCC-----TTC---
T ss_pred cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH----HcCCCCCCC-----ccc---
Confidence 34679999999999999999999999999999999998 89999766544433221 122221111 122
Q ss_pred HHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 631 QVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 631 ~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
...+.+++.+||+.||++|||+.+|++.|+.
T Consensus 236 -~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 236 -PREMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp -CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred -CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 2358899999999999999999999998873
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-50 Score=422.09 Aligned_cols=261 Identities=21% Similarity=0.364 Sum_probs=205.0
Q ss_pred hhcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
..++|+..+.||+|+||+||+|+ ..+|+.||||+++.. .......+.+|+.+|++++|||||+++++|.+++..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46789999999999999999999 467899999998654 3334567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE-SRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
|||++|+|.+++.+.+ .+++..+..++.|+++||+|||+. + |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999997553 699999999999999999999974 5 999999999999999999999999999865432
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh--Cc-----------
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ--GK----------- 614 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~--~~----------- 614 (733)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+.............. ..
T Consensus 159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 234568999999999999999999999999999999999999999654422211100000000 00
Q ss_pred -------------cc----ccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 615 -------------LM----ELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 615 -------------~~----~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.. ......+...........+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 00 000000000000111245889999999999999999999976
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=408.87 Aligned_cols=248 Identities=23% Similarity=0.356 Sum_probs=205.0
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|+..+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5688999999999999999994 67999999998643 2234567899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC-
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN- 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~- 547 (733)
|||++|+|.+++... ..+++..++.++.|++.||+|||+.+ ||||||||+|||+++++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 999999999988654 47999999999999999999999986 9999999999999999999999999998765432
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
........||+.|+|||++.+..++.++||||+||++|||++|+.||...+........ . .... . .....
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i---~-~~~~-~-----~p~~~ 233 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI---I-KLEY-D-----FPEKF 233 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H-TTCC-C-----CCTTC
T ss_pred ccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH---H-cCCC-C-----CCccC
Confidence 22344568999999999999999999999999999999999999999876655443211 1 1111 0 11122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+.+++.+||+.||++|||++|+++
T Consensus 234 ----s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 234 ----FPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 235889999999999999999999743
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=418.01 Aligned_cols=255 Identities=28% Similarity=0.396 Sum_probs=204.7
Q ss_pred hcCccccCcccCCCcccEEEcccCC-C-----cEEEEEEcccc-ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCe
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLAD-G-----TAIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 463 (733)
.++|...+.||+|+||+||+|+... + ..||||.+... .......|.+|+.+++++ +|||||+++++|.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999998532 2 36999998654 233346789999999998 89999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCC
Q 004732 464 LLLIYEYLENNSLARALFEHR----------------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKA 521 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~----------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~ 521 (733)
.++|||||++|+|.++++... ..+++..++.++.||++||+|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 999999999999999997543 24899999999999999999999986 99999999
Q ss_pred CcEEecCCCCeEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccch
Q 004732 522 TNVLLDKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDM 599 (733)
Q Consensus 522 ~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~ 599 (733)
+|||++.++.+||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||...+.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876544332 2345678999999999999999999999999999999998 8999965433
Q ss_pred hhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhc
Q 004732 600 FYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLE 661 (733)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~ 661 (733)
..... .....+...+. +......+.+++.+||+.||++|||++||++.|.
T Consensus 273 ~~~~~---~~~~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DANFY---KLIQNGFKMDQ---------PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHHHH---HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHH---HHHhcCCCCCC---------CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 22111 11112211111 1112245889999999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.8e-49 Score=410.01 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=192.4
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.+.|+..+.||+|+||+||+|+. .+|+.||||++.... ......+.+|++++++++|||||++++++.+++..|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 35688999999999999999994 578999999986543 2234568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec---CCCCeEEcccCccccCccc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD---KDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~---~~~~~kl~DfGla~~~~~~ 546 (733)
||++|+|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+|+.....
T Consensus 88 ~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~ 163 (307)
T d1a06a_ 88 LVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163 (307)
T ss_dssp CCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred ccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence 99999999999654 47999999999999999999999986 99999999999994 5788999999999865443
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
. .....+||+.|+|||++.+..++.++||||+||++|||++|+.||............. . .... ... .
T Consensus 164 ~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~---~-~~~~--~~~----~ 231 (307)
T d1a06a_ 164 S--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL---K-AEYE--FDS----P 231 (307)
T ss_dssp -----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---T-TCCC--CCT----T
T ss_pred C--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh---c-cCCC--CCC----c
Confidence 2 2344679999999999999999999999999999999999999997765544332211 1 1110 011 1
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
........+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 232 YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111223458899999999999999999999883
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-49 Score=401.72 Aligned_cols=245 Identities=27% Similarity=0.427 Sum_probs=196.4
Q ss_pred cccCcccCCCcccEEEccc-CCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe----CCeEEEEE
Q 004732 396 ATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE----GNQLLLIY 468 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 468 (733)
+..+.||+|+||+||+|+. .+++.||+|.+... .....+.|.+|++++++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 4556899999999999994 57889999998653 33445679999999999999999999999875 35689999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec-CCCCeEEcccCccccCcccC
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD-KDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~~~kl~DfGla~~~~~~~ 547 (733)
|||++|+|.+++.+. ..+++.++..++.||++||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+.....
T Consensus 92 E~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp ECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred eCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 999999999999754 47999999999999999999999874 4599999999999996 5789999999999864432
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchh-hHHHHHHHHHhhCcccccccCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMF-YLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
......||+.|+|||++.+ .++.++|||||||++|||++|+.||...... .+.. .. ..+.....++ ..
T Consensus 169 --~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~---~i-~~~~~~~~~~----~~ 237 (270)
T d1t4ha_ 169 --FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RV-TSGVKPASFD----KV 237 (270)
T ss_dssp --SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HH-TTTCCCGGGG----GC
T ss_pred --ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHH---HH-HcCCCCcccC----cc
Confidence 2345689999999998865 6999999999999999999999999644322 2211 11 1111111111 11
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.+ ..+.+++.+||+.||++|||+.|+++
T Consensus 238 ~~----~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 238 AI----PEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp CC----HHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CC----HHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 22 24788999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=9.3e-49 Score=414.12 Aligned_cols=252 Identities=22% Similarity=0.303 Sum_probs=211.5
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
++|++.+.||+|+||.||+|+ ..+|+.||||++........+.+.+|++++++++|||||++++++.+++..++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 578899999999999999999 4679999999997766666678999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC--CCCeEEcccCccccCcccCcc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK--DLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~--~~~~kl~DfGla~~~~~~~~~ 549 (733)
++|+|.+++......+++..+..++.||+.||+|||+++ ||||||||+|||++. ++.+||+|||+|+.......
T Consensus 106 ~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~- 181 (350)
T d1koaa2 106 SGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS- 181 (350)
T ss_dssp CSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC-
T ss_pred CCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccccc-
Confidence 999999999766668999999999999999999999996 999999999999964 57899999999987654332
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+........ .......... ...
T Consensus 182 -~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~--------~~~ 250 (350)
T d1koaa2 182 -VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV--KSCDWNMDDS--------AFS 250 (350)
T ss_dssp -EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHTCCCSCCG--------GGG
T ss_pred -cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCCcc--------ccc
Confidence 34467999999999999999999999999999999999999999766554433221 1111111100 001
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
.....+.+++.+||+.||++|||+.|+++.
T Consensus 251 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 251 GISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp GCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 122358899999999999999999999884
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.9e-49 Score=408.94 Aligned_cols=264 Identities=28% Similarity=0.450 Sum_probs=215.6
Q ss_pred hhhHHhhhcCccccCcccCCCcccEEEcccC------CCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeE
Q 004732 385 YLQIKAATNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGC 457 (733)
Q Consensus 385 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~ 457 (733)
+.+++...++|+..+.||+|+||+||+|++. +++.||||++.... ....++|.+|++++++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3445566788999999999999999999843 46789999997543 3345679999999999999999999999
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCe
Q 004732 458 CIEGNQLLLIYEYLENNSLARALFEHR-----------------------LKLDWPTRRRICLGIARGLAYLHGESRIKV 514 (733)
Q Consensus 458 ~~~~~~~~lV~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i 514 (733)
|.+++..++||||+++|+|.++++... ..+++..+..++.|+|.||+|||+.+ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---e
Confidence 999999999999999999999996422 24899999999999999999999986 9
Q ss_pred ecCCCCCCcEEecCCCCeEEcccCccccCcccC-cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCC-C
Q 004732 515 VHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN-THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR-S 592 (733)
Q Consensus 515 vH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~-~ 592 (733)
|||||||+|||+|.++.+||+|||+|+...... ........||+.|+|||.+.+..++.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 999999999999999999999999998654332 22334567899999999999999999999999999999999996 5
Q ss_pred CCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 593 NVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 593 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
||...+.......+ ..+...... ...+ ..+.+++.+||+.+|++||||.||+++|+++.
T Consensus 242 p~~~~~~~e~~~~v----~~~~~~~~p-----~~~~----~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHEEVIYYV----RDGNILACP-----ENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHHHHHHHH----HTTCCCCCC-----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHHHHHHHH----HcCCCCCCC-----ccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 67666555444322 222222211 1222 35889999999999999999999999998653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.2e-49 Score=409.08 Aligned_cols=244 Identities=27% Similarity=0.457 Sum_probs=201.6
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
.|+..+.||+|+||+||+|+ ..+|+.||||++.... ....+.+.+|++++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 47888999999999999998 5678999999986543 2334578999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
||++|+|..++.. ...+++..++.++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~--- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--- 168 (309)
T ss_dssp CCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---
T ss_pred ecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC---
Confidence 9999999776644 457999999999999999999999996 999999999999999999999999999865432
Q ss_pred cccccccCCCcccHHHHhh---CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCC
Q 004732 550 ISTRVAGTIGYMAPEYAMR---GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSN 626 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (733)
....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||........... ... +...... ...
T Consensus 169 --~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~---i~~-~~~~~~~----~~~ 238 (309)
T d1u5ra_ 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IAQ-NESPALQ----SGH 238 (309)
T ss_dssp --CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHH-SCCCCCS----CTT
T ss_pred --CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHH---HHh-CCCCCCC----CCC
Confidence 34679999999999964 4589999999999999999999999976554332211 111 1111111 112
Q ss_pred CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 627 FDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 627 ~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
++ ..+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~s----~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 239 WS----EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SC----HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC----HHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 22 35889999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-48 Score=411.10 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=211.8
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
++|+..+.||+|+||+||+|+ ..+|+.||||++..........+.+|++++++++|||||+++++|.+++..++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 468899999999999999999 4679999999997765555678899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec--CCCCeEEcccCccccCcccCcc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD--KDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~--~~~~~kl~DfGla~~~~~~~~~ 549 (733)
++|+|.+++......+++.+++.++.||+.||+|||+.| ||||||||+|||++ .++.+||+|||+|+.......
T Consensus 109 ~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 109 SGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp CCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred CCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence 999999988776678999999999999999999999986 99999999999998 578999999999987654332
Q ss_pred cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 550 ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+......... ..... .........
T Consensus 185 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~----~~~~~--~~~~~~~~~-- 255 (352)
T d1koba_ 185 -VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK----RCDWE--FDEDAFSSV-- 255 (352)
T ss_dssp -EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH----HCCCC--CCSSTTTTS--
T ss_pred -eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCC--CCcccccCC--
Confidence 344679999999999999999999999999999999999999997766544432211 11110 011111122
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
...+.+++.+||+.||.+|||+.|+++.
T Consensus 256 --s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 256 --SPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp --CHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred --CHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 2347899999999999999999999873
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-49 Score=403.15 Aligned_cols=255 Identities=26% Similarity=0.384 Sum_probs=199.5
Q ss_pred hcCccccCcccCCCcccEEEcccCC----CcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLAD----GTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.++|...+.||+|+||+||+|++.. +..||||.+... .....+.|.+|++++++++|||||+++++|. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578888999999999999998532 357899998654 3334567999999999999999999999985 567899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
||||+++|+|.+++......+++..++.++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999998877778999999999999999999999986 999999999999999999999999999876655
Q ss_pred CcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCC
Q 004732 547 NTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGS 625 (733)
Q Consensus 547 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (733)
.........||+.|+|||.+.+..++.++|||||||++|||++ |..||.......+.... ..+..... ..
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----~~~~~~~~-----~~ 232 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----ENGERLPM-----PP 232 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HTTCCCCC-----CT
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----HcCCCCCC-----CC
Confidence 4445556778999999999999999999999999999999998 88899766555444322 12221111 11
Q ss_pred CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 626 NFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 626 ~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.. ...+.+++.+||+.||++|||+.||++.|+.+
T Consensus 233 ~~----~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 233 NC----PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 22 34588999999999999999999999998854
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-48 Score=407.12 Aligned_cols=254 Identities=26% Similarity=0.442 Sum_probs=203.9
Q ss_pred cCccccCcccCCCcccEEEccc-CCCc----EEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGT----AIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 466 (733)
.+|+..+.||+|+||+||+|++ .+|+ +||||++... .....++|.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 4688999999999999999985 3444 6899988653 344567899999999999999999999999865 5678
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEE 546 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 546 (733)
|+||+.+|+|.+++......+++..+++++.|||+||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 88 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~ 164 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE 164 (317)
T ss_dssp EEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTT
T ss_pred EEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecccc
Confidence 89999999999999888889999999999999999999999986 999999999999999999999999999876543
Q ss_pred Ccc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 547 NTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 547 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.......+.... ..+....
T Consensus 165 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i----~~~~~~~------- 233 (317)
T d1xkka_ 165 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL----EKGERLP------- 233 (317)
T ss_dssp CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH----HHTCCCC-------
T ss_pred cccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCCCC-------
Confidence 332 2334568999999999999999999999999999999998 78888655444433221 1121111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.+......+.+++.+||+.||++|||+.||++.|+..
T Consensus 234 --~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 234 --QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp --CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1112234588999999999999999999999988754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=396.73 Aligned_cols=248 Identities=30% Similarity=0.451 Sum_probs=199.0
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC-CeEEEEEEcc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG-NQLLLIYEYL 471 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~ 471 (733)
++|+..+.||+|+||.||+|++. |+.||||+++... ..+.|.+|++++++++|||||+++|+|.++ +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 45677789999999999999984 7899999996543 347899999999999999999999999654 5689999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 472 ENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 472 ~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
++|+|.+++... ...++|..+++++.|||.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~---- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---- 156 (262)
T ss_dssp TTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC----
Confidence 999999999743 346899999999999999999999986 999999999999999999999999999864432
Q ss_pred ccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCCH
Q 004732 551 STRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFDK 629 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (733)
.....+|+.|+|||++.+..++.++|||||||++|||+| |+.||...+...+..+. ..+...+. +.
T Consensus 157 ~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i----~~~~~~~~---------~~ 223 (262)
T d1byga_ 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKGYKMDA---------PD 223 (262)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH----TTTCCCCC---------CT
T ss_pred CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCCCCC---------Cc
Confidence 223468899999999999999999999999999999998 67777665555554433 12222221 11
Q ss_pred HHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 630 EQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 630 ~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.....+.+++.+||+.||.+||||.+|+++|+.+
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 1223588999999999999999999999999854
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=399.53 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=199.8
Q ss_pred cCccccCcccCCCcccEEEcccC--CC--cEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA--DG--TAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
++|+..+.||+|+||.||+|++. ++ ..||||++... .....++|.+|++++++++|||||+++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888899999999999999843 22 37899988653 23345689999999999999999999999965 4678
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+||||+++|++.+.+......+++..+.+++.|||+||+|||+++ |+||||||+||+++.++.+||+|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence 999999999999998877678999999999999999999999986 99999999999999999999999999997654
Q ss_pred cCcc--cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHHHHHHHHhhCcccccccCC
Q 004732 546 ENTH--ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLDWALVLKEQGKLMELVDTN 622 (733)
Q Consensus 546 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (733)
.... ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...+......+.. ..+...+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~---~~~~~~~~~--- 237 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID---KEGERLPRP--- 237 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TSCCCCCCC---
T ss_pred CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHH---hCCCCCCCc---
Confidence 4332 2334568889999999999999999999999999999998 899997766655543321 222111111
Q ss_pred CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhcc
Q 004732 623 PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLEC 662 (733)
Q Consensus 623 ~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~ 662 (733)
...+ ..+.+++.+||+.||++||||.||++.|++
T Consensus 238 --~~~~----~~l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 238 --EDCP----QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp --TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred --cccc----HHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 1222 348899999999999999999999998874
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=398.25 Aligned_cols=251 Identities=24% Similarity=0.300 Sum_probs=207.0
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccC------hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKS------KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
.++|+..+.||+|+||+||+|+. .+|+.||||++.... ....+.|.+|+++|++++|||||+++++|.+++..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35788999999999999999994 679999999986431 12357899999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC----CeEEcccCcc
Q 004732 465 LLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL----NSKISDFGLA 540 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~----~~kl~DfGla 540 (733)
++|||||++|+|.+++... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||+|
T Consensus 89 ~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp EEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhh
Confidence 9999999999999999754 47999999999999999999999996 99999999999998776 4999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccccc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
+....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...+........ ............
T Consensus 165 ~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~ 240 (293)
T d1jksa_ 165 HKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV--SAVNYEFEDEYF 240 (293)
T ss_dssp EECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HTTCCCCCHHHH
T ss_pred hhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHH--HhcCCCCCchhc
Confidence 86654322 34567999999999999999999999999999999999999999776554433211 111111000000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.. ....+.+++.+||+.||++|||+.|+++
T Consensus 241 ----~~----~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 241 ----SN----TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp ----TT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----CC----CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01 1235789999999999999999999976
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=401.24 Aligned_cols=248 Identities=26% Similarity=0.321 Sum_probs=208.4
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 467 (733)
.++|+..+.||+|+||+||+|+ ..+|+.||||++.+. .....+.+.+|+.+|++++|||||++++++.+++..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 3578899999999999999999 468999999998653 233457789999999999999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
||||++|+|.+++... ..+++..++.++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+......
T Consensus 84 ~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 84 MEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp EECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred eeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence 9999999999998755 47899999999999999999999996 9999999999999999999999999998654332
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+...+.... ..+.. . .....
T Consensus 160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i----~~~~~-~-----~p~~~ 228 (337)
T d1o6la_ 160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI----LMEEI-R-----FPRTL 228 (337)
T ss_dssp C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----HHCCC-C-----CCTTS
T ss_pred c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH----hcCCC-C-----CCccC
Confidence 2 234578999999999999999999999999999999999999999877655443321 11111 1 11122
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPS-----MSSVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 658 (733)
+ ..+.+++.+|++.||.+||+ +.|+++
T Consensus 229 s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 229 S----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 3 34789999999999999995 777765
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.9e-47 Score=395.72 Aligned_cols=244 Identities=24% Similarity=0.378 Sum_probs=205.5
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|+..+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4688899999999999999994 67999999998643 2234577899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
|||++|+|..++... ..+++..+..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-- 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 157 (316)
T ss_dssp CCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred eecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc--
Confidence 999999999988654 47899999999999999999999986 999999999999999999999999999876543
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...+......-. . .+.. ......+
T Consensus 158 --~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~-~~~~------~~p~~~s 225 (316)
T d1fota_ 158 --TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI---L-NAEL------RFPPFFN 225 (316)
T ss_dssp --BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH---H-HCCC------CCCTTSC
T ss_pred --cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH---H-cCCC------CCCCCCC
Confidence 23468999999999999999999999999999999999999999776654433211 1 1111 0111222
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRP-----SMSSVLR 658 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 658 (733)
..+.+++.+|++.||.+|| |++++++
T Consensus 226 ----~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 226 ----EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp ----HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred ----HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 3488899999999999996 8888875
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=397.34 Aligned_cols=252 Identities=26% Similarity=0.419 Sum_probs=203.8
Q ss_pred cCcccCCCcccEEEcccCCC----cEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe-CCeEEEEEEcc
Q 004732 398 DNNIGEGGFGPVYKGLLADG----TAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIE-GNQLLLIYEYL 471 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~ 471 (733)
.++||+|+||+||+|++.++ ..||||++... .....++|.+|++++++++|||||+++|+|.+ +...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 46799999999999986432 36899998753 44455789999999999999999999999886 46899999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc--
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH-- 549 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~-- 549 (733)
++|+|.+++......+++..+++++.|+|+||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 112 KHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp TTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred ecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999877778899999999999999999999986 999999999999999999999999999876543222
Q ss_pred -cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccc-hhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 550 -ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKED-MFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 550 -~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
......||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ......+ .. .+...... ...
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~---i~-~g~~~~~p-----~~~ 259 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LL-QGRRLLQP-----EYC 259 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH---HH-TTCCCCCC-----TTC
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH---HH-cCCCCCCc-----ccC
Confidence 2334678999999999999999999999999999999999888885432 2222221 11 12211111 111
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
...+.+++.+||+.||++||+|.||++.|+++..
T Consensus 260 ----~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 260 ----PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 2358899999999999999999999999986543
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-47 Score=395.47 Aligned_cols=251 Identities=17% Similarity=0.251 Sum_probs=207.7
Q ss_pred hcCccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
.++|.+.+.||+|+||+||+|+. .+|+.||||.+..... ....+.+|+++|+.++|||||++++++.+++..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 35788999999999999999994 5789999999976543 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC--CCeEEcccCccccCcccCc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD--LNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~--~~~kl~DfGla~~~~~~~~ 548 (733)
|++|+|.+++......+++.+++.++.||+.||+|||+.+ |+||||||+|||++.+ ..+||+|||+++......
T Consensus 83 ~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 83 ISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp CCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 9999999999876668999999999999999999999986 9999999999999854 479999999998654432
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
......||+.|+|||...+..++.++||||+||++|||++|+.||...+........ ............ ...
T Consensus 159 -~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~----~~~- 230 (321)
T d1tkia_ 159 -NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI--MNAEYTFDEEAF----KEI- 230 (321)
T ss_dssp -EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HHTCCCCCHHHH----TTS-
T ss_pred -cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH--HhCCCCCChhhc----cCC-
Confidence 234467899999999999999999999999999999999999999776654433211 111111100000 011
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
...+.+++.+|++.||.+|||+.|+++
T Consensus 231 ---s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 231 ---SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ---CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ---CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 234789999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-47 Score=394.91 Aligned_cols=254 Identities=29% Similarity=0.419 Sum_probs=204.0
Q ss_pred cCccccCcccCCCcccEEEcccC-CCc--EEEEEEcccc-ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCeEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLA-DGT--AIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 467 (733)
++|+..+.||+|+||+||+|++. +|. .||||++... .....+.|.+|+++|+++ +|||||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57788899999999999999964 444 5788887543 344556899999999998 799999999999999999999
Q ss_pred EEccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCe
Q 004732 468 YEYLENNSLARALFEH---------------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNS 532 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 532 (733)
|||+++|+|.++++.. ...+++..+.+++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999743 357999999999999999999999986 9999999999999999999
Q ss_pred EEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCC-CCCccchhhHHHHHHHHHh
Q 004732 533 KISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRS-NVTKEDMFYLLDWALVLKE 611 (733)
Q Consensus 533 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~-p~~~~~~~~~~~~~~~~~~ 611 (733)
||+|||+|+....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||...+...+...+ .
T Consensus 167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i----~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL----P 240 (309)
T ss_dssp EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG----G
T ss_pred EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHH----H
Confidence 9999999986543322 234568999999999999999999999999999999999765 56655544443322 1
Q ss_pred hCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 612 QGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.+...+ .+......+.+++.+||+.||++||||+||++.|+++.
T Consensus 241 ~~~~~~---------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~ 284 (309)
T d1fvra_ 241 QGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 284 (309)
T ss_dssp GTCCCC---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hcCCCC---------CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 111111 11122345889999999999999999999999988654
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-47 Score=395.51 Aligned_cols=257 Identities=29% Similarity=0.435 Sum_probs=206.0
Q ss_pred hcCccccCcccCCCcccEEEcccC--------CCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA--------DGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEG 461 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 461 (733)
.++|...+.||+|+||.||+|+.. ++..||||+++... .....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 357778899999999999999842 23479999997653 34457889999999888 899999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe
Q 004732 462 NQLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 526 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill 526 (733)
+..++|||||++|+|.+++.... ..+++.++++++.|||.||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999997442 46899999999999999999999996 9999999999999
Q ss_pred cCCCCeEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHh-CCCCCCccchhhHHH
Q 004732 527 DKDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVS-GRSNVTKEDMFYLLD 604 (733)
Q Consensus 527 ~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~ellt-g~~p~~~~~~~~~~~ 604 (733)
+.++.+||+|||+++........ ......||+.|+|||.+.++.|+.++|||||||++|||++ |+.||..........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 99999999999999876544332 2345678999999999999999999999999999999998 678886655544333
Q ss_pred HHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 605 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
.. ..+..... ....+ ..+.+++.+||+.||++|||+.||++.|+++.
T Consensus 249 ~i----~~~~~~~~-----p~~~~----~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 249 LL----KEGHRMDK-----PSNCT----NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HH----HTTCCCCC-----CSSCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH----HcCCCCCC-----Cccch----HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence 22 12221111 11222 34889999999999999999999999998653
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.4e-47 Score=388.97 Aligned_cols=257 Identities=21% Similarity=0.301 Sum_probs=201.4
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC----e
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINEIGMISALQHPNLVKLYGCCIEGN----Q 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 463 (733)
.++|...+.||+|+||+||+|+ ..+|+.||||++.... ......|.+|+++++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 4578899999999999999999 5689999999997542 333467899999999999999999999988653 4
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.|+||||+++|+|.+++... ..+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||.++..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~ 161 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAI 161 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred EEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhh
Confidence 79999999999999988654 47999999999999999999999986 999999999999999999999999998755
Q ss_pred cccCc--ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 544 EEENT--HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 544 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||...+....... ..........
T Consensus 162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~---~~~~~~~~~~--- 235 (277)
T d1o6ya_ 162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ---HVREDPIPPS--- 235 (277)
T ss_dssp C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHCCCCCGG---
T ss_pred ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHH---HHhcCCCCCc---
Confidence 43222 234456799999999999999999999999999999999999999976655443221 1111111100
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCC-CHHHHHHHhcc
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRP-SMSSVLRMLEC 662 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RP-t~~~vl~~L~~ 662 (733)
......+ ..+.+++.+|++.||.+|| |++++.+.|.+
T Consensus 236 ~~~~~~s----~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 236 ARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp GTSSSCC----HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hhccCCC----HHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0111222 3488999999999999999 89999887764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.2e-46 Score=385.25 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=205.0
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh---------hcHHHHHHHHHHHHhCC-CCceeeEeeEEEeC
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK---------QGNREFINEIGMISALQ-HPNLVKLYGCCIEG 461 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 461 (733)
++|+..+.||+|+||+||+|+ ..+|+.||||++..... ...+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 578899999999999999999 46799999999865321 12246889999999997 99999999999999
Q ss_pred CeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 462 NQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 462 ~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
+..|+|||||++|+|.+++... ..+++.++..++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred cceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchhee
Confidence 9999999999999999999754 47999999999999999999999986 9999999999999999999999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhh------CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMR------GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL 615 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 615 (733)
....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+........ .. +..
T Consensus 159 ~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i---~~-~~~ 232 (277)
T d1phka_ 159 QLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI---MS-GNY 232 (277)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HH-TCC
T ss_pred EccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH---Hh-CCC
Confidence 7654322 344679999999999964 34688999999999999999999999776544432211 11 111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
. . ...........+.+++.+||+.||++|||+.||++
T Consensus 233 ~-~-----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 233 Q-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp C-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred C-C-----CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0 01011122345889999999999999999999865
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-47 Score=394.29 Aligned_cols=258 Identities=25% Similarity=0.424 Sum_probs=211.1
Q ss_pred hcCccccCcccCCCcccEEEcccC------CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSK-SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQL 464 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 464 (733)
.++|...+.||+|+||+||+|++. +++.||||+++.. .......|.+|++++++++|||||+++++|..++..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 357788899999999999999853 3578999999754 334446789999999999999999999999999999
Q ss_pred EEEEEccCCCCHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEc
Q 004732 465 LLIYEYLENNSLARALFEH---------RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKIS 535 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 535 (733)
++|||||++|+|.+++... ...+++..+.+++.|+|+||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999998632 235799999999999999999999985 9999999999999999999999
Q ss_pred ccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCC-CCCCccchhhHHHHHHHHHhhC
Q 004732 536 DFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR-SNVTKEDMFYLLDWALVLKEQG 613 (733)
Q Consensus 536 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 613 (733)
|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||+||+ .||...+........ ..+
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i----~~~ 251 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----MEG 251 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH----HTT
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhC
Confidence 99999866544332 234457899999999999999999999999999999999985 666555444333222 122
Q ss_pred cccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 614 KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
...... ...+ ..+.+++.+||+.+|++||||.+|++.|++..+
T Consensus 252 ~~~~~p-----~~~~----~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 252 GLLDKP-----DNCP----DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp CCCCCC-----TTCC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred CCCCCc-----ccch----HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 222211 1122 358899999999999999999999999986533
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-47 Score=396.90 Aligned_cols=257 Identities=26% Similarity=0.364 Sum_probs=197.0
Q ss_pred hcCccccCcccCCCcccEEEcccC------CCcEEEEEEcccc-ChhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeC-C
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLLA------DGTAIAVKQLSSK-SKQGNREFINEIGMISAL-QHPNLVKLYGCCIEG-N 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 462 (733)
.++|...+.||+|+||+||+|+.. +++.||||+++.. .....+.+.+|..++.++ +|+|||++++++.++ .
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 357888999999999999999742 3468999998754 334456788888888777 689999999998765 4
Q ss_pred eEEEEEEccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec
Q 004732 463 QLLLIYEYLENNSLARALFEHR---------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD 527 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~ 527 (733)
..++|||||++|+|.+++.... ..+++.++..++.|||+||+|||+++ ||||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeEC
Confidence 6899999999999999997432 35899999999999999999999986 99999999999999
Q ss_pred CCCCeEEcccCccccCcccCcc-cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCC-CCCCccchhhHHHH
Q 004732 528 KDLNSKISDFGLAKLDEEENTH-ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGR-SNVTKEDMFYLLDW 605 (733)
Q Consensus 528 ~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~-~p~~~~~~~~~~~~ 605 (733)
+++.+||+|||+|+........ ......||+.|+|||.+.+..++.++|||||||++|||++|. .||..........
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~- 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC- 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH-
T ss_pred CCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHH-
Confidence 9999999999999865543332 344567999999999999999999999999999999999975 5664433222111
Q ss_pred HHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 606 ALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.....+......+ .. ...+.+++.+||+.||++|||+.||++.|+.+
T Consensus 248 --~~~~~~~~~~~~~-----~~----~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 248 --RRLKEGTRMRAPD-----YT----TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp --HHHHHTCCCCCCT-----TC----CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHhcCCCCCCCc-----cC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 1112222222111 12 23488999999999999999999999999854
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-47 Score=395.56 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=208.0
Q ss_pred hcCccccCcccCCCcccEEEccc------CCCcEEEEEEccccC-hhcHHHHHHHHHHHHhC-CCCceeeEeeEEEeCCe
Q 004732 392 TNNFATDNNIGEGGFGPVYKGLL------ADGTAIAVKQLSSKS-KQGNREFINEIGMISAL-QHPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 463 (733)
.++|...+.||+|+||.||+|++ .+++.||||+++... ......|.+|+++++++ +|||||+++++|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 35777889999999999999974 356789999997643 33456789999999999 69999999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEe
Q 004732 464 LLLIYEYLENNSLARALFEHR-----------------LKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLL 526 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~-----------------~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill 526 (733)
.++|||||++|+|.++++... ..+++..+.+++.|||+||+|||+++ ||||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999997432 35899999999999999999999996 9999999999999
Q ss_pred cCCCCeEEcccCccccCcccCc-ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCC-CCccchhhHHH
Q 004732 527 DKDLNSKISDFGLAKLDEEENT-HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSN-VTKEDMFYLLD 604 (733)
Q Consensus 527 ~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p-~~~~~~~~~~~ 604 (733)
+.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+|++.| +..........
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987665433 234457899999999999999999999999999999999995555 43333222111
Q ss_pred HHHHHHhhCcccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccC
Q 004732 605 WALVLKEQGKLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECG 663 (733)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~ 663 (733)
.....+..... +......+.+++.+||+.||++||||.||+++|++.
T Consensus 259 ---~~i~~~~~~~~---------~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~ 305 (311)
T d1t46a_ 259 ---KMIKEGFRMLS---------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (311)
T ss_dssp ---HHHHHTCCCCC---------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHhcCCCCCC---------cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 11111211111 111224588999999999999999999999999853
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-46 Score=396.14 Aligned_cols=244 Identities=22% Similarity=0.329 Sum_probs=206.1
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 468 (733)
++|+..+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5788999999999999999984 57999999998643 2234467899999999999999999999999999999999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCc
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENT 548 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 548 (733)
||+.+|+|.+++...+ .+++..+..++.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC--
T ss_pred ccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc--
Confidence 9999999999997554 7999999999999999999999986 999999999999999999999999999876432
Q ss_pred ccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCCC
Q 004732 549 HISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNFD 628 (733)
Q Consensus 549 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (733)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+........ . .+.. ......+
T Consensus 195 --~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i---~-~~~~------~~p~~~s 262 (350)
T d1rdqe_ 195 --TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI---V-SGKV------RFPSHFS 262 (350)
T ss_dssp --BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---H-HCCC------CCCTTCC
T ss_pred --cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH---h-cCCC------CCCccCC
Confidence 23467999999999999999999999999999999999999999776654433321 1 1111 0111222
Q ss_pred HHHHHHHHHHHHHhhcCCCCCCC-----CHHHHHH
Q 004732 629 KEQVMVMINVALLCANASPTIRP-----SMSSVLR 658 (733)
Q Consensus 629 ~~~~~~l~~l~~~c~~~~P~~RP-----t~~~vl~ 658 (733)
..+.+++.+||+.||.+|+ |++|+++
T Consensus 263 ----~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 263 ----SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ----HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ----HHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 3488999999999999994 8888865
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=5.4e-46 Score=395.33 Aligned_cols=248 Identities=27% Similarity=0.329 Sum_probs=197.9
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC---hhcHHHHHHH---HHHHHhCCCCceeeEeeEEEeCCeEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS---KQGNREFINE---IGMISALQHPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E---~~~l~~l~h~niv~l~~~~~~~~~~~ 465 (733)
++|++.+.||+|+||.||+|+ ..+|+.||||++.... ......+.+| +++++.++|||||++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 578899999999999999999 4579999999985431 2223334444 66777788999999999999999999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
+|||||++|+|.+++... ..+++..++.++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCC
Confidence 999999999999999754 47899999999999999999999996 99999999999999999999999999986654
Q ss_pred cCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCC
Q 004732 546 ENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPG 624 (733)
Q Consensus 546 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (733)
.. .....||+.|+|||++.. ..++.++|||||||++|||++|+.||............. ..... .....
T Consensus 160 ~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----~~~~~---~~~~~ 229 (364)
T d1omwa3 160 KK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLTM---AVELP 229 (364)
T ss_dssp SC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----HSSSC---CCCCC
T ss_pred Cc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----hcccC---CCCCC
Confidence 32 234679999999999975 468999999999999999999999996543322211110 00000 00111
Q ss_pred CCCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004732 625 SNFDKEQVMVMINVALLCANASPTIRPS-----MSSVLR 658 (733)
Q Consensus 625 ~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 658 (733)
..++ ..+.+++.+||+.||++||| ++|+++
T Consensus 230 ~~~s----~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 DSFS----PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp SSSC----HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred CCCC----HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1223 34889999999999999999 577764
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=390.08 Aligned_cols=261 Identities=28% Similarity=0.371 Sum_probs=197.1
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHH--HHHHHhCCCCceeeEeeEEEeCC----eEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINE--IGMISALQHPNLVKLYGCCIEGN----QLLL 466 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~~l~~l~h~niv~l~~~~~~~~----~~~l 466 (733)
++|...+.||+|+||+||+|++ +|+.||||++.... ...+.+| +..+..++|||||+++++|.+++ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3566778999999999999986 58899999986432 3344444 44556789999999999998754 6899
Q ss_pred EEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC-----CCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 467 IYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGES-----RIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 467 V~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
|||||++|+|.+++++. .++|..+++++.|+|.||+|||+.+ ..+||||||||+|||++.++.+||+|||+++
T Consensus 79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999999764 6899999999999999999999741 2469999999999999999999999999998
Q ss_pred cCcccCcc---cccccccCCCcccHHHHhhCC------CCccchhHhHHHHHHHHHhCCCCCCccchh------------
Q 004732 542 LDEEENTH---ISTRVAGTIGYMAPEYAMRGH------LTEKADVYSFGIVALEIVSGRSNVTKEDMF------------ 600 (733)
Q Consensus 542 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~Dv~s~Gvil~elltg~~p~~~~~~~------------ 600 (733)
........ ......||+.|+|||++.... ++.++|||||||++|||+||..|+......
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 66543322 234567999999999987642 577999999999999999998877322110
Q ss_pred hHHHHHHHHHhhCcccccccCCCCCC-CCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 601 YLLDWALVLKEQGKLMELVDTNPGSN-FDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
............ ...+..... .+.+....+.+++.+||+.||++|||+.||++.|+++.
T Consensus 237 ~~~~~~~~~~~~-----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 296 (303)
T d1vjya_ 237 SVEEMRKVVCEQ-----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296 (303)
T ss_dssp CHHHHHHHHTTS-----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred hHHHHHHHHhcc-----ccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 011111111111 111111111 12345566889999999999999999999999998543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=391.00 Aligned_cols=247 Identities=24% Similarity=0.358 Sum_probs=203.9
Q ss_pred cCccccCcccCCCcccEEEccc-CCCcEEEEEEcccc---ChhcHHHHHHHHHHHH-hCCCCceeeEeeEEEeCCeEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSK---SKQGNREFINEIGMIS-ALQHPNLVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV 467 (733)
++|...+.||+|+||+||+|+. .+|+.||||++... .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5788899999999999999994 57999999999643 2233456777777765 68999999999999999999999
Q ss_pred EEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccC
Q 004732 468 YEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 468 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 547 (733)
||||++|+|.+++... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 82 mEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~ 157 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD 157 (320)
T ss_dssp EECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccccc
Confidence 9999999999999754 47899999999999999999999996 9999999999999999999999999998654332
Q ss_pred cccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccCCCCCCC
Q 004732 548 THISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDTNPGSNF 627 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (733)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+...+..... .+.. ......
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~----~~~~------~~p~~~ 226 (320)
T d1xjda_ 158 A-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR----MDNP------FYPRWL 226 (320)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----HCCC------CCCTTS
T ss_pred c-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH----cCCC------CCCccC
Confidence 2 2344679999999999999999999999999999999999999998766554432211 1111 111112
Q ss_pred CHHHHHHHHHHHHHhhcCCCCCCCCHH-HHHH
Q 004732 628 DKEQVMVMINVALLCANASPTIRPSMS-SVLR 658 (733)
Q Consensus 628 ~~~~~~~l~~l~~~c~~~~P~~RPt~~-~vl~ 658 (733)
...+.+++.+||+.||++||++. |+++
T Consensus 227 ----s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 227 ----EKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ----CHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ----CHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 23488999999999999999996 6653
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-45 Score=383.63 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=202.9
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
++|+..+.||+|+||+||+|+ ..+|+.||||+++... ......+.+|++++++++|||||++++++.++...++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 578899999999999999999 5679999999986542 2234688999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
|+.++.+..........+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+.......
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~- 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB-
T ss_pred ecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcc-
Confidence 99876555444455667999999999999999999999986 99999999999999999999999999986543322
Q ss_pred cccccccCCCcccHHHHhhCC-CCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhh-Cc--c---cccccCC
Q 004732 550 ISTRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQ-GK--L---MELVDTN 622 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~-~~--~---~~~~~~~ 622 (733)
......||+.|+|||.+.... ++.++||||+||++|||++|+.||...+......-....... .+ . ....+..
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 234457999999999987765 588999999999999999999999766544332211111100 00 0 0000000
Q ss_pred ---CC-CCCC-----HHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 623 ---PG-SNFD-----KEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 623 ---~~-~~~~-----~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
+. .... ......+.+++.+|++.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00 0000 0112458899999999999999999999873
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=383.51 Aligned_cols=256 Identities=23% Similarity=0.291 Sum_probs=197.8
Q ss_pred cCcccCCCcccEEEccc-CCCcEEEEEEccccChh-----cHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEcc
Q 004732 398 DNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQ-----GNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEYL 471 (733)
Q Consensus 398 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~ 471 (733)
.++||+|+||+||+|+. .+|+.||||++...... ..+.+.+|++++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 46899999999999994 57999999998654221 1246889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcccc
Q 004732 472 ENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHIS 551 (733)
Q Consensus 472 ~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 551 (733)
.++++..+. .....+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+........ .
T Consensus 83 ~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-~ 157 (299)
T d1ua2a_ 83 ETDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-Y 157 (299)
T ss_dssp SEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-C
T ss_pred cchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc-c
Confidence 988766554 45567999999999999999999999996 999999999999999999999999999865543322 2
Q ss_pred cccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccC---------
Q 004732 552 TRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT--------- 621 (733)
Q Consensus 552 ~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 621 (733)
....||+.|+|||++... .++.++||||+||++|||++|+.||...+..+..................+.
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence 346799999999998754 5899999999999999999999999776655544332222111100000000
Q ss_pred CCCCCCCH-----HHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 622 NPGSNFDK-----EQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 622 ~~~~~~~~-----~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
......+. .....+.+++.+|++.||++|||++|+++
T Consensus 238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 00000111 12246889999999999999999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-46 Score=391.86 Aligned_cols=251 Identities=19% Similarity=0.243 Sum_probs=196.9
Q ss_pred hcCcccc-CcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHh-CCCCceeeEeeEEEe----CCeE
Q 004732 392 TNNFATD-NNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISA-LQHPNLVKLYGCCIE----GNQL 464 (733)
Q Consensus 392 ~~~~~~~-~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~ 464 (733)
.++|.+. +.||+|+||+||+|+ ..+|+.||||++... ..+.+|++++.+ .+|||||+++++|.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3567765 469999999999998 467999999998542 457789998665 489999999999876 4668
Q ss_pred EEEEEccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC---CCCeEEcccCcc
Q 004732 465 LLIYEYLENNSLARALFEH-RLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK---DLNSKISDFGLA 540 (733)
Q Consensus 465 ~lV~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~DfGla 540 (733)
|+|||||+||+|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 9999999999999999754 357999999999999999999999996 999999999999985 457999999999
Q ss_pred ccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccccc
Q 004732 541 KLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 541 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
+....... .....||+.|+|||++.+..|+.++|||||||++|||+||+.||...+......... .. +. ...
T Consensus 162 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---~~--i~-~~~ 233 (335)
T d2ozaa1 162 KETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TR--IR-MGQ 233 (335)
T ss_dssp EECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------C--CC-SCS
T ss_pred eeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---HH--Hh-cCC
Confidence 86654332 345679999999999999899999999999999999999999996544322221110 00 00 000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
..............+.+++.+|++.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 00001111223456899999999999999999999987
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=7.9e-45 Score=375.35 Aligned_cols=261 Identities=26% Similarity=0.343 Sum_probs=201.7
Q ss_pred cCccccCcccCCCcccEEEcccCCCcEEEEEEccccC--hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKS--KQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~ 470 (733)
++|...+.||+|+||+||+|+..+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..++|+||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5788899999999999999998899999999986542 22357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCccc
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTHI 550 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 550 (733)
+.++.+..+. .....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+|++|||.|........ .
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-K 156 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc-c
Confidence 9887666655 45568999999999999999999999986 99999999999999999999999999986544322 2
Q ss_pred ccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc------ccccc----
Q 004732 551 STRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK------LMELV---- 619 (733)
Q Consensus 551 ~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~---- 619 (733)
.....|++.|+|||.+.+. .++.++||||+||++|||++|+.||...+..+............. .....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 3345689999999999764 579999999999999999999999976654443322111111000 00000
Q ss_pred -----cCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 620 -----DTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 620 -----~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.+.+...........+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000011112345889999999999999999999974
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-45 Score=378.79 Aligned_cols=264 Identities=25% Similarity=0.365 Sum_probs=202.2
Q ss_pred hhcCccccCcccCCCcccEEEccc-CC-CcEEEEEEccccC--hhcHHHHHHHHHHHHhC---CCCceeeEeeEEEe---
Q 004732 391 ATNNFATDNNIGEGGFGPVYKGLL-AD-GTAIAVKQLSSKS--KQGNREFINEIGMISAL---QHPNLVKLYGCCIE--- 460 (733)
Q Consensus 391 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~--- 460 (733)
+.++|+..+.||+|+||+||+|+. .+ ++.||||++.... ......+.+|+++++.+ +|||||+++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 357899999999999999999984 44 5679999986432 22223566777776655 89999999999864
Q ss_pred --CCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccC
Q 004732 461 --GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFG 538 (733)
Q Consensus 461 --~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 538 (733)
....+++|||++++++..........+++..++.++.|++.||+|||+++ ||||||||+|||++.++.+||+|||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchh
Confidence 24679999999998887666666678999999999999999999999986 9999999999999999999999999
Q ss_pred ccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccc
Q 004732 539 LAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMEL 618 (733)
Q Consensus 539 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 618 (733)
+++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+......-.............
T Consensus 162 ~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 239 (305)
T d1blxa_ 162 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239 (305)
T ss_dssp SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred hhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence 998654332 334578999999999999999999999999999999999999999776654443322211111000000
Q ss_pred ----------c-c--CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 619 ----------V-D--TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 619 ----------~-~--~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
. . ..+...+.......+.+++.+|++.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 0 000001111223457889999999999999999999763
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=378.60 Aligned_cols=240 Identities=23% Similarity=0.385 Sum_probs=196.1
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccCh------hcHHHHHHHHHHHHhCC--CCceeeEeeEEEeCCe
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSK------QGNREFINEIGMISALQ--HPNLVKLYGCCIEGNQ 463 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 463 (733)
++|.+.+.||+|+||+||+|+ ..+|+.||||++..... ....++.+|++++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 578899999999999999999 56799999999864311 11234678999999996 8999999999999999
Q ss_pred EEEEEEccCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCC-CCeEEcccCccc
Q 004732 464 LLLIYEYLEN-NSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKD-LNSKISDFGLAK 541 (733)
Q Consensus 464 ~~lV~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfGla~ 541 (733)
.++||||+.+ +++.+++... ..+++.+++.++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence 9999999986 5777777543 47999999999999999999999986 9999999999999855 789999999998
Q ss_pred cCcccCcccccccccCCCcccHHHHhhCCC-CccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccccccc
Q 004732 542 LDEEENTHISTRVAGTIGYMAPEYAMRGHL-TEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVD 620 (733)
Q Consensus 542 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 620 (733)
..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...+.. . ....
T Consensus 160 ~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i--~--------~~~~----- 221 (273)
T d1xwsa_ 160 LLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--I--------RGQV----- 221 (273)
T ss_dssp ECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--H--------HCCC-----
T ss_pred ecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH--h--------hccc-----
Confidence 65432 2345679999999999988765 67799999999999999999999654311 0 1110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 621 TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 621 ~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......+ ..+.+++.+||+.||++|||++|+++.
T Consensus 222 -~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 222 -FFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp -CCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0111223 348899999999999999999999763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.6e-43 Score=364.47 Aligned_cols=259 Identities=20% Similarity=0.244 Sum_probs=207.6
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCC-CceeeEeeEEEeCCeEEEEEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-PNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e 469 (733)
.++|.+.+.||+|+||+||+|+ ..+|+.||||.+..... ...+.+|++.++.++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 3678899999999999999999 45789999998855432 2457789999999975 899999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecC-----CCCeEEcccCccccCc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDK-----DLNSKISDFGLAKLDE 544 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~-----~~~~kl~DfGla~~~~ 544 (733)
|+ +++|.+++......+++.++..++.|++.||+|||+.| |+||||||+|||++. ++.+||+|||+|+...
T Consensus 82 ~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred ec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99 68999999877778999999999999999999999996 999999999999974 5679999999998765
Q ss_pred ccCcc------cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHH---HHHHHhhCcc
Q 004732 545 EENTH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDW---ALVLKEQGKL 615 (733)
Q Consensus 545 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~ 615 (733)
..... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 237 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCCh
Confidence 43221 23346799999999999999999999999999999999999999964432222111 1111111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCcc
Q 004732 616 MELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGVD 665 (733)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~~ 665 (733)
.++. ...+ ..+.+++..|++.+|++||+++.+.+.|+.+..
T Consensus 238 ~~l~-----~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 238 RELC-----AGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HHHT-----TTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred HHhc-----CCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 1111 1122 247889999999999999999999988876544
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-43 Score=365.72 Aligned_cols=257 Identities=22% Similarity=0.282 Sum_probs=199.0
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceee-EeeEEEeCCeEEEEEEc
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVK-LYGCCIEGNQLLLIYEY 470 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~ 470 (733)
++|+..+.||+|+||+||+|+ ..+|+.||||.+...... .++..|+++++.++|+|+|. +.+++.+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 468899999999999999998 467899999987654332 45788999999998776554 55566778899999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEec---CCCCeEEcccCccccCcccC
Q 004732 471 LENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLD---KDLNSKISDFGLAKLDEEEN 547 (733)
Q Consensus 471 ~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~---~~~~~kl~DfGla~~~~~~~ 547 (733)
+ ++++.+.+......+++..+..++.|++.||+|||+++ ||||||||+|||++ .+..+||+|||+|+......
T Consensus 85 ~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 85 L-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred c-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 9 45677777666778999999999999999999999997 99999999999985 45579999999998765433
Q ss_pred cc------cccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHh---hCccccc
Q 004732 548 TH------ISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKE---QGKLMEL 618 (733)
Q Consensus 548 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~ 618 (733)
.. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||................. .......
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (299)
T d1ckia_ 161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVL 240 (299)
T ss_dssp TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHH
T ss_pred cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHh
Confidence 22 23456799999999999999999999999999999999999999965433222211111111 1111111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHHhccCc
Q 004732 619 VDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRMLECGV 664 (733)
Q Consensus 619 ~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~L~~~~ 664 (733)
. ..++ ..+.+++..||+.+|++||++.++.+.|+...
T Consensus 241 ~-----~~~p----~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 241 C-----KGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp T-----TTSC----HHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred c-----cCCC----HHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 1 1122 34888999999999999999999998888643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-43 Score=373.62 Aligned_cols=256 Identities=24% Similarity=0.285 Sum_probs=193.7
Q ss_pred CccccCcccCCCcccEEEccc-CCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC------CeEEE
Q 004732 394 NFATDNNIGEGGFGPVYKGLL-ADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLVKLYGCCIEG------NQLLL 466 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l 466 (733)
+|+..++||+|+||+||+|+. .+|+.||||++..... .+.+|+++|++++|||||+++++|... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 466778999999999999994 5799999999865432 234799999999999999999998653 34789
Q ss_pred EEEccCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-CeEEcccCccccC
Q 004732 467 IYEYLENNSLARALF--EHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLD 543 (733)
Q Consensus 467 V~e~~~~gsL~~~l~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~ 543 (733)
|||||+++.+..... .....+++.++..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 999998775544433 45567999999999999999999999986 99999999999999875 8999999999866
Q ss_pred cccCcccccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHH----------hh
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK----------EQ 612 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~----------~~ 612 (733)
..... .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||...+......-..... ..
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 251 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence 54332 234679999999999875 468999999999999999999999996655433222111000 00
Q ss_pred CcccccccCCC-----CCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 613 GKLMELVDTNP-----GSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 613 ~~~~~~~~~~~-----~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
.......-+.. ...........+.+++.+|++.||++|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000000000 00011122345889999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-43 Score=366.68 Aligned_cols=264 Identities=21% Similarity=0.295 Sum_probs=199.4
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe--------
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE-------- 460 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 460 (733)
.++|+..+.||+|+||+||+|+ ..+|+.||||++... ......++.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 3678899999999999999999 468999999998543 23344678999999999999999999999865
Q ss_pred CCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcc
Q 004732 461 GNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLA 540 (733)
Q Consensus 461 ~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 540 (733)
+...++||||++++.+.... .....++...++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CceEEEEEeccCCCccchhh-hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeeccee
Confidence 34589999999887665443 45567899999999999999999999986 999999999999999999999999999
Q ss_pred ccCcccCcc---cccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCc--
Q 004732 541 KLDEEENTH---ISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGK-- 614 (733)
Q Consensus 541 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-- 614 (733)
+........ ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||...+................
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 866543222 22345799999999999865 689999999999999999999999976655444332222211100
Q ss_pred ccccc---------cCCCCCCCCHH-------HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 615 LMELV---------DTNPGSNFDKE-------QVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 615 ~~~~~---------~~~~~~~~~~~-------~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
..... ........... ....+++++.+|++.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00000 00000001111 12256789999999999999999999864
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-43 Score=370.30 Aligned_cols=263 Identities=22% Similarity=0.316 Sum_probs=198.7
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccC-hhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC----eEE
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKS-KQGNREFINEIGMISALQHPNLVKLYGCCIEGN----QLL 465 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 465 (733)
+.+|...+.||+|+||+||+|+ ..+|+.||||++.... ....+.+.+|+++|++++|||||++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 3468899999999999999998 5689999999996543 334567899999999999999999999997643 234
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcc
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEE 545 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 545 (733)
++++|+.+|+|.+++... .+++..++.++.|++.||+|||+++ ||||||||+|||++.++.+||+|||+|+....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence 555677799999999654 6999999999999999999999996 99999999999999999999999999986554
Q ss_pred cCcc--cccccccCCCcccHHHHhh-CCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCccc------
Q 004732 546 ENTH--ISTRVAGTIGYMAPEYAMR-GHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLM------ 616 (733)
Q Consensus 546 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------ 616 (733)
.... ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...+..................
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred CCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence 3222 2345679999999999854 567899999999999999999999997665433332221111100000
Q ss_pred -----ccccCCC-CCCCCHH-----HHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 617 -----ELVDTNP-GSNFDKE-----QVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 617 -----~~~~~~~-~~~~~~~-----~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
......+ ....+.. ....+.+++.+|++.||.+|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000 0011111 12358899999999999999999999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=366.78 Aligned_cols=261 Identities=21% Similarity=0.334 Sum_probs=196.2
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCC------
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGN------ 462 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 462 (733)
.++|...+.||+|+||+||+|+ ..+|+.||||++... .....+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 4678899999999999999999 467999999999753 3334567899999999999999999999998654
Q ss_pred eEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 463 QLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 463 ~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
..++||||+ +++|..+... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceec
Confidence 579999999 5677777654 36999999999999999999999996 99999999999999999999999999986
Q ss_pred CcccCcccccccccCCCcccHHHHhhC-CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhC--------
Q 004732 543 DEEENTHISTRVAGTIGYMAPEYAMRG-HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQG-------- 613 (733)
Q Consensus 543 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-------- 613 (733)
.... .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||...+...............
T Consensus 171 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (346)
T d1cm8a_ 171 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246 (346)
T ss_dssp CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred cCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence 5443 2346799999999998764 57899999999999999999999997665443322111110000
Q ss_pred ----------cccccccCCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH--hccC
Q 004732 614 ----------KLMELVDTNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLRM--LECG 663 (733)
Q Consensus 614 ----------~~~~~~~~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~--L~~~ 663 (733)
...+.. ..............+.+++.+|++.||++|||+.|+++. ++..
T Consensus 247 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 247 QSDEAKNYMKGLPELE-KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp SCHHHHHHHHHSCCCC-CCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred cchhhhhhhccCCccc-ccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000000 000000011112347889999999999999999999874 5543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-42 Score=356.90 Aligned_cols=261 Identities=21% Similarity=0.289 Sum_probs=203.7
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeCCeEEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~e 469 (733)
++|+..+.||+|+||+||+|+ ..+|+.||||+++.. .......+.+|+.+++.++|||||+++++|.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 478899999999999999999 568899999998543 23345788999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccCcccCcc
Q 004732 470 YLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLDEEENTH 549 (733)
Q Consensus 470 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 549 (733)
++.++++..++. ....+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||.|+........
T Consensus 82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC
T ss_pred eccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCcc
Confidence 999999888765 4458899999999999999999999986 999999999999999999999999999876543322
Q ss_pred cccccccCCCcccHHHHhhCC-CCccchhHhHHHHHHHHHhCCCCCCc-cchhhHHHHHHHHHhhCc---c---ccccc-
Q 004732 550 ISTRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNVTK-EDMFYLLDWALVLKEQGK---L---MELVD- 620 (733)
Q Consensus 550 ~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~p~~~-~~~~~~~~~~~~~~~~~~---~---~~~~~- 620 (733)
.....+++.|+|||.+.... ++.++||||+||++|||++|+.||.. .+................ . ....+
T Consensus 158 -~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T d1unla_ 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp -CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred -ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc
Confidence 23345788999999987665 69999999999999999999999743 333332221111111100 0 00000
Q ss_pred --------CCCCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 621 --------TNPGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 621 --------~~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
..............+.+++.+|++.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001111222345888999999999999999999876
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-43 Score=365.49 Aligned_cols=252 Identities=23% Similarity=0.288 Sum_probs=201.9
Q ss_pred cCccccCcccCCCcccEEEccc----CCCcEEEEEEccccC----hhcHHHHHHHHHHHHhCCC-CceeeEeeEEEeCCe
Q 004732 393 NNFATDNNIGEGGFGPVYKGLL----ADGTAIAVKQLSSKS----KQGNREFINEIGMISALQH-PNLVKLYGCCIEGNQ 463 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 463 (733)
++|+..+.||+|+||+||+|+. .+|+.||||.+.... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5688999999999999999973 258899999986531 2234568899999999976 899999999999999
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.++||||+.+|+|.+++.... .++...+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhh
Confidence 999999999999999997554 6788999999999999999999986 999999999999999999999999999876
Q ss_pred cccCcccccccccCCCcccHHHHhhC--CCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcccccccC
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRG--HLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKLMELVDT 621 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (733)
............|++.|+|||.+.+. .++.++||||+||++|||++|+.||...+.................
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~------ 253 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------ 253 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC------
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCC------
Confidence 65555555567899999999999764 4788999999999999999999999655433322211111111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHhhcCCCCCCCC-----HHHHHH
Q 004732 622 NPGSNFDKEQVMVMINVALLCANASPTIRPS-----MSSVLR 658 (733)
Q Consensus 622 ~~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt-----~~~vl~ 658 (733)
..+......+.+++.+||+.||.+||| ++|+++
T Consensus 254 ----~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 254 ----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----CCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 111122345889999999999999995 777764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=361.71 Aligned_cols=258 Identities=21% Similarity=0.286 Sum_probs=191.3
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEe------CCe
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIE------GNQ 463 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 463 (733)
++|+..+.||+|+||+||+|+ ..+|+.||||++... .......+.+|+.++++++|||||+++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 578899999999999999999 457999999999654 33445678899999999999999999999964 368
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.|+|||||.++.+.. +. ..+++..++.++.||+.||+|||+.| |+||||||+|||++.++.+|++|||+++..
T Consensus 97 ~~iv~Ey~~~~l~~~-~~---~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ---MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEEHHHH-HT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred eEEEEeccchHHHHh-hh---cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcc
Confidence 899999998765543 32 46899999999999999999999997 999999999999999999999999998865
Q ss_pred cccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHH-------------
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLK------------- 610 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~------------- 610 (733)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||...+......-.....
T Consensus 170 ~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 GTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred cccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 4432 2345679999999999999999999999999999999999999996654333221111000
Q ss_pred ------hhC-cc-----cccccCCCCC---CCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHHH
Q 004732 611 ------EQG-KL-----MELVDTNPGS---NFDKEQVMVMINVALLCANASPTIRPSMSSVLRM 659 (733)
Q Consensus 611 ------~~~-~~-----~~~~~~~~~~---~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~~ 659 (733)
... .. .......... .........+.+++.+|++.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 00 0000000001 1122345578999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.2e-41 Score=358.44 Aligned_cols=254 Identities=17% Similarity=0.265 Sum_probs=195.6
Q ss_pred cCccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeC--CeEEEEE
Q 004732 393 NNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEG--NQLLLIY 468 (733)
Q Consensus 393 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~ 468 (733)
++|++.+.||+|+||+||+|+ ..+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 578999999999999999999 467999999998643 3467899999999995 99999999999854 5689999
Q ss_pred EccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCC-CeEEcccCccccCcccC
Q 004732 469 EYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDL-NSKISDFGLAKLDEEEN 547 (733)
Q Consensus 469 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~~~ 547 (733)
|||++++|.... ..+++..+..++.||+.||+|||++| |+||||||+|||++.++ .+||+|||+|+......
T Consensus 112 e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 112 EHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp ECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 999999987653 46999999999999999999999997 99999999999998765 58999999998665432
Q ss_pred cccccccccCCCcccHHHHhhCC-CCccchhHhHHHHHHHHHhCCCCCCccch-hhHHHHHH-----------HHHhhCc
Q 004732 548 THISTRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNVTKEDM-FYLLDWAL-----------VLKEQGK 614 (733)
Q Consensus 548 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~p~~~~~~-~~~~~~~~-----------~~~~~~~ 614 (733)
. .....||+.|+|||.+.+.. ++.++||||+||++|||++|+.||..... ........ .......
T Consensus 185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~ 262 (328)
T d3bqca1 185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 262 (328)
T ss_dssp C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCC
T ss_pred c--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccc
Confidence 2 34467899999999988754 79999999999999999999999954322 11110000 0000000
Q ss_pred c----cccccCC--------CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH
Q 004732 615 L----MELVDTN--------PGSNFDKEQVMVMINVALLCANASPTIRPSMSSVLR 658 (733)
Q Consensus 615 ~----~~~~~~~--------~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~ 658 (733)
. ....... ............+.+++.+|++.||++|||++|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 263 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp CCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0000000 000111112345889999999999999999999976
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-41 Score=355.68 Aligned_cols=264 Identities=23% Similarity=0.320 Sum_probs=200.0
Q ss_pred hcCccccCcccCCCcccEEEcc-cCCCcEEEEEEcccc--ChhcHHHHHHHHHHHHhCCCCceeeEeeEEEeC-----Ce
Q 004732 392 TNNFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSK--SKQGNREFINEIGMISALQHPNLVKLYGCCIEG-----NQ 463 (733)
Q Consensus 392 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 463 (733)
.++|+..+.||+|+||+||+|+ ..+|+.||||++... .....+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 4678899999999999999999 568999999999754 233446788999999999999999999998643 34
Q ss_pred EEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEcccCccccC
Q 004732 464 LLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDFGLAKLD 543 (733)
Q Consensus 464 ~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 543 (733)
.++|++|+.+|+|.+++.. ..+++.++..++.||+.||+|||++| |+||||||+|||++.++.+|++|||++...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred eEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhccc
Confidence 5777888899999999854 46999999999999999999999997 999999999999999999999999999754
Q ss_pred cccCcccccccccCCCcccHHHHhhCC-CCccchhHhHHHHHHHHHhCCCCCCccchhhHHHHHHHHHhhCcc-------
Q 004732 544 EEENTHISTRVAGTIGYMAPEYAMRGH-LTEKADVYSFGIVALEIVSGRSNVTKEDMFYLLDWALVLKEQGKL------- 615 (733)
Q Consensus 544 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------- 615 (733)
... .....||+.|+|||...+.. ++.++||||+||++|||++|+.||.+.+.................
T Consensus 172 ~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (348)
T d2gfsa1 172 DDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247 (348)
T ss_dssp TGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred Ccc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence 432 23467899999999887754 689999999999999999999999766554433322111110000
Q ss_pred -------cccccCCCCCCC---CHHHHHHHHHHHHHhhcCCCCCCCCHHHHHH--HhccCc
Q 004732 616 -------MELVDTNPGSNF---DKEQVMVMINVALLCANASPTIRPSMSSVLR--MLECGV 664 (733)
Q Consensus 616 -------~~~~~~~~~~~~---~~~~~~~l~~l~~~c~~~~P~~RPt~~~vl~--~L~~~~ 664 (733)
...........+ .......+.+++.+|++.||++|||+.|+++ .+.+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000000000000 0011235789999999999999999999987 455443
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-36 Score=325.19 Aligned_cols=258 Identities=19% Similarity=0.231 Sum_probs=190.8
Q ss_pred CccccCcccCCCcccEEEcc-cCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-----------CCceeeEeeEEEe-
Q 004732 394 NFATDNNIGEGGFGPVYKGL-LADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-----------HPNLVKLYGCCIE- 460 (733)
Q Consensus 394 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~- 460 (733)
+|.+.+.||+|+||+||+|+ ..+|+.||||++... ....+.+.+|+++++.++ |+|||++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 58899999999999999999 468999999999754 233467788999888875 5789999998865
Q ss_pred -CCeEEEEEEccCCCCHHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHc-CCCCCeecCCCCCCcEEecCCCC-----
Q 004732 461 -GNQLLLIYEYLENNSLARAL--FEHRLKLDWPTRRRICLGIARGLAYLHG-ESRIKVVHRDIKATNVLLDKDLN----- 531 (733)
Q Consensus 461 -~~~~~lV~e~~~~gsL~~~l--~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~ivH~Dik~~Nill~~~~~----- 531 (733)
....++|++++..+...... ......+++..+..++.||+.||+|||+ . +|+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccc
Confidence 45667777776665433332 2445678999999999999999999997 5 4999999999999987654
Q ss_pred -eEEcccCccccCcccCcccccccccCCCcccHHHHhhCCCCccchhHhHHHHHHHHHhCCCCCCccchhh-------HH
Q 004732 532 -SKISDFGLAKLDEEENTHISTRVAGTIGYMAPEYAMRGHLTEKADVYSFGIVALEIVSGRSNVTKEDMFY-------LL 603 (733)
Q Consensus 532 -~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~s~Gvil~elltg~~p~~~~~~~~-------~~ 603 (733)
++++|||.|...... .....||+.|+|||.+....++.++||||+||+++||++|+.||...+... +.
T Consensus 170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~ 245 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 245 (362)
T ss_dssp EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence 899999999754432 234679999999999999999999999999999999999999995433211 11
Q ss_pred HHHHHHH-------hh-Cccccccc---------CC----------CCCCCCHHHHHHHHHHHHHhhcCCCCCCCCHHHH
Q 004732 604 DWALVLK-------EQ-GKLMELVD---------TN----------PGSNFDKEQVMVMINVALLCANASPTIRPSMSSV 656 (733)
Q Consensus 604 ~~~~~~~-------~~-~~~~~~~~---------~~----------~~~~~~~~~~~~l~~l~~~c~~~~P~~RPt~~~v 656 (733)
....... .. .......+ .. ............+.+++.+|++.||++|||++|+
T Consensus 246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 1111100 00 00000000 00 0112345667789999999999999999999999
Q ss_pred HHH
Q 004732 657 LRM 659 (733)
Q Consensus 657 l~~ 659 (733)
++.
T Consensus 326 L~H 328 (362)
T d1q8ya_ 326 VNH 328 (362)
T ss_dssp HTC
T ss_pred hcC
Confidence 863
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.98 E-value=1.3e-32 Score=287.23 Aligned_cols=262 Identities=27% Similarity=0.373 Sum_probs=237.0
Q ss_pred eecccce--------eeeeccccccccc--cCCccccCCCCCCeeeccc-cccccccchhccCCCCCCEEEccccccccc
Q 004732 12 FWKQKTV--------NQKRVLKEQNLTG--VLPPKLAELTFLQDISLIA-NRLKGPIPKYLANISTLVNLTVQYNQFSGE 80 (733)
Q Consensus 12 ~~~~~~~--------~~~l~L~~n~l~~--~~p~~l~~l~~L~~L~L~~-n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 80 (733)
.|+|++| ...|+|++|+++| .+|+.|++|++|++|+|++ |+++|.+|..|+++++|++|+|++|++.+.
T Consensus 37 ~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~ 116 (313)
T d1ogqa_ 37 TWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116 (313)
T ss_dssp CSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEE
T ss_pred cCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhcccccccc
Confidence 4999887 4667899999998 5899999999999999997 899999999999999999999999999999
Q ss_pred CCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCC-CEEEccCCCCccCCCCCCCC
Q 004732 81 LPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKL-EKLFIQPSGLAGPIPSGIFS 159 (733)
Q Consensus 81 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L-~~L~l~~N~l~~~~p~~l~~ 159 (733)
.+..+..+.+|+.+++++|.+.+.+|..+.++++|+.+++++|.+++.+|..+..+..+ +.+++++|++++..|..+..
T Consensus 117 ~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~ 196 (313)
T d1ogqa_ 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN 196 (313)
T ss_dssp CCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGG
T ss_pred ccccccchhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999999999999999999999999999999999886 88999999999999998888
Q ss_pred cCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEE
Q 004732 160 LENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIY 238 (733)
Q Consensus 160 l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 238 (733)
+..+ .++++.+......+..+... +++.+++++|.+++.+| .++.+++|+.|+|++|+++|.+|..|.++++|++|+
T Consensus 197 l~~~-~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~ 274 (313)
T d1ogqa_ 197 LNLA-FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLN 274 (313)
T ss_dssp CCCS-EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEE
T ss_pred cccc-cccccccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEE
Confidence 7655 69999988887777766655 79999999999997765 688999999999999999999999999999999999
Q ss_pred ecCCcccccCChhh-hcCCCeeecccCcCCCCCCcccc
Q 004732 239 FAGNLLTGAIPPWM-LERGDKIDLSYNNFTDGSAESSC 275 (733)
Q Consensus 239 l~~N~l~~~~p~~~-l~~l~~l~ls~N~l~~~~~~~~~ 275 (733)
|++|+++|.+|... +++|+.+++++|+..++.|...|
T Consensus 275 Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g~plp~c 312 (313)
T d1ogqa_ 275 VSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312 (313)
T ss_dssp CCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSSCC
T ss_pred CcCCcccccCCCcccCCCCCHHHhCCCccccCCCCCCC
Confidence 99999999999764 78899999999986555544444
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.95 E-value=1.6e-28 Score=256.04 Aligned_cols=230 Identities=21% Similarity=0.334 Sum_probs=216.2
Q ss_pred CCCCeeecccccccc--ccchhccCCCCCCEEEccc-ccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCE
Q 004732 41 TFLQDISLIANRLKG--PIPKYLANISTLVNLTVQY-NQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKD 117 (733)
Q Consensus 41 ~~L~~L~L~~n~l~~--~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 117 (733)
.+++.|+|++|.++| .+|.+++++++|++|+|++ |+++|.+|.+|++|++|++|+|++|+|.+..+..+..+++|+.
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 468999999999998 5789999999999999997 8999999999999999999999999999999999999999999
Q ss_pred EEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCc-CeeecccccCCCCCccccccccccEEEcccCcc
Q 004732 118 FRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENL-TDLRISDLNGPEATFPQLGNMKMTKLILRNCNI 196 (733)
Q Consensus 118 L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L-~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l 196 (733)
+++++|++.+.+|..+++++.|+.+++++|.+.+.+|..++.+.++ +.+++++|++....+..+.......+++++|..
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~ 209 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNML 209 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEE
T ss_pred cccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999999999999999999999999999999998886 889999999999888888888888999999999
Q ss_pred CCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCcCCCCCC
Q 004732 197 TGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDGSA 271 (733)
Q Consensus 197 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~~~ 271 (733)
.+.+|..+..+++|+.|++++|.+++.+| .+..+++|+.|++++|+++|.+|.++ +++|+.|++++|+++|..+
T Consensus 210 ~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP 285 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285 (313)
T ss_dssp EECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC
T ss_pred ccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCC
Confidence 99999999999999999999999998765 58889999999999999999999988 7899999999999987544
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2e-25 Score=228.79 Aligned_cols=248 Identities=18% Similarity=0.179 Sum_probs=212.6
Q ss_pred eeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc-Cc
Q 004732 21 KRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS-SN 99 (733)
Q Consensus 21 ~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls-~N 99 (733)
.+..++++++ .+|..+. +.+++|+|++|+|+...+..|.++++|++|++++|++....+..+..+..+..++.. .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 3557778888 6677664 678999999999997777789999999999999999998888889999999998765 67
Q ss_pred cccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCcc
Q 004732 100 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFP 179 (733)
Q Consensus 100 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~ 179 (733)
.++...+..|+++++|++|++++|.+....+..+..+++|+.+++++|+|++..+..|..+++|+.|++++|++......
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~ 171 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPER 171 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTT
T ss_pred ccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchh
Confidence 78877788899999999999999999977788899999999999999999977778888999999999999999988877
Q ss_pred ccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh-hcCCC
Q 004732 180 QLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM-LERGD 257 (733)
Q Consensus 180 ~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~-l~~l~ 257 (733)
.+..+ +|+.+++++|++++..|..|.++++|++||+++|++.+..+..|..+++|++|++++|++.+..+... ...++
T Consensus 172 ~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~ 251 (284)
T d1ozna_ 172 AFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQ 251 (284)
T ss_dssp TTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHH
T ss_pred hhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHH
Confidence 77765 89999999999999999999999999999999999998888899999999999999999988766432 33344
Q ss_pred eeecccCcCCCCCC
Q 004732 258 KIDLSYNNFTDGSA 271 (733)
Q Consensus 258 ~l~ls~N~l~~~~~ 271 (733)
.+....+++.|..+
T Consensus 252 ~~~~~~~~~~C~~p 265 (284)
T d1ozna_ 252 KFRGSSSEVPCSLP 265 (284)
T ss_dssp HCCSEECCCBEEES
T ss_pred hCcCCCCceEeCCc
Confidence 45555566655433
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=9.4e-24 Score=213.98 Aligned_cols=201 Identities=24% Similarity=0.260 Sum_probs=143.0
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
...+++.++++|+ .+|+.|. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|+|+
T Consensus 11 ~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls 85 (266)
T d1p9ag_ 11 SHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLS 85 (266)
T ss_dssp TCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECC
T ss_pred CCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-cccccccccccccc
Confidence 3445567777777 3565553 46777777777777555566777777777777777776 343 35667777777777
Q ss_pred CccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCC
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEAT 177 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~ 177 (733)
+|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.+|+.|++++|.+....+..+..++
T Consensus 86 ~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~---------------- 148 (266)
T d1p9ag_ 86 HNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTP---------------- 148 (266)
T ss_dssp SSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCT----------------
T ss_pred ccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccc----------------
Confidence 77776 4555666677777777777777665566666666666666666666644444444444
Q ss_pred ccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccC
Q 004732 178 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAI 248 (733)
Q Consensus 178 ~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 248 (733)
+++.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++.+..
T Consensus 149 -------~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC 211 (266)
T d1p9ag_ 149 -------KLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCNC 211 (266)
T ss_dssp -------TCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCSG
T ss_pred -------cchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCCc
Confidence 4556667778888777888899999999999999999 78888888999999999999997653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=3.3e-23 Score=212.10 Aligned_cols=223 Identities=20% Similarity=0.209 Sum_probs=199.6
Q ss_pred CeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEee-C
Q 004732 44 QDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS-D 122 (733)
Q Consensus 44 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~-~ 122 (733)
..++.++++++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|++++|+|....+..+.+++.+..+... .
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 45678888888 7787654 679999999999996666789999999999999999998888888999999998865 6
Q ss_pred CccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccc-cccEEEcccCccCCCCC
Q 004732 123 NQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNM-KMTKLILRNCNITGELP 201 (733)
Q Consensus 123 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~-~L~~L~l~~n~l~~~~p 201 (733)
|.++...+..|.++++|+.|++++|.+....+..+..+.+|+.+++++|.+..++...+... +|+.|++++|++++..+
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred cccccccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence 67776778899999999999999999987778888889999999999999999888777665 79999999999999889
Q ss_pred ccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcCCCeeecccCcCCCC
Q 004732 202 RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LERGDKIDLSYNNFTDG 269 (733)
Q Consensus 202 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~l~~l~ls~N~l~~~ 269 (733)
..|.++++|+.|++++|++++..|..|..+++|++|++++|.+.+..|..+ +++|+.|++++|++.|.
T Consensus 171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~ 240 (284)
T d1ozna_ 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred hhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence 999999999999999999999999999999999999999999997777666 67899999999998764
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.90 E-value=7.3e-23 Score=211.87 Aligned_cols=242 Identities=21% Similarity=0.241 Sum_probs=135.5
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCc
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 99 (733)
+.++=++++++ .+|..+. ++|++|+|++|+|+...+..|.++++|++|++++|.+....|.+|.++++|+.|+|++|
T Consensus 13 ~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n 89 (305)
T d1xkua_ 13 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN 89 (305)
T ss_dssp TEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCC
Confidence 33444444555 4455543 56677777777776444445666677777777777766555666666777777777777
Q ss_pred cccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCc--cCCCCCCCCcCCcCeeecccccCCCCC
Q 004732 100 NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA--GPIPSGIFSLENLTDLRISDLNGPEAT 177 (733)
Q Consensus 100 ~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~--~~~p~~l~~l~~L~~L~l~~n~~~~~~ 177 (733)
+|+ .+|..+ ...|..|++.+|.+.+..+..+.....+..+.+..|... ...+..+..+++|+.+++++|.+....
T Consensus 90 ~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~ 166 (305)
T d1xkua_ 90 QLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIP 166 (305)
T ss_dssp CCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCC
T ss_pred ccC-cCccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCccccC
Confidence 666 454432 245666666666666544444555555555555555332 223344555555555555555555433
Q ss_pred ccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh--hcC
Q 004732 178 FPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM--LER 255 (733)
Q Consensus 178 ~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~--l~~ 255 (733)
... ..+|+.|++++|.+++..+..|.+++.++.|++++|.+++..+..+.++++|+.|++++|.|+ .+|.++ +++
T Consensus 167 ~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~ 243 (305)
T d1xkua_ 167 QGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 243 (305)
T ss_dssp SSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSS
T ss_pred ccc--CCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccC
Confidence 221 224555555555555555555555555555555555555555555555555555555555555 334443 455
Q ss_pred CCeeecccCcCCCCC
Q 004732 256 GDKIDLSYNNFTDGS 270 (733)
Q Consensus 256 l~~l~ls~N~l~~~~ 270 (733)
|+.|++++|+++...
T Consensus 244 L~~L~Ls~N~i~~i~ 258 (305)
T d1xkua_ 244 IQVVYLHNNNISAIG 258 (305)
T ss_dssp CCEEECCSSCCCCCC
T ss_pred CCEEECCCCccCccC
Confidence 555555555555443
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.90 E-value=1.3e-22 Score=210.05 Aligned_cols=245 Identities=22% Similarity=0.273 Sum_probs=211.5
Q ss_pred ceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeec
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 96 (733)
+.++.|+|++|+|+...+..|.++++|+.|++++|.+....|..|.++++|++|++++|+++ .+|..+ ...|..|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~ 107 (305)
T d1xkua_ 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRV 107 (305)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEEC
T ss_pred CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccch--hhhhhhhhc
Confidence 45788999999999777778999999999999999999888889999999999999999999 677644 358999999
Q ss_pred cCccccccCCccccCCCCCCEEEeeCCccc--cCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCC
Q 004732 97 SSNNFTGELPKTFAKLTNMKDFRISDNQFT--GQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGP 174 (733)
Q Consensus 97 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~--~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~ 174 (733)
++|.+.+..+..+.....+..+++..|... ...+..+..+++|+.+++++|.+. .+|..+ +++|+.|++++|...
T Consensus 108 ~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L~l~~n~~~ 184 (305)
T d1xkua_ 108 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 184 (305)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEEECTTSCCC
T ss_pred cccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEEECCCCcCC
Confidence 999999777777888889999999988654 345678899999999999999998 566554 589999999999998
Q ss_pred CCCccccccc-cccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhh-
Q 004732 175 EATFPQLGNM-KMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWM- 252 (733)
Q Consensus 175 ~~~~~~~~~~-~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~- 252 (733)
......+... .++.|++++|.+++..+..+.++++|++|+|++|+|+ .+|..|..+++|+.|++++|+|+..-...+
T Consensus 185 ~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~ 263 (305)
T d1xkua_ 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 263 (305)
T ss_dssp EECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSS
T ss_pred CCChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhcc
Confidence 8877777665 7999999999999998999999999999999999999 678899999999999999999984322221
Q ss_pred -------hcCCCeeecccCcCCC
Q 004732 253 -------LERGDKIDLSYNNFTD 268 (733)
Q Consensus 253 -------l~~l~~l~ls~N~l~~ 268 (733)
+..++.|++++|++..
T Consensus 264 ~~~~~~~~~~L~~L~L~~N~~~~ 286 (305)
T d1xkua_ 264 PPGYNTKKASYSGVSLFSNPVQY 286 (305)
T ss_dssp CSSCCTTSCCCSEEECCSSSSCG
T ss_pred CcchhcccCCCCEEECCCCcCcc
Confidence 4678899999998753
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=5.1e-23 Score=208.47 Aligned_cols=178 Identities=22% Similarity=0.180 Sum_probs=155.7
Q ss_pred ceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeec
Q 004732 17 TVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHL 96 (733)
Q Consensus 17 ~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 96 (733)
+.+++|+|++|+|++..+..|..+++|++|+|++|+|+ .++ .++.+++|++|+|++|+++ ..+..+..+++|+.|++
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l 107 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDV 107 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEEC
T ss_pred cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccccccccccc-ccccccccccccccccc
Confidence 34789999999999887889999999999999999999 455 4688999999999999999 67888999999999999
Q ss_pred cCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCC
Q 004732 97 SSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEA 176 (733)
Q Consensus 97 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~ 176 (733)
++|.+.+..+..+..+.+|++|++++|.++...+..+..+++|+.|++++|+|++..+..|..+++|+.|+
T Consensus 108 ~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~--------- 178 (266)
T d1p9ag_ 108 SFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL--------- 178 (266)
T ss_dssp CSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEE---------
T ss_pred cccccceeeccccccccccccccccccccceeccccccccccchhcccccccccccCccccccccccceee---------
Confidence 99999988888889999999999999999987788889999999999999999977777787777776555
Q ss_pred CccccccccccEEEcccCccCCCCCccccCCCCCcEEEccCCccc
Q 004732 177 TFPQLGNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLR 221 (733)
Q Consensus 177 ~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~ 221 (733)
|++|+|+ .+|..+..+++|+.|+|++|.+.
T Consensus 179 --------------Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 179 --------------LQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp --------------CCSSCCC-CCCTTTTTTCCCSEEECCSCCBC
T ss_pred --------------cccCCCc-ccChhHCCCCCCCEEEecCCCCC
Confidence 5556666 56667777888999999998876
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.88 E-value=2.5e-23 Score=199.55 Aligned_cols=163 Identities=20% Similarity=0.181 Sum_probs=121.4
Q ss_pred cccCcccCCCcccEEEcccCCCcEEEEEEccccCh------------------hcHHHHHHHHHHHHhCCCCceeeEeeE
Q 004732 396 ATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSK------------------QGNREFINEIGMISALQHPNLVKLYGC 457 (733)
Q Consensus 396 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 457 (733)
...+.||+|+||+||+|+..+|+.||||.++.... .....+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 34678999999999999988899999998653210 011334568889999999999988765
Q ss_pred EEeCCeEEEEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCCCCeecCCCCCCcEEecCCCCeEEccc
Q 004732 458 CIEGNQLLLIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGESRIKVVHRDIKATNVLLDKDLNSKISDF 537 (733)
Q Consensus 458 ~~~~~~~~lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 537 (733)
. . .++||||++++.+. .++......++.|+++|++|||+.| |+||||||+|||++++ .++|+||
T Consensus 83 ~--~--~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 83 E--G--NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp E--T--TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECCC
T ss_pred c--C--CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEEEC
Confidence 3 2 37999999986543 3455667889999999999999986 9999999999999965 5899999
Q ss_pred CccccCcccCcccccccccCCCccc------HHHHhhCCCCccchhHhHHHHH
Q 004732 538 GLAKLDEEENTHISTRVAGTIGYMA------PEYAMRGHLTEKADVYSFGIVA 584 (733)
Q Consensus 538 Gla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~Dv~s~Gvil 584 (733)
|+|.....+... .|.. .|. ..+.|+.++|+||..--+
T Consensus 147 G~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 147 PQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp TTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence 999755432211 0111 122 245688999999965433
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=1.6e-20 Score=200.25 Aligned_cols=240 Identities=24% Similarity=0.296 Sum_probs=151.8
Q ss_pred cceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceee
Q 004732 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 95 (733)
Q Consensus 16 ~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 95 (733)
...+++|++++++|+.. +.+..+++|++|+|++|+|++. + .|+++++|++|+|++|.+.+. + .++.+++|+.|+
T Consensus 43 l~~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i-~-~l~~l~~L~~L~ 116 (384)
T d2omza2 43 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLT 116 (384)
T ss_dssp HTTCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEE
T ss_pred hCCCCEEECCCCCCCCc--cccccCCCCCEEeCcCCcCCCC-c-cccCCcccccccccccccccc-c-cccccccccccc
Confidence 34577888899988854 4688889999999999999854 3 388899999999999998853 3 378888888888
Q ss_pred ccCccccccC---------------------------------------------------------------CccccCC
Q 004732 96 LSSNNFTGEL---------------------------------------------------------------PKTFAKL 112 (733)
Q Consensus 96 Ls~N~l~~~~---------------------------------------------------------------p~~~~~l 112 (733)
+++|.+++.. ...+..+
T Consensus 117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 196 (384)
T d2omza2 117 LFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL 196 (384)
T ss_dssp CCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGC
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccc
Confidence 8887765311 1223445
Q ss_pred CCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcc
Q 004732 113 TNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILR 192 (733)
Q Consensus 113 ~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~ 192 (733)
++++.|++++|.+++..| +..+++|+.|++++|+++. + ..+..+++|+.|++++|.+..... .....+|+.|+++
T Consensus 197 ~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~ 271 (384)
T d2omza2 197 TNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLG 271 (384)
T ss_dssp TTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECC
T ss_pred cccceeeccCCccCCCCc--ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCCc-ccccccCCEeecc
Confidence 666677777777664433 3455666666666666653 2 245556666666666666554332 1122255555555
Q ss_pred cCccCCCCC--------------------ccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCCh-h
Q 004732 193 NCNITGELP--------------------RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP-W 251 (733)
Q Consensus 193 ~n~l~~~~p--------------------~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~ 251 (733)
+|.+++..+ ..+..+++++.|++++|++++.. .+..+++|+.|++++|.+++ ++. .
T Consensus 272 ~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~~l~ 348 (384)
T d2omza2 272 ANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VSSLA 348 (384)
T ss_dssp SSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CGGGG
T ss_pred CcccCCCCccccccccccccccccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-ChhHc
Confidence 555553321 23555666666666666666432 25666677777777776653 221 1
Q ss_pred hhcCCCeeecccCcCCCC
Q 004732 252 MLERGDKIDLSYNNFTDG 269 (733)
Q Consensus 252 ~l~~l~~l~ls~N~l~~~ 269 (733)
-+++|+.|++++|++++.
T Consensus 349 ~l~~L~~L~l~~N~l~~l 366 (384)
T d2omza2 349 NLTNINWLSAGHNQISDL 366 (384)
T ss_dssp GCTTCCEEECCSSCCCBC
T ss_pred CCCCCCEEECCCCcCCCC
Confidence 156666777777766654
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=1e-20 Score=201.90 Aligned_cols=237 Identities=23% Similarity=0.278 Sum_probs=180.0
Q ss_pred cccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccC------------
Q 004732 14 KQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGEL------------ 81 (733)
Q Consensus 14 ~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~------------ 81 (733)
+..+.+++|+|++|+|++.. .|.++++|++|+|++|.|.+.. .++++++|+.|++++|.+++..
T Consensus 63 ~~L~nL~~L~Ls~N~l~~l~--~l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~L~~~~~~~~~~~~~~~~~~~~~~~ 138 (384)
T d2omza2 63 EYLNNLTQINFSNNQLTDIT--PLKNLTKLVDILMNNNQIADIT--PLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLE 138 (384)
T ss_dssp GGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGTTCTTCSEEE
T ss_pred ccCCCCCEEeCcCCcCCCCc--cccCCccccccccccccccccc--cccccccccccccccccccccccccccccccccc
Confidence 44567899999999999753 4999999999999999999543 3899999999999988775311
Q ss_pred ---------------------------------------------------CccccCCcCCceeeccCccccccCCcccc
Q 004732 82 ---------------------------------------------------PEELGSLLNLEKLHLSSNNFTGELPKTFA 110 (733)
Q Consensus 82 ---------------------------------------------------p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~ 110 (733)
...+..+++++.|++++|.+++..| +.
T Consensus 139 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~--~~ 216 (384)
T d2omza2 139 LSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP--LG 216 (384)
T ss_dssp EEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG--GG
T ss_pred cccccccccccccccccccccccccccchhhhhccccccccccccccccccccccccccccceeeccCCccCCCCc--cc
Confidence 1234556678888888888875544 45
Q ss_pred CCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCc------------
Q 004732 111 KLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATF------------ 178 (733)
Q Consensus 111 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~------------ 178 (733)
..++|+.|++++|+++. + ..+..+++|+.|++++|++++.. .+..+++|+.|++++|.+.....
T Consensus 217 ~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~ 292 (384)
T d2omza2 217 ILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQISNLA--PLSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292 (384)
T ss_dssp GCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEEC
T ss_pred ccCCCCEEECCCCCCCC-c-chhhcccccchhccccCccCCCC--cccccccCCEeeccCcccCCCCccccccccccccc
Confidence 56778888888887773 3 35677777777777777777433 36667777777777766654321
Q ss_pred --------cccc-cccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCC
Q 004732 179 --------PQLG-NMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIP 249 (733)
Q Consensus 179 --------~~~~-~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p 249 (733)
..+. ..+++.|++++|++++.. .+..+++|++|++++|+|++ ++ .+..+++|++|++++|++++..|
T Consensus 293 ~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 293 NENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp CSSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred cccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence 1111 226889999999999754 38899999999999999995 44 68999999999999999997766
Q ss_pred hhhhcCCCeeecccC
Q 004732 250 PWMLERGDKIDLSYN 264 (733)
Q Consensus 250 ~~~l~~l~~l~ls~N 264 (733)
-.-+++|+.|++++|
T Consensus 369 l~~l~~L~~L~L~~N 383 (384)
T d2omza2 369 LANLTRITQLGLNDQ 383 (384)
T ss_dssp GTTCTTCSEEECCCE
T ss_pred hccCCCCCEeeCCCC
Confidence 444789999999987
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.78 E-value=5.8e-19 Score=175.60 Aligned_cols=219 Identities=14% Similarity=0.153 Sum_probs=165.8
Q ss_pred eeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCC-ccccCCcCCceeecc
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELP-EELGSLLNLEKLHLS 97 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls 97 (733)
.+.++.++++++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|+|++|.+...++ .+|..++++++|.+.
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 356677888888 7777664 689999999999996666679999999999999998876554 568899999999876
Q ss_pred C-ccccccCCccccCCCCCCEEEeeCCccccCCC-ccccccCCCCEEEccCCCCccCCCCCCCCcC-CcCeeecccccCC
Q 004732 98 S-NNFTGELPKTFAKLTNMKDFRISDNQFTGQIP-SFIQNWTKLEKLFIQPSGLAGPIPSGIFSLE-NLTDLRISDLNGP 174 (733)
Q Consensus 98 ~-N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~-~L~~L~l~~n~~~ 174 (733)
. |++....+..|.++++|+.|++++|++....+ ..+..+..|..+...++.+....+..+.+++ .++.|++++|.+.
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 4 78887888889999999999999999984332 2345567777777788888766566666654 6778888888887
Q ss_pred CCCccccccccccEE-EcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEec
Q 004732 175 EATFPQLGNMKMTKL-ILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFA 240 (733)
Q Consensus 175 ~~~~~~~~~~~L~~L-~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 240 (733)
......+...++..+ ++++|+++...+..|.++++|++|+|++|+|+...+..|..+++|+.+++.
T Consensus 167 ~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~ 233 (242)
T d1xwdc1 167 EIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTY 233 (242)
T ss_dssp EECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEE
T ss_pred ccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCC
Confidence 776666666665554 467777875555667888888888888888885555566666666665554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.77 E-value=1.3e-18 Score=171.20 Aligned_cols=202 Identities=21% Similarity=0.296 Sum_probs=128.2
Q ss_pred eeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCcc
Q 004732 21 KRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNN 100 (733)
Q Consensus 21 ~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 100 (733)
.+++..+++++.+ .+..+.+|+.|++.+|+|+. ++ .+.++++|++|+|++|.+++..| +..+++|+.|++++|.
T Consensus 23 ~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 23 KIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNP 96 (227)
T ss_dssp HHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCC
T ss_pred HHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccc
Confidence 3456677777654 45667788888888888873 43 47788888888888888874333 7788888888888888
Q ss_pred ccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccc
Q 004732 101 FTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQ 180 (733)
Q Consensus 101 l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~ 180 (733)
++ .++ .+.++++|+.+++++|...+. ..+...+.+..+.++++.+... ..+..+++|+.|++++|.+.....
T Consensus 97 ~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~~-- 168 (227)
T d1h6ua2 97 LK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTP-- 168 (227)
T ss_dssp CS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCGG--
T ss_pred cc-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchh--hhhccccccccccccccccccchh--
Confidence 77 443 477788888888888877642 2355677777777777777532 235556666666666665543221
Q ss_pred ccc-ccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEec
Q 004732 181 LGN-MKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFA 240 (733)
Q Consensus 181 ~~~-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~ 240 (733)
+.. .+|+.|+|++|++++. + .++++++|++|+|++|+|++. + .+..+++|+.|+++
T Consensus 169 l~~l~~L~~L~Ls~n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLT 225 (227)
T ss_dssp GTTCTTCCEEECCSSCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred hcccccceecccCCCccCCC-h-hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEee
Confidence 222 2555666666655532 2 255556666666666665532 2 25555555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.75 E-value=1.7e-18 Score=170.43 Aligned_cols=210 Identities=17% Similarity=0.196 Sum_probs=171.3
Q ss_pred CCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEE
Q 004732 39 ELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDF 118 (733)
Q Consensus 39 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 118 (733)
.+.++..+++..+++++.. .+..+.+|+.|++.+|.|+ .++ .+..+++|++|+|++|++++..| +..+++|+.|
T Consensus 17 ~l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l 90 (227)
T d1h6ua2 17 ALANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITEL 90 (227)
T ss_dssp HHHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEE
T ss_pred HHHHHHHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccc
Confidence 3455567788888888654 4677889999999999999 554 69999999999999999995544 8999999999
Q ss_pred EeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCC
Q 004732 119 RISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITG 198 (733)
Q Consensus 119 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~ 198 (733)
++++|.++ .++ .+..+++|+.+.+++|...+. ..+...+.+..+.++.+.+..... .....+|+.|++++|.+++
T Consensus 91 ~~~~n~~~-~i~-~l~~l~~L~~l~l~~~~~~~~--~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~L~~L~l~~n~~~~ 165 (227)
T d1h6ua2 91 ELSGNPLK-NVS-AIAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISP-LAGLTNLQYLSIGNAQVSD 165 (227)
T ss_dssp ECCSCCCS-CCG-GGTTCTTCCEEECTTSCCCCC--GGGTTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC
T ss_pred cccccccc-ccc-ccccccccccccccccccccc--chhccccchhhhhchhhhhchhhh-hcccccccccccccccccc
Confidence 99999998 444 578999999999999988743 346677889999998888765432 2334479999999999985
Q ss_pred CCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCeeeccc
Q 004732 199 ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSY 263 (733)
Q Consensus 199 ~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~ 263 (733)
.. .++++++|+.|+|++|++++ ++ .+..+++|++|++++|++++..|-.-+++|+.|++++
T Consensus 166 ~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 166 LT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTN 226 (227)
T ss_dssp CG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGGGTTCTTCCEEEEEE
T ss_pred ch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcccccCCCCCEEEeeC
Confidence 43 48899999999999999985 44 3889999999999999998655444488899999873
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.75 E-value=8.3e-19 Score=167.76 Aligned_cols=129 Identities=19% Similarity=0.303 Sum_probs=99.6
Q ss_pred eeeeccccccccccCCccccCCCCCCeeecccccccccc-chhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 19 NQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPI-PKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 19 ~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
...++.++++++ .+|+.+. +++++|+|++|+|++.+ +..|.++++|++|+|++|.+....+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 355677888888 5666653 67888888888887533 4567788888888888888887777778888888888888
Q ss_pred CccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCc
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLA 150 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 150 (733)
+|+|++..|..|.++++|++|+|++|+|++..++.|..+++|++|+|++|.+.
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccc
Confidence 88888777777888888888888888888777777777888888888777775
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.74 E-value=3.7e-18 Score=165.59 Aligned_cols=181 Identities=21% Similarity=0.317 Sum_probs=129.4
Q ss_pred eccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccc
Q 004732 22 RVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNF 101 (733)
Q Consensus 22 l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 101 (733)
..+..+++++.++. ..+.+|+.|++++|.++.. + .+..+++|++|+|++|++++ ++ .++.+++|+.|++++|+|
T Consensus 29 ~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i 102 (210)
T d1h6ta2 29 DNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKV 102 (210)
T ss_dssp HHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCC
T ss_pred HHhCcCccCCccCH--HHhcCccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccccccc
Confidence 35667777766653 3567888888888888843 3 37788888888888888884 33 367888888888888888
Q ss_pred cccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCcccc
Q 004732 102 TGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQL 181 (733)
Q Consensus 102 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~ 181 (733)
+ .+| .+..+++|+.|++++|.+. .+ ..+.+++.|+.+++++|.+++ +..+..+++
T Consensus 103 ~-~l~-~l~~l~~L~~L~l~~~~~~-~~-~~l~~l~~l~~l~~~~n~l~~--~~~~~~l~~------------------- 157 (210)
T d1h6ta2 103 K-DLS-SLKDLKKLKSLSLEHNGIS-DI-NGLVHLPQLESLYLGNNKITD--ITVLSRLTK------------------- 157 (210)
T ss_dssp C-CGG-GGTTCTTCCEEECTTSCCC-CC-GGGGGCTTCCEEECCSSCCCC--CGGGGGCTT-------------------
T ss_pred c-ccc-ccccccccccccccccccc-cc-ccccccccccccccccccccc--ccccccccc-------------------
Confidence 8 454 4778888888888888876 33 357778888888888888763 223334444
Q ss_pred ccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecC
Q 004732 182 GNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAG 241 (733)
Q Consensus 182 ~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~ 241 (733)
|+.+++++|++++. + .++++++|+.|+|++|+|+. ++ .+.++++|+.|++++
T Consensus 158 ----L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 158 ----LDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp ----CSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEE
T ss_pred ----cccccccccccccc-c-cccCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEccC
Confidence 44566666777643 2 37778888888888888873 44 478888888888763
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.73 E-value=2.3e-18 Score=164.68 Aligned_cols=175 Identities=17% Similarity=0.226 Sum_probs=148.2
Q ss_pred CCeeeccccccccccchhccCCCCCCEEEcccccccccC-CccccCCcCCceeeccCccccccCCccccCCCCCCEEEee
Q 004732 43 LQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGEL-PEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 121 (733)
Q Consensus 43 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 121 (733)
.+.++.++++|+ .+|..+. +++++|+|++|+|+..+ +..|..+++|+.|+|++|++++..+..|..+++|++|+|+
T Consensus 10 ~~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 10 GTTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TTEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CCEEEEeCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 468999999999 7887664 68999999999998645 5678999999999999999999999999999999999999
Q ss_pred CCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCC
Q 004732 122 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELP 201 (733)
Q Consensus 122 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p 201 (733)
+|+|+...++.|.++++|++|+|++|+|++..+..|..+++|+.|+|++|.+.......+-...+..+.+..+.++...|
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~~c~~p 166 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAP 166 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGCBBCSS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchHHHhhhhhhhcccCCCeEeCCC
Confidence 99999888889999999999999999999888889999999999999999887654332222245666778888887666
Q ss_pred ccccCCCCCcEEEccCCcccCC
Q 004732 202 RYLGKMTKLKVLDLSFNRLRGQ 223 (733)
Q Consensus 202 ~~~~~l~~L~~L~ls~N~l~~~ 223 (733)
.. +..++.++|+.|.++..
T Consensus 167 ~~---l~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 167 SK---VRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp TT---TTTSBGGGSCTTTCCCC
T ss_pred hh---hcCCEeeecCHhhCcCC
Confidence 54 45677889999998743
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=3.2e-18 Score=164.61 Aligned_cols=177 Identities=22% Similarity=0.348 Sum_probs=112.0
Q ss_pred eccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccc
Q 004732 22 RVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNF 101 (733)
Q Consensus 22 l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 101 (733)
+.+..+++++.++ ...+.+|+.|++++|.|+. +. .+..+++|++|+|++|++++. +. ++++++|++|++++|.+
T Consensus 23 ~~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~-~~-l~~l~~L~~L~l~~n~~ 96 (199)
T d2omxa2 23 TVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQI 96 (199)
T ss_dssp HHTTCSSTTSEEC--HHHHTTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCC
T ss_pred HHhCCCCCCCccC--HHHhcCCCEEECCCCCCCC-cc-ccccCCCcCcCccccccccCc-cc-ccCCccccccccccccc
Confidence 4566666665543 2456677777777777773 32 366777777777777777743 22 67777777777777776
Q ss_pred cccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCcccc
Q 004732 102 TGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQL 181 (733)
Q Consensus 102 ~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~ 181 (733)
. .++ .+.++++|+.|++++|.+... ..+..+++|+.|++++|++.. + ..+..+++
T Consensus 97 ~-~~~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~-~~l~~~~~------------------- 151 (199)
T d2omxa2 97 A-DIT-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLELSSNTISD-I-SALSGLTS------------------- 151 (199)
T ss_dssp C-CCG-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-C-GGGTTCTT-------------------
T ss_pred c-ccc-ccccccccccccccccccccc--cccchhhhhHHhhhhhhhhcc-c-cccccccc-------------------
Confidence 6 333 366777777777777776632 235666677777777666652 2 23444444
Q ss_pred ccccccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEE
Q 004732 182 GNMKMTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYI 237 (733)
Q Consensus 182 ~~~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 237 (733)
|+.|++++|++++.. .++++++|++|++++|+++. ++ .+.++++|+.|
T Consensus 152 ----L~~L~l~~n~l~~l~--~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 152 ----LQQLNFSSNQVTDLK--PLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp ----CSEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred ----ccccccccccccCCc--cccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 445556666666432 37778888888888888874 33 46777777765
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.5e-17 Score=165.25 Aligned_cols=212 Identities=17% Similarity=0.172 Sum_probs=165.2
Q ss_pred CCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccC-CccccCCCCCCEEEee
Q 004732 43 LQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGEL-PKTFAKLTNMKDFRIS 121 (733)
Q Consensus 43 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~l~ 121 (733)
.+.++.+++.++ .+|..+. +++++|+|++|+|+...+.+|.++++|++|+|++|.+...+ +..|.+++++++|.+.
T Consensus 10 ~~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 10 NRVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SSEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccc
Confidence 367888999999 7776653 58999999999999555567999999999999999988654 4578899999999986
Q ss_pred C-CccccCCCccccccCCCCEEEccCCCCccCCCC-CCCCcCCcCeeecccccCCCCCccccccc--cccEEEcccCccC
Q 004732 122 D-NQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPS-GIFSLENLTDLRISDLNGPEATFPQLGNM--KMTKLILRNCNIT 197 (733)
Q Consensus 122 ~-N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~-~l~~l~~L~~L~l~~n~~~~~~~~~~~~~--~L~~L~l~~n~l~ 197 (733)
. |++....+..|.++++|+.|++++|++....+. .+..++.+..+..+++.+.......+... .+..|++++|+++
T Consensus 87 ~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 87 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CCTTCCEECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 5 788878888999999999999999999844332 34446666666777777777666665543 6889999999999
Q ss_pred CCCCccccCCCCCcE-EEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCee
Q 004732 198 GELPRYLGKMTKLKV-LDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKI 259 (733)
Q Consensus 198 ~~~p~~~~~l~~L~~-L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~l 259 (733)
...+..+ ...++.. +++++|+|+...+..|.++++|+.|++++|.++ .+|...+.++..|
T Consensus 167 ~i~~~~~-~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~-~l~~~~~~~l~~L 227 (242)
T d1xwdc1 167 EIHNCAF-NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKL 227 (242)
T ss_dssp EECTTTT-TTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCC-CCCSSSCTTCCEE
T ss_pred ccccccc-cchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCC-ccCHHHHcCCccc
Confidence 6555444 4555544 467888999655667999999999999999998 5666655555444
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=4.2e-18 Score=165.22 Aligned_cols=184 Identities=21% Similarity=0.343 Sum_probs=130.2
Q ss_pred CCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEee
Q 004732 42 FLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRIS 121 (733)
Q Consensus 42 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~ 121 (733)
++...++..+.+++.++. ..+.+|++|++++|.++. ++ .+..+++|++|+|++|+|++ ++ .++.+++|+.|+++
T Consensus 25 ~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~ 98 (210)
T d1h6ta2 25 ETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLD 98 (210)
T ss_dssp HHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECC
T ss_pred HHHHHHhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCccccccccc
Confidence 344456667777765553 345678888888888873 33 37778888888888888874 33 36777888888888
Q ss_pred CCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeecccccCCCCCccccccccccEEEcccCccCCCCC
Q 004732 122 DNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLNGPEATFPQLGNMKMTKLILRNCNITGELP 201 (733)
Q Consensus 122 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p 201 (733)
+|+|++ ++ .+.++++|+.|++++|.+.. + ..+..+++ ++.+++++|.+++.
T Consensus 99 ~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~-----------------------l~~l~~~~n~l~~~-- 149 (210)
T d1h6ta2 99 ENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQ-----------------------LESLYLGNNKITDI-- 149 (210)
T ss_dssp SSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTT-----------------------CCEEECCSSCCCCC--
T ss_pred cccccc-cc-cccccccccccccccccccc-c-cccccccc-----------------------cccccccccccccc--
Confidence 888773 44 46777777777777777652 1 23333433 45666666777642
Q ss_pred ccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCCh-hhhcCCCeeeccc
Q 004732 202 RYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPP-WMLERGDKIDLSY 263 (733)
Q Consensus 202 ~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~-~~l~~l~~l~ls~ 263 (733)
..+..+++|+.+++++|++++ ++ .+.++++|+.|++++|.++. +|. .-+++|+.|++++
T Consensus 150 ~~~~~l~~L~~l~l~~n~l~~-i~-~l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 150 TVLSRLTKLDTLSLEDNQISD-IV-PLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFS 209 (210)
T ss_dssp GGGGGCTTCSEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEE
T ss_pred ccccccccccccccccccccc-cc-cccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEccC
Confidence 356789999999999999995 33 38899999999999999984 443 2278999999874
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=4.7e-17 Score=156.31 Aligned_cols=145 Identities=23% Similarity=0.336 Sum_probs=119.0
Q ss_pred cceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceee
Q 004732 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 95 (733)
Q Consensus 16 ~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 95 (733)
...++.|++++|+++.. +.+..+++|++|+|++|+|++..+ ++++++|++|++++|.+. .++ .+.++++|+.|+
T Consensus 39 l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~ 112 (199)
T d2omxa2 39 LDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLT 112 (199)
T ss_dssp HTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEE
T ss_pred hcCCCEEECCCCCCCCc--cccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-cccccccccccc
Confidence 44578899999999954 368899999999999999996543 999999999999999998 454 489999999999
Q ss_pred ccCccccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEEEccCCCCccCCCCCCCCcCCcCeeeccccc
Q 004732 96 LSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSGIFSLENLTDLRISDLN 172 (733)
Q Consensus 96 Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~ 172 (733)
+++|.+... ..+..+++|+.|++++|++. .++ .+..+++|+.|++.+|++++. + .+.++++|+.|++++|+
T Consensus 113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N~ 183 (199)
T d2omxa2 113 LFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSNK 183 (199)
T ss_dssp CCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTTCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSC
T ss_pred ccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccccccccccccccccccCC-c-cccCCCCCCEEECCCCC
Confidence 999999843 34889999999999999998 343 588999999999999999843 2 36666666655554433
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.67 E-value=1.9e-15 Score=158.13 Aligned_cols=232 Identities=19% Similarity=0.214 Sum_probs=161.0
Q ss_pred eeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeecc
Q 004732 18 VNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLS 97 (733)
Q Consensus 18 ~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 97 (733)
..++|+|++++++ .+|+. +++|++|+|++|+|+ .+|..+ .+|+.|++++|+++ .++.- .++|++|+|+
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 4678999999998 56753 478999999999999 777653 57999999999988 55531 1469999999
Q ss_pred CccccccCCccccCCCCCCEEEeeCCccccCCC------------------ccccccCCCCEEEccCCCCccC-------
Q 004732 98 SNNFTGELPKTFAKLTNMKDFRISDNQFTGQIP------------------SFIQNWTKLEKLFIQPSGLAGP------- 152 (733)
Q Consensus 98 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~------------------~~~~~l~~L~~L~l~~N~l~~~------- 152 (733)
+|.++ .+|. ++.+++|+.|++++|.+..... ..+..++.++.|.+++|.+...
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~ 184 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSL 184 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTC
T ss_pred ccccc-cccc-hhhhccceeeccccccccccccccccccchhhccccccccccccccccceecccccccccccccccccc
Confidence 99998 6664 6789999999999998873322 2345667788888888776531
Q ss_pred -----------CCCCCCCcCCcCeeecccccCCCCCccccc-----------------cccccEEEcccCccCC------
Q 004732 153 -----------IPSGIFSLENLTDLRISDLNGPEATFPQLG-----------------NMKMTKLILRNCNITG------ 198 (733)
Q Consensus 153 -----------~p~~l~~l~~L~~L~l~~n~~~~~~~~~~~-----------------~~~L~~L~l~~n~l~~------ 198 (733)
....+..++.|+.+++++|........... ...+..+++..+.+.+
T Consensus 185 ~~l~~~~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~ 264 (353)
T d1jl5a_ 185 ESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPP 264 (353)
T ss_dssp CEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 112345577888888888765543321100 0012333333332221
Q ss_pred ----------CCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCeeecccCcCCC
Q 004732 199 ----------ELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDLSYNNFTD 268 (733)
Q Consensus 199 ----------~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~l~ls~N~l~~ 268 (733)
.++.....+++|++|+|++|+|+ .+|.. +++|+.|++++|.|+ .+|. .+.+|+.|++++|+++.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~-~~~~L~~L~L~~N~L~~ 338 (353)
T d1jl5a_ 265 NLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPE-LPQNLKQLHVEYNPLRE 338 (353)
T ss_dssp TCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCC-CCTTCCEEECCSSCCSS
T ss_pred hhcccccccCccccccccCCCCCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-cccc-ccCCCCEEECcCCcCCC
Confidence 11112233578999999999998 56643 578899999999987 5664 35689999999998875
Q ss_pred C
Q 004732 269 G 269 (733)
Q Consensus 269 ~ 269 (733)
.
T Consensus 339 l 339 (353)
T d1jl5a_ 339 F 339 (353)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=2.7e-16 Score=159.77 Aligned_cols=250 Identities=14% Similarity=0.167 Sum_probs=156.9
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEccccccccc-CCccccCCcCCceeeccC
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGE-LPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~ 98 (733)
+.+||+++++.......+.. ..+..+.+....+..... ......+|++|||+++.++.. +...+..+++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccc
Confidence 45677777665332222221 234555666555553332 233445788888887777643 334467777888888888
Q ss_pred ccccccCCccccCCCCCCEEEeeCC-ccccC-CCccccccCCCCEEEccCC-CCccC-CCCCCCC-cCCcCeeecccc--
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDN-QFTGQ-IPSFIQNWTKLEKLFIQPS-GLAGP-IPSGIFS-LENLTDLRISDL-- 171 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~l~~L~~L~l~~N-~l~~~-~p~~l~~-l~~L~~L~l~~n-- 171 (733)
|.++...+..++.+++|++|++++| .++.. +...+.++++|++|+++++ .++.. +...+.. .++|+.|+++++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred cCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 8777767777777788888888774 45421 1223456778888888774 34321 1122222 356788888764
Q ss_pred cCCCCCcccc-cc-ccccEEEcccC-ccCCCCCccccCCCCCcEEEccCC-cccCCCCCCcCCCCCCCEEEecCCccccc
Q 004732 172 NGPEATFPQL-GN-MKMTKLILRNC-NITGELPRYLGKMTKLKVLDLSFN-RLRGQIPSNFDDLYDVDYIYFAGNLLTGA 247 (733)
Q Consensus 172 ~~~~~~~~~~-~~-~~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~ 247 (733)
.+.......+ .. .+|+.|++++| .+++.....+.++++|++|+|++| .+++.....+.++++|+.|+++++ ++..
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~ 239 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDG 239 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTT
T ss_pred ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHH
Confidence 3333323222 22 37889999876 477777788889999999999994 687777777888999999999987 4322
Q ss_pred CChhhhcCCCeeecccCcCCCCCCc
Q 004732 248 IPPWMLERGDKIDLSYNNFTDGSAE 272 (733)
Q Consensus 248 ~p~~~l~~l~~l~ls~N~l~~~~~~ 272 (733)
.-..+...+..|.+..++++....+
T Consensus 240 ~l~~l~~~lp~L~i~~~~ls~~~~~ 264 (284)
T d2astb2 240 TLQLLKEALPHLQINCSHFTTIARP 264 (284)
T ss_dssp CHHHHHHHSTTSEESCCCSCCTTCS
T ss_pred HHHHHHHhCccccccCccCCCCCCC
Confidence 2223344566667777777765443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.56 E-value=1.1e-13 Score=144.34 Aligned_cols=225 Identities=22% Similarity=0.219 Sum_probs=154.8
Q ss_pred cceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceee
Q 004732 16 KTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLH 95 (733)
Q Consensus 16 ~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 95 (733)
.+.++.|+|++|+|+ .+|..+ .+|+.|++++|+++ .++. + .+.|++|+|++|.++ .+|. ++.+++|+.|+
T Consensus 57 ~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~-l--p~~L~~L~L~~n~l~-~lp~-~~~l~~L~~L~ 126 (353)
T d1jl5a_ 57 PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSD-L--PPLLEYLGVSNNQLE-KLPE-LQNSSFLKIID 126 (353)
T ss_dssp CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCS-C--CTTCCEEECCSSCCS-SCCC-CTTCTTCCEEE
T ss_pred CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhh-h--ccccccccccccccc-cccc-hhhhccceeec
Confidence 456899999999999 667654 67899999999998 4442 1 146999999999998 6774 68899999999
Q ss_pred ccCccccccCC------------------ccccCCCCCCEEEeeCCccccCC------------------CccccccCCC
Q 004732 96 LSSNNFTGELP------------------KTFAKLTNMKDFRISDNQFTGQI------------------PSFIQNWTKL 139 (733)
Q Consensus 96 Ls~N~l~~~~p------------------~~~~~l~~L~~L~l~~N~l~~~~------------------~~~~~~l~~L 139 (733)
+++|.++.... ..+..++.++.|++++|.+.... ...+..++.|
T Consensus 127 l~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~l~~l~~l~~L~l~~n~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~L 206 (353)
T d1jl5a_ 127 VDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFL 206 (353)
T ss_dssp CCSSCCSCCCCCCTTCCEEECCSSCCSSCCCCTTCTTCCEEECCSSCCSSCCCCCTTCCEEECCSSCCSSCCCCTTCTTC
T ss_pred cccccccccccccccccchhhccccccccccccccccceecccccccccccccccccccccccccccccccccccccccc
Confidence 99998763221 23455778889999888876321 1234567899
Q ss_pred CEEEccCCCCccCCCCCCCC-----------------cCCcCeeecccccCCCCC---cc------------c-cc-ccc
Q 004732 140 EKLFIQPSGLAGPIPSGIFS-----------------LENLTDLRISDLNGPEAT---FP------------Q-LG-NMK 185 (733)
Q Consensus 140 ~~L~l~~N~l~~~~p~~l~~-----------------l~~L~~L~l~~n~~~~~~---~~------------~-~~-~~~ 185 (733)
+.+++++|.... ++..... ...++.+++..+.+.... .. . .. ..+
T Consensus 207 ~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 285 (353)
T d1jl5a_ 207 TTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPS 285 (353)
T ss_dssp CEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCCCCCTTCCEEECCSSCCSEESCCCTTCCEEECCSSCCSEECCCCTT
T ss_pred cccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccchhcccccccCccccccccCCC
Confidence 999999988763 3332221 122233333322221110 00 0 01 126
Q ss_pred ccEEEcccCccCCCCCccccCCCCCcEEEccCCcccCCCCCCcCCCCCCCEEEecCCcccccCChhhhcCCCeeec
Q 004732 186 MTKLILRNCNITGELPRYLGKMTKLKVLDLSFNRLRGQIPSNFDDLYDVDYIYFAGNLLTGAIPPWMLERGDKIDL 261 (733)
Q Consensus 186 L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~l~~l~~l~l 261 (733)
|++|+|++|+|+ .+|.. +++|+.|+|++|+|+ .+|.. +.+|+.|++++|+++ .+|. +...++.|.+
T Consensus 286 L~~L~Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~-~~~~L~~L~~ 351 (353)
T d1jl5a_ 286 LEELNVSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD-IPESVEDLRM 351 (353)
T ss_dssp CCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC-CCTTCCEEEC
T ss_pred CCEEECCCCccC-ccccc---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCC-CCCc-cccccCeeEC
Confidence 999999999999 56643 678999999999999 57753 568999999999997 5664 2344555544
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.56 E-value=2.1e-15 Score=139.07 Aligned_cols=127 Identities=13% Similarity=0.159 Sum_probs=93.3
Q ss_pred cccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCC
Q 004732 36 KLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNM 115 (733)
Q Consensus 36 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 115 (733)
.+.+..+|+.|+|++|+|+ .++..+..+++|++|+|++|.|+ .++ .|..+++|++|+|++|+|+...+..+..+++|
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L 89 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 89 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence 4556777888888888888 45666677888888888888887 443 47788888888888888885555556678888
Q ss_pred CEEEeeCCccccCCC--ccccccCCCCEEEccCCCCccCCCC----CCCCcCCcCeee
Q 004732 116 KDFRISDNQFTGQIP--SFIQNWTKLEKLFIQPSGLAGPIPS----GIFSLENLTDLR 167 (733)
Q Consensus 116 ~~L~l~~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~----~l~~l~~L~~L~ 167 (733)
+.|+|++|+|+. ++ ..+..+++|++|++++|.++ ..|. .+..+++|+.||
T Consensus 90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred ccceeccccccc-cccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeC
Confidence 888888888873 33 35777888888888888886 3332 356677777776
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.55 E-value=4.5e-15 Score=130.06 Aligned_cols=101 Identities=21% Similarity=0.297 Sum_probs=51.5
Q ss_pred eeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCc
Q 004732 45 DISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQ 124 (733)
Q Consensus 45 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~ 124 (733)
+|+|++|+|+ .++ .+.++++|++|++++|+|+ .+|..|+.+++|+.|++++|.|+ .+| .+..+++|++|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSSC
T ss_pred EEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCCc
Confidence 4555555555 333 2555555555555555555 44545555555555555555555 233 25555555555555555
Q ss_pred cccCC-CccccccCCCCEEEccCCCCc
Q 004732 125 FTGQI-PSFIQNWTKLEKLFIQPSGLA 150 (733)
Q Consensus 125 l~~~~-~~~~~~l~~L~~L~l~~N~l~ 150 (733)
|+... ...+..+++|+.|++++|+++
T Consensus 77 i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 77 LQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred cCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 55221 134455555555555555554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.54 E-value=9.5e-15 Score=127.94 Aligned_cols=118 Identities=19% Similarity=0.299 Sum_probs=98.8
Q ss_pred eeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCc
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN 99 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 99 (733)
+.|+|++|+|+ .++ .+..+++|++|+|++|+|+ .+|..|+.+++|++|++++|.|+ .+| .+..+++|+.|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 46899999999 444 5999999999999999999 67888999999999999999999 455 5999999999999999
Q ss_pred cccccC-CccccCCCCCCEEEeeCCccccCC---CccccccCCCCEE
Q 004732 100 NFTGEL-PKTFAKLTNMKDFRISDNQFTGQI---PSFIQNWTKLEKL 142 (733)
Q Consensus 100 ~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~---~~~~~~l~~L~~L 142 (733)
+|+... ...+..+++|++|++++|.++... ...+..+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 999433 257889999999999999998432 2334456777655
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.51 E-value=1.1e-14 Score=134.10 Aligned_cols=127 Identities=18% Similarity=0.183 Sum_probs=107.8
Q ss_pred ecccceeeeeccccccccccCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCc
Q 004732 13 WKQKTVNQKRVLKEQNLTGVLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLE 92 (733)
Q Consensus 13 ~~~~~~~~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 92 (733)
+.+...+++|+|++|+|+.+ +..+..+++|+.|+|++|+|+ .++ .|..+++|++|+|++|+++...+..+..+++|+
T Consensus 14 ~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~ 90 (162)
T d1a9na_ 14 YTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLT 90 (162)
T ss_dssp EECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCC
T ss_pred ccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccc
Confidence 45566789999999999955 667788999999999999999 444 589999999999999999965555577899999
Q ss_pred eeeccCccccccCC--ccccCCCCCCEEEeeCCccccCCCc----cccccCCCCEEEc
Q 004732 93 KLHLSSNNFTGELP--KTFAKLTNMKDFRISDNQFTGQIPS----FIQNWTKLEKLFI 144 (733)
Q Consensus 93 ~L~Ls~N~l~~~~p--~~~~~l~~L~~L~l~~N~l~~~~~~----~~~~l~~L~~L~l 144 (733)
.|+|++|+|+ .++ ..+..+++|++|++++|.++ ..|. .+..+++|+.|+.
T Consensus 91 ~L~L~~N~i~-~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 91 ELILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp EEECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETT
T ss_pred cceecccccc-ccccccccccccccchhhcCCCccc-cccchHHHHHHHCCCcCeeCC
Confidence 9999999998 444 46889999999999999998 4553 5788999999873
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.48 E-value=2e-15 Score=157.99 Aligned_cols=238 Identities=16% Similarity=0.101 Sum_probs=170.5
Q ss_pred cCCccccCCCCCCeeeccccccccc----cchhccCCCCCCEEEccccccccc----------CCccccCCcCCceeecc
Q 004732 32 VLPPKLAELTFLQDISLIANRLKGP----IPKYLANISTLVNLTVQYNQFSGE----------LPEELGSLLNLEKLHLS 97 (733)
Q Consensus 32 ~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----------~p~~~~~l~~L~~L~Ls 97 (733)
.+...+.....|+.|+|++|.|... +...+..+++|+.|+++++.+... +...+..+++|+.|+|+
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~ 101 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 101 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccc
Confidence 4456677789999999999998653 344567789999999998765411 12335667899999999
Q ss_pred Ccccccc----CCccccCCCCCCEEEeeCCccccCCCcc-------------ccccCCCCEEEccCCCCccC----CCCC
Q 004732 98 SNNFTGE----LPKTFAKLTNMKDFRISDNQFTGQIPSF-------------IQNWTKLEKLFIQPSGLAGP----IPSG 156 (733)
Q Consensus 98 ~N~l~~~----~p~~~~~l~~L~~L~l~~N~l~~~~~~~-------------~~~l~~L~~L~l~~N~l~~~----~p~~ 156 (733)
+|.++.. +...+...++|+.|++++|.++...... ....+.|+.|.+++|++... +...
T Consensus 102 ~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~ 181 (344)
T d2ca6a1 102 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181 (344)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred ccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccch
Confidence 9998754 3444567889999999999876321111 13567899999999998733 2334
Q ss_pred CCCcCCcCeeecccccCCCCCc-----cccc-cccccEEEcccCccCCC----CCccccCCCCCcEEEccCCcccCCCCC
Q 004732 157 IFSLENLTDLRISDLNGPEATF-----PQLG-NMKMTKLILRNCNITGE----LPRYLGKMTKLKVLDLSFNRLRGQIPS 226 (733)
Q Consensus 157 l~~l~~L~~L~l~~n~~~~~~~-----~~~~-~~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~ 226 (733)
+...+.|+.|++++|.+..... ..+. ..+|+.|+|++|.++.. +...+..+++|++|+|++|.|++....
T Consensus 182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~ 261 (344)
T d2ca6a1 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA 261 (344)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred hhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhH
Confidence 4567889999999998876422 1222 23799999999998643 345677889999999999999865333
Q ss_pred Cc----C--CCCCCCEEEecCCcccccC----Chhh---hcCCCeeecccCcCCCC
Q 004732 227 NF----D--DLYDVDYIYFAGNLLTGAI----PPWM---LERGDKIDLSYNNFTDG 269 (733)
Q Consensus 227 ~~----~--~l~~L~~L~l~~N~l~~~~----p~~~---l~~l~~l~ls~N~l~~~ 269 (733)
.+ . ....|+.|++++|.+...- ...+ .+.++.|++++|.+...
T Consensus 262 ~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence 33 2 2367999999999986432 2222 35789999999998653
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=7.5e-16 Score=167.28 Aligned_cols=84 Identities=19% Similarity=0.242 Sum_probs=48.2
Q ss_pred cccEEEcccCccCCCCCcc----ccCCCCCcEEEccCCcccCC----CCCCcC-CCCCCCEEEecCCccccc----CChh
Q 004732 185 KMTKLILRNCNITGELPRY----LGKMTKLKVLDLSFNRLRGQ----IPSNFD-DLYDVDYIYFAGNLLTGA----IPPW 251 (733)
Q Consensus 185 ~L~~L~l~~n~l~~~~p~~----~~~l~~L~~L~ls~N~l~~~----~p~~~~-~l~~L~~L~l~~N~l~~~----~p~~ 251 (733)
.|+.+++++|.++...... +...++|++|+|++|+|+.. ++..+. ..+.|+.|++++|.++.. ++..
T Consensus 313 ~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~ 392 (460)
T d1z7xw1 313 QLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAAT 392 (460)
T ss_dssp CCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHH
T ss_pred ccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHHH
Confidence 4666777777666443222 23345677777777777542 222222 345677777777777532 2222
Q ss_pred h--hcCCCeeecccCcCCC
Q 004732 252 M--LERGDKIDLSYNNFTD 268 (733)
Q Consensus 252 ~--l~~l~~l~ls~N~l~~ 268 (733)
+ .++|+.|++++|++++
T Consensus 393 l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 393 LLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp HHHCCCCCEEECCSSSCCH
T ss_pred HhcCCCCCEEECCCCcCCH
Confidence 2 3567777777777653
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.42 E-value=4.3e-15 Score=155.38 Aligned_cols=233 Identities=16% Similarity=0.167 Sum_probs=171.0
Q ss_pred cccceeeeeccccccccc----cCCccccCCCCCCeeeccccccccc----------cchhccCCCCCCEEEcccccccc
Q 004732 14 KQKTVNQKRVLKEQNLTG----VLPPKLAELTFLQDISLIANRLKGP----------IPKYLANISTLVNLTVQYNQFSG 79 (733)
Q Consensus 14 ~~~~~~~~l~L~~n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~----------~p~~l~~l~~L~~L~L~~N~l~~ 79 (733)
+..+.+++|+|++|.|+. .+...+...++|+.|+++++.+... +...+...++|+.|+|++|.++.
T Consensus 28 ~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~ 107 (344)
T d2ca6a1 28 LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGP 107 (344)
T ss_dssp HHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCT
T ss_pred hhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCccccccccccccc
Confidence 345567889999999875 3445677889999999998765421 23456678999999999999875
Q ss_pred c----CCccccCCcCCceeeccCccccccCCcc-------------ccCCCCCCEEEeeCCccccC----CCccccccCC
Q 004732 80 E----LPEELGSLLNLEKLHLSSNNFTGELPKT-------------FAKLTNMKDFRISDNQFTGQ----IPSFIQNWTK 138 (733)
Q Consensus 80 ~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~-------------~~~l~~L~~L~l~~N~l~~~----~~~~~~~l~~ 138 (733)
. +...+..+++|+.|+|++|.++...... ....+.|+.|.+++|+++.. +...+...+.
T Consensus 108 ~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~ 187 (344)
T d2ca6a1 108 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187 (344)
T ss_dssp TTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTT
T ss_pred ccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccccccccccccccchhhhhhh
Confidence 3 3334567889999999999876321111 23567899999999998732 2344567899
Q ss_pred CCEEEccCCCCccC-----CCCCCCCcCCcCeeecccccCCCCCccc----cc-cccccEEEcccCccCCCCCcc----c
Q 004732 139 LEKLFIQPSGLAGP-----IPSGIFSLENLTDLRISDLNGPEATFPQ----LG-NMKMTKLILRNCNITGELPRY----L 204 (733)
Q Consensus 139 L~~L~l~~N~l~~~-----~p~~l~~l~~L~~L~l~~n~~~~~~~~~----~~-~~~L~~L~l~~n~l~~~~p~~----~ 204 (733)
|+.|+|++|++... +...+..+++|+.|++++|.+....... +. ..+|++|+|++|.|++..... +
T Consensus 188 L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l 267 (344)
T d2ca6a1 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF 267 (344)
T ss_dssp CCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHH
T ss_pred hcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHHHHh
Confidence 99999999999742 4556778899999999999876543322 22 337999999999998653333 3
Q ss_pred cC--CCCCcEEEccCCcccCCC----CCCcC-CCCCCCEEEecCCcccc
Q 004732 205 GK--MTKLKVLDLSFNRLRGQI----PSNFD-DLYDVDYIYFAGNLLTG 246 (733)
Q Consensus 205 ~~--l~~L~~L~ls~N~l~~~~----p~~~~-~l~~L~~L~l~~N~l~~ 246 (733)
.. .+.|++|++++|+|+... ...+. ++++|+.|++++|.+..
T Consensus 268 ~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred hhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 33 467999999999987532 22232 56889999999999964
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.40 E-value=2.1e-15 Score=144.06 Aligned_cols=130 Identities=23% Similarity=0.303 Sum_probs=104.3
Q ss_pred cCCccccCCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccC
Q 004732 32 VLPPKLAELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAK 111 (733)
Q Consensus 32 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 111 (733)
.++..|..+++|++|+|++|+|+ .++ .|.++++|++|+|++|.|+ .+|..+..+++|+.|++++|+|+. ++ .+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccc
Confidence 34567888999999999999999 444 5889999999999999998 677666667789999999999984 43 4788
Q ss_pred CCCCCEEEeeCCccccCCC--ccccccCCCCEEEccCCCCccCCCCC----------CCCcCCcCeee
Q 004732 112 LTNMKDFRISDNQFTGQIP--SFIQNWTKLEKLFIQPSGLAGPIPSG----------IFSLENLTDLR 167 (733)
Q Consensus 112 l~~L~~L~l~~N~l~~~~~--~~~~~l~~L~~L~l~~N~l~~~~p~~----------l~~l~~L~~L~ 167 (733)
+++|+.|++++|+|+. ++ ..+..+++|+.|+|++|.+....+.. +..+++|+.||
T Consensus 114 l~~L~~L~L~~N~i~~-~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 114 LVNLRVLYMSNNKITN-WGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HHHSSEEEESEEECCC-HHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccccchhcc-ccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 9999999999999984 33 46889999999999999987544432 44567777765
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.37 E-value=5.3e-14 Score=142.53 Aligned_cols=222 Identities=18% Similarity=0.206 Sum_probs=154.4
Q ss_pred cccccccccCCccccCCCCCCeeeccccccccc-cchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCc-cc
Q 004732 24 LKEQNLTGVLPPKLAELTFLQDISLIANRLKGP-IPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN-NF 101 (733)
Q Consensus 24 L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l 101 (733)
+....+..... ......+|++|+|++|.++.. +...+.++++|++|+|+++.+++..+..++.+++|++|+|+++ .+
T Consensus 30 l~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~i 108 (284)
T d2astb2 30 CPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF 108 (284)
T ss_dssp CTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSC
T ss_pred ccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccc
Confidence 34444443333 334557899999999998754 4556788999999999999998888888999999999999984 56
Q ss_pred ccc-CCccccCCCCCCEEEeeCC-ccccC-CCccccc-cCCCCEEEccCC--CCccC-CCCCCCCcCCcCeeeccccc-C
Q 004732 102 TGE-LPKTFAKLTNMKDFRISDN-QFTGQ-IPSFIQN-WTKLEKLFIQPS--GLAGP-IPSGIFSLENLTDLRISDLN-G 173 (733)
Q Consensus 102 ~~~-~p~~~~~l~~L~~L~l~~N-~l~~~-~~~~~~~-l~~L~~L~l~~N--~l~~~-~p~~l~~l~~L~~L~l~~n~-~ 173 (733)
+.. +...+.++++|++|+++++ +++.. +...+.. .++|+.|+++++ .++.. +...+..+++|+.|++++|. +
T Consensus 109 td~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~i 188 (284)
T d2astb2 109 SEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVML 188 (284)
T ss_dssp CHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTC
T ss_pred cccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCC
Confidence 632 2223456899999999986 44421 2223333 478999999875 34422 22223457899999999864 6
Q ss_pred CCCCccccccc-cccEEEcccC-ccCCCCCccccCCCCCcEEEccCCcccC-CCCCCcCCCCCCCEEEecCCcccccCCh
Q 004732 174 PEATFPQLGNM-KMTKLILRNC-NITGELPRYLGKMTKLKVLDLSFNRLRG-QIPSNFDDLYDVDYIYFAGNLLTGAIPP 250 (733)
Q Consensus 174 ~~~~~~~~~~~-~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 250 (733)
++..+..+... +|++|++++| .++......++++++|+.|+++++ ++. .+......+++| .+..++++...++
T Consensus 189 td~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~-~~d~~l~~l~~~lp~L---~i~~~~ls~~~~~ 264 (284)
T d2astb2 189 KNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI-VPDGTLQLLKEALPHL---QINCSHFTTIARP 264 (284)
T ss_dssp CGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS-SCTTCHHHHHHHSTTS---EESCCCSCCTTCS
T ss_pred CchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC-CCHHHHHHHHHhCccc---cccCccCCCCCCC
Confidence 65666666555 7999999995 688777778899999999999988 332 222222345554 4677777755444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.36 E-value=1.2e-14 Score=138.79 Aligned_cols=90 Identities=20% Similarity=0.307 Sum_probs=57.6
Q ss_pred ccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCccccccCCccccCCCCCCEEEeeCCccccCCCccccc
Q 004732 56 PIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQN 135 (733)
Q Consensus 56 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 135 (733)
.++..|..+++|++|+|++|+|+ .++ .|..+++|+.|+|++|.|+ .+|..+..+++|+.|++++|+|+. + ..+..
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l-~~~~~ 113 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-L-SGIEK 113 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-H-HHHHH
T ss_pred hhhhHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-c-ccccc
Confidence 44566777777777777777777 444 4677777777777777776 555555555567777777777663 2 23555
Q ss_pred cCCCCEEEccCCCCc
Q 004732 136 WTKLEKLFIQPSGLA 150 (733)
Q Consensus 136 l~~L~~L~l~~N~l~ 150 (733)
+++|+.|+|++|+|+
T Consensus 114 l~~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 114 LVNLRVLYMSNNKIT 128 (198)
T ss_dssp HHHSSEEEESEEECC
T ss_pred cccccccccccchhc
Confidence 556666655555554
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.36 E-value=8.3e-15 Score=158.84 Aligned_cols=108 Identities=16% Similarity=0.077 Sum_probs=77.1
Q ss_pred CCcCeeecccccCCCCCccccc-----cccccEEEcccCccCCC----CCcccc-CCCCCcEEEccCCcccCC----CCC
Q 004732 161 ENLTDLRISDLNGPEATFPQLG-----NMKMTKLILRNCNITGE----LPRYLG-KMTKLKVLDLSFNRLRGQ----IPS 226 (733)
Q Consensus 161 ~~L~~L~l~~n~~~~~~~~~~~-----~~~L~~L~l~~n~l~~~----~p~~~~-~l~~L~~L~ls~N~l~~~----~p~ 226 (733)
..|+.+++++|.+.......+. +.+|++|+|++|+++.. ++..+. ..+.|++|+|++|.|+.. +..
T Consensus 312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence 4677788887776665444333 22699999999999753 333343 467799999999999843 344
Q ss_pred CcCCCCCCCEEEecCCcccccCChhh-------hcCCCeeecccCcCCC
Q 004732 227 NFDDLYDVDYIYFAGNLLTGAIPPWM-------LERGDKIDLSYNNFTD 268 (733)
Q Consensus 227 ~~~~l~~L~~L~l~~N~l~~~~p~~~-------l~~l~~l~ls~N~l~~ 268 (733)
.+..+++|++|++++|+++......+ ...|+.|++.+|.+..
T Consensus 392 ~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 392 TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred HHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCH
Confidence 56677999999999999975433332 2358899999988763
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.32 E-value=1.3e-12 Score=119.14 Aligned_cols=105 Identities=16% Similarity=0.130 Sum_probs=70.6
Q ss_pred eeeccccccccccCCccccCCCCCCeeecccc-ccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccC
Q 004732 20 QKRVLKEQNLTGVLPPKLAELTFLQDISLIAN-RLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSS 98 (733)
Q Consensus 20 ~~l~L~~n~l~~~~p~~l~~l~~L~~L~L~~n-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 98 (733)
+.+...+++++ ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccC
Confidence 44566666666 44666777777777777655 47755556677777777777777777766666777777777777777
Q ss_pred ccccccCCccccCCCCCCEEEeeCCccc
Q 004732 99 NNFTGELPKTFAKLTNMKDFRISDNQFT 126 (733)
Q Consensus 99 N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 126 (733)
|+|+ .+|.......+|+.|+|++|.|.
T Consensus 90 N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 90 NALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp SCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred CCCc-ccChhhhccccccccccCCCccc
Confidence 7777 44433333346777777777764
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=4.2e-12 Score=115.65 Aligned_cols=109 Identities=13% Similarity=0.084 Sum_probs=87.3
Q ss_pred CCCCCEEEcccccccccCCccccCCcCCceeeccCc-cccccCCccccCCCCCCEEEeeCCccccCCCccccccCCCCEE
Q 004732 64 ISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSN-NFTGELPKTFAKLTNMKDFRISDNQFTGQIPSFIQNWTKLEKL 142 (733)
Q Consensus 64 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L 142 (733)
......++.+++.+. ..|..+..+++|++|+|++| .|+...+.+|.++++|+.|+|++|+|+...+..|..+++|++|
T Consensus 7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL 85 (156)
T ss_dssp CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence 344567888888888 67888888999999999766 4886667789999999999999999997778889999999999
Q ss_pred EccCCCCccCCCCCCCCcCCcCeeecccccCC
Q 004732 143 FIQPSGLAGPIPSGIFSLENLTDLRISDLNGP 174 (733)
Q Consensus 143 ~l~~N~l~~~~p~~l~~l~~L~~L~l~~n~~~ 174 (733)
+|++|+|+ .+|.......+|+.|+|++|.+.
T Consensus 86 ~Ls~N~l~-~l~~~~~~~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCS-CCCSTTTCSCCCCEEECCSSCCC
T ss_pred eccCCCCc-ccChhhhccccccccccCCCccc
Confidence 99999998 55555555456777777776654
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.53 E-value=4.4e-09 Score=95.86 Aligned_cols=88 Identities=16% Similarity=0.137 Sum_probs=39.3
Q ss_pred CCCCCCeeeccccccccccchhccCCCCCCEEEcccccccccC--CccccCCcCCceeeccCccccccCCccccCCCCCC
Q 004732 39 ELTFLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGEL--PEELGSLLNLEKLHLSSNNFTGELPKTFAKLTNMK 116 (733)
Q Consensus 39 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 116 (733)
.+..+..|++.+|.+. .++..+.++++|++|+|++|+|+..- +..+..+++|+.|+|++|.|+...+-.+....+|+
T Consensus 40 ~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~ 118 (162)
T d1koha1 40 AQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118 (162)
T ss_dssp TTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCS
T ss_pred hccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccc
Confidence 3334444444444333 33333444555555555555555221 12344455555555555555522221222333455
Q ss_pred EEEeeCCcccc
Q 004732 117 DFRISDNQFTG 127 (733)
Q Consensus 117 ~L~l~~N~l~~ 127 (733)
.|++++|.+..
T Consensus 119 ~L~L~~Npl~~ 129 (162)
T d1koha1 119 ELWLDGNSLSD 129 (162)
T ss_dssp SCCCTTSTTSS
T ss_pred eeecCCCCcCc
Confidence 55555555543
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=4e-09 Score=96.14 Aligned_cols=121 Identities=21% Similarity=0.164 Sum_probs=83.1
Q ss_pred CCCeeeccccccccccchhccCCCCCCEEEcccccccccCCccccCCcCCceeeccCcccccc--CCccccCCCCCCEEE
Q 004732 42 FLQDISLIANRLKGPIPKYLANISTLVNLTVQYNQFSGELPEELGSLLNLEKLHLSSNNFTGE--LPKTFAKLTNMKDFR 119 (733)
Q Consensus 42 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~L~ 119 (733)
+.+.|+++++... + .+..+..+..|++.+|... .++..+..+++|++|+|++|+|+.. ++..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~---~-~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD---P-DLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC---T-TTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC---c-hhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 4566777665533 2 3555556666666666555 5566667889999999999999843 234567789999999
Q ss_pred eeCCccccCCCccccccCCCCEEEccCCCCccCCCCC-------CCCcCCcCeee
Q 004732 120 ISDNQFTGQIPSFIQNWTKLEKLFIQPSGLAGPIPSG-------IFSLENLTDLR 167 (733)
Q Consensus 120 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-------l~~l~~L~~L~ 167 (733)
|++|+|+...+-.+....+|+.|++++|.+....... +..+++|+.||
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 9999999433334445567899999999987554422 44567777765
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=3.6e-07 Score=89.89 Aligned_cols=148 Identities=14% Similarity=0.117 Sum_probs=101.4
Q ss_pred hHHhhhcCccccCcccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCC-CCceeeEeeEEEeCCeEE
Q 004732 387 QIKAATNNFATDNNIGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQ-HPNLVKLYGCCIEGNQLL 465 (733)
Q Consensus 387 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 465 (733)
+++.....|...+..+.++.+.||+... +++.+++|+...........+.+|...+..+. +--+.+++.++.+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4445555666666555555678998765 45667888876544333445778888888774 323556788888889999
Q ss_pred EEEEccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC------------------------------------
Q 004732 466 LIYEYLENNSLARALFEHRLKLDWPTRRRICLGIARGLAYLHGE------------------------------------ 509 (733)
Q Consensus 466 lV~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH~~------------------------------------ 509 (733)
+||++++|.++.+.... ......++.++++.++.||+.
T Consensus 87 lv~~~l~G~~~~~~~~~------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EEEECCSSEEHHHHTTT------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGST
T ss_pred EEEEecccccccccccc------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccc
Confidence 99999999887654321 122344556666666666641
Q ss_pred --------------------CCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 510 --------------------SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 510 --------------------~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
....++|+|+.|.|||+++++.+-|.||+.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 11227899999999999987666799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.01 E-value=1.1e-05 Score=78.44 Aligned_cols=130 Identities=18% Similarity=0.156 Sum_probs=84.0
Q ss_pred cccCCC-cccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCc--eeeEeeEEEeCCeEEEEEEccCCCCH
Q 004732 400 NIGEGG-FGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPN--LVKLYGCCIEGNQLLLIYEYLENNSL 476 (733)
Q Consensus 400 ~lg~G~-~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL 476 (733)
.+..|. -+.||+....++..+++|....... ..+..|+..++.+.... +.++++++.+++..++||+|++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 344454 3678999888888899998654432 34677888887774333 45678888888889999999988654
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q 004732 477 ARALFEHRLKLDWPTRRRICLGIARGLAYLH------------------------------------------------- 507 (733)
Q Consensus 477 ~~~l~~~~~~l~~~~~~~i~~~ia~~l~~LH------------------------------------------------- 507 (733)
.+. ... ....+.++++.|+-||
T Consensus 94 ~~~------~~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (255)
T d1nd4a_ 94 LSS------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 164 (255)
T ss_dssp TTS------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred ccc------ccc---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHH
Confidence 221 000 0111122222222222
Q ss_pred --cC----CCCCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 508 --GE----SRIKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 508 --~~----~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
.. .++.++|+|+.|.|||++.+..+-|+||+.+.
T Consensus 165 l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 165 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 21 12237999999999999987667899999775
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.82 E-value=4e-06 Score=76.05 Aligned_cols=110 Identities=15% Similarity=0.160 Sum_probs=64.1
Q ss_pred CCCCCCeeecccc-ccccc----cchhccCCCCCCEEEcccccccccCC----ccccCCcCCceeeccCcccccc----C
Q 004732 39 ELTFLQDISLIAN-RLKGP----IPKYLANISTLVNLTVQYNQFSGELP----EELGSLLNLEKLHLSSNNFTGE----L 105 (733)
Q Consensus 39 ~l~~L~~L~L~~n-~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~----~ 105 (733)
+.+.|+.|+|+++ .++.. +-..+...+.|++|+|++|.++.... ..+...+.|+.|+|++|.|+.. +
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 3467778888763 45432 33456666778888888777763222 2344556777777777777643 2
Q ss_pred CccccCCCCCCEEEeeCCccccC-------CCccccccCCCCEEEccCCC
Q 004732 106 PKTFAKLTNMKDFRISDNQFTGQ-------IPSFIQNWTKLEKLFIQPSG 148 (733)
Q Consensus 106 p~~~~~l~~L~~L~l~~N~l~~~-------~~~~~~~l~~L~~L~l~~N~ 148 (733)
-..+...+.|++|+|++|.+... +...+...++|+.|+++.+.
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 23355566677777777765421 22333444566666655443
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.61 E-value=5.2e-06 Score=75.25 Aligned_cols=89 Identities=11% Similarity=0.112 Sum_probs=58.5
Q ss_pred cCCCCCCEEEcccc-ccccc----CCccccCCcCCceeeccCccccccC----CccccCCCCCCEEEeeCCccccCC---
Q 004732 62 ANISTLVNLTVQYN-QFSGE----LPEELGSLLNLEKLHLSSNNFTGEL----PKTFAKLTNMKDFRISDNQFTGQI--- 129 (733)
Q Consensus 62 ~~l~~L~~L~L~~N-~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~----p~~~~~l~~L~~L~l~~N~l~~~~--- 129 (733)
.+.++|+.|+|+++ .++.. +-..+...++|++|+|++|.++... ...+...+.|++|+|++|.|+...
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34578888888864 45422 2234667778888888888886422 234445677888888888877422
Q ss_pred -CccccccCCCCEEEccCCCCc
Q 004732 130 -PSFIQNWTKLEKLFIQPSGLA 150 (733)
Q Consensus 130 -~~~~~~l~~L~~L~l~~N~l~ 150 (733)
...+...++|++|+|++|.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHhCCcCCEEECCCCcCC
Confidence 234555677777777777654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.46 E-value=0.00021 Score=73.90 Aligned_cols=75 Identities=16% Similarity=0.196 Sum_probs=46.9
Q ss_pred CcccCCCcccEEEcccCC-CcEEEEEEcccc-------ChhcHHHHHHHHHHHHhCC-C-Cc-eeeEeeEEEeCCeEEEE
Q 004732 399 NNIGEGGFGPVYKGLLAD-GTAIAVKQLSSK-------SKQGNREFINEIGMISALQ-H-PN-LVKLYGCCIEGNQLLLI 467 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h-~n-iv~l~~~~~~~~~~~lV 467 (733)
+.||.|....||+....+ ++.|+||.-... -.....+...|.+.|+.+. + |. +.+++.+ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 678999964321 0112234456888887663 2 33 4444433 45566899
Q ss_pred EEccCCCC
Q 004732 468 YEYLENNS 475 (733)
Q Consensus 468 ~e~~~~gs 475 (733)
|||+++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99998754
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.29 E-value=1.1e-05 Score=72.84 Aligned_cols=111 Identities=17% Similarity=0.211 Sum_probs=63.1
Q ss_pred cCCCCCCeeeccc-cccccc----cchhccCCCCCCEEEcccccccccCC----ccccCCcCCceeeccCcccccc----
Q 004732 38 AELTFLQDISLIA-NRLKGP----IPKYLANISTLVNLTVQYNQFSGELP----EELGSLLNLEKLHLSSNNFTGE---- 104 (733)
Q Consensus 38 ~~l~~L~~L~L~~-n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~p----~~~~~l~~L~~L~Ls~N~l~~~---- 104 (733)
.+.+.|++|+|++ +.|+.. +-..+...++|++|+|++|.++...- ..+...++|+.|++++|.++..
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred hcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHH
Confidence 3457777777776 456432 33445566777777777777653222 2345556777777777776532
Q ss_pred CCccccCCCCCCEEEe--eCCcccc----CCCccccccCCCCEEEccCCC
Q 004732 105 LPKTFAKLTNMKDFRI--SDNQFTG----QIPSFIQNWTKLEKLFIQPSG 148 (733)
Q Consensus 105 ~p~~~~~l~~L~~L~l--~~N~l~~----~~~~~~~~l~~L~~L~l~~N~ 148 (733)
+...+...++|+.++| ++|.+.. .+...+...++|+.|+++.+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 2344555666766554 3455542 223334455666666665544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.11 E-value=0.0012 Score=66.22 Aligned_cols=134 Identities=13% Similarity=0.146 Sum_probs=79.2
Q ss_pred cccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCCCce-----eeEe--eEEEeCCeEEEEEEccCCCCHH-
Q 004732 406 FGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQHPNL-----VKLY--GCCIEGNQLLLIYEYLENNSLA- 477 (733)
Q Consensus 406 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~--~~~~~~~~~~lV~e~~~~gsL~- 477 (733)
--.||+++.++|+.|++|+.... ....+++..|...+..+....+ +..- ..+..++..+.+++|++|..+.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35899999999999999997543 2345677888888877742221 1111 1234567789999999874221
Q ss_pred ----H---------HHHh--------cCCCCCHH-------------------HHHHHHHHHHHHHHHHH----cCCCCC
Q 004732 478 ----R---------ALFE--------HRLKLDWP-------------------TRRRICLGIARGLAYLH----GESRIK 513 (733)
Q Consensus 478 ----~---------~l~~--------~~~~l~~~-------------------~~~~i~~~ia~~l~~LH----~~~~~~ 513 (733)
. .++. .+...++. .+..+...+.+.++.+. +..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1 0110 01111211 11122222233333332 223445
Q ss_pred eecCCCCCCcEEecCCCCeEEcccCcccc
Q 004732 514 VVHRDIKATNVLLDKDLNSKISDFGLAKL 542 (733)
Q Consensus 514 ivH~Dik~~Nill~~~~~~kl~DfGla~~ 542 (733)
+||+|+.+.|||++++ ..+.||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999754 56899998763
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.79 E-value=0.00011 Score=65.95 Aligned_cols=112 Identities=24% Similarity=0.287 Sum_probs=83.5
Q ss_pred ccceeeeecccc-ccccc----cCCccccCCCCCCeeeccccccccc----cchhccCCCCCCEEEccccccccc----C
Q 004732 15 QKTVNQKRVLKE-QNLTG----VLPPKLAELTFLQDISLIANRLKGP----IPKYLANISTLVNLTVQYNQFSGE----L 81 (733)
Q Consensus 15 ~~~~~~~l~L~~-n~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~ 81 (733)
+.+.+++|+|++ ++++. .+-..+...++|+.|+|++|.++.. +-..+...+.|+.|++++|.++.. +
T Consensus 15 ~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l 94 (166)
T d1io0a_ 15 NDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILAL 94 (166)
T ss_dssp TCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHH
T ss_pred cCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHH
Confidence 346688899987 56764 2445666789999999999999754 334567789999999999998633 2
Q ss_pred CccccCCcCCceeec--cCccccc----cCCccccCCCCCCEEEeeCCccc
Q 004732 82 PEELGSLLNLEKLHL--SSNNFTG----ELPKTFAKLTNMKDFRISDNQFT 126 (733)
Q Consensus 82 p~~~~~l~~L~~L~L--s~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~ 126 (733)
-..+...++|+.++| ++|.+.. .+...+...++|+.|+++.|...
T Consensus 95 ~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~~ 145 (166)
T d1io0a_ 95 VEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 145 (166)
T ss_dssp HHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCCc
Confidence 355777888987555 5677764 34555667899999999887754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.26 E-value=0.004 Score=63.97 Aligned_cols=72 Identities=18% Similarity=0.257 Sum_probs=47.5
Q ss_pred CcccCCCcccEEEcccCC--------CcEEEEEEccccChhcHHHHHHHHHHHHhCCCCcee-eEeeEEEeCCeEEEEEE
Q 004732 399 NNIGEGGFGPVYKGLLAD--------GTAIAVKQLSSKSKQGNREFINEIGMISALQHPNLV-KLYGCCIEGNQLLLIYE 469 (733)
Q Consensus 399 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e 469 (733)
+.|+.|-.-.+|++...+ .+.|.++..... .......+|..+++.+.-.+++ ++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 467778888999987543 345777766532 2234556788888888533444 66766632 68999
Q ss_pred ccCCCCH
Q 004732 470 YLENNSL 476 (733)
Q Consensus 470 ~~~~gsL 476 (733)
|++|..+
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.62 E-value=0.023 Score=55.96 Aligned_cols=138 Identities=17% Similarity=0.082 Sum_probs=72.6
Q ss_pred ccCCCcccEEEcccCCCcEEEEEEccccChhcHHHHHHHHHHHHhCCC-----CceeeEee---EEEeCCeEEEEEEccC
Q 004732 401 IGEGGFGPVYKGLLADGTAIAVKQLSSKSKQGNREFINEIGMISALQH-----PNLVKLYG---CCIEGNQLLLIYEYLE 472 (733)
Q Consensus 401 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv~l~~---~~~~~~~~~lV~e~~~ 472 (733)
|..|---+.|+.+..+|+ +++|++...... .++..|++.+..+.. |..+...+ +...+...+.++.++.
T Consensus 26 i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~--~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~ 102 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKDP-LILTLYEKRVEK--NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE 102 (316)
T ss_dssp ECC---EEEEEEEESSCC-EEEEEECC---C--CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred CCCCcccCeEEEEECCCc-EEEEEcCCCCCH--HHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceeeeecc
Confidence 446666788998876654 889988643222 344456666666642 22222110 1233556677788777
Q ss_pred CCCHH--------------HHHHh--cCC------------------------CCCHHHHHHHHHHHHHHHHHHHc-CCC
Q 004732 473 NNSLA--------------RALFE--HRL------------------------KLDWPTRRRICLGIARGLAYLHG-ESR 511 (733)
Q Consensus 473 ~gsL~--------------~~l~~--~~~------------------------~l~~~~~~~i~~~ia~~l~~LH~-~~~ 511 (733)
+.... ..++. ... ..........+..+...+.-.+. .-+
T Consensus 103 g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~ 182 (316)
T d2ppqa1 103 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP 182 (316)
T ss_dssp CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred cccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCccccc
Confidence 64221 01110 000 00001112222233333333332 224
Q ss_pred CCeecCCCCCCcEEecCCCCeEEcccCccc
Q 004732 512 IKVVHRDIKATNVLLDKDLNSKISDFGLAK 541 (733)
Q Consensus 512 ~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 541 (733)
.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 458999999999999988777899999875
|